PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jiang, DP; Chen, J; Liu, YX; Lin, J; Liu, K; Chen, HZ; Jiang, XJ; Zhang, YJ; Chen, X; Cui, BL; Jiang, SP; Jiang, JC; Zhang, H; Hu, HY; Li, CD; Li, WJ; Li, E; Pan, H				Jiang, Depeng; Chen, Jian; Liu, Yixiu; Lin, Jing; Liu, Kun; Chen, Haizhu; Jiang, Xuejing; Zhang, Yingjie; Chen, Xuan; Cui, Binglin; Jiang, Shaoping; Jiang, Jianchang; Zhang, Hua; Hu, Huiyi; Li, Chendong; Li, Wenjuan; Li, E.; Pan, Hui			Patterns of mental health problems before and after easing COVID-19 restrictions: Evidence from a 105248-subject survey in general population in China	PLOS ONE			English	Article							PREVALENCE; DISORDERS; IMPACT; CARE	Background The COVID-19 pandemic has alarming implications for individual and population level mental health. Although the future of COVID-19 is unknown at present, more countries or regions start to ease restrictions. The findings from this study have provided the empirical evidence of prevalence and patterns of mental disorders in Chinese general population before and after easing most COVID-19 restrictions, and information of the factors associated with these patterns. Methods A cross-sectional population-based online survey was carried out from February to March 2020 in the general population across all provinces in China. The 12-item General Health Questionnaire (GHQ-12) was incorporated in the survey. Latent class analyses were performed to investigate the patterns of mental disorders and multinomial logistic regressions were used to examine how individual and regional risk factors can predict mental disorder patterns. Results Four distinctive patterns of mental health were revealed in the general population. After the ease of most COVID-19 restrictions, the prevalence of high risk of mental disorders decreased from 25.8% to 20.9% and prevalence of being high risk of unhappiness and loss of confidence decreased from 10.1% to 8.1%. However, the prevalence of stressed, social dysfunction and unhappy were consistently high before and after easing restrictions. Several regional factors, such as case mortality rate and healthcare resources, were associated with mental health status. Of note, healthcare workers were less likely to have mental disorders, compared to other professionals and students. Conclusions The dynamic management of mental health and psychosocial well-being is as important as that of physical health both before and after the ease of COVID-19 restrictions. Our findings may help in mental health interventions in other countries and regions while easing COVID-19 restrictions.	[Jiang, Depeng; Liu, Yixiu; Liu, Kun; Jiang, Xuejing; Li, Chendong] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Chen, Jian; Lin, Jing; Zhang, Yingjie; Cui, Binglin] Shantou Univ, Affiliated Hosp 1, Med Coll, Shantou, Guangdong, Peoples R China; [Chen, Haizhu; Li, E.; Pan, Hui] Shantou Longhu Peoples Hosp, Shantou, Guangdong, Peoples R China; [Chen, Xuan] Govt Manitoba, Manitoba Hlth Sr & Act Living, Winnipeg, MB, Canada; [Jiang, Shaoping] Yunnan Minzu Univ, Sch Math & Stat, Kunming, Yunnan, Peoples R China; [Jiang, Jianchang] Southern Med Univ, Affiliated Nanhai Hosp, Foshan, Guangdong, Peoples R China; [Zhang, Hua] Southeast Univ, Sch Publ Hlth, Nanjing, Peoples R China; [Li, Chendong] Nanjing Forest Univ, Sch Sci, Nanjing, Peoples R China; [Li, Wenjuan] AstraZeneca China Co Ltd, Shanghai, Peoples R China	University of Manitoba; Shantou University; Yunnan Minzu University; Southern Medical University - China; Southeast University - China; Nanjing Forestry University	Jiang, DP (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada.; Pan, H (corresponding author), Shantou Longhu Peoples Hosp, Shantou, Guangdong, Peoples R China.	depeng.jiang@umanitoba.ca; michaelhuipan@163.com			Li Ka Shing Foundation [378073]; Canadian Institute of Health Research [378073]	Li Ka Shing Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This project was partially funded by the Li Ka Shing Foundation (378073, 2020; HP) and Canadian Institute of Health Research (378073, 2016; DJ). The fund was mostly used for lucky lottery draw and a symbolic thanks of the participation of the survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No author had received a salary from any of these funders.	Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Cao XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170772; Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X; Chong MY, 2004, BRIT J PSYCHIAT, V185, P127, DOI 10.1192/bjp.185.2.127; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562; Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211; Hoeymans Nancy, 2004, Health Qual Life Outcomes, V2, P23; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; Huang YQ, 2019, LANCET PSYCHIAT, V6, P211, DOI 10.1016/S2215-0366(18)30511-X; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Liang Y, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0539-y; Makowska Zofia, 2002, Int J Occup Med Environ Health, V15, P353; McAlpine DD, 2000, HEALTH SERV RES, V35, P277; Muthen L.K., 2007, MPLUS STAT ANAL LATE; Naushad VA, 2019, PREHOSP DISASTER MED, V34, P632, DOI 10.1017/S1049023X19004874; NEWMAN SC, 1988, COMPR PSYCHIAT, V29, P402, DOI 10.1016/0010-440X(88)90021-1; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Shi L, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14053; Sprang G, 2013, DISASTER MED PUBLIC, V7, P105, DOI 10.1017/dmp.2013.22; Steenblock C, 2020, MOL PSYCHIATR, V25, P1611, DOI 10.1038/s41380-020-0758-9; Venkatesh A, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1379; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; [王文强 Wang Wenqiang], 2012, [中华精神科杂志, Chinese Journal of Psychiatry], V45, P349; Webb L, 2021, J PSYCHIATR MENT HLT, V28, P300, DOI 10.1111/jpm.12644; World Health Organization, 2021, NOV COR 2019 NCOV SI; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001; Yang HY, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113045; Zhangs W., 1998, CHINESE J PSYCHIAT, V31, P69	30	3	3	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255251	10.1371/journal.pone.0255251	http://dx.doi.org/10.1371/journal.pone.0255251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34344018	Green Published, gold			2022-12-26	WOS:000685264200006
J	Schell, E; Nouairia, G; Steiner, E; Weber, N; Lundin, D; Loderer, C				Schell, Eugen; Nouairia, Ghada; Steiner, Elisabeth; Weber, Niclas; Lundin, Daniel; Loderer, Christoph			Structural determinants and distribution of phosphate specificity in ribonucleotide reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SWISS-MODEL; BACTERIOPHAGE-T4; EXPRESSION; MECHANISM; EVOLUTION; SITE	Ribonucleotide reductases (RNRs) catalyze the reduction of ribonucleotides to the corresponding deoxyribonucleotides, the building blocks of DNA. RNRs are specific for either ribonucleoside diphosphates or triphosphates as substrates. As far as is known, oxygen-dependent class I RNRs (NrdAB) all reduce ribonucleoside diphosphates, and oxygen-sensitive class III RNRs (NrdD) are all ribonucleoside triphosphate reducers, whereas the adenosylcobalamin-dependent class II (NrdJ) contains both ribonucleoside diphosphate and triphosphate reducers. However, it is unknown how this specificity is conveyed by the active site of the enzymes and how this feature developed in RNR evolution. By structural comparison of the active sites in different RNRs, we identified the apical loop of the phosphate-binding site as a potential structural determinant of substrate specificity. Grafting two residues from this loop from a diphosphate- to a triphosphate-specific RNR caused a change in preference from ribonucleoside triphosphate to diphosphate substrates in a class II model enzyme, confirming them as the structural determinants of phosphate specificity. The investigation of the phylogenetic distribution of this motif in class II RNRs yielded a likely monophyletic clade with the diphosphate-defining motif. This indicates a single evolutionary-split event early in NrdJ evolution in which diphosphate specificity developed from the earlier triphosphate specificity. For those interesting cases where organisms contain more than one nrdJ gene, we observed a preference for encoding enzymes with diverse phosphate specificities, suggesting that this varying phosphate specificity confers a selective advantage.	[Schell, Eugen; Steiner, Elisabeth; Weber, Niclas; Loderer, Christoph] Tech Univ Dresden, Inst Microbiol, Dresden, Saxony, Germany; [Nouairia, Ghada; Lundin, Daniel] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden	Technische Universitat Dresden; Stockholm University	Loderer, C (corresponding author), Tech Univ Dresden, Inst Microbiol, Dresden, Saxony, Germany.	Christoph.loderer@tu-dresden.de		Loderer, Christoph/0000-0002-3795-8250; NOUAIRIA, Ghada/0000-0003-0081-7347	Fonds der Chemischen Industrie (FCI) [SK201/03]; Zukunftskonzept of TU Dresden (Federal); Swedish Research Council (Vetenskapsradet) [2019-01400]	Fonds der Chemischen Industrie (FCI)(Fonds der Chemischen Industrie); Zukunftskonzept of TU Dresden (Federal); Swedish Research Council (Vetenskapsradet)(Swedish Research Council)	C. L. was supported by Fonds der Chemischen Industrie (FCI) (SK201/03) and funds of the Zukunftskonzept of TU Dresden (Federal and State Excellence Initiative). G. N. was supported by a stipend from The WennerGren Foundation to Britt-Marie Sjoberg, and D. L. was supported by Grant 2019-01400 from the Swedish Research Council (Vetenskapsradet) to Britt-Marie Sjoberg.	Andersson J, 2000, J BIOL CHEM, V275, P19449, DOI 10.1074/jbc.M001278200; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; BOOKER S, 1993, P NATL ACAD SCI USA, V90, P8352, DOI 10.1073/pnas.90.18.8352; Crona M, 2016, MOL ONCOL, V10, P1375, DOI 10.1016/j.molonc.2016.07.008; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eliasson R, 1999, J BIOL CHEM, V274, P7182, DOI 10.1074/jbc.274.11.7182; Fontecave M, 2001, METHOD ENZYMOL, V334, P215; Gleason FK, 2002, J BACTERIOL, V184, P6544, DOI 10.1128/JB.184.23.6544-6550.2002; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; INUKAI S, 1979, AGR BIOL CHEM TOKYO, V43, P637, DOI 10.1080/00021369.1979.10863489; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; LARSEN IK, 1982, EUR J BIOCHEM, V125, P75; Larsson KM, 2010, ACS CHEM BIOL, V5, P933, DOI 10.1021/cb1000845; Larsson KM, 2004, NAT STRUCT MOL BIOL, V11, P1142, DOI 10.1038/nsmb838; Loderer C, 2019, PEERJ, V7, DOI 10.7717/peerj.6700; Loderer C, 2017, J BIOL CHEM, V292, P19044, DOI 10.1074/jbc.M117.806331; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Lundin Daniel, 2015, Life-Basel, V5, P604, DOI 10.3390/life5010604; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Parks DH, 2020, NAT BIOTECHNOL, V38, P1079, DOI 10.1038/s41587-020-0501-8; Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sievers Fabian, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0313s48; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; STUBBE JA, 1983, MOL CELL BIOCHEM, V50, P25; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wei YF, 2015, BIOCHEMISTRY-US, V54, P7019, DOI 10.1021/acs.biochem.5b01092; Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-7; Xu H, 2006, P NATL ACAD SCI USA, V103, P4022, DOI 10.1073/pnas.0600443103	33	3	3	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							101008	10.1016/j.jbc.2021.101008	http://dx.doi.org/10.1016/j.jbc.2021.101008			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34314684	Green Published, gold			2022-12-26	WOS:000690868100010
J	Gaspar, BR; Neto, ACD				Ribeiro Gaspar, Beatriz; de Assis Neto, Antonio Chaves			Three-dimensional printing educational anatomical model of the patellar luxation in dogs	PLOS ONE			English	Article							3D; RECONSTRUCTION	Background Few studies are available for assessing the current situation of 3D printing in veterinary medicine, due to the recent popularization of this technology. This study aimed to simulate a 3D model of the femorotibiopatellar joint of dogs based on the medial patellar luxation. The scanning, editing and printing of the femur, tibia, fibula and patella of a dog from the Laboratory of Anatomy of FMVZ USP were performed. Results Three femorotibiopatellar joint models were printed: one representing a healthy join without alterations; the second one with the medially deviated tibial tuberosity; and a last one representing the shifted tibial tuberosity and the trochlear sulcus flattened as consequence. The 3D edition consisted of medial rotation of the tibia and tibial tuberosity (22 degrees against the healthy tibia), and the flatten of the medial femoral condyle (0.2 cm) and femoral trochlear groove. After printing, the corresponding measurements were taken with the alterations and the bone models were made with elastics to represent the anatomical components of the dog joint. Finally, the measurements corresponding to the distance from the patellar ligament to the lateral femoral condyle were taken in each specimen, in order to observe the change in position of the ligament according to the occurrence of the bone alterations. Conclusion We printed 3D articular anatomical components of the femurotibiopatellar joint that could be valuable educational tools for the study of medial patellar luxation in dogs.	[Ribeiro Gaspar, Beatriz; de Assis Neto, Antonio Chaves] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Surg, Sao Paulo, Brazil	Universidade de Sao Paulo	Neto, ACD (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Surg, Sao Paulo, Brazil.	antonioassis@usp.br	ASSIS NETO, ANTONIO/B-4630-2012	ASSIS NETO, ANTONIO/0000-0002-6260-661X	Programa Unificado de Bolsa/University of Sao Paulo;  [CNPQ-435.065.148-90]	Programa Unificado de Bolsa/University of Sao Paulo; 	The authors wish to acknowledge the "Programa Unificado de Bolsa/University of Sao Paulo" and "CNPQ-435.065.148-90" for their undergraduate research assistant scholarship to Beatriz R. Gaspar.	Assis NetoAC., 2019, 3D PRINT MED, V5, P13; Bertti JVP, 2020, ARQ BRAS MED VET ZOO, V72, P1653, DOI 10.1590/1678-4162-11209; Bound N, 2009, VET COMP ORTHOPAED, V22, P32, DOI 10.3415/VCOT-08-01-0009; da Silveira EE, 2021, J VET MED EDUC, V48, P649, DOI 10.3138/jvme-2019-0132; Dejour H, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P19, DOI 10.1007/BF01552649; Elias NSR., 2021, REV BRAS MED VET; Fossum T., 2014, DIS JOINTS, V4th; Garas M, 2018, ANN ANAT, V219, P57, DOI 10.1016/j.aanat.2018.05.006; Hackmann CH, 2019, INT J MORPHOL, V37, P486, DOI 10.4067/S0717-95022019000200486; Hespel AM, 2014, VET RADIOL ULTRASOUN, V55, P347, DOI 10.1111/vru.12176; Hoang D, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.12.18; Lee J, 2020, BMC VET RES, V16, DOI 10.1186/s12917-020-02644-5; Lehmann SV, 2021, BMC VET RES, V17, DOI 10.1186/s12917-021-02787-z; Loudon JK, 2016, INT J SPORTS PHYS TH, V11, P820; Maria P. P., 2001, Clinica Veterinaria, V6, P25; Martelli N, 2016, SURGERY, V159, P1485, DOI 10.1016/j.surg.2015.12.017; Neto Assis., 2017, REV GRADUACAO USP, V2, P47, DOI [10.11606/issn.2525-376X.v2i3p47-53, DOI 10.11606/ISSN.2525-376X.V2I3P47-53]; Ni JL, 2018, ARTHROSCOPY, V34, P546, DOI 10.1016/j.arthro.2017.08.288; Perez P., 2014, Veterinary Ireland Journal, V4, P634; Petazzoni M., 2010, Proceedings, 3rd World Veterinary Orthopaedic Congress, ESVOT-VOS, 15th ESVOT Congress, Bologna, Italy, 15-18 September, 2010, P501; Piermattei DL., 2016, STIFFLE JOINT, V6; Rengier F, 2010, INT J COMPUT ASS RAD, V5, P335, DOI 10.1007/s11548-010-0476-x; Rodrigues H., 2005, TECNICAS ANATOMICAS, V3rd; ROUSH JK, 1993, VET CLIN N AM-SMALL, V23, P855, DOI 10.1016/S0195-5616(93)50087-6; Schoenfeld-Tacher RM, 2017, J VET MED EDUC, V44, P612, DOI [10.3138/jvme.0416-080R, 10.3138/jvme.0416-080r]; Schulz KS., 2013, SMALL ANIMAL SURG, V4th; Sunol A, 2019, J VET MED EDUC, V46, P523, DOI 10.3138/jvme.0817-109r; Tack P, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0236-4; Vasseur PB., 2003, TXB SMALL ANIMAL SUR, V2; Wang Bibo, 2018, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V32, P306, DOI 10.7507/1002-1892.201705068; Wang XX, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep42722	31	0	0	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255288	10.1371/journal.pone.0255288	http://dx.doi.org/10.1371/journal.pone.0255288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329358	Green Published, gold			2022-12-26	WOS:000685248600025
J	Eilertsen, HC; Elvevoll, E; Giaever, IH; Svenning, JB; Dalheim, L; Svalheim, RA; Vang, B; Siikavuopio, S; Dragoy, R; Ingebrigtsen, RA; Hansen, E; Hustad, A; Eilertsen, KE				Eilertsen, Hans Chr.; Elvevoll, Edel; Giaever, Ingeborg Hulda; Svenning, Jon Brage; Dalheim, Lars; Svalheim, Ragnhild Aven; Vang, Birthe; Siikavuopio, Sten; Dragoy, Ragnhild; Ingebrigtsen, Richard A.; Hansen, Espen; Hustad, Anette; Eilertsen, Karl-Erik			Inclusion of photoautotrophic cultivated diatom biomass in salmon feed can deter lice	PLOS ONE			English	Article							ACTIVATED CHEMICAL DEFENSE; FATTY-ACID-COMPOSITION; DIETARY FISH-OIL; ATLANTIC SALMON; SALAR-L.; LIQUID CHROMATOGRAPHY; LIPID-COMPOSITION; MARINE DIATOMS; GROWTH-RATE; SEA LICE	The aim of this study was to evaluate the potential of diatom (microalgae) biomass as a lice-reducing ingredient in salmon feed. The original hypothesis was based on the fact that polyunsaturated aldehydes (PUAs), e.g. 2-trans, 4-trans decadenial (A3) produced by diatoms can function as grazing deterrents and harm copepod development. Salmon lice (Lepeophtheirus salmonis) is a copepod, and we intended to test if inclusion of diatom biomass in the feed could reduce the infestation of lice on salmon. We performed experiments where salmon kept in tanks were offered four different diets, i.e. basic feed with diatoms, fish oil, Calanus sp. oil or rapeseed oil added. After a feeding period of 67 days a statistically representative group of fishes, tagged with diet group origin, were pooled in a 4000L tank and exposed to salmon lice copepodites whereafter lice infestation was enumerated. Salmon from all four diet groups had good growth with SGR values from 1.29 to 1.44% day(-1) (increase from ca. 130 g to 350 g). At the termination of the experiment the number of lice on salmon offered diatom feed were statistically significantly lower than on salmon fed the other diets. Mean lice infestation values increased from diatom feed through Calanus and fish oil to standard feed with terrestrial plant ingredients. Analysis of the chemical composition of the different diets (fatty acids, amino acids) failed to explain the differences in lice infestation. The only notable result was that diatom and Calanus feed contained more FFA (free fatty acids) than feed with fish oil and the control feed. None of the potential deleterious targeted polyunsaturated aldehydes could be detected in skin samples of the salmon. What was exclusive for salmon that experienced reduced lice was diatom inclusion in the feed. This therefore still indicates the presence of some lice deterring ingredient, either in the feed, or an ingredient can have triggered production of an deterrent in the fish. An obvious follow up of this will be to perform experiments with different degrees of diatom inclusion in the feeds, i.e. dose response experiments combined with targeted PUA analyses, as well as to perform large scale experiments under natural conditions in aquaculture pens.	[Eilertsen, Hans Chr.; Elvevoll, Edel; Giaever, Ingeborg Hulda; Svenning, Jon Brage; Dalheim, Lars; Ingebrigtsen, Richard A.; Hansen, Espen; Eilertsen, Karl-Erik] UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Tromso, Norway; [Svalheim, Ragnhild Aven; Vang, Birthe; Siikavuopio, Sten; Dragoy, Ragnhild; Hustad, Anette] NOFIMA Norwegian Inst Food Fisheries & Aquacultur, Tromso, Norway	UiT The Arctic University of Tromso; Nofima	Eilertsen, HC (corresponding author), UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Tromso, Norway.	hei000@uit.no	Hansen, Espen/A-9000-2012; Eilertsen, Karl-Erik/A-9063-2010	Hansen, Espen/0000-0003-0354-986X; Eilertsen, Karl-Erik/0000-0002-6033-7188; Elvevoll, Edel/0000-0002-1486-7372; Ingebrigtsen, Richard Andre/0000-0002-2871-8888	Norwegian Seafood Research Fund (FHF)	Norwegian Seafood Research Fund (FHF)	This study was financed by The Norwegian Seafood Research Fund (FHF).	Aas TS, 2019, AQUACULT REP, V15, DOI 10.1016/j.aqrep.2019.100216; Abreu S, 2017, J CHROMATOGR A, V1514, P54, DOI 10.1016/j.chroma.2017.07.063; Artamonova EY, 2017, J APPL PHYCOL, V29, P1241, DOI 10.1007/s10811-017-1055-0; AUSTRENG E, 1987, AQUACULTURE, V60, P157, DOI 10.1016/0044-8486(87)90307-3; Barrett LT, 2020, INT J PARASITOL, V50, P787, DOI 10.1016/j.ijpara.2019.12.005; Bell JG, 2010, AQUACULTURE, V306, P225, DOI 10.1016/j.aquaculture.2010.05.021; Bendiksen EA, 2011, AQUACULTURE, V314, P132, DOI 10.1016/j.aquaculture.2011.01.040; Burr GS, 2012, AQUACULTURE, V334, P110, DOI 10.1016/j.aquaculture.2011.12.044; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Carter CG, 2000, AQUACULTURE, V185, P299, DOI 10.1016/S0044-8486(99)00353-1; Cashion T, 2017, FISH FISH, V18, P837, DOI 10.1111/faf.12209; Cequier-Sanchez E, 2008, J AGR FOOD CHEM, V56, P4297, DOI 10.1021/jf073471e; Cribari-Neto F, 2004, COMPUT STAT DATA AN, V45, P215, DOI 10.1016/S0167-9473(02)00366-3; Cutignano A, 2011, J PHYCOL, V47, P233, DOI 10.1111/j.1529-8817.2011.00972.x; d'Ippolito G, 2004, BBA-MOL CELL BIOL L, V1686, P100, DOI 10.1016/j.bbalip.2004.09.002; d'Ippolito G, 2002, TETRAHEDRON LETT, V43, P6137, DOI 10.1016/S0040-4039(02)01283-2; de Roos B, 2017, PUBLIC HEALTH NUTR, V20, P2042, DOI 10.1017/S1368980017000696; Degerlund M, 2010, ESTUAR COAST, V33, P242, DOI 10.1007/s12237-009-9167-7; Douglas HD, 2013, INT J PARASITOL, V43, P399, DOI 10.1016/j.ijpara.2013.01.004; Eilertsen Hans C., 1995, Journal of Marine Biotechnology, V3, P115; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foroutani MB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198538; Fox J., 2012, REV JAVER, V16; Games P. A., 1976, J EDUCATIONAL STATIS, V1, P113, DOI [10.3102/10769986001002113, DOI 10.2307/1164979]; Grimnes A, 1996, J FISH BIOL, V48, P1179, DOI 10.1111/j.1095-8649.1996.tb01813.x; Hamre K, 2013, REV AQUACULT, V5, pS26, DOI 10.1111/j.1753-5131.2012.01086.x; Hansen E, 2004, TOXICOLOGY, V199, P207, DOI 10.1016/j.tox.2004.02.026; Hansen L, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00764; Jansen PA, 2012, P ROY SOC B-BIOL SCI, V279, P2330, DOI 10.1098/rspb.2012.0084; Jensen IJ, 2012, NUTR BULL, V37, P25, DOI 10.1111/j.1467-3010.2011.01941.x; Jonasdottir SH, 2019, MAR DRUGS, V17, DOI 10.3390/md17030151; Kaldheim O, 2019, THESIS U STAVANGER THESIS U STAVANGER; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; Maehre HK, 2013, AQUACULT NUTR, V19, P301, DOI 10.1111/j.1365-2095.2012.00960.x; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; MOORE S, 1963, METHOD ENZYMOL, V6, P819, DOI 10.1016/0076-6879(63)06257-1; Overton K, 2019, REV AQUACULT, V11, P1398, DOI 10.1111/raq.12299; Pohnert G, 2002, PLANT PHYSIOL, V129, P103, DOI 10.1104/pp.010974; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; R Core Team, 2020, R LANG ENV STAT COMP; Rikardsen AH, 2004, J FISH BIOL, V65, P711, DOI 10.1111/j.0022-1112.2004.00478.x; Schlegel A., 2016, R FUNCTION PERFORMIN; Sistiaga M, 2020, AQUACULT ENG, V89, DOI 10.1016/j.aquaeng.2020.102061; Skjelvareid MH, 2018, AQUAC RES, V49, P2684, DOI 10.1111/are.13729; Sprague M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21892; STOFFEL W, 1959, ANAL CHEM, V31, P307, DOI 10.1021/ac60146a047; Svenning JB, 2019, ALGAL RES, V37, P11, DOI 10.1016/j.algal.2018.10.009; Taelman SE, 2013, BIORESOURCE TECHNOL, V150, P513, DOI 10.1016/j.biortech.2013.08.044; Torrissen O, 2011, REV FISH SCI, V19, P257, DOI 10.1080/10641262.2011.597890; Torstensen BE, 2005, J AGR FOOD CHEM, V53, P10166, DOI 10.1021/jf051308i; Torstensen BE, 2004, AQUACULT NUTR, V10, P175, DOI 10.1111/j.1365-2095.2004.00289.x; Troncoso J, 2011, LAT AM J AQUAT RES, V39, P439, DOI [10.4067/S0718-560X2011000300005, 10.3856/vol39-issue3-fulltext-5]; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; WHO, 2003, WHO TECH REP SER, V916, P1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	55	1	1	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255370	10.1371/journal.pone.0255370	http://dx.doi.org/10.1371/journal.pone.0255370			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324572	Green Published, gold			2022-12-26	WOS:000685248200012
J	Surono, IS; Jalal, F; Bahri, S; Romulo, A; Kusumo, PD; Manalu, E; Yusnita; Venema, K				Surono, Ingrid S.; Jalal, Fasli; Bahri, Syukrini; Romulo, Andreas; Kusumo, Pratiwi Dyah; Manalu, Erida; Yusnita; Venema, Koen			Differences in immune status and fecal SCFA between Indonesian stunted children and children with normal nutritional status	PLOS ONE			English	Article							CHILDHOOD MALNUTRITION; MICROBIOTA; BUTYRATE; IMPACT	We recently showed that the gut microbiota composition of stunted children was different from that of children with normal nutritional status. Here, we compared immune status and fecal microbial metabolite concentrations between stunted and normal children, and we correlated macronutrient intake (including energy), metabolites and immune status to microbiota composition. The results show that macronutrient intake was lower in stunted children for all components, but after correction for multiple comparison significant only for energy and fat. Only TGF-beta was significantly different between stunted children and children of normal nutritional status after correction for multiple comparisons. TNF-alpha, IL-10, lipopolysaccharide binding protein in serum and secretory IgA in feces were not significantly different. Strikingly, all the individual short-chain and branched-chain fatty acids were higher in fecal samples of stunted children (significant for acetate, valerate and total SCFA). These metabolites correlated with a number of different microbial taxa, but due to extensive cross-feeding between microbes, did not show a specific pattern. However, the energy-loss due to higher excretion in stunted children of these metabolites, which can be used as substrate for the host, is striking. Several microbial taxa also correlated to the intake of macronutrients (including dietary fibre) and energy. Eisenbergiella positively correlated with all macronutrients, while an uncharacterized genus within the Succinivibrionaceae family negatively correlated with all macronutrients. These, and the other correlations observed, may provide indication on how to modulate the gut microbiota of stunted children such that their growth lag can be corrected.	[Surono, Ingrid S.; Romulo, Andreas] Bina Nusantara Univ, Dept Food Technol, Fac Engn, Jakarta, Indonesia; [Jalal, Fasli; Yusnita] YARSI Univ, Dept Nutr, Fac Med, Jakarta, Indonesia; [Bahri, Syukrini] YARSI Univ, Dept Clin Pathol, Fac Med, Jakarta, Indonesia; [Kusumo, Pratiwi Dyah; Manalu, Erida] Univ Kristen Indonesia, Fac Med, Jakarta, Indonesia; [Venema, Koen] Maastricht Univ Campus Venlo, Ctr Hlth Eating & Food Innovat, Venlo, Netherlands	Universitas Bina Nusantara; YARSI University; YARSI University; The Christian University of Indonesia; Maastricht University	Venema, K (corresponding author), Maastricht Univ Campus Venlo, Ctr Hlth Eating & Food Innovat, Venlo, Netherlands.	k.venema@maastrichtuniveristy.nl		Romulo, Andreas/0000-0002-1034-5817; , Yusnita/0000-0003-1094-3195	Research and Technology Transfer Office, Bina Nusantara University; "Korelasi Profil Mikrobiota, Status Imun dan Inflammasi Anak Balita Normal dan Stunting"(Correlation of Microbiota Profile, Immune Status and Inflammation of Normal and Stunted Toddlers) [026/VR.RTT/IV/2020]; Centre for Healthy Eating & Food Innovation (HEFI) of Maastricht University -campus Venlo; Dutch Province of Limburg; YARSI University; Universitas Kristen Indonesia	Research and Technology Transfer Office, Bina Nusantara University; "Korelasi Profil Mikrobiota, Status Imun dan Inflammasi Anak Balita Normal dan Stunting"(Correlation of Microbiota Profile, Immune Status and Inflammation of Normal and Stunted Toddlers); Centre for Healthy Eating & Food Innovation (HEFI) of Maastricht University -campus Venlo; Dutch Province of Limburg; YARSI University; Universitas Kristen Indonesia	The study was funded by a) Research and Technology Transfer Office, Bina Nusantara University as a part of Bina Nusantara University's International Research Grant entitled "Korelasi Profil Mikrobiota, Status Imun dan Inflammasi Anak Balita Normal dan Stunting"(Correlation of Microbiota Profile, Immune Status and Inflammation of Normal and Stunted Toddlers) with contract number: No.026/VR.RTT/IV/2020 and contract date: 6 April 2020 (ISS and AR); b) the Centre for Healthy Eating & Food Innovation (HEFI) of Maastricht University -campus Venlo, which has been made possible with the support of the Dutch Province of Limburg (KV); c) YARSI University (FJ, SB and Y); and d) Universitas Kristen Indonesia (PDK and EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir I, 2014, INT J SYST EVOL MICR, V64, P907, DOI 10.1099/ijs.0.057331-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Duncan SH, 2016, ENVIRON MICROBIOL, V18, P2214, DOI 10.1111/1462-2920.13158; FERGUSON A, 1995, CLIN EXP IMMUNOL, V99, P70; Gomez-Gallego C, 2019, ANNU REV NUTR, V39, P267, DOI 10.1146/annurev-nutr-082117-051716; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Group" UWWB, LEVELS TRENDS CHILD; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Huus KE, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00890-1; Ibrahim MK, 2017, CLIN MICROBIOL REV, V30, P919, DOI 10.1128/CMR.00119-16; Izhak MB., 2020, PROJECTION GUT MICRO, DOI [10.1101/2020.08.27.271312, DOI 10.1101/2020.08.27.271312]; Kamng'ona AW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49274-y; Kane AV, 2015, PEDIATR RES, V77, P256, DOI 10.1038/pr.2014.179; Kusumo PD, 2019, BENEF MICROBES, V10, P245, DOI 10.3920/BM2017.0178; Kusumo PD, 2019, IRAN J MICROBIOL, V11, P389; Li HZ, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00512; Mancabelli L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10663-w; Osendarp SJM, 2020, LANCET, V396, P813, DOI 10.1016/S0140-6736(20)31364-7; Sun MM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05901-2; Sun MM, 2017, J GASTROENTEROL, V52, P1, DOI 10.1007/s00535-016-1242-9; Surono IS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245399; Thompson DS, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.141316; Titaley CR, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051106; Togo A. H., 2016, New Microbes and New Infections, V13, P15, DOI 10.1016/j.nmni.2016.05.015; Torlesse H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3339-8; Vacca M, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8040573; Verbeke KA, 2015, NUTR RES REV, V28, P42, DOI 10.1017/S0954422415000037; WHO, WHO CHILD GROWTH STA; World Health Organization, 2017, GUID ASS MAN CHILDR; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112	31	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254300	10.1371/journal.pone.0254300	http://dx.doi.org/10.1371/journal.pone.0254300			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324500	Green Published, gold			2022-12-26	WOS:000685248200036
J	DeGroot, DW; Sitler, CA; Lustik, MB; Langan, KL; Hauret, KG; Gotschall, MH; Gehrich, AP				DeGroot, David W.; Sitler, Collin A.; Lustik, Michael B.; Langan, Kelly L.; Hauret, Keith G.; Gotschall, Michael H.; Gehrich, Alan P.			The effect of pregnancy and the duration of postpartum convalescence on the physical fitness of healthy women: A cohort study of active duty servicewomen receiving 6 weeks versus 12 weeks convalescence	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; RETENTION; ASSOCIATION; EXERCISE; OUTCOMES	Introduction Pregnancy profoundly affects cardiovascular and musculoskeletal performance requiring up to 12 months for recovery in healthy individuals. Objective To assess the effects of extending postpartum convalescence from 6 to 12 weeks on the physical fitness of Active Duty (AD) soldiers as measured by the Army Physical Fitness Test (APFT) and Body Mass Index (BMI). Methods We conducted a retrospective study of AD soldiers who delivered their singleton pregnancy of >= 32weeks gestation at a tertiary medical center. Pre- and post-pregnancy APFT results as well as demographic, pregnancy, and postpartum data were collected. Changes in APFT raw scores, body composition measures, and failure rates across the 6-week and 12-week convalescent cohorts were assessed. Multivariable regressions were utilized to associate risk factors with failure. Results Four hundred sixty women met inclusion criteria; N = 358 in the 6 week cohort and N = 102 in the 12 week cohort. Demographic variables were similar between the cohorts. APFT failure rates across pregnancy increased more than 3-fold in both groups, but no significant differences were found between groups in the decrement of performance or weight gain. With the combined cohort, multivariable regression analysis showed failure on the postpartum APFT to be independently associated with failure on the pre-pregnancy APFT (OR = 16.92, 95% CI 4.96-57.77), failure on pre-pregnancy BMI (OR = 8.44, 95% CI 2.23-31.92), elevated BMI at 6-8 weeks postpartum (OR = 4.02, 95% CI 1.42-11.35) and not breastfeeding at 2 months (OR = 3.23, 95% CI 1.48-7.02). Within 36 months of delivery date, 75% of women had achieved pre-pregnancy levels of fitness. Conclusion An additional 6 weeks of convalescence did not adversely affect physical performance or BMI measures in AD Army women following pregnancy. Modifiable factors such as pre- and post-pregnancy conditioning and weight, weight gain in pregnancy and always breastfeeding were found to be significant in recovery of physical fitness postpartum.	[DeGroot, David W.] Martin Army Community Hosp, Ft Benning Heat Ctr, Ft Benning, GA USA; [Sitler, Collin A.] Walter Reed Natl Mil Med Ctr, Dept Obstet & Gynecol, Bethesda, MD USA; [Lustik, Michael B.] Tripler Army Med Ctr, Dept Clin Invest, Honolulu, HI 96859 USA; [Langan, Kelly L.] Madigan Army Med Ctr, Dept Obstet & Gynecol, Joint Base Lewis McChord, Washington, DC USA; [Hauret, Keith G.] Army Publ Hlth Ctr, Aberdeen Proving Ground, MD USA; [Gotschall, Michael H.] Tripler Army Med Ctr, Dept Pediat, Honolulu, HI 96859 USA; [Gehrich, Alan P.] Tripler Army Med Ctr, Dept Obstet & Gynecol, Honolulu, HI USA	Walter Reed National Military Medical Center; United States Department of Defense; United States Army; United States Department of Defense; United States Army; United States Department of Defense; United States Army	Gehrich, AP (corresponding author), Tripler Army Med Ctr, Dept Obstet & Gynecol, Honolulu, HI USA.	apgurogyn@gmail.com		/0000-0001-5528-2525; Gehrich, Alan/0000-0001-5971-2385				Adegboye ARA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005627.pub3; Armitage NH, 2012, MIL MED, V177, P1519, DOI 10.7205/MILMED-D-12-00248; Bo K, 2017, BRIT J SPORT MED, V51, P1516, DOI 10.1136/bjsports-2017-097964; Chauhan SP, 2013, MIL MED, V178, P406, DOI 10.7205/MILMED-D-12-00394; Clapp JF, 1997, AM J CARDIOL, V80, P1469, DOI 10.1016/S0002-9149(97)00738-8; Deering Rita E, 2018, J Womens Health Phys Therap, V42, P128, DOI 10.1097/JWH.0000000000000109; Deering RE, 2018, MED SCI SPORT EXER, V50, P1558, DOI 10.1249/MSS.0000000000001609; Endres LK, 2015, OBSTET GYNECOL, V125, P144, DOI 10.1097/AOG.0000000000000565; Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635; Greer JA, 2012, J MATERN-FETAL NEO M, V25, P1433, DOI 10.3109/14767058.2011.639820; Gunderson EP, 2008, AM J EPIDEMIOL, V167, P178, DOI 10.1093/aje/kwm298; Hauschild VD, 2017, OCCUP ENVIRON MED, V74, P144, DOI 10.1136/oemed-2016-103684; Knapik JJ, 2004, INJURY PREV, V10, P37, DOI 10.1136/ip.2003.002808; Linne Y, 2003, INT J OBESITY, V27, P1516, DOI 10.1038/sj.ijo.0802441; Lombardi W, 1999, MIL MED, V164, P22, DOI 10.1093/milmed/164.1.22; Martin RC, 2016, J STRENGTH COND RES, V30, P26, DOI 10.1519/JSC.0000000000001026; Miller MJ, 2017, MIL MED, V182, pE1859, DOI 10.7205/MILMED-D-17-00093; Mota P, 2021, OBSTET GYNECOL, V137, P376, DOI 10.1097/AOG.0000000000004267; Murray-Davis B, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2508-z; Nehring I, 2011, AM J CLIN NUTR, V94, P1225, DOI 10.3945/ajcn.111.015289; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Rogers AE., 2019, MIL MED; Rogers AE, 2020, MIL MED, V185, pE227, DOI 10.1093/milmed/usz168; Saligheh M, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0908-x; Shelton Susan Liipfert, 2018, Nurs Womens Health, V22, P148, DOI 10.1016/j.nwh.2018.02.003; Stahlman Shauna, 2017, MSMR, V24, P2; Stuebe AM, 2014, OBSTET GYNECOL, V123, P643, DOI 10.1097/AOG.0000000000000142; Treuth MS, 2005, MED SCI SPORT EXER, V37, P832, DOI 10.1249/01.MSS.0000161749.38453.02; U.S. Department of the Army, 2012, FM 7 22 ARM PHYS REA, pA1; Weina SU, 2006, MIL MED, V171, P534, DOI 10.7205/MILMED.171.6.534	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0255248	10.1371/journal.pone.0255248	http://dx.doi.org/10.1371/journal.pone.0255248			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320030	gold, Green Published			2022-12-26	WOS:000685247800020
J	Mital, S; Nguyen, HV				Mital, Shweta; Nguyen, Hai V.			Cost-effectiveness of procedure-less intragastric balloon therapy as substitute or complement to bariatric surgery	PLOS ONE			English	Article							WEIGHT-LOSS; GASTRIC BYPASS; MORBID-OBESITY; MORTALITY; UTILITY	Background Procedure-less intragastric balloon (PIGB) eliminates costs and risks of endoscopic placement/removal and involves lower risk of serious complications compared with bariatric surgery, albeit with lower weight loss. Given the vast unmet need for obesity treatment, an important question is whether PIGB treatment is cost-effective-either stand-alone or as a bridge to bariatric surgery. Methods We developed a microsimulation model to compare the costs and effectiveness of six treatment strategies: PIGB, gastric bypass or sleeve gastrectomy as stand-alone treatments, PIGB as a bridge to gastric bypass or sleeve gastrectomy, and no treatment. Results PIGB as a bridge to bariatric surgery is less costly and more effective than bariatric surgery alone as it helps to achieve a lower post-operative BMI. Of the six strategies, PIGB as a bridge to sleeve gastrectomy is the most cost-effective with an ICER of $3,781 per QALY gained. While PIGB alone is not cost-effective compared with bariatric surgery, it is cost-effective compared with no treatment with an ICER of $21,711 per QALY. Conclusions PIGB can yield cost savings and improve health outcomes if used as a bridge to bariatric surgery and is cost-effective as a stand-alone treatment for patients lacking access or unwilling to undergo surgery.	[Mital, Shweta; Nguyen, Hai V.] Mem Univ Newfoundland, Sch Pharm, St John, NF, Canada	Memorial University Newfoundland	Nguyen, HV (corresponding author), Mem Univ Newfoundland, Sch Pharm, St John, NF, Canada.	hvnguyen@mun.ca						Abu Dayyeh BK, 2015, GASTROINTEST ENDOSC, V82, P425, DOI 10.1016/j.gie.2015.03.1964; Allurion, INSTR US ELIPSETM GA; Allurion, 2020, ELIPSETM BALL WEIGHT; Alsumali A, 2018, OBES SURG, V28, P2203, DOI 10.1007/s11695-017-3100-0; [Anonymous], 2018, SUN; [Anonymous], 2020, WHO IS CAND BAR SURG; Apollo Endosurgery Inc, ORB INTR BALL SYST P; Ball W, 2019, OBES SURG, V29, P1932, DOI 10.1007/s11695-019-03794-8; Borisenko O, 2017, BMC SURG, V17, DOI 10.1186/s12893-017-0284-0; Borrell LN, 2014, AM J PUBLIC HEALTH, V104, P512, DOI 10.2105/AJPH.2013.301597; Briggs A, 2006, DECISION MODELLING H; Business wire, 2020, BUSINESS WIRE 0407; Business wire, 2020, BUSINESS WIRE 0728; Campbell J, 2010, AM J MANAG CARE, V16, pE174; CDC, 2018, HLTH US TABL 058 NOR; Centers for Disease Control and Prevention, 2019, US LIFE TABLES 0826; Centers for Medicare and Medicaid Services, 2020, PROC PRIC LOOK OUTP; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; Drugs.com, 2020, APR PRIC COUP PAT AS; Drugs.com, 2020, LANS PRIC COUP PAT A; Drugs.com, 2020, OND PRIC COUP PAT AS; Exchange rates.org, 2018, BRIT POUNDS GBP US D; Fenwick E, 2020, VALUE HEALTH, V23, P139, DOI 10.1016/j.jval.2020.01.001; Food and Drug Administration, 2020, UPDATE POT RISKS LIQ; Ienca R., 2020, OBES SURG, P1; James R, 2017, SURG OBES RELAT DIS, V13, P2012, DOI 10.1016/j.soard.2016.12.016; Liu N, 2020, ANN SURG, V271, P210, DOI 10.1097/SLA.0000000000003714; Lyratzopoulos G, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-32; Maklin S, 2011, BRIT J SURG, V98, P1422, DOI 10.1002/bjs.7640; Melissas J, 2006, OBES SURG, V16, P897, DOI 10.1381/096089206777822188; Mital S, 2019, AM J GASTROENTEROL, V114, P1470, DOI 10.14309/ajg.0000000000000359; National Consensus Project for Quality Palliative Care, 2013, CLIN PRACTICE GUIDEL; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; Neto MG., 2019, INTRAGASTRIC BALLOON; Ochner CN, 2012, INT J OBESITY, V36, P1380, DOI 10.1038/ijo.2012.60; Salem L, 2008, SURG OBES RELAT DIS, V4, P26, DOI 10.1016/j.soard.2007.09.009; Salminen P, 2018, JAMA-J AM MED ASSOC, V319, P241, DOI 10.1001/jama.2017.20313; Saumoy M, 2018, GASTROENTEROLOGY, V155, P648, DOI 10.1053/j.gastro.2018.05.026; Shahnazarian V, 2019, TRANSL GASTROENT HEP, V4, DOI 10.21037/tgh.2019.03.01; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; TreeAge Software, 2020, TREEAGE PRO2020 R2; UpToDate, 2020, INTR BALL THER WEIGH; Vantanasiri K, 2020, OBES SURG, V30, P3341, DOI 10.1007/s11695-020-04522-3	43	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254063	10.1371/journal.pone.0254063	http://dx.doi.org/10.1371/journal.pone.0254063			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34319992	Green Accepted, gold, Green Published			2022-12-26	WOS:000685247800029
J	Rahman, MA; Shanjana, Y; Tushar, MI; Mahmud, T; Rahman, GMS; Milan, ZH; Sultana, T; Chowdhury, AMLH; Bhuiyan, MA; Islam, MR; Reza, HM				Rahman, Md. Ashrafur; Shanjana, Yeasna; Tushar, Md. Ismail; Mahmud, Tarif; Rahman, Ghazi Muhammad Sayedur; Milan, Zahid Hossain; Sultana, Tamanna; Chowdhury, Ali Mohammed Lutful Hoq; Bhuiyan, Mohiuddin Ahmed; Islam, Md. Rabiul; Reza, Hasan Mahmud			Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: Experience from Bangladesh	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TYPE-2 DIABETES-MELLITUS; CORONAVIRUS DISEASE 2019; CHRONIC KIDNEY-DISEASE; D-DIMER; CLINICAL CHARACTERISTICS; RISK; PROCALCITONIN; MARKERS; WUHAN	Background The hematological abnormalities are assumed to be involved in the disease progression of COVID-19. However, the actual associations between specific blood parameters and COVID-19 are not well understood. Here we aimed to assess the correlations between hematological parameters and the severity of COVID-19. Methods We included COVID-19 patients who were admitted to Evercare Hospital Ltd, Dhaka, Bangladesh, between November 10, 2020, to April 12, 2021, with a confirmed case of RT-PCR test. We recorded demographic information, clinical data, and routine hematological examination results of all COVID-19 patients. We performed statistical analyses and interpretation of data to compare severe COVID-19 patients (SCP) and non-severe COVID-19 patients (NSCP). Results The age and BMI of the admitted COVID-19 patients were 48.79 +/- 8.53 years and 25.82 +/- 3.75 kg/m(2). This study included a total of 306 hospitalized COVID-19 patients. Among them, NSCP and SCP were 198 and 108, respectively. And we recorded 12 deaths from SCP. We observed the alterations of several hematological parameters between SCP and NSCP. Among them, we noticed the increased levels of C-reactive protein (CRP), d-dimer, and ferritin showed good indicative value to evaluate the severity of COVID-19. Also, there were positive correlations among these parameters. Moreover, we found correlations between the outcomes of COVID-19 patients with patient's demographics and comorbid diseases. Conclusion Based on our results, CRP, d-dimer, and ferritin levels at admission to hospitals represent simple assessment factors for COVID-19 severity and the treatment decisions at the hospital setup. These blood parameters could serve as indicators for the prognosis and severity of COVID-19. Therefore, our study findings might help to develop a treatment protocol for COVID-19 patients at the hospital setup.	[Rahman, Md. Ashrafur; Tushar, Md. Ismail; Mahmud, Tarif; Rahman, Ghazi Muhammad Sayedur; Milan, Zahid Hossain; Sultana, Tamanna; Reza, Hasan Mahmud] North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh; [Shanjana, Yeasna] North South Univ, Dept Environm Sci, Dhaka, Bangladesh; [Chowdhury, Ali Mohammed Lutful Hoq] Evercare Hosp, Crit Care Dept, Dhaka, Bangladesh; [Bhuiyan, Mohiuddin Ahmed; Islam, Md. Rabiul] Univ Asia Pacific, Dept Pharm, Dhaka, Bangladesh	North South University (NSU); North South University (NSU); University of Asia Pacific (UAP)	Reza, HM (corresponding author), North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh.; Islam, MR (corresponding author), Univ Asia Pacific, Dept Pharm, Dhaka, Bangladesh.	robi.ayaan@gmail.com; hasan.reza@northsouth.edu	Islam, Rabiul/Q-3277-2019; Reza, Hasan Mahmud/AFL-0151-2022; Bhuiyan, Mohiuddin Ahmed/ABB-3632-2021	Islam, Rabiul/0000-0003-2820-3144; Reza, Hasan Mahmud/0000-0003-3287-942X; rahman, Md ashrafur/0000-0003-0146-5312				Abu-Farha M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.576818; Akpinar EE, 2013, J THORAC DIS, V5, P430, DOI 10.3978/j.issn.2072-1439.2013.07.34; Ali N, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00458; Anjum S, 2020, THER ADV PSYCHOPHARM, V10, DOI 10.1177/2045125320916655; [Anonymous], 2020, IEEE SENS J, DOI [10.1016/j.ijid.2020.03.017, DOI 10.1109/JSEN.2020.2965086]; Bajgain KT, 2021, AM J INFECT CONTROL, V49, P238, DOI 10.1016/j.ajic.2020.06.213; Chan JFW, 2015, CLIN MICROBIOL REV, V28, P465, DOI 10.1128/CMR.00102-14; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Clark CE, 2021, J HUM HYPERTENS, V35, P304, DOI 10.1038/s41371-020-00451-x; Coban E, 2005, EXP CLIN ENDOCR DIAB, V113, P35, DOI 10.1055/s-2004-830524; Corrao S, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.609470; Daria S, 2021, ASIA-PAC J PUBLIC HE, V33, P665, DOI 10.1177/10105395211021686; Daria S, 2021, INT J HEALTH PLAN M, V36, P1950, DOI 10.1002/hpm.3257; Daria S, 2021, INT J HEALTH PLAN M, V36, P1947, DOI 10.1002/hpm.3245; Das R, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045727; Das R, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113568; Deng YT, 2020, CAMB CHINA LIBR, P1; Emon MPZ, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-04952-3; Foldi M, 2020, OBES REV, V21, DOI 10.1111/obr.13095; Gaffney P J, 1980, J Clin Pathol Suppl (R Coll Pathol), V14, P10; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Hahn WH, 2018, J MATERN-FETAL NEO M, V31, P822, DOI 10.1080/14767058.2017.1297410; Haridas N., 2017, INT J ADV RES IJAR, V5, P2139, DOI DOI 10.21474/IJAR01/3387; Hasan MM, 2021, VIRUS RES, V297, DOI 10.1016/j.virusres.2021.198390; Henry BM, 2020, CLIN CHEM LAB MED, V58, P1021, DOI 10.1515/cclm-2020-0369; Hirano T, 2020, IMMUNITY, V52, P731, DOI 10.1016/j.immuni.2020.04.003; Islam JY, 2018, J HUM HYPERTENS, V32, P668, DOI 10.1038/s41371-018-0087-5; Islam MR, 2021, ASIA-PAC J PUBLIC HE, V33, P469, DOI 10.1177/10105395211004371; Islam MR, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1685-z; Islam MT, 2020, J PUBLIC HEALTH RES, V9, P389, DOI 10.4081/jphr.2020.1794; Kang HT, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111058; Kermali M, 2020, LIFE SCI, V254, DOI 10.1016/j.lfs.2020.117788; Khalil, 2016, AM J MED MED SCI, V6, P120; Khanam MA, 2011, J HEALTH POPUL NUTR, V29, P406, DOI 10.3329/jhpn.v29i4.8458; Kim JW, 2015, NEUROSCI LETT, V589, P126, DOI 10.1016/j.neulet.2014.12.064; Krakoff J, 2003, DIABETES CARE, V26, P1745, DOI 10.2337/diacare.26.6.1745; Lakoski SG, 2005, J AM COLL CARDIOL, V46, P1869, DOI 10.1016/j.jacc.2005.07.050; Lee CC, 2009, DIABETOLOGIA, V52, P1040, DOI 10.1007/s00125-009-1338-3; Lee DH, 2018, ANN OCCUP ENVIRON ME, V30, DOI 10.1186/s40557-018-0251-y; Li GD, 2020, NAT REV DRUG DISCOV, V19, P149, DOI 10.1038/d41573-020-00016-0; Li HQ, 2020, DIABETES OBES METAB, V22, P1897, DOI 10.1111/dom.14099; Li TH, 2020, EMERG MICROBES INFEC, V9, P687, DOI 10.1080/22221751.2020.1741327; Liang WH, 2020, NEW ENGL J MED, V382, P1708, DOI DOI 10.1038/s41586-020-2349-y; Liao DY, 2020, LANCET HAEMATOL, V7, pE671, DOI 10.1016/S2352-3026(20)30217-9; Lippi G, 2020, HEMATOL TRANSF CELL, V42, P116, DOI 10.1016/j.htct.2020.03.001; Lippi G, 2020, THROMB HAEMOSTASIS, V120, P876, DOI 10.1055/s-0040-1709650; Lippi G, 2020, CLIN CHIM ACTA, V505, P190, DOI 10.1016/j.cca.2020.03.004; Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8; Magleby R, 2021, CLIN INFECT DIS, V73, pE4197, DOI 10.1093/cid/ciaa851; Mahmudpour M, 2020, CYTOKINE, V133, DOI 10.1016/j.cyto.2020.155151; Mejia F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244171; Mohiuddin AK., 2019, INT J DIABETES RES, V2, P14, DOI DOI 10.17554/IJDR.V2I1.2457; Nishuty NL, 2019, CUREUS, V11, DOI 10.7759/cureus.3868; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2098, DOI 10.1001/jama.2020.7681; Rifai N, 1999, CLIN CHEM, V45, P2136; Roberts WL, 2000, CLIN CHEM, V46, P461; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Safdar AM, 2018, BANGLADESH CRITICAL, V6, P3; Salehi-Abari I, 2020, ADV INFECT DIS, V10, P67, DOI [10.4236/aid.2020.103008, DOI 10.4236/AID.2020.103008]; Sattar N, 2020, CIRCULATION, V142, P4, DOI 10.1161/CIRCULATIONAHA.120.047659; Shaheer AK, 2017, J CLIN DIAGN RES, V11, pBC1, DOI 10.7860/JCDR/2017/30272.10528; Shankar A, 2011, KIDNEY INT, V80, P1231, DOI 10.1038/ki.2011.283; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Shitrit D, 2002, CHEST, V122, P1674, DOI 10.1378/chest.122.5.1674; Sutradhar I, 2019, CUREUS J MED SCIENCE, V11, DOI 10.7759/cureus.3970; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Tang ZY, 2021, PHYS MED BIOL, V66, DOI 10.1088/1361-6560/abbf9e; Terpos E, 2020, AM J HEMATOL, V95, P834, DOI 10.1002/ajh.25829; Vargas-Vargas M, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.72; Velavan TP, 2020, INT J INFECT DIS, V95, P304, DOI 10.1016/j.ijid.2020.04.061; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang L, 2020, MED MALADIES INFECT, V50, P332, DOI 10.1016/j.medmal.2020.03.007; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Xiong Y, 2020, INVEST RADIOL, V55, P332, DOI 10.1097/RLI.0000000000000674; Yang L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00243-2; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Yeap BB, 2015, CLIN ENDOCRINOL, V82, P525, DOI 10.1111/cen.12529; Zavascki AP, 2020, NEW ENGL J MED, V382, P1859, DOI 10.1056/NEJMc2005203; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou Y, 2021, DIABETES-METAB RES, V37, DOI 10.1002/dmrr.3377	82	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255379	10.1371/journal.pone.0255379	http://dx.doi.org/10.1371/journal.pone.0255379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314447	Green Published, gold			2022-12-26	WOS:000685225200018
J	Saz, J; Dalmau-Bueno, A; Meulbroek, M; Pujol, F; Coll, J; Herraiz-Tomey, A; Perez, F; Marazzi, G; Taboada, H; Culqui, DR; Cayla, JA				Saz, Jorge; Dalmau-Bueno, Albert; Meulbroek, Michael; Pujol, Ferran; Coll, Josep; Herraiz-Tomey, Angel; Perez, Felix; Marazzi, Giovanni; Taboada, Hector; Culqui, Dante R.; Cayla, Joan A.		BCN Checpoint Working Grp	Use of fourth-generation rapid combined antigen and antibody diagnostic tests for the detection of acute HIV infection in a community centre for men who have sex with men, between 2016 and 2019	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; VIRAL LOAD; TRANSMISSION	Objective To assess the use of fourth-generation rapid diagnostic tests in identifying acute infection of Human Immunodeficiency Virus (HIV). Methods BCN Checkpoint promotes sexual health among men who have sex with men (MSM), with a focus on diagnosing HIV early, initiating combined antiretroviral treatment (cART) promptly, and recommending regular repeat testing for those who have tested negative. This cross-sectional study included all test results obtained at the centre between 25 March 2016 and 24 March 2019. The Alere (TM) HIV Combo (now rebranded to Determine (TM) HIV Ultra, from Abbott) was used to detect p24 antigen (p24 Ag) and/or immunoglobulin M (IgM) and G (IgG) antibodies to HIV-1/HIV-2 (HIV Ab). Rapid polymerase chain reaction (PCR) confirmatory testing and Western blot (WB) were performed for clients with a positive rapid test result. Confirmed HIV cases were promptly referred to the HIV unit for care and cART prescription. Results A total of 12,961 clients attended BCN Checkpoint during the study and 27,298 rapid tests were performed. 450 tests were found to be reactive, of which 430 confirmed as HIV-positive, representing a prevalence of 3.32%. Four confirmed cases (0.93%) were detected as "p24 Ag only", nine (2.09%) as "both p24 and HIV Ab" and 417 (96.98%) as "HIV Ab only". The "p24 Ag only" group had a 1-log higher viral load than the other groups and initiated treatment on the following working day. Overall, there were 20 false-positive results (0.07% and 4.44% of total and reactive tests, respectively), of which 10 positive for "p24 Ag only" and 10 for "HIV Ab only". Conclusions Four Acute HIV Infections (AHI), with very high viral loads, have been detected with the "p24 Ag only" while the HIV Ab were still absent. Referral to the HIV unit and initiation of cART on the following working day contributed to improving persons' health and to reduce HIV transmission chain.	[Saz, Jorge; Meulbroek, Michael; Pujol, Ferran; Perez, Felix; Marazzi, Giovanni; Taboada, Hector] Projecte NOMS Hispanosida, Barcelona, Spain; [Dalmau-Bueno, Albert] BCN Checkpoint, Barcelona, Spain; [Coll, Josep] Fight AIDS & Infect Dis Fdn, IrsiCaixa AIDS Res Inst, Badalona, Spain; [Culqui, Dante R.] Grp Pulso Co Evidenze Grp, Sant Cugat Del Valles, Spain; [Culqui, Dante R.] Isabel Roig Blauclin Sociosanit Ctr, Barcelona, Spain; [Cayla, Joan A.] TB Res Unit Barcelona UITB Fdn, Barcelona, Spain	Institut de Recerca de la Sida - IrsiCaixa	Saz, J (corresponding author), Projecte NOMS Hispanosida, Barcelona, Spain.	jsaz@hispanosida.com	Dalmau Bueno, Albert/AFL-6865-2022; Dalmau Bueno, Albert/AAG-6970-2022; TEJERA, FELIX/GXZ-8699-2022	TEJERA, FELIX/0000-0002-6799-9272; Mir, Joan Francesc/0000-0001-8501-0969; Culqui L., Dante R/0000-0003-1570-8012	Abbott Laboratories	Abbott Laboratories(Abbott Laboratories)	Abbott Laboratories has financed the editing and publishing of the results. However, the company had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alere, 2012, DETERMINETM HIV 1 2; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Branson BM., 2014, LAB TESTING DIAGNOSI; British HIV Association British Association of Sexual Health and HIV British Infection Society, 2008, UK NAT GUID HIV TEST; Chicago Department of Public Health, 2019, HIV EPIDEMIOLOGY ANN; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Edelstein PH., 2014, HIV ANT TEST HUP; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Guidasci T., 2009, 4 GENERATION POINT C; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holtgrave DR, 2010, PUBLIC HEALTH REP, V125, P372, DOI 10.1177/003335491012500305; Joint United Nations program on AIDS/HIV, 2014, PRESS REL UNAIDS REP; Joint United Nations program on AIDS/HIV, 2019, GLOB HIV STAT; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; MCRAE B, 1991, AIDS RES HUM RETROV, V7, P637, DOI 10.1089/aid.1991.7.637; Muessig KE, 2012, AIDS, V26, P2267, DOI 10.1097/QAD.0b013e328355713d; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2013, GUIDELINES USE ANTIR; Perez G., 2018, SALUT REPRODUCTIVA C; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Public Health England, 2019, ANN EPIDEMIOLOGICAL; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Thanawuth N, 2008, AIDS CARE, V20, P43, DOI 10.1080/09540120701439303	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255065	10.1371/journal.pone.0255065	http://dx.doi.org/10.1371/journal.pone.0255065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314468	gold, Green Published			2022-12-26	WOS:000685225200030
J	Tielker, JM; Weber, JP; Simon, ST; Bausewein, C; Stiel, S; Schneider, N				Tielker, Jannik M.; Weber, Jan P.; Simon, Steffen T.; Bausewein, Claudia; Stiel, Stephanie; Schneider, Nils			Experiences, challenges and perspectives for ensuring end-of-life patient care: A national online survey with general practitioners in Germany	PLOS ONE			English	Article							COVID-19; HEALTH	Background The SARS-CoV-2 (COVID-19) pandemic is posing major challenges for health care systems. In Germany, one such challenge has been that adequate palliative care for the severely ill and dying (with and without COVID-19), as well as their loved ones, has not been available at all times and in all settings., the pandemic has underlined the significance of the contribution of general practitioners (GPs) to the care of severely ill and dying patients. Objectives To describe GPs' experiences, challenges and perspectives with respect to end-of-life care during the first peak of the pandemic (spring 2020) in Germany. Materials and methods In November and December 2020, a link to an Unipark online survey was sent to GPs registered on nationwide distribution lists. Results In total, 410 GPs responded; 61.5% indicated that the quality of their patients' end-of-life care was maintained throughout the pandemic, 36.8% reported a decrease in quality compared to pre-pandemic times. Of the GPs who made home visits to severely ill and dying patients, 61.4% reported a stable number of visits, 28.5% reported fewer visits. 62.7% of the GPs reported increased telephone contact and reduced personal contact with patients; 36.1% offered video consultations in lieu of face-to-face contact. The GPs reported that relatives were restricted (48.5%) or prohibited from visiting (33.4%) patients in nursing homes. They observed a fear of loneliness among patients in nursing homes (91.9%), private homes (87.3%) and hospitals (86.1%). Conclusions The present work provides insights into the pandemic management of GPs and supports the development of a national strategy for palliative care during a pandemic. To effectively address end-of-life care, GPs and palliative care specialists should be involved in COVID-19 task forces on micro, meso and macro levels of health care.	[Tielker, Jannik M.; Weber, Jan P.; Stiel, Stephanie; Schneider, Nils] Hannover Med Sch, Inst Gen Practice, Hannover, Germany; [Simon, Steffen T.] Univ Cologne, Univ Hosp Cologne, Dept Palliat Med, Fac Med, Cologne, Germany; [Bausewein, Claudia] Ludwig Maximilians Univ Munchen, Dept Palliat Med, Univ Hosp Munich, Munich, Germany	Hannover Medical School; University of Cologne; University of Munich	Stiel, S (corresponding author), Hannover Med Sch, Inst Gen Practice, Hannover, Germany.	stiel.stephanie@mh-hannover.de		Stiel, Stephanie/0000-0002-5963-2526	German Ministry for Education [01KX2021]	German Ministry for Education	The project PallPan is funded by the German Ministry for Education and ResearchGrant Number: 01KX2021). https://www.netzwerk-universitaetsmedizin.de/projekte/pallpan The co-author NS received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	aerzteblatt.de, E HLTH POL TREIBT DI; AerzteZeitung.de [Internet], 2021, SARS COV 2 VERST BES; Alsnes IV, 2020, FAM MED COMMUNITY HE, V8, DOI 10.1136/fmch-2020-000512; [Anonymous], 2009, EUR J PALLIAT CARE; [Anonymous], COVID 19 GOVT RESPON; Arendt F, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113532; Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X; Bundesministerium fur Gesundheit, 2021, BES STAT PFLEG SICH; Cheung G, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09900-1; Dahlhaus A, 2013, SUPPORT CARE CANCER, V21, P3293, DOI 10.1007/s00520-013-1904-6; DEGAM, LEITL DEGAM, pC2021; Deutsche Gesellschaft fur Palliativmedizin, 2018, ERW S3 LEITL PALL SE; Deutsche Gesellschaft fur Palliativmedizin, 2018, DGP BEGR INF KBV ALL; Deutsche Gesellschaft fur Palliativmedizin [Internet], 2018, DEF HOSP PALL; Deutsches Arzteblatt, PSYCH BEL COVID 19 P; Deutschlandfunk, 2009, BES PFLEG WEG COR DE; Girum T, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00285-w; Global Family Doctor-WONCA, D LI COR 1 LAST OUT; Hawley CE, 2020, J AM GERIATR SOC, V68, P2431, DOI 10.1111/jgs.16845; Johnsen TM, 2021, J MED INTERNET RES, V23, DOI 10.2196/26433; Kassenarztliche Bundesvereinigung [Internet], 2021, VID DVPMG ENTW PASS; Kippen R, 2020, AUST J GEN PRACT, V49, P745, DOI 10.31128/AJGP-06-20-5465; Kuntz JG, 2020, J PAIN SYMPTOM MANAG, V60, pE28, DOI 10.1016/j.jpainsymman.2020.06.001; Lieneck C, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8040517; MAXQDA VERBI Software, VERS 18 SOFTW; Munch U, 2020, SCHMERZ, V34, P303, DOI 10.1007/s00482-020-00483-9; Nds, REIM VERH AUFN ALT P; Nussbaumer-Streit B, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013574.pub2, 10.1002/14651858.CD013574]; Oluyase AO., 2021, J PAIN SYMPTOM MANAG; Randhawa RS, 2018, PRIM HEALTH CARE RES, V20, DOI 10.1017/S1463423618000361; Rawaf S, 2020, EUR J GEN PRACT, V26, P129, DOI 10.1080/13814788.2020.1820479; Robert Koch-Institut, 2020, COR SARS COV 2 APR 2; Saint-Lary O, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-042119; Schweppe C, 2020, HAUSLICHE ALTENPFLEG; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Verhoeven V, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039674	36	5	5	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0254056	10.1371/journal.pone.0254056	http://dx.doi.org/10.1371/journal.pone.0254056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314417	Green Published, gold			2022-12-26	WOS:000685225200026
J	Bailey, DK; Clark, W; Kosman, DJ				Bailey, Danielle K.; Clark, Whitney; Kosman, Daniel J.			The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells	PLOS ONE			English	Article							FERROXIDASE ACTIVITY; ALZHEIMERS-DISEASE; FERROPORTIN; FERRITIN; PBT2; BETA; ACCUMULATION; MOBILIZATION; DEGRADATION; DEFERIPRONE	Iron and other transition metals, such as copper and manganese, are essential for supporting brain function, yet over-accumulation is cytotoxic. This over-accumulation of metals, particularly iron, is common to several neurological disorders; these include Alzheimer's disease, Parkinson's disease, Friedrich's ataxia and other disorders presenting with neurodegeneration and associated brain iron accumulation. The management of iron flux by the blood-brain barrier provides the first line of defense against the over-accumulation of iron in normal physiology and in these pathological conditions. In this study, we determined that the iron chelator PBT434, which is currently being developed for treatment of Parkinson's disease and multiple system atrophy, modulates the uptake of iron by human brain microvascular endothelial cells (hBMVEC) by chelation of extracellular Fe2+. Treatment of hBMVEC with PBT434 results in an increase in the abundance of the transcripts for transferrin receptor (TfR) and ceruloplasmin (Cp). Western blot and ELISA analyses reveal a corresponding increase in the proteins as well. Within the cell, PBT434 increases the detectable level of chelatable, labile Fe2+; data indicate that this Fe2+ is released from ferritin. In addition, PBT434 potentiates iron efflux likely due to the increase in cytosolic ferrous iron, the substrate for the iron exporter, ferroportin. PBT434 equilibrates rapidly and bi-directionally across an hBMVEC blood-brain barrier. These results indicate that the PBT434-iron complex is not substrate for hBMVEC uptake and thus support a model in which PBT434 would chelate interstitial iron and inhibit re-uptake of iron by endothelial cells of the blood-brain barrier, as well as inhibit its uptake by the other cells of the neurovascular unit. Overall, this presents a novel and promising mechanism for therapeutic iron chelation.	[Bailey, Danielle K.; Clark, Whitney; Kosman, Daniel J.] SUNY Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), SUNY Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14260 USA.	camkos@buffalo.edu		Bailey, Danielle/0000-0001-9128-0199	Alterity Therapeutics, Newark, CA; National Institutes of Health of the United States [RO1 NS102337]	Alterity Therapeutics, Newark, CA; National Institutes of Health of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was carried out with the support of Alterity Therapeutics, Newark, CA to DJK (alteritytherapeutics.com). Alterity provided partial support for Ms. Bailey's stipend and for supplies required to conduct this research. Further support for the Kosman Lab is provided by grant RO1 NS102337 to DJK from the National Institutes of Health of the United States (www.nih.gov).The funders played no role in the design nor conduct of this research. The contributions to this manuscript provided by Alterity scientific staff are acknowledged as appropriate.	Asano T, 2011, MOL CELL BIOL, V31, P2040, DOI 10.1128/MCB.01437-10; Aschemeyer S, 2018, BLOOD, V131, P899, DOI 10.1182/blood-2017-05-786590; Ashraf A, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00065; Atrian-Blasco E, 2018, COORDIN CHEM REV, V371, P38, DOI 10.1016/j.ccr.2018.04.007; Bailey DK, 2019, J BIOL INORG CHEM, V24, P1171, DOI 10.1007/s00775-019-01684-z; Billesbolle CB, 2020, NATURE, V586, P807, DOI 10.1038/s41586-020-2668-z; Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271; Cozzi A, 2019, STEM CELL REP, V13, P832, DOI 10.1016/j.stemcr.2019.09.002; Crichton RR, 2011, J NEURAL TRANSM, V118, P301, DOI 10.1007/s00702-010-0470-z; Crielaard BJ, 2017, NAT REV DRUG DISCOV, V16, P400, DOI 10.1038/nrd.2016.248; Cristovao JS, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9812178; Crouch PJ, 2011, J NEUROCHEM, V119, P220, DOI 10.1111/j.1471-4159.2011.07402.x; Dawson VL, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aba1659; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; De Domenico I, 2006, EMBO J, V25, P5396, DOI 10.1038/sj.emboj.7601409; De Domenico I, 2009, BLOOD, V114, P4546, DOI 10.1182/blood-2009-05-224188; Devos D, 2014, ANTIOXID REDOX SIGN, V21, P195, DOI 10.1089/ars.2013.5593; Di Meo I, 2018, EUR J PAEDIATR NEURO, V22, P272, DOI 10.1016/j.ejpn.2018.01.008; Duce JA, 2011, FUTUR NEUROL, V6, P641, DOI 10.2217/FNL.11.43; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Finkelstein D, 2019, NEUROLOGY, V92; Finkelstein DI, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0456-2; Fung E, 2015, BIOORG MED CHEM LETT, V25, P763, DOI 10.1016/j.bmcl.2014.12.094; Gaboriau F, 2010, BIOMETALS, V23, P231, DOI 10.1007/s10534-009-9281-9; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gerber H, 2017, J BIOL CHEM, V292, P3751, DOI 10.1074/jbc.M116.754101; Ghadery C, 2015, NEUROBIOL AGING, V36, P925, DOI 10.1016/j.neurobiolaging.2014.09.013; Ghazavi A, 2014, IRAN J CHILD NEUROL, V8, P12; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Hatcher HC, 2009, FUTURE MED CHEM, V1, P1643, DOI 10.4155/FMC.09.121; Hedera P, 2017, APPL CLIN GENET, V10, P9, DOI 10.2147/TACG.S79121; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Heras-Garvin A., 2020, ANN NEUROL; Heras-Garvin A, 2020, PARKINSONISM RELAT D, V73, P94, DOI 10.1016/j.parkreldis.2020.01.010; Hider R, 2014, THALASS REP, V4, P19, DOI 10.4081/thal.2014.2261; JAFFE EA, 1987, HUM PATHOL, V18, P234, DOI 10.1016/S0046-8177(87)80005-9; Khodayerdian V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39214-1; Kosman DJ, 2018, METALLOMICS, V10, P370, DOI 10.1039/c8mt00015h; Kosman DJ, 2013, COORDIN CHEM REV, V257, P210, DOI 10.1016/j.ccr.2012.06.030; Kuberl A, 2016, P NATL ACAD SCI USA, V113, P4806, DOI 10.1073/pnas.1514529113; La A, 2018, METALLOMICS, V10, P154, DOI [10.1039/c7mt00284j, 10.1039/C7MT00284J]; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Levi S, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12010027; Levi S, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00099; Li CH, 2010, J ALZHEIMERS DIS, V21, P1249, DOI 10.3233/JAD-2010-100024; Liu JL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00632; Martin-Bastida A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01402-2; McCarthy RC, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0065-7; McCarthy RC, 2014, EMBO REP, V15, P809, DOI 10.15252/embr.201338064; McCarthy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089003; McCarthy RC, 2013, J BIOL CHEM, V288, P17932, DOI 10.1074/jbc.M113.455428; McCarthy RC, 2012, BIOMETALS, V25, P665, DOI 10.1007/s10534-012-9538-6; Mehlhase J, 2005, FREE RADICAL BIO MED, V38, P276, DOI 10.1016/j.freeradbiomed.2004.10.025; Meyer E, 2015, ANNU REV GENOM HUM G, V16, P257, DOI 10.1146/annurev-genom-090314-025011; Mukhopadhyay CK, 2000, J BIOL CHEM, V275, P21048, DOI 10.1074/jbc.M000636200; Nunez MT, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11040109; Pandolfo M, 2014, ANN NEUROL, V76, P509, DOI 10.1002/ana.24248; Patel SJ, 2019, NAT CHEM BIOL, V15, P872, DOI 10.1038/s41589-019-0330-6; Pepe A, 2011, HAEMATOL-HEMATOL J, V96, P41, DOI 10.3324/haematol.2009.019042; Puschmann A, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0780-8; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singh A, 2019, MOLECULES, V24, DOI 10.3390/molecules24081583; SINGH S, 1992, DRUG METAB DISPOS, V20, P256; Stamler D, 2020, NEUROLOGY, V94; Stamler D, 2019, NEUROLOGY, V92; Steimle BL, 2019, J BIOL CHEM, V294, P19197, DOI 10.1074/jbc.RA119.009371; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Strowitzki MJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050384; Tosato M, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9070269; Llorens JV, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00075; Xia SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082662; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhou ZD, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0218-4	76	5	5	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254794	10.1371/journal.pone.0254794	http://dx.doi.org/10.1371/journal.pone.0254794			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310628	gold, Green Published			2022-12-26	WOS:000685224500022
J	Briggs, EV; Mazza, C				Briggs, Eloise V.; Mazza, Claudia			Automatic methods of hoof-on and -off detection in horses using wearable inertial sensors during walk and trot on asphalt, sand and grass	PLOS ONE			English	Article							WARMBLOOD HORSES; LAMENESS; SYSTEM; FORCE; LIMB; LOAD	Detection of hoof-on and -off events are essential to gait classification in horses. Wearable sensors have been endorsed as a convenient alternative to the traditional force plate-based method. The aim of this study was to propose and validate inertial sensor-based methods of gait event detection, reviewing different sensor locations and their performance on different gaits and exercise surfaces. Eleven horses of various breeds and ages were recruited to wear inertial sensors attached to the hooves, pasterns and cannons. Gait events detected by pastern and cannon methods were compared to the reference, hoof-detected events. Walk and trot strides were recorded on asphalt, grass and sand. Pastern-based methods were found to be the most accurate and precise for detecting gait events, incurring mean errors of between 1 and 6ms, depending on the limb and gait, on asphalt. These methods incurred consistent errors when used to measure stance durations on all surfaces, with mean errors of 0.1 to 1.16% of a stride cycle. In conclusion, the methods developed and validated here will enable future studies to reliably detect equine gait events using inertial sensors, under a wide variety of field conditions.	[Briggs, Eloise V.; Mazza, Claudia] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England; [Briggs, Eloise V.; Mazza, Claudia] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Briggs, EV (corresponding author), Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England.; Briggs, EV (corresponding author), Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England.	evbriggs1@sheffield.ac.uk		Briggs, Eloise/0000-0002-7665-2115; Mazza, Claudia/0000-0002-5215-1746	UK EPSRC [EP/K03877X/1, EP/S032940/1]	UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The research of EVB is funded by Worldbase Ltd. and this study was also supported by the UK EPSRC (EP/K03877X/1, EP/S032940/1, https://epsrc.ukri.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barstow A, 2019, EQUINE VET J, V51, P108, DOI 10.1111/evj.12952; Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Braganca FM, 2017, EQUINE VET J, V49, P545, DOI 10.1111/evj.12651; Buchner H., 1995, EQUINE VET J, V27, P161, DOI [DOI 10.1111/J.2042-3306.1995.TB04911.X, 10.1111/j.2042-3306.1995.tb04911.x]; Clayton H M, 1997, Equine Vet J Suppl, P54; Clayton H. M., 1986, Journal of Equine Veterinary Science, V6, P70, DOI 10.1016/S0737-0806(86)80037-5; Davies ZTS, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2018.0709; Davies ZTS, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.204107; Egan S, 2019, EQUINE VET J, V51, P813, DOI 10.1111/evj.13076; Higler MH, 2014, EQUINE VET J, V46, P611, DOI 10.1111/evj.12182; HOLMSTROM M, 1990, EQUINE VET J, V22, P186, DOI 10.1111/j.2042-3306.1990.tb04245.x; Holmstrom M., 1994, EQUINE VET J, V26, P51, DOI [DOI 10.1111/J.2042-3306.1994.TB04874.X, 10.1111/j.2042-3306.1994.tb04874.x]; Sanchez MJ, 2013, ARCH TIERZUCHT, V56, P137, DOI 10.7482/0003-9438-56-013; Keegan KG, 2013, AM J VET RES, V74, P17, DOI 10.2460/ajvr.74.1.17; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; McCracken MJ, 2012, EQUINE VET J, V44, P652, DOI 10.1111/j.2042-3306.2012.00571.x; Olsen E, 2012, SENSORS-BASEL, V12, P8145, DOI 10.3390/s120608145; Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595; Pratt W. K., 2007, DIGITAL IMAGE PROCES, P277; Rhodin M, 2016, EQUINE VET J, V48, P315, DOI 10.1111/evj.12446; Robilliard JJ, 2007, J EXP BIOL, V210, P187, DOI 10.1242/jeb.02611; Sapone M, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20102983; Braganca FSM, 2021, EQUINE VET J, V53, P600, DOI 10.1111/evj.13344; Tijssen M, 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0233266, 10.1371/journal.pone.0233266.r001, 10.1371/journal.pone.0233266.r002, 10.1371/journal.pone.0233266.r003, 10.1371/journal.pone.0233266.r004]; Weishaupt MA, 2006, VET J, V171, P135, DOI 10.1016/j.tvjl.2004.09.004; Willemen MA, 1999, EQUINE VET J, V31, P25, DOI 10.1111/j.2042-3306.1999.tb03787.x; Willemen MA, 1997, LIVEST PROD SCI, V52, P145, DOI 10.1016/S0301-6226(97)00130-9; Witte TH, 2004, J EXP BIOL, V207, P3639, DOI 10.1242/jeb.01182	28	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254813	10.1371/journal.pone.0254813	http://dx.doi.org/10.1371/journal.pone.0254813			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310630	Green Accepted, Green Published, gold			2022-12-26	WOS:000685224500051
J	Senoo, N; Akahori, T; Ichida, H; Miyoshi, N; Morita, A; Shimizu, T; Shindou, H; Miura, S				Senoo, Nanami; Akahori, Takumi; Ichida, Hiyori; Miyoshi, Noriyuki; Morita, Akihito; Shimizu, Takao; Shindou, Hideo; Miura, Shinji			Fasting increases 18:2-containing phosphatidylcholines to complement the decrease in 22:6-containing phosphatidylcholines in mouse skeletal muscle	PLOS ONE			English	Article							FATTY-ACID COMPOSITION; INCORPORATING DOCOSAHEXAENOIC ACID; PHOSPHOLIPIDS; PROFILE	Fasting stimulates catabolic reactions in skeletal muscle to survive nutrient deprivation. Cellular phospholipids have large structural diversity due to various polar-heads and acyl-chains that affect many cellular functions. Skeletal muscle phospholipid profiles have been suggested to be associated with muscle adaptations to nutritional and environmental status. However, the effect of fasting on skeletal muscle phospholipid profiles remains unknown. Here, we analyzed phospholipids using liquid chromatography mass spectrometry. We determined that fasting resulted in a decrease in 22:6-containing phosphatidylcholines (PCs) (22:6-PCs) and an increase in 18:2-containing PCs (18:2-PCs). The fasting-induced increase in 18:2-PCs was sufficient to complement 22:6-PCs loss, resulting in the maintenance of the total amount of polyunsaturated fatty acid (PUFA)-containing PCs. Similar phospholipid alterations occurred in insulin-deficient mice, which indicate that these observed phospholipid perturbations were characteristic of catabolic skeletal muscle. In lysophosphatidic acid acyltransferase 3-knockout muscles that mostly lack 22:6-PCs, other PUFA-containing PCs, mainly 18:2-PCs, accumulated. This suggests a compensatory mechanism for skeletal muscles to maintain PUFA-containing PCs.	[Senoo, Nanami; Akahori, Takumi; Ichida, Hiyori; Morita, Akihito; Miura, Shinji] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutr Biochem, Suruga Ku, Shizuoka, Japan; [Miyoshi, Noriyuki] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Biochem Lab, Suruga Ku, Shizuoka, Japan; [Shimizu, Takao; Shindou, Hideo] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Shinjuku Ku, Tokyo, Japan; [Shindou, Hideo] Univ Tokyo, Grad Sch Med, Dept Lipid Sci, Bunkyo Ku, Tokyo, Japan; [Senoo, Nanami] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	University of Shizuoka; University of Shizuoka; National Center for Global Health & Medicine - Japan; University of Tokyo; Johns Hopkins University	Miura, S (corresponding author), Univ Shizuoka, Grad Sch Nutr & Environm Sci, Lab Nutr Biochem, Suruga Ku, Shizuoka, Japan.	miura@u-shizuoka-ken.ac.jp	Miura, Shinji/K-6516-2013	Miura, Shinji/0000-0001-8806-9763; Miyoshi, Noriyuki/0000-0002-4233-4282	Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP) [14533567]; "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO), Grants-in-Aid for Scientific Research (KAKENHI) [26282184, 26560400, 21300240]; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo); Uehara Memorial Foundation (Tokyo, Japan); Kao Research Council for the Study of Healthcare Science (Tokyo, Japan) [A-31006]; Tojuro Iijima Foundation for Food Science and Technology (Chiba, Japan); University of Shizuoka Grant for Scientific and Educational Research; JSPS Fellows [17J11322]; Sasakawa Scientific Research Grant from The Japan Science Society; AMED-CREST [JP20gm0910011]	Council for Science, Technology and Innovation (CSTI); Cross-ministerial Strategic Innovation Promotion Program (SIP); "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO), Grants-in-Aid for Scientific Research (KAKENHI); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation (Tokyo, Japan)(Uehara Memorial Foundation); Kao Research Council for the Study of Healthcare Science (Tokyo, Japan); Tojuro Iijima Foundation for Food Science and Technology (Chiba, Japan); University of Shizuoka Grant for Scientific and Educational Research; JSPS Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sasakawa Scientific Research Grant from The Japan Science Society; AMED-CREST	This work was supported by the Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP, No.14533567), "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO), Grants-in-Aid for Scientific Research (KAKENHI, No. 26282184, 26560400, 21300240) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo), The Uehara Memorial Foundation (Tokyo, Japan), The Kao Research Council for the Study of Healthcare Science (Tokyo, Japan, No. A-31006), The Tojuro Iijima Foundation for Food Science and Technology (Chiba, Japan), and a University of Shizuoka Grant for Scientific and Educational Research (to SM). This work was also supported by a Grant-in-Aid for JSPS Fellows (No. 17J11322) and the Sasakawa Scientific Research Grant from The Japan Science Society (to NS). This work was supported by AMED-CREST (No. JP20gm0910011 to HS).	Akagi S, 2016, FASEB J, V30, P2027, DOI 10.1096/fj.201500149; Andersson A, 2000, AM J PHYSIOL-ENDOC M, V279, pE744, DOI 10.1152/ajpendo.2000.279.4.E744; Andersson A, 2002, AM J CLIN NUTR, V76, P1222, DOI 10.1093/ajcn/76.6.1222; Antonny B, 2015, TRENDS CELL BIOL, V25, P427, DOI 10.1016/j.tcb.2015.03.004; Bilodeau PA, 2016, AM J PHYSIOL-CELL PH, V311, pC392, DOI 10.1152/ajpcell.00125.2016; Caires R, 2017, CELL REP, V21, P246, DOI 10.1016/j.celrep.2017.09.029; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; COPPACK SW, 1994, J LIPID RES, V35, P177; CROSET M, 1989, ANN NUTR METAB, V33, P125, DOI 10.1159/000177530; Eto M, 2020, BIOCHEM BIOPH RES CO, V526, P246, DOI 10.1016/j.bbrc.2020.03.074; Eto M, 2014, BIOCHEM BIOPH RES CO, V443, P718, DOI 10.1016/j.bbrc.2013.12.043; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Goto-Inoue N, 2019, RAPID COMMUN MASS SP, V33, P185, DOI 10.1002/rcm.8319; Goto-Inoue N, 2013, SCI REP-UK, V3, DOI 10.1038/srep03267; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Helge JW, 2001, J APPL PHYSIOL, V90, P670, DOI 10.1063/1.1380406; Helge JW, 1999, J NUTR, V129, P1636, DOI 10.1093/jn/129.9.1636; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hoppeler H, 2016, J EXP BIOL, V219, P205, DOI 10.1242/jeb.128207; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Iizuka-Hishikawa Y, 2017, J BIOL CHEM, V292, P12065, DOI [10.1074/jbc.M117.791277, 10.1074/jbc.m117.791277]; Inoue M, 2017, J NUTR BIOCHEM, V50, P83, DOI 10.1016/j.jnutbio.2017.08.018; Kamei Y, 2003, FEBS LETT, V536, P232, DOI 10.1016/S0014-5793(03)00062-0; Matravadia S, 2014, AM J PHYSIOL-ENDOC M, V307, pE102, DOI 10.1152/ajpendo.00032.2014; McGlory C, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00144; Mitchell DC, 2001, J BIOL CHEM, V276, P42801, DOI 10.1074/jbc.M105772200; Montgomery MK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14214-1; Naoe S, 2019, METABOLITES, V9, DOI 10.3390/metabo9100241; Nealon JR, 2008, EXP EYE RES, V87, P502, DOI 10.1016/j.exer.2008.08.009; Niu SL, 2004, J BIOL CHEM, V279, P31098, DOI 10.1074/jbc.M404376200; Oemer G, 2020, CELL REP, V30, P4281, DOI 10.1016/j.celrep.2020.02.115; Owen AJ, 2004, LIPIDS, V39, P955, DOI 10.1007/s11745-004-1317-0; Park WJ, 2018, POLYUNSATURATED FATTY ACID METABOLISM, P87, DOI 10.1016/B978-0-12-811230-4.00005-3; Payet LA, 2013, TRAFFIC, V14, P1257, DOI 10.1111/tra.12117; Perez-Palacios T, 2007, J AGR FOOD CHEM, V55, P6191, DOI 10.1021/jf071354d; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Polozova A, 2007, J MOL NEUROSCI, V33, P56, DOI 10.1007/s12031-007-0039-y; Saltiel AR, 2016, HANDB EXP PHARMACOL, V233, P51, DOI 10.1007/164_2015_14; Senoo N, 2020, MUSCLE NERVE, V62, P413, DOI 10.1002/mus.26993; Senoo N, 2015, J LIPID RES, V56, P2286, DOI 10.1194/jlr.M060533; Shindou H, 2017, J BIOL CHEM, V292, P12054, DOI [10.1074/jbc.M117.790568, 10.1074/jbc.m117.790568]; Tanihata J, 2018, BIOCHEM BIOPH RES CO, V505, P51, DOI 10.1016/j.bbrc.2018.09.039; Tuazon MA, 2012, METABOLISM, V61, P801, DOI 10.1016/j.metabol.2011.10.019; Vainshtein A, 2014, J MOL MED, V92, P127, DOI 10.1007/s00109-013-1096-z; Yost TJ, 1998, AM J CLIN NUTR, V68, P296, DOI 10.1093/ajcn/68.2.296	47	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255178	10.1371/journal.pone.0255178	http://dx.doi.org/10.1371/journal.pone.0255178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310656	Green Published, gold			2022-12-26	WOS:000685224500005
J	Wu, S; Zou, JL				Wu, Shuang; Zou, Jialing			Does market segmentation hinder interregional CO2 flow in China? - Evidence from China's interprovincial MRIO table	PLOS ONE			English	Article							INTERNATIONAL-TRADE; GRAVITY EQUATION; CARBON; TRANSFERS; GROWTH	China is the key player in the globalization era and is eliminating its intra-national trade barrier. This process will affect interprovincial CO2 flows. This study recalculates interprovincial CO2 flows in China by using the latest MRIO table and applies a gravity model to assess how market segmentation affects interprovincial CO2 flows. Results show that the total volume of interprovincial embodied CO2 flow did not increase excessively from 2007 to 2012, but the pattern of embodied CO2 flow had changed a lot. Market segmentation significantly decreased the interprovincial embodied CO2 flows in China and within its sub-regions. At interregional level, market segmentation's negative effect was significant between Central and Western China. Other variables such as geographical distance showed a significant negative impact on interprovincial embodied CO2 flow in China. On the basis of our results, we raise some relevant policies to deal with the environmental inequality caused by the decrease in market segmentation.	[Wu, Shuang] Guangdong Univ Foreign Studies, Res Inst Guangdong Hong Kong Macau Greater Bay, Guangzhou, Peoples R China; [Wu, Shuang] Beijing Normal Univ, Hong Kong Baptist Univ, United Int Coll, Div Human & Social Sci, Zhuhai, Peoples R China; [Zou, Jialing] Guangdong Univ Foreign Studies, Guangdong Inst Int Strategies, Guangzhou, Peoples R China	Guangdong University of Foreign Studies; Beijing Normal University; Beijing Normal University - Hong Kong Baptist University United International College; Hong Kong Baptist University; Guangdong University of Foreign Studies	Zou, JL (corresponding author), Guangdong Univ Foreign Studies, Guangdong Inst Int Strategies, Guangzhou, Peoples R China.	202010012@oamails.gdufs.edu.cn			Youth Innovative Talents Project in Guangdong Universities [2020WQNCX016]; National Key Research and Development Program of China [2016YFA0602804]; National Natural Science Foundation of China [41571518]	Youth Innovative Talents Project in Guangdong Universities; National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the Youth Innovative Talents Project in Guangdong Universities(grants No.2020WQNCX016), the National Key Research and Development Program of China(2016YFA0602804), and the National Natural Science Foundation of China (grants No. No.41571518).	Anderson JE, 2003, AM ECON REV, V93, P170, DOI 10.1257/000282803321455214; BERGSTRAND JH, 1989, REV ECON STAT, V71, P143, DOI 10.2307/1928061; Chen SQ, 2015, APPL ENERG, V138, P99, DOI 10.1016/j.apenergy.2014.10.055; Duan CC, 2018, APPL ENERG, V227, P342, DOI 10.1016/j.apenergy.2018.01.028; Duarte R, 2018, ECON SYST RES, V30, P545, DOI 10.1080/09535314.2018.1450226; Fan X., 2017, ECON RES-EKON ISTRAZ, V52, P20; Fath BD, 1999, ECOSYSTEMS, V2, P167, DOI 10.1007/s100219900067; Feenstra RC, 2001, CAN J ECON, V34, P430, DOI 10.1111/0008-4085.00082; Feng KS, 2013, P NATL ACAD SCI USA, V110, P11654, DOI 10.1073/pnas.1219918110; Filimonau V, 2011, J CLEAN PROD, V19, P1917, DOI 10.1016/j.jclepro.2011.07.002; He WJ, 2018, ENERG ECON, V74, P263, DOI 10.1016/j.eneco.2018.06.010; Li YL, 2018, J CLEAN PROD, V172, P1336, DOI 10.1016/j.jclepro.2017.10.191; Liu LC, 2015, J CLEAN PROD, V103, P384, DOI 10.1016/j.jclepro.2014.07.009; Lu Y, 2015, ENVIRON SCI TECHNOL, V49, P7254, DOI 10.1021/es5056758; Ma X., 2008, CONT EC RES CONT EC RES, P30; Ma ZY, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms15378, 10.1038/s41467-017-01820-w]; National Geomatics Center of China, STAND MAP SERV STAND MAP SERV; Odeh NA, 2008, ENERG POLICY, V36, P367, DOI 10.1016/j.enpol.2007.09.026; Park HC, 2007, ENERG POLICY, V35, P2839, DOI 10.1016/j.enpol.2006.10.002; Parsley D.C., 2001, NBER WORKING PAPER S; Parsley DC, 1996, Q J ECON, V111, P1211, DOI 10.2307/2946713; Peters GP, 2011, P NATL ACAD SCI USA, V108, P8903, DOI 10.1073/pnas.1006388108; Poncet S., 2005, REV INT ECON, V13, P409, DOI [DOI 10.1111/J.1467-9396.2005.00514.X, 10.1111/j.1467-9396.2005.00514.x]; Steininger KW, 2016, NAT CLIM CHANGE, V6, P35, DOI 10.1038/NCLIMATE2867; Ulanowicz RE, 2004, COMPUT BIOL CHEM, V28, P321, DOI 10.1016/j.compbiolchem.2004.09.001; Wang H, 2017, ENERG POLICY, V107, P585, DOI 10.1016/j.enpol.2017.05.034; Wang ZH, 2018, J CLEAN PROD, V194, P12, DOI 10.1016/j.jclepro.2018.05.018; Zhang B, 2016, APPL ENERG, V184, P1093, DOI 10.1016/j.apenergy.2015.09.076	28	1	1	9	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255518	10.1371/journal.pone.0255518	http://dx.doi.org/10.1371/journal.pone.0255518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TT3IC	34339470	gold, Green Published			2022-12-26	WOS:000680243400014
J	Almubarak, A; Lavy, R; Srnic, N; Hu, YW; Maripuri, DP; Kume, T; Berry, FB				Almubarak, Asra; Lavy, Rotem; Srnic, Nikola; Hu, Yawen; Maripuri, Devi Priyanka; Kume, Tsutomo; Berry, Fred B.			Loss of Foxc1 and Foxc2 function in chondroprogenitor cells disrupts endochondral ossification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE DIFFERENTIATION; SOX9; GROWTH; SKELETAL; EXPRESSION; MUTATIONS; PROLIFERATION; GENERATION; INDUCTION; DYSPLASIA	Endochondral ossification initiates the growth of the majority of the mammalian skeleton and is tightly controlled through gene regulatory networks. The forkhead box transcription factors Foxc1 and Foxc2 regulate aspects of osteoblast function in the formation of the skeleton, but their roles in chondrocytes to control endochondral ossification are less clear. Here, we demonstrate that Foxc1 expression is directly regulated by the activity of SRY (sex-determining region Y)-box 9, one of the earliest transcription factors to specify the chondrocyte lineage. Moreover, we demonstrate that elevated expression of Foxc1 promotes chondrocyte differentiation in mouse embryonic stem cells and loss of Foxc1 function inhibits chondrogenesis in vitro. Using chondrocyte-targeted deletion of Foxc1 and Foxc2 in mice, we reveal a role for these factors in chondrocyte differentiation in vivo. Loss of both Foxc1 and Foxc2 caused a general skeletal dysplasia predominantly affecting the vertebral column. The long bones of the limbs were smaller, mineralization was reduced, and organization of the growth plate was disrupted; in particular, the stacked columnar organization of the proliferative chondrocyte layer was reduced in size and cell proliferation was decreased. Differential gene expression analysis indicated disrupted expression patterns of chondrogenesis and ossification genes throughout the entire process of endochondral ossification in chondrocyte-specific Foxc1/Foxc2 KO embryos. Our results suggest that Foxc1 and Foxc2 are required for normal chondrocyte differentiation and function, as loss of both genes results in disorganization of the growth plate, reduced chondrocyte proliferation, and delays in chondrocyte hypertrophy that prevents ossification of the skeleton.	[Almubarak, Asra; Hu, Yawen; Maripuri, Devi Priyanka; Berry, Fred B.] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Lavy, Rotem; Srnic, Nikola; Berry, Fred B.] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Kume, Tsutomo] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc & Renal Res Inst, Dept Med, Chicago, IL 60611 USA	University of Alberta; University of Alberta; Northwestern University; Feinberg School of Medicine	Berry, FB (corresponding author), Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.; Berry, FB (corresponding author), Univ Alberta, Dept Surg, Edmonton, AB, Canada.	fberry@ualberta.ca		Srnic, Nikola/0000-0003-0539-7046	Natural Sciences and Engineering Research Council of Canada [RGPIN-2019-05085]; Women and Children's Health Research Institute; Edmonton Civic Employees Charitable Trust; Gilbert K. Winter Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Women and Children's Health Research Institute; Edmonton Civic Employees Charitable Trust; Gilbert K. Winter Fund	This research was supported by grants awarded to F. B. B. from the Natural Sciences and Engineering Research Council of Canada (RGPIN-2019-05085), the Women and Children's Health Research Institute, the Edmonton Civic Employees Charitable Trust, and the Gilbert K. Winter Fund.	Aghajanian P, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0021-z; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Berendsen AD, 2015, BONE, V80, P14, DOI 10.1016/j.bone.2015.04.035; Berry FB, 2005, HUM MOL GENET, V14, P2619, DOI 10.1093/hmg/ddi295; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Caddy JC, 2020, J CELL BIOCHEM, V121, P3266, DOI 10.1002/jcb.29595; Correa-Cerro LS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00167; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; Geister KA, 2015, ANNU REV GENOM HUM G, V16, P199, DOI 10.1146/annurev-genom-090314-045904; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Hiemisch H, 1998, MECH DEVELOP, V73, P129, DOI 10.1016/S0925-4773(98)00039-2; Hong HK, 1999, HUM MOL GENET, V8, P625, DOI 10.1093/hmg/8.4.625; Hopkins A, 2017, MOL CANCER RES, V15, P1341, DOI 10.1158/1541-7786.MCR-17-0185; Hopkins A, 2016, J CELL BIOCHEM, V117, P1707, DOI 10.1002/jcb.25464; Karamboulas K, 2010, J CELL SCI, V123, P2067, DOI 10.1242/jcs.062901; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Liu CF, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.164459; Liu CF, 2017, SEMIN CELL DEV BIOL, V62, P34, DOI 10.1016/j.semcdb.2016.10.004; Mizuhashi K, 2019, J BONE MINER RES, V34, P1387, DOI 10.1002/jbmr.3719; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Ohba S, 2015, CELL REP, V12, P229, DOI 10.1016/j.celrep.2015.06.013; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Rigueur D, 2014, METHODS MOL BIOL, V1130, P113, DOI 10.1007/978-1-62703-989-5_9; Sasman A, 2012, GENESIS, V50, P766, DOI 10.1002/dvg.22036; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Shih HP, 2015, CELL REP, V13, P326, DOI 10.1016/j.celrep.2015.08.082; Tang L, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-0232-1; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Winnier GE, 1997, GENE DEV, V11, P926, DOI 10.1101/gad.11.7.926; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Yoshida M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7653	42	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101020	10.1016/j.jbc.2021.101020	http://dx.doi.org/10.1016/j.jbc.2021.101020			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	34331943	Green Submitted, Green Published, gold			2022-12-26	WOS:000706361700002
J	Haviland, ZK; Nong, DG; Kuntz, KLV; Starr, TJ; Ma, DB; Tien, M; Anderson, CT; Hancock, WO				Haviland, Zachary K.; Nong, Daguan; Kuntz, Kate L. Vasquez; Starr, Thomas J.; Ma, Dengbo; Tien, Ming; Anderson, Charles T.; Hancock, William O.			Nanoscale dynamics of cellulose digestion by the cellobiohydrolase TrCel7A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE IMAGING ANALYSIS; MOVEMENT; BINDING; STATE; DISSOCIATION; PROCESSIVITY; HYDROLYSIS; CELLULASES; KINETICS; DOMAINS	Understanding the mechanism by which cellulases from bacteria, fungi, and protozoans catalyze the digestion of lignocellulose is important for developing cost-effective strategies for bioethanol production. Cel7A from the fungus Trichoderma reesei is a model exoglucanase that degrades cellulose strands from their reducing ends by processively cleaving individual cellobiose units. Despite being one of the most studied cellulases, the binding and hydrolysis mechanisms of Cel7A are still debated. Here, we used single-molecule tracking to analyze the dynamics of 11,116 quantum dot-labeled TrCel7A molecules binding to and moving processively along immobilized cellulose. Individual enzyme molecules were localized with a spatial precision of a few nanometers and followed for hundreds of seconds. Most enzyme molecules bound to cellulose in a static state and dissociated without detectable movement, whereas a minority of molecules moved processively for an average distance of 39 nm at an average speed of 3.2 nm/s. These data were integrated into a three-state model in which TrCel7A molecules can bind from solution into either static or processive states and can reversibly switch between states before dissociating. From these results, we conclude that the rate-limiting step for cellulose degradation by Cel7A is the transition out of the static state, either by dissociation from the cellulose surface or by initiation of a processive run. Thus, accelerating the transition of Cel7A out of its static state is a potential avenue for improving cellulase efficiency.	[Haviland, Zachary K.; Nong, Daguan; Hancock, William O.] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA; [Kuntz, Kate L. Vasquez; Starr, Thomas J.; Anderson, Charles T.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Ma, Dengbo; Tien, Ming] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hancock, WO (corresponding author), Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA.	woh1@psu.edu	Hancock, William/E-7653-2016	Hancock, William/0000-0001-5547-8755; Anderson, Charles/0000-0001-7481-3571	Department of Energy Office of Science [DE-SC0019065, DE-SC0019364]	Department of Energy Office of Science(United States Department of Energy (DOE))	The authors thank Dannielle Gibson for technical assistance, Scott Pflumm for work in establishing the single-molecule assays, and Haw Yang for support. The authors also thank the Penn State CSL Behring Fermentation Facility-University Park, PA for assistance with cellulose preparation. This work was supported by the Department of Energy Office of Science grant number DE-SC0019065 and DE-SC0019364.	Asztalos A, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-55; Bae SO, 2005, APPL MICROBIOL BIOT, V67, P45, DOI 10.1007/s00253-004-1723-2; Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; Berg, 2018, RANDOM WALKS BIOL; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Brady SK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10149; Carpita NC, 2020, J BIOL CHEM, V295, P15144, DOI 10.1074/jbc.REV120.014561; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; DONER LW, 1992, ANAL BIOCHEM, V202, P50, DOI 10.1016/0003-2697(92)90204-K; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; DUCHESNE LC, 1989, BIOSCIENCE, V39, P238, DOI 10.2307/1311160; Fersht A., 1999, STRUCTURE MECH PROTE; Harris D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002897; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jeoh T, 2017, BIOTECHNOL BIOENG, V114, P1369, DOI 10.1002/bit.26277; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kongruang S, 2004, APPL BIOCHEM BIOTECH, V113, P213, DOI 10.1385/ABAB:113:1-3:213; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Kuusk S, 2015, J BIOL CHEM, V290, P11678, DOI 10.1074/jbc.M114.635631; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Mahamdeh M, 2018, J MICROSC-OXFORD, V272, P60, DOI 10.1111/jmi.12744; Mudinoor AR, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-1649-7; Murphy L, 2012, J BIOL CHEM, V287, P1252, DOI 10.1074/jbc.M111.276485; Nakamura A, 2016, J BIOL CHEM, V291, P22404, DOI 10.1074/jbc.M116.752048; Nong DG, 2021, BIOMED OPT EXPRESS, V12, P3253, DOI 10.1364/BOE.423798; Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10; Peri S, 2007, BIOTECHNOL PROGR, V23, P626, DOI 10.1021/bp060322s; Rojel N, 2020, J BIOL CHEM, V295, P1454, DOI 10.1074/jbc.RA119.011420; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Shang BZ, 2013, J BIOL CHEM, V288, P29081, DOI 10.1074/jbc.M113.497412; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; Simmert S, 2018, OPT EXPRESS, V26, P14499, DOI 10.1364/OE.26.014499; Vermaas JV, 2019, P NATL ACAD SCI USA, V116, P23061, DOI 10.1073/pnas.1913398116; Woody MS, 2016, BIOPHYS J, V111, P273, DOI 10.1016/j.bpj.2016.06.019	40	0	0	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101029	10.1016/j.jbc.2021.101029	http://dx.doi.org/10.1016/j.jbc.2021.101029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34339742	gold, Green Published			2022-12-26	WOS:000706408900001
J	Leon-Abarca, JA; Portmann-Baracco, A; Bryce-Alberti, M; Ruiz-Sanchez, C; Accinelli, RA; Soliz, J; Gonzales, GF				Leon-Abarca, Juan Alonso; Portmann-Baracco, Arianna; Bryce-Alberti, Mayte; Ruiz-Sanchez, Carlos; Accinelli, Roberto Alfonso; Soliz, Jorge; Gonzales, Gustavo Francisco			Diabetes increases the risk of COVID-19 in an altitude dependent manner: An analysis of 1,280,806 Mexican patients	PLOS ONE			English	Article							ULTRAVIOLET GERMICIDAL IRRADIATION; BODY-MASS INDEX; GLUCOSE-TRANSPORT; SARS CORONAVIRUS; SKELETAL-MUSCLE; CHRONIC HYPOXIA; SEA-LEVEL; INFLUENZA; POPULATION; MORTALITY	Aims The objective of this study is to analyze how the impact of Diabetes Mellitus [DM] in patients with COVID-19 varies according to altitudinal gradient. Methods We obtained 1,280,806 records from adult patients with COVID-19 and DM to analyze the probability of COVID-19, development of COVID-19 pneumonia, hospitalization, intubation, admission to the Intensive Care Unit [ICU] and case-fatality rates [CFR]. Variables were controlled by age, sex and altitude of residence to calculate adjusted prevalence and prevalence ratios. Results Patients with DM had a 21.8% higher prevalence of COVID-19 and an additional 120.2% higher prevalence of COVID-19 pneumonia. The adjusted prevalence was also higher for these outcomes as well as for hospitalization, intubation and ICU admission. COVID-19 and pneumonia patients with DM had a 97.0% and 19.4% higher CFR, respectively. With increasing altitudes, the probability of being a confirmed COVID-19 case and the development of pneumonia decreased along CFR for patients with and without DM. However, COVID-19 patients with DM were more likely to require intubation when residing at high altitude. Conclusions The study suggests that patients with DM have a higher probability of being a confirmed COVID-19 case and developing pneumonia. Higher altitude had a protective relationship against SARS-CoV-2 infection; however, it may be associated with more severe cases in patients with and without DM. High altitude decreases CFR for all COVID-19 patients. Our work also shows that women are less affected than men regardless of altitude.	[Leon-Abarca, Juan Alonso; Portmann-Baracco, Arianna; Bryce-Alberti, Mayte; Ruiz-Sanchez, Carlos; Accinelli, Roberto Alfonso; Gonzales, Gustavo Francisco] Univ Peruana Cayetano Heredia, Inst Invest Altura, Lima, Peru; [Leon-Abarca, Juan Alonso; Portmann-Baracco, Arianna; Bryce-Alberti, Mayte; Ruiz-Sanchez, Carlos; Accinelli, Roberto Alfonso] Univ Peruana Cayetano Heredia, Fac Med Albero Hurtado, Lima, Peru; [Accinelli, Roberto Alfonso] Hosp Cayetano Heredia, Serv Neumol, Lima, Peru; [Soliz, Jorge] Univ Laval, Inst Univ Cardiol & Pneumol Quebec IUCPQ, Fac Med, Laval, PQ, Canada; [Soliz, Jorge] High Altitude Pulm & Pathol Inst HAPPI IPPA, La Paz, Bolivia; [Gonzales, Gustavo Francisco] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Alberto Cazorla Talleri, Lab Invest & Desarrollo LID, Lima, Peru; [Accinelli, Roberto Alfonso] Av Honorio Delgado, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Laval University; Universidad Peruana Cayetano Heredia	Accinelli, RA (corresponding author), Univ Peruana Cayetano Heredia, Inst Invest Altura, Lima, Peru.; Accinelli, RA (corresponding author), Univ Peruana Cayetano Heredia, Fac Med Albero Hurtado, Lima, Peru.; Accinelli, RA (corresponding author), Hosp Cayetano Heredia, Serv Neumol, Lima, Peru.	roberto.accinelli@upch.pe	Soliz, Jorge/AAA-9752-2022	Soliz, Jorge/0000-0002-2335-5862; Leon-Abarca, Juan Alonso/0000-0001-6018-5666; Portmann, Arianna/0000-0003-3489-3751; Bryce-Alberti, Mayte/0000-0002-2396-4860; Accinelli, Roberto/0000-0002-9773-8778				Agren D, 2020, LANCET, V396, P807, DOI 10.1016/S0140-6736(20)31955-3; Accinelli RA, 2020, ARCH BRONCONEUMOL, V56, P760, DOI 10.1016/j.arbres.2020.06.015; Allard R, 2010, DIABETES CARE, V33, P1491, DOI 10.2337/dc09-2215; [Anonymous], 1979, ARCH I BIOL ANDINA; [Anonymous], 2021, SCI REP-UK; Arias-Reyes C, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0237294; Arias-Reyes C, 2020, RESP PHYSIOL NEUROBI, V277, DOI 10.1016/j.resp.2020.103443; AZEVEDO JL, 1995, DIABETES, V44, P695, DOI 10.2337/diabetes.44.6.695; Badawi A, 2016, INT J INFECT DIS, V49, P129, DOI 10.1016/j.ijid.2016.06.015; BERRY LJ, 1955, P SOC EXP BIOL MED, V88, P543; Beumer MC, 2019, J CRIT CARE, V50, P59, DOI 10.1016/j.jcrc.2018.11.013; Bornstein SR, 2020, NAT REV ENDOCRINOL, V16, P297, DOI 10.1038/s41574-020-0353-9; Brufsky A, 2020, J MED VIROL, V92, P770, DOI 10.1002/jmv.25887; CALDERON R, 1965, DIABETES, V14, P100, DOI 10.2337/diab.14.2.100; Cano-P&Atilde;&copy;rez E, 2020, AM J TROP MED HYG, V103, P2347, DOI 10.4269/ajtmh.20-1027; CARTEE GD, 1991, J APPL PHYSIOL, V70, P1593, DOI 10.1152/jappl.1991.70.4.1593; Castillo O, 2007, HIGH ALT MED BIOL, V8, P307, DOI 10.1089/ham.2007.8407; Dang ZC, 2020, J ETHNOPHARMACOL, V250, DOI 10.1016/j.jep.2019.112470; Duennwald T, 2013, DIABETES CARE, V36, P2183, DOI 10.2337/dc12-2113; Esenamanova MK, 2014, HIGH ALT MED BIOL, V15, P412, DOI 10.1089/ham.2013.1150; Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015; Gorman S, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.616527; Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319; Huang I, 2020, DIABETES METAB SYND, V14, P395, DOI 10.1016/j.dsx.2020.04.018; Hulme KD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00861; Hussain A, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108142; Intimayta-Escalante C, 2020, HIGH ALT MED BIOL, V21, P426, DOI 10.1089/ham.2020.0133; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Lecoultre V, 2013, DIABETES CARE, V36, pE197, DOI 10.2337/dc13-1350; Li S, 2019, DIABETES METAB J, V43, P319, DOI 10.4093/dmj.2018.0060; Lin EM, 2020, HIGH ALT MED BIOL, V21, P431, DOI 10.1089/ham.2020.0168; Lindgarde F, 2004, HIGH ALT MED BIOL, V5, P27, DOI 10.1089/152702904322963663; Luzi L, 2020, ACTA DIABETOL, V57, P759, DOI 10.1007/s00592-020-01522-8; Merrill RM, 2020, J OBES, V2020, DOI 10.1155/2020/1946723; Millet GP, 2021, PHYSIOL REP, V8, DOI 10.14814/phy2.14615; Moldobaeva MS, 2017, HIGH ALT MED BIOL, V18, P428, DOI 10.1089/ham.2017.0036; Muniyappa R, 2020, AM J PHYSIOL-ENDOC M, V318, pE736, DOI 10.1152/ajpendo.00124.2020; Ortiz-Prado E, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0008958; Ou CQ, 2019, CLIN CHARACTERISTICS, V382, DOI 10.1056/NEJMoa2002032; Paralikar Swapnil J, 2010, Indian J Occup Environ Med, V14, P6, DOI 10.4103/0019-5278.64608; PICONREATEGUI E, 1963, J CLIN ENDOCR METAB, V23, P1256, DOI 10.1210/jcem-23-12-1256; PICONREATEGUI E, 1966, J APPL PHYSIOL, V21, P1177, DOI 10.1152/jappl.1966.21.4.1177; Pitocco D, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.109923; Quevedo-Ramirez A, 2020, RESP PHYSIOL NEUROBI, V281, DOI 10.1016/j.resp.2020.103512; Rao ST, 2020, DIABETES CARE, V43, P1416, DOI 10.2337/dc20-0643; Reynolds TH, 1997, AM J PHYSIOL-ENDOC M, V272, pE320, DOI 10.1152/ajpendo.1997.272.2.E320; Santos JL, 2001, NUTRITION, V17, P305, DOI 10.1016/S0899-9007(00)00551-7; Seclen S, 1999, ACTA MED PERU, V17, P8; Seclen SN, 2020, DIABETES RES CLIN PR, V169, DOI 10.1016/j.diabres.2020.108463; Secretaria de Salud, 2020, DAT AB DIR GEN EP; Segovia-Juarez J, 2020, RESP PHYSIOL NEUROBI, V281, DOI 10.1016/j.resp.2020.103494; SINGH I, 1977, INT J BIOMETEOROL, V21, P93, DOI 10.1007/BF01553705; Stephens KE, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245055; Thomson TM, 2021, HIGH ALT MED BIOL, V22, P209, DOI 10.1089/ham.2020.0202; Tinoco YO, 2017, CLIN INFECT DIS, V65, P1532, DOI 10.1093/cid/cix565; Walker CM, 2007, ENVIRON SCI TECHNOL, V41, P5460, DOI 10.1021/es070056u; Woolcott OO, 2014, OBESITY, V22, P2080, DOI 10.1002/oby.20800; Wu Y, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.139051; Xia Y, 1997, AM J PHYSIOL-REG I, V273, pR1734, DOI 10.1152/ajpregu.1997.273.5.R1734; Xu P, 2003, ATMOS ENVIRON, V37, P405, DOI 10.1016/S1352-2310(02)00825-7; Xu SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129966; Yan YL, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001343; Yang JK, 2006, DIABETIC MED, V23, P623, DOI 10.1111/j.1464-5491.2006.01861.x; Yang JC, 2021, IEEE T INTELL TRANSP, V22, P3742, DOI 10.1109/TITS.2020.3023788; Yang JK, 2010, ACTA DIABETOL, V47, P193, DOI 10.1007/s00592-009-0109-4; Yang Min Kyu, 2021, Curr Eye Res, V46, P954, DOI 10.1080/02713683.2020.1857781; Yaxmehen Bello-Chavolla Omar, 2020, Journal of Clinical Endocrinology & Metabolism, V105, P2752, DOI 10.1210/clinem/dgaa346; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zhang RF, 2009, AM J PHYSIOL-LUNG C, V297, pL631, DOI 10.1152/ajplung.90415.2008; Zhao F, 2020, CLIN RES CARDIOL, V382, P1861	70	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255144	10.1371/journal.pone.0255144	http://dx.doi.org/10.1371/journal.pone.0255144			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343179	gold, Green Published			2022-12-26	WOS:000685264200046
J	Smith, EM; Mondragon, A				Smith, Eric M.; Mondragon, Alfonso			Basic residues at the C-gate of DNA gyrase are involved in DNA supercoiling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II; CRYSTAL-STRUCTURE; STRAND PASSAGE; MECHANISM; TRANSPORT; BINDING; ROLES; STEP	DNA gyrase is a type II topoisomerase that is responsible for maintaining the topological state of bacterial and some archaeal genomes. It uses an ATP-dependent two-gate strand passage mechanism that is shared among all type II topoisomerases. During this process, DNA gyrase creates a transient break in the DNA, the G-segment, to form a cleavage complex. This allows a second DNA duplex, known as the T segment, to pass through the broken G-segment. After the broken strand is religated, the T-segment is able to exit out of the enzyme through a gate called the C-gate. Although many steps of the type II topoisomerase mechanism have been studied extensively, many questions remain about how the T segment ultimately exits out of the C-gate. A recent cryo-EM structure of Streptococcus pneumoniae GyrA shows a putative T-segment in close proximity to the C-gate, suggesting that residues in this region may be important for coordinating DNA exit from the enzyme. Here, we show through site-directed mutagenesis and biochemical characterization that three conserved basic residues in the C-gate of DNA gyrase are important for DNA supercoiling activity, but not for ATPase or cleavage activity. Together with the structural information previously published, our data suggest a model in which these residues cluster to form a positively charged region that facilitates T-segment passage into the cavity formed between the DNA gate and C-gate.	[Smith, Eric M.; Mondragon, Alfonso] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Mondragon, A (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu		Smith, Eric/0000-0002-5385-4558; Mondragon, Alfonso/0000-0002-0423-6323	NIH [R35GM118108]; American Cancer Society Postdoctoral Fellowship [134255-PF-20-041-01-DMC]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Fellowship(American Cancer Society)	This work was supported by the NIH Grant R35GM118108 (to A. M.) and an American Cancer Society Postdoctoral Fellowship (134255-PF-20-041-01-DMC) (to E. M. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker NM, 2011, NUCLEIC ACIDS RES, V39, P755, DOI 10.1093/nar/gkq799; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Chen SF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05406-y; Corbett KD, 2007, NAT STRUCT MOL BIOL, V14, P611, DOI 10.1038/nsmb1264; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Fisher L. Mark, 2008, V142, P11, DOI 10.1007/978-1-59745-246-5_2; Gibson EG, 2019, ACS INFECT DIS, V5, P570, DOI 10.1021/acsinfecdis.8b00315; Hearnshaw SJ, 2014, J MOL BIOL, V426, P2023, DOI 10.1016/j.jmb.2014.02.017; Hevener KE, 2018, ACTA PHARM SIN B, V8, P844, DOI 10.1016/j.apsb.2018.07.008; Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414; Lanz MA, 2012, NUCLEIC ACIDS RES, V40, P10893, DOI 10.1093/nar/gks852; Lanz MA, 2011, NUCLEIC ACIDS RES, V39, P9681, DOI 10.1093/nar/gkr680; Laponogov I., 2016, PROTEIN DATA BANK; Lindsley J E, 2001, Methods Mol Biol, V95, P57; MIZUUCHI K, 1978, P NATL ACAD SCI USA, V75, P5960, DOI 10.1073/pnas.75.12.5960; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Olland S, 1999, J BIOL CHEM, V274, P21688, DOI 10.1074/jbc.274.31.21688; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; ROCA J, 1993, J BIOL CHEM, V268, P14250; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROCA J, 1994, CELL, V77, P609, DOI 10.1016/0092-8674(94)90222-4; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Rudolph MG, 2013, J MOL BIOL, V425, P2632, DOI 10.1016/j.jmb.2013.04.010; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Soczek KM, 2018, ELIFE, V7, DOI 10.7554/eLife.41215; Stelljes JT, 2018, NUCLEIC ACIDS RES, V46, P6773, DOI 10.1093/nar/gky470; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wendorff TJ, 2012, J MOL BIOL, V424, P109, DOI 10.1016/j.jmb.2012.07.014; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0	33	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							101000	10.1016/j.jbc.2021.101000	http://dx.doi.org/10.1016/j.jbc.2021.101000			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34303706	gold, Green Published			2022-12-26	WOS:000690868100012
J	Chen, T				Chen, Tuo			Seismic response analysis of loess site under far-field bedrock ground motion of the Wenchuan earthquake	PLOS ONE			English	Article							1999 CHI-CHI; SIMULATION	In this paper, considering the far-field seismic input, an accelerogram recorded in the bedrock at Wuquan Mountain in Lanzhou city during the 2008 Wenchuan Ms8.0 earthquake was selected, and numerical dynamic analyses were conducted. The one-dimensional equivalent linear method was implemented to estimate the ground motion effects in the loess regions. Thereafter, slope topographic effects on ground motion were studied by applying the dynamic finite-element method. The results revealed the relationship between the PGA amplification coefficients and the soil layer thickness, which confirmed that the dynamic response of the sites had obvious nonlinear characteristics. The results also showed that there was an obvious difference in the dynamic magnification factor between the short-period and long-period structures. Moreover, it was found that the amplification coefficient of the observation point at the free surface was greater than the point inside the soil at the same depth, which mainly occurred in the upper slope. Through this study, the quantitative assessment of ground motion effects in loess regions can be approximately estimated, and the amplification mechanism of the far-field ground motion mechanism can be further explained. In addition to the refraction and reflection theory of seismic waves, the resonance phenomenon may help explain the slope topographic effect through spectrum analysis.	[Chen, Tuo] China Univ Min & Technol, State Key Lab GeoMech & Deep Underground Engn, Sch Mech & Civil Engn, Xuzhou, Jiangsu, Peoples R China	China University of Mining & Technology	Chen, T (corresponding author), China Univ Min & Technol, State Key Lab GeoMech & Deep Underground Engn, Sch Mech & Civil Engn, Xuzhou, Jiangsu, Peoples R China.	lzchentuo@163.com			National Natural Science Foundation of China [41701058]; Open Fund of State Key Laboratory of Frozen Soil Engineering [SKLFSE201606]; China Postdoctoral Science Foundation [2015M570490]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of State Key Laboratory of Frozen Soil Engineering; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	National Natural Science Foundation of China (No. 41701058), the Open Fund of State Key Laboratory of Frozen Soil Engineering (Grant No. SKLFSE201606), and the China Postdoctoral Science Foundation(Grant No.2015M570490).	Arslan H, 2010, B ENG GEOL ENVIRON, V69, P287, DOI 10.1007/s10064-009-0254-6; BECK JL, 1986, GEOPHYS RES LETT, V13, P593, DOI 10.1029/GL013i006p00593; Boore DM, 2001, B SEISMOL SOC AM, V91, P1212, DOI 10.1785/0120000733; Che AL, 2006, ROCK SOIL MECH, V27, P1293; Cheng Y, 2017, J VIBROENG, V19, P5191, DOI 10.21595/jve.2017.18006; DERBYSHIRE E, 1988, ENG GEOL, V25, P135, DOI 10.1016/0013-7952(88)90024-5; Furumura T, 2002, PURE APPL GEOPHYS, V159, P2133, DOI 10.1007/s00024-002-8727-6; Glinsky N, 2019, SOIL DYN EARTHQ ENG, V116, P620, DOI 10.1016/j.soildyn.2018.10.020; Hartzell S, 2014, B SEISMOL SOC AM, V104, P451, DOI 10.1785/0120130088; IWAN WD, 1995, 10TH EUROPEAN CONFERENCE ON EARTHQUAKE ENGINEERING, PROCEEDINGS, VOLS 1-4, P229; Jousset P, 2007, EARTHQ ENG STRUCT D, V36, P949, DOI 10.1002/eqe.666; Koketsu K, 2008, J SEISMOL, V12, P133, DOI 10.1007/s10950-007-9080-0; Kuhlemeyer R. L., 1973, J SOIL MECH FDN DIV, V99, P421, DOI 10.1061/JSFEAQ.0001885; Li X.J., 1989, SEISMIC MICROZONATIO, P250; Li XJ, 2008, EARTHQ ENG ENG VIB, V7, P235, DOI 10.1007/s11803-008-0892-x; Maeda T, 2008, J SEISMOL, V12, P243, DOI 10.1007/s10950-007-9076-9; Pandey B, 2016, NAT HAZARDS, V81, P1073, DOI 10.1007/s11069-015-2120-0; Song BH, 2017, SOIL DYN EARTHQ ENG, V95, P96, DOI 10.1016/j.soildyn.2017.01.041; Stewart JP, 2002, SOIL DYN EARTHQ ENG, V22, P765, DOI 10.1016/S0267-7261(02)00097-0; Tran TT, 2018, SOILS FOUND, V58, P1339, DOI 10.1016/j.sandf.2018.07.006; Wang L.M., 2010, J ARCHITECTURE CIVIL, V32, P175; Wang LM, 2017, J MT SCI-ENGL, V14, P1185, DOI 10.1007/s11629-016-3921-7; [王志杰 Wang Zhijie], 2010, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V32, P1464; Wu ZJ, 2013, J CENT SOUTH UNIV, V20, P2333, DOI 10.1007/s11771-013-1741-2; Zhang ZZ., 1999, FORECAST SEISMIC DIS; 石玉成, 1999, [西北地震学报, Northwestern Seismological Journal], V21, P203	26	0	0	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0254871	10.1371/journal.pone.0254871	http://dx.doi.org/10.1371/journal.pone.0254871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329313	gold, Green Published			2022-12-26	WOS:000685248600023
J	Streicher, SA; Lim, U; Park, SL; Li, YQ; Sheng, X; Hom, V; Xia, L; Pooler, L; Shepherd, J; Loo, LWM; Darst, BF; Highland, HM; Polfus, LM; Bogumil, D; Ernst, T; Buchthal, S; Franke, AA; Setiawan, VW; Tiirikainen, M; Wilkens, LR; Haiman, CA; Stram, DO; Cheng, I; Le Marchand, L				Streicher, Samantha A.; Lim, Unhee; Park, S. Lani; Li, Yuqing; Sheng, Xin; Hom, Victor; Xia, Lucy; Pooler, Loreall; Shepherd, John; Loo, Lenora W. M.; Darst, Burcu F.; Highland, Heather M.; Polfus, Linda M.; Bogumil, David; Ernst, Thomas; Buchthal, Steven; Franke, Adrian A.; Setiawan, Veronica Wendy; Tiirikainen, Maarit; Wilkens, Lynne R.; Haiman, Christopher A.; Stram, Daniel O.; Cheng, Iona; Le Marchand, Loic			Genome-wide association study of pancreatic fat: The Multiethnic Cohort Adiposity Phenotype Study	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; BETA-CELL FUNCTION; GLUCOSE; STRATIFICATION; ACCUMULATION; METAANALYSIS; DISEASE; WEIGHT; PLASMA; PDX1	Several studies have found associations between higher pancreatic fat content and adverse health outcomes, such as diabetes and the metabolic syndrome, but investigations into the genetic contributions to pancreatic fat are limited. This genome-wide association study, comprised of 804 participants with MRI-assessed pancreatic fat measurements, was conducted in the ethnically diverse Multiethnic Cohort-Adiposity Phenotype Study (MEC-APS). Two genetic variants reaching genome-wide significance, rs73449607 on chromosome 13q21.2 (Beta = -0.67, P = 4.50x10(-8)) and rs7996760 on chromosome 6q14 (Beta = -0.90, P = 4.91x10(-8)) were associated with percent pancreatic fat on the log scale. Rs73449607 was most common in the African American population (13%) and rs79967607 was most common in the European American population (6%). Rs73449607 was also associated with lower risk of type 2 diabetes (OR = 0.95, 95% CI = 0.89-1.00, P = 0.047) in the Population Architecture Genomics and Epidemiology (PAGE) Study and the DIAbetes Genetics Replication and Meta-analysis (DIAGRAM), which included substantial numbers of non-European ancestry participants (53,102 cases and 193,679 controls). Rs73449607 is located in an intergenic region between GSX1 and PLUTO, and rs79967607 is in intron 1 of EPM2A. PLUTO, a lncRNA, regulates transcription of an adjacent gene, PDX1, that controls beta-cell function in the mature pancreas, and EPM2A encodes the protein laforin, which plays a critical role in regulating glycogen production. If validated, these variants may suggest a genetic component for pancreatic fat and a common etiologic link between pancreatic fat and type 2 diabetes.	[Streicher, Samantha A.; Lim, Unhee; Park, S. Lani; Shepherd, John; Loo, Lenora W. M.; Buchthal, Steven; Franke, Adrian A.; Tiirikainen, Maarit; Wilkens, Lynne R.; Le Marchand, Loic] Univ Hawaii Manoa, Univ Hawaii, Canc Ctr, Honolulu, HI 96822 USA; [Li, Yuqing; Cheng, Iona] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA; [Sheng, Xin; Hom, Victor; Xia, Lucy; Pooler, Loreall; Darst, Burcu F.; Polfus, Linda M.; Bogumil, David; Setiawan, Veronica Wendy; Haiman, Christopher A.; Stram, Daniel O.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Ctr Genet Epidemiol, Los Angeles, CA 90007 USA; [Highland, Heather M.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Ernst, Thomas] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii Manoa; University of California System; University of California San Francisco; University of Southern California; University of North Carolina; University of North Carolina Chapel Hill; University System of Maryland; University of Maryland Baltimore	Streicher, SA (corresponding author), Univ Hawaii Manoa, Univ Hawaii, Canc Ctr, Honolulu, HI 96822 USA.	Sstreicher@cc.hawaii.edu	Tirikainen, M/B-6954-2012; Bogumil, David/GVU-1340-2022; Lim, Unhee/AEA-8591-2022; Shepherd, John/S-3146-2018	Tirikainen, M/0000-0002-8124-3818; Lim, Unhee/0000-0001-6221-7190; Shepherd, John/0000-0003-2280-2541; Pooler, Loreall/0000-0001-5388-6640	U.S. National Institutes of Health (NIH); National Cancer Institute (NCI) for the Adiposity Phenotype Study [P01 CA168530]; NCI [P30 CA071789]; National Center for Advancing Translational Science, NIH [UL1TR000130]; National Human Genome Research Institute (NHGRI); National Institute on Minority Health and Health Disparities (NIMHD) [U01HG007416, U01HG007417, U01HG007397, U01HG007376, U01HG007419]; NHLBI training grants [U01HG007419, T32 HL007055, T32 HL129982, 1-19-PDF045, R01HL142825, U01HG004801]; CIDR/University of Washington; Center for Inherited Disease Research (CIDR); National Institutes of Health [HHSN268201200008I]; CIDR; National Science Foundation MRI [1920304]	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI) for the Adiposity Phenotype Study; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Science, NIH; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NHLBI training grants; CIDR/University of Washington; Center for Inherited Disease Research (CIDR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIDR; National Science Foundation MRI(National Science Foundation (NSF))	This work was supported by the U.S. National Institutes of Health (NIH), National Cancer Institute (NCI) for the Adiposity Phenotype Study (P01 CA168530 to L.L.M.) and Multiethnic Cohort Study (U01 CA164973 to L.L.M., L.R.W., and C.A. H.); NCI (P30 CA071789 to University of Hawaii Cancer Center Shared Resources for Biostatistics, Analytical Biochemistry, Genomics, and Nutrition Support services); and the National Center for Advancing Translational Science, NIH, for recruitment activities at USC (UL1TR000130 to Southern California Clinical and Translational Science Institute) (www.nih.gov and www.cancer.gov).The Population Architecture Using Genomics and Epidemiology (PAGE) program is funded by the National Human Genome Research Institute (NHGRI) with co-funding from the National Institute on Minority Health and Health Disparities (NIMHD), supported by U01HG007416 (CALiCo), U01HG007417 (ISMMS), U01HG007397 (MEC), U01HG007376 (WHI), and U01HG007419 (Coordinating Center). The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the NIH (www.genome.gov and www.nimhd.nih.gov).H.M.H.was funded by NHLBI training grants (T32 HL007055, T32 HL129982) ADA Grant #1-19-PDF045, and R01HL142825 (www.nhlbi.nih.gov and www.diabetes.org).PAGE Coordinating Center: Assistance with data management, data integration, data dissemination, genotype imputation, ancestry deconvolution, population genetics, analysis pipelines, and general study coordination was provided by the PAGE Coordinating Center (U01HG007419, U01HG004801)(www.nih.gov).CIDR/University of Washington for the PAGE's MEGA genotype data: Genotyping services were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268201200008I. Genotype data quality control and quality assurance services were provided by the Genetic Analysis Center in the Biostatistics Department of the University of Washington, through support provided by the CIDR contract (www.nih.gov).The technical support and advanced computing resources from University of Hawaii Information Technology Services - Cyberinfrastructure, funded in part by the National Science Foundation MRI award #1920304, are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Montano P, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040393; Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; Akerman I, 2017, CELL METAB, V25, P400, DOI 10.1016/j.cmet.2016.11.016; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bien SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167758; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Chouhan MD, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20180941; Ding EL, 2009, NEW ENGL J MED, V361, P1152, DOI 10.1056/NEJMoa0804381; Dite P, 2020, DIGEST DIS, V38, P143, DOI 10.1159/000505366; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ellingwood SS, 2018, J ENDOCRINOL, V238, pR131, DOI 10.1530/JOE-18-0120; Fridlyand LE, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00129; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Gentry MS, 2013, FEBS J, V280, P525, DOI 10.1111/j.1742-4658.2012.08549.x; Gerst F, 2019, MOL METAB, V25, P1, DOI 10.1016/j.molmet.2019.05.001; Hannukainen JC, 2011, J HEPATOL, V54, P545, DOI 10.1016/j.jhep.2010.07.029; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Kanai M, 2018, NAT GENET, V50, P390, DOI 10.1038/s41588-018-0047-6; Kato S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224921; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Le KA, 2011, DIABETES CARE, V34, P485, DOI 10.2337/dc10-0760; Le Marchand L, 2020, CANCER EPIDEM BIOMAR, V29, P966, DOI 10.1158/1055-9965.EPI-19-1469; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Lim U, 2019, GASTROENTEROLOGY, V156, P966, DOI 10.1053/j.gastro.2018.11.021; Liu Y., 2020, SYSTEMATIC QUANTIFIC; MacDonald RJ, 2010, PROG MOL BIOL TRANSL, V97, P1, DOI 10.1016/B978-0-12-385233-5.00001-5; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Medina-Gomez C, 2015, EUR J EPIDEMIOL, V30, P317, DOI 10.1007/s10654-015-9998-4; Mojiminiyi OA, 2010, CLIN CHEM LAB MED, V48, P1629, DOI 10.1515/CCLM.2010.303; Nagy R, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0414-4; Ogilvie RF, 1933, J PATHOL BACTERIOL, V37, P473, DOI 10.1002/path.1700370314; Park SL, 2020, HEPATOL COMMUN, V4, P1112, DOI 10.1002/hep4.1533; Peila R, 2020, CANCER EPIDEM BIOMAR, V29, P1832, DOI 10.1158/1055-9965.EPI-20-0246; Peng H, 2019, CLIN PROTEOM, V16, DOI 10.1186/s12014-019-9251-3; Polfus LM, 2021, HUM GENET GENOM ADV, V2, DOI 10.1016/j.xhgg.2021.100029; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Sakai NS, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20180267; Schaefer JH, 1926, ANAT REC, V32, P119, DOI 10.1002/ar.1090320204; Scott RV, 2018, PEPTIDES, V100, P36, DOI 10.1016/j.peptides.2017.11.013; Shepherd JA, 2017, BONE, V104, P101, DOI 10.1016/j.bone.2017.06.010; Singh PK, 2012, MOL CELL BIOL, V32, P652, DOI 10.1128/MCB.06353-11; Singh RG, 2017, METABOLISM, V69, P1, DOI 10.1016/j.metabol.2016.12.012; Smits MM, 2011, NAT REV GASTRO HEPAT, V8, P169, DOI 10.1038/nrgastro.2011.4; Steven S, 2016, DIABETES CARE, V39, P158, DOI 10.2337/dc15-0750; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Szczepaniak LS, 2012, DIABETES CARE, V35, P2377, DOI 10.2337/dc12-0701; Taylor R, 2013, DIABETES CARE, V36, P1047, DOI 10.2337/dc12-1805; Turnbull J, 2016, EPILEPTIC DISORD, V18, pS38; Wang HS, 2010, HUM GENET, V128, P165, DOI 10.1007/s00439-010-0841-4; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wojcik GL, 2019, NATURE, V570, P514, DOI 10.1038/s41586-019-1310-4; Wolpin BM, 2014, NAT GENET, V46, P994, DOI 10.1038/ng.3052; Yu TY, 2017, J DIABETES INVEST, V8, P735, DOI 10.1111/jdi.12665	60	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0249615	10.1371/journal.pone.0249615	http://dx.doi.org/10.1371/journal.pone.0249615			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329319	gold, Green Submitted, Green Published			2022-12-26	WOS:000685248600018
J	Kuroda, R; Tominaga, K; Kasashima, K; Kuroiwa, K; Sakashita, E; Hayakawa, H; Kouki, T; Ohno, N; Kawai, K; Endo, H				Kuroda, Rintaro; Tominaga, Kaoru; Kasashima, Katsumi; Kuroiwa, Kenji; Sakashita, Eiji; Hayakawa, Hiroko; Kouki, Tom; Ohno, Nobuhiko; Kawai, Kensuke; Endo, Hitoshi			Loss of mitochondrial transcription factor A in neural stem cells leads to immature brain development and triggers the activation of the integral stress response in vivo	PLOS ONE			English	Article							NEURONAL MIGRATION; KNOCKOUT MICE; DNA; DYNAMICS; NEUROGENESIS; METABOLISM; EXPRESSION; REGULATOR; DIFFERENTIATION; PROLIFERATION	Mitochondrial dysfunction is significantly associated with neurological deficits and age-related neurological diseases. While mitochondria are dynamically regulated and properly maintained during neurogenesis, the manner in which mitochondrial activities are controlled and contribute to these processes is not fully understood. Mitochondrial transcription factor A (TFAM) contributes to mitochondrial function by maintaining mitochondrial DNA (mtDNA). To clarify how mitochondrial dysfunction affects neurogenesis, we induced mitochondrial dysfunction specifically in murine neural stem cells (NSCs) by inactivating Tfam. Tfam inactivation in NSCs resulted in mitochondrial dysfunction by reducing respiratory chain activities and causing a severe deficit in neural differentiation and maturation both in vivo and in vitro. Brain tissue from Tfam-deficient mice exhibited neuronal cell death primarily at layer V and microglia were activated prior to cell death. Cultured Tfam-deficient NSCs showed a reduction in reactive oxygen species produced by the mitochondria. Tfam inactivation during neurogenesis resulted in the accumulation of ATF4 and activation of target gene expression. Therefore, we propose that the integrated stress response (ISR) induced by mitochondrial dysfunction in neurogenesis is activated to protect the progression of neurodegenerative diseases.	[Kuroda, Rintaro; Tominaga, Kaoru; Kasashima, Katsumi; Kuroiwa, Kenji; Sakashita, Eiji; Endo, Hitoshi] Jichi Med Univ, Dept Biochem, Shimotsuke, Tochigi, Japan; [Kuroda, Rintaro; Kawai, Kensuke] Jichi Med Univ, Dept Neurosurg, Shimotsuke, Tochigi, Japan; [Hayakawa, Hiroko] Jichi Med Univ, Core Ctr Res Apparat, Shimotsuke, Tochigi, Japan; [Kouki, Tom; Ohno, Nobuhiko] Jichi Med Univ, Dept Anat, Shimotsuke, Tochigi, Japan; [Ohno, Nobuhiko] Natl Inst Physiol Sci, Div Ultrastruct Res, Okazaki, Aichi, Japan	Jichi Medical University; Jichi Medical University; Jichi Medical University; Jichi Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Tominaga, K; Endo, H (corresponding author), Jichi Med Univ, Dept Biochem, Shimotsuke, Tochigi, Japan.	tominaga@jichi.ac.jp; hendo@jichi.ac.jp		Tominaga, Kaoru/0000-0001-8799-528X	JMU Graduate Student Research Award; Japan Society for the Promotion of Sciences [17K08497, 17K11248, 20K07576]	JMU Graduate Student Research Award; Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a JMU Graduate Student Research Award (to R.K.) and the Japan Society for the Promotion of Sciences Grant-in-Aid for Scientific Research (KAKENHI) Grant 17K08497 (to K.T.) and 17K11248 and 20K07576 (to H.E.).	Agnew T, 2018, CELL REP, V25, P3315, DOI 10.1016/j.celrep.2018.11.080; Agostini M, 2016, CELL DEATH DIFFER, V23, P1502, DOI 10.1038/cdd.2016.36; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Augustyniak J, 2017, TOXICOL IN VITRO, V45, P434, DOI 10.1016/j.tiv.2017.05.017; Augustyniak J, 2017, BIOGERONTOLOGY, V18, P665, DOI 10.1007/s10522-017-9718-4; Augustyniak J, 2019, MOL NEUROBIOL, V56, P4346, DOI 10.1007/s12035-018-1368-2; Baker K, 1998, J PHARMACOL EXP THER, V284, P215; Bartesaghi S, 2015, P NATL ACAD SCI USA, V112, P1059, DOI 10.1073/pnas.1413165112; Chakrabarty RP, 2021, CELL STEM CELL, V28, P394, DOI 10.1016/j.stem.2021.02.011; Chen MZ, 2011, STEM CELL RES, V7, P75, DOI 10.1016/j.scr.2011.04.002; Chen M, 2009, J NEUROSCI RES, V87, P1522, DOI 10.1002/jnr.21976; Fessler E, 2020, NATURE, V579, P433, DOI 10.1038/s41586-020-2076-4; Filograna R, 2021, FEBS LETT, V595, P976, DOI 10.1002/1873-3468.14021; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Girardin SE, 2021, FEBS J, V288, P3094, DOI 10.1111/febs.15553; Guo XY, 2020, NATURE, V579, P427, DOI 10.1038/s41586-020-2078-2; Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402; Hamanaka RB, 2016, CELL REP, V15, P451, DOI 10.1016/j.celrep.2016.03.044; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Hopfner KP, 2020, NAT REV MOL CELL BIO, V21, P501, DOI 10.1038/s41580-020-0244-x; Hu M., 2020, J CLIN INVEST, DOI [10.1172/JCI139333, DOI 10.1172/JCI139333]; Iwata R, 2020, SCIENCE, V369, P858, DOI 10.1126/science.aba9760; Kang I, 2018, FEBS LETT, V592, P793, DOI 10.1002/1873-3468.12989; Kasashima K, 2015, GENES CELLS, V20, P1017, DOI 10.1111/gtc.12306; Kasashima K, 2011, EXP CELL RES, V317, P210, DOI 10.1016/j.yexcr.2010.10.008; Khacho M, 2018, DEV DYNAM, V247, P47, DOI 10.1002/dvdy.24538; Khacho M, 2016, CELL STEM CELL, V19, P232, DOI 10.1016/j.stem.2016.04.015; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Knobloch M, 2017, CURR OPIN NEUROBIOL, V42, P45, DOI 10.1016/j.conb.2016.11.006; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee P, 2020, NAT REV MOL CELL BIO, V21, P268, DOI 10.1038/s41580-020-0227-y; Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467; Maffezzini C, 2020, CELL MOL LIFE SCI, V77, P2483, DOI 10.1007/s00018-019-03430-9; Martinez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3; Mukhtar T, 2018, J EXP NEUROSCI, V12, DOI 10.1177/1179069518759332; Namba T, 2021, NEURON, V109, P408, DOI 10.1016/j.neuron.2020.11.014; Ng MYW, 2021, DEV CELL, V56, P881, DOI 10.1016/j.devcel.2021.02.009; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Ohtsuka T, 2019, SEMIN CELL DEV BIOL, V95, P4, DOI 10.1016/j.semcdb.2019.01.007; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Paridaen JTML, 2014, EMBO REP, V15, P351, DOI 10.1002/embr.201438447; Pereira RO, 2017, EMBO J, V36, P2126, DOI 10.15252/embj.201696179; Perez-Trevino P, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165761; Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Restelli LM, 2018, CELL REP, V24, P1407, DOI 10.1016/j.celrep.2018.07.023; Ribeiro MF, 2019, MOL NEUROBIOL, V56, P3922, DOI 10.1007/s12035-018-1342-z; Shintani T, 2012, J NEUROSCI, V32, P6468, DOI 10.1523/JNEUROSCI.0590-12.2012; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Sorensen L, 2001, J NEUROSCI, V21, P8082, DOI 10.1523/JNEUROSCI.21-20-08082.2001; Sorrentino V, 2018, ANNU REV PHARMACOL, V58, P353, DOI 10.1146/annurev-pharmtox-010716-104908; Sumitani M, 2017, GENE, V608, P103, DOI 10.1016/j.gene.2016.12.021; Timper K, 2020, CELL METAB, V31, P1189, DOI 10.1016/j.cmet.2020.05.001; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vasan K, 2020, CELL METAB, V32, P341, DOI 10.1016/j.cmet.2020.06.019; Wang CR, 2017, J CELL BIOL, V216, P2581, DOI 10.1083/jcb.201609093; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Weidling I, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020039; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Wu Z, 2019, NAT METAB, V1, P1209, DOI 10.1038/s42255-019-0150-8; Zheng X., 2016, ELIFE, V5, P859, DOI [10.7554/eLife.13374, DOI 10.7554/ELIFE.13374]	64	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0255355	10.1371/journal.pone.0255355	http://dx.doi.org/10.1371/journal.pone.0255355			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320035	Green Published, gold			2022-12-26	WOS:000685247800025
J	Flinspach, AN; Booke, H; Zacharowski, K; Balaban, U; Herrmann, E; Adam, EH				Flinspach, Armin Niklas; Booke, Hendrik; Zacharowski, Kai; Balaban, Uemniye; Herrmann, Eva; Adam, Elisabeth Hannah			High sedation needs of critically ill COVID-19 ARDS patients-A monocentric observational study	PLOS ONE			English	Article							TERM SEDATION; MIDAZOLAM; CARE; CLONIDINE; DEXMEDETOMIDINE; PROPOFOL; DELIRIUM; ADULTS; IMPACT; TIME	Background Therapy of severely affected coronavirus patient, requiring intubation and sedation is still challenging. Recently, difficulties in sedating these patients have been discussed. This study aims to describe sedation practices in patients with 2019 coronavirus disease (COVID-19)-induced acute respiratory distress syndrome (ARDS). Methods We performed a retrospective monocentric analysis of sedation regimens in critically ill intubated patients with respiratory failure who required sedation in our mixed 32-bed university intensive care unit. All mechanically ventilated adults with COVID-19-induced ARDS requiring continuously infused sedative therapy admitted between April 4, 2020, and June 30, 2020 were included. We recorded demographic data, sedative dosages, prone positioning, sedation levels and duration. Descriptive data analysis was performed; for additional analysis, a logistic regression with mixed effect was used. Results In total, 56 patients (mean age 67 (+/- 14) years) were included. The mean observed sedation period was 224 (+/- 139) hours. To achieve the prescribed sedation level, we observed the need for two or three sedatives in 48.7% and 12.8% of the cases, respectively. In cases with a triple sedation regimen, the combination of clonidine, esketamine and midazolam was observed in most cases (75.7%). Analgesia was achieved using sufentanil in 98.6% of the cases. The analysis showed that the majority of COVID-19 patients required an unusually high sedation dose compared to those available in the literature. Conclusion The global pandemic continues to affect patients severely requiring ventilation and sedation, but optimal sedation strategies are still lacking. The findings of our observation suggest unusual high dosages of sedatives in mechanically ventilated patients with COVID-19. Prescribed sedation levels appear to be achievable only with several combinations of sedatives in most critically ill patients suffering from COVID-19-induced ARDS and a potential association to the often required sophisticated critical care including prone positioning and ECMO treatment seems conceivable.	[Flinspach, Armin Niklas; Booke, Hendrik; Zacharowski, Kai; Adam, Elisabeth Hannah] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Anaesthesiol Intens Care Med & Pain Therapy, Hessen, Germany; [Balaban, Uemniye; Herrmann, Eva] Goethe Univ Frankfurt, Dept Biostat & Math Modelling, Hessen, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Flinspach, AN (corresponding author), Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Anaesthesiol Intens Care Med & Pain Therapy, Hessen, Germany.	armin.flinspach@kgu.de	Flinspach, Armin/ABH-8128-2020	Flinspach, Armin/0000-0003-2886-8947				Alhazzani W., 2020, INTENS CARE MED, V46, P854, DOI [DOI 10.1007/s00134-020-06022-5, 10.1007/s00134-020-06022-5]; [Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; Balas MC, 2014, CRIT CARE MED, V42, P1024, DOI 10.1097/CCM.0000000000000129; Baron R., 2015, GMS German Medical Science, V13, pDoc19; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Boldrini M, 2021, JAMA PSYCHIAT, V78, P682, DOI 10.1001/jamapsychiatry.2021.0500; Bourenne J, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.07.19; CARRASCO G, 1993, CHEST, V103, P557, DOI 10.1378/chest.103.2.557; Chamorro C, 1996, CRIT CARE MED, V24, P932, DOI 10.1097/00003246-199606000-00010; Chanques G, 2020, INTENS CARE MED, V46, P2342, DOI 10.1007/s00134-020-06307-9; Cruickshank M, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20250; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Farasatinasab M, 2015, IRAN J PHARM RES, V14, P167; Flinspach Armin Niklas, 2020, Crit Care Explor, V2, pe0256, DOI 10.1097/CCE.0000000000000256; Gattinoni L, 2015, INTENS CARE MED, V41, P2201, DOI 10.1007/s00134-015-4040-6; Gill KV, 2012, ANN PHARMACOTHER, V46, P1331, DOI 10.1345/aph.1R037; Guerin C, 2015, PRONE POSITIONING NE, DOI [10.1007/s00134-015-3918-7, DOI 10.1007/S00134-015-3918-7]; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Ha MA, 2017, PHARMACOTHERAPY, V37, P221, DOI 10.1002/phar.1882; Hanaoka K, 2002, CRIT CARE MED, V30, P1256, DOI 10.1097/00003246-200206000-00016; Hanidziar D, 2020, ANESTH ANALG, V131, pE40, DOI 10.1213/ANE.0000000000004887; Hayden JC, 2019, PEDIATR ANESTH, V29, P1002, DOI 10.1111/pan.13715; Hraiech S, 2012, CURR OPIN CRIT CARE, V18, P495, DOI 10.1097/MCC.0b013e328357efe1; Kapp CM, 2020, ANESTH ANALG, V131, pE198, DOI 10.1213/ANE.0000000000005131; Kluge S, 2020, MED KLIN-INTENSIVMED, V115, P111, DOI 10.1007/s00063-020-00689-w; Lim ZJ, 2021, AM J RESP CRIT CARE, V203, P54, DOI 10.1164/rccm.202006-2405OC; Manasco AT, 2020, J CRIT CARE, V56, P80, DOI 10.1016/j.jcrc.2019.12.004; Marini JJ, 2020, JAMA-J AM MED ASSOC, V323, P2329, DOI 10.1001/jama.2020.6825; Murias G, 2013, MINERVA ANESTESIOL, V79, P434; Nasraway SA, 2002, CRIT CARE MED, V30, P117, DOI 10.1097/00003246-200201000-00019; Nouchi A, 2021, EUR J CLIN MICROBIOL, V40, P691, DOI 10.1007/s10096-020-04056-7; Pinheiro J., 2021, NLME LINEAR NONLINEA; Putensen C, 2001, AM J RESP CRIT CARE, V164, P43, DOI 10.1164/ajrccm.164.1.2001078; Reese JM, 2018, MIL MED, V183, pE409, DOI 10.1093/milmed/usy121; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rubino AS, 2010, INTERACT CARDIOV TH, V10, P58, DOI 10.1510/icvts.2009.217562; Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259; Shah FA, 2017, CURR OPIN CRIT CARE, V23, P45, DOI 10.1097/MCC.0000000000000382; Srivastava U, 2014, INDIAN J CRIT CARE M, V18, P431, DOI 10.4103/0972-5229.136071; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Wang JG, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1610-8; Wongtangman K, 2021, CRIT CARE MED, V49, P1524, DOI 10.1097/CCM.0000000000005053; Yoshida T, 2017, AM J RESP CRIT CARE, V195, P985, DOI 10.1164/rccm.201604-0748CP; Ziehr DR, 2020, AM J RESP CRIT CARE, V201, P1560, DOI 10.1164/rccm.202004-1163LE; Zuppa AF, 2019, CRIT CARE MED, V47, pE301, DOI 10.1097/CCM.0000000000003638	45	11	11	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0253778	10.1371/journal.pone.0253778	http://dx.doi.org/10.1371/journal.pone.0253778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314422	Green Published, gold			2022-12-26	WOS:000685225200016
J	Rajagopalan, N; Venkateswaran, N; Josephraj, AN; Srithaladevi, E				Rajagopalan, Nithya; Venkateswaran, N.; Josephraj, Alex Noel; Srithaladevi, E.			Diagnosis of retinal disorders from Optical Coherence Tomography images using CNN	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; AUTOMATED DETECTION; LAYER SEGMENTATION; CLASSIFICATION; GLAUCOMA	An efficient automatic decision support system for detection of retinal disorders is important and is the need of the hour. Optical Coherence Tomography (OCT) is the current imaging modality for the early detection of retinal disorders non-invasively. In this work, a Convolution Neural Network (CNN) model is proposed to classify three types of retinal disorders namely: Choroidal neovascularization (CNV), Drusen macular degeneration (DMD) and Diabetic macular edema (DME). The hyperparameters of the model like batch size, number of epochs, dropout rate, and the type of optimizer are tuned using random search optimization method for better performance to classify different retinal disorders. The proposed architecture provides an accuracy of 97.01%, sensitivity of 93.43%, and 98.07% specificity and it outperformed other existing models, when compared. The proposed model can be used for the large-scale screening of retinal disorders effectively.	[Rajagopalan, Nithya; Srithaladevi, E.] Sri Sivasubramaniya Nadar Coll Engn, Dept Biomed Engn, Chennai, Tamil Nadu, India; [Venkateswaran, N.] Sri Sivasubramaniya Nadar Coll Engn, Dept Elect & Commun Engn, Chennai, Tamil Nadu, India; [Josephraj, Alex Noel] Shantou Univ, Coll Engn, Dept Elect Engn, Shantou, Peoples R China	SSN College of Engineering; SSN College of Engineering; Shantou University	Rajagopalan, N (corresponding author), Sri Sivasubramaniya Nadar Coll Engn, Dept Biomed Engn, Chennai, Tamil Nadu, India.	nithyar@ssn.edu.in						Abramoff MD, 2016, INVEST OPHTH VIS SCI, V57, P5200, DOI 10.1167/iovs.16-19964; Ahmed E, 2015, PROC CVPR IEEE, P3908, DOI 10.1109/CVPR.2015.7299016; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Asaoka R, 2016, OPHTHALMOLOGY, V123, P1974, DOI 10.1016/j.ophtha.2016.05.029; Bergstra J, 2012, J MACH LEARN RES, V13, P281; GeethaRamani R, 2016, BIOCYBERN BIOMED ENG, V36, P102, DOI 10.1016/j.bbe.2015.06.004; Geng L, 2019, COMPUT ASSIST SURG, V24, P27, DOI 10.1080/24699322.2019.1649071; Golebiewska J, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/3048013; Grassmann F, 2018, OPHTHALMOLOGY, V125, P1410, DOI 10.1016/j.ophtha.2018.02.037; Grm K, 2018, IET BIOMETRICS, V7, P81, DOI 10.1049/iet-bmt.2017.0083; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hassan T, 2015, IEEE CONF IMAGING SY, P100; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kuwayama S, 2019, J OPHTHALMOL, V2019, DOI 10.1155/2019/6319581; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; Lang A, 2013, BIOMED OPT EXPRESS, V4, P1133, DOI 10.1364/BOE.4.001133; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lee CS, 2017, OPHTHALMOL RETINA, V1, P322, DOI 10.1016/j.oret.2016.12.009; Lee R, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0026-2; Mao JF, 2018, SYST SCI CONTROL ENG, V6, P57, DOI 10.1080/21642583.2018.1446056; Motamedi S, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01117; Nugroho KA, 2018, 2018 2ND INTERNATIONAL CONFERENCE ON INFORMATICS AND COMPUTATIONAL SCIENCES (ICICOS), P141; Oh SL, 2020, NEURAL COMPUT APPL, V32, P10927, DOI 10.1007/s00521-018-3689-5; Perdomo O, 2018, I S BIOMED IMAGING, P1423; Rajathi V, 2019, IMAGING SCI J, V67, P374, DOI 10.1080/13682199.2019.1663083; Samagaio G, 2018, COMPUT METH PROG BIO, V163, P47, DOI 10.1016/j.cmpb.2018.05.033; Schlegl T, 2018, OPHTHALMOLOGY, V125, P549, DOI 10.1016/j.ophtha.2017.10.031; Schmidt-Erfurth U, 2018, PROG RETIN EYE RES, V67, P1, DOI 10.1016/j.preteyeres.2018.07.004; Seth S, 2018, J STAT MANAG SYST, V21, P569, DOI 10.1080/09720510.2018.1466965; Shanthi T, 2019, COMPUT ELECTR ENG, V76, P56, DOI 10.1016/j.compeleceng.2019.03.004; SIMONYAN K, 2015, COMPUTER SCI; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Strom C, 2002, INVEST OPHTH VIS SCI, V43, P241; Sun J, 2016, IEEE ICCSS 2016 - 2016 3RD INTERNATIONAL CONFERENCE ON INFORMATIVE AND CYBERNETICS FOR COMPUTATIONAL SOCIAL SYSTEMS (ICCSS), P363, DOI 10.1109/ICCSS.2016.7586482; Talu S-D, 2013, ISRN BIOMEDICAL IMAG, V2013, DOI DOI 10.1155/2013/910641; Wang J, 2019, BIOMED OPT EXPRESS, V10, P2639, DOI 10.1364/BOE.10.002639; Wenick AS, 2012, MIDDLE EAST AFR J OP, V19, P4, DOI 10.4103/0974-9233.92110; Wu L, 2013, WORLD J DIABETES, V4, P290, DOI 10.4239/wjd.v4.i6.290; Yang Q, 2010, OPT EXPRESS, V18, P21293, DOI 10.1364/OE.18.021293; Zeng XL, 2019, IEEE ACCESS, V7, P30744, DOI 10.1109/ACCESS.2019.2903171	42	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0254180	10.1371/journal.pone.0254180	http://dx.doi.org/10.1371/journal.pone.0254180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314421	gold, Green Published			2022-12-26	WOS:000685225200002
J	Vercelli, C; Tursi, M; Miretti, S; Giusto, G; Gandini, M; Re, G; Valle, E				Vercelli, Cristina; Tursi, Massimiliano; Miretti, Silvia; Giusto, Gessica; Gandini, Marco; Re, Giovanni; Valle, Emanuela			Effect of sugar metabolite methylglyoxal on equine lamellar explants: An ex vivo model of laminitis	PLOS ONE			English	Article							CARBOHYDRATE OVERLOAD; EXPRESSION; SEPARATION; STRESS; HORSES	Laminitis is one of the most devastating diseases in equine medicine, and although several etiopathogenetic mechanisms have been proposed, few clear answers have been identified to date. Several lines of evidence point towards its underlying pathology as being metabolism-related. In the carbonyl stress pathway, sugars are converted to methylglyoxal (MG)-a highly reactive alpha-oxoaldehyde, mainly derived during glycolysis in eukaryotic cells from the triose phosphates: D-glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. One common hypothesis is that MG could be synthesized during the digestive process in horses, and excessive levels absorbed into peripheral blood could be delivered to the foot and lead to alterations in the hoof lamellar structure. In the present study, employing an ex vivo experimental design, different concentrations of MG were applied to hoof explants (HE), which were then incubated and maintained in a specific medium for 24 and 48 h. Macroscopic and histological analyses and a separation force test were performed at 24 and 48 h post-MG application. Gene expression levels of matrix metalloproteinase (MMP)-2 and -14 and tissue inhibitor of metalloproteinase (TIMP)-2 were also measured at each time point for all experimental conditions. High concentrations of MG induced macroscopic and histological changes mimicking laminitis. The separation force test revealed that hoof tissue samples incubated for 24 h in a high concentration of MG, or with lower doses but for a longer period (48 h), demonstrated significant weaknesses, and samples were easily separated. All results support that high levels of MG could induce irreversible damage in HEs, mimicking laminitis in an ex vivo model.	[Vercelli, Cristina; Tursi, Massimiliano; Miretti, Silvia; Giusto, Gessica; Gandini, Marco; Re, Giovanni; Valle, Emanuela] Univ Turin, Dept Vet Sci, Grugliasco, TO, Italy	University of Turin	Vercelli, C (corresponding author), Univ Turin, Dept Vet Sci, Grugliasco, TO, Italy.	cristina.vercelli@unito.it	gandini, marco/AAW-1355-2020; valle, emanuela/AFX-9345-2022	gandini, marco/0000-0002-1402-8261; valle, emanuela/0000-0002-5519-3554	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); University of Turin	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Turin	This study was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) under the programme "Dipartimento di Eccellenza ex L.232/2016" to the Department of Veterinary Science, University of Turin (to authors EV, MG, and GG); and by the ex 60% fund of the University of Turin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Daradka M, 2004, EQUINE VET J, V36, P236, DOI 10.2746/0425164044877198; de Laat MA, 2012, VET IMMUNOL IMMUNOP, V145, P395, DOI 10.1016/j.vetimm.2011.12.016; de Laat MA, 2011, VET IMMUNOL IMMUNOP, V140, P275, DOI 10.1016/j.vetimm.2011.01.013; Ewaschuk JB, 2002, J CHROMATOGR B, V781, P39, DOI 10.1016/S1570-0232(02)00500-7; Fleming T, 2012, DIABETOLOGIA, V55, P1151, DOI 10.1007/s00125-012-2452-1; French KR, 2004, EQUINE VET J, V36, P261, DOI 10.2746/0425164044877170; Hidmark A, 2014, EXP CLIN ENDOCR DIAB, V122, P201, DOI 10.1055/s-0034-1367023; Hoffman RM, 2009, REV BRAS ZOOTECN, V38, P270, DOI 10.1590/S1516-35982009001300027; Jiang WG, 2006, INT J MOL MED, V17, P583; Johnson PJ, 1998, VET REC, V142, P392, DOI 10.1136/vr.142.15.392; Katz LM, 2012, EQUINE VET J, V44, P752, DOI 10.1111/j.2042-3306.2012.00664.x; Kosmachevskaya OV, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1655, DOI 10.1134/S0006297915130039; Kyaw-Tanner MT, 2008, EQUINE VET J, V40, P482, DOI 10.2746/042516408X270353; Lameness & Laminitis in U.S. Horses, 2000, N3180400 USDA N3180400 USDA, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medina-Torres Carlos E, 2011, Vet J, V190, pe54, DOI 10.1016/j.tvjl.2011.02.026; Milinovich GJ, 2008, ISME J, V2, P1089, DOI 10.1038/ismej.2008.67; Miretti S, 2017, ANIMAL, V11, P227, DOI 10.1017/S1751731116001488; Mungall BA, 2002, J COMP PATHOL, V126, P9, DOI 10.1053/jcpa.2001.0515; Pass M A, 1998, Equine Vet J Suppl, P133; Pass MA., 2010, EQUINE VET J, V30, P133; Pollitt CC, 1996, EQUINE VET J, V28, P38, DOI 10.1111/j.2042-3306.1996.tb01588.x; Pollitt CC., 2010, EQUINE VET J, V30, P119; Pollitt CC, 2010, VET CLIN N AM-EQUINE, V26, P65, DOI 10.1016/j.cveq.2010.01.006; Reisinger N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143754; Reisinger N, 2014, TOXINS, V6, P2962, DOI 10.3390/toxins6102962; Sandow C, 2019, EQUINE VET J, V51, P131, DOI 10.1111/evj.12964; Steelman SM, 2013, VET IMMUNOL IMMUNOP, V153, P217, DOI 10.1016/j.vetimm.2013.03.001; Teodorowicz M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02088; Toth F, 2009, EQUINE VET J, V41, P852, DOI 10.2746/042516409X479027; Valle E, 2013, VET J, V196, P445, DOI 10.1016/j.tvjl.2012.10.030; Valle E, 2019, J FELINE MED SURG, V21, P465, DOI 10.1177/1098612X18783858; Visser MB, 2012, EQUINE VET J, V44, P88, DOI 10.1111/j.2042-3306.2011.00393.x; Wang L, 2014, J VET INTERN MED, V28, P215, DOI 10.1111/jvim.12252; Wells-Smith L, 2015, VET REC, V176, P70, DOI 10.1136/vr.h53; Ziegler D, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2811	36	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0253840	10.1371/journal.pone.0253840	http://dx.doi.org/10.1371/journal.pone.0253840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314429	gold, Green Published			2022-12-26	WOS:000685225200036
J	Zemmour, A; Dali-Yahia, R; Maatallah, M; Saidi-Ouahrani, N; Rahmani, B; Benhamouche, N; Al-Farsi, HM; Giske, CG				Zemmour, Assia; Dali-Yahia, Radia; Maatallah, Makaoui; Saidi-Ouahrani, Nadjia; Rahmani, Bouabdallah; Benhamouche, Nora; Al-Farsi, Hissa M.; Giske, Christian G.			High-risk clones of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolated from the University Hospital Establishment of Oran, Algeria (2011-2012)	PLOS ONE			English	Article							MEDIATED QUINOLONE RESISTANCE; FIELD GEL-ELECTROPHORESIS; ESCHERICHIA-COLI; CTX-M; ENTEROBACTERIACEAE; PREVALENCE; PLASMIDS; SALMONELLA; ESBL; SUSCEPTIBILITY	The purpose of the study was to characterize the resistome, virulome, mobilome and Clustered Regularly Interspaced Short Palindromic Repeats-associated (CRISPR-Cas) system of extended-spectrum beta-lactamase producing Klebsiella pneumoniae (ESBL-KP) clinical isolates and to determine their phylogenetic relatedness. The isolates were from Algeria, isolated at the University Hospital Establishment of Oran, between 2011 and 2012. ESBL-KP isolates (n = 193) were screened for several antibiotic resistance genes (ARGs) using qPCR followed by Pulsed-Field Gel Electrophoresis (PFGE). Representative isolates were selected from PFGE clusters and subjected to whole-genome sequencing (WGS). Genomic characterization of the WGS data by studying prophages, CRISPR-Cas systems, Multi-Locus Sequence Typing (MLST), serotype, ARGs, virulence genes, plasmid replicons, and their pMLST. Phylogenetic and comparative genomic were done using core genome MLST and SNP-Based analysis. Generally, the ESBL-KP isolates were polyclonal. The whole genome sequences of nineteen isolates were taken of main PFGE clusters. Sixteen sequence types (ST) were found including high-risk clones ST14, ST23, ST37, and ST147. Serotypes K1 (n = 1), K2 (n = 2), K3 (n = 1), K31 (n = 1), K62 (n = 1), and K151 (n = 1) are associated with hyper-virulence. CRISPR-Cas system was found in 47.4%, typed I-E and I-E*. About ARGs, from 193 ESBL-KP, the majority of strains were multidrug-resistant, the CTX-M-1 enzyme was predominant (99%) and the prevalence of plasmid-mediated quinolone resistance (PMQR) genes was high with aac(6 ')-lb-cr (72.5%) and qnr's (65.8%). From 19 sequenced isolates we identified ESBL, AmpC, and carbapenemase genes: bla(CTX-M-15) (n = 19), bla(OXA-48) (n = 1), bla(CMY-2) (n = 2), and bla(CMY-16) (n = 2), as well as non-ESBL genes: qnrB1 (n = 12), qnrS1 (n = 1) and armA (n = 2). We found IncF, IncN, IncL/M, IncA/C2, and Col replicon types, at least once per isolate. This study is the first to report qnrS in ESBL-KP in Algeria. Our analysis shows the concerning co-existence of virulence and resistance genes and would support that genomic surveillance should be a high priority in the hospital environment.	[Zemmour, Assia; Saidi-Ouahrani, Nadjia; Benhamouche, Nora] Univ Sci & Technol Oran Mohamed Boudiaf USTOMB, Dept Genet Mol Appl, Fac Sci Nat & Vie, Oran, Algeria; [Zemmour, Assia] Univ Oran 1, Lab Genet Med Appl Ophtalmol, Oran, Algeria; [Dali-Yahia, Radia] Etab Hosp Univ 1er Novembre 1954, Serv Bacteriol, Oran, Algeria; [Dali-Yahia, Radia] Univ Oran 1, Fac Med, Oran, Algeria; [Maatallah, Makaoui] Univ Monastir, Lab Anal Traitement & Valorisat Polluants Environ, Fac Pharm Monastir, Monastir, Tunisia; [Rahmani, Bouabdallah] Univ Sci & Technol Oran Mohamed Boudiaf USTOMB, Dept Elect, Fac Genie Elect, Oran, Algeria; [Al-Farsi, Hissa M.; Giske, Christian G.] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Al-Farsi, Hissa M.] Minist Hlth, Cent Publ Hlth Labs, Muscat, Oman; [Giske, Christian G.] Karolinska Univ Hosp Solna, Clin Microbiol, Stockholm, Sweden	Universite de Monastir; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Zemmour, A (corresponding author), Univ Sci & Technol Oran Mohamed Boudiaf USTOMB, Dept Genet Mol Appl, Fac Sci Nat & Vie, Oran, Algeria.; Zemmour, A (corresponding author), Univ Oran 1, Lab Genet Med Appl Ophtalmol, Oran, Algeria.	assia.zemmour@usto-univ.dz			Universite des Sciences et de la Technologie d'Oran Mohamed BOUDIAF; University Hospital Establishment of Oran	Universite des Sciences et de la Technologie d'Oran Mohamed BOUDIAF; University Hospital Establishment of Oran	For this work, author Assia Zemmour, received the financial support from << Universite des Sciences et de la Technologie d'Oran Mohamed BOUDIAF and material support from Karolinska Institutet and the University Hospital Establishment of Oran. The financial funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitta A., 2013, RESEARCHER, V5, P1; [Anonymous], J CLIN MICROBIOL; Anssour L, 2016, J INFECT DEV COUNTR, V10, P728, DOI 10.3855/jidc.6727; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Barguigua A, 2013, J ANTIBIOT, V66, P11, DOI 10.1038/ja.2012.91; Bercot B, 2008, ANTIMICROB AGENTS CH, V52, P4526, DOI 10.1128/AAC.00882-08; Bialek-Davenet S, 2014, EMERG INFECT DIS, V20, P1812, DOI 10.3201/eid2011.140206; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bonomo ME, 2018, PHYS BIOL, V15, DOI 10.1088/1478-3975/aab6d6; Breurec S, 2013, CLIN MICROBIOL INFEC, V19, P349, DOI 10.1111/j.1469-0691.2012.03805.x; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Castanheira M, 2008, ANTIMICROB AGENTS CH, V52, P1587, DOI 10.1128/AAC.01502-07; Clinical and Laboratory Standards Institute, 2020, M100 I CALS; Coelho A, 2010, INT J ANTIMICROB AG, V36, P73, DOI 10.1016/j.ijantimicag.2010.03.005; Colavecchio A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01108; Cubero M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222628; da Roza FT, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01657; Dolejska M, 2012, INT J ANTIMICROB AG, V40, P510, DOI 10.1016/j.ijantimicag.2012.07.016; Feng Y, 2021, NUCLEIC ACIDS RES, V49, pD644, DOI 10.1093/nar/gkaa821; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Giske CG, 2009, J ANTIMICROB CHEMOTH, V63, P1, DOI 10.1093/jac/dkn444; Gonzalez-Zorn B, 2005, EMERG INFECT DIS, V11, P954; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Iabadene H, 2008, J ANTIMICROB CHEMOTH, V62, P133, DOI 10.1093/jac/dkn145; Iabadene H, 2009, INT J ANTIMICROB AG, V34, P340, DOI 10.1016/j.ijantimicag.2009.05.011; Jansen Rund, 2002, OMICS A Journal of Integrative Biology, V6, P23, DOI 10.1089/15362310252780816; JARLIER V, 1988, REV INFECT DIS, V10, P867; Koeck JL, 1997, FEMS MICROBIOL LETT, V152, P255, DOI 10.1111/j.1574-6968.1997.tb10436.x; Lam MMC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05114-7; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li HY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01595; Liu C, 2018, INFECT DRUG RESIST, V11, P1031, DOI 10.2147/IDR.S161075; Livermore DM, 2007, J ANTIMICROB CHEMOTH, V59, P165, DOI 10.1093/jac/dkl483; Loucif L, 2016, ANTIMICROB AGENTS CH, V60, P7494, DOI 10.1128/AAC.00525-16; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; MERINO S, 1992, INFECT IMMUN, V60, P2529, DOI 10.1128/IAI.60.6.2529-2535.1992; Mohamed ER, 2017, J MED MICROBIOL, V66, P628, DOI 10.1099/jmm.0.000473; Ostria-Hernandez Martha Lorena, 2015, BMC Res Notes, V8, P332, DOI 10.1186/s13104-015-1285-7; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Poirel L, 2008, CLIN MICROBIOL INFEC, V14, P295, DOI 10.1111/j.1469-0691.2007.01930.x; Reseau Algerien de Surveillance de la Resistance des Bacteries aux Antibiotiques, 2012, 14 RES ALG SURV RES 14 RES ALG SURV RES; Reseau Algerien de Surveillance de la Resistance des Bacteries aux Antibiotiques, 2011, 13 RES ALG SURV RES 13 RES ALG SURV RES; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rodrigues C, 2014, INT J MED MICROBIOL, V304, P1100, DOI 10.1016/j.ijmm.2014.08.003; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Schurch AC, 2018, CLIN MICROBIOL INFEC, V24, P350, DOI 10.1016/j.cmi.2017.12.016; Sekowska A, 2012, ARCH MED SCI, V8, P993, DOI 10.5114/aoms.2012.32404; Shehreen S, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0384; Shen JT, 2017, J BASIC MICROB, V57, P325, DOI 10.1002/jobm.201600589; Shin SY, 2009, KOREAN J LAB MED, V29, P541, DOI 10.3343/kjlm.2009.29.6.541; Solovjev V, 2011, METAGENOMICITAPP, P61; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; The European Committee on Antimicrobial Susceptibility Testing, 2017, EUCAST GUIDELINES DE; Tokajian S, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00032; van Beek J, 2019, EUROSURVEILLANCE, V24, P7, DOI 10.2807/1560-7917.ES.2019.24.38.1800522; Wang X, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00595; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412; World Health Organization, 2014, ANT RES GLOB REP SUR; Wyres KL, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000102; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang F, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0184-6; Zhang YF, 2008, VET MICROBIOL, V129, P418, DOI 10.1016/j.vetmic.2007.11.032; Zhou HJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00371; Zhou TL, 2011, JPN J INFECT DIS, V64, P55; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	70	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254805	10.1371/journal.pone.0254805	http://dx.doi.org/10.1371/journal.pone.0254805			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310625	gold, Green Published			2022-12-26	WOS:000685224500042
J	El-Shaer, S; Abdel-Rhman, SH; Barwa, R; Hassan, R				El-Shaer, Soha; Abdel-Rhman, Shaymaa H.; Barwa, Rasha; Hassan, Ramadan			Genetic characterization of extended-spectrum beta-Lactamase- and carbapenemase-producing Escherichia coli isolated from Egyptian hospitals and environments	PLOS ONE			English	Article							PATHOGENICITY ISLAND MARKERS; ENTEROPATHOGENIC E.-COLI; PHYLOGENETIC GROUPS; STRAINS; RESISTANCE; VIRULENCE; COMMENSAL; PROFILES; FOOD	Over the past decades, Escherichia coli (E. coli) have acquired extensive resistance to antibiotics; especially beta- lactams. This study aimed to investigate the frequency of Extended-spectrum beta-lactamase (ESBL) and carbapenemase producers among E. coli isolates and their correlation with serotypes, phylogenetic background, and pathogenicity associated islands. A total of 105 E. coli strains were isolated and subjected to antimicrobial susceptibility testing against beta-lactam antibiotics. All isolates showed a high resistance profile. Resistant isolates were tested for ESBL and carbapenemase production. Fifty-three and 18 isolates were positive for ESBL and carbapenemase producers, respectively. ESBL and carbapenemase genes were detected by PCR. TEM gene was the most prevalent gene among all isolates followed by SHV and CTX-M15. In carbapenemase-producers, OXA-48 and IMP were the predominant genes. Enteropathogenic E. coli (EPEC) and Enterohemorrhagic E. coli (EHEC) were the major producers of ESBL and carbapenemase, respectively as indicated by serodiagnosis. They were further assessed for the presence of pathogenicity islands (PAIs) and phylogenetic background. The most predominant DEC PAI and ExPEC PAI were HPI and IICFT073. Most clinically ESBL-producers were group D and B2 while environmentally ones were group B1 and A. On contrary, clinically carbapenemase-producers belonged to group C and D. In conclusion, our study confirms the importance of phylogenetic group D, B2, and C origin for antibiotic resistance in E. coli. Ultimately, our findings support the fact that environmental isolates contribute to the local spread of E. coli pathogenicity in Egypt and these isolates maybe serve as reservoirs for transmission of resistance.	[El-Shaer, Soha; Abdel-Rhman, Shaymaa H.; Barwa, Rasha; Hassan, Ramadan] Mansoura Univ, Fac Pharm, Microbiol & Immunol Dept, Mansoura, Egypt; [Abdel-Rhman, Shaymaa H.] Taibah Univ, Fac Pharm, Dept Pharmaceut & Pharmaceut Biotechnol, Almadinah Al Munawwarah, Saudi Arabia	Egyptian Knowledge Bank (EKB); Mansoura University; Taibah University	Abdel-Rhman, SH (corresponding author), Mansoura Univ, Fac Pharm, Microbiol & Immunol Dept, Mansoura, Egypt.; Abdel-Rhman, SH (corresponding author), Taibah Univ, Fac Pharm, Dept Pharmaceut & Pharmaceut Biotechnol, Almadinah Al Munawwarah, Saudi Arabia.	shaymaahassan@mans.edu.eg	Abdel-Rhman, Shaymaa/ABE-4730-2021					Abbas HA, 2019, MICROB PATHOGENESIS, V132, P266, DOI 10.1016/j.micpath.2019.05.022; Alizade Hesam, 2015, Gastroenterol Hepatol Bed Bench, V8, P207; Amezquita-Montes Z, 2015, FOODBORNE PATHOG DIS, V12, P454, DOI 10.1089/fpd.2014.1881; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 2017, LANCET HIV, V2017, pPE475; Beceiro A, 2013, CLIN MICROBIOL REV, V26, P185, DOI 10.1128/CMR.00059-12; Bush K, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01076-18; Campos LC, 2004, MEM I OSWALDO CRUZ, V99, P545, DOI 10.1590/S0074-02762004000600001; Canizalez-Roman A, 2013, INT J FOOD MICROBIOL, V164, P36, DOI 10.1016/j.ijfoodmicro.2013.03.020; Clermont O, 2004, J CLIN MICROBIOL, V42, P1770, DOI 10.1128/JCM.42.4.1770-1772.2004; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2008, ENVIRON MICROBIOL, V10, P1000, DOI 10.1111/j.1462-2920.2007.01520.x; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clinical and Laboratory Standards Institute (CLSI), 2015, M07A10 CLIN LAB STAN, V10th; Dagher C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203323; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Daoud Ziad, 2011, Chemother Res Pract, V2011, P218431, DOI 10.1155/2011/218431; Dobrindt U, 2002, INFECT IMMUN, V70, P6365, DOI 10.1128/IAI.70.11.6365-6372.2002; Doi Y, 2017, J TRAVEL MED, V24, pS44, DOI 10.1093/jtm/taw102; Gomez-Aldapa CA, 2014, J SCI FOOD AGR, V94, P2705, DOI 10.1002/jsfa.6614; Hindler JF., 2007, TXB DIAGNOSTIC MICRO; Hoseinzadeh T, 2016, IRAN J MICROBIOL, V8, P187; Indrajith S, 2021, J INFECT PUBLIC HEAL, V14, P131, DOI 10.1016/j.jiph.2020.09.018; Ingti B, 2020, RES MICROBIOL, V171, P128, DOI 10.1016/j.resmic.2020.01.002; Ishii S, 2007, APPL ENVIRON MICROB, V73, P5703, DOI 10.1128/AEM.00275-07; Kalasseril SG, 2020, CURR MICROBIOL, V77, P2886, DOI 10.1007/s00284-020-02107-y; Kariyawasam S, 2006, AVIAN DIS, V50, P405, DOI 10.1637/7462-102705R.1; Kok TW, 1996, PRACTICAL MED MICROB, V14th, P179; Lescat M, 2013, ENV MICROBIOL REP, V5, P49, DOI 10.1111/j.1758-2229.2012.00374.x; Liu BT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01147; Middendorf B, 2004, J BACTERIOL, V186, P3086, DOI 10.1128/JB.186.10.3086-3096.2004; Naderi Ghazal, 2016, Gastroenterol Hepatol Bed Bench, V9, P316; Najafi A, 2018, FOLIA MICROBIOL, V63, P335, DOI 10.1007/s12223-017-0570-3; Nascimento JAS, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9040693; Natarajan M, 2018, J HEALTH POPUL NUTR, V37, DOI 10.1186/s41043-018-0147-z; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; Roussel C, 2017, FUTURE MICROBIOL, V12, P73, DOI 10.2217/fmb-2016-0101; Sabate M, 2006, CLIN MICROBIOL INFEC, V12, P880, DOI 10.1111/j.1469-0691.2006.01461.x; Saleem R, 2017, PAK J MED SCI, V33, P886, DOI 10.12669/pjms.334.12647; Schroeder M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010039; Singh RE, 2011, INT J APPL BIOL PHAR, V2, P415; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Vila J, 2016, FEMS MICROBIOL REV, V40, P437, DOI 10.1093/femsre/fuw005; WHO, 1987, PROGR CONTR DIARRH D; Ye QH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01709	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255219	10.1371/journal.pone.0255219	http://dx.doi.org/10.1371/journal.pone.0255219			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297783	gold, Green Published			2022-12-26	WOS:000678128300006
J	Taghioff, SM; Slavin, BR; Holton, T; Singh, D				Taghioff, Susan M.; Slavin, Benjamin R.; Holton, Tripp; Singh, Devinder			Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients	PLOS ONE			English	Article							COVID-19	Introduction Recently, several single center studies have suggested a protective effect of the influenza vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This study utilizes a continuously updated Electronic Medical Record (EMR) network to assess the possible benefits of influenza vaccination mitigating critical adverse outcomes in SARS-CoV-2 positive patients from 56 healthcare organizations (HCOs). Methods The de-identified records of 73,346,583 patients were retrospectively screened. Two cohorts of 37,377 patients, having either received or not received influenza vaccination six months-two weeks prior to SARS-CoV-2 positive diagnosis, were created using Common Procedural Terminology (CPT) and logical observation identifiers names and codes (LOINC) codes. Adverse outcomes within 30, 60, 90, and 120 days of positive SARS-CoV-2 diagnosis were compared between cohorts. Outcomes were assessed with stringent propensity score matching including age, race, ethnicity, gender, hypertension, diabetes, hyperlipidemia, chronic obstructive pulmonary disease (COPD), obesity, heart disease, and lifestyle habits such as smoking. Results SARS-CoV-2-positive patients who received the influenza vaccine experienced decreased sepsis (p<0.01, Risk Ratio: 1.361-1.450, 95% CI:1.123-1.699, NNT:286) and stroke (p<0.02, RR: 1.451-1.580, 95% CI:1.075-2.034, NNT:625) across all time points. ICU admissions were lower in SARS-CoV-2-positive patients receiving the influenza vaccine at 30, 90, and 120 days (p<0.03, RR: 1.174-1.200, 95% CI:1.003-1.385, NNT:435), while approaching significance at 60 days (p = 0.0509, RR: 1.156, 95% CI:0.999-1.338). Patients who received the influenza vaccine experienced fewer DVTs 60-120 days after positive SARS-CoV-2 diagnosis (p<0.02, RR:1.41-1.530, 95% CI:1.082-2.076, NNT:1000) and experienced fewer emergency department (ED) visits 90-120 days post SARS-CoV-2-positive diagnosis (p<0.01, RR:1.204-1.580, 95% CI: 1.050-1.476, NNT:176). Conclusion Our analysis outlines the potential protective effect of influenza vaccination in SARS-CoV-2-positive patients against adverse outcomes within 30, 60, 90, and 120 days of a positive diagnosis. Significant findings favoring influenza vaccination mitigating the risks of sepsis, stroke, deep vein thrombosis (DVT), emergency department (ED) & Intensive Care Unit (ICU) admissions suggest a potential protective effect that could benefit populations without readily available access to SARS-CoV-2 vaccination. Thus further investigation with future prospective studies is warranted.	[Taghioff, Susan M.; Slavin, Benjamin R.; Singh, Devinder] Univ Miami, Miller Sch Med, Div Plast & Reconstruct Surg, Miami, FL 33136 USA; [Holton, Tripp] Anne Arundel Med Ctr, Annapolis, MD USA	University of Miami	Singh, D (corresponding author), Univ Miami, Miller Sch Med, Div Plast & Reconstruct Surg, Miami, FL 33136 USA.	DSingh.MD@med.miami.edu		Taghioff, Susan/0000-0002-7595-0591				[Anonymous], JHU EDU JHU EDU; [Anonymous], FLU SHOT MAY SHIELD; [Anonymous], HEALIO; Behrouzi B, 2020, J AM COLL CARDIOL, V76, P1777, DOI 10.1016/j.jacc.2020.08.028; Bermudez-Fajardo A, 2011, ATHEROSCLEROSIS, V217, P97, DOI 10.1016/j.atherosclerosis.2011.03.019; Cdc.gov, 2021, FLU SEASON; Conlon A, 2021, AM J INFECT CONTROL, V49, P694, DOI 10.1016/j.ajic.2021.02.012; Erismis B, 2021, CENT EUR J PUBL HEAL, V29, P14, DOI 10.21101/cejph.a6573; Ferdinand KC, 2020, J NATL MED ASSOC, V112, P681, DOI 10.1016/j.jnma.2020.11.001; Grohskopf LA, 2018, MMWR RECOMM REP, V67, DOI 10.15585/mmwr.rr6703a1; Gupta T, 2020, INT IMMUNOPHARMACOL, V86, DOI 10.1016/j.intimp.2020.106717; Halpin SJ, 2021, J MED VIROL, V93, P1013, DOI 10.1002/jmv.26368; Hashim A, 2015, VACCINE, V33, P753, DOI 10.1016/j.vaccine.2014.12.033; Jewett A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01692; Jiang SB, 2020, TRENDS IMMUNOL, V41, P853, DOI 10.1016/j.it.2020.08.003; Jorge A, 2020, LANCET RHEUMATOL, V3, pe131, DOI 10.1016/S2665-9913(20)30422-7; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Massoudi N, 2021, J CLIN IMMUNOL, V41, P324, DOI 10.1007/s10875-020-00925-0; Pawlowski C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83641-y; Pedote PD, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040358; Perisetti A, 2020, SSRN, DOI [10.2139/ssrn.3697160, DOI 10.2139/SSRN.3697160]; Ragni P, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040675; Shouman K, 2021, CLIN AUTON RES, V31, P385, DOI 10.1007/s10286-021-00803-8; Singh S, 2020, GASTROENTEROLOGY, V159, DOI 10.1053/j.gastro.2020.08.028; Taquet M, 2021, LANCET PSYCHIAT, V8, P130, DOI 10.1016/S2215-0366(20)30462-4; Tenny S., 2021, STATPEARLS; Topaloglu U, 2018, JCO CLIN CANCER INFO, V2, DOI 10.1200/CCI.17.00067; Tramer MR, 2005, WORLD J SURG, V29, P576, DOI 10.1007/s00268-005-7916-8; Umasabor-Bubu OQ, 2021, AM J INFECT CONTROL; Vandenberg O, 2021, NAT REV MICROBIOL, V19, P171, DOI 10.1038/s41579-020-00461-z; Veljkovic V, 2014, VACCINE, V32, P6569, DOI 10.1016/j.vaccine.2014.07.007; Wehenkel C, 2020, PEERJ, V8, DOI 10.7717/peerj.10112; Yang MJ, 2021, J AM BOARD FAM MED, V34, pS179, DOI 10.3122/jabfm.2021.S1.200528; Zanettini Claudio, 2020, medRxiv, DOI 10.1101/2020.06.24.20129817	34	16	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255541	10.1371/journal.pone.0255541	http://dx.doi.org/10.1371/journal.pone.0255541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343191	Green Published, gold			2022-12-26	WOS:000685264200043
J	Benwell, CJ; Taylor, JAGE; Robinson, SD				Benwell, Christopher J.; Taylor, James A. G. E.; Robinson, Stephen D.			Endothelial neuropilin-2 influences angiogenesis by regulating actin pattern development and alpha 5-integrin-p-FAK complex recruitment to assembling adhesion sites	FASEB JOURNAL			English	Article						angiogenesis; endothelium; integrins; neuropilin-2; protein trafficking	ARP2/3 COMPLEX; CELL-MIGRATION; GROWTH-FACTOR; INTEGRIN; FAK; ACTIVATION; VEGF; EXPRESSION; BINDING; DYNAMICS	The ability to form a variety of cell-matrix connections is crucial for angiogenesis to take place. Without stable anchorage to the extracellular matrix (ECM), endothelial cells (ECs) are unable to sense, integrate and disseminate growth factor stimulated responses that drive growth of a vascular bed. Neuropilin-2 (NRP2) is a widely expressed membrane-bound multifunctional non-tyrosine kinase receptor, which has previously been implicated in influencing cell adhesion and migration by interacting with alpha 5-integrin and regulating adhesion turnover. alpha 5-integrin, and its ECM ligand fibronectin (FN) are both known to be upregulated during the formation of neo-vasculature. Despite being descriptively annotated as a candidate biomarker for aggressive cancer phenotypes, the EC-specific roles for NRP2 during developmental and pathological angiogenesis remain unexplored. The data reported here support a model whereby NRP2 actively promotes EC adhesion and migration by regulating dynamic cytoskeletal remodeling and by stimulating Rab11-dependent recycling of alpha 5-integrin-p-FAK complexes to newly assembling adhesion sites. Furthermore, temporal depletion of EC-NRP2 in vivo impairs primary tumor growth by disrupting vessel formation. We also demonstrate that EC-NRP2 is required for normal postnatal retinal vascular development, specifically by regulating cell-matrix adhesion. Upon loss of endothelial NRP2, vascular outgrowth from the optic nerve during superficial plexus formation is disrupted, likely due to reduced FAK phosphorylation within sprouting tip cells.	[Benwell, Christopher J.; Taylor, James A. G. E.; Robinson, Stephen D.] Norwich Res Pk, Gut Microbes & Hlth, Quadram Inst Biosci, Norwich, Norfolk, England; [Robinson, Stephen D.] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Robinson, SD (corresponding author), Norwich Res Pk, Gut Microbes & Hlth, Quadram Inst Biosci, Norwich, Norfolk, England.	Stephen.Robinson@quadram.ac.uk		Benwell, Christopher/0000-0003-0579-7920; Robinson, Stephen/0000-0002-6606-7588	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) [BB/R012490/1]; British Heart Foundation (BHF) [PG/15/25/31369]	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation (BHF)(British Heart Foundation)	RCUK | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/M011216/1; RCUK | Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/R012490/1; British Heart Foundation (BHF), Grant/Award Number: PG/15/25/31369	Ajeian JN, 2016, PROTEOM CLIN APPL, V10, P51, DOI 10.1002/prca.201500033; Alarcon-Martinez L, 2018, ELIFE, V7, DOI 10.7554/eLife.34861; Alghamdi AAA, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00395; Bachelder RE, 2001, CANCER RES, V61, P5736; Benz PM, 2009, J CELL SCI, V122, P3954, DOI 10.1242/jcs.044537; Bernusso VA, 2015, BBA-MOL CELL RES, V1853, P388, DOI 10.1016/j.bbamcr.2014.11.008; Bielenberg DR, 2012, AM J PATHOL, V181, P548, DOI 10.1016/j.ajpath.2012.04.013; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Bielenberg DR, 2004, J CLIN INVEST, V114, P1260, DOI 10.1172/JCI200421378; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Borkowetz A, 2020, INT J CANCER, V146, P2619, DOI 10.1002/ijc.32679; Brash JT, 2020, CIRC RES, V127, P849, DOI 10.1161/CIRCRESAHA.120.317025; Buskermolen ABC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195201; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Cao Y, 2013, CANCER RES, V73, P4579, DOI 10.1158/0008-5472.CAN-13-0529; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; CLARK RAF, 1982, J INVEST DERMATOL, V79, P269, DOI 10.1111/1523-1747.ep12500076; De Pascalis C, 2017, MOL BIOL CELL, V28, P1833, DOI 10.1091/mbc.E17-03-0134; Deshpande PP, 2013, NANOMEDICINE-UK, V8, P1509, DOI [10.2217/NNM.13.118, 10.2217/nnm.13.118]; Fakhari M, 2002, CANCER-AM CANCER SOC, V94, P258, DOI 10.1002/cncr.10177; Fantin A, 2015, CELL REP, V11, P1577, DOI 10.1016/j.celrep.2015.05.018; Fantin A, 2011, DEVELOPMENT, V138, P4185, DOI 10.1242/dev.070037; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Fukahi K, 2004, CLIN CANCER RES, V10, P581, DOI 10.1158/1078-0432.CCR-0930-03; Gao CX, 2015, ELIFE, V4, DOI 10.7554/eLife.10072; Ghosh Dastidar D. Ghosh, 2020, VESSEL PLUS, V14, DOI [10.20517/2574-1209.2019.36, DOI 10.20517/2574-1209.2019.36]; Goel HL, 2012, J CELL SCI, V125, P497, DOI 10.1242/jcs.094433; Goel HL, 2011, DEVELOPMENT, V138, P2969, DOI 10.1242/dev.051318; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Golubovskaya VM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-280; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herzog B, 2011, MOL BIOL CELL, V22, P2766, DOI 10.1091/mbc.E09-12-1061; Holt MR, 1998, INT J BIOCHEM CELL B, V30, P307, DOI 10.1016/S1357-2725(97)00101-5; Hu P, 2013, J CELL PHYSIOL, V228, P306, DOI 10.1002/jcp.24154; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579; Jalal S, 2019, J CELL SCI, V132, DOI 10.1242/jcs.220780; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; Kragtorp KA, 2006, DEVELOPMENT, V133, P685, DOI 10.1242/dev.02230; Krilleke D, 2007, J BIOL CHEM, V282, P28045, DOI 10.1074/jbc.M700319200; Lambert J, 2020, J CELL SCI, V133, DOI 10.1242/jcs.235762; Lantuejoul S, 2003, J PATHOL, V200, P336, DOI 10.1002/path.1367; Lenzo FL, 2017, TRANSL CANCER RES, V6, pS957, DOI 10.21037/tcr.2017.06.05; Luo X, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00472-6; Mana G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13546; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Milde F, 2013, INTEGR BIOL-UK, V5, P1426, DOI 10.1039/c3ib40085a; Nader GPF, 2016, NAT CELL BIOL, V18, P491, DOI 10.1038/ncb3333; Nagano Makoto, 2012, Int J Cell Biol, V2012, P310616, DOI 10.1155/2012/310616; Pan L, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2502-0; Plein A, 2014, MICROCIRCULATION, V21, P315, DOI 10.1111/micc.12124; Raimondi C, 2014, J EXP MED, V211, P1167, DOI 10.1084/jem.20132330; Reynolds LE, 2006, METH MOLEC MED, V120, P503; Robinson SD, 2011, CURR OPIN CELL BIOL, V23, P630, DOI 10.1016/j.ceb.2011.03.014; Robinson SD, 2009, J BIOL CHEM, V284, P33966, DOI 10.1074/jbc.M109.030700; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schimmel L, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.185405; Srichai M., 2010, INTEGRIN STRUCTURE F; Sundararaman A, 2020, CURR BIOL, V30, P2146, DOI 10.1016/j.cub.2020.03.042; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Vales A, 2007, LEUKEMIA LYMPHOMA, V48, P1997, DOI 10.1080/10428190701534424; WOO MK, 1994, J CELL SCI, V107, P1359; Woodside DG, 2001, THROMB HAEMOSTASIS, V86, P316, DOI 10.1055/s-0037-1616229; Yamakita Y, 1996, J BIOL CHEM, V271, P12632, DOI 10.1074/jbc.271.21.12632; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zhang JL, 2014, PHARMACOL THERAPEUT, V142, P154, DOI 10.1016/j.pharmthera.2013.12.003	70	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21679	10.1096/fj.202100286R	http://dx.doi.org/10.1096/fj.202100286R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314542	Green Accepted, Green Submitted			2022-12-26	WOS:000678975300008
J	Fleck, N; Grundner, C				Fleck, Neil; Grundner, Christoph			A Cas12a-based CRISPR interference system for multigene regulation in mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CPF1	Mycobacteria are responsible for a heavy global disease burden, but their relative genetic intractability has long frustrated research efforts. The introduction of clustered regularly interspaced short palindromic repeats (CRISPR) interference (CRISPRi) has made gene repression in mycobacteria much more efficient, but limitations of the prototypical Cas9-based platform, for example, in multigene regulation, remain. Here, we introduce an alternative CRISPRi platform for mycobacteria that is based on the minimal type V Cas12a enzyme in combination with synthetic CRISPR arrays. This system is simple, tunable, reversible, can efficiently regulate essential genes and multiple genes simultaneously, and works as efficiently in infected macrophages as it does in vitro. Together, Cas12abased CRISPRi provides a facile tool to probe higher-order genetic interactions in mycobacteria including Mycobacterium tuberculosis (Mtb), which will enable the development of synthetically lethal drug targets and the study of genes conditionally essential during infection.	[Fleck, Neil; Grundner, Christoph] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98105 USA; [Grundner, Christoph] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Grundner, Christoph] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Grundner, C (corresponding author), Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98105 USA.; Grundner, C (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Grundner, C (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	christoph.grundner@seattlechildrens.org		Fleck, Neil/0000-0001-8327-4688; Grundner, Christoph/0000-0003-0596-6798	NIH [R01AI117023, R21AI137571, R03AI131223]; American Lung Association	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association	This work was supported by NIH grants R01AI117023, R21AI137571, and R03AI131223 and by a grant by the American Lung Association to C. G. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Agarwal N, 2020, PLASMID, V110, DOI 10.1016/j.plasmid.2020.102515; Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Choi SY, 2020, ACS SYNTH BIOL, V9, P2351, DOI 10.1021/acssynbio.0c00091; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; Ehrt S, 2006, FUTURE MICROBIOL, V1, P177, DOI 10.2217/17460913.1.2.177; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; Kleinstiver BP, 2019, NAT BIOTECHNOL, V37, P276, DOI 10.1038/s41587-018-0011-0; Knoot CJ, 2020, ACS SYNTH BIOL, V9, P132, DOI 10.1021/acssynbio.9b00417; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Lai Y, 2020, CELL SYST, V11, P239, DOI 10.1016/j.cels.2020.08.010; Lakshmanan V, 2015, MBIO, V6, DOI 10.1128/mBio.02330-14; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Li L, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00827-18; Miao CS, 2019, SYN SYST BIOTECHNO, V4, P1, DOI 10.1016/j.synbio.2018.11.002; Pham TT, 2007, MICROBIOL-SGM, V153, P2711, DOI 10.1099/mic.0.2007/008904-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rock JM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.274; Singh AK, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw625; Theus SA, 2004, INFECT IMMUN, V72, P1169, DOI 10.1128/IAI.72.2.1169-1173.2004; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Vignali M, 2011, J CLIN INVEST, V121, P1119, DOI 10.1172/JCI43457; Wang MG, 2017, MOL PLANT, V10, P1011, DOI 10.1016/j.molp.2017.03.001; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang XC, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.18	29	1	1	4	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100990	10.1016/j.jbc.2021.100990	http://dx.doi.org/10.1016/j.jbc.2021.100990			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34298016	gold, Green Published			2022-12-26	WOS:000690868100005
J	Rugolo, F; Bazan, NG; Calandria, J; Jun, BK; Raschella, G; Melino, G; Agostini, M				Rugolo, Francesco; Bazan, Nicolas G.; Calandria, Jorgelina; Jun, Bokkyoo; Raschella, Giuseppe; Melino, Gerry; Agostini, Massimiliano			The expression of ELOVL4, repressed by MYCN, defines neuroblastoma patients with good outcome	ONCOGENE			English	Article							FATTY-ACID SYNTHESIS; LIPID-METABOLISM; RETINOIC ACID; INHIBITION; CELLS	Cancer cells exhibit dysregulation of critical genes including those involved in lipid biosynthesis, with subsequent defects in metabolism. Here, we show that ELOngation of Very Long chain fatty acids protein 4 (ELOVL4), a rate-limiting enzyme in the biosynthesis of very-long polyunsaturated fatty acids (n-3, >= 28 C), is expressed and transcriptionally repressed by the oncogene MYCN in neuroblastoma cells. In keeping, ELOVL4 positively regulates neuronal differentiation and lipids droplets accumulation in neuroblastoma cells. At the molecular level we found that MYCN binds to the promoter of ELOVL4 in close proximity to the histone deacetylases HDAC1, HDAC2, and the transcription factor Sp1 that can cooperate in the repression of ELOVL4 expression. Accordingly, in vitro differentiation results in an increase of fatty acid with 34 carbons with 6 double bonds (FA34:6); and when MYCN is silenced, FA34:6 metabolite is increased compared with the scrambled. In addition, analysis of large neuroblastoma datasets revealed that ELOVL4 expression is highly expressed in localized clinical stages 1 and 2, and low in high-risk stages 3 and 4. More importantly, high expression of ELOVL4 stratifies a subsets of neuroblastoma patients with good prognosis. Indeed, ELOVL4 expression is a marker of better overall clinical survival also in MYCN not amplified patients and in those with neuroblastoma-associated mutations. In summary, our findings indicate that MYCN, by repressing the expression of ELOVL4 and lipid metabolism, contributes to the progression of neuroblastoma.	[Rugolo, Francesco; Melino, Gerry; Agostini, Massimiliano] Univ Roma Tor Vergata, Dept Expt Med, TOR, Rome, Italy; [Bazan, Nicolas G.; Calandria, Jorgelina; Jun, Bokkyoo] Louisiana State Univ Hlth New Orleans, Sch Med, Neurosci Ctr Excellence, New Orleans, LA USA; [Raschella, Giuseppe] Italian Natl Agcy New Technol, Lab Hlth & Environm, Energy & Sustainable Econ Dev ENEA, Rome, Italy	University of Rome Tor Vergata; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Italian National Agency New Technical Energy & Sustainable Economics Development	Melino, G; Agostini, M (corresponding author), Univ Roma Tor Vergata, Dept Expt Med, TOR, Rome, Italy.	melino@uniroma2.it; m.agostini@med.uniroma2.it	; Agostini, Massimiliano/G-9579-2014	Rugolo, Francesco/0000-0002-3174-100X; MELINO, GERRY/0000-0001-9428-5972; Bazan, Nicolas/0000-0002-9243-5444; Agostini, Massimiliano/0000-0003-3124-2072	Associazione Italiana per la Ricerca contro il Cancro (AIRC) [20473]; Ministry of Health and MAECI Italy-China Science and Technology Cooperation [PGR00961]; Regione Lazio through LazioInnova Progetto Gruppo di Ricerca [85-2017-14986]	Associazione Italiana per la Ricerca contro il Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministry of Health and MAECI Italy-China Science and Technology Cooperation; Regione Lazio through LazioInnova Progetto Gruppo di Ricerca	This research was funded by Associazione Italiana per la Ricerca contro il Cancro (AIRC) to GM (IG#20473; 2018-2022), Ministry of Health and MAECI Italy-China Science and Technology Cooperation (#PGR00961) to GM. Work has been also supported by Regione Lazio through LazioInnova Progetto Gruppo di Ricerca n 85-2017-14986.	Agbaga MP, 2008, P NATL ACAD SCI USA, V105, P12843, DOI 10.1073/pnas.0802607105; Agostini M, 2016, CELL DEATH DIFFER, V23, P1502, DOI 10.1038/cdd.2016.36; Amelio I, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00373-0; Amelio I, 2020, BIOL DIRECT, V15, DOI 10.1186/s13062-020-00274-3; Bazan NG, 2018, MOL ASPECTS MED, V64, P18, DOI 10.1016/j.mam.2018.09.003; Bellomaria A, 2012, CELL CYCLE, V11, P3638, DOI 10.4161/cc.21918; Bhattacharjee S, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700735; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Carroll PA, 2015, CANCER CELL, V27, P271, DOI 10.1016/j.ccell.2014.11.024; Chen JCY, 2020, BIOL DIRECT, V15, DOI 10.1186/s13062-020-00287-y; Chierici M, 2020, BIOL DIRECT, V15, DOI 10.1186/s13062-020-0259-4; Ciocci M, 2016, ONCOTARGET, V7, P84338, DOI 10.18632/oncotarget.12609; DeBose-Boyd RA, 2018, TRENDS BIOCHEM SCI, V43, P358, DOI 10.1016/j.tibs.2018.01.005; Depuydt P, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.240; Dickerman BA, 2019, NAT MED, V25, P1601, DOI 10.1038/s41591-019-0597-x; Han YT, 2019, BIOL DIRECT, V14, DOI 10.1186/s13062-019-0244-y; Han YT, 2019, BIOL DIRECT, V14, DOI 10.1186/s13062-018-0229-2; Harris ZN, 2019, BIOL DIRECT, V14, DOI 10.1186/s13062-019-0242-0; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Iraci N, 2011, CANCER RES, V71, P404, DOI 10.1158/0008-5472.CAN-10-2627; Jun B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05433-7; Lamastra FR, 2014, RSC ADV, V4, P61809, DOI 10.1039/c4ra12519c; Lin YC, 2008, CANCER RES, V68, P2375, DOI 10.1158/0008-5472.CAN-07-5807; Liu L, 2020, BIOL DIRECT, V15, DOI 10.1186/s13062-020-00264-5; Lutz W, 1996, ONCOGENE, V13, P803; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matthay KK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.78; McGregor GH, 2020, CANCER RES, V80, P175, DOI 10.1158/0008-5472.CAN-19-0644; Mihaylov I, 2019, BIOL DIRECT, V14, DOI 10.1186/s13062-019-0249-6; Mizutani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067317; Nicolai S, 2020, MOL ONCOL, V14, P294, DOI 10.1002/1878-0261.12605; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Pallucca R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090764; Petroni A, 1996, J LIPID MEDIAT CELL, V14, P39, DOI 10.1016/0929-7855(96)00506-8; PIACENTINI M, 1992, INT J CANCER, V52, P271, DOI 10.1002/ijc.2910520220; Pieraccioli M, 2018, P NATL ACAD SCI USA, V115, P7356, DOI 10.1073/pnas.1801435115; Riscal R, 2019, MOL CELL, V76, P220, DOI 10.1016/j.molcel.2019.09.008; Rohrig F, 2016, NAT REV CANCER, V16, P732, DOI 10.1038/nrc.2016.89; ROSS RA, 1983, J NATL CANCER I, V71, P741; Snaebjornsson MT, 2020, CELL METAB, V31, P62, DOI 10.1016/j.cmet.2019.11.010; Snaebjornsson MT, 2019, NATURE, V566, P333, DOI 10.1038/d41586-019-00352-1; Sulciner ML, 2018, CANCER METAST REV, V37, P557, DOI 10.1007/s10555-018-9754-9; Sumsion GR, 2020, BIOL DIRECT, V15, DOI 10.1186/s13062-019-0257-6; Teo W, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016897118; Thiam AR, 2017, J CELL SCI, V130, P315, DOI 10.1242/jcs.192021; THIELE CJ, 1991, CANCER METAST REV, V10, P311, DOI 10.1007/BF00554793; Ruiz-Perez MV, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102128; Yao L, 2015, CANCER RES, V75, P1388, DOI 10.1158/0008-5472.CAN-14-2561; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817; Zirath H, 2013, P NATL ACAD SCI USA, V110, P10258, DOI 10.1073/pnas.1222404110	50	8	8	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 23	2021	40	38					5741	5751		10.1038/s41388-021-01959-3	http://dx.doi.org/10.1038/s41388-021-01959-3		JUL 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UU4CG	34333551				2022-12-26	WOS:000679771600001
J	Aboumrad, M; Shiner, B; Riblet, N; Huizenga, H; Neupane, N; Young-Xu, Y				Aboumrad, Maya; Shiner, Brian; Riblet, Natalie; Huizenga, Hugh; Neupane, Nabin; Young-Xu, Yinong			Trends in COVID-19 cases and clinical management in Veterans Health Administration medical facilities: A national cohort study	PLOS ONE			English	Article								Objective We explored longitudinal trends in sociodemographic characteristics, reported symptoms, laboratory findings, pharmacological and non-pharmacological treatment, comorbidities, and 30-day in-hospital mortality among hospitalized patients with coronavirus disease 2019 (COVID-19). Methods This retrospective cohort study included patients diagnosed with COVID-19 in the United States Veterans Health Administration between 03/01/20 and 08/31/20 and followed until 09/30/20. We focused our analysis on patients that were subsequently hospitalized, and categorized them into groups based on the month of hospitalization. We summarized our findings through descriptive statistics. We used Cuzick's Trend Test to examine any differences in the distribution of our study variables across the six months. Results During our study period, we identified 43,267 patients with COVID-19. A total of 8,240 patients were hospitalized, and 13.1% (N = 1,081) died within 30 days of admission. Hospitalizations increased over time, but the proportion of patients that died consistently declined from 24.8% (N = 221/890) in March to 8.0% (N = 111/1,396) in August. Patients hospitalized in March compared to August were younger on average, mostly black, urban-dwelling, febrile and dyspneic. They also had a higher frequency of baseline comorbidities, including hypertension and diabetes, and were more likely to present with abnormal laboratory findings including low lymphocyte counts and elevated creatinine. Lastly, there was a decline from March to August in receipt of mechanical ventilation (31.4% to 13.1%) and hydroxychloroquine (55.3% to <1.0%), while treatment with dexamethasone (3.7% to 52.4%) and remdesivir (1.1% to 38.9%) increased. Conclusion Among hospitalized patients with COVID-19, we observed a trend towards decreased disease severity and mortality over time.	[Aboumrad, Maya; Shiner, Brian; Riblet, Natalie; Huizenga, Hugh; Neupane, Nabin; Young-Xu, Yinong] White River Junct Vet Affairs Med Ctr, White River Jct, VT USA; [Shiner, Brian; Riblet, Natalie; Huizenga, Hugh; Young-Xu, Yinong] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA	Dartmouth College	Aboumrad, M (corresponding author), White River Junct Vet Affairs Med Ctr, White River Jct, VT USA.	maya.aboumrad@va.gov		Aboumrad, Maya/0000-0001-6140-4250	U.S. Department of Veterans Affairs Office of Rural Health	U.S. Department of Veterans Affairs Office of Rural Health(US Department of Veterans Affairs)	MA, NN, and YYX received funding for this project by the U.S. Department of Veterans Affairs Office of Rural Health (Number Not Applicable). Visit www.ruralhealth.va.gov to learn more. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph C, 2021, J HEALTH POLIT POLIC, V46, P211, DOI 10.1215/03616878-8802162; [Anonymous], 2002, Bull World Health Organ, V80, P983; Bhargava A, 2020, CLIN INFECT DIS, V71, P1962, DOI 10.1093/cid/ciaa674; Bhimraj Adarsh, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa478; Centers for Disease Control and Prevention, 2021, COR DIS 2019 COV 19; COVID-19 Treatment Guidelines Panel, 2021, COR DIS 2019 COVID 1; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; de Lusignan S, 2020, LANCET INFECT DIS, V20, P1034, DOI 10.1016/S1473-3099(20)30371-6; Department of Veterans Affairs Office of Inspector General, 2020, REV VET HLTH ADM COV; Eibner Christine, 2016, Rand Health Q, V5, P13; Fauver JR, 2020, CELL, V181, P990, DOI 10.1016/j.cell.2020.04.021; Gianfrancesco MA, 2021, LANCET RHEUMATOL, V3, pE88, DOI 10.1016/S2665-9913(21)00008-4; Grein J, 2020, NEW ENGL J MED, V382, P2327, DOI 10.1056/NEJMoa2007016; Henry BM, 2020, CLIN CHEM LAB MED, V58, P1021, DOI 10.1515/cclm-2020-0369; Heyworth L, 2020, NEJM CATAL INNOV CAR, P1, DOI DOI 10.1056/CAT.20.0327; Hoerster KD, 2012, AM J PREV MED, V43, P483, DOI 10.1016/j.amepre.2012.07.029; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Ioannou GN, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22310; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Magagnoli J, 2020, MED-CAMBRIDGE, V1, P114, DOI [10.1016/j.medj.2020.06.001, 10.1101/2020.04.16.20065920]; Mahajan UV, 2020, J PUBLIC HEALTH-UK, V42, P445, DOI 10.1093/pubmed/fdaa070; Miller IF, 2020, NAT MED, V26, P1212, DOI 10.1038/s41591-020-0952-y; Peterson K, 2018, AM J PUBLIC HEALTH, V108, pE1, DOI [10.2105/AJPH.2017.304246, 10.2105/ajph.2017.304246]; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Rentsch CT, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003379; Sattui SE, 2020, EXPERT REV CLIN IMMU, V16, P659, DOI 10.1080/1744666X.2020.1792778; Silva A, 2016, MIL MED, V181, P469, DOI 10.7205/MILMED-D-15-00094; United States Census Bureau, FACTS FEAT VET DAY 2; Veterans Health Administration Office of Emergency Management, 2020, COVID 19 RESP PLAN; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0246217	10.1371/journal.pone.0246217	http://dx.doi.org/10.1371/journal.pone.0246217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324514	Green Published, gold			2022-12-26	WOS:000685248200051
J	Chen, LJ; Chang, YJ; Shieh, CF; Yu, JH; Yang, MC				Chen, Li-Ju; Chang, Yun-Jau; Shieh, Chun-Fu; Yu, Jy-Haw; Yang, Ming-Chin			Relationship between practices of eye protection against solar ultraviolet radiation and cataract in a rural area	PLOS ONE			English	Article							EXPOSURE; POPULATION; SUNGLASSES; KNOWLEDGE; SETTINGS; BEHAVIOR; LIGHT; RISK; AGE	Background Cataract is a public health concern worldwide that differentially affects rural residents of outlying islands where ultraviolet radiation (UVR) may have greater penetration because of less shading. Objectives To assess the relationships between attitudes and practices of eye protection and eye diseases for residents of an offshore island of Taiwan. Methods Questionnaire survey was administered to local residents (age > 50 years) regarding socio-demographic information, attitudes/practices of eye protection under sun exposure and eye diseases. Results A total of 816 participants (response rate 90.7%, 816/900) completed the questionnaires. Mean age was 63.7 (+ 10.8) years. Among these participants, 44.4%, 15.1% and 8.3% had cataract, dry eye and glaucoma, respectively. Although 86.3% and 88.2% of participants agreed that they should avoid outdoor activities and wear glasses/broad-brimmed hats in harsh daylight, 69.4% and 48.3% of participants never/rarely used glasses or hats/umbrellas in harsh daylight, respectively. Predictors of less practices of eye protection against solar UVR included residents who were male, with lower education level, with longer residence and lack of commercial health insurance. Multivariate logistic regression revealed that practices of eye protection under sun exposure were significantly associated with less cataract, but not glaucoma or dry eye. Participants who did not wear glasses, broad-brimmed hats/use umbrellas or both in harsh sunlight (almost) every time were respectively associated with a 57% (P = 0.028), 45% (P = 0.027) or 70% (P = 0.026) increase of cataract than those who did in harsh sunlight (almost) every time. Conclusions Practices of eye protection under sun exposure is associated with lower risk of cataract.	[Chen, Li-Ju; Yu, Jy-Haw] Taipei City Hosp, Heping Fuyou Branch, Dept Ophthalmol, Taipei, Taiwan; [Chen, Li-Ju] Univ Taipei, Taipei, Taiwan; [Chen, Li-Ju; Yang, Ming-Chin] Natl Taiwan Univ, Inst Hlth Policy & Management, Coll Publ Hlth, Taipei, Taiwan; [Chang, Yun-Jau] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Chang, Yun-Jau] Taipei City Hosp, Zhongxing Branch, Dept Surg, Taipei, Taiwan; [Shieh, Chun-Fu] Lienchiang Cty Hosp, Matsu, Taiwan	Taipei City Hospital; University of Taipei; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Taipei City Hospital	Chen, LJ (corresponding author), Taipei City Hosp, Heping Fuyou Branch, Dept Ophthalmol, Taipei, Taiwan.; Chen, LJ (corresponding author), Univ Taipei, Taipei, Taiwan.; Chen, LJ; Yang, MC (corresponding author), Natl Taiwan Univ, Inst Hlth Policy & Management, Coll Publ Hlth, Taipei, Taiwan.	lijuchen2013@gmail.com; mcyang637@ntu.edu.tw	Chang, Yun-Jau/AAW-2238-2021	Chang, Yun-Jau/0000-0002-2433-0544	Department of Health, Taipei City Government, Taipei, Taiwan [TPCH-103-032]	Department of Health, Taipei City Government, Taipei, Taiwan	The study was supported by the Department of Health, Taipei City Government, Taipei, Taiwan (TPCH-103-032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2015, INVEST OPHTH VIS SCI, V56, P1023, DOI 10.1167/iovs.14-16019; Athanasiov PA, 2008, BRIT J OPHTHALMOL, V92, P1169, DOI 10.1136/bjo.2008.139725; Backes C, 2019, J EXPO SCI ENV EPID, V29, P753, DOI 10.1038/s41370-018-0087-0; Behar-Cohen F, 2014, CLIN OPHTHALMOL, V8, P87, DOI 10.2147/OPTH.S46189; Chen LJ, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1501-8; Chen N, 2015, RURAL REMOTE HEALTH, V15; Cheng C Y, 2000, Zhonghua Yi Xue Za Zhi (Taipei), V63, P641; Cheng SW, 2010, PHOTODERMATOL PHOTO, V26, P177, DOI 10.1111/j.1600-0781.2010.00513.x; Chua J, 2015, OPHTHALMOLOGY, V122, P2169, DOI 10.1016/j.ophtha.2015.06.052; Delcourt C, 2000, ARCH OPHTHALMOL-CHIC, V118, P385, DOI 10.1001/archopht.118.3.385; Falk M, 2013, CANCER EPIDEMIOL, V37, P127, DOI 10.1016/j.canep.2012.12.006; Gao Q, 2014, J PHOTOCH PHOTOBIO B, V140, P14, DOI 10.1016/j.jphotobiol.2014.07.002; Koch S, 2017, AUSTRALAS J DERMATOL, V58, P111, DOI 10.1111/ajd.12433; Lagerlund M, 2006, PREV MED, V42, P291, DOI 10.1016/j.ypmed.2006.01.003; Lucas RM, 2011, EYE CONTACT LENS, V37, P168, DOI 10.1097/ICL.0b013e31821cb0cf; Maddock JE, 2009, OPTOMETRY VISION SCI, V86, P165, DOI 10.1097/OPX.0b013e318194eae7; Miyashita H, 2019, PLOS ONE, V14, DOI [10.1371/journal.pone.0215338, 10.1371/journal.pone.0222679]; Modenese A, 2018, ACTA OPHTHALMOL, V96, P779, DOI 10.1111/aos.13734; Pastor-Valero Maria, 2007, BMC Ophthalmol, V7, P18, DOI 10.1186/1471-2415-7-18; Robman L, 2005, EYE, V19, P1074, DOI 10.1038/sj.eye.6701964; ROSENTHAL FS, 1985, PHOTOCHEM PHOTOBIOL, V42, P163, DOI 10.1111/j.1751-1097.1985.tb01555.x; Saliba AJ, 2008, RURAL REMOTE HEALTH, V8; Shih YH, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-128; Sliney DH, 2011, EYE CONTACT LENS, V37, P250, DOI 10.1097/ICL.0b013e31822126d4; Tang YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135870; TAYLOR HR, 1989, PHOTOCHEM PHOTOBIOL, V50, P489, DOI 10.1111/j.1751-1097.1989.tb05553.x; TAYLOR HR, 1988, NEW ENGL J MED, V319, P1429, DOI 10.1056/NEJM198812013192201; Utrillas MP, 2010, PHOTOCHEM PHOTOBIOL, V86, P449, DOI 10.1111/j.1751-1097.2009.00677.x; Vashist P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227868; World Health Organization, PROT EXP ULTR RAD; World Health Organization, BLINDN VIS IMP; Yam JCS, 2014, INT OPHTHALMOL, V34, P383, DOI 10.1007/s10792-013-9791-x	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255136	10.1371/journal.pone.0255136	http://dx.doi.org/10.1371/journal.pone.0255136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324583	gold, Green Published			2022-12-26	WOS:000685248200018
J	Galarneau, LR; Hilburt, J; O'Neill, ZR; Buxton, JA; Scheuermeyer, FX; Dong, K; Kaczorowski, J; Orkin, AM; Barbic, SP; Bath, M; Moe, J; Miles, I; Tobin, D; Grier, S; Garrod, E; Kestler, A				Galarneau, Lexis R.; Hilburt, Jesse; O'Neill, Zoe R.; Buxton, Jane A.; Scheuermeyer, Frank X.; Dong, Kathryn; Kaczorowski, Janusz; Orkin, Aaron M.; Barbic, Skye Pamela; Bath, Misty; Moe, Jessica; Miles, Isabelle; Tobin, Dianne; Grier, Sherry; Garrod, Emma; Kestler, Andrew			Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study	PLOS ONE			English	Article								Aim To capture pandemic experiences of people with opioid use disorder (OUD) to better inform the programs that serve them. Design We designed, conducted, and analyzed semi-structured qualitative interviews using grounded theory. We conducted interviews until theme saturation was reached and we iteratively developed a codebook of emerging themes. Individuals with lived experience of substance use provided feedback at all steps of the study. Setting We conducted phone or in-person interviews in compliance with physical distancing and public health regulations in outdoor Vancouver parks or well-ventilated indoor spaces between June to September 2020. Participants Using purposive sampling, we recruited participants (n = 19) who were individuals with OUD enrolled in an intensive community outreach program, had visited one of two emergency departments, were over 18, lived within catchment, and were not already receiving opioid agonist therapy. Measurements We audio-recorded interviews, which were later transcribed verbatim and checked for accuracy while removing all identifiers. Interviews explored participants' knowledge of COVID-19 and related safety measures, changes to drug use and healthcare services, and community impacts of COVID-19. Results One third of participants were women, approximately two thirds had stable housing, and ages ranged between 23 and 59 years old. Participants were knowledgeable on COVID-19 public health measures. Some participants noted that fear decreased social connection and reluctance to help reverse overdoses; others expressed pride in community cohesion during crisis. Several participants mentioned decreased access to housing, harm reduction, and medical care services. Several participants reported using drugs alone more frequently, consuming different or fewer drugs because of supply shortages, or using more drugs to replace lost activities. Conclusion COVID-19 had profound effects on the social lives, access to services, and risk-taking behaviour of people with opioid use disorder. Pandemic public health measures must include risk mitigation strategies to maintain access to critical opioid-related services.	[Galarneau, Lexis R.; Buxton, Jane A.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Galarneau, Lexis R.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Hilburt, Jesse; Bath, Misty] Vancouver Coastal Hlth, Vancouver, BC, Canada; [O'Neill, Zoe R.] McGill Univ, Fac Med & Hlth Sci, Montreal, PQ, Canada; [Buxton, Jane A.; Moe, Jessica] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Scheuermeyer, Frank X.; Miles, Isabelle; Kestler, Andrew] Univ British Columbia, St Pauls Hosp, Dept Emergency Med, Vancouver, BC, Canada; [Scheuermeyer, Frank X.; Barbic, Skye Pamela; Kestler, Andrew] Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Dong, Kathryn] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada; [Kaczorowski, Janusz] Univ Montreal, Ctr Hosp Univ Montreal, Ctr Rech, Dept Family & Emergency Med, Montreal, PQ, Canada; [Orkin, Aaron M.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Orkin, Aaron M.] Inner City Hlth Associates, Toronto, ON, Canada; [Barbic, Skye Pamela] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Fac Med, Vancouver, BC, Canada; [Kaczorowski, Janusz; Moe, Jessica] Univ British Columbia, Dept Emergency Med, Vancouver, BC, Canada; [Tobin, Dianne] Vancouver Area Network, Drug Users, Vancouver, BC, Canada; [Grier, Sherry] Portland Hotel Soc Community Serv Soc, Portland, BC, Canada; [Garrod, Emma] Providence Hlth Care, Providence, BC, Canada; [Garrod, Emma; Kestler, Andrew] British Columbia Ctr Substance Use, Vancouver, BC, Canada	University of British Columbia; University of Alberta; Vancouver Coastal Health Research Institute; McGill University; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of Alberta; Universite de Montreal; University of Toronto; University of British Columbia; University of British Columbia	Galarneau, LR (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.; Galarneau, LR (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.; Kestler, A (corresponding author), Univ British Columbia, St Pauls Hosp, Dept Emergency Med, Vancouver, BC, Canada.; Kestler, A (corresponding author), Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada.; Kestler, A (corresponding author), British Columbia Ctr Substance Use, Vancouver, BC, Canada.	lexis@ualberta.ca; andrew.kestler@ubc.ca	Orkin, Aaron/K-2500-2014; Orkin, Aaron/AAY-8860-2021	Orkin, Aaron/0000-0002-1111-8720; Orkin, Aaron/0000-0002-1111-8720	Canadian Institutes of Health Research (CIHR) [NRF 154893]; Providence Health Care Research Institute; Vancouver Coastal Health Research Institute [F19-02338]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Providence Health Care Research Institute; Vancouver Coastal Health Research Institute	The principal investigator (AK) received two grants from separate funders to support this study. The first funder was the Canadian Institutes of Health Research (CIHR) to the Canadian Research Initiative in Substance Misuse (CRISM) (grant number: CRISM Implementation Science Program on Opioid Interventions & Services NRF 154893). The URL of this funder is: https://crism.ca/.The second funder was the Providence Health Care Research Institute and Vancouver Coastal Health Research Institute (grant number: Innovation & Translation Research Award F19-02338). The URLs of this funder is https://www.providenceresearch.ca/and https://www.vchri.ca/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advocacy Resource Center, 2020, ISS BRIEF REP INCR O; Ali FS, 2021, IEEE T IND INFORM, V17, P5769, DOI 10.1109/TII.2020.3046744; [Anonymous], 2018, NVIVO PROQUALITATIVE; [Anonymous], ALB COVID 19 OP RESP; [Anonymous], 2020, YAL PROGR ADD MED GL; Farhoudian A, 2020, BASIC CLIN NEUROSCI, V11, P133, DOI 10.32598/bcn.11.covid19.1; Islam MM, 2008, INT J DRUG POLICY, V19, P436, DOI 10.1016/j.drugpo.2007.07.006; Karamouzian M, 2020, LANCET PSYCHIAT, V7, P390, DOI 10.1016/S2215-0366(20)30144-9; Kennedy TJT, 2006, MED EDUC, V40, P101, DOI 10.1111/j.1365-2929.2005.02378.x; Lau, 2021, OTTERAI BASIC TRANSC; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Russell C, 2021, J SUBST ABUSE TREAT, V129, DOI 10.1016/j.jsat.2021.108374; Santo Thomas Jr, 2021, JAMA Psychiatry, V78, P979, DOI 10.1001/jamapsychiatry.2021.0976; Sordo L, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1550; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; United States Department of Health and Human Services Food and Drug Administration Office of Medical Products and Tobacco Center for Drug Evaluation and Research Office of Generic Drugs Office of Generic Drug Policy, 2021, APPR DRUG PROD THER; Wang QQ, 2021, MOL PSYCHIATR, V26, P30, DOI 10.1038/s41380-020-00880-7; Whitfield M, 2020, INT J DRUG POLICY, V83, DOI 10.1016/j.drugpo.2020.102851	18	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255396	10.1371/journal.pone.0255396	http://dx.doi.org/10.1371/journal.pone.0255396			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324589	Green Published, gold			2022-12-26	WOS:000685248200076
J	Amit, LN; Mori, D; John, JL; Chin, AZ; Mosiun, AK; Jeffree, MS; Ahmed, K				Amit, Lia Natasha; Mori, Daisuke; John, Jecelyn Leaslie; Chin, Abraham Zefong; Mosiun, Andau Konodan; Jeffree, Mohammad Saffree; Ahmed, Kamruddin			Emergence of equine-like G3 strains as the dominant rotavirus among children under five with diarrhea in Sabah, Malaysia during 2018-2019	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; VP4 ANTIGENIC EPITOPES; GENE REASSORTANT; BOVINE-LIKE; GASTROENTERITIS; SEROTYPE; EPIDEMIOLOGY; DS-1-LIKE; BURDEN; NEUTRALIZATION	Rotavirus infection is a dilemma for developing countries, including Malaysia. Although commercial rotavirus vaccines are available, these are not included in Malaysia's national immunization program. A scarcity of data about rotavirus genotype distribution could be partially to blame for this policy decision, because there are no data for rotavirus genotype distribution in Malaysia over the past 20 years. From January 2018 to March 2019, we conducted a study to elucidate the rotavirus burden and genotype distribution in the Kota Kinabalu and Kunak districts of the state of Sabah. Stool specimens were collected from children under 5 years of age, and rotavirus antigen in these samples was detected using commercially available kit. Electropherotypes were determined by polyacrylamide gel electrophoresis of genomic RNA. G and P genotypes were determined by RT-PCR using type specific primers. The nucleotide sequence of the amplicons was determined by Sanger sequencing and phylogenetic analysis was performed by neighbor-joining method. Rotavirus was identified in 43 (15.1%) children with watery diarrhea. The male:female ratio (1.9:1) of the rotavirus-infected children clearly showed that it affected predominantly boys, and children 12-23 months of age. The genotypes identified were G3P[8] (74% n = 31), followed by G1P[8] (14% n = 6), G12P[6](7% n = 3), G8P[8](3% n = 1), and GxP[8] (3% n = 1). The predominant rotavirus circulating among the children was the equine-like G3P[8] (59.5% n = 25) with a short electropherotype. Eleven electropherotypes were identified among 34 strains, indicating substantial diversity among the circulating strains. The circulating genotypes were also phylogenetically diverse and related to strains from several different countries. The antigenic epitopes present on VP7 and VP4 of Sabahan G3 and equine-like G3 differed considerably from that of the RotaTeq vaccine strain. Our results also indicate that considerable genetic exchange is occurring in Sabahan strains. Sabah is home to a number of different ethnic groups, some of which culturally are in close contact with animals, which might contribute to the evolution of diverse rotavirus strains. Sabah is also a popular tourist destination, and a large number of tourists from different countries possibly contributes to the diversity of circulating rotavirus genotypes. Considering all these factors which are contributing rotavirus genotype diversity, continuous surveillance of rotavirus strains is of utmost importance to monitor the pre- and post-vaccination efficacy of rotavirus vaccines in Sabah.	[Amit, Lia Natasha; Mori, Daisuke; Ahmed, Kamruddin] Univ Malaysia Sabah, Dept Pathobiol & Med Diagnost, Fac Med & Hlth Sci, Kota Kinabalu, Sabah, Malaysia; [John, Jecelyn Leaslie; Ahmed, Kamruddin] Univ Malaysia Sabah, Borneo Med & Hlth Res Ctr, Fac Med & Hlth Sci, Kota Kinabalu, Sabah, Malaysia; [Chin, Abraham Zefong; Jeffree, Mohammad Saffree] Univ Malaysia Sabah, Dept Community & Family Med, Fac Med & Hlth Sci, Kota Kinabalu, Sabah, Malaysia; [Mosiun, Andau Konodan] Minist Hlth Malaysia, Kunak Dist Hlth Off, Kunak, Sabah, Malaysia	Universiti Malaysia Sabah; Universiti Malaysia Sabah; Universiti Malaysia Sabah; Kementerian Kesihatan Malaysia	Ahmed, K (corresponding author), Univ Malaysia Sabah, Dept Pathobiol & Med Diagnost, Fac Med & Hlth Sci, Kota Kinabalu, Sabah, Malaysia.; Ahmed, K (corresponding author), Univ Malaysia Sabah, Borneo Med & Hlth Res Ctr, Fac Med & Hlth Sci, Kota Kinabalu, Sabah, Malaysia.	ahmed@ums.edu.my	Jeffree, Mohammad Saffree/G-1156-2017	Jeffree, Mohammad Saffree/0000-0002-0373-4451	Ministry of High Education under FRGS (Fundamental Research Grant Scheme) grant [FRGS 0457-2017]	Ministry of High Education under FRGS (Fundamental Research Grant Scheme) grant	This study was funded by Ministry of High Education under FRGS (Fundamental Research Grant Scheme) grant (FRGS 0457-2017) (URL: https://mygrants.gov.my) to KA. The funder played no role in the study design, data collected and analysis, decision to publish, or preparation of the manuscript.	Agbemabiese CA, 2015, INFECT GENET EVOL, V35, P184, DOI 10.1016/j.meegid.2015.07.033; Ahmed K, 2005, J MED VIROL, V77, P323, DOI 10.1002/jmv.20451; Ahmed K, 2007, EMERG INFECT DIS, V13, P1232, DOI 10.3201/eid1308.061038; Ahmed K, 2010, VIRUS GENES, V40, P347, DOI 10.1007/s11262-010-0463-x; Ahmed K, 2010, ARCH VIROL, V155, P71, DOI 10.1007/s00705-009-0552-0; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P49; Azemi Mehmedali, 2013, Mater Sociomed, V25, P9, DOI 10.5455/msm.2013.25.9-13; Banerjee A, 2018, INFECT GENET EVOL, V63, P158, DOI 10.1016/j.meegid.2018.05.026; Bayard V, 2012, INT J INFECT DIS, V16, pE94, DOI 10.1016/j.ijid.2011.09.003; Borade Ashwin, 2010, Indian J Med Sci, V64, P210, DOI 10.4103/0019-5359.98942; Bozdayi G, 2008, J MED VIROL, V80, P733, DOI 10.1002/jmv.21120; Collins PJ, 2010, ARCH VIROL, V155, P1247, DOI 10.1007/s00705-010-0713-1; Cowley D, 2018, VACCINE, V36, P5872, DOI 10.1016/j.vaccine.2018.08.027; Delogu R, 2013, J CLIN MICROBIOL, V51, P1583, DOI 10.1128/JCM.00396-13; Desselberger U, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6040065; DYALLSMITH ML, 1986, P NATL ACAD SCI USA, V83, P3465, DOI 10.1073/pnas.83.10.3465; ESTES MK, 1989, MICROBIOL REV, V53, P410, DOI 10.1128/MMBR.53.4.410-449.1989; Fredj MB, 2013, INFECT GENET EVOL, V18, P132, DOI 10.1016/j.meegid.2013.05.008; Gastanaduy PA, 2013, JAMA-J AM MED ASSOC, V310, P851, DOI 10.1001/jama.2013.170800; George S, 2018, J CLIN DIAGN RES, V12, pDC1, DOI 10.7860/JCDR/2018/35403.11964; Goh C T, 2009, Med J Malaysia, V64, P146; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; GUNASENA S, 1993, J CLIN MICROBIOL, V31, P2195, DOI 10.1128/JCM.31.8.2195-2197.1993; Harrison SC., 2016, STRUCTURE FUNCTION R, P89; Hegazi MA, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006574; Henschke N., 2019, COCHRANE DB SYST REV; Heylen E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100953; Hoa-Tran TN, 2016, ARCH VIROL, V161, P479, DOI 10.1007/s00705-015-2682-x; Hoque SA, 2018, VACCINE, V36, P43, DOI 10.1016/j.vaccine.2017.11.056; HOSHINO Y, 1985, P NATL ACAD SCI USA, V82, P8701, DOI 10.1073/pnas.82.24.8701; Hsu VP, 2005, J INFECT DIS, V192, pS80, DOI 10.1086/431494; Hung LC, 2006, INT J INFECT DIS, V10, P470, DOI 10.1016/j.ijid.2006.05.008; Intamaso U, 2017, ARCH CLIN MICROBIOL, V8, P60; Junaid SA, 2011, VIROL J, V8, DOI [10.1186/1743-422X-8-233, 10.1186/1743-422X-8-244]; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; KIRKWOOD C, 1993, VIROLOGY, V196, P79, DOI 10.1006/viro.1993.1456; Kondo K, 2017, EMERG INFECT DIS, V23, P968, DOI 10.3201/eid2306.160038; Koshimura Y, 2000, MICROBIOL IMMUNOL, V44, P499, DOI 10.1111/j.1348-0421.2000.tb02525.x; Kotloff KL, 2017, PEDIATR CLIN N AM, V64, P799, DOI 10.1016/j.pcl.2017.03.006; Lee WS, 2012, HUM VACC IMMUNOTHER, V8, P1401, DOI 10.4161/hv.21577; Loganathan T, 2016, PEDIATR INFECT DIS J, V35, P601, DOI 10.1097/INF.0000000000001129; Lucero Y, 2019, J PEDIATR-US, V204, P298, DOI 10.1016/j.jpeds.2018.08.037; Luchs A, 2018, INT J INFECT DIS, V73, P190, DOI 10.1016/j.ijid.2018.04.3845; Maguire JE, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-1024; Martella V, 2007, J CLIN MICROBIOL, V45, P577, DOI 10.1128/JCM.02262-06; MATSUNO S, 1985, J VIROL, V54, P623, DOI 10.1128/JVI.54.2.623-624.1985; Mazid R, 2020, NEW MICROB NEW INFEC, V33, DOI 10.1016/j.nmni.2019.100621; Mitui MT, 2011, J CLIN VIROL, V50, P325, DOI 10.1016/j.jcv.2011.01.008; Morozova OV, 2015, ARCH VIROL, V160, P1693, DOI 10.1007/s00705-015-2439-6; Motamedi-Rad M, 2020, J MED VIROL, V92, P1110, DOI 10.1002/jmv.25642; Mukherjee A, 2013, J MED VIROL, V85, P537, DOI 10.1002/jmv.23483; Myat TW., 2019, OUTBREAK SURVEILL IN, V12; Nakagomi T, 2017, ARCH VIROL, V162, P739, DOI 10.1007/s00705-016-3155-6; Nayak MK, 2019, VACCINE, V37, P6842, DOI 10.1016/j.vaccine.2019.06.062; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Payne DC, 2008, PEDIATRICS, V122, P1235, DOI 10.1542/peds.2007-3378; Sadiq A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220387; Guerra SFS, 2016, J GEN VIROL, V97, P3131, DOI 10.1099/jgv.0.000626; Schoondermark-van de Ven E, 2013, VET MICROBIOL, V166, P154, DOI 10.1016/j.vetmic.2013.05.028; Tacharoenmuang R, 2020, J MED VIROL, V92, P174, DOI 10.1002/jmv.25591; Tacharoenmuang R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165826; Tamim S, 2013, INFECT GENET EVOL, V14, P161, DOI 10.1016/j.meegid.2012.10.009; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Theamboonlers A, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-569; Uchida R, 2006, J CLIN MICROBIOL, V44, P3499, DOI 10.1128/JCM.01089-06; Utsumi T, 2018, INFECT GENET EVOL, V61, P224, DOI 10.1016/j.meegid.2018.03.027; VELAZQUEZ FR, 1993, PEDIATR INFECT DIS J, V12, P54, DOI 10.1097/00006454-199301000-00013; Vizzi E, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0721-9; Wangchuk S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110795; Watanabe M, 2001, ARCH VIROL, V146, P557, DOI 10.1007/s007050170162; World Health Organization, 2021, MAL WHO UNICEF EST I; Yahiro T, 2018, INFECT GENET EVOL, V65, P170, DOI 10.1016/j.meegid.2018.07.014; Zeller M, 2012, J CLIN MICROBIOL, V50, P966, DOI 10.1128/JCM.05590-11; Zuridah H, 2009, Med J Malaysia, V64, P193	74	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254784	10.1371/journal.pone.0254784	http://dx.doi.org/10.1371/journal.pone.0254784			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320003	gold, Green Published			2022-12-26	WOS:000685247800038
J	Hirabayashi, A; Yahara, K; Mitsuhashi, S; Nakagawa, S; Imanishi, T; Ha, VTT; Nguyen, AV; Nguyen, ST; Shibayama, K; Suzuki, M				Hirabayashi, Aki; Yahara, Koji; Mitsuhashi, Satomi; Nakagawa, So; Imanishi, Tadashi; Ha, Van Thi Thu; Nguyen, An Van; Nguyen, Son Thai; Shibayama, Keigo; Suzuki, Masato			Plasmid analysis of NDM metallo-beta-lactamase-producing Enterobacterales isolated in Vietnam	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; KLEBSIELLA-PNEUMONIAE; CARBAPENEM RESISTANCE; ESCHERICHIA-COLI; GENES; ACQUISITION; ENVIRONMENT	Carbapenem-resistant Enterobacterales (CRE) represent a serious threat to public health due to the lack of treatment and high mortality. The rate of antimicrobial resistance of Enterobacterales isolates to major antimicrobials, including carbapenems, is much higher in Vietnam than in Western countries, but the reasons remain unknown due to the lack of genomic epidemiology research. A previous study suggested that carbapenem resistance genes, such as the carbapenemase gene bla(NDM), spread via plasmids among Enterobacterales in Vietnam. In this study, we characterized bla(NDM)-carrying plasmids in Enterobacterales isolated in Vietnam, and identified several possible cases of horizontal transfer of plasmids both within and among species of bacteria. Twenty-five carbapenem-nonsusceptible isolates from a medical institution in Hanoi were sequenced on Illumina short-read sequencers, and 13 bla(NDM)-positive isolates, including isolates of Klebsiella pneumoniae, Escherichia coli, Citrobacter freundii, Morganella morganii, and Proteus mirabilis, were further sequenced on an Oxford Nanopore Technologies long-read sequencer to obtain complete plasmid sequences. Almost identical 73 kb IncFII(pSE11)::IncN hybrid plasmids carrying bla(NDM-1) were found in a P. mirabilis isolate and an M. morganii isolate. A 112 kb IncFII(pRSB107)::IncN hybrid plasmid carrying bla(NDM-1) in an E. coli isolate had partially identical sequences with a 39 kb IncR plasmid carrying bla(NDM-1) and an 88 kb IncFII(pHN7A8)::IncN hybrid plasmid in a C. freundii isolate. 148-149 kb IncFIA(Hl1)::IncA/C2 plasmids and 75-76 kb IncFII(Yp) plasmids, both carrying bla(NDM-1) were shared among three sequence type 11 (ST11) isolates and three ST395 isolates of K. pneumoniae, respectively. Most of the plasmids co-carried genes conferring resistance to clinically relevant antimicrobials, including third-generation cephalosporins, aminoglycosides, and fluoroquinolones, in addition to bla(NDM-1). These results provide insight into the genetic basis of CRE in Vietnam, and could help control nosocomial infections.	[Hirabayashi, Aki; Yahara, Koji; Suzuki, Masato] Natl Inst Infect Dis, AMR Res Ctr, Tokyo, Japan; [Mitsuhashi, Satomi; Nakagawa, So; Imanishi, Tadashi] Tokai Univ, Dept Mol Life Sci, Sch Med, Shibuya, Kanagawa, Japan; [Ha, Van Thi Thu; Nguyen, An Van; Nguyen, Son Thai] Mil Med Univ, Dept Microbiol, Hosp 103, Dept Microbiol, Hanoi, Vietnam; [Shibayama, Keigo] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Tokai University; National Institute of Infectious Diseases (NIID)	Suzuki, M (corresponding author), Natl Inst Infect Dis, AMR Res Ctr, Tokyo, Japan.; Shibayama, K (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan.	keigo@nih.go.jp; suzuki-m@nih.go.jp	Suzuki, Masato/B-7568-2013; Nakagawa, So/Q-2712-2015	Suzuki, Masato/0000-0001-8975-2193; Nakagawa, So/0000-0003-1760-3839; , NGUYEN VAN AN/0000-0002-4973-203X	Nagasaki University [2019-Ippan-20]; Japan Society for the Promotion of Science [20K07509, 21K15440]; Japan Agency for Medical Research and Development [JP20fk0108061, JP18fm0108003, JP19fm0108006, JP21fk0108604, JP21fk0108093, JP21fk0108139, JP21fk0108133, JP21wm0325003, JP21wm0325022, JP21wm0225004, JP21wm0225008, JP17fm0108023]	Nagasaki University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by Nagasaki University (2019-Ippan-20 to MS), the Japan Society for the Promotion of Science (20K07509 to MS and 21K15440 to AH), and the Japan Agency for Medical Research and Development (JP20fk0108061, JP18fm0108003, JP19fm0108006, and JP21fk0108604 to KS) (JP21fk0108093, JP21fk0108139, JP21fk0108133, JP21wm0325003, JP21wm0325022, JP21wm0225004, and JP21wm0225008 to MS) (JP17fm0108023 to TI).	Baraniak A, 2019, J ANTIMICROB CHEMOTH, V74, P3199, DOI 10.1093/jac/dkz315; Bi DX, 2013, NUCLEIC ACIDS RES, V41, pD660, DOI 10.1093/nar/gks1248; Bontron S, 2016, ANTIMICROB AGENTS CH, V60, P7245, DOI 10.1128/AAC.01755-16; Bowers JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133727; Compain F, 2014, ANTIMICROB AGENTS CH, V58, P4207, DOI 10.1128/AAC.02773-13; Conlan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009845; Dolejska M, 2013, J ANTIMICROB CHEMOTH, V68, P333, DOI 10.1093/jac/dks387; Ecdc, 2013, SURV REP; Gorrie CL, 2018, CLIN INFECT DIS, V67, P161, DOI 10.1093/cid/ciy027; He LY, 2013, J ANTIMICROB CHEMOTH, V68, P46, DOI 10.1093/jac/dks369; He SS, 2016, MBIO, V7, DOI 10.1128/mBio.01987-16; Isozumi R, 2012, EMERG INFECT DIS, V18, P1383, DOI 10.3201/eid1808.111816; Jiang LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084578; Kohler PP, 2017, INFECT CONT HOSP EP, V38, P1319, DOI 10.1017/ice.2017.197; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Lemon JK, 2017, J CLIN MICROBIOL, V55, P3530, DOI 10.1128/JCM.01069-17; Li H, 2016, BIOINFORMATICS, V32, P2103, DOI 10.1093/bioinformatics/btw152; Martin A, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy150; Mathers AJ, 2015, CLIN MICROBIOL REV, V28, P565, DOI 10.1128/CMR.00116-14; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P6065, DOI 10.1128/AAC.00117-12; Pfeifer Y, 2011, J ANTIMICROB CHEMOTH, V66, P1998, DOI 10.1093/jac/dkr256; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P1087, DOI 10.1128/AAC.05620-11; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Rozwandowicz M, 2018, J ANTIMICROB CHEMOTH, V73, P1121, DOI 10.1093/jac/dkx488; Runcharoen C, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0397-1; Sanchez GV, 2013, EMERG INFECT DIS, V19, P133, DOI 10.3201/eid1901.120310; Tada T, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2570-y; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Dung VTV, 2019, J GLOB ANTIMICROB RE, V18, P269, DOI 10.1016/j.jgar.2019.06.002; Wailan AM, 2016, ANTIMICROB AGENTS CH, V60, P4082, DOI 10.1128/AAC.00368-16; Wailan AM, 2016, ANTIMICROB AGENTS CH, V60, P136, DOI 10.1128/AAC.01243-15; Weber RE, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02817; Wertheim HFL, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001429; Wu WJ, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00115-18; Yamane K, 2007, ANTIMICROB AGENTS CH, V51, P3354, DOI 10.1128/AAC.00339-07	38	3	3	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0231119	10.1371/journal.pone.0231119	http://dx.doi.org/10.1371/journal.pone.0231119			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34319973	Green Published, gold			2022-12-26	WOS:000685247800048
J	El-Attar, EA; Hosny, TA; Ichihara, K; Bedair, RN; Tork, ASE				El-Attar, Eman Ahmed; Hosny, Tamer A.; Ichihara, Kiyoshi; Bedair, Rania N.; Tork, Ahmed Salah El-Din			Nomogram of age-specific anti-Mullerian hormone levels in healthy Egyptian females	PLOS ONE			English	Article							ANTIMULLERIAN HORMONE; OVARIAN RESERVE; WOMEN; VARIABILITY; STIMULATION; MENOPAUSE; CYCLE	Background Anti-Mullerian hormone (AMH) is an important determinant of ovarian reserve in fertility workups in many clinical settings. Thus, we investigated the age dependent decline in AMH specific to the Egyptian population and sought to establish an age dependent reference interval parametrically. Methods Serum samples were collected from 841 apparently healthy women. AMH was measured using an electro-chemiluminescent technique. Box-Cox power transformation was used to make the AMH distribution Gaussian for parametric derivation of reference intervals. Results Power of 0.4 was found optimal for Gaussian transformation of AMH reference values. We demonstrate the strong negative relation between circulating AMH and female age with Spearman's correlation coefficient of r(S) = -0.528. Age-specific reference interval was determined for every 5 years of age from 16 to 49, and nomogram was constructed by smoothing the lines connecting adjacent lower and upper reference limits. Conclusion The age-specific reference intervals and the age-AMH nomogram could be valuable in the clinical practice of in reproductive medicine. To our knowledge, this is the first study to confirm AMH levels in Egyptian females. We were able to explore age-related AMH levels specific to Egyptian females in the fertile age group and to treat skewed AMH data in a multi-step scheme using power transformation. Thus, a more accurate nomogram was constructed accommodating a profile delineated for a wide age range and a rescaled AMH axis improving its usability.	[El-Attar, Eman Ahmed; Bedair, Rania N.; Tork, Ahmed Salah El-Din] Alexandria Univ, Med Res Inst, Dept Chem Pathol, Alexandria, Egypt; [Hosny, Tamer A.] Alexandria Univ, Fac Med, Dept Obstet & Gynecol, Alexandria, Egypt; [Ichihara, Kiyoshi] Yamaguchi Univ, Grad Sch Med, Dept Clin Lab Sci, Fac Hlth Sci, Ube, Japan	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; Yamaguchi University	El-Attar, EA (corresponding author), Alexandria Univ, Med Res Inst, Dept Chem Pathol, Alexandria, Egypt.	eman.elattar@alexu.edu.eg	El-Attar, Eman A/M-1028-2017	El-Attar, Eman A/0000-0003-1335-2673; Tork, Ahmed/0000-0001-8815-0748				Andersen AN, 2017, FERTIL STERIL, V107, P387, DOI 10.1016/j.fertnstert.2016.10.033; Anderson RA, 2012, MATURITAS, V71, P28, DOI 10.1016/j.maturitas.2011.11.008; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Capuzzo M, 2021, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.616766; de Vet A, 2002, FERTIL STERIL, V77, P357, DOI 10.1016/S0015-0282(01)02993-4; Ferguson JMC, 2018, REPROD BIOMED ONLINE, V37, P631, DOI 10.1016/j.rbmo.2018.08.012; Gorkem U, 2017, AUST NZ J OBSTET GYN, V57, P464, DOI 10.1111/ajo.12625; Hadlow N, 2016, FERTIL STERIL, V106, P1230, DOI 10.1016/j.fertnstert.2016.06.009; Iwase A, 2018, J OBSTET GYNAECOL RE, V44, P998, DOI 10.1111/jog.13633; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; Kim C, 2017, MATURITAS, V102, P18, DOI 10.1016/j.maturitas.2017.04.018; La Marca A, 2006, CLIN ENDOCRINOL, V64, P603, DOI 10.1111/j.1365-2265.2006.02533.x; Laven JSE, 2004, J CLIN ENDOCR METAB, V89, P318, DOI 10.1210/jc.2003-030932; Maciel GAR, 2004, J CLIN ENDOCR METAB, V89, P5321, DOI 10.1210/jc.2004-0643; Moolhuijsen LME, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgaa513; Nelson SM, 2011, FERTIL STERIL, V95, P736, DOI 10.1016/j.fertnstert.2010.08.022; Pellatt L, 2007, J CLIN ENDOCR METAB, V92, P240, DOI 10.1210/jc.2006-1582; Piltonen T, 2005, HUM REPROD, V20, P1820, DOI 10.1093/humrep/deh850; Robertson DM, 2008, MENOPAUSE, V15, P1139, DOI 10.1097/gme.0b013e3181735687; Rombauts L, 2015, FERTIL STERIL, V104, P884, DOI 10.1016/j.fertnstert.2015.06.027; SOLBERG HE, 1987, J CLIN CHEM CLIN BIO, V25, P645; Streuli I, 2008, FERTIL STERIL, V90, P395, DOI 10.1016/j.fertnstert.2007.06.023; Tan EC, 2019, FERTIL REPROD, V1, P99; van Disseldorp J, 2010, HUM REPROD, V25, P221, DOI 10.1093/humrep/dep366	24	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254858	10.1371/journal.pone.0254858	http://dx.doi.org/10.1371/journal.pone.0254858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310641	Green Published, gold			2022-12-26	WOS:000685224500031
J	Mary-Krause, M; Bustamante, JJH; Heron, M; Andersen, AJ; El Aarbaoui, T; Melchior, M				Mary-Krause, Murielle; Herranz Bustamante, Joel Jose; Heron, Megane; Andersen, Astrid Juhl; El Aarbaoui, Tarik; Melchior, Maria			Impact of COVID-19-like symptoms on occurrence of anxiety/depression during lockdown among the French general population	PLOS ONE			English	Article							MENTAL-HEALTH; ANXIETY DISORDERS; DEPRESSION; TRAJECTORIES; COMMUNITY	Background The outbreak of the COVID-19 epidemic lead to high levels of morbidity and mortality around the globe. Consequences of this outbreak and possible associated infection are an increase in mental health disorders and an increased likelihood of internalizing problems, particularly depression. However, to date few studies have tested this hypothesis while taking into account individuals' preexisting mental health difficulties. Methods We used longitudinal data collected among 729 persons in the context of the French TEMPO cohort between March and June 2020 (7 waves of data collection). COVID-19-like symptoms as well as anxiety/depression (assessed by the Adult Self Report), were reported at each wave of data collection. To study the relationship between COVID-19-like symptoms and anxiety/depression, we used generalized estimation equation (GEE) models controlled for socio-demographic and health-related characteristics, including anxiety/depression prior to 2020. Results Overall, 27.2% of study participants reported anxiety/depression during lockdown. 17.1% of participants reported COVID-19-like symptoms during the course of follow-up, 7.3% after the beginning of lockdown, with an average number of 2.7 symptoms, and 3.6% reported respiratory distress. In multivariate analyses, nearly all the considered indicators of COVID-19-like symptoms were associated with higher odds of symptoms of anxiety/depression (symptoms Yes/No: OR = 1.66, 95% CI = 1.08-2.55; symptoms after the beginning of lockdown: OR = 1.91, 95% CI = 1.03-3.52; number of symptoms: OR for each additional symptom = 1.19, 95% CI = 1.02-1.39. This relationship exists after taking into account prior symptoms of anxiety/depression, which are associated with a 5-fold increased likelihood of psychological distress. And this impact is stronger among men than women. Conclusions Our study shows higher risk of anxiety/depression among persons who experienced COVID-19-like symptoms, even after accounting for prior mental health difficulties. COVID-19 infection could have both a direct and indirect impact on the occurrence of psychological difficulties, and this association should be studied in greater detail.	[Mary-Krause, Murielle; Herranz Bustamante, Joel Jose; Heron, Megane; Andersen, Astrid Juhl; El Aarbaoui, Tarik; Melchior, Maria] Sorbonne Univ, Equipe Rech Epidemiol Sociale ERES, Inst Pierre Louis Epidemiol & Sante Publ IPLESP, INSERM, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Mary-Krause, M (corresponding author), Sorbonne Univ, Equipe Rech Epidemiol Sociale ERES, Inst Pierre Louis Epidemiol & Sante Publ IPLESP, INSERM, Paris, France.	murielle.mary-krause@inserm.fr		MARY-KRAUSE, Murielle/0000-0002-8156-1007	European Union [101016127]	European Union(European Commission)	This project has received funding from the European Union's Horizon 2020 research and innovation program under Grant Agreement numbers 101016127 (RESPOND).	ACAPS, 2020, COVID 19 IMP GEND DY; Achenbach T.M., 2014, ENCY CLIN PSYCHOL, P1, DOI [DOI 10.1002/9781118625392.WBECP150, 10.1002/9781118625392.wbecp150]; Achenbach TM, 2003, MANUAL ASEBA ADULT F; Al Zubayer A, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05057; Allchin A, 2016, DEPRESS ANXIETY, V33, P1031, DOI 10.1002/da.22538; Alpert Orna, 2020, Brain Behav Immun Health, V9, P100173, DOI 10.1016/j.bbih.2020.100173; Bauerle A, 2020, J PUBLIC HEALTH-UK, V42, P672, DOI 10.1093/pubmed/fdaa106; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Cenat JM, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113599; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]; Fancourt D, 2021, LANCET PSYCHIAT, V8, P141, DOI 10.1016/S2215-0366(20)30482-X; Filipovic-Pierucci A, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-016-1163-4; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Fond G, 2019, PRESSE MED, V48, P365, DOI 10.1016/j.lpm.2018.12.004; Glenister KM, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020722; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Ivanova MY, 2015, J PSYCHOPATHOL BEHAV, V37, P171, DOI 10.1007/s10862-014-9448-8; Jaunin-Stalder N, 2012, Rev Med Suisse, V8, P1470; Ko CH, 2006, PSYCHIAT CLIN NEUROS, V60, P397, DOI 10.1111/j.1440-1819.2006.01522.x; Mary-Krause M, 2021, INT J EPIDEMIOL, V50, P1067, DOI 10.1093/ije/dyab026; Mazza C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093165; McCracken LM, 2020, EUR PSYCHIAT, V63, DOI 10.1192/j.eurpsy.2020.81; Melchior M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114526; Merikangas KR, 2003, ARCH GEN PSYCHIAT, V60, P993, DOI 10.1001/archpsyc.60.9.993; Newby JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236562; Odriozola-Gonzalez P, 2022, J HEALTH PSYCHOL, V27, P825, DOI 10.1177/1359105320967086; Olagoke AA, 2020, BRIT J HEALTH PSYCH, V25, P865, DOI 10.1111/bjhp.12427; Ozdin S, 2020, INT J SOC PSYCHIATR, V66, P504, DOI 10.1177/0020764020927051; Pan KY, 2021, LANCET PSYCHIAT, V8, P121, DOI 10.1016/S2215-0366(20)30491-0; Penninx BWJH, 2011, J AFFECT DISORDERS, V133, P76, DOI 10.1016/j.jad.2011.03.027; Peretti-Watel P, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-10048-1; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Pieraccini M, 2020, LEGAL PERSPECTIVES ON SUSTAINABILITY, P1, DOI 10.1016/S2215-0366(20)30308-4; Pierce M, 2020, LANCET PSYCHIAT, V7, P567, DOI 10.1016/S2215-0366(20)30237-6; Pignon B, 2018, J PSYCHIATR RES, V102, P38, DOI 10.1016/j.jpsychires.2018.03.007; Pine DS, 1998, ARCH GEN PSYCHIAT, V55, P56, DOI 10.1001/archpsyc.55.1.56; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Rescorla LA, 2004, USE PSY CHOLOGICAL T, V3, P115; Ribeiro DE, 2021, MOL PSYCHIATR, V26, P1044, DOI 10.1038/s41380-020-00965-3; Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w; Sante Publique France, 2020, PREV EV IND SANT MEN; Serafini G, 2020, QJM-INT J MED, V113, P529, DOI 10.1093/qjmed/hcaa201; Service Public, 2020, TESTS PCR PLUS BES U; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shevlin M, 2020, BJPSYCH OPEN, V6, DOI 10.1192/bjo.2020.109; Smith L, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113138; Szczesniak D, 2021, PROG NEURO-PSYCHOPH, V104, DOI 10.1016/j.pnpbp.2020.110046; Taquet M, 2021, LANCET PSYCHIAT, V8, P130, DOI 10.1016/S2215-0366(20)30462-4; Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212; Twenge JM, 2020, J CLIN PSYCHOL, V76, P2170, DOI 10.1002/jclp.23064; Vahia IV, 2020, JAMA-J AM MED ASSOC, V324, P2253, DOI 10.1001/jama.2020.21753; Van Bortel T, 2016, B WORLD HEALTH ORGAN, V94, P210, DOI 10.2471/BLT.15.158543; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wenham C, GENDERED IMPACT COVI; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wilson JM, 2020, J OCCUP ENVIRON MED, V62, P686, DOI 10.1097/JOM.0000000000001962; Wu D, 2020, MEDRXIV, DOI [10.1101/2020.03.22.20040899, 10.1101/2020.03.22.20040899v1, DOI 10.1101/2020.03.22.20040899]; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	61	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255158	10.1371/journal.pone.0255158	http://dx.doi.org/10.1371/journal.pone.0255158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TN	34310661	gold, Green Published			2022-12-26	WOS:000685224500041
J	Yokoyama, A; Yokoyama, T; Kimura, M; Matsushita, S; Yokoyama, M				Yokoyama, Akira; Yokoyama, Tetsuji; Kimura, Mitsuru; Matsushita, Sachio; Yokoyama, Masako			Combinations of alcohol-induced flushing with genetic polymorphisms of alcohol and aldehyde dehydrogenases and the risk of alcohol dependence in Japanese men and women	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ALDH2; DRINKING; GENOTYPES; HISTAMINE; CANCER; ADH1B; ASIANS	Objective The risk of alcohol dependence (AD) in Japanese men and women was evaluated according to combinations of alcohol flushing and aldehyde dehydrogenase-2 (ALDH2, rs671) and alcohol dehydrogenase-1B (ADH1B, rs1229984) genotypes, all of which are known to determine AD susceptibility in Asians. Previous studies have focused on men, since women account for a smaller proportion of AD subjects. Methods Case control studies were conducted between 3721 male and 335 female AD Japanese and 610 male and 406 female controls who were asked about their current or former tendency to experience facial flushing after drinking a glass of beer and underwent ALDH2 and ADH1B genotyping. The time at which alcohol-induced facial flushing tendencies had disappeared in former-flushing AD subjects was also evaluated. Results Current alcohol flushing, the inactive ALDH2*1/*2 genotype, and the fast-metabolizing ADH1B*2 allele were less frequently found in the AD groups. Although alcohol flushing was strongly influenced by the ALDH2 and ADH1B genotypes, multiple logistic model showed that never or former flushing and the genotype combinations were independent strong risk factors of AD in men and women. Never or former flushing (vs. current flushing) markedly increased the odds ratios of AD in carriers of each of the ALDH2 and ADH1B genotype combinations. The temporal profiles for drinking and flushing in former-flushing AD subjects revealed that the flushing response disappeared soon after or before the start of habitual drinking during young adulthood, regardless of the ALDH2 genotype. Conclusion Although alcohol flushing is influenced by the ALDH2 and ADH1B genotypes, constitutional or acquired flushing tolerance is an independent susceptibility trait for AD. The combination of the alcohol flushing status and the ALDH2 and ADH1B genotypes can provide a better new strategy for AD risk assessment than the alcohol flushing status alone or the genotypes alone in Asian men and women.	[Yokoyama, Akira; Kimura, Mitsuru; Matsushita, Sachio] Natl Hosp Org Kurihama Med & Addict Ctr, Yokosuka, Kanagawa, Japan; [Yokoyama, Tetsuji] Natl Inst Publ Hlth, Dept Hlth Promot, Wako, Saitama, Japan; [Yokoyama, Masako] Mitsukoshi Hlth & Welf Fdn, Shinjuku Ku, Tokyo, Japan	National Institute of Public Health - Japan	Yokoyama, A (corresponding author), Natl Hosp Org Kurihama Med & Addict Ctr, Yokosuka, Kanagawa, Japan.	a-yoko@ab.auone-net.jp						American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Aoyama I, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.24; Babor TF., 2001, AUDIT ALCOHOL USE DI; Chen CC, 1999, AM J HUM GENET, V65, P795, DOI 10.1086/302540; Chen WJ, 1998, ALCOHOL CLIN EXP RES, V22, P1048, DOI 10.1111/j.1530-0277.1998.tb03697.x; Du XY, 2021, ALCOHOL CLIN EXP RES, V45, P307, DOI 10.1111/acer.14527; HARADA S, 1993, ALCOHOL ALCOHOLISM, V28, P11; Hayashida Mariko, 2015, Nihon Eiseigaku Zasshi, V70, P134, DOI 10.1265/jjh.70.134; Health and Welfare Statistics Association, 2003, J HLTH WELFARE STAT, V50, P49; HIGUCHI S, 1992, J STUD ALCOHOL, V53, P170, DOI 10.15288/jsa.1992.53.170; HIGUCHI S, 1992, J STUD ALCOHOL, V53, P553, DOI 10.15288/jsa.1992.53.553; HIGUCHI S, 1995, AM J PSYCHIAT, V152, P1219; HO SB, 1988, ALCOHOL CLIN EXP RES, V12, P705, DOI 10.1111/j.1530-0277.1988.tb00269.x; Hsiao JR, 2019, ALCOHOL CLIN EXP RES, V43, P1225, DOI 10.1111/acer.14049; Kim DJ, 2008, HUM MOL GENET, V17, P854, DOI 10.1093/hmg/ddm357; Luczak SE, 2006, PSYCHOL BULL, V132, P607, DOI 10.1037/0033-2909.132.4.607; Luczak SE, 2011, ALCOHOL CLIN EXP RES, V35, P1238, DOI 10.1111/j.1530-0277.2011.01458.x; Matsuo K, 2006, CANCER EPIDEM BIOMAR, V15, P1009, DOI 10.1158/1055-9965.EPI-05-0911; MILLER NS, 1988, J STUD ALCOHOL, V49, P16, DOI 10.15288/jsa.1988.49.16; Ministry of Health Labour and Welfare, 2003, KOK EIYO GENJ 2001, P65; Newman IM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060622; Osaki Y, 2016, ALCOHOL ALCOHOLISM, V51, P465, DOI 10.1093/alcalc/agw002; Peng GS, 2014, PHARMACOGENET GENOM, V24, P607, DOI 10.1097/FPC.0000000000000096; Shin CM, 2018, ALCOHOL CLIN EXP RES, V42, P387, DOI 10.1111/acer.13569; SLUTSKE WS, 1995, ALCOHOL CLIN EXP RES, V19, P582, DOI 10.1111/j.1530-0277.1995.tb01552.x; Takeshita T, 1996, HUM GENET, V97, P409, DOI 10.1007/BF02267057; TAN OT, 1982, BRIT J DERMATOL, V107, P647, DOI 10.1111/j.1365-2133.1982.tb00522.x; TAN OT, 1979, LANCET, V2, P365; Truitt E B Jr, 1987, Alcohol Alcohol Suppl, V1, P595; WALL TL, 1992, ALCOHOL CLIN EXP RES, V16, P991, DOI 10.1111/j.1530-0277.1992.tb01907.x; Wall TL, 1996, J STUD ALCOHOL, V57, P267, DOI 10.15288/jsa.1996.57.267; World Health Organization, 1992, INT STAT CLASS DIS R; XU Y, 1988, Genomics, V2, P209, DOI 10.1016/0888-7543(88)90004-3; Yang SJ, 2010, WORLD J GASTROENTERO, V16, P4210, DOI 10.3748/wjg.v16.i33.4210; Yokoyama A, 2006, ALCOHOL CLIN EXP RES, V30, P491, DOI 10.1111/j.1530-0277.2006.00053.x; Yokoyama A, 2002, CARCINOGENESIS, V23, P1851, DOI 10.1093/carcin/23.11.1851; Yokoyama A, 2020, PHARMACOGENET GENOM, V30, P54, DOI 10.1097/FPC.0000000000000395; Yokoyama A, 2010, CANCER SCI, V101, P2497, DOI 10.1111/j.1349-7006.2010.01709.x; Yokoyama T, 2003, CANCER EPIDEM BIOMAR, V12, P1227; Zimatkin SM, 1999, ALCOHOL ALCOHOLISM, V34, P141, DOI 10.1093/alcalc/34.2.141	40	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255276	10.1371/journal.pone.0255276	http://dx.doi.org/10.1371/journal.pone.0255276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TN	34310648	Green Published, gold			2022-12-26	WOS:000685224500032
J	Ishikiriyama, T; Nakashima, H; Endo-Umeda, K; Nakashima, M; Ito, S; Kinoshita, M; Ikarashi, M; Makishima, M; Seki, S				Ishikiriyama, Takuya; Nakashima, Hiroyuki; Endo-Umeda, Kaori; Nakashima, Masahiro; Ito, Seigo; Kinoshita, Manabu; Ikarashi, Masami; Makishima, Makoto; Seki, Shuhji			Contrasting functional responses of resident Kupffer cells and recruited liver macrophages to irradiation and liver X receptor stimulation	PLOS ONE			English	Article							AG+ T-CELLS; TNF-ALPHA; GENE-EXPRESSION; MICE LACKING; PPAR-GAMMA; LXR; METABOLISM; CHOLESTEROL; PROTEIN; TRANSREPRESSION	In the murine liver, there are two major macrophage populations, namely resident Kupffer cells (resKCs) with phagocytic activity and recruited macrophages (recM phi s) with cytokine-producing capacity. This study was performed to clarify the functional differences between these two populations, focusing on their susceptibility to radiation and response to stimulation via liver X receptors (LXRs), which are implicated in cholesterol metabolism and immune regulation. Liver mononuclear cells (MNCs) were obtained from C57BL/6 (WT) mice with or without 2 Gy irradiation, and the phagocytic activity against Escherichia coli (E. coli) as well as TNF-alpha production were compared between the two macrophage populations. To assess LXR functions, phagocytosis, TNF-alpha production, and endocytosis of acetylated low-density lipoprotein (LDL) were compared after synthetic LXR ligand stimulation. Furthermore, LXR alpha/beta knockout (KO) mice and LXR alpha KO mice were compared with WT mice. Irradiation decreased intracellular TNF-alpha production by recM phi s but did not affect the phagocytic activity of resKCs. In vitro LXR stimulation enhanced E. coli phagocytosis by resKCs but decreased E. coli-stimulated TNF-alpha production by recM phi s. Phagocytic activity and acetylated LDL endocytosis were decreased in both LXR alpha/beta KO mice and LXR alpha KO mice, with serum TNF-alpha levels after E. coli injection in the former being higher than those in WT mice. In conclusion, resKCs and recM phi s exhibited different functional features in response to radiation and LXR stimulation, highlighting their distinct roles liver immunity and lipid metabolism.	[Ishikiriyama, Takuya; Nakashima, Hiroyuki; Nakashima, Masahiro; Kinoshita, Manabu; Ikarashi, Masami; Seki, Shuhji] Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama, Japan; [Endo-Umeda, Kaori; Makishima, Makoto] Nihon Univ, Dept Biomed Sci, Div Biochem, Sch Med, Tokyo, Tokyo, Japan; [Ito, Seigo] Natl Def Med Coll, Dept Nephrol & Endocrinol, Tokorozawa, Saitama, Japan	National Defense Medical College - Japan; Nihon University; National Defense Medical College - Japan	Nakashima, H (corresponding author), Natl Def Med Coll, Dept Immunol & Microbiol, Tokorozawa, Saitama, Japan.	hiro1618@ndmc.ac.jp		Nakashima, Hiroyuki/0000-0001-6066-3031	JSPS KAKENHI [JP 18K02907, JP 16K08751, JP 20K07438, JP 25860248, JP 16K19061, JP 17K08611]; Nihon University School of Medicine Toki Fund Research Grant	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nihon University School of Medicine Toki Fund Research Grant	JSPS KAKENHI Grant Number JP 16K08751 (H N) JSPS KAKENHI Grant Number JP 20K07438 (H N) JSPS KAKENHI Grant Number JP 25860248 (K.E.-U) JSPS KAKENHI Grant Number JP 16K19061 (K.E.-U) Nihon University School of Medicine Toki Fund Research Grant (K.E.-U) JSPS KAKENHI Grant Number JP 17K08611 (M N) JSPS KAKENHI Grant Number JP 18K02907 (M K).	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Calvo D, 1998, J LIPID RES, V39, P777; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Du H, 2001, J LIPID RES, V42, P489; Endo-Umeda K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27615-7; Fontaine C, 2007, CIRC RES, V101, P40, DOI 10.1161/CIRCRESAHA.106.135814; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Ikarashi M, 2013, J LEUKOCYTE BIOL, V94, P1325, DOI 10.1189/jlb.0313144; Inui T, 2005, J HEPATOL, V43, P670, DOI 10.1016/j.jhep.2005.02.027; Inui T, 2002, J IMMUNOL, V169, P6127, DOI 10.4049/jimmunol.169.11.6127; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kawabata T, 2008, HEPATOLOGY, V48, P1586, DOI 10.1002/hep.22489; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Korner A, 2019, P NATL ACAD SCI USA, V116, P20623, DOI 10.1073/pnas.1911992116; Korf H, 2009, J CLIN INVEST, V119, P1626, DOI 10.1172/JCI35288; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Lierova A, 2018, J RADIAT RES, V59, P709, DOI 10.1093/jrr/rry067; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Nakashima H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34466; Nakashima H, 2008, HEPATOLOGY, V48, P1979, DOI 10.1002/hep.22561; Nomura S, 2015, ACS MED CHEM LETT, V6, P902, DOI 10.1021/acsmedchemlett.5b00170; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Shono S, 2011, SHOCK, V36, P484, DOI 10.1097/SHK.0b013e31822dc6e4; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Tsukimoto M, 2009, RADIAT RES, V171, P219, DOI 10.1667/RR1351.1; Uchida T, 2018, AM J PHYSIOL-RENAL, V315, pF618, DOI 10.1152/ajprenal.00160.2018; Umeda N, 2019, J LEUKOCYTE BIOL, V106, P791, DOI 10.1002/JLB.3HI0219-048R; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; van der Tuin SJL, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008105; Wang YY, 2009, SHOCK, V32, P548, DOI 10.1097/SHK.0b013e3181a47f85; Yang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065070; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254886	10.1371/journal.pone.0254886	http://dx.doi.org/10.1371/journal.pone.0254886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297734	Green Published, gold			2022-12-26	WOS:000678128300008
J	Roccaro, M; Diana, A; Linte, N; Rinnovati, R; Freo, M; Pen, A				Roccaro, Mariana; Diana, Alessia; Linte, Nikolina; Rinnovati, Riccardo; Freo, Marzia; Pen, Angelo			Limb development in skeletally-immature large-sized dogs: A radiographic study	PLOS ONE			English	Article							POSTNATAL-GROWTH; PUPPIES; CENTERS; AGE	Despite the extreme morphological variability of the canine species, data on limb development are limited and the time windows for the appearance of the limb ossification centres (OCs) reported in veterinary textbooks, considered universally valid for all dogs, are based on dated studies. The aim of this study was to acquire up-to-date information regarding the arm, forearm and leg bone development in skeletally-immature large-sized dogs from 6 weeks to 16 weeks of age. Nine litters of 5 large-sized breeds (Boxer, German Shepherd, Labrador Retriever, Saarloos Wolfdog, White Swiss Shepherd Dog) were included, for a total of 54 dogs, which were subject to radiographic examination on a bi-weekly basis. The appearance of 18 limb OCs was recorded and 14 radiographic measurements were performed; their relationship with age and body weight was investigated and any breed differences were analysed using different statistical non-parametric tests. The number of OCs present was significantly different at 6 and 8 weeks of age between the investigated breeds. The appearance of the OCs occurred earlier in the Saarloos Wolfdog, while the Labrador Retriever was the later breed. In Boxers and Labrador Retrievers, various OCs showed a delayed appearance compared to the data reported in the literature. The number of OCs was strongly and positively correlated to body weight. Breed differences were also observed in the relative increase of the measured OCs and were not limited to dogs of different morphotypes. Statistically significant differences were most frequently observed between Saarloos Wolfdogs and the other breeds. The OCs that showed a greater variability in their development were the olecranon tuber, the patella and the tibial tuberosity. Their increase was more strongly correlated with the dog's age and body weight. Our data strongly suggest that differences in limb development exist in dog breeds of similar size and morphotype.	[Roccaro, Mariana; Diana, Alessia; Linte, Nikolina; Rinnovati, Riccardo; Pen, Angelo] Alma Mater Studiorum Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Freo, Marzia] Alma Mater Studiorum Univ Bologna, Dept Stat Sci, Bologna, Italy; [Freo, Marzia] European Commiss, Div Genet Med, Ispra, Italy	University of Bologna; University of Bologna; European Commission Joint Research Centre	Roccaro, M; Diana, A (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Vet Med Sci, Bologna, Italy.	mariana.roccaro2@unibo.it; alessia.diana@unibo.it	Roccaro, Mariana/GXF-7654-2022; PELI, ANGELO/AAX-8423-2021	PELI, ANGELO/0000-0003-3488-2948; ROCCARO, MARIANA/0000-0002-5904-7968	Italian Ministry of Health [IZSLER 12/15 RC]	Italian Ministry of Health(Ministry of Health, Italy)	This research is part of the project "Nuovi strumenti con finalita medico-legali per la valutazione dell'eta dei cuccioli di cane" (IZSLER 12/15 RC), funded by the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1975, Acta Radiol Suppl, V344, P81; Bonetti F, 1995, ZOOGNOSTICA CANE, P207; BRESSOU C., 1957, Recueil de Medecine Veterinaire, V133, P449; Burk RL, 2003, SMALL ANIMAL RADIOLO, V3rd, P477; Burwell RG, 1986, CONTROL MANIPULATION, P53; CHAPMAN WL, 1965, J AM VET MED ASSOC, V147, P138; DELAQUERRIERERICHARDSON L, 1982, AM J VET RES, V43, P2255; Dennis M, 2010, MEMORIAL DAY MASSACRE AND THE MOVEMENT FOR INDUSTRIAL DEMOCRACY, P51; Dyce K, 2018, TXB VET ANATOMY, V5th, P464; HARE W. C. D., 1960, JOUR AMER VET MED ASSOC, V136, P603; HARE W. C. D., 1959, JOUR AMER VET MED ASSOC, V135, P305; HARE WC, 1961, AM J VET RES, V22, P825; Hawthorne AJ, 2004, J NUTR, V134, p2027S, DOI 10.1093/jn/134.8.2027S; Hoskins JD, 2001, VET PEDIAT DOGS CATS, V3rd, P7; Kealy JK, 2011, DIAGNOSTIC RADIOLOGY, V5th, P351, DOI DOI 10.1016/B978-1-4377-0150-0.10004-9; Lavin LM, 2003, RADIOGRAPHY VET TECH, V3rd, P37; Lopate C, 2008, THERIOGENOLOGY, V70, P397, DOI 10.1016/j.theriogenology.2008.05.034; McMillan CJ, 2006, J AM ANIM HOSP ASSOC, V42, P57, DOI 10.5326/0420057; Modina SC, 2019, FORENSIC SCI INT, V297, P8, DOI 10.1016/j.forsciint.2019.01.003; Modina SC, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1092-6; NAP RC, 1994, VET QUART, V16, P50, DOI 10.1080/01652176.1994.9694417; Newton CD, 1985, TXB SMALL ANIMAL ORT, P1107; Peterson ME, 2011, SMALL ANIMAL PEDIAT, P169; Petrie A., 2013, STAT VET ANIMAL SCI; Pomriaskinsky-Kobozieff N, 1954, RECL MED VET, V130, P617; Riser W. H., 1973, Journal of the American Veterinary Radiology Society, V14, P24; Roccaro M, 2020, VET ITAL, V56, P149, DOI 10.12834/VetIt.1876.9968.2; Salt C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182064; Schebitz H, 1989, ATLAS RADIOGRAPHIC A, V5th, P56; Schulze A, 2007, TIERAERZTL PRAX K H, V35, P200; Schulze A, 2003, TIERARZTL PRAX K H, V31, P219; SEOUDI KAMAL, 1948, VET JOUR, V104, P150; SMITH R. N., 1960, Veterinary Record, V72, P75; Smith RN, 1960, J SMALL ANIM PRACT, V1, P84; Sumner-Smith G, 1966, J Small Anim Pract, V7, P303, DOI 10.1111/j.1748-5827.1966.tb04447.x; Thrall D, 2011, ATLAS NORMAL RADIOGR, P2; Ticer JW, 1984, RADIOGRAPHIC TECHNIQ, V2nd, P103; YONAMINE H, 1980, JPN J VET SCI, V42, P417	38	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254788	10.1371/journal.pone.0254788	http://dx.doi.org/10.1371/journal.pone.0254788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297750	Green Published, gold			2022-12-26	WOS:000678128300043
J	Vecchiotti, G; Colafarina, S; Aloisi, M; Zarivi, O; Di Carlo, P; Poma, A				Vecchiotti, Giulia; Colafarina, Sabrina; Aloisi, Massimo; Zarivi, Osvaldo; Di Carlo, Piero; Poma, Anna			Genotoxicity and oxidative stress induction by polystyrene nanoparticles in the colorectal cancer cell line HCT116	PLOS ONE			English	Article							IN-VITRO; MICROPLASTICS; NANOPLASTICS; TOXICITY; EXPOSURE; PLASTICS; HEALTH; IMPACT; MICRO; CYTOTOXICITY	The potential risks of environmental nanoparticles (NPs), in particular Polystyrene Nanoparticles (PNPs), is an emerging problem; specifically, the interaction of PNPs with intestinal cells has not been characterized so far. The mechanism by which polystyrene particles are transferred to humans has not yet been clarified, whether directly through ingestion from contaminated food. We evaluated the interaction between PNPs and colorectal adenocarcinoma cells (HCT116). Cells were exposed to different concentrations of PNPs, metabolic activity and the consequent cytotoxic potential were assessed through viability test; we evaluated the PNP genotoxic potential through the Cytokinesis-Block Micronucleus cytome (CBMN cyt) assay. Finally, we detected Reactive Oxygen Species (ROS) production after NPs exposure and performed Western Blot analysis to analyze the enzymes (SOD1, SOD2, Catalase, Glutathione Peroxidase) involved in the cell detoxification process that comes into play during the cell-PNPs interaction. This work analyzes the cyto and genotoxicity of PNPs in the colorectal HCT116 cell line, in particular the potential damage from oxidative stress produced by PNPs inside the cells related to the consequent nuclear damage. Our results show moderate toxicity of PNPs both in terms of ROS production and DNA damage. Further studies will be needed on different cell lines to have a more complete picture of the impact of environmental pollution on human health in terms of PNPs cytotoxicity and genotoxicity.	[Vecchiotti, Giulia; Colafarina, Sabrina; Aloisi, Massimo; Zarivi, Osvaldo; Poma, Anna] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Di Carlo, Piero] Univ G dAnnunzio, Dept Psychol Hlth & Terr Sci, Chieti, Italy; [Di Carlo, Piero] Univ G dAnnunzio, Ctr Adv Studies & Technol CAST, Chieti, Italy	University of L'Aquila; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Poma, A (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy.	annamariagiuseppina.poma@univaq.it	Zarivi, Osvaldo/ABG-8795-2021; Zarivi, Osvaldo/AAB-2150-2022; Di Carlo, Piero/Q-4450-2016	Zarivi, Osvaldo/0000-0002-8312-9955; Di Carlo, Piero/0000-0003-4971-4509; Aloisi, Massimo/0000-0002-3978-2850; Vecchiotti, Giulia/0000-0001-6747-4225	University of L'Aquila; University "G. d'Annunzio" of Chieti-Pescara	University of L'Aquila; University "G. d'Annunzio" of Chieti-Pescara	This research received Institutional funding to Anna Poma from University of L'Aquila and Piero Di Carlo from University "G. d'Annunzio" of Chieti-Pescara.	Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Andrady AL, 2009, PHILOS T R SOC B, V364, P1977, DOI 10.1098/rstb.2008.0304; [Anonymous], 2016, J NATL COMPR CANC NE, V14, pr34; Barboza LGA, 2018, AQUAT TOXICOL, V195, P49, DOI 10.1016/j.aquatox.2017.12.008; Bandi SP, 2020, J NANOPART RES, V22, DOI 10.1007/s11051-020-04785-y; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Beyler C., 2002, SFPE HDB FIRE PROTEC, V3rd; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Bouwmeester H, 2015, ENVIRON SCI TECHNOL, V49, P8932, DOI 10.1021/acs.est.5b01090; Carbery M, 2018, ENVIRON INT, V115, P400, DOI 10.1016/j.envint.2018.03.007; Chellappa M, 2015, Int J Nanomedicine, V10 Suppl 1, P31, DOI 10.2147/IJN.S79978; Chen QQ, 2017, SCI TOTAL ENVIRON, V584, P1022, DOI 10.1016/j.scitotenv.2017.01.156; Corbalan JJ, 2011, INT J NANOMED, V6, P2821, DOI 10.2147/IJN.S25071; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Duis K, 2016, ENVIRON SCI EUR, V28, DOI 10.1186/s12302-015-0069-y; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Geys J, 2006, TOXICOL LETT, V160, P218, DOI 10.1016/j.toxlet.2005.07.005; Gigault J, 2018, ENVIRON POLLUT, V235, P1030, DOI 10.1016/j.envpol.2018.01.024; Gilbert S. F., 2016, BIOL SVILUPPO, V7, P272; Greven AC, 2016, ENVIRON TOXICOL CHEM, V35, P3093, DOI 10.1002/etc.3501; Guo CX, 2016, INT J NANOMED, V11, P5257, DOI 10.2147/IJN.S112030; Hahladakis JN, 2018, J HAZARD MATER, V344, P179, DOI 10.1016/j.jhazmat.2017.10.014; Handy RD, 2008, ECOTOXICOLOGY, V17, P396, DOI 10.1007/s10646-008-0205-1; Hesler M, 2019, TOXICOL IN VITRO, V61, DOI 10.1016/j.tiv.2019.104610; Ioakeimidis C, 2016, SCI REP-UK, V6, DOI 10.1038/srep23501; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Karbalaei S, 2018, ENVIRON SCI POLLUT R, V25, P36046, DOI 10.1007/s11356-018-3508-7; Kidney Dis Improving Global, 2017, KIDNEY INT SUPPL, V7, P1, DOI 10.1016/j.kisu.2017.04.001; Koelmans AA, 2019, WATER RES, V155, P410, DOI 10.1016/j.watres.2019.02.054; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert S, 2016, CHEMOSPHERE, V161, P510, DOI 10.1016/j.chemosphere.2016.07.042; Law KL, 2014, SCIENCE, V345, P144, DOI 10.1126/science.1254065; Le LL, 2018, ENVIRON SCI-NANO, V5, P2009, DOI [10.1039/c8en00412a, 10.1039/C8EN00412A]; Mahler GJ, 2012, NAT NANOTECHNOL, V7, P264, DOI [10.1038/NNANO.2012.3, 10.1038/nnano.2012.3]; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel A, 2013, ACCOUNTS CHEM RES, V46, P607, DOI 10.1021/ar300022h; Paul-Pont I, 2016, ENVIRON POLLUT, V216, P724, DOI 10.1016/j.envpol.2016.06.039; Pitt JA, 2018, SCI TOTAL ENVIRON, V643, P324, DOI 10.1016/j.scitotenv.2018.06.186; Pivokonsky M, 2018, SCI TOTAL ENVIRON, V643, P1644, DOI 10.1016/j.scitotenv.2018.08.102; Poma A, 2019, NANOMATERIALS-BASEL, V9, DOI 10.3390/nano9091299; Powell JJ, 2007, BRIT J NUTR, V98, pS59, DOI 10.1017/S0007114507832922; Qiao RX, 2019, SCI TOTAL ENVIRON, V662, P246, DOI 10.1016/j.scitotenv.2019.01.245; Rubio L, 2020, J TOXICOL ENV HEAL B, V23, P51, DOI 10.1080/10937404.2019.1700598; Shi JP, 2014, BIOMATERIALS, V35, P6657, DOI 10.1016/j.biomaterials.2014.04.093; Singh N, 2009, BIOMATERIALS, V30, P3891, DOI 10.1016/j.biomaterials.2009.04.009; Tang J, 2018, ENVIRON POLLUT, V243, P66, DOI 10.1016/j.envpol.2018.08.045; Therezien M, 2014, SCI TOTAL ENVIRON, V485, P309, DOI 10.1016/j.scitotenv.2014.03.020; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Van Cauwenberghe L, 2014, ENVIRON POLLUT, V193, P65, DOI 10.1016/j.envpol.2014.06.010; von Moos N, 2012, ENVIRON SCI TECHNOL, V46, P11327, DOI 10.1021/es302332w; Wang JY, 2016, INT J NANOMED, V11, P3475, DOI 10.2147/IJN.S106073; Waring RH, 2018, MATURITAS, V115, P64, DOI 10.1016/j.maturitas.2018.06.010; Wen B, 2018, ENVIRON POLLUT, V243, P462, DOI 10.1016/j.envpol.2018.09.029; Wright SL, 2017, ENVIRON SCI TECHNOL, V51, P6634, DOI 10.1021/acs.est.7b00423; Wu B, 2019, CHEMOSPHERE, V221, P333, DOI 10.1016/j.chemosphere.2019.01.056; Xanthos D, 2017, MAR POLLUT BULL, V118, P17, DOI 10.1016/j.marpolbul.2017.02.048; Yang YF, 2019, J HAZARD MATER, V366, P703, DOI 10.1016/j.jhazmat.2018.12.048; Yin H, 2005, BIOMATERIALS, V26, P5818, DOI 10.1016/j.biomaterials.2005.02.036; Yousif E, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-398; Yu F, 2019, SCI TOTAL ENVIRON, V694, DOI 10.1016/j.scitotenv.2019.133643; ZITKO V, 1991, MAR POLLUT BULL, V22, P41, DOI 10.1016/0025-326X(91)90444-W	61	5	5	8	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255120	10.1371/journal.pone.0255120	http://dx.doi.org/10.1371/journal.pone.0255120			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297768	gold, Green Published			2022-12-26	WOS:000678128300018
J	Arni, S; Maeyashiki, T; Opitz, I; Inci, I				Arni, Stephan; Maeyashiki, Tatsuo; Opitz, Isabelle; Inci, Ilhan			Subnormothermic ex vivo lung perfusion attenuates ischemia reperfusion injury from donation after circulatory death donors	PLOS ONE			English	Article							MACHINE PERFUSION; PROTEIN CARBONYLATION; FUNCTIONAL RECOVERY; PRESERVATION; HIBERNATION; LIVER; HYPOTHERMIA; IMPROVES; OXYGEN; MITOCHONDRIA	Use of normothermic ex vivo lung perfusion (EVLP) was adopted in clinical practice to assess the quality of marginal donor lungs. Subnormothermic perfusion temperatures are in use among other solid organs to improve biochemical, clinical and immunological parameters. In a rat EVLP model of donation after circulatory death (DCD) lung donors, we tested the effect of four subnormothermic EVLP temperatures that could further improve organ preservation. Warm ischemic time was of 2 hours. EVLP time was of 4 hours. Lung physiological data were recorded and metabolic parameters were assessed. Lung oxygenation at 21 degrees C and 24 degrees C were significantly improved whereas pulmonary vascular resistance and edema formation at 21 degrees C EVLP were significantly worsened when compared to 37 degrees C EVLP. The perfusate concentrations of potassium ions and lactate exiting the lungs with 28 degrees C EVLP were significantly lower whereas sodium and chlorine ions with 32 degrees C EVLP were significantly higher when compared to 37 degrees C EVLP. Also compared to 37 degrees C EVLP, the pro-inflammatory chemokines MIP2, MIP-1 alpha, GRO-alpha, the cytokine IL-6 were significantly lower with 21 degrees C, 24 degrees C and 28 degrees C EVLP, the IL-18 was significantly lower but only with 21 degrees C EVLP and IL-1 beta was significantly lower at 21 degrees C and 24 degrees C EVLP. Compared to the 37 degrees C EVLP, the lung tissue ATP content after 21 degrees C, 24 degrees C and 28 degrees C EVLP were significantly higher, the carbonylated protein content after 28 degrees C EVLP was significantly lower and we measured significantly higher myeloperoxidase activities in lung tissues with 21 degrees C, 24 degrees C and 32 degrees C. The 28 degrees C EVLP demonstrated acceptable physiological variables, significantly higher lung tissue ATP content and decreased tissue carbonylated proteins with reduced release of pro-inflammatory cytokines. In conclusion, the 28 degrees C EVLP is a non inferior setting in comparison to the clinically approved 37 degrees C EVLP and significantly improve biochemical, clinical and immunological parameters and may reduce I/R injuries of DCD lung donors.	[Arni, Stephan; Maeyashiki, Tatsuo; Opitz, Isabelle; Inci, Ilhan] Univ Hosp Zurich, Dept Thorac Surg, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Inci, I (corresponding author), Univ Hosp Zurich, Dept Thorac Surg, Zurich, Switzerland.	Ilhan.inci@usz.ch	Inci, Ilhan/GYA-4402-2022		Swiss Lung Foundation; Fondation A.P. Naef; Jubilaumsstiftung der Lungen Liga Graubunden	Swiss Lung Foundation; Fondation A.P. Naef; Jubilaumsstiftung der Lungen Liga Graubunden	Financial disclosure statement. The authors would like to thank the following: The Swiss Lung Foundation, the Fondation A.P. Naef and the Jubilaumsstiftung der Lungen Liga Graubunden.	Ali RB, 2009, EUR SURG RES, V43, P348, DOI 10.1159/000241716; Arni S, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10040748; Bhattacharjee RN, 2020, TRANSPLANTATION, V104, P482, DOI 10.1097/TP.0000000000002967; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Bouma HR, 2011, P NATL ACAD SCI USA, V108, P2052, DOI 10.1073/pnas.1008823108; Chouchani ET, 2016, CELL METAB, V23, P254, DOI 10.1016/j.cmet.2015.12.009; Council NR, 2011, GUIDE CARE USE LAB A, VEighth; Couto-Mallon D, 2019, REV ESP CARDIOL, V72, P208, DOI 10.1016/j.rec.2018.02.021; Cypel M, 2011, NEW ENGL J MED, V364, P1431, DOI 10.1056/NEJMoa1014597; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Eshmuminov D, 2020, NAT BIOTECHNOL, V38, P189, DOI 10.1038/s41587-019-0374-x; Fontes P, 2015, AM J TRANSPLANT, V15, P381, DOI 10.1111/ajt.12991; Galasso M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08261-z; Gloria JN, 2022, J THORAC CARDIOV SUR, V164, pE59, DOI 10.1016/j.jtcvs.2021.01.066; Guibert EE, 2011, TRANSFUS MED HEMOTH, V38, P125, DOI 10.1159/000327033; Halpern Scott D, 2013, Ann Am Thorac Soc, V10, P73, DOI 10.1513/AnnalsATS.201211-109OC; Honda HM, 2005, ANN NY ACAD SCI, V1047, P248, DOI 10.1196/annals.1341.022; Hong SB, 2005, CRIT CARE MED, V33, P2049, DOI 10.1097/01.CCM.0000178186.37167.53; Inci I, 2017, J THORAC DIS, V9, P2660, DOI 10.21037/jtd.2017.07.82; Jassem W, 2002, TRANSPLANTATION, V73, P493, DOI 10.1097/00007890-200202270-00001; Knaak Jan M, 2014, J Vis Exp, pe51419, DOI 10.3791/51419; Koike T, 2011, J HEART LUNG TRANSPL, V30, P1312, DOI 10.1016/j.healun.2011.07.014; Le Gal Y M, 1994, Acta Biomed Ateneo Parmense, V65, P181; Luer B, 2010, TRANSPL INT, V23, P944, DOI 10.1111/j.1432-2277.2010.01067.x; Machuca TN, 2015, ANN SURG, V261, P591, DOI 10.1097/SLA.0000000000000974; Motoyama H, 2014, J HEART LUNG TRANSPL, V33, P1093, DOI 10.1016/j.healun.2014.06.004; Muller X, 2019, ANN SURG, V270, P783, DOI 10.1097/SLA.0000000000003513; Nakajima D, 2012, TRANSPLANTATION, V94, P999, DOI 10.1097/TP.0b013e31826f632e; Nakajima D, 2011, TRANSPLANTATION, V92, P858, DOI 10.1097/TP.0b013e31822d8778; Noda K, 2017, TRANSPLANTATION, V101, P2841, DOI 10.1097/TP.0000000000001798; Noda K, 2014, TRANSPLANTATION, V98, P499, DOI 10.1097/TP.0000000000000254; Obara H, 2018, TRANSPL P, V50, P2830, DOI 10.1016/j.transproceed.2018.03.055; Quinones QJ, 2014, INTEGR COMP BIOL, V54, P497, DOI 10.1093/icb/icu047; Rauen U, 2002, BIOL CHEM, V383, P477, DOI 10.1515/BC.2002.050; Selten J, 2017, BEST PRACT RES CL GA, V31, P171, DOI 10.1016/j.bpg.2017.04.001; Shoji T, 2005, EUR SURG RES, V37, P348, DOI 10.1159/000090335; Steen S, 2001, LANCET, V357, P825, DOI 10.1016/S0140-6736(00)04195-7; Suri LNM, 2013, BBA-BIOMEMBRANES, V1828, P1707, DOI 10.1016/j.bbamem.2013.03.005; Talaei F, 2011, J EXP BIOL, V214, P1276, DOI 10.1242/jeb.052704; Vairetti M, 2007, TRANSPL P, V39, P1765, DOI 10.1016/j.transproceed.2007.06.002; Valapour M, 2019, Am J Transplant, V19 Suppl 2, P404, DOI 10.1111/ajt.15279; Van Caenegem O, 2016, EUR J CARDIO-THORAC, V49, P1348, DOI 10.1093/ejcts/ezv409; Van Caenegem O, 2015, TRANSPL INT, V28, P224, DOI 10.1111/tri.12468; Van Raemdonck D, 2018, J THORAC DIS, V10, pS910, DOI 10.21037/jtd.2018.02.85; WARD LC, 1979, BIOMEDICINE, V30, P181; Wierup P, 2006, ANN THORAC SURG, V81, P460, DOI 10.1016/j.athoracsur.2005.08.015	47	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255155	10.1371/journal.pone.0255155	http://dx.doi.org/10.1371/journal.pone.0255155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339443	gold, Green Accepted, Green Published			2022-12-26	WOS:000680243400029
J	Babkoff, A; Cohen-Kfir, E; Aharon, H; Ravid, S				Babkoff, Aryeh; Cohen-Kfir, Einav; Aharon, Hananel; Ravid, Shoshana			Aurora-B phosphorylates the myosin II heavy chain to promote cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PASSENGER COMPLEX; REGULATORY LIGHT-CHAIN; HUMAN-PLATELET MYOSIN; PROTEIN-KINASE-C; SPINDLE CHECKPOINT; SURVIVIN; LOCALIZATION; INCENP; ISOFORMS; BINDING	Cytokinesis, the final step of mitosis, is mediated by an actomyosin contractile ring, the formation of which is temporally and spatially regulated following anaphase onset. AuroraB is a member of the chromosomal passenger complex, which regulates various processes during mitosis; it is not understood, however, how Aurora-B is involved in cytokinesis. Here, we show that Aurora-B and myosin-IIB form a complex in vivo during telophase. Aurora-B phosphorylates the myosin-IIB rod domain at threonine 1847 (T1847), abrogating the ability of myosin-IIB monomers to form filaments. Furthermore, phosphorylation of myosin-IIB filaments by Aurora-B also promotes filament disassembly. We show that myosin-IIB possessing a phosphomimetic mutation at T1847 was unable to rescue cytokinesis failure caused by myosin-IIB depletion. Cells expressing a phosphoresistant mutation at T1847 had significantly longer intercellular bridges, implying that Aurora-Bmediated phosphorylation of myosin-IIB is important for abscission. We propose that myosin-IIB is a substrate of Aurora-B and reveal a new mechanism of myosin-IIB regulation by Aurora-B in the late stages of mitosis.	[Babkoff, Aryeh; Cohen-Kfir, Einav; Aharon, Hananel; Ravid, Shoshana] Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, Jerusalem, Israel	Hebrew University of Jerusalem	Ravid, S (corresponding author), Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, Jerusalem, Israel.	shoshr@ekmd.huji.ac.il		Ravid, Shoshana/0000-0001-8017-3259				Adriaans IE, 2020, CURR BIOL, V30, P2628, DOI 10.1016/j.cub.2020.04.081; Adriaans IE, 2019, J CELL BIOL, V218, P1250, DOI 10.1083/jcb.201805036; Amaral N, 2016, NAT CELL BIOL, V18, P516, DOI 10.1038/ncb3343; Azzariti A, 2011, BRIT J CANCER, V104, P769, DOI 10.1038/bjc.2011.21; Babkoff A, 2019, J CELL SCI, V132, DOI 10.1242/jcs.233130; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Basant A, 2015, DEV CELL, V33, P204, DOI 10.1016/j.devcel.2015.03.015; Beach JR, 2014, CURR BIOL, V24, P1160, DOI 10.1016/j.cub.2014.03.071; Beach JR, 2009, J BIOL CHEM, V284, P27377, DOI 10.1074/jbc.M109.028316; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Capalbo L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12507-9; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; Cohen C, 1998, J STRUCT BIOL, V122, P180, DOI 10.1006/jsbi.1998.3983; D'Avino PP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00221; Dahan I, 2012, MOL BIOL CELL, V23, P591, DOI 10.1091/mbc.E11-01-0015; Delacour-Larose M, 2007, CELL CYCLE, V6, P1878, DOI 10.4161/cc.6.15.4482; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Fenix AM, 2016, MOL BIOL CELL, V27, P1465, DOI 10.1091/mbc.E15-10-0725; Field CM, 2019, CURR BIOL, V29, P1999, DOI 10.1016/j.cub.2019.05.016; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Fung SYS, 2017, CURR BIOL, V27, P78, DOI 10.1016/j.cub.2016.10.042; Gelens L, 2018, TRENDS CELL BIOL, V28, P6, DOI 10.1016/j.tcb.2017.09.005; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Gonzalez-Loyola A, 2015, MOL CELL BIOL, V35, P3566, DOI 10.1128/MCB.01286-14; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; HOSOYA H, 1991, J BIOL CHEM, V266, P22173; Inaba H, 2018, BIOCHEM BIOPH RES CO, V498, P544, DOI 10.1016/j.bbrc.2018.03.016; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Juanes-Garcia A, 2015, J CELL BIOL, V209, P23, DOI 10.1083/jcb.201407059; KATSURAGAWA Y, 1989, EUR J BIOCHEM, V184, P611, DOI 10.1111/j.1432-1033.1989.tb15057.x; KAWAMOTO S, 1989, J BIOL CHEM, V264, P2258; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064826; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Landino J, 2017, MOL BIOL CELL, V28, P3634, DOI 10.1091/mbc.E17-06-0399; Landino J, 2016, CURR BIOL, V26, P698, DOI 10.1016/j.cub.2016.01.018; Lens SMA, 2019, NAT REV CANCER, V19, P32, DOI 10.1038/s41568-018-0084-6; Li ZH, 2003, BIOCHEMISTRY-US, V42, P14258, DOI 10.1021/bi0354379; Lin ZZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-461; Lister IM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-19; Manukyan A, 2015, J CELL SCI, V128, P50, DOI 10.1242/jcs.151647; Matsumura F, 2011, ARCH BIOCHEM BIOPHYS, V510, P76, DOI 10.1016/j.abb.2011.03.002; Meppelink A, 2015, CELL REP, V11, P508, DOI 10.1016/j.celrep.2015.03.052; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Motegi F, 2004, J CELL BIOL, V165, P685, DOI 10.1083/jcb.200402097; Murakami N, 1998, BIOCHEMISTRY-US, V37, P1989, DOI 10.1021/bi971959a; Murakami N, 2000, BIOCHEMISTRY-US, V39, P11441, DOI 10.1021/bi000347e; Murata-Hori M, 2000, J BIOCHEM-TOKYO, V128, P903, DOI 10.1093/oxfordjournals.jbchem.a022840; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Nilsson J, 2019, J CELL BIOL, V218, P395, DOI 10.1083/jcb.201809138; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Papini D, 2019, J CELL SCI, V132, DOI 10.1242/jcs.234401; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; PHILLIPS CL, 1995, J MUSCLE RES CELL M, V16, P379, DOI 10.1007/BF00114503; Pike T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13853; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Pollard TD, 2020, ADV EXP MED BIOL, V1239, P233, DOI 10.1007/978-3-030-38062-5_11; Pollard TD, 2019, ANNU REV BIOCHEM, V88, P661, DOI 10.1146/annurev-biochem-062917-012530; Ronen D, 2009, J BIOL CHEM, V284, P24948, DOI 10.1074/jbc.M109.023754; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; Rosenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001496; Rovner AS, 2002, J CELL BIOL, V156, P113, DOI 10.1083/jcb.200107131; Sabry JH, 1997, MOL BIOL CELL, V8, P2605, DOI 10.1091/mbc.8.12.2605; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Smith SL, 2005, BRIT J CANCER, V93, P719, DOI 10.1038/sj.bjc.6602779; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; Straussman R., 2005, THESIS HEBREW U JERU; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; Terry SJ, 2018, P NATL ACAD SCI USA, V115, P2138, DOI 10.1073/pnas.1722281115; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang CW, 2020, GENOM PROTEOM BIOINF, V18, P72, DOI 10.1016/j.gpb.2020.01.001; Wang FW, 2011, CURR BIOL, V21, P1061, DOI 10.1016/j.cub.2011.05.016; Wheatley SP, 2007, CELL CYCLE, V6, P1220, DOI 10.4161/cc.6.10.4179; Wheatley SP, 2004, J BIOL CHEM, V279, P5655, DOI 10.1074/jbc.M311299200; Willems E, 2018, CELL DIV, V13, DOI 10.1186/s13008-018-0040-6; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Wu Z, 2018, ANAL CHEM, V90, P9700, DOI 10.1021/acs.analchem.8b02448; Xu ZJ, 2010, J BIOL CHEM, V285, P40163, DOI 10.1074/jbc.M110.181545; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Yumura S, 2005, MOL BIOL CELL, V16, P4256, DOI 10.1091/mbc.E05-03-0219; Zhang DL, 2015, ELIFE, V4, DOI 10.7554/eLife.08898	93	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101024	10.1016/j.jbc.2021.101024	http://dx.doi.org/10.1016/j.jbc.2021.101024			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34343568	gold, Green Published			2022-12-26	WOS:000706408900006
J	Rutbeek, NR; Rezasoltani, H; Patel, TR; Khajehpour, M; Prehna, G				Rutbeek, Nicole R.; Rezasoltani, Hanieh; Patel, Trushar R.; Khajehpour, Mazdak; Prehna, Gerd			Molecular mechanism of quorum sensing inhibition in Streptococcus by the phage protein paratox	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL MACROMOLECULES; COMPETENCE; VIRULENCE; PNEUMONIAE; PYOGENES; TRANSFORMATION; SYSTEM; GENES; CLONE	Streptococcus pyogenes, or Group A Streptococcus, is a Grampositive bacterium that can be both a human commensal and a pathogen. Central to this dichotomy are temperate bacteriophages that incorporate into the bacterial genome as prophages. These genetic elements encode both the phage proteins and the toxins harmful to the human host. One such conserved phage protein, paratox (Prx), is always found encoded adjacent to the toxin genes, and this linkage is preserved during all stages of the phage life cycle. Within S. pyogenes, Prx functions to inhibit the quorum-sensing receptor-signal pair ComRS, the master regulator of natural competence, or the ability to uptake endogenous DNA. However, the mechanism by which Prx directly binds and inhibits the receptor ComR is unknown. To understand how Prx inhibits ComR at the molecular level, we pursued an X-ray crystal structure of Prx bound to ComR. The structural data supported by solution X-ray scattering data demonstrate that Prx induces a conformational change in ComR to directly access its DNA-binding domain. Furthermore, electromobility shift assays and competition binding assays reveal that Prx effectively uncouples the interdomain conformational change required for activation of ComR via the signaling molecule XIP. Although to our knowledge the molecular mechanism of quorum-sensing inhibition by Prx is unique, it is analogous to the mechanism employed by the phage protein Aqs1 in Pseudomonas aeruginosa. Together, this demonstrates an example of convergent evolution between Gram-positive and Gram-negative phages to inhibit quorum sensing and highlights the versatility of small phage proteins.	[Rutbeek, Nicole R.; Prehna, Gerd] Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada; [Rezasoltani, Hanieh; Khajehpour, Mazdak] Univ Manitoba, Dept Chem, Winnipeg, MB, Canada; [Patel, Trushar R.] Univ Lethbridge, Dept Chem & Biochem, Lethbridge, AB, Canada	University of Manitoba; University of Manitoba; University of Lethbridge	Prehna, G (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada.	gerd.prehna@umanitoba.ca	Patel, Trushar/F-2776-2011	Patel, Trushar/0000-0003-0627-2923; Rezasoltani, Hanieh/0000-0001-5212-3799; Rutbeek, Nicole/0000-0002-6851-8223; Prehna, Gerd/0000-0001-5539-7533; Khajehpour, Mazdak/0000-0002-6080-9333	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2018-04968]; Manitoba Medical Service Foundation Operating Grant (MMSF) [8-2020-10]; Canadian Foundation for Innovation award (CFI) [37841]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Medical Service Foundation Operating Grant (MMSF); Canadian Foundation for Innovation award (CFI)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) grant RGPIN-2018-04968 to G. P., a Manitoba Medical Service Foundation Operating Grant (MMSF) 8-2020-10 to G. P., and a Canadian Foundation for Innovation award (CFI) 37841 to G. P. T. R. P. acknowledges Canada Research Chair program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aggarwal C, 2014, J BIOL CHEM, V289, P22427, DOI 10.1074/jbc.M114.583989; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Campbell EA, 1998, MOL MICROBIOL, V27, P929, DOI 10.1046/j.1365-2958.1998.00737.x; Capodagli GC, 2020, P NATL ACAD SCI USA, V117, P24494, DOI 10.1073/pnas.2008427117; Chung IY, 2014, P NATL ACAD SCI USA, V111, P11503, DOI 10.1073/pnas.1403537111; Diab J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1428; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Euler CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146408; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Fontaine L, 2015, INFECT GENET EVOL, V33, P343, DOI 10.1016/j.meegid.2014.09.010; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; Grant TD, 2018, NAT METHODS, V15, P191, DOI [10.1038/NMETH.4581, 10.1038/nmeth.4581]; Hauser R, 2012, ADV VIRUS RES, V83, P219, DOI 10.1016/B978-0-12-394438-2.00006-2; Imohl M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180757; James NG, 2014, METHODS MOL BIOL, V1076, P29, DOI 10.1007/978-1-62703-649-8_2; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim DN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13942-4; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koul A, 2020, BIOPHYS J, V118, P2726, DOI 10.1016/j.bpj.2020.04.025; Manalastas-Cantos K, 2021, J APPL CRYSTALLOGR, V54, P343, DOI 10.1107/S1600576720013412; Marks LR, 2014, J INFECT DIS, V210, P25, DOI 10.1093/infdis/jiu058; Mashburn-Warren L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34816-7; Mashburn-Warren L, 2012, J BACTERIOL, V194, P4589, DOI 10.1128/JB.00830-12; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; McShan WM, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0059-2018; Meier-Stephenson V, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100589; Moon AF, 2016, NUCLEIC ACIDS RES, V44, P3946, DOI 10.1093/nar/gkw143; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neiditch MB, 2017, ANNU REV GENET, V51, P311, DOI 10.1146/annurev-genet-120116-023507; Norrby-Teglund A, 2000, J MED MICROBIOL, V49, P849, DOI 10.1099/0022-1317-49-10-849; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Panjkovich A, 2018, BIOINFORMATICS, V34, P1944, DOI 10.1093/bioinformatics/btx846; Penades JR, 2015, CURR OPIN MICROBIOL, V23, P171, DOI 10.1016/j.mib.2014.11.019; Peterson S, 2000, J BACTERIOL, V182, P6192, DOI 10.1128/JB.182.21.6192-6202.2000; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Shah MG, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.12.011; Shanker E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005979; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Talagas A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005980; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	48	0	0	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100992	10.1016/j.jbc.2021.100992	http://dx.doi.org/10.1016/j.jbc.2021.100992			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34298018	Green Submitted, gold, Green Published			2022-12-26	WOS:000706418900006
J	Willis, CRG; Gallagher, IJ; Wilkinson, DJ; Brook, MS; Bass, JJ; Phillips, BE; Smith, K; Etheridge, T; Stokes, T; McGlory, C; Gorissen, SHM; Szewczyk, NJ; Phillips, SM; Atherton, PJ				Willis, Craig R. G.; Gallagher, Iain J.; Wilkinson, Daniel J.; Brook, Matthew S.; Bass, Joseph J.; Phillips, Bethan E.; Smith, Kenneth; Etheridge, Timothy; Stokes, Tanner; McGlory, Chris; Gorissen, Stefan H. M.; Szewczyk, Nathaniel J.; Phillips, Stuart M.; Atherton, Philip J.			Transcriptomic links to muscle mass loss and declines in cumulative muscle protein synthesis during short-term disuse in healthy younger humans	FASEB JOURNAL			English	Article						atrophy; disuse; gene network analysis; muscle protein synthesis; skeletal muscle	HUMAN SKELETAL-MUSCLE; NEUROMUSCULAR ELECTRICAL-STIMULATION; GENE-EXPRESSION PATTERNS; INSULIN-RESISTANCE; EXTRACELLULAR-MATRIX; ANABOLIC RESISTANCE; ATROPHY; EXERCISE; PACKAGE; IMMOBILIZATION	Muscle disuse leads to a rapid decline in muscle mass, with reduced muscle protein synthesis (MPS) considered the primary physiological mechanism. Here, we employed a systems biology approach to uncover molecular networks and key molecular candidates that quantitatively link to the degree of muscle atrophy and/or extent of decline in MPS during short-term disuse in humans. After consuming a bolus dose of deuterium oxide (D2O; 3 mL.kg(-1)), eight healthy males (22 +/- 2 years) underwent 4 days of unilateral lower-limb immobilization. Bilateral muscle biopsies were obtained post-intervention for RNA sequencing and D2O-derived measurement of MPS, with thigh lean mass quantified using dual-energy X-ray absorptiometry. Application of weighted gene co-expression network analysis identified 15 distinct gene clusters ("modules") with an expression profile regulated by disuse and/or quantitatively connected to disuse-induced muscle mass or MPS changes. Module scans for candidate targets established an experimentally tractable set of candidate regulatory molecules (242 hub genes, 31 transcriptional regulators) associated with disuse-induced maladaptation, many themselves potently tied to disuse-induced reductions in muscle mass and/or MPS and, therefore, strong physiologically relevant candidates. Notably, we implicate a putative role for muscle protein breakdown-related molecular networks in impairing MPS during short-term disuse, and further establish DEPTOR (a potent mTOR inhibitor) as a critical mechanistic candidate of disuse driven MPS suppression in humans. Overall, these findings offer a strong benchmark for accelerating mechanistic understanding of short-term muscle disuse atrophy that may help expedite development of therapeutic interventions.	[Willis, Craig R. G.; Etheridge, Timothy] Univ Exeter, Coll Life & Environm Sci, Dept Sport & Hlth Sci, Exeter, Devon, England; [Gallagher, Iain J.] Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland; [Wilkinson, Daniel J.; Brook, Matthew S.; Bass, Joseph J.; Phillips, Bethan E.; Smith, Kenneth; Szewczyk, Nathaniel J.; Atherton, Philip J.] Univ Nottingham, Royal Derby Hosp Ctr, Nottingham Biomed Res Ctr,Sch Med, MRC Versus Arthrit Ctr Musculoskeletal Ageing Res, Derby DE22 3DT, England; [Wilkinson, Daniel J.; Brook, Matthew S.; Bass, Joseph J.; Phillips, Bethan E.; Smith, Kenneth; Szewczyk, Nathaniel J.; Atherton, Philip J.] Univ Nottingham, Royal Derby Hosp Ctr, Nottingham Biomed Res Ctr, Natl Inst Hlth Res,Sch Med, Derby DE22 3DT, England; [Stokes, Tanner; McGlory, Chris; Gorissen, Stefan H. M.; Phillips, Stuart M.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Szewczyk, Nathaniel J.] Ohio Univ, Ohio Musculoskeletal & Neurol Inst OMNI, Athens, OH 45701 USA; [Szewczyk, Nathaniel J.] Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA	University of Exeter; University of Stirling; University of Nottingham; University of Nottingham; McMaster University; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Atherton, PJ (corresponding author), Univ Nottingham, Royal Derby Hosp Ctr, Nottingham Biomed Res Ctr,Sch Med, MRC Versus Arthrit Ctr Musculoskeletal Ageing Res, Derby DE22 3DT, England.; Atherton, PJ (corresponding author), Univ Nottingham, Royal Derby Hosp Ctr, Nottingham Biomed Res Ctr, Natl Inst Hlth Res,Sch Med, Derby DE22 3DT, England.	philip.atherton@nottingham.ac.uk	Phillips, Stuart/B-2343-2009; Gorissen, Stefan/ABA-1008-2021	Phillips, Stuart/0000-0002-1956-4098; Gorissen, Stefan/0000-0003-3737-9053; Szewczyk, Nathaniel/0000-0003-4425-9746; Bass, Joseph/0000-0002-8236-681X; Phillips, Bethan/0000-0002-1430-1870	RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J014400/1, BB/M009122/1, BB/N015894/1]; Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); RCUK \ Medical Research Council (MRC) [MR/P021220/1, MR/R502364/1]	RCUK \ Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); RCUK \ Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RCUK vertical bar Biotechnology and Biological Sciences Research Council (BBSRC), Grant/Award Number: BB/J014400/1, BB/M009122/1 and BB/N015894/1; Gouvernement du Canada vertical bar Natural Sciences and Engineering Research Council of Canada (NSERC); RCUK vertical bar Medical Research Council (MRC), Grant/Award Number: MR/P021220/1 and MR/R502364/1	Abadi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006518; Alibegovic AC, 2010, AM J PHYSIOL-ENDOC M, V299, pE752, DOI 10.1152/ajpendo.00590.2009; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Atherton PJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE594, DOI 10.1152/ajpendo.00257.2016; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Brook MS, 2016, ACTA PHYSIOL, V216, P15, DOI 10.1111/apha.12532; Brook MS, 2016, J PHYSIOL-LONDON, V594, P7399, DOI 10.1113/JP272857; Brook MS, 2015, FASEB J, V29, P4485, DOI 10.1096/fj.15-273755; Catena V, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0484-y; Chen YW, 2007, PHYSIOL GENOMICS, V31, P510, DOI 10.1152/physiolgenomics.00115.2006; Clark BC, 2004, ARCH PHYS MED REHAB, V85, P1555, DOI 10.1016/j.apmr.2003.09.011; de Boer MD, 2007, J PHYSIOL-LONDON, V585, P241, DOI 10.1113/jphysiol.2007.142828; Dirks ML, 2016, ACTA PHYSIOL, V218, P10, DOI 10.1111/apha.12699; Dirks ML, 2014, ACTA PHYSIOL, V210, P628, DOI 10.1111/apha.12200; Dirks ML, 2020, J CLIN ENDOCR METAB, V105, P276, DOI 10.1210/clinem/dgz049; Dirks ML, 2018, J APPL PHYSIOL, V125, P850, DOI 10.1152/japplphysiol.00985.2016; Dirks ML, 2016, DIABETES, V65, P2862, DOI 10.2337/db15-1661; Edwards SJ, 2020, AM J CLIN NUTR, V112, P1368, DOI 10.1093/ajcn/nqaa229; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Ferrando AA, 1996, AM J PHYSIOL-ENDOC M, V270, pE627, DOI 10.1152/ajpendo.1996.270.4.E627; Fisher SR, 2010, ARCH INTERN MED, V170, P1942, DOI 10.1001/archinternmed.2010.422; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; Franchi MV, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12593; Gustafsson T, 2010, J APPL PHYSIOL, V109, P721, DOI 10.1152/japplphysiol.00110.2009; Hector AJ., 2015, CELL MOL EXERC PHYSL, V4, P1, DOI [10.7457/cmep.v4i1.e8, DOI 10.7457/CMEP.V4I1.E8]; Holloway TM, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00105; Homma T, 2009, ACTA PHYSIOL, V197, P313, DOI 10.1111/j.1748-1716.2009.02003.x; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Institute for Government, 2019, HOSPITALS; Jones SW, 2004, FASEB J, V18, P1025, DOI 10.1096/fj.03-1228fje; Kazi AA, 2011, MOL MED, V17, P925, DOI 10.2119/molmed.2011.00070; Kilroe SP, 2020, AM J PHYSIOL-ENDOC M, V318, pE117, DOI 10.1152/ajpendo.00360.2019; Kilroe SP, 2020, MED SCI SPORT EXER, V52, P944, DOI 10.1249/MSS.0000000000002200; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Urso M, 2006, J APPL PHYSIOL, V101, P1136, DOI 10.1152/japplphysiol.00180.2006; Langfelder P., 2017, WGCNA PACKAGE FREQUE; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee CG, 2011, J AM GERIATR SOC, V59, P1217, DOI 10.1111/j.1532-5415.2011.03472.x; Li JQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18705-z; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Londhe P, 2015, BONE, V80, P131, DOI 10.1016/j.bone.2015.03.015; Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19; Mahmassani ZS, 2019, J APPL PHYSIOL, V126, P894, DOI 10.1152/japplphysiol.00811.2018; Mason MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-327; Mouisel E, 2006, NEUROSCI RES, V55, P389, DOI 10.1016/j.neures.2006.05.002; NHS Digital, 2019, HOSP ADM PAT CAR AD; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Oldham MC, 2014, OMICS APPL NEUROSCIE, P85; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Phillips BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003389; Phillips SM, 2014, J PHYSIOL-LONDON, V592, P5341, DOI 10.1113/jphysiol.2014.273615; Rakobowchuk M, 2011, EUR J APPL PHYSIOL, V111, P203, DOI 10.1007/s00421-010-1636-y; Reich KA, 2010, J APPL PHYSIOL, V109, P1404, DOI 10.1152/japplphysiol.00444.2010; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rudrappa SS, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00361; Shad BJ, 2019, MED SCI SPORT EXER, V51, P2125, DOI 10.1249/MSS.0000000000002034; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimkus KL., 2013, INT J EXERC SCI C P, V2, P7; Smith DA, 2014, ANAT REC, V297, P1637, DOI 10.1002/ar.22980; Spangenburg EE, 2009, APPL PHYSIOL NUTR ME, V34, P328, DOI 10.1139/H09-010; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Stokes T, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107980; Suetta C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051238; Symons TB, 2009, J APPL PHYSIOL, V107, P34, DOI 10.1152/japplphysiol.91137.2008; Tesch PA, 2008, J APPL PHYSIOL, V105, P902, DOI 10.1152/japplphysiol.90558.2008; Thalacker-Mercer A, 2013, PHYSIOL GENOMICS, V45, P499, DOI 10.1152/physiolgenomics.00167.2012; Tidball JG, 2005, J APPL PHYSIOL, V98, P1900, DOI 10.1152/japplphysiol.01178.2004; Tully MA, 2012, BRIT J SPORT MED, V46, P877, DOI 10.1136/bjsports-2011-090692; Ulbricht Anna, 2013, Commun Integr Biol, V6, pe24925, DOI 10.4161/cib.24925; van Dam S, 2018, BRIEF BIOINFORM, V19, P575, DOI 10.1093/bib/bbw139; Varusai TM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18400-z; Wall BT, 2014, ACTA PHYSIOL, V210, P600, DOI 10.1111/apha.12190; Wall BT, 2016, AM J PHYSIOL-ENDOC M, V310, pE137, DOI 10.1152/ajpendo.00227.2015; Wall BT, 2013, J CLIN ENDOCR METAB, V98, P4872, DOI 10.1210/jc.2013-2098; Wall BT, 2013, AGEING RES REV, V12, P898, DOI 10.1016/j.arr.2013.07.003; Weigl LG, 2012, CURR OPIN PHARMACOL, V12, P377, DOI 10.1016/j.coph.2012.02.017; Wilkinson DJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12433; Wilkinson DJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE571, DOI 10.1152/ajpendo.00650.2013; Willis CRG, 2020, AGING-US, V12, P740, DOI 10.18632/aging.102653; World Health Organization, 2019, AV LENGTH STAY ALL H; World Health Organization, 2018, AG HLTH; Yasuda N, 2005, J APPL PHYSIOL, V99, P1085, DOI 10.1152/japplphysiol.00247.2005; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	92	3	3	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21830	10.1096/fj.202100276RR	http://dx.doi.org/10.1096/fj.202100276RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34342902	Green Published			2022-12-26	WOS:000691122900054
J	Garcia-Dominguez, DJ; Hajji, N; Sanchez-Molina, S; Figuerola-Bou, E; de Pablos, RM; Espinosa-Oliva, AM; Andres-Leon, E; Terron-Camero, LC; Flores-Campos, R; Pascual-Pasto, G; Robles, MJ; Carcaboso, AM; Mora, J; de Alava, E; Hontecillas-Prieto, L; Machado, I; Llombart-Bosch, A; Magagnoli, G; Scotlandi, K				Garcia-Dominguez, Daniel J.; Hajji, Nabil; Sanchez-Molina, Sara; Figuerola-Bou, Elisabet; de Pablos, Rocio M.; Espinosa-Oliva, Ana M.; Andres-Leon, Eduardo; Terron-Camero, Laura Carmen; Flores-Campos, Rocio; Pascual-Pasto, Guillem; Robles, Maria Jose; Carcaboso, Angel M.; Mora, Jaume; de Alava, Enrique; Hontecillas-Prieto, Lourdes; Machado, Isidro; Llombart-Bosch, Antonio; Magagnoli, Giovanna; Scotlandi, Katia			Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma	ONCOGENE			English	Article							HISTONE DEACETYLASE 6; EWS-FLI1; SP1; OVEREXPRESSION; PROLIFERATION; TRANSCRIPTION; COMBINATION; MECHANISMS; REPRESSION; BORTEZOMIB	Ewing sarcoma (EWS) is an aggressive bone and soft tissue tumor of children and young adults in which the principal driver is a fusion gene, EWSR1-FLI1. Although the essential role of EWSR1-FLI1 protein in the regulation of oncogenesis, survival, and tumor progression processes has been described in-depth, little is known about the regulation of chimeric fusion-gene expression. Here, we demonstrate that the active nuclear HDAC6 in EWS modulates the acetylation status of specificity protein 1 (SP1), consequently regulating the SP1/P300 activator complex binding to EWSR1 and EWSR1-FLI1 promoters. Selective inhibition of HDAC6 impairs binding of the activator complex SP1/P300, thereby inducing EWSR1-FLI1 downregulation and significantly reducing its oncogenic functions. In addition, sensitivity of EWS cell lines to HDAC6 inhibition is higher than other tumor or non-tumor cell lines. High expression of HDAC6 in primary EWS tumor samples from patients correlates with a poor prognosis in two independent series accounting 279 patients. Notably, a combination treatment of a selective HDAC6 and doxorubicin (a DNA damage agent used as a standard therapy of EWS patients) dramatically inhibits tumor growth in two EWS murine xenograft models. These results could lead to suitable and promising therapeutic alternatives for patients with EWS.	[Garcia-Dominguez, Daniel J.; de Pablos, Rocio M.; Espinosa-Oliva, Ana M.; Flores-Campos, Rocio; Robles, Maria Jose; de Alava, Enrique; Hontecillas-Prieto, Lourdes] Univ Seville, CIBERONC, Inst Biomed Seville IBiS, Hosp Univ Virgen Rocio,CSIC, Seville, Spain; [Hajji, Nabil] Imperial Coll London, Div Brain Sci, London, England; [Sanchez-Molina, Sara; Figuerola-Bou, Elisabet; Mora, Jaume] Hosp St Joan Deu, Dev Tumour Biol Lab, Barcelona, Spain; [de Pablos, Rocio M.; Espinosa-Oliva, Ana M.] Univ Seville, Fac Pharm, Dept Biochem & Mol Biol, Seville, Spain; [Andres-Leon, Eduardo; Terron-Camero, Laura Carmen] Consejo Super Invest Cient IPBLN CSIC, Bioinformat Unit, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Pascual-Pasto, Guillem; Carcaboso, Angel M.] Hosp St Joan de Deu, Pediat Hematol & Oncol, Inst Recerca St Joan de Deu, Barcelona, Spain; [Robles, Maria Jose; de Alava, Enrique] Univ Seville, CIBERONC, Pathol Unit, Hosp Univ Virgen Rocio,CSIC, Seville, Spain; [Machado, Isidro] Inst Valenciano Oncol, Pathol Dept, Valencia, Spain; [Llombart-Bosch, Antonio] Univ Valencia, Pathol Dept, Valencia, Spain; [Magagnoli, Giovanna] IRCCS Ist Ortoped Rizzoli, Dept Pathol, Bologna, Italy; [Scotlandi, Katia] IRRCS Ist Ortoped Rizzoli, Expt Oncol Lab, Bologna, Italy; [de Alava, Enrique] Univ Seville, Sch Med, Dept Normal & Pathol Cytol & Histol, Seville, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Imperial College London; University of Barcelona; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; Virgen del Rocio University Hospital; Instituto Valenciano De Oncologia; University of Valencia; University of Sevilla	Garcia-Dominguez, DJ; de Alava, E; Hontecillas-Prieto, L (corresponding author), Univ Seville, CIBERONC, Inst Biomed Seville IBiS, Hosp Univ Virgen Rocio,CSIC, Seville, Spain.; Hajji, N (corresponding author), Imperial Coll London, Div Brain Sci, London, England.; de Alava, E (corresponding author), Univ Seville, CIBERONC, Pathol Unit, Hosp Univ Virgen Rocio,CSIC, Seville, Spain.; de Alava, E (corresponding author), Univ Seville, Sch Med, Dept Normal & Pathol Cytol & Histol, Seville, Spain.	dgarcia-ibis@us.es; n.hajji@imperial.ac.uk; enrique.alava.sspa@juntadeandalucia.es; lhontecillas-ibis@us.es	Garcia, Daniel Jose/B-5366-2016; Scotlandi, Katia/J-9009-2016; Andrés-León., Eduardo/K-8944-2014; de Alava, Enrique/GOH-0368-2022; Sanchez-Molina, Sara/B-2148-2017; magagnoli, giovanna/D-1723-2019	Garcia, Daniel Jose/0000-0001-8150-2747; Scotlandi, Katia/0000-0001-6114-9499; Andrés-León., Eduardo/0000-0002-0621-9914; de Alava, Enrique/0000-0001-8400-046X; Sanchez-Molina, Sara/0000-0002-1430-131X; Hajji, Nabil/0000-0002-0695-920X; Pascual-Pasto, Guillem/0000-0001-8537-261X; magagnoli, giovanna/0000-0002-6430-1318; Flores-Campos, Rocio/0000-0002-2563-4136; Carcaboso, Angel/0000-0002-8485-426X; Figuerola-Bou, Elisabet/0000-0002-6839-9586	Asociacion Espanola Contra el Cancer (AECC); Ministry of Science of Spain-FEDER (CIBERONC) [PI1700464, PI2000003, RD06/0020/0059]; CIBERONC [CB16/12/00361]; Consejeria de Salud, Junta de Andalucia [PI-0197-2016, PI-0013-2018, ECAI F2-0012-2018]	Asociacion Espanola Contra el Cancer (AECC); Ministry of Science of Spain-FEDER (CIBERONC); CIBERONC; Consejeria de Salud, Junta de Andalucia(Junta de Andalucia)	Research in the E.D.A. lab is supported by Asociacion Espanola Contra el Cancer (AECC), the Ministry of Science of Spain-FEDER (CIBERONC, PI1700464, PI2000003, RD06/0020/0059)S. D.G.D. and L.H.P. are supported by CIBERONC (CB16/12/00361). D.G.D., M.J.R. and L.H.P. are PhD researchers funded by the Consejeria de Salud, Junta de Andalucia (PI-0197-2016, ECAI F2-0012-2018 and PI-0013-2018, respectively).	Abdul-Salam VB, 2020, NOVEL NUCLEAR ROLE H, DOI [DOI 10.1101/2020.11.02.356121V1, 10.1101/2020.11.02.356121v1]; Amengual JE, 2015, CLIN CANCER RES, V21, P4663, DOI 10.1158/1078-0432.CCR-14-3068; Azahri NSM, 2012, J CELL BIOCHEM, V113, P2597, DOI 10.1002/jcb.24135; Ban J, 2011, ONCOGENE, V30, P2173, DOI 10.1038/onc.2010.581; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Cao JL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0788-2; de Nigris F, 2021, BONE, V143, DOI 10.1016/j.bone.2020.115605; Formisano L, 2015, J NEUROSCI, V35, P7332, DOI 10.1523/JNEUROSCI.2174-14.2015; Furumai R, 2002, CANCER RES, V62, P4916; Garcia-Dominguez DJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234243; Garcia-Dominguez Daniel Jose, 2018, Oncotarget, V9, P31397, DOI 10.18632/oncotarget.25829; Giorgi C, 2015, ONCOTARGET, V6, P28895, DOI 10.18632/oncotarget.5000; Grunewald TGP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0003-x; Herrero-Martin D, 2009, BRIT J CANCER, V101, P80, DOI 10.1038/sj.bjc.6605104; Hontecillas-Prieto L, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.578011; Huang PY, 2017, ONCOTARGET, V8, P2694, DOI 10.18632/oncotarget.13738; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Kanno K, 2012, ONCOL REP, V28, P867, DOI 10.3892/or.2012.1898; Keskin T, 2020, CELL REP, V30, P4567, DOI 10.1016/j.celrep.2019.12.053; Lee DH, 2018, INT J ONCOL, V53, P844, DOI 10.3892/ijo.2018.4405; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Liu YJ, 2012, J BIOL CHEM, V287, P29168, DOI 10.1074/jbc.M112.371120; Llombart-Bosch A, 2009, VIRCHOWS ARCH, V455, P397, DOI 10.1007/s00428-009-0842-7; Machado I, 2018, VIRCHOWS ARCH, V472, P815, DOI 10.1007/s00428-018-2316-2; Mackintosh C, 2012, ONCOGENE, V31, P1287, DOI 10.1038/onc.2011.317; Martinez-Lage M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18875-x; Moller E, 2009, ONCOL REP, V21, P641, DOI 10.3892/or_00000267; Montoya C, 2020, ONCOL REP, V43, P1199, DOI 10.3892/or.2020.7489; Nacev BA, 2020, NAT REV CANCER, V20, P608, DOI 10.1038/s41568-020-0288-4; Negmeldin AT, 2017, ACS MED CHEM LETT, V8, P281, DOI 10.1021/acsmedchemlett.6b00124; Pattenden SG, 2016, P NATL ACAD SCI USA, V113, P3018, DOI 10.1073/pnas.1521827113; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Ray A, 2018, LEUKEMIA, V32, P843, DOI 10.1038/leu.2017.322; Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004; Sakimura R, 2005, INT J CANCER, V116, P784, DOI 10.1002/ijc.21069; Sanchez-Molina S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba3058; Sankar S, 2013, ONCOGENE, V32, P5089, DOI 10.1038/onc.2012.525; Santo L, 2012, BLOOD, V119, P2579, DOI 10.1182/blood-2011-10-387365; Scotlandi K, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040968; Seidel C, 2015, EPIGENOMICS-UK, V7, P103, DOI [10.2217/EPI.14.69, 10.2217/epi.14.69]; Sun YJ, 2018, CURR TOP MED CHEM, V18, P2420, DOI 10.2174/1568026619666181210152115; Tang F, 2017, CANCER TREAT REV, V59, P33, DOI 10.1016/j.ctrv.2017.06.006; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Wang XX, 2018, EUR J MED CHEM, V143, P1406, DOI 10.1016/j.ejmech.2017.10.040; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wang ZH, 2016, CANCER LETT, V379, P134, DOI 10.1016/j.canlet.2016.06.001; Yang CJ, 2015, ONCOTARGET, V6, P30263, DOI 10.18632/oncotarget.4749; Yee AJ, 2016, LANCET ONCOL, V17, P1569, DOI 10.1016/S1470-2045(16)30375-8; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	50	6	6	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 30	2021	40	39					5843	5853		10.1038/s41388-021-01974-4	http://dx.doi.org/10.1038/s41388-021-01974-4		AUG 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UZ8WB	34345016	Green Published, hybrid			2022-12-26	WOS:000681523500004
J	Su, JC; Wu, GD; Ye, Y; Zhang, JL; Zeng, LX; Huang, XD; Zheng, YF; Bai, RH; Zhuang, LS; Li, M; Pan, L; Deng, JG; Li, R; Deng, S; Zhang, SP; Zuo, ZX; Liu, ZX; Lin, JZ; Lin, DX; Zheng, J				Su, Jiachun; Wu, Guandi; Ye, Ying; Zhang, Jialiang; Zeng, Lingxing; Huang, Xudong; Zheng, Yanfen; Bai, Ruihong; Zhuang, Lisha; Li, Mei; Pan, Ling; Deng, Junge; Li, Rui; Deng, Shuang; Zhang, Shaoping; Zuo, Zhixiang; Liu, Zexian; Lin, Junzhong; Lin, Dongxin; Zheng, Jian			NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization	ONCOGENE			English	Article							POOR-PROGNOSIS; GENE-EXPRESSION; MISU NSUN2; METHYLTRANSFERASE; METHYLATION; PROLIFERATION; BINDING; TRANSFORMATION; METASTASIS; INHIBITION	5-Methylcytosine (m(5)C) is a posttranscriptional RNA modification participating in many critical bioprocesses, but its functions in human cancer remain unclear. Here, by detecting the transcriptome-wide m(5)C profiling in esophageal squamous cell carcinoma (ESCC), we showed increased m(5)C methylation in ESCC tumors due to the overexpressed m(5)C methyltransferase NSUN2. Aberrant expression of NSUN2 was positively regulated by E2F Transcription Factor 1 (E2F1). High NSUN2 levels predicted poor survival of ESCC patients. Moreover, silencing NSUN2 suppressed ESCC tumorigenesis and progression in Nsun2 knockout mouse models. Mechanistically, NSUN2 induced m(5)C modification of growth factor receptor-bound protein 2 (GRB2) and stabilized its mRNA, which was mediated by a novel m(5)C mediator, protein lin-28 homolog B (LIN28B). Elevated GRB2 levels increased the activation of PI3K/AKT and ERK/MAPK signalling. These results demonstrate that NSUN2 enhances the initiation and progression of ESCC via m(5)C-LIN28B dependent stabilization of GRB2 transcript, providing a promising epitranscriptomic-targeted therapeutic strategy for ESCC.	[Su, Jiachun; Wu, Guandi; Ye, Ying; Zhang, Jialiang; Zeng, Lingxing; Huang, Xudong; Zheng, Yanfen; Bai, Ruihong; Li, Mei; Pan, Ling; Deng, Junge; Li, Rui; Deng, Shuang; Zhang, Shaoping; Zuo, Zhixiang; Liu, Zexian; Lin, Junzhong; Lin, Dongxin; Zheng, Jian] Sun Yat Sen Univ Canc Ctr, State Key Lab Oncol South China, Guangzhou, Peoples R China; [Su, Jiachun; Wu, Guandi; Ye, Ying; Zhang, Jialiang; Zeng, Lingxing; Huang, Xudong; Zheng, Yanfen; Bai, Ruihong; Li, Mei; Pan, Ling; Deng, Junge; Li, Rui; Deng, Shuang; Zhang, Shaoping; Zuo, Zhixiang; Liu, Zexian; Lin, Junzhong; Lin, Dongxin; Zheng, Jian] Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China; [Zhuang, Lisha] Sun Yat Sen Univ Canc Ctr, Dept Pathol, Guangzhou, Peoples R China; [Lin, Junzhong] Sun Yat Sen Univ Canc Ctr, Dept Surg, Guangzhou, Peoples R China; [Lin, Dongxin] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr,Dept Etiol & Carcinogenesis, Beijing, Peoples R China; [Lin, Dongxin; Zheng, Jian] Nanjing Med Univ, Collaborat Innovat Ctr Canc Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Nanjing Medical University	Lin, JZ; Lin, DX; Zheng, J (corresponding author), Sun Yat Sen Univ Canc Ctr, State Key Lab Oncol South China, Guangzhou, Peoples R China.; Lin, JZ; Lin, DX; Zheng, J (corresponding author), Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China.; Lin, JZ (corresponding author), Sun Yat Sen Univ Canc Ctr, Dept Surg, Guangzhou, Peoples R China.; Lin, DX (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr,Dept Etiol & Carcinogenesis, Beijing, Peoples R China.; Lin, DX; Zheng, J (corresponding author), Nanjing Med Univ, Collaborat Innovat Ctr Canc Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Peoples R China.	linjzh@sysucc.org.cn; lindx@sysucc.org.cn; zhengjian@sysucc.org.cn	Zhang, Jialiang/HDN-0467-2022; Zuo, Zhixiang/M-4441-2016	Zuo, Zhixiang/0000-0002-2492-2689; Su, Jiachun/0000-0002-8445-4901; Zeng, Lingxing/0000-0002-0846-8762; Zheng, Jian/0000-0001-9831-7038	Program for Guangdong Introducing Innovative and Entrepreneurial Teams [2017ZT07S096]; Natural Science Foundation of China [U1601229]; National Young Top-notch Talent Support Program; Sun Yat-sen University Intramural Funds	Program for Guangdong Introducing Innovative and Entrepreneurial Teams; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Young Top-notch Talent Support Program; Sun Yat-sen University Intramural Funds	We thank Dr. Bin Shen (Department of Histology and Embryology, Nanjing Medical University, Nanjing, China) for his generous donation of Nsun2 +/- C57BL/6J mice. This study was supported by the Program for Guangdong Introducing Innovative and Entrepreneurial Teams (2017ZT07S096 to DL), Natural Science Foundation of China (U1601229 to DL), National Young Top-notch Talent Support Program (to JZ) and Sun Yat-sen University Intramural Funds (to DL and to JZ).	Amort T, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1139-1; Blanco S, 2016, NATURE, V534, P335, DOI 10.1038/nature18282; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Bourgeois G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133321; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Budkina KS, 2020, BIOCHEMISTRY-MOSCOW+, V85, P1, DOI 10.1134/S0006297920140011; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Chen X, 2019, NAT CELL BIOL, V21, P978, DOI 10.1038/s41556-019-0361-y; CHENG J, 2018, NAT COMMUN, V9; David R, 2017, PLANT CELL, V29, P445, DOI 10.1105/tpc.16.00751; Delaunay S, 2019, NAT CELL BIOL, V21, P552, DOI 10.1038/s41556-019-0319-0; Flores JV, 2017, STEM CELL REP, V8, P112, DOI 10.1016/j.stemcr.2016.11.014; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Frye M, 2010, CANCER LETT, V289, P71, DOI 10.1016/j.canlet.2009.08.004; Giubellino A, 2007, CANCER RES, V67, P6012, DOI 10.1158/0008-5472.CAN-07-0022; Hamano R, 2012, BRIT J CANCER, V106, P1415, DOI 10.1038/bjc.2012.90; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; Ijaz M, 2017, PROTEIN PEPTIDE LETT, V24, P1084, DOI 10.2174/0929866525666171123213148; Keskin T, 2020, CELL REP, V30, P4567, DOI 10.1016/j.celrep.2019.12.053; Khan MA, 2012, AM J HUM GENET, V90, P856, DOI 10.1016/j.ajhg.2012.03.023; Khoddami V, 2013, NAT BIOTECHNOL, V31, P458, DOI 10.1038/nbt.2566; Khosronezhad N, 2015, J ASSIST REPROD GEN, V32, P807, DOI 10.1007/s10815-015-0443-0; Li B, 2016, CLIN CANCER RES, V22, P1243, DOI 10.1158/1078-0432.CCR-15-1196; Li LY, 2015, J PROTEOMICS, V117, P145, DOI 10.1016/j.jprot.2015.01.016; Li LY, 2014, INT J CLIN EXP PATHO, V7, P3132; Lu LG, 2018, CANCER INVEST, V36, P246, DOI 10.1080/07357907.2018.1466896; Luo YH, 2016, CIRC RES, V118, P944, DOI 10.1161/CIRCRESAHA.115.307674; Madison BB, 2013, GENE DEV, V27, P2233, DOI 10.1101/gad.224659.113; Motorin Y, 2010, NUCLEIC ACIDS RES, V38, P1415, DOI 10.1093/nar/gkp1117; Nan P, 2020, CARCINOGENESIS, V41, P1263, DOI 10.1093/carcin/bgz200; Nicolau-Neto Pedro, 2018, Oncotarget, V9, P16634, DOI 10.18632/oncotarget.24621; Ohanian M, 2018, LANCET HAEMATOL, V5, pE136, DOI 10.1016/S2352-3026(18)30021-8; Piovesan D, 2016, NUCLEIC ACIDS RES, V44, pW367, DOI 10.1093/nar/gkw315; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Sajini AA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10020-7; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Schumann U, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00769-5; Selmi T, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1193; Shi QZ, 2018, CELL PHYSIOL BIOCHEM, V46, P2187, DOI 10.1159/000489548; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smyth EC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.48; Song MQ, 2018, MOL CANCER THER, V17, P1540, DOI 10.1158/1535-7163.MCT-17-0823; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Trixl L, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1510; Van Haute L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12039; Veschi V, 2017, CANCER CELL, V31, P50, DOI 10.1016/j.ccell.2016.12.002; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang WG, 2016, WIRES RNA, V7, P838, DOI 10.1002/wrna.1380; Wang XC, 2018, BIOMED PHARMACOTHER, V104, P383, DOI 10.1016/j.biopha.2018.05.064; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Yang JC, 2017, FUTURE ONCOL, V13, P1981, DOI 10.2217/fon-2017-0084; Yang X, 2017, CELL RES, V27, P606, DOI 10.1038/cr.2017.55; Yang Y, 2019, MOL CELL, V75, P1188, DOI 10.1016/j.molcel.2019.06.033; Zhang JP, 2019, BLOOD, V134, P171, DOI 10.1182/blood.2019001043	57	11	11	6	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 30	2021	40	39					5814	5828		10.1038/s41388-021-01978-0	http://dx.doi.org/10.1038/s41388-021-01978-0		AUG 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UZ8WB	34345012	Green Published, hybrid			2022-12-26	WOS:000681523500001
J	Zheng, JX; Yang, T; Gao, SH; Cheng, MR; Shao, Y; Xi, YF; Guo, LZ; Zhang, D; Gao, W; Zhang, GZ; Yang, LJ; Yang, T				Zheng, Jinxiu; Yang, Ting; Gao, Shuhua; Cheng, Minrong; Shao, Ying; Xi, Yanfeng; Guo, Linzhi; Zhang, Dong; Gao, Wei; Zhang, Guozhen; Yang, Lijun; Yang, Tao			miR-148a-3p silences the CANX/MHC-I pathway and impairs CD8(+) T cell-mediated immune attack in colorectal cancer	FASEB JOURNAL			English	Article						calnexin (CANX); colorectal cancer (CRC); immune system; major histocompatibility complex class I (MHC-I); miR-148a-3p	ANTIGEN-PROCESSING MACHINERY; DENDRITIC CELLS; CALNEXIN; EXPRESSION; RESISTANCE; DEFECTS	Nonresponse, or acquired resistance to immune checkpoint inhibitors in colorectal cancer (CRC) highlight the importance of finding potential tolerance mechanisms. Low expression of major histocompatibility complex, class I (MHC-I) on the cell surface of the tumor is one of the main mechanisms of tumor escape from T-cell recognition and destruction. In this study, we demonstrated that a high level of calnexin (CANX) in the tumors is positively correlated with the overall survival in colorectal cancer patients. CANX is a chaperone protein involved in the folding and assembly of MHC-I molecules. Using miRNA target prediction databases and luciferase assays, we identified miR-148a-3p as a potential regulator of CANX. Inhibition of miR-148a-3p restores surface levels of MHC-I and significantly enhanced the effects of CD8(+) T-cell-mediated immune attack in vitro and in vivo by promoting CANX expression. These results reveal that miR-148a-3p can function as a tumor promotor in CRC by targeting the CANX/MHC-I axis, which provides a rationale for immunotherapy through targeting the miR-148a-3p/CANX/MHC-I pathway in patients with CRC.	[Zheng, Jinxiu; Yang, Lijun] Shanxi Med Univ, Dept Pharmacol, 56 Xinjian South Rd, Taiyuan, Shanxi, Peoples R China; [Yang, Ting; Gao, Shuhua; Cheng, Minrong; Zhang, Dong; Yang, Tao] Shanxi Med Univ, Dept Biochem & Mol Biol, 56 Xinjian South Rd, Taiyuan, Shanxi, Peoples R China; [Shao, Ying] Shanxi Med Univ, Dept Pathophysiol, Taiyuan, Peoples R China; [Zheng, Jinxiu; Yang, Ting; Shao, Ying; Yang, Lijun; Yang, Tao] Shanxi Med Univ, Key Lab Cellular Physiol, Minist Educ, Taiyuan, Peoples R China; [Xi, Yanfeng] Shanxi Prov Canc Hosp, Dept Pathol, Taiyuan, Peoples R China; [Guo, Linzhi] Shanxi Med Univ, Lab Morphol, Taiyuan, Peoples R China; [Gao, Wei] Shanxi Med Univ, Hosp 1, Shanxi Key Lab Otorhinolaryngol Head & Neck Canc, Taiyuan, Peoples R China; [Zhang, Guozhen] Shanxi Med Univ, Hosp 2, Dept Pathol, Taiyuan, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University	Yang, LJ (corresponding author), Shanxi Med Univ, Dept Pharmacol, 56 Xinjian South Rd, Taiyuan, Shanxi, Peoples R China.; Yang, T (corresponding author), Shanxi Med Univ, Dept Biochem & Mol Biol, 56 Xinjian South Rd, Taiyuan, Shanxi, Peoples R China.	yanglijunmm@sxmu.edu.cn; yangtao056cn@sxmu.edu.cn	Gao, Wei/E-8505-2013	Gao, Wei/0000-0001-7836-2851	National Natural Science Foundation of China [81972325]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China, Grant/Award Number: 81972325	Afferni C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02601; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alles J, 2017, ONCOTARGET, V8, P56417, DOI 10.18632/oncotarget.17662; [Anonymous], 2018, N Engl J Med, V379, P2185, DOI 10.1056/NEJMx180040; Ashizawa M, 2019, MOL CANCER RES, V17, P1403, DOI 10.1158/1541-7786.MCR-18-0831; Benci JL, 2019, CELL, V178, P933, DOI 10.1016/j.cell.2019.07.019; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Burr ML, 2019, CANCER CELL, V36, P385, DOI 10.1016/j.ccell.2019.08.008; Carosella ED, 2015, EUR UROL, V68, P267, DOI 10.1016/j.eururo.2015.02.032; Chen YC, 2019, CANCER IMMUNOL RES, V7, P123, DOI 10.1158/2326-6066.CIR-18-0124; Cheng NL, 2015, AGING CELL, V14, P200, DOI 10.1111/acel.12294; Ciardiello D, 2019, CANCER TREAT REV, V76, P22, DOI 10.1016/j.ctrv.2019.04.003; Cortez MA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv303; Diedrich G, 2001, J IMMUNOL, V166, P1703, DOI 10.4049/jimmunol.166.3.1703; Dissemond J, 2004, CANCER LETT, V203, P225, DOI 10.1016/j.canlet.2003.09.036; Dong PX, 2018, ONCOGENE, V37, P5257, DOI 10.1038/s41388-018-0347-4; Donia M, 2017, CANCER RES, V77, P4562, DOI 10.1158/0008-5472.CAN-16-3172; Facoetti A, 2005, CLIN CANCER RES, V11, P8304, DOI 10.1158/1078-0432.CCR-04-2588; Franke AJ, 2019, JNCI-J NATL CANCER I, V111, P1131, DOI 10.1093/jnci/djz093; Hasim A, 2011, CHINESE MED J-PEKING, V124, P341, DOI 10.3760/cma.j.issn.0366-6999.2011.03.004; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuipers EJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.65; Lakkaraju AKK, 2013, MOL CELL, V51, P386, DOI 10.1016/j.molcel.2013.07.009; Lee CH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236101; Leone P, 2013, JNCI-J NATL CANCER I, V105, P1172, DOI 10.1093/jnci/djt184; Liston A, 2010, J CLIN IMMUNOL, V30, P339, DOI 10.1007/s10875-010-9378-5; Liu RH, 2018, GASTROENTEROLOGY, V154, P637, DOI 10.1053/j.gastro.2017.09.045; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Liu Y, 2012, CANCER IMMUNOL IMMUN, V61, P789, DOI 10.1007/s00262-011-1137-9; Lu TX, 2018, J ALLERGY CLIN IMMUN, V141, P1202, DOI 10.1016/j.jaci.2017.08.034; Mari L, 2018, GASTROENTEROLOGY, V155, P784, DOI 10.1053/j.gastro.2018.06.030; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Seliger B, 2008, CANCER IMMUNOL IMMUN, V57, P1719, DOI 10.1007/s00262-008-0515-4; Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI 10.3322/caac.21654; Strauss J, 2018, CLIN CANCER RES, V24, P1287, DOI 10.1158/1078-0432.CCR-17-2653; Ugurel S, 2019, CANCER IMMUNOL IMMUN, V68, P983, DOI 10.1007/s00262-019-02341-9; Wang B, 2009, IMMUNOLOGY, V128, P43, DOI 10.1111/j.1365-2567.2009.03067.x; Wang XH, 2017, CANCER RES, V77, P839, DOI 10.1158/0008-5472.CAN-15-3142; Wang Y, 2020, AM J TRANSL RES, V12, P541; Wiersma VR, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00007; Wu J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00745; Xu SH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11406; Xu SJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101140; Yang W, 2020, ONCOGENE, V39, P1098, DOI 10.1038/s41388-019-1045-6; Zhu XP, 2005, J IMMUNOL, V175, P967, DOI 10.4049/jimmunol.175.2.967	45	14	16	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21776	10.1096/fj.202100235R	http://dx.doi.org/10.1096/fj.202100235R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34324740				2022-12-26	WOS:000678975300034
J	Sandoval, M; Nguyen, DT; Vahidy, FS; Graviss, EA				Sandoval, Micaela; Nguyen, Duc T.; Vahidy, Farhaan S.; Graviss, Edward A.			Risk factors for severity of COVID-19 in hospital patients age 18-29 years	PLOS ONE			English	Article							UNITED-STATES; ETHNICITY; RACE	Background Since February 2020, over 2.5 million Texans have been diagnosed with COVID-19, and 20% are young adults at risk for SARS-CoV-2 exposure at work, academic, and social settings. This study investigated demographic and clinical risk factors for severe disease and readmission among young adults 18-29 years old, who were diagnosed at a hospital encounter in Houston, Texas, USA. Methods and findings A retrospective registry-based chart review was conducted investigating demographic and clinical risk factors for severe COVID-19 among patients aged 18-29 with positive SARS-CoV-2 tests within a large metropolitan healthcare system in Houston, Texas, USA. In the cohort of 1,853 young adult patients diagnosed with COVID-19 infection at a hospital encounter, including 226 pregnant women, 1,438 (78%) scored 0 on the Charlson Comorbidity Index, and 833 (45%) were obese (>= 30 kg/m(2)). Within 30 days of their diagnostic encounter, 316 (17%) patients were diagnosed with pneumonia, 148 (8%) received other severe disease diagnoses, and 268 (14%) returned to the hospital after being discharged home. In multivariable logistic regression analyses, increasing age (adjusted odds ratio [aOR] 1.1, 95% confidence interval [CI] 1.1-1.2, p<0.001), male gender (aOR 1.8, 95% CI 1.2-2.7, p = 0.002), Hispanic ethnicity (aOR 1.9, 95% CI 1.2-3.1, p = 0.01), obesity (3.1, 95% CI 1.9-5.1, p<0.001), asthma history (aOR 2.3, 95% CI 1.3-4.0, p = 0.003), congestive heart failure (aOR 6.0, 95% CI 1.5-25.1, p = 0.01), cerebrovascular disease (aOR 4.9, 95% CI 1.7-14.7, p = 0.004), and diabetes (aOR 3.4, 95% CI 1.9-6.2, p<0.001) were predictive of severe disease diagnoses within 30 days. Non-Hispanic Black race (aOR 1.6, 95% CI 1.0-2.4, p = 0.04), obesity (aOR 1.7, 95% CI 1.0-2.9, p = 0.046), asthma history (aOR 1.7, 95% CI 1.0-2.7, p = 0.03), myocardial infarction history (aOR 6.2, 95% CI 1.7-23.3, p = 0.01), and household exposure (aOR 1.5, 95% CI 1.1-2.2, p = 0.02) were predictive of 30-day readmission. Conclusions This investigation demonstrated the significant risk of severe disease and readmission among young adult populations, especially marginalized communities and people with comorbidities, including obesity, asthma, cardiovascular disease, and diabetes. Health authorities must emphasize COVID-19 awareness and prevention in young adults and continue investigating risk factors for severe disease, readmission and long-term sequalae.	[Sandoval, Micaela; Nguyen, Duc T.; Graviss, Edward A.] Houston Methodist Res Inst, Dept Pathol & Genom Med, Houston, TX 77030 USA; [Sandoval, Micaela] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Vahidy, Farhaan S.] Houston Methodist Res Inst, Ctr Outcomes Res, Houston, TX USA; [Graviss, Edward A.] Houston Methodist Hosp, Dept Surg, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Graviss, EA (corresponding author), Houston Methodist Res Inst, Dept Pathol & Genom Med, Houston, TX 77030 USA.; Graviss, EA (corresponding author), Houston Methodist Hosp, Dept Surg, Houston, TX 77030 USA.	eagraviss@houstonmethodist.org	Nguyen, Duc T/ABH-7913-2020; Sandoval, Micaela/AAX-3853-2021	Nguyen, Duc T/0000-0002-5059-4404; Sandoval, Micaela/0000-0002-0777-3933	Houston Methodist Hospital, Department of Pathology and Genomic Medicine	Houston Methodist Hospital, Department of Pathology and Genomic Medicine	This study was internally funded through the Houston Methodist Hospital, Department of Pathology and Genomic Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiolfi A, 2020, ANN THORAC SURG, V110, pE413, DOI 10.1016/j.athoracsur.2020.04.011; Altonen BL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243343; Bellinvia S, 2020, INFLAMM RES, V69, P757, DOI 10.1007/s00011-020-01366-6; Buckholz A, 2021, GASTROINTEST ENDOSC, V93, P263, DOI 10.1016/j.gie.2020.07.010; CDC, DEF AD OV OB; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng YLJ, 2019, JAMA-J AM MED ASSOC, V322, P2389, DOI 10.1001/jama.2019.19365; Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941; Cunningham JW, 2021, JAMA INTERN MED, V181, P379, DOI 10.1001/jamainternmed.2020.5313; DeBiasi RL, 2020, J PEDIATR-US, V223, P199, DOI 10.1016/j.jpeds.2020.05.007; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Flanagan BE, 2011, J HOMEL SECUR EMERG, V8, DOI 10.2202/1547-7355.1792; Gattinoni L, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02880-z; Graham G, 2015, CURR CARDIOL REV, V11, P238, DOI 10.2174/1573403X11666141122220003; Hall T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218236; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Hastie T., 2015, STAT LEARNING SPARSI; Hutchins HJ, 2020, MMWR-MORBID MORTAL W, V69, P1584, DOI 10.15585/mmwr.mm6943e4; Iba T, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03077-0; Jimenez T, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2020.100615; Kind AJH, 2018, NEW ENGL J MED, V378, P2456, DOI 10.1056/NEJMp1802313; Masi P, 2020, CIRCULATION, V142, P611, DOI 10.1161/CIRCULATIONAHA.120.048925; Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787; Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430; Rossen LM, 2020, MMWR-MORBID MORTAL W, V69, P1522, DOI [10.1101/2020.06.06.20120857v1.full.pdf, 10.15585/mmwr.mm6942e2]; Ryan BJ, 2020, DISASTER MED PUBLIC, V14, P623, DOI 10.1017/dmp.2020.109; Texas Department of State Health Services, TEX COVID 19 DAT; Thakur N, 2020, AM J RESP CRIT CARE, V202, P943, DOI 10.1164/rccm.202005-1523PP; University of Wisconsin School of Medicine and Public Health, AR DEPR IND; Utych S.M., 2020, J BEHAV PUBLIC ADM, V3, DOI [10.30636/jbpa.31.151, DOI 10.30636/JBPA.31.151]; Vahidy F, 2021, JMIR MED INF, V9, DOI 10.2196/26773; Vahidy FS, 2020, JAMA-J AM MED ASSOC, V324, P998, DOI 10.1001/jama.2020.15301; Wang KG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73136-7	33	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255544	10.1371/journal.pone.0255544	http://dx.doi.org/10.1371/journal.pone.0255544			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329347	gold, Green Published			2022-12-26	WOS:000685248600069
J	He, Y; Xu, R; Peng, L; Hu, XY				He, Ying; Xu, Rui; Peng, Li; Hu, Xiaoyu			Tumor infiltrating lymphocytes associated competitive endogenous RNA networks as predictors of outcome in hepatic carcinoma based on WGCNA analysis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; CANCER STATISTICS; GROWTH; INVASION; EXPRESSION; MIGRATION; LIVER; CONSTRUCTION; PATHOGENESIS	Background The important regulatory role of competitive endogenous RNAs (ceRNAs) in hepatocellular carcinoma (HCC) has been confirmed. Tumor infiltrating lymphocytes (TILs) are of great significance to tumor outcome and prognosis. This study will systematically analyze the key factors affecting the prognosis of HCC from the perspective of ceRNA and TILs. Methods The Cancer Genome Atlas (TCGA) database was used for transcriptome data acquisition of HCC. Through the analysis of the Weighted Gene Co-expression Network Analysis (WCGNA), the two modules for co-expression of the disease were determined, and a ceRNA network was constructed. We used Cox regression and LASSO regression analysis to screen prognostic factors and constructed a risk score model. The Gene Expression Omnibus (GEO) was used to validate the model. The Kyoto Encyclopedia of Genes and Genomes (KEGG) was used for mRNAs functional analysis. The cell composition of TILs was analyzed by the CIBERSORT algorithm, and Pearson correlation analysis was utilized to explore the correlation between TILs and prognostic factors. Results We constructed a ceRNA regulatory network composed of 67 nodes through WGCNA, including 44 DElncRNAs, 19 DEGs, and 4 DEmiRNAs. And based on the expression of 4 DEGs in this network (RRM2, LDLR, TXNIP, and KIF23), a prognostic model of HCC with good specificity and sensitivity was developed. CIBERSORT analyzed the composition of TILs in HCC tumor tissues. Correlation analysis showed that RRM2 is significantly correlated with T cells CD4 memory activated, T cells CD4 memory resting, T cells CD8, and T cells follicular helper, and TXNIP is negatively correlated with B cells memory. Conclusions In this study, a ceRNA with prognostic value in HCC was created, and a prognostic risk model for HCC was constructed based on it. This risk score model is closely related to TILs and is expected to become a potential therapeutic target and a new predictive indicator.	[He, Ying; Xu, Rui; Peng, Li] Chengdu Univ Tradit Chinese Med, Dept Coll Clin Med, Chengdu, Sichuan, Peoples R China; [Hu, Xiaoyu] Hosp Chengdu Univ Tradit Chinese Med, Dept Infect Dis, Chengdu, Sichuan, Peoples R China	Chengdu University of Traditional Chinese Medicine; Chengdu University of Traditional Chinese Medicine	Hu, XY (corresponding author), Hosp Chengdu Univ Tradit Chinese Med, Dept Infect Dis, Chengdu, Sichuan, Peoples R China.	xiaoyuhu@aliyun.com						Alhamzawi R, 2018, MATH BIOSCI, V303, P75, DOI 10.1016/j.mbs.2018.06.004; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bosetti C, 2014, BEST PRACT RES CL GA, V28, P753, DOI 10.1016/j.bpg.2014.08.007; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Cheng CX, 2020, CANCER MANAG RES, V12, P13241, DOI 10.2147/CMAR.S285367; Deng X, 2017, BIOMED PHARMACOTHER, V90, P100, DOI 10.1016/j.biopha.2017.03.031; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Finn RS, 2020, NEW ENGL J MED, V382, P1894, DOI 10.1056/NEJMoa1915745; Fiscon G, 2018, GENES-BASEL, V9, DOI 10.3390/genes9090437; Gallagher EJ, 2017, ONCOGENE, V36, P6462, DOI 10.1038/onc.2017.247; Gao J, 2013, BIOMATERIALS, V34, P10084, DOI 10.1016/j.biomaterials.2013.08.088; Garnelo M, 2017, GUT, V66, P342, DOI 10.1136/gutjnl-2015-310814; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Guillaumond F, 2015, P NATL ACAD SCI USA, V112, P2473, DOI 10.1073/pnas.1421601112; Hauptman N, 2013, RADIOL ONCOL, V47, P311, DOI 10.2478/raon-2013-0062; He Y., 2020, J CLIN INVEST; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Huang N, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01103; Kaadige MR, 2009, P NATL ACAD SCI USA, V106, P14878, DOI 10.1073/pnas.0901221106; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Koyama S, 2001, J CANCER RES CLIN, V127, P20, DOI 10.1007/s004320000181; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li P, 2019, J CELL MOL MED, V23, P2475, DOI 10.1111/jcmm.14121; Li SQ, 2020, AM J PATHOL, V190, P1095, DOI 10.1016/j.ajpath.2019.11.010; Linnebacher M, 2012, ONCOIMMUNOLOGY, V1, P1186, DOI 10.4161/onci.20641; Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92; Liu YH, 2016, AM J TRANSL RES, V8, P2159; Ma LC, 2019, CANCER CELL, V36, P418, DOI 10.1016/j.ccell.2019.08.007; Mossanen JC, 2019, GASTROENTEROLOGY, V156, P1877, DOI 10.1053/j.gastro.2019.01.247; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Pan RS, 2018, ONCOTARGETS THER, V11, P8409, DOI 10.2147/OTT.S160963; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shahabi S, 2019, CANCER RES, V79, P3050, DOI 10.1158/0008-5472.CAN-18-2034; Shao Y, 2010, IMMUNOL LETT, V129, P78, DOI 10.1016/j.imlet.2010.02.002; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Speiser DE, 2016, NAT REV IMMUNOL, V16, P500, DOI 10.1038/nri.2016.80; Stadthagen G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003913; Stegmann KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26157; Su LS, 2020, CANCER MANAG RES, V12, P9883, DOI 10.2147/CMAR.S269215; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Waldmann P, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2743-3; Wan S, 2020, CANCER MANAG RES, V12, P9741, DOI 10.2147/CMAR.S262215; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; Wang LX, 2019, MED SCI MONITOR, V25, P2896, DOI 10.12659/MSM.913881; Wang ZP, 2020, CANCER MANAG RES, V12, P3903, DOI 10.2147/CMAR.S245990; Wu HK, 2020, AGING-US, V12, P12812, DOI 10.18632/aging.103246; Wu J, 2019, ONCOTARGETS THER, V12, P6623, DOI 10.2147/OTT.S196630; Xu WQ, 2019, THER ADV MED ONCOL, V11, DOI 10.1177/1758835919862692; Yang JH, 2020, J CELL BIOCHEM, V121, P1823, DOI 10.1002/jcb.29417; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Yue CS, 2019, ONCOTARGETS THER, V12, P561, DOI 10.2147/OTT.S188913; Zhai SY, 2021, ONCOGENE, V40, P277, DOI 10.1038/s41388-020-01525-3; Zhang J, 2014, CANCER INFORM, V13, P137, DOI 10.4137/CIN.S14021; Zhang ZQ, 2019, CANCER SCI, V110, P2905, DOI 10.1111/cas.14138; Zheng JF, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00382-19	61	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254829	10.1371/journal.pone.0254829	http://dx.doi.org/10.1371/journal.pone.0254829			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324544	gold, Green Published			2022-12-26	WOS:000685248200019
J	Rothman, JA; Loope, KJ; McFrederick, QS; Rankin, EEW				Rothman, Jason A.; Loope, Kevin J.; McFrederick, Quinn S.; Wilson Rankin, Erin E.			Microbiome of the wasp Vespula pensylvanica in native and invasive populations, and associations with Moku virus	PLOS ONE			English	Article							HONEY-BEE; COMMUNITY COMPOSITION; HYMENOPTERA; DISPLACEMENT; PLASTICITY; ECOLOGY; HAWAII; ANTS; MAUI	Invasive species present a worldwide concern as competition and pathogen reservoirs for native species. Specifically, the invasive social wasp, Vespula pensylvanica, is native to western North America and has become naturalized in Hawaii, where it exerts pressures on native arthropod communities as a competitor and predator. As invasive species may alter the microbial and disease ecology of their introduced ranges, there is a need to understand the microbiomes and virology of social wasps. We used 16S rRNA gene sequencing to characterize the microbiome of V. pensylvanica samples pooled by colony across two geographically distinct ranges and found that wasps generally associate with taxa within the bacterial genera Fructobacillus, Fructilactobacillus, Lactococcus, Leuconostoc, and Zymobacter, and likely associate with environmentally-acquired bacteria. Furthermore, V. pensylvanica harbors-and in some cases were dominated by-many endosymbionts including Wolbachia, Sodalis, Arsenophonus, and Rickettsia, and were found to contain bee-associated taxa, likely due to scavenging on or predation upon honey bees. Next, we used reverse-transcriptase quantitative PCR to assay colony-level infection intensity for Moku virus (family: Iflaviridae), a recently-described disease that is known to infect multiple Hymenopteran species. While Moku virus was prevalent and in high titer, it did not associate with microbial diversity, indicating that the microbiome may not directly interact with Moku virus in V. pensylvanica in meaningful ways. Collectively, our results suggest that the invasive social wasp V. pensylvanica associates with a simple microbiome, may be infected with putative endosymbionts, likely acquires bacterial taxa from the environment and diet, and is often infected with Moku virus. Our results suggest that V. pensylvanica, like other invasive social insects, has the potential to act as a reservoir for bacteria pathogenic to other pollinators, though this requires experimental demonstration.	[Rothman, Jason A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Loope, Kevin J.] Georgia Southern Univ, Dept Biol, Statesboro, GA 30458 USA; [McFrederick, Quinn S.; Wilson Rankin, Erin E.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Irvine; University System of Georgia; Georgia Southern University; University of California System; University of California Riverside	Rothman, JA (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.; Loope, KJ (corresponding author), Georgia Southern Univ, Dept Biol, Statesboro, GA 30458 USA.	rothmanj@uci.edu; kjloope@gmail.com	Wilson Rankin, E E/GLS-9381-2022; Rothman, Jason/I-2382-2019; Rankin, Erin E Wilson/J-7044-2014	Wilson Rankin, E E/0000-0001-7741-113X; Rothman, Jason/0000-0002-4848-8901; Rankin, Erin E Wilson/0000-0001-7741-113X; McFrederick, Quinn/0000-0003-0740-6954	United States Department of Agriculture National Institute of Food and Agriculture (USDA NIFA) Predoctoral Fellowship [2018-67011-28123]; USDA NIFA Postdoctoral Fellowship [201667012-24681]; USDA NIFA Hatch funds [CA-R-ENT-5109-H, CA-R-ENT5091-H]; United States National Science Foundation [1557163]	United States Department of Agriculture National Institute of Food and Agriculture (USDA NIFA) Predoctoral Fellowship; USDA NIFA Postdoctoral Fellowship; USDA NIFA Hatch funds; United States National Science Foundation(National Science Foundation (NSF))	This work was supported by a United States Department of Agriculture National Institute of Food and Agriculture (USDA NIFA) Predoctoral Fellowship (Award No. 2018-67011-28123) to JAR, a USDA NIFA Postdoctoral Fellowship (201667012-24681) to KJL, USDA NIFA Hatch funds to QSM (CA-R-ENT-5109-H) and EWR (CA-R-ENT5091-H) and a United States National Science Foundation grant (DEB #1557163) to EWR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Hagimori T, 2020, ANN ENTOMOL SOC AM, V113, P355, DOI 10.1093/aesa/saaa007; Beggs JR, 2011, BIOCONTROL, V56, P505, DOI 10.1007/s10526-011-9389-z; Betelman K, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix107; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Boudjelas S, 2000, 8565 INV SPEC SPEC G; Brenton-Rule EC, 2018, BIOL INVASIONS, V20, P3445, DOI 10.1007/s10530-018-1786-0; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cheng CH, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0518-0; Cheng DF, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007942; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; Dittmer J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01478; Dobelmann J, 2017, OIKOS, V126, P1208, DOI 10.1111/oik.04117; Emery O, 2017, MOL ECOL, V26, P2576, DOI 10.1111/mec.14058; Engel P, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.07; GAMBINO P, 1991, NEW ZEAL J ZOOL, V18, P139, DOI 10.1080/03014223.1991.10757960; GAMBINO P, 1990, ANN ENTOMOL SOC AM, V83, P1088, DOI 10.1093/aesa/83.6.1088; Gerth M, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv047; Graystock P, 2017, CONSERV GENET, V18, P701, DOI 10.1007/s10592-017-0937-7; Graystock P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1371; Grozinger CM, 2019, ANNU REV ENTOMOL, V64, P205, DOI 10.1146/annurev-ento-011118-111942; Gruber MAM, 2019, ECOL ENTOMOL, V44, P512, DOI 10.1111/een.12732; Gualtieri L, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix087; Hammer TJ, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz117; Hanna C, 2014, BIOL INVASIONS, V16, P283, DOI 10.1007/s10530-013-0517-9; Hanshew AS, 2013, J MICROBIOL METH, V95, P149, DOI 10.1016/j.mimet.2013.08.007; Highfield A, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12060607; Holway DA, 1999, ECOLOGY, V80, P238, DOI 10.1890/0012-9658(1999)080[0238:CMUTDO]2.0.CO;2; Hu Y, 2014, MOL ECOL, V23, P1284, DOI 10.1111/mec.12607; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kembel SW, 2014, P NATL ACAD SCI USA, V111, P13715, DOI 10.1073/pnas.1216057111; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kolde Raivo, 2019, CRAN; Kwong WK, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600513; Kwong WK, 2014, P NATL ACAD SCI USA, V111, P11509, DOI 10.1073/pnas.1405838111; Lester PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121358; Loope KJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89607-4; Loope KJ, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2499; Loope KJ, 2018, BIOL INVASIONS, V20, P3431, DOI 10.1007/s10530-018-1783-3; Lopez-Madrigal S, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz232; MACDONALD J F, 1974, Melanderia, V18, P1; Maes PW, 2016, MOL ECOL, V25, P5439, DOI 10.1111/mec.13862; Malacrino A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240996; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Martin SJ, 2019, ANNU REV VIROL, V6, P49, DOI [10.1146/annurev-virology-092818-015700, 10.1146/annurev-virology-092818- 015700]; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; McFrederick QS, 2017, MICROB ECOL, V73, P188, DOI 10.1007/s00248-016-0838-1; Mcfrederick QS, 2016, MOL ECOL, V25, P2302, DOI 10.1111/mec.13608; McFrederick QS, 2013, APPL ENVIRON MICROB, V79, P1803, DOI 10.1128/AEM.03681-12; Mordecai GJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34983; Oksanen J., 2017, **DATA OBJECT**; Palmer-Young EC, 2019, ENVIRON MICROBIOL, V21, P4706, DOI 10.1111/1462-2920.14805; Parratt SR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005629; Paulson AR, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0224-4; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Quinn O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209589; R Core Team, 2020, R LANG ENV STAT COMP; Rankin EEW, 2021, CURR OPIN INSECT SCI, V46, P72, DOI 10.1016/j.cois.2021.02.014; Reeson AF, 2003, INSECT MOL BIOL, V12, P85, DOI 10.1046/j.1365-2583.2003.00390.x; Rothman JA, 2020, INSECTS, V11, DOI 10.3390/insects11090645; Rothman JA, 2019, MICROB ECOL, V78, P506, DOI 10.1007/s00248-018-1300-3; Rothman JA, 2018, MICROB ECOL, V76, P814, DOI 10.1007/s00248-018-1151-y; Rubanovl A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40347-6; Rubin BER, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180369;180369; Saeed A, 2015, J INVERTEBR PATHOL, V132, P111, DOI 10.1016/j.jip.2015.09.011; Sanders JG, 2014, MOL ECOL, V23, P1268, DOI 10.1111/mec.12611; SHERMAN PW, 1995, BEHAV ECOL, V6, P102, DOI 10.1093/beheco/6.1.102; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Stout JC, 2009, APIDOLOGIE, V40, P388, DOI 10.1051/apido/2009023; Suenami S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46388-1; Visscher PK, 2003, INSECT SOC, V50, P160, DOI 10.1007/s00040-003-0636-x; Voulgari-Kokota A, 2019, TRENDS MICROBIOL, V27, P1034, DOI 10.1016/j.tim.2019.07.011; Vuong HQ, 2019, GENOME BIOL EVOL, V11, P2151, DOI 10.1093/gbe/evz136; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson EE, 2010, ECOLOGY, V91, P3294, DOI 10.1890/09-1187.1; Wilson EE, 2009, P NATL ACAD SCI USA, V106, P12809, DOI 10.1073/pnas.0902979106	77	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255463	10.1371/journal.pone.0255463	http://dx.doi.org/10.1371/journal.pone.0255463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324610	gold, Green Published			2022-12-26	WOS:000685248200045
J	Yadav, UN; Yadav, OP; Singh, DR; Ghimire, S; Rayamajhee, B; Mistry, SK; Rawal, LB; Ali, ARMM; Tamang, MK; Mehta, S				Yadav, Uday Narayan; Yadav, Om Prakash; Singh, Devendra Raj; Ghimire, Saruna; Rayamajhee, Binod; Kanti Mistry, Sabuj; Rawal, Lal Bahadur; Ali, A. R. M. Mehrab; Kumar Tamang, Man; Mehta, Suresh			Perceived fear of COVID-19 and its associated factors among Nepalese older adults in eastern Nepal: A cross-sectional study	PLOS ONE			English	Article							SUBSYNDROMAL SYMPTOMATIC DEPRESSION	Background Coronavirus disease 2019 (COVID-19) has affected all age groups worldwide, but older adults have been affected greatly with an increased risk of severe illness and mortality. Nepal is struggling with the COVID-19 pandemic. The normal life of older adults, one of the vulnerable populations to COVID-19 infection, has been primarily impacted. The current evidence shows that the COVID-19 virus strains are deadly, and non-compliance to standard protocols can have serious consequences, increasing fear among older adults. This study assessed the perceived fear of COVID-19 and associated factors among older adults in eastern Nepal. Methods A cross-sectional study was conducted between July and September 2020 among 847 older adults (>= 60 years) residing in three districts of eastern Nepal. Perceived fear of COVID-19 was measured using the seven-item Fear of COVID-19 Scale (FCV-19S). Multivariate logistic regression identified the factors associated with COVID-19 fear. Results The mean score of the FCV-19S was 18.1 (SD = 5.2), and a sizeable proportion of older adults, ranging between 12%-34%, agreed with the seven items of the fear scale. Increasing age, Dalit ethnicity, remoteness to the health facility, and being concerned or overwhelmed with the COVID-19 were associated with greater fear of COVID-19. In contrast, preexisting health conditions were inversely associated with fear. Conclusion Greater fear of the COVID-19 among the older adults in eastern Nepal suggests that during unprecedented times such as the current pandemic, the psychological needs of older adults should be prioritized. Establishing and integrating community-level mental health support as a part of the COVID-19 preparedness and response plan might help to combat COVID-19 fear among them.	[Yadav, Uday Narayan; Kanti Mistry, Sabuj] UNSW, Ctr Primary Hlth Care & Equ, Sydney, NSW, Australia; [Yadav, Uday Narayan] UNSW, Sch Populat Hlth, Sydney, NSW, Australia; [Yadav, Uday Narayan; Kumar Tamang, Man] Ctr Res Policy & Implementat, Biratnagar, Nepal; [Yadav, Uday Narayan] Torrens Univ, Sydney, NSW, Australia; [Yadav, Uday Narayan; Rawal, Lal Bahadur] Cent Queensland Univ, Sch Hlth Med & Social Sci, Sydney, NSW, Australia; [Yadav, Om Prakash; Mehta, Suresh] Minist Hlth & Populat, Kathmandu, Nepal; [Singh, Devendra Raj] Purbanchal Univ, Asian Coll Adv Studies, Dept Publ Hlth, Biratnagar, Nepal; [Ghimire, Saruna] Miami Univ, Dept Sociol & Gerontol, Oxford, OH 45056 USA; [Ghimire, Saruna] Miami Univ, Scripps Gerontol Ctr, Oxford, OH 45056 USA; [Rayamajhee, Binod] UNSW, Fac Med & Hlth Sci, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Rayamajhee, Binod] Kathmandu Res Inst Biol Sci, Dept Infect & Immunol, Lalitpur, Nepal; [Kanti Mistry, Sabuj] BRAC Univ, Dhaka, Bangladesh; [Ali, A. R. M. Mehrab] Aureolin Res Consultancy & Expertise Dev Fdn, Dhaka, Bangladesh; [Kumar Tamang, Man] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Torrens University Australia; Central Queensland University; University System of Ohio; Miami University; University System of Ohio; Miami University; University of New South Wales Sydney; Bangladesh Rural Advancement Committee BRAC; BRAC University; University of Queensland	Yadav, UN (corresponding author), UNSW, Ctr Primary Hlth Care & Equ, Sydney, NSW, Australia.; Yadav, UN (corresponding author), UNSW, Sch Populat Hlth, Sydney, NSW, Australia.; Yadav, UN (corresponding author), Ctr Res Policy & Implementat, Biratnagar, Nepal.; Yadav, UN (corresponding author), Torrens Univ, Sydney, NSW, Australia.; Yadav, UN (corresponding author), Cent Queensland Univ, Sch Hlth Med & Social Sci, Sydney, NSW, Australia.	unyadav1@gmail.com	Singh, Devendra Raj/R-2197-2019; Rayamajhee, Binod/H-6897-2019; Ali, ARM Mehrab/ABA-9605-2021	Singh, Devendra Raj/0000-0003-1450-9476; Ali, ARM Mehrab/0000-0001-5442-7147; Yadav, Uday Narayan/0000-0002-6626-1604; Rayamajhee, Binod/0000-0003-3007-8901				Aburub AS, 2020, J GERIATR ONCOL, V11, P603, DOI 10.1016/j.jgo.2019.09.001; Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X; Arora A, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102384; Banerjee D, 2020, INT J GERIATR PSYCH, V35, P1466, DOI 10.1002/gps.5320; Bentler PM, 1999, MULTIVAR BEHAV RES, V34, P181, DOI 10.1207/S15327906Mb340203; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Central Bureau of Statistics, 2012, NAT POP HOUS CENS 20, V33, P34; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dubey S, 2020, DIABETES METAB SYND, V14, P779, DOI 10.1016/j.dsx.2020.05.035; Freckelton QCI, 2020, INT J LAW PSYCHIAT, V72, DOI 10.1016/j.ijlp.2020.101611; Garcia-Portilla P, 2021, AGING MENT HEALTH, V25, P1297, DOI 10.1080/13607863.2020.1805723; Grossman ES, 2021, PERS INDIV DIFFER, V168, DOI 10.1016/j.paid.2020.110371; Harvard Humanitarian Initiative, 2020, KOBOTOOLBOX SIMPL RO; JUDD LL, 1994, J CLIN PSYCHIAT, V55, P18; Kantamneni N, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103439; Karagiannidis C, 2020, LANCET RESP MED, V8, P853, DOI 10.1016/S2213-2600(20)30316-7; Khademi F, 2021, INT J MENT HEALTH NU, V30, P346, DOI 10.1111/inm.12824; Kohler H, 2021, J PRIM CARE COMMUNIT, V12, DOI 10.1177/2150132721996898; Ministry of Health and Population, 2021, COVID 19 CAS UPD NEP; Mistry SK, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00698-0; Nepal Law Commission, 2006, SEN CIT ACT NEP LAW; Office of Disease Prevention and Health Promotion: Healthy People, 2020, DETERMINANTS HLTH; Parlapani E, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00842; Payette MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152848; Poudel K, 2020, INT J SOC PSYCHIATR, V66, P748, DOI 10.1177/0020764020942247; Sadek N, 2000, DEPRESS ANXIETY, V12, P30, DOI 10.1002/1520-6394(2000)12:1<30::AID-DA4>3.0.CO;2-P; Shrestha DB, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02904-6; Sim K, 2010, J PSYCHOSOM RES, V68, P195, DOI 10.1016/j.jpsychores.2009.04.004; Singh DR, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010378; Su ZH, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-020-00654-4; Thapa D K, 2018, Kathmandu Univ Med J (KUMJ), V16, P181; Thapa DK, 2020, NURS HEALTH SCI, V22, P1139, DOI 10.1111/nhs.12783; United Nations Department of Economic and Social Affairs Population Division, 2019, PROF AG 2019; Vahia IV, 2020, AM J GERIAT PSYCHIAT, V28, P695, DOI 10.1016/j.jagp.2020.03.007; Vahia VN, 2020, INT PSYCHOGERIATR, V32, P1125, DOI 10.1017/S1041610220001441; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; WHO, 2020, COVID 19 STRAT UPD; WHO, 2018, LIF EXP HLTH LIF EXP; Wu B, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00154-3; Wylie LE, 2014, ELDERLY EYEWITNESS IN COURT, P38; Yadav UN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233488; Yadav UN, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02680-3; Yadav UN, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8404-7; Yadav UN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198410	45	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254825	10.1371/journal.pone.0254825	http://dx.doi.org/10.1371/journal.pone.0254825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TN	34310639	Green Published, gold			2022-12-26	WOS:000685224500015
J	Bai, Y; Parker, EJ				Bai, Yu; Parker, Emily J.			Reciprocal allostery arising from a bienzyme assembly controls aromatic amino acid biosynthesis in Prevotella nigrescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; CHORISMATE MUTASE; 3-DIMENSIONAL STRUCTURE; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DAHP SYNTHASE; COMPLEX; ENZYME; PURIFICATION	Modular protein assembly has been widely reported as a mechanism for constructing allosteric machinery. Recently, a distinctive allosteric system has been identified in a bienzyme assembly comprising a 3-deoxy-D-arabino heptulosonate-7-phosphate synthase (DAH7PS) and chorismate mutase (CM). These enzymes catalyze the first and branch point reactions of aromatic amino acid biosynthesis in the bacterium Prevotella nigrescens (PniDAH7PS), respectively. The interactions between these two distinct catalytic domains support functional interreliance within this bifunctional enzyme. The binding of prephenate, the product of CM-catalyzed reaction, to the CM domain is associated with a striking rearrangement of overall protein conformation that alters the interdomain interactions and allosterically inhibits the DAH7PS activity. Here, we have further investigated the complex allosteric communication demonstrated by this bifunctional enzyme. We observed allosteric activation of CM activity in the presence of all DAH7PS substrates. Using small-angle X-ray scattering (SAXS) experiments, we show that changes in overall protein conformations and dynamics are associated with the presence of different DAH7PS substrates and the allosteric inhibitor prephenate. Furthermore, we have identified an extended interhelix loop located in CM domain, loopC320-F333, as a crucial segment for the interdomain structural and catalytic communications. Our results suggest that the dual-function enzyme PniDAH7PS contains a reciprocal allosteric system between the two enzymatic moieties as a result of this bidirectional interdomain communication. This arrangement allows for a complex feedback and feedforward system for control of pathway flux by connecting the initiation and branch point of aromatic amino acid biosynthesis.	[Bai, Yu; Parker, Emily J.] Victoria Univ Wellington, Maurice Wilkins Ctr, Ferrier Res Inst, Wellington, New Zealand	Victoria University Wellington	Parker, EJ (corresponding author), Victoria Univ Wellington, Maurice Wilkins Ctr, Ferrier Res Inst, Wellington, New Zealand.	emily.parker@vuw.ac.nz		Parker, Emily/0000-0002-9571-9987	Marsden Fund [VUW1426]	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	Marsden Fund VUW1426.	Bai Y, 2019, J BIOL CHEM, V294, P4828, DOI 10.1074/jbc.RA118.005220; Blackmore NJ, 2015, J BIOL CHEM, V290, P18187, DOI 10.1074/jbc.M115.638700; BLACKMORE PF, 1976, FEBS LETT, V64, P222, DOI 10.1016/0014-5793(76)80288-8; Burschowsky D, 2018, BIOCHEMISTRY-US, V57, P557, DOI 10.1021/acs.biochem.7b01018; Cross PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145187; Cross PJ, 2013, PROTEIN SCI, V22, P1087, DOI 10.1002/pro.2293; Cross PJ, 2013, P NATL ACAD SCI USA, V110, P2111, DOI 10.1073/pnas.1217923110; Cross PJ, 2011, J BIOL CHEM, V286, P10216, DOI 10.1074/jbc.M110.209924; Fan YF, 2018, P NATL ACAD SCI USA, V115, P3006, DOI 10.1073/pnas.1717621115; Furdui C, 2004, J BIOL CHEM, V279, P45618, DOI 10.1074/jbc.M404753200; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Helmstaedt K, 2004, ARCH MICROBIOL, V181, P195, DOI 10.1007/s00203-003-0639-z; Huang QJ, 2020, CURR OPIN STRUC BIOL, V62, P175, DOI 10.1016/j.sbi.2020.01.017; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Jiao WT, 2020, CURR OPIN STRUC BIOL, V65, P159, DOI 10.1016/j.sbi.2020.06.015; Jiao WT, 2012, J MOL BIOL, V415, P716, DOI 10.1016/j.jmb.2011.11.037; Kirby N., 2007, AIP C P; Kirby NM, 2013, J APPL CRYSTALLOGR, V46, P1670, DOI 10.1107/S002188981302774X; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; LEE AY, 1995, CHEM BIOL, V2, P195, DOI 10.1016/1074-5521(95)90269-4; LEE AY, 1995, J AM CHEM SOC, V117, P3627, DOI 10.1021/ja00117a038; Lee D., 2005, PDB ID 1YBZ CONSERVE; Light SH, 2013, PROTEIN SCI, V22, P395, DOI 10.1002/pro.2233; Light SH, 2012, PROTEIN SCI, V21, P887, DOI 10.1002/pro.2075; MacBeath G, 1998, BIOCHEMISTRY-US, V37, P10062, DOI 10.1021/bi980449t; Mistry J, 2021, NUCLEIC ACIDS RES, V49, pD412, DOI 10.1093/nar/gkaa913; Nazmi AR, 2016, J BIOL CHEM, V291, P21836, DOI 10.1074/jbc.M116.741637; Nazmi AR, 2014, J MOL BIOL, V426, P656, DOI 10.1016/j.jmb.2013.11.008; Okvist M, 2009, ACTA CRYSTALLOGR F, V65, P1048, DOI 10.1107/S1744309109035878; Palmer T., 2007, ENZYMES BIOCH BIOTEC; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Ryan TM, 2018, J APPL CRYSTALLOGR, V51, P97, DOI 10.1107/S1600576717017101; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasso S, 2005, FEBS J, V272, P375, DOI 10.1111/j.1742-4658.2004.04478.x; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schofield LR, 2005, BIOCHEMISTRY-US, V44, P11950, DOI 10.1021/bi050577z; SCHONER R, 1976, J BIOL CHEM, V251, P5440; Shumilin IA, 2004, J MOL BIOL, V341, P455, DOI 10.1016/j.jmb.2004.05.077; Singh H, 2014, P NATL ACAD SCI USA, V111, P3389, DOI 10.1073/pnas.1321621111; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7; Wu J, 2006, J BIOL CHEM, V281, P4042, DOI 10.1074/jbc.M512223200; Xie J, 2020, CURR OPIN STRUC BIOL, V62, P158, DOI 10.1016/j.sbi.2020.01.011; Zhou L, 2012, BIOORG CHEM, V40, P79, DOI 10.1016/j.bioorg.2011.09.002	48	0	0	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101038	10.1016/j.jbc.2021.101038	http://dx.doi.org/10.1016/j.jbc.2021.101038			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34343567	Green Submitted, gold, Green Published			2022-12-26	WOS:000704369100003
J	Huang, X; Lee, SJ; Kim, CZ; Choi, SH				Huang, Xilang; Lee, Sang Joon; Kim, Chang Zoo; Choi, Seon Han			An automatic screening method for strabismus detection based on image processing	PLOS ONE			English	Article							AMBLYOPIA; RISK; EYE	Purpose This study aims to provide an automatic strabismus screening method for people who live in remote areas with poor medical accessibility. Materials and methods The proposed method first utilizes a pretrained convolutional neural network-based face-detection model and a detector for 68 facial landmarks to extract the eye region for a frontal facial image. Second, Otsu's binarization and the HSV color model are applied to the image to eliminate the influence of eyelashes and canthi. Then, the method samples all of the pixel points on the limbus and applies the least square method to obtain the coordinate of the pupil center. Lastly, we calculated the distances from the pupil center to the medial and lateral canthus to measure the deviation of the positional similarity of two eyes for strabismus screening. Result We used a total of 60 frontal facial images (30 strabismus images, 30 normal images) to validate the proposed method. The average value of the iris positional similarity of normal images was smaller than one of the strabismus images via the method (p-value<0.001). The sample mean and sample standard deviation of the positional similarity of the normal and strabismus images were 1.073 +/- 0.014 and 0.039, as well as 1.924 +/- 0.169 and 0.472, respectively. Conclusion The experimental results of 60 images show that the proposed method is a promising automatic strabismus screening method for people living in remote areas with poor medical accessibility.	[Huang, Xilang; Choi, Seon Han] Pukyong Natl Univ, Dept Artificial Intelligent Convergence, Busan, South Korea; [Lee, Sang Joon; Kim, Chang Zoo] Kosin Univ, Coll Med, Dept Ophthalmol, Busan, South Korea; [Kim, Chang Zoo] Kosin Univ, Gospel Hosp, Kosin Innovat Smart Healthcare Res Ctr, Busan, South Korea	Pukyong National University	Choi, SH (corresponding author), Pukyong Natl Univ, Dept Artificial Intelligent Convergence, Busan, South Korea.; Kim, CZ (corresponding author), Kosin Univ, Coll Med, Dept Ophthalmol, Busan, South Korea.; Kim, CZ (corresponding author), Kosin Univ, Gospel Hosp, Kosin Innovat Smart Healthcare Res Ctr, Busan, South Korea.	changzoo@hanmail.net; shchoi@pknu.ac.kr	Kim, Changzoo/GLT-8071-2022		Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT) [2019M3E5D1A0207086221]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	All authors received the same funding: This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (2019M3E5D1A0207086221).	Valente TLA, 2017, COMPUT METH PROG BIO, V140, P295, DOI 10.1016/j.cmpb.2017.01.002; Chen ZH, 2018, HEALTHC TECHNOL LETT, V5, P1, DOI 10.1049/htl.2016.0081; Chernov N, 2005, J MATH IMAGING VIS, V23, P239, DOI 10.1007/s10851-005-0482-8; Chia A, 2010, INVEST OPHTH VIS SCI, V51, P3411, DOI 10.1167/iovs.09-4461; Cotter SA, 2009, OPHTHALMOLOGY, V116, P145, DOI 10.1016/j.ophtha.2008.08.031; Economides JR, 2016, JAMA OPHTHALMOL, V134, P63, DOI 10.1001/jamaophthalmol.2015.4486; Gou C, 2017, PATTERN RECOGN, V67, P23, DOI 10.1016/j.patcog.2017.01.023; Indriani OR., 2017, P INT C INN CREAT IN, P1; Jiang HZ, 2017, IEEE INT CONF AUTOMA, P650, DOI [10.1109/MWSYM.2017.8058653, 10.1109/FG.2017.82]; Kazemi V, 2014, PROC CVPR IEEE, P1867, DOI 10.1109/CVPR.2014.241; King DE, 2009, J MACH LEARN RES, V10, P1755; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Lu J.Y, 2018, THESIS SE U; Martin SJ, 2020, CLIN OPHTHALMOL, V14, P1427, DOI 10.2147/OPTH.S251451; Miao Y, 2020, COMPUT METH PROG BIO, V185, DOI 10.1016/j.cmpb.2019.105132; Moon HS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85265-8; Mu YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149561; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pineles SL, 2015, JAMA OPHTHALMOL, V133, P60, DOI 10.1001/jamaophthalmol.2014.3941; Prasetyo E, 2017, 2017 3RD INTERNATIONAL CONFERENCE ON SCIENCE AND TECHNOLOGY - COMPUTER (ICST), P99, DOI 10.1109/ICSTC.2017.8011860; Qin HW, 2016, PROC CVPR IEEE, P3456, DOI 10.1109/CVPR.2016.376; Ramdani AH., 2017, P 2 ANN APPL SCI ENG, P1; Razalli H, 2020, 2020 16TH IEEE INTERNATIONAL COLLOQUIUM ON SIGNAL PROCESSING & ITS APPLICATIONS (CSPA 2020), P284, DOI 10.1109/CSPA48992.2020.9068695; Repka MX, 2018, OPHTHALMOLOGY, V125, P1646, DOI 10.1016/j.ophtha.2018.04.024; Rowe F, 2010, EYE, V24, P682, DOI 10.1038/eye.2009.138; Sagonas C, 2016, IMAGE VISION COMPUT, V47, P3, DOI 10.1016/j.imavis.2016.01.002; de Almeida JDS, 2015, J DIGIT IMAGING, V28, P462, DOI 10.1007/s10278-014-9758-0; de Almeida JDS, 2012, COMPUT BIOL MED, V42, P135, DOI 10.1016/j.compbiomed.2011.11.001; Suleiman A, 2017, IEEE INT SYMP CIRC S, P444; Sural S, 2002, 2002 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL II, PROCEEDINGS, P589; Taylor K, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006461.pub4; TOMMILA V, 1981, BRIT J OPHTHALMOL, V65, P575, DOI 10.1136/bjo.65.8.575; Yan XR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126052; Yehezkel O, 2020, AM J OPHTHALMOL, V213, P226, DOI 10.1016/j.ajo.2019.12.018; Yu MX, 2018, INTELL DATA ANAL, V22, P345, DOI 10.3233/IDA-173361; Zheng C, 2021, TRANSL VIS SCI TECHN, V10, DOI 10.1167/tvst.10.1.33	36	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255643	10.1371/journal.pone.0255643	http://dx.doi.org/10.1371/journal.pone.0255643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343204	Green Published, gold			2022-12-26	WOS:000685264200028
J	Towle-Miller, LM; Miecznikowski, JC; Zhang, F; Tritchler, DL				Towle-Miller, Lorin M.; Miecznikowski, Jeffrey C.; Zhang, Fan; Tritchler, David L.			SuMO-Fil: Supervised multi-omic filtering prior to performing network analysis	PLOS ONE			English	Article							ENDOMETRIAL CANCER; IDENTIFICATION; VARIANTS; PATHWAY	Multi-omic analyses that integrate many high-dimensional datasets often present significant deficiencies in statistical power and require time consuming computations to execute the analytical methods. We present SuMO-Fil to remedy against these issues which is a pre-processing method for Supervised Multi-Omic Filtering that removes variables or features considered to be irrelevant noise. SuMO-Fil is intended to be performed prior to downstream analyses that detect supervised gene networks in sparse settings. We accomplish this by implementing variable filters based on low similarity across the datasets in conjunction with low similarity with the outcome. This approach can improve accuracy, as well as reduce run times for a variety of computationally expensive downstream analyses. This method has applications in a setting where the downstream analysis may include sparse canonical correlation analysis. Filtering methods specifically for cluster and network analysis are introduced and compared by simulating modular networks with known statistical properties. The SuMO-Fil method performs favorably by eliminating non-network features while maintaining important biological signal under a variety of different signal settings as compared to popular filtering techniques based on low means or low variances. We show that the speed and accuracy of methods such as supervised sparse canonical correlation are increased after using SuMO-Fil, thus greatly improving the scalability of these approaches.	[Towle-Miller, Lorin M.; Miecznikowski, Jeffrey C.; Zhang, Fan; Tritchler, David L.] Univ Buffalo, Dept Biostat, Buffalo, NY 14203 USA; [Tritchler, David L.] Univ Toronto, Biostat Div, Toronto, ON, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Toronto	Towle-Miller, LM (corresponding author), Univ Buffalo, Dept Biostat, Buffalo, NY 14203 USA.	lorinmil@buffalo.edu			National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001412]	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Research reported in this publication was partially supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award Number UL1TR001412. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. There was no additional external funding received for this study.	Ames CL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2944-3; Ayhan A, 2018, J GYNECOL ONCOL, V29, DOI 10.3802/jgo.2018.29.e48; BORONOW RC, 1984, OBSTET GYNECOL, V63, P825; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Buldukoglu OC, 2020, INT J GYNECOL OBSTET, V151, P267, DOI 10.1002/ijgo.13309; Chan JK, 2007, BRIT J CANCER, V97, P605, DOI 10.1038/sj.bjc.6603898; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Costa RL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33498-5; Creixell P, 2015, NAT METHODS, V12, P615, DOI [10.1038/nmeth.3440, 10.1038/NMETH.3440]; Danussi C, 2013, CANCER RES, V73, P5140, DOI 10.1158/0008-5472.CAN-13-1168-T; Dong X, 2017, NAT METHODS, V14, P491, DOI [10.1038/NMETH.4227, 10.1038/nmeth.4227]; Fan ZL, 2020, METABOLITES, V10, DOI 10.3390/metabo10040144; Frazee AC, 2015, NAT BIOTECHNOL, V33, P243, DOI 10.1038/nbt.3172; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Koh HWL, 2019, NPJ SYST BIOL APPL, V5, DOI 10.1038/s41540-019-0099-y; Larance M, 2015, NAT REV MOL CELL BIO, V16, P269, DOI 10.1038/nrm3970; Liu Han, 2010, Adv Neural Inf Process Syst, V24, P1432; Love KR, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2876-y; Mahdi H, 2015, CANCER-AM CANCER SOC, V121, P688, DOI 10.1002/cncr.29106; Melloy PG, 2020, GENE CHROMOSOME CANC, V59, P189, DOI 10.1002/gcc.22820; Meng C, 2019, MOL CELL PROTEOMICS, V18, pS153, DOI 10.1074/mcp.TIR118.001251; Meng C, 2016, BRIEF BIOINFORM, V17, P628, DOI 10.1093/bib/bbv108; Miecznikowski JC, 2016, STAT APPL GENET MOL, V15, P1, DOI 10.1515/sagmb-2015-0026; Pare G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000981; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; R Core Team, 2020, R LANG ENV STAT COMP; Ramanan VK, 2012, TRENDS GENET, V28, P323, DOI 10.1016/j.tig.2012.03.004; Reuter JA, 2015, MOL CELL, V58, P586, DOI 10.1016/j.molcel.2015.05.004; Schlitt T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S9; Sha Y, 2015, IEEE ENG MED BIO, P6461, DOI 10.1109/EMBC.2015.7319872; Shaukat A, 2020, PAK J ZOOL, V52, P1587, DOI 10.17582/journal.pjz/20191019021035; Surget S, 2014, ONCOTARGETS THER, V7, P57, DOI 10.2147/OTT.S53876; Thum A., 2014, SUPERVISED PENALIZED; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Tritchler D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-193; Venkatesh T, 2015, MOL CELL ENDOCRINOL, V416, P88, DOI 10.1016/j.mce.2015.08.026; Waaijenborg S, 2008, STAT APPL GENET MOL, V7; Wainwright MJ, 2009, IEEE T INFORM THEORY, V55, P2183, DOI 10.1109/TIT.2009.2016018; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Wu L., 2014, IDENTIFICATION GENE; Zhang F, 2020, STAT APPL GENET MOL, V19, DOI 10.1515/sagmb-2018-0026; Zhang XJ, 2013, BIOINFORMATICS, V29, P106, DOI 10.1093/bioinformatics/bts619	47	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255579	10.1371/journal.pone.0255579	http://dx.doi.org/10.1371/journal.pone.0255579			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343218	gold, Green Published			2022-12-26	WOS:000685264200010
J	Kanack, AJ; Aoki, K; Tiemeyer, M; Dahms, NM				Kanack, Adam J.; Aoki, Kazuhiro; Tiemeyer, Michael; Dahms, Nancy M.			Platelet and myeloid cell phenotypes in a rat model of Fabry disease	FASEB JOURNAL			English	Article						animal model; glycobiology; glycosphingolipids; lysosomal storage disease	CORONARY MICROVASCULAR DYSFUNCTION; CLINICAL-MANIFESTATIONS; ACTIVATION; INVOLVEMENT; DISORDER; IMPACT; ENZYME; SKIN	Fabry disease results from a deficiency of the lysosomal enzyme alpha-Galactosidase-A (alpha-Gal A) and is estimated to occur in approximately 1:4100 live births. Characteristic of the disease is the accumulation of alpha-Gal-A substrates, primarily the glycosphingolipids (GSLs) globotriaosylceramide and glohotriaosylsphingosine. Thrombotic events are a significant concern for Fabry patients, with strokes contributing to a. significant decrease in overall lifespan. Currently, the mechanisms underlying the increased risk of thrombotic events experienced by Fabry patients are incompletely defined. Using a rat model of Fabry disease, we provide an improved understanding of the mechanisms linking GSL, accumulation to thrombotic risk. We found that alpha-Gal A-deficient rats accumulate myeloid-derived leukocytes at sites of GST, accumulation, including in the hone marrow and circulation, and that myeloid-derived leukocyte and megakaryocyte populations were prominent among cell types that accumulated GSLs. In the circulation, alpha-Gal A-deficient rats had increases in cytokine-producing cell types and a corresponding elevation of pro-inflammatory cytokines. Lastly, circulating platelets from alpha-Gal A-deficient rats accumulated a similar set of alpha-Galactosidase-A substrates as was observed in megakaryocytes in the bone marrow, and exhibited increased platelet binding to fibrinogen in microfluidic and flow cytometric assays.	[Kanack, Adam J.; Dahms, Nancy M.] Med Coll Wisconsin, Dept Biochem, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA; [Aoki, Kazuhiro; Tiemeyer, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Medical College of Wisconsin; University System of Georgia; University of Georgia	Dahms, NM (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 W Watertown Plank Rd, Milwaukee, WI 53226 USA.	ndahms@mcw.edu			HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [K12HL141954, R24HL114474]; HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK042667]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [P41GM103490]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID) [R21AI129873]	HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: K12HL141954, K12HL141954 and R24HL114474; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R01DK042667; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: P41GM103490; Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID), Grant/Award Number: R21AI129873	Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; Anderson W., 1898, BRIT J DERMATOL, V10, P113, DOI [10.1111/j.1365-2133.1898.tb16317.x, DOI 10.1111/J.1365-2133.1898.TB16317.X]; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Biancini GB, 2012, BBA-MOL BASIS DIS, V1822, P226, DOI 10.1016/j.bbadis.2011.11.001; Boccuto L, 2014, HUM MOL GENET, V23, P418, DOI 10.1093/hmg/ddt434; Branton M, 2002, J AM SOC NEPHROL, V13, pS139, DOI 10.1097/01.ASN.0000016683.73778.78; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; De Francesco PN, 2013, MOL GENET METAB, V109, P93, DOI 10.1016/j.ymgme.2013.02.003; DeGraba T, 2000, ANN NEUROL, V47, P229, DOI 10.1002/1531-8249(200002)47:2<229::AID-ANA13>3.3.CO;2-K; del Pino MD, 2018, KIDNEY BLOOD PRESS R, V43, P406, DOI 10.1159/000488121; Elliott PM, 2006, HEART, V92, P357, DOI 10.1136/hrt.2004.054015; Estevez B, 2017, PHYSIOLOGY, V32, P162, DOI 10.1152/physiol.00020.2016; Fabry J., 1898, ARCH DERMATOL SYPHIL, V43, P187; FELISTE R, 1987, THROMB RES, V48, P403, DOI 10.1016/0049-3848(87)90398-7; Ferreira CR, 2017, METABOLIC DISEASES: FOUNDATIONS OF CLINICAL MANAGEMENT, GENETICS, AND PATHOLOGY, 2ND EDITION, P367, DOI 10.3233/978-1-61499-718-4-367; Fitzgerald DJ, 2013, CIRC RES, V112, P174, DOI 10.1161/CIRCRESAHA.111.300271; FLYNN DM, 1972, ARCH DIS CHILD, V47, P26, DOI 10.1136/adc.47.251.26; Forstenpointner J, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00448; Germain DP, 2019, MOL GENET METAB REP, V19, DOI 10.1016/j.ymgmr.2019.100454; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004; Hofmann L, 2018, ELIFE, V7, DOI 10.7554/eLife.39300; Hopkins PV, 2015, J PEDIATR-US, V166, P172, DOI 10.1016/j.jpeds.2014.09.023; IGARASHI T, 1986, AM J HEMATOL, V22, P63, DOI 10.1002/ajh.2830220110; Inoue T, 2013, J HUM GENET, V58, P548, DOI 10.1038/jhg.2013.48; Junttila IS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00888; Koping M, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0882-7; Kolodny E, 2015, STROKE, V46, P302, DOI 10.1161/STROKEAHA.114.006283; Korver S, 2018, MOL GENET METAB, V125, P205, DOI 10.1016/j.ymgme.2018.08.014; Lanfranca MP, 2016, J MOL MED, V94, P523, DOI 10.1007/s00109-016-1391-6; Lin HY, 2009, CIRC-CARDIOVASC GENE, V2, P450, DOI 10.1161/CIRCGENETICS.109.862920; Lorenzen JM, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0311-3; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Manz XD, 2020, JOVE-J VIS EXP, DOI 10.3791/61068; MARGUERIE GA, 1979, J BIOL CHEM, V254, P5357; Mehta N, 2016, J PROTEOME RES, V15, P2969, DOI 10.1021/acs.jproteome.6b00132; MEUWISSEN SGM, 1982, HEPATOLOGY, V2, P263; Miller JJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45837-1; Miller JJ, 2019, FASEB J, V33, P418, DOI 10.1096/fj.201800771R; Miller JJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99171; Mosevoll KA, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00147; MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x; Navarro C, 2006, ACTA NEUROPATHOL, V111, P178, DOI 10.1007/s00401-005-0026-8; Neelamegham S, 2019, GLYCOBIOLOGY, V29, P620, DOI 10.1093/glycob/cwz045; Nimrichter L, 2008, BLOOD, V112, P3744, DOI 10.1182/blood-2008-04-149641; Nylander S, 2006, THROMB RES, V117, P543, DOI 10.1016/j.thromres.2005.04.026; Orteu CH, 2007, BRIT J DERMATOL, V157, P331, DOI 10.1111/j.1365-2133.2007.08002.x; Ortiz A, 2017, MED CLIN-BARCELONA, V148, P132, DOI 10.1016/j.medcli.2016.09.047; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Parks OB, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00085; Ries M, 2003, EUR J PEDIATR, V162, P767, DOI 10.1007/s00431-003-1299-3; Rombach SM, 2012, HYPERTENSION, V60, P998, DOI 10.1161/HYPERTENSIONAHA.112.195685; de Morales JMGR, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2019.102429; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott CR, 2013, J PEDIATR-US, V163, P498, DOI 10.1016/j.jpeds.2013.01.031; SHER NA, 1979, ARCH OPHTHALMOL-CHIC, V97, P671; Shu LM, 2014, KIDNEY INT, V86, P58, DOI 10.1038/ki.2013.520; Sims K, 2009, STROKE, V40, P788, DOI 10.1161/STROKEAHA.108.526293; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; SPAETH GL, 1965, ARCH OPHTHALMOL-CHIC, V74, P760, DOI 10.1001/archopht.1965.00970040762005; SUGIYAMA T, 1987, BLOOD, V69, P1712; Tomberli B, 2013, EUR J HEART FAIL, V15, P1363, DOI 10.1093/eurjhf/hft104; Uceyler N, 2014, CLIN J PAIN, V30, P915, DOI 10.1097/AJP.0000000000000041; Utsumi K, 2009, J NEUROL SCI, V283, P83, DOI 10.1016/j.jns.2009.02.319; Vedder AC, 2009, NEPHROL DIAL TRANSPL, V24, P3074, DOI 10.1093/ndt/gfp263; Vukelic Z, 2005, J AM SOC MASS SPECTR, V16, P571, DOI 10.1016/j.jasms.2005.01.013; Waldek S, 2009, GENET MED, V11, P790, DOI 10.1097/GIM.0b013e3181bb05bb; Wells L, 2013, MOL CELL PROTEOMICS, V12, P833, DOI 10.1074/mcp.E113.027904; Yazdanfard PD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225071; Yogasundaram H, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009098; York WS, 2014, GLYCOBIOLOGY, V24, P402, DOI 10.1093/glycob/cwu018	73	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21818	10.1096/fj.202001727RR	http://dx.doi.org/10.1096/fj.202001727RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34320241	Green Accepted			2022-12-26	WOS:000678975300029
J	Agulles, M; Jorda, G; Hoteit, I; Agusti, S; Duarte, CM				Agulles, Miguel; Jorda, Gabriel; Hoteit, Ibrahim; Agusti, Susana; Duarte, Carlos M.			Assessment of Red Sea temperatures in CMIP5 models for present and future climate	PLOS ONE			English	Article							CHANGE PROJECTIONS; MARINE; CORDEX; CORALS	The increase of the temperature in the Red Sea basin due to global warming could have a large negative effect on its marine ecosystem. Consequently, there is a growing interest, from the scientific community and public organizations, in obtaining reliable projections of the Red Sea temperatures throughout the 21(st) century. However, the main tool used to do climate projections, the global climate models (GCM), may not be well suited for that relatively small region. In this work we assess the skills of the CMIP5 ensemble of GCMs in reproducing different aspects of the Red Sea 3D temperature variability. The results suggest that some of the GCMs are able to reproduce the present variability at large spatial scales with accuracy comparable to medium and high-resolution hindcasts. In general, the skills of the GCMs are better inside the Red Sea than outside, in the Gulf of Aden. Based on their performance, 8 of the original ensemble of 43 GCMs have been selected to project the temperature evolution of the basin. Bearing in mind the GCM limitations, this can be an useful benchmark once the high resolution projections are available. Those models project an averaged warming at the end of the century (2080-2100) of 3.3 +/-> 0.6 degrees C and 1.6 +/-> 0.4 degrees C at the surface under the scenarios RCP8.5 and RCP4.5, respectively. In the deeper layers the warming is projected to be smaller, reaching 2.2 +/-> 0.5 degrees C and 1.5 +/-> 0.3 degrees C at 300 m. The projected warming will largely overcome the natural multidecadal variability, which could induce temporary and moderate decrease of the temperatures but not enough to fully counteract it. We have also estimated how the rise of the mean temperature could modify the characteristics of the marine heatwaves in the region. The results show that the average length of the heatwaves would increase similar to 15 times and the intensity of the heatwaves similar to 4 times with respect to the present conditions under the scenario RCP8.5 (10 time and 3.6 times, respectively, under scenario RCP4.5).	[Agulles, Miguel; Jorda, Gabriel] Inst Espanol Oceanog, Ctr Oceanog Balears, Palma De Mallorca, Spain; [Hoteit, Ibrahim; Agusti, Susana; Duarte, Carlos M.] King Abdullah Univ Sci & Technol KAUST, Red Sea Res Ctr RSRC, Thuwal, Saudi Arabia	Spanish Institute of Oceanography; King Abdullah University of Science & Technology	Agulles, M (corresponding author), Inst Espanol Oceanog, Ctr Oceanog Balears, Palma De Mallorca, Spain.	miguel.agulles@ieo.es	Duarte Quesada, Carlos Manuel/ABD-6208-2021; Agusti, Susana/G-2864-2017; Duarte, Carlos M./A-7670-2013	Hoteit, Ibrahim/0000-0002-3751-4393; Agusti, Susana/0000-0003-0536-7293; Duarte, Carlos M./0000-0002-1213-1361	King Abdullah University of Science and Technology KAUST [BAS/1/1072-01-01]; European Union's Horizon 2020 research and innovation programme [776661]; Proyecto Intramurales Especial REDTEM - CSIC [202030E234]	King Abdullah University of Science and Technology KAUST(King Abdullah University of Science & Technology); European Union's Horizon 2020 research and innovation programme; Proyecto Intramurales Especial REDTEM - CSIC	This research was funded by King Abdullah University of Science and Technology KAUST) through funds provided to S.A. and C.M.D (BAS/1/1072-01-01). M.A. has been partly funded by the European Union's Horizon 2020 research and innovation programme under grant agreement No 776661 (SOCLIMPACT project), and "Proyecto Intramurales Especial REDTEM -CSIC (202030E234)" Each named author has substantially contributed to conducting the underlying research and drafting this manuscript. Additionally, to the best of our knowledge, the named authors have no conflict of interest, financial or otherwise.	Agulles M, 2020, OCEAN SCI, V16, P149, DOI 10.5194/os-16-149-2020; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cabanes C, 2013, OCEAN SCI, V9, P1, DOI 10.5194/os-9-1-2013; Calafat F.M., J GEOPHYS RES OCEAN, V117, P2012; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Chaidez V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08146-z; Darmaraki S, 2019, CLIM DYNAM, V53, P1371, DOI 10.1007/s00382-019-04661-z; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dreano D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168440; Frolicher TL, 2018, NATURE, V560, P360, DOI 10.1038/s41586-018-0383-9; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Genevier LGC, 2019, GLOBAL CHANGE BIOL, V25, P2338, DOI 10.1111/gcb.14652; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gittings JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20560-5; GITTINGS SR, 1992, B MAR SCI, V51, P420; Hayashida H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18241-x; Hobday AJ, 2016, PROG OCEANOGR, V141, P227, DOI 10.1016/j.pocean.2015.12.014; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Jacob D, 2014, REG ENVIRON CHANGE, V14, P563, DOI 10.1007/s10113-013-0499-2; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/NCLIMATE1533, 10.1038/nclimate1533]; Kobayashi S, 2015, J METEOROL SOC JPN, V93, P5, DOI 10.2151/jmsj.2015-001; Krokos G, 2019, GEOPHYS RES LETT, V46, P3454, DOI 10.1029/2018GL081397; Llasses J, 2018, CLIM DYNAM, V51, P1119, DOI 10.1007/s00382-016-3242-0; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5733, DOI 10.1029/96JC02776; Monroe AA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195814; Oliver ECJ, 2019, CLIM DYNAM, V53, P1653, DOI 10.1007/s00382-019-04707-2; Oliver ECJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03732-9; Osman EO, 2018, GLOBAL CHANGE BIOL, V24, pE474, DOI 10.1111/gcb.13895; Parent L., 1992, GLORYS GLOBAL OCEAN, V2011; Poloczanska ES, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00062; Raitsos DE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08729-w; Shaltout M, 2019, OCEANOLOGIA, V61, P484, DOI 10.1016/j.oceano.2019.05.002; Somot S, 2018, CLIM DYNAM, V51, P771, DOI 10.1007/s00382-018-4325-x; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4; Thorne K.S., 2010, REFERENCES NOTES 1, V327, P1543, DOI [10.1126/science.1206034, DOI 10.1126/SCIENCE.1206034]; Wernberg T, 2013, NAT CLIM CHANGE, V3, P78, DOI [10.1038/NCLIMATE1627, 10.1038/nclimate1627]; Yao FC, 2014, J GEOPHYS RES-OCEANS, V119, P2238, DOI 10.1002/2013JC009004; Zenetos A., 2005, ANNOTATED LIST MARIN, V4, P57; Zhan P, 2016, J GEOPHYS RES-OCEANS, V121, P4732, DOI 10.1002/2015JC011589	41	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255505	10.1371/journal.pone.0255505	http://dx.doi.org/10.1371/journal.pone.0255505			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329351	gold, Green Published			2022-12-26	WOS:000685248600060
J	Soares, PET; Dantas, MDA; Silva-Portela, RDB; Agnez-Lima, LF; Lanza, DCF				Soares, Paulo Eduardo T.; Dantas, Marcia Danielle A.; Silva-Portela, Rita de Cassia B.; Agnez-Lima, Lucymara F.; Lanza, Daniel Carlos F.			Characterization of Penaeus vannamei mitogenome focusing on genetic diversity	PLOS ONE			English	Article							SPOT SYNDROME VIRUS; LITOPENAEUS-VANNAMEI; MITOCHONDRIAL-DNA; GENOME; POLYMORPHISM	The diversity of the Penaeus vannamei mitochondrial genome has still been poorly characterized, there are no validated mitochondrial markers available for populational studies, and the heteroplasmy has not yet been investigated in this species. In this study, metagenomic reads extracted from the muscle of a single individual were used to assemble the mitochondrial genome (mtDNA). These data associated with mitochondrial genomes previously described allowed to evaluate the inter-individual variability and heteroplasmy. Comparison among 45 mtDNA control regions led to the detection of conserved and variable segments and the characterization of two hypervariable regions. The analysis of diversity revealed mostly low frequency polymorphisms, and heteroplasmy was found in practically all mitochondrial genes, with a high occurrence of indels. These results indicate that the design of mitochondrial markers for P. vannamei must be done with caution. The mapping of conserved and variable regions and the characterization of heteroplasmy presented here will contribute to increasing the efficiency of mitochondrial markers for population or individual studies.	[Soares, Paulo Eduardo T.; Dantas, Marcia Danielle A.; Lanza, Daniel Carlos F.] Univ Fed Rio Grande do Norte, Dept Biochem, Appl Mol Biol Lab LAPLIC, Natal, RN, Brazil; [Soares, Paulo Eduardo T.; Dantas, Marcia Danielle A.; Agnez-Lima, Lucymara F.; Lanza, Daniel Carlos F.] Univ Fed Rio Grande do Norte, Postgrad Program Biochem, Natal, RN, Brazil; [Silva-Portela, Rita de Cassia B.; Agnez-Lima, Lucymara F.] Univ Fed Rio Grande do Norte, Dept Cellular Biol & Genet, Lab Mol Biol & Genom, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Dept Biochem, Appl Mol Biol Lab LAPLIC, Natal, RN, Brazil.; Lanza, DCF (corresponding author), Univ Fed Rio Grande do Norte, Postgrad Program Biochem, Natal, RN, Brazil.	danielclanza@gmail.com		Silva-Portela, Rita/0000-0002-2547-5788	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We would like to thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for financial support.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ayad LAK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3477-5; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bronstein O, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1198-x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Dantas MDA, 2018, VIRUS RES, V245, P52, DOI 10.1016/j.virusres.2017.12.006; de la Chaux N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-191; Dumont LFC, 2009, MTDNA CONTROL REGION; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Grabowski M., 1999, CRUSTACEANS BIODIVER, VI, P333; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu QN, 2016, MITOCHONDRIAL DNA A, V27, P4693, DOI 10.3109/19401736.2015.1106506; Liu YY, 2018, FORENSIC SCI INT-GEN, V33, P117, DOI 10.1016/j.fsigen.2017.12.005; Mendoza-Cano F, 2013, CIENC MAR, V39, P401, DOI 10.7773/cm.v39i4.2269; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Perez-Enriquez R, 2018, GENOMICS, V110, P423, DOI 10.1016/j.ygeno.2018.10.001; Perez-Enriquez R, 2009, AQUACULTURE, V297, P44, DOI 10.1016/j.aquaculture.2009.08.038; Robledo D, 2018, REV AQUACULT, V10, P670, DOI 10.1111/raq.12193; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Santos CA, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00120; Scarcelli N, 2016, MOL ECOL RESOUR, V16, P434, DOI 10.1111/1755-0998.12462; Shen X, 2007, GENE, V403, P98, DOI 10.1016/j.gene.2007.06.021; Walther E, 2011, MOL PHYLOGENET EVOL, V58, P404, DOI 10.1016/j.ympev.2010.11.028; Wang HC, 2007, DEV COMP IMMUNOL, V31, P672, DOI 10.1016/j.dci.2006.11.001; Yu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15612; Yue GH, 2017, AQUACULTURE, V468, P337, DOI 10.1016/j.aquaculture.2016.10.036; Zhang XJ, 2019, NAT COMMUN, V10, DOI [10.1038/s41467-018-08197-4, 10.1038/s41467-019-13333-9]	35	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255291	10.1371/journal.pone.0255291	http://dx.doi.org/10.1371/journal.pone.0255291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329352	Green Published, gold			2022-12-26	WOS:000685248600006
J	Vickers, ME; Heisey, ML; Taylor, LA				Vickers, Michael E.; Heisey, Madison L.; Taylor, Lisa A.			Lack of neophobic responses to color in a jumping spider that uses color cues when foraging (Habronattus pyrrithrix)	PLOS ONE			English	Article							DIETARY CONSERVATISM; WARNING COLORATION; DOMESTIC CHICKS; APOSEMATIC PREY; WILD BIRDS; EXPERIENCE; EVOLUTION; NOVELTY; VISION; BIASES	Chemically defended prey often advertise their toxins with bright and conspicuous colors. To understand why such colors are effective at reducing predation, we need to understand the psychology of key predators. In bird predators, there is evidence that individuals avoid novelty-including prey of novel colors (with which they have had no prior experience). Moreover, the effect of novelty is sometimes strongest for colors that are typically associated with aposematic prey (e.g., red, orange, yellow). Given these findings in the bird literature, color neophobia has been argued to be a driving force in the evolution of aposematism. However, no studies have yet asked whether invertebrate predators respond similarly to novel colors. Here, we tested whether naive lab-raised jumping spiders (Habronattus pyrrithrix) exhibit similar patterns of color neophobia to birds. Using color-manipulated living prey, we first color-exposed spiders to prey of two out of three colors (blue, green, or red), with the third color remaining novel. After this color exposure phase, we gave the spiders tests where they could choose between all three colors (two familiar, one novel). We found that H. pyrrithrix attacked novel and familiar-colored prey at equal rates with no evidence that the degree of neophobia varied by color. Moreover, we found no evidence that either prey novelty nor color (nor their interaction) had an effect on how quickly prey was attacked. We discuss these findings in the context of what is known about color neophobia in other animals and how this contributes to our understanding of aposematic signals.	[Vickers, Michael E.; Heisey, Madison L.; Taylor, Lisa A.] Univ Florida, Entomol & Nematol Dept, Gainesville, FL 32611 USA; [Vickers, Michael E.] Univ Free State, Dept Zool & Entomol, Bloemfontein, South Africa; [Taylor, Lisa A.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; University of the Free State; State University System of Florida; University of Florida	Vickers, ME (corresponding author), Univ Florida, Entomol & Nematol Dept, Gainesville, FL 32611 USA.; Vickers, ME (corresponding author), Univ Free State, Dept Zool & Entomol, Bloemfontein, South Africa.	michaelvickers@ufl.edu			National Science Foundation [IOS-1557867, IOS-1831751]; United States Department of Agriculture [1016166]; McIntire-Stennis project [1017978]; Entomology and Nematology Department at the University of Florida; Florida Museum of Natural History	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); McIntire-Stennis project; Entomology and Nematology Department at the University of Florida; Florida Museum of Natural History	This work was supported by grants from the National Science Foundation (IOS-1557867 and IOS-1831751 to LAT), including a Research Experiences for Undergraduates supplement that supported MLH, and by grants from the United States Department of Agriculture (Hatch project 1016166 and McIntire-Stennis project 1017978 to LAT). This work was also supported by funds from the Entomology and Nematology Department at the University of Florida and the Florida Museum of Natural History. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamova-Jezova D, 2016, BEHAV PROCESS, V131, P24, DOI 10.1016/j.beproc.2016.07.014; COPPINGER RP, 1970, AM NAT, V104, P323, DOI 10.1086/282666; Exnerova A, 2007, BEHAV ECOL, V18, P148, DOI 10.1093/beheco/arl061; Foelix R. F, 2011, BIOL SPIDERS; Forrest J, 2009, P ROY SOC B-BIOL SCI, V276, P935, DOI 10.1098/rspb.2008.1434; FORSTER L, 1982, AM SCI, V70, P165; Griswold CE., 1987, REVISION JUMPING SPI; Guilford T., 1992, NATURAL ENEMIEPOPU, P375; HILL DE, 2006, PECKHAMIA, V1, P1; Jakob Elizabeth, 2011, P307; JONES RB, 1986, BEHAV PROCESS, V12, P261, DOI 10.1016/0376-6357(86)90040-9; Kelly DJ, 2004, ANIM BEHAV, V68, P1049, DOI 10.1016/j.anbehav.2004.07.001; Land MF, 2012, OXF ANIMAL BIOL SER, P1; Lecuelle S, 2011, APPL ANIM BEHAV SCI, V135, P78, DOI 10.1016/j.applanim.2011.08.007; Lee TJ, 2010, ANIM BEHAV, V79, P63, DOI 10.1016/j.anbehav.2009.10.004; Li JJ, 2008, CURR BIOL, V18, P699, DOI 10.1016/j.cub.2008.04.020; Lindstrom L, 2001, P ROY SOC B-BIOL SCI, V268, P159, DOI 10.1098/rspb.2000.1344; Marples NM, 2007, BEHAV ECOL, V18, P803, DOI 10.1093/beheco/arm053; Marples NM, 1996, ANIM BEHAV, V51, P1417, DOI 10.1006/anbe.1996.0145; Marples NM, 1999, EVOL ECOL, V13, P641, DOI 10.1023/A:1011077731153; Marples NM, 1998, OIKOS, V83, P161, DOI 10.2307/3546557; Martin LB, 2005, BEHAV ECOL, V16, P702, DOI 10.1093/beheco/ari044; McMahon K, 2014, ANIM BEHAV, V89, P63, DOI 10.1016/j.anbehav.2013.12.025; Miller CT, 2012, ANIM BEHAV, V83, P331, DOI 10.1016/j.anbehav.2011.11.025; Montgomerie Robert, 2006, P90; Muller H, 2010, ANIM BEHAV, V80, P1065, DOI 10.1016/j.anbehav.2010.09.016; NENTWIG W, 1986, OECOLOGIA, V68, P595, DOI 10.1007/BF00378777; PEASLEE AG, 1989, J COMP PHYSIOL A, V164, P359, DOI 10.1007/BF00612995; Powell EC, 2019, ETHOLOGY, V125, P351, DOI 10.1111/eth.12859; Puurtinen M, 2006, EVOLUTION, V60, P2246; Raska J, 2017, ANIM BEHAV, V130, P107, DOI 10.1016/j.anbehav.2017.06.012; Razeng E, 2015, J AVIAN BIOL, V46, P89, DOI 10.1111/jav.00475; ROPER TJ, 1990, ANIM BEHAV, V39, P466, DOI 10.1016/S0003-3472(05)80410-5; Ruxton GD, 2018, AVOIDING ATTACK: THE EVOLUTIONARY ECOLOGY OF CRYPSIS, APOSEMATISM, AND MIMICRY, 2ND EDITION, P1, DOI 10.1093/oso/9780199688678.001.0001; SCHLENOFF DH, 1984, ANIM BEHAV, V32, P919, DOI 10.1016/S0003-3472(84)80172-4; SCHULER W, 1985, BEHAV ECOL SOCIOBIOL, V16, P249, DOI 10.1007/BF00310988; SILLENTULLBERG B, 1985, OECOLOGIA, V67, P411, DOI 10.1007/BF00384948; Speed MP, 2001, ANIM BEHAV, V61, P205, DOI 10.1006/anbe.2000.1558; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Taylor LA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223015; Taylor LA, 2016, BEHAV ECOL, V27, P520, DOI 10.1093/beheco/arv182; Taylor LA, 2014, J ARACHNOL, V42, P268, DOI 10.1636/0161-8202-42.3.268; Taylor LA, 2014, ANIM BEHAV, V90, P149, DOI 10.1016/j.anbehav.2014.01.025; Taylor LA, 2013, BEHAV ECOL, V24, P955, DOI 10.1093/beheco/art011; Thomas RJ, 2003, OIKOS, V101, P458, DOI 10.1034/j.1600-0706.2003.12061.x; Thomas RJ, 2004, OIKOS, V106, P285, DOI 10.1111/j.0030-1299.2004.13089.x; Vickers ME., J ARACHNOL; Vickers ME, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78952-5; Vickers ME, 2018, BEHAV ECOL, V29, P833, DOI 10.1093/beheco/ary068; WALDBAUER G P, 1988, American Naturalist, V131, pS103, DOI 10.1086/284768; Winsor AM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231205; Zurek DB, 2015, CURR BIOL, V25, pR403, DOI 10.1016/j.cub.2015.03.033; Zurek DB, 2010, J EXP BIOL, V213, P2372, DOI 10.1242/jeb.042382	53	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254865	10.1371/journal.pone.0254865	http://dx.doi.org/10.1371/journal.pone.0254865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324526	Green Published, gold			2022-12-26	WOS:000685248200085
J	Akilimali, PZ; Nzuka, HE; LaNasa, KH; Wumba, AM; Kayembe, P; Wisniewski, J; Bertrand, JT				Akilimali, Pierre Z.; Nzuka, Henri Engale; LaNasa, Katherine H.; Wumba, Angele Mavinga; Kayembe, Patrick; Wisniewski, Janna; Bertrand, Jane T.			The gap in contraceptive knowledge and use between the military and non-military populations of Kinshasa, DRC, 2016-2019	PLOS ONE			English	Article							BARRACKS; STUDENTS	Introduction The objective of this study is to assess change over time in the modern contraceptive prevalence rate (MCPR) and related variables among married women of reproductive age (15-49 years) in the military population in Kinshasa, Democratic Republic of Congo, compared to women in the non-military population, based on cross-sectional surveys in 2016 and 2019. Methods Data among women living in military camps were collected as a special study of contraceptive knowledge, use, and exposure to FP messaging, for comparison to women in the non-military population from the annual PMA2020 survey. Both used a two-stage cluster sampling design to randomly select participants. This analysis is limited to women married or in union. Bivariate and multivariate analysis was used to compare the military and non-military populations. Results The socio-demographic profile of women in the military camps differed between 2016 and 2019, which may reflect the more mobile nature of this population. In both populations, knowledge of modern contraceptive methods increased significantly. Similarly, use of a modern contraceptive method also increased significantly in both, though by 2019 women in the military camps were less likely to use modern contraception (24.9%) than their non-military counterparts (29.7%). Multivariate analysis showed no significant difference in the amount of increase in MCPR for the two populations. Among contraceptive users in both populations, the implant was the leading method. Potential effects of FP programming were evident in the military population: exposure to FP messaging increased (in comparison to a decrease among the non-military population). Moreover, women who had lived in the camps for 4+ years had a higher MCPR than those living in the camps for less than four years. Conclusions This study demonstrates the feasibility and importance of collecting data in military camps for better understanding contraceptive dynamics among this specialized population.	[Akilimali, Pierre Z.; Kayembe, Patrick] Univ Kinshasa, Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Nzuka, Henri Engale; Wumba, Angele Mavinga] Congolese Armed Forces, Med Div, Kinshasa, DEM REP CONGO; [LaNasa, Katherine H.; Bertrand, Jane T.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Hlth Policy & Management, New Orleans, LA 70118 USA; [Wisniewski, Janna] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Int Hlth & Sustainable Dev, New Orleans, LA USA	Universite de Kinshasa; Tulane University; Tulane University	LaNasa, KH (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Hlth Policy & Management, New Orleans, LA 70118 USA.	kschulze@tulane.edu		, Katherine/0000-0002-7868-353X	Bill and Melinda Gates Foundation [009285, 007330]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Financial support for this research came from the Bill and Melinda Gates Foundation (INV#009285, INV#-007330), https://www.gatesfoundation.org/.All authors (PZA, HNE, KHS, AWM, PAK, JW, JTB) received partial salary support or consulting fees from this grant for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrazaq AG, 2014, AFR J REPROD HEALTH, V18, P93; Akilimali P, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022295; [Anonymous], 2017, PERFORMANCE MONITORI; [Anonymous], 2020, PERFORMANCE MONITORI; Bertrand JT, 2017, CONTRACEPTION, V96, P211, DOI 10.1016/j.contraception.2017.05.014; Chimah UC, 2016, NIGER J CLIN PRACT, V19, P182, DOI 10.4103/1119-3077.175970; Hernandez JH, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-00993-9; Hussain NA, 2013, AFR HEALTH SCI, V13, P415, DOI 10.4314/ahs.v13i2.31; INS, 2019, ENQ GRAPP IND MULT 2; Jacobstein R, 2018, GLOB HEALTH-SCI PRAC, V6, P17, DOI 10.9745/GHSP-D-17-00396; Lerch M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219624; Muanda M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167560; Skrondal A., 2004, GEN LATENT VARIABLE; White MJ, 2008, DEMOGRAPHY, V45, P803, DOI 10.1353/dem.0.0035	14	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0254915	10.1371/journal.pone.0254915	http://dx.doi.org/10.1371/journal.pone.0254915			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314439	Green Published, gold			2022-12-26	WOS:000685225200001
J	Kusuma, P; Westmoreland, FM; Zhen, SY; Bugbee, B				Kusuma, Paul; Westmoreland, F. Mitchell; Zhen, Shuyang; Bugbee, Bruce			Photons from NIR LEDs can delay flowering in short-day soybean and Cannabis: Implications for phytochrome activity	PLOS ONE			English	Article							ACTION SPECTRA; LIGHT QUALITY; PHOTOPERIODIC CONTROL; SATIVA-L; RED; PHOTOPERCEPTION; DIFFERENTIATION; CHRYSANTHEMUM; MECHANISMS; EXPRESSION	Photons during the dark period delay flowering in short-day plants (SDP). Red photons applied at night convert phytochromes to the active far-red absorbing form (P-fr), leading to inhibition of flowering. Far-red photons (greater than 700 nm) re-induce flowering when applied after a pulse of red photons during the dark period. However, far-red photons at sufficiently high intensity and duration delay flowering in sensitive species. Mechanistically, this response occurs because phytochrome-red (P-r) absorbance is not zero beyond 700 nm. We applied nighttime photons from near infrared (NIR) LEDs (peak 850 nm) over a 12 h dark period. Flowering was delayed in Glycine max and Cannabis sativa (two photosensitive species) by 3 and 12 days, respectively, as the flux of photons from NIR LEDs was increased up to 83 and 116 mu mol m(-2) s(-1). This suggests that long wavelength photons from NIR LEDs can activate phytochromes (convert P-r to P-fr) and thus alter plant development.	[Kusuma, Paul; Westmoreland, F. Mitchell; Bugbee, Bruce] Utah State Univ, Dept Plants Soils & Climate, Crop Physiol Lab, Logan, UT 84322 USA; [Zhen, Shuyang] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA	Utah System of Higher Education; Utah State University; Texas A&M University System; Texas A&M University College Station	Kusuma, P (corresponding author), Utah State Univ, Dept Plants Soils & Climate, Crop Physiol Lab, Logan, UT 84322 USA.	paul.kusuma@aggiemail.usu.edu		Kusuma, Paul/0000-0001-8569-4627	Utah Agricultural Experiment Station, Utah State University [9398]; NASA-CUBES project award [NNX17AJ31G]	Utah Agricultural Experiment Station, Utah State University; NASA-CUBES project award	This work was supported by the Utah Agricultural Experiment Station (https://uaes.usu.edu/), Utah State University [journal paper number 9398]. The soybean portion of this work was supported by the NASA-CUBES project award number NNX17AJ31G. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORTHWICK HA, 1952, P NATL ACAD SCI USA, V38, P662, DOI 10.1073/pnas.38.8.662; BORTHWICK HA, 1952, P NATL ACAD SCI USA, V38, P929, DOI 10.1073/pnas.38.11.929; Breitler JC, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-2238-4; Briggs W.R., 1985, SENSORY PERCEPTION T, P265; CATHEY H. M., 1957, BOT GAZ, V119, P71, DOI 10.1086/335964; Chen M, 2011, TRENDS CELL BIOL, V21, P664, DOI 10.1016/j.tcb.2011.07.002; Craig DS, 2012, ACTA HORTIC, V956, P179, DOI 10.17660/ActaHortic.2012.956.18; Craig DS, 2013, J AM SOC HORTIC SCI, V138, P167, DOI 10.21273/JASHS.138.3.167; DOWNS RJ, 1956, PLANT PHYSIOL, V31, P279, DOI 10.1104/pp.31.4.279; Faux AM, 2014, EUPHYTICA, V196, P183, DOI 10.1007/s10681-013-1023-y; Higuchi Y, 2013, P NATL ACAD SCI USA, V110, P17137, DOI 10.1073/pnas.1307617110; Higuchi Y, 2012, J PLANT PHYSIOL, V169, P1789, DOI 10.1016/j.jplph.2012.07.003; Hitz T, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9080428; Ishikawa R, 2009, GENES GENET SYST, V84, P179, DOI 10.1266/ggs.84.179; Jung JH, 2016, SCIENCE, V354, P886, DOI 10.1126/science.aaf6005; KADMANZAHAVI A, 1987, ANN BOT-LONDON, V60, P621, DOI 10.1093/oxfordjournals.aob.a087491; KASPERBAUER M. J., 1963, BOT GAZ, V124, P444, DOI 10.1086/336234; KELLY JM, 1985, BIOCHEMISTRY-US, V24, P6003, DOI 10.1021/bi00342a047; Klose C, 2020, MOL PLANT, V13, P386, DOI 10.1016/j.molp.2019.12.004; Klose C, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.90, 10.1038/nplants.2015.90]; Kusuma P, 2021, J AM SOC HORTIC SCI, V146, P3, DOI 10.21273/JASHS05002-20; LAGARIAS JC, 1987, PHOTOCHEM PHOTOBIOL, V46, P5, DOI 10.1111/j.1751-1097.1987.tb04729.x; LebelHardenack S, 1997, TRENDS PLANT SCI, V2, P130, DOI 10.1016/S1360-1385(97)01012-1; Legris M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13045-0; Liao Yi, 2014, Environmental Control in Biology, V52, P45, DOI 10.2525/ecb.52.45; MANCINELLI AL, 1967, PLANT PHYSIOL, V42, P95, DOI 10.1104/pp.42.1.95; MANCINELLI AL, 1988, PLANT CELL ENVIRON, V11, P429, DOI 10.1111/j.1365-3040.1988.tb01780.x; Mancinelli Alberto L., 1994, P211; Moliterni VMC, 2004, EUPHYTICA, V140, P95, DOI 10.1007/s10681-004-4758-7; Oakenfull RJ, 2017, PLANT CELL ENVIRON, V40, P2571, DOI 10.1111/pce.13033; Osugi A, 2011, PLANT PHYSIOL, V157, P1128, DOI 10.1104/pp.111.181792; Park YG, 2019, HORTIC ENVIRON BIOTE, V60, P167, DOI 10.1007/s13580-018-0114-z; PARKER MW, 1946, BOT GAZ, V108, P1, DOI 10.1086/335392; Punja ZK, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00718; Rausenberger J, 2011, CELL, V146, P813, DOI 10.1016/j.cell.2011.07.023; Rausenberger J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010721; SAGER JC, 1988, T ASAE, V31, P1882; SCHAFER E, 1982, PLANTA, V154, P231, DOI 10.1007/BF00387869; Sellaro R, 2019, PLANT CELL ENVIRON, V42, P606, DOI 10.1111/pce.13445; SEYFRIED M, 1985, PHOTOCHEM PHOTOBIOL, V42, P319, DOI 10.1111/j.1751-1097.1985.tb08947.x; Shinomura T, 1996, P NATL ACAD SCI USA, V93, P8129, DOI 10.1073/pnas.93.15.8129; Shinomura T, 2000, PLANT PHYSIOL, V122, P147, DOI 10.1104/pp.122.1.147; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; SMITH H, 1982, ANNU REV PLANT PHYS, V33, P481, DOI 10.1146/annurev.pp.33.060182.002405; Song YH, 2015, ANNU REV PLANT BIOL, V66, P441, DOI 10.1146/annurev-arplant-043014-115555; Viczian A, 2020, NEW PHYTOL, V225, P1635, DOI 10.1111/nph.16243; Vince-Prue D., 1975, PHOTOPERIODISM PLANT, P70; Vince-Prue D., PHOTOMORPHOGENESIS P, P447, DOI [10.1007/978-94-011-1884-2%5F17, DOI 10.1007/978-94-011-1884-2%5F17]; Wang H, 2015, MOL PLANT, V8, P540, DOI 10.1016/j.molp.2014.11.021; Zheng TH, 2019, NEW PHYTOL, V224, P306, DOI 10.1111/nph.16010	50	1	1	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255232	10.1371/journal.pone.0255232	http://dx.doi.org/10.1371/journal.pone.0255232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314454	Green Published, gold			2022-12-26	WOS:000685225200008
J	Lee, JH; Jang, JH; Park, JH; Jang, HJ; Park, CS; Lee, S; Kim, SH; Kim, JY; Kim, HK				Lee, Jae Ha; Jang, Ji Hoon; Park, Jin Han; Jang, Hang-Jea; Park, Chan Sun; Lee, Sunggun; Kim, Seong-Ho; Kim, Ji Yeon; Kim, Hyun Kuk			The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; RISK-FACTORS; STANDARDIZATION; IL-6	Background Interstitial lung diseases (ILDs) are chronic, parenchymal lung diseases with a variable clinical course and a poor prognosis. Within various clinical courses, acute exacerbation (AE) is a devastating condition with significant morbidity and high mortality. The aim of this study was to investigate the role of interleukin-6 (IL-6) to predict AE and prognosis in patients with ILD. Methods Eighty-three patients who were diagnosed with ILD from 2016 to 2019 at the Haeundae Paik Hospital, Busan, South Korea, were included and their clinical data were retrospectively analyzed. Results The median follow-up period was 20 months. The mean age was 68.1 years and 65.1% of the patients were men with 60.2% of patients being ever-smokers. Among ILDs, idiopathic pulmonary fibrosis was the most common disease (68.7%), followed by connective tissue disease-associated ILD (14.5%), cryptogenic organizing pneumonia (9.6%), and nonspecific interstitial pneumonia (6.0%). The serum levels of IL-6 were measured at diagnosis with ILD and sequentially at follow-up visits. During the follow-ups, 15 (18.1%) patients experienced an acute exacerbation (AE) of ILD and among them, four (26.7%) patients died. In the multivariable analysis, high levels of IL-6 (OR 1.014, 95% CI: 1.001-1.027, p = 0.036) along with lower baseline saturations of peripheral oxygen (SpO(2)) were independent risk factors for AE. In the receiver operating characteristic curve analysis, the area under the curve was 0.815 (p < 0.001) and the optimal cut-off value of serum IL-6 to predict AE was 25.20 pg/mL with a sensitivity of 66.7% and specificity of 80.6%. In the multivariable Cox analysis, a high level of serum IL-6 (HR 1.007, 95% CI: 1.001-1.014, p = 0.018) was only an independent risk factor for mortality in ILD patients. Conclusions In our study, a high level of serum IL-6 is a useful biomarker to predict AE and poor prognosis in patients with ILD.	[Lee, Jae Ha; Jang, Ji Hoon; Park, Jin Han; Jang, Hang-Jea; Kim, Hyun Kuk] Inje Univ, Coll Med, Div Pulmonol, Dept Internal Med,Haeundae Paik Hosp, Busan, South Korea; [Park, Chan Sun] Inje Univ, Coll Med, Div Allergy, Dept Internal Med,Haeundae Paik Hosp, Busan, South Korea; [Lee, Sunggun; Kim, Seong-Ho] Inje Univ, Coll Med, Div Rheumatol, Dept Internal Med,Haeundae Paik Hosp, Busan, South Korea; [Kim, Ji Yeon] Inje Univ, Coll Med, Div Pathol, Haeundae Paik Hosp, Busan, South Korea	Inje University; Inje University; Inje University; Inje University	Kim, HK (corresponding author), Inje Univ, Coll Med, Div Pulmonol, Dept Internal Med,Haeundae Paik Hosp, Busan, South Korea.	khkmd1205@hanmail.net		Jang, Ji Hoon/0000-0002-5048-8820; lee, jae ha/0000-0003-0932-2826; Lee, Sunggun/0000-0003-3640-9185	 [20190041]		This work was supported by 2019 Inje university research grant (20190041). The grant did not have any influence on the research results and was a support to promote the research activities.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Antoniou KM, 2016, ARTHRITIS RHEUMATOL, V68, P1004, DOI 10.1002/art.39528; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Collard HR, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01339-2016; Collard HR, 2016, AM J RESP CRIT CARE, V194, P265, DOI 10.1164/rccm.201604-0801CI; Collard HR, 2010, AM J PHYSIOL-LUNG C, V299, pL3, DOI 10.1152/ajplung.90637.2008; Shochet GE, 2020, RESP RES, V21, DOI 10.1186/s12931-020-1319-0; Heukels P, 2019, RESP MED, V147, P79, DOI 10.1016/j.rmed.2018.12.015; Holland AE, 2014, EUR RESPIR J, V44, P1428, DOI 10.1183/09031936.00150314; Kim DS, 2006, EUR RESPIR J, V27, P143, DOI 10.1183/09031936.06.00114004; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Kolb M, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0071-2018; Le TTT, 2014, J IMMUNOL, V193, P3755, DOI 10.4049/jimmunol.1302470; Leuschner G, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00176; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Okuda R, 2019, SARCOIDOSIS VASC DIF, V36, P39, DOI 10.36141/svdld.v36i1.7117; Papiris SA, 2018, CYTOKINE, V102, P168, DOI 10.1016/j.cyto.2017.08.019; Qiu MH, 2018, CLIN RESPIR J, V12, P1084, DOI 10.1111/crj.12631; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Saito-Fujita T, 2011, J RADIAT RES, V52, P270, DOI 10.1269/jrr.10094; Simon-Blancal V, 2012, RESPIRATION, V83, P28, DOI 10.1159/000329891; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Suda T, 2009, RESP MED, V103, P846, DOI 10.1016/j.rmed.2008.12.019; Suzuki A, 2020, RESPIROLOGY, V25, P525, DOI 10.1111/resp.13682; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Phan THG, 2021, CELL MOL LIFE SCI, V78, P2031, DOI 10.1007/s00018-020-03693-7; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Zeserson E, 2018, J INTENSIVE CARE MED, V33, P176, DOI 10.1177/0885066616652597	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255365	10.1371/journal.pone.0255365	http://dx.doi.org/10.1371/journal.pone.0255365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314462	Green Published, gold			2022-12-26	WOS:000685225200027
J	Baldeon, ME; Felix, C; Fornasini, M; Zertuche, F; Largo, C; Paucar, MJ; Ponce, L; Rangarajan, S; Yusuf, S; Lopez-Jaramillo, P				Baldeon, Manuel E.; Felix, Camilo; Fornasini, Marco; Zertuche, Federico; Largo, Carolina; Jose Paucar, Maria; Ponce, Liz; Rangarajan, Sumathy; Yusuf, Salim; Lopez-Jaramillo, Patricio			Prevalence of metabolic syndrome and diabetes mellitus type-2 and their association with intake of dairy and legume in Andean communities of Ecuador	PLOS ONE			English	Article							LUPINUS-MUTABILIS; PROSPECTIVE URBAN; PEPTIDES; MIDDLE; PURE	Metabolic syndrome (MetS) and type 2 diabetes (T2D) are metabolic alterations associated with high morbidity and mortality, particularly in low and middle-income countries. Diet has a significant impact on the risk to develop MetS and T2D; in this regard, consumption of fruits, vegetables, and protein rich foods (from plant and animals) are important to prevent and manage these pathologies. There are limited studies regarding the potential association between Andean foods rich in proteins and the presence of cardio-metabolic conditions in Ecuador. It is necessary to develop new low-cost, local-culturally acceptable strategies to reduce the burden of cardio-metabolic diseases. We describe the prevalence (baseline data) of MetS and T2D in the Ecuadorian cohort of the Prospective Urban and Rural Epidemiology (PURE) study and their potential association with the consumption of protein rich foods, including beef, white meat, dairy and legumes. In this cross-sectional study, we assessed 1,997 individuals aged 35-70 years (mean age 51 years, 72% women), included in the Ecuadorian cohort of the PURE study, from February to December 2018. The prevalence of MetS was 42% for male and 44% for female participants; the prevalence of T2D was 9% for male and 10% for female. Metabolic syndrome and T2D were more common in women older than 50 years of age with primary education or less, low economic income, and with obesity; MetS was more frequent in the rural area while T2D was more frequent in the urban area. Using logistic regression analysis, we observed a significant protective effect of higher consumption of dairy and legumes in the prevalence of MetS and T2D compared with low consumption. It will be important to develop policies for ample production and consumption of protein rich foods such as legumes and dairy, part of traditional diets, to reduce the burden of cardio-metabolic diseases.	[Baldeon, Manuel E.; Felix, Camilo; Fornasini, Marco; Zertuche, Federico; Largo, Carolina; Jose Paucar, Maria; Ponce, Liz] Univ UTE, Fac Ciencias Salud Eugenio Espejo, Quito, Ecuador; [Rangarajan, Sumathy; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Rangarajan, Sumathy; Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON, Canada; [Lopez-Jaramillo, Patricio] Santander Univ UDES, Med Sch, Masira Res Inst, Santander, Colombia	McMaster University; Population Health Research Institute; McMaster University	Baldeon, ME (corresponding author), Univ UTE, Fac Ciencias Salud Eugenio Espejo, Quito, Ecuador.	mabaldeonti@uide.edu.ec	Paucar, MJ/GSD-2205-2022	Felix, Camilo/0000-0003-0224-2321; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Baldeon, Manuel E./0000-0002-1243-7467; Yusuf, Salim/0000-0003-4776-5601	Universidad UTE; Population Health Research Institute, Canada (PHRI)	Universidad UTE; Population Health Research Institute, Canada (PHRI)	This work was funded by Universidad UTE and The Population Health Research Institute, Canada (PHRI) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldeon ME, 2012, NUTR HOSP, V27, P1261, DOI 10.3305/nh.2012.27.4.5761; Baldeon ME, 2020, MED PLANTS TREATMENT, P289; Barcelo A, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020410; Bhavadharini B, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2019-000826; Carbone JW, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051136; Cefalu WT, 2019, DIABETES CARE, V42, pS29, DOI 10.2337/dc19-S003; Celis-Morales CA, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1651; Chaudhari DD, 2017, INDIAN J MED RES, V146, P409, DOI 10.4103/ijmr.IJMR_802_15; Dagenais GR, 2016, DIABETES CARE, V39, P780, DOI 10.2337/dc15-2338; Dehghan M, 2018, LANCET, V392, P2288, DOI 10.1016/S0140-6736(18)31812-9; Distritio Metropolitano de Quito, 2020, GOB PROV PICH; Elliott P, 2006, ARCH INTERN MED, V166, P79, DOI 10.1001/archinte.166.1.79; Escobedo J, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-52; Fornasini M, 2012, NUTR HOSP, V27, P425, DOI [10.3305/nh.2012.27.2.5412, 10.1590/S0212-16112012000200012]; Fornasini M, 2019, NUTR HOSP, V36, P905, DOI 10.20960/nh.02590; Freire WB., 2012, ENCUESTA NACL SALUD; Huang JQ, 2020, JAMA INTERN MED, V180, P1173, DOI 10.1001/jamainternmed.2020.2790; Instituto Nacional de Estadisticas y Censos, 2019, EST VIT REG EST NAC; International Diabetes Federation,, 2019, IDF DIABETES ATLAS; Lee Jihye, 2016, J Prev Med Public Health, V49, P35, DOI 10.3961/jpmph.15.055; Lopez-Jaramillo P, 2019, J HYPERTENS, V37, P1126, DOI 10.1097/HJH.0000000000002072; Miller V, 2017, LANCET, V390, P2037, DOI [10.1016/s0140-6736(17)32253-5, 10.1016/S0140-6736(17)32253-5]; Ministerio de Salud Piblica del Ecuador, 2018, ENC SPEPS EC 2018 VI; Mojica L, 2016, FOOD FUNCT, V7, P713, DOI [10.1039/C5FO01204J, 10.1039/c5fo01204j]; Munoz EB, 2018, J FUNCT FOODS, V45, P339, DOI 10.1016/j.jff.2018.04.021; Naghshi S, 2020, BMJ-BRIT MED J, V370, DOI [10.1136/bmj.m2412, 10.1136bmj.m2412]; Ortega MA, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092749; Rosas-Saucedo J, 2017, REV ALAD, V7, P184, DOI [10.24875/ALAD.17000307, DOI 10.24875/ALAD.17000307, 10.1002/jcsm.12112]; Sayer AA, 2005, DIABETES CARE, V28, P2541, DOI 10.2337/diacare.28.10.2541; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Tamayo T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-525; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Wong-McClure RA, 2015, REV PANAM SALUD PUBL, V38, P202; World Health Organization, 2016, INF MUND DIAB VERS A	34	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254812	10.1371/journal.pone.0254812	http://dx.doi.org/10.1371/journal.pone.0254812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297755	gold, Green Published			2022-12-26	WOS:000678128300058
J	Lee, Y; Mun, E; Park, S; Lee, W				Lee, Yesung; Mun, Eunchan; Park, Soyoung; Lee, Woncheol			Long working hours are associated with a higher risk of non-alcoholic fatty liver disease: A large population-based Korean cohort study	PLOS ONE			English	Article							NIGHT-SHIFT WORK; UNPUBLISHED DATA; FIBROSIS; HEALTH; METAANALYSIS; GLUCOSE; OBESITY	Background Non-alcoholic fatty liver disease (NAFLD), a common chronic liver disease, may progress to fibrosis, cirrhosis, hepatocellular carcinoma, and liver failure. But only a few cross-sectional studies have reported an association of NAFLD with working hours. This cohort study further examined the association between working hours and the development of NAFLD. Methods We included 79,048 Korean adults without NAFLD at baseline who underwent a comprehensive health examination and categorized weekly working hours into 35-40, 41-52, 53-60, and >60 hours. NAFLD was defined as the presence of fatty liver, in the absence of excessive alcohol use, as observed by ultrasound. Results During a median follow-up of 6.6 years, 15,095 participants developed new-onset NAFLD (incidence rate, 5.55 per 100 person-years). After adjustment for confounders, the hazard ratios (95% confidence interval) for the development of NAFLD in 41-52, 53-60, and >60 working hours compared with that in 35-40 working hours were 1.07 (1.02-1.13), 1.06 (1.00-1.13), and 1.13 (1.05-1.23), respectively. Furthermore, the association remained significant after confounders were treated as time-varying covariates. Conclusion In this large-scale cohort, long working hours, especially >60 working hours a week, were independently associated with incident NAFLD. Our findings indicate that long working hours are a risk factor for NAFLD.	[Lee, Yesung; Mun, Eunchan; Park, Soyoung; Lee, Woncheol] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, W (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Occupat & Environm Med, Sch Med, Seoul, South Korea.	doctor.oem@gmail.com	Lee, Woncheol/GWC-9953-2022	Lee, Woncheol/0000-0001-8535-3988; LEE, YESUNG/0000-0002-8844-492X; Mun, Eunchan/0000-0002-2808-0423				Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Artazcoz L, 2009, J EPIDEMIOL COMMUN H, V63, P521, DOI 10.1136/jech.2008.082123; Balakrishnan M, 2017, DIGEST DIS SCI, V62, P526, DOI 10.1007/s10620-016-4401-1; Bannai A, 2014, SCAND J WORK ENV HEA, V40, P5, DOI 10.5271/sjweh.3388; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chang Y, 2007, CLIN CHEM, V53, P686, DOI 10.1373/clinchem.2006.081257; Chang Y, 2019, HEPATOLOGY, V69, P64, DOI 10.1002/hep.30170; Chang Y, 2016, AM J GASTROENTEROL, V111, P1133, DOI 10.1038/ajg.2016.178; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Ikeda H, 2018, SCAND J WORK ENV HEA, V44, P622, DOI 10.5271/sjweh.3752; Jang TW, 2013, J OCCUP HEALTH, V55, P359, DOI 10.1539/joh.13-0043-OA; Jung HS, 2019, AM J GASTROENTEROL, V114, P453, DOI 10.1038/s41395-018-0283-5; Jung JY, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e199; Kim BM, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0110-7; Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156; Kim S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184506; Kim Y, 2019, LIVER INT, V39, P1884, DOI 10.1111/liv.14184; Kivimaki M, 2015, LANCET DIABETES ENDO, V3, P27, DOI 10.1016/S2213-8587(14)70178-0; Kivimaki M, 2015, LANCET, V386, P1739, DOI 10.1016/S0140-6736(15)60295-1; Kobayashi T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-395; Lee J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172666; Lee K, 2017, IND HEALTH, V55, P46, DOI 10.2486/indhealth.2015-0173; Mathiesen UL, 2002, DIGEST LIVER DIS, V34, P516, DOI 10.1016/S1590-8658(02)80111-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Organisation for Economic Cooperation and Development, 2020, HOURS WORK IND; Paradis V, 2001, HEPATOLOGY, V34, P738, DOI 10.1053/jhep.2001.28055; Park H, 2019, CHRONOBIOL INT, V36, P1671, DOI 10.1080/07420528.2019.1670671; Park JW, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0140-1; Ryu S, 2015, J HEPATOL, V62, P1164, DOI 10.1016/j.jhep.2014.11.041; Spurgeon A., 2003, WORKING TIME ITS IMP; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Wang F, 2019, OCCUP ENVIRON MED, V76, P83, DOI 10.1136/oemed-2018-105273; Wang HL, 2018, LIVER INT, V38, P2277, DOI 10.1111/liv.13896; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Yoon JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129142; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Yu J, 2017, ASIAN NURS RES, V11, P36, DOI 10.1016/j.anr.2017.02.003; Zhang SK, 2020, OCCUP ENVIRON MED, V77, P333, DOI 10.1136/oemed-2019-106220	38	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255118	10.1371/journal.pone.0255118	http://dx.doi.org/10.1371/journal.pone.0255118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297733	gold, Green Published			2022-12-26	WOS:000678128300044
J	Nagati, JS; Kobeissy, PH; Nguyen, MQ; Xu, M; Garcia, T; Comerford, SA; Hammer, RE; Garcia, JA				Nagati, Jason S.; Kobeissy, Philippe H.; Nguyen, Minh Q.; Xu, Min; Garcia, Trent; Comerford, Sarah A.; Hammer, Robert E.; Garcia, Joseph A.			Mammalian acetate-dependent acetyl CoA synthetase 2 contains multiple protein destabilization and masking elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGRADATION SIGNALS; CRYSTAL-STRUCTURE; COENZYME; ACTIVATION; DEGRON; DEACETYLATION; SEQUENCES; PATHWAYS; BINDING; ENZYME	Besides contributing to anabolism, cellular metabolites serve as substrates or cofactors for enzymes and may also have signaling functions. Given these roles, multiple control mechanisms likely ensure fidelity of metabolite-generating enzymes. Acetate-dependent acetyl CoA synthetases (ACS) are de novo sources of acetyl CoA, a building block for fatty acids and a substrate for acetyltransferases. Eukaryotic acetate-dependent acetyl CoA synthetase 2 (Acss2) is predominantly cytosolic, but is also found in the nucleus following oxygen or glucose deprivation, or upon acetate exposure. Acss2-generated acetyl CoA is used in acetylation of Hypoxia-Inducible Factor 2 (HIF2), a stress-responsive transcription factor. Mutation of a putative nuclear localization signal in endogenous Acss2 abrogates HIF-2 acetylation and signaling, but surprisingly also results in reduced Acss2 protein levels due to unmasking of two protein destabilization elements (PDE) in the Acss2 hinge region. In the current study, we identify up to four additional PDE in the Acss2 hinge region and determine that a previously identified PDE, the ABC domain, consists of two functional PDE. We show that the ABC domain and other PDE are likely masked by intramolecular interactions with other domains in the Acss2 hinge region. We also characterize mice with a prematurely truncated Acss2 that exposes a putative ABC domain PDE, which exhibits reduced Acss2 protein stability and impaired HIF-2 signaling. Finally, using primary mouse embryonic fi- broblasts, we demonstrate that the reduced stability of select Acss2 mutant proteins is due to a shortened half-life, which is a result of enhanced degradation via a nonproteasome, nonautophagy pathway.	[Nagati, Jason S.; Kobeissy, Philippe H.; Nguyen, Minh Q.; Garcia, Joseph A.] Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA; [Xu, Min; Garcia, Trent] Univ Texas Southwestern Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA; [Comerford, Sarah A.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Hammer, Robert E.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Garcia, Joseph A.] James J Peters VA Med Ctr, Dept Res, New York, NY 10468 USA	Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Garcia, JA (corresponding author), Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA.; Garcia, JA (corresponding author), James J Peters VA Med Ctr, Dept Res, New York, NY 10468 USA.	jag2369@cumc.columbia.edu		Comerford, Sarah Ann/0000-0002-7452-7759; Garcia, Joseph/0000-0002-5621-7538; Nagati, Jason/0000-0002-4507-6581; Hammer, Robert E./0000-0001-5487-7551	US Department of Veterans Affairs [I01BX000446]; US National Institutes of Health [HL108104, HL130142, P309DK079328]	US Department of Veterans Affairs(US Department of Veterans Affairs); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by funds provided by the US Department of Veterans Affairs (I01BX000446 -J. A. G.) and the US National Institutes of Health (HL108104, HL130142 -J. A. G.; P309DK079328 -O'Brien Kidney Research Core Center). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Bulusu V, 2017, CELL REP, V18, P647, DOI 10.1016/j.celrep.2016.12.055; Chen R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190241; Chen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116515; Chen R, 2012, J BIOL CHEM, V287, P30800, DOI 10.1074/jbc.M111.244780; Costantini LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8670; Davey NE, 2019, CURR OPIN STRUC BIOL, V56, P155, DOI 10.1016/j.sbi.2019.03.009; Davey NE, 2016, MOL CELL, V64, P12, DOI 10.1016/j.molcel.2016.09.006; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Fortmann KT, 2015, J MOL BIOL, V427, P2748, DOI 10.1016/j.jmb.2015.07.008; Fredrickson EK, 2012, SEMIN CELL DEV BIOL, V23, P530, DOI 10.1016/j.semcdb.2011.12.006; Geffen Y, 2016, MOL CELL, V63, P1055, DOI 10.1016/j.molcel.2016.08.005; Guharoy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10239; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hu A, 2020, MOL CARCINOGEN, V59, P1280, DOI 10.1002/mc.23256; Im S, 2017, CELL SIGNAL, V36, P127, DOI 10.1016/j.cellsig.2017.05.001; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Li XJ, 2017, MOL CELL, V66, P684, DOI 10.1016/j.molcel.2017.04.026; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Maurer MJ, 2016, G3-GENES GENOM GENET, V6, P1853, DOI 10.1534/g3.116.027953; Miller KD, 2021, CANCER RES, V81, P1252, DOI 10.1158/0008-5472.CAN-20-1847; Nagati JS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225105; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Sahar S, 2014, J BIOL CHEM, V289, P6091, DOI 10.1074/jbc.M113.537191; Sharma S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152731; Shumway SD, 2004, BIOCHEM J, V380, P173, DOI 10.1042/BJ20031796; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sontag EM, 2014, CURR OPIN CELL BIOL, V26, P139, DOI 10.1016/j.ceb.2013.12.006; Starai VJ, 2005, J BIOL CHEM, V280, P26200, DOI 10.1074/jbc.M504863200; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Stein A, 2019, TRENDS BIOCHEM SCI, V44, P575, DOI 10.1016/j.tibs.2019.01.003; Takasugi T, 2016, J BIOL CHEM, V291, P4649, DOI 10.1074/jbc.M115.692871; Takeuchi J, 2008, BIOCHEM J, V410, P401, DOI 10.1042/BJ20071239; Tao T, 2013, CELL RES, V23, P620, DOI 10.1038/cr.2013.16; Tekirdag K, 2018, J BIOL CHEM, V293, P5414, DOI 10.1074/jbc.R117.818237; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Varshavsky A, 2019, P NATL ACAD SCI USA, V116, P358, DOI 10.1073/pnas.1816596116; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Xu M, 2014, NAT MED, V20, P1018, DOI 10.1038/nm.3587	49	0	0	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101037	10.1016/j.jbc.2021.101037	http://dx.doi.org/10.1016/j.jbc.2021.101037			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34343565	Green Published, gold			2022-12-26	WOS:000704369100013
J	Wilkes, MC; Jung, K; Lee, BE; Saxena, M; Sathianathen, RS; Mercado, JD; Perez, C; Flygare, J; Narla, A; Glader, B; Sakamoto, KM				Wilkes, Mark C.; Jung, Kevin; Lee, Britney E.; Saxena, Mallika; Sathianathen, Ryan S.; Mercado, Jacqueline D.; Perez, Cristina; Flygare, Johan; Narla, Anupama; Glader, Bertil; Sakamoto, Kathleen M.			The active component of ginseng, ginsenoside Rb1, improves erythropoiesis in models of Diamond-Blackfan anemia by targeting Nemo-like kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CANCER; EXPRESSION; NLK; IDENTIFICATION; EXTRACT	Nemo-like kinase (NLK) is a member of the mitogenactivated protein kinase family of kinases and shares a highly conserved kinase domain with other mitogen-activated protein kinase family members. The activation of NLK contributes to the pathogenesis of Diamond-Blackfan anemia (DBA), reducing c-myb expression and mechanistic target of rapamycin activity, and is therefore a potential therapeutic target. Unlike other anemias, the hematopoietic effects of DBA are largely restricted to the erythroid lineage. Mutations in ribosomal genes induce ribosomal insufficiency and reduced protein translation, dramatically impacting early erythropoiesis in the bone marrow of patients with DBA. We sought to identify compounds that suppress NLK and increases erythropoiesis in ribosomal insufficiency. We report that the active component of ginseng, ginsenoside Rb1, suppresses NLK expression and improves erythropoiesis in in vitro models of DBA. Ginsenoside Rb1-mediated suppression of NLK occurs through the upregulation of miR-208, which binds to the 30-UTR of NLK mRNA and targets it for degradation. We also compare ginsenoside Rb1-mediated upregulation of miR-208 with metformin-mediated upregulation of miR-26. We conclude that targeting NLK expression through miRNA binding of the unique 30-UTR is a viable alternative to the challenges of developing small-molecule inhibitors to target the highly conserved kinase domain of this specific kinase.	[Wilkes, Mark C.; Jung, Kevin; Lee, Britney E.; Saxena, Mallika; Sathianathen, Ryan S.; Mercado, Jacqueline D.; Perez, Cristina; Narla, Anupama; Glader, Bertil; Sakamoto, Kathleen M.] Stanford Univ, Dept Pediat, Div Hematol Oncol, Stanford, CA 94305 USA; [Flygare, Johan] Lund Univ, Lund Stem Cell Ctr, Dept Mol Med & Gene Therapy, Lund, Sweden	Stanford University; Lund University	Sakamoto, KM (corresponding author), Stanford Univ, Dept Pediat, Div Hematol Oncol, Stanford, CA 94305 USA.	kmsakamo@stanford.edu		Narla, Anupama/0000-0003-2325-3388; Jung, Kevin/0000-0002-5578-395X; Sakamoto, Kathleen/0000-0003-0494-8838; Wilkes, Mark/0000-0002-9600-6831	National Institutes of Health [DK098132]; Maternal Child Health Research Institute fellowship [1111239-442-JHACT]; DBA Foundation [138290]; Department of Defense [BM180024]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maternal Child Health Research Institute fellowship; DBA Foundation; Department of Defense(United States Department of Defense)	This work was funded by the National Institutes of Health T32 training grant (DK098132) and Maternal Child Health Research Institute fellowship (1111239-442-JHACT) (to M. C. W.), DBA Foundation (138290) (to K. M. S./M. C. W.), and Department of Defense (BM180024) (to K. M. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bibikova E, 2014, BLOOD, V124, P3791, DOI 10.1182/blood-2014-06-584656; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; Chen HW, 2015, TUMOR BIOL, V36, P8447, DOI 10.1007/s13277-015-3609-6; Chen JB, 2015, MOL MED REP, V11, P1181, DOI 10.3892/mmr.2014.2851; Cichocki F, 2011, J IMMUNOL, V187, P6171, DOI 10.4049/jimmunol.1100835; Da Costa Lydie, 2018, F1000Res, V7, DOI 10.12688/f1000research.15542.1; Dong S, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0203-8; Flygare J, 2005, BLOOD, V105, P4627, DOI 10.1182/blood-2004-08-3115; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Han Y, 2014, BIOMED PHARMACOTHER, V68, P497, DOI 10.1016/j.biopha.2014.05.003; He XY, 2017, CLIN CANCER RES, V23, P2905, DOI 10.1158/1078-0432.CCR-16-1591; Hwang JW, 2012, AM J CHINESE MED, V40, P187, DOI 10.1142/S0192415X12500152; Jiang SL, 2017, CHIN J INTEGR MED, V23, P331, DOI 10.1007/s11655-015-2146-x; Jin H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-6; Jin X, 2016, J GINSENG RES, V40, P269, DOI 10.1016/j.jgr.2015.08.007; Lazare SS, 2014, EXP CELL RES, V329, P234, DOI 10.1016/j.yexcr.2014.08.033; Li X, 2012, CELL DEATH DIFFER, V19, P378, DOI 10.1038/cdd.2011.127; Lv LT, 2014, J CELL BIOCHEM, V115, P81, DOI 10.1002/jcb.24635; Narla A, 2011, SEMIN HEMATOL, V48, P117, DOI 10.1053/j.seminhematol.2011.01.004; Shen Q, 2014, CANCER LETT, V344, P204, DOI 10.1016/j.canlet.2013.10.030; Shergis JL, 2013, PHYTOTHER RES, V27, P949, DOI 10.1002/ptr.4832; Tai J, 2015, MOL MED REP, V12, P5619, DOI 10.3892/mmr.2015.4189; Tanno T, 2017, BLOOD ADV, V1, P1107, DOI 10.1182/bloodadvances.2017004705; Ulirsch JC, 2018, AM J HUM GENET, V103, P930, DOI 10.1016/j.ajhg.2018.10.027; Vlachos A, 2010, BLOOD, V116, P3715, DOI 10.1182/blood-2010-02-251090; Wang CZ, 2008, AM J CHINESE MED, V36, P1019, DOI 10.1142/S0192415X08006545; Wilkes MC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17100-z; Wilkes MC, 2020, EXP HEMATOL, V91, P65, DOI 10.1016/j.exphem.2020.09.187; Wilkes MC, 2017, MOL GENET METAB, V122, P28, DOI 10.1016/j.ymgme.2017.07.008; Yan X, 2016, CELL PHYSIOL BIOCHEM, V39, P1187, DOI 10.1159/000447825; Yasuda J, 2007, P JPN ACAD B-PHYS, V83, P16, DOI 10.2183/pjab.83.16; Zeng X, 2010, J CLIN PHARMACOL, V50, P285, DOI 10.1177/0091270009344334; Zhang HY, 2020, J ETHNOPHARMACOL, V253, DOI 10.1016/j.jep.2020.112658; Zhang L, 2017, ACTA BIOCH BIOPH SIN, V49, P746, DOI 10.1093/abbs/gmx062; Zhang W, 2015, WORLD J GASTROENTERO, V21, P8836, DOI 10.3748/wjg.v21.i29.8836; Zhang XW, 2015, INT J CLIN EXP PATHO, V8, P15086	37	4	4	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100988	10.1016/j.jbc.2021.100988	http://dx.doi.org/10.1016/j.jbc.2021.100988			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34298020	gold, Green Published			2022-12-26	WOS:000706418900005
J	Moonga, G; Bose-O'Reilly, S; Berger, U; Harttgen, K; Michelo, C; Nowak, D; Siebert, U; Yabe, J; Seiler, J				Moonga, Given; Bose-O'Reilly, Stephan; Berger, Ursula; Harttgen, Kenneth; Michelo, Charles; Nowak, Dennis; Siebert, Uwe; Yabe, John; Seiler, Johannes			Modelling chronic malnutrition in Zambia: A Bayesian distributional regression approach	PLOS ONE			English	Article							CHILD UNDERNUTRITION; AFRICA; HEALTH; MORTALITY; NIGERIA; INCOME	Background The burden of child under-nutrition still remains a global challenge, with greater severity being faced by low- and middle-income countries, despite the strategies in the Sustainable Development Goals (SDGs). Globally, malnutrition is the one of the most important risk factors associated with illness and death, affecting hundreds of millions of pregnant women and young children. Sub-Saharan Africa is one of the regions in the world struggling with the burden of chronic malnutrition. The 2018 Zambia Demographic and Health Survey (ZDHS) report estimated that 35% of the children under five years of age are stunted. The objective of this study was to analyse the distribution, and associated factors of stunting in Zambia. Methods We analysed the relationships between socio-economic, and remote sensed characteristics and anthropometric outcomes in under five children, using Bayesian distributional regression. Georeferenced data was available for 25,852 children from two waves of the ZDHS, 31% observation were from the 2007 and 69% were from the 2013/14. We assessed the linear, non-linear and spatial effects of covariates on the height-for-age z-score. Results Stunting decreased between 2007 and 2013/14 from a mean z-score of 1.59 (credible interval (CI): -1.63; -1.55) to -1.47 (CI: -1.49; -1.44). We found a strong non-linear relationship for the education of the mother and the wealth of the household on the height-for-age z-score. Moreover, increasing levels of maternal education above the eighth grade were associated with a reduced variation of stunting. Our study finds that remote sensed covariates alone explain little of the variation of the height-for-age z-score, which highlights the importance to collect socio-economic characteristics, and to control for socio-economic characteristics of the individual and the household. Conclusions While stunting still remains unacceptably high in Zambia with remarkable regional inequalities, the decline is lagging behind goal two of the SDGs. This emphasises the need for policies that help to reduce the share of chronic malnourished children within Zambia.	[Moonga, Given] Ludwig Maximilian Univ Munich, Ctr Int Hlth, Munich, Germany; [Moonga, Given; Bose-O'Reilly, Stephan; Siebert, Uwe; Seiler, Johannes] UMIT Univ Hlth Sci Med Informat & Technol, Hlth Serv Res & Hlth Technol Assessment, Dept Publ Hlth, Hall In Tirol, Austria; [Moonga, Given; Michelo, Charles] Univ Zambia, Dept Epidemiol & Biostat, Lusaka, Zambia; [Bose-O'Reilly, Stephan; Nowak, Dennis] Ludwig Maximilian Univ Munich, Clin Ctr, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Berger, Ursula] Ludwig Maximilian Univ Munich, Inst Med Informat Proc Biometry & Epidemiol, Munich, Germany; [Harttgen, Kenneth] Swiss Fed Inst Technol, Dept Humanities Social & Polit Sci, Zurich, Switzerland; [Yabe, John] Univ Zambia, Sch Vet Med, Lusaka, Zambia; [Seiler, Johannes] Univ Innsbruck, Dept Stat, Innsbruck, Austria	University of Munich; UMIT - Private University for Health Sciences, Medical Informatics & Technology GmbH; University of Zambia; University of Munich; University of Munich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zambia; University of Innsbruck	Moonga, G (corresponding author), Ludwig Maximilian Univ Munich, Ctr Int Hlth, Munich, Germany.; Moonga, G (corresponding author), UMIT Univ Hlth Sci Med Informat & Technol, Hlth Serv Res & Hlth Technol Assessment, Dept Publ Hlth, Hall In Tirol, Austria.; Moonga, G (corresponding author), Univ Zambia, Dept Epidemiol & Biostat, Lusaka, Zambia.	Given.Moonga@lrz.uni-muenchen.de	Johannes, Seiler/ABB-6194-2021; Seiler, Johannes/GQB-3418-2022; Seiler, Johannes/AAC-9435-2022	Johannes, Seiler/0000-0001-5714-9234; Seiler, Johannes/0000-0001-5714-9234; Yabe, Dr. John/0000-0003-4580-3416	University of Innsbruck	University of Innsbruck	Johannes Seiler acknowledges financial support from the University of Innsbruck through a postdoctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebayo SB, 2005, STAT MED, V24, P709, DOI 10.1002/sim.1842; Adebayo SB., 2003, STAT METHOD APPL-GER, V12, P227, DOI [10.1007/s10260-003-0057-z, DOI 10.1007/S10260-003-0057-Z]; Amoah B, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0127-y; Angdembe MR, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-0944-z; [Anonymous], 2003, REV INCOME WEALTH; Barichivich J, 2019, B AM METEOROLOGICAL, pS39; Belitz C., 2015, BAYESX BAYESIAN INFE; Belitz C, 2010, STATISTICAL MODELLING AND REGRESSION STRUCTURES, P155, DOI 10.1007/978-3-7908-2413-1_9; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brown ME, 2014, POPUL ENVIRON, V36, P48, DOI 10.1007/s11111-013-0201-0; Center for International Earth Science Information Network-CIESIN-Columbia University, 2017, GRIDDED POPULATION W; Central Statistical Office (CSO) [Zambia]  Ministry of Health (MOH) [Zambia] and II, 2014, ZAMB DEM HLTH SURV 2; Corsi DJ, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1328185; Dunn PK., 1996, J COMPUTATIONAL GRAP, V5, P236, DOI DOI 10.2307/1390802; Dwyer-Lindgren L, 2014, SPAT SPATIO-TEMPORAL, V11, P89, DOI 10.1016/j.sste.2014.09.002; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Fahrmeir L., 2013, REGRESSION, DOI DOI 10.1007/978-3-642-34333-9; FAO IFAD UNICEF WFP WHO, 2018, STAT FOOD SEC NUTR W; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Frongillo EA, 1997, J NUTR, V127, P2302, DOI 10.1093/jn/127.12.2302; Gayawan E, 2019, APPL SPAT ANAL POLIC, V12, P229, DOI 10.1007/s12061-017-9240-8; GORSTEIN J, 1988, World Health Statistics Quarterly, V41, P48; HASTIE T, 1993, J ROY STAT SOC B MET, V55, P757; Hijmans Robert J, 2018, GLOBAL ADM AREAS GAD; Hong Rathavuth, 2006, Int J Equity Health, V5, P15, DOI 10.1186/1475-9276-5-15; Kandala NB., 2001, SEMIPARAMETRIC ANAL; Kandala NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-261; Kandala NB, 2009, POPUL SPACE PLACE, V15, P461, DOI 10.1002/psp.524; Klein N., 2013, INTRO BAYESIAN STRUC; Klein N, 2015, ANN APPL STAT, V9, P1024, DOI 10.1214/15-AOAS823; Klein N, 2015, J R STAT SOC C-APPL, V64, P569, DOI 10.1111/rssc.12090; Kneib T, 2013, STAT MODEL, V13, P275, DOI 10.1177/1471082X13494159; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Marx S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1189; Menon P, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12620; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Mzumara B, 2018, BMC NUTR, V4, DOI 10.1186/s40795-018-0260-9; Ngoma C, 2017, ANN MED HEALTH SCI R, V7, P442; Osei FB, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-118; Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760; Perumal N, 2018, J NUTR, V148, P311, DOI 10.1093/jn/nxx064; Seiler J, 2021, ECON HUM BIOL, V40, DOI 10.1016/j.ehb.2020.100950; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; SVEDBERG P, 1990, J DEV STUD, V26, P469, DOI 10.1080/00220389008422165; Svefors P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149700; Tette EMA, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0496-3; Umlauf N, 2018, STAT MODEL, V18, P219, DOI 10.1177/1471082X18759140; UNICEF, 1990, UNICEF POL REV; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; van der Schrier G, 2013, J GEOPHYS RES-ATMOS, V118, P4025, DOI 10.1002/jgrd.50355; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; WHO/UNICEF, 2014, GLOB NUTR TARG 2025, DOI [10.1057/9781137477699_6, DOI 10.1057/9781137477699_6]	54	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2021	16	8							e0255073	10.1371/journal.pone.0255073	http://dx.doi.org/10.1371/journal.pone.0255073			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6IY	34347795	gold, Green Published			2022-12-26	WOS:000685264900049
J	Wilson, ES; Murphy, CE; Wong, C; Rinehart, JP; Yocum, GD; Bowsher, JH				Wilsonid, Elisabeth S.; Murphy, Claire E.; Wong, Covey; Rinehart, Joseph P.; Yocum, George D.; Bowsher, Julia H.			Environmental impacts on diapause and survival of the alfalfa leafcutting bee, Megachile rotundata	PLOS ONE			English	Article							NESTING-BEHAVIOR; HYMENOPTERA; TEMPERATURE; POLLINATOR; EMERGENCE; APICALIS; FEMALE	Megachile rotundata exhibits a facultative prepupal diapause but the cues regulating diapause initiation are not well understood. Possible cues include daylength and temperature. Megachile rotundata females experience changing daylengths over the nesting season that may influence diapause incidence in their offspring through a maternal effect. Juvenile M. rotundata spend their developmental period confined in a nesting cavity, potentially subjected to stressful temperatures that may affect diapause incidence and survival. To estimate the impact of daylength and nest cavity temperature on offspring diapause, we designed a 3D printed box with iButtons that measured nest cavity temperature. We observed nest building throughout the season, monitored nest cavity temperature, and followed offspring through development to measure diapause incidence and mortality. We found that daylength was a cue for diapause, and nest cavity temperature did not influence diapause incidence. Eggs laid during long days had a lower probability of diapause. Siblings tended to have the same diapause status, explaining a lot of the remaining variance in diapause incidence. Some females established nests that contained both diapausing and nondiapausing individuals, which were distributed throughout the nest. Nest cavities reached stressful temperatures, which decreased survival. Mortality was significantly higher in nondiapausing bees and the individuals that were laid first in the nest. In conclusion, we demonstrate a maternal effect for diapause that is mediated by daylength and is independent of nest box temperature.	[Wilsonid, Elisabeth S.; Wong, Covey; Bowsher, Julia H.] North Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA; [Murphy, Claire E.] William & Mary, Biol Dept, Williamsburg, VA USA; [Rinehart, Joseph P.; Yocum, George D.] USDA, Biosci Res Lab, Agr Res Stn, Fargo, ND USA	North Dakota State University Fargo; United States Department of Agriculture (USDA)	Bowsher, JH (corresponding author), North Dakota State Univ, Dept Biol Sci, Fargo, ND 58105 USA.	julia.bowsher@ndsu.edu		Murphy, Claire/0000-0002-1718-1309; Bowsher, Julia/0000-0001-6347-9635; Wilson, Elisabeth/0000-0003-0666-5735	National Science Foundation [RII Track-2 FEC 1826834, IOS1557940]; US Department of Agriculture, Agricultural Research Service [3060-21220-032-00D]	National Science Foundation(National Science Foundation (NSF)); US Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was funded by National Science Foundation RII Track-2 FEC 1826834, IOS1557940 (https://www.nsf.gov/) to JHB and JPR and US Department of Agriculture, Agricultural Research Service 3060-21220-032-00D (https://www.ars.usda.gov/) to JPR and GDY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Barthell JF, 2002, PAN-PAC ENTOMOL, V78, P235; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berry R, 2020, COMP BIOCHEM PHYS A, V242, DOI 10.1016/j.cbpa.2020.110658; CaraDonna PJ, 2018, FUNCT ECOL, V32, P2345, DOI 10.1111/1365-2435.13151; Colinet H, 2015, ANNU REV ENTOMOL, V60, P123, DOI 10.1146/annurev-ento-010814-021017; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Fischman BJ, 2017, ENVIRON ENTOMOL, V46, P1070, DOI 10.1093/ee/nvx119; Grolemond G, 2011, J STAT SOFTW, V40, P1; Hartig F., DHARMA RESIDUAL DIAG; Hijmans RJ, GEOSPHERE SPHERICAL; JOHANSEN C A, 1973, Environmental Entomology, V2, P23, DOI 10.1093/ee/2.1.23; Kemp WP, 2000, ANN ENTOMOL SOC AM, V93, P904, DOI 10.1603/0013-8746(2000)093[0904:DAEOTA]2.0.CO;2; Kemp WP, 2001, ANN ENTOMOL SOC AM, V94, P244, DOI 10.1603/0013-8746(2001)094[0244:PTADIT]2.0.CO;2; KLOSTERMEYER EC, 1969, ANN ENTOMOL SOC AM, V62, P1321, DOI 10.1093/aesa/62.6.1321; Kostal V, 1997, J INSECT PHYSIOL, V43, P767, DOI 10.1016/S0022-1910(97)00032-2; KRUNIC MD, 1972, CAN ENTOMOL, V104, P889, DOI 10.4039/Ent104889-6; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Ludecke D., 2018, J OPEN SOURCE SOFTW, V3, P772, DOI [10.21105/joss.00772, DOI 10.21105/JOSS.00772]; Maeta Y., 2005, CHUGOKU KONTYU, V19, P39; McWatters HG, 1998, PHYSIOL ENTOMOL, V23, P369, DOI 10.1046/j.1365-3032.1998.00101.x; MuMIn Barton K., MULTIMODEL INFERENCE; Nowosad J., POLLEN ANAL AEROBIOL; O'Neill KM, 2011, ENVIRON ENTOMOL, V40, P917, DOI 10.1603/EN10320; PANKIW P, 1980, CAN ENTOMOL, V112, P555, DOI 10.4039/Ent112555-6; PARKER FD, 1982, ANN ENTOMOL SOC AM, V75, P407, DOI 10.1093/aesa/75.4.407; Pitts-Singer TL, 2008, J ECON ENTOMOL, V101, P674, DOI 10.1603/0022-0493(2008)101[674:DWCCWF]2.0.CO;2; Pitts-Singer TL, 2020, ENVIRON ENTOMOL, V49, P516, DOI 10.1093/ee/nvaa004; Pitts-Singer TL, 2011, ANNU REV ENTOMOL, V56, P221, DOI 10.1146/annurev-ento-120709-144836; R Core Team, 2020, R LANG ENV STAT COMP; Reynolds JA, 2017, ADV INSECT PHYSIOL, V53, P115, DOI 10.1016/bs.aiip.2017.03.003; Rossi BH, 2010, ANIM BEHAV, V79, P165, DOI 10.1016/j.anbehav.2009.10.023; Royaute R, 2018, J EVOLUTION BIOL, V31, P944, DOI 10.1111/jeb.13259; STEPHEN WP, 1965, J ECON ENTOMOL, V58, P284, DOI 10.1093/jee/58.2.284; Team R, 2019, RSTUDIO INT DEV R, V1.1.419 ed; TEPEDINO VJ, 1984, BEHAV ECOL SOCIOBIOL, V15, P19, DOI 10.1007/BF00310210; TEPEDINO VJ, 1986, J ECON ENTOMOL, V79, P974, DOI 10.1093/jee/79.4.974; TEPEDINO VJ, 1988, ANN ENTOMOL SOC AM, V81, P467, DOI 10.1093/aesa/81.3.467; TROSTLE G, 1994, J KANSAS ENTOMOL SOC, V67, P53; Wickham H, DPLYR GRAMMAR DATA M; Wickham H, TIDYR EASILY TIDY DA; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson ES, 2020, ENVIRON ENTOMOL, V49, P296, DOI 10.1093/ee/nvaa012; Xu Zhijing, 2019, Epidemics, V27, P19, DOI 10.1016/j.epidem.2018.12.003; Yocum GD, 2005, J INSECT PHYSIOL, V51, P621, DOI 10.1016/j.jinsphys.2004.11.008; Yocum GD, 2014, ENVIRON ENTOMOL, V43, P1045, DOI 10.1603/EN13222	46	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0254651	10.1371/journal.pone.0254651	http://dx.doi.org/10.1371/journal.pone.0254651			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343176	gold, Green Submitted, Green Published			2022-12-26	WOS:000685264200042
J	Jokoji, G; Maeda, S; Oishi, K; Ijuin, T; Nakajima, M; Tawaratsumida, H; Kawamura, I; Tominaga, H; Taketomi, E; Ikegawa, S; Taniguchi, N				Jokoji, Go; Maeda, Shingo; Oishi, Kazuki; Ijuin, Toshiro; Nakajima, Masahiro; Tawaratsumida, Hiroki; Kawamura, Ichiro; Tominaga, Hiroyuki; Taketomi, Eiji; Ikegawa, Shiro; Taniguchi, Noboru			CDC5L promotes early chondrocyte differentiation and proliferation by modulating pre-mRNA splicing of SOX9, COL2A1, and WEE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTERIOR LONGITUDINAL LIGAMENT; CERVICAL-SPINE; OSSIFICATION; GENE; EXPRESSION; MATURATION; PROTEIN; IDENTIFICATION; REGULATOR; HEDGEHOG	Ossification of the posterior longitudinal ligament (OPLL) of the spine is a common pathological condition that causes intractablemyelopathy and radiculopathy, mainly the result of an endochondral ossification-like process. Our previous genome-wide association study identified six susceptibility loci for OPLL, including the cell division cycle 5-like (CDC5L) gene region. Here, we found CDC5L to be expressed in type II collagen-producing chondrocyte-like fibroblasts in human OPLL specimens, as well as in differentiating ATDC5 chondrocytes. Cdc5l siRNA transfection in murine chondrocytes decreased the expression of the early chondrogenic genes Sox9 and Col2a1, diminished the cartilage matrix production, and enhanced the expression of parathyroid-hormone-related protein (a resting chondrocyte marker). We also showed that Cdc5l shRNA suppressed the growth of cultured murine embryonal metatarsal cartilage rudiments and that Cdc5l knockdown suppressed the growth of ATDC5 cells. Fluorescence-activated cell sorting analysis revealed that the G2/Mcell cycle transition was blocked; our data showed that Cdc5l siRNA transfection enhanced expression of Wee1, an inhibitor of the G2/M transition. Cdc5l siRNA also decreased the pre-mRNA splicing efficiency of Sox9 and Col2a1 genes in both ATDC5 cells and primary chondrocytes; conversely, loss of Cdc5l resulted in enhanced splicing of Wee1 pre-mRNA. Finally, an RNA-binding protein immuno-precipitation assay revealed that Cdc5l bound directly to these target gene transcripts. Overall, we conclude thatCdc5l promotes both early chondrogenesis and cartilage growth and may play a role in the etiology of OPLL, at least in part by fine-tuning the pre-mRNA splicing of chondrogenic genes and Wee1, thus initiating the endochondral ossification process.	[Jokoji, Go; Maeda, Shingo; Ijuin, Toshiro; Tawaratsumida, Hiroki; Taniguchi, Noboru] Kagoshima Univ, Dept Bone & Joint Med, Grad Sch Med & Dent Sci, Kagoshima, Japan; [Jokoji, Go; Oishi, Kazuki; Ijuin, Toshiro; Tawaratsumida, Hiroki; Kawamura, Ichiro; Tominaga, Hiroyuki; Taniguchi, Noboru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthopaed Surg, Kagoshima, Japan; [Nakajima, Masahiro; Ikegawa, Shiro] RIKEN, Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo, Japan; [Taketomi, Eiji] Japanese Red Cross Kagoshima Hosp, Dept Orthopaed Surg, Kagoshima, Japan	Kagoshima University; Kagoshima University; RIKEN	Maeda, S (corresponding author), Kagoshima Univ, Dept Bone & Joint Med, Grad Sch Med & Dent Sci, Kagoshima, Japan.	s-maeda@m3.kufm.kagoshima-u.ac.jp		Maeda, Shingo/0000-0002-2737-3902	Japan Agency for Medical Research and Development [19ek0109223s0403]; Japan Society for the Promotion of Science [18K09111, 17K10933, 20K09482]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Useful suggestions and supports were provided by the Genetic Study Group of the Investigation Committee on the Ossification of Spinal Ligaments. We thank Hui Gao for technical assistance. We thank Eva Lasic, PhD, from Edanz Group (https://jp.edanz.com/ac) for editing a draft of this manuscript. This study was supported by research grants from the Japan Agency for Medical Research and Development (contract no. 19ek0109223s0403) and Japan Society for the Promotion of Science, grant-in-aid for scientific research (C) (contract no. 18K09111, 17K10933, and 20K09482).	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Alvarez J, 2002, DEVELOPMENT, V129, P1913; AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; Bernstein HS, 1998, J BIOL CHEM, V273, P4666, DOI 10.1074/jbc.273.8.4666; Boudrez A, 2000, J BIOL CHEM, V275, P25411, DOI 10.1074/jbc.M001676200; Burns CG, 1999, P NATL ACAD SCI USA, V96, P13789, DOI 10.1073/pnas.96.24.13789; Chen YP, 2011, GENE DEV, V25, P701, DOI 10.1101/gad.2002611; Furushima K, 2002, J BONE MINER RES, V17, P128, DOI 10.1359/jbmr.2002.17.1.128; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; Hamer PCD, 2011, CLIN CANCER RES, V17, P4200, DOI 10.1158/1078-0432.CCR-10-2537; HASHIZUME Y, 1980, ACTA PATHOL JAPON, V30, P255; Hu JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089352; IGARASHI M, 1991, NATURE, V353, P80, DOI 10.1038/353080a0; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Karasugi T, 2013, J BONE MINER METAB, V31, P136, DOI 10.1007/s00774-012-0404-y; Kawamura I, 2012, J BIOL CHEM, V287, P29101, DOI 10.1074/jbc.M112.349415; Kreahling JM, 2012, MOL CANCER THER, V11, P174, DOI 10.1158/1535-7163.MCT-11-0529; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Li J, 2017, CELL PHYSIOL BIOCHEM, V41, P2475, DOI 10.1159/000475916; Li X, 2018, CANCER RES, V78, P4138, DOI 10.1158/0008-5472.CAN-18-0688; Liao CC, 1999, J NEUROSURG, V91, P230, DOI 10.3171/spi.1999.91.2.0230; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115; Maeda S, 2001, J BONE MINER RES, V16, P948, DOI 10.1359/jbmr.2001.16.5.948; Maeda S, 2020, OPLL OSSIFICATION PO, P39; Martin JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095843; Matsunaga S, 2012, SPINE, V37, pE309, DOI 10.1097/BRS.0b013e318241ad33; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; Mizuhashi K, 2018, NATURE, V563, P254, DOI 10.1038/s41586-018-0662-5; Mu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.117; Nakajima M, 2016, AM J HUM GENET, V99, P202, DOI 10.1016/j.ajhg.2016.05.018; Nakajima M, 2014, NAT GENET, V46, P1012, DOI 10.1038/ng.3045; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Qiu HY, 2016, DIGEST DIS SCI, V61, P795, DOI 10.1007/s10620-015-3937-9; Saito M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20622; Sato R, 2007, J NEUROSURG-SPINE, V7, P174, DOI 10.3171/SPI-07/08/174; Sugita D, 2013, SPINE, V38, pE1388, DOI 10.1097/BRS.0b013e3182a40489; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; Zhang CM, 2020, CANCER MED-US, V9, P3500, DOI 10.1002/cam4.2929; Zhang ZW, 2020, J CANCER, V11, P353, DOI 10.7150/jca.32850	46	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100994	10.1016/j.jbc.2021.100994	http://dx.doi.org/10.1016/j.jbc.2021.100994			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34298017	Green Published, gold			2022-12-26	WOS:000690868100007
J	Ramirez-Sagredo, A; Quiroga, C; Garrido-Moreno, V; Lopez-Crisosto, C; Leiva-Navarrete, S; Norambuena-Soto, I; Ortiz-Quintero, J; Diaz-Vesga, MC; Perez, W; Hendrickson, T; Parra, V; Pedrozo, Z; Altamirano, F; Chiong, M; Lavandero, S				Ramirez-Sagredo, Andrea; Quiroga, Clara; Garrido-Moreno, Valeria; Lopez-Crisosto, Camila; Leiva-Navarrete, Sebastian; Norambuena-Soto, Ignacio; Ortiz-Quintero, Jafet; Diaz-Vesga, Magda C.; Perez, William; Hendrickson, Troy; Parra, Valentina; Pedrozo, Zully; Altamirano, Francisco; Chiong, Mario; Lavandero, Sergio			Polycystin-1 regulates cardiomyocyte mitophagy	FASEB JOURNAL			English	Article						cardiomyocyte; FoxO1; mitochondrial dynamics; mitochondrial metabolism; mitophagy; polycystin-1	FOXO TRANSCRIPTION FACTORS; MITOCHONDRIAL DYNAMICS; OXIDATIVE STRESS; HEART; FISSION; AKT; PHOSPHORYLATION; DYSFUNCTION; PATHWAYS; SURVIVAL	Polycystin-1 (PC1) is a transmembrane protein found in different cell types, including cardiomyocytes. Alterations in PC1 expression have been linked to mitochondrial damage in renal tubule cells and in patients with autosomal dominant polycystic kidney disease. However, to date, the regulatory role of PC1 in cardiomyocyte mitochondria is not well understood. The analysis of mitochondrial morphology from cardiomyocytes of heterozygous PC1 mice (PDK1(+/-)) using transmission electron microscopy showed that cardiomyocyte mitochondria were smaller with increased mitochondria density and circularity. These parameters were consistent with mitochondrial fission. We knocked-down PC1 in cultured rat cardiomyocytes and human-induced pluripotent stem cells (iPSC)-derived cardiomyocytes to evaluate mitochondrial function and morphology. The results showed that downregulation of PC1 expression results in reduced protein levels of sub-units of the OXPHOS complexes and less functional mitochondria (reduction of mitochondrial membrane potential, mitochondrial respiration, and ATP production). This mitochondrial dysfunction activates the elimination of defective mitochondria by mitophagy, assessed by an increase of autophagosome adapter protein LC3B and the recruitment of the Parkin protein to the mitochondria. siRNA-mediated PC1 knockdown leads to a loss of the connectivity of the mitochondrial network and a greater number of mitochondria per cell, but of smaller sizes, which characterizes mitochondrial fission. PC1 silencing also deregulates the AKT-FoxO1 signaling pathway, which is involved in the regulation of mitochondrial metabolism, mitochondrial morphology, and processes that are part of cell quality control, such as mitophagy. Together, these data provide new insights about the controls that PC1 exerts on mitochondrial morphology and function in cultured cardiomyocytes dependent on the AKT-FoxO1 signaling pathway.	[Ramirez-Sagredo, Andrea; Garrido-Moreno, Valeria; Lopez-Crisosto, Camila; Leiva-Navarrete, Sebastian; Norambuena-Soto, Ignacio; Ortiz-Quintero, Jafet; Diaz-Vesga, Magda C.; Parra, Valentina; Pedrozo, Zully; Chiong, Mario; Lavandero, Sergio] Univ Chile, Adv Ctr Chron Dis ACCDiS, Fac Ciencias Quim & Farmaceut, Olivos 1007, Santiago 8380492, Chile; [Ramirez-Sagredo, Andrea; Garrido-Moreno, Valeria; Lopez-Crisosto, Camila; Leiva-Navarrete, Sebastian; Norambuena-Soto, Ignacio; Ortiz-Quintero, Jafet; Diaz-Vesga, Magda C.; Parra, Valentina; Pedrozo, Zully; Chiong, Mario; Lavandero, Sergio] Univ Chile, Fac Med, Olivos 1007, Santiago 8380492, Chile; [Quiroga, Clara; Lopez-Crisosto, Camila] Pontificia Univ Catolica Chile, Fac Med, Div Enfermedades Cardiovasc, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Leiva-Navarrete, Sebastian; Parra, Valentina] Univ Chile, Autophagy Res Ctr, Santiago, Chile; [Leiva-Navarrete, Sebastian; Parra, Valentina; Pedrozo, Zully] Univ Chile, Network Study High Lethal Cardiopulm Dis REECPAL, Santiago, Chile; [Ortiz-Quintero, Jafet] Univ Nacl Autonoma Honduras, Dept Bioanal & Inmunol, Escuela Microbiol, Fac Ciencias, Tegucigalpa, Honduras; [Diaz-Vesga, Magda C.; Pedrozo, Zully] Univ Chile, Fac Med, Programa Fisiol & Biofis, ICBM, Santiago, Chile; [Diaz-Vesga, Magda C.] Pontificia Univ Javeriana Cali, Grp Invest Ciencias Basicas & Clin Salud, Cali, Colombia; [Perez, William; Hendrickson, Troy; Altamirano, Francisco] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX USA; [Hendrickson, Troy] Texas A&M Hlth Sci Ctr, Texas A&M MD PhD Program, College Stn, TX USA; [Altamirano, Francisco] Cornell Univ, Dept Cardiothorac Surg, Weill Cornell Med Coll, Ithaca, NY USA; [Lavandero, Sergio] Corp Ctr Estudios Cient Enfermedades Cron CECEC, Santiago, Chile; [Lavandero, Sergio] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX USA	Universidad de Chile; Universidad de Chile; Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad de Chile; Universidad Nacional Autonoma de Honduras; Universidad de Chile; Pontificia Universidad Javeriana; The Methodist Hospital System; The Methodist Hospital - Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Cornell University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lavandero, S (corresponding author), Univ Chile, Adv Ctr Chron Dis ACCDiS, Fac Ciencias Quim & Farmaceut, Olivos 1007, Santiago 8380492, Chile.; Lavandero, S (corresponding author), Univ Chile, Fac Med, Olivos 1007, Santiago 8380492, Chile.	slavander@uchile.cl	Chiong, Mario/I-1043-2013; Parra, Valentina/N-3972-2018	Chiong, Mario/0000-0002-5174-6545; Lopez-Crisosto, Camila/0000-0003-1055-099X; Ramirez Sagredo, Andrea/0000-0003-1081-0704; Garrido Moreno, Valeria Soraya/0000-0002-3298-2622; Diaz Vesga, Magda Carolina/0000-0002-7807-2050; Parra, Valentina/0000-0002-0080-6472; Ortiz-Quintero, Jafet/0000-0001-7656-6367; Quiroga, Clara/0000-0002-0251-4772; Norambuena, Ignacio/0000-0002-2676-2674; Perez, William/0000-0003-0344-4160	Agencia Nacional de Investigacion y Desarrollo (ANID), Chile [FONDECYT 3190546, 1190743, 1200490, 1180613, 3210443, 3210496, FONDAP 15130011, 21191341, 21171588]; International Centre for Genetic Engineering and Biotechnology (ICGEB) [CRP/CHL18-04]; University of Chile grant U-Redes Generacion [VID G_2018-35]; Houston Methodist Start-Up funds	Agencia Nacional de Investigacion y Desarrollo (ANID), Chile; International Centre for Genetic Engineering and Biotechnology (ICGEB); University of Chile grant U-Redes Generacion; Houston Methodist Start-Up funds	The authors thank Gindra Latorre and Fidel Albornoz for their excellent technical support. This work was supported by the Agencia Nacional de Investigacion y Desarrollo (ANID), Chile, Grant/Award Numbers: FONDECYT 3190546, 1190743, 1200490, 1180613, 3210443, 3210496, FONDAP 15130011, and PhD fellowships 21191341 and 21171588; International Centre for Genetic Engineering and Biotechnology (ICGEB), Grant/Award Number: CRP/CHL18-04; University of Chile grant U-Redes Generacion, Grant/Award Number: VID G_2018-35, Houston Methodist Start-Up funds.	Altamirano F, 2019, CIRCULATION, V140, P921, DOI 10.1161/CIRCULATIONAHA.118.034731; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chebib FT, 2017, KIDNEY INT REP, V2, P913, DOI 10.1016/j.ekir.2017.05.014; Chiong M, 2010, APOPTOSIS, V15, P887, DOI 10.1007/s10495-010-0505-9; Cordova-Casanova A, 2018, BBA-MOL CELL RES, V1865, P289, DOI 10.1016/j.bbamcr.2017.11.001; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Di Lisa F, 2006, CARDIOVASC RES, V70, P191, DOI 10.1016/j.cardiores.2006.01.016; Galvez A, 2001, CELL TISSUE RES, V304, P279, DOI 10.1007/s004410100358; Hong TT, 2014, NAT MED, V20, P624, DOI 10.1038/nm.3543; Huang CY, 2018, J MOL CELL CARDIOL, V122, P58, DOI 10.1016/j.yjmcc.2018.08.006; Ishimoto Y, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00337-17; Jasova M, 2017, J BIOENERG BIOMEMBR, V49, P357, DOI 10.1007/s10863-017-9720-1; Klawitter J, 2014, AM J PHYSIOL-RENAL, V307, pF1198, DOI 10.1152/ajprenal.00327.2014; Kubli DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130707; Li W, 2017, ENDOCRINOLOGY, V158, P2155, DOI 10.1210/en.2016-1970; Lin CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20856-6; MANGOOKARIM R, 1989, FASEB J, V3, P2629, DOI 10.1096/fasebj.3.14.2480260; Marin-Garcia J, 2016, HEART FAIL REV, V21, P123, DOI 10.1007/s10741-016-9530-2; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Menezes LF, 2016, EBIOMEDICINE, V5, P183, DOI 10.1016/j.ebiom.2016.01.027; Menezes LF, 2019, NAT REV NEPHROL, V15, P736, DOI 10.1038/s41581-019-0183-y; Menon V, 2011, CLIN J AM SOC NEPHRO, V6, P7, DOI 10.2215/CJN.04140510; Morales PE, 2020, MOL ASPECTS MED, V71, DOI 10.1016/j.mam.2019.09.006; Munoz JP, 2010, FREE RADICAL BIO MED, V48, P526, DOI 10.1016/j.freeradbiomed.2009.11.017; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nguyen TN, 2016, TRENDS CELL BIOL, V26, P733, DOI 10.1016/j.tcb.2016.05.008; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Ning YZ, 2015, J TOXICOL SCI, V40, P637, DOI 10.2131/jts.40.637; Padovano V, 2017, MOL BIOL CELL, V28, P261, DOI 10.1091/mbc.E16-08-0597; Parra V, 2018, CIRC RES, V122, pE20, DOI 10.1161/CIRCRESAHA.117.311522; Parra V, 2014, DIABETES, V63, P75, DOI 10.2337/db13-0340; Pedrozo Z, 2015, CIRCULATION, V131, P2131, DOI 10.1161/CIRCULATIONAHA.114.013537; Pennanen C, 2014, J CELL SCI, V127, P2659, DOI 10.1242/jcs.139394; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Pryde KR, 2016, J CELL BIOL, V213, P163, DOI 10.1083/jcb.201509003; Puri R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11636-5; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rowe I, 2013, NAT MED, V19, P488, DOI 10.1038/nm.3092; Sanchez AMJ, 2014, CELL MOL LIFE SCI, V71, P1657, DOI 10.1007/s00018-013-1513-z; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Shi YD, 2018, BBA-MOL BASIS DIS, V1864, P2481, DOI 10.1016/j.bbadis.2018.04.005; Stiles BL, 2009, ADV DRUG DELIVER REV, V61, P1276, DOI 10.1016/j.addr.2009.07.017; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Trotta AP, 2017, CELL MOL LIFE SCI, V74, P1999, DOI 10.1007/s00018-016-2451-3; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wallace DP, 2011, BBA-MOL BASIS DIS, V1812, P1291, DOI 10.1016/j.bbadis.2010.11.005; Wang D, 2020, BRIT J PHARMACOL, V177, P432, DOI 10.1111/bph.14878; Yang MJ, 2019, BBA-MOL BASIS DIS, V1865, P2293, DOI 10.1016/j.bbadis.2019.05.007; Yoo SM, 2018, MOL CELLS, V41, P18, DOI 10.14348/molcells.2018.2277; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	55	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21796	10.1096/fj.202002598R	http://dx.doi.org/10.1096/fj.202002598R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34324238	hybrid			2022-12-26	WOS:000678975300004
J	Tsinman, TK; Jiang, X; Han, L; Koyama, E; Mauck, RL; Dyment, NA				Tsinman, Tonia K.; Jiang, Xi; Han, Lin; Koyama, Eiki; Mauck, Robert L.; Dyment, Nathaniel A.			Intrinsic and growth-mediated cell and matrix specialization during murine meniscus tissue assembly	FASEB JOURNAL			English	Article						extracellular matrix; growth; mechanobiology; meniscus	HUMAN KNEE MENISCI; GENE-EXPRESSION; OSTEOARTHRITIS DEVELOPMENT; REGIONAL-VARIATIONS; LAPINE MENISCI; COLLAGEN; JOINT; MATURATION; AGGRECAN; FIBROCARTILAGE	The incredible mechanical strength and durability of mature fibrous tissues and their extremely limited turnover and regenerative capacity underscores the importance of proper matrix assembly during early postnatal growth. In tissues with composite extracellular matrix (ECM) structures, such as the adult knee meniscus, fibrous (Collagen-I rich), and cartilaginous (Collagen-II, proteoglycan-rich) matrix components are regionally segregated to the outer and inner portions of the tissue, respectively. While this spatial variation in composition is appreciated to be functionally important for resisting complex mechanical loads associated with gait, the establishment of these specialized zones is poorly understood. To address this issue, the following study tracked the growth of the murine meniscus from its embryonic formation through its first month of growth, encompassing the critical time-window during which animals begin to ambulate and weight bear. Using histological analysis, region specific high-throughput qPCR, and Col-1, and Col-2 fluorescent reporter mice, we found that matrix and cellular features defining specific tissue zones were already present at birth, before continuous weight-bearing had occurred. These differences in meniscus zones were further refined with postnatal growth and maturation, resulting in specialization of mature tissue regions. Taken together, this work establishes a detailed timeline of the concurrent spatiotemporal changes that occur at both the cellular and matrix level throughout meniscus maturation. The findings of this study provide a framework for investigating the reciprocal feedback between cells and their evolving microenvironments during assembly of a mechanically robust fibrocartilage tissue, thus providing insight into mechanisms of tissue degeneration and effective regenerative strategies.	[Tsinman, Tonia K.; Jiang, Xi; Mauck, Robert L.; Dyment, Nathaniel A.] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, McKay Orthopaed Res Lab, 371 Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA; [Tsinman, Tonia K.; Jiang, Xi; Mauck, Robert L.; Dyment, Nathaniel A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Tsinman, Tonia K.; Mauck, Robert L.] Corporal Michael Crescenz VA Med Ctr, Translat Musculoskeletal Res Ctr, Philadelphia, PA USA; [Han, Lin] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA; [Koyama, Eiki] Childrens Hosp Philadelphia, Translat Res Program Pediat Orthopaed, Dept Surg, Div Orthopaed Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Drexel University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Mauck, RL; Dyment, NA (corresponding author), Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, McKay Orthopaed Res Lab, 371 Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA.	lemauck@pennmedicine.upenn.edu; dyment@pennmedicine.upenn.edu	Han, Lin/D-2602-2014	Han, Lin/0000-0003-4180-1288; Tsinman, Tonia/0000-0002-9150-4321	U.S. Department of Veterans Affairs (VA) [IK6 RX003416]; National Science Foundation (NSF) [CMMI-1548571]; HHS \ National Institutes of Health (NIH) [R01 AR075418, R00 AR067283, P30 AR069619]	U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); National Science Foundation (NSF)(National Science Foundation (NSF)); HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	U.S. Department of Veterans Affairs (VA), Grant/Award Number: IK6 RX003416; National Science Foundation (NSF), Grant/Award Number: CMMI--1548571; HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: R01 AR075418, R00 AR067283 and P30 AR069619	Llacua LA, 2018, DIABETOLOGIA, V61, P1261, DOI 10.1007/s00125-017-4524-8; Andrews SHJ, 2017, CONNECT TISSUE RES, V58, P271, DOI 10.1080/03008207.2017.1303489; Andrews SHJ, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-21; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Caceres MD, 2018, STEM CELLS DEV, V27, P1161, DOI 10.1089/scd.2018.0121; Chevrier A, 2009, J ORTHOP RES, V27, P1197, DOI 10.1002/jor.20869; Chokalingam K, 2009, TISSUE ENG PT A, V15, P2807, DOI 10.1089/ten.TEA.2008.0560; Clark AL, 2010, ARTHRITIS RHEUM-US, V62, P2973, DOI 10.1002/art.27624; CLARK CR, 1983, J BONE JOINT SURG AM, V65, P538, DOI 10.2106/00004623-198365040-00018; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Di Giancamillo A, 2014, J CELL MOL MED, V18, P1964, DOI 10.1111/jcmm.12367; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Dyment NA, 2016, JOVE-J VIS EXP, DOI 10.3791/54468; Dyment NA, 2015, DEV BIOL, V405, P96, DOI 10.1016/j.ydbio.2015.06.020; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fox AJS, 2012, SPORTS HEALTH, V4, P340, DOI 10.1177/1941738111429419; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; Gamer LW, 2018, J BONE MINER RES, V33, P1708, DOI 10.1002/jbmr.3441; Gamer LW, 2017, J ORTHOP RES, V35, P1683, DOI 10.1002/jor.23446; Gamer LW, 2017, CONNECT TISSUE RES, V58, P238, DOI 10.1080/03008207.2016.1271797; Grinstein M, 2019, ELIFE, V8, DOI 10.7554/eLife.48689; Han WM, 2016, NAT MATER, V15, P477, DOI [10.1038/NMAT4520, 10.1038/nmat4520]; Hyde G, 2008, J ANAT, V213, P531, DOI 10.1111/j.1469-7580.2008.00966.x; Ionescu LC, 2011, TISSUE ENG PT A, V17, P193, DOI [10.1089/ten.tea.2010.0272, 10.1089/ten.TEA.2010.0272]; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kambic HE, 2005, J ORTHOP RES, V23, P142, DOI 10.1016/j.orthres.2004.06.016; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Killian ML, 2010, ANAT REC, V293, P1991, DOI 10.1002/ar.21296; Koyama E, 2021, J BONE MINER RES, V36, P1387, DOI 10.1002/jbmr.4291; Kumar A, 2017, DEVELOPMENT, V144, P4261, DOI 10.1242/dev.158469; Kwok J, 2016, OSTEOARTHR CARTILAGE, V24, P709, DOI 10.1016/j.joca.2015.11.006; Le Graverand MPH, 2001, J ANAT, V198, P525, DOI 10.1046/j.1469-7580.2000.19850525.x; Le Graverand MPH, 2001, OSTEOARTHR CARTILAGE, V9, P56, DOI 10.1053/joca.2000.0350; Le Graverand MPH, 2001, ARTHRITIS RHEUM, V44, P1808, DOI 10.1002/1529-0131(200108)44:8<1808::AID-ART318>3.0.CO;2-B; Le Graverand MPH, 2001, OSTEOARTHR CARTILAGE, V9, P65, DOI 10.1053/joca.2000.0351; Li Q, 2017, ACTA BIOMATER, V54, P356, DOI 10.1016/j.actbio.2017.02.043; Li Q, 2015, J BIOMECH, V48, P1364, DOI 10.1016/j.jbiomech.2015.02.064; Liu WJ, 2010, MOL CELL BIOL, V30, P4797, DOI 10.1128/MCB.00207-10; Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037; Malarkey DE, 2005, TOXICOL PATHOL, V33, P27, DOI 10.1080/01926230590881826; Maye P, 2011, GENESIS, V49, P410, DOI 10.1002/dvg.20733; McNulty AL, 2015, J BIOMECH, V48, P1469, DOI 10.1016/j.jbiomech.2015.02.008; Melrose J, 2005, HISTOCHEM CELL BIOL, V124, P225, DOI 10.1007/s00418-005-0005-0; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mikic B, 2000, J REHABIL RES DEV, V37, P127; Pauli C, 2011, OSTEOARTHR CARTILAGE, V19, P1132, DOI 10.1016/j.joca.2011.05.008; Pazin DE, 2014, J ORTHOP RES, V32, P46, DOI 10.1002/jor.22490; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Qu FN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21212-4; Roughley Peter J, 2014, J Exp Orthop, V1, P8, DOI 10.1186/s40634-014-0008-7; Sanchez-Adams J, 2013, J ORTHOP RES, V31, P1218, DOI 10.1002/jor.22362; Sanchez-Adams J, 2012, BIOMECH MODEL MECHAN, V11, P1047, DOI 10.1007/s10237-012-0372-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Screen HRC, 2015, J ORTHOP RES, V33, P793, DOI 10.1002/jor.22818; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Shwartz Y, 2016, CELL REP, V15, P2577, DOI 10.1016/j.celrep.2016.05.055; Smith SM, 2010, HISTOCHEM CELL BIOL, V134, P251, DOI 10.1007/s00418-010-0730-x; Son M, 2012, EUR CELLS MATER, V23, P195, DOI 10.22203/eCM.v023a15; Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161; Utreja A, 2016, OSTEOARTHR CARTILAGE, V24, P335, DOI 10.1016/j.joca.2015.08.010; Valiyaveettil M, 2005, CONNECT TISSUE RES, V46, P83, DOI 10.1080/03008200590954113; Vanderploeg EJ, 2012, J ANAT, V221, P174, DOI 10.1111/j.1469-7580.2012.01523.x; Wilusz RE, 2014, MATRIX BIOL, V39, P25, DOI 10.1016/j.matbio.2014.08.009	65	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21779	10.1096/fj.202100499R	http://dx.doi.org/10.1096/fj.202100499R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314047	Green Accepted			2022-12-26	WOS:000678975300035
J	Bista, B; Dhimal, M; Bhattarai, S; Neupane, T; Xu, YY; Pandey, AR; Townsend, N; Gyanwali, P; Jha, AK				Bista, Bihungum; Dhimal, Meghnath; Bhattarai, Saroj; Neupane, Tamanna; Xu, Yvonne Yiru; Pandey, Achyut Raj; Townsend, Nick; Gyanwali, Pradip; Jha, Anjani Kumar			Prevalence of non-communicable diseases risk factors and their determinants: Results from STEPS survey 2019, Nepal	PLOS ONE			English	Article							GENDER-DIFFERENCES; GLUCOSE-TRANSPORT; ALTITUDE; OBESITY	Background The World Health Organization (WHO) recommends ongoing surveillance of non-communicable diseases (NCDs) and their risk factors, using the WHO STEPwise approach to surveillance (STEPS). The aim of this study was to assess the distribution and determinants of NCD risk factors in Nepal, a low-income country, in which two-thirds (66%) of annual deaths are attributable to NCDs. Methods A nationally representative NCD risk factors STEPS survey (instrument version 3.2), was conducted between February and May 2019, among 6,475 eligible participants of age 15-69 years sampled from all 7 provinces through multistage sampling process. Data collection involved assessment of behavioral and biochemical risk factors. Complex survey analysis was completed in STATA 15, along with Poisson regression modelling to examine associations between covariates and risk factor prevalence. Results The most prevalent risk factor was consumption of less than five servings of fruit and vegetables a day (97%; 95% CI: 94.3-98.0). Out of total participants, 17% (95% CI: 15.1-19.1) were current smoker, 6.8% (95% CI: 5.3-8.2) were consuming >= 60g/month alcohol per month and 7.4% (95% CI:5.7-10.1) were having low level of physical activity. Approximately, 24.3% (95% CI: 21.6-27.2) were overweight or obese (BMI >= 25kg/m(2)) while 24.5% (95% CI: 22.4-26.7) and 5.8% (95% CI: 4.3-7.3) had raised blood pressure (BP) and raised blood glucose respectively. Similarly, the prevalence of raised total cholesterol was 11% (95% CI: 9.6-12.6). Sex and education level of participants were statistically associated with smoking, harmful alcohol use and raised BP. Participants of age 30-44 years and 45-69 years were found to have increased risk of overweight, raised BP, raised blood sugar and raised blood cholesterol. Similarly, participants in richest wealth quintile had higher odds of insufficient physical inactivity, overweight and raised blood cholesterol. On average, each participant had 2 NCD related risk factors (2.04, 95% CI: 2.02-2.08). Conclusion A large portion of the Nepalese population are living with a variety of NCD risk factors. These surveillance data should be used to support and monitor province specific NCD prevention and control interventions throughout Nepal, supported by a multi-sectoral national coordination mechanism.	[Bista, Bihungum; Dhimal, Meghnath; Bhattarai, Saroj; Neupane, Tamanna; Pandey, Achyut Raj; Gyanwali, Pradip; Jha, Anjani Kumar] Nepal Hlth Res Council, Kathmandu, Nepal; [Xu, Yvonne Yiru] WHO, South East Asia Reg Off, New Delhi, India; [Townsend, Nick] Univ Bath, Dept Hlth, Bath, Avon, England	World Health Organization; University of Bath	Dhimal, M (corresponding author), Nepal Hlth Res Council, Kathmandu, Nepal.	meghdhimal@gmail.com	Dhimal, Meghnath/AAD-7261-2021	Dhimal, Meghnath/0000-0001-7176-7821; Gyanwali, Pradip/0000-0001-8609-6717; Pandey, Achyut Raj/0000-0002-1037-1273; Bhattarai, Saroj/0000-0003-1932-8236; Townsend, Nick/0000-0001-9890-0901	Government of Nepal; World Health Organization	Government of Nepal; World Health Organization(World Health Organization)	This survey was funded by the Government of Nepal and the World Health Organization.	Ahmed SM, 2009, GLOBAL HEALTH ACTION, V2, P68, DOI 10.3402/gha.v2i0.1986; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; CARTEE GD, 1991, J APPL PHYSIOL, V70, P1593, DOI 10.1152/jappl.1991.70.4.1593; Castillo O, 2007, HIGH ALT MED BIOL, V8, P307, DOI 10.1089/ham.2007.8407; Central Bureau of Statistics, 2011, NEP LIV STAND SURV 2; Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002; Commar A., 2018, WHO GLOBAL REPORT TR; Dhimal M, 2020, REPORT NONCOMMUNICAB; Dhimal Meghnath, 2019, J Nepal Health Res Counc, V17, P394, DOI 10.33314/jnhrc.v17i3.2327; Government of Nepal, 2014, MULT ACT PLAN PREV C; Gupta R, 2006, INT J CARDIOL, V108, P291, DOI 10.1016/j.ijcard.2005.05.044; Hanewinkel R, 2007, AM J PREV MED, V32, P466, DOI 10.1016/j.amepre.2007.02.025; Hasan M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198028; Indian Council of Medical Research Public Health Foundation of India and Institute for Health Metrics and Evaluation, 2017, IND HLTH NAT STAT IN; Jayawardena R, 2013, OBESITY FACTS, V6, P405, DOI 10.1159/000355598; Kanter R, 2012, ADV NUTR, V3, P491, DOI 10.3945/an.112.002063; Karmacharya B M, 2018, Kathmandu Univ Med J (KUMJ), V16, P83; Khuwaja AK, 2010, CHRONIC ILLN, V6, P163, DOI 10.1177/1742395309352255; Ministry of Health Nepal and Population New ERA ICF, 2017, NEP DEM HLTH SURV 20; Ministy of Health World Health Organization, 2014, NAT SURV NONC DIS RI; Nepal Health Research Council (NHRC) Ministry of Health and Population(MoHP) Monitoring Evaluation and Operational Research (MEOR), 2019, NEP BURD DIS 2017 CO; Nepali S, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-020-01710-y; Organization WH, 2018, NONCOMMUNICABLE DIS; Pachankis JE, 2011, J CONSULT CLIN PSYCH, V79, P142, DOI 10.1037/a0022917; Pedisic Z, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7215-1; Pelzom D, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4989-x; Poudel A, 2008, Y G WHO STEPS SURVEI; Pradhan PMS., 2015, TOB CONTROL; Reynolds TH, 1997, AM J PHYSIOL-ENDOC M, V272, pE320, DOI 10.1152/ajpendo.1997.272.2.E320; Sandberg K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-7; Shrestha N, 2020, HLTH SYSTEM PREPARED; Shrestha N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39635-y; Sreeramareddy CT, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0022-0; Thapa N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152535; Uranga Romina M, 2010, Curr Gerontol Geriatr Res, P219683, DOI 10.1155/2010/219683; Vitale C, 2010, FUND CLIN PHARMACOL, V24, P675, DOI 10.1111/j.1472-8206.2010.00817.x; Wang Y, 2006, J HUM HYPERTENS, V20, P898, DOI 10.1038/sj.jhh.1002086; WHO, 2017, GLOBAL ADULT TOBACCO; WHO, 2018, GLOB HLTH EST 2019 D; WHO, 2016, GLOB REP PSOR; Woolcott OO, 2014, OBESITY, V22, P2080, DOI 10.1002/oby.20800; WOrld Health Organization, 2020, NONC DIS WHO; World Health Organization, 2018, WHO STEPS SURV MAN 2; World Health Organization, 2011, NONC DIS GLOB MON FR; World Health Organization, 2020, STEPS INSTR SUPP MAT; World Health Organization, 2014, NONC DIS COUNTR PROF; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zaman MM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1938-4	49	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0253605	10.1371/journal.pone.0253605	http://dx.doi.org/10.1371/journal.pone.0253605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329300	gold, Green Published			2022-12-26	WOS:000685248600034
J	Arambepola, C; Wickramasinghe, ND; Jayakody, S; Hewage, SA; Wijewickrema, A; Gunawardena, N; Dhanapala, S; Prathapan, S				Arambepola, Carukshi; Wickramasinghe, Nuwan Darshana; Jayakody, Surangi; Hewage, Sumudu Avanthi; Wijewickrema, Ananda; Gunawardena, Nalika; Dhanapala, Sapumal; Prathapan, Shamini			Sri Lanka's early success in the containment of COVID-19 through its rapid response: Clinical & epidemiological evidence from the initial case series	PLOS ONE			English	Article								Background Despite the rising global burden, Sri Lanka reported a relatively low caseload and mortality (13 deaths as of 20 October 2020) for COVID-19. This warrants exploration of the clinical and epidemiological characteristics of the case series during the initial passive case detection phase in Sri Lanka, in order to understand the success in containment of the disease for more than nine months in the country through its initial early and rapid pandemic response. Methods A retrospective study was conducted using secondary data (hospital records and investigation reports) extracted from all laboratory-confirmed patients admitted to the three main state-sector hospitals in Sri Lanka from 11 March to 7 April 2020. Clinical outcomes were categorized as mild, severe and critical, as per the international classification. Kruskal-Wallis H, Mann Whitney U and Fisher's exact tests compared differences between the variables. Results The case series comprised 146 live discharges and six deaths. Majority were males (63.2%); mean age of 40.9 (SD = 17.9); and symptomatic (72.4%). Sixty-one (40.1%) had co-morbidities, the commonest being diabetes (20.4%) and hypertension (17.8%). Mild (93.4%), severe (2.6%) and critical (4.0%) disease outcomes were noted. Disease severity was significantly higher with older age (p = 0.037), co-morbidities (p = 0.026); and higher white-cell (p = 0.045) and lymphocyte (p = 0.043) counts; but not with being symptomatic (p = 0.683). The commonest symptoms were fever (62.5%), dry cough (48.0%) and sore throat (26.9%). The median duration (IQR) was 3.0 (1.0-5.0) and 18.0 (15.0-29.5) days, respectively before and during hospitalization. Conclusions In contrast to high-risk countries, the younger age, milder disease and low mortality observed in local patients during the initial phase of the pandemic, reflect the early success in containment of the pandemic in Sri Lanka. However, once the disease becomes severe, the factors determining disease fatality remain the same as in other countries. This highlights the value of establishing strong public health systems and disease surveillance in a country, which could provide long-term effects on disease control.	[Arambepola, Carukshi] Univ Colombo, Dept Community Med, Fac Med, Colombo, Sri Lanka; [Wickramasinghe, Nuwan Darshana] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Community Med, Anuradhapura, Sri Lanka; [Jayakody, Surangi; Prathapan, Shamini] Univ Sri Jayewardenepura, Dept Community Med, Fac Med Sci, Nugegoda, Sri Lanka; [Hewage, Sumudu Avanthi] Minist Hlth & Indigenous Med Serv, Colombo, Sri Lanka; [Gunawardena, Nalika] Natl Inst Infect Dis, Angoda, Sri Lanka; [Gunawardena, Nalika; Dhanapala, Sapumal] World Hlth Org, Country Off, Colombo, Sri Lanka	University of Colombo; Rajarata University of Sri Lanka; University Sri Jayewardenepura; World Health Organization	Arambepola, C (corresponding author), Univ Colombo, Dept Community Med, Fac Med, Colombo, Sri Lanka.	carukshi@commed.cmb.ac.lk	Hewage, Sumudu Avanthi/H-9218-2017; Wickramasinghe, Nuwan Darshana/I-3578-2019	Hewage, Sumudu Avanthi/0000-0001-8079-4338; Wickramasinghe, Nuwan Darshana/0000-0001-6025-6022				Epidemiology Unit, 2020, COV 19 LAB TEST STRA; Epidemiology Unit, 2020, COV 19 REL CIR GUID; Epidemiology Unit, 2020, NOV COR 2019 NCOV S; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; International Severe Acute Respiratory and Emerging Consortium (ISARIC), 2020, COV 19 REP 8 APR 202; Ministry of Health, 2018, ESS HLTH SERV PACK E, P10; Ministry of Health, ANN HLTH B 2018, V2021, P105; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; The College of Community Physicians in Sri Lanka (CCPSL), 2020, JCCPSL, V26, P56, DOI [10.4038/jccpsl.v26i1.8311, DOI 10.4038/JCCPSL.V26I1.8311]; WHO, 2020, WHO COR COVID 19 DAS; World Health Organization, 2020, ROLL UPD COR DIS COV; World Health Organization, 2020, COR DIS COV 19 TECHN; Worldometer 2020, 2020, COR COV 19; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017	16	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255394	10.1371/journal.pone.0255394	http://dx.doi.org/10.1371/journal.pone.0255394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324587	Green Published, gold			2022-12-26	WOS:000685248200078
J	Raines, KS; Doniach, S; Bhanot, G				Raines, Kevin S.; Doniach, Sebastian; Bhanot, Gyan			The transmission of SARS-CoV-2 is likely comodulated by temperature and by relative humidity	PLOS ONE			English	Article							INFLUENZA; WEATHER; VIRUSES	Inferring the impact of climate upon the transmission of SARS-CoV-2 has been confounded by variability in testing, unknown disease introduction rates, and changing weather. Here we present a data model that accounts for dynamic testing rates and variations in disease introduction rates. We apply this model to data from Colombia, whose varied and seasonless climate, central port of entry, and swift, centralized response to the COVID-19 pandemic present an opportune environment for assessing the impact of climate factors on the spread of COVID-19. We observe strong attenuation of transmission in climates with sustained daily temperatures above 30 degrees Celsius and simultaneous mean relative humidity below 78%, with outbreaks occurring at high humidity even where the temperature is high. We hypothesize that temperature and relative humidity comodulate the infectivity of SARS-CoV-2 within respiratory droplets.	[Raines, Kevin S.] Cra 13 9aN 58, Armenia, Quindio, Armenia; [Doniach, Sebastian] Stanford Univ, Appl Phys, Stanford, CA 94305 USA; [Bhanot, Gyan] Rutgers State Univ, Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Bhanot, Gyan] Rutgers State Univ, Phys & Astron, Piscataway, NJ 08854 USA; [Bhanot, Gyan] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08854 USA; [Bhanot, Gyan] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	Stanford University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of California System; University of California San Diego	Bhanot, G (corresponding author), Rutgers State Univ, Mol Biol & Biochem, Piscataway, NJ 08854 USA.; Bhanot, G (corresponding author), Rutgers State Univ, Phys & Astron, Piscataway, NJ 08854 USA.; Bhanot, G (corresponding author), Rutgers Canc Inst New Jersey, New Brunswick, NJ 08854 USA.; Bhanot, G (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.	gyanbhanot@gmail.com			Department of Defense/Kidney Cancer Research Program (KCRP) [KC180159]; National Institute of Health/National Cancer Institute [1R01CA243547-01A1]	Department of Defense/Kidney Cancer Research Program (KCRP); National Institute of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	GB M2GEN/ORIEN https://www.m2gen.com/https://www.oriencancer.org/GB the Department of Defense/Kidney Cancer Research Program (KCRP) KC180159 https://cdmrp.army.mil/kcrp/default GB National Institute of Health/National Cancer Institute 1R01CA243547-01A1 https://www.cancer.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeronautica Civil de Colombia, 2019, B EST EN 2019 TRAD A; [Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2020, WORLD WEATHER ONLINE; Arana P, 2014, TRANSPORT RES A-POL, V59, P1, DOI 10.1016/j.tra.2013.10.019; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bocker L, 2016, TRANSPORT RES A-POL, V94, P360, DOI 10.1016/j.tra.2016.09.021; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Chan K, 2011, ADV OPTOELECTRON, V2011, DOI [10.1155/2011/734690, 10.1155/2011/196707]; Chen SC, 2009, INDOOR AIR, V19, P401, DOI 10.1111/j.1600-0668.2009.00603.x; Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI [10.1016/S2666-5247(20)30003-3, 10.1016/S2666-5247(20)30095-1]; Cools M, 2010, TRANSPORT RES REC, P22, DOI 10.3141/2157-03; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Halloran SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037088; HEMMES JH, 1960, NATURE, V188, P430, DOI 10.1038/188430a0; Herfst S, 2017, CURR OPIN VIROL, V22, P22, DOI 10.1016/j.coviro.2016.11.006; Kutter JS, 2018, CURR OPIN VIROL, V28, P142, DOI 10.1016/j.coviro.2018.01.001; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Lassauniere R., 2020, PREPRINT, DOI [10.1101/2020.04.09.20056325, DOI 10.1101/2020.04.09.20056325]; Leung C, 2020, INFECT CONT HOSP EP, V41, P594, DOI 10.1017/ice.2020.81; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Lin KS, 2020, ENVIRON SCI TECHNOL, V54, P1024, DOI 10.1021/acs.est.9b04959; Liu CX, 2014, J TRANSP GEOGR, V39, P36, DOI 10.1016/j.jtrangeo.2014.06.019; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Lowen Anice, 2009, PLoS Curr, V1, pRRN1002; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Marr LC, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2018.0298; Moovit, 2020, PUBL TRANS IND; Ortiz O, 2010, APPL ENERG, V87, P673, DOI 10.1016/j.apenergy.2009.08.002; Otoya-Tono AM, 2020, ACTA OTORRINOLARINGO, P4; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; Prussin AJ, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00551-18; Shao WJ, 2021, ENVIRON RES, V194, DOI 10.1016/j.envres.2020.110608; Tan JG, 2005, J EPIDEMIOL COMMUN H, V59, P186, DOI 10.1136/jech.2004.020180; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; Tanne JH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1090; WALKER JE, 1961, AM J MED, V30, P259, DOI 10.1016/0002-9343(61)90097-3; WHO, 2020, COR DIS 2019 COVID 1, P51; Yang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046789; Yang W, 2012, APPL ENVIRON MICROB, V78, P6781, DOI 10.1128/AEM.01658-12; Zhang L, 2012, BUILD ENVIRON, V47, P58, DOI 10.1016/j.buildenv.2011.03.015	41	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255212	10.1371/journal.pone.0255212	http://dx.doi.org/10.1371/journal.pone.0255212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324570	gold, Green Submitted, Green Published			2022-12-26	WOS:000685248200054
J	Raspopovic, ED; Meissner, W; Zaslansky, R; Kadija, M; Vujadinovic, ST; Tulic, G				Dubljanin Raspopovic, Emilija; Meissner, Winfried; Zaslansky, Ruth; Kadija, Marko; Tomanovic Vujadinovic, Sanja; Tulic, Goran			Associations between early postoperative pain outcome measures and late functional outcomes in patients after knee arthroplasty	PLOS ONE			English	Article							LOCAL INFILTRATION ANALGESIA; INTRATHECAL MORPHINE; MANAGEMENT; SURGERY; INTENSITY; RECOVERY; BLOCK	Introduction/Aim Early rehabilitation, return to daily life activities and function are the ultimate goals of perioperative care. It is unclear which pain-related patient-reported outcome measures (PROM) mirror treatment effects or are related with early and late functional outcomes. Methods We examined associations between two approaches of pain management (scheduled vs 'on demand') and PROMs on post-operative days one and five (POD1, 5) with function on POD5 and 3 months after surgery in patients undergoing Total Knee Arthroplasty (TKA) in a single centre. The scheduled pain management consisted of pain assessment and routine administration of non-opioid drugs, and a weak opioid based on severity of pain reported by patients. The 'on demand' group received non-opioids and/or a weak opioid only when asking 'on demand' for analgesics. Results On POD1, patients in the scheduled treatment group reported reduced severity of worst pain, less interference of pain with activities in-bed and sleep, and a higher proportion got out of bed. On POD5, these patients reported as well significantly less worst pain, spent significantly less time in severe pain, experienced less interference of pain with activities in bed, and felt less helpless. Furthermore, tests of function, extension and flexion ranges, Barthel index and 6 minutes walking test on POD5, and the Knee Injury and Osteoarthritis Outcome Score (KOOS) 3 months later were significantly better in the scheduled treatment group compared to the 'on demand' treatment group. Pain related PROMs assessed at POD1 and especially at POD5 are associated with better knee range of motion, better performance in activities of daily living, and faster gait speed, as well as less pain, better performance in activities of daily living, as well as higher knee-related quality of life 3 months postoperatively. Conclusions Our study demonstrates that severe postoperative pain after TKA might have long lasting consequences, and even small improvements in treatment, although being far from optimal, are accompanied by improved outcomes.	[Dubljanin Raspopovic, Emilija; Tomanovic Vujadinovic, Sanja] Clin Ctr Serbia, Clin Phys Med & Rehabil, Belgrade, Serbia; [Dubljanin Raspopovic, Emilija; Kadija, Marko; Tomanovic Vujadinovic, Sanja; Tulic, Goran] Univ Belgrade, Fac Med, Belgrade, Serbia; [Meissner, Winfried; Zaslansky, Ruth] Jena Univ Hosp, Dept Anesthesiol & Intens Care, Jena, Germany; [Kadija, Marko; Tulic, Goran] Clin Ctr Serbia, Clin Orthopaed Surg & Traumatol, Belgrade, Serbia	Clinical Centre of Serbia; University of Belgrade; Friedrich Schiller University of Jena; Clinical Centre of Serbia	Raspopovic, ED (corresponding author), Clin Ctr Serbia, Clin Phys Med & Rehabil, Belgrade, Serbia.; Raspopovic, ED (corresponding author), Univ Belgrade, Fac Med, Belgrade, Serbia.	edubljaninraspopovic@gmail.com		Tulic, Goran/0000-0002-4988-341X				Biswas A, 2018, REGION ANESTH PAIN M, V43, P154, DOI 10.1097/AAP.0000000000000724; Bugada D, 2017, EUR J ANAESTH, V34, P665, DOI 10.1097/EJA.0000000000000656; Busch CA, 2006, J BONE JOINT SURG AM, V88A, P959, DOI 10.2106/JBJS.E.00344; Carli F, 2010, BRIT J ANAESTH, V105, P185, DOI 10.1093/bja/aeq112; Chapman C Richard, 2013, J Pain Palliat Care Pharmacother, V27, P350, DOI 10.3109/15360288.2013.846955; Essving P, 2010, ACTA ORTHOP, V81, P354, DOI 10.3109/17453674.2010.487241; Fletcher D, 2015, EUR J ANAESTH, V32, P725, DOI 10.1097/EJA.0000000000000319; Foadi N, 2017, J PAIN RES, V10, P1059, DOI 10.2147/JPR.S135142; Gerbershagen HJ, 2013, ANESTHESIOLOGY, V118, P934, DOI 10.1097/ALN.0b013e31828866b3; Kosse NM, 2018, KNEE SURG SPORT TR A, V26, P1792, DOI 10.1007/s00167-017-4792-3; Kovalak E, 2015, ACTA ORTHOP TRAUMATO, V49, P260, DOI 10.3944/AOTT.2015.14.0263; MAHONEY F I, 1965, Md State Med J, V14, P61; Meissner W, 2015, CURR MED RES OPIN, V31, P2131, DOI 10.1185/03007995.2015.1092122; Nerhus TK, 2010, ACTA ORTHOP, V81, P727, DOI 10.3109/17453674.2010.533929; Parvataneni HK, 2007, J ARTHROPLASTY, V22, P33, DOI 10.1016/j.arth.2007.03.034; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Rothaug J, 2013, J PAIN, V14, P1361, DOI 10.1016/j.jpain.2013.05.016; van Boekel RLM, 2019, ANN SURG, V269, P856, DOI 10.1097/SLA.0000000000002583; Zinkus J, 2017, MED SCI MONITOR, V23, P3019, DOI 10.12659/MSM.899320	19	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0253147	10.1371/journal.pone.0253147	http://dx.doi.org/10.1371/journal.pone.0253147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320012	gold, Green Published			2022-12-26	WOS:000685247800019
J	Fujiwara, K; Abe, A; Masatsugu, T; Hirano, T; Hiraka, K; Sada, M				Fujiwara, Kenji; Abe, Atsushi; Masatsugu, Toshihiro; Hirano, Tatsuya; Hiraka, Kiyohisa; Sada, Masayuki			Usefulness of several factors and clinical scoring models in preoperative diagnosis of complicated appendicitis	PLOS ONE			English	Article							APPENDECTOMY; MANAGEMENT	Background The preoperative distinction between uncomplicated and complicated appendicitis is important to determine the appropriate treatments, such as antibiotics, surgery, or interval appendectomy. Computed tomography (CT) plays an important role; however, combining clinical and imaging factors may make preoperative evaluation more reliable. This study evaluated and analyzed cases and the usefulness of several preoperative factors and clinical scoring models to detect complicated appendicitis. Methods A total of 203 patients preoperatively diagnosed with acute appendicitis at our facility were included. Complicated appendicitis was defined as appendicitis with gangrene, perforated appendix, and/or abscess formation. Preoperative factors were collected from published clinical scoring models; patient information, symptoms, signs, results of laboratory tests, and findings of CT. Factors were analyzed using a chi-squared test and the Mann-Whitney U test. Results The preoperative factors were compared between 151 uncomplicated and 52 complicated appendicitis patients. The significant factors were age >= 40, duration of symptoms >24 hours, body temperature >= 37.3 degrees C, high levels of CRP, findings in CT scan (appendix diameter >= 10 mm, stranding of the adjacent fat, presence of fluid collection, and suspicion of abscess or perforation). We also evaluated the usefulness of clinical scoring models for the detection of complicated appendicitis and found the Appendicitis Inflammatory Response score and two prediction models (Atema score and Imaoka score) showed significance (p < 0.05). High serum CRP level was significantly associated with complicated appendicitis (p < 0.001), and the predicted existence rates of complicated appendicitis were 52.7% for serum CRP level >= 50mg/L, 74.4% for >= 100mg/L, and 82.6% for >= 150mg/L. Conclusion The results demonstrated several preoperative factors and clinical scoring models to increase suspicion of complicated appendicitis. Specifically, high serum levels of CRP may be a useful factor in predicting complicated appendicitis prior to surgery when supported by clinical findings and imaging; however, further research is needed.	[Fujiwara, Kenji; Abe, Atsushi; Masatsugu, Toshihiro; Hirano, Tatsuya; Sada, Masayuki] Sada Hosp, Dept Surg, Fukuoka, Japan; [Fujiwara, Kenji] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka, Japan; [Hiraka, Kiyohisa] Sada Hosp, Dept Radiol, Fukuoka, Japan	Kyushu University	Fujiwara, K (corresponding author), Sada Hosp, Dept Surg, Fukuoka, Japan.; Fujiwara, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka, Japan.	kengdom@surg1.med.kyushu-u.ac.jp	Fujiwara, Kenji/AAI-8431-2021	Fujiwara, Kenji/0000-0001-5900-9382				Andersson RE, 2007, ANN SURG, V246, P741, DOI 10.1097/SLA.0b013e31811f3f9f; Atema JJ, 2015, BRIT J SURG, V102, P979, DOI 10.1002/bjs.9835; Bhangu A, 2015, LANCET, V386, P1278, DOI 10.1016/S0140-6736(15)00275-5; Di Saverio S, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00306-3; Drake FT, 2012, ANN SURG, V256, P586, DOI 10.1097/SLA.0b013e31826a9602; Flum DR, 2015, NEW ENGL J MED, V372, P1937, DOI 10.1056/NEJMcp1215006; Friedell ML, 2000, AM SURGEON, V66, P1158; Gorter RR, 2016, SURG ENDOSC, V30, P4668, DOI 10.1007/s00464-016-5245-7; Imaoka Y., 2015, J JPN SURG ASS, V76, P1, DOI [10.3919/jjsa.76.1, DOI 10.3919/JJSA.76.1]; Imaoka Y, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0107-0; KARP MP, 1986, J PEDIATR SURG, V21, P506, DOI 10.1016/S0022-3468(86)80221-4; Karul M, 2014, ROFO-FORTSCHR RONTG, V186, P551, DOI 10.1055/s-0034-1366074; Kim JY, 2019, ANN SURG TREAT RES, V97, P103, DOI 10.4174/astr.2019.97.2.103; Salminen P, 2015, JAMA-J AM MED ASSOC, V313, P2340, DOI 10.1001/jama.2015.6154; Sammalkorpi HE, 2017, SCAND J SURG, V106, P196, DOI 10.1177/1457496916683099; Thornton E, 2011, AM J ROENTGENOL, V197, pW1, DOI 10.2214/AJR.10.4375; Vons C, 2011, LANCET, V377, P1573, DOI 10.1016/S0140-6736(11)60410-8	17	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255253	10.1371/journal.pone.0255253	http://dx.doi.org/10.1371/journal.pone.0255253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314464	gold, Green Published			2022-12-26	WOS:000685225200012
J	Kaur, K; Awasthi, P; Tiwari, S				Kaur, Karambir; Awasthi, Praveen; Tiwari, Siddharth			Comparative transcriptome analysis of unripe and ripe banana (cv. Nendran) unraveling genes involved in ripening and other related processes	PLOS ONE			English	Article							XYLOGLUCAN ENDOTRANSGLUCOSYLASE/HYDROLASE XTH; TOMATO FRUIT; RNA-SEQ; DIFFERENTIAL GENE; EXPRESSION; SYNTHASE; BIOSYNTHESIS; MANIPULATION; GENOME; FAMILY	Banana is one of the most important fruit crops consumed globally owing to its high nutritional value. Previously, we demonstrated that the ripe pulp of the banana cultivar (cv.) Nendran (AAB) contained a high amount of pro-vitamin A carotenoids. However, the molecular factors involved in the ripening process in Nendran fruit are unexplored. Hence, we commenced a transcriptome study by using the Illumina HiSeq 2500 at two stages i.e. unripe and ripe fruit-pulp of Nendran. Overall, 3474 up and 4727 down-regulated genes were obtained. A large number of identified transcripts were related to genes involved in ripening, cell wall degradation and aroma formation. Gene ontology analysis highlighted differentially expressed genes that play a key role in various pathways. These pathways were mainly linked to cellular, molecular and biological processes. The present transcriptome study also reveals a crucial role of up-regulated carotenoid biosynthesis pathway genes namely, lycopene beta cyclase and geranylgeranyl pyrophosphate synthase at the ripening stage. Genes related to the ripening and other processes like aroma and flavor were highly expressed in the ripe pulp. Expression of numerous transcription factor family genes was also identified. This study lays a path towards understanding the ripening, carotenoid accumulation and other related processes in banana.	[Kaur, Karambir; Awasthi, Praveen; Tiwari, Siddharth] Govt India, Minist Sci & Technol, Natl Agrifood Biotechnol Inst NABI, Dept Biotechnol,Plant Tissue Culture & Genet Engn, Mohali, Punjab, India; [Awasthi, Praveen] Czech Acad Sci, Inst Plant Mol Biol, Dept Mol Genet, Ceske Budejovice, Czech Republic	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Czech Academy of Sciences	Tiwari, S (corresponding author), Govt India, Minist Sci & Technol, Natl Agrifood Biotechnol Inst NABI, Dept Biotechnol,Plant Tissue Culture & Genet Engn, Mohali, Punjab, India.	siddharth@nabi.res.in	Awasthi, Praveen/X-5765-2019; Tiwari, Siddharth/V-3054-2017	Awasthi, Praveen/0000-0003-3196-3427; Tiwari, Siddharth/0000-0003-3958-8465	Department of Biotechnology (DBT), Government of India [BT/PR25789/GET/119/97/2017]; Biotechnology Industry Research Assistance Council (BIRAC) [BIRAC/Tech Transfer/08/I2/QUT-BBF]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Biotechnology Industry Research Assistance Council (BIRAC)	The authors express their gratitude to the National Agri-Food Biotechnology Institute (NABI) for research facilities and the Department of Biotechnology (DBT), Government of India for the grant (BT/PR25789/GET/119/97/2017) under the scheme of Genome Engineering Technology and Their Applications. The present research was also supported by the Biotechnology Industry Research Assistance Council (BIRAC) for a banana biofortification project grant (BIRAC/Tech Transfer/08/I2/QUT-BBF dated 04.09.2012).	Adams-Phillips L, 2004, TRENDS PLANT SCI, V9, P331, DOI 10.1016/j.tplants.2004.05.004; Asif MH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0316-1; Asif MH, 2005, PLANT PHYSIOL BIOCH, V43, P177, DOI 10.1016/j.plaphy.2005.01.011; Beck G, 2013, PLANT MOL BIOL, V82, P393, DOI 10.1007/s11103-013-0070-z; Blanca J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-280; Bleecker AB, 1996, PLANT PHYSIOL, V111, P653, DOI 10.1104/pp.111.3.653; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Clendennen SK, 1997, PLANT PHYSIOL, V115, P463, DOI 10.1104/pp.115.2.463; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; de Jesus ON, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-41; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Droc G, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat035; Du H, 2010, PLANT PHYSIOL, V154, P1304, DOI 10.1104/pp.110.163741; Elitzur T, 2010, J EXP BOT, V61, P1523, DOI 10.1093/jxb/erq017; Englberger L, 2006, FOOD NUTR BULL, V27, P281, DOI 10.1177/156482650602700401; Heslop-Harrison JS, 2007, ANN BOT-LONDON, V100, P1073, DOI 10.1093/aob/mcm191; Hrdlickova R, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1364; Iqbal N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00475; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kaur N, 2020, METAB ENG, V59, P76, DOI 10.1016/j.ymben.2020.01.008; Kaur N, 2018, FUNCT INTEGR GENOMIC, V18, P89, DOI 10.1007/s10142-017-0577-5; Kaur N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00462; Kulkarni SG, 2011, J FOOD SCI TECH MYS, V48, P730, DOI 10.1007/s13197-010-0133-y; Li T, 2013, SCI HORTIC-AMSTERDAM, V157, P119, DOI 10.1016/j.scienta.2013.04.016; Liu MC, 2015, PLANT PHYSIOL, V169, P2380, DOI 10.1104/pp.15.01361; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Maqbool M AA., 2010, CONTROL POSTHARVEST, P639; Munoz-Bertomeu J, 2013, J PLANT PHYSIOL, V170, P1194, DOI 10.1016/j.jplph.2013.03.015; Murmu SB, 2018, INNOV FOOD SCI EMERG, V49, P20, DOI 10.1016/j.ifset.2018.07.011; Naing AH, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0491-z; Nakano M, 2020, PLANT PHYSIOL, V182, P136, DOI 10.1104/pp.19.00957; Nakatsuka A, 1998, PLANT PHYSIOL, V118, P1295, DOI 10.1104/pp.118.4.1295; PAULL RE, 1983, PLANT PHYSIOL, V72, P382, DOI 10.1104/pp.72.2.382; Payasi Anurag, 2009, Physiology and Molecular Biology of Plants, V15, P103, DOI 10.1007/s12298-009-0012-z; Qi XP, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2073-7; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Saladie M, 2006, PLANT J, V47, P282, DOI 10.1111/j.1365-313X.2006.02784.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Srivastava S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32557; Su LY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0459-8; Sun JM, 2019, PLANT PHYSIOL BIOCH, V141, P83, DOI 10.1016/j.plaphy.2019.05.022; Sun YY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030610; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vallabhaneni R, 2010, ARCH BIOCHEM BIOPHYS, V504, P104, DOI 10.1016/j.abb.2010.07.019; Van de Poel B, 2012, PLANT PHYSIOL, V160, P1498, DOI 10.1104/pp.112.206086; Wang JH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4366-2; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wang Z, 2019, NAT PLANTS, V5, P810, DOI 10.1038/s41477-019-0452-6; Xiao CW, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00067; Yan SC, 2011, J SCI FOOD AGR, V91, P650, DOI 10.1002/jsfa.4226; Ye J, 2018, NUCLEIC ACIDS RES, V46, pW71, DOI 10.1093/nar/gky400; Yu KQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-10; Zeng J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0514-5; Zhan YH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201124; Zhang AD, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-2314-9	57	2	2	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0254709	10.1371/journal.pone.0254709	http://dx.doi.org/10.1371/journal.pone.0254709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314413	Green Published, gold			2022-12-26	WOS:000685225200022
J	Kim, JJ; Liang, WC; Kang, CC; Pegram, MD; Herr, AE				Kim, John J.; Liang, Wenchuan; Kang, Chi-Chih; Pegram, Mark D.; Herr, Amy E.			Single-cell immunoblotting resolves estrogen receptor-alpha isoforms in breast cancer	PLOS ONE			English	Article							TAMOXIFEN; ANTIESTROGEN; RESISTANCE; GENE; IDENTIFICATION; PROLIFERATION; ACTIVATION; RESOLUTION; INHIBITION; MECHANISM	An array of isoforms of the nuclear estrogen receptor alpha (ER-alpha) protein contribute to heterogeneous response in breast cancer (BCa); yet, a single-cell analysis tool that distinguishes the full-length ER-alpha 66 protein from the activation function-1 deficient ER-alpha 46 isoform has not been reported. Specific detection of protein isoforms is a gap in single-cell analysis tools, as the de facto standard immunoassay requires isoform-specific antibody probes. Consequently, to scrutinize hormone response heterogeneity among BCa tumor cells, we develop a precision tool to specifically measure ER-alpha 66, ER- alpha 46, and eight ER-signaling proteins with single-cell resolution in the highly hetero-clonal MCF-7 BCa cell line. With a literature-validated pan-ER immunoprobe, we distinguish ER-alpha 66 from ER-alpha 46 in each individual cell. We identify ER-alpha 46 in 5.5% of hormone-sensitive (MCF-7) and 4.2% of hormone-insensitive (MDA-MB-231) BCa cell lines. To examine whether the single-cell immunoblotting can capture cellular responses to hormones, we treat cells with tamoxifen and identify different sub-populations of ER-alpha 46: (i) ER-alpha 46 induces phospho-AKT at Ser473, (ii) S6-ribosomal protein, an upstream ER target, activates both ER-alpha 66 and ER-alpha 46 in MCF-7 cells, and (iii) ER-alpha 46 partitions MDA-MB-231 subpopulations, which are responsive to tamoxifen. Unlike other single-cell immunoassays, multiplexed single-cell immunoblotting reports-in the same cell-tamoxifen effects on ER signaling proteins and on distinct isoforms of the ER-alpha protein.	[Kim, John J.; Kang, Chi-Chih; Herr, Amy E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Liang, Wenchuan; Pegram, Mark D.] Stanford Univ, Dept Med, Div Med Oncol, Stanford, CA 94305 USA	University of California System; University of California Berkeley; Stanford University	Herr, AE (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	aeh@berkeley.edu			Department of Defense [W81XWH-16-1-0010]; National Institute of Health [RO1: 1R01CA203018, 1R33CA225296-01]; Innovative Molecular Analysis Technology award [CA183679]; National Science Foundation Graduate Research Fellowship; UC Berkeley Bakar Fellowship; Susan G. Komen Investigator Initiated Award [IIR12222976]; Chan Zuckerberg Biohub	Department of Defense(United States Department of Defense); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Innovative Molecular Analysis Technology award; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); UC Berkeley Bakar Fellowship; Susan G. Komen Investigator Initiated Award(Susan G. Komen Breast Cancer Foundation); Chan Zuckerberg Biohub	This work is supported by a Department of Defense (W81XWH-16-1-0010) to A.E.H., National Institute of Health grants (RO1: 1R01CA203018, 1R33CA225296-01), Innovative Molecular Analysis Technology award (CA183679) to A.E.H., Chan Zuckerberg Biohub to A.E.H., a National Science Foundation Graduate Research Fellowship to J.J.K., a UC Berkeley Bakar Fellowship to A.E.H., and a Susan G. Komen Investigator Initiated Award (IIR12222976) to M.D. P.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzubi MA, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1123-2; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bogina G, 2012, AM J CLIN PATHOL, V138, P697, DOI 10.1309/AJCPLX0QJROV2IJG; Bostner J, 2013, BREAST CANCER RES TR, V137, P397, DOI 10.1007/s10549-012-2376-y; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Chan M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132449; Chantalat E., 2016, BREAST CANCER RES, P18, DOI [10.1186/s13058-016-0681-9, DOI 10.1186/S13058-016-0681-9]; Clarke R, 2015, MOL CELL ENDOCRINOL, V418, P220, DOI 10.1016/j.mce.2015.09.035; COEZY E, 1982, CANCER RES, V42, P317; Dai XF, 2015, AM J CANCER RES, V5, P2929; Ding YQ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231895; Fan P, 2014, EUR J CANCER, V50, P2866, DOI 10.1016/j.ejca.2014.08.011; Flouriot G, 2000, EMBO J, V19, P4688, DOI 10.1093/emboj/19.17.4688; GAUB MP, 1990, CELL, V63, P1267, DOI 10.1016/0092-8674(90)90422-B; Ghayad SE, 2008, CANCER SCI, V99, P1992, DOI 10.1111/j.1349-7006.2008.00955.x; Giesen C, 2014, NAT METHODS, V11, P417, DOI [10.1038/NMETH.2869, 10.1038/nmeth.2869]; Gopal A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51849-8; Gschwantler-Kaulich D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185566; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hassan F., 2018, J UNEXPLORED MED DAT, V3, P3; Hill SM, 2017, CELL SYST, V4, P73, DOI 10.1016/j.cels.2016.11.013; Hua H, 2018, EXP HEMATOL ONCOL, V7, DOI 10.1186/s40164-018-0116-7; Huang Y, 2017, GENOM PROTEOM BIOINF, V15, P73, DOI 10.1016/j.gpb.2017.03.001; Jerusalem G, 2018, JAMA ONCOL, V4, P1367, DOI 10.1001/jamaoncol.2018.2262; JORDAN VC, 1977, BRIT MED J, V1, P1534, DOI 10.1136/bmj.1.6075.1534-d; Jordan VC, 1986, IN PRESS; Kanaizumi H, 2019, ONCOL LETT, V17, P1962, DOI 10.3892/ol.2018.9759; Kang CC, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0052-3; Kang CC, 2016, NAT PROTOC, V11, P1508, DOI 10.1038/nprot.2016.089; Katzenellenbogen BS., 1984, HUMAN BREAST CANC CE; Klinge CM, 2010, MOL CELL ENDOCRINOL, V323, P268, DOI 10.1016/j.mce.2010.03.013; Koenigs MB, 2019, JNCI-J NATL CANCER I, V111, P933, DOI 10.1093/jnci/djy224; Kornblum N, 2018, J CLIN ONCOL, V36, P1556, DOI 10.1200/JCO.2017.76.9331; Kruger DT, 2018, BRIT J CANCER, V119, P832, DOI 10.1038/s41416-018-0221-8; Lappano R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3096; Lenz M., 2016, NAT PUBL GR, DOI [10.1038/srep25696, DOI 10.1038/SREP25696]; Leung E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/836769; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Lin AHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063199; Liu CY, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0431-9; Manna Subrata, 2016, Sign Transduct Insights, V5, P1; Marczell I, 2018, EUR J MED RES, V23, DOI 10.1186/s40001-018-0328-7; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Maximov PY, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju283; Miller MM, 2017, CRIT REV TOXICOL, V47, P564, DOI 10.1080/10408444.2017.1289150; Murphy AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005539; Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841; Nugoli M, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-13; Osborn JL, 2010, LAB CHIP, V10, P2659, DOI 10.1039/c004821f; Pan Hongchao, 2016, ASCO M LIB, P1; Paplomata E, 2014, THER ADV MED ONCOL, V6, P154, DOI 10.1177/1758834014530023; Penot G, 2005, ENDOCRINOLOGY, V146, P5474, DOI 10.1210/en.2005-0866; Perey L, 2007, ANN ONCOL, V18, P64, DOI 10.1093/annonc/mdl341; Pinzone JJ, 2004, MOL CELL BIOL, V24, P4605, DOI 10.1128/MCB.24.11.4605-4612.2004; Poola I, 2005, ENDOCRINE, V27, P227, DOI 10.1385/ENDO:27:3:227; Rainville J, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00018; Raj GV, 2017, ELIFE, V6, DOI 10.7554/eLife.26857; Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200; Rhodes A, 2000, J CLIN PATHOL, V53, P688, DOI 10.1136/jcp.53.9.688; Roforth MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095987; Rubira E.R., 2011, EVOLUTION DRUG DISCO, Vfirst; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sadler TM, 2006, ENDOCR-RELAT CANCER, V13, P863, DOI 10.1677/erc.1.01170; Sahasrabuddhe NA, 2015, BIOCHEM BIOPH RES CO, V463, P389, DOI 10.1016/j.bbrc.2015.05.077; Sarwar M, 2019, ONCOGENE, V38, P375, DOI 10.1038/s41388-018-0438-2; Speirs V, 2004, LANCET ONCOL, V5, P174, DOI 10.1016/S1470-2045(04)01413-5; Sridharan S, 2011, CANCER RES, V71, P2590, DOI 10.1158/0008-5472.CAN-10-3253; Stevens TA, 2006, ONCOGENE, V25, P5426, DOI 10.1038/sj.onc.1209529; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Veronesi U, 2005, LANCET, V365, P1727, DOI 10.1016/S0140-6736(05)66546-4; Villegas VE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030308; Wang LJ, 2013, ONCOL REP, V29, P1563, DOI 10.3892/or.2013.2245; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wardell SE, 2019, ELIFE, V8, DOI 10.7554/eLife.44181; Watanabe T, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-2; Wu XL, 2009, CANCER RES, V69, P1722, DOI 10.1158/0008-5472.CAN-08-3933; Xue M, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0139-x; Yamnik RL, 2009, J BIOL CHEM, V284, P6361, DOI 10.1074/jbc.M807532200; Yanai A, 2015, CLIN BREAST CANCER, V15, P197, DOI 10.1016/j.clbc.2014.12.002; Yasar P, 2017, REPROD MED BIOL, V16, P4, DOI 10.1002/rmb2.12006; Yeh WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060889	82	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0254783	10.1371/journal.pone.0254783	http://dx.doi.org/10.1371/journal.pone.0254783			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314438	gold, Green Published			2022-12-26	WOS:000685225200006
J	Ahmed, F; Adnan, M; Malik, A; Tariq, S; Kamal, F; Ijaz, B				Ahmed, Fayyaz; Adnan, Muhammad; Malik, Ayesha; Tariq, Somayya; Kamal, Farukh; Ijaz, Bushra			Perception of breast cancer risk factors: Dysregulation of TGF-beta/miRNA axis in Pakistani females	PLOS ONE			English	Article							EXPRESSION; SURVIVAL; INHIBITION; MECHANISMS; INVASION; STRESS; CELLS	Breast cancer poses a serious health risk for women throughout the world. Among the Asian population, Pakistani women have the highest risk of developing breast cancer. One out of nine women is diagnosed with breast cancer in Pakistan. The etiology and the risk factor leading to breast cancer are largely unknown. In the current study the risk factors that are most pertinent to the Pakistani population, the etiology, molecular mechanisms of tumor progression, and therapeutic targets of breast cancer are studied. A correlative, cross-sectional, descriptive, and questionnaire-based study was designed to predict the risk factors in breast cancer patients. Invasive Ductal Carcinoma (90%) and grade-II tumor (73.2%) formation are more common in our patient's data set. Clinical parameters such as mean age of 47.5 years (SD +/- 11.17), disturbed menstrual cycle (> 2), cousin marriages (repeated), and lactation period (< 0.5 Y) along with stress, dietary and environmental factors have an essential role in the development of breast cancer. In addition to this in silico analysis was performed to screen the miRNA regulating the TGF-beta pathway using TargetScanHuman, and correlation was depicted through Mindjet Manager. The information thus obtained was observed in breast cancer clinical samples both in peripheral blood mononuclear cells, and biopsy through quantitative real-time PCR. There was a significant dysregulation (**P>0.001) of the TGF-beta 1 signaling pathway and the miRNAs (miR-29a, miR-140, and miR-148a) in patients' biopsy in grade and stage specifically, correlated with expression in blood samples. miRNAs (miR-29a and miR-140, miR-148a) can be an effective diagnostic and prognostic marker as they regulate SMAD4 and SMAD2 expression respectively in breast cancer blood and biopsy samples. Therefore, proactive therapeutic strategies can be devised considering negatively regulated cascade genes and amalgamated miRNAs to control breast cancer better.	[Ahmed, Fayyaz; Adnan, Muhammad; Malik, Ayesha; Tariq, Somayya; Ijaz, Bushra] Univ Punjab Lahore, Natl Ctr Excellence Mol Biol, Lab Appl & Funct Genom, Lahore, Pakistan; [Kamal, Farukh] Fatima Jinnah Med Univ, Dept Pathol, Lahore, Pakistan	National Center of Excellence in Molecular Biology - Pakistan; University of Punjab	Ijaz, B (corresponding author), Univ Punjab Lahore, Natl Ctr Excellence Mol Biol, Lab Appl & Funct Genom, Lahore, Pakistan.	bijaz@cemb.edu.pk	Adnan, Muhammad/HDL-9249-2022					[Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; [Anonymous], 2018, ANISHINABEK NEWS, V28, P2; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2017, EMISS CONTROL SCI TE, V3, P1; Asghar K, 2019, CANCER MANAG RES, V11, P475, DOI 10.2147/CMAR.S184221; Azubuike SO, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1345-2; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Braune EB, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6040101; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Coughlin SS, 2019, BREAST CANCER RES TR, V177, P537, DOI 10.1007/s10549-019-05340-7; Dai XM, 2017, ONCOL LETT, V14, P6929, DOI 10.3892/ol.2017.7007; Denkert C, 2018, LANCET ONCOL, V19, P40, DOI 10.1016/S1470-2045(17)30904-X; Ding YL, 2017, INT J ONCOL, V50, P1701, DOI 10.3892/ijo.2017.3945; Figueroa JD, 2010, BREAST CANCER RES TR, V121, P727, DOI 10.1007/s10549-009-0590-z; Gangane Nitin, 2017, Asian Pac J Cancer Prev, V18, P3325, DOI 10.22034/APJCP.2017.18.12.3325; Garrido-Castro AC, 2017, CURR BREAST CANCER R, V9, P26, DOI 10.1007/s12609-017-0232-0; Gray JM, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0287-4; Guo QC, 2020, BIOTECHNOL LETT, V42, P2123, DOI 10.1007/s10529-020-02943-9; Hadj-Ahmed Mariem, 2019, Tumour Biol, V41, p1010428319869096, DOI 10.1177/1010428319869096; Hata A, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022061; Hiatt RA, 2018, ANNU REV PUBL HEALTH, V39, P113, DOI 10.1146/annurev-publhealth-040617-014101; Javed S, 2015, ADV LIFE SCI-PAK, V2, P115; Jiang F, 2016, MOL CARCINOGEN, V55, P929, DOI 10.1002/mc.22333; Kreis NN, 2019, CANCERS, V11, DOI 10.3390/cancers11070989; Kuchenbaecker KB, 2017, JAMA-J AM MED ASSOC, V317, P2402, DOI 10.1001/jama.2017.7112; Lacerda Jessica Zani, 2019, Microrna, V8, P237, DOI 10.2174/2211536608666190219095426; Lappano R, 2020, EXPERT OPIN THER TAR, V24, P559, DOI 10.1080/14728222.2020.1751819; Lawson J, 2019, MOL CARCINOGEN, V58, P376, DOI 10.1002/mc.22935; Lee A, 2019, GENET MED, V21, P1708, DOI 10.1038/s41436-018-0406-9; Liu NN, 2020, ONCOL LETT, V19, P1789, DOI 10.3892/ol.2020.11297; Lu Y, 2017, CANCER GENE THER, V24, P386, DOI 10.1038/cgt.2017.30; Macedo NJ, MAXIMIZING TOTAL RNA; Majidinia M, 2017, DNA REPAIR, V54, P22, DOI 10.1016/j.dnarep.2017.03.009; Mathew Aleyamma, 2016, Asian Pac J Cancer Prev, V17, P2895; Mauro A. D., 2020, IEEE T CIRCUITS-I, P1; Mehrgou A, 2017, J RES MED SCI, V22, DOI 10.4103/jrms.JRMS_967_16; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Milosevic M, 2018, TECHNOL HEALTH CARE, V26, P729, DOI 10.3233/THC-181277; Miyazawa K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022095; Moussa RS, 2019, FREE RADICAL BIO MED, V133, P276, DOI 10.1016/j.freeradbiomed.2018.03.027; Mubarik S, 2019, CANCER MANAG RES, V11, P8145, DOI 10.2147/CMAR.S208323; O'Brien J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00402; Park DS, 2020, EMBO REP, V21, DOI 10.15252/embr.201948693; Park EH, 2017, J BREAST CANCER, V20, P1, DOI 10.4048/jbc.2017.20.1.1; Pooja S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075979; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Ramachandran A, 2018, ELIFE, V7, DOI 10.7554/eLife.31756; Rodriguez-Ruiz A, 2019, RADIOLOGY, V290, P305, DOI 10.1148/radiol.2018181371; Sathipati SY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34604-3; Shi M, 2010, CANCER METAST REV, V29, P785, DOI 10.1007/s10555-010-9265-9; Sun YS, 2017, INT J BIOL SCI, V13, P1387, DOI 10.7150/ijbs.21635; Tang JQ, 2018, CANCERS, V10, DOI 10.3390/cancers10060159; Tang X, 2019, CANCER LETT, V452, P79, DOI 10.1016/j.canlet.2019.02.044; Toyoda Yasuhiro, 2016, Asian Pac J Cancer Prev, V17, P2847; Ujan EIA, 2015, USE INFORM TECHNOLOG, P403; Wang JY, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171265; Wang LL, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17071572; Wu WZ, 2017, DIGEST DIS SCI, V62, P3495, DOI 10.1007/s10620-017-4798-1; Youlden Danny R., 2014, Cancer Biology Medicine, V11, P101, DOI 10.7497/j.issn.2095-3941.2014.02.005; Yu L, 2018, INT J BIOL SCI, V14, P971, DOI 10.7150/ijbs.23350; Zarzynska JM, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/141747; Zhai HY, 2015, ONCOTARGET, V6, P19735, DOI 10.18632/oncotarget.3771; Zhang B, 2018, ONCOL LETT, V16, P91, DOI 10.3892/ol.2018.8689; Zhao LM, 2018, ONCOL LETT, V16, P3955, DOI 10.3892/ol.2018.9134	65	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255243	10.1371/journal.pone.0255243	http://dx.doi.org/10.1371/journal.pone.0255243			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297787	gold, Green Published			2022-12-26	WOS:000678128300016
J	Xu, GQ; Yang, ZJ; Ding, YZ; Liu, Y; Zhang, L; Wang, BS; Tang, M; Jing, TT; Jiao, K; Xu, XL; Chen, ZH; Xiang, L; Xu, C; Fu, YJ; Zhao, XJ; Jin, WL; Liu, YZ				Xu, Guiqin; Yang, Zhaojuan; Ding, Yizong; Liu, Yun; Zhang, Li; Wang, Boshi; Tang, Ming; Jing, Tiantian; Jiao, Kun; Xu, Xiaoli; Chen, Zehong; Xiang, Lvzhu; Xu, Chen; Fu, Yujie; Zhao, Xiaojing; Jin, Weilin; Liu, Yongzhong			The deubiquitinase USP16 functions as an oncogenic factor in K-RAS-driven lung tumorigenesis	ONCOGENE			English	Article							P38-ALPHA MAP KINASE; P38 MAPK; OXIDATIVE STRESS; GENE-EXPRESSION; ACTIVATION; STEM; STAT3; PHOSPHORYLATION; STABILIZATION; PROGRESSION	K-RAS mutation and molecular alterations of its surrogates function essentially in lung tumorigenesis and malignant progression. However, it remains elusive how tumor-promoting and deleterious events downstream of K-RAS signaling are coordinated in lung tumorigenesis. Here, we show that USP16, a deubiquitinase involved in various biological processes, functions as a promoter for the development of K-RAS-driven lung tumor. Usp16 deletion significantly attenuates K-ras(G12D)-mutation-induced lung tumorigenesis in mice. USP16 upregulation upon RAS activation averts reactive oxygen species (ROS)-induced p38 activation that would otherwise detrimentally influence the survival and proliferation of tumor cells. In addition, USP16 interacts with and deubiquitinates JAK1, and thereby promoting lung tumor growth by augmenting JAK1 signaling. Therefore, our results reveal that USP16 functions critically in the K-RAS-driven lung tumorigenesis through modulating the strength of p38 and JAK1 signaling.	[Xu, Guiqin; Yang, Zhaojuan; Liu, Yun; Zhang, Li; Wang, Boshi; Tang, Ming; Jing, Tiantian; Chen, Zehong; Xiang, Lvzhu; Xu, Chen; Liu, Yongzhong] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai, Peoples R China; [Ding, Yizong; Fu, Yujie; Zhao, Xiaojing] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Thorac Surg, Shanghai, Peoples R China; [Jiao, Kun; Xu, Xiaoli] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China; [Jin, Weilin] Lanzhou Univ, Clin Med Coll 1, Hosp 1, Inst Canc Neurosci,Med Frontier Innovat Res Ctr, Lanzhou, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Lanzhou University	Liu, YZ (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai, Peoples R China.	liuyzg@shsci.org	Jin, Wei-Lin/A-8355-2013	Jin, Wei-Lin/0000-0001-8011-2405; Liu, Yongzhong/0000-0002-1477-116X	National Natural Science Foundation of China [81802746, 81572694, 81972579]; Natural Science Foundation of Shanghai [20ZR1454100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was supported by the National Natural Science Foundation of China (81802746, 81572694, and 81972579), and the Natural Science Foundation of Shanghai (20ZR1454100).	Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Adorno M, 2013, NATURE, V501, P380, DOI 10.1038/nature12530; Ali SA, 2016, CANCER CELL, V29, P367, DOI 10.1016/j.ccell.2016.02.012; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Brooks GD, 2016, CANCER RES, V76, P866, DOI 10.1158/0008-5472.CAN-15-2388; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Cai SY, 1999, P NATL ACAD SCI USA, V96, P2828, DOI 10.1073/pnas.96.6.2828; Chen X, 2019, CANCER LETT, V456, P49, DOI 10.1016/j.canlet.2019.04.020; Chuang CH, 2017, NAT MED, V23, P291, DOI 10.1038/nm.4285; D'Amico S, 2018, GENE DEV, V32, P1175, DOI 10.1101/gad.311852.118; Deng KY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0126-x; Deng L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0107-0; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Fasbender A, 1998, J CLIN INVEST, V102, P184, DOI 10.1172/JCI2732; Grabner B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7285; Gu Y, 2016, P NATL ACAD SCI USA, V113, pE51, DOI 10.1073/pnas.1517041113; Gwinn DM, 2018, CANCER CELL, V33, P91, DOI 10.1016/j.ccell.2017.12.003; Hayes JD, 2020, CANCER CELL, V38, P167, DOI 10.1016/j.ccell.2020.06.001; Hill KS, 2014, ONCOGENE, V33, P2134, DOI 10.1038/onc.2013.147; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kennedy NJ, 2007, CANCER CELL, V11, P101, DOI 10.1016/j.ccr.2007.01.009; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Lim JKM, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2192-y; Liu CM, 2020, AGING-US, V12, P8680, DOI 10.18632/aging.103191; Liu D, 2017, ONCOL LETT, V14, P3959, DOI 10.3892/ol.2017.6690; Lu L, 2018, ONCOGENE, V37, P5292, DOI 10.1038/s41388-018-0340-y; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Metz HE, 2016, P NATL ACAD SCI USA, V113, P8795, DOI 10.1073/pnas.1601989113; Miotto B, 2018, NUCLEIC ACIDS RES, V46, P4392, DOI 10.1093/nar/gky149; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Obana M, 2012, AM J PHYSIOL-HEART C, V303, pH569, DOI 10.1152/ajpheart.00060.2012; Pan J, 2015, ONCOGENE, V34, P3957, DOI 10.1038/onc.2014.327; Qi XM, 2004, J BIOL CHEM, V279, P22138, DOI 10.1074/jbc.M313964200; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Song LX, 2011, MOL CANCER THER, V10, P481, DOI 10.1158/1535-7163.MCT-10-0502; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Taverna JA, 2020, CANCER RES, V80, P1551, DOI 10.1158/0008-5472.CAN-19-3183; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Xu Y, 2013, CELL CYCLE, V12, P3219, DOI 10.4161/cc.26278; Yan MX, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1479-2; Yang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4818; Zhang JG, 2020, THER ADV MED ONCOL, V12, DOI 10.1177/1758835920917558; Zhang JS, 2013, NAT CELL BIOL, V15, P1486, DOI 10.1038/ncb2874; Zhang Y, 2019, J CLIN INVEST, V129, P2856, DOI 10.1172/JCI123801; Zhou J, 2015, ONCOGENE, V34, P3804, DOI 10.1038/onc.2014.318; Zhu ZH, 2014, CANCER DISCOV, V4, P452, DOI 10.1158/2159-8290.CD-13-0646; Zhuo XL, 2015, J CELL BIOL, V210, P727, DOI 10.1083/jcb.201502044	50	2	2	7	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 9	2021	40	36					5482	5494		10.1038/s41388-021-01964-6	http://dx.doi.org/10.1038/s41388-021-01964-6		JUL 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UO7MC	34294846				2022-12-26	WOS:000678017100001
J	Chepkwony, EC; Gitao, GC; Muchemi, GM; Sangula, AK; Kairu-Wanyoike, SW				Chepkwony, Eunice C.; Gitao, George C.; Muchemi, Gerald M.; Sangula, Abraham K.; Kairu-Wanyoike, Salome W.			Epidemiological study on foot-and-mouth disease in small ruminants: Sero-prevalence and risk factor assessment in Kenya	PLOS ONE			English	Article							CORRELATION-COEFFICIENTS; CATTLE PRODUCTION; VIRUS; SEROPREVALENCE; PATHOGENESIS	Foot-and-mouth disease (FMD) is endemic in Kenya affecting cloven-hoofed ruminants. The epidemiology of the disease in small ruminants (SR) in Kenya is not documented. We carried out a cross-sectional study, the first in Kenya, to estimate the sero-prevalence of FMD in SR and the associated risk factors nationally. Selection of animals to be sampled used a multistage cluster sampling approach. Serum samples totaling 7564 were screened for FMD antibodies of non-structural-proteins using ID Screen(R) NSP Competition ELISA kit. To identify the risk factors, generalized linear mixed effects (GLMM) logistic regression analysis with county and villages as random effect variables was used. The country animal level sero-prevalence was 22.5% (95% CI: 22.3%-24.3%) while herd level sero-prevalence was 77.6% (95% CI: 73.9%-80.9%). The risk factor that was significantly positively associated with FMD sero-positivity in SR was multipurpose production type (OR = 1.307; p = 0.042). The risk factors that were significantly negatively associated with FMD sero-positivity were male sex (OR = 0.796; p = 0.007), young age (OR = 0.470; p = 0.010), and sedentary production zone (OR = 0.324; p<0.001). There were no statistically significant intra class correlations among the random effect variables but interactions between age and sex variables among the studied animals were statistically significant (p = 0.019). This study showed that there may be widespread undetected virus circulation in SR indicated by the near ubiquitous spatial distribution of significant FMD sero-positivity in the country. Strengthening of risk-based FMD surveillance in small ruminants is recommended. Adjustment of husbandry practices to control FMD in SR and in-contact species is suggested. Cross-transmission of FMD and more risk factors need to be researched.	[Chepkwony, Eunice C.; Sangula, Abraham K.] State Dept Livestock, Foot & Mouth Dis Natl Lab, Embakasi, Directorate Vet Serv, Nairobi, Kenya; [Gitao, George C.] Univ Nairobi, Dept Vet Pathol Microbiol & Parasitol, Nairobi, Kenya; [Muchemi, Gerald M.] Univ Nairobi, Dept Publ Hlth Pharmacol & Toxicol, Nairobi, Kenya; [Kairu-Wanyoike, Salome W.] Meat Training Inst, State Dept Livestock, Directorate Vet Serv, Nairobi, Kenya	University of Nairobi; University of Nairobi	Kairu-Wanyoike, SW (corresponding author), Meat Training Inst, State Dept Livestock, Directorate Vet Serv, Nairobi, Kenya.	swwanyoike@yahoo.com	Gitao, George/GRX-4337-2022; Wanyoike, Salome/GZK-4542-2022	Wanyoike, Salome/0000-0001-8235-5566	European Union (EU); Directorate of Veterinary Services	European Union (EU)(CGIAREuropean Commission); Directorate of Veterinary Services	This study had support from a project titled "Improving Animal Disease Surveillance in Support of Trade in IGAD Member States", in short "Surveillance of Trade Sensitive Diseases -STSD". This was a regional component of the Supporting the Horn of Africa's Resilience (SHARE). The project was implemented by IGAD member states through AU-IBAR and IGAD. The project was implemented with financial support from the European Union (EU). The direct recipient of the funding in Kenya was the Directorate of Veterinary Services with SWK as the National Focal Person. The ELISA Kits used in this work on FMD in small ruminants were provided by Eu-FMD through the Nakuru FMD Real -Time Training Course credit points. The direct recipient of the kits was ECC at the FMD laboratory of the Directorate of Veterinary Services. The AU-IBAR and IGAD Secretariat played a role in study design as well as training on data collection and data management in the main project. Sample testing, data analysis and publication was not funded by the main project as it fell outside the scope of the project.	Abdela N, 2017, ACTA TROP, V169, P125, DOI 10.1016/j.actatropica.2017.02.017; Abdullahi AM., 1990, FARMING SYSTEMS RESO, V8; Ahmed Beyan, 2020, Vet Med Int, V2020, P6821809, DOI 10.1155/2020/6821809; Altman D., 2013, STAT CONFIDENCE CONF; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P305, DOI 10.1111/j.1865-1682.2011.01236.x; Balinda SN, 2009, TRANSBOUND EMERG DIS, V56, P362, DOI 10.1111/j.1865-1682.2009.01094.x; Barnett PV, 1999, VET J, V158, P6, DOI 10.1053/tvjl.1998.0338; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Casey-Bryars M, 2016, THESIS U GLASGOW SCO THESIS U GLASGOW SCO; Cavanaugh JE, 2019, WIRES COMPUT STAT, V11, DOI 10.1002/wics.1460; Chepkwony E. C., 2012, International Journal of Animal and Veterinary Advances, V4, P198; Chilonda P, 2000, OUTLOOK AGR, V29, P109, DOI 10.5367/000000000101293112; Donaldson A. I., 2000, Diseases of sheep, P254; Eldaghayes I, 2017, OPEN VET J, V7, P1, DOI 10.4314/ovj.v7i1.1; Elnekave E, 2016, PREV VET MED, V125, P82, DOI 10.1016/j.prevetmed.2015.12.019; Eubanks Diana L, 2012, J Vet Dent, V29, P200; Falvey Lindsay, 2015, Chiang Mai University Journal of Natural Sciences, V14, P103, DOI 10.12982/CMUJNS.2015.0074; Farooq U, 2017, J ANIM PLANT SCI, V27, P1197; Grace-Martin K, STRATEGIES CHOOSING; Greiner M, 2000, PREV VET MED, V45, P43, DOI 10.1016/S0167-5877(00)00116-1; Hegde R., 2016, SM VIROL, V1, P1006; Humphry RW, 2004, PREV VET MED, V65, P173, DOI 10.1016/j.prevetmed.2004.07.003; Hussain MH, 2019, ACTA TROP, V199, DOI 10.1016/j.actatropica.2019.105106; Jahnke H. E., 1982, Livestock production systems and livestock development in tropical Africa.; Jenbere TS, 2011, J ANIM VET ADV, V10, P1368; Kennedy P., 1985, AP GUIDE EC, Vsecond; Kibore B., 2013, Journal of Veterinary Medicine and Animal Health, V5, P262; Kitching RP, 2002, REV SCI TECH OIE, V21, P505, DOI 10.20506/rst.21.3.1342; KNBS, 2010, 2009 NAT POP HOUS CE 2009 NAT POP HOUS CE; Kosgey IS, 2008, SMALL RUMINANT RES, V77, P11, DOI 10.1016/j.smallrumres.2008.02.005; Lazarus DD, 2012, AFR J MICROBIOL RES, V6, P1756, DOI 10.5897/AJMR11.1026; Mahmoud MAE., 2019, INT J DAIRY SCI, V14, P45, DOI [10.3923/ijds.2019.45.52, DOI 10.3923/IJDS.2019.45.52]; Mason PW, 2003, VIRUS RES, V91, P9, DOI 10.1016/S0168-1702(02)00257-5; Mburu JWS, 1986, P WORKSH IMPR SMALL P WORKSH IMPR SMALL; Megersa B, 2009, TROP ANIM HEALTH PRO, V41, P891, DOI 10.1007/s11250-008-9276-5; Mesfine M, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00130; Mwanyumba PM, 2015, PASTORALISM, V5, DOI 10.1186/s13570-015-0045-6; Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446; Nyaguthii DM, 2019, VET RES, V50, DOI 10.1186/s13567-019-0652-0; Nyariki DM, 2019, PASTORALISM, V9, DOI 10.1186/s13570-019-0144-x; Onono JO, 2013, TROP ANIM HEALTH PRO, V45, P1415, DOI 10.1007/s11250-013-0379-2; Otte M.J., 2002, CATTLE SMALL RUMINAN; Otte MJ, 1997, PREV VET MED, V31, P147, DOI 10.1016/S0167-5877(96)01108-7; Parida S, 2007, J VET DIAGN INVEST, V19, P539, DOI 10.1177/104063870701900513; Parida S, 2009, EXPERT REV VACCINES, V8, P347, DOI 10.1586/14760584.8.3.347; Phyoe HMM, 2017, J ADV VET ANIM RES, V4, P161, DOI 10.5455/javar.2017.d204; Radostits O., 2007, VET MED TXB DIS CATT, V10; Raouf Y. A., 2017, Bulletin of Animal Health and Production in Africa, V65, P145; Reiczigel J, 2010, EPIDEMIOL INFECT, V138, P1674, DOI 10.1017/S0950268810000385; Richardson JTE, 2011, STAT MED, V30, P890, DOI 10.1002/sim.4116; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Rowe AK, 2002, INT J QUAL HEALTH C, V14, P521, DOI 10.1093/intqhc/14.6.521; Shabana II, 2020, J ADV VET ANIM RES, V7, P42, DOI 10.5455/javar.2020.g391; Sombroek WG, 1980, SCALE 11 000 000 EXP; Stenfeldt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106859; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Thrusfield M, 2007, VET EPIDEMIOLOGY, V3rd ed, DOI [10.1038/nature05604 17287765, DOI 10.1038/NATURE0560417287765]; Torsson Emeli, 2017, Infection Ecology & Epidemiology, V7, P1368336, DOI 10.1080/20008686.2017.1368336; Ur-Rehman S, 2014, TRANSBOUND EMERG DIS, V61, P25, DOI 10.1111/tbed.12194; Wanyoike S.W, 2009, THESIS U READING REA; Wanyoike S.W, 1999, THESIS FREIE U BERLI; Wekesa SN, 2015, TRANSBOUND EMERG DIS, V62, P305, DOI 10.1111/tbed.12152; World Organisation for Animal Health (OIE), 2018, MANUAL DIAGNOSTIC TE; Zaal F., 1998, THESIS U AMSTERDAM N THESIS U AMSTERDAM N	65	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0234286	10.1371/journal.pone.0234286	http://dx.doi.org/10.1371/journal.pone.0234286			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339447	Green Submitted, Green Published, gold			2022-12-26	WOS:000680243400020
J	Li, YX; Chen, XY; Nie, YY; Tian, YH; Xiao, X; Yang, F				Li, Yanxin; Chen, Xiaoying; Nie, Yingying; Tian, Yuhua; Xiao, Xian; Yang, Fan			Endocannabinoid activation of the TRPV1 ion channel is distinct from activation by capsaicin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMER GENERATION; STRUCTURAL BASIS; VOLTAGE SENSOR; DESIGN; CONFORMATIONS; VALIDATION; PREDICTION; SYSTEM; LIGAND	Transient receptor potential vanilloid 1 (TRPV1) ion channel serves as the detector for noxious temperature above 42 degrees C, pungent chemicals like capsaicin, and acidic extracellular pH. This channel has also been shown to function as an ionotropic cannabinoid receptor. Despite the solving of high-resolution three-dimensional structures of TRPV1, how endocannabinoids such as anandamide and N-arachidonoyl dopamine bind to and activate this channel remains largely unknown. Here we employed a combination of patch-clamp recording, site directed mutagenesis, and molecular docking techniques to investigate how the endocannabinoids structurally bind to and open the TRPV1 ion channel. We found that these endocannabinoid ligands bind to the vanilloid-binding pocket of TRPV1 in the "tail-up, head-down" configuration, similar to capsaicin; however, there is a unique interaction with TRPV1 Y512 residue critical for endocannabinoid activation of TRPV1 channels. These data suggest that a differential structural mechanism is involved in TRPV1 activation by endocannabinoids compared with the classic agonist capsaicin.	[Li, Yanxin; Nie, Yingying; Tian, Yuhua] Qingdao Univ, Med Coll, Dept Pharmacol, Sch Pharm, Qingdao, Peoples R China; [Chen, Xiaoying; Yang, Fan] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Biophys, Hangzhou, Zhejiang, Peoples R China; [Chen, Xiaoying; Yang, Fan] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Kidney Dis Ctr, Hangzhou, Zhejiang, Peoples R China; [Xiao, Xian] Westlake Univ, Westlake Inst Adv Study, Inst Basic Med Sci, Hangzhou, Zhejiang, Peoples R China	Qingdao University; Zhejiang University; Zhejiang University; Westlake University	Tian, YH (corresponding author), Qingdao Univ, Med Coll, Dept Pharmacol, Sch Pharm, Qingdao, Peoples R China.; Yang, F (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Biophys, Hangzhou, Zhejiang, Peoples R China.; Yang, F (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Kidney Dis Ctr, Hangzhou, Zhejiang, Peoples R China.; Xiao, X (corresponding author), Westlake Univ, Westlake Inst Adv Study, Inst Basic Med Sci, Hangzhou, Zhejiang, Peoples R China.	yhtian05250@qdu.edu.cn; xiaoxian@westlake.edu.cn; fanyang@zju.edu.cn	Yang, Fan/AAA-6904-2022	Yang, Fan/0000-0002-0520-5254; Tian, Yuhua/0000-0001-8239-6560	National Natural Science Foundation of China [31971040, 31800990]; Zhejiang Provincial Natural Science Foundation of China [LR20C050002, LQ19H090009]; Natural Science Foundation of Shandong Province [ZR2020MH161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by National Natural Science Foundation of China (31971040 and 31800990 to F. Y.), Zhejiang Provincial Natural Science Foundation of China (LR20C050002 to F. Y.; LQ19H090009 to X. X.), and Natural Science Foundation of Shandong Province (ZR2020MH161 to Y. T.).	Akopian AN, 2009, TRENDS PHARMACOL SCI, V30, P79, DOI 10.1016/j.tips.2008.10.008; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Di Marzo V, 2002, CURR OPIN NEUROBIOL, V12, P372, DOI 10.1016/S0959-4388(02)00340-9; Dong YW, 2019, BIOCHEM BIOPH RES CO, V516, P365, DOI 10.1016/j.bbrc.2019.06.039; Donvito G, 2018, NEUROPSYCHOPHARMACOL, V43, P52, DOI 10.1038/npp.2017.204; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Gavva N.R., 2009, OPEN DRUG DISCOV J, V1, P1, DOI 10.2174/1877381800901010001; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Howlett AC, 2002, PROSTAG OTH LIPID M, V68-9, P619, DOI 10.1016/S0090-6980(02)00060-6; Hughes TET, 2018, NAT STRUCT MOL BIOL, V25, P53, DOI 10.1038/s41594-017-0009-1; Huynh KW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11130; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kaszas K, 2012, J PHARMACOL EXP THER, V340, P152, DOI 10.1124/jpet.111.183053; Kort ME, 2012, PROGR MED CHEM, V51, P57, DOI 10.1016/B978-0-12-396493-9.00002-9; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lebovitz EE, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-70; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Manning BH, 2001, J NEUROSCI, V21, P8238, DOI 10.1523/JNEUROSCI.21-20-08238.2001; Muller C, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00144; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pumroy RA, 2019, ELIFE, V8, DOI 10.7554/eLife.48792; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Singh AK, 2018, NAT STRUCT MOL BIOL, V25, P805, DOI 10.1038/s41594-018-0108-7; Xu LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17582-x; Yang F, 2020, ADV SCI, V7, DOI 10.1002/advs.202000575; Yang F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05339-6; Yang F, 2016, P NATL ACAD SCI USA, V113, pE3657, DOI 10.1073/pnas.1604180113; Yang F, 2015, NAT CHEM BIOL, V11, P518, DOI [10.1038/NCHEMBIO.1835, 10.1038/nchembio.1835]; Yang SL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700810; Yang SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9297; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Yin Y, 2019, BRIT J PHARMACOL, V176, P3364, DOI 10.1111/bph.14766; Zhang F, 2019, ELIFE, V8, DOI 10.7554/eLife.42756; Zhang F, 2016, ELIFE, V5, DOI 10.7554/eLife.16409; Zhu AQ, 2020, TOXICON, V178, P41, DOI 10.1016/j.toxicon.2020.02.016; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	45	9	9	3	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101022	10.1016/j.jbc.2021.101022	http://dx.doi.org/10.1016/j.jbc.2021.101022			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34332978	gold, Green Published			2022-12-26	WOS:000706408900010
J	Safren, N; Tank, EM; Malik, AM; Chua, JP; Santoro, N; Barmada, SJ				Safren, Nathaniel; Tank, Elizabeth M.; Malik, Ahmed M.; Chua, Jason P.; Santoro, Nicholas; Barmada, Sami J.			Development of a specific live-cell assay for native autophagic flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MOUSE MODEL; HEXANUCLEOTIDE REPEAT; CARGO RECOGNITION; MUTANT HUNTINGTIN; PROTEIN; MUTATIONS; DISEASE; C9ORF72	Autophagy is an evolutionarily conserved pathway mediating the breakdown of cellular proteins and organelles. Emphasizing its pivotal nature, autophagy dysfunction contributes to many diseases; nevertheless, development of effective autophagy modulating drugs is hampered by fundamental deficiencies in available methods for measuring autophagic activity or flux. To overcome these limitations, we introduced the photo convertible protein Dendra2 into the MAP1LC3B locus of human cells via CRISPR/Cas9 genome editing, enabling accurate and sensitive assessments of autophagy in living cells by optical pulse labeling. We used this assay to perform high throughput drug screens of four chemical libraries comprising over 30,000 diverse compounds, identifying several clinically relevant drugs and novel autophagy modulators. A select series of candidate compounds also modulated autophagy flux in human motor neurons modified by CRISPR/Cas9 to express GFP-labeled LC3. Using automated microscopy, we tested the therapeutic potential of autophagy induction in several distinct neuronal models of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). In doing so, we found that autophagy induction exhibited discordant effects, improving survival in disease models involving the RNA binding protein TDP-43, while exacerbating toxicity in neurons expressing mutant forms of UBQLN2 and C9ORF72 associated with familial ALS/FTD. These studies confirm the utility of the Dendra2-LC3 assay, while illustrating the contradictory effects of autophagy induction in different ALS/FTD subtypes.	[Safren, Nathaniel; Tank, Elizabeth M.; Malik, Ahmed M.; Chua, Jason P.; Barmada, Sami J.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Santoro, Nicholas] Univ Michigan, Ctr Chem Gen, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Barmada, SJ (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	sbarmada@umich.edu		Malik, Ahmed/0000-0002-2625-7483; Safren, Nathaniel/0000-0003-4866-4837; Barmada, Sami/0000-0002-9604-968X	National Institutes of Health National Institute on Aging [P30 AG053760]; National Institute of Neurological Disorders and Stroke [R01-NS097542, R01-NS113943]; University of Michigan Protein Folding Disease Initiative; Center for Chemical Genomics (CCG) at the University of Michigan Life Sciences Institute, Michigan Drug Discovery; Robert Packard Center for ALS Research; Ann Arbor Active Against ALS	National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Michigan Protein Folding Disease Initiative; Center for Chemical Genomics (CCG) at the University of Michigan Life Sciences Institute, Michigan Drug Discovery; Robert Packard Center for ALS Research; Ann Arbor Active Against ALS	This article contains supporting information. Acknowledgments-This work was supported by the National Institutes of Health National Institute on Aging P30 AG053760, Na-tional Institute of Neurological Disorders and Stroke R01-NS097542 and R01-NS113943, the University of Michigan Protein Folding Disease Initiative, the Center for Chemical Genomics (CCG) at the University of Michigan Life Sciences Institute, Michigan Drug Discovery, the Robert Packard Center for ALS Research, and Ann Arbor Active Against ALS. We thank Dr Vincent Groppi of Michigan Drug Discovery for his continued support and insights; Dr Lois Weisman and Prof. Tamotsu Yoshimori for RFP-GFP-LC3 HeLa cells; and Dr Paula Gedraitis (Molecular Devices, LLC) for technical assistance. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akar U, 2007, MOL CANCER RES, V5, P241, DOI 10.1158/1541-7786.MCR-06-0229; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Amick J, 2016, MOL BIOL CELL, V27, P3040, DOI 10.1091/mbc.E16-01-0003; Archbold HC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22858-w; Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Ashkenazi A, 2017, NATURE, V545, P108, DOI 10.1038/nature22078; Awad O, 2015, HUM MOL GENET, V24, P5775, DOI 10.1093/hmg/ddv297; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Barmada SJ, 2015, P NATL ACAD SCI USA, V112, P7821, DOI 10.1073/pnas.1509744112; Barmada SJ, 2014, NAT CHEM BIOL, V10, P677, DOI 10.1038/nchembio.1563; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Boecker CA, 2020, TRAFFIC, V21, P138, DOI 10.1111/tra.12701; Boivin M, 2020, EMBO J, V39, DOI 10.15252/embj.2018100574; Bolognesi B, 2016, CELL REP, V16, P222, DOI 10.1016/j.celrep.2016.05.076; Castillo K, 2013, AUTOPHAGY, V9, P1308, DOI 10.4161/auto.25188; Cerbini T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116032; Chauhan S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9620; CHRISTENSEN E, 1987, HEPATOLOGY, V7, P1346, DOI 10.1002/hep.1840070628; Chudakov DM, 2007, NAT PROTOC, V2, P2024, DOI 10.1038/nprot.2007.291; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; DeBosch BJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac5472; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Eguchi Y, 2018, ELIFE, V7, DOI 10.7554/eLife.34595; Evans CS, 2019, NEUROBIOL DIS, V122, P35, DOI 10.1016/j.nbd.2018.07.005; Fernandopulle Michael S, 2018, Curr Protoc Cell Biol, V79, pe51, DOI 10.1002/cpcb.51; Flores BN, 2019, CELL REP, V27, P1133, DOI 10.1016/j.celrep.2019.03.093; Florey O, 2015, AUTOPHAGY, V11, P88, DOI 10.4161/15548627.2014.984277; Fox JH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-26; Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22; Galluzzi L, 2017, NAT REV CLIN ONCOL, V14, P247, DOI 10.1038/nrclinonc.2016.183; Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z; Gijselinck I, 2015, NEUROLOGY, V85, P2116, DOI 10.1212/WNL.0000000000002220; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Gorrie GH, 2014, P NATL ACAD SCI USA, V111, P14524, DOI 10.1073/pnas.1405741111; Guo JY, 2013, CELL, V155, P1216, DOI 10.1016/j.cell.2013.11.019; Gupta A, 2010, P NATL ACAD SCI USA, V107, P14333, DOI 10.1073/pnas.1000248107; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hjerpe R, 2016, CELL, V166, P935, DOI 10.1016/j.cell.2016.07.001; Joo JH, 2016, MOL CELL, V62, P491, DOI 10.1016/j.molcel.2016.04.020; Kaizuka T, 2016, MOL CELL, V64, P835, DOI 10.1016/j.molcel.2016.09.037; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kliosnky D, 2016, AUTOPHAGY, V12, P443, DOI 10.1080/15548627.2016.1147886; Kocaturk NM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00128; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kuoa SY, 2015, P NATL ACAD SCI USA, V112, pE4281, DOI 10.1073/pnas.1512289112; Le Ber I, 2013, JAMA NEUROL, V70, P1403, DOI 10.1001/jamaneurol.2013.3849; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Lee HJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0749-9; Leestemaker Y, 2017, CELL CHEM BIOL, V24, P725, DOI 10.1016/j.chembiol.2017.05.010; Liang CC, 2010, J BIOL CHEM, V285, P3499, DOI 10.1074/jbc.M109.072389; Liu QS, 2012, METHODS MOL BIOL, V821, P447, DOI 10.1007/978-1-61779-430-8_29; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malik AM, 2018, ELIFE, V7, DOI 10.7554/eLife.35977; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Meijer AJ, 2015, AMINO ACIDS, V47, P2037, DOI 10.1007/s00726-014-1765-4; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Moriya H, 2015, MOL BIOL CELL, V26, P3932, DOI 10.1091/mbc.E15-07-0512; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nguyen DKH, 2019, NEUROSCI LETT, V697, P34, DOI 10.1016/j.neulet.2018.04.006; Nishiyama J, 2007, AUTOPHAGY, V3, P591, DOI 10.4161/auto.4964; O'Rourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Pottier C, 2015, ACTA NEUROPATHOL, V130, P77, DOI 10.1007/s00401-015-1436-x; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rao S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4056; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Rudnick ND, 2017, P NATL ACAD SCI USA, V114, pE8294, DOI 10.1073/pnas.1704294114; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sarkar S, 2014, NEUROTOXICOLOGY, V44, P250, DOI 10.1016/j.neuro.2014.07.006; Sellier C, 2016, EMBO J, V35, P1276, DOI 10.15252/embj.201593350; Senturk M, 2019, NAT CELL BIOL, V21, P384, DOI 10.1038/s41556-019-0281-x; Shakeri A, 2019, J CELL PHYSIOL, V234, P5643, DOI 10.1002/jcp.27404; Sharkey LM, 2018, P NATL ACAD SCI USA, V115, pE10495, DOI 10.1073/pnas.1810522115; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13; Shi YX, 2018, NAT MED, V24, P313, DOI 10.1038/nm.4490; Subach OM, 2011, NAT METHODS, V8, P771, DOI 10.1038/nmeth.1664; Synofzik M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.002; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Teyssou E, 2013, ACTA NEUROPATHOL, V125, P511, DOI 10.1007/s00401-013-1090-0; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Ugolino J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006443; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valenzuela V, 2018, AUTOPHAGY, V14, P733, DOI 10.1080/15548627.2018.1432327; Waite AJ, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.016; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Watanabe-Asano T, 2014, BIOCHEM BIOPH RES CO, V445, P334, DOI 10.1016/j.bbrc.2014.01.180; Weskamp K, 2020, J CLIN INVEST, V130, P1139, DOI 10.1172/JCI130988; Weskamp K, 2019, JOVE-J VIS EXP, DOI 10.3791/59036; Wolfson RL, 2017, CELL METAB, V26, P301, DOI 10.1016/j.cmet.2017.07.001; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wong YC, 2014, J NEUROSCI, V34, P1293, DOI 10.1523/JNEUROSCI.1870-13.2014; Wu JJ, 2020, P NATL ACAD SCI USA, V117, P15230, DOI 10.1073/pnas.1917371117; Xiao SX, 2015, ANN NEUROL, V78, P568, DOI 10.1002/ana.24469; Yang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130953; Yang M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601167; Yoon S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.501; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang LJ, 2017, MED SCI MONITOR, V23, P801, DOI 10.12659/MSM.898679; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	115	4	4	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101003	10.1016/j.jbc.2021.101003	http://dx.doi.org/10.1016/j.jbc.2021.101003			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	34303705	Green Published, gold			2022-12-26	WOS:000706361700003
J	Rink, MR; Baptista, MAP; Flomm, FJ; Hennig, T; Whisnant, AW; Wolf, N; Seibel, J; Dolken, L; Bosse, JB				Rink, Marco R.; Baptista, Marisa A. P.; Flomm, Felix J.; Hennig, Thomas; Whisnant, Adam W.; Wolf, Natalia; Seibel, Juergen; Doelken, Lars; Bosse, Jens B.			Concatemeric Broccoli reduces mRNA stability and induces aggregates	PLOS ONE			English	Article							RECOMBINATION; MIMICS	Fluorogenic aptamers are an alternative to established methodology for real-time imaging of RNA transport and dynamics. We developed Broccoli-aptamer concatemers ranging from 4 to 128 substrate-binding site repeats and characterized their behavior fused to an mCherry-coding mRNA in transient transfection, stable expression, and in recombinant cytomegalovirus infection. Concatemerization of substrate-binding sites increased Broccoli fluorescence up to a concatemer length of 16 copies, upon which fluorescence did not increase and mCherry signals declined. This was due to the combined effects of RNA aptamer aggregation and reduced RNA stability. Unfortunately, both cellular and cytomegalovirus genomes were unable to maintain and express high Broccoli concatemer copy numbers, possibly due to recombination events. Interestingly, negative effects of Broccoli concatemers could be partially rescued by introducing linker sequences in between Broccoli repeats warranting further studies. Finally, we show that even though substrate-bound Broccoli is easily photobleached, it can still be utilized in live-cell imaging by adapting a time-lapse imaging protocol.	[Rink, Marco R.; Baptista, Marisa A. P.; Hennig, Thomas; Whisnant, Adam W.; Doelken, Lars] Julius Maximilians Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Rink, Marco R.] Univ Birmingham, Ctr Liver & Gastrointestinal Res, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Flomm, Felix J.; Bosse, Jens B.] Ctr Struct Syst Biol, Hamburg, Germany; [Flomm, Felix J.; Bosse, Jens B.] Hannover Med Sch, Cluster Excellence RESIST EXC 2155, Hannover, Germany; [Flomm, Felix J.; Bosse, Jens B.] Leibniz Inst Expt Virol HPI, Hamburg, Germany; [Flomm, Felix J.; Bosse, Jens B.] Hannover Med Sch, Inst Virol, Hannover, Germany; [Wolf, Natalia; Seibel, Juergen] Julius Maximilians Univ Wurzburg, Inst Organ Chem, Wurzburg, Germany; [Doelken, Lars] Helmholtz Ctr Infect Res HZI, Helmholtz Inst RNA Based Infect Res HIRI, Wurzburg, Germany	University of Wurzburg; University of Birmingham; Hannover Medical School; Heinrich Pette Institute; Hannover Medical School; University of Wurzburg; Helmholtz Association; Helmholtz-Center for Infection Research	Bosse, JB (corresponding author), Ctr Struct Syst Biol, Hamburg, Germany.; Bosse, JB (corresponding author), Hannover Med Sch, Cluster Excellence RESIST EXC 2155, Hannover, Germany.; Bosse, JB (corresponding author), Leibniz Inst Expt Virol HPI, Hamburg, Germany.; Bosse, JB (corresponding author), Hannover Med Sch, Inst Virol, Hannover, Germany.	jens.bosse@cssb-hamburg.de	Bosse, Jens Bernhard/D-7336-2011; Seibel, Juergen/A-6908-2015	Bosse, Jens Bernhard/0000-0001-7252-5541; Pereira Baptista, Marisa Alexandra/0000-0002-1176-663X; Rink, Marco/0000-0001-8741-8466; Seibel, Juergen/0000-0002-8036-4853	Infect-ERA grant eDEVILLI; DFG (German Research Foundation) [EXC 2155, 390874280]; Humboldt Foundation; German Federal Foreign Office; Studienstiftung des deutschen Volkes	Infect-ERA grant eDEVILLI; DFG (German Research Foundation)(German Research Foundation (DFG)); Humboldt Foundation(Alexander von Humboldt Foundation); German Federal Foreign Office; Studienstiftung des deutschen Volkes	LD: Infect-ERA grant eDEVILLI JB: DFG (German Research Foundation, www.dfg.de) EXC 2155 "RESIST" - Project ID 390874280 AWW: Humboldt Foundation and the German Federal Foreign Office FJF: graduate student fellowship by the Studienstiftung des deutschen Volkes The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autour A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02993-8; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Braselmann E, 2018, NAT CHEM BIOL, V14, P964, DOI 10.1038/s41589-018-0103-7; Cicin-Sain L, 2007, J VIROL, V81, P13825, DOI 10.1128/JVI.01911-07; Di Stefano B, 2019, CELL STEM CELL, V25, P622, DOI 10.1016/j.stem.2019.08.018; Filonov GS, 2014, J AM CHEM SOC, V136, P16299, DOI 10.1021/ja508478x; Jain A, 2017, NATURE, V546, P243, DOI 10.1038/nature22386; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Li X, 2020, ANGEW CHEM INT EDIT, V59, P4511, DOI 10.1002/anie.201914576; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Park HY, 2014, SCIENCE, V343, P422, DOI 10.1126/science.1239200; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Song WJ, 2017, NAT CHEM BIOL, V13, P1187, DOI [10.1038/NCHEMBIO.2477, 10.1038/nchembio.2477]; Standart N, 2018, TRENDS GENET, V34, P612, DOI 10.1016/j.tig.2018.05.005; Stoecklin G, 2013, ADV EXP MED BIOL, V768, P197, DOI 10.1007/978-1-4614-5107-5_12; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; You MX, 2015, ANNU REV BIOPHYS, V44, P187, DOI 10.1146/annurev-biophys-060414-033954; Zhang JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17295	20	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2021	16	8							e0244166	10.1371/journal.pone.0244166	http://dx.doi.org/10.1371/journal.pone.0244166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IY	34347781	Green Published, gold			2022-12-26	WOS:000685264900021
J	Maarala, AI; Arasalo, O; Valenzuela, D; Makinen, V; Heljanko, K				Maarala, Altti Ilari; Arasalo, Ossi; Valenzuela, Daniel; Makinen, Veli; Heljanko, Keijo			Distributed hybrid-indexing of compressed pan-genomes for scalable and fast sequence alignment	PLOS ONE			English	Article							SHORT READ ALIGNMENT; RETRIEVAL; STORAGE	Computational pan-genomics utilizes information from multiple individual genomes in large-scale comparative analysis. Genetic variation between case-controls, ethnic groups, or species can be discovered thoroughly using pan-genomes of such subpopulations. Whole-genome sequencing (WGS) data volumes are growing rapidly, making genomic data compression and indexing methods very important. Despite current space-efficient repetitive sequence compression and indexing methods, the deployed compression methods are often sequential, computationally time-consuming, and do not provide efficient sequence alignment performance on vast collections of genomes such as pan-genomes. For performing rapid analytics with the ever-growing genomics data, data compression and indexing methods have to exploit distributed and parallel computing more efficiently. Instead of strict genome data compression methods, we will focus on the efficient construction of a compressed index for pan-genomes. Compressed hybrid-index enables fast sequence alignments to several genomes at once while shrinking the index size significantly compared to traditional indexes. We propose a scalable distributed compressed hybrid-indexing method for large genomic data sets enabling pan-genome-based sequence search and read alignment capabilities. We show the scalability of our tool, DHPGIndex, by executing experiments in a distributed Apache Spark-based computing cluster comprising 448 cores distributed over 26 nodes. The experiments have been performed both with human and bacterial genomes. DHPGIndex built a BLAST index for n = 250 human pan-genome with an 870:1 compression ratio (CR) in 342 minutes and a Bowtie2 index with 157:1 CR in 397 minutes. For n = 1,000 human pan-genome, the BLAST index was built in 1520 minutes with 532:1 CR and the Bowtie2 index in 1938 minutes with 76:1 CR. Bowtie2 aligned 14.6 GB of paired-end reads to the compressed (n = 1,000) index in 31.7 minutes on a single node. Compressing n = 13,375,031 (488 GB) GenBank database to BLAST index resulted in CR of 62:1 in 575 minutes. BLASTing 189,864 Crispr-Cas9 gRNA target sequences (23 MB in total) to the compressed index of human pan-genome (n = 1,000) finished in 45 minutes on a single node. 30 MB mixed bacterial sequences were (n = 599) were blasted to the compressed index of 488 GB GenBank database (n = 13,375,031) in 26 minutes on 25 nodes. 78 MB mixed sequences (n = 4,167) were blasted to the compressed index of 18 GB E. coli sequence database (n = 745,409) in 5.4 minutes on a single node.	[Maarala, Altti Ilari; Valenzuela, Daniel; Makinen, Veli; Heljanko, Keijo] Univ Helsinki, Dept Comp Sci, Espoo, Finland; [Arasalo, Ossi] Aalto Univ, Dept Comp Sci, Espoo, Finland; [Makinen, Veli; Heljanko, Keijo] Helsinki Inst Informat Technol, Espoo, Finland	Aalto University; University of Helsinki; Aalto University; Aalto University; University of Helsinki	Maarala, AI (corresponding author), Univ Helsinki, Dept Comp Sci, Espoo, Finland.	ilari.maarala@helsinki.fi	Heljanko, Keijo/C-7603-2011	Heljanko, Keijo/0000-0002-4547-2701; Maarala, Altti/0000-0001-8851-4265; Makinen, Veli/0000-0003-4454-1493	Academy of Finland [336092]	Academy of Finland(Academy of Finland)	This work was funded by the Academy of Finland (Decision No. 336092, given to Dr. Heljanko). The Academy of Finland website www.aka.fi.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2019, LECT NOTES COMPUTER; Decap D, 2015, BIOINFORMATICS, V31, P2482, DOI 10.1093/bioinformatics/btv179; Ferrada H, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0137; Gagie T, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00012; Gu W, 2019, ANNU REV PATHOL-MECH, V14, P319, DOI 10.1146/annurev-pathmechdis-012418-012751; Hoobin C, 2011, PROC VLDB ENDOW, V5, P265, DOI 10.14778/2078331.2078341; Huang L, 2013, BIOINFORMATICS, V29, P361, DOI 10.1093/bioinformatics/btt215; Karkkainen J., 1996, Proceedings of the Third South American Workshop on String Processing. WSP 1996, P141; Karkkainen J., 2016, ACM J EXPT ALGORITHM, V21, P2; Karkkainen J, 2013, LECT NOTES COMPUT SC, V7922, P189, DOI 10.1007/978-3-642-38905-4_19; Kulski JK., 2016, NEXT GENERATION SEQU, P3; Kuruppu S, 2010, LECT NOTES COMPUT SC, V6393, P201, DOI 10.1007/978-3-642-16321-0_20; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Maarala AI., 2020, LECT NOTES COMPUTER, V12402; Maarala AI, 2018, BIOINFORMATICS, V34, P928, DOI 10.1093/bioinformatics/btx702; Makinen V., 2015, GENOME SCALE ALGORIT; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marcshall T, 2016, COMPUTATIONAL PAN GE; National Human Genome Research Institute, 2020, COST SEQ HUM GEN; Navarro G, 2007, ACM COMPUT SURV, V39, DOI 10.1145/1216370.1216372; Niemenmaa M, 2012, BIOINFORMATICS, V28, P876, DOI 10.1093/bioinformatics/bts054; Papageorgiou Louis, 2018, EMBnet J, V24; Paten B., 2014, MAPPING REFERENCE GE; Pireddu L, 2011, BIOINFORMATICS, V27, P2159, DOI 10.1093/bioinformatics/btr325; Poplin R., 2018, BIORXIV, DOI DOI 10.1101/201178; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Schumacher A, 2014, BIOINFORMATICS, V30, P119, DOI 10.1093/bioinformatics/btt601; Sherman RM, 2020, NAT REV GENET, V21, P243, DOI 10.1038/s41576-020-0210-7; Shvachko K, 2010, IEEE S MASS STOR SYS; Siren J, 2014, IEEE ACM T COMPUT BI, V11, P375, DOI 10.1109/TCBB.2013.2297101; Suwinski P, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00049; Valenzuela D., 2017, CHIC SHORT READ ALIG; Valenzuela D., 2017, ALGORITHMS DATA STRU; Valenzuela D, 2016, LECT NOTES COMPUT SC, V9685, P326, DOI 10.1007/978-3-319-38851-9_22; Zaharia M., 2012, P 9 USENIX S NETW SY, P15, DOI DOI 10.1111/J.1095-8649.2005.00662.X; ZIV J, 1977, IEEE T INFORM THEORY, V23, P337, DOI 10.1109/TIT.1977.1055714	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255260	10.1371/journal.pone.0255260	http://dx.doi.org/10.1371/journal.pone.0255260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343181	gold, Green Published			2022-12-26	WOS:000685264200048
J	Zhang, QY; Jiang, SY; Yang, SX; Song, H				Zhang, Qingyang; Jiang, Shouyong; Yang, Shengxiang; Song, Hui			Solving dynamic multi-objective problems with a new prediction-based optimization algorithm	PLOS ONE			English	Article							EVOLUTIONARY ALGORITHM; DECOMPOSITION; MOEA/D	This paper proposes a new dynamic multi-objective optimization algorithm by integrating a new fitting-based prediction (FBP) mechanism with regularity model-based multi-objective estimation of distribution algorithm (RM-MEDA) for multi-objective optimization in changing environments. The prediction-based reaction mechanism aims to generate high-quality population when changes occur, which includes three subpopulations for tracking the moving Pareto-optimal set effectively. The first subpopulation is created by a simple linear prediction model with two different stepsizes. The second subpopulation consists of some new sampling individuals generated by the fitting-based prediction strategy. The third subpopulation is created by employing a recent sampling strategy, generating some effective search individuals for improving population convergence and diversity. Experimental results on a set of benchmark functions with a variety of different dynamic characteristics and difficulties illustrate that the proposed algorithm has competitive effectiveness compared with some state-of-the-art algorithms.	[Zhang, Qingyang; Song, Hui] Jiangsu Normal Univ, Sch Comp Sci & Technol, Xuzhou, Jiangsu, Peoples R China; [Jiang, Shouyong] Univ Lincoln, Sch Comp Sci, Lincoln, England; [Yang, Shengxiang] De Montfort Univ, Sch Comp Sci & Informat, Leicester, Leics, England	Jiangsu Normal University; University of Lincoln; De Montfort University	Zhang, QY (corresponding author), Jiangsu Normal Univ, Sch Comp Sci & Technol, Xuzhou, Jiangsu, Peoples R China.	sweqyian@126.com	Yang, Shengxiang/A-4176-2009	Yang, Shengxiang/0000-0001-7222-4917; Jiang, Shouyong/0000-0001-5099-2093	National Natural Science Foundation of China [62006103, 61872168]; Jiangsu national science research of high education [20KJB110021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu national science research of high education	This work is supported by the National Natural Science Foundation of China under Grants 62006103 and 61872168, in part by the Jiangsu national science research of high education under Grand 20KJB110021.	Auger A, 2012, THEOR COMPUT SCI, V425, P75, DOI 10.1016/j.tcs.2011.03.012; Azzouz R, 2017, SOFT COMPUT, V21, P885, DOI 10.1007/s00500-015-1820-4; Branke J., 1999, Proceedings of the 1999 Congress on Evolutionary Computation-CEC99 (Cat. No. 99TH8406), P1875, DOI 10.1109/CEC.1999.785502; Branke J, 2000, EVOLUTIONARY DESIGN AND MANUFACTURE, P299; Bringmann K., 2011, PROC 21 INT JOINT C, P1198; Chang RI, 2017, IEEE ACCESS, V5, P7648, DOI 10.1109/ACCESS.2017.2694843; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K, 2014, IEEE T EVOLUT COMPUT, V18, P577, DOI 10.1109/TEVC.2013.2281535; Feng GR, 2015, IEEE T CYBERNETICS, V45, P279, DOI 10.1109/TCYB.2014.2325594; Goh CK, 2009, IEEE T EVOLUT COMPUT, V13, P103, DOI 10.1109/TEVC.2008.920671; GREFENSTETTE JJ, 1992, PARALLEL PROBLEM SOLVING FROM NATURE, 2, P137; Hu YR, 2020, KNOWL-BASED SYST, V194, DOI 10.1016/j.knosys.2019.105175; Isaacs A, 2008, IEEE IJCNN, P548, DOI 10.1109/IJCNN.2008.4633847; Jiang M, 2018, IEEE T EVOLUT COMPUT, V22, P501, DOI 10.1109/TEVC.2017.2771451; Jiang S., 2018, 2018 IEEE C EV COMP; Jiang SY, 2017, IEEE T EVOLUT COMPUT, V21, P65, DOI 10.1109/TEVC.2016.2574621; Kalyanmoy D, 2007, LECT NOTES COMPUT SC, V4403, P803; Ke LJ, 2014, IEEE T CYBERNETICS, V44, P1808, DOI 10.1109/TCYB.2013.2295886; Ke LJ, 2013, IEEE T CYBERNETICS, V43, P1845, DOI 10.1109/TSMCB.2012.2231860; Khouadjia M., 2000, EVOLUTIONARY DESIGN, P299; Li CH, 2012, IEEE T EVOLUT COMPUT, V16, P556, DOI 10.1109/TEVC.2011.2169966; Li CH, 2008, ICNC 2008: FOURTH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, VOL 7, PROCEEDINGS, P624, DOI 10.1109/ICNC.2008.313; Li K, 2015, IEEE T EVOLUT COMPUT, V19, P694, DOI 10.1109/TEVC.2014.2373386; Li QY, 2019, SOFT COMPUT, V23, P3723, DOI 10.1007/s00500-018-3033-0; Li YM, 2015, IEEE T CYBERNETICS, V45, P138, DOI 10.1109/TCYB.2014.2333738; Liu CA, 2006, LECT NOTES COMPUT SC, V4221, P889; Lu C, 2018, EXPERT SYST APPL, V107, P89, DOI 10.1016/j.eswa.2018.04.012; Mashwani WK, 2016, APPL SOFT COMPUT, V39, P292, DOI 10.1016/j.asoc.2015.08.059; Mavrovouniotis M, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P2130; Mirjalili S, 2017, ADV ENG SOFTW, V114, P163, DOI 10.1016/j.advengsoft.2017.07.002; Mirjalili S, 2017, KNOWL-BASED SYST, V134, P50, DOI 10.1016/j.knosys.2017.07.018; Mirjalili S, 2017, APPL INTELL, V46, P79, DOI 10.1007/s10489-016-0825-8; Mirjalili SZ, 2018, APPL INTELL, V48, P805, DOI 10.1007/s10489-017-1019-8; Muruganantham A, 2016, IEEE T CYBERNETICS, V46, P2862, DOI 10.1109/TCYB.2015.2490738; Nauck D., 1997, FDN NEUROFUZZY SYSTE, DOI DOI 10.1029/2009GL041009; Padhye N., 2009, P 11 ANN C GEN EV CO; Pham QT, 2021, MECH MATER, V154, DOI 10.1016/j.mechmat.2020.103729; Phan DH, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1836; Rambabu R, 2020, IEEE T CYBERNETICS, V50, P5099, DOI 10.1109/TCYB.2019.2909806; Rong M, 2020, IEEE T EVOLUT COMPUT, V24, P290, DOI 10.1109/TEVC.2019.2925358; Ruan G, 2017, APPL SOFT COMPUT, V58, P631, DOI 10.1016/j.asoc.2017.05.008; Salarieh B, 2021, ELECTR POW SYST RES, V196, DOI 10.1016/j.epsr.2021.107254; Saxena DK, 2013, IEEE T EVOLUT COMPUT, V17, P77, DOI 10.1109/TEVC.2012.2185847; Sohn W, 2020, ANN NUCL ENERGY, V135, DOI 10.1016/j.anucene.2019.106945; Wang DJ, 2017, COMPUT OPER RES, V79, P279, DOI 10.1016/j.cor.2016.04.024; Wu PPY, 2011, IEEE T SYST MAN CY B, V41, P621, DOI 10.1109/TSMCB.2010.2061225; Wu XL, 2015, IEEE COMMUN LETT, V19, P1822, DOI 10.1109/LCOMM.2015.2458861; Xiong J, 2017, J IND MANAG OPTIM, V13, P1189, DOI 10.3934/jimo.2016068; Xu L., 2017, ASIA PACIFIC C SIMUL, P644; Yang SX, 2008, EVOL COMPUT, V16, P385, DOI 10.1162/evco.2008.16.3.385; Yang SX, 2010, IEEE T EVOLUT COMPUT, V14, P959, DOI 10.1109/TEVC.2010.2046667; Yazici A, 2014, IEEE T CYBERNETICS, V44, P305, DOI 10.1109/TCYB.2013.2253605; Zeng SY, 2011, IEEE C EVOL COMPUTAT, P2041; Zhang QF, 2007, IEEE T EVOLUT COMPUT, V11, P712, DOI 10.1109/TEVC.2007.892759; Zhang QY, 2020, IEEE T EVOLUT COMPUT, V24, P260, DOI 10.1109/TEVC.2019.2922834; Zhang Z, 2008, APPL SOFT COMPUT, V8, P959, DOI 10.1016/j.asoc.2007.07.005; Zhou AM, 2007, LECT NOTES COMPUT SC, V4403, P832; Zhou AM, 2014, IEEE T CYBERNETICS, V44, P40, DOI 10.1109/TCYB.2013.2245892; Zitzler E., 2001, SPEA2 IMPROVING STRE, VVolume 103, DOI 10.3929/ethz-a-004284029; Zou J, 2017, APPL SOFT COMPUT, V61, P806, DOI 10.1016/j.asoc.2017.08.004	60	0	0	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0254839	10.1371/journal.pone.0254839	http://dx.doi.org/10.1371/journal.pone.0254839			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343178	Green Published, gold, Green Submitted			2022-12-26	WOS:000685264200001
J	Ferreira, JC; Fadl, S; Ilter, M; Pekel, H; Rezgui, R; Sensoy, O; Rabeh, WM				Ferreira, Juliana C.; Fadl, Samar; Ilter, Metehan; Pekel, Hanife; Rezgui, Rachid; Sensoy, Ozge; Rabeh, Wael M.			Dimethyl sulfoxide reduces the stability but enhances catalytic activity of the main SARS-CoV-2 protease 3CLpro	FASEB JOURNAL			English	Article						3-chymotrypsin-like protease (3CLpro); COVID-19; DMSO; initial velocity; SARS-CoV-2; thermodynamic stability	RESPIRATORY-SYNDROME-CORONAVIRUS; SARS-CORONAVIRUS; INHIBITORS; IDENTIFICATION; DIMERIZATION; HYDROLYSIS; PROTEINASE; PARAMETERS; ASSAYS; GUI	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for coronavirus disease 2019 (COVID-19), one of the most challenging global pandemics of the modern era. Potential treatment strategies against COVID-19 are yet to be devised. It is crucial that antivirals that interfere with the SARS-CoV-2 life cycle be identified and developed. 3-Chymotrypsin-like protease (3CLpro) is an attractive antiviral drug target against SARS-CoV-2, and coronaviruses in general, because of its role in the processing of viral polyproteins. Inhibitors of 3CLpro activity are screened in enzyme assays before further development of the most promising leads. Dimethyl sulfoxide (DMSO) is a common additive used in such assays and enhances the solubility of assay components. However, it may also potentially affect the stability and efficiency of 3CLpro but, to date, this effect had not been analyzed in detail. Here, we investigated the effect of DMSO on 3CLpro-catalyzed reaction. While DMSO (5%-20%) decreased the optimum temperature of catalysis and thermodynamic stability of 3CLpro, it only marginally affected the kinetic stability of the enzyme. Increasing the DMSO concentration up to 20% improved the catalytic efficiency and peptide-binding affinity of 3CLpro. At such high DMSO concentration, the solubility and stability of peptide substrate were improved because of reduced aggregation. In conclusion, we recommend 20% DMSO as the minimum concentration to be used in screens of 3CLpro inhibitors as lead compounds for the development of antiviral drugs against COVID-19.	[Ferreira, Juliana C.; Fadl, Samar; Rabeh, Wael M.] New York Univ Abu Dhabi, Sci Div, POB 129188, Abu Dhabi, U Arab Emirates; [Ilter, Metehan] Istanbul Medipol Univ, Grad Sch Engn & Nat Sci, Istanbul, Turkey; [Pekel, Hanife] Istanbul Medipol Univ, Vocat Sch Hlth Serv, Dept Pharm Serv, Istanbul, Turkey; [Pekel, Hanife; Sensoy, Ozge] Istanbul Medipol Univ, Res Inst Hlth Sci & Technol SABITA, Regenerat & Restorat Med Res Ctr REMER, Istanbul, Turkey; [Rezgui, Rachid] New York Univ Abu Dhabi, Core Technol Platforms, Abu Dhabi, U Arab Emirates; [Sensoy, Ozge] Istanbul Medipol Univ, Sch Engn & Nat Sci, Dept Comp Engn, Istanbul, Turkey	Istanbul Medipol University; Istanbul Medipol University; Istanbul Medipol University; Istanbul Medipol University	Rabeh, WM (corresponding author), New York Univ Abu Dhabi, Sci Div, POB 129188, Abu Dhabi, U Arab Emirates.	wael.rabeh@nyu.edu		rabeh, wael/0000-0001-6071-8581; ILTER, Metehan/0000-0003-3579-4552	New York University Abu Dhabi [ADC05]	New York University Abu Dhabi	New York University Abu Dhabi, Grant/Award Number: COVID--19 Facilitator Research Fund (grant number: ADC05)	Abian O, 2020, INT J BIOL MACROMOL, V164, P1693, DOI 10.1016/j.ijbiomac.2020.07.235; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Acter T, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138996; Aggarwal M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14753; Ahn DG, 2020, J MICROBIOL BIOTECHN, V30, P313, DOI 10.4014/jmb.2003.03011; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Arakawa T, 2007, BIOPHYS CHEM, V131, P62, DOI 10.1016/j.bpc.2007.09.004; ARNTFIELD SD, 1981, CAN I FOOD SC TECH J, V14, P289, DOI 10.1016/S0315-5463(81)72929-8; Bacha U, 2008, CHEM BIOL DRUG DES, V72, P34, DOI 10.1111/j.1747-0285.2008.00679.x; Bawazir A, 2018, J INFECT PUBLIC HEAL, V11, P89, DOI 10.1016/j.jiph.2017.05.003; Bereau T, 2015, J CHEM THEORY COMPUT, V11, P2783, DOI 10.1021/acs.jctc.5b00056; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chan JFW, 2013, J FORMOS MED ASSOC, V112, P372, DOI 10.1016/j.jfma.2013.05.010; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Ferreira JC., 2020, J BIOL CHEM, V296, P1; Ferreira JC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79357-0; Gioia M, 2020, BIOCHEM PHARMACOL, V182, DOI 10.1016/j.bcp.2020.114225; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Grum-Tokars V, 2008, VIRUS RES, V133, P63, DOI 10.1016/j.virusres.2007.02.015; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hilgenfeld R, 2014, FEBS J, V281, P4085, DOI 10.1111/febs.12936; Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7; Huang CK, 2004, BIOCHEMISTRY-US, V43, P4568, DOI 10.1021/bi036022q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JACKSON M, 1991, BIOCHIM BIOPHYS ACTA, V1078, P231, DOI 10.1016/0167-4838(91)90563-F; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kahn Jeffrey S, 2005, Pediatr Infect Dis J, V24, pS223, DOI 10.1097/01.inf.0000188166.17324.60; Kao RY, 2004, FEBS LETT, V576, P325, DOI 10.1016/j.febslet.2004.09.026; Khan S, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00187-20; Kuo CJ, 2004, BIOCHEM BIOPH RES CO, V318, P862, DOI 10.1016/j.bbrc.2004.04.098; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lee H, 2014, BIOORGAN MED CHEM, V22, P167, DOI 10.1016/j.bmc.2013.11.041; Lee J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19662-4; Li GD, 2020, NAT REV DRUG DISCOV, V19, P149, DOI 10.1038/d41573-020-00016-0; Guo LY, 2020, APMIS, V128, P423, DOI 10.1111/apm.13047; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; McCartney CSE, 2019, METHODS MOL BIOL, V1915, P39, DOI 10.1007/978-1-4939-8988-1_4; Mody V, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01577-x; Nawaz MH., 2018, BIOSCIENCE REP, V38, P1; Needle D, 2015, ACTA CRYSTALLOGR D, V71, P1102, DOI 10.1107/S1399004715003521; Ortiz SEM, 2001, J THERM ANAL CALORIM, V66, P489; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Qi YF, 2015, J CHEM THEORY COMPUT, V11, P4486, DOI 10.1021/acs.jctc.5b00513; Rathnayake AD, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc5332; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Ratia K, 2008, P NATL ACAD SCI USA, V105, P16119, DOI 10.1073/pnas.0805240105; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Tomar S, 2015, J BIOL CHEM, V290, P19403, DOI 10.1074/jbc.M115.651463; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; Ye G, 2016, VIROLOGY, V494, P225, DOI 10.1016/j.virol.2016.04.018; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	59	4	4	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21774	10.1096/fj.202100994	http://dx.doi.org/10.1096/fj.202100994			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34324734	Green Published			2022-12-26	WOS:000678975300032
J	Gasparotto, J; Senger, MR; Moreira, ETD; Brum, PO; Kessler, FGC; Peixoto, DO; Panzenhagen, AC; Ong, LK; Soares, MC; Reis, PA; Schirato, GV; Valente, WCG; Montoya, BOA; Silva, FP; Moreira, JCF; Dal-Pizzol, F; Castro-Faria-Neto, HC; Gelain, DP				Gasparotto, Juciano; Senger, Mario Roberto; de Sa Moreira, Emilio Telles; Brum, Pedro Ozorio; Carazza Kessler, Flavio Gabriel; Peixoto, Daniel Oppermann; Panzenhagen, Alana Castro; Ong, Lin Kooi; Soares, Marlene Campos; Reis, Patricia Alves; Schirato, Giuliana Viegas; Goes Valente, Walter Cesar; Araujo Montoya, Bogar Omar; Silva, Floriano P.; Fonseca Moreira, Jose Claudio; Dal-Pizzol, Felipe; Castro-Faria-Neto, Hugo C.; Gelain, Daniel Pens			Neurological impairment caused by Schistosoma mansoni systemic infection exhibits early features of idiopathic neurodegenerative disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; TAU; NEUROSCHISTOSOMIASIS; PHOSPHORYLATION; PATHOLOGY; MICROGLIA; RECEPTOR; PROTEIN; SEPSIS	Schistosomiasis, a neglected tropical disease caused by trematodes of the Schistosoma genus, affects over 250 million people around the world. This disease has been associated with learning and memory deficits in children, whereas reduced attention levels, impaired work capacity, and cognitive deficits have been observed in adults. Strongly correlated with poverty and lack of basic sanitary conditions, this chronic endemic infection is common in Africa, South America, and parts of Asia and contributes to inhibition of social development and low quality of life in affected areas. Nonetheless, studies on the mechanisms involved in the neurological impairment caused by schistosomiasis are scarce. Here, we used a murine model of infection with Schistosoma mansoni in which parasites do not invade the central nervous system to evaluate the consequences of systemic infection on neurologic function. We observed that systemic infection with S. mansoni led to astrocyte and microglia activation, expression of oxidative stress-induced transcription factor Nrf2, oxidative damage, Tau phosphorylation, and amyloid-beta peptide accumulation in the prefrontal cortex of infected animals. We also found impairment in spatial learning and memory as evaluated by the Morris water maze task. Administration of anthelmintic (praziquantel) and antioxidant (N-acetylcysteine plus deferoxamine) treatments was effective in inhibiting most of these phenotypes, and the combination of both treatments had a synergistic effect to prevent such changes. These data demonstrate new perspectives toward the understanding of the pathology and possible therapeutic approaches to counteract long-term effects of systemic schistosomiasis on brain function.	[Gasparotto, Juciano; Senger, Mario Roberto; Brum, Pedro Ozorio; Carazza Kessler, Flavio Gabriel; Peixoto, Daniel Oppermann; Panzenhagen, Alana Castro; Soares, Marlene Campos; Fonseca Moreira, Jose Claudio; Gelain, Daniel Pens] Univ Fed Rio Grande do Sul, Dept Bioquim, Ctr Estudos Estresse Oxidat, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil; [Senger, Mario Roberto; de Sa Moreira, Emilio Telles; Schirato, Giuliana Viegas; Goes Valente, Walter Cesar; Araujo Montoya, Bogar Omar; Silva, Floriano P.] Fundacao Oswaldo Cruz, Lab Bioquim Expt & Comp Formacos, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Ong, Lin Kooi] Monash Univ Malaysia, Sch Pharm, Bandar Sunway, Selangor, Malaysia; [Ong, Lin Kooi] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [Ong, Lin Kooi] Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW, Australia; [Reis, Patricia Alves; Castro-Faria-Neto, Hugo C.] Fundacao Oswaldo Cruz, Lab Imunofarmacol, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Dal-Pizzol, Felipe] Univ Extremo Sul Catarinense, Lab Fisiopatol Expt, Programa Posgrad Ciencias Saude, Criciuma, SC, Brazil	Universidade Federal do Rio Grande do Sul; Fundacao Oswaldo Cruz; Monash University; Monash University Sunway; University of Newcastle; University of Newcastle; Fundacao Oswaldo Cruz; Universidade do Extremo Sul Catarinense	Gelain, DP (corresponding author), Univ Fed Rio Grande do Sul, Dept Bioquim, Ctr Estudos Estresse Oxidat, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil.	daniel.gelain@ufrgs.br	Panzenhagen, Alana Castro/ABG-8126-2021; Reis, Patricia/L-9045-2015; Silva-Jr, Floriano/B-1343-2013; Panzenhagen, Alana Castro/AAA-4545-2021; Panzenhagen, Alana Castro/ABH-2680-2021; Ong, Lin Kooi/H-2797-2012; Gasparotto, Juciano/K-3239-2013; Araujo Montoya, Bogar Omar/G-8545-2019	Panzenhagen, Alana Castro/0000-0002-8844-3468; Reis, Patricia/0000-0003-1861-9517; Silva-Jr, Floriano/0000-0003-4560-1291; Ong, Lin Kooi/0000-0001-8664-0540; , Marlene/0000-0001-6480-7151; Ozorio Brum, Pedro/0000-0002-5858-8017; Gasparotto, Juciano/0000-0003-2545-7288; Araujo Montoya, Bogar Omar/0000-0002-2954-2271	PQ-CNPq fellowship; PDS-CNPq fellowship	PQ-CNPq fellowship; PDS-CNPq fellowship	M. R. S. was a recipient of a PDS-CNPq fellowship, and D. P. G. was a recipient of a PQ-CNPq fellowship.	Alafuzoff I, 2008, BRAIN PATHOL, V18, P484, DOI 10.1111/j.1750-3639.2008.00147.x; Aloe L, 1998, PARASITOL TODAY, V14, P314, DOI 10.1016/S0169-4758(98)01283-6; Bourdenx M, 2017, PROG NEUROBIOL, V155, P171, DOI 10.1016/j.pneurobio.2015.07.003; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cervellati C, 2020, ANTIOXID REDOX SIGN, V33, P191, DOI 10.1089/ars.2020.8076; Chia R, 2018, LANCET NEUROL, V17, P94, DOI 10.1016/S1474-4422(17)30401-5; Colley DG, 2014, PARASITE IMMUNOL, V36, P347, DOI 10.1111/pim.12087; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; de Oliveira RB, 2013, INT J PARASITOL, V43, P371, DOI 10.1016/j.ijpara.2012.12.006; Escobedo G, 2009, NEUROIMMUNOMODULAT, V16, P78, DOI 10.1159/000180262; Ezeamama AE, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0005524; Ferrari TCA, 2011, LANCET NEUROL, V10, P853, DOI 10.1016/S1474-4422(11)70170-3; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Gasparotto J, 2018, J BIOL CHEM, V293, P226, DOI 10.1074/jbc.M117.786756; Gasparotto J, 2017, BRAIN BEHAV IMMUN, V62, P124, DOI 10.1016/j.bbi.2017.01.008; Gasparotto J, 2015, BRAIN BEHAV IMMUN, V43, P37, DOI 10.1016/j.bbi.2014.06.204; Gouras GK, 2014, NEURODEGENER DIS, V13, P142, DOI 10.1159/000354776; Guimaraes AG, 2012, N-S ARCH PHARMACOL, V385, P253, DOI 10.1007/s00210-011-0715-x; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Johnson SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10607; Jukes MCH, 2002, TROP MED INT HEALTH, V7, P104, DOI 10.1046/j.1365-3156.2002.00843.x; Kimura T, 1996, DEMENTIA, V7, P177, DOI 10.1159/000106875; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Kongsui R, 2015, NEUROSCIENCE, V310, P629, DOI 10.1016/j.neuroscience.2015.09.061; KVALSVIG JD, 1991, ANN TROP MED PARASIT, V85, P551, DOI 10.1080/00034983.1991.11812608; KVALSVIG JD, 1988, ANN TROP MED PARASIT, V82, P471, DOI 10.1080/00034983.1988.11812278; KVALSVIG JD, 1988, PARASITOL TODAY, V4, P206, DOI 10.1016/0169-4758(88)90158-5; Lambertucci JR, 2014, REV SOC BRAS MED TRO, V47, P251, DOI 10.1590/0037-8682-0083-2013; Magalhaes TNC, 2018, MOL NEUROBIOL, V55, P5689, DOI 10.1007/s12035-017-0795-9; McManus DP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0013-8; Mondragon-Rodriguez S, 2014, NEUROPATH APPL NEURO, V40, P121, DOI 10.1111/nan.12084; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nunez Joseph, 2008, J Vis Exp, DOI 10.3791/897; Salminen LE, 2014, REV NEUROSCIENCE, V25, P805, DOI 10.1515/revneuro-2014-0046; Schaffert LN, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10040232; Silva LM, 2002, MEM I OSWALDO CRUZ, V97, P599, DOI 10.1590/S0074-02762002000400028; Steckert AV, 2014, CURR NEUROVASC RES, V11, P83, DOI 10.2174/1567202610666131211111012; Thal DR, 2014, J ALZHEIMERS DIS, V42, pS421, DOI 10.3233/JAD-141461; Vale TC, 2012, NEUROLOGIST, V18, P333, DOI 10.1097/NRL.0b013e3182704d1e; Verjovski-Almeida S, 2004, TRENDS PARASITOL, V20, P304, DOI 10.1016/j.pt.2004.04.012; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031	43	3	3	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100979	10.1016/j.jbc.2021.100979	http://dx.doi.org/10.1016/j.jbc.2021.100979			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34303703	gold, Green Published, Green Accepted			2022-12-26	WOS:000690873500014
J	Tomiga, Y; Sakai, K; Ra, SG; Kusano, M; Ito, A; Uehara, Y; Takahashi, H; Kawanaka, K; Soejima, H; Higaki, Y				Tomiga, Yuki; Sakai, Kazuya; Ra, Song-Gyu; Kusano, Masaki; Ito, Ai; Uehara, Yoshinari; Takahashi, Hirokazu; Kawanaka, Kentaro; Soejima, Hidenobu; Higaki, Yasuki			Short-term running exercise alters DNA methylation patterns in neuronal nitric oxide synthase and brain-derived neurotrophic factor genes in the mouse hippocampus and reduces anxiety-like behaviors	FASEB JOURNAL			English	Article						anxiety; BDNF; DNA methylation; exercise; hippocampus; nNOS	PHYSICAL-EXERCISE; ENVIRONMENTAL ENRICHMENT; CELL-PROLIFERATION; 5-HT1A RECEPTOR; UP-REGULATION; BDNF; EXPRESSION; MEMORY; NEUROGENESIS; NNOS	Running exercise has beneficial effects on brain health. However, the effects of relatively short-term running exercise (STEx) on behavior, and its underlying signaling pathways, are poorly understood. In this study, we evaluated the possibility that the regulation by STEx of brain-derived neurotrophic factor (BDNF) and neuronal nitric oxide synthase (nNOS, encoded by NOS1), which are important molecules for anxiety regulation, might involve mechanisms of epigenetic modification, such as DNA methylation. C57BL/6J male mice were divided into sedentary (SED, n = 12) and STEx (EX, n = 15) groups; STEx was conducted with the mice for a duration of 11 days. STEx reduced anxiety-like behaviors, and STEx reduced Nos1 alpha and increased Bdnf exon I and IV mRNA levels in the hippocampus. Interestingly, behavioral parameters were associated with Bdnf exon I and IV and Nos1 alpha mRNA levels in the ventral, but not dorsal, hippocampal region. However, STEx had no effect on peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (Pgc-1 alpha) or fibronectin type III domain-containing 5 (Fndc5) mRNA levels, which are relatively long-term exercise-induced upstream regulators of BDNF. In parallel with gene expression changes, we found, for the first time, that STEx downregulated Bdnf promoter IV and upregulated Nos1 DNA methylation levels in the hippocampus, and these patterns were partially different between the dorsal and ventral regions. These findings suggest that the beneficial effects of running exercise on mood regulation may be controlled by alterations in epigenetic mechanisms, especially in the ventral hippocampus. These effects occur even after a relatively short-term period of exercise.	[Tomiga, Yuki; Ra, Song-Gyu; Ito, Ai; Uehara, Yoshinari; Kawanaka, Kentaro; Higaki, Yasuki] Fukuoka Univ, Inst Phys Act, Fukuoka, Japan; [Tomiga, Yuki; Takahashi, Hirokazu] Saga Univ, Fac Med, Divis Metab & Endocrinol, Saga, Japan; [Tomiga, Yuki] Japan Soc Promot Sci, Tokyo, Japan; [Sakai, Kazuya; Kusano, Masaki] Fukuoka Univ, Grad Sch Sports & Hlth Sci, Fukuoka, Japan; [Ra, Song-Gyu] Tokushima Univ, Inst Liberal Arts & Sci, Tokushima, Japan; [Ra, Song-Gyu; Uehara, Yoshinari; Kawanaka, Kentaro; Higaki, Yasuki] Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka, Japan; [Takahashi, Hirokazu] Saga Univ Hosp, Liver Ctr, Saga, Japan; [Soejima, Hidenobu] Saga Univ, Fac Med, Dept Biomol Sci, Div Mol Genet & Epigenet, Saga, Japan	Fukuoka University; Saga University; Japan Society for the Promotion of Science; Fukuoka University; Tokushima University; Fukuoka University; Saga University; Saga University	Tomiga, Y (corresponding author), Fukuoka Univ, Inst Phys Act, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	tomiga0507@gmail.com	Ra, Song-Gyu/AFM-3003-2022	Ra, Song-Gyu/0000-0002-8685-4554; Soejima, Hidenobu/0000-0001-5076-6563	Japan Society for the Promotion of Science (JSPS) KAKENHI [19H04012, 19K21505, 20K19502]; Fukuoka University [177011, 197110]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fukuoka University	Japan Society for the Promotion of Science (JSPS) KAKENHI, Grant/Award Number: 19H04012, 19K21505 and 20K19502; Fukuoka University, Grant/Award Number: 177011 and 197110	Abbasian S, 2020, BRAIN RES, V1729, DOI 10.1016/j.brainres.2019.146618; Alomari MA, 2013, BEHAV BRAIN RES, V247, P34, DOI 10.1016/j.bbr.2013.03.007; Azimi M, 2018, PEPTIDES, V102, P78, DOI 10.1016/j.peptides.2017.12.027; Baj G, 2012, NEUROPSYCHOPHARMACOL, V37, P1600, DOI 10.1038/npp.2012.5; Baldelli S, 2014, J CELL SCI, V127, P4813, DOI 10.1242/jcs.154229; Balke JE, 2019, NITRIC OXIDE-BIOL CH, V82, P35, DOI 10.1016/j.niox.2018.11.004; Bannerman DM, 2014, NAT REV NEUROSCI, V15, P181, DOI 10.1038/nrn3677; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Bartling B, 2017, EXP GERONTOL, V87, P139, DOI 10.1016/j.exger.2016.04.011; Belviranli M, 2018, NEUROMOL MED, V20, P386, DOI 10.1007/s12017-018-8500-3; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; CHAOULOFF F, 1994, NEUROSCI LETT, V176, P226, DOI 10.1016/0304-3940(94)90088-4; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; de Mello MT, 2013, J AFFECT DISORDERS, V149, P241, DOI 10.1016/j.jad.2013.01.035; El Hayek L, 2019, J NEUROSCI, V39, P2369, DOI 10.1523/JNEUROSCI.1661-18.2019; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Ferreira AFB, 2011, BRAIN RES, V1425, P111, DOI 10.1016/j.brainres.2011.10.004; Garza AA, 2004, PHARMACOL BIOCHEM BE, V77, P209, DOI 10.1016/j.pbb.2003.10.020; Gasparoni G, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0211-3; Gomez-Pinilla F, 2011, EUR J NEUROSCI, V33, P383, DOI 10.1111/j.1460-9568.2010.07508.x; Heldt SA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.101; Ihara H, 2006, NITRIC OXIDE-BIOL CH, V15, P13, DOI 10.1016/j.niox.2005.11.011; JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q; Kashimoto RK, 2016, BEHAV BRAIN RES, V296, P286, DOI 10.1016/j.bbr.2015.08.038; King-Himmelreich TS, 2016, BIOCHEM BIOPH RES CO, V474, P284, DOI 10.1016/j.bbrc.2016.04.078; Klein C, 2016, NEUROBIOL LEARN MEM, V131, P26, DOI 10.1016/j.nlm.2016.03.002; Klempin F, 2013, J NEUROSCI, V33, P8270, DOI 10.1523/JNEUROSCI.5855-12.2013; Koehl M, 2008, FASEB J, V22, P2253, DOI 10.1096/fj.07-099101; Kondo M, 2015, MOL PSYCHIATR, V20, P1428, DOI 10.1038/mp.2014.153; Kundakovic M, 2015, P NATL ACAD SCI USA, V112, P6807, DOI 10.1073/pnas.1408355111; Liu SG, 2017, NEUROCHEM INT, V108, P230, DOI 10.1016/j.neuint.2017.04.005; Liu YF, 2008, NEUROBIOL LEARN MEM, V90, P81, DOI 10.1016/j.nlm.2008.02.005; Llorens-Martin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012188; LLorens-Martin M, 2010, MOL CELL NEUROSCI, V44, P109, DOI 10.1016/j.mcn.2010.02.006; Moon HY, 2016, CELL METAB, V24, P332, DOI 10.1016/j.cmet.2016.05.025; Morgan JA, 2018, BEHAV BRAIN RES, V337, P193, DOI 10.1016/j.bbr.2017.09.022; O'Callaghan RM, 2007, BEHAV BRAIN RES, V176, P362, DOI 10.1016/j.bbr.2006.10.018; Otsuka T, 2016, BEHAV BRAIN RES, V298, P44, DOI 10.1016/j.bbr.2015.10.055; Petrus DS, 2009, EUR J NEUROSCI, V29, P244, DOI 10.1111/j.1460-9568.2008.06579.x; Pinar Cristina, 2018, Brain Plast, V4, P185, DOI 10.3233/BPL-170052; Putzke J, 2000, MOL BRAIN RES, V85, P13, DOI 10.1016/S0169-328X(00)00220-5; Schoenfeld TJ, 2013, J NEUROSCI, V33, P7770, DOI 10.1523/JNEUROSCI.5352-12.2013; Sleiman SF, 2016, ELIFE, V5, DOI 10.7554/eLife.15092; Soya H, 2007, BIOCHEM BIOPH RES CO, V358, P961, DOI 10.1016/j.bbrc.2007.04.173; Stanquini LA, 2018, ACTA NEUROPSYCHIATR, V30, P127, DOI 10.1017/neu.2017.28; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Takahashi H, 2019, NAT METAB, V1, P291, DOI 10.1038/s42255-018-0030-7; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tillmann S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182698; Tomiga Y, 2019, J PHYSIOL-LONDON, V597, P5145, DOI 10.1113/JP277019; Tomiga Y, 2019, J PHYSIOL SCI, V69, P711, DOI 10.1007/s12576-019-00686-5; Tomiga Y, 2017, NITRIC OXIDE-BIOL CH, V66, P71, DOI 10.1016/j.niox.2017.03.002; Tomiga Y, 2016, BIOCHEM BIOPH RES CO, V476, P635, DOI 10.1016/j.bbrc.2016.06.010; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Volke V, 2003, BEHAV BRAIN RES, V140, P141, DOI 10.1016/S0166-4328(02)00312-1; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Zhang J, 2010, J NEUROSCI, V30, P2433, DOI 10.1523/JNEUROSCI.5880-09.2010; Zheng J, 2017, J NEUROSCI, V37, P4145, DOI 10.1523/JNEUROSCI.3333-16.2017	61	6	6	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21767	10.1096/fj.202100630R	http://dx.doi.org/10.1096/fj.202100630R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34325488				2022-12-26	WOS:000678975300047
J	Abdel-Sattar, M; Al-Obeed, RS; Aboukarima, AM; Eshra, DH				Abdel-Sattar, Mahmoud; Al-Obeed, Rashid S.; Aboukarima, Abdulwahed M.; Eshra, Dalia H.			Development of an artificial neural network as a tool for predicting the chemical attributes of fresh peach fruits	PLOS ONE			English	Article							SOLUBLE SOLIDS; FLESH PEACH; QUALITY; ACID; CULTIVARS; COLOR; ACCEPTANCE; STABILITY; DENSITY; FLAVOR	This investigation aimed to develop a method to predict the total soluble solids (TSS), titratable acidity, TSS/titratable acidity, vitamin C, anthocyanin, and total carotenoids contents using surface color values (L*, Hue and chroma), single fruit weight, juice volume, and sphericity percent of fresh peach fruit. Multiple regression analysis (MLR) and an artificial neural network (ANN) were employed. An ANN model was developed with six inputs and 15 neurons in the first hidden layer for the prediction of six chemical composition parameters. The results confirmed that the ANN model R-2 = 974-0.998 outperformed the MLR models R-2 = 0.473-0.840 using testing dataset. Moreover, sensitivity analysis revealed that the juice volume was the most dominating parameter for the prediction of titratable acidity, TSS/titratable acidity and vitamin C with corresponding contribution values of 39.97%, 50.40%, and 33.08%, respectively. In addition, sphericity percent contributed by 23.70% to anthocyanin and by 24.08% to total carotenoids. Furthermore, hue on TSS prediction was the highest compared with the other parameters, with a contribution percentage of 20.86%. Chroma contributed by different values to all variables in the range of 5.29% to 19.39%. Furthermore, fruit weight contributed by different values to all variables in the range of 16.67% to 23.48%. The ANN prediction method denotes a promising methodology to estimate targeted chemical composition levels of fresh peach fruits. The information of peach quality reported in this investigation can be used as a baseline for understanding and further examining peach fruit quality.	[Abdel-Sattar, Mahmoud; Al-Obeed, Rashid S.] King Saud Univ, Dept Plant Prod, Coll Food & Agr Sci, Riyadh, Saudi Arabia; [Abdel-Sattar, Mahmoud] Alexandria Univ, Pomol Dept, Fac Agr, Alexandria, Egypt; [Aboukarima, Abdulwahed M.] King Saud Univ, Dept Agr Engn, Coll Food & Agr Sci, Riyadh, Saudi Arabia; [Aboukarima, Abdulwahed M.] Agr Res Ctr, Agr Engn Res Inst, Giza, Egypt; [Eshra, Dalia H.] Alexandria Univ, Food Sci & Technol Dept, Fac Agr, Alexandria, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Alexandria University; King Saud University; Egyptian Knowledge Bank (EKB); Agricultural Research Center - Egypt; Egyptian Knowledge Bank (EKB); Alexandria University	Abdel-Sattar, M (corresponding author), King Saud Univ, Dept Plant Prod, Coll Food & Agr Sci, Riyadh, Saudi Arabia.; Abdel-Sattar, M (corresponding author), Alexandria Univ, Pomol Dept, Fac Agr, Alexandria, Egypt.	mmarzouk1@ksu.edu.sa		Abdel-Sattar, Mahmoud/0000-0002-9317-109X	Deanship of Scientific Research at King Saud University through College of Food and Agriculture Sciences Research Center	Deanship of Scientific Research at King Saud University through College of Food and Agriculture Sciences Research Center	The authors extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for supporting the work through College of Food and Agriculture Sciences Research Center.	Abd El-Megeed N A, 2017, TIKRIT J AGR SCI, V17, P1; Adobe Systems, 2002, AD PHOT 7 0 US GUID; Alexandre H.V., 2014, COMUNICATA SCI, V5, P83, DOI [10.5327/rcaa.v16i1.1400, DOI 10.5327/RCAA.V16I1.1400]; Barrett DM, 2010, CRIT REV FOOD SCI, V50, P369, DOI 10.1080/10408391003626322; Bassi D., 1990, Advances in Horticultural Science, V4, P107; Baykal H, 2013, CRIT REV FOOD SCI, V53, P415, DOI 10.1080/10408398.2010.540359; Belisle C, 2018, HORTTECHNOLOGY, V28, P189, DOI 10.21273/HORTTECH03870-17; Bertolaccini L, 2017, J THORAC DIS, V9, P924, DOI 10.21037/jtd.2017.03.157; Cantin CM, 2009, J SCI FOOD AGR, V89, P1909, DOI 10.1002/jsfa.3672; Chayjan R. A., 2007, International Journal of Agriculture and Biology, V9, P816; Cimpoiu C, 2011, FOOD CHEM, V127, P1323, DOI 10.1016/j.foodchem.2011.01.091; Cirilli M, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2015.67; Clareton M., 2000, SUMM PRUN BREED M EM, P83; Colaric M, 2005, J SCI FOOD AGR, V85, P2611, DOI 10.1002/jsfa.2316; Contador L, 2011, J HORTIC SCI BIOTECH, V86, P255, DOI 10.1080/14620316.2011.11512758; Crisosto CH, 2005, POSTHARVEST BIOL TEC, V38, P239, DOI 10.1016/j.postharvbio.2005.07.007; Di Vaio C, 2015, J SCI FOOD AGR, V95, P2124, DOI 10.1002/jsfa.6929; Eftekhari M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00837; Fathi H., 2013, Crop Breeding Journal, V3, P31; Furferi R, 2007, COMPUT ELECTRON AGR, V55, P115, DOI 10.1016/j.compag.2006.12.006; Gaithersburg Maryl D.C., 2005, OFFICIAL METHODS ANA, V17; García Enrique Quevedo, 2018, Rev. Bras. Frutic., V40, pe, DOI 10.1590/0100-29452018040; Harker FR, 2002, POSTHARVEST BIOL TEC, V24, P241, DOI 10.1016/S0925-5214(01)00157-0; Hassan-Beygi S. R., 2007, International Journal of Agriculture and Biology, V9, P494; Suarez MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128566; Huang X, 2021, SCI HORTIC-AMSTERDAM, V278, DOI 10.1016/j.scienta.2020.109873; Itle RA, 2009, HORTSCIENCE, V44, P633, DOI 10.21273/HORTSCI.44.3.633; Jamshidi S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00274; Kader AA, 1999, ACTA HORTIC, P203, DOI 10.17660/ActaHortic.1999.485.27; Kader AA., 2002, POSTHARVEST TECHNOLO, P3311; Kader AA, 2008, J SCI FOOD AGR, V88, P1863, DOI 10.1002/jsfa.3293; Khairunniza-Bejo S., 2014, J FOOD ENG, V4, P1, DOI DOI 10.17265/2159-5828/2014.01.001; Khalifa SM., 2018, ANN AGR SCI MOSHTOHO, V56, P397; Khalifa S, 2011, AUST J CROP SCI, V5, P516; Kortei N. K., 2015, Hrvatski Casopis za Prehrambenu Tehnologiju Biotehnologiju i Nutricionizam - Croatian Journal of Food Technology, Biotechnology and Nutrition, V10, P66; Lopez G, 2011, HORTTECHNOLOGY, V21, P712, DOI 10.21273/HORTTECH.21.6.712; Lyu J, 2017, J FOOD SCI TECH MYS, V54, P3818, DOI 10.1007/s13197-017-2788-0; Magwaza LS, 2015, SCI HORTIC-AMSTERDAM, V184, P179, DOI 10.1016/j.scienta.2015.01.001; MARINI RP, 1994, J AM SOC HORTIC SCI, V119, P180, DOI 10.21273/JASHS.119.2.180; Matias Rosana Gonçalves Pires, 2017, Rev. Ceres, V64, P516, DOI 10.1590/0034-737x201764050009; Morais KD B., 2017, ENGENHARIA AGR, V25, P157; MORAN R, 1980, PLANT PHYSIOL, V65, P478, DOI 10.1104/pp.65.3.478; Mori K, 2007, J EXP BOT, V58, P1935, DOI 10.1093/jxb/erm055; Moulton K.S., 1991, CALIF AGR, V45, P14, DOI DOI 10.3733/CA.V045N02P14; Ortiz A, 2008, ACTA HORTIC, P225, DOI 10.17660/ActaHortic.2008.796.30; Pagano M., 2012, PRINCIPIOS BIOESTATI, P506; Matias RGP, 2016, CROP BREED APPL BIOT, V16, P348, DOI 10.1590/1984-70332016v16n4n51; Quilot B, 2004, SCI HORTIC-AMSTERDAM, V99, P387, DOI 10.1016/S0304-4238(03)00110-9; RABINO I, 1977, PLANT PHYSIOL, V59, P569, DOI 10.1104/pp.59.4.569; Rai P, 2005, J FOOD ENG, V68, P527, DOI 10.1016/j.jfoodeng.2004.07.003; Rakonjac V, 2008, J CENT EUR AGRIC, V9, P161; Sansavini S, 1997, ACTA HORTIC, P559, DOI 10.17660/ActaHortic.1997.451.65; Silva D. F. P. da, 2016, Comunicata Scientiae, V7, P149, DOI 10.14295/cs.v7i1.781; Silva SF, 2015, FOOD CHEM, V179, P35, DOI 10.1016/j.foodchem.2015.01.100; Vesta Services Inc, 2000, QNET 2000 SHAR, P60093; Vivek K, 2018, J FOOD MEAS CHARACT, V12, P923, DOI 10.1007/s11694-017-9708-x; Wahdan M. T., 2011, The Journal of American Science, V7, P373; Williams JG, 2000, CIR, V299D, P10; Yalcin H, 2012, EUR J LIPID SCI TECH, V114, P1217, DOI 10.1002/ejlt.201200040; Yam KL, 2004, J FOOD ENG, V61, P137, DOI 10.1016/S0260-8774(03)00195-X; Zhang D., 2005, INT J COMPUTATIONAL, V1, P106; Zohrabi S., 2013, WORLD SCI J, V4, P107	62	4	4	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0251185	10.1371/journal.pone.0251185	http://dx.doi.org/10.1371/journal.pone.0251185			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329308	Green Published, gold			2022-12-26	WOS:000685248600058
J	Nozad-Bonab, Z; Hejazi, MJ; Iranipour, S; Arzanlou, M; Biondi, A				Nozad-Bonab, Zahra; Hejazi, Mir Jalil; Iranipour, Shahzad; Arzanlou, Mehdi; Biondi, Antonio			Lethal and sublethal effects of synthetic and bio-insecticides on Trichogramma brassicae parasitizing Tuta absoluta	PLOS ONE			English	Article							MEYRICK LEPIDOPTERA-GELECHIIDAE; FUNGUS METARHIZIUM-ANISOPLIAE; SEX PHEROMONAL COMMUNICATION; TOMATO LEAF MINER; BIOLOGICAL-CONTROL; HYMENOPTERA TRICHOGRAMMATIDAE; NATURAL ENEMIES; 1ST REPORT; ENTOMOPATHOGENIC NEMATODES; BACILLUS-THURINGIENSIS	The tomato leaf miner (TLM), Tuta absoluta (Meyrick), is an invasive tomato pest found worldwide. Sustainable control strategies aimed at increasing biological control approaches and decreasing chemical inputs are required, due to the tendency to develop insecticide resistance. In this study, the lethal and sublethal effects of four chemical insecticides (abamectin, indoxacarb, chlorantraniliprole, and spinosad) and the sublethal effects of the entomopathogenic fungus Metarhizium anisopliae (Metschnikoff) on a widespread TLM egg parasitoid, Trichogramma brassicae Bezdenko, were estimated. Concentration mortality response bioassays enabled the estimation of lethal concentrations of the tested insecticides for the parasitoids, with chlorantraniliprole having the lowest LC50 and indoxacarb the highest. The LC25 and LC50 of the tested insecticides on the TLM were sprayed on eggs and then offered at three time intervals to the parasitoids. The fertility and other life table parameters of the individuals emerging from the treated eggs were estimated. All of the chemical insecticides, but not the fungus, had harmful effects on T. brassicae. The insecticide applications caused a 3.84-5.17 times reduction in the net reproductive rate (R-0) compared with the control. No parameters were affected by spraying the fungus in the 0h treatment, but effects were recorded at 24 and/or 48h, except for the gross reproduction rate (GRR). The value of the intrinsic rate of increase (r(m)) also decreased to 0.528-0.617 after the insecticide treatments. The doubling time (DT) increased in all treatments compared to the control. Nevertheless, the generation time (T) was only very slightly affected. In addition, in the combination experiments, M. anisopliae showed a remarkable synergism with T. brassicae in controlling TLM eggs. These results indicate that low levels of lethal effects on key biological control agents should be considered in the choice of insecticides to be included in sustainable TLM control packages.	[Nozad-Bonab, Zahra] Univ Tabriz, Tabriz, Iran; [Hejazi, Mir Jalil; Iranipour, Shahzad; Arzanlou, Mehdi] Univ Tabriz, Dept Plant Protect, Fac Agr, Tabriz, Iran; [Biondi, Antonio] Univ Catania, Dept Agr Food & Environm, Catania, Italy	University of Tabriz; University of Tabriz; University of Catania	Nozad-Bonab, Z (corresponding author), Univ Tabriz, Tabriz, Iran.	nozadbonab@yahoo.com	BIONDI, Antonio/I-6381-2012	BIONDI, Antonio/0000-0002-1982-7716				Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abdelmaksoud NM., 2020, B NATL RES CENT, V44, P126; Ahmadi S, 2018, J ECON ENTOMOL, V111, P2667, DOI 10.1093/jee/toy212; Ahmadipour R., 2015, BIOCONTROL PLANT PRO, V3, P109; Alsaedi Ghazwan, 2017, Open Journal of Ecology, V7, P112, DOI 10.4236/oje.2017.72009; Arno J, 2018, BIOL CONTROL, V122, P41, DOI 10.1016/j.biocontrol.2018.03.016; Baniameri V., 2012, Bulletin OEPP, V42, P322, DOI 10.1111/epp.2577; Bielza P, 2020, PEST MANAG SCI, V76, P3517, DOI 10.1002/ps.5857; Biondi A, 2018, ANNU REV ENTOMOL, V63, P239, DOI 10.1146/annurev-ento-031616-034933; Biondi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076548; Biondi A, 2012, PEST MANAG SCI, V68, P1523, DOI 10.1002/ps.3396; Blibech I., 2015, ADV CHEM ENG SCI, V5, P362, DOI [10.4236/aces.2015.53038, DOI 10.4236/ACES.2015.53038]; Bodino N, 2019, J PEST SCI, V92, P1467, DOI 10.1007/s10340-018-1025-6; Cabello T, 2012, J ECON ENTOMOL, V105, P2085, DOI 10.1603/EC12221; Campolo O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13413-0; Campos MR, 2017, J PEST SCI, V90, P787, DOI 10.1007/s10340-017-0867-7; Carey J. R., 1993, APPL DEMOGRAPHY BIOL; Carvalho G. A., 2003, Acta Scientiarum - Agronomy, V25, P275; Chailleux A, 2013, J ECON ENTOMOL, V106, P2310, DOI 10.1603/EC13092; Chailleux A, 2013, J PEST SCI, V86, P533, DOI 10.1007/s10340-013-0498-6; Chailleux A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048068; Cherif A, 2019, ENTOMOL GEN, V39, P1, DOI 10.1127/entomologia/2019/0685; Chi H, 2006, ENVIRON ENTOMOL, V35, P10, DOI 10.1603/0046-225X-35.1.10; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Chi H., 2021, 2 SEX MSCHART COMPUT; Chi H, 2020, ENTOMOL GEN, V40, P103, DOI 10.1127/entomologia/2020/0936; Consoli FL, 1998, J APPL ENTOMOL, V122, P43, DOI 10.1111/j.1439-0418.1998.tb01459.x; Consoli FL, 2001, J APPL ENTOMOL, V125, P37, DOI 10.1046/j.1439-0418.2001.00513.x; Contreras J, 2014, J ECON ENTOMOL, V107, P121, DOI 10.1603/EC13404; Dai CC, 2020, CHEMOSPHERE, V256, DOI 10.1016/j.chemosphere.2020.126986; Fernandes MED, 2008, SOCIOBIOLOGY, V51, P765; Dehliz A., 2015, Academic Journal of Entomology, V8, P72; Delpuech JM, 1998, CHEMOSPHERE, V36, P1775, DOI 10.1016/S0045-6535(97)10071-6; Delpuech JM, 1999, CHEMOSPHERE, V38, P729, DOI 10.1016/S0045-6535(98)00310-5; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Doganlar M, 2011, KAHRAMANMARAS SUTCU, V14, P28; Efron B., 1994, INTRO BOOTSTRAP; El-Arnaouty SA, 2014, AFR ENTOMOL, V22, P801, DOI 10.4001/003.022.0410; Fernandes Flavio Lemes, 2010, EntomoBrasilis, V3, P1; Finney DJ, PROBIT ANAL; FORSCHLER BT, 1991, J INVERTEBR PATHOL, V58, P396, DOI 10.1016/0022-2011(91)90186-T; Garcia-del-Pino F, 2013, BIOCONTROL, V58, P723, DOI 10.1007/s10526-013-9525-z; Ghoneim K., 2014, Journal of Entomology and Zoology Studies, V2, P52; Ghoneim K, 2014, INT J ADV RES, V2, P81, DOI DOI 10.1017/S0007485310000404; Gomez-Valderrama J, 2014, INT J PEST MANAGE, V60, P136, DOI 10.1080/09670874.2014.941043; Gontijo L, 2019, J PEST SCI, V92, P1479, DOI 10.1007/s10340-019-01091-y; Guedes RNC, 2019, J PEST SCI, V92, P1329, DOI 10.1007/s10340-019-01086-9; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Gul H, 2019, ENTOMOL GEN, V39, P81, DOI 10.1127/entomologia/2019/0861; Guo XJ, 2019, ENTOMOL GEN, V39, P239, DOI 10.1127/entomologia/2019/0853; Han P, 2019, J PEST SCI, V92, P1317, DOI 10.1007/s10340-018-1062-1; Hewa-Kapuge S, 2003, J ECON ENTOMOL, V96, P1083, DOI 10.1603/0022-0493-96.4.1083; Hossain MB, 2006, J APPL ENTOMOL, V130, P360, DOI 10.1111/j.1439-0418.2006.01072.x; Huang HW, 2018, J ECON ENTOMOL, V111, P1, DOI 10.1093/jee/tox330; Kaaya GP, 2000, EXP APPL ACAROL, V24, P913, DOI 10.1023/A:1010722914299; Khan MA, 2020, J PLANT DIS PROTECT, V127, P81, DOI 10.1007/s41348-019-00280-2; Koppenhofer AM, 1997, BIOL CONTROL, V8, P131, DOI 10.1006/bcon.1996.0498; Li XY, 2019, ENTOMOL GEN, V39, P313, DOI 10.1127/entomologia/2019/0857; Liang HY, 2021, ENTOMOL GEN, V41, P219, DOI 10.1127/entomologia/2020/0902; Lietti MMM, 2005, NEOTROP ENTOMOL, V34, P113, DOI 10.1590/S1519-566X2005000100016; Luckmann W.H., 1982, INTRO INSECT PEST MA, P135, DOI [10.1016/0013-9351%2882%2990067-6, DOI 10.1016/0013-9351%2882%2990067-6]; Luna M. G., 2012, Bulletin OEPP, V42, P260, DOI 10.1111/epp.2564; Lundgren JG, 2003, BIOL CONTROL, V26, P68, DOI 10.1016/S1049-9644(02)00117-2; Magda S.M., 2014, INT J SCI RES, V3, P2067, DOI [10.13140/RG.2.1.3355.3765, DOI 10.13140/RG.2.1.3355.3765]; Mahmoud Y. A., 2014, International Journal of Agricultural Research, V9, P210, DOI 10.3923/ijar.2014.210.218; Mansour R, 2018, ENTOMOL GEN, V38, P83, DOI 10.1127/entomologia/2018/0749; Medina P, 2008, BIOCONTROL, V53, P569, DOI 10.1007/s10526-007-9096-y; Mohammadpour M, 2019, J INSECT SCI, V19, DOI 10.1093/jisesa/iez040; Motaki E., 2014, PLANT PROT Q, V37, P61; Nozad-Bonab Z, 2017, J ECON ENTOMOL, V110, P1138, DOI 10.1093/jee/tox079; Orr DB, 2000, NONTARGET EFFECTS OF BIOLOGICAL CONTROL, P111; Parsaeyan E, 2020, ECOTOXICOLOGY, V29, P1052, DOI 10.1007/s10646-020-02235-y; Passos LC, 2018, ENTOMOL GEN, V38, P127, DOI 10.1127/entomologia/2018/0744; Payer Rosângela, 2012, Rev. de Ciências Agrárias, V35, P236; Perez-Aguilar DA, 2018, ECOTOXICOLOGY, V27, P719, DOI 10.1007/s10646-018-1954-0; Peterson RKD, 2006, PEST MANAG SCI, V62, P46, DOI 10.1002/ps.1126; Polar P, 2008, EXP APPL ACAROL, V46, P119, DOI 10.1007/s10493-008-9170-x; Parra JRP, 2010, PROG BIOL CONTROL, V9, P267, DOI 10.1007/978-1-4020-9110-0_10; Preetha G, 2010, CHEMOSPHERE, V80, P498, DOI 10.1016/j.chemosphere.2010.04.070; Rastegar Zh, 2014, 21 PLANT PROT C IRA; Reyes M, 2012, PESTIC BIOCHEM PHYS, V102, P45, DOI 10.1016/j.pestbp.2011.10.008; Roditakis E, 2015, J PEST SCI, V88, P9, DOI 10.1007/s10340-015-0643-5; Roditakis E, 2013, PEST MANAG SCI, V69, P217, DOI 10.1002/ps.3404; Ruiz L, 2008, BIOL CONTROL, V44, P296, DOI 10.1016/j.biocontrol.2007.10.022; Gervassio NGS, 2019, J PEST SCI, V92, P1343, DOI 10.1007/s10340-018-01078-1; Santana PA, 2019, J PEST SCI, V92, P1373, DOI 10.1007/s10340-018-1057-y; Sattar S, 2011, PAK J ZOOL, V43, P1117; Schneider MI, 2004, BIOL CONTROL, V31, P189, DOI 10.1016/j.biocontrol.2004.04.013; Schrank A, 2010, TOXICON, V56, P1267, DOI 10.1016/j.toxicon.2010.03.008; Shalaby HH., 2013, NAT SCI, V11, P63; Silva GA, 2011, PEST MANAG SCI, V67, P913, DOI 10.1002/ps.2131; Soares MA, 2019, J PEST SCI, V92, P1433, DOI 10.1007/s10340-018-01074-5; Sohrabi Fariba, 2015, Journal of Plant Protection Research, V55, P322, DOI 10.1515/jppr-2015-0029; Suh CPC, 2000, J ECON ENTOMOL, V93, P577, DOI 10.1603/0022-0493-93.3.577; Sylla S, 2019, J PEST SCI, V92, P1387, DOI 10.1007/s10340-019-01094-9; Talebi K., 2008, PEST TECHNOLOGY, V2, P87; Thiery D, 2018, ENTOMOL GEN, V38, P47, DOI 10.1127/entomologia/2018/0675; Tuan SJ, 2014, PEST MANAG SCI, V70, P1936, DOI 10.1002/ps.3920; Tuan SJ, 2014, PEST MANAG SCI, V70, P805, DOI 10.1002/ps.3618; Ullah F, 2019, ENTOMOL GEN, V39, P259, DOI 10.1127/entomologia/2019/0887; Ullah F, 2019, ENTOMOL GEN, V39, P325, DOI 10.1127/entomologia/2019/0892; Ullah F, 2019, ENTOMOL GEN, V39, P137, DOI 10.1127/entomologia/2019/0865; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Verheggen F, 2019, ENTOMOL GEN, V38, P349, DOI 10.1127/entomologia/2019/0778; Wang YH, 2012, CROP PROT, V34, P76, DOI 10.1016/j.cropro.2011.12.007; Wang Z, 2019, PEST MANAG SCI, V75, P2716, DOI 10.1002/ps.5380; Yii JE, 2016, PLANT PROTECT SCI, V52, P35, DOI 10.17221/82/2015-PPS; Zang LS, 2021, ANNU REV ENTOMOL, V66, P463, DOI 10.1146/annurev-ento-060120-091620; Zappala L, 2013, J PEST SCI, V86, P635, DOI 10.1007/s10340-013-0531-9; Zhang Y, 2019, ENTOMOL GEN, V39, P221, DOI 10.1127/entomologia/2019/0816; ZIMMERMANN G, 1993, PESTIC SCI, V37, P375, DOI 10.1002/ps.2780370410	112	8	8	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0243334	10.1371/journal.pone.0243334	http://dx.doi.org/10.1371/journal.pone.0243334			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329292	Green Submitted, gold, Green Published			2022-12-26	WOS:000685248600054
J	Assefa, G; Desta, K; Araya, S; Girma, S; Mihret, A; Hailu, T; Atnafu, A; Endalafer, N; Abera, A; Bekele, S; Birhanu, L; Diriba, G; Mengistu, Y; Dagne, B; Bobosha, K; Aseffa, A				Assefa, Gebeyehu; Desta, Kassu; Araya, Shambel; Girma, Selfu; Mihret, Adane; Hailu, Tsegaye; Atnafu, Abay; Endalafer, Nigatu; Abera, Adugna; Bekele, Shiferaw; Birhanu, Leila; Diriba, Getu; Mengistu, Yordanos; Dagne, Biniyam; Bobosha, Kidist; Aseffa, Abraham			Diagnostic efficacy of Light-Emitting Diode (LED) Fluorescence based Microscope for the diagnosis of Tuberculous lymphadenitis	PLOS ONE			English	Article							MYCOBACTERIA; PERFORMANCE; REDUCTION	Background The comparatively straightforward and cheaper light-emitting diode fluorescent microscope (LEDFM) was suggested by WHO to replace conventional microscope in tuberculosis (TB) laboratories. However, the comparable efficacy of each of those techniques differs from laboratory to laboratory. We investigated the efficacy of LEDFM for the diagnosis of tuberculous lymphadenitis (TBLN) patients. Methods A cross-sectional study was conducted on 211 samples from clinically suspected tuberculous lymphadenitis patients. Three smears were prepared from FNA on microscope slides for cytomorphology study, Auramine O (AO), and for Ziehl-Neelsen (ZN) staining. The left-over samples were inoculated onto Lowenstein-Jensen (LJ) media. Statistical analysis was done using STATA version 11. The sensitivity, specificity, positive and negative predictive values were calculated by considering the culture results as the gold standard using a 95% confidence interval. Results Among 211 samples 49.7% (105) were positive by cytomorphology, 32.7% (69) by LEDFM, 23.69% (50) by LJ culture, and 13.7% (29) by ZN. Compared to the gold standard sensitivity of ZN, LEDFM, and cytomorphology were 30% [95% CI: 17.9-44.6], 66% [95% CI: 51.2-78.8] 78% [95% CI: 64-88.5], respectively. The specificity of ZN, LEDFM, and cytomorphology was 91.3% [95% CI: 85.8-95.2], 77.6% [95% CI: 70.4-83.8], 58.8% [95% CI: 50.7-66.5], respectively. Conclusion LED fluorescence microscopy gives a legitimate option in contrast to conventional ZN techniques in terms of its higher sensitivity, a bit lower specificity, time-saving, and minimal effort.	[Assefa, Gebeyehu; Girma, Selfu; Mihret, Adane; Hailu, Tsegaye; Atnafu, Abay; Endalafer, Nigatu; Bekele, Shiferaw; Mengistu, Yordanos; Bobosha, Kidist; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Assefa, Gebeyehu; Desta, Kassu; Araya, Shambel] Addis Ababa Univ, Dept Med Lab Sci, Addis Ababa, Ethiopia; [Abera, Adugna; Diriba, Getu; Dagne, Biniyam] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Birhanu, Leila] St Peter Specialized Hosp, Addis Ababa, Ethiopia	Addis Ababa University	Assefa, G (corresponding author), Armauer Hansen Res Inst, Addis Ababa, Ethiopia.; Assefa, G (corresponding author), Addis Ababa Univ, Dept Med Lab Sci, Addis Ababa, Ethiopia.	gebeyehu03@yahoo.com	Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150; Mihret, Adane/0000-0003-3183-4772; Araya, Shambel/0000-0002-0109-6062; Mitku, Gebeyehu Assefa/0000-0003-1308-7566; Ayele, Abay/0000-0001-7594-4004; Girma, Selfu/0000-0002-1866-0950	Armauer Hansen Research Institute core budget; Sida; Government of Ethiopia; Norad	Armauer Hansen Research Institute core budget; Sida; Government of Ethiopia; Norad(CGIAR)	This work is supported by Armauer Hansen Research Institute core budget. AHRI Receives core support from Sida, Norad, and the Government of Ethiopia.	Abdissa K, 2015, TROP MED INT HEALTH, V20, P1543, DOI 10.1111/tmi.12585; Ahmed Hussain Gad Elkarim, 2011, Patholog Res Int, V2011, P417635, DOI 10.4061/2011/417635; Alfred N, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004093; Ben Ayed H., 2018, INT J TROP DIS, V1; Berg S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0846-7; Bhalla M, 2013, INT J MYCOBACT, V2, P174, DOI 10.1016/j.ijmyco.2013.05.001; Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017214; Brainard JA, 2012, MONOGR CLIN CYTOL, V21, P10, DOI 10.1159/000331023; Deveci HS, 2016, NORTH CLIN ISTANB, V3, P150, DOI 10.14744/nci.2016.20982; Fogel N, 2015, TUBERCULOSIS, V95, P527, DOI 10.1016/j.tube.2015.05.017; Girma S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006706; GUPTA AK, 1992, ACTA CYTOL, V36, P391; Khan MS, 2007, LANCET, V369, P1955, DOI 10.1016/S0140-6736(07)60916-7; Kulchavenya E, 2014, THER ADV INFECT DIS, V2, P61, DOI 10.1177/2049936114528173; Lumb R, 2013, LAB DIAGNOSIS TUBERC, P3; Mekonnen D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215647; Moore DF, 2005, DIAGN MICR INFEC DIS, V52, P247, DOI 10.1016/j.diagmicrobio.2005.02.014; Mycobacteriology Laboratory Manual, 2014, PUBL GLOB LAB IN WOR, VFirst, P1; Palomino JC, 2006, CURR OPIN PULM MED, V12, P172, DOI 10.1097/01.mcp.0000219265.50310.9b; Ramsay A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007760; Salvador F, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000509; Shenai S, 2011, INT J TUBERC LUNG D, V15, P483, DOI 10.5588/ijtld.10.0229; Tadesse M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106726; Thakur Brijesh, 2013, Patholog Res Int, V2013, P824620, DOI 10.1155/2013/824620; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2018, GLOBAL TUBERCULOSIS; World Health Organization Policy Statement, 2011, FLUOR LIGHT EM DIOD; Zewdie O, 2016, INT J TUBERC LUNG D, V20, P1529, DOI 10.5588/ijtld.15.1023	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255146	10.1371/journal.pone.0255146	http://dx.doi.org/10.1371/journal.pone.0255146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324565	gold, Green Published			2022-12-26	WOS:000685248200096
J	Bou-Hamad, I; Hoteit, R; Harajli, D				Bou-Hamad, Imad; Hoteit, Reem; Harajli, Dunia			Health worries, life satisfaction, and social well-being concerns during the COVID-19 pandemic: Insights from Lebanon	PLOS ONE			English	Article							MENTAL-HEALTH; ATTITUDE ACCESSIBILITY; IMPACT; METAANALYSIS; WORK	The COVID-19 outbreak has struck Lebanon in its worst period of instability, not only impacting physical health, but also increasing psychological distress. Using an online survey enhanced by response time measurement, this study describes the overall patterns in mental well-being outcomes and examines their association with sociodemographic characteristics during the COVID-19 pandemic. Furthermore, it identifies significant predictors for COVID-19 good practices. A total of 988 Lebanese were surveyed, with participants providing written online consent prior to filling the survey. Regression-based models were estimated. Findings show that individuals with higher education levels exhibit lower health concerns. People with children face higher health worries than those without. Men are more worried than women about their health and they are less satisfied with their lives during the pandemic. Descriptive statistics show that most Lebanese are very satisfied with their families (93.1%), but they are highly dissatisfied with their country (63%). Young adults and individuals who live alone exhibit significantly higher social well-being concerns. Age and having children were strong predictors for good COVID-19 practices. The odds of having good practices for older adults are 3.13 times higher than that of youth, while the odds for those with children are 3.18 times higher than those without. The findings of this study could pave the way for a well-coordinated national strategy and increased collaboration with public health professionals to mitigate the pandemic's adverse effects on mental health in the long-term.	[Bou-Hamad, Imad] Amer Univ Beirut, Suliman S Olayan Sch Business, Dept Business Informat & Decis Syst, Beirut, Lebanon; [Hoteit, Reem] Amer Univ Beirut, Fac Hlth Sci, Dept Epidemiol & Populat Hlth, Beirut, Lebanon; [Harajli, Dunia] Lebanese Amer Univ, Adnan Kassar Sch Business, Dept Informat Technol & Operat Management, Beirut, Lebanon	American University of Beirut; American University of Beirut; Lebanese American University	Bou-Hamad, I (corresponding author), Amer Univ Beirut, Suliman S Olayan Sch Business, Dept Business Informat & Decis Syst, Beirut, Lebanon.	ib12@aub.edu.lb	Hoteit, Reem/AGO-3172-2022	Hoteit, Reem/0000-0001-8139-9321; Bou-Hamad, Imad/0000-0003-0344-673X; Harajli, Dunia/0000-0003-0965-4249				Ajrouch KJ, 2013, GEROPSYCH, V26, P15, DOI 10.1024/1662-9647/a000076; Ammar A, 2020, SOCIAL PARTICIPATION, DOI [10.1101/2020.05.05.20091066v1, DOI 10.1101/2020.05.05.20091066, 10.1101/2020.05.05.20091066]; Baig M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243526; Bhagavathula AS., 2020, KNOWLEDGE ATTITUDE P; Bjelland I, 2008, SOC SCI MED, V66, P1334, DOI 10.1016/j.socscimed.2007.12.019; Bonsaksen T., 2020, CROSS NATL STUDY WOR, DOI [10.21203/rs.3.rs-34850/v2, DOI 10.21203/RS.3.RS-34850/V2]; Bou-Hamad I, 2020, CHILD YOUTH SERV REV, V118, DOI 10.1016/j.childyouth.2020.105425; Bu F, 2020, PUBLIC HEALTH, V186, P31, DOI 10.1016/j.puhe.2020.06.036; Bu FF, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113521; Bughin JR., 2020, GREAT EMPLOYEE DIVID, DOI [10.2139/ssrn.3752252, DOI 10.2139/SSRN.3752252]; Carpenter TP, 2019, BEHAV RES METHODS, V51, P2194, DOI 10.3758/s13428-019-01293-3; Chaaban J., 2016, SPOTLIGHT YOUTH LEBA; Chkoniya V., 2021, SMART INNOV SYST TEC, V205, P283, DOI [10.1007/978-981-33-4183-8_23, DOI 10.1007/978-981-33-4183-8_23]; Curto JD, 2011, J APPL STAT, V38, P1499, DOI 10.1080/02664763.2010.505956; Dawson DL, 2020, J CONTEXT BEHAV SCI, V17, P126, DOI 10.1016/j.jcbs.2020.07.010; Domiati S, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00542; Erdogan B, 2012, J MANAGE, V38, P1038, DOI 10.1177/0149206311429379; Fares J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017214; FAZIO RH, 1989, J CONSUM RES, V16, P280, DOI 10.1086/209214; FAZIO RH, 1986, J PERS SOC PSYCHOL, V51, P505, DOI 10.1037/0022-3514.51.3.505; Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X; Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254; Fitch C, 2011, MENT HEALTH REV J, V16, P153, DOI 10.1108/13619321111202313; Freyne Aideen, 2005, Irish Journal of Psychological Medicine, V22, P87, DOI 10.1017/S0790966700009083; Friman M, 2019, CHILD INDIC RES, V12, P1319, DOI 10.1007/s12187-018-9584-x; Gao JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231924; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 2006, CALIF LAW REV, V94, P945, DOI 10.2307/20439056; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Groarke JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239698; Hawton A, 2011, QUAL LIFE RES, V20, P57, DOI 10.1007/s11136-010-9717-2; Huebner ES, 2002, SOC INDIC RES, V60, P115, DOI 10.1023/A:1021252812882; Jaspal R, 2020, MENT HEALTH REV J, V25, P215, DOI 10.1108/MHRJ-05-2020-0027; Karam EG, 2006, LANCET, V367, P1000, DOI 10.1016/S0140-6736(06)68427-4; Khalil RB, 2019, ASIAN J PSYCHIATR, V42, P85, DOI 10.1016/j.ajp.2019.04.002; Khraiche D, 2020, LEBANONS 1 SLAMS CEN; Kim TJ, 2016, INT ARCH OCC ENV HEA, V89, P561, DOI 10.1007/s00420-015-1107-1; Korajlija AL, 2020, BRIT J HEALTH PSYCH, V25, P849, DOI 10.1111/bjhp.12425; Lei L, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924609; Leigh-Hunt N, 2017, PUBLIC HEALTH, V152, P157, DOI 10.1016/j.puhe.2017.07.035; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Li LZ, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113267; Lim J., 2019, CONS IMP SELF REG DI; Liu CH, 2021, J PERINATOL, V41, P1191, DOI 10.1038/s41372-021-01000-1; Lopez J, 2020, INT PSYCHOGERIATR, V32, P1365, DOI 10.1017/S1041610220000964; McCulloch A, 2001, BRIT MED J, V323, P208, DOI 10.1136/bmj.323.7306.208; McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796; McMillan J. H., 2010, RES ED EVIDENCE BASE; Merikangas K., 2020, CORONAVIRUS HLTH IMP; Mouawad Jamil, 2017, ARAB STUDIES J, V25, P60; Nigussie TF, 2020, GSJ, V8, P1283; Ohme Rafal, 2020, ANTHROPOLOGICAL APPR, P427; Olson, 2008, IMPLICIT EXPLICIT ME; ONS OfNS, 2020, COR SOC IMP GREAT BR; Organization WH, 2019, COR DIS COVID 19 ADV; Patrick SW, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-016824; Rarrbo K., 2009, STUDIES YOUTH POLICI; Rieber R., 2013, WILHELM WUNDT MAKING; Rossell SL, 2021, PSYCHIAT RES, V296, DOI 10.1016/j.psychres.2020.113660; Saadeh D, 2021, PERSPECT PSYCHIATR C, V57, P1212, DOI 10.1111/ppc.12676; Saladino V, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.577684; Saqlain M, 2020, PUBLIC KNOWLEDGE PRA; Shehadeh MJH, 2020, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00986; Statista, INT PEN RAT MIDDL E; The World Bank, 2020, LEB EC UPD APR 2020; Tlaiss H, 2011, GEND MANAG, V26, P8, DOI 10.1108/17542411111109291; Ursachi G, 2015, PROC ECON FINANC, V20, P679, DOI 10.1016/S2212-5671(15)00123-9; Wang CY, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.569981; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Winer BJ, 1971, STAT PRINCIPLES EXPT; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001; Zhang YF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072381	73	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254989	10.1371/journal.pone.0254989	http://dx.doi.org/10.1371/journal.pone.0254989			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324533	Green Published, gold			2022-12-26	WOS:000685248200084
J	Chang, FC; Wong, TT; Wu, KS; Lu, CF; Weng, TW; Liang, ML; Wu, CC; Guo, WY; Chen, CY; Hsieh, KLC				Chang, Feng-Chi; Wong, Tai-Tong; Wu, Kuo-Sheng; Lu, Chia-Feng; Weng, Ting-Wei; Liang, Muh-Lii; Wu, Chih-Chun; Guo, Wan Yuo; Chen, Cheng-Yu; Hsieh, Kevin Li-Chun			Magnetic resonance radiomics features and prognosticators in different molecular subtypes of pediatric Medulloblastoma	PLOS ONE			English	Article							CT TEXTURE ANALYSIS; TUMOR HETEROGENEITY; GENE-EXPRESSION; SUBGROUP; CLASSIFICATION; SENSITIVITY; SURROGATES; CHILDREN; SYSTEM; STAGE	Purpose Medulloblastoma (MB) is a highly malignant pediatric brain tumor. In the latest classification, medulloblastoma is divided into four distinct groups: wingless (WNT), sonic hedgehog (SHH), Group 3, and Group 4. We analyzed the magnetic resonance imaging radiomics features to find the imaging surrogates of the 4 molecular subgroups of MB. Material and methods Frozen tissue, imaging data, and clinical data of 38 patients with medulloblastoma were included from Taipei Medical University Hospital and Taipei Veterans General Hospital. Molecular clustering was performed based on the gene expression level of 22 subgroup-specific signature genes. A total 253 magnetic resonance imaging radiomic features were generated from each subject for comparison between different molecular subgroups. Results Our cohort consisted of 7 (18.4%) patients with WNT medulloblastoma, 12 (31.6%) with SHH tumor, 8 (21.1%) with Group 3 tumor, and 11 (28.9%) with Group 4 tumor. 8 radiomics gray-level co-occurrence matrix texture (GLCM) features were significantly different between 4 molecular subgroups of MB. In addition, for tumors with higher values in a gray-level run length matrix feature-Short Run Low Gray-Level Emphasis, patients have shorter survival times than patients with low values of this feature (p = 0.04). The receiver operating characteristic analysis revealed optimal performance of the preliminary prediction model based on GLCM features for predicting WNT, Group 3, and Group 4 MB (area under the curve = 0.82, 0.72, and 0.78, respectively). Conclusion The preliminary result revealed that 8 contrast-enhanced T1-weighted imaging texture features were significantly different between 4 molecular subgroups of MB. Together with the prediction models, the radiomics features may provide suggestions for stratifying patients with MB into different risk groups.	[Chang, Feng-Chi; Wu, Chih-Chun; Guo, Wan Yuo] Taipei Vet Gen Hosp, Sch Med, Dept Radiol, Taipei, Taiwan; [Chang, Feng-Chi; Wong, Tai-Tong; Wu, Chih-Chun; Guo, Wan Yuo] Natl Yang Ming Chiao Tung Univ, Taipei, Taiwan; [Wong, Tai-Tong; Wu, Kuo-Sheng] Taipei Med Univ, Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Wong, Tai-Tong] Taipei Vet Gen Hosp, Neurol Inst, Sch Med, Dept Neurosurg, Taipei, Taiwan; [Lu, Chia-Feng] Natl Yang Ming Chiao Tung Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Weng, Ting-Wei; Chen, Cheng-Yu; Hsieh, Kevin Li-Chun] Taipei Med Univ Hosp, Dept Med Imaging, Taipei, Taiwan; [Liang, Muh-Lii] Mackay Mem Hosp, Dept Neurosurg, Taipei, Taiwan; [Chen, Cheng-Yu; Hsieh, Kevin Li-Chun] Taipei Med Univ, Sch Med, Dept Radiol, Coll Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Medical University Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Medical University Hospital; Mackay Memorial Hospital; Taipei Medical University	Hsieh, KLC (corresponding author), Taipei Med Univ Hosp, Dept Med Imaging, Taipei, Taiwan.; Hsieh, KLC (corresponding author), Taipei Med Univ, Sch Med, Dept Radiol, Coll Med, Taipei, Taiwan.	kevinh9396@gmail.com			Ministry of Science and Technology, Taiwan [MOST 1062314-B-038-033]; Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan [DP2-110-21121-03-C-02-03]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	K.H received funding from Ministry of Science and Technology, Taiwan (MOST 1062314-B-038-033) and the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan (DP2-110-21121-03-C-02-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; ALBRIGHT AL, 1993, NEUROSURGERY, V33, P1026; Batista GEAPA., 2002, SER FRONT ARTIF INTE, V87, P48; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Buch K, 2017, AM J NEURORADIOL, V38, P981, DOI 10.3174/ajnr.A5139; Cavalli FMG, 2017, CANCER CELL, V31, P737, DOI 10.1016/j.ccell.2017.05.005; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; Ellison DW, 2010, ACTA NEUROPATHOL, V120, P305, DOI 10.1007/s00401-010-0726-6; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Ganeshan B, 2012, CLIN RADIOL, V67, P157, DOI 10.1016/j.crad.2011.08.012; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Gottardo NG, 2014, ACTA NEUROPATHOL, V127, P189, DOI 10.1007/s00401-013-1213-7; Grammel D, 2012, ACTA NEUROPATHOL, V123, P601, DOI 10.1007/s00401-012-0961-0; Huang SJ, 2018, CANCER GENOM PROTEOM, V15, P41, DOI 10.21873/cgp.20063; Iv M, 2019, AM J NEURORADIOL, V40, P154, DOI 10.3174/ajnr.A5899; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu CF, 2018, CLIN CANCER RES, V24, P4429, DOI 10.1158/1078-0432.CCR-17-3445; Ng F, 2013, EUR J RADIOL, V82, P342, DOI 10.1016/j.ejrad.2012.10.023; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Perreault S, 2014, AM J NEURORADIOL, V35, P1263, DOI 10.3174/ajnr.A3990; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; Pope WB, 2008, RADIOLOGY, V249, P268, DOI 10.1148/radiol.2491072000; Radovic M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1423-9; Robinson GW, 2015, J CLIN ONCOL, V33, P2646, DOI 10.1200/JCO.2014.60.1591; Roussel MF, 2018, CEREBELLUM, V17, P28, DOI 10.1007/s12311-017-0899-9; Simonsen CZ, 2015, STROKE, V46, P98, DOI 10.1161/STROKEAHA.114.007107; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Thompson EM, 2016, LANCET ONCOL, V17, P484, DOI 10.1016/S1470-2045(15)00581-1; UNSER M, 1986, IEEE T PATTERN ANAL, V8, P118, DOI 10.1109/TPAMI.1986.4767760; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; Varoquaux G, 2017, NEUROIMAGE, V145, P166, DOI 10.1016/j.neuroimage.2016.10.038; Wefers AK, 2014, ACTA NEUROPATHOL, V127, P931, DOI 10.1007/s00401-014-1271-5; Wu KS, 2020, CANCERS, V12, DOI 10.3390/cancers12030653; Yang DL, 2015, MED PHYS, V42, P6725, DOI 10.1118/1.4934373; Yin P, 2019, STAT METHODS MED RES, V28, P289, DOI 10.1177/0962280217722382; Zeltzer PM, 1999, J CLIN ONCOL, V17, P832, DOI 10.1200/JCO.1999.17.3.832; Zwanenburg A, 2020, RADIOLOGY, V295, P328, DOI 10.1148/radiol.2020191145	47	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255500	10.1371/journal.pone.0255500	http://dx.doi.org/10.1371/journal.pone.0255500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324588	Green Published, gold			2022-12-26	WOS:000685248200050
J	Karimi, SM; Salunkhe, SS; White, KB; Little, BB; McKinney, WP; Mitra, R; Chen, YT; Adkins, ER; Barclay, JA; Ezekekwu, E; He, CX; Hurst, DM; Popescu, MM; Swinney, DN; Johnson, DA; Hollenbach, R; Moyer, SS; DuPre, NC				Karimi, Seyed M.; Salunkhe, Sonali S.; White, Kelsey B.; Little, Bert B.; McKinney, W. Paul; Mitra, Riten; Chen, YuTing; Adkins, Emily R.; Barclay, Julia A.; Ezekekwu, Emmanuel; He, Caleb X.; Hurst, Dylan M.; Popescu, Martha M.; Swinney, Devin N.; Johnson, David A.; Hollenbach, Rebecca; Moyer, Sarah S.; DuPre, Natalie C.			Prevalence of unmasked and improperly masked behavior in indoor public areas during the COVID-19 pandemic: Analysis of a stratified random sample from Louisville, Kentucky	PLOS ONE			English	Article							SEAT-BELT USE; HEALTH BEHAVIORS; MORTALITY; OUTCOMES; CARE	Wearing a facial mask can limit COVID-19 transmission. Measurements of communities' mask use behavior have mostly relied on self-report. This study's objective was to devise a method to measure the prevalence of improper mask use and no mask use in indoor public areas without relying on self-report. A stratified random sample of retail trade stores (public areas) in Louisville, Kentucky, USA, was selected and targeted for observation by trained surveyors during December 14-20, 2020. The stratification allowed for investigating mask use behavior by city district, retail trade group, and public area size. The total number of visited public areas was 382 where mask use behavior of 2,080 visitors and 1,510 staff were observed. The average prevalence of mask use among observed visitors was 96%, while the average prevalence of proper use was 86%. In 48% of the public areas, at least one improperly masked visitor was observed and in 17% at least one unmasked visitor was observed. The average prevalence of proper mask use among staff was 87%, similar to the average among visitors. However, the percentage of public areas where at least one improperly masked staff was observed was 33. Significant disparities in mask use and its proper use were observed among both visitors and staff by public area size, retail trade type, and geographical area. Observing unmasked and improperly masked visitors was more common in small (less than 1500 square feet) public areas than larger ones, specifically in food and grocery stores as compared to other retail stores. Also, the majority of the observed unmasked persons were male and middle-aged.	[Karimi, Seyed M.; Salunkhe, Sonali S.; White, Kelsey B.; Little, Bert B.; Adkins, Emily R.; Barclay, Julia A.; Ezekekwu, Emmanuel; Swinney, Devin N.; Johnson, David A.; Moyer, Sarah S.] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Hlth Management & Syst Sci, Louisville, KY 40292 USA; [Karimi, Seyed M.; Chen, YuTing; Hollenbach, Rebecca; Moyer, Sarah S.] Louisville Metro Dept Publ Hlth & Wellness, Louisville, KY 40258 USA; [McKinney, W. Paul] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Hlth Promot & Behav Sci, Louisville, KY USA; [Mitra, Riten] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Bioinformat & Biostat, Louisville, KY USA; [He, Caleb X.] Univ Louisville, Dept Polit Sci, Coll Arts & Sci, Louisville, KY USA; [Hurst, Dylan M.] Univ Louisville, Dept Psychol & Brain Sci, Coll Arts & Sci, Louisville, KY USA; [Popescu, Martha M.] Univ Louisville, Dept Anthropol, Coll Arts & Sci, Louisville, KY USA; [DuPre, Natalie C.] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Epidemiol & Populat Hlth, Louisville, KY USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville	Karimi, SM (corresponding author), Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Hlth Management & Syst Sci, Louisville, KY 40292 USA.; Karimi, SM (corresponding author), Louisville Metro Dept Publ Hlth & Wellness, Louisville, KY 40258 USA.	Seyed.Karimi@louisville.edu		Ezekekwu, Emmanuel/0000-0002-3080-9463; Dupre, Natalie/0000-0003-4587-0467; Little, Bert/0000-0002-6485-4641	Louisville Metro Department of Public Health & Wellness through the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act)	Louisville Metro Department of Public Health & Wellness through the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act)	This study was funded by the Louisville Metro Department of Public Health & Wellness through the Coronavirus Aid, Relief, and Economic Security Act (the CARES Act). The funder did not play any role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The authors who received the award were Sonali S. Salunkhe, Kelsey B. White, Emmanuel Ezekekwu, Emily R. Adkins, Julia A. Barclay, Caleb X. He, Dylan M. Hurst, Martha M. Popescu, and Devin N. Swinney.	Abkarian M, 2020, P NATL ACAD SCI USA, V117, P25237, DOI 10.1073/pnas.2012156117; Arp N, 2020, USE FACE COVERINGS P, DOI [10.1101/2020.06.09.20126946, DOI 10.1101/2020.06.09.20126946]; Bahl P, 2020, THORAX, V75, P1024, DOI 10.1136/thoraxjnl-2020-215748; Ballotpedia, GOV KENT; Beasher Andy, 2020, 2020586 GOV; Beasher Andy, 2021, 2021212 GOV; Briggs NC, 2008, AM J PREV MED, V35, P224, DOI 10.1016/j.amepre.2008.03.038; Cameron KA, 2006, HEALTH COMMUN, V20, P277, DOI 10.1207/s15327027hc2003_7; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2; Chu DK., 2020, LANCET, V395, P1973, DOI [DOI 10.1111/irv.12369, DOI 10.1016/S0140-6736(20)31142-9]; Crabtree S., 2020, GALLUP; Data Axle, BUS DAT; Davis KC, 2014, J SEX RES, V51, P454, DOI 10.1080/00224499.2013.776660; Edwards, 2019, SURVEY REDESIGNS MAK; Fischer EP, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd3083; Gandhi M, 2020, J GEN INTERN MED, V35, P3063, DOI 10.1007/s11606-020-06067-8; Gelberg L, 2000, HEALTH SERV RES, V34, P1273; Haischer MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240785; Heck TG, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246520; Honein MA, 2020, MMWR-MORBID MORTAL W, V69, P1860, DOI 10.15585/mmwr.mm6949e2; Hornik R, 2021, HEALTH COMMUN, V36, P6, DOI 10.1080/10410236.2020.1847437; Howard MC, 2020, BRIT J HEALTH PSYCH, V25, P912, DOI 10.1111/bjhp.12453; Hubbard K, US NEWS WORLD REPORT; Johansson MA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.35057; Kahane LH, 2021, EAST ECON J, V47, P163, DOI 10.1057/s41302-020-00186-0; Karimi S., 2020, RESULTS OBSERVATIONA; Karimi S., 2021, U LOUISVILLE J RESP, V5, P1, DOI [10.18297/jri/vol5/iss1/7, DOI 10.18297/JRI/VOL5/ISS1/7]; Kramer, 2020, MORE AM SAY THEY ARE; Krishnamachari B, 2021, AM J INFECT CONTROL, V49, P1036, DOI 10.1016/j.ajic.2021.02.002; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lawson V, 2007, ANN ASSOC AM GEOGR, V97, P1, DOI 10.1111/j.1467-8306.2007.00520.x; Lerner EB, 2001, ACCIDENT ANAL PREV, V33, P659, DOI 10.1016/S0001-4575(00)00080-4; LouisvilleKy.gov, CIT BEG COMM CONV CO; Mock B., 2017, LOUISVILLE CONFRONTS; Newman MG, 2020, EUR J OBSTET GYN R B, V255, P268, DOI 10.1016/j.ejogrb.2020.10.048; North American Industry Classification System Association, SIC COD IND; Philips B, 2020, EAGLE EYE TV; Poe J, REDLINING LOUISVILLE; Price PC., 2017, RES METHODS PSYCHOL, VThird, P121; Princeton Gerrymandering Project, 2019, C EL RES POST 1948; Sabina L, 2020, J COMMUNITY PRACT, VXX, P97, DOI [10.35782/JCPP.2020.1.06, DOI 10.35782/JCPP.2020.1.06]; Sanger-Katz, 2020, NEW YORK TIMES; Symptom Surveys-Fb Survey, DELPH ED API 2020; Taylor S, 2020, FEM PSYCHOL, V30, P63, DOI 10.1177/0959353519864390; Teasdale E, 2012, BRIT J HEALTH PSYCH, V17, P44, DOI 10.1111/j.2044-8287.2011.02017.x; Understanding Coronavirus in America, UND AM STUD; United States Census Bureau, QUICK FACTS J COUNT; van den Berk-Clark C, 2018, HEALTH SERV RES, V53, P1777, DOI 10.1111/1475-6773.12737; Vaughn MG, 2012, ANN EPIDEMIOL, V22, P825, DOI 10.1016/j.annepidem.2012.09.010; Verma S, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0016018; WVU, 2020, WVUTODAY; Zabihi F, 2019, INT J INJ CONTROL SA, V26, P431, DOI 10.1080/17457300.2019.1660377; Zhang L, 2020, J BIOMED RES, V34, P446, DOI 10.7555/JBR.34.20200135	55	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0248324	10.1371/journal.pone.0248324	http://dx.doi.org/10.1371/journal.pone.0248324			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CM	34319978	Green Published, gold			2022-12-26	WOS:000685247800011
J	Ribeiro, S; Label, P; Garcia, D; Montoro, P; Pujade-Renaud, V				Ribeiro, Sebastien; Label, Philippe; Garcia, Dominique; Montoro, Pascal; Pujade-Renaud, Valerie			Transcriptome profiling in susceptible and tolerant rubber tree clones in response to cassiicolin Cas1, a necrotrophic effector from Corynespora cassiicola	PLOS ONE			English	Article							TRIGGERED SUSCEPTIBILITY; PLANT DEFENSE; MAPK CASCADES; CAUSAL AGENT; CELL-DEATH; RESISTANCE; RECEPTOR; PATHOGEN; DISEASE; GENE	Corynespora cassiicola, a fungal plant pathogen with a large host range, causes important damages in rubber tree (Hevea brasiliensis), in Asia and Africa. A small secreted protein named cassiicolin was previously identified as a necrotrophic effector required for the virulence of C. cassiicola in specific rubber tree clones. The objective of this study was to decipher the cassiicolin-mediated molecular mechanisms involved in this compatible interaction. We comparatively analyzed the RNA-Seq transcriptomic profiles of leaves treated or not with the purified cassiicolin Cas1, in two rubber clones: PB260 (susceptible) and RRIM600 (tolerant). The reads were mapped against a synthetic transcriptome composed of all available transcriptomic references from the two clones. Genes differentially expressed in response to cassiicolin Cas1 were identified, in each clone, at two different time-points. After de novo annotation of the synthetic transcriptome, we analyzed GO enrichment of the differentially expressed genes in order to elucidate the main functional pathways impacted by cassiicolin. Cassiicolin induced qualitatively similar transcriptional modifications in both the susceptible and the tolerant clones, with a strong negative impact on photosynthesis, and the activation of defense responses via redox signaling, production of pathogenesis-related protein, or activation of the secondary metabolism. In the tolerant clone, transcriptional reprogramming occurred earlier but remained moderate. By contrast, the susceptible clone displayed a late but huge transcriptional burst, characterized by massive induction of phosphorylation events and all the features of a hypersensitive response. These results confirm that cassiicolin Cas1 is a necrotrophic effector triggering a hypersensitive response in susceptible rubber clones, in agreement with the necrotrophic-effector-triggered susceptibility model.	[Ribeiro, Sebastien; Label, Philippe; Pujade-Renaud, Valerie] Univ Clermont Auvergne, Inst Natl Rech Agr Alimentat & Environm, UMR PIAF, Clermont Ferrand, France; [Garcia, Dominique; Montoro, Pascal; Pujade-Renaud, Valerie] Univ Montpellier, UMR AGAP Inst, Inst Natl Rech Agr Alimentat & Environm, CIRAD,Inst Agro, Montpellier, France; [Garcia, Dominique; Montoro, Pascal] UMR AGAP Inst, CIRAD, Montpellier, France; [Pujade-Renaud, Valerie] UMR AGAP Inst, CIRAD, Clermont Ferrand, France	INRAE; Universite Clermont Auvergne (UCA); CIRAD; INRAE; Institut Agro; Universite de Montpellier; CIRAD; Universite de Montpellier; CIRAD	Pujade-Renaud, V (corresponding author), Univ Clermont Auvergne, Inst Natl Rech Agr Alimentat & Environm, UMR PIAF, Clermont Ferrand, France.; Pujade-Renaud, V (corresponding author), Univ Montpellier, UMR AGAP Inst, Inst Natl Rech Agr Alimentat & Environm, CIRAD,Inst Agro, Montpellier, France.; Pujade-Renaud, V (corresponding author), UMR AGAP Inst, CIRAD, Clermont Ferrand, France.	valerie.pujade-renaud@cirad.fr		Label, Philippe/0000-0001-7852-5868	IFC ("Institut Francais du Caoutchouc", Paris, France); SIPH ("Societe Internationale de Plantations d'Hevea"); Socfin; Michelin	IFC ("Institut Francais du Caoutchouc", Paris, France); SIPH ("Societe Internationale de Plantations d'Hevea"); Socfin; Michelin	Researches were supported by IFC ("Institut Francais du Caoutchouc", Paris, France) and the companies Michelin (http://www.michelin.com/), SIPH ("Societe Internationale de Plantations d'Hevea", http://www.siph.com/), and Socfin (http://www.socfin.com/).This support included salary for SR. These funders had no role in the study design, data collection and analysis, or preparation of the manuscript. All funders have read the manuscript and agreed to its publication. CIRAD (https://www.cirad.fr/) provided support in the form of salaries for authors [DG, PM and VPR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section".	Ahmad P, 2008, J PLANT BIOL, V51, P167, DOI 10.1007/BF03030694; Andrews S, FASTQC QUALITY CONTR; Balint-Kurti P, 2019, MOL PLANT PATHOL, V20, P1163, DOI 10.1111/mpp.12821; Barthe P, 2007, J MOL BIOL, V367, P89, DOI 10.1016/j.jmb.2006.11.086; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Bouwmeester K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001327; Breton F., 2000, Journal of Rubber Research, V3, P115; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen KG, 2004, PLANT MOL BIOL, V56, P271, DOI 10.1007/s11103-004-3381-2; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; De Cremer K, 2013, PLANT CELL ENVIRON, V36, P1992, DOI 10.1111/pce.12106; de Lamotte F, 2007, J CHROMATOGR B, V849, P357, DOI 10.1016/j.jchromb.2006.10.051; Deon M, 2012, PLANT SCI, V185, P227, DOI 10.1016/j.plantsci.2011.10.017; Tran DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162807; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Duan CF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-30; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Garavillon-Tournayre M., 2015, JOBIM, P6; Gervasi F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196590; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Haugrud ARP, 2019, PLANT PHYSIOL, V180, P420, DOI 10.1104/pp.19.00149; Huang P, 2013, PLANT SCI, V203, P98, DOI 10.1016/j.plantsci.2012.12.019; Jain S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159338; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kvam VM, 2012, AM J BOT, V99, P248, DOI 10.3732/ajb.1100340; Lewis LA, 2015, PLANT CELL, V27, P3038, DOI 10.1105/tpc.15.00471; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINTHORST HJM, 1991, CRIT REV PLANT SCI, V10, P123, DOI 10.1080/07352689109382309; Liu ZH, 2017, THEOR APPL GENET, V130, P1267, DOI 10.1007/s00122-017-2886-4; Liu ZH, 2016, NEW PHYTOL, V211, P1052, DOI 10.1111/nph.13959; Liu ZH, 2015, MOL PLANT PATHOL, V16, P188, DOI 10.1111/mpp.12172; Lopez D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00276; Lorang J, 2012, SCIENCE, V338, P659, DOI 10.1126/science.1226743; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Makita Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4333-y; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Pandelova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040240; Pandelova I, 2009, MOL PLANT, V2, P1067, DOI 10.1093/mp/ssp045; Passardi F, 2004, TRENDS PLANT SCI, V9, P534, DOI 10.1016/j.tplants.2004.09.002; Ribeiro S, 2019, FUNGAL GENET BIOL, V129, P101, DOI 10.1016/j.fgb.2019.05.004; Robles JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-484; Roy CB, 2019, CURR PLANT BIOL, V17, P2, DOI 10.1016/j.cpb.2019.02.002; Salgado LR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-236; Sekhwal MK, 2015, INT J MOL SCI, V16, P19248, DOI 10.3390/ijms160819248; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; Staal J, 2006, PLANT J, V46, P218, DOI 10.1111/j.1365-313X.2006.02688.x; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Suzuki N, 2011, CURR OPIN PLANT BIOL, V14, P691, DOI 10.1016/j.pbi.2011.07.014; Tan KC, 2010, FUNCT PLANT BIOL, V37, P907, DOI 10.1071/FP10067; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Warnes GR, 2016, VARIOUS R PROGRAMMIN; WELCH TA, 1984, COMPUTER, V17, P8, DOI 10.1109/MC.1984.1659158; Wen CL, 2015, THEOR APPL GENET, V128, P2495, DOI 10.1007/s00122-015-2604-z; Winterberg B, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0215-5; Xing XX, 2017, BIOCHEM BIOPH RES CO, V482, P1114, DOI 10.1016/j.bbrc.2016.11.167; Yoshioka H, 2008, PLANT SIGNAL BEHAV, V3, P153, DOI 10.4161/psb.3.3.5537; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zhang Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42197-8; Zhang ZC, 2011, PLANT J, V65, P27, DOI 10.1111/j.1365-313X.2010.04407.x; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zubini P, 2009, PLANT PHYSIOL, V150, P1235, DOI 10.1104/pp.109.139543	69	2	2	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254541	10.1371/journal.pone.0254541	http://dx.doi.org/10.1371/journal.pone.0254541			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320014	Green Published, gold			2022-12-26	WOS:000685247800026
J	Zhang, MX; Zhang, LZ; Fu, LM; Yao, HH; Tan, L; Feng, ZH; Li, JY; Lu, J; Pan, YH; Shu, GN; Li, PJ; Tang, YM; Liao, ZY; Wei, JH; Chen, W; Guo, JP; Luo, JH; Chen, ZH				Zhang, Ming-xiao; Zhang, Li-zhen; Fu, Liang-min; Yao, Hao-hua; Tan, Lei; Feng, Zi-hao; Li, Jia-ying; Lu, Jun; Pan, Yi-hui; Shu, Guan-nan; Li, Peng-ju; Tang, Yi-ming; Liao, Zhuang-yao; Wei, Jin-huan; Chen, Wei; Guo, Jian-ping; Luo, Jun-hang; Chen, Zhen-hua			Positive feedback regulation of lncRNA PVT1 and HIF2 alpha contributes to clear cell renal cell carcinoma tumorigenesis and metastasis	ONCOGENE			English	Article							LONG NONCODING RNAS; PROMOTES PROLIFERATION; CANCER; HSP90; BINDING; DOMAIN; ALPHA; ANTAGONIST; GROWTH; HIF-2	Long noncoding RNAs (lncRNAs) have been reported to exert important roles in tumors, including clear cell renal cell carcinoma (ccRCC). PVT1 is an important oncogenic lncRNA which has critical effects on onset and development of various cancers, however, the underlying mechanism of PVT1 functioning in ccRCC remains largely unknown. VHL deficiency-induced HIF2 alpha accumulation is one of the major factors for ccRCC. Here, we identified the potential molecular mechanism of PVT1 in promoting ccRCC development by stabilizing HIF2 alpha. PVT1 was significantly upregulated in ccRCC tissues and high PVT1 expression was associated with poor prognosis of ccRCC patients. Both gain-of-function and loss-of function experiments revealed that PVT1 enhanced ccRCC cells proliferation, migration, and invasion and induced tumor angiogenesis in vitro and in vivo. Mechanistically, PVT1 interacted with HIF2 alpha protein and enhanced its stability by protecting it from ubiquitination-dependent degradation, thereby exerting its biological significance. Meanwhile, HIF2 alpha bound to the enhancer of PVT1 to transactivate its expression. Furthermore, HIF2 alpha specific inhibitor could repress PVT1 expression and its oncogenic functions. Therefore, our study demonstrates that the PVT1/ HIF2 alpha positive feedback loop involves in tumorigenesis and progression of ccRCC, which may be exploited for anticancer therapy.	[Zhang, Ming-xiao; Zhang, Li-zhen; Fu, Liang-min; Yao, Hao-hua; Tan, Lei; Feng, Zi-hao; Li, Jia-ying; Lu, Jun; Pan, Yi-hui; Shu, Guan-nan; Li, Peng-ju; Tang, Yi-ming; Liao, Zhuang-yao; Wei, Jin-huan; Chen, Wei; Luo, Jun-hang; Chen, Zhen-hua] Sun Yat Sen Univ, Dept Urol, Affiliated Hosp 1, Guangzhou, Peoples R China; [Tan, Lei] Southern Med Univ, Nanfang Hosp, Dept Urol, Guangzhou, Peoples R China; [Guo, Jian-ping; Luo, Jun-hang] Sun Yat Sen Univ, Affiliated Hosp 1, Inst Precis Med, Guangzhou, Peoples R China; [Luo, Jun-hang] Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou, Peoples R China	Sun Yat Sen University; Southern Medical University - China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Luo, JH; Chen, ZH (corresponding author), Sun Yat Sen Univ, Dept Urol, Affiliated Hosp 1, Guangzhou, Peoples R China.; Guo, JP; Luo, JH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Inst Precis Med, Guangzhou, Peoples R China.; Luo, JH (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou, Peoples R China.	guojp6@mail.sysu.edu.cn; luojunh@mail.sysu.edu.cn; chenzhh75@mail.sysu.edu.cn		Zhang, Li-Zhen/0000-0002-3106-6825	National Natural Science Foundation of China [81902576, 81725016, 81872094, 82002684]; Natural Science Foundation of Guangdong Province, China [2017B020227004, 2017A030313538, 2018A030310327]; Medical Scientific Research Foundation of Guangdong Province, China [A2018051]; Guangdong Basic and Applied Basic Research Foundation [2020A1515111077]; China Postdoctoral Science Foundation [236464]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Medical Scientific Research Foundation of Guangdong Province, China; Guangdong Basic and Applied Basic Research Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (No.81902576, No.81725016, No. 81872094 and No. 82002684), the Natural Science Foundation of Guangdong Province, China (2017B020227004, 2017A030313538, 2018A030310327), the Medical Scientific Research Foundation of Guangdong Province, China (A2018051), Guangdong Basic and Applied Basic Research Foundation (2020A1515111077), and China Postdoctoral Science Foundation Funded Project (No. 236464).	Baba M, 2003, ONCOGENE, V22, P2728, DOI 10.1038/sj.onc.1206373; Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796; Clark PE, 2009, KIDNEY INT, V76, P939, DOI 10.1038/ki.2009.296; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Courtney KD, 2018, J CLIN ONCOL, V36, P867, DOI 10.1200/JCO.2017.74.2627; Ehrlich ES, 2009, P NATL ACAD SCI USA, V106, P20330, DOI 10.1073/pnas.0810571106; Escudier B, 2007, DRUGS, V67, P1257, DOI 10.2165/00003495-200767090-00002; Frank I, 2003, J UROLOGY, V170, P2225, DOI 10.1097/01.ju.0000095541.10333.a7; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Grampp S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13183; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Li MY, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00787; Li WC, 2018, ONCOL LETT, V15, P7855, DOI 10.3892/ol.2018.8315; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Ljungberg B, 2019, EUR UROL, V75, P799, DOI 10.1016/j.eururo.2019.02.011; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Oudard S, 2007, ANN ONCOL, V18, P25, DOI 10.1093/annonc/mdm411; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Ren Y, 2019, ONCOTARGETS THER, V12, P2563, DOI 10.2147/OTT.S190239; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Sun M, 2015, ENDOCR REV, V36, P25, DOI 10.1210/er.2014-1034; Takeda N, 2004, CIRC RES, V95, P146, DOI 10.1161/01.RES.0000134920.10128.b4; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Turajlic S, 2018, CELL, V173, P581, DOI 10.1016/j.cell.2018.03.057; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wallace EM, 2016, CANCER RES, V76, P5491, DOI 10.1158/0008-5472.CAN-16-0473; Wang F, 2014, HEPATOLOGY, V60, P1278, DOI 10.1002/hep.27239; Wang H, 2020, J CANCER, V11, P2737, DOI 10.7150/jca.36822; Wang Y, 2020, CELL DEATH DIFFER, V27, P695, DOI 10.1038/s41418-019-0381-y; Wu QJ, 2017, ONCOTARGET, V8, P101865, DOI 10.18632/oncotarget.21706; Xu MD, 2017, CLIN CANCER RES, V23, P2071, DOI 10.1158/1078-0432.CCR-16-0742; Xu Y, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1064-5; Yang T, 2017, ONCOTARGET, V8, P85353, DOI 10.18632/oncotarget.19743; Yu XG, 2018, J BUON, V23, P48; Zhao J, 2018, ONCOGENE, V37, P4094, DOI 10.1038/s41388-018-0250-z; Zhao L, 2018, J CELL PHYSIOL, V233, P4044, DOI 10.1002/jcp.26072	41	8	8	2	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 16	2021	40	37					5639	5650		10.1038/s41388-021-01971-7	http://dx.doi.org/10.1038/s41388-021-01971-7		JUL 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UR2PS	34321604	Green Published, hybrid			2022-12-26	WOS:000678443300001
J	Shen, SR; Chen, WJ; Chu, HF; Wu, SH; Wang, YR; Shen, TL				Shen, Siou-Ru; Chen, Wei-Jen; Chu, Hui-Fang; Wu, Shiuan-Huei; Wang, Yu-Ru; Shen, Tang-Long			Amelioration of 5-fluorouracil-induced intestinal mucositis by Streptococcus thermophilus ST4 in a mouse model	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; CELL-PROLIFERATION; ESCHERICHIA-COLI; EPITHELIAL-CELLS; ANIMAL-MODEL; TNF-ALPHA; CHEMOTHERAPY; PROBIOTICS; BARRIER; PATHOBIOLOGY	Intestinal mucositis is a commonly encountered toxic side effect in patients undergoing 5-fluorouracil (5-FU)-based chemotherapy. Numerous studies have shown that probiotics enable improving chemotherapy-induced intestinal mucositis, but the beneficial effects of probiotics differ depending on the strain. Therefore, in the present studies we suggest that S. thermophilus ST4 separated from raw milk may assess mucoprotective activity in 5-FU-induced intestinal mucositis. In our causal-comparative study design, fifteen mice were randomized assigned into three groups (n = 5/each group): control group, 5-FU group and 5-FU+S. thermophilus ST4 group. The control group was orally administrated saline only, and the 5-FU group was followed by intraperitoneal injection of 5-FU for 3 days after 10-day saline administration, and the 5-FU+S. thermophilus ST4 group was intragastrically subjected for S. thermophilus ST4 once per day during the whole experiment, starting from the first day of the experiment, followed by 5-FU intraperitoneal injection for 3 days after 10-day S. thermophilus ST4 pretreatment. Diarrhea score, pro-inflammatory cytokines serum levels, intestinal histopathology and short chain fatty acid were assessed. Here, we demonstrated the beneficial effects of S. thermophilus ST4 derived from raw milk against 5-FU-induced intestinal mucositis, including body weight reduction, appetite loss and diarrhea. Intrinsically, S. thermophilus ST4 effectively maintained epithelium structure in small intestines and colons as well as reduced the intestinal inflammation. Besides, S. thermophilus ST4 significantly increased the expression of acetic acid, reinforcing the muco-protective effects. In conclusion, our results demonstrate that S. thermophilus ST4 supplementation ameliorates 5-FU-induced intestinal mucositis. This suggests probiotic may serve as an alternative therapeutic strategy for the prevention or management of 5-FU-induced mucositis in the future.	[Shen, Siou-Ru; Wang, Yu-Ru; Shen, Tang-Long] Natl Taiwan Univ, Ctr Biotechnol, Taipei, Taiwan; [Shen, Siou-Ru; Chen, Wei-Jen; Chu, Hui-Fang; Wu, Shiuan-Huei] Syngen Biotech Co Ltd, Tainan, Taiwan; [Chen, Wei-Jen] Minghsin Univ Sci & Technol, Grad Inst Management, Hsinchu, Taiwan; [Wang, Yu-Ru; Shen, Tang-Long] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei, Taiwan	National Taiwan University; National Taiwan University	Shen, TL (corresponding author), Natl Taiwan Univ, Ctr Biotechnol, Taipei, Taiwan.; Shen, TL (corresponding author), Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei, Taiwan.	shentl@ntu.edu.tw		Shen, Tang-Long/0000-0001-6264-3608	Ministry of Science and Technology [109-2321-B002-005]; Syngen Biotech Co., Ltd.	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Syngen Biotech Co., Ltd.	This study was partially supported by Ministry of Science and Technology (109-2321-B002-005) to T-LS. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This study also received funding from Syngen Biotech Co., Ltd. In the form of salaries to S-RS, W-JC, HFC, and S-HW. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JR, 2017, BENEF MICROBES, V8, P605, DOI 10.3920/BM2016.0110; Bao SS, 2011, IMMUNOL CELL BIOL, V89, P853, DOI 10.1038/icb.2011.4; Bojrab G, 2001, EUROPEAN PATENT APPL, V1, P794; Bowen JM, 2007, CANCER BIOL THER, V6, P1449, DOI 10.4161/cbt.6.9.4622; Bowen JM, 2006, SUPPORT CARE CANCER, V14, P713, DOI 10.1007/s00520-005-0004-7; Bruno-Barcena JM, 2004, APPL ENVIRON MICROB, V70, P4702, DOI 10.1128/AEM.70.8.4702-4710.2004; Chen Y, 2019, MOLECULES, V24, DOI 10.3390/molecules24030513; Cinausero M, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00354; Cool JC, 2005, GROWTH HORM IGF RES, V15, P72, DOI 10.1016/j.ghir.2004.12.002; Da Silva APB, 2006, J CELL PHYSIOL, V208, P629, DOI 10.1002/jcp.20701; de Koning BAE, 2006, INT IMMUNOL, V18, P941, DOI 10.1093/intimm/dxl030; Delia P, 2007, WORLD J GASTROENTERO, V13, P912, DOI 10.3748/wjg.v13.i6.912; Delorme C, 2008, INT J FOOD MICROBIOL, V126, P274, DOI 10.1016/j.ijfoodmicro.2007.08.014; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; GAMET L, 1992, INT J CANCER, V52, P286, DOI 10.1002/ijc.2910520222; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Huang YL, 2012, J AGR FOOD CHEM, V60, P4854, DOI 10.1021/jf300942p; Jin XL, 2010, GUT, V59, P186, DOI 10.1136/gut.2008.151175; Kato S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116213; Keefe DMK, 2000, GUT, V47, P632, DOI 10.1136/gut.47.5.632; Keefe DM, 2007, CURR OPIN ONCOL, V19, P323, DOI 10.1097/CCO.0b013e3281214412; Kim H, 2018, J FUNCT FOODS, V48, P243, DOI 10.1016/j.jff.2018.07.011; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; La Fata G, 2018, PROBIOTICS ANTIMICRO, V10, P11, DOI 10.1007/s12602-017-9322-6; Li HL, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00455; Logan RM, 2007, CANCER TREAT REV, V33, P448, DOI 10.1016/j.ctrv.2007.03.001; Lu Z, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24978; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Markowiak-Kopec P, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041107; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Melo MLP, 2008, CANCER CHEMOTH PHARM, V61, P775, DOI 10.1007/s00280-007-0534-4; Nikolaus S, 2018, INT J COLORECTAL DIS, V33, P927, DOI 10.1007/s00384-018-3069-8; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; Olaya J, 1999, IN VITRO CELL DEV-AN, V35, P43; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Resta-Lenert S, 2003, GUT, V52, P988, DOI 10.1136/gut.52.7.988; Rizkalla SW, 2000, AM J CLIN NUTR, V72, P1474; Roy MJ, 2009, NUTRITION, V25, P1193, DOI 10.1016/j.nut.2009.04.008; SAKATA T, 1987, BRIT J NUTR, V58, P95, DOI 10.1079/BJN19870073; SONIS ST, 1990, ORAL SURG ORAL MED O, V69, P437, DOI 10.1016/0030-4220(90)90376-4; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Sonis Stephen T, 2010, Curr Opin Support Palliat Care, V4, P26, DOI 10.1097/SPC.0b013e328335fb76; Stanton C, 2001, AM J CLIN NUTR, V73, p476S, DOI 10.1093/ajcn/73.2.476s; Sultani Masooma, 2012, Chemother Res Pract, V2012, P490804, DOI 10.1155/2012/490804; Tooley KL, 2006, CANCER BIOL THER, V5, P593, DOI 10.4161/cbt.5.6.2659; Vanhoecke B, 2015, EXP BIOL MED, V240, P725, DOI 10.1177/1535370215581309; Vermeire S, 2004, INFLAMM BOWEL DIS, V10, P661, DOI 10.1097/00054725-200409000-00026; Wang X, 2014, PHARMACOL RES, V82, P21, DOI 10.1016/j.phrs.2014.03.007; Whitford EJ, 2009, CANCER BIOL THER, V8, P505, DOI 10.4161/cbt.8.6.7594; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Zeng HW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051214; Zhang T, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00786; Zheng B, 2016, BENEF MICROBES, V7, P205, DOI [10.3920/bm2015.0037, 10.3920/BM2015.0037]	54	4	4	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0253540	10.1371/journal.pone.0253540	http://dx.doi.org/10.1371/journal.pone.0253540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310611	Green Published, gold			2022-12-26	WOS:000685224500020
J	Huang, JD; Liu, SY; Hassan, SG; Xu, LQ				Huang, Jiande; Liu, Shuangyin; Hassan, Shahbaz Gul; Xu, Longqin			Pollution index of waterfowl farm assessment and prediction based on temporal convoluted network	PLOS ONE			English	Article							ALTERNATIVE HOUSING SYSTEMS; DISSOLVED-OXYGEN CONTENT; AIR-QUALITY; OPTICAL-PROPERTIES; AEROSOL-PARTICLES; LIVESTOCK; COEFFICIENT; TRANSPORT; MODELS; IMPACT	Environmental quality is a major factor that directly impacts waterfowl productivity. Accurate prediction of pollution index (PI) is the key to improving environmental management and pollution control. This study applied a new neural network model called temporal convolutional network and a denoising algorithm called wavelet transform (WT) for predicting future 12-, 24-, and 48-hour PI values at a waterfowl farm in Shanwei, China. The temporal convoluted network (TCN) model performance was compared with that of recurrent architectures with the same capacity, long-short time memory neural network (LSTM), and gated recurrent unit (GRU). Denoised environmental data, including ammonia, temperature, relative humidity, carbon dioxide (CO2), and total suspended particles (TSP), were used to construct the forecasting model. The simulation results showed that the TCN model in general produced a more precise PI prediction and provided the highest prediction accuracy for all phases (MAE = 0.0842, 0.0859, and 0.1115; RMSE = 0.0154, 0.0167, and 0.0273; R2 = 0.9789, 0.9791, and 0.9635). The PI assessment prediction model based on TCN exhibited the best prediction accuracy and general performance compared with other parallel forecasting models and is a suitable and useful tool for predicting PI in waterfowl farms.	[Huang, Jiande; Liu, Shuangyin; Hassan, Shahbaz Gul; Xu, Longqin] Zhongkai Univ Agr & Engn, Coll Informat Sci & Technol, Guangzhou, Peoples R China; [Huang, Jiande; Liu, Shuangyin; Hassan, Shahbaz Gul; Xu, Longqin] Zhongkai Univ Agr & Engn, Smart Agr Engn Technol Res Ctr Guangdong Higher E, Guangzhou, Peoples R China; [Huang, Jiande; Liu, Shuangyin; Hassan, Shahbaz Gul; Xu, Longqin] Zhongkai Univ Agr & Engn, Guangzhou Key Lab Agr Prod Qual Safety Traceabil, Guangzhou, Peoples R China; [Huang, Jiande; Liu, Shuangyin; Hassan, Shahbaz Gul; Xu, Longqin] Zhongkai Univ Agr & Engn, Guangdong Prov Agr Prod Safety Big Data Engn Tech, Guangzhou, Peoples R China; [Huang, Jiande; Liu, Shuangyin; Hassan, Shahbaz Gul; Xu, Longqin] Guangdong Prov Key Lab Waterfowl Hlth Breeding, Guangzhou, Peoples R China; [Huang, Jiande; Liu, Shuangyin; Hassan, Shahbaz Gul; Xu, Longqin] Zhongkai Univ Agr & Engn, Acad Smart Agr Engn Innovat, Guangzhou, Peoples R China	Zhongkai University of Agriculture & Engineering; Zhongkai University of Agriculture & Engineering; Zhongkai University of Agriculture & Engineering; Zhongkai University of Agriculture & Engineering; Zhongkai University of Agriculture & Engineering	Liu, SY; Hassan, SG (corresponding author), Zhongkai Univ Agr & Engn, Coll Informat Sci & Technol, Guangzhou, Peoples R China.; Liu, SY; Hassan, SG (corresponding author), Zhongkai Univ Agr & Engn, Smart Agr Engn Technol Res Ctr Guangdong Higher E, Guangzhou, Peoples R China.; Liu, SY; Hassan, SG (corresponding author), Zhongkai Univ Agr & Engn, Guangzhou Key Lab Agr Prod Qual Safety Traceabil, Guangzhou, Peoples R China.; Liu, SY; Hassan, SG (corresponding author), Zhongkai Univ Agr & Engn, Guangdong Prov Agr Prod Safety Big Data Engn Tech, Guangzhou, Peoples R China.; Liu, SY; Hassan, SG (corresponding author), Guangdong Prov Key Lab Waterfowl Hlth Breeding, Guangzhou, Peoples R China.; Liu, SY; Hassan, SG (corresponding author), Zhongkai Univ Agr & Engn, Acad Smart Agr Engn Innovat, Guangzhou, Peoples R China.	shuangyinliu@zhku.edu.cn; mhasan387@zhku.edu.cn		huang, jiande/0000-0003-3266-1885	National Natural Science Foundation of China [61871475, 61471133, 61571444]; special project of laboratory construction of Guangzhou Innovation Platform Construction Plan [201905010006]; Guangzhou key research and development project [202103000033, 2020B0202080002]; Guangdong Science and Technology Plan of Project [2017B0101260016]; National Key Technologies R&D Program of China [2016YFD0500510]; foundation for High-level Talents in Higher Education of Guangdong Province [2017GCZX0014, 2016KZDXM0013, 2017KTSCX094, 2018LM2168]; Beijing Natural Science Foundation [4182023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special project of laboratory construction of Guangzhou Innovation Platform Construction Plan; Guangzhou key research and development project; Guangdong Science and Technology Plan of Project; National Key Technologies R&D Program of China(National Key Technology R&D Program); foundation for High-level Talents in Higher Education of Guangdong Province; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported in part by the National Natural Science Foundation of China under Grants 61871475, 61471133, and 61571444, awarded to Dr. Shuangyin Liu, in part by the special project of laboratory construction of Guangzhou Innovation Platform Construction Plan under Grant 201905010006 awarded to Dr. Shuangyin Liu, Guangzhou key research and development project under Grant 202103000033 awarded to Dr. Shuangyin Liu, Guangdong Science and Technology Plan of Project under Grant 2017B0101260016 awarded to Dr. Shuangyin Liu, National Key Technologies R&D Program of China under Grant 2016YFD0500510 awarded to Dr. Shuangyin Liu, Guangdong key research and development project under Grant 2020B0202080002 awarded to Dr. Shuangyin Liu, the foundation for High-level Talents in Higher Education of Guangdong Province under Grants 2017GCZX0014, 2016KZDXM0013, 2017KTSCX094, and 2018LM2168 awarded to Dr. Shuangyin Liu, and Beijing Natural Science Foundation under Grant 4182023 awarded to Dr. Shuangyin Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh MJ, 2018, ENG APPL COMP FLUID, V12, P810, DOI 10.1080/19942060.2018.1528480; Asadollah SBHS, 2021, J ENVIRON CHEM ENG, V9, DOI 10.1016/j.jece.2020.104599; Astill J, 2020, COMPUTERS ELECT AGR, DOI [10.1016/j.compag.2020.105759, DOI 10.1016/J.COMPAG.2020.105759]; Bai Shaojie, 2018, ARXIV180301271; Bavkar S, 2020, 2020 INTERNATIONAL CONFERENCE ON EMERGING SMART COMPUTING AND INFORMATICS (ESCI), P153, DOI 10.1109/ESCI48226.2020.9167564; Behrendt A, 2011, ATMOS ENVIRON, V45, P2795, DOI 10.1016/j.atmosenv.2011.02.061; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bustamante E, 2012, SENSORS-BASEL, V12, P5752, DOI 10.3390/s120505752; Chen Li, 2018, Information Processing in Agriculture, V5, P11, DOI 10.1016/j.inpa.2017.11.002; Choi HL, 2014, FUEL, V116, P772, DOI 10.1016/j.fuel.2013.08.064; Csabragi A, 2017, ECOL ENG, V100, P63, DOI 10.1016/j.ecoleng.2016.12.027; David B, 2015, ANIMALS-BASEL, V5, P886, DOI 10.3390/ani5030389; David B, 2015, ANIMALS, V5, P495, DOI 10.3390/ani5030368; Eyob Gebregeziabhear, 2015, Journal of Biology, Agriculture and Healthcare, V5, P165; Gers FA, 2000, NEURAL COMPUT, V12, P2451, DOI 10.1162/089976600300015015; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Jackman P, 2015, AGR ENG INT CIGR J; Jorfi S, 2017, DATA BRIEF, V15, P584, DOI 10.1016/j.dib.2017.10.017; Kargar K, 2020, ENG APPL COMP FLUID, V14, P311, DOI 10.1080/19942060.2020.1712260; Khanoranga, 2019, J CLEAN PROD, V229, P727, DOI 10.1016/j.jclepro.2019.05.050; Kumar A, 2021, ISA T, V114, P251, DOI 10.1016/j.isatra.2020.12.029; Lashari MH, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON INTERNET OF THINGS AND INTELLIGENCE SYSTEM (IOTAIS), P1; Leong WC, 2020, J ENVIRON CHEM ENG, V8, DOI 10.1016/j.jece.2019.103208; Liu SY, 2014, ENG APPL ARTIF INTEL, V29, P114, DOI 10.1016/j.engappai.2013.09.019; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Martinus Y, 2018, IOP C SER EARTH ENV, V106, DOI 10.1088/1755-1315/106/1/012022; Najafi P, 2015, INT J BIOMETEOROL, V59, P1577, DOI 10.1007/s00484-015-0964-3; Odiete WE, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05555; Othman J K., 2014, INT J COMPUTER APPL, DOI [10.5120/18093-9149, DOI 10.5120/18093-9149]; Peng Q, 2020, CHIN CONTR CONF, P5423, DOI 10.23919/CCC50068.2020.9188453; Pereira WF, 2020, COMPUT ELECTRON AGR, V170, DOI 10.1016/j.compag.2020.105257; Qian Y, 2018, SCI TOTAL ENVIRON, V622, P702, DOI 10.1016/j.scitotenv.2017.12.045; Ramsey DSL, 2016, PREV VET MED, V134, P26, DOI 10.1016/j.prevetmed.2016.09.022; Rankovi V., 2010, SERBIA ECOL MODELL, V221, P1239, DOI DOI 10.1016/j.ecolmodel.2009.12.023; Rubio-Arias H, 2012, INT J ENV RES PUB HE, V9, P1687, DOI 10.3390/ijerph9051687; Saraiva SV, 2021, APPL SOFT COMPUT, V102, DOI 10.1016/j.asoc.2021.107081; Seng DW, 2021, ALEX ENG J, V60, P2021, DOI 10.1016/j.aej.2020.12.009; Sun M, 2016, COMPUT ELECTRON AGR, V127, P425, DOI 10.1016/j.compag.2016.06.024; Suriadikusumah A., 2021, Acta Ecologica Sinica - International Journal, V41, P177, DOI 10.1016/j.chnaes.2020.08.001; Thach TQ, 2018, INT J HYG ENVIR HEAL, V221, P17, DOI 10.1016/j.ijheh.2017.09.012; Valdebenito AM, 2011, ATMOS ENVIRON, V45, P2981, DOI 10.1016/j.atmosenv.2010.09.004; Wei YG, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19183995; Yan XT, 2020, IEEE ENG MED BIO, P944, DOI 10.1109/EMBC44109.2020.9176488; Yang HR, 2021, ENVIRON RES, V192, DOI 10.1016/j.envres.2020.110246; You Shingchern D., 2020, 2020 2nd International Conference on Computer Communication and the Internet (ICCCI), P93, DOI 10.1109/ICCCI49374.2020.9145984; Zhang L, 2021, J APPL GEOPHYS, V186, DOI 10.1016/j.jappgeo.2021.104273; Zhang Z, 2020, 2020 IEEE IAS IND CO, DOI 10.1109/ICPSAsia48933.2020.9208545	48	0	0	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254179	10.1371/journal.pone.0254179	http://dx.doi.org/10.1371/journal.pone.0254179			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297737	gold, Green Published			2022-12-26	WOS:000678128300067
J	Lind, L; Kullberg, J; Ahlstrom, H; Strand, R				Lind, Lars; Kullberg, Joel; Ahlstrom, Hakan; Strand, Robin			Relationships between carotid artery intima-media thickness and echogenicity and body composition using a new magnetic resonance imaging voxel-based technique	PLOS ONE			English	Article							VISCERAL ADIPOSE-TISSUE; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; ATHEROSCLEROSIS; COMPLEX; ASSOCIATION; PREDICTOR; MASS	Background We evaluated how carotid artery intima-media thickness (IMT) and the echogenicity of the intima-media (IM-GSM), measured by ultrasound, were related to body composition, evaluated by both traditional imaging techniques, as well as with a new voxel-based "Imiomics" technique. Methods In 321 subjects all aged 50 years in the POEM study, IMT and IM-GSM were measured together with a DXA scan for determination of fat and lean mass. Also a whole-body MRI scan was performed and the body volume was divided into >1 million voxels in a standardized fashion. IMT and IM-GSM were related to each of these voxels to create a 3D-view of how these measurements were related to size of each part of the body. Results IM-GSM was inversely related to almost all traditional measurements of body composition, like fat and lean mass, liver fat, visceral and subcutaneous fat, but this was not seen for IMT. Using Imiomics, IMT was positively related to the intraabdominal fat volume, as well of the leg skeletal muscle in women. In males, IMT was mainly positively related to the leg skeletal muscle volume. IM-GSM was inversely related to the volume of the SAT in the upper part of the body, leg skeletal muscle, the liver and intraabdominal fat in both men and women. Conclusion The voxel-based Imiomics technique provided a detailed view of how the echogenicity of the carotid artery wall was related to body composition, being inversely related to the volume of the major fat depots, as well as leg skeletal muscle.	[Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Kullberg, Joel; Ahlstrom, Hakan; Strand, Robin] Uppsala Univ, Dept Surg Sci, Div Radiol, Uppsala, Sweden; [Kullberg, Joel; Ahlstrom, Hakan] Antaros Med AB, BioVentu Re Hub, Molndal, Sweden; [Strand, Robin] Uppsala Univ, Dept Informat Technol, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Strand, R (corresponding author), Uppsala Univ, Dept Surg Sci, Div Radiol, Uppsala, Sweden.; Strand, R (corresponding author), Uppsala Univ, Dept Informat Technol, Uppsala, Sweden.	Robin.Strand@it.uu.se	Kullberg, Joel/ABE-3997-2021		Swedish Research Council [2016-01040]; Swedish Heart-Lung Foundation [2170492]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	Swedish Research Council grant no 2016-01040 and Swedish Heart-Lung Foundation grant no 2170492. Joel Kullberg and Hakan Ahlstrom are cofounders, co-owners of and part time employees of Antaros Medical AB, BioVenture Hub, Molndal, Sweden. The funder provided support in the form of salaries for authors JK and HA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Andersson J, 2009, ATHEROSCLEROSIS, V204, P612, DOI 10.1016/j.atherosclerosis.2008.10.038; Andersson J, 2018, MAGN RESON IMAGING, V50, P78, DOI 10.1016/j.mri.2018.03.015; Carmina E, 2009, EUR J ENDOCRINOL, V161, P583, DOI 10.1530/EJE-09-0398; Czernichow S, 2005, INT J OBESITY, V29, P826, DOI 10.1038/sj.ijo.0802986; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Eickemberg M, 2019, ARQ BRAS CARDIOL, V112, P220, DOI 10.5935/abc.20180273; Ekstrom S, 2020, COMPUT MED IMAG GRAP, V84, DOI 10.1016/j.compmedimag.2020.101745; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Lear SA, 2007, STROKE, V38, P2422, DOI 10.1161/STROKEAHA.107.484113; Lind L, 2020, RADIOLOGY, V294, P559, DOI 10.1148/radiol.2019191035; Lind L, 2019, NUTR METAB CARDIOVAS, V29, P1077, DOI 10.1016/j.numecd.2019.06.017; Lind L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43690-w; Lind L, 2013, J HYPERTENS, V31, P1570, DOI 10.1097/HJH.0b013e3283619d50; Lind L, 2013, CLIN PHYSIOL FUNCT I, V33, P137, DOI 10.1111/cpf.12006; Liu YY, 2019, J ATHEROSCLER THROMB, V26, P1102, DOI 10.5551/jat.47977; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Maher V, 2009, INT J OBESITY, V33, P136, DOI 10.1038/ijo.2008.254; Moreno M, 2015, ATHEROSCLEROSIS, V243, P493, DOI 10.1016/j.atherosclerosis.2015.09.012; Rallidis LS, 2014, ULTRASOUND MED BIOL, V40, P1083, DOI 10.1016/j.ultrasmedbio.2013.12.017; Song YM, 2012, EUR J CLIN NUTR, V66, P39, DOI 10.1038/ejcn.2011.150; Strand R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169966; Sugiura T, 2020, J ATHEROSCLER THROMB, V27, P342, DOI 10.5551/jat.50633; Wohlin M, 2009, ATHEROSCLEROSIS, V205, P486, DOI 10.1016/j.atherosclerosis.2009.01.032; Yu RHY, 2008, MENOPAUSE, V15, P185, DOI 10.1097/gme.0b013e31806458c9	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254732	10.1371/journal.pone.0254732	http://dx.doi.org/10.1371/journal.pone.0254732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297762	gold, Green Published			2022-12-26	WOS:000678128300066
J	Gunnes, M; Aksetoy, ILA; Follestad, T; Indredavik, B; Askim, T				Gunnes, Mari; Aksetoy, Inger-Lise Aamot; Follestad, Turid; Indredavik, Bent; Askim, Torunn			Can functional walk tests add value to the prediction of cardiorespiratory fitness after stroke? A prospective cohort study	PLOS ONE			English	Article							6-MINUTE WALK; PHYSICAL-ACTIVITY; AMBULATORY ACTIVITY; EXERCISE CAPACITY; ASSOCIATION; SPEED; RELIABILITY; GUIDELINES; CARDIOLOGY; PROGNOSIS	Background Cardiorespiratory fitness is often impaired following stroke, and peak oxygen consumption (VO2peak) is an important prognostic value of all-cause mortality. The primary objective was to investigate whether functional walk tests assessed in the subacute phase after stroke added value in predicting VO2peak in chronic stroke, in addition to age, sex and functional dependency. Secondary objectives were to investigate associations between daily physical activity and functional walk tests, and with VO2peak in chronic stroke. Methods This prospective cohort study included eligible participants originally included in the randomized controlled trial Life After Stroke. Functional walk tests, i.e., six-minute walk test (6MWT) and maximal gait speed, were assessed at inclusion and 18 months later. VO2peak [ml/kg/min] was assessed by a cardiopulmonary exercise test on a treadmill 20 months after inclusion. Daily physical activity was measured by a uniaxial accelerometer (activPAL) at 18-month follow-up. Results Ninety-two community-dwelling individuals, with a mean (SD) age of 69.2 (10.6) years and 33 (35.9%) women, were included 3 months after stroke onset. Eighty-three (90.2%) participants had a modified Rankin Scale (mRS) score of 1 or 2, indicating functional independence. An overall assessment of four prediction models indicated the combination of age, sex, mRS and 6MWT as predictors to be the best fitted model in predicting VO2peak (adjusted R-2 = 0.612). Secondary results showed statistically significant, but not clinically significant, associations between daily physical activity and functional walk tests, and with VO2peak. Conclusions 6MWT add significant value to the prediction of mean VO2peak in the chronic phase in mild strokes, in combination with age, sex and functional dependency. This prediction model may facilitate clinical decisions and rehabilitation strategies for mildly affected stroke survivors in risk of low levels of VO2peak. Future studies should validate the model in various stages after stroke and in patients moderately and severely affected.	[Gunnes, Mari; Indredavik, Bent; Askim, Torunn] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Trondheim, Norway; [Gunnes, Mari; Indredavik, Bent; Askim, Torunn] St Olavs Univ Hosp, Stroke Unit, Dept Internal Med, Trondheim, Norway; [Aksetoy, Inger-Lise Aamot] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, Trondheim, Norway; [Follestad, Turid] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Clin & Mol Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Gunnes, M (corresponding author), Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Trondheim, Norway.; Gunnes, M (corresponding author), St Olavs Univ Hosp, Stroke Unit, Dept Internal Med, Trondheim, Norway.	mari.gunnes@gmail.com	Askim, Torunn/B-7655-2017	Askim, Torunn/0000-0002-9818-9272	Norwegian Fund for Postgraduate Training in Physiotherapy; Research Council of Norway [205309/H10]	Norwegian Fund for Postgraduate Training in Physiotherapy; Research Council of Norway(Research Council of Norway)	The financial support for this study was granted as a doctoral scholarship from The Norwegian Fund for Postgraduate Training in Physiotherapy, in addition to the Liaison Committee for education, research and innovation in Central Norway (TA). Life After Stroke (LAST), the original study on which the present article is based, was funded by the Research Council of Norway (grant no 205309/H10) (BI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askim T, 2018, STROKE, V49, P426, DOI 10.1161/STROKEAHA.117.018827; Askim T, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/392101; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Boss HM, 2017, J STROKE CEREBROVASC, V26, P1114, DOI 10.1016/j.jstrokecerebrovasdis.2016.12.029; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; Courbon A, 2006, AM J PHYS MED REHAB, V85, P436, DOI 10.1097/01.phm.0000214359.94735.c8; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dalgas U, 2012, ARCH PHYS MED REHAB, V93, P1167, DOI 10.1016/j.apmr.2012.02.026; Dobrovolny CL, 2003, ARCH PHYS MED REHAB, V84, P1308, DOI 10.1016/S0003-9993(03)00150-3; Echouffo-Tcheugui JB, 2015, CIRC-HEART FAIL, V8, P853, DOI 10.1161/CIRCHEARTFAILURE.115.002070; Fjaertoft H., 2018, NORWEGIAN STROKE REG; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fulk GD, 2010, ARCH PHYS MED REHAB, V91, P1582, DOI 10.1016/j.apmr.2010.07.005; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Gordon NF, 2004, CIRCULATION, V109, P2031, DOI 10.1161/01.CIR.0000126280.65777.A4; GORDON NF, 1991, MED SCI SPORT EXER, V23, P668; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Harmsen WJ, 2017, TOP STROKE REHABIL, V24, P250, DOI 10.1080/10749357.2016.1260263; Kaminsky LA, 2019, PROG CARDIOVASC DIS, V62, P86, DOI 10.1016/j.pcad.2019.01.002; Katoh J, 2002, J PHYS THER SCI, V14, P77, DOI [10.1589/jpts.14.77, DOI 10.1589/JPTS.14.77]; Ketcyian SJ, 2008, AM HEART J, V156, P292, DOI 10.1016/j.ahj.2008.03.017; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kwakkel G, 2013, INT J STROKE, V8, P25, DOI 10.1111/j.1747-4949.2012.00967.x; Luo L, 2020, ANN PHYS REHABIL MED, V63, P59, DOI 10.1016/j.rehab.2019.07.006; Mattlage Anna E, 2016, Cardiopulm Phys Ther J, V27, P96; Medbo JI, 2002, SCAND J CLIN LAB INV, V62, P585, DOI 10.1080/003655102764654321; Michael K, 2007, TOP STROKE REHABIL, V14, P5, DOI 10.1310/tsr1402-5; Michael KM, 2005, ARCH PHYS MED REHAB, V86, P1552, DOI 10.1016/j.apmr.2004.12.026; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Mudge S, 2009, ARCH PHYS MED REHAB, V90, P296, DOI 10.1016/j.apmr.2008.07.025; Outermans J, 2015, PHYS THER, V95, P835, DOI 10.2522/ptj.20140081; Patterson SL, 2007, ARCH PHYS MED REHAB, V88, P115, DOI 10.1016/j.apmr.2006.10.025; Rand D, 2009, STROKE, V40, P163, DOI 10.1161/STROKEAHA.108.523621; Ross RM, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-31; Salbach NM, 2014, NEUROREHAB NEURAL RE, V28, P111, DOI 10.1177/1545968313498826; Smith AC, 2012, INT J STROKE, V7, P499, DOI 10.1111/j.1747-4949.2012.00791.x; Tang A, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-23; Taraldsen K, 2011, PHYS THER, V91, P277, DOI 10.2522/ptj.20100159; van de Port IGL, 2015, J REHABIL MED, V47, P881, DOI 10.2340/16501977-2031; Wasserman K, 2005, PRINCIPLES EXERCISE	42	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255308	10.1371/journal.pone.0255308	http://dx.doi.org/10.1371/journal.pone.0255308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339475	gold, Green Published			2022-12-26	WOS:000680243400049
J	Esperante, SA; Varejao, N; Pinheiro, F; Sant'Anna, R; Luque-Ortega, JR; Alfonso, C; Sora, V; Papaleo, E; Rivas, G; Reverter, D; Ventura, S				Esperante, Sebastian A.; Varejao, Nathalia; Pinheiro, Francisca; Sant'Anna, Ricardo; Roman Luque-Ortega, Juan; Alfonso, Carlos; Sora, Valentina; Papaleo, Elena; Rivas, German; Reverter, David; Ventura, Salvador			Disease-associated mutations impacting BC-loop flexibility trigger long-range transthyretin tetramer destabilization and aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL AMYLOID POLYNEUROPATHY; DENATURATION; VARIANT; TAFAMIDIS; PROTEIN; ULTRACENTRIFUGATION; AMYLOIDOGENESIS; STABILIZATION; DISSOCIATION; STABILITY	Hereditary transthyretin amyloidosis (ATTR) is an autosomal dominant disease characterized by the extracellular deposition of the transport protein transthyretin (TTR) as amyloid fibrils. Despite the progress achieved in recent years, understanding why different TTR residue substitutions lead to different clinical manifestations remains elusive. Here, we studied the molecular basis of disease-causing missense mutations affecting residues R34 and K35. R34G and K35T variants cause vitreous amyloidosis, whereas R34T and K35N mutations result in amyloid polyneuropathy and restrictive cardiomyopathy. All variants are more sensitive to pH-induced dissociation and amyloid formation than the wild-type (WT)-TTR counterpart, specifically in the variants deposited in the eyes amyloid formation occurs close to physiological pHs. Chemical denaturation experiments indicate that all the mutants are less stable than WTTTR, with the vitreous amyloidosis variants, R34G and K35T, being highly destabilized. Sequence-induced stabilization of the dimer-dimer interface with T119M rendered tetramers containing R34G or K35T mutations resistant to pH-induced aggregation. Because R34 and K35 are among the residues more distant to the TTR interface, their impact in this region is therefore theorized to occur at long range. The crystal structures of double mutants, R34G/T119M and K35T/T119M, together with molecular dynamics simulations indicate that their strong destabilizing effect is initiated locally at the BC loop, increasing its flexibility in a mutation-dependent manner. Overall, the present findings help us to understand the sequence-dynamic-structural mechanistic details of TTR amyloid aggregation triggered by R34 and K35 variants and to link the degree of mutation-induced conformational flexibility to protein aggregation propensity.	[Esperante, Sebastian A.; Varejao, Nathalia; Pinheiro, Francisca; Sant'Anna, Ricardo; Reverter, David; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Barcelona, Spain; [Esperante, Sebastian A.; Varejao, Nathalia; Pinheiro, Francisca; Sant'Anna, Ricardo; Reverter, David; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain; [Roman Luque-Ortega, Juan] CSIC, Ctr Invest Biol Margarita Salas, Mol Interact Facil, Madrid, Spain; [Alfonso, Carlos; Rivas, German] CSIC, Ctr Invest Biol Margarita Salas, Syst Biochem Bacterial Div Lab, Madrid, Spain; [Sora, Valentina; Papaleo, Elena] Danish Canc Soc Res Ctr, Computat Biol Lab, Copenhagen, Denmark; [Sora, Valentina; Papaleo, Elena] Tech Univ Denmark, Canc Syst Biol Hlth & Technol Dept, Sect Bioinformat, Lyngby, Denmark; [Esperante, Sebastian A.] INFANT Fdn, Buenos Aires, DF, Argentina; [Esperante, Sebastian A.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Danish Cancer Society; Technical University of Denmark; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Esperante, SA; Ventura, S (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Barcelona, Spain.; Esperante, SA; Ventura, S (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain.; Esperante, SA (corresponding author), INFANT Fdn, Buenos Aires, DF, Argentina.; Esperante, SA (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	sesperante@infant.org.ar; salvador.ventura@uab.es	Rivas, German/AAG-7458-2022; Alfonso, Carlos/K-1316-2014; Ventura, Salvador/C-7021-2008; Ventura, Salvador/AAY-3170-2021; Pinheiro, Francisca/U-1397-2019; Rivas, German/AFL-7528-2022; Reverter, David/H-5360-2015	Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Ventura, Salvador/0000-0002-9652-6351; Ventura, Salvador/0000-0002-9652-6351; Pinheiro, Francisca/0000-0003-3778-1528; Rivas, German/0000-0003-3450-7478; Reverter, David/0000-0002-5347-0992	Spanish Ministry of Science and Innovation [PID2019-105017RB-100, PID2019-104544GB-I00]; ICREA, ICREA-Academia 2020; Danmarks Grundforsknings-fond [DNRF125]; Carlsbergfondet Distinguished Fellowship [CF18-0314]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA, ICREA-Academia 2020; Danmarks Grundforsknings-fond(Danmarks Grundforskningsfond); Carlsbergfondet Distinguished Fellowship	This work was funded by the Spanish Ministry of Science and Innovation PID2019-105017RB-100 to S. V., PID2019-104544GB-I00 to C. A., and by ICREA, ICREA-Academia 2020 to S. V. and Danmarks Grundforsknings-fond (DNRF125) and Carlsbergfondet Distinguished Fellowship (CF18-0314) to E. P.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALMEIDA MR, 1991, BASIC RES CARDIOL, V86, P567, DOI 10.1007/BF02190707; Almeida MR, 2000, BIOCHEM BIOPH RES CO, V270, P1024, DOI 10.1006/bbrc.2000.2554; Ankarcrona M, 2016, J INTERN MED, V280, P177, DOI 10.1111/joim.12506; Azevedo EPC, 2011, BIOCHEMISTRY-US, V50, P11070, DOI 10.1021/bi201365r; Babbes ARH, 2008, BIOCHEMISTRY-US, V47, P6969, DOI 10.1021/bi800636q; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Buxbaum JN, 2009, CELL MOL LIFE SCI, V66, P3095, DOI 10.1007/s00018-009-0109-0; Cendron L, 2009, J BIOL CHEM, V284, P25832, DOI 10.1074/jbc.M109.017657; CHRISTMANSON L, 1991, FEBS LETT, V281, P177, DOI 10.1016/0014-5793(91)80387-I; Coelho T, 1996, CURR OPIN NEUROL, V9, P355, DOI 10.1097/00019052-199610000-00007; Coelho T., 1996, NEUROMUSCUL DISORD, V6, pS20, DOI 10.1016/0960-8966(96)88826-2; Coelho T, 2016, NEUROL THER, V5, P1, DOI 10.1007/s40120-016-0040-x; Coelho T, 2013, J NEUROL, V260, P2802, DOI 10.1007/s00415-013-7051-7; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Dasari AKR, 2020, BIOCHEMISTRY-US, V59, P2319, DOI 10.1021/acs.biochem.0c00079; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finsterer J, 2019, ACTA NEUROL SCAND, V139, P92, DOI 10.1111/ane.13035; Foss TR, 2005, J MOL BIOL, V347, P841, DOI 10.1016/j.jmb.2005.01.050; HAGEN GA, 1973, J CLIN ENDOCR METAB, V37, P415, DOI 10.1210/jcem-37-3-415; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; Harding S. E., 1992, ANAL ULTRACENTRIFUGA; Jiang X, 2001, P NATL ACAD SCI USA, V98, P14943, DOI 10.1073/pnas.261419998; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Juanhuix J, 2014, J SYNCHROTRON RADIAT, V21, P679, DOI 10.1107/S160057751400825X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lai ZH, 1997, BIOCHEMISTRY-US, V36, P10230, DOI 10.1021/bi963195p; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lashuel HA, 1998, BIOCHEMISTRY-US, V37, P17851, DOI 10.1021/bi981876+; Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c; Levy J, 2012, AMYLOID, V19, P201, DOI 10.3109/13506129.2012.724035; Long D, 2012, OPHTHALMIC GENET, V33, P28, DOI 10.3109/13816810.2011.599356; Maurer MS, 2018, NEW ENGL J MED, V379, P1007, DOI 10.1056/NEJMoa1805689; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michael J.A., 2014, ENCY NEUROLOGICAL SC, V2; Miller M, 2018, J MED CHEM, V61, P7862, DOI 10.1021/acs.jmedchem.8b00817; Nygaard M, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00078; Palaninathan SK, 2012, CURR MED CHEM, V19, P2324; Palhano FL, 2009, J BIOL CHEM, V284, P1443, DOI 10.1074/jbc.M807100200; Patrosso MC, 1998, AM J MED GENET, V77, P135, DOI 10.1002/(SICI)1096-8628(19980501)77:2<135::AID-AJMG5>3.0.CO;2-R; Penchala SC, 2013, P NATL ACAD SCI USA, V110, P9992, DOI 10.1073/pnas.1300761110; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Pinheiro F, 2021, FEBS J, V288, P310, DOI 10.1111/febs.15339; REILLY MM, 1995, BRAIN, V118, P849, DOI 10.1093/brain/118.4.849; Sant'Anna R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44709; Sant'Anna R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10787; Sant'Anna R, 2014, J BIOL CHEM, V289, P28324, DOI 10.1074/jbc.M114.563981; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Sekijima Y, 2006, AMYLOID, V13, P57, DOI 10.1080/13506120600722449; Sekijima Y, 2006, AMYLOID, V13, P236, DOI 10.1080/13506120600960882; Sipe JD, 2016, AMYLOID, V23, P209, DOI 10.1080/13506129.2016.1257986; Srinivasan E, 2020, COMPUT BIOL CHEM, V87, DOI 10.1016/j.compbiolchem.2020.107290; van Holde KE, 2005, PRINCIPLES PHYS BIOC; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	60	2	2	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101039	10.1016/j.jbc.2021.101039	http://dx.doi.org/10.1016/j.jbc.2021.101039			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34343569	Green Published, gold			2022-12-26	WOS:000704369100012
J	Tang, Q; Caglayan, M				Tang, Qun; Caglayan, Melike			The scaffold protein XRCC1 stabilizes the formation of pol beta/gap DNA and ligase III alpha/nick DNA complexes in base excision repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; COMPLEMENTING GROUP 1; POLYMERASE-BETA; CANCER-RISK; APRATAXIN DEFICIENCY; INSERTION PRODUCTS; GENE XRCC1; POLYMORPHISMS; DAMAGE; VARIANTS	The base excision repair (BER) pathway involves gap filling by DNA polymerase (pol) beta and subsequent nick sealing by ligase III alpha. X-ray cross-complementing protein 1 (XRCC1), a nonenzymatic scaffold protein, assembles multiprotein complexes, although the mechanism by which XRCC1 orchestrates the final steps of coordinated BER remains incompletely defined. Here, using a combination of biochemical and biophysical approaches, we revealed that the pol beta/XRCC1 complex increases the processivity of BER reactions after correct nucleotide insertion into gaps in DNA and enhances the handoff of nicked repair products to the final ligation step. Moreover, the mutagenic ligation of nicked repair intermediate following pol beta 8-oxodGTP insertion is enhanced in the presence of XRCC1. Our results demonstrated a stabilizing effect of XRCC1 on the formation of pol beta/dNTP/gap DNA and ligase III alpha/ATP/nick DNA catalytic ternary complexes. Real-time monitoring of protein-protein interactions and DNA-binding kinetics showed stronger binding of XRCC1 to pol beta than to ligase III alpha or aprataxin, and higher affinity for nick DNA with undamaged or damaged ends than for one nucleotide gap repair intermediate. Finally, we demonstrated slight differences in stable pol beta/XRCC1 complex formation, pol beta and ligase III alpha protein interaction kinetics, and handoff process as a result of cancer-associated (P161L, R194W, R280H, R399Q, Y576S) and cerebellar ataxia-related (K431N) XRCC1 variants. Overall, our findings provide novel insights into the coordinating role of XRCC1 and the effect of its disease-associated variants on substrate-product channeling in multiprotein/DNA complexes for efficient BER.	[Tang, Qun; Caglayan, Melike] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Caglayan, M (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	caglayanm@ufl.edu	Tang, Qun/AHC-5915-2022	Tang, Qun/0000-0001-8943-0012; CAGLAYAN, MELIKE/0000-0003-1107-1042	National Institutes of Health/National Institute of Environmental Health Sciences [4R00ES026191]; University of Florida Thomas H. Maren Junior Investigator Fund [P0158597]	National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of Florida Thomas H. Maren Junior Investigator Fund	This work was supported by the National Institutes of Health/National Institute of Environmental Health Sciences Grant 4R00ES026191 and the University of Florida Thomas H. Maren Junior Investigator Fund P0158597.	Abbotts R, 2017, FREE RADICAL BIO MED, V107, P228, DOI 10.1016/j.freeradbiomed.2016.11.039; Akbari M, 2010, DNA REPAIR, V9, P785, DOI 10.1016/j.dnarep.2010.04.002; Ali R, 2018, CANCER RES, V78, P6818, DOI 10.1158/0008-5472.CAN-18-0633; Barbisan G, 2011, EUR J GYNAECOL ONCOL, V32, P274; Beard WA, 2006, METHOD ENZYMOL, V408, P91, DOI 10.1016/S0076-6879(06)08007-4; Beard WA, 2019, ANNU REV BIOCHEM, V88, P137, DOI 10.1146/annurev-biochem-013118-111315; Beernink PT, 2005, J BIOL CHEM, V280, P30206, DOI 10.1074/jbc.M502155200; Berquist BR, 2010, NUCLEIC ACIDS RES, V38, P5023, DOI 10.1093/nar/gkq193; Brem R, 2005, NUCLEIC ACIDS RES, V33, P2512, DOI 10.1093/nar/gki543; Caglayan M, 2020, DNA REPAIR, V95, DOI 10.1016/j.dnarep.2020.102945; Caglayan M, 2020, NUCLEIC ACIDS RES, V48, P3708, DOI 10.1093/nar/gkaa151; Caglayan M, 2019, J MOL BIOL, V431, P2068, DOI 10.1016/j.jmb.2019.04.028; Caglayan M, 2017, NUCLEIC ACIDS RES, V45, P10079, DOI 10.1093/nar/gkx654; Caglayan M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14045; Caglayan M, 2015, DNA REPAIR, V35, P85, DOI 10.1016/j.dnarep.2015.09.010; Caglayan M, 2015, NUCLEIC ACIDS RES, V43, P2271, DOI 10.1093/nar/gkv079; Caglayan M, 2014, NAT STRUCT MOL BIOL, V21, P497, DOI 10.1038/nsmb.2818; Caldecott KW, 2019, DNA REPAIR, V81, DOI 10.1016/j.dnarep.2019.102664; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Campalans A, 2005, DNA REPAIR, V4, P826, DOI 10.1016/j.dnarep.2005.04.014; Campalans A, 2015, MOL CELL BIOL, V35, P1648, DOI 10.1128/MCB.00134-15; Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970; Chandirasekar R, 2011, ENVIRON TOXICOL PHAR, V32, P185, DOI 10.1016/j.etap.2011.05.002; Chatterjee N, 2017, ENVIRON MOL MUTAGEN, V58, P235, DOI 10.1002/em.22087; Chiang FY, 2008, CLIN CANCER RES, V14, P5919, DOI 10.1158/1078-0432.CCR-08-0906; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Cuneo MJ, 2011, NUCLEIC ACIDS RES, V39, P7816, DOI 10.1093/nar/gkr419; Dianova II, 2004, NUCLEIC ACIDS RES, V32, P2550, DOI 10.1093/nar/gkh567; Fortini P, 1999, J BIOL CHEM, V274, P15230, DOI 10.1074/jbc.274.21.15230; Ganos C, 2017, MOVEMENT DISORD, V32, P720, DOI 10.1002/mds.26971; Geng J, 2009, UROLOGY, V74, P648, DOI 10.1016/j.urology.2009.02.046; Ginsberg G, 2011, MUTAT RES-REV MUTAT, V727, P1, DOI 10.1016/j.mrrev.2011.02.001; Gryk MR, 2002, STRUCTURE, V10, P1709, DOI 10.1016/S0969-2126(02)00908-5; Halasova E, 2012, INT ARCH OCC ENV HEA, V85, P473, DOI 10.1007/s00420-011-0684-x; Hanssen-Bauer A, 2012, DNA REPAIR, V11, P357, DOI 10.1016/j.dnarep.2012.01.001; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hoch NC, 2017, NATURE, V541, P87, DOI 10.1038/nature20790; Horton JK, 2008, CELL RES, V18, P48, DOI 10.1038/cr.2008.7; Horton JK, 2018, DNA REPAIR, V64, P26, DOI 10.1016/j.dnarep.2018.02.004; Horton JK, 2013, DNA REPAIR, V12, P774, DOI 10.1016/j.dnarep.2013.06.004; Jiang Jun, 2009, V471, P305, DOI 10.1007/978-1-59745-416-2_16; Kamble P, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100427; Karahalil B, 2012, HUM EXP TOXICOL, V31, P981, DOI 10.1177/0960327112444476; Kelley MR, 2014, FUTURE ONCOL, V10, P1215, DOI 10.2217/fon.14.60; Kim Yun-Jeong, 2012, Curr Mol Pharmacol, V5, P3; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Kukshal V, 2015, NUCLEIC ACIDS RES, V43, P7021, DOI 10.1093/nar/gkv652; Lee KJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223725; Lindahl T, 2001, PROG NUCLEIC ACID RE, V68, pXVII; Liu YA, 2007, J BIOL CHEM, V282, P13532, DOI 10.1074/jbc.M611295200; London RE, 2015, DNA REPAIR, V30, P90, DOI 10.1016/j.dnarep.2015.02.005; Mani RS, 2019, J BIOL CHEM, V294, P520, DOI 10.1074/jbc.RA118.004262; Mani RS, 2004, BIOCHEMISTRY-US, V43, P16505, DOI 10.1021/bi048615m; Marintchev A, 2003, NUCLEIC ACIDS RES, V31, P580, DOI 10.1093/nar/gkg159; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Marintchev A, 2000, NUCLEIC ACIDS RES, V28, P2049, DOI 10.1093/nar/28.10.2049; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Mok MCY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39543-1; Moor NA, 2018, BIOCHEMISTRY-MOSCOW+, V83, P411, DOI 10.1134/S0006297918040120; Moor NA, 2015, NUCLEIC ACIDS RES, V43, P6009, DOI 10.1093/nar/gkv569; Moullan N, 2003, CANCER EPIDEM BIOMAR, V12, P1168; Nelson BC, 2020, MUTAGENESIS, V35, P1, DOI 10.1093/mutage/gez048; Parikh SS, 1997, STRUCTURE, V5, P1543, DOI 10.1016/S0969-2126(97)00303-1; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Prasad R, 2011, MOL BIOL+, V45, P536, DOI 10.1134/S0026893311040091; Prasad R, 2012, NUCLEIC ACIDS RES, V40, P11571, DOI 10.1093/nar/gks898; Prasad R, 2010, J BIOL CHEM, V285, P40479, DOI 10.1074/jbc.M110.155267; Roberts MR, 2011, CARCINOGENESIS, V32, P1223, DOI 10.1093/carcin/bgr096; Roszak A, 2011, INT J BIOL MARKER, V26, P216, DOI 10.5301/JBM.2011.8581; Ryu RA, 2011, J KOREAN MED SCI, V26, P991, DOI 10.3346/jkms.2011.26.8.991; Shen NR, 1998, NUCLEIC ACIDS RES, V26, P1032, DOI 10.1093/nar/26.4.1032; Sizova DV, 2015, DNA REPAIR, V31, P73, DOI 10.1016/j.dnarep.2015.05.005; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Sultana R, 2013, CANCER RES, V73, P1621, DOI 10.1158/0008-5472.CAN-12-2929; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Takanami T, 2005, MUTAT RES-GEN TOX EN, V582, P135, DOI 10.1016/j.mrgentox.2005.01.007; Tang Q, 2020, MUTAGENESIS, V35, P391, DOI 10.1093/mutage/geaa023; Tebbs RS, 2003, DNA REPAIR, V2, P1405, DOI 10.1016/j.dnarep.2003.08.007; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; THOMPSON LH, 1982, MUTAT RES, V95, P427, DOI 10.1016/0027-5107(82)90276-7; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Vodicka P, 2007, CARCINOGENESIS, V28, P657, DOI 10.1093/carcin/bgl187; Wallace SS, 2012, CANCER LETT, V327, P73, DOI 10.1016/j.canlet.2011.12.038; Wei B, 2011, PROSTATE CANCER P D, V14, P225, DOI 10.1038/pcan.2011.26; Whitaker AM, 2018, DNA REPAIR, V71, P93, DOI 10.1016/j.dnarep.2018.08.012; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Wong HK, 2005, J CELL BIOCHEM, V95, P794, DOI 10.1002/jcb.20448; Xue HP, 2011, AM J EPIDEMIOL, V173, P363, DOI 10.1093/aje/kwq378; Yoon Grace, 2018, Handb Clin Neurol, V155, P105, DOI 10.1016/B978-0-444-64189-2.00007-X	95	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101025	10.1016/j.jbc.2021.101025	http://dx.doi.org/10.1016/j.jbc.2021.101025			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34339737	Green Published, gold			2022-12-26	WOS:000706408900013
J	Bell, ML; Catalfamo, CJ; Farland, LV; Ernst, KC; Jacobs, ET; Klimentidis, YC; Jehn, M; Pogreba-Brown, K				Bell, Melanie L.; Catalfamo, Collin J.; Farland, Leslie V.; Ernst, Kacey C.; Jacobs, Elizabeth T.; Klimentidis, Yann C.; Jehn, Megan; Pogreba-Brown, Kristen			Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT	PLOS ONE			English	Article								Clinical presentation, outcomes, and duration of COVID-19 has ranged dramatically. While some individuals recover quickly, others suffer from persistent symptoms, collectively known as long COVID, or post-acute sequelae of SARS-CoV-2 (PASC). Most PASC research has focused on hospitalized COVID-19 patients with moderate to severe disease. We used data from a diverse population-based cohort of Arizonans to estimate prevalence of PASC, defined as experiencing at least one symptom 30 days or longer, and prevalence of individual symptoms. There were 303 non-hospitalized individuals with a positive lab-confirmed COVID-19 test who were followed for a median of 61 days (range 30-250). COVID-19 positive participants were mostly female (70%), non-Hispanic white (68%), and on average 44 years old. Prevalence of PASC at 30 days post-infection was 68.7% (95% confidence interval: 63.4, 73.9). The most common symptoms were fatigue (37.5%), shortness-of-breath (37.5%), brain fog (30.8%), and stress/anxiety (30.8%). The median number of symptoms was 3 (range 1-20). Amongst 157 participants with longer follow-up (>= 60 days), PASC prevalence was 77.1%.	[Bell, Melanie L.; Catalfamo, Collin J.; Farland, Leslie V.; Ernst, Kacey C.; Jacobs, Elizabeth T.; Klimentidis, Yann C.; Pogreba-Brown, Kristen] Univ Arizona, Dept Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85721 USA; [Jehn, Megan] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA	University of Arizona; Arizona State University; Arizona State University-Tempe	Bell, ML (corresponding author), Univ Arizona, Dept Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85721 USA.	melaniebell@email.arizona.edu	Jehn, Megan/D-1578-2016; Bell, Melanie/D-1839-2011	Jehn, Megan/0000-0002-6742-417X; Bell, Melanie/0000-0003-4821-4094; Catalfamo, Collin/0000-0001-8244-9044				Al-Aly Z, 2021, NATURE, V594, P259, DOI 10.1038/s41586-021-03553-9; [Anonymous], 2020, LANCET, V396, P1861, DOI 10.1016/S0140-6736(20)32662-3; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Catalfamo CJ, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.620060; Davis HE, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.101019; Havervall S, 2021, JAMA-J AM MED ASSOC, V325, P2015, DOI 10.1001/jama.2021.5612; Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8; Lee K, 2009, GLOB INST, P1; Lee KJ, 2021, J CLIN EPIDEMIOL, V134, P79, DOI 10.1016/j.jclinepi.2021.01.008; Logue JK, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0830; Lopez-Leon S, 2021, SCI REP-UK, V11, DOI [10.1038/s41598-021-95565-8, 10.1101/2021.01.27.21250617]; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Brown KP, 2021, PUBLIC HEALTH REP, V136, P154, DOI 10.1177/0033354920974664; Sudre CH, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01292-y	14	34	34	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2021	16	8							e0254347	10.1371/journal.pone.0254347	http://dx.doi.org/10.1371/journal.pone.0254347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IY	34347785	Green Published, Green Submitted, gold			2022-12-26	WOS:000685264900053
J	Charry, B; Tissier, E; Iacozza, J; Marcoux, M; Watt, CA				Charry, Bertrand; Tissier, Emily; Iacozza, John; Marcoux, Marianne; Watt, Cortney A.			Mapping Arctic cetaceans from space: A case study for beluga and narwhal	PLOS ONE			English	Article							MONODON-MONOCEROS; AERIAL SURVEYS; IMAGERY; MOVEMENTS; SUMMER; SOUND	Emergence of new technologies in remote sensing give scientists a new way to detect and monitor wildlife populations. In this study we assess the ability to detect and classify two emblematic Arctic cetaceans, the narwhal (Monodon monoceros) and beluga whale (Delphinapterus leucas), using very high-resolution (VHR) satellite imagery. We analyzed 12 VHR images acquired in August 2017 and 2019, collected by the WorldView-3 satellite, which has a maximum resolution of 0.31 m per pixel. The images covered Clearwater Fiord (138.8 km(2)), an area on eastern Baffin Island, Canada where belugas spend a large part of the summer, and Tremblay Sound (127.0 km(2)), a narrow water body located on the north shore of Baffin Island that is used by narwhals during the open water season. A total of 292 beluga whales and 109 narwhals were detected in the images. This study contributes to our understanding of Arctic cetacean distribution and highlights the capabilities of using satellite imagery to detect marine mammals.	[Charry, Bertrand; Tissier, Emily] Whale Seeker, Montreal, PQ, Canada; [Iacozza, John] Univ Manitoba, Dept Environm & Geog, Ctr Earth Observat Sci, Winnipeg, MB, Canada; [Marcoux, Marianne; Watt, Cortney A.] Fisheries & Oceans Canada, Arctic Aquat Res Div, Winnipeg, MB, Canada; [Watt, Cortney A.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada	University of Manitoba; Fisheries & Oceans Canada; University of Manitoba	Charry, B (corresponding author), Whale Seeker, Montreal, PQ, Canada.	bertrand@whaleseeker.com						Bama B. Sathya, 2013, Pattern Recognition and Machine Intelligence. 5th International Conference, PReMI 2013. Proceedings: LNCS 8251, P313, DOI 10.1007/978-3-642-45062-4_42; BEST RC, 1981, CAN J ZOOL, V59, P2386, DOI 10.1139/z81-319; Booy K., 2021, ARCT SCI; Borowicz A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212532; Buckland S.T., 2001, pi; Charry B, 2020, J WILDLIFE MANAGE, V84, P311, DOI 10.1002/jwmg.21799; Chirayath V, 2016, AQUAT CONSERV, V26, P237, DOI 10.1002/aqc.2654; Cubaynes HC, 2020, REMOTE SENS ECOL CON, V6, P411, DOI 10.1002/rse2.155; Cubaynes HC, 2019, MAR MAMMAL SCI, V35, P466, DOI 10.1111/mms.12544; Dawson S, 2008, MAMMAL REV, V38, P19, DOI 10.1111/j.1365-2907.2008.00119.x; Dowman I., 2012, HIGH RESOLUTION OPTI; Ferguson S.H., 2020, NAMMCO SCI PUBL, V11, DOI [10.7557/3.5100, DOI 10.7557/3.5100]; Fretwell PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088655; Gonzalez LF, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010097; Guirado E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50795-9; Heide-Jorgensen MP, 2018, ENCYCLOPEDIA OF MARINE MAMMALS, 3RD EDITION, P627; Heide-Jorgensen MP, 2013, ANIM CONSERV, V16, P331, DOI 10.1111/acv.12000; Heide-Jorgensen MP, 2003, CAN J ZOOL, V81, P1298, DOI 10.1139/Z03-117; Hodgson JC, 2018, METHODS ECOL EVOL, V9, P1160, DOI 10.1111/2041-210X.12974; Hoschle C, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21030963; Hollings T, 2018, METHODS ECOL EVOL, V9, P881, DOI 10.1111/2041-210X.12973; Kelley TC, 2015, MAR MAMMAL SCI, V31, P479, DOI 10.1111/mms.12165; Kingsley MS., 1994, MEDD GRON BIOSCI NWT MEDD GROENL BIOS, V39, P163; Kovacs Kit M., 2011, Marine Biodiversity, V41, P181, DOI 10.1007/s12526-010-0061-0; Kutser T, 2006, ESTUAR COAST SHELF S, V70, P449, DOI 10.1016/j.ecss.2006.06.026; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; LaRue MA, 2017, CONSERV BIOL, V31, P213, DOI 10.1111/cobi.12809; LaRue MA, 2011, POLAR BIOL, V34, P1727, DOI 10.1007/s00300-011-1023-0; Lyons MB, 2019, METHODS ECOL EVOL, V10, P1024, DOI 10.1111/2041-210X.13194; Mann J., 2000, CETACEAN SOC FIELD S; MANSFIELD AW, 1975, J FISH RES BOARD CAN, V32, P1041, DOI 10.1139/f75-122; Marcoux M., 2019, CAN SCI ADVIS SEC RE; Marcoux M, 2009, POLAR BIOL, V32, P1705, DOI 10.1007/s00300-009-0670-x; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; Matthews CJ., 2017, DFO CAN SCI ADVIS SE; McLAREN IAN A., 1961, ARCTIC, V14, P162; Nweeia MT, 2014, ANAT REC, V297, P599, DOI 10.1002/ar.22886; O'Corry-Crowe GM., ENCY MARINE MAMMALS, VThird, P93; Patenaude NJ, 2002, MAR MAMMAL SCI, V18, P309, DOI 10.1111/j.1748-7692.2002.tb01040.x; Pollock KH, 2006, J WILDLIFE MANAGE, V70, P255, DOI 10.2193/0022-541X(2006)70[255:EAAIHE]2.0.CO;2; Rees W.G., 2012, PHYS PRINCIPLES REMO, DOI [10.1017/CBO9781139017411, DOI 10.1017/CBO9781139017411]; Richard P., 1994, MEDDELELSER GRONLAND MEDDELELSER GRONLAND, V39; Richard P., 2009, DFO CAN SCI ADVIS SE; Richard PR, 2001, ARCTIC, V54, P207; Robbins WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083456; Roberge MM., 1990, CAN TECH REP FISH AQ, V1747; Stapleton S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101513; Stewart DB., 1995, CAN TECH REP FISH AQ, V2065; Vermaire JC, 2013, GEOPHYS RES LETT, V40, DOI 10.1002/grl.50191; Vrabel J, 1996, PHOTOGRAMM ENG REM S, V62, P1075; Watt CA., 2012, DFO CAN SCI ADVIS SE, P46; Watt CA, 2021, ARCT SCI, V7, P545, DOI 10.1139/as-2019-0030; Williamson MJ, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00135	53	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2021	16	8							e0254380	10.1371/journal.pone.0254380	http://dx.doi.org/10.1371/journal.pone.0254380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IY	34347780	gold, Green Published			2022-12-26	WOS:000685264900048
J	Hu, LJ; Xu, XQ; Li, QJ; Chen, XJ; Yuan, XF; Qiu, S; Yao, CS; Zhang, DP; Wang, F				Hu, Lijuan; Xu, Xiaoqing; Li, Qiuju; Chen, Xijuan; Yuan, Xiangfei; Qiu, Shuai; Yao, Chuanshan; Zhang, Dapeng; Wang, Feng			Caveolin-1 increases glycolysis in pancreatic cancer cells and triggers cachectic states	FASEB JOURNAL			English	Article						cancer cachexia; caveolin-1; glycolysis; pancreatic cancer	MESENCHYMAL TRANSITION; GLUCOSE-METABOLISM; AEROBIC GLYCOLYSIS; INSULIN-RECEPTOR; DOWN-REGULATION; BREAST-CANCER; EXPRESSION; OVEREXPRESSION; PROGRESSION; MECHANISMS	In pancreatic cancer, autocrine insulin-like growth factor-1 (IGF-1) and paracrine insulin stimulate both IGF-1 receptor (IGF1R) and insulin receptor (IR) to increase tumor growth and glycolysis. In pancreatic cancer patients, cancer-induced glycolysis increases hepatic gluconeogenesis, skeletal muscle proteolysis, and fat lipolysis and, thereby, causes cancer cachexia. As a protein coexisting with IGF1R and IR, caveolin-1 (cav-1) may be involved in pancreatic cancer-induced cachexia. We undertook the present study to test this hypothesis. Out of wild-type MiaPaCa2 and AsPC1 human pancreatic cancer cell lines, we created their stable sub-lines whose cav-1 expression was diminished with RNA interference or increased with transgene expression. When these cells were studied in vitro, we found that cav-1 regulated IGF1R/IR expression and activation and also regulated cellular glycolysis. We transplanted the different types of MiaPaCa2 cells in growing athymic mice for 8 weeks, using intact athymic mice as tumor-free controls. We found that cav-1 levels in tumor grafts were correlated with expression levels of the enzymes that regulated hepatic gluconeogenesis, skeletal muscle proteolysis, and fat lipolysis in the respective tissues. When the tumors had original or increased cav-1, their carriers' body weight gain was less than the tumor-free reference. When cav-1 was diminished in tumors, the tumor carriers' body weight gain was not changed significantly, compared to the tumor-free reference. In conclusion, cav-1 in pancreatic cancer cells stimulated IGF1R/IR and glycolysis in the cancer cells and triggered cachectic states in the tumor carrier.	[Hu, Lijuan; Yuan, Xiangfei; Zhang, Dapeng; Wang, Feng] Nankai Univ, Nankai Hosp Affiliated, Lab Acute Abdomen Dis Associated Organ Injury & R, 6 Changjiang Rd, Tianjin 300100, Peoples R China; [Xu, Xiaoqing; Li, Qiuju; Chen, Xijuan; Qiu, Shuai] Tianjin Med Univ, Grad Sch, Tianjin, Peoples R China; [Yao, Chuanshan] Nankai Univ, Sch Med, Tianjin, Peoples R China	Nankai University; Tianjin Medical University; Nankai University	Wang, F (corresponding author), Nankai Univ, Nankai Hosp Affiliated, Lab Acute Abdomen Dis Associated Organ Injury & R, 6 Changjiang Rd, Tianjin 300100, Peoples R China.	fengwangpi@163.com			National Natural Science Foundation of China (NSFC) [81572318]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81572318	BURT ME, 1981, CANCER-AM CANCER SOC, V47, P2138, DOI 10.1002/1097-0142(19810501)47:9<2138::AID-CNCR2820470906>3.0.CO;2-#; Chai F, 2019, J CELL PHYSIOL, V234, P1937, DOI 10.1002/jcp.27074; Cordes N, 2007, ONCOGENE, V26, P6851, DOI 10.1038/sj.onc.1210498; Diffee GM, 2002, AM J PHYSIOL-CELL PH, V283, pC1376, DOI 10.1152/ajpcell.00154.2002; Duxbury MS, 2004, J BIOL CHEM, V279, P23176, DOI 10.1074/jbc.M402051200; Ha TK, 2012, CANCER RES, V72, P4097, DOI 10.1158/0008-5472.CAN-12-0448; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hotz Hubert G, 2003, Pancreas, V26, pe89, DOI 10.1097/00006676-200305000-00020; Hu LJ, 2020, AM J CHINESE MED, V48, P1005, DOI 10.1142/S0192415X20500482; Jung AC, 2015, ONCOTARGET, V6, P41884, DOI 10.18632/oncotarget.6099; Kang F, 2014, J NUCL MED, V55, P439, DOI 10.2967/jnumed.113.121327; Kannan A, 2014, EUR J CANCER, V50, P204, DOI 10.1016/j.ejca.2013.08.016; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; Liu ZW, 2013, CANCER BIOL THER, V14, P428, DOI 10.4161/cbt.23786; LUNDHOLM K, 1982, CANCER-AM CANCER SOC, V50, P1142, DOI 10.1002/1097-0142(19820915)50:6<1142::AID-CNCR2820500618>3.0.CO;2-I; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Parton RG, 2016, P NATL ACAD SCI USA, V113, P14170, DOI 10.1073/pnas.1617954113; PERMERT J, 1993, EUR J SURG, V159, P101; Raikar LS, 2006, J CELL BIOCHEM, V98, P861, DOI 10.1002/jcb.20732; Salani B, 2008, ENDOCRINOLOGY, V149, P461, DOI 10.1210/en.2007-0312; Shi Y, 2015, AUTOPHAGY, V11, P769, DOI 10.1080/15548627.2015.1034411; Simon L, 2020, CANCER METAST REV, V39, P435, DOI 10.1007/s10555-020-09890-x; Suzuoki M, 2002, BRIT J CANCER, V87, P1140, DOI 10.1038/sj.bjc.6600619; Tahir SA, 2013, CANCER RES, V73, P1900, DOI 10.1158/0008-5472.CAN-12-3040; Talbert EE, 2019, CELL REP, V28, P1612, DOI 10.1016/j.celrep.2019.07.016; Tanase CP, 2009, J MOL HISTOL, V40, P23, DOI 10.1007/s10735-008-9209-7; Tanno S, 2001, CANCER RES, V61, P589; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Trajkovic-Arsic M, 2013, J MOL ENDOCRINOL, V50, pR67, DOI 10.1530/JME-12-0259; Vallejo J, 2005, FASEB J, V19, P586, DOI 10.1096/fj.04-2380fje; Varewijck AJ, 2012, ENDOCR-RELAT CANCER, V19, pF63, DOI 10.1530/ERC-12-0026; Wang F, 2007, AM J PATHOL, V170, P469, DOI 10.2353/ajpath.2007.060489; Wang F, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4271-3; Wang XM, 2018, BMC UROL, V18, DOI 10.1186/s12894-018-0418-4; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang J, 2019, AM J CHINESE MED, V47, P675, DOI 10.1142/S0192415X19500356; Yim S, 2003, J BIOL CHEM, V278, P38260, DOI 10.1074/jbc.M306016200; Yu M, 2015, CANCER LETT, V360, P187, DOI 10.1016/j.canlet.2015.02.002; Zhang C, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1703-1; Zhang DP, 2015, ONCOL LETT, V10, P1545, DOI 10.3892/ol.2015.3384	40	8	8	2	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21826	10.1096/fj.202100121RRR	http://dx.doi.org/10.1096/fj.202100121RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34320244				2022-12-26	WOS:000678975300012
J	Kang, Y; Kim, YW; Kang, J; Kim, A				Kang, Yujin; Kim, Yea Woon; Kang, Jin; Kim, AeRi			Histone H3K4me1 and H3K27ac play roles in nucleosome eviction and eRNA transcription, respectively, at enhancers	FASEB JOURNAL			English	Article						enhancers; eRNA transcription; nucleosome eviction	LOCUS-CONTROL REGION; GLOBIN LOCUS; CHROMATIN; GENE; RNAS; MONOMETHYLATION; ACETYLATION; PROMOTERS; PROTEINS; GATA-1	Histone H3K4me1 and H3K27ac are enhancer-specific modifications and are required for enhancers to activate transcription of target genes. However, the reciprocal effects of these histone modifications on each other and their roles in enhancers are not clear. Here to comparatively analyze the role of these modifications, we inhibited H3K4me1 and H3K27ac by deleting the SET domains of histone methyltransferases MLL3 and MLL4 and the HAT domain of histone acetyltransferase p300, respectively, in erythroid K562 cells. The loss of H3K4me1 reduced H3K27ac at the beta-globin enhancer LCR HSs, but H3K27ac reduction did not affect H3K4me1. This unequal relationship between two modifications was revealed in putative enhancers by genome-wide analysis using ChIP-seq. Histone H3 eviction at putative enhancers was weakened by the loss of H3K4me1 but not by the loss of H3K27ac. Chromatin remodeling complexes were recruited into the beta-globin LCR HSs in a H3K4me1-dependent manner. In contrast, H3K27ac was required for enhancer RNA (eRNA) transcription, and H3K4me1 was not enough for it. Forced H3K27ac-induced eRNA transcription without affecting H3K4me1 at the beta-globin LCR HSs. These results indicate that H3K4me1 and H3K27ac affect each other in different ways and play more direct roles in nucleosome eviction and eRNA transcription, respectively, at enhancers.	[Kang, Yujin; Kim, Yea Woon; Kang, Jin; Kim, AeRi] Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Busan 46241, South Korea	Pusan National University	Kim, A (corresponding author), Pusan Natl Univ, Coll Nat Sci, Dept Mol Biol, Busan 46241, South Korea.	kimaeri@pusan.ac.kr			National Research Foundation of Korea (NRF); Ministry of Science, ICT, and Future Planning [NRF--2014R1A2A1A11051702]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT, and Future Planning	National Research Foundation of Korea (NRF); Ministry of Science, ICT, and Future Planning, Grant/Award Number: NRF--2014R1A2A1A11051702	Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cho Y, 2008, NUCLEIC ACIDS RES, V36, P4521, DOI 10.1093/nar/gkn368; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorighi KM, 2017, MOL CELL, V66, P568, DOI 10.1016/j.molcel.2017.04.018; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Ebrahimi A, 2019, NAT CHEM BIOL, V15, P519, DOI 10.1038/s41589-019-0264-z; Fang XD, 2009, J MOL BIOL, V394, P197, DOI 10.1016/j.jmb.2009.09.046; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Grossman SR, 2018, P NATL ACAD SCI USA, V115, pE7222, DOI 10.1073/pnas.1804663115; Guertin MJ, 2013, CURR OPIN GENET DEV, V23, P116, DOI 10.1016/j.gde.2012.11.008; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hsieh CL, 2014, P NATL ACAD SCI USA, V111, P7319, DOI 10.1073/pnas.1324151111; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Inukai S, 2017, CURR OPIN GENET DEV, V43, P110, DOI 10.1016/j.gde.2017.02.007; Jang Y, 2019, NUCLEIC ACIDS RES, V47, P607, DOI 10.1093/nar/gky982; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Johnson TA, 2018, NUCLEIC ACIDS RES, V46, P203, DOI 10.1093/nar/gkx1044; Kang J, 2018, BBA-GENE REGUL MECH, V1861, P637, DOI 10.1016/j.bbagrm.2018.05.005; Kang Y, 2017, BBA-GENE REGUL MECH, V1860, P416, DOI 10.1016/j.bbagrm.2017.01.013; Kang Y, 2015, BBA-GENE REGUL MECH, V1849, P282, DOI 10.1016/j.bbagrm.2014.12.010; Kim A, 2007, NUCLEIC ACIDS RES, V35, P5831, DOI 10.1093/nar/gkm620; Kim SI, 2009, NUCLEIC ACIDS RES, V37, P6019, DOI 10.1093/nar/gkp677; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim YW, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170976; Kim YW, 2013, BBA-GENE REGUL MECH, V1829, P963, DOI 10.1016/j.bbagrm.2013.04.006; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02403-5; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Local A, 2018, NAT GENET, V50, P73, DOI 10.1038/s41588-017-0015-6; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Maruyama A, 2014, NUCLEIC ACIDS RES, V42, P13599, DOI 10.1093/nar/gku1169; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Nagarajan S, 2014, CELL REP, V8, P459, DOI 10.1016/j.celrep.2014.06.016; Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015; Rahnamoun H, 2018, J BIOL CHEM, V293, P13234, DOI 10.1074/jbc.RA118.003387; Raisner R, 2018, CELL REP, V24, P1722, DOI 10.1016/j.celrep.2018.07.041; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rickels R, 2017, NAT GENET, V49, P1647, DOI 10.1038/ng.3965; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schaukowitch K, 2014, MOL CELL, V56, P29, DOI 10.1016/j.molcel.2014.08.023; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Wang CC, 2016, P NATL ACAD SCI USA, V113, P11871, DOI 10.1073/pnas.1606857113; Wang SP, 2017, MOL CELL, V67, P308, DOI 10.1016/j.molcel.2017.06.028; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhu Y, 2018, TOXICOL APPL PHARM, V357, P70, DOI 10.1016/j.taap.2018.08.011; Zhu Y, 2013, NUCLEIC ACIDS RES, V41, P10032, DOI 10.1093/nar/gkt826	58	10	10	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21781	10.1096/fj.202100488R	http://dx.doi.org/10.1096/fj.202100488R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34309923				2022-12-26	WOS:000678975300037
J	Yang, SR; Hua, KF; Yang, CY; Chen, A; Weng, JC; Tsai, YL; Wan, CJ; Wu, CY; Lee, CC; Chan, JF; Hsieh, CY; Hsu, YJ; Wu, CC; Mukhopadhyay, D; Huang, HS; Liu, FC; Ka, SM				Yang, Shin-Ruen; Hua, Kuo-Feng; Yang, Chih-Yu; Chen, Ann; Weng, Jui-Chun; Tsai, Yu-Ling; Wan, Chih-Jun; Wu, Chung-Yao; Lee, Chia-Chung; Chan, Jia-Feng; Hsieh, Chih-Yu; Hsu, Yu-Juei; Wu, Chia-Chao; Mukhopadhyay, Debabrata; Huang, Hsu-Shan; Liu, Feng-Cheng; Ka, Shuk-Man			Cf-02, a novel benzamide-linked small molecule, blunts NF-kappa B activation and NLRP3 inflammasome assembly and improves acute onset of accelerated and severe lupus nephritis in mice	FASEB JOURNAL			English	Article						severe lupus nephritis; autophagy; benzamide-linked small molecule; NF-kappa B/NLRP3; inflammasome axis	DENDRITIC CELLS; T-CELLS; ERYTHEMATOSUS; INHIBITORS; CD14; INTERLEUKIN-18; THERAPIES; MECHANISM; AUTOPHAGY; DISEASE	In the present study, acute onset of severe lupus nephritis was successfully treated in mice using a new, benzamide-linked, small molecule that targets immune modulation and the NLRP3 inflammasome. Specifically, 6-(2,4-difluorophenyl)-3-(3-(trifluoromethyl)phenyl)-2H-benzo[e][1,3]oxazine-2,4(3H)-dione (Cf-02) (a) reduced serum levels of IgG anti-dsDNA, IL-1 beta, IL-6, and TNF-alpha, (b) inhibited activation of dendritic cells and differentially regulated T cell functions, and (c) suppressed the NF-kappa B/NLRP3 inflammasome axis, targeting priming and activating signals of the inflammasome. Moreover, treatment with Cf-02 significantly inhibited secretion of IL-1 beta in lipopolysaccharide-stimulated macrophages, but this effect was abolished by autophagy induction. These results recommend Cf-02 as a promising drug candidate for the serious renal conditions associated with systemic lupus erythematosus. Future investigations should examine whether Cf-02 may also be therapeutic in other types of chronic kidney disease involving NLRP3 inflammasome-driven signaling.	[Yang, Shin-Ruen; Wan, Chih-Jun] Natl Def Med Ctr, Med Acad, Grad Inst Aerosp & Undersea Med, Dept Med, Taipei, Taiwan; [Yang, Shin-Ruen; Chen, Ann; Tsai, Yu-Ling; Wu, Chung-Yao] Triserv Gen Hosp, Dept Pathol, Natl Def Med Ctr, Taipei, Taiwan; [Hua, Kuo-Feng] Natl Ilan Univ, Dept Biotechnol & Anim Sci, Ilan, Taiwan; [Hua, Kuo-Feng] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Yang, Chih-Yu] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Sch Med, Taipei, Taiwan; [Yang, Chih-Yu] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan; [Weng, Jui-Chun; Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lee, Chia-Chung; Huang, Hsu-Shan] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Chan, Jia-Feng; Hsieh, Chih-Yu] Chu Kong Hosp, Div Nephrol, Dept Internal Med, New Taipei, Taiwan; [Hsieh, Chih-Yu] Taipei Med Univ, Coll Biomed Engn, Taipei, Taiwan; [Hsu, Yu-Juei; Wu, Chia-Chao] Triserv Gen Hosp, Dept Med, Natl Def Med Ctr, Div Nephrol, Taipei, Taiwan; [Mukhopadhyay, Debabrata] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Huang, Hsu-Shan] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Liu, Feng-Cheng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Dept Rheumatol Immunol & Allergy, 325,Sec 2,Cheng Gung Rd, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Ilan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Defense Medical Center; Taipei Medical University; Taipei Medical University; National Defense Medical Center; Tri-Service General Hospital; Mayo Clinic; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Liu, FC (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Dept Rheumatol Immunol & Allergy, 325,Sec 2,Cheng Gung Rd, Taipei, Taiwan.; Ka, SM (corresponding author), Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Dept Med, 161,Sec 6,Min Quan E Rd, Taipei, Taiwan.	lfc10399@yahoo.com.tw; shukmanka@gmail.com	Hsieh, Chih-Yu/GWQ-8343-2022	Yang, Chih-Yu/0000-0001-9899-3159; Huang, Hsu-Shan/0000-0001-8162-5608	Ministry of Science and Technology [MOST 109-2320-B-016-008, MOST 109-2314-B-016-034-MY3]; National Defense Medical Center [MAB-109-028]; Tri-Service General Hospital, Taipei, Taiwan [TSGH-D-109090]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Defense Medical Center; Tri-Service General Hospital, Taipei, Taiwan	This work was supported by grants MOST 109--2320--B--016--008, MOST 109--2314--B--016--034--MY3 from the Ministry of Science and Technology, MAB-109--028 from the National Defense Medical Center, and TSGH--D--109090 from the Tri--Service General Hospital, Taipei, Taiwan.	Akhtar S, 2011, MOL MED, V17, P88, DOI 10.2119/molmed.2010.00080; Alessandri C, 2012, FASEB J, V26, P4722, DOI 10.1096/fj.12-206060; Almaani S, 2017, CLIN J AM SOC NEPHRO, V12, P825, DOI 10.2215/CJN.05780616; Ayyappan P, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00658; Bickert T, 2007, MED MICROBIOL IMMUN, V196, P31, DOI 10.1007/s00430-006-0026-x; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Bruschi M, 2020, J RHEUMATOL, V47, P377, DOI 10.3899/jrheum.181232; Chi HH, 2017, J AM SOC NEPHROL, V28, P2022, DOI 10.1681/ASN.2016080840; Chiu HW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42130-z; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; El-Ghoneimy DH, 2019, CLIN RHEUMATOL, V38, P2585, DOI 10.1007/s10067-019-04547-9; Flanc RS, 2004, AM J KIDNEY DIS, V43, P197, DOI 10.1053/j.ajkd.2003.10.012; Fu R, 2017, ARTHRITIS RHEUMATOL, V69, P1636, DOI 10.1002/art.40155; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Hsieh CY, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020279; Hsieh CY, 2019, J CELL PHYSIOL, V234, P4081, DOI 10.1002/jcp.27204; Hsu WH, 2020, NEPHROL DIAL TRANSPL, V35, P74, DOI 10.1093/ndt/gfz073; Hung YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46299; Illei GG, 2001, ANN INTERN MED, V135, P248, DOI 10.7326/0003-4819-135-4-200108210-00009; Ka SM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0844-6; Kelley N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133328; Kronbichler A, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/858027; Landmann R, 1996, INFECT IMMUN, V64, P1762, DOI 10.1128/IAI.64.5.1762-1769.1996; Lawal B, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9010092; Lee CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149317; Lee CC, 2015, BIOORGAN MED CHEM, V23, P4522, DOI 10.1016/j.bmc.2015.06.007; Lee CC, 2015, EUR J MED CHEM, V98, P115, DOI 10.1016/j.ejmech.2015.05.015; Lin TJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01951; Liou JT, 2014, EUR J PHARMACOL, V726, P124, DOI 10.1016/j.ejphar.2014.01.049; Liphaus BL, 2013, LUPUS, V22, P940, DOI 10.1177/0961203313496300; Liu FC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051453; Liu FC, 2011, J CLIN IMMUNOL, V31, P1131, DOI 10.1007/s10875-011-9576-9; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Mokgautsi N, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052464; Molino C, 2009, EUR J INTERN MED, V20, P447, DOI 10.1016/j.ejim.2008.12.018; NOCKHER WA, 1994, CLIN EXP IMMUNOL, V96, P15; Parikh SV, 2016, J AM SOC NEPHROL, V27, P2929, DOI 10.1681/ASN.2016040415; Ponticelli C, 2006, CLIN J AM SOC NEPHRO, V1, P863, DOI 10.2215/CJN.00880306; Rother N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01136; Shui HA, 2007, RHEUMATOLOGY, V46, P1277, DOI 10.1093/rheumatology/kem136; Silliman CC, 2010, AM J PHYSIOL-CELL PH, V298, pC714, DOI 10.1152/ajpcell.00011.2009; Takahama M, 2018, IMMUNOL REV, V281, P62, DOI 10.1111/imr.12613; Tam LS, 2003, LUPUS, V12, P665, DOI 10.1191/0961203303lu446oa; Tsai YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41123; Wan SG, 2007, J IMMUNOL, V178, P271, DOI 10.4049/jimmunol.178.1.271; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Whittall-Garcia LP, 2019, LUPUS, V28, P1549, DOI 10.1177/0961203319883936; Wong WT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01920; Wu CY, 2020, J IMMUNOL, V204, P1448, DOI 10.4049/jimmunol.1801610; Yang SR, 2020, KIDNEY INT, V98, P378, DOI 10.1016/j.kint.2020.02.033; Yang SM, 2013, FREE RADICAL BIO MED, V61, P285, DOI 10.1016/j.freeradbiomed.2013.03.024; Zanoni I, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00032; Zhou XJ, 2019, AUTOPHAGY, V15, P908, DOI 10.1080/15548627.2019.1580512	55	2	2	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21785	10.1096/fj.202100047R	http://dx.doi.org/10.1096/fj.202100047R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314075				2022-12-26	WOS:000678975300016
J	Dinwiddie, EV; Rendahl, A; Veytsman, S; Ragetly, G; Lynch, AC; Miniter, B; Ben-Amotz, R				Dinwiddie, Elaine V.; Rendahl, Aaron; Veytsman, Stan; Ragetly, Guillaume; Lynch, Albert C.; Miniter, Brianna; Ben-Amotz, Ron			Evaluation of post-operative complications, outcome, and long-term owner satisfaction of elbow arthrodesis (EA) in 22 dogs	PLOS ONE			English	Article							JOINT ANGLES; INFECTION; SURGERY	The objective of this study was to report post-operative complications and outcomes in canines undergoing elbow arthrodesis (EA) with fixation techniques including bone plate fixation with a non-locking dynamic compression plate (DCP), bone plate fixation with a locking plate (LCP), and external skeletal fixator (ESF). Medical records of twenty-two cases that underwent EA between January 2009-December 2019 from 8 referral hospitals including both private practice and academic institutions were reviewed. Post-operative complications were classified as either minor or major, surgical evaluations were performed 8 weeks post operatively, and a follow-up questionnaire was sent to owners. Of the total 22 cases that met inclusion criteria, a total of 19/22 cases had complications, 12 major and 7 minor. Complications reported in 8/9, 7/9, and 4/4, for the DCP, LCP, and ESF fixation groups, respectively. Mild to moderate mechanical lameness was identified at surgical evaluation in 16/22 cases. Complete radiographic bone healing was achieved after 9 weeks in 19/22 cases. Long term owner follow up was available in 14/22 cases. Owners reported a good to normal quality of life in 13/14 cases and poor in one case. The majority of owners (11/14) reported good to excellent satisfaction with the outcome irrespective of persistent lameness. This study demonstrates that successful EA can be achieved using a variety of fixation methods, but persistent lameness is expected and complication rate is high.	[Dinwiddie, Elaine V.; Lynch, Albert C.] Vet Specialty & Emergency Ctr, Small Anim Surg Dept, Levittown, PA USA; [Rendahl, Aaron] Univ Minnesota, Stat & Informat Dept, Coll Vet Med, St Paul, MN USA; [Veytsman, Stan] Univ Minnesota, Small Anim Surg Dept, Coll Vet Med, St Paul, MN USA; [Ragetly, Guillaume] Ctr Hosp Vet Fregis, Small Anim Surg Dept, Arcueil, France; [Miniter, Brianna] BluePearl Pet Hosp, Small Anim Surg Dept, Clearwater, FL USA; [Ben-Amotz, Ron] Hebrew Univ Jerusalem, Koret Sch Vet Med, Small Anim Orthoped Dept, Rehovot, Israel	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Hebrew University of Jerusalem	Ben-Amotz, R (corresponding author), Hebrew Univ Jerusalem, Koret Sch Vet Med, Small Anim Orthoped Dept, Rehovot, Israel.	ron.benamotz@mail.huji.ac.il	Veytsman, Stan/GYJ-4112-2022	Rendahl, Aaron/0000-0001-5434-3592; Dinwiddie, Elaine/0000-0002-5768-9190				Aiken MJ, 2015, VET SURG, V44, P661, DOI 10.1111/vsu.12327; Beever LJ, 2016, VET COMP ORTHOPAED, V29, P142, DOI 10.3415/VCOT-15-05-0083; Beever LJ, 2018, VET COMP ORTHOPAED, V31, P137, DOI 10.1055/s-0038-1627477; Benson JA, 2002, J AM ANIM HOSP ASSOC, V38, P370, DOI 10.5326/0380370; Brinker WO., 2016, HDB SMALL ANIMAL ORT, V5th ed; Budsberg SC, 2006, VET CLIN N AM-SMALL, V36, P1307, DOI 10.1016/j.cvsm.2006.08.007; Conzemius M, 2009, VET SURG, V38, P279, DOI 10.1111/j.1532-950X.2008.00494.x; Cook JL, 2010, VET SURG, V39, P905, DOI 10.1111/j.1532-950X.2010.00763.x; deHaan JJ, 1996, VET COMP ORTHOPAED, V9, P115; Frey TN, 2010, JAVMA-J AM VET MED A, V236, P88, DOI 10.2460/javma.236.1.88; Frye CW, 2016, VET CLIN N AM-SMALL, V46, P831, DOI 10.1016/j.cvsm.2016.04.006; Gallagher AD, 2012, VET SURG, V41, P705, DOI 10.1111/j.1532-950X.2012.00971.x; Jaegger G, 2002, AM J VET RES, V63, P979, DOI 10.2460/ajvr.2002.63.979; Johnson KA., 2014, PIERMATTEIS ATLAS SU, V5th ed, P250; Johnston S., 2003, VET SURG SMALL ANIMA, V2nd ed; LESSER AS, 2003, TXB SMALL ANIMAL SUR, P2170; McCarthy J, 2020, VET COMP ORTHOPAED, V33, P51, DOI 10.1055/s-0039-1694783; Michelsen J, 2013, VET J, V196, P12, DOI 10.1016/j.tvjl.2012.11.009; Milgram J, 2004, VET COMP ORTHOPAED, V17, P82; Owen MR, 2004, VET COMP ORTHOPAED, V17, P141; Pratesi A, 2015, VET SURG, V44, P653, DOI 10.1111/vsu.12326; Rychel JK, 2010, TOP COMPANION ANIM M, V25, P20, DOI 10.1053/j.tcam.2009.10.005; Smith ZF, 2013, VET COMP ORTHOPAED, V26, P356, DOI 10.3415/VCOT-12-09-0115; Solano MA, 2015, VET SURG, V44, P59, DOI 10.1111/j.1532-950X.2014.12212.x; Spencer DD, 2018, VET SURG, V47, pE79, DOI 10.1111/vsu.12958; Valkki KJ, 2020, ACTA VET SCAND, V62, DOI 10.1186/s13028-020-00545-z; Verwilghen D, 2015, VET CLIN N AM-SMALL, V45, P243, DOI 10.1016/j.cvsm.2014.11.001; Watson C, 2003, VET COMP ORTHOPAED, V16, P250; Weese JS, 2008, VET COMP ORTHOPAED, V21, P99, DOI 10.3415/VCOT-07-11-0105; Zamprogno H, 2011, VET J, V190, P220, DOI 10.1016/j.tvjl.2010.10.015	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255388	10.1371/journal.pone.0255388	http://dx.doi.org/10.1371/journal.pone.0255388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329353	Green Published, gold			2022-12-26	WOS:000685248600055
J	He, SN; Zimmerman, MW; Layden, HM; Berezovskaya, A; Etchin, J; Martel, MW; Thurston, G; Jing, CB; van Rooijen, E; Kaufman, CK; Rodig, SJ; Zon, LI; Patton, EE; Mansour, MR; Look, AT				He, Shuning; Zimmerman, Mark W.; Layden, Hillary M.; Berezovskaya, Alla; Etchin, Julia; Martel, Megan W.; Thurston, Grace; Jing, Chang-Bin; van Rooijen, Ellen; Kaufman, Charles K.; Rodig, Scott J.; Zon, Leonard I.; Patton, E. Elizabeth; Mansour, Marc R.; Look, A. Thomas			Synergistic melanoma cell death mediated by inhibition of both MCL1 and BCL2 in high-risk tumors driven by NF1/PTEN loss	ONCOGENE			English	Article							MUTATIONS; AUTOPHAGY; NF1; GENES; TUMORIGENESIS; TEMSIROLIMUS; SENSITIVITY; CHLOROQUINE; RESISTANCE; SCREEN	Melanomas driven by loss of the NF1 tumor suppressor have a high risk of treatment failure and effective therapies have not been developed. Here we show that loss-of-function mutations of nf1 and pten result in aggressive melanomas in zebrafish, representing the first animal model of NF1-mutant melanomas harboring PTEN loss. MEK or PI3K inhibitors show little activity when given alone due to cross-talk between the pathways, and high toxicity when given together. The mTOR inhibitors, sirolimus, everolimus, and temsirolimus, were the most active single agents tested, potently induced tumor-suppressive autophagy, but not apoptosis. Because addition of the BCL2 inhibitor venetoclax resulted in compensatory upregulation of MCL1, we established a three-drug combination composed of sirolimus, venetoclax, and the MCL1 inhibitor S63845. This well-tolerated drug combination potently and synergistically induces apoptosis in both zebrafish and human NF1/PTEN-deficient melanoma cells, providing preclinical evidence justifying an early-stage clinical trial in patients with NF1/PTEN-deficient melanoma.	[He, Shuning; Zimmerman, Mark W.; Layden, Hillary M.; Berezovskaya, Alla; Etchin, Julia; Martel, Megan W.; Thurston, Grace; Jing, Chang-Bin; Mansour, Marc R.; Look, A. Thomas] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [van Rooijen, Ellen; Kaufman, Charles K.; Zon, Leonard I.] Howard Hughes Med Inst, Childrens Hosp Boston, Stem Cell Program, Boston, MA 02115 USA; [van Rooijen, Ellen; Kaufman, Charles K.] Howard Hughes Med Inst, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA; [Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Patton, E. Elizabeth] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Mansour, Marc R.] UCL, UCL Canc Inst, Dept Hematol, London, England	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; University of Edinburgh; University of London; University College London	He, SN; Mansour, MR; Look, AT (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Mansour, MR (corresponding author), UCL, UCL Canc Inst, Dept Hematol, London, England.	shuning_he@dfci.harvard.edu; m.mansour@ucl.ac.uk; Thomas_Look@dfci.harvard.edu		Layden, Hillary/0000-0001-8583-620X; Zimmerman, Mark/0000-0003-2489-3889	Melanoma Research Alliance award [509233]	Melanoma Research Alliance award	We would like to thank John Gilbert for critical review of the manuscript and editorial suggestions; Kassandra Bacon and Daniel Debiasi for zebrafish husbandry; Jeoren den Hertog, Alejandro Gutierrez and David M. Langenau for providing zebrafish lines; Yi Zhou and Andrew Hong for stimulating suggestions; Christine L. Unitt, Benjamin Ferland and Dana-Farber/Harvard Cancer Center Research Pathology Core for technical support. This study was funded by Melanoma Research Alliance award #509233.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; ANDERSEN LB, 1993, NAT GENET, V3, P118, DOI 10.1038/ng0293-118; Avniel-Polak S, 2016, NEUROENDOCRINOLOGY, V103, P724, DOI 10.1159/000442589; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chen KG, 2009, JNCI-J NATL CANCER I, V101, P1259, DOI 10.1093/jnci/djp259; Cirenajwis H, 2017, MOL ONCOL, V11, P438, DOI 10.1002/1878-0261.12050; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; De Raedt T, 2014, NATURE, V514, P247, DOI 10.1038/nature13561; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; Faucherre A, 2008, ONCOGENE, V27, P1079, DOI 10.1038/sj.onc.1210730; Garman B, 2017, CELL REP, V21, P1936, DOI 10.1016/j.celrep.2017.10.052; Gutierrez A, 2011, J EXP MED, V208, P1595, DOI 10.1084/jem.20101691; Hayward NK, 2017, NATURE, V545, P175, DOI 10.1038/nature22071; He SN, 2012, J PATHOL, V227, P431, DOI 10.1002/path.4013; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; JOHNSON MR, 1993, P NATL ACAD SCI USA, V90, P5539, DOI 10.1073/pnas.90.12.5539; Kaneko M, 2014, J CANCER RES CLIN, V140, P769, DOI 10.1007/s00432-014-1628-0; Kaufman CK, 2016, ADV EXP MED BIOL, V916, P439, DOI 10.1007/978-3-319-30654-4_19; Kaufman CK, 2016, SCIENCE, V351, DOI 10.1126/science.aad2197; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; Kuzu OF, 2015, CANCER GROWTH METAST, P81, DOI 10.4137/CGM.S21214; Lam LT, 2010, MOL CANCER THER, V9, P2943, DOI 10.1158/1535-7163.MCT-10-0427; Leverson JD, 2017, CANCER DISCOV, V7, P1376, DOI 10.1158/2159-8290.CD-17-0797; Li ZD, 2019, LEUKEMIA, V33, P262, DOI 10.1038/s41375-018-0201-2; Lister JA, 2014, J INVEST DERMATOL, V134, P133, DOI 10.1038/jid.2013.293; Macintosh RL, 2013, SEMIN CANCER BIOL, V23, P344, DOI 10.1016/j.semcancer.2013.05.006; Maertens Ophelia, 2014, Advances in Biological Regulation, V55, P1, DOI 10.1016/j.jbior.2014.04.002; Maertens O, 2013, CANCER DISCOV, V3, P338, DOI 10.1158/2159-8290.CD-12-0313; Mar VJ, 2013, CLIN CANCER RES, V19, P4589, DOI 10.1158/1078-0432.CCR-13-0398; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mohana-Kumaran N, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12242; Mukherjee N, 2015, J INVEST DERMATOL, V135, P2155, DOI 10.1038/jid.2015.145; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Potter DS, 2016, COLD SH Q B, V81, P131, DOI 10.1101/sqb.2016.81.030841; Rangwala R, 2014, AUTOPHAGY, V10, P1391, DOI 10.4161/auto.29119; Sharma K, 2014, INT J MOL SCI, V15, P10034, DOI 10.3390/ijms150610034; Shin J, 2012, DIS MODEL MECH, V5, P881, DOI 10.1242/dmm.009779; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tang Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10358; Whittaker SR, 2013, CANCER DISCOV, V3, P350, DOI 10.1158/2159-8290.CD-12-0470; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026343	45	2	2	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 23	2021	40	38					5718	5729		10.1038/s41388-021-01926-y	http://dx.doi.org/10.1038/s41388-021-01926-y		JUL 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UU4CG	34331013	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000679620500002
J	Brodie, A; Pavey, T; Newton, C; Sendall, MC				Brodie, Alison; Pavey, Toby; Newton, Cameron; Sendall, Marguerite C.			Australian bus drivers' modifiable and contextual risk factors for chronic disease: A workplace study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DUTCH TRUCK DRIVERS; PHYSICAL-ACTIVITY; HEALTH; INTERVENTION; PREVALENCE; WELLNESS; OBESITY; WORK	Introduction Little is known about workplace health promotion for bus drivers. Bus drivers are at-risk of chronic disease because they are exposed to the risk factor combination of poor nutrition, low levels of physical activity, high levels of sedentary time and are often overweight or obese. The purpose of this paper is to situate the quantitative baseline data collected from bus drivers within qualitative findings about the socio-cultural context of the workplace. Materials and methods Baseline data about physical activity, dietary intake and sedentary hours was collected from 58 drivers employed by a large bus company in southeast Queensland. Ten drivers and seven key workplace informants participated in interviews and discussion groups about driver health behaviours, workplace structure, culture, and resources. Results The quantitative results of our study reveal bus drivers have a cluster of poor health behaviours-limited physical activity, lower than recommended consumption of fruit and vegetables and high levels of sitting time during working-hours-which contribute to a high prevalence of overweight and obesity and a heightened risk of chronic disease. The qualitative findings suggest there are individual and structural barriers to improving drivers' modifiable health behaviours. Individual barriers include ingrained poor habits and more pressing life concerns, while structural barriers in the context of the workplace include time constraints, shift work, long days, a lack of work amenities and a general disconnect of drivers with their workplace. Conclusion In this workplace, health promotion strategies for bus drivers should be prioritised as a means of improving drivers' health. To maximise uptake and effectiveness, these strategies should make use of existing workplace resources and consider the context of workplace health behaviour change. Further research is warranted in a broader sample of Australian bus companies to explore the context of workplace health behavior change so targeted strategies to improve bus drivers' health can be developed.	[Brodie, Alison; Sendall, Marguerite C.] Queensland Univ Technol, Sch Publ Hlth & Social Work, Fac Hlth, Brisbane, Qld, Australia; [Pavey, Toby] Queensland Univ Technol, Sch Exercise & Nutr Sci, Fac Hlth, Brisbane, Qld, Australia; [Newton, Cameron] Queensland Univ Technol, QUT Business Sch, Sch Management Fac Business & Law, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Sendall, MC (corresponding author), Queensland Univ Technol, Sch Publ Hlth & Social Work, Fac Hlth, Brisbane, Qld, Australia.	m.sendall@qut.edu.au	Useche, Sergio A./O-7552-2014	Useche, Sergio A./0000-0002-5099-4627; Newton, Cameron/0000-0003-4310-0143; Brodie, Alison/0000-0003-2786-8152; Sendall, Marguerite Claire/0000-0002-1239-9173	Institute of Health and Biomedical Innovation, Queensland University of Technology	Institute of Health and Biomedical Innovation, Queensland University of Technology	This study was funded by a small internal institutional grant to authors Marguerite Sendall, Toby Pavey and Cameron Newton, from the Institute of Health and Biomedical Innovation, Queensland University of Technology. This funding does not have a grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. the funding details of this grant are not provided on the institutional website. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedokun A. O., 2017, The Open Public Health Journal, V10, P303, DOI 10.2174/1874944501710010303; Amadi CE, 2018, CARDIOVASC J AFR, V29, P106, DOI 10.5830/CVJA-2018-006; [Anonymous], 2012, SCI WORLD J, DOI [DOI 10.1100/2012/216702, 10.1100/2012/216702]; [Anonymous], 2014, AUSTR PHYS ACT SED B; [Anonymous], WORKPLACE HLTH SAFET; Australian Government Department of Health, BOD MASS IND BMI; Australian Government Department of Infrastructure TransportCities and Regional Development, NAT PROF TRANSP POST; Australian Government National Health and Medical Research Council, FOOD ESS REC NUMB SE; Australian Institute of Health and Welfare, 2020, ARTHR; Australian Institute of Health and Welfare, 2020, OST; Boeijinga A, 2017, INT J COMMUN-US, V11, P5007; Boeijinga A, 2017, WORK, V56, P539, DOI 10.3233/WOR-172503; Bonn SE, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6595-6; Bowles NP, 2017, AM J IND MED, V60, P350, DOI 10.1002/ajim.22701; Crizzle A, 2018, INT J WORKPLACE HEAL, V11, P319, DOI 10.1108/IJWHM-04-2018-0041; Crizzle AM, 2017, J TRANSP HEALTH, V7, P90, DOI 10.1016/j.jth.2017.05.359; Davies KAB, 2019, THER ADV ENDOCRINOL, V10, DOI 10.1177/2042018819888824; Dobson M, 2017, AM J IND MED, V60, P991, DOI 10.1002/ajim.22760; Dunstan DW, 2011, CURR OPIN CARDIOL, V26, P412, DOI 10.1097/HCO.0b013e3283496605; French SA, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-52; Ghasemi S, 2019, INT J PREVENTIVE MED, V10, DOI 10.4103/ijpvm.IJPVM_339_18; Gilson ND, 2016, AUST NZ J PUBL HEAL, V40, P91, DOI 10.1111/1753-6405.12501; Grimani A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-8033-1; Hege A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207322; Hill M.A., 2015, J HLTH SAF ENV, V31, P1; Howarth A, 2018, DIGIT HEALTH, V4, DOI 10.1177/2055207618770861; Ihlstrom J, 2017, WORK, V56, P531, DOI 10.3233/WOR-172520; Joshi B A, 2013, J Indian Med Assoc, V111, P157; Kompier M.A.J., 1996, BUS DRIVERS OCCUPATI; LaBond C, 2022, CRIT PUBLIC HEALTH, V32, P392, DOI 10.1080/09581596.2020.1846684; Lalla-Edward ST, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032025; Mato VV, 2018, J OCCUP ENVIRON MED, V60, P368, DOI 10.1097/JOM.0000000000001128; Mitchell WK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00260; MORRIS JN, 1953, LANCET, V265, P1053; Muni Sakar K., LECT NOTES NETWORKS, V118, DOI [10.1007/978-981-15-3284-9%5F49, DOI 10.1007/978-981-15-3284-9%5F49]; Murray KE, 2019, HEALTH PROMOT INT, V34, P323, DOI 10.1093/heapro/dax082; Naug HL, 2016, INT J OCCUP MED ENV, V29, P573, DOI 10.13075/ijomeh.1896.00570; OzHelp Foundation, 2020, PHYS MENTAL HLTH WEL; Puhkala Jatta, 2016, Prev Med Rep, V4, P435, DOI 10.1016/j.pmedr.2016.08.012; Robbins RB, 2020, J OCCUP ENVIRON MED, V62, P453, DOI 10.1097/JOM.0000000000001863; Rodrigues JGP, 2015, IEEE T INTELL TRANSP, V16, DOI 10.1109/TITS.2015.2445314; ROSENGREN A, 1991, INT J EPIDEMIOL, V20, P82, DOI 10.1093/ije/20.1.82; Rosso GL, 2015, AM J IND MED, V58, P212, DOI 10.1002/ajim.22400; Safe Work Australia, AUSTR WORK HLTH SAF; SafeWork Australia, 2018, ROAD TRANSP PRIOR IN; Sendall MC, 2019, INT J OCCUP ENV MED, V10, P145, DOI 10.15171/ijoem.2019.1533; Sendall MC, 2016, ROAD TRANSP RES, V25, P31; Shin SY, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-34; Useche SA, 2018, PEERJ, V6, DOI 10.7717/peerj.6249; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; van Vreden C, 2020, DRIVING HLTH STUDY R; Varela-Mato V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013162; Varela-Mato Veronica, 2016, Prev Med Rep, V3, P36, DOI 10.1016/j.pmedr.2015.11.011; Wong JYL, 2014, AUST NZ J PUBL HEAL, V38, P314, DOI 10.1111/1753-6405.12214; Yeary KHK, 2019, PREV CHRONIC DIS, V16, DOI 10.5888/pcd16.180413; Yook JH, 2018, ANN OCCUP ENVIRON ME, V30, DOI 10.1186/s40557-018-0242-z; Zavanela PM, 2012, J STRENGTH COND RES, V26, P811, DOI 10.1519/JSC.0b013e318225ff4d; Zhong B, 2021, INT J OCCUP SAF ERGO, V27, P874, DOI 10.1080/10803548.2019.1662980	58	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255225	10.1371/journal.pone.0255225	http://dx.doi.org/10.1371/journal.pone.0255225			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324584	Green Published, gold			2022-12-26	WOS:000685248200049
J	Dankova, M; Jerabek, J; Jester, DJ; Zumrova, A; Schwabova, JP; Cerny, R; Kmetonyova, S; Vyhnalek, M				Dankova, Michaela; Jerabek, Jaroslav; Jester, Dylan J.; Zumrova, Alena; Paulasova Schwabova, Jaroslava; Cerny, Rudolf; Kmetonyova, Silvia; Vyhnalek, Martin			Clinical dynamic visual acuity in patients with cerebellar ataxia and vestibulopathy	PLOS ONE			English	Article							CLASSIFICATION; OSCILLOPSIA; REFLEX; MOTION; LIFE	Deterioration of dynamic visual acuity (DVA) as a result of impaired vestibulo-ocular reflex (VOR) has been well described in peripheral vestibulopathies, however, changes in DVA in patients with degenerative cerebellar ataxias (CA) and its relation to VOR impairment in these patients has not yet been evaluated. Our aim was to assess the alterations of DVA in CA and to evaluate its relation to vestibular function. 32 patients with CA and 3 control groups: 13 patients with unilateral and 13 with bilateral vestibulopathy and 21 age matched healthy volunteers were examined by clinical DVA test, VOR was assessed by video Head Impulse Test and caloric irrigation. The severity of ataxia in CA was assessed by Scale for the assessment and rating of ataxia (SARA). Relationship between DVA and vestibular function in CA patients was examined by linear regressions. DVA impairment was highly prevalent in CA patients (84%) and its severity did not differ between CA and bilateral vestibulopathy patients. The severity of DVA impairment in CA was linked mainly to VOR impairment and only marginally to the degree of ataxia. However, DVA impairment was present also in CA patients without significant vestibular lesion showing that central mechanisms such as impairment of central adaptation of VOR are involved. We suggest that the evaluation of DVA should be a standard part of clinical evaluation in patients with progressive CA, as this information can help to target vestibular and oculomotor rehabilitation.	[Dankova, Michaela; Jerabek, Jaroslav; Paulasova Schwabova, Jaroslava; Cerny, Rudolf; Kmetonyova, Silvia; Vyhnalek, Martin] Charles Univ Prague, Fac Med 2, Ctr Hereditary Ataxias, Dept Neurol, Prague, Czech Republic; [Dankova, Michaela; Jerabek, Jaroslav; Paulasova Schwabova, Jaroslava; Cerny, Rudolf; Kmetonyova, Silvia; Vyhnalek, Martin] Motol Univ Hosp, Prague, Czech Republic; [Jester, Dylan J.] Univ S Florida, Sch Aging Studies, Tampa, FL 33620 USA; [Zumrova, Alena] Charles Univ Prague, Fac Med 2, Dept Paediat Neurol, Prague, Czech Republic; [Zumrova, Alena] Univ Hosp Motol, Prague, Czech Republic	Charles University Prague; Motol University Hospital; State University System of Florida; University of South Florida; Charles University Prague; Motol University Hospital	Vyhnalek, M (corresponding author), Charles Univ Prague, Fac Med 2, Ctr Hereditary Ataxias, Dept Neurol, Prague, Czech Republic.; Vyhnalek, M (corresponding author), Motol Univ Hosp, Prague, Czech Republic.	martin.vyhnalek@fnmotol.cz	Schwabová, Jaroslava Paulasová/ABE-8194-2021; , Rudolf/GYR-1318-2022; Danková, Michaela/GLT-4496-2022	Schwabová, Jaroslava Paulasová/0000-0002-8465-8269; Dankova, Michaela/0000-0002-4290-1777; Kmetonyova, Silvia/0000-0003-4765-3378	Charles University Grant Agency [608218]; MH CZ - DRO, Motol University Hospital, Prague, Czech Republic [00064203]; Institutional Support of Excellence 2. LF UK [6990332]; European Reference Network for Rare Neurological Diseases [739510]	Charles University Grant Agency; MH CZ - DRO, Motol University Hospital, Prague, Czech Republic; Institutional Support of Excellence 2. LF UK; European Reference Network for Rare Neurological Diseases	The research was supported by Charles University Grant Agency, Project No. 608218 (M. D.); MH CZ - DRO, Motol University Hospital, Prague, Czech Republic Project No. 00064203; Institutional Support of Excellence 2. LF UK Grant No. 6990332. All authors of this publication are members of the European Reference Network for Rare Neurological Diseases - Project ID No 739510. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad H, 2017, NEUROLOGY, V89, P1179, DOI 10.1212/WNL.0000000000004360; Baloh RW., 1990, CLIN NEUROPHYSIOLOGY, VEdition 2, P153; Baloh RW., 2001, CLIN NEUROPHYSIOLOGY, V3rd ed, P53; BARBER HO, 1984, OTOLARYNG HEAD NECK, V92, P55, DOI 10.1177/019459988409200112; Bisdorff A, 2009, J VESTIBUL RES-EQUIL, V19, P1, DOI 10.3233/VES-2009-0343; Bronstein AM, 2005, CURR OPIN NEUROL, V18, P1, DOI 10.1097/00019052-200502000-00002; Burgio D L, 1992, J Vestib Res, V2, P221; Cakrt O, 2012, NEUROREHABILITATION, V31, P429, DOI 10.3233/NRE-2012-00813; COHEN H, 1994, AM J OCCUP THER, V48, P919, DOI 10.5014/ajot.48.10.919; DEMER JL, 1995, OTOLARYNG HEAD NECK, V112, P16, DOI 10.1016/S0194-5998(95)70301-2; DIETERICH M, 1987, CLIN VISION SCI, V1, P337; Fahey MC, 2008, BRAIN, V131, P1035, DOI 10.1093/brain/awm323; Gordon CR, 2003, J NEUROL NEUROSUR PS, V74, P1403, DOI 10.1136/jnnp.74.10.1403; Grunfeld EA, 2000, BRAIN, V123, P277, DOI 10.1093/brain/123.2.277; Guinand N, 2012, ANN OTO RHINOL LARYN, V121, P471, DOI 10.1177/000348941212100708; Halmagyi GM, 2001, ANN NY ACAD SCI, V942, P192; HALMAGYI GM, 1990, EXP BRAIN RES, V81, P479, DOI 10.1007/BF02423496; Henry DF, 1999, AM J OTOL, V20, P220; Herdman SJ, 2001, ARCH OTOLARYNGOL, V127, P1205, DOI 10.1001/archotol.127.10.1205; Herdman SJ, 1998, AM J OTOL, V19, P790; Hillman EJ, 1999, J VESTIBUL RES-EQUIL, V9, P49; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Ito M, 1998, TRENDS COGN SCI, V2, P313, DOI 10.1016/S1364-6613(98)01222-4; Kaeser PF, 2010, ACTA OPHTHALMOL, V88, P791, DOI 10.1111/j.1755-3768.2009.01544.x; Kheradmand Amir, 2011, Front Neurol, V2, P53, DOI 10.3389/fneur.2011.00053; Lee MH, 1997, AVIAT SPACE ENVIR MD, V68, P111; Leigh RJ., 2015, NEUROLOGY EYE MOVEME, P836; Leigh RJ, 2006, NEUROLOGY EYE MOVEME, V3rd ed, P20; LONGRIDGE NS, 1987, ACTA OTO-LARYNGOL, V103, P273, DOI 10.3109/00016488709107794; Manago MM, 2016, J VESTIBUL RES-EQUIL, V26, P469, DOI 10.3233/VES-160593; Mantokoudis G, 2015, OTOL NEUROTOL, V36, P457, DOI 10.1097/MAO.0000000000000638; McGarvie LA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00154; Peters BT, 2012, J VESTIBUL RES-EQUIL, V22, P145, DOI 10.3233/VES-2012-0440; Rine RM, 2003, INT J PEDIATR OTORHI, V67, P1195, DOI 10.1016/j.ijporl.2003.07.004; Strupp M, 2017, J VESTIBUL RES-EQUIL, V27, P177, DOI 10.3233/VES-170619; Subramony SH, 2007, NAT CLIN PRACT NEURO, V3, P136, DOI 10.1038/ncpneuro0426; Szmulewicz DJ, 2011, ANN NY ACAD SCI, V1233, P139, DOI 10.1111/j.1749-6632.2011.06158.x; Tian JR, 2001, EXP BRAIN RES, V137, P12, DOI 10.1007/s002210000640; Weber KP, 2009, ANN NY ACAD SCI, V1164, P486, DOI 10.1111/j.1749-6632.2008.03730.x; Zeigelboim BS., 2010, TINNITUS J, V16, P161	40	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255299	10.1371/journal.pone.0255299	http://dx.doi.org/10.1371/journal.pone.0255299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324564	gold, Green Published			2022-12-26	WOS:000685248200055
J	Gupta, A; Ma, S; Che, KP; Pobbati, AV; Rubin, BP				Gupta, Anu; Ma, Shuang; Che, Kepeng; Pobbati, Ajaybabu V.; Rubin, Brian P.			Inhibition of PI3K and MAPK pathways along with KIT inhibitors as a strategy to overcome drug resistance in gastrointestinal stromal tumors	PLOS ONE			English	Article							OF-FUNCTION MUTATIONS; IMATINIB MESYLATE; ACQUIRED-RESISTANCE; KINASE INHIBITOR; BRAF MUTATIONS; EFFICACY; SAFETY; REGORAFENIB; MECHANISMS; MANAGEMENT	Activating mutations in KIT/PDGFRA receptor tyrosine kinases drive gastrointestinal stromal tumors (GIST). KIT/PDGFRA inhibitors, such as imatinib do not evoke an effective cytocidal response, leaving room for quiescence and development of multiple secondary resistance mutations. As the majority of the secondary resistance clones activate PI3K and MAPK pathways, we investigated whether combined targeting of KIT/PI3K/MAPK (KPM) pathways overcomes drug resistance and quiescence in GIST cells. We monitored the proliferation of imatinib-sensitive and-resistant GIST cell lines after treating them with various combinations of drugs to inhibit KPM pathways. Cytocidal response was evaluated through proliferation, apoptosis and colony outgrowth assays. Combined inhibition of KPM signaling pathways using a KPM inhibitor cocktail decreased the survival of drug-resistant GIST cells and dramatically reduced their proliferation. Downstream pathway analysis showed that the residual PI3K/MAPK signaling observed after KIT inhibitor treatment plays a role in mediating quiescence and drug resistance. The KPM inhibitor cocktail with sunitinib or regorafenib effectively induced apoptosis and prevented colony outgrowth after long-term drug removal, suggesting that it can be used as an effective strategy against quiescence and drug resistance in metastatic GIST.	[Gupta, Anu; Ma, Shuang; Che, Kepeng; Pobbati, Ajaybabu V.; Rubin, Brian P.] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Rubin, Brian P.] Cleveland Clin Fdn, Robert J Tomsich Pathol & Lab Med Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Rubin, BP (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.; Rubin, BP (corresponding author), Cleveland Clin Fdn, Robert J Tomsich Pathol & Lab Med Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	rubinb2@ccf.org		Rubin, Brian/0000-0002-0657-3024	Life Raft Group	Life Raft Group	This work was funded by a grant from The Life Raft Group.	Agaram NP, 2008, GENE CHROMOSOME CANC, V47, P853, DOI 10.1002/gcc.20589; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Banks E, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz2481; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Blanke CD, 2008, J CLIN ONCOL, V26, P620, DOI 10.1200/JCO.2007.13.4403; Boichuk S, 2018, MOLECULES, V23, DOI 10.3390/molecules23102643; Bosbach B, 2017, P NATL ACAD SCI USA, V114, pE8448, DOI 10.1073/pnas.1711449114; Cohen MH, 2010, ONCOLOGIST, V15, P300, DOI 10.1634/theoncologist.2009-0120; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Floris G, 2013, CLIN CANCER RES, V19, P620, DOI 10.1158/1078-0432.CCR-12-2853; Gramza AW, 2009, CLIN CANCER RES, V15, P7510, DOI 10.1158/1078-0432.CCR-09-0190; Gupta A, 2018, EORTC NCI AACR ANN M; Gupta A, 2010, P NATL ACAD SCI USA, V107, P14333, DOI 10.1073/pnas.1000248107; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hirota S, 2003, GASTROENTEROLOGY, V125, P660, DOI 10.1016/S0016-5085(03)01046-1; Infante JR, 2012, LANCET ONCOL, V13, P773, DOI 10.1016/S1470-2045(12)70270-X; Janku F, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.00522; Javidi-Sharifi N, 2015, CANCER RES, V75, P880, DOI 10.1158/0008-5472.CAN-14-0573; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kim GP, 2013, J TARGETED THERAPIES, V1; Kissel M, 2017, ONCOTARGET, V8, P107096, DOI 10.18632/oncotarget.22334; Lasota J, 2016, MODERN PATHOL, V29, P275, DOI 10.1038/modpathol.2015.160; Li B, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.e22520; Mazzocca A, 2019, THER ADV MED ONCOL, V11, DOI 10.1177/1758835919841946; Miranda C, 2012, CLIN CANCER RES, V18, P1769, DOI 10.1158/1078-0432.CCR-11-2230; Mirzayans R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050708; Montemurro M, 2013, EUR J CANCER, V49, P1027, DOI 10.1016/j.ejca.2012.10.009; Niinuma T, 2018, TRANSL GASTROENT HEP, V3, DOI 10.21037/tgh.2018.01.02; Park SH, 2012, INVEST NEW DRUG, V30, P2377, DOI 10.1007/s10637-012-9795-9; Ran LL, 2015, CANCER DISCOV, V5, P304, DOI 10.1158/2159-8290.CD-14-0985; Rizzo A, 2021, CANCERS, V13, DOI 10.3390/cancers13040705; Rubin BP, 2007, LANCET, V369, P1731, DOI 10.1016/S0140-6736(07)60780-6; Rubin BP, 2006, LAB INVEST, V86, P981, DOI 10.1038/labinvest.3700466; Serrano Cesar, 2019, Oncotarget, V10, P6286, DOI 10.18632/oncotarget.27277; Serrano C, 2019, CLIN CANCER RES, V25, P7287, DOI 10.1158/1078-0432.CCR-19-2150; Serrano C, 2019, BRIT J CANCER, V120, P612, DOI 10.1038/s41416-019-0389-6; Serrano C, 2015, J CLIN ONCOL, V33, pE93, DOI 10.1200/JCO.2013.48.7488; Sircar K, 1999, AM J SURG PATHOL, V23, P377, DOI 10.1097/00000478-199904000-00002; Smith BD, 2019, CANCER CELL, V35, P738, DOI 10.1016/j.ccell.2019.04.006; Szucs Z, 2017, FUTURE ONCOL, V13, P185, DOI 10.2217/fon-2016-0194; Taguchi T, 2002, LAB INVEST, V82, P663, DOI 10.1038/labinvest.3780461; Von Mehren M., 2019, EUR SOC MED ONCOL, V30, pv925, DOI [10.1093/annonc/mdz394.087, DOI 10.1093/ANNONC/MDZ394.087]; Wardelmann E, 2005, LANCET ONCOL, V6, P249, DOI 10.1016/S1470-2045(05)70097-8; Welsh SJ, 2015, THER ADV MED ONCOL, V7, P122, DOI 10.1177/1758834014566428	49	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0252689	10.1371/journal.pone.0252689	http://dx.doi.org/10.1371/journal.pone.0252689			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324512	Green Published, gold			2022-12-26	WOS:000685248200083
J	Wicher, SA; Roos, BB; Teske, JJ; Fang, YH; Pabelick, C; Prakash, YS				Wicher, Sarah A.; Roos, Benjamin B.; Teske, Jacob J.; Fang, Yun Hua; Pabelick, Christina; Prakash, Y. S.			Aging increases senescence, calcium signaling, and extracellular matrix deposition in human airway smooth muscle	PLOS ONE			English	Article							OPERATED CA2+ INFLUX; CELL SENESCENCE; AGE; HYPERRESPONSIVENESS; RESPONSIVENESS; MITOCHONDRIA; INFLAMMATION; PREVALENCE; FIBROSIS; IMPACT	Lung function declines as people age and their lungs become stiffer. With an increasing elderly population, understanding mechanisms that contribute to these structural and functional changes in the aging lung is important. Part of the aging process is characterized by thicker, more fibrotic airways, and senile emphysema caused by changes in lung parenchyma. There is also senescence, which occurs throughout the body with aging. Here, using human airway smooth muscle (ASM) cells from patients in different age groups, we explored senescence pathways and changes in intracellular calcium signaling and extracellular matrix (ECM) deposition to elucidate potential mechanisms by which aging leads to thicker and stiffer lungs. Senescent markers p21, gamma H2AX, and beta-gal, and some senescence-associated secretory proteins (SASP) increased with aging, as shown by staining and biochemical analyses. Agonist-induced intracellular Ca2+ responses, measured using fura-2 loaded cells and fluorescence imaging, increased with age. However, biochemical analysis showed that expression of the following markers decreased with age: M-3 muscarinic receptor, TRPC3, Orai1, STIM1, SERCA2, MMP2 and MMP9. In contrast, collagen III, and fibronectin deposition increased with age. These data show that senescence increases in the aging airways that is associated with a stiffer but surprisingly greater intracellular calcium signaling as a marker for contractility. ASM senescence may enhance fibrosis in a feed forward loop promoting remodeling and altered calcium storage and buffering.	[Wicher, Sarah A.; Roos, Benjamin B.; Teske, Jacob J.; Pabelick, Christina; Prakash, Y. S.] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN 55901 USA; [Fang, Yun Hua; Pabelick, Christina; Prakash, Y. S.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55901 USA	Mayo Clinic; Mayo Clinic	Prakash, YS (corresponding author), Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN 55901 USA.; Prakash, YS (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55901 USA.	Prakash.ys@mayo.edu	; Teske, Jacob/B-6831-2019	Prakash, Y S/0000-0002-2968-224X; Teske, Jacob/0000-0002-3361-5859; Pabelick, Christina/0000-0002-4632-2174; Wicher, Sarah/0000-0002-0079-7924	AHA [19POST34430017]; Mayo Clinic Kogod Center on Aging Career Development Award; NIH [R01 HL088029, R01 HL142061]	AHA(American Heart Association); Mayo Clinic Kogod Center on Aging Career Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by AHA grant 19POST34430017 (Wicher), Mayo Clinic Kogod Center on Aging Career Development Award (Wicher), NIH grants R01 HL088029 (Prakash), R01 HL142061 (Pabelick).	Abcejo AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044343; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Alvarez D, 2017, AM J PHYSIOL-LUNG C, V313, pL1164, DOI 10.1152/ajplung.00220.2017; Ambhore NS, 2019, FASEB J, V33, P13935, DOI 10.1096/fj.201901340R; Ay B, 2004, AM J PHYSIOL-LUNG C, V286, pL909, DOI 10.1152/ajplung.00317.2003; Bai TR, 2000, AM J RESP CRIT CARE, V162, P663, DOI 10.1164/ajrccm.162.2.9907151; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Behringer EJ, 2017, J GERONTOL A-BIOL, V72, P1627, DOI 10.1093/gerona/glx079; Birch J, 2018, PHARMACOL THERAPEUT, V183, P34, DOI 10.1016/j.pharmthera.2017.10.005; Borok Zea, 2011, Proc Am Thorac Soc, V8, P215, DOI 10.1513/pats.201012-067CB; Britt RD, 2016, ANN AM THORAC SOC, V13, pS97, DOI 10.1513/AnnalsATS.201508-540MG; Burgess JK, 2016, J PATHOL, V240, P397, DOI 10.1002/path.4808; Burgstaller G, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.01805-2016; Caporarello N, 2019, THORAX, V74, P749, DOI 10.1136/thoraxjnl-2019-213064; Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498; Chen X, 2020, AGING-US, V12, P242, DOI 10.18632/aging.102613; Choy DKL, 2002, CLIN EXP ALLERGY, V32, P702, DOI 10.1046/j.1365-2222.2002.01395.x; CONNOLLY MJ, 1992, THORAX, V47, P410, DOI 10.1136/thx.47.6.410; Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862; Correia-Melo Clara, 2014, Longev Healthspan, V3, P1, DOI 10.1186/2046-2395-3-1; Cui HC, 2017, AM J RESP CELL MOL, V56, P168, DOI 10.1165/rcmb.2016-0163OC; de Magalhaes JP, 2018, MECH AGEING DEV, V170, P2, DOI 10.1016/j.mad.2017.07.001; Dekkers BGJ, 2007, AM J PHYSIOL-LUNG C, V292, pL1405, DOI 10.1152/ajplung.00331.2006; Delmotte P, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00374; Eickelberg O, 1999, AM J PHYSIOL-LUNG C, V276, pL814, DOI 10.1152/ajplung.1999.276.5.L814; Freeman MR, 2017, AM J PHYSIOL-LUNG C, V313, pL360, DOI 10.1152/ajplung.00580.2016; Gulati S, 2019, AM J MED SCI, V357, P384, DOI 10.1016/j.amjms.2019.02.008; HORSLEY JR, 1993, GERONTOLOGY, V39, P38; Ichimaru Y, 2012, AM J PHYSIOL-LUNG C, V302, pL325, DOI 10.1152/ajplung.00453.2010; Janssens JP, 2005, CLIN CHEST MED, V26, P469, DOI 10.1016/j.ccm.2005.05.004; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Justice JN, 2019, EBIOMEDICINE, V40, P554, DOI 10.1016/j.ebiom.2018.12.052; Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013; Lopes GS, 2006, EXP GERONTOL, V41, P55, DOI 10.1016/j.exger.2005.10.004; Malavia NK, 2009, AM J RESP CELL MOL, V41, P297, DOI 10.1165/rcmb.2008-0358OC; Martin-Cano FE, 2014, J PINEAL RES, V56, P163, DOI 10.1111/jpi.12109; Miller MR, 2010, SEMIN RESP CRIT CARE, V31, P521, DOI 10.1055/s-0030-1265893; Morty RE, 2019, AM J PHYSIOL-LUNG C, V316, pL822, DOI 10.1152/ajplung.00081.2019; Panettieri RA, 2008, AM J RESP CRIT CARE, V177, P248, DOI 10.1164/rccm.200708-1217PP; Parikh P, 2019, AM J PHYSIOL-LUNG C, V316, pL826, DOI 10.1152/ajplung.00424.2018; Parikh P, 2019, AM J RESP CELL MOL, V61, P51, DOI 10.1165/rcmb.2018-0176OC; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Polio SR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45716-9; Prakash YS, 2007, AM J PHYSIOL-LUNG C, V293, pL1118, DOI 10.1152/ajplung.00136.2007; Prakash YS, 2006, ANESTHESIOLOGY, V105, P976, DOI 10.1097/00000542-200611000-00019; Prakash YS, 2016, AM J PHYSIOL-LUNG C, V311, pL1113, DOI 10.1152/ajplung.00370.2016; Puzianowska-Kuznicka M, 2009, AGEING RES REV, V8, P160, DOI 10.1016/j.arr.2009.05.002; Rezwan FI, 2020, AGING-US, V12, P518, DOI 10.18632/aging.102639; Roesler AM, 2019, J CELL PHYSIOL, V234, P14187, DOI 10.1002/jcp.28115; Sathish V, 2012, EUR RESPIR J, V40, P470, DOI 10.1183/09031936.00090511; Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532; Scichilone N, 2005, EUR RESPIR J, V25, P364, DOI 10.1183/09031936.05.00080204; Scichilone N, 2004, RESP MED, V98, P838, DOI 10.1016/j.rmed.2004.02.023; Shkumatov A, 2015, AM J PHYSIOL-LUNG C, V308, pL1125, DOI 10.1152/ajplung.00154.2014; Sicard D, 2018, AM J PHYSIOL-LUNG C, V314, pL946, DOI 10.1152/ajplung.00415.2017; Sieck GC, 2008, AM J PHYSIOL-LUNG C, V294, pL378, DOI 10.1152/ajplung.00394.2007; Skloot GS, 2017, CLIN GERIATR MED, V33, P447, DOI 10.1016/j.cger.2017.06.001; Sparrow D, 1997, AM J RESP CRIT CARE, V155, P888, DOI 10.1164/ajrccm.155.3.9117022; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Sueblinvong Viranuj, 2014, Adv Biosci Biotechnol, V5, P19; Thompson MA, 2014, AM J RESP CELL MOL, V51, P68, DOI 10.1165/rcmb.2013-0144OC; WATANABE S, 1974, AM REV RESPIR DIS, V109, P530; WHO, 2021, WHAT IS HLTH AG; Wicher SA, 2019, EXPERT REV RESP MED, V13, P291, DOI 10.1080/17476348.2019.1575733; Yang J, 2016, ONCOTARGET, V7, P15632, DOI 10.18632/oncotarget.6695; You K, 2019, AM J PHYSIOL-LUNG C, V317, pL525, DOI 10.1152/ajplung.00067.2019; Zhu Y, 2019, MICROSC MICROANAL, V25, P267, DOI 10.1017/S1431927618016203	68	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254710	10.1371/journal.pone.0254710	http://dx.doi.org/10.1371/journal.pone.0254710			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324543	Green Published, gold			2022-12-26	WOS:000685248200026
J	van den Tillaar, R				van den Tillaar, Roland			Comparison of development of step-kinematics of assisted 60 m sprints with different pulling forces between experienced male and female sprinters	PLOS ONE			English	Article							PERFORMANCE; VELOCITY; ACCELERATION; SPEEDS	The purpose of this study was to compare step-by-step kinematics of normal and assisted 60 m sprints with different loads in experienced sprinters. Step-by-step kinematics were measured using inertial measuring units (IMU) integrated with a 3-axis gyroscope and a laser gun in 24 national level male and female sprinters during a normal 60 m sprint and sprints with a 3, 4, and 5 kg pulling force. The main findings were that using increasing assisted loads resulted in faster 60 m times, as a result of higher step velocity mainly caused by longer step lengths in both genders and by shorter contact times in women. Men had longer step lengths, longer contact times, and shorter flight times than women. However, the assisted loads had a greater effect on women than on men, as shown by their larger decrease in sprint times. These time differences in gender were the result of more and longer duration increases in maximal step velocity with increasing assisted loads for women (70-80% of distance) than men (65-70% of distance). This was mainly caused by shorter contact times, and by more increased step lengths in women compared to men. In terms of practical application, it is notable that employing this approach, when using assisted loads can help athletes to reach higher step velocities and hold this for longer, which may be a training impulse to move the speed barrier upwards.	[van den Tillaar, Roland] Nord Univ, Dept Sport Sci & Phys Educ, Levanger, Norway	Nord University	van den Tillaar, R (corresponding author), Nord Univ, Dept Sport Sci & Phys Educ, Levanger, Norway.	roland.v.tillaar@nord.no						Abe Takashi, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P141, DOI 10.2114/jpa.20.141; [Anonymous], 2017, HUM MOV, DOI DOI 10.1515/HUMO-2017-0013; Brechue William F., 2011, IJASS(International Journal of Applied Sports Sciences), V23, P313; Clark DA, 2009, J STRENGTH COND RES, V23, P1162, DOI 10.1519/JSC.0b013e318194df84; Cohen J.E., 1988, STAT POWER ANAL BEHA; DELECLUSE C, 1995, MED SCI SPORT EXER, V27, P1203; Haugen TA, 2014, INT J SPORT PHYSIOL, V9, P432, DOI [10.1123/IJSPP.2013-0121, 10.1123/ijspp.2013-0121]; Higham DG, 2013, INT J SPORT PHYSIOL, V8, P19, DOI 10.1123/ijspp.8.1.19; Hill A.V, 1970, 1 LAST EXPT MUSCLE M; Kratky S, 2016, J STRENGTH COND RES, V30, P102, DOI 10.1519/JSC.0000000000001070; Kristensen GO, 2006, J STRENGTH COND RES, V20, P833; Kumagai K, 2000, J APPL PHYSIOL, V88, P811, DOI 10.1152/jappl.2000.88.3.811; Lahti J, 2020, SPORTS, V8, DOI 10.3390/sports8050074; MAJDELL R, 1991, J HUM MOVEMENT STUD, V21, P19; Malina R M, 1971, Med Sci Sports, V3, P32; Mangine GT, 2018, J STRENGTH COND RES, V32, P1531, DOI 10.1519/JSC.0000000000002030; Mann R, MECH SPRINTING HURDL; MERO A, 1986, EUR J APPL PHYSIOL O, V55, P553, DOI 10.1007/BF00421652; MERO A, 1987, MED SCI SPORT EXER, V19, P266; Mero A, 1985, INT J SPORT BIOMECH, V1, P240, DOI [https://doi.org/10.1123/ijsb.1.3.240, DOI 10.1123/IJSB.1.3.240]; Nagahara R, 2019, SPORTS, V7, DOI 10.3390/sports7060133; Nagahara R, 2018, J APPL BIOMECH, V34, P104, DOI 10.1123/jab.2016-0356; Nagahara R, 2014, BIOL OPEN, V3, P689, DOI 10.1242/bio.20148284; Paradisis GP, 2001, J SPORT SCI, V19, P149, DOI 10.1080/026404101300036370; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Plamondon A, 1984, Can J Appl Sport Sci, V9, P42; Rakovic E, 2018, J SPORT SCI, V36, P2802, DOI 10.1080/02640414.2018.1474536; Salo AIT, 2011, MED SCI SPORT EXER, V43, P1055, DOI 10.1249/MSS.0b013e318201f6f8; Slawinski J, 2017, SCAND J MED SCI SPOR, V27, P45, DOI 10.1111/sms.12627; Smirniotou A, 2011, J BIOL EXER, V7, P7, DOI DOI 10.4127/JBE.2011.0040; Spinks CD, 2007, J STRENGTH COND RES, V21, P77, DOI 10.1519/00124278-200702000-00015; van den Tillaar R, 2018, TRANSL SPORTS MED, V1, P151, DOI 10.1002/tsm2.27; van den Tillaar R., 2018, SPORTS BIOMECH, P1, DOI [10.1080/14763141.2018.1442871, DOI 10.1080/14763141.2018.1442871]; Zafeiridis A, 2005, J SPORT MED PHYS FIT, V45, P284	34	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255302	10.1371/journal.pone.0255302	http://dx.doi.org/10.1371/journal.pone.0255302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314453	Green Published, gold			2022-12-26	WOS:000685225200040
J	Yu, YY; Li, CD; Yang, WM; Xu, W				Yu, Yinyun; Li, Congdong; Yang, Weiming; Xu, Wei			Determining the critical factors of air-conditioning innovation using an integrated model of fuzzy Kano-QFD during the COVID-19 pandemic: The perspective of air purification	PLOS ONE			English	Article							QUALITY FUNCTION DEPLOYMENT; DECISION-MAKING; PRODUCT DESIGN; CAPABILITY; SELECTION; DEMAND; TRIZ; SETS	At present, people are demanding better indoor air quality during the COVID-19 pandemic. In addition to maintaining the basic functions, new air-conditioning should also add air purification functions to improve indoor air quality and reduce the possibility of virus transmission. Nowadays, there is lack of research results on the innovation of air-conditioning. The aim of this study is to present a two-stage mathematical model for identifying critical manufacturing factors in the innovation process of air conditioning. In this paper, Kano and quality function deployment (QFD) are used to analyze the critical factors affecting air-conditioning innovation. Some studies have proposed using Kano-QFD model to analyze product innovation, but the study only studies one stage, which loses the analysis of the subsequent stages of product innovation. Based on this, this paper studies the priority method of two-stage critical factors for air-conditioning innovation. Firstly, the questionnaire survey and fuzzy sets are used to collect demand information of multi-agent (customers and professional technicians). Secondly, the Kano model is used to classify and calculate satisfaction of multi-agent. Then, QFD is used to transform multi-agent demands into engineering property indexes (first stage) and technical property indexes (second stage) and calculate the weight of each index. Finally, the applicability and superiority of this method is illustrated by taking the central air-conditioning as an example.	[Yu, Yinyun; Li, Congdong; Yang, Weiming] Jinan Univ, Sch Management, Guangzhou, Peoples R China; [Xu, Wei] Shenyang Univ Technol, Sch Management, Shenyang, Peoples R China	Jinan University; Shenyang University of Technology	Li, CD; Yang, WM (corresponding author), Jinan Univ, Sch Management, Guangzhou, Peoples R China.	licd@jnu.edu.cn; yangweiming626@163.com	Liu, Hai-Ying/P-5557-2014	Liu, Hai-Ying/0000-0001-8667-3465	National Natural Science Foundation of China [72072072]; Natural Science Foundation of Guangdong Province of China [2019A1515010045]; 2018 Guangzhou Leading Innovation Team Program (China) [201909010006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); 2018 Guangzhou Leading Innovation Team Program (China)	The authors would like to acknowledge partial financial support from National Natural Science Foundation of China (72072072), Natural Science Foundation of Guangdong Province of China (2019A1515010045), 2018 Guangzhou Leading Innovation Team Program (China) (201909010006).	Abernathy W. J., 1983, J OPERATIONS MANAGEM, V3, P155, DOI [10.1016/0272-6963(83)90001-3, DOI 10.1016/0272-6963(83)90001-3]; Ali S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238743; Chaudhuri A, 2009, INT J PROD RES, V47, P6633, DOI 10.1080/00207540802350757; Chen CC, 2008, INT J PROD ECON, V114, P667, DOI 10.1016/j.ijpe.2008.02.015; Chen LH, 2017, EUR J OPER RES, V259, P654, DOI 10.1016/j.ejor.2016.10.028; [程永波 Cheng Yongbo], 2016, [系统工程理论与实践, Systems Engineering-Theory & Practice], V36, P2867; Cho J, 2017, MATH PROBL ENG, V2017, DOI 10.1155/2017/9010857; Choudhary S, 2017, PAC BUS REV INT, V9, P24; [丛东升 Cong Dongsheng], 2018, [系统工程理论与实践, Systems Engineering-Theory & Practice], V38, P2409; Dangelico RM, 2017, BUS STRATEG ENVIRON, V26, P490, DOI 10.1002/bse.1932; Dedehayir O, 2014, J ENG TECHNOL MANAGE, V33, P174, DOI 10.1016/j.jengtecman.2014.06.002; Deveci M, 2019, RES TRANSP BUS MANAG, V33, DOI 10.1016/j.rtbm.2019.100387; Ding Y, 2018, SOC INDIC RES, V139, P871, DOI 10.1007/s11205-017-1765-3; Eum W, 2019, TECHNOVATION, V84-85, P1, DOI 10.1016/j.technovation.2019.02.002; Fu YL, 2020, SOC INDIC RES, V152, P117, DOI 10.1007/s11205-020-02422-8; Geng LS, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/4615320; Ginting R, 2016, PERTANIKA J SCI TECH, V24, P1; Gokasar I, 2022, RES TRANSP ECON, V91, DOI 10.1016/j.retrec.2021.101029; Ji P, 2014, INT J PROD RES, V52, P6335, DOI 10.1080/00207543.2014.939777; Jia Tian, 2018, Industrial Engineering Journal, V21, P87, DOI 10.3969/j.issn.1007-7375.e17-2045; Kano N, 1984, J JPN SOC QUAL CONTR, V14, P147, DOI [10.20684/quality.14.2_147, DOI 10.20684/QUALITY.14.2_147]; Kumar A, 2020, INT J SERV TECHNOL M, V26, P341, DOI 10.1504/IJSTM.2020.107436; Li AD, 2019, EUR J OPER RES, V274, P978, DOI 10.1016/j.ejor.2018.10.051; Liao HC, 2015, KNOWL-BASED SYST, V76, P127, DOI 10.1016/j.knosys.2014.12.009; Liao HC, 2014, INFORM SCIENCES, V271, P125, DOI 10.1016/j.ins.2014.02.125; Liao YC, 2019, BUS STRATEG ENVIRON, V28, P316, DOI 10.1002/bse.2232; Loucanova E, 2020, ACTA FAC XYLOLOG ZVO, V62, P165, DOI 10.17423/afx.2020.62.2.15; Meng WD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236626; Ocampo LA, 2020, SUSTAIN PROD CONSUMP, V24, P62, DOI 10.1016/j.spc.2020.06.013; Pamucar D, 2021, SUSTAIN PROD CONSUMP, V27, P1093, DOI 10.1016/j.spc.2021.02.016; [任磊 Ren Lei], 2018, [计算机集成制造系统, Computer Integrated Manufacturing Systems], V24, P838; Safizadeh MH, 1996, MANAGE SCI, V42, P1576, DOI 10.1287/mnsc.42.11.1576; Silva GBL, 2018, HOLOS, V34, P50, DOI 10.15628/holos.2018.6669; Suh Y, 2019, TECHNOL FORECAST SOC, V148, DOI 10.1016/j.techfore.2019.119740; Sun Yuan-yuan, 2014, Computer Integrated Manufacturing Systems, V20, P2697, DOI 10.13196/j.cims.201411007; Tan KC, 2000, TOTAL QUAL MANAGE, V11, P1141, DOI 10.1080/095441200440395; Tirkolaee EB, 2020, J CLEAN PROD, V250, DOI 10.1016/j.jclepro.2019.119517; Torkayesh AE, 2021, SUSTAIN CITIES SOC, V67, DOI 10.1016/j.scs.2021.102712; Torkayesh AE, 2021, WASTE MANAGE, V122, P100, DOI 10.1016/j.wasman.2020.12.040; Turk S, 2021, INFORM SCIENCES, V547, P641, DOI 10.1016/j.ins.2020.08.076; Wang H, 2020, COMPUT IND ENG, V140, DOI 10.1016/j.cie.2019.106212; Wang TJ, 2020, SOC INDIC RES, V149, P1, DOI 10.1007/s11205-019-02236-3; Wang TX, 2020, INT J IND ERGONOM, V76, DOI 10.1016/j.ergon.2019.102901; Xu W, 2018, COMPLEXITY, DOI 10.1155/2018/1410957; [杨强 Yang Qiang], 2018, [计算机集成制造系统, Computer Integrated Manufacturing Systems], V24, P978; Yazdani M., 2021, EXPERT SYST APPL, P183, DOI [10.1016/j.eswa.2021.115354, DOI 10.1016/J.ESWA.2021.115354]; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhang FL, 2014, COMPUT IND ENG, V76, P60, DOI 10.1016/j.cie.2014.07.019	48	3	3	16	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255051	10.1371/journal.pone.0255051	http://dx.doi.org/10.1371/journal.pone.0255051			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TU	34314471	gold, Green Published			2022-12-26	WOS:000685225200015
J	Carpinetti, PD; Fioresi, VS; da Cruz, TI; de Almeida, FAN; Canal, D; Ferreira, A; Ferreira, MFD				Carpinetti, Paola de Avelar; Fioresi, Vinicius Sartori; Ignez da Cruz, Thais; de Almeida, Francine Alves Nogueira; Canal, Drielli; Ferreira, Adesio; Ferreira, Marcia Flores da Silva			Efficient method for isolation of high-quality RNA from Psidium guajava L. tissues	PLOS ONE			English	Article							NUCLEIC-ACIDS; SATIVA L.; DNA; PLANT; EXTRACTION; INHIBITION; PROTOCOL; GENES; PCR; TRANSCRIPTOME	Acquiring high-quality RNA in sufficient amounts is crucial in plant molecular biology and genetic studies. Several methods for RNA extraction from plants are available in the literature, mainly due to the great biochemical diversity present in each species and tissue, which can complicate or prevent the extraction. Psidium guajava (Myrtaceae family) is a perennial fruit tree of medicinal and economic value; nevertheless, only a few molecular studies are available for the species. One reason is the difficulty in obtaining RNA due to the content of the samples, which are rich in polyphenols, polysaccharides, and secondary metabolites. Furthermore, there are few studies available for the isolation of RNA from guava or Psidium samples, which hampers advances in the study of the genus. Here, quality and yields of RNA isolates were compared using six extraction protocols: two protocols based on the application of cetyltrimethylammonium bromide (CTAB) lysis buffer, one protocol which uses the TRIzol reagent, one which applies guanidine thiocyanate lysis buffer followed by organic phase extraction, and two commercial kits (PureLink RNA Mini Kit and RNeasy Plant Mini Kit). The CTAB-based method provided the highest RNA yields and quality for five different tissues (flower bud, immature leaf, young leaf, mature leaf, and root), genotypes, and stress conditions. For the most efficient protocol, the average yield of RNA from guava leaves was 203.06 mu g/g of tissue, and the A(260)/A(280) and A(260)/A(230) ratios were 2.1 and 2.2, respectively. RT-qPCR analysis demonstrated that the purity of the samples was sufficient for molecular biology experiments. CTAB-based methods for RNA isolation were found to be the most efficient, providing the highest RNA yields and quality for tissues from P. guajava. Additionally, they were compatible for downstream RNA-based applications, besides being simple and cost-effective.	[Carpinetti, Paola de Avelar; Fioresi, Vinicius Sartori; Ignez da Cruz, Thais; de Almeida, Francine Alves Nogueira; Canal, Drielli; Ferreira, Adesio; Ferreira, Marcia Flores da Silva] Univ Fed Espirito Santo, Ctr Agr Sci & Engn, Dept Agron, Lab Genet & Plant Improvement, Alegre, ES, Brazil	Universidade Federal do Espirito Santo	Ferreira, MFD (corresponding author), Univ Fed Espirito Santo, Ctr Agr Sci & Engn, Dept Agron, Lab Genet & Plant Improvement, Alegre, ES, Brazil.	marcia.ferreira@ufes.br		Canal, Drielli/0000-0002-5771-3912; Almeida, Francine/0000-0002-1633-9477; /0000-0003-1541-6634				Arruabarrena A, 2016, J VIROL METHODS, V237, P14, DOI 10.1016/j.jviromet.2016.08.011; Arseneau JR, 2017, MOL ECOL RESOUR, V17, P686, DOI 10.1111/1755-0998.12616; Babu S, 2016, APPL NOTE ASSESSING; Baldridge GD, 1998, PLANT MOL BIOL, V38, P999, DOI 10.1023/A:1006182908528; Behnam B, 2019, FEBS OPEN BIO, V9, P814, DOI 10.1002/2211-5463.12561; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Bontempo P, 2012, CELL PROLIFERAT, V45, P22, DOI 10.1111/j.1365-2184.2011.00797.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen XP, 2002, PLANT CELL PHYSIOL, V43, P869, DOI 10.1093/pcp/pcf100; Choi JH, 2012, FOOD CHEM TOXICOL, V50, P2923, DOI 10.1016/j.fct.2012.04.044; Clark M. S., 2013, PLANT MOL BIOL LAB M; Deepa K, 2014, PHYSIOL MOL BIOL PLA, V20, P263, DOI 10.1007/s12298-013-0218-y; delaCruz M, 1995, MOL ECOL, V4, P787, DOI 10.1111/j.1365-294X.1995.tb00281.x; DELLACORTE C, 1994, TISSUE CELL, V26, P613, DOI 10.1016/0040-8166(94)90013-2; Dutta S, 2010, PHARMACOGN RES, V2, P313, DOI 10.4103/0974-8490.72331; FAO. Food and Agriculture Organization of the United Nations, 2018, STAT DIV FAOSTAT; Farrell RE., 2011, ENCY MOL CELL BIOL M, DOI [10.1002/3527600906.mcb.201100008, DOI 10.1002/3527600906.MCB.201100008]; Favreau B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218528; Flores G, 2015, FOOD CHEM, V170, P327, DOI 10.1016/j.foodchem.2014.08.076; Furlan Cláudia Maria, 2012, Braz. J. Plant Physiol., V24, P29, DOI 10.1590/S1677-04202012000100005; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Gehrig HH, 2000, PLANT MOL BIOL REP, V18, P369, DOI 10.1007/BF02825065; Ghawana Sanjay, 2011, BMC Res Notes, V4, P85, DOI 10.1186/1756-0500-4-85; Guillemaut P, 1992, PLANT MOL BIOL REP, V10, P60, DOI 10.1007/BF02669265; Gupta Pooja, 2015, J Ayurveda Integr Med, V6, P50, DOI 10.4103/0975-9476.146557; Guzman F, 2014, PLANT SCI, V229, P238, DOI 10.1016/j.plantsci.2014.10.003; Jaakola L, 2001, MOL BIOTECHNOL, V19, P201, DOI 10.1385/MB:19:2:201; JONES AS, 1953, BIOCHIM BIOPHYS ACTA, V10, P607, DOI 10.1016/0006-3002(53)90304-7; Joseph B, INT J PHARM BIOL SCI, V201, P53, DOI DOI 10.7205/MILMED-D-11-00030; KATCHER HL, 1994, BIOTECHNIQUES, V16, P84; Kim WS, 2014, APPL NOTE 80 EVALUAT; Kumar A, 2012, MOL BIOTECHNOL, V52, P269, DOI 10.1007/s12033-011-9492-5; Lakhvir Lal, 2001, Plant Molecular Biology Reporter, V19, P181, DOI 10.1007/BF02772161; Lins TH., 2014, BMC P, V8, pP79, DOI [10.1186/1753-6561-8-S4-P79, DOI 10.1186/1753-6561-8-S4-P79]; Liu LL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196592; Meher, 2018, SAUDI J BIOL SCI, V25, P285, DOI 10.1016/j.sjbs.2017.04.008; MUDLIAR VS, 2008, J CELL TISSUE RES, V8, P1313; Nadiya F, 2015, ANAL BIOCHEM, V485, P25, DOI 10.1016/j.ab.2015.05.017; Nimisha S, 2013, SCI HORTIC-AMSTERDAM, V164, P578, DOI 10.1016/j.scienta.2013.10.017; Opel KL, 2010, J FORENSIC SCI, V55, P25, DOI 10.1111/j.1556-4029.2009.01245.x; Pandey RN, 1996, PLANT MOL BIOL REP, V14, P17, DOI 10.1007/BF02671898; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; POWELL HA, 1994, LETT APPL MICROBIOL, V18, P59, DOI 10.1111/j.1472-765X.1994.tb00802.x; Racki N, 2014, PLANT METHODS, V10, DOI 10.1186/s13007-014-0042-6; Rai MK, 2010, TREES-STRUCT FUNCT, V24, P1, DOI 10.1007/s00468-009-0384-2; Ramirez I. M., 2004, Cultivos Tropicales, V25, P33; Ritter E, 2012, ACTA HORTIC, V959, P131, DOI 10.17660/ActaHortic.2012.959.16; ROSSEN L, 1992, INT J FOOD MICROBIOL, V17, P37, DOI 10.1016/0168-1605(92)90017-W; Sajeevan R. S., 2014, American Journal of Plant Sciences, V5, P2057; Salzman RA, 1999, PLANT MOL BIOL REP, V17, P11, DOI 10.1023/A:1007520314478; SAULNIER P, 1992, J CLIN MICROBIOL, V30, P2080, DOI 10.1128/JCM.30.8.2080-2083.1992; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SHAHJAHAN RM, 1995, BIOTECHNIQUES, V19, P332; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Sheng QH, 2017, BRIEF FUNCT GENOMICS, V16, P194, DOI 10.1093/bfgp/elw035; Sidstedt M, 2020, ANAL BIOANAL CHEM, V412, P2009, DOI 10.1007/s00216-020-02490-2; Sumra Naseer, 2018, Clinical Phytoscience, V4, DOI 10.1186/s40816-018-0093-8; Sundell D, 2017, PLANT CELL, V29, P1585, DOI 10.1105/tpc.17.00153; Tella T, 2019, BIOMED PHARMACOTHER, V109, P2441, DOI 10.1016/j.biopha.2018.11.137; Velegraki A, 1999, MED MYCOL, V37, P69; Vining KJ, 2015, NEW PHYTOL, V206, P1406, DOI 10.1111/nph.13077; Wang GF, 2012, PHYTOCHEM ANALYSIS, V23, P159, DOI 10.1002/pca.1337; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Wong L.-M., 2014, J MED BIOENG, V3, P236, DOI [10.12720/jomb.3.4.236-240, DOI 10.12720/JOMB.3.4.236-240]; Zeng Ying, 2002, Plant Molecular Biology Reporter, V20, P417, DOI 10.1007/BF02772130; Zhao L, 2012, PHYTOCHEM ANALYSIS, V23, P647, DOI 10.1002/pca.2368; ZOUBENKO OV, 1994, NUCLEIC ACIDS RES, V22, P3819, DOI 10.1093/nar/22.19.3819	67	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255245	10.1371/journal.pone.0255245	http://dx.doi.org/10.1371/journal.pone.0255245			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310664	Green Published, gold, Green Submitted			2022-12-26	WOS:000685224500018
J	Liu, XF; Ahmad, Z; Gemeay, AM; Abdulrahman, AT; Hafez, EH; Khalil, N				Liu, Xiaofeng; Ahmad, Zubair; Gemeay, Ahmed M.; Abdulrahman, Alanazi Talal; Hafez, E. H.; Khalil, N.			Modeling the survival times of the COVID-19 patients with a new statistical model: A case study from China	PLOS ONE			English	Article							PANDEMIC DYNAMICS; DISTRIBUTIONS; EPIDEMIC	Over the past few months, the spread of the current COVID-19 epidemic has caused tremendous damage worldwide, and unstable many countries economically. Detailed scientific analysis of this event is currently underway to come. However, it is very important to have the right facts and figures to take all possible actions that are needed to avoid COVID-19. In the practice and application of big data sciences, it is always of interest to provide the best description of the data under consideration. The recent studies have shown the potential of statistical distributions in modeling data in applied sciences, especially in medical science. In this article, we continue to carry this area of research, and introduce a new statistical model called the arcsine modified Weibull distribution. The proposed model is introduced using the modified Weibull distribution with the arcsine-X approach which is based on the trigonometric strategy. The maximum likelihood estimators of the parameters of the new model are obtained and the performance these estimators are assessed by conducting a Monte Carlo simulation study. Finally, the effectiveness and utility of the arcsine modified Weibull distribution are demonstrated by modeling COVID-19 patients data. The data set represents the survival times of fifty-three patients taken from a hospital in China. The practical application shows that the proposed model out-classed the competitive models and can be chosen as a good candidate distribution for modeling COVID-19, and other related data sets.	[Liu, Xiaofeng] Shanghai Univ Finance & Econ, Zhejiang Coll, Jinhua, Zhejiang, Peoples R China; [Ahmad, Zubair] Yazd Univ, Dept Stat, Yazd, Iran; [Gemeay, Ahmed M.] Tanta Univ, Dept Math, Fac Sci, Tanta, Egypt; [Abdulrahman, Alanazi Talal] Univ Hail, Coll Sci, Dept Math, Hail, Saudi Arabia; [Hafez, E. H.] Helwan Univ, Fac Sci, Dept Math, Cairo, Egypt; [Khalil, N.] Qassim Univ, Coll Arts & Sci, Dept Math, Ar Rass, Saudi Arabia	Shanghai University of Finance & Economics; University of Yazd; Egyptian Knowledge Bank (EKB); Tanta University; University Ha'il; Egyptian Knowledge Bank (EKB); Helwan University; Qassim University	Ahmad, Z (corresponding author), Yazd Univ, Dept Stat, Yazd, Iran.	z.ferry21@gmail.com	Abdulrahman, Alanazi Talal/AAQ-1223-2021; Khalil, Nora/GZA-9103-2022; hossam, eslam/AAF-4673-2019	Khalil, Nora/0000-0001-6785-6274; hossam, eslam/0000-0002-2527-5938; Gemeay, Ahmed/0000-0001-6767-4016				Abdy M, 2021, ADV DIFFER EQU-NY, V2021, DOI 10.1186/s13662-021-03263-6; Abid K, 2020, ASIA-PAC J PUBLIC HE, V32, P154, DOI 10.1177/1010539520927259; Ahmad Z., 2021, COMPLEXITY, V2021; Ahmad Z, 2020, J TAIBAH UNIV SCI, V14, P359, DOI 10.1080/16583655.2020.1741942; Al-Babtain AA, 2021, SYMMETRY-BASEL, V13, DOI 10.3390/sym13030474; Al-Babtain AA, 2021, J KING SAUD UNIV SCI, V33, DOI 10.1016/j.jksus.2020.10.021; Atangana Ernestine, 2020, Results Phys, V19, P103425, DOI 10.1016/j.rinp.2020.103425; de Leon UAP, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110165; Bhattacharya S, 2020, RESULTS PHYS, V19, DOI 10.1016/j.rinp.2020.103568; Chang SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19393-6; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Chen Y, 2020, J INVERSE ILL-POSE P, V28, P243, DOI 10.1515/jiip-2020-0010; Din A, 2020, RESULTS PHYS, V19, DOI 10.1016/j.rinp.2020.103510; Dong BW, 2018, J ADV TRANSPORT, DOI 10.1155/2018/2702360; He WJ, 2020, COMPLEXITY, V2020, DOI 10.1155/2020/8394815; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kharroubi SA, 2020, FRONT APPL MATH STAT, V6, DOI 10.3389/fams.2020.00040; Li Q., 2020, NEW ENGL J MED, V382, P1199; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Lobo AD, 2020, INT J INFECT DIS, V97, P382, DOI 10.1016/j.ijid.2020.06.044; Maier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557; Nesteruk I., 2020, COMP CORONAVIRUS PAN; Nesteruk I.G., 2020, KPI SCI NEWS, V1, P10; Roosa K, 2020, INFECT DIS MODEL, V5, P256, DOI 10.1016/j.idm.2020.02.002; Ahmar AS, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138883; Samui P, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110173; Sarhan A.M., 2009, APPS APPL SCI, V11, P123; Sarkodie SA, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03747; Teamah A.E.A., 2020, PAK J STAT, V36, P1; Thabet STM, 2020, RESULTS PHYS, V19, DOI 10.1016/j.rinp.2020.103507; Tung Y.L., 2021, COMPUTER SYSTEMS SCI, V37, P1; Zhao J, 2021, CMC-COMPUT MATER CON, V67, P2111, DOI 10.32604/cmc.2021.014259; Zhao J, 2021, CMC-COMPUT MATER CON, V67, P965, DOI 10.32604/cmc.2021.014553; Zuo M, 2020, COMPUT MATH METHOD M, V2020, DOI 10.1155/2020/4296806	35	15	16	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254999	10.1371/journal.pone.0254999	http://dx.doi.org/10.1371/journal.pone.0254999			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310646	Green Published, gold			2022-12-26	WOS:000685224500027
J	Boggio, GM; Meynadier, A; Daunis-i-Estadella, P; Marie-Etancelin, C				Martinez Boggio, Guillermo; Meynadier, Annabelle; Daunis-i-Estadella, Pepus; Marie-Etancelin, Christel			Compositional analysis of ruminal bacteria from ewes selected for somatic cell score and milk persistency	PLOS ONE			English	Article							PRODUCTION TRAITS; SUNFLOWER OIL; RUMEN FLUID; R-PACKAGE; COMMUNITY	Ruminants are dependent on their rumen microbiota to obtain energy from plants. The composition of the microbiome was well-known to be associated with health status, and production traits, but published results are difficult to reproduce due to large sources of variation. The objectives of this study were to evaluate the associations of ruminal microbiota and its association with genetic lines selected by somatic cell score (SCS) or milk persistency (PERS), as well as milk production, somatic cell score, fat and protein contents, and fatty acids and proteins of milk, using the principles of compositional data. A large sample of 700 Lacaune dairy ewes from INRAE La Fage feeding the same diet and belonging to two divergent genetic lines selected for SCS or PERS was used. The ruminal bacterial metagenome was sequenced using the 16S rRNA gene, resulting in 2,059 operational taxonomic units affiliated with 112 genera. The abundance data were centred log-transformed after the replacement of zeros with the geometric Bayesian method. Discriminant analysis of the SCS showed differences between SCS+ and SCS- ewes, while for PERS no difference was obtained. Milk traits as fat content, protein content, saturated fatty acids and caseins of milk were negatively associated with Prevotella (R = [-0.08;-0.16]), Suttonella (R = [-0.09;-0.16]) and Ruminococcus (R = [-0.08;-0.16]), and positively associated with Lachnospiraceae (R = [0.09;0.16]) and Christensenellaceae (R = [0.09;0.16]). Our findings provide an understanding of the application of compositional data to microbiome analysis, and the potential association of Prevotella, Suttonella, Ruminococcaceae and Lachnospiraceae with milk production traits such as milk fatty acids and proteins in dairy sheep.	[Martinez Boggio, Guillermo; Meynadier, Annabelle; Marie-Etancelin, Christel] Univ Toulouse, ENVT, INPT, GenPhySE,INRAE, Castanet Tolosan, France; [Daunis-i-Estadella, Pepus] Univ Girona, Dept Comp Sci Appl Math & Stat, Girona, Spain	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Universitat de Girona	Boggio, GM (corresponding author), Univ Toulouse, ENVT, INPT, GenPhySE,INRAE, Castanet Tolosan, France.	guillermo.martinez-boggio@inrae.fr	Daunis-i-Estadella, Pepus/B-9082-2011; Martinez-Boggio, Guillermo/ABF-6498-2021	Daunis-i-Estadella, Pepus/0000-0001-6134-9255; Martinez-Boggio, Guillermo/0000-0003-3597-9426; Meynadier, Annabelle/0000-0003-0631-6949; Marie-Etancelin, Christel/0000-0001-8950-0420	INRAE; La Region Occitanie	INRAE; La Region Occitanie	GMB Funders: INRAE and La Region Occitanie https://www.inrae.fr/https://www.laregion.fr/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; Amaretti A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02614; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Bach A, 2019, J DAIRY SCI, V102, P6180, DOI 10.3168/jds.2018-16105; Bainbridge ML, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw059; Belenguer A, 2010, J DAIRY SCI, V93, P3275, DOI 10.3168/jds.2010-3101; Bickhart DM, 2018, J DAIRY SCI, V101, P7680, DOI 10.3168/jds.2017-13328; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Castro-Carrera T, 2014, J DAIRY SCI, V97, P1661, DOI 10.3168/jds.2013-7243; DEWHIRST FE, 1990, INT J SYST BACTERIOL, V40, P426, DOI 10.1099/00207713-40-4-426; Difford GF, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007580; Egozcue JJ, 2003, MATH GEOL, V35, P279, DOI 10.1023/A:1023818214614; Escudie F, 2018, BIOINFORMATICS, V34, P1287, DOI 10.1093/bioinformatics/btx791; Fernandes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067019; Ferrand-Calmels M, 2014, J DAIRY SCI, V97, P17, DOI 10.3168/jds.2013-6648; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Gloor GB, 2016, CAN J MICROBIOL, V62, P692, DOI 10.1139/cjm-2015-0821; Greenacre M, 2019, EC WORKING PAPER SER; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Henderson G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074787; Hernandez-Sanabria E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058461; Huang S, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.630605; Indugu N, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1098-z; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Kittelmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103171; Lahalle, ICAR 38 ANN M 2012, P5; Li FY, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00061-17; Li H, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00609; Lima FS, 2015, APPL ENVIRON MICROB, V81, P1327, DOI 10.1128/AEM.03138-14; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Ma C, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0578-1; Martin-Fernandez JA, 2015, STAT MODEL, V15, DOI 10.1177/1471082X14535524; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; Pawlowsky-Glahn V, 2015, STAT PRACT, P8; Pearson K., 1896, P ROY SOC LONDON, V60, P489, DOI DOI 10.1098/RSPL.1896.0076; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Rupp R, 2009, J DAIRY SCI, V92, P1203, DOI 10.3168/jds.2008-1435; Rupp R, 2003, J DAIRY SCI, V86, P1476, DOI 10.3168/jds.S0022-0302(03)73732-1; Scharen M, 2018, J DAIRY SCI, V101, P4615, DOI 10.3168/jds.2017-13736; Stewart CS., 1997, RUMEN MICROBIAL ECOS, P10, DOI [10.1007/978-94-009-1453-7_2, DOI 10.1007/978-94-009-1453-7_2]; Tong JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198225; Toral PG, 2012, J DAIRY SCI, V95, P794, DOI 10.3168/jds.2011-4561; Vacca M, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8040573; van den Boogaart KG, 2008, COMPUT GEOSCI-UK, V34, P320, DOI 10.1016/j.cageo.2006.11.017; Wallace RJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav8391; WANG Y, 2019, BIOELECTRICITY ITS F, P1, DOI DOI 10.1002/ADBI.201900101.; Xue MY, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/AEM.00970-18, 10.1128/aem.00970-18]; Zhong YF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03217	50	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254874	10.1371/journal.pone.0254874	http://dx.doi.org/10.1371/journal.pone.0254874			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310617	Green Published, gold			2022-12-26	WOS:000685224500028
J	Jiang, WX; Wang, XZ; Li, RH; Wang, PP; Shan, GL; Jia, XD; Gu, ML				Jiang, Wenxi; Wang, Xizi; Li, Ronghui; Wang, Panpan; Shan, Guangle; Jia, Xiaodong; Gu, Mingliang			Targeted capture sequencing identifies genetic variations of GRK4 and RDH8 in Han Chinese with essential hypertension in Xinjiang	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; BLOOD-PRESSURE; PART I; DISEASE; POLYMORPHISMS; ASSOCIATION; VARIANTS; DOPAMINE; RISK	Essential hypertension is a common cardiovascular disease with complex etiology, closely related to genetic and environmental factors. The pathogenesis of hypertension involves alteration in vascular resistance caused by sympathetic nervous system (SNS) and renin angiotensin system (RAS). Susceptibility factors of hypertension vary with regions and ethnicities. In this study, we conducted target capture sequencing on 54 genes related to SNS and RAS derived from a collection of Han nationality, consisting of 151 hypertension patients and 65 normal subjects in Xinjiang, China. Six non-synonymous mutations related to hypertension were identified, including GRK4 rs1644731 and RDH8 rs1801058, Mutations are predicted to affect 3D conformation, force field, transmembrane domain and RNA secondary structure of corresponding genes. Based on protein interaction network and pathway enrichment, GRK4 is predicted to participate in hypertension by acting on dopaminergic synapse, together with interacting components. RDH8 is involved in vitamin A (retinol) metabolism and consequent biological processes related to hypertension. Thus, GRK4 and RDH8 may serve as susceptibility genes for hypertension. This finding provides new genetic evidence for elucidating risk factors of hypertension in Han nationality in Xinjiang, which in turn, enriches genetic resource bank of hypertension susceptibility genes.	[Jiang, Wenxi] Xinjiang Med Univ, Affiliated Hosp 1, Dept Med, Urumqi, Peoples R China; [Wang, Xizi; Gu, Mingliang] Chinese Acad Sci, Beijing Inst Genom, Joint Lab Translat Med Res, Liaocheng, Shandong, Peoples R China; [Wang, Xizi; Gu, Mingliang] Liaocheng Peoples Hosp, Liaocheng, Shandong, Peoples R China; [Li, Ronghui; Wang, Panpan; Shan, Guangle; Jia, Xiaodong; Gu, Mingliang] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China	Xinjiang Medical University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Gu, ML (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Joint Lab Translat Med Res, Liaocheng, Shandong, Peoples R China.; Gu, ML (corresponding author), Liaocheng Peoples Hosp, Liaocheng, Shandong, Peoples R China.; Gu, ML (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China.	minglianggu@hotmail.com			National Natural Science Foundation of China [81260057]; Natural Science Foundation of Xinjiang Autonomous Region [2010211A33, 2012211A033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Xinjiang Autonomous Region	This work was supported by grants from the National Natural Science Foundation of China (81260057) and the Natural Science Foundation of Xinjiang Autonomous Region (2010211A33, 2012211A033).	Beetz N, 2009, J CLIN INVEST, V119, P3597, DOI 10.1172/JCI38433; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bovolenta LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-405; Caligiuri SPB, 2017, CRIT REV FOOD SCI, V57, P3508, DOI 10.1080/10408398.2016.1142420; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Crowe-White KM, 2020, CURR DEV NUTR, V4, DOI 10.1093/cdn/nzaa102; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Elliott WI, 2007, CURR PROB CARDIOLOGY, V32, P201, DOI 10.1016/j.cpcardiol.2007.01.002; Felder RA, 2002, P NATL ACAD SCI USA, V99, P3872, DOI 10.1073/pnas.062694599; Harris RC, 2012, CURR HYPERTENS REP, V14, P138, DOI 10.1007/s11906-012-0253-z; Ji LD, 2017, J HUM HYPERTENS, V32, P34, DOI 10.1038/s41371-017-0012-3; Kumar R, 2015, AM J HYPERTENS, V28, P239, DOI 10.1093/ajh/hpu130; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li TB, 2017, NAT METHODS, V14, P61, DOI 10.1038/nmeth.4083; Li ZY, 2019, J HYPERTENS, V37, P2371, DOI 10.1097/HJH.0000000000002200; Liang XH, 2021, CLIN EXP HYPERTENS, V43, P151, DOI 10.1080/10641963.2020.1833023; Light KC, 2001, PSYCHOSOM MED, V63, P744, DOI 10.1097/00006842-200109000-00007; Liu CB, 2012, INT J MED SCI, V9, P274, DOI 10.7150/ijms.4171; Valencia DM, 2013, BIOMEDICA, V33, P598, DOI 10.7705/biomedica.v33i4.1489; Munzel T, 2017, EUR HEART J, V38, P550, DOI 10.1093/eurheartj/ehw269; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Saari JC, 1998, VISION RES, V38, P1325, DOI 10.1016/S0042-6989(97)00198-3; Soudani NY, 2014, SAUDI MED J, V35, P255; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Teekakirikul P, 2011, CURRENT SEQUENCING U, V7, P7, DOI DOI 10.1002/0471142905.hg0718s69; Villar VM, 2009, J BIOL CHEM, V284, P21425, DOI 10.1074/jbc.M109.003665; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang ZW, 2018, CIRCULATION, V137, P2344, DOI 10.1161/CIRCULATIONAHA.117.032380; Yang J, 2015, HYPERTENSION, V65, P1148, DOI 10.1161/HYPERTENSIONAHA.115.05189; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255311	10.1371/journal.pone.0255311	http://dx.doi.org/10.1371/journal.pone.0255311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297769	Green Published, gold			2022-12-26	WOS:000678128300034
J	Baer, J; Gugele, SM; Bretzel, J; DeWeber, JT; Brinker, A				Baer, Jan; Gugele, Sarah Maria; Bretzel, Joachim; DeWeber, J. Tyrell; Brinker, Alexander			All day-long: Sticklebacks effectively forage on whitefish eggs during all light conditions	PLOS ONE			English	Article							GASTEROSTEUS-ACULEATUS; 3-SPINED STICKLEBACKS; COREGONUS-LAVARETUS; FOOD-CONSUMPTION; POPULATION; PREY; BEHAVIOR; EXAMPLE; GROWTH	The three-spined stickleback Gasterosteus aculeatus invaded Lake Contance in the 1940s and expanded in large numbers from an exclusively shoreline habitat into the pelagic zone in 2012. Stickleback abundance is very high in the pelagic zone in winter near the spawning time of pelagic whitefish Coregonus wartmanni, and it is hypothesized that this is triggered by the opportunity to consume whitefish eggs. Field sampling has qualitatively confirmed predation of whitefish eggs by stickleback, but quantification has proven difficult due to stormy conditions that limit sampling. One fundamental unknown is if freshwater stickleback, known as visual feeders, can successfully find and eat whitefish eggs during twilight and night when whitefish spawn. It is also unknown how long eggs can be identified in stomachs following ingestion, which could limit efforts to quantify egg predation through stomach content analysis. To answer these questions, 144 individuals were given the opportunity to feed on whitefish roe under daylight, twilight, and darkness in controlled conditions. The results showed that stickleback can ingest as many as 100 whitefish eggs under any light conditions, and some individuals even consumed maximum numbers in complete darkness. Furthermore, eggs could be unambiguously identified in the stomach 24 hours after consumption. Whitefish eggs have 28% more energy content than the main diet of sticklebacks (zooplankton) based on bomb-calorimetric measurements, underlining the potential benefits of consuming eggs. Based on experimental results and estimates of stickleback abundance and total egg production, stickleback could potentially consume substantial proportions of the total eggs produced even if relatively few sticklebacks consume eggs. Given the evidence that stickleback can feed on eggs during nighttime spawning and may thereby hamper recruitment, future studies aimed at quantifying actual egg predation and resulting effects on the whitefish population are urgently needed.	[Baer, Jan; Gugele, Sarah Maria; Bretzel, Joachim; DeWeber, J. Tyrell; Brinker, Alexander] Fisheries Res Stn BadenWurttembery, Langenargen, Germany; [Gugele, Sarah Maria; Brinker, Alexander] Univ Constance, Inst Limnol, Constance, Germany; [Gugele, Sarah Maria] State Govt Vorarlberg, Dept Fisheries & Water Ecol Hard, Vienna, Austria; [Bretzel, Joachim] Charles Sturt Univ, Inst Land Water & Soc, Albury, NSW, Australia	University of Konstanz; Charles Sturt University	Baer, J (corresponding author), Fisheries Res Stn BadenWurttembery, Langenargen, Germany.	jan.baer@lazbw.bwl.de		Brinker, Alexander/0000-0002-2433-5652; Baer, Jan/0000-0001-8388-6684; DeWeber, Jefferson/0000-0001-5840-8488	Fischereiabgabe Baden-Wurttemberg; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [298726046/GRK2272]; grant "SeeWandel: Life in Lake Constance -the past, present and future" by European Regional Development Fund; Swiss Confederation	Fischereiabgabe Baden-Wurttemberg; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); grant "SeeWandel: Life in Lake Constance -the past, present and future" by European Regional Development Fund; Swiss Confederation	Sarah Gugele was funded by the "Fischereiabgabe Baden-Wurttemberg". Sarah Gugele was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-298726046/GRK2272 and by the grant "SeeWandel: Life in Lake Constance -the past, present and future" within the framework of the Interreg V programme "Alpenrhein-Bodensee-Hochrhein (Germany/Austria/Switzerland/Liechtenstein)"which funds are provided by the European Regional Development Fund as well as the Swiss Confederation and cantons. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JRM, 1982, J FISH BIOL, V21, P95, DOI 10.1111/j.1095-8649.1982.tb02827.x; Barber I, 1995, BEHAVIOUR, V132, P1223, DOI 10.1163/156853995X00540; BERBEROVIC R, 1990, OECOLOGIA, V84, P340, DOI 10.1007/BF00329757; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bretzel JB, 2021, FRONT ENV SCI-SWITZ, V9, DOI 10.3389/fenvs.2021.670125; Cleves PA, 2014, P NATL ACAD SCI USA, V111, P13912, DOI 10.1073/pnas.1407567111; CROY MI, 1991, ANIM BEHAV, V42, P131, DOI 10.1016/S0003-3472(05)80613-X; ECKMANN R, 1991, CAN J FISH AQUAT SCI, V48, P995, DOI 10.1139/f91-116; Eckmann R, 2019, FISH RES, V210, P189, DOI 10.1016/j.fishres.2018.08.002; Gugele SM, 2020, FISH RES, V232, DOI 10.1016/j.fishres.2020.105746; HAYTER AJ, 1984, ANN STAT, V12, P61, DOI 10.1214/aos/1176346392; Johannesen A, 2012, ANIM BEHAV, V84, P151, DOI 10.1016/j.anbehav.2012.04.024; Kotterba P, 2014, LIMNOL OCEANOGR, V59, P578, DOI 10.4319/lo.2014.59.2.0578; McLean J., 1987, ANIMAL HUMAN CALORIM; Mehlis M, 2008, ANIM COGN, V11, P643, DOI 10.1007/s10071-008-0154-3; Mehlis M, 2010, P ROY SOC B-BIOL SCI, V277, P2627, DOI 10.1098/rspb.2010.0234; Mobley RB, 2020, ANIM COGN, V23, P101, DOI 10.1007/s10071-019-01319-5; Mussen TD, 2001, BEHAVIOUR, V138, P857, DOI 10.1163/156853901753172683; RAJASILTA M, 1980, ANN ZOOL FENN, V17, P123; Roch S, 2018, FISH RES, V204, P172, DOI 10.1016/j.fishres.2018.02.014; Rosch R, 2018, HYDROBIOLOGIA, V824, P243, DOI 10.1007/s10750-017-3479-6; Thomas G, 2007, CAN J FISH AQUAT SCI, V64, P402, DOI 10.1139/F07-019; Webster MM, 2007, BEHAVIOUR, V144, P1347, DOI 10.1163/156853907782418222; Willson MF, 2006, REV FISH BIOL FISHER, V16, P183, DOI 10.1007/s11160-006-9009-7; Wootton R.J., 1976, BIOL STICKLEBACKS; ZOTIN AI, 1958, J EMBRYOL EXP MORPH, V6, P546	26	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255497	10.1371/journal.pone.0255497	http://dx.doi.org/10.1371/journal.pone.0255497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339467	Green Published, gold			2022-12-26	WOS:000680243400004
J	Wendelboe, KI; Smith-Nielsen, J; Stuart, AC; Luyten, P; Vaever, MS				Wendelboe, Katrine I.; Smith-Nielsen, Johanne; Stuart, Anne C.; Luyten, Patrick; Vaever, Mette Skovgaard			Factor structure of the parental reflective functioning questionnaire and association with maternal postpartum depression and comorbid symptoms of psychopathology	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; INTERNATIONAL DIAGNOSTIC INTERVIEW; POSTNATAL DEPRESSION; INFANT ATTACHMENT; MIND-MINDEDNESS; MAJOR DEPRESSION; SOCIAL COGNITION; MOTHERS; DISTRESS; CHILD	Parental reflective functioning (PRF) refers to the parent's capacity to envision mental states in the infant and in themselves as a parent, and to link such underlying mental process with behavior, which is important for parenting sensitivity and child socio-emotional development. Current findings have linked maternal postpartum depression to impaired reflective skills, imposing a risk on the developing mother-infant relationship, but findings are mixed, and studies have generally used extensive methods for investigating PRF. The present study examined the factor structure and measurement invariance of the Danish version of the 18-item self-report Parental Reflective Functioning Questionnaire (PRFQ) in a sample of mothers with and without diagnosed postpartum depression. Moreover, the association between PRF and maternal postpartum depression in mothers with and without comorbid symptoms of personality disorder and/or clinical levels of psychological distress was investigated. Participants included 423 mothers of infants aged 1-11 months. Confirmatory factor analysis supported a three-factor structure of the PRFQ; however, item loadings suggested that a 15-item version was a more accurate measure of PRF in mothers of infants. Multi-group factor analysis of the 15-item PRFQ infant version indicated measurement invariance among mothers with and without diagnosed postpartum depression. Multinomial logistic regression showed that impaired PRF was associated with maternal psychopathology, although only for mothers with postpartum depression combined with other symptoms of psychopathology. These results provide new evidence for the assessment of maternal self-reported reflective skills as measured by a modified infant version of the PRFQ, as well as a more nuanced understanding of how variance in symptomatology is associated with impaired PRF in mothers in the postpartum period in differing ways.	[Wendelboe, Katrine I.; Smith-Nielsen, Johanne; Stuart, Anne C.; Vaever, Mette Skovgaard] Univ Copenhagen, Dept Psychol, Ctr Early Intervent & Family Studies, Copenhagen, Denmark; [Luyten, Patrick] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Luyten, Patrick] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Luyten, Patrick] Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT USA	University of Copenhagen; KU Leuven; University of London; University College London; Yale University	Wendelboe, KI (corresponding author), Univ Copenhagen, Dept Psychol, Ctr Early Intervent & Family Studies, Copenhagen, Denmark.	katrine.isabella.wendelboe@psy.ku.dk		Smith-Nielsen, Johanne/0000-0003-3571-6335; Stuart, Anne Christine/0000-0003-3829-9995; vaever, mette skovgaard/0000-0002-9675-3423; Wendelboe, Katrine/0000-0002-8079-1775				Aber J.L., 1985, PARENT DEV INTERVIEW; Akman C, 2007, COMPR PSYCHIAT, V48, P343, DOI 10.1016/j.comppsych.2007.03.005; Anis L, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.574719; Antonsen BT, 2016, COMPR PSYCHIAT, V64, P46, DOI 10.1016/j.comppsych.2015.05.016; Apter G, 2012, J PERS DISORD, V26, P357, DOI 10.1521/pedi.2012.26.3.357; Austin M-P, 2004, Arch Womens Ment Health, V7, P1, DOI 10.1007/s00737-003-0034-4; Barnes J, 2019, INFANT MENT HEALTH J, V40, P817, DOI 10.1002/imhj.21812; Bateman A., 2012, HDB MENTALIZING MENT, VSecond ed.; Beaujean AA, 2012, ASSESSMENT, V19, P462, DOI 10.1177/1073191111399037; Beck A.T., 1979, COGNITIVE THERAPY EM; Beeney JE, 2015, PERSONAL DISORD, V6, P207, DOI 10.1037/per0000110; Bernard K, 2018, ATTACH HUM DEV, V20, P578, DOI 10.1080/14616734.2018.1430839; Bigelow AE, 2018, INFANT BEHAV DEV, V51, P33, DOI 10.1016/j.infbeh.2018.02.006; Borelli JL, 2017, DEV PSYCHOL, V53, P1680, DOI 10.1037/dev0000371; Borelli JL, 2016, AM J ORTHOPSYCHIAT, V86, P24, DOI 10.1037/ort0000141; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Buttitta KV, 2019, ATTACH HUM DEV, V21, P445, DOI 10.1080/14616734.2019.1582596; Camoirano A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00014; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Chiesa M, 2014, PERSONAL MENT HEALTH, V8, P52, DOI 10.1002/pmh.1245; Cordes K, 2017, PSYCHOANAL PSYCHOL, V34, P414, DOI 10.1037/pap0000135; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; De Roo M, 2019, JMIR PEDIATR PARENT, V2, DOI 10.2196/11561; Derogatis L.R., 1992, SCL 90 R ADM SCORING, P1; Derogatis LR., 1983, MANUAL 2 R EVISED VE; Dutton DG, 2011, J CHILD CUSTODY, V8, P268, DOI 10.1080/15379418.2011.620928; Ekeblad A, 2016, J CONSULT CLIN PSYCH, V84, P67, DOI 10.1037/ccp0000055; Elliot RL, 2014, INFANT MENT HEALTH J, V35, P21, DOI 10.1002/imhj.21426; Emmanuel E, 2010, J ADV NURS, V66, P2104, DOI 10.1111/j.1365-2648.2010.05371.x; Ensink K, 2017, PSYCHIAT RES, V257, P361, DOI 10.1016/j.psychres.2017.07.051; Ensink K, 2015, BRIT J DEV PSYCHOL, V33, P203, DOI 10.1111/bjdp.12074; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; First M.B., 2015, J TRAUMA STRESS; Fischer-Kern M, 2013, J NERV MENT DIS, V201, P202, DOI 10.1097/NMD.0b013e3182845c0a; Fonagy P., 1998, REFLECTIVE FUNCTIONI; Fonagy P., 2007, J MENT HEALTH, V16, P83, DOI DOI 10.1080/09638230601182045; Garset-Zamani S, 2020, INFANT BEHAV DEV, V61, DOI 10.1016/j.infbeh.2020.101486; GOTLIB IH, 1995, J CONSULT CLIN PSYCH, V63, P90, DOI 10.1037/0022-006X.63.1.90; Grienenberger J, 2005, ATTACH HUM DEV, V7, P299, DOI 10.1080/14616730500245963; Hayden MC, 2018, J CLIN PSYCHOL, V74, P2276, DOI 10.1002/jclp.22673; Hesse M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-10; Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P268, DOI 10.4088/JCP.v61n0405; Katznelson H, 2014, CLIN PSYCHOL REV, V34, P107, DOI 10.1016/j.cpr.2013.12.003; Kennedy N, 2007, BIPOLAR DISORD, V9, P25, DOI 10.1111/j.1399-5618.2007.00326.x; Kettunen P, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0402-2; Kingston D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126929; Kingston D, 2012, CHILD PSYCHIAT HUM D, V43, P683, DOI 10.1007/s10578-012-0291-4; Kline P., 1999, HDB PSYCHOL TESTING, V2nd ed.; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Krink S, 2018, J CHILD FAM STUD, V27, P1671, DOI 10.1007/s10826-017-1000-5; Kyriazos T., 2018, PSYCHOLOGY, V9, DOI [10.4236/psych.2018.98126, DOI 10.4236/PSYCH.2018.98126]; Ladegaard N, 2014, PSYCHIAT RES, V216, P37, DOI 10.1016/j.psychres.2013.12.010; Lampe L, 2018, PSYCHOL RES BEHAV MA, V11, P55, DOI 10.2147/PRBM.S121073; Laulik S, 2013, AGGRESS VIOLENT BEH, V18, P644, DOI 10.1016/j.avb.2013.07.017; Leon MJ, 2020, INFANT MENT HEALTH J, V41, P431, DOI 10.1002/imhj.21844; Lundy BL, 2003, INFANT BEHAV DEV, V26, P200, DOI 10.1016/S0163-6383(03)00017-1; Luyten P., 2009, PARENTAL REFLECTIVE; Luyten P., 2019, HDB MENTALIZING MENT, V2 ed.; Luyten P, 2020, ANNU REV CLIN PSYCHO, V16, P297, DOI 10.1146/annurev-clinpsy-071919-015355; Luyten P, 2018, CLIN PSYCHOL REV, V64, P87, DOI 10.1016/j.cpr.2017.09.008; Luyten P, 2017, PSYCHOANAL STUD CHIL, V70, P174, DOI 10.1080/00797308.2016.1277901; Luyten P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176218; Macfie J, 2017, J PERS DISORD, V31, P721, DOI 10.1521/pedi_2017_31_275; Marcoux AA, 2017, PERSONAL MENT HEALTH, V11, P14, DOI 10.1002/pmh.1362; Matthey S, 2019, J AFFECT DISORDERS, V256, P156, DOI 10.1016/j.jad.2019.05.037; Mazzeschi C, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00263; Meins E, 2012, INFANCY, V17, P393, DOI 10.1111/j.1532-7078.2011.00087.x; Meins E, 2011, INFANCY, V16, P137, DOI 10.1111/j.1532-7078.2010.00039.x; Miller RL, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-12; Moran P, 2003, BRIT J PSYCHIAT, V183, P228, DOI 10.1192/bjp.183.3.228; Morsbach SK, 2006, CLIN CHILD FAM PSYCH, V9, P1, DOI 10.1007/s10567-006-0001-5; Mousawi W., 2020, J APPL PSYCHOL RES, V11; Murray L, 1997, PSYCHOL MED, V27, P253, DOI 10.1017/S0033291796004564; Murray L, 2015, IDENTIFYING PERINATAL DEPRESSION AND ANXIETY: EVIDENCE-BASED PRACTICE IN SCREENING, PSYCHOSOCIAL ASSESSMENT, AND MANAGEMENT, P139; Murri MB, 2017, CHILD ADOL MENT H-UK, V22, P69, DOI 10.1111/camh.12195; Nijssens L, 2018, J CHILD FAM STUD, V27, P2025, DOI 10.1007/s10826-018-1029-0; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; O'Hara MW, 2009, J CLIN PSYCHOL, V65, P1258, DOI 10.1002/jclp.20644; Olsen LR, 2004, ACTA PSYCHIAT SCAND, V110, P225, DOI 10.1111/j.1600-0447.2004.00399.x; Olsen LR, 2006, ACTA PSYCHIAT SCAND, V113, P477, DOI 10.1111/j.1600-0447.2005.00743.x; Pajulo M, 2012, INFANT MENT HEALTH J, V33, P70, DOI 10.1002/imhj.20342; Parsons CE, 2012, BRIT MED BULL, V101, P57, DOI 10.1093/bmb/ldr047; Pazzagli C, 2018, J CHILD FAM STUD, V27, P80, DOI 10.1007/s10826-017-0856-8; Putnick DL, 2016, DEV REV, V41, P71, DOI 10.1016/j.dr.2016.06.004; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rosenblum KL, 2008, INFANT MENT HEALTH J, V29, P362, DOI 10.1002/imhj.20184; Rostad WL, 2016, J CHILD FAM STUD, V25, P2164, DOI 10.1007/s10826-016-0388-7; Rutherford HJV, 2018, J CHILD FAM STUD, V27, P944, DOI 10.1007/s10826-017-0928-9; Rutherford HJV, 2015, INFANT BEHAV DEV, V40, P54, DOI 10.1016/j.infbeh.2015.04.005; Rutherford HJV, 2013, INFANT BEHAV DEV, V36, P635, DOI 10.1016/j.infbeh.2013.06.008; Salo SJ, 2021, J CHILD FAM STUD, V30, P1214, DOI 10.1007/s10826-021-01934-2; Cristobal PS, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00449; Sandanger I, 1999, SOC PSYCH PSYCH EPID, V34, P53, DOI 10.1007/s001270050112; Schacht R, 2017, DEV PSYCHOPATHOL, V29, P555, DOI 10.1017/S0954579417000177; Schultheis AM, 2019, J CHILD FAM STUD, V28, P1094, DOI 10.1007/s10826-018-01326-z; Senehi N, 2018, EARLY CHILD RES Q, V44, P1, DOI 10.1016/j.ecresq.2018.02.001; Sharp C, 2008, SOC DEV, V17, P737, DOI 10.1111/j.1467-9507.2007.00457.x; Shek D.T., 2014, INT J DISABIL HUM DE, V13, P157, DOI DOI 10.1515/IJDHD-2014-0302; SHIFFLER RE, 1988, AM STAT, V42, P79, DOI 10.2307/2685269; Shorey S, 2018, J PSYCHIATR RES, V104, P235, DOI 10.1016/j.jpsychires.2018.08.001; Slade A, 2005, ATTACH HUM DEV, V7, P269, DOI 10.1080/14616730500245906; Sliwerski A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082675; Smaling HJA, 2016, INFANT BEHAV DEV, V44, P263, DOI 10.1016/j.infbeh.2016.06.007; Smith-Nielsen J, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1965-7; Smith-Nielsen J, 2016, INFANT BEHAV DEV, V44, P148, DOI 10.1016/j.infbeh.2016.06.002; Stacks AM, 2014, ATTACH HUM DEV, V16, P515, DOI 10.1080/14616734.2014.935452; Van Praag HM., 2004, STRESS BRAIN DEPRESS; Vaver Mette Skovgaard, 2016, BMC Psychol, V4, P57; Vliegen N, 2014, HARVARD REV PSYCHIAT, V22, P1, DOI 10.1097/HRP.0000000000000013; Weinberg MK, 2001, AM J ORTHOPSYCHIAT, V71, P87, DOI 10.1037/0002-9432.71.1.87; Yatziv T, 2018, INFANCY, V23, P591, DOI 10.1111/infa.12233; Zeanah C., 1995, WORKING MODEL CHILD; Zettl M, 2020, PERSONAL DISORD, V11, P191, DOI 10.1037/per0000356	115	2	2	7	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0254792	10.1371/journal.pone.0254792	http://dx.doi.org/10.1371/journal.pone.0254792			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TT3IC	34339422	Green Published, gold			2022-12-26	WOS:000680243400018
J	Wu, YJ; Xu, KL; Wang, RJ; Xu, XH				Wu, Yaju; Xu, Kaili; Wang, Ruojun; Xu, Xiaohu			Human reliability analysis of high-temperature molten metal operation based on fuzzy CREAM and Bayesian network	PLOS ONE			English	Article							QUANTIFICATION; MODEL	Human errors are considered to be the main causation factors of high-temperature molten metal accidents in metallurgical enterprises. The complex working environment of high- temperature molten metal in metallurgical enterprises has an important influence on the reliability of human behavior. A review of current human reliability techniques confirms that there is a lack of quantitative analysis of human errors in high-temperature molten metal operating environments. In this paper, a model was proposed to support the human reliability analysis of high-temperature molten metal operation in the metallurgy industry based on cognitive reliability and error analysis method (CREAM), fuzzy logic theory, and Bayesian network (BN). The comprehensive rules of common performance conditions in conventional CREAM approach were provided to evaluate various conditions for high-temperature molten metal operation in the metallurgy industry. This study adopted fuzzy CREAM to consider the uncertainties and used the BN to determine the control mode and calculate human error probability (HEP). The HEP for workers involved in high-temperature melting in steelmaking production process was calculated in a case with 13 operators being engaged in different high-temperature molten metal operations. The human error probability of two operators with different control modes was compared with the calculation result of basic CREAM, and the result showed that the method proposed in this paper is validated. This paper quantified point values of human error probability in high-temperature molten metal operation for the first time, which can be used as input in the risk evaluation of metallurgical industry.	[Wu, Yaju; Xu, Kaili; Wang, Ruojun; Xu, Xiaohu] Northeastern Univ, Sch Resources & Civil Engn, Shenyang, Peoples R China; [Wu, Yaju] Shenyang Aerosp Univ, Sch Safety Engn, Shenyang, Peoples R China; [Wu, Yaju; Xu, Kaili; Wang, Ruojun; Xu, Xiaohu] 3-11 Wenhua Rd, Shenyang, Peoples R China; [Wu, Yaju] 37 Daoyi St, Shenyang, Peoples R China	Northeastern University - China; Shenyang Aerospace University	Wu, YJ; Xu, KL (corresponding author), Northeastern Univ, Sch Resources & Civil Engn, Shenyang, Peoples R China.; Wu, YJ (corresponding author), Shenyang Aerosp Univ, Sch Safety Engn, Shenyang, Peoples R China.; Wu, YJ; Xu, KL (corresponding author), 3-11 Wenhua Rd, Shenyang, Peoples R China.; Wu, YJ (corresponding author), 37 Daoyi St, Shenyang, Peoples R China.	wuyaju1016@163.com; xukaili@mail.neu.edu.cn			National Key Research and Development Program of China [2017YFC0805100]	National Key Research and Development Program of China	This paper is funded by The National Key Research and Development Program of China (Grant No.2017YFC0805100).	Alizadeh R, 2014, 13 INT C CLEAN ENERG, P399; Alizadeh R, 2020, ENERG ECON, V91, DOI 10.1016/j.eneco.2020.104894; Alizadeh R, 2020, RENEW SUST ENERG REV, V134, DOI 10.1016/j.rser.2020.110326; Alizadeh R, 2020, RES ENG DES, V31, P275, DOI 10.1007/s00163-020-00336-7; Alizadeh R, 2020, ENERG POLICY, V137, DOI 10.1016/j.enpol.2019.111174; Baziuk PA, 2016, ADV FUZZY SYST, V2016, DOI 10.1155/2016/4612086; Bin L., 2012, CHINA J SAFETY SCI T, V8, P46; [柴松 Chai Song], 2012, [天津大学学报, Journal of Tianjin University], V45, P958; Chen DK, 2019, QUAL RELIAB ENG INT, V35, P2261, DOI 10.1002/qre.2501; Chen XQ, 2021, QUAL RELIAB ENG INT, V37, P284, DOI 10.1002/qre.2736; Ge J, 2019, SAFETY SCI, V118, P119, DOI 10.1016/j.ssci.2019.05.006; Golestani N, 2020, PROCESS SAF ENVIRON, V140, P1, DOI 10.1016/j.psep.2020.04.026; He XH, 2008, RELIAB ENG SYST SAFE, V93, P298, DOI 10.1016/j.ress.2006.10.026; Hollnagel E, 1998, COGNITIVE RELIABILIT; Hou Q., 2017, CHINA IND SAFETY ENV, V43, P63; Kim MC, 2006, RELIAB ENG SYST SAFE, V91, P191, DOI 10.1016/j.ress.2004.12.003; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Ribeiro AC, 2016, SAFETY SCI, V87, P269, DOI 10.1016/j.ssci.2016.04.009; Roychowdhury S, 2001, INT J INTELL SYST, V16, P679, DOI 10.1002/int.1030; Soltanisehat L, 2020, IEEE T ENG MANAG EAR, DOI [10.1109/TEM.2020.3013507, DOI 10.1109/TEM.2020.3013507]; [孙志强 SUN Zhiqiang], 2007, [中国安全科学学报, China Safety Science Journal], V17, P21; Trucco P, 2008, RELIAB ENG SYST SAFE, V93, P845, DOI 10.1016/j.ress.2007.03.035; Ung ST, 2015, SAFETY SCI, V72, P144, DOI 10.1016/j.ssci.2014.08.012; Wang Y., 2015, CHINA IND ENG MANAGE, V3, P17; Wu B, 2017, RISK ANAL, V37, P1936, DOI 10.1111/risa.12757; Yan F, 2019, SAFETY SCI, V120, P312, DOI 10.1016/j.ssci.2019.07.018; Yan F, 2018, J LOSS PREVENT PROC, V55, P313, DOI 10.1016/j.jlp.2018.07.007; Yang ZL, 2013, OCEAN ENG, V58, P293, DOI 10.1016/j.oceaneng.2012.11.003; Yuan H, CHINA MODERN OCCUPAT, V2017, P45; Zhang RY, 2018, SAFETY SCI, V101, P86, DOI 10.1016/j.ssci.2017.08.010; Zhao YQ, 2020, SAFETY SCI, V131, DOI 10.1016/j.ssci.2020.104934; Zhou QJ, 2018, SAFETY SCI, V105, P149, DOI 10.1016/j.ssci.2018.02.011; Zhou QJ, 2017, SAFETY SCI, V95, P140, DOI 10.1016/j.ssci.2017.02.014	33	3	3	8	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0254861	10.1371/journal.pone.0254861	http://dx.doi.org/10.1371/journal.pone.0254861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TT3IC	34339427	Green Published, gold			2022-12-26	WOS:000680243400036
J	Ovrebo, B; Bergh, IH; Stea, TH; Bere, E; Suren, P; Magnus, PM; Juliusson, PB; Wills, AK				Ovrebo, Bente; Bergh, Ingunn H.; Stea, Tonje H.; Bere, Elling; Suren, Pal; Magnus, Per M.; Juliusson, Petur B.; Wills, Andrew K.			Overweight, obesity, and thinness among a nationally representative sample of Norwegian adolescents and changes from childhood: Associations with sex, region, and population density	PLOS ONE			English	Article							CHILDREN; PREVALENCE; TRENDS; BODY	Objective To estimate the prevalence of overweight, obesity, and thinness among Norwegian 13-year-olds and the changes from childhood (age 8 years) to adolescence (age 13 years); and to explore associations with sex, region, and population density from childhood to adolescence. Design We used longitudinal, anthropometric data collected by school health nurses conducted in Norway. Weight status was classified according to the International Obesity Task Force cut-offs for overweight, obesity, and thinness, and according to mean body mass index (kg/m(2)). Participants The Norwegian Youth Growth Study, consisting of a nationally representative sample of Norwegian 13-year-olds (n = 1852; 50.7% girls), which is a part of The Norwegian Growth Cohort. Results Among 13-year-old Norwegians, the prevalence of overweight (including obesity), obesity, and thinness was 15.8%, 2.5%, and 7.3%, respectively. There was little evidence that these had changed from 8 to 13 years. From 8 to 13 years, the odds of obesity was highest in the Northern region of Norway compared to the South-East (odds ratio (OR): 3.78 (95% confidence interval (CI): 1.13, 12.65; p = 0.036) and in rural areas (OR: 4.76 (95% CI: 1.52, 14.90; p = 0.027). Over the same age period, girls had a trend towards a higher odds of thinness compared to boys (OR: 1.65 (95% CI: 0.98, 2.78; p = 0.057). Conclusions In Norway, the prevalence of overweight, obesity, and thinness among 13-year-olds seem to be established by age 8 years. The prevalence of obesity was higher in the North and in rural areas. The results indicate the continued need for early prevention and treatment, and targeted interventions to certain areas.	[Ovrebo, Bente; Bere, Elling] Univ Agder, Dept Sport Sci & Phys Educ, Kristiansand, Norway; [Ovrebo, Bente; Bergh, Ingunn H.; Bere, Elling] Norwegian Inst Publ Hlth, Dept Hlth & Inequal, Oslo, Norway; [Ovrebo, Bente; Bere, Elling] Ctr Evaluat Publ Hlth Measures, Norwegian Inst Publ Hlth, Oslo, Norway; [Stea, Tonje H.] Univ Agder, Dept Hlth & Nursing Sci, Kristiansand, Norway; [Suren, Pal] Norwegian Inst Publ Hlth, Dept Child Hlth & Dev, Oslo, Norway; [Magnus, Per M.] Norwegian Inst Publ Hlth, Ctr Fertil & Hlth, Oslo, Norway; [Juliusson, Petur B.] Norwegian Inst Publ Hlth, Dept Hlth Registry Res & Dev, Bergen, Norway; [Wills, Andrew K.] Univ Bristol, Bristol, Avon, England	University of Agder; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); University of Agder; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); University of Bristol	Ovrebo, B (corresponding author), Univ Agder, Dept Sport Sci & Phys Educ, Kristiansand, Norway.; Ovrebo, B (corresponding author), Norwegian Inst Publ Hlth, Dept Hlth & Inequal, Oslo, Norway.; Ovrebo, B (corresponding author), Ctr Evaluat Publ Hlth Measures, Norwegian Inst Publ Hlth, Oslo, Norway.	bente.ovrebo@uia.no		, Bente/0000-0002-2928-4575; Wills, Andrew/0000-0002-9751-4707	Norwegian Research Council [260408/H10]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Norwegian Research Council (grant number 260408/H10). The Norwegian Research Council had no role in the design, analysis or writing of this article.	Andersen LF, 2005, SCAND J PUBLIC HEALT, V33, P99, DOI 10.1080/140349404100410019172; Ask H, 2020, EUR CHILD ADOLES PSY, V29, P1063, DOI 10.1007/s00787-019-01419-0; Biehl A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-842; Borresen R, 2003, Eat Weight Disord, V8, P238; Brug J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034742; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Donkor HM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014548; Eriksson M, 2018, ACTA PAEDIATR, V107, P1818, DOI 10.1111/apa.14356; Evensen E, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0599-5; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Garrido-Miguel M, 2020, EUR J PUBLIC HEALTH, V30, P1019, DOI 10.1093/eurpub/ckaa092; Garrido-Miguel M, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2019.2430; Groholt EK, 2008, J PUBLIC HEALTH-UK, V30, P258, DOI 10.1093/pubmed/fdn037; Helsedirektoratet, 2017, HELS SKOL; Hemmingsson E, 2021, SCAND J PUBLIC HEALT, V49, P377, DOI 10.1177/1403494820914802; Heyerdahl Nora, 2012, Tidsskr Nor Laegeforen, V132, P1080, DOI 10.4045/tidsskr.11.1078; Juliusson PB, 2010, ACTA PAEDIATR, V99, P900, DOI 10.1111/j.1651-2227.2010.01730.x; Lazzeri G, 2014, PUBLIC HEALTH NUTR, V17, P2207, DOI 10.1017/S1368980013002541; Meyer HE., 2011, OVERWEIGHT OBESITY N; Moraeus L, 2012, INT J OBESITY, V36, P969, DOI 10.1038/ijo.2012.79; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Reneflot A., 2018, PSYKISK HELSE NORGE; Schonbeck Y, 2015, EUR J PUBLIC HEALTH, V25, P268, DOI 10.1093/eurpub/cku130; Scrimshaw NS, 1997, AM J CLIN NUTR, V66, P464; Shah Bindra, 2020, BMJ Nutr Prev Health, V3, P387, DOI 10.1136/bmjnph-2020-000074; Tatangelo G, 2016, BODY IMAGE, V18, P86, DOI 10.1016/j.bodyim.2016.06.003; Twig G, 2016, NEW ENGL J MED, V374, P2430, DOI 10.1056/NEJMoa1503840; Vanhelst J, 2020, PUBLIC HEALTH NUTR, V23, P2478, DOI 10.1017/S1368980020000476; Westmoreland P, 2016, AM J MED, V129, P30, DOI 10.1016/j.amjmed.2015.06.031; Wills AK., 2020, SCREENING DIAGNOSING, DOI [10.1101/2020.11.19.20234872, DOI 10.1101/2020.11.19.20234872]	33	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255699	10.1371/journal.pone.0255699	http://dx.doi.org/10.1371/journal.pone.0255699			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6IR	34343207	Green Published, gold			2022-12-26	WOS:000685264200013
J	Kerr, M; Dennis, KMJH; Carr, CA; Fuller, W; Berridge, G; Rohling, S; Aitken, CL; Lopez, C; Fischer, R; Miller, JJ; Clarke, K; Tyler, DJ; Heather, LC				Kerr, M.; Dennis, K. M. J. H.; Carr, C. A.; Fuller, W.; Berridge, G.; Rohling, S.; Aitken, C. L.; Lopez, C.; Fischer, R.; Miller, J. J.; Clarke, K.; Tyler, D. J.; Heather, L. C.			Diabetic mitochondria are resistant to palmitoyl CoA inhibition of respiration, which is detrimental during ischemia	FASEB JOURNAL			English	Article						diabetes; energetics; fatty acids; heart; ischemia; mitochondria	ADENINE-NUCLEOTIDE TRANSLOCASE; FATTY-ACID-METABOLISM; COENZYME-A; OXIDATIVE-PHOSPHORYLATION; KINETIC-PROPERTIES; CHAIN; CARRIER; SAFRANINE; CARNITINE; BINDING	The bioactive lipid intermediate palmitoyl CoA (PCoA) can inhibit mitochondrial ADP/ATP transport, though the physiological relevance of this regulation remains unclear. We questioned whether myocardial ischemia provides a pathological setting in which PCoA regulation of ADP/ATP transport would be beneficial, and secondly, whether the chronically elevated lipid content within the diabetic heart could make mitochondria less sensitive to the effects of PCoA. PCoA acutely decreased ADP-stimulated state 3 respiration and increased the apparent K-m for ADP twofold. The half maximal inhibitory concentration (IC50) of PCoA in control mitochondria was 22 mu M. This inhibitory effect of PCoA on respiration was blunted in diabetic mitochondria, with no significant difference in the K-m for ADP in the presence of PCoA, and an increase in the IC50 to 32 mu M PCoA. The competitive inhibition by PCoA was localised to the phosphorylation apparatus, particularly the ADP/ATP carrier (AAC). During ischemia, the AAC imports ATP into the mitochondria, where it is hydrolysed by reversal of the ATP synthase, regenerating the membrane potential. Addition of PCoA dose-dependently prevented this wasteful ATP hydrolysis for membrane repolarisation during ischemia, however, this beneficial effect was blunted in diabetic mitochondria. Finally, using P-31-magnetic resonance spectroscopy we demonstrated that diabetic hearts lose ATP more rapidly during ischemia, with a threefold higher ATP decay rate compared with control hearts. In conclusion, PCoA plays a role in protecting mitochondrial energetics during ischemia, by preventing wasteful ATP hydrolysis. However, this beneficial effect is blunted in diabetes, contributing to the impaired energy metabolism seen during myocardial ischemia in the diabetic heart.	[Kerr, M.; Dennis, K. M. J. H.; Carr, C. A.; Rohling, S.; Aitken, C. L.; Lopez, C.; Miller, J. J.; Clarke, K.; Tyler, D. J.; Heather, L. C.] Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England; [Fuller, W.] Univ Glasgow, Inst Cardiovas & Med Sci, Glasgow, Lanark, Scotland; [Berridge, G.; Fischer, R.] Univ Oxford, Target Discovery Inst, Oxford, England; [Miller, J. J.] Univ Oxford, Dept Phys, Oxford, England; [Miller, J. J.] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Tyler, D. J.] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford, England	University of Oxford; University of Glasgow; University of Oxford; University of Oxford; Aarhus University; University of Oxford	Heather, LC (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	lisa.heather@dpag.ox.ac.uk	Fischer, Roman/N-4408-2017	Fischer, Roman/0000-0002-9715-5951; Fuller, William/0000-0002-5883-4433	British Heart Foundation [FS/17/58/33072, FS/15/68/32042, FS/19/18/34252, FS/19/61/34900, FS/20/34132]; Oxford Novo Nordisk Fellowship	British Heart Foundation(British Heart Foundation); Oxford Novo Nordisk Fellowship	British Heart Foundation, Grant/Award Number: FS/17/58/33072, FS/15/68/32042, FS/19/18/34252, FS/19/61/34900 and FS/20/34132; Oxford Novo Nordisk Fellowship	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; BAYDOUN AR, 1988, BIOCHEM PHARMACOL, V37, P3103, DOI 10.1016/0006-2952(88)90307-3; Blachnio-Zabielska AU, 2012, LIPIDS, V47, P1131, DOI 10.1007/s11745-012-3722-x; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; Ciapaite J, 2005, DIABETES, V54, P944, DOI 10.2337/diabetes.54.4.944; Ciapaite J, 2006, FEBS J, V273, P5288, DOI 10.1111/j.1742-4658.2006.05523.x; Davis S, 2017, J PROTEOME RES, V16, P1288, DOI 10.1021/acs.jproteome.6b00915; DEVILLIERS M, 1986, BIOCHIM BIOPHYS ACTA, V876, P309, DOI 10.1016/0005-2760(86)90289-4; Dorner A, 2006, EUR J HEART FAIL, V8, P81, DOI 10.1016/j.ejheart.2005.05.003; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Heather LC, 2006, CARDIOVASC RES, V72, P430, DOI 10.1016/j.cardiores.2006.08.020; Heather LC, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0268-2; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Kerr M, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140326; Kerr M, 2017, CLIN SCI, V131, P2079, DOI [10.1042/cs20160671, 10.1042/CS20160671]; KHOLODENKO B, 1987, FEBS LETT, V223, P247, DOI 10.1016/0014-5793(87)80298-3; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Kunji ERS, 2020, BIOCHEM SOC T, V48, P1419, DOI 10.1042/BST20190933; Liepinsh E, 2016, BIOCHEM J, V473, P1191, DOI 10.1042/BCJ20160164; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lynn EG, 2010, J MOL CELL CARDIOL, V49, P693, DOI 10.1016/j.yjmcc.2010.06.008; Mansor LS, 2017, CARDIOVASC RES, V113, P737, DOI 10.1093/cvr/cvx045; McCoin CS, 2015, NAT REV ENDOCRINOL, V11, P617, DOI 10.1038/nrendo.2015.129; Mielke C, 2014, BIOCHEMISTRY-US, V53, P3817, DOI 10.1021/bi401651e; Minkler PE, 2008, ANAL BIOCHEM, V376, P275, DOI 10.1016/j.ab.2008.02.022; Miotto PM, 2018, DIABETES, V67, P2199, DOI 10.2337/db18-0417; MOREL F, 1974, FEBS LETT, V39, P133, DOI 10.1016/0014-5793(74)80035-9; Mukamal KJ, 2001, DIABETES CARE, V24, P1422, DOI 10.2337/diacare.24.8.1422; PANDE SV, 1971, J BIOL CHEM, V246, P402; Pinkosky SL, 2020, NAT METAB, V2, P873, DOI 10.1038/s42255-020-0245-2; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Purvis LAB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185356; ROUSLIN W, 1987, J MOL CELL CARDIOL, V19, P661, DOI 10.1016/S0022-2828(87)80374-7; ROUSLIN W, 1986, AM J PHYSIOL, V250, pH503, DOI 10.1152/ajpheart.1986.250.3.H503; Ruprecht JJ, 2019, CELL, V176, P435, DOI 10.1016/j.cell.2018.11.025; Seifert EL, 2016, J BIOL CHEM, V291, P26126, DOI 10.1074/jbc.M116.744714; Seo JB, 2019, NAT METAB, V1, P86, DOI 10.1038/s42255-018-0003-x; Sharma V, 2009, EUR J PHARMACOL, V607, P156, DOI 10.1016/j.ejphar.2009.02.016; STUBBS M, 1979, PHARMACOL THERAPEUT, V7, P329, DOI 10.1016/0163-7258(79)90035-4; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Vinnakota KC, 2004, AM J PHYSIOL-HEART C, V286, pH1742, DOI 10.1152/ajpheart.00478.2003; Wang Y, 2009, EXP PHYSIOL, V94, P220, DOI 10.1113/expphysiol.2008.044800; WHITMER JT, 1978, J BIOL CHEM, V253, P4305; WOLDEGIORGIS G, 1979, BIOCHEM BIOPH RES CO, V89, P837, DOI 10.1016/0006-291X(79)91854-0; WOLKOWICZ PE, 1980, BIOCHEM J, V186, P257, DOI 10.1042/bj1860257	49	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21765	10.1096/fj.202100394R	http://dx.doi.org/10.1096/fj.202100394R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34318967	Green Published, Green Accepted			2022-12-26	WOS:000678975300046
J	Okuda, S; Sato, M; Kato, S; Nagashima, S; Inatome, R; Yanagi, S; Fukuda, T				Okuda, Shohei; Sato, Mariko; Kato, Saho; Nagashima, Shun; Inatome, Ryoko; Yanagi, Shigeru; Fukuda, Toshifumi			Oscillation of Cdc20-APC/C-mediated CAMDI stability is critical for cortical neuron migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; CYTOPLASMIC DILATION; RADIAL MIGRATION; MYOSIN-II; KEN BOX; CENTROSOME; PHOSPHORYLATION; IDENTIFICATION; NUCLEOKINESIS; REVEALS	Radial migration during cortical development is required for formation of the six-layered structure of the mammalian cortex. Defective migration of neurons is linked to several developmental disorders such as autism and schizophrenia. A unique swollen structure called the dilation is formed in migrating neurons and is required for movement of the centrosome and nucleus. However, the detailed molecular mechanism by which this dilation forms is unclear. We report that CAMDI, a gene whose deletion is associated with psychiatric behavior, is degraded by cell division cycle protein 20 (Cdc20)-anaphase-promoting complex/cyclosome (APC/C) cell-cycle machinery after centrosome migration into the dilation in mouse brain development. We also show that CAMDI is restabilized in the dilation until the centrosome enters the dilation, at which point it is once again immediately destabilized. CAMDI degradation is carried out by binding to Cdc20-APC/C via the destruction box degron of CAMDI. CAMDI destruction box mutant overexpression inhibits dilation formation and neuronal cell migration via maintaining the stabilized state of CAMDI. These results indicate that CAMDI is a substrate of the Cdc20-APC/C system and that the oscillatory regulation of CAMDI protein correlates with dilation formation for proper cortical migration.	[Okuda, Shohei; Sato, Mariko; Kato, Saho; Nagashima, Shun; Fukuda, Toshifumi] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Mol Biochem, Hachioji, Tokyo, Japan; [Inatome, Ryoko; Yanagi, Shigeru] Gakushuin Univ, Fac Sci, Dept Life Sci, Toshima Ku, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences; Gakushuin University	Fukuda, T (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Mol Biochem, Hachioji, Tokyo, Japan.	tfukuda@toyaku.ac.jp		Fukuda, Toshifumi/0000-0003-2400-5319	Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science; Takeda Science foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology and the Japan Society for the Promotion of Science (to T. F.). T. F. was supported by Takeda Science foundation.	Akbarian S, 1996, ARCH GEN PSYCHIAT, V53, P425; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Beckmann H, 1999, EUR ARCH PSY CLIN N, V249, P44; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Fukuda T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224967; Fukuda T, 2017, CELL MOL LIFE SCI, V74, P3533, DOI 10.1007/s00018-017-2539-4; Fukuda T, 2016, EMBO REP, V17, P1785, DOI 10.15252/embr.201642416; Fukuda T, 2010, J BIOL CHEM, V285, P40554, DOI 10.1074/jbc.M110.179481; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Huang J, 2016, GENE DEV, V30, P622, DOI 10.1101/gad.274324.115; Hutchins BI, 2016, ENDOCRINOLOGY, V157, P1956, DOI 10.1210/en.2015-1846; Hutsler JJ, 2007, BIOL PSYCHIAT, V61, P449, DOI 10.1016/j.biopsych.2006.01.015; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lian GW, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00099; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nishimura YV, 2014, DEVELOPMENT, V141, P3540, DOI 10.1242/dev.111294; Pfleger CM, 2000, GENE DEV, V14, P655; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Shinohara R, 2012, NAT NEUROSCI, V15, P373, DOI 10.1038/nn.3020; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Trivedi N, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms14484; Trivedi N, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-26; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; van de Weerdt BCM, 2005, MOL CELL BIOL, V25, P2031, DOI 10.1128/MCB.25.5.2031-2044.2005; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Yang T, 2012, CELL REP, V2, P640, DOI 10.1016/j.celrep.2012.08.007; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201	38	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100986	10.1016/j.jbc.2021.100986	http://dx.doi.org/10.1016/j.jbc.2021.100986			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34298015	gold, Green Published			2022-12-26	WOS:000690868100003
J	Stelmach, RD; Rabkin, M; Abo, K; Ahoba, I; Anago, MG; Boccanera, R; Brou, H; Flueckiger, R; Hartsough, K; Msukwa, M; Zech, J; Young, F; Nugent, R				Stelmach, Rachel D.; Rabkin, Miriam; Abo, Kouame; Ahoba, Irma; Gildas Anago, Mahena; Boccanera, Rodrigo; Brou, Hermann; Flueckiger, Rebecca; Hartsough, Kieran; Msukwa, Martin; Zech, Jennifer; Young, Felicity; Nugent, Rachel			Financial burdens of HIV and chronic disease on people living with HIV in Cote d'Ivoire: A cross-sectional out-of-pocket expenditure study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ADHERENCE	Background Although people living with HIV in Cote d'Ivoire receive antiretroviral therapy (ART) at no cost, other out-of-pocket (OOP) spending related to health can still create a barrier to care. Methods A convenience sample of 400 adults living with HIV for at least 1 year in Cote d'Ivoire completed a survey on their health spending for HIV and chronic non-communicable diseases (NCDs). In addition to descriptive statistics, we performed simple linear regression analyses with bootstrapped 95% confidence intervals. Findings 365 participants (91%) reported OOP spending for HIV care, with a median of $16/year (IQR 5-48). 34% of participants reported direct costs with a median of $2/year (IQR 1-41). No participants reported user fees for HIV services. 87% of participants reported indirect costs, with a median of $17/year (IQR 7-41). 102 participants (26%) reported at least 1 NCD. Of these, 80 (78%) reported OOP spending for NCD care, with a median of $50/year (IQR 6-107). 76 participants (95%) with both HIV and NCDs reported direct costs, and 48% reported paying user fees for NCD services. Participants had missed a median of 2 HIV appointments in the past year (IQR 2-3). Higher OOP costs were not associated with the number of HIV appointments missed. 21% of participants reported spending over 10% of household income on HIV and/or NCD care. Discussion and conclusions Despite the availability of free ART, most participants reported OOP spending. OOP costs were much higher for participants with co-morbid NCDs.	[Stelmach, Rachel D.] RTI Int, Washington, DC 20005 USA; [Rabkin, Miriam; Gildas Anago, Mahena; Brou, Hermann; Hartsough, Kieran; Msukwa, Martin; Zech, Jennifer] Columbia Univ, ICAP, New York, NY USA; [Abo, Kouame; Ahoba, Irma] Programme Natl Lutte SIDA PNLS, Abidjan, Cote Ivoire; [Boccanera, Rodrigo] Hlth Resources & Serv Adm, Rockville, MD USA; [Flueckiger, Rebecca] RTI Int, Atlanta, GA USA; [Young, Felicity] RTI Int, Brisbane, Qld, Australia; [Nugent, Rachel] RTI Int, Seattle, WA USA	Research Triangle Institute; Columbia University; United States Health Resources & Service Administration (HRSA); Research Triangle Institute; Research Triangle Institute	Stelmach, RD (corresponding author), RTI Int, Washington, DC 20005 USA.	rstelmach@rti.org	Msukwa, Martin/GXF-8370-2022	Stelmach, Rachel/0000-0002-4903-4995; Flueckiger, Rebecca/0000-0003-4294-2816; Nugent, Rachel/0000-0001-6421-9077	U.S. President's Emergency Plan for AIDS Relief, through the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) [UJ7HA31180]	U.S. President's Emergency Plan for AIDS Relief, through the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS)	This project is supported by the U.S. President's Emergency Plan for AIDS Relief, through the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant UJ7HA31180, Optimizing Momentum toward Sustainable Epidemic Control. This information or content and conclusions should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauliere A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011213; Bisson IA, 2015, ECOHEALTH, V12, P98, DOI 10.1007/s10393-014-0988-x; Blakely T, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002716; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Coetzee L, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25364; Efron B., 2018, AUTOMATIC CONSTRUCTI; Etiaba E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167117; Euloge KK, 2019, EUR HEART J SUPPL, V21, pD47, DOI 10.1093/eurheartj/suz086; Gogolishvili D., 2019, RAPID RESPONSE SERVI; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Harris TG, 2018, AIDS, V32, P1563, DOI 10.1097/QAD.0000000000001870; Hyle EP, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4940-1; Institute for Health Metrics and Evaluation, 2019, COT IV; International Diabetes Federation, 2019, COT IV DIAB REP 2010, V9th; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Jan S, 2018, LANCET, V391, P2047, DOI 10.1016/S0140-6736(18)30323-4; Lee JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127199; Medecins Sans Frontieres, 2016, OUT FOC MILL PEOPL W; Mnzava Thomas, 2018, J Int Assoc Provid AIDS Care, V17, p2325958218774775, DOI 10.1177/2325958218774775; Msukwa M., 2020, AIDS 2020; Ndukwe CD, 2018, INT J HLTH ALLIED SC, V7, P1, DOI 10.4103/ijhas.IJHAS_3_17; Patel P, 2018, AIDS, V32, pS5, DOI 10.1097/QAD.0000000000001888; Rabkin M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140298; Smit M, 2018, AIDS, V32, P773, DOI [10.1097/QAD.0000000000001754, 10.1097/qad.0000000000001754]; UNAIDS, 2017, W CTR AFR CATCH PLAN; UNAIDS, 2019, COT IV SIGN REN TAC; UNAIDS,, 2017, COT IV OFF ANT TREAT; UNAIDS, 2014, UND FAST TRACK ACC A; UNAIDS, 2019, OUT OF POCK EXP HAMP; UNAIDS, 2018, COUNTR FACTSH COT IV; World Health Organization, MON SUST DEV GOALS I; World Health Organization, 2018, COT IV WORLD HLTH OR; XE.com, 2019, XOF USD CHART; Yao HK, 2018, SAUDI J KIDNEY DIS T, V29, P153, DOI 10.4103/1319-2442.225201	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255074	10.1371/journal.pone.0255074	http://dx.doi.org/10.1371/journal.pone.0255074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324545	Green Published, gold			2022-12-26	WOS:000685248200031
J	Wu, CM; Ma, X; Kong, XX; Zhu, HC				Wu, Chunming; Ma, Xin; Kong, Xiangxu; Zhu, Haichao			Research on insulator defect detection algorithm of transmission line based on CenterNet	PLOS ONE			English	Article								The reliability of the insulator has directly affected the stable operation of electric power system. The detection of defective insulators has always been an important issue in smart grid systems. However, the traditional transmission line detection method has low accuracy and poor real-time performance. We present an insulator defect detection method based on CenterNet. In order to improve detection efficiency, we simplified the backbone network. In addition, an attention mechanism is utilized to suppress useless information and improve the accuracy of network detection. In image preprocessing, the blurring of some detected images results in the samples being discarded, so we use super-resolution reconstruction algorithm to reconstruct the blurred images to enhance the dataset. The results show that the AP of the proposed method reaches 96.16% and the reasoning speed reaches 30FPS under the test condition of NVIDIA GTX 1080 test conditions. Compared with Faster R-CNN, YOLOV3, RetinaNet and FSAF, the detection accuracy of proposed method is greatly improved, which fully proves the effectiveness of the proposed method.	[Wu, Chunming] Northeast Elect Power Univ, Key Lab Modern Power Syst Simulat & Control & Ren, Minist Educ, Jilin, Jilin, Peoples R China; [Wu, Chunming; Ma, Xin; Kong, Xiangxu; Zhu, Haichao] Northeast Elect Power Univ, Dept Elect Engn, Jilin, Jilin, Peoples R China	Northeast Electric Power University; Northeast Electric Power University	Ma, X (corresponding author), Northeast Elect Power Univ, Dept Elect Engn, Jilin, Jilin, Peoples R China.	2457937904@qq.com						Ali Farhadi, 2018, Arxiv, DOI arXiv:1804.02767; Dai J, 2016, PROCEEDINGS 2016 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P1796, DOI 10.1109/ICIT.2016.7475036; Dong C, 2016, LECT NOTES COMPUT SC, V9906, P391, DOI 10.1007/978-3-319-46475-6_25; Dong C, 2016, IEEE T PATTERN ANAL, V38, P295, DOI 10.1109/TPAMI.2015.2439281; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; Girshick R, 2014, PROC CVPR IEEE, P580, DOI 10.1109/CVPR.2014.81; Hao X, 2016, INT J SEMANT COMPUT, V10, P417, DOI 10.1142/S1793351X16500045; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Kingma D. P., 2015, 3 INT C LEARN REPR, P1, DOI DOI 10.48550/ARXIV.1412.6980; Kong T, 2020, IEEE T IMAGE PROCESS, V29, P7389, DOI 10.1109/TIP.2020.3002345; Law H, 2020, INT J COMPUT VISION, V128, P642, DOI 10.1007/s11263-019-01204-1; Lin Tsung-Yi, 2020, IEEE Trans Pattern Anal Mach Intell, V42, P318, DOI 10.1109/TPAMI.2018.2858826; Martinez C, 2014, INT CONF UNMAN AIRCR, P284, DOI 10.1109/ICUAS.2014.6842267; Redmon J, 2017, PROC CVPR IEEE, P6517, DOI 10.1109/CVPR.2017.690; Redmon J, 2016, PROC CVPR IEEE, P779, DOI 10.1109/CVPR.2016.91; Ren SQ, 2017, IEEE T PATTERN ANAL, V39, P1137, DOI 10.1109/TPAMI.2016.2577031; Sajjadi M S M., 2018, 32 C NEUR INF P SYST, P31; Tian Z, 2019, IEEE I CONF COMP VIS, P9626, DOI 10.1109/ICCV.2019.00972; Nguyen VN, 2018, INT J ELEC POWER, V99, P107, DOI 10.1016/j.ijepes.2017.12.016; Wei Liu, 2016, Computer Vision - ECCV 2016. 14th European Conference. Proceedings: LNCS 9905, P21, DOI 10.1007/978-3-319-46448-0_2; Woo SH, 2018, LECT NOTES COMPUT SC, V11211, P3, DOI 10.1007/978-3-030-01234-2_1; Xing WW, 2017, AUTOM CONTROL COMPUT, V51, P180, DOI 10.3103/S0146411617030099; Yao JD, 2017, AUTOM CONTROL COMPUT, V51, P442, DOI 10.3103/S0146411617060104; Zhu R, 2019, PROC CVPR IEEE, P2263, DOI 10.1109/CVPR.2019.00237	26	4	4	9	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255135	10.1371/journal.pone.0255135	http://dx.doi.org/10.1371/journal.pone.0255135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324568	gold, Green Published			2022-12-26	WOS:000685248200003
J	Mera-Gaona, M; Neumann, U; Vargas-Canas, R; Lopez, DM				Mera-Gaona, Maritza; Neumann, Ursula; Vargas-Canas, Rubiel; Lopez, Diego M.			Evaluating the impact of multivariate imputation by MICE in feature selection	PLOS ONE			English	Article							MULTIPLE IMPUTATION; MISSING DATA; CHAINED EQUATIONS; VALUES; ERROR	Handling missing values is a crucial step in preprocessing data in Machine Learning. Most available algorithms for analyzing datasets in the feature selection process and classification or estimation process analyze complete datasets. Consequently, in many cases, the strategy for dealing with missing values is to use only instances with full data or to replace missing values with a mean, mode, median, or a constant value. Usually, discarding missing samples or replacing missing values by means of fundamental techniques causes bias in subsequent analyzes on datasets. Aim: Demonstrate the positive impact of multivariate imputation in the feature selection process on datasets with missing values. Results: We compared the effects of the feature selection process using complete datasets, incomplete datasets with missingness rates between 5 and 50%, and imputed datasets by basic techniques and multivariate imputation. The feature selection algorithms used are well-known methods. The results showed that the datasets imputed by multivariate imputation obtained the best results in feature selection compared to datasets imputed by basic techniques or non-imputed incomplete datasets. Conclusions: Considering the results obtained in the evaluation, applying multivariate imputation by MICE reduces bias in the feature selection process.	[Mera-Gaona, Maritza; Vargas-Canas, Rubiel; Lopez, Diego M.] Univ Cauca, Popayan, Cauca, Colombia; [Neumann, Ursula] Fraunhofer Ctr Appl Res Supply Chain Serv SCS, Data Sci & Optimizat, Nurnberg, Bayern, Germany	Universidad del Cauca	Mera-Gaona, M (corresponding author), Univ Cauca, Popayan, Cauca, Colombia.	maritzag@unicauca.edu.co	Lopez, Diego/GXV-9878-2022	Mera-Gaona, Maritza/0000-0001-8511-213X	Colciencias, Colombian Agency of Science, Technology, and Innovation [647-2015]; University of Cauca and Fraunhofer Center for Applied Research on Supply Chain Services SCS	Colciencias, Colombian Agency of Science, Technology, and Innovation; University of Cauca and Fraunhofer Center for Applied Research on Supply Chain Services SCS	The work was funded by a grant from Colciencias, Colombian Agency of Science, Technology, and Innovation, under Funding call 647-2015, project: "Mechanism of selection of relevant features for the automatic detection of epileptic seizures"; the funder provided support in the form of a scholarship for MMG but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally, University of Cauca and Fraunhofer Center for Applied Research on Supply Chain Services SCS provided support in the form of salaries for DML and RVC, and UN, respectively. However, the employers did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Acuna E, 2004, ST CLASS DAT ANAL, P639; Ali L, 2019, IEEE ACCESS, V7, P54007, DOI 10.1109/ACCESS.2019.2909969; Anani L., 2017, AFRICAN J APPL STAT, V4, P241; Aussem A, 2010, NEUROCOMPUTING, V73, P585, DOI 10.1016/j.neucom.2009.05.019; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; Cheliotis M, 2019, OCEAN ENG, V188, DOI 10.1016/j.oceaneng.2019.106220; Chittora P, 2021, IEEE ACCESS, V9, P17312, DOI 10.1109/ACCESS.2021.3053763; Delaporte G, 2019, CHEMOMETR INTELL LAB, V188, P54, DOI 10.1016/j.chemolab.2019.03.005; Dheeru D., 2017, UCI MACHINE LEARNING; Doquire G, 2012, NEUROCOMPUTING, V90, P3, DOI 10.1016/j.neucom.2012.02.031; Quinteros ME, 2019, ATMOS ENVIRON, V200, P40, DOI 10.1016/j.atmosenv.2018.11.053; Farhangfar A, 2008, PATTERN RECOGN, V41, P3692, DOI 10.1016/j.patcog.2008.05.019; FREY PW, 1991, MACH LEARN, V6, P161, DOI 10.1007/BF00114162; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; He Y, 2010, STAT METHODS MED RES, V19, P653, DOI 10.1177/0962280208101273; Hopkins M., 1999, SAMP E MAIL DATABASE; Janosi Andras, 1988, UCI Machine Learning Repository; Lan QJ, 2020, EXPERT SYST APPL, V141, DOI 10.1016/j.eswa.2019.112926; Landgrebe TCW, 2006, INT C PATT RECOG, P123; McKnight P. E., 2007, MISSING DATA GENTLE; Menze BH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-213; Mera M., 2021, FEATURE SELECTION EE; Mera-Gaona M., 2021, FRAMEWORK ENSEMBLE F; Mera-Gaona M, 2016, STUD HEALTH TECHNOL, V228, P722, DOI 10.3233/978-1-61499-678-1-722; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Mundfrom D.J., 1998, MULTIPLE REGRESSION, V25, P13; Murray JS, 2018, STAT SCI, V33, P142, DOI 10.1214/18-STS644; Musil CM, 2002, WESTERN J NURS RES, V24, P815, DOI 10.1177/019394502762477004; Orczyk T., 2013, J MED INFORM TECHNOL, V22, P111; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perkins NJ, 2018, AM J EPIDEMIOL, V187, P568, DOI 10.1093/aje/kwx348; Petersen K, 2015, INFORM SOFTWARE TECH, V64, P1, DOI 10.1016/j.infsof.2015.03.007; Qian WB, 2015, NEUROCOMPUTING, V168, P210, DOI 10.1016/j.neucom.2015.05.105; Raghunathan T.E., 2001, MULTIVARIATE TECHNIQ; Raihan-Al-Masud M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228422; Rubin D., 1990, MULTIPLE IMPUTATION, V31; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schmitt P., 2015, J BIOMETRICS BIOSTAT, V6, P224, DOI DOI 10.4172/2155-6180.1000224; Seaman S, 2013, STAT SCI, V28, P257, DOI 10.1214/13-STS415; Tan M., 1988, BREAST CANC DATASET; Torres Munguia J.A., 2014, J QUANTITATIVE METHO, V17, P101; van Buuren S, 2011, J STAT SOFTW, V45, P1; Veerasamy R., 2011, INT J DRUG DISCOV, V3, P511, DOI DOI 10.1016/J.FEBSLET.2005.06.031; Williams DA, 2018, ENVIRON MODELL SOFTW, V102, P172, DOI 10.1016/j.envsoft.2018.01.012; Young-Saver DF, 2018, J STROKE CEREBROVASC, V27, P3662, DOI 10.1016/j.jstrokecerebrovasdis.2018.08.040	48	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254720	10.1371/journal.pone.0254720	http://dx.doi.org/10.1371/journal.pone.0254720			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320016	Green Published, gold			2022-12-26	WOS:000685247800005
J	Furth, N; Shilo, S; Cohen, N; Erez, N; Fedyuk, V; Schrager, AM; Weinberger, A; Dror, AA; Zigron, A; Shehadeh, M; Sela, E; Srouji, S; Amit, S; Levy, I; Segal, E; Dahan, R; Jones, D; Douek, DC; Shema, E				Furth, Noa; Shilo, Shay; Cohen, Niv; Erez, Nir; Fedyuk, Vadim; Schrager, Alexander M.; Weinberger, Adina; Dror, Amiel A.; Zigron, Asaf; Shehadeh, Mona; Sela, Eyal; Srouji, Samer; Amit, Sharon; Levy, Itzchak; Segal, Eran; Dahan, Rony; Jones, Dan; Douek, Daniel C.; Shema, Efrat			Unified platform for genetic and serological detection of COVID-19 with single-molecule technology	PLOS ONE			English	Article								The COVID-19 pandemic raises the need for diverse diagnostic approaches to rapidly detect different stages of viral infection. The flexible and quantitative nature of single-molecule imaging technology renders it optimal for development of new diagnostic tools. Here we present a proof-of-concept for a single-molecule based, enzyme-free assay for detection of SARS-CoV-2. The unified platform we developed allows direct detection of the viral genetic material from patients' samples, as well as their immune response consisting of IgG and IgM antibodies. Thus, it establishes a platform for diagnostics of COVID-19, which could also be adjusted to diagnose additional pathogens.	[Furth, Noa; Shilo, Shay; Cohen, Niv; Erez, Nir; Fedyuk, Vadim; Shema, Efrat] Weizmann Inst Sci, Dept Regulat Biol, Rehovot, Israel; [Schrager, Alexander M.; Douek, Daniel C.] NIH, Human Immunol Sect, Vaccine Res Ctr, Bldg 10, Bethesda, MD 20892 USA; [Weinberger, Adina; Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Dror, Amiel A.; Sela, Eyal] Galilee Med Ctr, Dept Otolaryngol Head & Neck Surg, Nahariyya, Israel; [Dror, Amiel A.; Zigron, Asaf; Shehadeh, Mona; Sela, Eyal; Srouji, Samer] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel; [Zigron, Asaf; Srouji, Samer] Galilee Med Ctr, Oral & Maxillofacial Dept, Nahariyya, Israel; [Shehadeh, Mona] Galilee Med Ctr, Div Clin Labs, Clin Biochem & Endocrinol Lab, Nahariyya, Israel; [Amit, Sharon; Levy, Itzchak] Sheba Med Ctr, Ramat Gan, Israel; [Levy, Itzchak] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Dahan, Rony] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Jones, Dan] SeqLL, Woburn, MA USA	Weizmann Institute of Science; National Institutes of Health (NIH) - USA; Weizmann Institute of Science; Western Galilee Hospital; Bar Ilan University; Western Galilee Hospital; Western Galilee Hospital; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science	Shema, E (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, Rehovot, Israel.	Efrat.shema@weizmann.ac.il	Dror, Amiel/AAD-3348-2022; Furth, Noa/AAZ-7585-2020	Dror, Amiel/0000-0002-7178-6771; Furth, Noa/0000-0001-8728-519X; Dahan, Rony/0000-0002-8420-7601; Jones, Daniel/0000-0001-8108-0169	Israel Cancer Research Fund; Weizmann Institute of Science; Quinquin Foundation; Benoziyo Fund for the Advancement of Science; Sagol Institute for Longevity Research; Willner Family Center for Vascular Biology	Israel Cancer Research Fund; Weizmann Institute of Science; Quinquin Foundation; Benoziyo Fund for the Advancement of Science; Sagol Institute for Longevity Research; Willner Family Center for Vascular Biology	N.F. is supported by the Israel Cancer Research Fund. E.S. is an incumbent of the Lisa and Jeffrey Aronin Family Career Development chair. This research was supported by internal grants of the Weizmann Institute of Science, as well as Quinquin Foundation, The Benoziyo Fund for the Advancement of Science, The Sagol Institute for Longevity Research and The Willner Family Center for Vascular Biology.	A.-K.Schmidtner, 2020, medRxiv, DOI 10.1101/2020.08.08.20170746; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1101/2020.03.17.20037713, 10.1038/s41591-020-0913-5]; Barbulovic-Nad I, 2006, CRIT REV BIOTECHNOL, V26, P237, DOI 10.1080/07388550600978358; Broughton JP, 2020, NAT BIOTECHNOL, V38, P870, DOI 10.1038/s41587-020-0513-4; Butler D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21361-7; C. F.Yen, 2020, bioRxiv, DOI 10.1101/2020.06.02.131144; Cheong J, 2021, NAT BIOMED ENG, V5, P125, DOI 10.1038/s41551-020-00676-8; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Guglielmi G, 2020, NATURE, V583, P506, DOI 10.1038/d41586-020-02140-8; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7; Johnson-Buck A, 2015, NAT BIOTECHNOL, V33, P730, DOI 10.1038/nbt.3246; Joung J, 2020, NEW ENGL J MED, V383, P1492, DOI 10.1056/NEJMc2026172; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Mandal S, 2021, ACCOUNTS CHEM RES, V54, P388, DOI 10.1021/acs.accounts.0c00621; McNally B, 2010, NANO LETT, V10, P2237, DOI 10.1021/nl1012147; Norman M, 2020, NAT BIOMED ENG, V4, P1180, DOI 10.1038/s41551-020-00611-x; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Rozevsky Y, 2020, ACS NANO, V14, P13964, DOI 10.1021/acsnano.0c06375; Shema E, 2019, NAT GENET, V51, P19, DOI 10.1038/s41588-018-0290-x; Shema E, 2016, SCIENCE, V352, P717, DOI 10.1126/science.aad7701; Shental N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5961; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; Ter-Ovanesyan D, 2021, ANAL CHEM, V93, P5365, DOI 10.1021/acs.analchem.1c00515; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Woo CH, 2020, NAT BIOMED ENG, V4, P1168, DOI 10.1038/s41551-020-00617-5; Yu L, 2020, CLIN CHEM, V66, P975, DOI 10.1093/clinchem/hvaa102; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344	31	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255096	10.1371/journal.pone.0255096	http://dx.doi.org/10.1371/journal.pone.0255096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310620	gold, Green Published, Green Submitted			2022-12-26	WOS:000685224500008
J	Song, PC; Zong, XY; Chen, XM; Zhao, Q; Guo, LBZ				Song, Pengcheng; Zong, Xiangyu; Chen, Ximing; Zhao, Qin; Guo, Lubingzhi			The Shortest Duration Constrained Hidden Markov Model: Data denoise and forecast optimization on the country-product matrix for the Fitness-Complexity Algorithm	PLOS ONE			English	Article								The Economic Fitness Index describes industrial completeness and comprehensively reflects product diversification with competitiveness and product complexity in production globalization. The Fitness-Complexity Algorithm offers a scientific approach to predicting GDP and obtains fruitful results. As a recursion algorithm, the non-linear iteration processes give novel insights into product complexity and country fitness without noise data. However, the Country-Product Matrix and Revealed Comparative Advantage data have abnormal noises which contradict the relative stability of product diversity and the transformation of global production. The data noise entering the iteration algorithm, combined with positively related Fitness and Complexity, will be amplified in each recursion step. We introduce the Shortest Duration Constrained Hidden Markov Model (SDC-HMM) to denoise the Country-Product Matrix for the first time. After the country-product matrix test, the country case test, the noise estimation test and the panel regression test of national economic fitness indicators to predict GDP growth, we show that the SDC-HMM could reduce abnormal noise by about 25% and identify change points. This article provides intra-sample predictions that theoretically confirm that the SDC-HMM can improve the effectiveness of economic fitness indicators in interpreting economic growth.	[Song, Pengcheng] Xi An Jiao Tong Univ, Sch Econ & Finance, Xian, Peoples R China; [Zong, Xiangyu] Univ Glasgow, Business Sch, Glasgow, Lanark, Scotland; [Chen, Ximing] Chinese Acad Int Trade & Econ Cooperat, Beijing, Peoples R China; [Zhao, Qin] Peking Univ, Sch Math Sci, Beijing, Peoples R China; [Guo, Lubingzhi] Univ Glasgow, Sch Comp Sci, Glasgow, Lanark, Scotland	Xi'an Jiaotong University; University of Glasgow; Peking University; University of Glasgow	Zong, XY (corresponding author), Univ Glasgow, Business Sch, Glasgow, Lanark, Scotland.	x.zong.1@research.gla.ac.uk		Zong, Xiangyu/0000-0002-1862-7501				[Anonymous], 2015, PENN WORLD TABLE 90; ARROW KJ, 1961, REV ECON STAT, V43, P225, DOI 10.2307/1927286; BALASSA B, 1965, MANCH SCH ECON SOC, V33, P99, DOI 10.1111/j.1467-9957.1965.tb00050.x; Battiston C., 2014, COMPLEXECONOMIC TIME, V41, P1; Bilmes JA, 2006, IEICE T INF SYST, VE89D, P869, DOI 10.1093/ietisy/e89-d.3.869; Dedrick J, 2010, IND CORP CHANGE, V19, P81, DOI 10.1093/icc/dtp032; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Gaulier G., 2010, 201023 CEPII; Gereffi G., 1994, COMMODITY CHAINS GLO; Hidalgo CA, 2009, P NATL ACAD SCI USA, V106, P10570, DOI 10.1073/pnas.0900943106; [黄晓彬 Huang Xiaobin], 2012, [系统工程理论与实践, Systems Engineering-Theory & Practice], V32, P713; PAGE ES, 1954, BIOMETRIKA, V41, P100, DOI 10.1093/biomet/41.1-2.100; Ricardo D., 1891, PRINCIPLES POLITICAL; Rossi A., 2006, J EMPIR FINANC, V13, P203, DOI 10.1016/j.jempfin.2005.09.003; Schuster-Bockler Benjamin, 2007, Curr Protoc Bioinformatics, VAppendix 3, p3A, DOI 10.1002/0471250953.bia03as18; Smith Adam, 1976, WEALTH NATIONS; Stock JH, 2003, NBER MACROEC ANN-SER, V17, P159; Tacchella A, 2018, NAT PHYS, V14, P861, DOI 10.1038/s41567-018-0204-y; Tacchella A, 2013, J ECON DYN CONTROL, V37, P1683, DOI 10.1016/j.jedc.2013.04.006; Luong TM, 2013, COMPUT STAT DATA AN, V68, P129, DOI 10.1016/j.csda.2013.06.020; UN, 2020, COMM TRAD STAT DAT; WB, 2020, WORLD BANK OPEN DATA; Yamato J., 1992, Proceedings. 1992 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No.92CH3168-2), P379, DOI 10.1109/CVPR.1992.223161; Yang Tianyu., 2010, EC RES J, V1, P115; Zaccaria A, 2016, J ECON INTERACT COOR, V11, P151, DOI 10.1007/s11403-015-0145-9; Zhuang Yu., 2017, COMPUTER SYSTEMS APP, V26, P133	26	0	0	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0253845	10.1371/journal.pone.0253845	http://dx.doi.org/10.1371/journal.pone.0253845			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310612	Green Published, Green Accepted, gold			2022-12-26	WOS:000685224500050
J	Birladeanu, AM; Rogalska, M; Potiri, M; Papadaki, V; Andreadou, M; Kontoyiannis, DL; Lewis, JD; Erpapazoglou, Z; Kafasla, P				Birladeanu, Andrada-Maria; Rogalska, Malgorzata; Potiri, Myrto; Papadaki, Vasiliki; Andreadou, Margarita; Kontoyiannis, Dimitris L.; Lewis, Joe D.; Erpapazoglou, Zoi; Kafasla, Panagiota			The scaffold protein IQGAP1 links heat-induced stress signals to alternative splicing regulation in gastric cancer cells	ONCOGENE			English	Article							PRE-MESSENGER-RNA; SUMO MODIFICATION; NUCLEAR; HNRNP; SUMOYLATION; IDENTIFICATION; TRANSCRIPTOME; REVEALS; SITES; ASSOCIATION	In response to oncogenic signals, Alternative Splicing (AS) regulators such as SR and hnRNP proteins show altered expression levels, subnuclear distribution and/or post-translational modification status, but the link between signals and these changes remains unknown. Here, we report that a cytosolic scaffold protein, IQGAP1, performs this task in response to heat-induced signals. We show that in gastric cancer cells, a nuclear pool of IQGAP1 acts as a tethering module for a group of spliceosome components, including hnRNPM, a splicing factor critical for the response of the spliceosome to heat-shock. IQGAP1 controls hnRNPM's sumoylation, subnuclear localisation and the relevant response of the AS machinery to heat-induced stress. Genome-wide analyses reveal that IQGAP1 and hnRNPM co-regulate the AS of a cell cycle-related RNA regulon in gastric cancer cells, thus favouring the accelerated proliferation phenotype of gastric cancer cells. Overall, we reveal a missing link between stress signals and AS regulation.	[Birladeanu, Andrada-Maria; Potiri, Myrto; Papadaki, Vasiliki; Andreadou, Margarita; Kontoyiannis, Dimitris L.; Erpapazoglou, Zoi; Kafasla, Panagiota] BSRC Alexander Fleming, Inst Fundamental Biomed Res, 34 Fleming St, Athens 16672, Greece; [Rogalska, Malgorzata] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Dr Aiguader 88, Barcelona 08003, Spain; [Rogalska, Malgorzata] Univ Pompeu Fabra UPF, Barcelona 08003, Spain; [Kontoyiannis, Dimitris L.] Aristotle Univ Thessaloniki, Dept Biol, Thessaloniki, Greece; [Lewis, Joe D.] European Mol Biol Lab, D-69117 Heidelberg, Germany	Alexander Fleming Biomedical Sciences Research Center; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Aristotle University of Thessaloniki; European Molecular Biology Laboratory (EMBL)	Kafasla, P (corresponding author), BSRC Alexander Fleming, Inst Fundamental Biomed Res, 34 Fleming St, Athens 16672, Greece.	kafasla@fleming.gr	Kafasla, Panagiota/GRR-3951-2022; Kafasla, Panagiota/B-9187-2009; , Panagiota/AAZ-2732-2021; Rogalska, Malgorzata Ewa/O-5962-2016	Kafasla, Panagiota/0000-0002-9730-0397; Lewis, Joe/0000-0002-9926-1328; Kontoyiannis, Dimitris/0000-0003-4682-9490; Rogalska, Malgorzata Ewa/0000-0002-6331-9815; Potiri, Myrto/0000-0001-9051-5881	European Union (European Regional Development Fund) [NSRF 2014-2020] [MIS 5002135]; Hellenic Foundation for Research & Innovation (HFRI); General Secretariat for Research and Technology (GSRT) [846]; European Research Council [ERC] [ERC AdvG 670146]; European Commission [274837]	European Union (European Regional Development Fund) [NSRF 2014-2020]; Hellenic Foundation for Research & Innovation (HFRI); General Secretariat for Research and Technology (GSRT)(Greek Ministry of Development-GSRT); European Research Council [ERC](European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	InfrafrontierGR/Phenotypos Infrastructure, co-funded by Greece and the European Union (European Regional Development Fund) [NSRF 2014-2020, MIS 5002135]; Hellenic Foundation for Research & Innovation (HFRI) and the General Secretariat for Research and Technology (GSRT) [grant agreement 846 to ZE]; MR was supported by the European Research Council [ERC AdvG 670146]; European Commission Grant FP7PEOPLE-2010-IEF [274837] to PK; Stavros Niarchos Foundation (SNF) donation to BSRC "Al. Fleming".	Alfieri C, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170204; Biamonti G, 2009, TRENDS BIOCHEM SCI, V34, P146, DOI 10.1016/j.tibs.2008.11.004; Cherry S, 2020, GENE DEV, V34, P1005, DOI 10.1101/gad.338962.120; CHOI YD, 1984, P NATL ACAD SCI-BIOL, V81, P7471, DOI 10.1073/pnas.81.23.7471; Cvitkovic I, 2013, NUCLEIC ACIDS RES, V41, pD132, DOI 10.1093/nar/gks999; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Damianov A, 2016, CELL, V165, P606, DOI 10.1016/j.cell.2016.03.040; Denegri M, 2001, MOL BIOL CELL, V12, P3502, DOI 10.1091/mbc.12.11.3502; El Marabti E, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00080; ENGSTROM Y, 1985, J BIOL CHEM, V260, P9114; Gattoni R, 1996, NUCLEIC ACIDS RES, V24, P2535, DOI 10.1093/nar/24.13.2535; Gohr A, 2019, BIOINFORMATICS, V35, P130, DOI 10.1093/bioinformatics/bty606; Hendriks IA, 2017, NAT STRUCT MOL BIOL, V24, P325, DOI 10.1038/nsmb.3366; Hendriks IA, 2016, METHODS MOL BIOL, V1475, P171, DOI 10.1007/978-1-4939-6358-4_13; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Hendriks IA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8289; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Heyd F, 2011, TRENDS BIOCHEM SCI, V36, P397, DOI 10.1016/j.tibs.2011.04.003; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Hu W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44048-y; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Johnson M, 2011, INT J BIOCHEM CELL B, V43, P65, DOI 10.1016/j.biocel.2010.09.014; Johnson MA, 2013, BBA-MOL CELL RES, V1833, P2334, DOI 10.1016/j.bbamcr.2013.06.002; Kafasla P, 2000, BIOCHEM J, V350, P495, DOI 10.1042/0264-6021:3500495; Kafasla P, 2002, BIOCHEM J, V363, P793, DOI 10.1042/0264-6021:3630793; Kahles A, 2018, CANCER CELL, V34, P211, DOI 10.1016/j.ccell.2018.07.001; Kim YS, 2014, BIOORG MED CHEM LETT, V24, P1094, DOI 10.1016/j.bmcl.2014.01.010; Lamm N, 2020, NAT CELL BIOL, V22, P1460, DOI 10.1038/s41556-020-00605-6; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Lian ATY, 2015, CELL CYCLE, V14, P2058, DOI 10.1080/15384101.2015.1044168; Liang ZW, 2017, CANCER LETT, V411, P90, DOI 10.1016/j.canlet.2017.09.046; Liebelt F, 2019, CELL REP, V26, P236, DOI 10.1016/j.celrep.2018.12.027; Liu JQ, 2019, J CELL BIOCHEM, V120, P15790, DOI 10.1002/jcb.28849; Lleres D, 2010, EMBO REP, V11, P445, DOI 10.1038/embor.2010.64; MAHL P, 1989, J CELL BIOL, V109, P1921, DOI 10.1083/jcb.109.5.1921; Marko M, 2010, EXP CELL RES, V316, P390, DOI 10.1016/j.yexcr.2009.10.021; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Meissner M, 2000, J CELL BIOCHEM, V76, P559, DOI 10.1002/(SICI)1097-4644(20000315)76:4<559::AID-JCB4>3.0.CO;2-U; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Osman MA, 2013, BBA-REV CANCER, V1836, P166, DOI 10.1016/j.bbcan.2013.04.005; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Passacantilli I, 2017, NUCLEIC ACIDS RES, V45, P12270, DOI 10.1093/nar/gkx831; Penas C, 2012, FRONT ONCOL, V1, DOI 10.3389/fonc.2011.00060; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Pozzi B, 2017, NUCLEIC ACIDS RES, V45, P6729, DOI 10.1093/nar/gkx213; Rando OJ, 2000, TRENDS CELL BIOL, V10, P92, DOI 10.1016/S0962-8924(99)01713-4; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Santos A, 2015, NUCLEIC ACIDS RES, V43, pD1140, DOI 10.1093/nar/gku1092; Saraiva-Agostinho N, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gky888; Sayedyahossein S, 2016, J BIOL CHEM, V291, P19261, DOI 10.1074/jbc.M116.732529; Shalgi R, 2014, CELL REP, V7, P1362, DOI 10.1016/j.celrep.2014.04.044; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Suganuma T, 2010, CELL, V142, P726, DOI 10.1016/j.cell.2010.07.045; Sveen A, 2016, ONCOGENE, V35, P2413, DOI 10.1038/onc.2015.318; Tammsalu T, 2015, NAT PROTOC, V10, P1374, DOI 10.1038/nprot.2015.095; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Vassileva MT, 2004, MOL CELL BIOL, V24, P3623, DOI 10.1128/MCB.24.9.3623-3632.2004; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Yamano Hiroyuki, 2019, F1000Res, V8, DOI 10.12688/f1000research.18582.1; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109; Zhou ZA, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0021-6	72	3	3	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 9	2021	40	36					5518	5532		10.1038/s41388-021-01963-7	http://dx.doi.org/10.1038/s41388-021-01963-7		JUL 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UO7MC	34294847	Green Submitted, Green Accepted			2022-12-26	WOS:000678016900001
J	Sahu, B; Pihlajamaa, P; Zhang, KY; Palin, K; Ahonen, S; Cervera, A; Ristimaki, A; Aaltonen, LA; Hautaniemi, S; Taipale, J				Sahu, Biswajyoti; Pihlajamaa, Paivi; Zhang, Kaiyang; Palin, Kimmo; Ahonen, Saija; Cervera, Alejandra; Ristimaki, Ari; Aaltonen, Lauri A.; Hautaniemi, Sampsa; Taipale, Jussi			Human cell transformation by combined lineage conversion and oncogene expression	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; HUMAN FIBROBLASTS; RAS ONCOGENES; CANCER; TUMOR; GENES; MYC; METHYLATION; INDUCTION; TUMORIGENESIS	Cancer is the most complex genetic disease known, with mutations implicated in more than 250 genes. However, it is still elusive which specific mutations found in human patients lead to tumorigenesis. Here we show that a combination of oncogenes that is characteristic of liver cancer (CTNNB1, TERT, MYC) induces senescence in human fibroblasts and primary hepatocytes. However, reprogramming fibroblasts to a liver progenitor fate, induced hepatocytes (iHeps), makes them sensitive to transformation by the same oncogenes. The transformed iHeps are highly proliferative, tumorigenic in nude mice, and bear gene expression signatures of liver cancer. These results show that tumorigenesis is triggered by a combination of three elements: the set of driver mutations, the cellular lineage, and the state of differentiation of the cells along the lineage. Our results provide direct support for the role of cell identity as a key determinant in transformation and establish a paradigm for studying the dynamic role of oncogenic drivers in human tumorigenesis.	[Sahu, Biswajyoti; Pihlajamaa, Paivi; Palin, Kimmo; Ahonen, Saija; Ristimaki, Ari; Aaltonen, Lauri A.; Taipale, Jussi] Univ Helsinki, Fac Med, Res Programs Unit, Appl Tumor Genom Res Program, Helsinki, Finland; [Sahu, Biswajyoti; Ristimaki, Ari] Univ Helsinki, Fac Med, Med, Helsinki, Finland; [Sahu, Biswajyoti; Pihlajamaa, Paivi; Taipale, Jussi] Univ Cambridge, Dept Biochem, Cambridge, England; [Sahu, Biswajyoti; Palin, Kimmo; Aaltonen, Lauri A.] iCAN Digital Precis Canc Med Flagship, Helsinki, Finland; [Zhang, Kaiyang; Cervera, Alejandra; Hautaniemi, Sampsa] Univ Helsinki, Fac Med, Res Programs Unit, Res Program Syst Oncol, Helsinki, Finland; [Palin, Kimmo; Aaltonen, Lauri A.] Univ Helsinki, Dept Med & Clin Genet, Helsinki, Finland; [Cervera, Alejandra] Inst Nacl Med Gen6m, Mexico City, DF, Mexico; [Ristimaki, Ari] Univ Helsinki, HUSLAB, Dept Pathol, Helsinki, Finland; [Ristimaki, Ari] Univ Helsinki, HUS Diagnost Ctr, Helsinki, Finland; [Ristimaki, Ari] Helsinki Univ Hosp, Helsinki, Finland; [Taipale, Jussi] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	University of Helsinki; University of Helsinki; University of Cambridge; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet	Taipale, J (corresponding author), Univ Helsinki, Fac Med, Res Programs Unit, Appl Tumor Genom Res Program, Helsinki, Finland.; Taipale, J (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.; Taipale, J (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	ajt208@cam.ac.uk	Pihlajamaa, Paivi/AAD-8065-2020; Aaltonen, Lauri/A-5375-2010; Cervera, Alejandra/ABD-8200-2020; Hautaniemi, Sampsa/CAG-0362-2022; Sahu, Biswajyoti/U-6724-2017; Pihlajamaa, Paivi/AAY-2063-2021; Hautaniemi, Sampsa/A-3122-2009	Pihlajamaa, Paivi/0000-0001-9725-6907; Aaltonen, Lauri/0000-0001-6839-4286; Cervera, Alejandra/0000-0002-6274-1168; Hautaniemi, Sampsa/0000-0002-7749-2694; Sahu, Biswajyoti/0000-0001-6576-5440; Pihlajamaa, Paivi/0000-0001-9725-6907; Hautaniemi, Sampsa/0000-0002-7749-2694; Zhang, Kaiyang/0000-0002-0470-9581; Ahonen, Saija/0000-0003-3313-784X; Palin, Kimmo/0000-0002-4621-6128	Academy of Finland (Finnish Center of Excellence in Tumor Genetics Research) [312042, 250345]; Finnish Cancer Foundation; Cancer Research UK [RG99643]; Academy of Finland [250345, 312041, 335823, 319083, 320149, 288836, 274555, 317807]; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; Finska Lakaresallskapet; iCAN Digital Precision Cancer Medicine Flagship [320185]; European Union's Horizon 2020 research and innovation program [667403]; University of Helsinki; Helsinki University Central Hospital Research Funds; Helsinki University Central Hospital; iCAN Digital Precision Cancer Medicine Flagship	Academy of Finland (Finnish Center of Excellence in Tumor Genetics Research); Finnish Cancer Foundation; Cancer Research UK(Cancer Research UK); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jane and Aatos Erkko Foundation; Finska Lakaresallskapet; iCAN Digital Precision Cancer Medicine Flagship; European Union's Horizon 2020 research and innovation program; University of Helsinki; Helsinki University Central Hospital Research Funds; Helsinki University Central Hospital; iCAN Digital Precision Cancer Medicine Flagship	JT was supported by grants from Academy of Finland (Finnish Center of Excellence in Tumor Genetics Research 2018-2025, grant number 312042 and 2012-2017; 250345), Finnish Cancer Foundation, and Cancer Research UK (grant number RG99643). BS was supported by the Academy of Finland (post-doctoral fellowship, 274555; research fellowship, 317807), Finnish Cancer Foundation, Sigrid Juselius Foundation, Jane and Aatos Erkko Foundation and iCAN Digital Precision Cancer Medicine Flagship. PP was supported by the post-doctoral fellowship 288836 from Academy of Finland. AR was supported by Finska Lakaresallskapet, Helsinki University Central Hospital Research Funds, and Sigrid Juselius Foundation. LA was supported by Academy of Finland (grant numbers 312041, 335823, 250345, 319083, 320149), iCAN Digital Precision Cancer Medicine Flagship (grant number 320185), Finnish Cancer Foundation, Sigrid Juselius Foundation and Jane and Aatos Erkko Foundation. SH was supported by the European Union's Horizon 2020 research and innovDation program under Grant Agreement No. 667403 for HERCULES. Open access funding provided by University of Helsinki including Helsinki University Central Hospital.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; [Anonymous], 2019, WHO CLASSIFICATION T, V5th; Barr FG, 1998, NAT GENET, V19, P121, DOI 10.1038/475; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Bou-Nader M, 2020, GUT, V69, P355, DOI 10.1136/gutjnl-2018-318021; Broutier L, 2017, NAT MED, V23, P1424, DOI 10.1038/nm.4438; Cai SH, 2017, THER ADV GASTROENTER, V10, P761, DOI 10.1177/1756283X17725998; Cairo S, 2008, CANCER CELL, V14, P471, DOI 10.1016/j.ccr.2008.11.002; Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, 2017, Cell, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Chaffer CL, 2015, CANCER DISCOV, V5, P22, DOI 10.1158/2159-8290.CD-14-0788; Chen HJ, 2019, J EXP MED, V216, P674, DOI 10.1084/jem.20181155; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; DALEY GQ, 1987, SCIENCE, V237, P532, DOI 10.1126/science.2440107; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Diamond L, 1980, Adv Cancer Res, V32, P1, DOI 10.1016/S0065-230X(08)60360-7; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Farrell JA, 2018, SCIENCE, V360, P979, DOI 10.1126/science.aar3131; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Haigis KM, 2019, SCIENCE, V363, P1150, DOI 10.1126/science.aaw3472; Hooks KB, 2018, HEPATOLOGY, V68, P89, DOI 10.1002/hep.29672; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Icay K, 2016, BIODATA MIN, V9, DOI 10.1186/s13040-016-0099-z; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Korotkevich G, 2019, FAST GENE SET ENRICH, DOI 10.1101/060012; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee I, 2020, NAT METHODS, V17, P1191, DOI 10.1038/s41592-020-01000-7; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Liu ML, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3183; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Marthandan S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154531; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; METZ T, 1995, CELL, V82, P29, DOI 10.1016/0092-8674(95)90049-7; Moinzadeh P, 2005, BRIT J CANCER, V92, P935, DOI 10.1038/sj.bjc.6602448; Moore PS, 2010, NAT REV CANCER, V10, P878, DOI 10.1038/nrc2961; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Ning BF, 2010, CANCER RES, V70, P7640, DOI 10.1158/0008-5472.CAN-10-0824; Ovaska K, 2010, GENOME MED, V2, DOI 10.1186/gm186; Palin K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06132-1; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park JW, 2018, SCIENCE, V362, P91, DOI 10.1126/science.aat5749; Rackham OJL, 2016, NAT GENET, V48, P331, DOI 10.1038/ng.3487; Rahman M, 2015, BIOINFORMATICS, V31, P3666, DOI 10.1093/bioinformatics/btv377; RANGANATHAN S, 2016, SCI REP-UK, V6; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Roadmap Epigenomics Consortium, 2015, Nature, V518, P317, DOI 10.1038/nature14248; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; Shin S, 2016, HEPATOLOGY, V64, P1163, DOI 10.1002/hep.28602; Shipony Z, 2020, NAT METHODS, V17, P319, DOI 10.1038/s41592-019-0730-2; Simpson JT, 2017, NAT METHODS, V14, P407, DOI 10.1038/nmeth.4184; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; STEVENSON M, 1986, MOL CELL BIOL, V6, P3410, DOI 10.1128/MCB.6.10.3410; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun R, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.591507; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor AM, 2018, CANCER CELL, V33, P676, DOI 10.1016/j.ccell.2018.03.007; Timek DT, 2012, AM J CLIN PATHOL, V138, P203, DOI 10.1309/AJCPK1ZC9WNHCCMU; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Villanueva A, 2012, GASTROENTEROLOGY, V143, P1660, DOI 10.1053/j.gastro.2012.09.002; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; YAMAGIWA K, 1977, CA-CANCER J CLIN, V27, P172, DOI 10.3322/canjclin.27.3.174; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhu B, 2017, ONCOTARGET, V8, P23289, DOI 10.18632/oncotarget.15576	87	3	3	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 9	2021	40	36					5533	5547		10.1038/s41388-021-01940-0	http://dx.doi.org/10.1038/s41388-021-01940-0		JUL 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UO7MC	34302118	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000676064800002
J	Kumar, SK; Arya, S; Singh, A; Misra, R; Aggarwal, A; Sinha, S				Kumar, Shashi Kant; Arya, Suvrat; Singh, Ankita; Misra, Ramnath; Aggarwal, Amita; Sinha, Sudhir			Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection	PLOS ONE			English	Article							AVIUM SUBSP-PARATUBERCULOSIS; EPSTEIN-BARR-VIRUS; ANTIBODY-RESPONSES; IMMUNE-RESPONSE; HIGH-PREVALENCE; SKIN-TESTS; PROTEINS; ALPHA; HSPX; REACTIVITY	This study was aimed at exploring whether latent tuberculosis infection (LTBI) contributes to the pathogenesis of immune-mediated inflammatory diseases in a TB endemic setting. We screened 198 rheumatoid arthritis (RA) patients with tuberculin skin test (TST) and studied 61 (median DAS28-ESR = 6.3) who were positive. Whole blood T cell proliferative responses to Mycobacterium tuberculosis (Mtb) membrane (MtM) antigens, including the latency-induced protein alpha crystallin (Acr), were determined by flow cytometry using Ki67 expression as the marker for nuclear proliferation. Serum antibody levels were determined by ELISA. Follow-up investigations (at 3-6, 9-12 and 15-18 months after baseline) were performed in 41 patients who were classified empirically as 'high' (HR-T/HR-B) or 'low' (LR-T/LR-B) responders based on their dynamic T cell or antibody responses. Significant correlations were seen between baseline T cell responses to MtM and Acr, and between IgG, IgA and IgM antibody responses to MtM. However, no correlation was seen between T and B cell responses. At all time points during the follow-up, T cell responses to both antigens (except for MtM at one point) were significantly higher in HR-T (n = 25) than LR-T (n = 16) patients. Levels of IgA and IgM (but not IgG) antibodies to MtM were also significantly higher in HR-B (n = 13) than LR-B (n = 28) at all time points. Importantly, HR-T patients exhibited significantly higher baseline and follow-up DAS28 scores than LR-T. Ten (of 61) patients had a history of TB and developed RA 6 years (median) after contracting TB. Three new TB cases (1 from TST-positive and 2 from TST-negative groups) emerged during the follow-up. Our results suggest that persistently elevated T cell responses to Mtb antigens may contribute to disease activity in RA.	[Kumar, Shashi Kant; Arya, Suvrat; Singh, Ankita; Misra, Ramnath; Aggarwal, Amita; Sinha, Sudhir] Sanjay Gandhi Postgrad Inst Med Sci SGPGIMS, Dept Clin Immunol & Rheumatol, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences	Aggarwal, A; Sinha, S (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci SGPGIMS, Dept Clin Immunol & Rheumatol, Lucknow, Uttar Pradesh, India.	amita@sgpgi.ac.in; sinha.sudhir@gmail.com	Sinha, Sudhir/C-7268-2009	Sinha, Sudhir/0000-0003-3149-1116				Abebe F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190989; Anderson J, 2012, ARTHRIT CARE RES, V64, P640, DOI 10.1002/acr.21649; Arya S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204429; Baronnet L, 2011, JOINT BONE SPINE, V78, P279, DOI 10.1016/j.jbspin.2010.12.004; Baumann R, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/364758; Bo M, 2018, CLIN EXP RHEUMATOL, V36, P376; Bo M, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8101459; Bo M, 2020, J TRANSL AUTOIMMUN, V3, DOI 10.1016/j.jtauto.2020.100048; Bo M, 2019, J INFLAMM RES, V12, P301, DOI 10.2147/JIR.S220960; DEGRAEFFMEEDER ER, 1990, AM J PATHOL, V137, P1013; Elkayam O, 2006, ANN RHEUM DIS, V65, P1110, DOI 10.1136/ard.2005.045229; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Feruglio SL, 2015, CLIN EXP IMMUNOL, V179, P454, DOI 10.1111/cei.12468; Gaikwad AN, 2008, CLIN EXP IMMUNOL, V151, P414, DOI 10.1111/j.1365-2249.2007.03585.x; Geluk A, 2007, INFECT IMMUN, V75, P2914, DOI 10.1128/IAI.01990-06; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; HOLOSHITZ J, 1986, LANCET, V2, P305; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; KEAT A, 1993, BRIT J RHEUMATOL, V32, P769; Kumar SK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228359; Kumar SK, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150171; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lee KH, 2012, RHEUMATOL INT, V32, P1421, DOI 10.1007/s00296-011-1889-8; Li HF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39402-z; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Lortholary O, 2020, ANN RHEUM DIS, V79, P1532, DOI 10.1136/annrheumdis-2020-217092; Lu LL, 2019, NAT MED, V25, P977, DOI 10.1038/s41591-019-0441-3; Malaviya AN, 2018, INT J RHEUM DIS, V21, P1563, DOI 10.1111/1756-185X.13261; Malmstrom V, 2017, NAT REV IMMUNOL, V17, P60, DOI 10.1038/nri.2016.124; Mattos AMM, 2010, INT IMMUNOL, V22, P775, DOI 10.1093/intimm/dxq429; MCCONKEY B, 1988, J RHEUMATOL, V15, P46; Mills KHG, 2011, NAT REV IMMUNOL, V11, P807, DOI 10.1038/nri3095; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; OTTENHOFF THM, 1986, LANCET, V2, P310; PANAYI GS, 1978, BMJ-BRIT MED J, V2, P1326, DOI 10.1136/bmj.2.6148.1326; Reynisdottir G, 2016, ANN RHEUM DIS, V75, P1722, DOI 10.1136/annrheumdis-2015-208216; Reynisdottir G, 2014, ARTHRITIS RHEUMATOL, V66, P31, DOI 10.1002/art.38201; Rieder HL, 2011, INT J TUBERC LUNG D, V15, pS1; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; SCHATZ M, 1976, ANN INTERN MED, V84, P261, DOI 10.7326/0003-4819-84-3-261; Sharma SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169539; Shen TC, 2015, INT J TUBERC LUNG D, V19, P1401, DOI 10.5588/ijtld.15.0057; Sinha S, 2005, MICROBIOL-SGM, V151, P2411, DOI 10.1099/mic.0.27799-0; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Silva BDS, 2014, MEM I OSWALDO CRUZ, V109, P29, DOI [10.1590/0074-0276140140, 10.1590/0074-02760140140]; VANEDEN W, 1985, P NATL ACAD SCI USA, V82, P5117; Wang PH, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-01274-9; Wilkinson RJ, 1998, SCAND J IMMUNOL, V48, P403; Winthrop KL, 2013, NAT REV RHEUMATOL, V9, P524, DOI 10.1038/nrrheum.2013.82; World Health Organization, 2018, LAT TB INF UPD CONS; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yamamoto S, 2017, INT J RHEUM DIS, V20, P584, DOI 10.1111/1756-185X.13101; Zimmermann N, 2016, EMBO MOL MED, V8, P1325, DOI 10.15252/emmm.201606330	57	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255639	10.1371/journal.pone.0255639	http://dx.doi.org/10.1371/journal.pone.0255639			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339423	gold, Green Published			2022-12-26	WOS:000680243400013
J	Read, S; Morgan, J; Gillespie, D; Nollett, C; Weiss, M; Allen, D; Anderson, P; Waterman, H				Read, Simon; Morgan, James; Gillespie, David; Nollett, Claire; Weiss, Marjorie; Allen, Davina; Anderson, Pippa; Waterman, Heather			Normalisation process theory and the implementation of a new glaucoma clinical pathway in hospital eye services: Perspectives of doctors, nurses and optometrists	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; LATANOPROST; SYSTEMS	Background Normalisation process theory reports the importance of contextual integration in successfully embedding novel interventions, with recent propositions detailing the role that 'plasticity' of intervention components and 'elasticity' of an intended setting contribute. We report on the introduction of a clinical pathway assessing patient non-responsiveness to treatment for glaucoma and ocular hypertension. The aim of this study was to assess the feasibility of implementing the Cardiff Model of Glaucoma Care into hospital eye services, identifying any issues of acceptability for staff through the filter of normalisation process theory. Methods A prospective observational study was undertaken in four hospital eye services. This incorporated detailed qualitative semi-structured interviews with staff (n = 8) to gather their perceptions on the intervention's usefulness and practicality. In addition, observational field notes of patient and staff consultations (n = 88) were collected, as well as broader organisational observations from within the research sites (n = 52). Data collection and analysis was informed by the normalisation process theory framework. Results Staff reported the pathway led to beneficial knowledge on managing patient treatment, but the model was sometimes perceived as overly prescriptive. This perception varied significantly based on the composition of clinics in relation to staff experience, staff availability and pre-existing clinical structures. The most commonly recounted barrier came in contextually integrating into sites where wider administrative systems were inflexible to intervention components. Conclusions Flexibility will be the key determinant of whether the clinical pathway can progress to wider implementation. Addressing the complexity and variation associated with practice between clinics required a remodelling of the pathway to maintain its central benefits but enhance its plasticity. Our study therefore helps to confirm propositions developed in relation to normalisation process theory, contextual integration, intervention plasticity, and setting elasticity. This enables the transferability of findings to healthcare settings other than ophthalmology, where any novel intervention is implemented.	[Read, Simon; Allen, Davina; Waterman, Heather] Cardiff Univ, Sch Healthcare Sci, Cardiff, Wales; [Morgan, James] Cardiff & Vale Univ Hlth Board, Cardiff, Wales; [Gillespie, David; Nollett, Claire] Cardiff Univ, Ctr Trials Res, Cardiff, Wales; [Weiss, Marjorie] Cardiff Univ, Sch Pharmaceut Sci, Cardiff, Wales; [Anderson, Pippa] Swansea Univ, Swansea Ctr Hlth Econ, Swansea, W Glam, Wales	Cardiff University; Cardiff University; Cardiff University; Swansea University	Read, S (corresponding author), Cardiff Univ, Sch Healthcare Sci, Cardiff, Wales.	readsm@cardiff.ac.uk		Read, Simon/0000-0003-2445-283X; Weiss, Marjorie/0000-0001-8065-4108	Health and Care Research Wales Research for Patient and Public Benefit fund [RfPPB-16a-1296]	Health and Care Research Wales Research for Patient and Public Benefit fund	JM was awarded the funding for this research alongside several co-applicants forming some of the research team (HW, DG, CN, MW, DA, PA). This research was funded in full by the Health and Care Research Wales Research for Patient and Public Benefit fund, ref: RfPPB-16a-1296. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dryden-Palmer KD, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-4935-y; Fetterman D, 1989, ETHNOGRAPHY STEP BY; Finch TL, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-69; Hall A, 2017, INT J NURS STUD, V72, P60, DOI 10.1016/j.ijnurstu.2017.04.008; Harn B, 2013, EXCEPT CHILDREN, V79, P181, DOI 10.1177/001440291307900204; Hawe P, 2004, J EPIDEMIOL COMMUN H, V58, P788, DOI 10.1136/jech.2003.014415; Hawe P, 2015, ANNU REV PUBL HEALTH, V36, P307, DOI 10.1146/annurev-publhealth-031912-114421; Health NIf and Excellence C, 2017, IRR BOW SYNDR AD DIA; Hitch D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235055; Jeffries M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205419; Lewis A, 2019, INT J NURS STUD, V94, P32, DOI 10.1016/j.ijnurstu.2018.12.016; Li SA, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0734-5; Lincoln YS, 1985, NATURALISTIC INQUIRY, P75, DOI DOI 10.1016/0147-1767(85)90062-8; Lloyd A, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-102; Lodge AC, 2017, ADM POLICY MENT HLTH, V44, P413, DOI 10.1007/s10488-016-0732-7; Mair FS, 2012, B WORLD HEALTH ORGAN, V90, P357, DOI 10.2471/BLT.11.099424; May C, 2015, NORMALIZATION PROCES; May CR, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0506-3; McEvoy R, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-2; Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0; Quaranta L, 2008, BRIT J OPHTHALMOL, V92, P1227, DOI 10.1136/bjo.2008.138024; Rapley T, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0590-y; Richards L., 2005, HANDLING QUALITATIVE; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Rostami P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192224; Russo A, 2008, CLIN OPHTHALMOL, V2, P897; Sanders T, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-49; Scherer WJ, 2002, J OCUL PHARMACOL TH, V18, P287, DOI 10.1089/108076802760116205; Scott SD, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-41; Shaw EK, 2012, J AM BOARD FAM MED, V25, P676, DOI 10.3122/jabfm.2012.05.110281; Sommerbakk R, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0132-5; Sutton E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195890; The Royal College of Ophthalmologists, 2017, WAY FORW GLAUC; Thomas LH, 2014, INT J NURS STUD, V51, P1308, DOI 10.1016/j.ijnurstu.2014.02.009; Vamos CA, 2017, J PERINATOL, V37, P150, DOI 10.1038/jp.2016.199; Waterman H, 2020, BRIT J OPHTHALMOL, V104, P1704, DOI 10.1136/bjophthalmol-2019-315436; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255564	10.1371/journal.pone.0255564	http://dx.doi.org/10.1371/journal.pone.0255564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TT3IC	34339462	gold, Green Published, Green Accepted			2022-12-26	WOS:000680243400016
J	Liu, HQ; Lu, ZW; Shi, XF; Liu, LL; Zhang, PS; Golemis, EA; Tu, ZG				Liu, Hanqing; Lu, Ziwen; Shi, Xiaofeng; Liu, Lanlan; Zhang, Peishan; Golemis, Erica A.; Tu, Zhigang			HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANTLE CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; POTENT ANTITUMOR-ACTIVITY; MOLECULAR CHAPERONE; GANETESPIB STA-9090; ONCOGENIC RAS; IN-VITRO; EXPRESSION; CANCER; TRANSCRIPTION	Mantle cell lymphoma (MCL) is an especially aggressive and highly heterogeneous mature B-cell lymphoma. Heat shock protein 90 (HSP90) is considered an attractive therapeutic target in a variety of cancers, including MCL, but no HSP90 inhibitors have succeeded in the clinical trials to date. Exploring fine mechanisms of HSP90 inhibition in cancer cells may shed light on novel therapeutic strategies. Here, we found that HSP90 knockdown and continuous inhibition with ganetespib inhibited growth of MCL cells in vitro and in vivo. To our surprise, transient exposure over 12 h was almost as efficient as continuous exposure, and treatment with ganetespib for 12 h efficiently inhibited growth and induced G1 cell cycle arrest and apoptosis of MCL cells. Transcriptome analysis complemented by functional studies was performed to define critical MCL signaling pathways that are exceptionally sensitive to HSP90 inhibition and vital to cell fate. Six genes (cell division cycle 6, cell division cycle 45, minichromosome maintenance 4, minichromosome maintenance 7, RecQ-mediated genome instability 2, and DNA primase polypeptide 1) involved in DNA replication and repair were identified as consistently downregulated in three MCL cell lines after transient ganetespib treatment. E2F1, an important transcription factor essential for cell cycle progression, was identified as a ganetespib target mediating transcriptional downregulation of these six genes, and its stability was also demonstrated to be maintained by HSP90. This study identifies E2F1 as a novel client protein of HSP90 that is very sensitive and worthy of targeting and also finds that HSP90 inhibitors may be useful in combination therapies for MCL.	[Liu, Hanqing; Lu, Ziwen; Zhang, Peishan] Jiangsu Univ, Sch Pharm, Zhenjiang, Jiangsu, Peoples R China; [Shi, Xiaofeng] Jiangsu Univ, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China; [Liu, Lanlan; Tu, Zhigang] Jiangsu Univ, Sch Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Peishan; Golemis, Erica A.] Fox Chase Canc Ctr, Mol Therapeut Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA	Jiangsu University; Jiangsu University; Jiangsu University; Fox Chase Cancer Center	Tu, ZG (corresponding author), Jiangsu Univ, Sch Life Sci, Zhenjiang, Jiangsu, Peoples R China.; Golemis, EA (corresponding author), Fox Chase Canc Ctr, Mol Therapeut Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Erica.Golemis@fccc.edu; zhigangtu@ujs.edu.cn			National Natural Science Foundation of China [81672582, 31771521]; Natural Science Foundation of Jiangsu Province for Distinguished Young Scholars [BK20160013]; Natural Science Foundation of Jiangsu Province [BE2016718]; Top Talent of Innovative Research Team of Jiangsu Province; Six Talent Peak Project from Government of Jiangsu Province [2015-SWYY-019, 2016-SWYY-011]; Start-up Scientific Research Fund for the Returned Oversea Scholars from Chinese Ministry of Education [P30 CA006927]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province for Distinguished Young Scholars; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Top Talent of Innovative Research Team of Jiangsu Province; Six Talent Peak Project from Government of Jiangsu Province; Start-up Scientific Research Fund for the Returned Oversea Scholars from Chinese Ministry of Education	The authors and this work were supported by the National Natural Science Foundation of China 81672582 (to H. L.) and 31771521 (to Z. T.); Natural Science Foundation of Jiangsu Province for Distinguished Young Scholars BK20160013 (to H. L.); Natural Science Foundation of Jiangsu Province BE2016718 (to Z. T.); Top Talent of Innovative Research Team of Jiangsu Province (to H. L. and Z. T.); Six Talent Peak Project from Government of Jiangsu Province 2015-SWYY-019 (to H. L.) and 2016-SWYY-011 (to Z. T.); Start-up Scientific Research Fund for the Returned Oversea Scholars from Chinese Ministry of Education (to Z. T.); and P30 CA006927 (to Fox Chase Cancer Center).	Alvarez S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9548; Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Braun KA, 2007, MOL BIOL CELL, V18, P1447, DOI 10.1091/mbc.E06-09-0792; Cerchietti LC, 2009, NAT MED, V15, P1369, DOI 10.1038/nm.2059; Chiarle R, 2000, BLOOD, V95, P619, DOI 10.1182/blood.V95.2.619; Chung W, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15081; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Ding H, 2017, LEUKEMIA, V31, P1593, DOI 10.1038/leu.2016.357; Divakar SKA, 2016, LEUKEMIA, V30, P86, DOI 10.1038/leu.2015.185; Dougherty DC, 2005, BIOTECHNIQUES, V39, P203, DOI 10.2144/05392ST02; Drakos E, 2009, LEUKEMIA, V23, P784, DOI 10.1038/leu.2008.348; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; Gabbasov R., 2019, CANCER BIOL THER, V20, P1035, DOI DOI 10.1080/15384047.2019.1595279; Ganji PN, 2013, ANGIOGENESIS, V16, P903, DOI 10.1007/s10456-013-9364-7; Giulino-Roth L, 2017, MOL CANCER THER, V16, P1779, DOI 10.1158/1535-7163.MCT-16-0848; Gopalakrishnan R, 2013, CLIN CANCER RES, V19, P5016, DOI 10.1158/1078-0432.CCR-12-3510; Guan LL, 2020, ONCOTARGETS THER, V13, P2997, DOI 10.2147/OTT.S245813; Hayashi R, 2006, GENE, V367, P126, DOI 10.1016/j.gene.2005.10.002; He SQ, 2014, INVEST NEW DRUG, V32, P577, DOI 10.1007/s10637-014-0095-4; Hertlein E, 2010, BLOOD, V116, P45, DOI 10.1182/blood-2010-01-263756; Hoadley KA, 2012, P NATL ACAD SCI USA, V109, P4437, DOI 10.1073/pnas.1117279109; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hudson DF, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006483; Jacobson C, 2016, BLOOD, V128, P2517, DOI 10.1182/blood-2016-04-711176; Jares P, 2008, BRIT J HAEMATOL, V142, P149, DOI 10.1111/j.1365-2141.2008.07124.x; Jhaveri K, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S65804; Jin L, 2011, BRIT J CANCER, V104, P91, DOI 10.1038/sj.bjc.6606007; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Korz C, 2002, BLOOD, V99, P4554, DOI 10.1182/blood.V99.12.4554; Kotwal A, 2021, EUR J CELL BIOL, V100, DOI 10.1016/j.ejcb.2020.151148; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Li ZL, 2012, CANCER RES, V72, P5014, DOI 10.1158/0008-5472.CAN-12-0635; Lin SF, 2017, ONCOTARGET, V8, P41294, DOI 10.18632/oncotarget.17180; Liu H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.555; Liu HQ, 2013, CLIN CANCER RES, V19, P5053, DOI 10.1158/1078-0432.CCR-13-1115; Marzec M, 2006, BLOOD, V108, P1744, DOI 10.1182/blood-2006-04-016634; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; O'Leary B, 2016, NAT REV CLIN ONCOL, V13, P417, DOI 10.1038/nrclinonc.2016.26; Ohtani K, 1999, ONCOGENE, V18, P2299, DOI 10.1038/sj.onc.1202544; Parekh S, 2011, SEMIN CANCER BIOL, V21, P335, DOI 10.1016/j.semcancer.2011.09.008; Perez-Galan P, 2011, BLOOD, V117, P26, DOI 10.1182/blood-2010-04-189977; Pillai RN, 2020, J CLIN ONCOL, V38, P613, DOI 10.1200/JCO.19.00816; Proia DA, 2014, CANCER RES, V74, P1294, DOI 10.1158/0008-5472.CAN-13-3263; Proia DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018552; Roue G, 2011, BLOOD, V117, P1270, DOI 10.1182/blood-2010-04-278853; Shang DS, 2018, CLIN EXP PHARMACOL P, V45, P452, DOI 10.1111/1440-1681.12891; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Sheu YJ, 2016, GENOME RES, V26, P315, DOI 10.1101/gr.195248.115; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Shimamura T, 2012, CLIN CANCER RES, V18, P4973, DOI 10.1158/1078-0432.CCR-11-2967; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Smid M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12910; Solier S, 2012, P NATL ACAD SCI USA, V109, P12866, DOI 10.1073/pnas.1203617109; Sun MM, 2018, NUCLEIC ACIDS RES, V46, P6697, DOI 10.1093/nar/gky487; Suzuki M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00280; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Tu ZG, 2013, MOL CELL BIOL, V33, P1819, DOI 10.1128/MCB.01744-12; Tu ZG, 2011, DEV CELL, V21, P1077, DOI 10.1016/j.devcel.2011.10.010; Valbuena JR, 2005, MODERN PATHOL, V18, P1343, DOI 10.1038/modpathol.3800459; Wang M, 2014, BRIT J HAEMATOL, V165, P510, DOI 10.1111/bjh.12780; Wei CL, 2015, IEEE T BIOMED CIRC S, V9, P105, DOI 10.1109/TBCAS.2014.2315532; Witzig TE, 2011, LEUKEMIA, V25, P341, DOI 10.1038/leu.2010.226; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755; Yoshida K, 2004, ONCOGENE, V23, P3802, DOI 10.1038/sj.onc.1207488	69	8	8	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100996	10.1016/j.jbc.2021.100996	http://dx.doi.org/10.1016/j.jbc.2021.100996			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34302809	gold, Green Published			2022-12-26	WOS:000690868100013
J	Liu, QJ; Kong, YL; Guo, XD; Liang, BE; Xie, HX; Hu, S; Han, MK; Zhao, XD; Feng, PN; Lyu, QQ; Dong, W; Liang, XL; Wang, WD; Li, CL				Liu, Qiaojuan; Kong, Yonglun; Guo, Xiangdong; Liang, Baien; Xie, Haixia; Hu, Shan; Han, Mengke; Zhao, Xiaoduo; Feng, Pinning; Lyu, Qianqian; Dong, Wei; Liang, Xinling; Wang, Weidong; Li, Chunling			GSK-3 beta inhibitor TDZD-8 prevents reduction of aquaporin-1 expression via activating autophagy under renal ischemia reperfusion injury	FASEB JOURNAL			English	Article						AQP1; autophagy; GSK-3 beta; ischemia/reperfusion	NF-KAPPA-B; AQP2 EXPRESSION; DOWN-REGULATION; KIDNEY; INFLAMMASOME; PATHOPHYSIOLOGY; HYPERCALCEMIA; DEGRADATION; TUBULE; CELLS	Renal ischemia/reperfusion (I/R) injury is a main cause of acute kidney injury (AKI). Aquaporin (AQP)-1 water channel in the kidney is critical for the maintenance of water homeostasis and the urinary concentrating ability. Increasing evidence supports an important role of autophagy in the pathogenesis of AKI induced by renal I/R. The purpose of the present study is to investigate whether activation of autophagy prevents downregulation of AQP1 protein induced by renal I/R and potential molecular mechanisms. Renal I/R induced consistently reduced protein expression of AQP1, 2, and 3, as well as sodium cotransporters Na+-K+-2Cl(-) cotransporter and alpha-Na,K-ATPase, which was associated with increased urine output and decreased creatinine clearance in rats. Renal I/R also suppressed autophagy and increased inflammatory responses in the kidney. 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-di one (TDZD-8), the glycogen synthase kinase-3 beta inhibitor, ameliorated renal injury under I/R, activated autophagy and markedly increased expression of AQPs and sodium transporters in the kidney, which was associated with improved urine output and creatinine clearance in rats. Hypoxia/reoxygenation (H/R) induced suppression of autophagy and downregulation of AQP1 in murine inner medullary collecting duct 3 (IMCD3) cells, which was fully prevented by TDZD-8 treatment. Inhibition of autophagy by 3-methyladenine or Atg5 gene knockdown attenuated recovery of AQP1 protein expression induced by TDZD-8 in IMCD3 cells with H/R. Interleukin-1 beta (IL-1 beta) decreased the abundance of AQP1 protein in IMCD3 cells. H/R induced increases in protein expression of nod-like receptor pyrin domain-containing 3 and IL-1 beta, which was reversed by TDZD-8. In conclusion, TDZD-8 treatment prevented downregulation of AQP1 expression under renal I/R injury, likely via activating autophagy and decreasing IL-1 beta production.	[Liu, Qiaojuan; Kong, Yonglun; Guo, Xiangdong; Liang, Baien; Xie, Haixia; Hu, Shan; Han, Mengke; Zhao, Xiaoduo; Wang, Weidong; Li, Chunling] Sun Yat Sen Univ, Sch Med, Inst Hypertens, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Liu, Qiaojuan] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Immunol, Guangzhou, Peoples R China; [Feng, Pinning] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Clin Lab, Guangzhou, Peoples R China; [Lyu, Qianqian] Ocean Univ China, Coll Marine Life Sci, MOE Key Lab Marine Genet & Breeding, Qingdao, Peoples R China; [Dong, Wei; Liang, Xinling] Guangdong Acad Med Sci, Guangdong Prov Peoples Hosp, Divis Nephrol, Guangzhou, Peoples R China; [Wang, Weidong] Sun Yat Ssen Univ, Affiliated Hosp 7, Dept Nephrol, Shenzhen, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Ocean University of China; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Wang, WD; Li, CL (corresponding author), Sun Yat Sen Univ, Sch Med, Inst Hypertens, 74 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	wangwd6@mail.sysu.edu.cn; lichl3@mail.sysu.edu.cn		Wang, Weidong/0000-0003-2523-3145	National Natural Science Foundation of China [81870465, 81970623, 81570635, 81670646]; Natural Science Foundation of Guangzhou [201904010255]; Natural Science Foundation of Guangdong Province [2021A1515011482, 2016A020215034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangzhou; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	National Natural Science Foundation of China, Grant/Award Number: 81870465, 81970623, 81570635 and 81670646; Natural Science Foundation of Guangzhou, Grant/Award Number: 201904010255; Natural Science Foundation of Guangdong Province, Grant/Award Number: 2021A1515011482 and 2016A020215034	Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Chatauret N, 2014, PROG UROL, V24, pS4, DOI 10.1016/S1166-7087(14)70057-0; Chou CL, 1999, J CLIN INVEST, V103, P491, DOI 10.1172/JCI5704; Covington MD, 2005, AM J PHYSIOL-RENAL, V289, pF280, DOI 10.1152/ajprenal.00351.2004; Decuypere JP, 2015, AM J KIDNEY DIS, V66, P699, DOI 10.1053/j.ajkd.2015.05.021; Deretic V, 2018, AUTOPHAGY, V14, P179, DOI 10.1080/15548627.2017.1412229; Deretic V, 2018, AUTOPHAGY, V14, P243, DOI 10.1080/15548627.2017.1402992; Devarajan P, 2015, NEPHRON, V131, P85, DOI 10.1159/000437237; Duann P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050662; Gong H, 2004, KIDNEY INT, V66, P683, DOI 10.1111/j.1523-1755.2004.00791.x; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Helbert MJF, 1997, KIDNEY INT, V52, P414, DOI 10.1038/ki.1997.348; Hu S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01157; Hua Y, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20182303; Jang HR, 2009, CLIN IMMUNOL, V130, P41, DOI 10.1016/j.clim.2008.08.016; Khositseth S, 2017, KIDNEY INT, V91, P1070, DOI 10.1016/j.kint.2016.12.005; Khositseth S, 2015, SCI REP-UK, V5, DOI 10.1038/srep18311; Kim WY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39702-4; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; Kwon TH, 1999, AM J PHYSIOL-RENAL, V277, pF413, DOI 10.1152/ajprenal.1999.277.3.F413; Lanaspa MA, 2010, J BIOL CHEM, V285, P31694, DOI 10.1074/jbc.M109.093690; Leemans JC, 2014, NAT REV NEPHROL, V10, P398, DOI 10.1038/nrneph.2014.91; Lempiainen J, 2013, ACTA PHYSIOL, V208, P410, DOI 10.1111/apha.12120; Li CL, 2003, AM J PHYSIOL-RENAL, V284, pF1066, DOI 10.1152/ajprenal.00090.2002; Liu SY, 2012, AUTOPHAGY, V8, P826, DOI 10.4161/auto.19419; Liu T, 2016, CELL REP, V16, P1988, DOI 10.1016/j.celrep.2016.07.019; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Ma ZW, 2014, BBA-MOL BASIS DIS, V1842, P1088, DOI 10.1016/j.bbadis.2014.04.002; Mancinelli R, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4629495; Nakagawa S, 2012, EUR J PHARMACOL, V696, P143, DOI 10.1016/j.ejphar.2012.09.010; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Norregaard R, 2015, AM J PHYSIOL-RENAL, V308, pF650, DOI 10.1152/ajprenal.00516.2014; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Shimura T, 2011, J RADIAT RES, V52, P539, DOI 10.1269/jrr.11098; Singh SP, 2015, DIS MODEL MECH, V8, P931, DOI 10.1242/dmm.020511; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Wang FF, 2018, AM J PHYSIOL-RENAL, V315, pF199, DOI 10.1152/ajprenal.00609.2017; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Wang WD, 2002, AM J PHYSIOL-RENAL, V283, pF1313, DOI 10.1152/ajprenal.00040.2002; Wang WD, 2008, AM J PHYSIOL-RENAL, V294, pF1473, DOI 10.1152/ajprenal.00036.2008; Wang WD, 2015, AM J PHYSIOL-RENAL, V308, pF910, DOI 10.1152/ajprenal.00649.2014; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhong ZY, 2016, CELL, V164, P896, DOI 10.1016/j.cell.2015.12.057; Zuk A, 2016, ANNU REV MED, V67, P293, DOI 10.1146/annurev-med-050214-013407	49	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21809	10.1096/fj.202100549R	http://dx.doi.org/10.1096/fj.202100549R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314052				2022-12-26	WOS:000678975300041
J	Lorenzetti, L; Swann, M; Martinez, A; O'Regan, A; Taylor, J; Hoyt, A				Lorenzetti, Lara; Swann, Mandy; Martinez, Andres; O'Regan, Amy; Taylor, Jamilah; Hoyt, Alexis			Using financial diaries to understand the economic lives of HIV-positive pregnant women and new mothers in PMTCT in Zomba, Malawi	PLOS ONE			English	Article							OPTION B PLUS; ANTIRETROVIRAL THERAPY; RETENTION; CARE; LILONGWE; PROGRAM; CASCADE; IMPACT	Background Economic strengthening (ES) interventions can address economic barriers to retention and adherence (R&A) to antiretroviral therapy in prevention of mother-to-child transmission (PMTCT) services. To inform tailoring of ES activities for PMTCT, we used financial diaries to understand the economic lives of women in PMTCT and examine associations between participants' finances and their R&A. Methods We collected financial data from a stratified sample (n = 241) of HIV-positive pregnant women and new mothers enrolled in PMTCT from three clinics in Zomba, Malawi. For 30 weeks, participants met with staff to record cash and in-kind inflows and outflows. We used clinical records to calculate a measure of R&A for each participant. We summarized diary data using R and used cox proportional hazard models to examine the relationship between R&A and participant characteristics and behavior. Results There were 68,097 cash transactions over 30 weeks, with 10% characterized as inflows. The median value of cash inflows was US$3.54 compared with US$0.42 for cash outflows. Fewer than 7% of total transactions were considered related to PMTCT, with the majority classified as food or drink. Participants in the rural site had the lowest hazard of non-adherence. Decreased hazard of non-adherence was also linked to having dependents and years on ART. There were significant differences in cash inflows and outflows between those who were always adherent and those who were not. Conclusions Financial inflows were large and erratic, whereas outflows were small but consistent. PMTCT expenses comprised a small proportion of overall expenses and focused on proper nutrition. The influence of inflows and outflows on adherence was significant but small; however, always adherent participants demonstrated smoother inflows and outflows, indicating an association between greater adherence and economic stability. Participants would benefit from interventions that bolster and stabilize their economic lives, including income generating activities in the agricultural industry and inclusion in village banks.	[Lorenzetti, Lara; Martinez, Andres; O'Regan, Amy; Taylor, Jamilah; Hoyt, Alexis] Global Hlth & Populat Res, Durham, NC 27710 USA; [Swann, Mandy] Global Educ Employment & Engagement, Washington, DC USA		Lorenzetti, L (corresponding author), Global Hlth & Populat Res, Durham, NC 27710 USA.	llorenzetti@fhi360.org		Lorenzetti, Lara/0000-0003-4758-7390	American people through the United States Agency for International Development (USAID); United States President's Emergency Plan for AIDS Relief (PEPFAR) [AIDOAALA-13-00001]	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was produced with the generous financial support of the American people through the United States Agency for International Development (USAID) (https://www.usaid.gov/) and the United States President's Emergency Plan for AIDS Relief (PEPFAR) (https://www.state.gov/pepfar/) under Cooperative Agreement No. AIDOAALA-13-00001. USAID reviewed and approved the study design and a draft of this manuscript. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.	[Anonymous], 2009, PRINCET U PRESS, DOI DOI 10.1080/09614524.2010.491535; Brittain K., 2018, J ACQUIRED IMMUNE DE, V18, P379; Cataldo F, 2017, JAIDS-J ACQ IMM DEF, V75, pS224, DOI [10.1097/QAI.0000000000001375, 10.1097/qai.0000000000001375]; Flax VL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175590; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; HIarlaithe MO, 2014, AIDS BEHAV, V18, pS516, DOI 10.1007/s10461-014-0756-5; Iroezi Ngozi D, 2013, Afr J Reprod Health, V17, P118; Joint United Nations Programme on HIV/AIDS, 2019, GLOB AIDS UPD 2019 C; Kamuyango Alfred A, 2014, World J AIDS, V4, P332; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V70, P99, DOI 10.1097/QAI.0000000000000692; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V68, pE77, DOI 10.1097/QAI.0000000000000517; Knettel BA, 2018, JAIDS-J ACQ IMM DEF, V77, P427, DOI 10.1097/QAI.0000000000001616; Rotheram-Borus MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084867; Swann M, 2018, AIDS CARE, V30, P99, DOI 10.1080/09540121.2018.1479030; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; UNAIDS, 2014, CAM DEV SUBN EST HIV, P19; Watt MH, 2018, AIDS BEHAV, V22, P3945, DOI 10.1007/s10461-018-2272-5; WHO/AFRO, 2014, IMPL OPT B PREV MOTH IMPL OPT B PREV MOTH; Yacobson I., 2016, INT J POPULATION RES, V2016, P1; Yotebieng M, 2016, LANCET HIV, V3, pE85, DOI 10.1016/S2352-3018(15)00247-7	22	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0252083	10.1371/journal.pone.0252083	http://dx.doi.org/10.1371/journal.pone.0252083			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329327	Green Published, gold			2022-12-26	WOS:000685248600044
J	Hledik, M; Polechova, J; Beiglbock, M; Herdina, AN; Strassl, R; Posch, M				Hledik, Michal; Polechova, Jitka; Beiglbock, Mathias; Herdina, Anna Nele; Strassl, Robert; Posch, Martin			Analysis of the specificity of a COVID-19 antigen test in the Slovak mass testing program	PLOS ONE			English	Article								Aims Mass antigen testing programs have been challenged because of an alleged insufficient specificity, leading to a large number of false positives. The objective of this study is to derive a lower bound of the specificity of the SD Biosensor Standard Q Ag-Test in large scale practical use. Methods Based on county data from the nationwide tests for SARS-CoV-2 in Slovakia between 31.10.-1.11. 2020 we calculate a lower confidence bound for the specificity. As positive test results were not systematically verified by PCR tests, we base the lower bound on a worst case assumption, assuming all positives to be false positives. Results 3,625,332 persons from 79 counties were tested. The lowest positivity rate was observed in the county of Roznava where 100 out of 34307 (0.29%) tests were positive. This implies a test specificity of at least 99.6% (97.5% one-sided lower confidence bound, adjusted for multiplicity). Conclusion The obtained lower bound suggests a higher specificity compared to earlier studies in spite of the underlying worst case assumption and the application in a mass testing setting. The actual specificity is expected to exceed 99.6% if the prevalence in the respective regions was non-negligible at the time of testing. To our knowledge, this estimate constitutes the first bound obtained from large scale practical use of an antigen test.	[Hledik, Michal] Inst Sci & Technol Austria IST Austria, Klosterneuburg, Austria; [Polechova, Jitka; Beiglbock, Mathias] Univ Vienna, Dept Math, Vienna, Austria; [Herdina, Anna Nele; Strassl, Robert] Med Univ Vienna, Dept Lab Med, Div Clin Virol, Vienna, Austria; [Posch, Martin] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria	Institute of Science & Technology - Austria; University of Vienna; Medical University of Vienna; Medical University of Vienna	Posch, M (corresponding author), Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria.	martin.posch@meduniwien.ac.at	Posch, Martin/C-7907-2009	Posch, Martin/0000-0001-8499-8573; Polechova, Jitka/0000-0003-0951-3112				Boova K., 2020, CHARACTERISTIC SPATI, DOI [10.1101/2020.12.23.20248808, DOI 10.1101/2020.12.23.20248808]; Cerutti F, 2020, J CLIN VIROL, V132, DOI 10.1016/j.jcv.2020.104654; Corman VM, 2021, LANCET MICROBE, V2, pE311, DOI 10.1016/S2666-5247(21)00056-2; Dinnes J, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013705, 10.1002/14651858.CD013705.pub2]; Fuentes C, 2018, ELECTRON J STAT, V12, P58, DOI 10.1214/17-EJS1374; Holt E, 2020, LANCET, V396, P1386, DOI 10.1016/S0140-6736(20)32261-3; IZA, I HEALTHC AN IZA MIN; Kruger LJ, 2020, EVALUATION ACCURACY, DOI [10.01.20203836, 10.1101/2020.10.01.20203836]; Larremore DB, 2021, SCI ADV, V7, DOI [10.1101/2020.06.22.20136309, 10.1126/sciadv.abd5393]; Lindner AK, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03961-2020; Mina MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2025631; Pavelka M, 2021, SCIENCE, V372, P635, DOI 10.1126/science.abf9648; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; SD Biosensor, 2021, Q COVID 19 AG INSTR; Statistical Office of Slovak Republic, DEM SOC STAT	15	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255267	10.1371/journal.pone.0255267	http://dx.doi.org/10.1371/journal.pone.0255267			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324553	gold, Green Published			2022-12-26	WOS:000685248200095
J	Lepinay, J; Taragnat, C; Dubois, JP; Chesneau, D; Jockers, R; Delagrange, P; Bozon, V				Lepinay, Julie; Taragnat, Catherine; Dubois, Jean-Philippe; Chesneau, Didier; Jockers, Ralf; Delagrange, Philippe; Bozon, Veronique			Negative regulation of melatonin secretion by melatonin receptors in ovine pinealocytes	PLOS ONE			English	Article							ARYLALKYLAMINE N-ACETYLTRANSFERASE; PARS-TUBERALIS; MOLECULAR PHARMACOLOGY; SIGNAL-TRANSDUCTION; CALCIUM-CHANNELS; SERUM MELATONIN; BINDING-SITES; MT1; ASTROCYTES; CELLS	Melatonin (MLT) is a biological modulator of circadian and seasonal rhythms and reproduction. The photoperiodic information is detected by retinal photoreceptors and transmitted through nerve transmissions to the pineal gland, where MLT is synthesized and secreted at night into the blood. MLT interacts with two G protein-coupled receptors, MT1 and MT2. The aim of our work was to provide evidence for the presence of MLT receptors in the ovine pineal gland and define their involvement on melatonin secretion. For the first time, we identified the expression of MLT receptors with the specific 2-[I-125]-MLT agonistic radioligand in ovin pinealocytes. The values of Kd and Bmax are 2.24 +/- 1.1 nM and 20 +/- 6.8 fmol/mg. MLT receptors are functional and inhibit cAMP production and activate ERK1/2 through pertussis toxin-sensitive G(i/o) proteins. The MLT receptor antagonist/ inverse agonist luzindole increased cAMP production (189 +/- 30%) and MLT secretion (866 +/- 13%). The effect of luzindole on MLT secretion was additive with the effect of well-described activators of this pathway such as the beta-adrenergic agonist isoproterenol and the alpha-adrenergic agonist phenylephrine. Co-incubation of all three compounds increased MLT secretion by 1236 +/- 199%. These results suggest that MLT receptors are involved in the negative regulation of the synthesis of its own ligand in pinealocytes. While adrenergic receptors promote MLT secretion, MLT receptors mitigate this effect to limit the quantity of MLT secreted by the pineal gland.	[Lepinay, Julie; Taragnat, Catherine; Dubois, Jean-Philippe; Chesneau, Didier; Bozon, Veronique] Univ Tours, Physiol Reprod & Comportements, Nouzilly, France; [Jockers, Ralf] Univ Paris, CNRS, Inst Cochin, INSERM, Paris, France; [Delagrange, Philippe] Inst Rech Servier, Croissy Sur Seine, France	Universite de Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Servier; Institut de Recherches Internationales Servier	Bozon, V (corresponding author), Univ Tours, Physiol Reprod & Comportements, Nouzilly, France.	veronique.bozon@inrae.fr		Chesneau, Didier/0000-0003-4006-7878	INRAE; l'Institut de Recherche Servier (IDRS, Croissy sur Seine, France) [32000432]	INRAE; l'Institut de Recherche Servier (IDRS, Croissy sur Seine, France)	This study was supported by INRAE and a grant from l'Institut de Recherche Servier (IDRS, Croissy sur Seine, France). Grant no: 32000432. The funders had role in study design, analysis of results and decision to publish.	Acuna-Castroviejo D, 2014, CELL MOL LIFE SCI, V71, P2997, DOI 10.1007/s00018-014-1579-2; Adachi A, 2002, GLIA, V39, P268, DOI 10.1002/glia.10109; Afeche SC, 2006, CELL BIOCHEM FUNCT, V24, P499, DOI 10.1002/cbf.1270; Al-Ghoul WM, 1998, NEUROREPORT, V9, P4063, DOI 10.1097/00001756-199812210-00011; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Arendt J., 1995, MELATONIN MAMMALIAN; Arendt J, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00391; Audinot V, 2008, BIOCHEM PHARMACOL, V75, P2007, DOI 10.1016/j.bcp.2008.02.022; Barbosa R, 2008, LIFE SCI, V82, P529, DOI 10.1016/j.lfs.2007.12.011; Bondi CD, 2008, J PINEAL RES, V44, P288, DOI 10.1111/j.1600-079X.2007.00525.x; Boutin JA, 2019, J PHARMACOL EXP THER, V368, P59, DOI 10.1124/jpet.118.253260; Browning C, 2000, BRIT J PHARMACOL, V129, P877, DOI 10.1038/sj.bjp.0703130; Brunet AG, 2002, J ENDOCRINOL, V172, P397, DOI 10.1677/joe.0.1720397; Cecon E, 2018, BRIT J PHARMACOL, V175, P3263, DOI 10.1111/bph.13950; Chan ASL, 2002, CELL SIGNAL, V14, P249, DOI 10.1016/S0898-6568(01)00240-6; Chen M, 2020, J PINEAL RES, V68, DOI 10.1111/jpi.12641; Cipolla-Neto J, 2018, ENDOCR REV, V39, P990, DOI 10.1210/er.2018-00084; Coge F, 2009, BRIT J PHARMACOL, V158, P1248, DOI 10.1111/j.1476-5381.2009.00453.x; DEREVIERS MM, 1989, NEUROSCI LETT, V100, P89, DOI 10.1016/0304-3940(89)90665-4; Desagher S, 1996, J NEUROSCI, V16, P2553; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; DUBOCOVICH ML, 1988, FASEB J, V2, P2765, DOI 10.1096/fasebj.2.12.2842214; Dubocovich ML, 1997, N-S ARCH PHARMACOL, V355, P365, DOI 10.1007/PL00004956; Dubocovich ML, 1998, FASEB J, V12, P1211, DOI 10.1096/fasebj.12.12.1211; Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102; GAUER F, 1993, BRAIN RES, V602, P153, DOI 10.1016/0006-8993(93)90256-M; Gonzalez J, 2020, FRONT NEUROINFORM, V14, DOI 10.3389/fninf.2020.00035; Gonzalez S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001347; Guesdon V, 2013, PSYCHONEUROENDOCRINO, V38, P1426, DOI 10.1016/j.psyneuen.2012.12.011; Guillaume JL, 2008, J BIOL CHEM, V283, P16762, DOI 10.1074/jbc.M802069200; Gupta B. B. P., 2005, Indian Journal of Experimental Biology, V43, P115; Hazlerigg DG, 1996, ENDOCRINOLOGY, V137, P210, DOI 10.1210/en.137.1.210; Hertz L, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00042; HOWELL HE, 1991, J PINEAL RES, V10, P122, DOI 10.1111/j.1600-079X.1991.tb00828.x; Jockers R, 2016, BRIT J PHARMACOL, V173, P2702, DOI 10.1111/bph.13536; Korf HW, 2018, GEN COMP ENDOCR, V258, P236, DOI 10.1016/j.ygcen.2017.05.011; Legros C, 2016, J PHARMACOL EXP THER, V356, P681, DOI 10.1124/jpet.115.229989; Legros C, 2014, BRIT J PHARMACOL, V171, P186, DOI 10.1111/bph.12457; Legros C, 2013, INT J MOL SCI, V14, P8948, DOI 10.3390/ijms14058948; Lewczuk B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/715708; Li T, 2019, FRONT NEUROENDOCRIN, V52, P22, DOI 10.1016/j.yfrne.2018.06.004; Liu JB, 2016, ANNU REV PHARMACOL, V56, P361, DOI 10.1146/annurev-pharmtox-010814-124742; Lopez-Bayghen E, 2007, NEURON GLIA BIOL, V3, P155, DOI 10.1017/S1740925X0700066X; Mailliet F, 2004, BIOCHEM PHARMACOL, V67, P667, DOI 10.1016/j.bcp.2003.09.037; Malpaux B, 1998, ENDOCRINOLOGY, V139, P1508, DOI 10.1210/en.139.4.1508; Malpaux B, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2231; Maronde E, 2011, J PINEAL RES, V51, P145, DOI 10.1111/j.1600-079X.2011.00880.x; Maurice P, 2010, EMBO J, V29, P3646, DOI 10.1038/emboj.2010.236; Mays JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205883; McNulty S, 1996, J NEUROENDOCRINOL, V8, P635; MCNULTY S, 1994, J NEUROENDOCRINOL, V6, P523, DOI 10.1111/j.1365-2826.1994.tb00615.x; Migaud M, 2005, BIOL REPROD, V72, P393, DOI 10.1095/biolreprod.104.030064; Moller M, 2002, CELL TISSUE RES, V309, P139, DOI 10.1007/s00441-002-0580-5; MORGAN PJ, 1989, J NEUROENDOCRINOL, V1, P1, DOI 10.1111/j.1365-2826.1989.tb00068.x; MORGAN PJ, 1992, J NEUROENDOCRINOL, V4, P557, DOI 10.1111/j.1365-2826.1992.tb00204.x; MORGAN PJ, 1991, CELL TISSUE RES, V263, P529, DOI 10.1007/BF00327285; NAMBOODIRI MAA, 1985, J NEUROCHEM, V45, P832, DOI 10.1111/j.1471-4159.1985.tb04069.x; NAMBOODIRI MAA, 1985, COMP BIOCHEM PHYS B, V80, P731, DOI 10.1016/0305-0491(85)90453-5; Nosjean O, 2000, J BIOL CHEM, V275, P31311, DOI 10.1074/jbc.M005141200; Privat K., 2002, CELL MOL NEUROBIOL, P13, DOI [10.1023/a%3A1015385527187, DOI 10.1023/A%3A1015385527187]; Rath MF, 2016, ENDOCRINOLOGY, V157, P2028, DOI 10.1210/en.2015-1888; Ravault JP, 1996, J NEUROENDOCRINOL, V8, P387, DOI 10.1046/j.1365-2826.1996.04667.x; Reiter RJ, 2007, ACTA BIOCHIM POL, V54, P1; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; ROLLAG MD, 1978, BIOL REPROD, V18, P279, DOI 10.1095/biolreprod18.2.279; ROLLAG MD, 1976, ENDOCRINOLOGY, V98, P482, DOI 10.1210/endo-98-2-482; Saha S, 2019, GEN COMP ENDOCR, V279, P27, DOI 10.1016/j.ygcen.2018.07.010; Samanta S, 2022, ARCH PHYSIOL BIOCHEM, V128, P1346, DOI 10.1080/13813455.2020.1770799; Schomerus C, 2004, J NEUROENDOCRINOL, V16, P741, DOI 10.1111/j.1365-2826.2004.01228.x; Shiu SYW, 2010, J PINEAL RES, V49, P301, DOI 10.1111/j.1600-079X.2010.00795.x; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Stehle JH, 2011, J PINEAL RES, V51, P17, DOI 10.1111/j.1600-079X.2011.00856.x; SUGDEN D, 1985, J NEUROCHEM, V44, P769, DOI 10.1111/j.1471-4159.1985.tb12881.x; Sung JY., 2018, MOLECULES, V23, P1; TILLET Y, 1986, CR ACAD SCI III-VIE, V303, P77; Trecherel E, 2010, ANIM REPROD SCI, V122, P328, DOI 10.1016/j.anireprosci.2010.10.007; VAKKURI O, 1984, ANAL BIOCHEM, V142, P284, DOI 10.1016/0003-2697(84)90466-4; VANECEK J, 1987, BRAIN RES, V435, P359, DOI 10.1016/0006-8993(87)91625-8; Villela D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/618432; ViviD D, 2018, MOLECULES, V23, DOI 10.3390/molecules23030652; Yamada H, 1998, J NEUROSCI, V18, P2056; Yamada H, 2002, J NEUROCHEM, V81, P533, DOI 10.1046/j.1471-4159.2002.00839.x; Yamada H, 1998, J NEUROSCI, V18, P4946; ZANG X, 1985, J NEUROPATH EXP NEUR, V44, P486, DOI 10.1097/00005072-198509000-00004; Zhao D, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00249	86	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255249	10.1371/journal.pone.0255249	http://dx.doi.org/10.1371/journal.pone.0255249			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324562	gold, Green Published			2022-12-26	WOS:000685248200025
J	Master, A; Kontzias, A; Huang, LQ; Huang, W; Tsioulias, A; Zarabi, S; Wolek, M; Wollocko, BM; Honkanen, R; Rigas, B				Master, Adam; Kontzias, Apostolos; Huang, Liqun; Huang, Wei; Tsioulias, Anna; Zarabi, Samaneh; Wolek, Michael; Wollocko, Brian M.; Honkanen, Robert; Rigas, Basil			The transcriptome of rabbit conjunctiva in dry eye disease: Large-scale changes and similarity to the human dry eye	PLOS ONE			English	Article							OCULAR SURFACE; TEAR PROTEOME; EXPRESSION; CELLS; SYMPTOMS; SIGNS; TH17	The pathophysiology of dry eye disease (DED) remains largely unknown, accounting in part for the lack of successful treatments. We explored the pathophysiology of DED using a rabbit model of chronic DED induced with 3 weekly injections of Concanavalin A into the periorbital lacrimal glands. The transcriptome of full-thickness's conjunctival tissue from rabbits with DED and from normal controls was determined using microarrays and, as needed, confirmatory real-time polymerase chain reactions. Results were subjected to bioinformatic analysis. DED induced large-scale changes in gene transcription involving 5,184 genes (22% of the total). Differentially expressed genes could be segregated into: functional modules and clusters; altered pathways; functionally linked genes; and groups of individual genes of known or suspected pathophysiological relevance to DED. A common feature of these subgroups is the breadth and magnitude of the changes that encompass ocular immunology and essentially all aspects of cell biology. Prominent changes concerned innate and adaptive immune responses; ocular surface inflammation; at least 25 significantly altered signaling pathways; a large number of chemokines; cell cycle; and apoptosis. Comparison of our findings to the limited extant transcriptomic data from DED patients associated with either Sjogren's syndrome or non-Sjogren's etiologies revealed a significant correlation between human and rabbit DED transcriptomes. Our data, establishing the large-scale transcriptomic changes of DED and their potential similarity to the human, underscore the enormous complexity of DED; establish a robust animal model of DED; will help expand our understanding of its pathophysiology; and could guide the development of successful therapeutic strategies.	[Master, Adam; Huang, Liqun; Tsioulias, Anna; Rigas, Basil] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Kontzias, Apostolos] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Huang, Liqun] Medicon Pharmaceut Inc, Setauket, NY USA; [Huang, Wei; Honkanen, Robert] SUNY Stony Brook, Dept Ophthalmol, Stony Brook, NY 11794 USA; [Zarabi, Samaneh] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Wolek, Michael; Wollocko, Brian M.] SUNY Stony Brook, Renaissance Med Sch, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Rigas, B (corresponding author), SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA.	basil.rigas@stonybrookmedicine.edu	huang, wei/GLT-8234-2022	Wollocko, Brian/0000-0002-1422-9987; Wolek, Michael/0000-0002-4040-4507; zarabi, samaneh/0000-0001-9109-2040	NIH [R44EY031193]; Medicon Pharmaceuticals, Inc.	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medicon Pharmaceuticals, Inc.	LH was supported in part by NIH Grant R44EY031193 and by Medicon Pharmaceuticals, Inc. in the form of salary. Medicon Pharmaceuticals, Inc. did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JD, 2015, CLIN OPHTHALMOL, V9, P1719, DOI 10.2147/OPTH.S89700; Boehm N, 2013, INVEST OPHTH VIS SCI, V54, P2385, DOI 10.1167/iovs.11-8751; Bradley JL, 2014, CURR EYE RES, V39, P31, DOI 10.3109/02713683.2013.823213; Brignole F, 2000, INVEST OPHTH VIS SCI, V41, P1356; Brignole-Baudouin F, 2017, INVEST OPHTH VIS SCI, V58, P2438, DOI 10.1167/iovs.15-16555; Bron AJ, 2014, OCUL SURF, V12, pS1, DOI 10.1016/j.jtos.2014.02.002; Chauhan SK, 2009, MUCOSAL IMMUNOL, V2, P375, DOI 10.1038/mi.2009.21; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen YT, 2010, AM J PATHOL, V177, P1333, DOI 10.2353/ajpath.2010.100227; Clayton JA, 2018, NEW ENGL J MED, V378, P2212, DOI 10.1056/NEJMra1407936; Craig DB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-84; Craig JP, 2017, OCUL SURF, V15, P276, DOI 10.1016/j.jtos.2017.05.008; Dogru M, 2018, INVEST OPHTH VIS SCI, V59, DOI 10.1167/iovs.17-23402; El Annan J, 2009, INVEST OPHTH VIS SCI, V50, P3802, DOI 10.1167/iovs.08-2417; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Galor A, 2015, EYE, V29, P301, DOI 10.1038/eye.2014.263; Gipson IK, 2016, PROG RETIN EYE RES, V54, P49, DOI 10.1016/j.preteyeres.2016.04.005; Golebiowski B, 2011, EXP EYE RES, V92, P408, DOI 10.1016/j.exer.2011.02.016; Honkanen RA., 2019, J VIS EXP; Honkanen R, 2021, CURR EYE RES, V46, P622, DOI 10.1080/02713683.2020.1830115; Honkanen R, 2019, CURR EYE RES, V44, P863, DOI 10.1080/02713683.2019.1594933; Honkanen RA, 2018, TRANSL RES, V198, P58, DOI 10.1016/j.trsl.2018.04.002; Jung JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13817-y; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Karnati R, 2013, EXP EYE RES, V117, P39, DOI 10.1016/j.exer.2013.05.020; Kessal K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02271; Kuntova B, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00026; Li B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05772; Liang H, 2019, OCUL SURF, V17, P516, DOI 10.1016/j.jtos.2019.03.005; Lollett IV, 2018, CLIN OPHTHALMOL, V12, P125, DOI 10.2147/OPTH.S126668; Mantelli F, 2009, INVEST OPHTH VIS SCI, V50, P2666, DOI 10.1167/iovs.08-2734; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ogawa Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113548; Oyelade J, 2016, BIOINFORM BIOL INSIG, V10, P237, DOI 10.4137/BBI.S38316; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pflugfelder SC, 2017, OPHTHALMOLOGY, V124, pS4, DOI 10.1016/j.ophtha.2017.07.010; Pflugfelder SC, 2015, INVEST OPHTH VIS SCI, V56, P7545, DOI 10.1167/iovs.15-17627; Reyes JL, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/2532314; Rhee MK, 2017, OPHTHALMOLOGY, V124, pS14, DOI 10.1016/j.ophtha.2017.08.029; Stern Michael E, 2017, Int Ophthalmol Clin, V57, P109, DOI 10.1097/IIO.0000000000000169; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tong L, 2014, OCUL SURF, V12, P23, DOI 10.1016/j.jtos.2013.10.001; Wei Y, 2014, EYE CONTACT LENS, V40, P248, DOI 10.1097/ICL.0000000000000042; Yoon KC, 2007, INVEST OPHTH VIS SCI, V48, P2561, DOI 10.1167/iovs.07-0002; Yu JH, 2011, CORNEA, V30, P379, DOI 10.1097/ICO.0b013e3181f7f363; Zhou L, 2009, J PROTEOME RES, V8, P4889, DOI 10.1021/pr900686s	48	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254036	10.1371/journal.pone.0254036	http://dx.doi.org/10.1371/journal.pone.0254036			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324523	Green Published, gold			2022-12-26	WOS:000685248200028
J	Matloko, K; Fri, J; Ateba, TP; Molale-Tom, LG; Ateba, CN				Matloko, Keduetswe; Fri, Justine; Ateba, Tshepiso Pleasure; Molale-Tom, Lesego G.; Ateba, Collins Njie			Evidence of potentially unrelated AmpC beta-lactamase producing Enterobacteriaceae from cattle, cattle products and hospital environments commonly harboring the bla(ACC) resistance determinant	PLOS ONE			English	Article							NORTH-WEST PROVINCE; ESCHERICHIA-COLI; EXTENDED-SPECTRUM; ANTIBIOTIC-RESISTANCE; KLEBSIELLA-PNEUMONIAE; SOUTH-AFRICA; BEEF-CATTLE; SHIGELLA; PREVALENCE; INFECTIONS	The occurrence and genetic relatedness of AmpC beta-lactamase producing Enterobacteriaceae isolated from clinical environments, groundwater, beef, human and cattle faeces were investigated. One hundred seventy-seven (177) samples were collected and cultured on MacConkey agar. A total of 203 non-repetitive isolates were characterised using genus/species-specific PCRs and the identified isolates were subjected to antibiotic susceptibility testing. The production of AmpC beta-lactamases was evaluated using cefoxitin disc, confirmed by the D96C detection test and their encoding genes detected by PCR. The D64C extended-spectrum beta-lactamases (ESBL) test was also performed to appraise ESBLs/AmpC co-production. The genetic fingerprints of AmpC beta-lactamase producers were determined by ERIC-PCR. A total of 116 isolates were identified as E. coli (n = 65), Shigella spp. (n = 36) and Klebsiella pneumoniae (n = 15). Ciprofloxacin resistance (44.4-55.4%) was the most frequent and resistance against the Cephem antibiotics ranged from 15-43.1% for E. coli, 25-36.1% for Shigella spp., and 20-40% for K. pneumoniae. On the other hand, these bacteria strains were most sensitive to Amikacin (0%), Meropenem (2.8%) and Piperacillin-Tazobactam (6.7%) respectively. Nineteen (16.4%) isolates comprising 16 E. coli and 3 Shigella spp. were confirmed as AmpC beta-lactamase producers. However, only E. coli isolates possessed the corresponding resistance determinants: bla(ACC) (73.7%, n = 14), bla(CIT) (26%, n = 5), bla(DHA) (11%, n = 2) and bla(FOX) (16%, n = 3). Thirty-four (27.3%) Enterobacteriaceae strains were confirmed as ESBL producers and a large proportion (79.4%, n = 27) harboured the bla(TEM) gene, however, only two were ESBLs/AmpC co-producers. Genetic fingerprinting of the AmpC beta-lactamase-producing E. coli isolates revealed low similarity between isolates. In conclusion, the findings indicate the presence of AmpC beta-lactamase-producing Enterobacteriaceae from cattle, beef products and hospital environments that commonly harbour the associated resistance determinants especially the bla(ACC) gene, nonetheless, there is limited possible cross-contamination between these environments.	[Matloko, Keduetswe; Fri, Justine; Ateba, Collins Njie] North West Univ, Antimicrobial Resistance & Phage Biocontrol Res G, Dept Microbiol, Sch Biol Sci,Fac Nat & Agr Sci, Mmabatho, South Africa; [Fri, Justine; Ateba, Collins Njie] North West Univ, Fac Nat & Agr Sci, Food Secur & Safety Niche Area, Mmabatho, South Africa; [Ateba, Tshepiso Pleasure] North West Univ, Ctr Anim Hlth Studies, Fac Nat & Agr Sci, Mmabatho, South Africa; [Molale-Tom, Lesego G.] North West Univ, Unit Environm Sci & Management Microbiol, Potchefstroom, South Africa	North West University - South Africa; North West University - South Africa; North West University - South Africa; North West University - South Africa	Ateba, CN (corresponding author), North West Univ, Antimicrobial Resistance & Phage Biocontrol Res G, Dept Microbiol, Sch Biol Sci,Fac Nat & Agr Sci, Mmabatho, South Africa.; Ateba, CN (corresponding author), North West Univ, Fac Nat & Agr Sci, Food Secur & Safety Niche Area, Mmabatho, South Africa.	collins.ateba@nwu.ac.za		Molale-Tom, Lesego/0000-0002-0057-7171; Justine, Fri/0000-0003-0338-5121	National Research Foundation of South Africa under the DST-NRF Internship Programme; National Research Fund of South Africa [109187]	National Research Foundation of South Africa under the DST-NRF Internship Programme; National Research Fund of South Africa	The authors are grateful to the National Research Foundation of South Africa for their financial support provided to MK under the DST-NRF Internship Programme (2018 -2019). The North-West University is highly appreciated for providing the space for bench work. This project was also supported in part by an incentive funding for rated researchers funding (grant UID number 109187) awarded to CNA by the National Research Fund of South Africa.	Abebe W, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1221-9; Algammal AM, 2020, AMB EXPRESS, V10, DOI 10.1186/s13568-020-01037-z; [Anonymous], 2014, CTR DIS CONTROL PREV; [Anonymous], 2011, ENTEROBACTERIACEAE T; APHA, 1995, STANDARD METHODS EXA, Vnineteenth; Ateba CN, 2008, S AFR J SCI, V104, P7; Ateba CN, 2011, J LIFE SC, V8; Ateba CN, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9110745; Ateba Collins Njie, 2014, J FOOD NUTRIT RES, V2, P288, DOI [10.12691/jfnr-2-6-4, DOI 10.12691/JFNR-2-6-4]; Bajpai Trupti, 2017, Avicenna J Med, V7, P12, DOI 10.4103/2231-0770.197508; Baker S, 2018, CURR OPIN INFECT DIS, V31, P449, DOI 10.1097/QCO.0000000000000475; Baral P, 2013, BRAZ J INFECT DIS, V17, P256, DOI 10.1016/j.bjid.2012.09.012; BEJ AK, 1991, APPL ENVIRON MICROB, V57, P1013, DOI 10.1128/AEM.57.4.1013-1017.1991; Bello OO., 2013, INT J PHARM BIOL SCI, V8, P18; Black JA, 2005, J CLIN MICROBIOL, V43, P3110, DOI 10.1128/JCM.43.7.3110-3113.2005; Brolund Alma, 2014, Infection Ecology & Epidemiology, V4, P24555, DOI 10.3402/iee.v4.24555; Bush K., 2010, ANTIMICROB AGENTS CH, V54, P969, DOI [DOI 10.1128/AAC.01009-09, 10.1128/aac.01009-09]; Bush K, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01076-18; Clinical Laboratory Standards Institute, 2016, PERFORMANCE STANDARD, VM100S; Coertze RD, 2018, WATER SCI TECHNOL, P603, DOI 10.2166/wst.2018.188; Coudron PE, 2000, J CLIN MICROBIOL, V38, P1791, DOI 10.1128/JCM.38.5.1791-1796.2000; DeFrancesco AS, 2017, SAMJ S AFR MED J, V107, P205, DOI [10.7196/SAMJ.2017.v107i3.12111, 10.7196/samj.2017.v107i3.12111]; Dirar M, 2020, CUREUS, V12, DOI 10.7759/cureus.7260; Dos Santos G.S., 2015, BATTLE MICROBIAL PAT, V2, P794; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ejikeugwu C, 2016, ARCH CLIN MICROBIOL, V7, P1; El-Hady S.A., 2015, J MED HUM GENET, V16, P239, DOI DOI 10.1016/J.EJMHG.2015.03.001; El-Sayed ME, 2019, REV MED VET-TOULOUSE, V170, P80; Ewers C., 2015, ZOONOSES INFECT AFFE, P379; Flokas ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171216; Founou RC., 2019, SCI REP-UK, V9, P1; Fri J, 2020, INT J MICROBIOL, V2020, DOI 10.1155/2020/9803903; Greenhill AR, 2014, J INFECT DEV COUNTR, V8, P1391, DOI 10.3855/jidc.4396; Grover Naveen, 2013, Med J Armed Forces India, V69, P4, DOI 10.1016/j.mjafi.2012.02.001; Gwida Mayada, 2014, Int Sch Res Notices, V2014, P565671, DOI 10.1155/2014/565671; Halstead FD, 2012, J ANTIMICROB CHEMOTH, V67, P2303, DOI 10.1093/jac/dks170; Hanson ND, 1999, CURR PHARM DESIGN, V5, P881; Haque M, 2018, INFECT DRUG RESIST, V11, P2321, DOI 10.2147/IDR.S177247; Helmy MM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/171548; Hujer KM, 2006, ANTIMICROB AGENTS CH, V50, P4114, DOI 10.1128/AAC.00778-06; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Karadiya R, 2016, J EVOL MED DENT SCI-, V5, P1729, DOI 10.14260/jemds/2016/408; Karkaba A, 2017, NEW ZEAL VET J, V65, P105, DOI 10.1080/00480169.2016.1271730; Khalil IA, 2018, LANCET INFECT DIS, V18, P1229, DOI [10.1016/S1473-3099(18)30475-4, 10.1016/s1473-3099(18)30475-4]; Khan F., 2011, Biology and Medicine, V3, P313; Khari FIM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150643; Kilonzo-Nthenge A, 2013, POULTRY SCI, V92, P1098, DOI 10.3382/ps.2012-02581; King CW, 2010, S AFR J SCI, V106, P73, DOI 10.4102/sajs.v106i11/12.211; Kinge CNW, 2010, S AFR J SCI, V106, P44, DOI 10.4102/sajs.v106i1/2.14; Liu Y, 2008, INT J FOOD MICROBIOL, V125, P230, DOI 10.1016/j.ijfoodmicro.2008.03.005; Makabanyane IN., 2015, J FOOD NUTR RES, V3, P121; Min BR, 2020, J ANIM SCI, V98, P386, DOI 10.1093/jas/skaa278.680; Montso Kotsoana Peter, 2019, Biomed Res Int, V2019, P4318306, DOI 10.1155/2019/4318306; Morrissey I, 2013, PHARMACEUTICALS-BASE, V6, P1335, DOI 10.3390/ph6111335; Moxon CA, 2016, J INFECTION, V72, pS41, DOI 10.1016/j.jinf.2016.04.021; Nakaye Martha, 2014, Br Biotechnol J, V4, P1026; Obioma A., 2017, ANN CLIN LAB RES, V5, P183; Oduro-Mensah D, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0144-2; Paczosa MK, 2016, MICROBIOL MOL BIOL R, V80, P629, DOI 10.1128/MMBR.00078-15; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Polsfuss S, 2011, J CLIN MICROBIOL, V49, P2798, DOI 10.1128/JCM.00404-11; Pormohammad A, 2019, INFECT DRUG RESIST, V12, P1181, DOI 10.2147/IDR.S201324; Ranjbar R, 2014, IRAN J PUBLIC HEALTH, V43, P1657; Rensing KL, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0494-6; Richards VP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119799; Richter L, 2019, FOODBORNE PATHOG DIS, V16, P421, DOI 10.1089/fpd.2018.2558; Robin F, 2006, ANTIMICROB AGENTS CH, V50, P2403, DOI 10.1128/AAC.01639-05; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Sudarwanto MB, 2017, ASIAN PAC J TROP BIO, V7, P708, DOI 10.1016/j.apjtb.2017.07.012; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/s1473-3099(17)30753-3, 10.1016/S1473-3099(17)30753-3]; Thomson KS, 2010, J CLIN MICROBIOL, V48, P1019, DOI 10.1128/JCM.00219-10; Toval F, 2014, J CLIN MICROBIOL, V52, P407, DOI 10.1128/JCM.02069-13; Tshitshi L, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9110820; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Wanger A., 2017, MICROBIOL MOL DIAGN, P51, DOI [10.1016/B978-0-12-805351-5.00004-1, DOI 10.1016/B978-0-12-805351-5.00004-1]; Wassef M, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.8556; Weaver JM., 2007, WATER RES COMMISSION; World Health Organization, 2018, B WORLD HEALTH ORGAN; Yang K, 2007, ANN PHARMACOTHER, V41, P1427, DOI 10.1345/aph.1K213; Yang SC, 2015, MICROBIOL RES, V181, P43, DOI 10.1016/j.micres.2015.08.006; Ye QH, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01709; Yismaw O., 2006, ETHIOP J HEALTH DEV, V20	83	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0253647	10.1371/journal.pone.0253647	http://dx.doi.org/10.1371/journal.pone.0253647			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324493	gold, Green Published			2022-12-26	WOS:000685248200101
J	Babicka-Wirkus, A; Wirkus, L; Stasiak, K; Kozlowski, P				Babicka-Wirkus, Anna; Wirkus, Lukasz; Stasiak, Krzysztof; Kozlowski, Pawel			University students' strategies of coping with stress during the coronavirus pandemic: Data from Poland	PLOS ONE			English	Article							MENTAL-HEALTH; DEPRESSION; COVID-19; PREVALENCE; RESILIENCE; BURNOUT; SEEKING; GENDER	The COVID-19 pandemic has changed the functioning of universities worldwide. In Poland, the transfer to online teaching was announced without prior warning, which radically changed students' daily functioning. This situation clearly showed the students' helplessness and difficulties with coping with this new, stressful situation, highlighted in many previous studies. A sudden and far-reaching change in daily functioning caused anxiety, depression, and stress in this group. Thus, from a pedagogical and psychological point of view, it is pertinent to examine the students' strategies of coping with stress caused by the COVID-19 pandemic. To this end, in 2020, a sample of Polish students was anonymously measured using the Mini-COPE questionnaire. Data was gathered from 577 students from 17 universities. The statistical analysis showed that during the coronavirus pandemic, Polish students most often used the coping strategies of: acceptance, planning, and seeking emotional support. Such factors as age, gender, and place of residence influenced the choice of specific strategies of coping with stress during the COVID-19 pandemic. The results also showed that the youngest students had the lowest coping skills. The results allow for concluding that the students' maladaptive strategies of coping with stress, especially during the pandemic, may result in long-term consequences for their psychophysiological health and academic achievements. Thus, based on the current results and on the participatory model of intervention, a support program for students is proposed which would involve psychological, organizational, and instrumental support.	[Babicka-Wirkus, Anna; Kozlowski, Pawel] Pomeranian Univ Slupsk, Inst Pedag, Slupsk, Poland; [Wirkus, Lukasz] Univ Gdansk, Inst Pedag, Fac Social Sci, Gdansk, Poland; [Stasiak, Krzysztof] Univ Gdansk, Fac Law & Adm, Dept Mat Criminal Law & Criminol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Babicka-Wirkus, A (corresponding author), Pomeranian Univ Slupsk, Inst Pedag, Slupsk, Poland.	anna.babicka-wirkus@apsl.edu.pl	Stasiak, Krzysztof/AAC-3663-2022	Stasiak, Krzysztof/0000-0001-5669-5583; Wirkus, Lukasz/0000-0003-2281-0939; Babicka-Wirkus, Anna/0000-0002-1292-7351				American College Health Association, 2014, NATL COLL HLTH ASS R NATL COLL HLTH ASS R; American College Health Association, NATL COLL HLTH ASS R NATL COLL HLTH ASS R; [Anonymous], 2021, POLAND NUMBERS; [Anonymous], 2020, TERTIARY ED STAT; [Anonymous], 2021, COVID 19 DASHBOARD C; [Anonymous], 2021, GEN ASSESSMENT MACRO; Beiter R, 2015, J AFFECT DISORDERS, V173, P90, DOI 10.1016/j.jad.2014.10.054; Bernabe M, 2016, J HEALTH PSYCHOL, V21, P1778, DOI 10.1177/1359105314566258; Bronfenbrenner U., 1992, 6 THEORIES CHILD DEV, P187, DOI DOI 10.1037/10518-046; Browning MHEM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245327; Cantillon B., 2017, CHILDREN AUSTERITY I; CANTOR N, 1994, PERS SOC PSYCHOL B, V20, P235, DOI 10.1177/0146167294203001; Cappella E, 2011, SCHOOL PSYCHOL REV, V40, P486; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Charles S.C., 2009, NARZEDZIA POMIARU ST, V1st ed., P45; Cohen J, 2020, SCIENCE, V367, P1287, DOI 10.1126/science.367.6484.1287; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Cohen S, 2000, SOCIAL SUPPORT MEASU; Costa PT., 1995, DEV STRUCTURE TEMPER, P139; Dabska O., 2017, PIEL ZDR PUBL, V26, P27, DOI [10.17219/pzp/64695, DOI 10.17219/PZP/64695]; de Barbaro B., 2015, TEOLOGIA MORALNO, V2, P25, DOI [10.14746/tim.2015.18.2.2, DOI 10.14746/TIM.2015.18.2.2]; Araujo FJD, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112977; Ellis WE, 2020, CAN J BEHAV SCI, V52, P177, DOI 10.1037/cbs0000215; Elmer T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236337; Erikson E.H., 1968, IDENTITY YOUTH CRISI; FOLKMAN S, 1984, J PERS SOC PSYCHOL, V46, P839, DOI 10.1037/0022-3514.46.4.839; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Gallagher R.P., 2008, NATL SURVEY COUNSELI; Gao WJ, 2020, J AFFECT DISORDERS, V263, P292, DOI 10.1016/j.jad.2019.11.121; George D., 2020, IBM SPSS STAT 25 STE, V16th Edn, DOI 10.4324/9780429056765; Guio AC, 2018, CHILD INDIC RES, V11, P835, DOI 10.1007/s12187-017-9491-6; Hankin BL, 2015, J ABNORM PSYCHOL, V124, P803, DOI 10.1037/abn0000089; Hoban M, 2009, J AM COLL HEALTH, V57, P477; Hobfoll SE., 2006, STRESS CULTURE SOC P; HOLAHAN CJ, 1987, J PERS SOC PSYCHOL, V52, P946, DOI 10.1037/0022-3514.52.5.946; Horwitz A., 2007, PSYCHIATRY TRANSFORM PSYCHIATRY TRANSFORM; Hunt J, 2010, J ADOLESCENT HEALTH, V46, P3, DOI 10.1016/j.jadohealth.2009.08.008; Juczyriski Z, 1999, PRZEGLAD PSYCHOLOGIC, V42, P43; Klein J, 2010, INT J QUAL HEALTH C, V22, P525, DOI 10.1093/intqhc/mzq056; Kozlowski P., 2016, WARTOSCI CELE PLANY WARTOSCI CELE PLANY; Lazarus R.S., 1984, EMOTION ADAPTATION; Loda T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241660; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Machado D.B., 2020, RESSQUARE, P1, DOI [10.21203/rs.3.rs-58186/v1, DOI 10.21203/RS.3.RS-58186/V1]; Mackenzie S, 2011, AM J ORTHOPSYCHIAT, V81, P101, DOI 10.1111/j.1939-0025.2010.01077.x; Makarowski R, 2020, ARCH BUDO, V16, P161; Marcia J. E, 1980, HDB ADOLESCENT PSYCH, V9, P159, DOI DOI 10.1002/9780470479193; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 2016, WORLD PSYCHIATRY, V15, P103, DOI 10.1002/wps.20311; Masten AS., 1990, DEV PSYCHOPATHOL, V2, P425, DOI [10.1017/S0954579400005812, DOI 10.1017/S0954579400005812]; Masten AS., 1994, RISK RESILIENCE INNE, P3; Metzger IW, 2017, J SEX RES, V54, P374, DOI 10.1080/00224499.2016.1179709; Mikolajczyk RT, 2008, SOC PSYCH PSYCH EPID, V43, P105, DOI 10.1007/s00127-007-0282-0; Nastasi BK, 2000, SCHOOL PSYCHOL QUART, V15, P207, DOI 10.1037/h0088785; Nearchou F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228479; Neetu AJ., 2017, GENDER SOCIALIZATION; Oginska-Bulik N., 2008, OSOBOWO STRES ZDROWI; Owusu P, 2017, THESIS SEINAIOKI U A THESIS SEINAIOKI U A, P30; Pariat L., 2014, J HUMANITIES SOCIAL, V19, P40; Park CL, 2003, HEALTH PSYCHOL, V22, P627, DOI 10.1037/0278-6133.22.6.627; Player MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128180; Ridgeway CL, 2004, GENDER SOC, V18, P510, DOI 10.1177/0891243204265269; Singh S, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113429; Skalski S, 2022, CURR PSYCHOL, V41, P7393, DOI 10.1007/s12144-021-01731-6; Son C, 2020, J MED INTERNET RES, V22, DOI 10.2196/21279; Statistic Poland, 2019, HIGHER ED I THEIR FI; Statistical Office in Gdansk Centre for Education and Human Capital Statistic, 2020, HIGHER ED ITS FINANC; Statistics Poland, SZKOLNICTWO WYZSZE R; Teixeira RJ, 2022, CURR PSYCHOL, V41, P7618, DOI 10.1007/s12144-020-01304-z; Thomas E., 2020, CORONAVIRUS IMPACT Y; Trzebinski J, 2020, J LOSS TRAUMA, V25, P544, DOI 10.1080/15325024.2020.1765098; Van Lancker W, 2020, LANCET PUBLIC HEALTH, V5, pE243, DOI 10.1016/S2468-2667(20)30084-0; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang PS, 2007, WORLD PSYCHIATRY, V6, P177; Wirkus L., 2018, POL J SOC REHABIL, V15, P191, DOI [10.22432/pjsr.2018.15.12, DOI 10.22432/PJSR.2018.15.12]; Wirkus L, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010355; Wrzeniewski K., 1996, CZLOWIEK SYTUACJI ST, P44; Yang CJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246676; Yang X, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243605; Zhou SJ, 2020, EUR CHILD ADOLES PSY, V29, P749, DOI 10.1007/s00787-020-01541-4	83	36	36	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255041	10.1371/journal.pone.0255041	http://dx.doi.org/10.1371/journal.pone.0255041			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TN	34310649	Green Published, gold			2022-12-26	WOS:000685224500025
J	Mansour, NM; Elkalla, WS; Ragab, YM; Ramadan, MA				Mansour, Nahla M.; Elkalla, Wagiha S.; Ragab, Yasser M.; Ramadan, Mohamed A.			Inhibition of acetic acid-induced colitis in rats by new Pediococcus acidilactici strains, vitamin producers recovered from human gut microbiota	PLOS ONE			English	Article							REGULATORY T-CELLS; SOLUBLE VITAMINS; BACTERIA; MODEL; ASSOCIATION; RESISTANCE; LUNG; B-2	Our aim was to isolate, identify and characterize probiotic bacteria as vitamin producers in particular B2 and B9. 150 human fecal samples were collected and used for isolation of vitamin producers-probiotics. 49 isolates were chosen for screening their genome by PCR for the presence of riboflavin and folic acid genes. As a result, three isolates were selected and their production of the B2 and B9 were confirmed by HPLC. The three isolates were identified on species level by sequencing their 16S rRNA gene which showed 100% identical to strains of Pediococcus acidilactici. Thus, they were named as P. acidilactici WNYM01, P. acidilactici WNYM02, P. acidilactici WNYM03 and submitted to the Genbank database with accession numbers. They met the probiotic criteria by expressing 90-95% survival rate at pH (2.0-9.0) and bile salt up to 2% for 3 h in addition to their antimicrobial activity against gram positive and negative microorganisms. They also showed no hemolytic activity and common pattern for antibiotic susceptibility. Our three strains were tested individually or in mixture in vivo on rat colitis model compared to ulcerative group. The strains were administrated orally to rats in daily dose containing CFU 10(9) for 14 days then followed by induction of colitis using acetic acid then the oral administration was continued for more four days. The histology results, the anti-inflammatory and anti-oxidative stress biomarkers showed the protective role of the strains compared to the ulcerative group. As a conclusion, we introduce novel three probiotic candidates for pharmaceutical preparations and health applications.	[Mansour, Nahla M.] Natl Res Ctr, Gut Microbiol & Immunol Grp, Chem Nat & Microbial Prod Dept, Pharmaceut Ind Div, Cairo, Egypt; [Elkalla, Wagiha S.] Badr Univ Cairo, Dept Microbiol & Immunol, Fac Pharm, Cairo, Egypt; [Ragab, Yasser M.; Ramadan, Mohamed A.] Cairo Univ, Dept Microbiol & Immunol, Fac Pharm, Cairo, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Badr University in Cairo; Egyptian Knowledge Bank (EKB); Cairo University	Mansour, NM (corresponding author), Natl Res Ctr, Gut Microbiol & Immunol Grp, Chem Nat & Microbial Prod Dept, Pharmaceut Ind Div, Cairo, Egypt.	nahla_mansour@hotmail.com		Mansour, Nahla/0000-0002-8045-7531	National Research Centre (Egypt)	National Research Centre (Egypt)(National Research Centre (NRC))	This research work was done at the National Research Centre (Egypt).	Aleisa AM, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-49; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ammor MS, 2008, J MOL MICROB BIOTECH, V14, P6, DOI 10.1159/000106077; ARAKI S, 1995, J VET MED SCI, V57, P599, DOI 10.1292/jvms.57.599; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Atef RM, 2018, MOL NEUROBIOL, V55, P1284, DOI 10.1007/s12035-017-0401-1; Azad MA, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9478630; Ballester I, 2007, BRIT J PHARMACOL, V151, P206, DOI 10.1038/sj.bjp.0707227; Bazireh H, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.597946; Bellows L., 2012, WATER SOLUBLE VITAMI; Bender A, 2017, J PSYCHIATR RES, V95, P9, DOI 10.1016/j.jpsychires.2017.07.019; Bhagat D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58676-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charteris WP, 2001, J FOOD PROTECT, V64, P2007, DOI 10.4315/0362-028X-64.12.2007; Cortes-Perez NG, 2007, VACCINE, V25, P6581, DOI 10.1016/j.vaccine.2007.06.062; de Crecy-Lagard V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-245; Ribeiro MCD, 2014, BRAZ ARCH BIOL TECHN, V57, P755, DOI 10.1590/S1516-8913201402258; Dehler CE, 2017, AQUACULTURE, V467, P149, DOI 10.1016/j.aquaculture.2016.07.017; FAO/WHO, 2002, GUIDELINES EVALUATIO, P1; Gao XH, 2018, P NATL ACAD SCI USA, V115, pE2960, DOI 10.1073/pnas.1720696115; GILLILAND SE, 1984, J DAIRY SCI, V67, P3045, DOI 10.3168/jds.S0022-0302(84)81670-7; Guan QD, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4810258; Gyorgy P, 1935, BIOCHEM J, V29, P741; Hinks TSC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01014; Jeong SH, 2014, ANN CLIN LAB SCI, V44, P49; Joseph N, 2020, EVOL BIOINFORM, V16, DOI 10.1177/1176934320965943; Kanmani P, 2019, BIOFACTORS, V45, P223, DOI 10.1002/biof.1475; Kinoshita M, 2012, J IMMUNOL, V189, P2869, DOI 10.4049/jimmunol.1200420; Klejdus B, 2004, ANAL CHIM ACTA, V520, P57, DOI 10.1016/j.aca.2004.02.027; Kobyliak N, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0067-0; LeBlanc JG, 2020, APPL MICROBIOL BIOT, V104, P3331, DOI 10.1007/s00253-020-10487-1; Levit R, 2021, J APPL MICROBIOL, V130, P1412, DOI 10.1111/jam.14854; Levit R, 2017, BENEF MICROBES, V8, P65, DOI 10.3920/BM2016.0063; Liu ML, 2019, FOOD FUNCT, V10, P1132, DOI 10.1039/c8fo02301h; Matuszyk A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2834386; Mayo Clinic Staff, 2016, VIT DEF AN; Mazur-Bialy AI, 2016, MOLECULES, V21, DOI 10.3390/molecules21121724; Menezes RR, 2017, PHARMACOL REP, V69, P1036, DOI 10.1016/j.pharep.2017.04.011; Millette M, 2007, J APPL MICROBIOL, V102, P274, DOI 10.1111/j.1365-2672.2006.03044.x; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; Motavallian-Naeini A, 2012, RES PHARM SCI, V7, P159; Mulaw G, 2019, INT J MICROBIOL, V2019, DOI 10.1155/2019/7179514; Nandini K. N., 2020, Journal of Global Trends in Pharmaceutical Sciences, V11, P7371; National Committee for Clinical Laboratory Standards (NCCLS), 1993, STAND ANT DISC SUSC, pM2; Nemeth ZH, 2017, CUREUS, V9, DOI 10.7759/cureus.1177; Rubio R, 2014, FOOD MICROBIOL, V38, P303, DOI 10.1016/j.fm.2013.07.015; Said HM, 2013, AM J PHYSIOL-GASTR L, V305, pG601, DOI 10.1152/ajpgi.00231.2013; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schramm M, 2014, EUR J IMMUNOL, V44, P728, DOI 10.1002/eji.201343940; Seekamp A, 1999, INFLAMMATION, V23, P449, DOI 10.1023/A:1021965026580; Singla V, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1514-6; Turpin W, 2011, APPL ENVIRON MICROB, V77, P8722, DOI 10.1128/AEM.05988-11; Vaikunthanathan T, 2016, IMMUNOL LETT, V171, P36, DOI 10.1016/j.imlet.2016.01.008; Vincenzi A, 2021, CYTOKINE GROWTH F R, V57, P27, DOI 10.1016/j.cytogfr.2020.10.004; Wang J, 2015, ANN MICROBIOL, V65, P1753, DOI 10.1007/s13213-014-1014-9; Watanabe A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0215113; Wayne P., 2007, PERFORMANCE STANDARD, V17; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WHO/FAO, 2004, VIT MIN REQ HUM NUTR, VSecond; Yoshii K, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00048	61	1	1	10	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255092	10.1371/journal.pone.0255092	http://dx.doi.org/10.1371/journal.pone.0255092			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310635	gold, Green Published			2022-12-26	WOS:000685224500001
J	Bezzo, FB; Silva, L; van Ham, M				Bezzo, Franco Bonomi; Silva, Laura; van Ham, Maarten			The combined effect of Covid-19 and neighbourhood deprivation on two dimensions of subjective well-being: Empirical evidence from England	PLOS ONE			English	Article							MENTAL-HEALTH	Objectives The Covid-19 pandemic is hitting societies hard, and people living in disadvantaged circumstances are among the most affected. We investigate the combined effects of the Covid-19 crisis and living in a deprived neighbourhood on two dimensions of subjective well-being: hedonic (i.e. mental health) and evaluative (i.e. life satisfaction) subjective well-being. Methods We use longitudinal data from the Understanding Society UK panel. We combine data gathered in the main survey between 2015 and 2019 with very recent data from the Covid-19 online survey between April and July 2020. Leveraging a sample of nearly 9,600 English individuals, we first run a set of cross-sectional OLS regressions to analyse changes over time in the relationship between neighbourhood deprivation and subjective well-being. Then, as our main model of interest, we use a fixed effect difference-in-differences model to provide more robust evidence. Results Since the beginning of the crisis, both levels of hedonic and evaluative well-being have decreased as a result of the pandemic and lockdown. However, for those living in more deprived neighbourhoods the level of hedonic well-being decreased more than for those living in better areas. We found no such difference for evaluative well-being. Conclusion Our results highlight the importance of reducing neighbourhood inequalities as the spatial clustering of disadvantages has increased by the pandemic.	[Bezzo, Franco Bonomi] Univ Milan, La Statale, Milan, Italy; [Silva, Laura] Sci Po, Dept Sociol, Paris, France; [Silva, Laura] ENSAE Paris, CREST, Palaiseau, France; [van Ham, Maarten] Delft Univ Technol, Fac Architecture & Built Environm, Dept Urbanism, Delft, Netherlands; [van Ham, Maarten] Univ St Andrews, Sch Geog & Sustainable Dev, St Andrews, Fife, Scotland	University of Milan; Institut d'Etudes Politiques Paris (Sciences Po); Delft University of Technology; University of St Andrews	Bezzo, FB (corresponding author), Univ Milan, La Statale, Milan, Italy.	franco.bonomi@unimi.it		Bonomi Bezzo, Franco/0000-0002-0899-552X				Alsan M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12403; [Anonymous], 2020, HLTH TECHNOL ASSESS, V24, P1; Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401; Banks J, 2020, FISC STUD, V41, P685, DOI 10.1111/1475-5890.12239; Barton Jo, 2017, BJPsych Int, V14, P79; Boardman JD, 2000, SOCIOL PERSPECT, V43, P117, DOI 10.2307/1389785; Bond L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-48; Borkowska M, 2021, EUR SOC, V23, pS618, DOI 10.1080/14616696.2020.1833067; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Daly M, 2022, PSYCHOL MED, V52, P2549, DOI 10.1017/S0033291720004432; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Etheridge B, 2020, GENDER GAP MENTAL WE; Fancourt D, 2021, LANCET PSYCHIAT, V8, P141, DOI 10.1016/S2215-0366(20)30482-X; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Graham C, 2011, BROOK FOCUS BK; Gray NS, 2020, FRONT PSYCHIATRY, V11, DOI [10.3389/fpsyt.2020.00011, DOI 10.3389/FPSYT.2020.00011]; Groarke JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239698; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Jivraj S, 2020, EUR J PUBLIC HEALTH, V30, P922, DOI 10.1093/eurpub/ckz153; Kahneman D., 1999, WELL BEING FDN HEDON, P3, DOI DOI 10.7758/9781610443258; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kaminska O, 2020, SELECTING WEIGHTS UN; Knies G, 2021, URBAN STUD, V58, P2640, DOI 10.1177/0042098020956930; Kraus MW, 2012, PSYCHOL REV, V119, P546, DOI 10.1037/a0028756; Krueger AB, 2014, SCIENCE, V346, P42, DOI 10.1126/science.1256392; Lombardo P, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5235-x; Niedzwiedz C. L., 2020, Journal of Epidemiology & Community Health, V75, P224, DOI 10.1136/jech-2020-215060; Ornell F, 2020, BRAZ J PSYCHIAT, V42, P232, DOI 10.1590/1516-4446-2020-0008; Otu A, 2020, INT J MENT HEALTH SY, V14, DOI 10.1186/s13033-020-00371-w; Pieraccini M, 2020, LEGAL PERSPECTIVES ON SUSTAINABILITY, P1, DOI 10.1016/S2215-0366(20)30308-4; Propper C, 2005, SOC SCI MED, V61, P2065, DOI 10.1016/j.socscimed.2005.04.013; Proto E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244419; Recchi E, 2020, RES SOC STRAT MOBIL, V68, DOI 10.1016/j.rssm.2020.100508; Ross M, 2014, RELATIVE DEPRIVATION, V4; Routen A, 2021, J PUBLIC HEALTH-UK, V43, pE241, DOI 10.1093/pubmed/fdaa160; Ryan RM, 2001, ANNU REV PSYCHOL, V52, P141, DOI 10.1146/annurev.psych.52.1.141; Sibley CG, 2020, AM PSYCHOL, V75, P618, DOI 10.1037/amp0000662; Society. ISM, 2020, ISMS COVID 19 RISK S; Stafford M, 2003, INT J EPIDEMIOL, V32, P357, DOI 10.1093/ije/dyg084; University of Essex Institute for Social and Economic Research, 2020, UND SOC WAV 1 9 2019, DOI 10.5255/UKDA-SN-8644-4 .; Wanberg CR, 2020, J APPL PSYCHOL, V105, P1382, DOI 10.1037/apl0000831; Willsher K, 2021, GUARDIAN        0114; Zacher H, 2021, AM PSYCHOL, V76, P50, DOI 10.1037/amp0000702	43	3	3	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255156	10.1371/journal.pone.0255156	http://dx.doi.org/10.1371/journal.pone.0255156			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TQ2PW	34297763	Green Published, gold			2022-12-26	WOS:000678128300038
J	Dixon, BE; Grannis, SJ; Lembcke, LR; Valvi, N; Roberts, AR; Embi, PJ				Dixon, Brian E.; Grannis, Shaun J.; Lembcke, Lauren R.; Valvi, Nimish; Roberts, Anna R.; Embi, Peter J.			The synchronicity of COVID-19 disparities: Statewide epidemiologic trends in SARS-CoV-2 morbidity, hospitalization, and mortality among racial minorities and in rural America	PLOS ONE			English	Article							OUTCOMES	Background Early studies on COVID-19 identified unequal patterns in hospitalization and mortality in urban environments for racial and ethnic minorities. These studies were primarily single center observational studies conducted within the first few weeks or months of the pandemic. We sought to examine trends in COVID-19 morbidity, hospitalization, and mortality over time for minority and rural populations, especially during the U.S. fall surge. Methods Data were extracted from a statewide cohort of all adult residents in Indiana tested for SARS-CoV-2 infection between March 1 and December 31, 2020, linked to electronic health records. Primary measures were per capita rates of infection, hospitalization, and death. Age adjusted rates were calculated for multiple time periods corresponding to public health mitigation efforts. Comparisons across time within groups were compared using ANOVA. Results Morbidity and mortality increased over time with notable differences among sub-populations. Initially, hospitalization rates among racial minorities were 3-4 times higher than whites, and mortality rates among urban residents were twice those of rural residents. By fall 2020, hospitalization and mortality rates in rural areas surpassed those of urban areas, and gaps between black/brown and white populations narrowed. Changes across time among demographic groups was significant for morbidity and hospitalization. Cumulative morbidity and mortality were highest among minority groups and in rural communities. Conclusions The synchronicity of disparities in COVID-19 by race and geography suggests that health officials should explicitly measure disparities and adjust mitigation as well as vaccination strategies to protect those sub-populations with greater disease burden.	[Dixon, Brian E.] Indiana Univ, Fairbanks Sch Publ Hlth, Dept Epidemiol, Bloomington, IN 47405 USA; [Dixon, Brian E.; Grannis, Shaun J.; Valvi, Nimish; Embi, Peter J.] Regenstrief Inst Hlth Care, Ctr Biomed Informat, Indianapolis, IN 46202 USA; [Grannis, Shaun J.] Indiana Univ, Sch Med, Dept Family Med, Indianapolis, IN USA; [Lembcke, Lauren R.; Roberts, Anna R.] Regenstrief Inst Hlth Care, Res Data Serv, Indianapolis, IN USA; [Embi, Peter J.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; Indiana University System; Indiana University-Purdue University Indianapolis	Dixon, BE (corresponding author), Indiana Univ, Fairbanks Sch Publ Hlth, Dept Epidemiol, Bloomington, IN 47405 USA.; Dixon, BE (corresponding author), Regenstrief Inst Hlth Care, Ctr Biomed Informat, Indianapolis, IN 46202 USA.	bedixon@regenstrief.org	Dixon, Brian E/A-9494-2013	Dixon, Brian E/0000-0002-1121-0607	U.S. Agency for Healthcare Research and Quality [R21HS025502]; State of Indiana; Marion County Public Health Department	U.S. Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); State of Indiana; Marion County Public Health Department	BED receives funding from the U.S. Agency for Healthcare Research and Quality (R21HS025502) to study health information exchange. The Regenstrief Institute as well as the IU Fairbanks School of Public Health received funds from the State of Indiana and Marion County Public Health Department to support COVID-19 response and mitigation, including disease surveillance and outcomes measurement. The funders did not have influence over the findings or this publication.	Alcendor DJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082442; [Anonymous], 2020, MMWR Morb Mortal Wkly Rep, V69, P1753, DOI 10.15585/mmwr.mm6946a6; Barrett C, 2020, WILL COVID 19 TRIGGE; Bergdall A., 2012, CLIN MED RES, V10, P172, DOI [10.3121/cmr.2012.1100.cb3-01, DOI 10.3121/CMR.2012.1100.CB3-01]; Blonde L, 2018, ADV THER, V35, P1763, DOI 10.1007/s12325-018-0805-y; Buckner FS, 2020, CLIN INFECT DIS, V71, P2167, DOI 10.1093/cid/ciaa632; Comer KF, 2011, PUBLIC HEALTH REP, V126, P54, DOI 10.1177/00333549111260S310; Davoodi NM, 2020, GERONTOL GERIATR MED, V6, DOI 10.1177/2333721420936168; DeSalvo KB, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.170017; DeSalvo KB, 2016, AM J PUBLIC HEALTH, V106, P621, DOI 10.2105/AJPH.2016.303063; DiMaggio C, 2020, ANN EPIDEMIOL, V51, P7, DOI 10.1016/j.annepidem.2020.08.012; Dixon B, 2016, GIS AND GEOCOMPUTATION FOR WATER RESOURCE SCIENCE AND ENGINEERING, P3; Dixon BE, 2021, INDIANA COVID 19 TES; Dixon BE, 2021, J AM MED INFORM ASSN, V28, P1363, DOI 10.1093/jamia/ocab004; Doidge JC, 2021, AM J RESP CRIT CARE, V203, P565, DOI 10.1164/rccm.202008-3212OC; Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P545, DOI 10.15585/mmwr.mm6918e1; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Hasnain-Wynia R, 2010, J NATL MED ASSOC, V102, P769, DOI 10.1016/S0027-9684(15)30673-8; Holcomb E, 2020, BACK TRACK INDIANA G; Karim SA, 2021, J RURAL HEALTH, V37, P124, DOI 10.1111/jrh.12533; Kaufman BG, 2020, J RURAL HEALTH, V36, P584, DOI 10.1111/jrh.12481; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; National Center for Immunization and Respiratory Diseases Division of Viral Diseases, 2020, HLTH EQ CONS RAC ETH; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Overhage JM, 2016, HLTH INFORM EXCHANGE, P267; Peters DJ, 2020, J RURAL HEALTH, V36, P446, DOI 10.1111/jrh.12477; Purdue Extension, 2019, GEOGR CLASS W LAF; Regenstrief Institute, 2020, REG COVID 19 DASHB I; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Romano SD, 2021, MMWR-MORBID MORTAL W, V70, P560, DOI 10.15585/mmwr.mm7015e2externalicon; Shah P, 2020, ANN MED, V52, P354, DOI 10.1080/07853890.2020.1791356; Tan TQ, 2020, J INFECT DIS, V222, P1951, DOI 10.1093/infdis/jiaa583; The Center for Systems Science and Engineering at Johns Hopkins University, 2020, COVID 19 DASHB; van Halem K, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05605-3; Wang ZL, 2020, CLIN INFECT DIS, V71, P769, DOI 10.1093/cid/ciaa272; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5	38	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255063	10.1371/journal.pone.0255063	http://dx.doi.org/10.1371/journal.pone.0255063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TQ2PW	34297747	Green Published, gold			2022-12-26	WOS:000678128300056
J	Mamdouh, F; Bazaraa, H; Baz, A; Algebaly, HF				Mamdouh, Fatma; Bazaraa, Hafez; Baz, Ahmed; Algebaly, HebatAllah Fadel			Prognostic value of baseline carotid blood flow in critically ill children with septic shock	PLOS ONE			English	Article							PEDIATRIC SEVERE SEPSIS; INTENSIVE-CARE; EPIDEMIOLOGY; OUTCOMES; DOPPLER; MORTALITY; TRENDS	Background and aim Hemodynamic monitoring and cardiac output (CO) assessment in the ICU have been trending toward less invasive methods. Carotid blood flow (CBF) was suggested as a candidate for CO assessment. The present study aimed to test the value of carotid artery ultrasound analysis in prediction of mortality in pediatric patients with septic shock. Methodology/Principal finding Forty children with septic shock were included in the study. Upon admission, patients were subjected to careful history taking and thorough clinical examination. The consciousness level was assessed by the Glasgow Coma Scale (GCS). Laboratory assessment included complete blood count, C-reactive protein, arterial blood gases, serum electrolytes, and liver and kidney function tests. Electrical cardiometry was used to evaluate hemodynamic parameters. Patients were also subjected to transthoracic 2-D echocardiography. CBF was evaluated using GE Vivid S5 ultrasound device through dedicated software. At the end of study, 14 patients (35.0%) died. It was found that survivors had significantly higher CBF when compared non-survivors [median (IQR): 166.0 (150.0-187.3) versus 141.0 (112.8-174.3), p = 0.033]. In addition, it was noted that survivors had longer ICU stay when compared with non-survivors [16.5 (9.8-31.5) versus 6.5 (3.0-19.5) days, p = 0.005]. ROC curve analysis showed that CBF could significantly distinguish survivors from non-survivors [AUC (95% CI): 0.3 (0.11-0.48), p = 0.035] (Fig 2). Univariate logistic regression analysis identified type of shock [OR (95% CI): 28.1 (4.9-162.4), p<0.001], CI [OR (95% CI): 0.6 (0.43-0.84), p = 0.003] and CBF [OR (95% CI): 0.98 (0.96-0.99), p = 0.031]. However, in multivariate analysis, only type of shock significantly predicted mortality. Conclusions CBF assessment may be a useful prognostic marker in children with septic shock.	[Mamdouh, Fatma; Bazaraa, Hafez; Algebaly, HebatAllah Fadel] Cairo Univ, Specialized Children Hosp, Dept Crit Care, Cairo, Egypt; [Mamdouh, Fatma; Bazaraa, Hafez; Algebaly, HebatAllah Fadel] Cairo Univ, Specialized Children Hosp, Dept Pediat, Cairo, Egypt; [Baz, Ahmed] Cairo Univ, Kasr Al Aini Hosp, Dept Radiol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Algebaly, HF (corresponding author), Cairo Univ, Specialized Children Hosp, Dept Crit Care, Cairo, Egypt.; Algebaly, HF (corresponding author), Cairo Univ, Specialized Children Hosp, Dept Pediat, Cairo, Egypt.	HebatAllah.gebaly@kasralainy.edu.eg		Algebaly, hebat Allah/0000-0003-3570-0421				Adedipe AA, 2015, RESUSCITATION, V96, P121, DOI 10.1016/j.resuscitation.2015.07.024; Alhashemi JA, 2011, CRIT CARE, V15, DOI 10.1186/cc9996; Chaiyakulsil C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199203; El-nady G, 2008, EGYPT J MED MICROBIO, V17, P411; Gassner M, 2015, J ULTRASOUND, V18, P127, DOI 10.1007/s40477-014-0139-9; Hartman ME, 2013, PEDIATR CRIT CARE ME, V14, P686, DOI 10.1097/PCC.0b013e3182917fad; Hossein-Nejad H, 2015, J CRIT CARE, V30, P1199, DOI 10.1016/j.jcrc.2015.08.014; Ibrahiem SK, 2016, ALLERGOL IMMUNOPATH, V44, P46, DOI 10.1016/j.aller.2015.07.005; Kaur G, 2014, INDIAN J CRIT CARE M, V18, P437, DOI 10.4103/0972-5229.136072; Khan MR, 2012, INDIAN J PEDIATR, V79, P1454, DOI 10.1007/s12098-012-0706-z; Ma IWY, 2017, CRIT ULTRASOUND J, V9, DOI 10.1186/s13089-017-0065-0; Marik PE, 2013, CHEST, V143, P364, DOI 10.1378/chest.12-1274; Pedro Tais da Costa Sao, 2015, Rev Bras Ter Intensiva, V27, P240, DOI 10.5935/0103-507X.20150044; Pollack MM, 2015, CRIT CARE MED, V43, P1699, DOI 10.1097/CCM.0000000000001081; Ruth A, 2014, PEDIATR CRIT CARE ME, V15, P828, DOI 10.1097/PCC.0000000000000254; Stolz LA, 2015, WEST J EMERG MED, V16, P255, DOI 10.5811/westjem.2015.1.24301; Weiss SL, 2020, PEDIATR CRIT CARE ME, V21, pE52, DOI [10.1097/PCC.0000000000002198, 10.1007/s00134-019-05878-6]; Weiss SL, 2015, AM J RESP CRIT CARE, V191, P1147, DOI 10.1164/rccm.201412-2323OC	18	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0251154	10.1371/journal.pone.0251154	http://dx.doi.org/10.1371/journal.pone.0251154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34298550	Green Published, gold			2022-12-26	WOS:000678128300046
J	de la Concepcion, MC; Sargent, DJ; Surbanovski, N; Colgan, RJ; Moretto, M				Carcamo de la Concepcion, Maria; Sargent, Daniel James; Surbanovski, Nada; Colgan, Richard John; Moretto, Marco			De novo sequencing and analysis of the transcriptome of two highbush blueberry (Vaccinium corymbosum L.) cultivars 'Bluecrop' and 'Legacy' at harvest and following post-harvest storage	PLOS ONE			English	Article							CELL-WALL METABOLISM; GENE-EXPRESSION; FRUIT FIRMNESS; COLD-STORAGE; PLANT-GROWTH; WATER-LOSS; TOMATO; QUALITY; TEXTURE; CUTICLE	Fruit firmness and in particular the individual components of texture and moisture loss, are considered the key quality traits when describing blueberry fruit quality, and whilst these traits are genetically regulated, the mechanisms governing their control are not clearly understood. In this investigation, RNAseq was performed on fruits of two blueberry cultivars with very different storage properties, 'Bluecrop' and 'Legacy', at harvest, three weeks storage in a non-modified environment at 4 degrees C and after three weeks storage at 4 degrees C followed by three days at 21 degrees C, with the aim of understanding the transcriptional changes that occur during storage in cultivars with very different post-harvest fruit quality. De novo assemblies of the transcriptomes of the two cultivars were performed separately and a total of 39,335 and 41,896 unigenes for 'Bluecrop' and 'Legacy' respectively were resolved. Differential gene expression analyses were grouped into four cluster profiles based on changes in transcript abundance between harvest and 24 days post-harvest. A total of 290 unigenes were up-regulated in 'Legacy' only, 685 were up-regulated in 'Bluecrop', 252 were up-regulated in both cultivars and 948 were down-regulated in both cultivars between harvest and 24 days post-harvest. Unigenes showing significant differential expression between harvest and following post-harvest cold-storage were grouped into classes of biological processes including stress responses, cell wall metabolism, wax metabolism, calcium metabolism, cellular components, and biological processes. In total 21 differentially expressed unigenes with a putative role in regulating the response to post-harvest cold-storage in the two cultivars were identified from the de novo transcriptome assemblies performed. The results presented provide a stable foundation from which to perform further analyses with which to functionally validate the candidate genes identified, and to begin to understand the genetic mechanisms controlling changes in firmness in blueberry fruits post-harvest.	[Carcamo de la Concepcion, Maria; Sargent, Daniel James; Colgan, Richard John] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England; [Sargent, Daniel James; Surbanovski, Nada] NIAB EMR, East Malling, Kent, OH USA; [Moretto, Marco] Fdn Edmund Mach FEM, Res & Innovat Ctr, Unit Computat Biol, San Michele All Adige, Italy	University of Greenwich; Fondazione Edmund Mach	Colgan, RJ (corresponding author), Univ Greenwich, Nat Resources Inst, Chatham, Kent, England.	R.J.Colgan@greenwich.ac.uk			University of Greenwich [VCS-ES-08-17]	University of Greenwich	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MCC received PhD stipend number VCS-ES-08-17 from the University of Greenwich.	Aghdam MS, 2012, SCI HORTIC-AMSTERDAM, V144, P102, DOI 10.1016/j.scienta.2012.07.007; Bouzo CA, 2016, ACTA SCI POL-HORTORU, V15, P13; Allan-Wojtas PM, 2001, LEBENSM-WISS TECHNOL, V34, P23, DOI 10.1006/fstl.2000.0738; Asif MH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0316-1; Bashline L, 2014, MOL PLANT, V7, P586, DOI 10.1093/mp/ssu018; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Blaker KM, 2014, J AM SOC HORTIC SCI, V139, P553, DOI 10.21273/JASHS.139.5.553; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boron AK, 2015, ANN BOT-LONDON, V115, P67, DOI 10.1093/aob/mcu221; Brummell DA, 2002, POSTHARVEST BIOL TEC, V25, P209, DOI 10.1016/S0925-5214(01)00179-X; Brummell David A., 2006, New Zealand Journal of Forestry Science, V36, P99; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cappai F, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8090174; Cayla T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118122; Chakravarthy S, 2003, PLANT CELL, V15, P3033, DOI 10.1105/tpc.017574; Chang Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0596-2; Chea S, 2019, SCI HORTIC-AMSTERDAM, V245, P163, DOI 10.1016/j.scienta.2018.10.019; Chen HJ, 2015, SCI HORTIC-AMSTERDAM, V188, P44, DOI 10.1016/j.scienta.2015.03.018; Chen L, 2013, FOOD RES INT, V51, P823, DOI 10.1016/j.foodres.2013.01.046; Chung SW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220015; Colle M, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz012; Costa F, 2012, POSTHARVEST BIOL TEC, V69, P54, DOI 10.1016/j.postharvbio.2012.03.003; COSTICH DE, 1993, THEOR APPL GENET, V86, P1001, DOI 10.1007/BF00211053; Deng J, 2014, FOOD SCI TECHNOL INT, V20, P287, DOI 10.1177/1082013213483611; Die JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073354; Dotto MC, 2006, PLANT PHYSIOL BIOCH, V44, P301, DOI 10.1016/j.plaphy.2006.06.008; Edelmann HG, 2005, J PLANT GROWTH REGUL, V24, P116, DOI 10.1007/s00344-004-0015-5; Farneti B, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00617; Forney CF, 2009, ACTA HORTIC, V810, P785; Fukuda H, 2015, PLANT CELL WALL PATT, V1; Ghosh S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01886; Giongo L, 2013, POSTHARVEST BIOL TEC, V76, P34, DOI 10.1016/j.postharvbio.2012.09.004; Guengerich FP, 2018, ACS CATAL, V8, P10964, DOI 10.1021/acscatal.8b03401; Gupta V, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0046-9; Hamberger B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0426; Harker FR, 2006, J FOOD SCI, V71, pS77, DOI 10.1111/j.1365-2621.2006.tb08925.x; Hayama H, 2003, POSTHARVEST BIOL TEC, V29, P1, DOI 10.1016/S0925-5214(02)00216-8; Hejnowicz Z, 2011, SIGNAL COMMUN PLANTS, P241, DOI 10.1007/978-3-642-19091-9_10; Hocking B, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00569; Huang BL, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1997-2; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Iwanami H, 2008, HORTSCIENCE, V43, P1377, DOI 10.21273/HORTSCI.43.5.1377; Jin XY, 2019, DNA CELL BIOL, V38, P1056, DOI 10.1089/dna.2019.4881; Konarska A, 2015, BOTANY, V93, P589, DOI 10.1139/cjb-2015-0050; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lara I, 2014, POSTHARVEST BIOL TEC, V87, P103, DOI 10.1016/j.postharvbio.2013.08.012; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021; Li ZY, 2020, SCI HORTIC-AMSTERDAM, V269, DOI 10.1016/j.scienta.2020.109391; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Liu BH, 2019, SCI HORTIC-AMSTERDAM, V246, P557, DOI 10.1016/j.scienta.2018.11.042; Liu JC, 2017, ADV EXP MED BIOL, V982, P49, DOI 10.1007/978-3-319-55330-6_3; Liu WP, 2020, TROP PLANT BIOL, V13, P251, DOI 10.1007/s12042-020-09259-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maalekuu K., 2003, ADV HORTIC SCI, P1000; Marowa P, 2016, PLANT CELL REP, V35, P949, DOI 10.1007/s00299-016-1948-4; Matas AJ, 2005, AM J BOT, V92, P462, DOI 10.3732/ajb.92.3.462; Mellidou I, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0328-x; Mine T, 2003, PLANT CELL PHYSIOL, V44, P10, DOI 10.1093/pcp/pcg004; Minoia S, 2016, PLANT SCI, V242, P195, DOI 10.1016/j.plantsci.2015.07.001; Mitalo OW, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00888; Moggia C, 2017, POSTHARVEST BIOL TEC, V132, P88, DOI 10.1016/j.postharvbio.2017.05.019; Moggia C, 2016, SCI HORTIC-AMSTERDAM, V211, P449, DOI 10.1016/j.scienta.2016.09.018; Mondal S, 2020, INT J BIOL MACROMOL, V164, P3656, DOI 10.1016/j.ijbiomac.2020.08.246; Nardi CF, 2016, POSTHARVEST BIOL TEC, V114, P17, DOI 10.1016/j.postharvbio.2015.11.008; Neto CC, 2007, MOL NUTR FOOD RES, V51, P652, DOI 10.1002/mnfr.200600279; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Paniagua A, 2012, 7 INT POSTH S 7 INT POSTH S, V1012; Paniagua AC, 2013, POSTHARVEST BIOL TEC, V79, P13, DOI 10.1016/j.postharvbio.2012.12.016; Paya-Milans M, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3967-0; Prange RK, 1997, HORTSCIENCE, V32, P824, DOI 10.21273/HORTSCI.32.5.824; Qi XP, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2073-7; RCore Team, 2020, R LANG ENV STAT COMP; Retamales JB, 2012, CROP PROD SCI HORTIC, P1, DOI 10.1079/9781845939045.0000; Romero P, 2019, FOOD CHEM, V295, P300, DOI 10.1016/j.foodchem.2019.05.118; Rowland LJ, 2014, MOL BREEDING, V34, P2033, DOI 10.1007/s11032-014-0161-9; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; SEYMOUR GB, 1990, PHYTOCHEMISTRY, V29, P725, DOI 10.1016/0031-9422(90)80008-5; Seymour GB, 2013, PLANT BIOTECHNOL J, V11, P269, DOI 10.1111/j.1467-7652.2012.00738.x; Seymour GB, 2011, J EXP BOT, V62, P1179, DOI 10.1093/jxb/erq360; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suh MC, 2005, PLANT PHYSIOL, V139, P1649, DOI 10.1104/pp.105.070805; Valenzuela-Riffo F, 2018, COMPUT BIOL CHEM, V76, P79, DOI 10.1016/j.compbiolchem.2018.05.018; Vashisth T, 2011, PLANT CELL REP, V30, P2167, DOI 10.1007/s00299-011-1121-z; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Vicente AR, 2005, POSTHARVEST BIOL TEC, V38, P213, DOI 10.1016/j.postharvbio.2005.06.005; Vicente AR, 2007, J SCI FOOD AGR, V87, P1435, DOI 10.1002/jsfa.2837; Walker JA, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0703-6; Walz C, 2004, PHYTOCHEMISTRY, V65, P1795, DOI 10.1016/j.phytochem.2004.04.006; Wang SY, 2020, FOOD CHEM, V310, DOI 10.1016/j.foodchem.2019.125965; Waskom M., 2017, MWASK SEAB V0 8 1, DOI [10.5281/zenodo.883859, DOI 10.5281/ZENODO.883859]; Xie XL, 2016, CRIT REV PLANT SCI, V35, P120, DOI 10.1080/07352689.2016.1213119; Ye J, 2018, NUCLEIC ACIDS RES, V46, pW71, DOI 10.1093/nar/gky400; Yeoman CJ, 2010, ADV APPL MICROBIOL, V70, P1, DOI 10.1016/S0065-2164(10)70001-0; Zhang F, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-2281-1; Zhang LF, 2010, LWT-FOOD SCI TECHNOL, V43, P26, DOI 10.1016/j.lwt.2009.06.015; Zhu HS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187117	104	1	1	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255139	10.1371/journal.pone.0255139	http://dx.doi.org/10.1371/journal.pone.0255139			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339434	Green Accepted, gold, Green Published			2022-12-26	WOS:000680243400011
J	Xie, L; Huang, RF; Wang, HW; Liu, SH				Xie, Ling; Huang, Ruifang; Wang, Hongwei; Liu, Suhong			Spatial-temporal heterogeneity and meteorological factors of hand-foot-and-mouth disease in Xinjiang, China from 2008 to 2016	PLOS ONE			English	Article							CLIMATE FACTORS; TEMPERATURE; PROVINCE; HUMIDITY; CHILDREN; REGION	The study aims to depict the temporal and spatial distributions of hand-foot-and-mouth disease (HFMD) in Xinjiang, China and reveal the relationships between the incidence of HFMD and meteorological factors in Xinjiang. With the national surveillance data of HFMD in Xinjiang and meteorological parameters in the study area from 2008 to 2016, in GeoDetector Model, we examined the effects of meteorological factors on the incidence of HFMD in Xinjiang, China, tested the spatial-temporal heterogeneity of HFMD risk, and explored the temporal-spatial patterns of HFMD through the spatial autocorrelation analysis. From 2008 to 2016, the HFMD distribution showed a distinct seasonal pattern and HFMD cases typically occurred from May to July and peaked in June in Xinjiang. Relative humidity, precipitation, barometric pressure and temperature had the more significant influences on the incidence of HFMD than other meteorological factors with the explanatory power of 0.30, 0.29, 0.29 and 0.21 (P<0.000). The interaction between any two meteorological factors had a nonlinear enhancement effect on the risk of HFMD. The relative risk in Northern Xinjiang was higher than that in Southern Xinjiang. Global spatial autocorrelation analysis results indicated a fluctuating trend over these years: the positive spatial dependency on the incidence of HFMD in 2008, 2010, 2012, 2014 and 2015, the negative spatial autocorrelation in 2009 and a random distribution pattern in 2011, 2013 and 2016. Our findings revealed the correlation between meteorological factors and the incidence of HFMD in Xinjiang. The correlation showed obvious spatiotemporal heterogeneity. The study provides the basis for the government to control HFMD based on meteorological information. The risk of HFMD can be predicted with appropriate meteorological factors for HFMD prevention and control.	[Xie, Ling; Wang, Hongwei] Xinjiang Univ, Coll Resources & Environm Sci, Urumqi, Peoples R China; [Xie, Ling] Guangxi Normal Univ, Sch Environm & Resources, Guilin, Peoples R China; [Huang, Ruifang] Ctr Dis Control & Prevent Xinjiang Uygur Autonomo, Urumqi, Peoples R China; [Liu, Suhong] Beijing Normal Univ, Fac Geog Sci, Beijing, Peoples R China	Xinjiang University; Guangxi Normal University; Beijing Normal University	Wang, HW (corresponding author), Xinjiang Univ, Coll Resources & Environm Sci, Urumqi, Peoples R China.; Liu, SH (corresponding author), Beijing Normal Univ, Fac Geog Sci, Beijing, Peoples R China.	wanghw@xju.edu.cn; liush@bnu.edu.cn		Wang, Hongwei/0000-0002-1427-143X; xie, ling/0000-0002-1033-0420	National Natural Science Fund of China [4186010245]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Fund of China. HONGWEI WANG received the fund. Grant No 4186010245. The funders participate in the study design.	Chen C, 2014, INT J BIOMETEOROL, V58, P1605, DOI 10.1007/s00484-013-0764-6; Chen SL, 2019, PUBLIC HEALTH, V174, P42, DOI 10.1016/j.puhe.2019.05.032; Du ZC, 2019, SCI TOTAL ENVIRON, V656, P1358, DOI 10.1016/j.scitotenv.2018.11.391; Du ZC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179623; Du ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36351; Phung D, 2018, SCI TOTAL ENVIRON, V610, P983, DOI 10.1016/j.scitotenv.2017.08.158; Gou FX, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-017-2860-4; Gu JY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54495-2; Hii YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016796; Huang R F, 2019, Zhonghua Liu Xing Bing Xue Za Zhi, V40, P1563, DOI 10.3760/cma.j.issn.0254-6450.2019.12.011; Huang RX, 2019, ENVIRON SCI POLLUT R, V26, P17974, DOI 10.1007/s11356-018-2619-5; Nguyen HX, 2020, INT J BIOMETEOROL, V64, P389, DOI 10.1007/s00484-019-01824-9; Nguyen HX, 2017, SCI TOTAL ENVIRON, V581, P766, DOI [10.1016/j.scitotenv2017.01.006, 10.1016/j.scitotenv.2017.01.006]; Kim BI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157500; Lau SYF, 2021, ATMOS ENVIRON, V244, DOI 10.1016/j.atmosenv.2020.117984; Li J, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7758-1; Liao JQ, 2016, SCI TOTAL ENVIRON, V563, P152, DOI 10.1016/j.scitotenv.2016.03.159; Liu H, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7619-y; Liu WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131311; Lu B, 2014, LANCET INFECT DIS, V14, P1041, DOI 10.1016/S1473-3099(14)70972-7; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Mao Y, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4400-x; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Wang H, 2015, INT J INFECT DIS, V34, P66, DOI 10.1016/j.ijid.2015.03.007; Wang JF, 2016, ECOL INDIC, V67, P250, DOI 10.1016/j.ecolind.2016.02.052; Wang JF, 2010, INT J GEOGR INF SCI, V24, P107, DOI 10.1080/13658810802443457; [王劲峰 Wang Jinfeng], 2017, [地理学报, Acta Geographica Sinica], V72, P116; Wang P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161006; Wang YJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071191; Wang Y, 2011, EPIDEMIOLOGY, V22, P781, DOI 10.1097/EDE.0b013e318231d67a; Wei JN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003572; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu CD, 2019, SCI TOTAL ENVIRON, V657, P509, DOI 10.1016/j.scitotenv.2018.12.039; Xu J, 2016, PUBLIC HEALTH, V134, P86, DOI 10.1016/j.puhe.2015.10.029; Xu ZC, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4594-y; Zhang HY., 2019, EPIDEMIC CHARACTERIS; Zhang Z, 2016, SCI TOTAL ENVIRON, V539, P576, DOI 10.1016/j.scitotenv.2015.09.027	37	0	0	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255222	10.1371/journal.pone.0255222	http://dx.doi.org/10.1371/journal.pone.0255222			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339424	gold, Green Published			2022-12-26	WOS:000680243400040
J	Sasaki, S; Tamogami, J; Nishiya, K; Demura, M; Kikukawa, T				Sasaki, Syogo; Tamogami, Jun; Nishiya, Koki; Demura, Makoto; Kikukawa, Takashi			Replaceability of Schiff base proton donors in light-driven proton pump rhodopsins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOCHEMICAL-REACTION CYCLE; VOLUME CHANGES; EXIGUOBACTERIUM-SIBIRICUM; HYDROSTATIC-PRESSURE; ESCHERICHIA-COLI; BACTERIORHODOPSIN; PHOTOCYCLE; MEMBRANE; PROTEIN; EXPRESSION	Many H+-pump rhodopsins conserve "H+ donor" residues in cytoplasmic (CP) half channels to quickly transport H+ from the CP medium to Schiff bases at the center of these proteins. For conventional H+ pumps, the donors are conserved as Asp or Glu but are replaced by Lys in the minority, such as Exi-guobacterium sibiricum rhodopsin (ESR). In dark states, carboxyl donors are protonated, whereas the Lys donor is deprotonated. As a result, carboxyl donors first donate H+ to the Schiff bases and then capture the other H+ from the me-dium, whereas the Lys donor first captures H+ from the me-dium and then donates it to the Schiff base. Thus, carboxyl and Lys-type H+ pumps seem to have different mechanisms, which are probably optimized for their respective H+-transfer re-actions. Here, we examined these differences via replacement of donor residues. For Asp-type deltarhodopsin (DR), the embedded Lys residue distorted the protein conformation and did not act as the H+ donor. In contrast, for Glu-type proteo-rhodopsin (PR) and ESR, the embedded residues functioned well as H+ donors. These differences were further examined by focusing on the activation volumes during the H+-transfer re-actions. The results revealed essential differences between archaeal H+ pump (DR) and eubacterial H+ pumps PR and ESR. Archaeal DR requires significant hydration of the CP channel for the H+-transfer reactions; however, eubacterial PR and ESR require the swing-like motion of the donor residue rather than hydration. Given this common mechanism, donor residues might be replaceable between eubacterial PR and ESR.	[Sasaki, Syogo; Nishiya, Koki] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Tamogami, Jun] Matsuyama Univ, Coll Pharmaceut Sci, Matsuyama, Ehime, Japan; [Demura, Makoto; Kikukawa, Takashi] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Tamogami, J (corresponding author), Matsuyama Univ, Coll Pharmaceut Sci, Matsuyama, Ehime, Japan.; Kikukawa, T (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan.	jtamoga@g.matsuyama-u.ac.jp; kikukawa@sci.hokudai.ac.jp	Kikukawa, Takashi/F-5266-2011; Demura, Makoto/F-5272-2011	Kikukawa, Takashi/0000-0002-6185-7281; Demura, Makoto/0000-0003-0912-9284; TAMOGAMI, JUN/0000-0002-0799-0815	Japan Society for the Promotion of Science KAKENHI [16K18519, 17K07326]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI granted to J. T. (16K18519) and T. K. (17K07326).	AMES JB, 1990, BIOCHEMISTRY-US, V29, P7181, DOI 10.1021/bi00483a005; Balashov SP, 2013, J BIOL CHEM, V288, P21254, DOI 10.1074/jbc.M113.465138; Balashov SP, 2000, BBA-BIOENERGETICS, V1460, P75, DOI 10.1016/S0005-2728(00)00131-6; Balashov SP, 1999, BIOCHEMISTRY-US, V38, P2026, DOI 10.1021/bi981926a; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2013, ENCY BIODIVERSITY, V6, P280; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; CAO Y, 1991, BIOCHEMISTRY-US, V30, P10972, DOI 10.1021/bi00109a023; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; Dioumaev AK, 2013, J PHYS CHEM B, V117, P7235, DOI 10.1021/jp402430w; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Govorunova EG, 2017, ANNU REV BIOCHEM, V86, P845, DOI 10.1146/annurev-biochem-101910-144233; Gushchin I, 2013, P NATL ACAD SCI USA, V110, P12631, DOI 10.1073/pnas.1221629110; Hasemi T, 2019, BBA-BIOENERGETICS, V1860, P136, DOI 10.1016/j.bbabio.2018.12.001; Hasemi T, 2016, J BIOL CHEM, V291, P355, DOI 10.1074/jbc.M115.688614; Iizuka A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47178-5; Inoue K, 2004, BIOPHYS J, V87, P2587, DOI 10.1529/biophysj.104.043521; Kajimoto K, 2017, J PHYS CHEM B, V121, P4431, DOI 10.1021/acs.jpcb.7b02421; Kamo N, 2006, BIOCHEM BIOPH RES CO, V341, P285, DOI 10.1016/j.bbrc.2005.12.181; Kandori Hideki, 2020, Biophys Rev, V12, P355, DOI 10.1007/s12551-020-00645-0; Kikukawa T, 2008, PHOTOCHEM PHOTOBIOL, V84, P880, DOI 10.1111/j.1751-1097.2008.00318.x; Kikukawa T, 2015, BBA-BIOENERGETICS, V1847, P748, DOI 10.1016/j.bbabio.2015.05.002; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Lee KA, 2015, BBA-GEN SUBJECTS, V1850, P1694, DOI 10.1016/j.bbagen.2015.04.002; Murabe K, 2020, J AM CHEM SOC, V142, P16023, DOI 10.1021/jacs.0c07264; Nakamura S, 2016, BBA-BIOENERGETICS, V1857, P1900, DOI 10.1016/j.bbabio.2016.09.006; Nishioku Y, 2002, BIOPHYS J, V83, P1136, DOI 10.1016/S0006-3495(02)75237-5; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; Petrovskaya LE, 2015, BIOCHEMISTRY-MOSCOW+, V80, P688, DOI 10.1134/S000629791506005X; Petrovskaya LE, 2010, FEBS LETT, V584, P4193, DOI 10.1016/j.febslet.2010.09.005; SCHULENBERG PJ, 1995, J PHYS CHEM-US, V99, P9617, DOI 10.1021/j100023a046; SCHULENBERG PJ, 1994, BIOPHYS J, V66, P838, DOI 10.1016/S0006-3495(94)80860-4; Tamogami J, 2009, PHOTOCHEM PHOTOBIOL, V85, P578, DOI 10.1111/j.1751-1097.2008.00520.x; Tittor J, 2002, J MOL BIOL, V319, P555, DOI 10.1016/S0022-2836(02)00307-8; VARO G, 1995, BIOCHEMISTRY-US, V34, P12161, DOI 10.1021/bi00038a009; Varo G, 2003, BIOPHYS J, V84, P1202, DOI 10.1016/S0006-3495(03)74934-0; Wickstrand C, 2015, BBA-GEN SUBJECTS, V1850, P536, DOI 10.1016/j.bbagen.2014.05.021; Zscherp C, 1999, P NATL ACAD SCI USA, V96, P5498, DOI 10.1073/pnas.96.10.5498	40	4	5	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101013	10.1016/j.jbc.2021.101013	http://dx.doi.org/10.1016/j.jbc.2021.101013			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34329681	gold, Green Published			2022-12-26	WOS:000706408900007
J	Sinn, DH; Kang, D; Hong, YS; Koh, KC; Guallar, E; Cho, J; Gwak, GY				Sinn, Dong Hyun; Kang, Danbee; Hong, Yun Soo; Koh, Kwang Cheol; Guallar, Eliseo; Cho, Juhee; Gwak, Geum-Youn			Prior antiviral treatment and mortality among patients with hepatitis C virus-related hepatocellular carcinoma: A national cohort study	PLOS ONE			English	Article							LIVER-DISEASE; RISK-FACTOR; IMPACT	Background The current antiviral treatments available for hepatitis C virus (HCV) infection decrease the risk of hepatocellular carcinoma (HCC). Hence, patients with HCV infection who have not received antiviral treatment and have developed HCC may be those who missed timely antiviral treatment for HCV. However, the proportion of patients who missed timely antiviral treatment and its implications are largely unexplored. Methods A nationwide retrospective cohort of 4,592 newly diagnosed HCV-related HCC patients (2013-2017) was identified from the Korean National Health Insurance Service database. Prior antiviral treatment for HCV was defined as a history of at least one HCV-specific antiviral treatment before HCC diagnosis. The outcome was all-cause mortality. Results Prior antiviral treatment for HCV was identified in 802 (17.4%) patients, and 16%, 16%, 17%, 19%, and 19% of patients received antiviral treatment in the years 2013, 2014, 2015, 2016, and 2017, respectively (P = 0.21). During 8,085 person-years of follow-up (median, 1.4; maximum, 5.3 years of follow-up), 1,970 patients died. Mortality rates were lower in patients with prior antiviral treatment (15 deaths/100 person-years) than in those without prior antiviral treatment (27 deaths/100 person-years). The adjusted hazard ratio (95% confidence interval) for all-cause mortality on comparing patients who did and did not receive prior antiviral treatment was 0.68 (0.59, 0.79). Conclusion Timely antiviral treatment for HCV was suboptimal at the population level. Prior antiviral treatment for HCV reduced mortality rate in HCV-related HCC patients. Intensive HCV control strategies are needed to reduce the number of patients with HCV infection who miss timely HCV treatment.	[Sinn, Dong Hyun; Koh, Kwang Cheol; Gwak, Geum-Youn] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Kang, Danbee; Cho, Juhee] Sungkyunkwan Univ, SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea; [Kang, Danbee; Guallar, Eliseo; Cho, Juhee] Sungkyunkwan Univ, Ctr Clin Epidemiol, Samsung Med Ctr, Seoul, South Korea; [Hong, Yun Soo; Guallar, Eliseo; Cho, Juhee] Johns Hopkins Med Inst, Dept Epidemiol & Med, Baltimore, MD 21205 USA; [Hong, Yun Soo; Guallar, Eliseo; Cho, Juhee] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Gwak, GY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.; Cho, J (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea.; Cho, J (corresponding author), Sungkyunkwan Univ, Ctr Clin Epidemiol, Samsung Med Ctr, Seoul, South Korea.; Cho, J (corresponding author), Johns Hopkins Med Inst, Dept Epidemiol & Med, Baltimore, MD 21205 USA.; Cho, J (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA.	jcho@skku.edu; gy.gwak@samsung.com	Cho, Juhee/ABD-2280-2021; Kang, Danbee/AAN-5933-2020	Kang, Danbee/0000-0003-0244-7714; Gwak, Geum-Youn/0000-0002-6453-3450				[Anonymous], 2009, HLTH SYSTEMS TRANSIT, DOI DOI 10.1016/j.cmpb.2003.10.004; Bang CS, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0606-9; Baumert TF, 2019, GASTROENTEROLOGY, V156, P431, DOI 10.1053/j.gastro.2018.10.024; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choi GH, 2020, GUT LIVER, V14, P808, DOI 10.5009/gnl19296; Federico A, 2016, REV RECENT CLIN TRIA, V11, P201, DOI 10.2174/1574887111666160126144940; Hoshida Y, 2014, J HEPATOL, V61, pS79, DOI 10.1016/j.jhep.2014.07.010; Huang CF, 2020, CLIN MOL HEPATOL, V26, P251, DOI 10.3350/cmh.2020.0018; Im S, 2019, CANCER RES TREAT, V51, P1357, DOI 10.4143/crt.2018.430; Ioannou GN, 2019, GASTROENTEROLOGY, V157, P1264, DOI 10.1053/j.gastro.2019.07.033; Ioannou GN, 2019, GASTROENTEROLOGY, V156, P446, DOI 10.1053/j.gastro.2018.10.033; Jang ES, 2019, HEPATOL INT, V13, P599, DOI 10.1007/s12072-019-09975-y; Jang JW, 2014, WORLD J GASTROENTERO, V20, P7675, DOI 10.3748/wjg.v20.i24.7675; Jeong SH, 2016, CLIN MOL HEPATOL, V22, P76, DOI 10.3350/cmh.2016.22.1.76; KASL, 2014, CLIN MOL HEPATOL, V20, P89, DOI 10.3350/cmh.2014.20.2.89; Kim KM, 2018, SCAND J GASTROENTERO, V53, P727, DOI 10.1080/00365521.2018.1458895; Kim Kyoung Hoon, 2010, J Prev Med Public Health, V43, P42, DOI 10.3961/jpmph.2010.43.1.42; Kubo S, 1999, JPN J CANCER RES, V90, P162, DOI 10.1111/j.1349-7006.1999.tb00729.x; Mauss S, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0856-y; Ohata K, 2003, CANCER-AM CANCER SOC, V97, P3036, DOI 10.1002/cncr.11427; Shin A, 2009, CANCER EPIDEM BIOMAR, V18, P1894, DOI 10.1158/1055-9965.EPI-08-1228; Singal AG, 2019, GASTROENTEROLOGY, V157, P1253, DOI 10.1053/j.gastro.2019.07.040; Sinn DH, 2008, LIVER INT, V28, P1363, DOI 10.1111/j.1478-3231.2008.01860.x; Sinn DH, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5508-5; Sinn DH, 2017, CLIN MOL HEPATOL, V23, P189, DOI 10.3350/cmh.2017.0033; Sinn DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112184; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Stickel F, 2020, HEPATOLOGY, V72, P88, DOI 10.1002/hep.30996; van der Meer AJ, 2015, EXPERT REV GASTROENT, V9, P559, DOI 10.1586/17474124.2015.1001366; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Yeon JE, 2018, CLIN MOL HEPATOL, V24, P169, DOI 10.3350/cmh.2018.1004; Yurkovich M, 2015, J CLIN EPIDEMIOL, V68, P3, DOI 10.1016/j.jclinepi.2014.09.010	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255624	10.1371/journal.pone.0255624	http://dx.doi.org/10.1371/journal.pone.0255624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343200	gold, Green Published			2022-12-26	WOS:000685264200050
J	Ullah, GMW; Nehring, M				Ullah, G. M. Wali; Nehring, Micah			A multi-objective mathematical model of a water management problem with environmental impacts: An application in an irrigation project	PLOS ONE			English	Article							OPTIMIZATION	The study proposes applying an efficient but straightforward multi-objective constrained optimization model for optimal water allocation among irrigation and environmental sectors. The model has been implemented in the Muhuri Irrigation Project (MIP), Bangladesh, where the irrigation systems lead to unjustifiable use of groundwater. This study explores how water can be optimised to increase agricultural production and sustain the local environment in the MIP. Hence, the paper has two objectives-to maximise the net return and minimise the deficit in environmental flow. The study uses a Non-Dominating Sorting Genetic Algorithm, NSGA-II, to solve the research problem. Results indicate that crops more profitable to trade should be cultivated. Furthermore, the rainfall has more impact on the net return and environmental flow deficit than water inflow. The findings of this study can help plan irrigation water and cropland resources and be a reference for further studies.	[Ullah, G. M. Wali] Univ Chittagong, Dept Math, Chattogram, Bangladesh; [Nehring, Micah] Univ Queensland, Sch Mech & Min Engn, Brisbane, Qld, Australia	University of Chittagong; University of Queensland	Ullah, GMW (corresponding author), Univ Chittagong, Dept Math, Chattogram, Bangladesh.	wali@cu.ac.bd		Ullah, G M Wali/0000-0001-5491-1289; Nehring, Micah/0000-0002-0404-5332				Adama G. J., 2020, Journal of Water Resource and Protection, V12, P316, DOI 10.4236/jwarp.2020.124019; Asian Development Bank, 2013, BAN IRR MAN IMPR INV; Chowdhury MMRK, 2015, COUNTRY REPORT BANGL; De Jong K. A., 1992, Annals of Mathematics and Artificial Intelligence, V5, P1, DOI 10.1007/BF01530777; Deb K., 2000, Parallel Problem Solving from Nature PPSN VI. 6th International Conference. Proceedings (Lecture Notes in Computer Science Vol.1917), P849; Food and Agriculture Organization of the United Nations (FAO), 2014, AQUASTAT COUNTR PROF; Hossain M., 2009, IMPACT SHALLOW TUBEW; Ikudayisi A, 2018, COGENT ENG, V5, DOI 10.1080/23311916.2018.1535749; Lalehzari R, 2016, J IRRIG DRAIN ENG, V142, DOI 10.1061/(ASCE)IR.1943-4774.0000933; Lewis A, 2017, J ENVIRON MANAGE, V204, P179, DOI 10.1016/j.jenvman.2017.08.044; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Mainuddin M, 2015, IRRIGATION SCI, V33, P107, DOI 10.1007/s00271-014-0451-3; Marzban Z, 2021, ENVIRON SCI POLLUT R, V28, P6146, DOI 10.1007/s11356-020-10905-x; Masood M, 2021, ARAB J SCI ENG, V46, P10597, DOI 10.1007/s13369-021-05480-3; Miettinen K., 2012, NONLINEAR MULTIOBJEC; Musa AA, 2021, ENVIRON DEV SUSTAIN, V23, P5956, DOI 10.1007/s10668-020-00856-1; Reddy MS., 2004, HONOLULU; Roeva O., 2015, RECENT ADV COMPUTATI, P107, DOI DOI 10.1007/978-3-319-12631-9_7; Srinivas N., 1994, Evolutionary Computation, V2, P221, DOI 10.1162/evco.1994.2.3.221; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Twum SB., 2020, J APPL MATH PHYS, V8, P424, DOI [10.4236/jamp.2020.83032, DOI 10.4236/JAMP.2020.83032]; Wardlaw R, 2004, IRRIG DRAIN, V53, P397, DOI 10.1002/ird.121; Xevi E, 2005, J ENVIRON MANAGE, V77, P269, DOI 10.1016/j.jenvman.2005.06.013; Yu, 2013, MULTIPLE CRITERIA DE; Zeinali M, 2020, J WATER RES PLAN MAN, V146, DOI 10.1061/(ASCE)WR.1943-5452.0001189	25	2	2	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255441	10.1371/journal.pone.0255441	http://dx.doi.org/10.1371/journal.pone.0255441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343172	Green Published, gold			2022-12-26	WOS:000685264200017
J	Shalaginova, IG; Tuchina, OP; Sidorova, MV; Levina, AS; Khlebaeva, D; Vaido, AI; Dyuzhikova, NA				Shalaginova, I. G.; Tuchina, O. P.; Sidorova, M. V.; Levina, A. S.; Khlebaeva, D.; Vaido, A. I.; Dyuzhikova, N. A.			Effects of psychogenic stress on some peripheral and central inflammatory markers in rats with the different level of excitability of the nervous system	PLOS ONE			English	Article							LYMPHOCYTE RATIO; MICROGLIA; NEUROINFLAMMATION; NEUTROPHIL; ACTIVATION; MECHANISMS; DISTRESS; ANXIETY; MICE	Patients with post-stress pathologies display the signs of inflammation in the peripheral blood as well as in the brain. The mechanisms of such post-stress neuroimmune changes, their contribution to the behavior, the relationship of the intensity of inflammation with genetically determined features have not been clarified. The goal of this work was to evaluate the dynamics of post-stress inflammation in the blood and hippocampus of rats which differ in level of excitability of the nervous system. Rats of two strains (high/low excitability threshold) were subjected to stress according to the K. Hecht protocol and their behavior, neutrophil:lymphocyte ratio and the number of Iba+ cells in the hippocampus were analysed 24 hours, 7 and 24 days after stress exposure. Highly excitable animals show an increase in anxiety-like behavior, in the number of neutrophils compared to lymphocytes as well as in the number of Iba1+ cells in CA1, CA3 and DG areas of the hippocampus in response to stress. Thus, hereditary high excitability of the nervous system is a possible risk factor for the development of post-stress pathologies.	[Shalaginova, I. G.; Tuchina, O. P.; Sidorova, M. V.] Immanuel Kant Balt Fed Univ, Kaliningrad, Russia; [Levina, A. S.; Khlebaeva, D.; Vaido, A. I.; Dyuzhikova, N. A.] Russian Acad Sci, Pavlov Inst Physiol, St Petersburg, Russia	Immanuel Kant Baltic Federal University; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences	Shalaginova, IG (corresponding author), Immanuel Kant Balt Fed Univ, Kaliningrad, Russia.	shalaginova_i@mail.ru	Dyuzhikova, Natalia/AFO-9318-2022; Tuchina, Oksana/M-6627-2016; Shalaginova, Irina/J-3626-2018	Dyuzhikova, Natalia/0000-0003-3617-5948; Tuchina, Oksana/0000-0003-1480-1311; Sidorova, Maria/0000-0003-3347-2920; Shalaginova, Irina/0000-0002-0140-3077; Levina, Anna/0000-0002-1082-1801	Russian Academic Excellence Project at the Immanuel Kant Baltic Federal University	Russian Academic Excellence Project at the Immanuel Kant Baltic Federal University	This research was supported from the Russian Academic Excellence Project at the Immanuel Kant Baltic Federal University.	Badimon A, 2020, NATURE, V586, P417, DOI 10.1038/s41586-020-2777-8; Bi LL, 2013, NEUROPHARMACOLOGY, V72, P148, DOI 10.1016/j.neuropharm.2013.04.048; Bondarenko NA, 2019, 7 SEZD VAV OBSHCH GE, P1051; Bustan Y, 2018, PSYCHIAT RES, V262, P149, DOI 10.1016/j.psychres.2018.02.002; Calcia MA, 2016, PSYCHOPHARMACOLOGY, V233, P1637, DOI 10.1007/s00213-016-4218-9; COX G, 1995, J IMMUNOL, V154, P4719; Davis AK, 2018, METHODS ECOL EVOL, V9, P1556, DOI 10.1111/2041-210X.13020; Deslauriers J, 2017, CURR OPIN BEHAV SCI, V14, P123, DOI 10.1016/j.cobeha.2017.01.005; DiSabato DJ, 2016, J NEUROCHEM, V139, P136, DOI 10.1111/jnc.13607; [Дюжикова Наталья Алековна Dyuzhikova Natalya A.], 2018, [Экологическая генетика, Ekologicheskaya genetika], V16, P4, DOI 10.17816/ecogen1614-26; Flammer JR, 2011, MOL ENDOCRINOL, V25, P1075, DOI 10.1210/me.2011-0068; Friedman AK, 2014, SCIENCE, V344, P313, DOI 10.1126/science.1249240; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Greene T., 2018, TRAUMATOLOGY, V24, P83, DOI [10.1037/trm0000136, DOI 10.1037/TRM0000136]; Hickman DL, 2017, LAB ANIMAL, V46, P303, DOI 10.1038/laban.1298; Inagaki R, 2018, NEUROSCIENCE, V388, P448, DOI 10.1016/j.neuroscience.2018.08.004; Lindstrom Nicole M, 2015, Vet Clin North Am Exot Anim Pract, V18, P21, DOI 10.1016/j.cvex.2014.09.004; Mazza MG, 2018, PROG NEURO-PSYCHOPH, V84, P229, DOI 10.1016/j.pnpbp.2018.03.012; McLaughlin K., 2020, OXFORD HDB STRESS ME; Michopoulos V, 2015, BIOL PSYCHIAT, V78, P344, DOI 10.1016/j.biopsych.2015.01.005; Ordyan NE, 1998, B EXP BIOL MED+, V125, P393, DOI 10.1007/BF02499168; Radhakrishnan A, 2018, ANN NEUROSCI, V25, P234, DOI 10.1159/000492268; Rau AR, 2015, J NEUROSCI, V35, P9730, DOI 10.1523/JNEUROSCI.0384-15.2015; Reus GZ, 2015, NEUROSCIENCE, V300, P141, DOI 10.1016/j.neuroscience.2015.05.018; Ronchetti S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124090; Sivachenko IB, 2020, ZH VYSSH NERV DEYAT+, V70, P655, DOI 10.31857/S0044467720050123; Swan MP, 2014, LAB ANIMAL, V43, P276, DOI 10.1038/laban.529; Tuchina OP., 2018, GENES CELLS, V13; Vaido A., 2018, LAB ZHIVOTNYE DLYA N, P205; Wohleb ES, 2017, PROG NEURO-PSYCHOPH, V79, P40, DOI 10.1016/j.pnpbp.2016.04.013; Wohleb ES, 2014, BIOL PSYCHIAT, V75, P970, DOI 10.1016/j.biopsych.2013.11.029; Yamamoto M, 2019, CELL REP, V28, P2923, DOI 10.1016/j.celrep.2019.07.078	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255380	10.1371/journal.pone.0255380	http://dx.doi.org/10.1371/journal.pone.0255380			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324596	gold, Green Published			2022-12-26	WOS:000685248200092
J	Wissmath, B; Mast, FW; Kraus, F; Weibel, D				Wissmath, Bartholomaus; Mast, Fred W.; Kraus, Fabian; Weibel, David			Understanding the psychological impact of the COVID-19 pandemic and containment measures: An empirical model of stress	PLOS ONE			English	Article							CHILDHOOD MALTREATMENT; DEPRESSION; DISORDER; RISK	Epidemics such as COVID-19 and corresponding containment measures are assumed to cause psychological stress. In a survey during the lockdown in Switzerland (n = 1565), we found substantially increased levels of stress in the population. In particular, individuals who did not agree with the containment measures, as well as those who saw nothing positive in the crisis, experienced high levels of stress. In contrast, individuals who are part of a risk group or who are working in healthcare or in essential shops experienced similar stress levels as the general public. The psychological mechanisms that determine stress, caused by the COVID-19 pandemic and containment measures, are not yet clear. Thus, we conducted a path analysis to gain a deeper understanding of the psychological mechanisms that lead to stress. Experiencing fear of the disease is a key driver for being worried. Our model further shows that worries about the individual, social, and economic consequences of the crisis, strongly boost stress. The infection rate in the canton (i.e., state) of residence also contributes to stress. Positive thinking and perceived social, organizational, and governmental support mitigate worries and stress. Our findings indicate that containment measures increase worries and stress, especially for those who feel that these measures either are not sufficient or go too far. Thus, highlighting positive aspects of the crisis and convincing people of the effectiveness and necessity of mitigation measures can, not only promote compliance, but also reduce stress. Our model suggests that people who feel protected by the authorities have fewer worries, which can, in turn, limit the negative impact of the crisis on mental health.	[Wissmath, Bartholomaus; Mast, Fred W.; Kraus, Fabian; Weibel, David] Univ Bern, Inst Psychol, Bern, Switzerland; [Wissmath, Bartholomaus; Kraus, Fabian; Weibel, David] W Hoch 2 GmbH, Bern, Switzerland; [Wissmath, Bartholomaus; Mast, Fred W.; Weibel, David] Swiss Distance Learning Univ, Brig, Switzerland	University of Bern	Wissmath, B (corresponding author), Univ Bern, Inst Psychol, Bern, Switzerland.; Wissmath, B (corresponding author), W Hoch 2 GmbH, Bern, Switzerland.; Wissmath, B (corresponding author), Swiss Distance Learning Univ, Brig, Switzerland.	wissmath@psy.unibe.ch		Kraus, Fabian/0000-0001-6142-784X; Mast, Fred/0000-0002-0665-4457; Wissmath, Bartholomaus/0000-0002-6222-6094; Weibel, David/0000-0002-1848-9065				Andrews JL, 2020, TRENDS COGN SCI, V24, P585, DOI 10.1016/j.tics.2020.05.001; Arbuckle JL., 2020, AMOS VERSION 25 0; Barbisch D, 2015, DISASTER MED PUBLIC, V9, P547, DOI 10.1017/dmp.2015.38; Ben Loubir D, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.280.6430; Betsch C, 2020, NAT HUM BEHAV, V4, P438, DOI 10.1038/s41562-020-0866-1; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; BRUCE ML, 1994, SOC PSYCH PSYCH EPID, V29, P165; COHEN S, 1988, CLAR SYMP, P31; De Berardis D, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00148; Fiorillo A, 2020, EUR PSYCHIAT, V63, DOI 10.1192/j.eurpsy.2020.35; Fossati A., 2010, TRADUZIONE ITALIANA; Guo J, 2020, CHILD ABUSE NEGLECT, V110, DOI 10.1016/j.chiabu.2020.104667; IBM Corp, 2016, IBM SPSS STAT WIND V; Kelloway EK, 2012, STRESS HEALTH, V28, P91, DOI 10.1002/smi.1406; Klein EM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0875-9; Kline R., 2011, HDB INNOVATION SOCIA, P562, DOI [10.4135/9781446268261, DOI 10.4135/9781446268261, 10.4135/9781446268261.n31]; Lienert G.A., 1998, TESTAUFBAU TESTANALY; Limcaoco R.S.G., 2020, ANXIETY WORRY PERCEI, DOI [10.1101/2020.04.03.20043992, DOI 10.1101/2020.04.03.20043992, DOI 10.1101/2020.04.030.20043992]; Liu S, 2021, PERS INDIV DIFFER, V168, DOI 10.1016/j.paid.2020.110351; Mehta K, 2015, J CLIN PSYCHIAT, V76, pE499, DOI 10.4088/JCP.14m09637; Miranda R, 2007, COGNITIVE THER RES, V31, P71, DOI 10.1007/s10608-006-9063-4; Naseem Z., 2010, J RES REFLECTIONS ED, V4, P42, DOI [10.1155/2021/7814159, DOI 10.1155/2021/7814159]; Norem JK, 2001, OPTIMISM PESSIMISM I, P77, DOI DOI 10.1037/10385-004; Pellecchia U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143036; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Pompili M, 2014, PSYCHIAT RES, V220, P571, DOI 10.1016/j.psychres.2014.07.056; Probst D., 2020, COVID 19 INFORM SWIT; Santiago CD, 2011, J ECON PSYCHOL, V32, P218, DOI 10.1016/j.joep.2009.10.008; Schmitt M., 2017, STATISTIK FORSCHUNGS; Schneider EE, 2020, INT J CLIN HLTH PSYC, V20, P173, DOI 10.1016/j.ijchp.2020.03.004; Tang WJ, 2020, PERS INDIV DIFFER, V165, DOI 10.1016/j.paid.2020.110131; Varshney M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233874; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wanklyn SG, 2012, CHILD MALTREATMENT, V17, P306, DOI 10.1177/1077559512466956; West S. G., 1995, STRUCTURAL EQUATION, P56; Wong TY, 2008, ANN ACAD MED SINGAP, V37, P96; Wu M.L, 2010, STRUCTURAL EQUATION; Zhao SZ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186692	38	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254883	10.1371/journal.pone.0254883	http://dx.doi.org/10.1371/journal.pone.0254883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324498	Green Published, Green Submitted, gold			2022-12-26	WOS:000685248200063
J	ElAshmawy, WR; Abdelfattah, EM; Williams, DR; Gerry, AC; Rossow, HA; Lehenbauer, TW; Aly, SS				ElAshmawy, Wagdy R.; Abdelfattah, Essam M.; Williams, Deniece R.; Gerry, Alec C.; Rossow, Heidi A.; Lehenbauer, Terry W.; Aly, Sharif S.			Stable fly activity is associated with dairy management practices and seasonal weather conditions	PLOS ONE			English	Article							STOMOXYS-CALCITRANS DIPTERA; SHORT-COMMUNICATION RELATIONSHIP; NIGER-NIGER DIPTERA; FLIES DIPTERA; MILK-PRODUCTION; BEHAVIORAL-RESPONSES; EASTERN NEBRASKA; FEED-EFFICIENCY; WEIGHT-GAIN; FACE-FLY	Stable flies (Stomoxys calcitrans) are blood-sucking insects commonly associated with cattle production systems worldwide and are known to cause severe irritation to cattle due to painful bites. Cattle react to biting stable flies with an aggregating behavior known as bunching. Bunching behavior reduces grazing or feed consumption and thus reduces cattle productivity and welfare. Cattle's fly-repelling behaviors include foot stomping, head tossing, tail switching and skin twitching. A longitudinal study was conducted in 2017 on 20 California dairies (average lactating herd size = 2,466 (SE +/- 28.392)) during the stable fly season from April to July. The study objectives were to estimate the association between environmental factors and dairy characteristics including facility design, feed and manure management, total mixed ration (TMR) components fed to cattle, and operational pest management procedures and the outcome stable fly activity on California dairies. Stable fly activity was measured by counting stable flies on cow forelimbs (leg count) and on Alsynite traps (trap count) over the 13-week study period. Weekly leg counts were performed for cattle in lactating cow pens (31 pens from 10 study dairies) with counts made during the morning (AM) and again during the afternoon (PM). Trap counts were performed on all 20 study dairies. Data were analyzed using linear mixed models which revealed temporal variation in the average leg and trap counts with stable fly activity increasing from May to June and then decreasing to the lowest activity in July. Leg counts were higher during the afternoon compared to morning. Ambient temperatures <= 30SUPERSCRIPT ZEROC and relative humidity (RH) measurements <50% were associated with higher leg and trap counts. Traps located at the periphery of study dairies had higher stable fly counts compared to traps located in the interior of the dairy. Cow pens with trees on the periphery had higher leg counts in comparison to pens away from trees. Specific TMR components were associated with both leg and trap counts. Dairies feeding by-products including almond hulls, wet distillers' grain, fruits, and vegetables had higher trap counts compared to dairies that did not feed these ingredients. At the pen level, pens with rations that contained straw had lower average leg counts compared to pens fed with rations that did not contain straw. A similar association was observed for pens with rations that contained wheat silage when ambient temperatures were <= 30SUPERSCRIPT ZEROC. In contrast, pens with water added to the TMR while the RH was >= 50% had higher average leg counts compared to pens without water added to the TMR. Dairies that applied insecticides for fly control to their entire facility had lower trap counts compared to dairies that did not apply insecticides. Stable fly activity measured on California dairies using leg and trap counts varied according to the month, environmental factors, pen surroundings, trap location, TMR components, and insecticide use.	[ElAshmawy, Wagdy R.; Abdelfattah, Essam M.; Williams, Deniece R.; Rossow, Heidi A.; Lehenbauer, Terry W.; Aly, Sharif S.] Univ Calif Davis, Sch Vet Med, Vet Med Teaching & Res Ctr, Davis, CA 95616 USA; [ElAshmawy, Wagdy R.] Cairo Univ, Dept Internal Med & Infect Dis, Fac Vet Med, Giza, Egypt; [Abdelfattah, Essam M.] Benha Univ, Dept Anim Hyg & Vet Management, Fac Vet Med, Qalyubia, Egypt; [Gerry, Alec C.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Aly, Sharif S.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California Davis; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Benha University; University of California System; University of California Riverside; University of California System; University of California Davis	Aly, SS (corresponding author), Univ Calif Davis, Sch Vet Med, Vet Med Teaching & Res Ctr, Davis, CA 95616 USA.; Aly, SS (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	saly@ucdavis.edu	Abdelfattah, Essam/D-2365-2016; Elashmawy, Wagdy R/M-3263-2016; Williams, Deniece/AAD-6368-2020	Abdelfattah, Essam/0000-0002-7267-8406; Williams, Deniece/0000-0002-7534-732X; rossow, heidi/0000-0002-3753-4263; ElAshmawy, Wagdy/0000-0002-2167-2442; ElAshmawy, Wagdy/0000-0001-6466-1455	Center of Food Animal Health, School of Veterinary Medicine, University of California Davis (USDA NIFA) [CA-V-VME-4077-H]	Center of Food Animal Health, School of Veterinary Medicine, University of California Davis (USDA NIFA)	Funding for this study was provided by the Center of Food Animal Health, School of Veterinary Medicine, University of California Davis (USDA NIFA project number: CA-V-VME-4077-H, PI Aly). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly SS, 2010, J DAIRY SCI, V93, P1030, DOI 10.3168/jds.2009-2611; BERKEBILE DR, 1994, J ECON ENTOMOL, V87, P1555, DOI 10.1093/jee/87.6.1555; BERRY IL, 1985, ENVIRON ENTOMOL, V14, P336, DOI 10.1093/ee/14.3.336; BERRY IL, 1986, ENVIRON ENTOMOL, V15, P706, DOI 10.1093/ee/15.3.706; Bishopp FC., 1926, FARMERS B, V1097, P1; BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; BRUCE WN, 1958, J ECON ENTOMOL, V51, P269, DOI 10.1093/jee/51.3.269; CAMPBELL JB, 1971, J ECON ENTOMOL, V64, P1188, DOI 10.1093/jee/64.5.1188; CAMPBELL JB, 1987, J ECON ENTOMOL, V80, P117, DOI 10.1093/jee/80.1.117; Cook DF, 2018, AUSTRAL ENTOMOL, V57, P344, DOI 10.1111/aen.12282; Cook DF, 2011, INT J PEST MANAGE, V57, P315, DOI 10.1080/09670874.2011.603063; Denning SS, 2014, J DAIRY SCI, V97, P4624, DOI 10.3168/jds.2013-7872; El Ashmawy WR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224987; Felton CA, 2010, J DAIRY SCI, V93, P2651, DOI 10.3168/jds.2009-3009; Freeborn SB, 1928, J ECON ENTOMOL, V21, P494, DOI 10.1093/jee/21.3.494; Friesen KM, 2013, ENVIRON ENTOMOL, V42, P49, DOI 10.1603/EN12231; Gerry A. C., 2007, PREDICTING CONTROLLI; Gerry AC, VETPESTX DATABASE PE; Gilles J, 2005, J MED ENTOMOL, V42, P959, DOI 10.1603/0022-2585(2005)042[0959:EOTOTR]2.0.CO;2; Gilles J, 2005, J MED ENTOMOL, V42, P260, DOI 10.1603/0022-2585(2005)042[0260:TEODAS]2.0.CO;2; GRANETT P, 1956, J ECON ENTOMOL, V49, P465, DOI 10.1093/jee/49.4.465; Guo YJ, 1998, J ECON ENTOMOL, V91, P159, DOI 10.1093/jee/91.1.159; JONES CJ, 1985, ENVIRON ENTOMOL, V14, P223, DOI 10.1093/ee/14.3.223; JONES CJ, 1992, ENVIRON ENTOMOL, V21, P141, DOI 10.1093/ee/21.1.141; Kienitz MJ, 2018, J DAIRY SCI, V101, P4667, DOI 10.3168/jds.2017-13367; Lorn S, 2020, J MED ENTOMOL, V57, P252, DOI 10.1093/jme/tjz128; Lysyk TJ, 1998, J MED ENTOMOL, V35, P107, DOI 10.1093/jmedent/35.2.107; LYSYK TJ, 1993, J MED ENTOMOL, V30, P888, DOI 10.1093/jmedent/30.5.888; Masmeatathip R, 2006, PARASITE, V13, P245, DOI 10.1051/parasite/2006133245; MEYER J A, 1990, California Agriculture, V44, P28; MEYER JA, 1983, J ECON ENTOMOL, V76, P103, DOI 10.1093/jee/76.1.103; Mihok S, 1996, MED VET ENTOMOL, V10, P392, DOI 10.1111/j.1365-2915.1996.tb00762.x; MILLER RW, 1973, J ECON ENTOMOL, V66, P711, DOI 10.1093/jee/66.3.711; Muller GC, 2012, MED VET ENTOMOL, V26, P178, DOI 10.1111/j.1365-2915.2011.01001.x; Muenworn V, 2010, J MED ENTOMOL, V47, P791, DOI 10.1603/ME10001; MULLENS B A, 1988, California Agriculture, V42, P20; Mullens BA, 2006, MED VET ENTOMOL, V20, P122, DOI 10.1111/j.1365-2915.2006.00608.x; Mullens BA, 2005, J MED ENTOMOL, V42, P705, DOI 10.1603/0022-2585(2005)042[0705:RBRASF]2.0.CO;2; MULLENS BA, 1987, J ECON ENTOMOL, V80, P1039, DOI 10.1093/jee/80.5.1039; O'Hea EL, 2016, J HEALTH PSYCHOL, V21, P1145, DOI 10.1177/1359105314547752; Olafson PU, 2019, J MED ENTOMOL, V56, P1145, DOI 10.1093/jme/tjz012; Perttu RK, 2020, J DAIRY SCI, V103, P846, DOI 10.3168/jds.2019-17267; Phasuk J, 2013, PARASITE, V20, DOI 10.1051/parasite/2013016; Sahgal S, 2021, NEUROCRIT CARE, V34, P193, DOI 10.1007/s12028-020-01018-x; SCHMIDTMANN ET, 1982, APPL ANIM ETHOL, V8, P429, DOI 10.1016/0304-3762(82)90056-6; SCHMIDTMANN ET, 1985, VET PARASITOL, V18, P203, DOI 10.1016/0304-4017(85)90045-7; Semelbauer M, 2018, INSECTS, V9, DOI 10.3390/insects9040142; Serra NSJ, 2017, MED VET ENTOMOL, V31, P381, DOI 10.1111/mve.12246; Showler Allan T., 2015, International Journal of Insect Science, V7, P19, DOI 10.4137/IJIS.S21647; Sjostrom LS, 2016, J DAIRY SCI, V99, P9942, DOI 10.3168/jds.2016-11038; SUTHERLAND B, 1979, ONDERSTEPOORT J VET, V46, P223; Talley J, 2009, J MED ENTOMOL, V46, P1310, DOI 10.1603/033.046.0609; Taylor DB, 2008, ENVIRON ENTOMOL, V37, P625, DOI 10.1603/0046-225X(2008)37[625:SFIASF]2.0.CO;2; Taylor DB, 2007, J MED ENTOMOL, V44, P765, DOI 10.1603/0022-2585(2007)44[765:SFPDIE]2.0.CO;2; Taylor DB, 2017, ENVIRON ENTOMOL, V46, P434, DOI 10.1093/ee/nvx032; Taylor DB, 2012, J MED ENTOMOL, V49, P198, DOI 10.1603/ME10050; Thomas GD, 1996, J ECON ENTOMOL, V89, P411, DOI 10.1093/jee/89.2.411; Vitela-Mendoza I, 2016, J DAIRY SCI, V99, P9912, DOI 10.3168/jds.2016-11484; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; WARNES ML, 1987, MED VET ENTOMOL, V1, P53, DOI 10.1111/j.1365-2915.1987.tb00322.x; WIEMAN GA, 1992, J ECON ENTOMOL, V85, P1835, DOI 10.1093/jee/85.5.1835	61	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0253946	10.1371/journal.pone.0253946	http://dx.doi.org/10.1371/journal.pone.0253946			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320006	Green Published, gold			2022-12-26	WOS:000685247800002
J	Nakagawa, P; Gomez, J; Lu, KT; Grobe, JL; Sigmund, CD				Nakagawa, Pablo; Gomez, Javier; Lu, Ko-Ting; Grobe, Justin L.; Sigmund, Curt D.			Studies of salt and stress sensitivity on arterial pressure in renin-b deficient mice	PLOS ONE			English	Article							ANGIOTENSIN SYSTEM; BLOOD-PRESSURE; INDUCED HYPERTENSION; SELECTIVE DELETION; SODIUM REDUCTION; EXPRESSION; TRANSCRIPT; RESPONSES; ISOFORMS; LACKING	Excessive sodium intake is known to increase the risk for hypertension, heart disease, and stroke. Individuals who are more susceptible to the effects of high salt are at higher risk for cardiovascular diseases even independent of their blood pressure status. Local activation of the renin-angiotensin system (RAS) in the brain, among other mechanisms, has been hypothesized to play a key role in contributing to salt balance. We have previously shown that deletion of the alternative renin isoform termed renin-b disinhibits the classical renin-a encoding preprorenin in the brain resulting in elevated brain RAS activity. Thus, we hypothesized that renin-b deficiency results in higher susceptibility to salt-induced elevation in blood pressure. Telemetry implanted Ren-b(Null) and wildtype littermate mice were first offered a low salt diet for a week and subsequently a high salt diet for another week. A high salt diet induced a mild blood pressure elevation in both Ren-b(Null) and wildtype mice, but mice lacking renin-b did not exhibit an exaggerated pressor response. When renin-b deficient mice were exposed to a high salt diet for a longer duration (4 weeks), there was a trend for increased myocardial enlargement in Ren-b(Null) mice when compared with control mice, but this did not reach statistical significance. Multiple studies have also demonstrated the association of environmental stress with hypertension. Activation of the RAS in the rostral ventrolateral medulla and the hypothalamus is required for stress-induced hypertension. Thus, we next questioned whether the lack of renin-b would result in exacerbated response to an acute restraint-stress. Wildtype and Ren-b(Null) mice equally exhibited elevated blood pressure in response to restraint-stress, which was similar in mice fed either a low or high salt diet. These studies suggest that mechanisms unrelated to salt and acute stress alter the cardiovascular phenotype in mice lacking renin-b.	[Nakagawa, Pablo; Gomez, Javier; Lu, Ko-Ting; Grobe, Justin L.; Sigmund, Curt D.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53201 USA	Medical College of Wisconsin	Nakagawa, P (corresponding author), Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53201 USA.	pnakagawa@mcw.edu			National Institutes of Health (NIH) [HL084207, HL144807, HL134850, HL153101]; American Heart Association [15SFRN23480000, 18EIA33890055]; NIH [2T32HL007121041, 4T32DK007690, 5T32HL134643]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported through research grants from the National Institutes of Health (NIH) to CDS (HL084207 and HL144807), JLG (HL134850), PN (HL153101) and grants from the American Heart Association to CDS (15SFRN23480000), JLGrobe (18EIA33890055). PN was funded with training awards from the NIH for this study (2T32HL007121041, 4T32DK007690, and 5T32HL134643).	Adams JM, 2007, HYPERTENSION, V50, P354, DOI 10.1161/HYPERTENSIONAHA.107.091843; Bader M, 2002, J MOL CELL CARDIOL, V34, P1455, DOI 10.1006/jmcc.2002.2077; Baltatu O, 2000, HYPERTENSION, V35, P409, DOI 10.1161/01.HYP.35.1.409; CAMPESE VM, 1982, KIDNEY INT, V21, P371, DOI 10.1038/ki.1982.32; Clausmeyer S, 1999, CIRC RES, V84, P337, DOI 10.1161/01.RES.84.3.337; Clausmeyer S, 2000, ENDOCRINOLOGY, V141, P2963, DOI 10.1210/en.141.8.2963; COWLEY AW, 1992, PHYSIOL REV, V72, P231, DOI 10.1152/physrev.1992.72.1.231; Dahl LK, 2005, INT J EPIDEMIOL, V34, P967, DOI 10.1093/ije/dyh317; DENTON D, 1995, NAT MED, V1, P1009, DOI 10.1038/nm1095-1009; Gao F, 2011, CLIN EXP HYPERTENS, V33, P492, DOI 10.3109/10641963.2010.551795; Grobe JL, 2008, PHYSIOLOGY, V23, P187, DOI 10.1152/physiol.00002.2008; Hartner A, 2003, NEPHROL DIAL TRANSPL, V18, P1999, DOI 10.1093/ndt/gfg299; Juraschek SP, 2017, J AM COLL CARDIOL, V70, P2841, DOI 10.1016/j.jacc.2017.10.011; KNARDAHL S, 1990, AM J PHYSIOL, V259, pH248, DOI 10.1152/ajpheart.1990.259.1.H248; Lee-Kirsch MA, 1999, CIRC RES, V84, P240, DOI 10.1161/01.RES.84.2.240; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACGREGOR GA, 1982, LANCET, V1, P351, DOI 10.1016/S0140-6736(82)91389-7; McDougall SJ, 2000, HYPERTENSION, V35, P126, DOI 10.1161/01.HYP.35.1.126; Mu S, 2011, NAT MED, V17, P573, DOI 10.1038/nm.2337; NAFTILAN AJ, 1991, J CLIN INVEST, V87, P1300, DOI 10.1172/JCI115133; Nakagawa P, 2020, HYPERTENSION, V76, P468, DOI 10.1161/HYPERTENSIONAHA.120.14972; Nakagawa P, 2020, CURR HYPERTENS REP, V22, DOI 10.1007/s11906-019-1011-2; Nakagawa P, 2017, HYPERTENSION, V70, P10, DOI 10.1161/HYPERTENSIONAHA.117.08550; Navar LG, 2002, HYPERTENSION, V39, P316, DOI 10.1161/hy0202.103821; Ralph AF, 2021, HYPERTENSION, V77, P158, DOI 10.1161/HYPERTENSIONAHA.120.16186; RANKIN LI, 1981, AM J KIDNEY DIS, V1, P177, DOI 10.1016/S0272-6386(81)80025-X; Shinohara K, 2017, HYPERTENSION, V70, P990, DOI 10.1161/HYPERTENSIONAHA.117.09923; Shinohara K, 2016, HYPERTENSION, V68, P1385, DOI 10.1161/HYPERTENSIONAHA.116.08242; Sinn PL, 2000, PHYSIOL GENOMICS, V3, P25, DOI 10.1152/physiolgenomics.2000.3.1.25; Susic D, 2009, AM J NEPHROL, V29, P639, DOI 10.1159/000195633; Varagic J, 2008, AM J PHYSIOL-HEART C, V294, pH853, DOI 10.1152/ajpheart.00737.2007; Wang LH, 2015, LIFE SCI, V121, P135, DOI 10.1016/j.lfs.2014.12.004; Wanka H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76712-z; Wanka H, 2016, J MOL MED, V94, P61, DOI 10.1007/s00109-015-1321-z; Weinberger MH, 2001, HYPERTENSION, V37, P429, DOI 10.1161/01.HYP.37.2.429; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; Wu J, 2021, CARDIOVASC RES, V117, P308, DOI 10.1093/cvr/cvaa147; Xue B., 2019, AM J HYPERTENS, DOI [10.1093/ajh/hpz075, DOI 10.1093/AJH/HPZ075]; Xue BJ, 2012, HYPERTENSION, V59, P459, DOI 10.1161/HYPERTENSIONAHA.111.185116; Zhao Z, 2017, NEURON, V95, P138, DOI 10.1016/j.neuron.2017.05.031; Zhou X, 2019, HYPERTENS RES, V42, P1142, DOI 10.1038/s41440-019-0242-6	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0250807	10.1371/journal.pone.0250807	http://dx.doi.org/10.1371/journal.pone.0250807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34319999	Green Submitted, Green Published, gold			2022-12-26	WOS:000685247800040
J	Huang, SS; Huang, PH; Leu, HB; Wu, TC; Chen, JW; Lin, SJ				Huang, Shao-Sung; Huang, Po-Hsun; Leu, Hsin-Bang; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong			Significance of serum FGF-23 for risk assessment of contrast-associated acute kidney injury and clinical outcomes in patients undergoing coronary angiography	PLOS ONE			English	Article							GROWTH-FACTOR 23; ACUTE-RENAL-FAILURE; C-REACTIVE PROTEIN; INDUCED NEPHROPATHY; CARDIOVASCULAR EVENTS; FACTOR-23; MORTALITY; DEATH; DISEASE; IMPACT	Background Fibroblast growth factor (FGF)-23 levels rise as kidney function declines. Whether elevated FGF-23 levels are associated with an increased risk for contrast-associated acute kidney injury (CA-AKI) and major adverse cardiovascular events (MACE) in patients undergoing coronary angiography remain uncertain. Methods In total, 492 patients receiving coronary angiography were enrolled. Their serum FGF-23 levels were measured before administration of contrast media. The occurrence of CA-AKI was defined as a rise in serum creatinine of 0.5 mg/dL or a 25% increase from the baseline value within 48 h after the procedure. All patients were followed up for at least 1 year or until the occurrence of MACE including death, nonfatal myocardial infarction (MI), and ischemic stroke. Results Overall, CA-AKI occurred in 41 (8.3%) patients. During a median follow-up of 2.6 years, there were 24 deaths, 3 nonfatal MIs, and 7 ischemic strokes. Compared with those in the lowest FGF-23 tertile, individuals in the highest FGF-23 tertile had a significantly higher incidence of CA-AKI (P < 0.001) and lower incidence of MACE-free survival (P = 0.001). In multivariate regression analysis, higher FGF-23 level was found to be independently associated with a graded risk for CA-AKI (OR per doubling, 1.90; 95% CI 1.48-2.44) and MACE (HR per doubling, 1.25; 95% CI 1.02-1.52). Conclusions Elevated FGF-23 levels were associated with an increased risk for CA-AKI and future MACE among patients undergoing coronary angiography. FGF-23 may play a role in early diagnosis of CA-AKI and predicting clinical outcomes after coronary angiography.	[Huang, Shao-Sung; Huang, Po-Hsun; Leu, Hsin-Bang; Wu, Tao-Cheng; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Huang, Shao-Sung; Leu, Hsin-Bang; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Huang, Shao-Sung; Chen, Jaw-Wen] Natl Yang Ming Chiao Tung Univ, Sch Med, Tainan, Taiwan; [Huang, Po-Hsun] Taipei Vet Gen Hosp, Dept Crit Care Med, Taipei, Taiwan; [Huang, Po-Hsun; Leu, Hsin-Bang; Wu, Tao-Cheng; Lin, Shing-Jong] Natl Yang Ming Chiao Tung Univ, Cardiovasc Res Ctr, Inst Clin Med, Tainan, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Huang, PH (corresponding author), Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.; Huang, PH (corresponding author), Taipei Vet Gen Hosp, Dept Crit Care Med, Taipei, Taiwan.; Huang, PH (corresponding author), Natl Yang Ming Chiao Tung Univ, Cardiovasc Res Ctr, Inst Clin Med, Tainan, Taiwan.	huangbs@vghtpe.gov.tw		Chen, Jaw-Wen/0000-0002-7178-2316				Bergmark BA, 2018, JAMA CARDIOL, V3, P473, DOI 10.1001/jamacardio.2018.0653; Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X; Brown JR, 2014, CLIN J AM SOC NEPHRO, V9, P239, DOI 10.2215/CJN.05830513; Christov M, 2019, SEMIN NEPHROL, V39, P57, DOI 10.1016/j.semnephrol.2018.10.005; Dangas G, 2005, AM J CARDIOL, V95, P13, DOI 10.1016/j.amjcard.2004.08.056; Gao F, 2011, AM J NEPHROL, V34, P203, DOI 10.1159/000329534; Gleeson TG, 2004, AM J ROENTGENOL, V183, P1673, DOI 10.2214/ajr.183.6.01831673; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Ix JH, 2012, J AM COLL CARDIOL, V60, P200, DOI 10.1016/j.jacc.2012.03.040; Kanagala P, 2020, ESC HEART FAIL, V7, P4089, DOI 10.1002/ehf2.13020; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Laskey WK, 2003, ACTA RADIOL, V44, P498, DOI 10.1034/j.1600-0455.2003.00119.x; Leaf DE, 2018, CLIN J AM SOC NEPHRO, V13, P531, DOI 10.2215/CJN.10810917; Leaf DE, 2017, J AM SOC NEPHROL, V28, P1877, DOI 10.1681/ASN.2016080836; Leaf DE, 2016, KIDNEY INT, V89, P939, DOI 10.1016/j.kint.2015.12.035; Leaf DE, 2012, CLIN J AM SOC NEPHRO, V7, P1217, DOI 10.2215/CJN.00550112; Li HH, 2018, RENAL FAILURE, V40, P547, DOI 10.1080/0886022X.2018.1487860; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; McCullough PA, 2005, CRIT CARE CLIN, V21, P261, DOI 10.1016/j.ccc.2004.12.003; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; Mehran R, 2006, KIDNEY INT, V69, pS11, DOI 10.1038/sj.ki.5000368; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Mendoza FA, 2012, CLIN J AM SOC NEPHRO, V7, P1155, DOI 10.2215/CJN.13281211; NasrAllah MM, 2013, NEPHRON EXTRA, V3, P106, DOI 10.1159/000356118; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Qin ZX, 2017, ATHEROSCLEROSIS, V261, P1, DOI 10.1016/j.atherosclerosis.2017.03.042; Quintavalle C, 2012, CIRCULATION, V126, P3008, DOI 10.1161/CIRCULATIONAHA.112.103317; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Scialla JJ, 2014, J AM SOC NEPHROL, V25, P349, DOI 10.1681/ASN.2013050465; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; Tumlin J, 2006, AM J CARDIOL, V98, p14K, DOI 10.1016/j.amjcard.2006.01.020; Wolf M, 2012, KIDNEY INT, V82, P737, DOI 10.1038/ki.2012.176; Zhang JW, 2014, ANGIOLOGY, V65, P402, DOI 10.1177/0003319713482177; 2019, LANCET DIGITAL HLTH, V1, pe0016	38	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254835	10.1371/journal.pone.0254835	http://dx.doi.org/10.1371/journal.pone.0254835			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297744	gold, Green Published			2022-12-26	WOS:000678128300020
J	Joshua, PE; Nwauzor, CO; Odimegwu, DC; Ukachukwu, UG; Asomadu, RO; Ezeorba, TPC				Joshua, Parker Elijah; Nwauzor, Cynthia Ogochukwu; Odimegwu, Damian Chukwu; Ukachukwu, Uzochukwu Gospel; Asomadu, Rita Onyekachukwu; Ezeorba, Timothy Prince Chidike			Experimental and molecular predictions of the adjuvanticity of snail mucin on hepatitis B vaccine in albino mice	PLOS ONE			English	Article							NEUTROPHILS; IMMUNITY	Although aluminum-containing adjuvants are widely used in human vaccination due to their excellent safety profile, they exhibit low effectiveness with many recombinant antigens. This study investigated the adjuvanticity of snail mucin with recombinant Hepatitis B Vaccine (rHBsAg). Twenty-five (25) female mice distributed unbiasedly into 5 groups were used in the study and were administered different rHBsAg/Mucin formulation at 7 days intervals. Blood samples were collected a day following the administration for analysis. The results of liver function and body weight analysis were indications that snail mucin had no adverse effect on the mice. The treatment group (administer mucin and rHBsAg) showed significantly (P<0.05) higher mean titres of anti-HBsAg antibodies when compared with the negative controls and the positive control administered with two doses of rHBsAg after the boost doses (day 28). Furthermore, a comparable immune response to positive control administered with three doses rHBaAG was recorded. In silico prediction, studies of the protein-protein interaction of a homology modelled snail mucus protein and HBsAg gave an indication of enhanced HBV antigen-antibody interaction. Therefore, this study has shown that snail mucin possesses some adjuvant properties and enhances immune response towards rHBsAg vaccine. However, there is a need for further molecular dynamics studies to understand its mechanism of action.	[Joshua, Parker Elijah; Nwauzor, Cynthia Ogochukwu; Ukachukwu, Uzochukwu Gospel; Asomadu, Rita Onyekachukwu; Ezeorba, Timothy Prince Chidike] Univ Nigeria, Fac Biol Sci, Dept Biochem, Nsukka, Nigeria; [Odimegwu, Damian Chukwu] Univ Nigeria, Dept Pharmaceut Microbiol & Biotechnol, Nsukka, Nigeria	University of Nigeria; University of Nigeria	Ezeorba, TPC (corresponding author), Univ Nigeria, Fac Biol Sci, Dept Biochem, Nsukka, Nigeria.	timothy.ezeorba@unn.edu.ng		Ezeorba, Timothy/0000-0002-7077-3282; ASOMADU, RITA/0000-0002-2424-1488				Adikwu MU, 2005, BIORESEARCH, V5, P1; [Anonymous], 2020, NAT METHODS, V17, P1, DOI 10.1038/s41592-019-0703-5; [Anonymous], 2015, NAT METHODS, V12, P1; [Anonymous], 2017, ONCOGENESIS, V6, pe345; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2019, MONTHLY NEWSLETTER M; Carr H., 2009, CLIN HEMATOLOGY ATLA, Vthird; Chiu ML, 2019, ANTIBODIES, V8, DOI 10.3390/antib8040055; Di Pasquale A, 2015, VACCINES-BASEL, V3, P320, DOI 10.3390/vaccines3020320; Gebrecherkos T, 2020, INT J HEPATOL, V2020, DOI 10.1155/2020/5617603; Gutjahr A, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040034; Harti AS, 2016, INT J PHARM BIO SCI, V5, P76; Irvine DJ, 2020, ADV DRUG DELIVER REV, V158, P91, DOI 10.1016/j.addr.2020.06.019; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Joshi VB, 2013, HUM VACC IMMUNOTHER, V9, P2584, DOI 10.4161/hv.26136; Kalu AA, 2019, GSC BIOL PHARM SCI, V9, P077, DOI [10.30574/gscbps.2019.9.1.0163, DOI 10.30574/GSCBPS.2019.9.1.0163]; Kondo Yasuteru, 2013, ISRN Gastroenterol, V2013, P935295, DOI 10.1155/2013/935295; Launay G, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-427; Lin CY, 2015, HUM VACC IMMUNOTHER, V11, P650, DOI 10.1080/21645515.2015.1009345; McGill MR, 2016, EXCLI J, V15, P817, DOI 10.17179/excli2016-800; Meireles LC, 2015, WORLD J HEPATOL, V7, P2127, DOI 10.4254/wjh.v7.i18.2127; Momoh MA, 2019, TROP J PHARM RES, V18, P927, DOI 10.4314/tjpr.v18i5.3; Moss DW, 1999, CLIN ENZYMOLOGY; Nanishi E, 2020, CURR OPIN PEDIATR, V32, P125, DOI 10.1097/MOP.0000000000000868; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; Nejati S, 2017, HEPAT MON, V17, DOI 10.5812/hepatmon.44536; O'Connell KE, 2015, COMPARATIVE MED, V65, P96; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Provencher BA, 2010, HEMATOLOGY LAB ANIMA, DOI [10.1258/la.2010.009049, DOI 10.1258/LA.2010.009049]; Schijns V, 2020, IMMUNOL REV, V296, P169, DOI 10.1111/imr.12889; Selders GS, 2017, REGEN BIOMATER, V4, P55, DOI 10.1093/rb/rbw041; Shinde P, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01516; Sivakumar SM, 2016, SM J HEPAT RES TREAT, V2, P1007; Teng Tie-Shan, 2017, J Immunol Res, V2017, P9671604, DOI 10.1155/2017/9671604; Thomas L., 1998, CLIN LAB DIAGNOSTICS, P55; Vono M, 2017, BLOOD, V129, P1991, DOI 10.1182/blood-2016-10-744441; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Yuan LJ, 2020, VACCINE, V38, P5343, DOI 10.1016/j.vaccine.2020.05.063; Zimmermann P, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00084-18	39	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0246915	10.1371/journal.pone.0246915	http://dx.doi.org/10.1371/journal.pone.0246915			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297725	Green Published, Green Submitted, gold			2022-12-26	WOS:000678128300029
J	Khaitov, V; Marchenko, J; Katolikova, M; Vainola, R; Kingston, SE; Carlon, DB; Gantsevich, M; Strelkov, P				Khaitov, Vadim; Marchenko, Julia; Katolikova, Marina; Vainola, Risto; Kingston, Sarah E.; Carlon, David B.; Gantsevich, Michael; Strelkov, Petr			Species identification based on a semi-diagnostic marker: Evaluation of a simple conchological test for distinguishing blue mussels Mytilus edulis L. and M. trossulus Gould	PLOS ONE			English	Article							COMPARATIVE GROWTH; NORTH-ATLANTIC; HYBRIDIZATION; ALLOZYMES; GENOTYPE; HYBRIDS; WATERS	Cryptic and hybridizing species may lack diagnostic taxonomic characters leaving researchers with semi-diagnostic ones. Identification based on such characters is probabilistic, the probability of correct identification depending on the species composition in a mixed population. Here we test the possibilities of applying a semi-diagnostic conchological character for distinguishing two cryptic species of blue mussels, Mytilus edulis and M. trossulus. These ecologically, stratigraphically and economically important molluscs co-occur and hybridize in many areas of the North Atlantic and the neighboring Arctic. Any cues for distinguishing them in sympatry without genotyping would save much research effort. Recently these species have been shown to statistically differ in the White Sea, where a simple character of the shell was used to distinguish two mussel morphotypes. In this paper, we analyzed the associations between morphotypes and species-specific genotypes based on an abundant material from the waters of the Kola Peninsula (White Sea, Barents Sea) and a more limited material from Norway, the Baltic Sea, Scotland and the Gulf of Maine. The performance of the "morphotype test" for species identification was formally evaluated using approaches from evidence-based medicine. Interspecific differences in the morphotype frequencies were ubiquitous and unidirectional, but their scale varied geographically (from 75% in the White Sea to 15% in the Baltic Sea). In addition, salinity-related variation of this character within M. edulis was revealed in the Arctic Barents Sea. For every studied region, we established relationships between the proportions of the morphotypes in the populations as well as between the proportions of the morphotypes in samples and the probabilities of mussels of different morphotypes being M. trossulus and M. edulis. We provide recommendations for the application of the morphotype test to mussels from unstudied contact zones and note that they may apply equally well to other taxa identified by semi-diagnostic traits.	[Khaitov, Vadim; Marchenko, Julia; Katolikova, Marina; Strelkov, Petr] St Petersburg State Univ, St Petersburg, Russia; [Khaitov, Vadim] Kandalaksha State Nat Reserve, Kandalaksha, Murmansk Region, Russia; [Katolikova, Marina] Murmansk Marine Biol Inst, Murmansk, Russia; [Vainola, Risto] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Kingston, Sarah E.; Carlon, David B.] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; [Kingston, Sarah E.; Carlon, David B.] Bowdoin Coll, Schiller Coastal Studies Ctr, Brunswick, ME 04011 USA; [Kingston, Sarah E.] Univ Maine, Sch Marine Sci, Walpole, ME USA; [Kingston, Sarah E.] Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA; [Gantsevich, Michael] Lomonosov Moscow State Univ, Dept Invertebrate Zool, Moscow, Russia; [Strelkov, Petr] Murmansk Arctic State Univ, Lab Monitoring & Conservat Nat Arctic Ecosyst, Murmansk, Russia	Saint Petersburg State University; Russian Academy of Sciences; University of Helsinki; Bowdoin College; Bowdoin College; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; Lomonosov Moscow State University; Murmansk Arctic State University	Khaitov, V (corresponding author), St Petersburg State Univ, St Petersburg, Russia.; Khaitov, V (corresponding author), Kandalaksha State Nat Reserve, Kandalaksha, Murmansk Region, Russia.	polydora@rambler.ru	Марченко, Юлия/HDO-3519-2022; Gantsevich, Mikhail/B-4792-2012	Марченко, Юлия/0000-0002-5567-1827; Gantsevich, Mikhail/0000-0002-4854-2787; Kingston, Sarah/0000-0003-1607-1789; Khaitov, Vadim/0000-0001-5567-8554	Russian Science Foundation [19-74-20024]; National Institute of General Medical Sciences of the National Institutes of Health [P20GM103423]; Bowdoin College Phocus	Russian Science Foundation(Russian Science Foundation (RSF)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bowdoin College Phocus	This work was supported by Russian Science Foundation, Grant Number: 19-74-20024 awarded to VKh, JM, MK & PS, Bowdoin College Phocus, Rusack and Doherty research funds as well as Maine INBRE - an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health, P20GM103423 awarded to SEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADON DEAN, 1949, CONDOR, V51, P250, DOI 10.2307/1364805; [Anonymous], 2020, LANCET RESP MED, V8, P1, DOI [10.1016/S2213-2600(19)30449-7, 10.1016/S22132600(19)30402-3]; [Anonymous], 2002, IRRAWADDY, V10, P5; [Anonymous], 2015, J STAT SOFTW, DOI [DOI 10.18637/JSS.V067.I01, DOI 10.18637/jss.v067.i01]; Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Beaumont AR, 2008, J EXP MAR BIOL ECOL, V367, P100, DOI 10.1016/j.jembe.2008.08.021; Beyer J, 2017, MAR ENVIRON RES, V130, P338, DOI 10.1016/j.marenvres.2017.07.024; Bierne N, 2003, MOL ECOL, V12, P2505, DOI 10.1046/j.1365-294X.2003.01936.x; Bobkov A, 2010, VESTNIK SANKT PETERB, V2010, P86; Bufalova E.N., 2005, Vestnik Sankt-Peterburgskogo Universiteta Seriya 3 Biologiya, V3, P99; Chenuil A, 2019, HIST PHIL THEOR LIFE, V24, P77, DOI 10.1007/978-3-030-10991-2_4; CURREY JD, 1974, J ZOOL, V173, P395; Derjugin K, 1928, EXPLOR FAUNA SEAS US, V78, P512; Derjugin KM, 1915, MEMOIRES ACAD IMPE 8, V34, P1; Dias PJ, 2009, AQUACULT INT, V17, P437, DOI 10.1007/s10499-008-9214-6; Dias PJ, 2011, HYDROBIOLOGIA, V670, P127, DOI 10.1007/s10750-011-0664-x; Duarte CM, 2020, ESTUAR COAST, V43, P387, DOI 10.1007/s12237-019-00682-3; FAO, 2020, FISH AQ SOFTW FISHST; Fitzpatrick BM, 2015, CURR ZOOL, V61, P206, DOI 10.1093/czoolo/61.1.206; Fraisse C, 2016, MOL ECOL, V25, P269, DOI 10.1111/mec.13299; Geist J, 2008, J MOLLUS STUD, V74, P337, DOI 10.1093/mollus/eyn025; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Harrington B, 2020, INKSCAPE 0 92 ONLINE; Innes DJ, 1999, MAR BIOL, V133, P691, DOI 10.1007/s002270050510; Katolikova M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152963; Khaitov V, 2018, BIOL BULL-US, V234, P85, DOI 10.1086/697944; Kingston SE, 2018, J EVOLUTION BIOL, V31, P346, DOI 10.1111/jeb.13224; Leeflang MMG, 2013, CAN MED ASSOC J, V185, pE537, DOI 10.1503/cmaj.121286; Leeflang MMG, 2009, J CLIN EPIDEMIOL, V62, P5, DOI 10.1016/j.jclinepi.2008.04.007; LOBEL PB, 1990, ARCH ENVIRON CON TOX, V19, P508, DOI 10.1007/BF01059068; Lowen JB, 2013, MAR ECOL PROG SER, V475, P135, DOI 10.3354/meps10106; MALLET AL, 1995, CAN J FISH AQUAT SCI, V52, P1873, DOI 10.1139/f95-780; Mangerud J, 2018, HOLOCENE, V28, P65, DOI 10.1177/0959683617715701; Martino PA, 2019, J SHELLFISH RES, V38, P587, DOI 10.2983/035.038.0310; Matishov G.G, 2009, KOLA BAY DEV RATIONA; MCDONALD JH, 1991, MAR BIOL, V111, P323, DOI 10.1007/BF01319403; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Michalek K, 2016, MAR GENOM, V27, P3, DOI 10.1016/j.margen.2016.04.008; MIETANKA B, 2017, MAR BIOL, V164, P209, DOI DOI 10.1007/s00227-017-3235-5; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Penney RW, 2002, AQUAC RES, V33, P693, DOI 10.1046/j.1365-2109.2002.00706.x; Pritchard JK, 2000, GENETICS, V155, P945; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rawson PD, 2009, MAR BIOL, V156, P1857, DOI 10.1007/s00227-009-1218-x; Ridgway G, 2004, HELGOLAND MAR RES, V58, P104, DOI 10.1007/s10152-004-0175-5; Riginos C, 2005, MOL ECOL, V14, P381, DOI 10.1111/j.1365-294X.2004.02379.x; Seed R., 1992, Developments in Aquaculture and Fisheries Science, V25, P87; Simon A, 2019, BIORXIV; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Telesca L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20122-9; VAINOLA R, 1991, BIOL J LINN SOC, V43, P127, DOI 10.1111/j.1095-8312.1991.tb00589.x; VARVIO SL, 1988, MAR BIOL, V98, P51, DOI 10.1007/BF00392658; Vervoenen M, 2000, MEDEDELINGEN WERKGRO, V37, P73; Wenne R, 2016, POLAR BIOL, V39, P343, DOI 10.1007/s00300-015-1785-x; Wenne R, 2020, GENES-BASEL, V11, DOI 10.3390/genes11050530; Wiens JJ, 2000, P ROY SOC B-BIOL SCI, V267, P631, DOI 10.1098/rspb.2000.1049; Wilson J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200654; Zenkevitch L., 1963, BIOL SEAS USSR GEORG; Zolotarev V.N., 1997, Biologiya Morya (Vladivostok), V23, P26	61	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0249587	10.1371/journal.pone.0249587	http://dx.doi.org/10.1371/journal.pone.0249587			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297723	Green Published, gold			2022-12-26	WOS:000678128300032
J	Sadato, D; Hirama, C; Kaiho-Soma, A; Yamaguchi, A; Kogure, H; Takakuwa, S; Ogawa, M; Doki, N; Ohashi, K; Harada, H; Oboki, K; Harada, Y				Sadato, Daichi; Hirama, Chizuko; Kaiho-Soma, Ai; Yamaguchi, Ayaka; Kogure, Hiroko; Takakuwa, Sonomi; Ogawa, Mina; Doki, Noriko; Ohashi, Kazuteru; Harada, Hironori; Oboki, Keisuke; Harada, Yuka			Archival bone marrow smears are useful in targeted next-generation sequencing for diagnosing myeloid neoplasms	PLOS ONE			English	Article							DNA	Gene abnormalities, including mutations and fusions, are important determinants in the molecular diagnosis of myeloid neoplasms. The use of bone marrow (BM) smears as a source of DNA and RNA for next-generation sequencing (NGS) enables molecular diagnosis to be done with small amounts of bone marrow and is especially useful for patients without stocked cells, DNA or RNA. The present study aimed to analyze the quality of DNA and RNA derived from smear samples and the utility of NGS for diagnosing myeloid neoplasms. Targeted DNA sequencing using paired BM cells and smears yielded sequencing data of adequate quality for variant calling. The detected variants were analyzed using the bioinformatics approach to detect mutations reliably and increase sensitivity. Noise deriving from variants with extremely low variant allele frequency (VAF) was detected in smear sample data and removed by filtering. Consequently, various driver gene mutations were detected across a wide range of allele frequencies in patients with myeloid neoplasms. Moreover, targeted RNA sequencing successfully detected fusion genes using smear-derived, very low-quality RNA, even in a patient with a normal karyotype. These findings demonstrated that smear samples can be used for clinical molecular diagnosis with adequate noise-reduction methods even if the DNA and RNA quality is inferior.	[Sadato, Daichi; Hirama, Chizuko; Kaiho-Soma, Ai; Yamaguchi, Ayaka; Kogure, Hiroko; Takakuwa, Sonomi; Ogawa, Mina; Harada, Yuka] Tokyo Metropolitan Canc & Infect Dis Ctr, Clin Res Ctr, Komagome Hosp, Tokyo, Japan; [Sadato, Daichi; Hirama, Chizuko; Kaiho-Soma, Ai; Ogawa, Mina; Oboki, Keisuke] Tokyo Metropolitan Inst Med Sci, Ctr Med Res Cooperat, Tokyo, Japan; [Doki, Noriko; Ohashi, Kazuteru; Harada, Hironori] Tokyo Metropolitan Canc & Infect Dis Ctr, Komagome Hosp, Div Hematol, Tokyo, Japan; [Harada, Hironori] Tokyo Univ Pharm & Life Sci, Lab Oncol, Tokyo, Japan	Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Tokyo University of Pharmacy & Life Sciences	Harada, Y (corresponding author), Tokyo Metropolitan Canc & Infect Dis Ctr, Clin Res Ctr, Komagome Hosp, Tokyo, Japan.	yharada@cick.jp		Sadato, Daichi/0000-0002-3873-8268	Tokyo Metropolitan Government [R010302001]; JSPS KAKENHI of Japan Society for the Promotion of Science [JP20K07840]	Tokyo Metropolitan Government(Tokyo Metropolitan Government); JSPS KAKENHI of Japan Society for the Promotion of Science	This research was supported in part by Clinical Research Fund (R010302001) of Tokyo Metropolitan Government (https://www.metro.tokyo.lg.jp/), and JSPS KAKENHI (Grant Number JP20K07840) of Japan Society for the Promotion of Science (https://www.jsps.go.jp/).All grants were awarded to Y.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablordeppey KK, 2020, J MOL DIAGN, V22, P355, DOI 10.1016/j.jmoldx.2019.11.003; Al Hinai ASA, 2020, LEUKEMIA, V34, P2220, DOI 10.1038/s41375-020-0744-x; [Anonymous], 2018, REV METAPHYS, V71, P522; [Anonymous], 2016, DIAGN PATHOL, V11, P11; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bullinger L, 2017, J CLIN ONCOL, V35, P934, DOI 10.1200/JCO.2016.71.2208; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Davidson NM, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0167-x; Haas BJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1842-9; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Najima Y, 2020, BONE MARROW TRANSPL; Ogawa S, 2019, BLOOD, V133, P1049, DOI 10.1182/blood-2018-10-844621; Okonechnikov K, 2016, BIOINFORMATICS, V32, P292, DOI 10.1093/bioinformatics/btv566; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Treece AL, 2016, CANCER CYTOPATHOL, V124, P406, DOI 10.1002/cncy.21699; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoshizato T, 2017, BLOOD, V129, P2347, DOI 10.1182/blood-2016-12-754796	19	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255257	10.1371/journal.pone.0255257	http://dx.doi.org/10.1371/journal.pone.0255257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297770	Green Published, gold			2022-12-26	WOS:000678128300011
J	Ali, B; Khan, A; Alyami, HS; Ullah, M; Wahab, A; Badshah, M; Naz, A				Ali, Beenish; Khan, Amjad; Alyami, Hamad S.; Ullah, Majeed; Wahab, Abdul; Badshah, Munair; Naz, Attiqa			Evaluation of the effect of carrier material on modification of release characteristics of poor water soluble drug from liquisolid compacts	PLOS ONE			English	Article							DISSOLUTION RATE ENHANCEMENT; IN-VITRO; SOLID DISPERSION; CLOPIDOGREL; PHARMACOKINETICS; PHARMACODYNAMICS; BIOEQUIVALENCE; FORMULATIONS; SOLUBILITY; PRASUGREL	Liquisolid compact is a novel dosage form in which a liquid medication (liquid drug, drug solution/dispersion in non-volatile solvent/solvent system) is converted to a dry, free flowing powder and compressed. Objective of the study was to elucidate the effect of carrier material on release characteristics of clopidogrel from liquisolid compacts. Different formulations of liquisolid compacts were developed using microcrystalline cellulose, starch maize, polyvinyl pyrollidone and hydroxypropyl methylcellulose as carrier material in three concentrations (40, 30 and 20%, w/w). Liquid vehicle was selected on the basis of solubility of clopidogrel. Colloidal silicondioxide was used as coating material and ratio of carrier to coating material was kept 10. A control formulation comprised of microcrystalline cellulose (diluents), tabletose-80 (diluents), primojel (disintegrant) and magnesium stearate (lubricant) was prepared by direct compression technique and was used for comparison. All the formulations were evaluated at pre and post compression level. Acid solubility profile showed higher solubility in HCl buffer pH2 (296.89 +/- 3.49 mu g/mL). Mixture of propylene glycol and water (2:1, v/v) was selected as liquid vehicle. Drug content was in the range of 99-101% of the claimed quantity. All the formulations showed better mechanical strength and their friability was within the official limits (<1%). Microcrystalline cellulose and starch maize resulted in faster drug release while polyvinyl pyrollidone and HPMC resulted in sustaining drug release by gel formation. It is concluded from results that both fast release and sustained release of clopidogrel can be achieved by proper selection of carrier material.	[Ali, Beenish; Naz, Attiqa] Abasyn Univ, Dept Pharm, Peshawar, Pakistan; [Khan, Amjad; Ullah, Majeed; Wahab, Abdul] Kohat Univ Sci & Technol, Dept Pharm, Kohat, Pakistan; [Alyami, Hamad S.] Najran Univ, Dept Pharmaceut, Najran, Saudi Arabia; [Badshah, Munair] Islam Coll Pharm, Sialkot, Pakistan	Kohat University of Science & Technology; Najran University	Khan, A (corresponding author), Kohat Univ Sci & Technol, Dept Pharm, Kohat, Pakistan.	dr.amjad@kust.edu.pk	Naz, Attiqa/AAW-9422-2021; Ullah, Majeed/GRS-5563-2022	Naz, Attiqa/0000-0002-6125-5643; Khan, Dr. Amjad/0000-0002-4121-2400	Ferozsons Laboratories Ltd.	Ferozsons Laboratories Ltd.	Funder Name: Ferozsons Laboratories Ltd.; Grant Number: None; Grant Recipient: None This study received material support from the following sources: Ferozsons Laboratories Ltd. Nowshera, Pakistan provided API and facilities to carry out this study. The model drug clopidogrel (Mithri Laboratories Ltd. India; purity 99.81% with reference to USP standard) was obtained from Ferozsons Laboratories Ltd. Nowshera, Pakistan. Excipients used in the study, included tablettose-80 (Molkerei Meggle, Germany), microcrystalline cellulose (F.M.C International, Ireland), primojel {sodium starch glycolate} (F.M.C International, Ire Land), Colloidal silicon dioxide {Aerosil-200} (F.M.C International, Ireland), hydroxylpropyl methylcellulose (Merck KGA, Germany), polyvinyl pyrollidone (I.S.P. Technology, Texas), starch maize (I.C.I, Pakistan) and magnesium stearate (Coin Powder International Company Ltd, Taiwan) were purchased from local market of Peshawar, Pakistan. All the excipients were of pharmaceutical grade and were used as received.	Akinlade Babatunde, 2010, Sci Pharm, V78, P325, DOI 10.3797/scipharm.0912-23; Aparna TN., 2017, WORLD J PHARM PHARM, P1219, DOI [10.20959/wjpps20177-9529, DOI 10.20959/WJPPS20177-9529]; Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1; Di Girolamo G, 2010, CLIN THER, V32, P161, DOI 10.1016/j.clinthera.2010.01.010; Fahmy RH, 2008, EUR J PHARM BIOPHARM, V69, P993, DOI 10.1016/j.ejpb.2008.02.017; Farid NA, 2007, CLIN PHARMACOL THER, V81, P735, DOI 10.1038/sj.clpt.6100139; Gavhane YN, 2012, SAUDI PHARM J, V20, P331, DOI 10.1016/j.jsps.2012.03.005; Gonjari ID, 2009, DIG J NANOMATER BIOS, V4, P651; Hart M.L., 2013, J DEV DRUGS, V2, P1, DOI [10.4172/2329-6631.1000115, DOI 10.4172/2329-6631.1000115]; Hentzschel CM, 2012, EUR J PHARM BIOPHARM, V80, P130, DOI 10.1016/j.ejpb.2011.08.001; Javadzadeh Y., 2005, Farmaco (Lausanne), V60, P361, DOI 10.1016/j.farmac.2004.09.005; Javadzadeh Y, 2007, INT J PHARM, V341, P26, DOI 10.1016/j.ijpharm.2007.03.034; Javadzadeh Y, 2008, INT J PHARMACEUT, V362, P102, DOI 10.1016/j.ijpharm.2008.06.022; Karazniewicz-Lada M, 2014, CLIN PHARMACOKINET, V53, P155, DOI 10.1007/s40262-013-0105-2; Khan A, 2015, SAUDI PHARM J, V23, P650, DOI 10.1016/j.jsps.2015.01.025; Kim YI, 2011, INT J PHARMACEUT, V415, P129, DOI 10.1016/j.ijpharm.2011.05.059; Lima AAN, 2008, LAT AM J PHARM, V27, P789; Loh ZH, 2015, ASIAN J PHARM SCI, V10, P255, DOI 10.1016/j.ajps.2014.12.006; Lu M, 2017, ASIAN J PHARM SCI, V12, P115, DOI 10.1016/j.ajps.2016.09.007; Mamani PL, 2012, AAPS PHARMSCITECH, V13, P1073, DOI 10.1208/s12249-012-9829-9; Mega JL, 2016, J THROMB THROMBOLYS, V41, P374, DOI 10.1007/s11239-015-1264-9; Nokhodchi A, 2007, J PHARM PHARMACOL, V59, pA19; Patole T, 2014, INT J PHARM SCI RES, V5, P3566, DOI 10.13040/IJPSR.0975-8232.5(9).3566-76; Rashmi VT., 2011, PHARMACIA LETTRE, V3, P8; Raymond C. Rowe, 2009, HDB PHARM EXCIPIENTS; Sangkuhl K, 2011, PHARMACOGENET GENOM, V21, P516, DOI 10.1097/FPC.0b013e3283406323; Sangkuhl K, 2010, PHARMACOGENET GENOM, V20, P463, DOI 10.1097/FPC.0b013e3283385420; Singh SK, 2012, DRUG DEV IND PHARM, V38, P961, DOI 10.3109/03639045.2011.634810; Skillman KL, 2010, AM J HEALTH-SYST PH, V67, P559, DOI 10.2146/ajhp090163; Spireas S, 1998, J PHARM SCI, V87, P867, DOI 10.1021/js970346g; Spireas S, 1998, INT J PHARM, V166, P177, DOI 10.1016/S0378-5173(98)00046-5; Tayel SA, 2008, EUR J PHARM BIOPHARM, V69, P342, DOI 10.1016/j.ejpb.2007.09.003; The United States Pharmacopeia, 2015, USP38NF33 USP38NF33; Tiong N, 2009, EUR J PHARM BIOPHARM, V73, P373, DOI 10.1016/j.ejpb.2009.08.002; Ullah F, 2020, LAT AM J PHARM, V39, P73; Yadav V. B., 2009, J PHARM SCI RES, V1, P44	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0249075	10.1371/journal.pone.0249075	http://dx.doi.org/10.1371/journal.pone.0249075			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339440	gold, Green Published			2022-12-26	WOS:000680243400048
J	Blumenthal, DK; Cheng, XL; Fajer, M; Ho, KY; Rohrer, J; Gerlits, O; Taylor, P; Juneja, P; Kovalevsky, A; Radic, Z				Blumenthal, Donald K.; Cheng, Xiaolin; Fajer, Mikolai; Ho, Kwok-Yiu; Rohrer, Jacqueline; Gerlits, Oksana; Taylor, Palmer; Juneja, Puneet; Kovalevsky, Andrey; Radic, Zoran			Covalent inhibition of hAChE by organophosphates causes homodimer dissociation through long-range allosteric effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; ACETYLCHOLINESTERASE INHIBITION; INTERACTION KINETICS; TORPEDO-CALIFORNICA; PROTEIN; COMPLEX; BUTYRYLCHOLINESTERASE; EXPRESSION; LANGEVIN; SYSTEM	Acetylcholinesterase (EC 3.1.1.7), a key acetylcholine hydrolyzing enzyme in cholinergic neurotransmission, is present in a variety of states in situ, including monomers, C-terminally disulfide-linked homodimers, homotetramers, and up to three tetramers covalently attached to structural subunits. Could oligomerization that ensures high local concentrations of catalytic sites necessary for efficient neurotransmission be affected by environmental factors? Using small-angle X-ray scattering (SAXS) and cryo-EM, we demonstrate that homodimerization of recombinant monomeric human acetylcholinesterase (hAChE) in solution occurs through a C-terminal four-helix bundle at micromolar concentrations. We show that diethylphosphorylation of the active serine in the catalytic gorge or isopropylmethylphosphonylation by the RP enantiomer of sarin promotes a 10-fold increase in homodimer dissociation. We also demonstrate the dissociation of organophosphate (OP)-conjugated dimers is reversed by structurally diverse oximes 2PAM, HI6, or RS194B, as demonstrated by SAXS of diethylphosphoryl-hAChE. However, binding of oximes to the native ligand-free hAChE, binding of high-affinity reversible ligands, or formation of an SP-sarin-hAChE conjugate had no effect on homodimerization. Dissociation monitored by time-resolved SAXS occurs in milliseconds, consistent with rates of hAChE covalent inhibition. OP-induced dissociation was not observed in the SAXS profiles of the double mutant Y337A/F338A, where the active center gorge volume is larger than in wildtype hAChE. These observations suggest a key role of the tightly packed acyl pocket in allosterically triggered OP-induced dimer dissociation, with the potential for local reduction of acetylcholine-hydrolytic power in situ. Computational models predict allosteric correlated motions extending from the acyl pocket toward the four-helix bundle dimerization interface 25 angstrom away.	[Blumenthal, Donald K.] Univ Utah, Dept Pharmacol & Toxicol, 112 Skaggs Hall, Salt Lake City, UT 84112 USA; [Cheng, Xiaolin; Fajer, Mikolai] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, 500 W 12Th Ave, Columbus, OH 43210 USA; [Ho, Kwok-Yiu; Rohrer, Jacqueline; Taylor, Palmer; Radic, Zoran] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gerlits, Oksana] Tennessee Wesleyan Univ, Dept Nat Sci, Athens, TN USA; [Juneja, Puneet] Iowa State Univ, CryoEM Facil, Ames, IA USA; [Kovalevsky, Andrey] Oak Ridge Natl Lab, Neutron Scattering Div, Oak Ridge, TN USA	Utah System of Higher Education; University of Utah; University System of Ohio; Ohio State University; University of California System; University of California San Diego; Iowa State University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Radic, Z (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	zradic@ucsd.edu	Juneja, Puneet/HHC-1232-2022	Juneja, Puneet/0000-0002-6774-2821; Cheng, Xiaolin/0000-0002-7396-3225; Blumenthal, Donald/0000-0002-8614-1167; Rohrer, Jacqueline/0000-0002-6436-161X; Kovalevsky, Andrey/0000-0003-4459-9142; Juneja, Puneet/0000-0002-8934-4509	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NIH; NIGMS, National Institutes of Health [P41GM103393]; CounterACT Program; National Institute of Neurological Disorders and Stroke (NINDS) [U01 NS083451, R21 NS098998]; UCSD Academic Senate [BG084144]; National Institutes of Health Office of the Director (NIH OD)	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CounterACT Program; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); UCSD Academic Senate; National Institutes of Health Office of the Director (NIH OD)	The highly professional and creative assistance of the Stanford Synchrotron Radiation Lightsource (SSRL) BioSAXS beamline (BL 4-2) scientists Dr Thomas Weiss, Dr Tsutomu Matsui, and Dr Ivan Rajkovic is highly appreciated. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the NIH and the NIGMS, National Institutes of Health (P41GM103393). We are grateful to Dr Jonah Cheung, NYSBC, New York, for providing us with atomic coordinates of PDB ID 5HF5 well before their deposition to the PDB. We thank Dina Schneidman-Duhovny (dina@salilab.org) for her assistance in using MultiFoXS. This research was supported by the CounterACT Program, National Institutes of Health Office of the Director (NIH OD), the National Institute of Neurological Disorders and Stroke (NINDS) (grant numbers U01 NS083451 and R21 NS098998), and the UCSD Academic Senate grant BG084144. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute of General Medical Sciences or National Institutes of Health.	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; AUGUSTINSSON KB, 1949, SCIENCE, V110, P98, DOI 10.1126/science.110.2847.98; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bester SM, 2019, PROTEIN SCI, V28, P1106, DOI 10.1002/pro.3625; Bester SM, 2018, CHEM RES TOXICOL, V31, P1405, DOI 10.1021/acs.chemrestox.8b00294; Blotnick-Rubin E, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00123; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x; Cochran R, 2011, J BIOL CHEM, V286, P29718, DOI 10.1074/jbc.M111.264739; Coscia F, 2020, NATURE, V578, P627, DOI 10.1038/s41586-020-1995-4; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Franklin MC, 2016, PROTEINS, V84, P1246, DOI 10.1002/prot.25073; Gerlits O, 2019, CHEM-BIOL INTERACT, V309, DOI 10.1016/j.cbi.2019.06.011; Gerlits O, 2019, J BIOL CHEM, V294, P10607, DOI 10.1074/jbc.RA119.008725; Gorecki L, 2020, J BIOL CHEM, V295, P4079, DOI 10.1074/jbc.RA119.012400; Hajizadeh NR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25355-2; Kikhney AG, 2020, PROTEIN SCI, V29, P66, DOI 10.1002/pro.3731; Kousba AA, 2004, TOXICOL SCI, V80, P239, DOI 10.1093/toxsci/kfh163; MAULET Y, 1990, NEURON, V4, P289, DOI 10.1016/0896-6273(90)90103-M; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; Park YN, 2004, J BIOL CHEM, V279, P17085, DOI 10.1074/jbc.M314042200; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RADIC Z, 1992, BIOCHEMISTRY-US, V31, P9760, DOI 10.1021/bi00155a032; Radic Z, 2001, J BIOL CHEM, V276, P4622, DOI 10.1074/jbc.M006855200; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Radic Z., 2006, TOXICOLOGY ORGANOPHO, P161; Radic Z, 2010, CHEM-BIOL INTERACT, V187, P163, DOI 10.1016/j.cbi.2010.04.014; Rosenfeld CA, 2006, TOXICOL SCI, V90, P460, DOI 10.1093/toxsci/kfj094; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scalmani G., 2016, GAUSSIAN 09; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2011, J STRUCT BIOL, V173, P461, DOI 10.1016/j.jsb.2010.09.023; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TAYLOR P, 1991, J BIOL CHEM, V266, P4025; TAYLOR P, 1993, CHEM-BIOL INTERACT, V87, P199, DOI 10.1016/0009-2797(93)90043-X; Taylor P., 2009, ENCY NEUROSCIENCE, P5, DOI [10.1016/B978-008045046-9.01132-3, DOI 10.1016/B978-008045046-9.01132-3]; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; VELLOM DC, 1993, BIOCHEMISTRY-US, V32, P12, DOI 10.1021/bi00052a003; Wang XF, 2010, J BIOL CHEM, V285, P17564, DOI 10.1074/jbc.M110.111641; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	51	2	2	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101007	10.1016/j.jbc.2021.101007	http://dx.doi.org/10.1016/j.jbc.2021.101007			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34324828	Green Published, gold			2022-12-26	WOS:000706418900009
J	Selivanov, VA; Zagubnaya, OA; Nartsissov, YR; Cascante, M				Selivanov, Vitaly A.; Zagubnaya, Olga A.; Nartsissov, Yaroslav R.; Cascante, Marta			Unveiling a key role of oxaloacetate-glutamate interaction in regulation of respiration and ROS generation in nonsynaptic brain mitochondria using a kinetic model	PLOS ONE			English	Article							COMPLEX II; MEDIATED EXCITOTOXICITY; EXTRACELLULAR-SPACE; FUMARATE REDUCTASE; HYDROGEN-PEROXIDE; OXYGEN; TRANSPORT; BINDING; DIFFUSION; H2O2	Glutamate plays diverse roles in neuronal cells, affecting cell energetics and reactive oxygen species (ROS) generation. These roles are especially vital for neuronal cells, which deal with high amounts of glutamate as a neurotransmitter. Our analysis explored neuronal glutamate implication in cellular energy metabolism and ROS generation, using a kinetic model that simulates electron transport details in respiratory complexes, linked ROS generation and metabolic reactions. The analysis focused on the fact that glutamate attenuates complex II inhibition by oxaloacetate, stimulating the latter's transformation into aspartate. Such a mechanism of complex II activation by glutamate could cause almost complete reduction of ubiquinone and deficiency of oxidized form (Q), which closes the main stream of electron transport and opens a way to massive ROS generating transfer in complex III from semiquinone radicals to molecular oxygen. In this way, under low workload, glutamate triggers the respiratory chain (RC) into a different steady state characterized by high ROS generation rate. The observed stepwise dependence of ROS generation on glutamate concentration experimentally validated this prediction. However, glutamate's attenuation of oxaloacetate's inhibition accelerates electron transport under high workload. Glutamate-oxaloacetate interaction in complex II regulation underlies the observed effects of uncouplers and inhibitors and acceleration of Ca2+ uptake. Thus, this theoretical analysis uncovered the previously unknown roles of oxaloacetate as a regulator of ROS generation and glutamate as a modifier of this regulation. The model predicted that this mechanism of complex II activation by glutamate might be operative in situ and responsible for excitotoxicity. Spatial-time gradients of synthesized hydrogen peroxide concentration, calculated in the reaction-diffusion model with convection under a non-uniform local approximation of nervous tissue, have shown that overproduction of H2O2 in a cell causes excess of its level in neighbor cells.	[Selivanov, Vitaly A.; Cascante, Marta] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biomed, Barcelona, Spain; [Selivanov, Vitaly A.; Cascante, Marta] Inst Hlth Carlos III ISCIII, CIBER Hepat & Digest Dis CIBEREHD & Metabol Node, Spanish Natl Bioinformat Inst INB ISCIII ES ELIXI, Madrid, Spain; [Zagubnaya, Olga A.; Nartsissov, Yaroslav R.] Inst Cytochem & Mol Pharmacol, Dept Math Modeling & Stat Anal, Moscow, Russia	University of Barcelona	Selivanov, VA; Cascante, M (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biomed, Barcelona, Spain.; Selivanov, VA; Cascante, M (corresponding author), Inst Hlth Carlos III ISCIII, CIBER Hepat & Digest Dis CIBEREHD & Metabol Node, Spanish Natl Bioinformat Inst INB ISCIII ES ELIXI, Madrid, Spain.	seliv55@gmail.com; martacascante@ub.edu	CASCANTE, MARTA/AAG-4355-2022; Nartsissov, Yaroslav R/F-7904-2011; Zagubnaya, Olga/CAJ-2030-2022; CASCANTE, MARTA/AFK-5991-2022	CASCANTE, MARTA/0000-0002-2062-4633; Nartsissov, Yaroslav R/0000-0001-9020-7686; CASCANTE, MARTA/0000-0002-2062-4633; Selivanov, Vitaly/0000-0002-7937-9249	Ministerio de Ciencia e Innovacion -European Commission FEDER funds-"Una manera de hacer Europa" [SAF2017-89673-R, PID2020-115051RB-I00]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Generalitat de Catalunya [2017SGR1033]; CIBERehd (ISCIII, Spain) [CB17/04/00023]; ICREA foundation-Generalitat de Catalunya; Spanish Ministerio de Economia y Competitividad (MINECO)	Ministerio de Ciencia e Innovacion -European Commission FEDER funds-"Una manera de hacer Europa"; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); CIBERehd (ISCIII, Spain); ICREA foundation-Generalitat de Catalunya(ICREA); Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government)	MC:Spanish Ministerio de Economia y Competitividad (MINECO) and Ministerio de Ciencia e Innovacion -European Commission FEDER funds-"Una manera de hacer Europa" (SAF2017-89673-R and PID2020-115051RB-I00) https://www.nanbiosis.es/european-regionaldevelopment-fund/, Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) Generalitat de Catalunya (2017SGR1033) https://agaur.gencat. cat/ca/lagaur/, CIBERehd (CB17/04/00023) (ISCIII, Spain) https://www.ciberehd.org/en, MC also received support through the prize "ICREA Academia" for excellence in research, funded by ICREA foundation-Generalitat de Catalunya https:// www.icrea.cat/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogini P, 2019, BBA-MOL BASIS DIS, V1865, P1098, DOI 10.1016/j.bbadis.2019.01.026; Armbruster M, 2016, J NEUROSCI, V36, P10404, DOI 10.1523/JNEUROSCI.2066-16.2016; Barnes JR, 2020, J NEUROSCI, V40, P2793, DOI 10.1523/JNEUROSCI.1655-19.2020; Belosludtsev KN, 2019, BIOCHEMISTRY-MOSCOW+, V84, P593, DOI 10.1134/S0006297919060026; Belousov AB, 2012, BRAIN RES, V1487, P123, DOI 10.1016/j.brainres.2012.05.063; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Choi DW, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.579953; Collin F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102407; Cooper AJL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020016; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dantzer R, 2014, J NEURAL TRANSM, V121, P925, DOI 10.1007/s00702-014-1187-1; Drechsel DA, 2010, J BIOL CHEM, V285, P27850, DOI 10.1074/jbc.M110.101196; Esposito Z, 2013, CNS NEUROSCI THER, V19, P549, DOI 10.1111/cns.12095; Fato R, 2008, BIOFACTORS, V32, P31, DOI 10.1002/biof.5520320105; Featherstone DE, 2008, NEUROSCIENTIST, V14, P171, DOI 10.1177/1073858407308518; Fink BD, 2019, FASEB J, V33, P11696, DOI 10.1096/fj.201900690R; Grewer C, 2005, J MEMBRANE BIOL, V203, P1, DOI 10.1007/s00232-004-0731-6; Grivennikova VG, 2017, BBA-BIOENERGETICS, V1858, P109, DOI 10.1016/j.bbabio.2016.10.008; Gudino-Cabrera G, 2014, ARCH MED RES, V45, P653, DOI 10.1016/j.arcmed.2014.11.014; Hawkins Richard A., 2016, Biology-Basel, V5, P37, DOI 10.3390/biology5040037; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; IMLAY JA, 1995, J BIOL CHEM, V270, P19767; Iovino L, 2020, J PHARMACOL SCI, V144, P151, DOI 10.1016/j.jphs.2020.07.011; Jasielec JJ, 2020, MEMBRANES-BASEL, V10, DOI 10.3390/membranes10050081; Javitt DC, 2012, SCHIZOPHRENIA BULL, V38, P958, DOI 10.1093/schbul/sbs069; Jia M, 2015, CNS DRUGS, V29, P153, DOI 10.1007/s40263-015-0225-3; Jin BJ, 2016, J GEN PHYSIOL, V148, P489, DOI 10.1085/jgp.201611684; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Kinney JP, 2013, J COMP NEUROL, V521, P448, DOI 10.1002/cne.23181; Kirdajova DB, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00051; Kutzing MK, 2012, ANN BIOMED ENG, V40, P1170, DOI 10.1007/s10439-011-0494-z; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Liguz-Lecznar M, 2007, ACTA NEUROBIOL EXP, V67, P207; Lim JB, 2016, FREE RADICAL BIO MED, V90, P85, DOI 10.1016/j.freeradbiomed.2015.11.005; Liubinas SV, 2014, J CLIN NEUROSCI, V21, P899, DOI 10.1016/j.jocn.2014.02.012; Lobysheva NV, 2013, FREE RADICAL BIO MED, V65, P428, DOI 10.1016/j.freeradbiomed.2013.07.030; Machtens JP, 2015, CELL, V160, P542, DOI 10.1016/j.cell.2014.12.035; Majdi A, 2016, NEUROL SCI, V37, P1765, DOI 10.1007/s10072-016-2643-5; Mazat JP, 2019, METABOLITES, V9, DOI 10.3390/metabo9050081; McKenna MC, 2016, J NEUROSCI RES, V94, P1561, DOI 10.1002/jnr.23908; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Mwaura J, 2012, ACS CHEM NEUROSCI, V3, P1073, DOI 10.1021/cn300163p; Nicholson C, 2017, BIOPHYS J, V113, P2133, DOI 10.1016/j.bpj.2017.06.052; Nicholson C, 2015, BIOPHYS J, V108, P2091, DOI 10.1016/j.bpj.2015.03.043; Okubo Y, 2010, P NATL ACAD SCI USA, V107, P6526, DOI 10.1073/pnas.0913154107; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Panov A, 2009, J BIOL CHEM, V284, P14448, DOI 10.1074/jbc.M900985200; Petr GT, 2015, J NEUROSCI, V35, P5187, DOI 10.1523/JNEUROSCI.4255-14.2015; Pinky XF, 2018, J NEUROSCI, V38, pS351, DOI 10.1523/JNEUROSCI.3213-17.2018; Plitman E, 2014, EUR NEUROPSYCHOPHARM, V24, P1591, DOI 10.1016/j.euroneuro.2014.07.015; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Rodriguez-Rodriguez P, 2013, NEUROCHEM INT, V62, P750, DOI 10.1016/j.neuint.2013.02.005; Selivanov VA., 2021, COMPUTATIONAL SYSTEM; Selivanov VA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002700; Selivanov VA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001115; Selivanov VA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000619; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; Starkov AA, 2001, BIOCHEM BIOPH RES CO, V281, P645, DOI 10.1006/bbrc.2001.4409; Starkov AA, 2014, J BIOENERG BIOMEMBR, V46, P471, DOI 10.1007/s10863-014-9581-9; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Stepanova A, 2016, BBA-BIOENERGETICS, V1857, P1561, DOI 10.1016/j.bbabio.2016.06.002; Takeda Atsushi, 2010, Int J Alzheimers Dis, V2011, P491597, DOI 10.4061/2011/491597; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tehse J, 2019, EUR J NEUROSCI, V49, P1157, DOI 10.1111/ejn.14307; Torres-Salazar D, 2016, CHANNELS, V10, P86, DOI 10.1080/19336950.2015.1119631; Valtcheva S, 2019, FRONT SYNAPTIC NEURO, V11, DOI 10.3389/fnsyn.2019.00010; VANSTROEBIEZEN SAM, 1993, ANAL CHIM ACTA, V273, P553, DOI 10.1016/0003-2670(93)80202-V; Vishnoi S, 2016, J ENVIRON PATHOL TOX, V35, P365, DOI 10.1615/JEnvironPatholToxicolOncol.2016016399; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Yu L., 2020, METABOLOMICS SYSTEMS, V7, P11; Zagubnaya OA, 2018, J PHYS C SERIES, V1141; Zhan WB, 2017, PHARM RES-DORDR, V34, P860, DOI 10.1007/s11095-017-2114-6; Zhang LN, 2015, ADV CLIN EXP MED, V24, P161, DOI 10.17219/acem/38144; Zhou Y, 2014, J NEURAL TRANSM, V121, P799, DOI 10.1007/s00702-014-1180-8; Zhu HY, 2018, CELL, V173, P1716, DOI 10.1016/j.cell.2018.04.014	77	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255164	10.1371/journal.pone.0255164	http://dx.doi.org/10.1371/journal.pone.0255164			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343196	Green Published, gold			2022-12-26	WOS:000685264200018
J	Priyanka, P; Sharma, M; Das, S; Saxena, S				Priyanka, Priyanka; Sharma, Madhur; Das, Sanjeev; Saxena, Sandeep			The lncRNA HMS recruits RNA-binding protein HuR to stabilize the 3 '-UTR of HOXC10 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOSARCOMA CELL-LINES; NONCODING RNA; EXPRESSION; IDENTIFICATION; TRANSCRIPTION; METASTASIS; CHROMATIN; CYCLIN; FAMILY; GROWTH	YLong noncoding RNAs (lncRNAs) have been reported to drive key cancer pathways but the functions of majority of lncRNAs are unknown making a case for comprehensive functional evaluation of lncRNAs. With an aim to identify lncRNAs dysregulated in human cancers, we analyzed the cancer patient database of lung adenocarcinoma (LUAD), which revealed an upregulated lncRNA, LINC02381 (renamed HOXC10 mRNA stabilizing factor or HMS in this study), whose depletion results in proliferation defects and inhibition of colony formation of human cancer cells. In order to identify the binding targets of HMS, we screened for cis-genes and discovered that HOXC10, an oncogene, is downregulated in the absence of HMS. Depletion of HMS does not affect the HOXC10 promoter activity but inhibits the HOXC10 30-UTR-linked luciferase reporter activity. Since lncRNAs have been known to associate with RNA-binding proteins (RBPs) to stabilize mRNA transcripts, we screened for different RBPs and discovered that HuR, an ELAV family protein, stabilizes HOXC10 mRNA. Using RNA pull-down and deletion mapping experiments, we show that HuR physically interacts with the cytosine-rich stretch of HMS and HOXC10 30-UTR to stabilize HOXC10 mRNA. HOXC10 is overexpressed in many human cancers, and our discovery highlights that lncRNA HMS sustains the HOXC10 mRNA levels to maintain the invasive phenotypes of cancer cells.	[Priyanka, Priyanka; Das, Sanjeev; Saxena, Sandeep] Natl Inst Immunol, DNA Replicat & Cell Cycle Lab, New Delhi, India; [Sharma, Madhur] UDSC, Dept Biochem, New Delhi, India; [Saxena, Sandeep] JNU, Dept Biotechnol, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jawaharlal Nehru University, New Delhi	Saxena, S (corresponding author), Natl Inst Immunol, DNA Replicat & Cell Cycle Lab, New Delhi, India.; Saxena, S (corresponding author), JNU, Dept Biotechnol, New Delhi, India.	sandeepsaxena@mail.jnu.ac.in		Priyanka, Fnu/0000-0001-7933-3809; Das, Sanjeev/0000-0002-3594-1033	Government of India [BT/PR22824/BRB/10/1578/2016, EMR/2016/001702]	Government of India	We thank Bharti Sharma, Ritu Shekhar, Ananya Kar, and Sunder Bisht for helping in various parts of this paper. This study was partly funded by project numbers BT/PR22824/BRB/10/1578/2016 and EMR/2016/001702 from Government of India.	Bhatlekar S, 2014, J MOL MED, V92, P811, DOI 10.1007/s00109-014-1181-y; Bian X, 2021, BIOCHEM BIOPH RES CO, V548, P112, DOI 10.1016/j.bbrc.2021.02.072; BOTHWELL ALM, 1991, J BIOL CHEM, V266, P24657; Cao LM, 2017, ELIFE, V6, DOI 10.7554/eLife.30433; Carlson MRJ, 2001, DEV BIOL, V229, P396, DOI 10.1006/dbio.2000.0104; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; Chen XH, 2020, CANCER MANAG RES, V12, P3971, DOI 10.2147/CMAR.S237285; Ciarlo E, 2013, DIS MODEL MECH, V6, P424, DOI 10.1242/dmm.009761; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dong D, 2019, BIOMED PHARMACOTHER, V111, P917, DOI 10.1016/j.biopha.2018.12.143; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Geuens T, 2016, HUM GENET, V135, P851, DOI 10.1007/s00439-016-1683-5; Ghosh T, 2017, J BIOL CHEM, V292, P21264, DOI 10.1074/jbc.M117.808287; Guerra SL, 2020, CANCER CELL, V37, P705, DOI 10.1016/j.ccell.2020.03.004; Hostikka SL, 2009, INT J BIOL SCI, V5, P397; Huang JG, 2016, NUCLEIC ACIDS RES, V44, P3059, DOI 10.1093/nar/gkv1353; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jafarzadeh M, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.562253; Jafarzadeh M, 2020, BIOCHIMIE, V171, P63, DOI 10.1016/j.biochi.2020.02.009; Kawasaki Y, 2016, CELL REP, V16, P2554, DOI 10.1016/j.celrep.2016.08.015; Kim J, 2016, NUCLEIC ACIDS RES, V44, P2378, DOI 10.1093/nar/gkw017; Kornienko AE, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-59; Lauvrak SU, 2013, BRIT J CANCER, V109, P2228, DOI 10.1038/bjc.2013.549; Lee YS, 2012, P NATL ACAD SCI USA, V109, P15520, DOI 10.1073/pnas.1116224109; Li BZ, 2019, STEM CELLS, V37, P247, DOI 10.1002/stem.2925; Li DF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04072-4; Li J, 2015, CANCER RES, V75, P3728, DOI 10.1158/0008-5472.CAN-15-0273; Li LL, 2019, CANCER LETT, V450, P14, DOI 10.1016/j.canlet.2019.02.036; Long B, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03205-2; Lv XJ, 2019, EUR REV MED PHARMACO, V23, P1947, DOI 10.26355/eurrev_201903_17233; Maamar H, 2013, GENE DEV, V27, P1260, DOI 10.1101/gad.217018.113; Militello G, 2017, BRIEF BIOINFORM, V18, P780, DOI 10.1093/bib/bbw053; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Niknafs YS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12791; Pautke C, 2004, ANTICANCER RES, V24, P3743; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sadik H, 2016, CANCER RES, V76, P4443, DOI 10.1158/0008-5472.CAN-16-0774; Shekhar R, 2019, J BIOL CHEM, V294, P4381, DOI 10.1074/jbc.RA118.005778; Shi HS, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0840-1; Simion V, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19664-2; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Wang CF, 2019, P NATL ACAD SCI USA, V116, P14620, DOI 10.1073/pnas.1903432116; Wang J, 2020, CELL TRANSPLANT, V29, DOI 10.1177/0963689720938023; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang LJ, 2015, CELL RES, V25, P335, DOI 10.1038/cr.2015.21; Wang XH, 2019, MOL MED REP, V20, P640, DOI 10.3892/mmr.2019.10292; Wu BL, 2021, ENVIRON TOXICOL, V36, P840, DOI 10.1002/tox.23087; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Yang JH, 2020, NUCLEIC ACIDS RES, V48, P12943, DOI 10.1093/nar/gkaa1151; Yang JL, 2014, THORAC CANCER, V5, P149, DOI 10.1111/1759-7714.12074; YAO KM, 1993, J NEUROBIOL, V24, P723, DOI 10.1002/neu.480240604; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Zhang GH, 2019, J CELL PHYSIOL, V234, P5163, DOI 10.1002/jcp.27320	57	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100997	10.1016/j.jbc.2021.100997	http://dx.doi.org/10.1016/j.jbc.2021.100997			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34302808	gold, Green Published			2022-12-26	WOS:000690868100006
J	Bogicevic, L; Verhoeven, M; van Baar, AL				Bogicevic, Lilly; Verhoeven, Marjolein; van Baar, Anneloes L.			Exploring predictors at toddler age of distinct profiles of attentional functioning in 6-year-old children born moderate-to-late preterm and full term	PLOS ONE			English	Article							COGNITIVE-ABILITIES; EXECUTIVE FUNCTION; PROCESSING SPEED; PREMATURITY; CHILDHOOD; OUTCOMES; SYSTEM; TASKS	Objective Examining relationships of toddler abilities in attention, cognitive, motor, and language development, and behavioral problems, with distinct attention profiles at 6 years of age in children born moderate-to-late preterm and full term. Method Longitudinal study with a cohort of 88 moderate-to-late preterm and 83 full term born children. At 18 months attention abilities were assessed. At 24 months cognitive, motor, and language development was examined and behavioral problems were screened. At 6 years ten measures of attention were administered, which were used to classify children in one of four attentional functioning profiles (normal attention, overall poorer attention, poorer cognitive attention, and behavioral attention problems). Performance at 18 and 24 months was examined in relation to these four distinct attention profiles, as well as in relation to normal (first profile) versus subaverage attention (second, third, and fourth profiles) using multinomial logistic regressions. Results Orienting and alerting attention, and receptive language were related to distinct attention profiles. Specifically, children with an overall poorer attention profile at 6 years were differentiated by lower orienting attention and receptive language scores at toddler age, while those with a poorer cognitive attention profile showed lower early alerting attention at 18 months. Children with a behavioral attention problems profile at 6 years were differentiated by lower orienting attention but higher alerting attention scores at toddler age. Orienting attention and receptive language, but not alerting attention, at toddler age were related to normal versus subaverage attention, with lower scores predicting subaverage attention. Conclusions Children at risk of poorer attentional functioning at school-age, expressed in distinct attention profiles, already showed differentiated functioning in attention abilities and in language comprehension as toddlers. Distinguishing distinct attention profiles could be important for future research and clinical practice, as is early monitoring of attention and language abilities in children at risk.	[Bogicevic, Lilly; Verhoeven, Marjolein; van Baar, Anneloes L.] Univ Utrecht, Child & Adolescent Studies, Utrecht, Netherlands	Utrecht University	Bogicevic, L (corresponding author), Univ Utrecht, Child & Adolescent Studies, Utrecht, Netherlands.	l.bogicevic@uu.nl		Bogicevic, Lilly/0000-0003-4229-6973				Andrade BF, 2009, J ATTEN DISORD, V12, P341, DOI 10.1177/1087054708320440; Bogicevic Lilly, 2021, J Int Neuropsychol Soc, V27, P970, DOI 10.1017/S1355617720001411; Bogicevic L, 2020, J PEDIATR PSYCHOL, V45, P685, DOI 10.1093/jpepsy/jsaa038; Bogicevic L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223690; Breeman LD, 2016, J CHILD PSYCHOL PSYC, V57, P132, DOI 10.1111/jcpp.12456; Brito NH, 2019, DEV NEUROPSYCHOL, V44, P220, DOI 10.1080/87565641.2018.1564310; Cserjesi R, 2012, PEDIATRICS, V130, pE838, DOI 10.1542/peds.2011-2079; de Jong M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00669; de Jong M, 2016, J ATTEN DISORD, V20, P230, DOI 10.1177/1087054713516002; De Schuymer L, 2011, EARLY HUM DEV, V87, P265, DOI 10.1016/j.earlhumdev.2011.01.029; dos Santos ESL, 2013, EARLY HUM DEV, V89, P487, DOI 10.1016/j.earlhumdev.2013.03.008; Feldman R, 1998, CODING INTERACTIVE B; Gartstein MA, 2008, CHILD PSYCHIAT HUM D, V39, P9, DOI 10.1007/s10578-007-0067-4; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Hendriksen J., 2010, WECHSLER PRIMARY PRE, V2nd ed; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hutchon B, 2019, DEV MED CHILD NEUROL, V61, P1362, DOI 10.1111/dmcn.14187; Jaekel J, 2013, PSYCHOL MED, V43, P183, DOI 10.1017/S0033291712001031; Krasner AJ, 2018, J ATTEN DISORD, V22, P827, DOI 10.1177/1087054715617532; Lawson KR, 2004, J DEV BEHAV PEDIATR, V25, P399, DOI 10.1097/00004703-200412000-00003; Lean RE, 2017, J INT NEUROPSYCH SOC, V23, P539, DOI 10.1017/S1355617717000388; Linsell L, 2019, EUR CHILD ADOLES PSY, V28, P531, DOI 10.1007/s00787-018-1219-8; Manly T., 2014, HANDLEIDING TEST EVE; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Mirsky AF, 2001, ANN NY ACAD SCI, V931, P17; Mulder H, 2011, J INT NEUROPSYCH SOC, V17, P445, DOI 10.1017/S1355617711000373; Mulder H, 2009, DEV NEUROPSYCHOL, V34, P393, DOI 10.1080/87565640902964524; Nordhov SM, 2012, PEDIATRICS, V129, pE9, DOI 10.1542/peds.2011-0248; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Potharst ES, 2012, DEV MED CHILD NEUROL, V54, P240, DOI 10.1111/j.1469-8749.2011.04181.x; R Core Team, 2020, R LANG ENV STAT COMP; Reuner G, 2015, CHILD NEUROPSYCHOL, V21, P314, DOI 10.1080/09297049.2014.899571; Ribeiro LA, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-59; Romeo DM, 2012, EUR J PAEDIATR NEURO, V16, P243, DOI 10.1016/j.ejpn.2011.07.012; Rommelse N., 2018, COGNITIEVE TEST APPL; ROSE SA, 1995, DEV PSYCHOL, V31, P685, DOI 10.1037/0012-1649.31.4.685; Rose SA, 2005, CHILD DEV, V76, P1172, DOI 10.1111/j.1467-8624.2005.00842.x-i1; Rose SA, 2003, J PEDIATR-US, V143, pS54, DOI 10.1067/S0022-3476(03)00402-5; Rose SA, 2002, DEV PSYCHOL, V38, P895, DOI 10.1037//0012-1649.38.6.895; Rose SA, 2011, DEVELOPMENTAL SCI, V14, P1161, DOI 10.1111/j.1467-7687.2011.01068.x; Rose SA, 2009, CHILD DEV, V80, P134, DOI 10.1111/j.1467-8624.2008.01250.x; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Sayal K, 2015, J AM ACAD CHILD PSY, V54, P360, DOI 10.1016/j.jaac.2015.02.007; Snijders VE, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17217926; Twilhaar ES, 2020, CHILD NEUROPSYCHOL, V26, P274, DOI 10.1080/09297049.2019.1639652; Van Baar AL., 2014, BAYLEY SCALES INFANT; van Baar AL, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01179; van Veen S, 2016, J PEDIATR-US, V173, P90, DOI 10.1016/j.jpeds.2016.02.043; Verhulst F.C., 2013, HANDLEIDING ASEBA VR; Verhulst FC., 2000, GEDRAGSVRAGENLIJST K; Yu C, 2019, DEVELOPMENTAL SCI, V22, DOI 10.1111/desc.12735; Zijlstra HP., 2010, TECHNISCHE HANDLEIDI	53	0	0	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254797	10.1371/journal.pone.0254797	http://dx.doi.org/10.1371/journal.pone.0254797			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324546	Green Published, gold			2022-12-26	WOS:000685248200024
J	Llavall, AC; de Wildt, G; Meza, G; Tattsbridge, J; Jones, L				Clave Llavall, Anna; de Wildt, Gilles; Meza, Graciela; Tattsbridge, Jasmine; Jones, Laura			Nurses' and teachers' perceived barriers and facilitators to the uptake of the Human Papilloma Virus (HPV) vaccination program in Iquitos, Peru: A qualitative study	PLOS ONE			English	Article							CERVICAL-CANCER; LATIN-AMERICA; PARENTS; ACCEPTABILITY; STRATEGIES; PREDICTORS	Globally, over 300,000 women die of cervical cancer annually. Given that human papillomavirus vaccines are highly effective in the primary prevention of cervical cancer, it is important to explore the barriers and facilitators to vaccination uptake in areas where the burden of disease remains high. This study, informed by the socio-ecological model, aimed to qualitatively explore vaccination uptake via in-depth interviews with eleven nurses and ten teachers involved in vaccine delivery in Iquitos, Peru. The results highlighted that vaccine uptake was influenced by multiple factors including individuals' knowledge and attitudes, community beliefs, geography, and policy level variables. Findings suggested that professionals were informed and supportive of the HPV vaccination program but perceived that parents were uninformed about the vaccine. There is a need for community education programs, for a revision of the process of obtaining parental consent, for improved communication between professionals and for involvement of grassroots staff in policy making.	[Clave Llavall, Anna; Tattsbridge, Jasmine] Univ Birmingham, Med Sch, Birmingham, W Midlands, England; [de Wildt, Gilles] Univ Birmingham, Inst Clin Sci, Birmingham, W Midlands, England; [Meza, Graciela] Univ Nacl Amazonia Peruana, Fac Med Humana, Iquitos, Peru; [Jones, Laura] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; Universidad Nacional de la Amazonia Peruana; University of Birmingham	Jones, L (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England.	L.L.Jones@bham.ac.uk		Jones, Laura/0000-0002-4018-3855; Tattsbridge, Jasmine/0000-0002-6877-9191	Population Sciences and Humanities department at the University of Birmingham, United Kingdom [FIN 7N]; Sir Arthur Thomson Charitable Trust at the University of Birmingham, United Kingdom [FIN 42]; Arthur Thomson Trust; University of Birmingham BMedSc degree program	Population Sciences and Humanities department at the University of Birmingham, United Kingdom; Sir Arthur Thomson Charitable Trust at the University of Birmingham, United Kingdom; Arthur Thomson Trust; University of Birmingham BMedSc degree program	The first author received awards from the Population Sciences and Humanities department (grant number FIN 7N, https://www.birmingham.ac.uk/undergraduate/courses/med/publichealthpopulationsciencebmedsc-intercalateddegree.aspx) and the Sir Arthur Thomson Charitable Trust (grant number FIN 42 https://www.birmingham.ac.uk/research/activity/mds/icat/undergraduate/index.aspx), both at the University of Birmingham, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank all the participants. We would also like to thank the University of Birmingham BMedSc degree program and the Arthur Thomson Trust for their guidance and financial support.	Almonte M, 2008, VACCINE, V26, pL16, DOI 10.1016/j.vaccine.2008.06.008; Anney V.N., 2014, J EMERG TRENDS ED RE, V5, P272, DOI DOI 10.3109/08941939.2012.723954; Bartolini RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048017; Boerner F, 2013, HUM VACC IMMUNOTHER, V9, P1477, DOI 10.4161/hv.24427; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; Bruni L.A.G., 2019, HUMAN PAPILLOMAVIRUS; Burghouts J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170227; Carter N, 2014, ONCOL NURS FORUM, V41, P545, DOI 10.1188/14.ONF.545-547; Cartmell KB, 2018, PAPILLOMAVIRUS RES, V5, P21, DOI 10.1016/j.pvr.2017.11.003; Caskey R, 2009, J ADOLESCENT HEALTH, V45, P453, DOI 10.1016/j.jadohealth.2009.04.021; Cates JR, 2010, J ADOLESCENT HEALTH, V47, P305, DOI 10.1016/j.jadohealth.2010.04.003; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Etikan I., 2016, BIOM BIOSTAT INT J, V3, P6, DOI [10.15406/bbij.2016.03.00055, DOI 10.15406/BBIJ.2016.03.00055]; Farias CC, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1677-y; Gallagher KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177773; Glanz K., 2015, HLTH BEHAV THEORY RE; Guerry SL, 2011, VACCINE, V29, P2235, DOI 10.1016/j.vaccine.2011.01.052; Hilton S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-226; Instituto Nacional de Estadistica e Informatica, ENC DEM SAL FAM ENDE; Instituto Nacional de Estadistica e Informatica, 3 CENS COM NAT 2017; Instituto Nacional de Estadistica e Informatica, PROGR PREV CONTR CAN; Instituto Nacional de Estadistica e Informatica, AUT ETN POBL IND AFR; Instituto Nacional de Estadistica e Informatica, 2020, PER IND ED DEP 2009; Instituto Nacional de Estadistica e Informatica, 2012, B ESPECIAL, V23; Instituto Nacional de Estadistica e Informatica, 2015, EST PROYECC POBL; Jamshed Shazia, 2014, J Basic Clin Pharm, V5, P87, DOI 10.4103/0976-0105.141942; Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040; Kabakama S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3517-8; Kolb S. M., 2012, J EMERGING TRENDS ED, V3, P83, DOI DOI 10.10520/EJC135409; Kumar S, 2012, HEALTH EDUC BEHAV, V39, P229, DOI 10.1177/1090198111415105; Ladner J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-370; Lobao WM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206726; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; Ministerio de Cultura del Peru, LIST PUEBL IND OR 20; Ministerio de Educacion del Peru, 2017, LOR COM VAM ED; Ministerio de Salud del Peru, ANALISIS SITUACION S; Ministerio de Salud del Peru, 2017, THAILAND REPORT 506, P1, DOI DOI 10.1094/ASBCMOA-MALT-15; Ministerio de Transportes y Comunicaciones del Peru, PROBL COM RUR 2013; Nyambe A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3802-6; PATH and Child Health Development Centre (CHDC), 2009, SHAP STRAT INTR HPV; Rosenthal SL, 2011, VACCINE, V29, P890, DOI 10.1016/j.vaccine.2009.12.063; Sargent A, 2008, BRIT J CANCER, V98, P1704, DOI 10.1038/sj.bjc.6604324; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Silverman D., 2021, QUAL RES; Squires A, 2009, INT J NURS STUD, V46, P277, DOI 10.1016/j.ijnurstu.2008.08.006; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Voces Ciudadanas, 2016, COB HIST VAC VPH SEG; Vorsters Alex, 2020, BMC Proc, V14, P8, DOI 10.1186/s12919-020-00192-2; World Health Organization, 2014, WHOIVB1404; World Health Organization, GUID INTR HPV VACC N	65	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255218	10.1371/journal.pone.0255218	http://dx.doi.org/10.1371/journal.pone.0255218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324573	Green Published, gold			2022-12-26	WOS:000685248200057
J	Jenkins, M; Ahmed, S; Barnes, AN				Jenkins, Meg; Ahmed, Sabrina; Barnes, Amber N.			A systematic review of waterborne and water-related disease in animal populations of Florida from 1999-2019	PLOS ONE			English	Review							WEST-NILE-VIRUS; BOTTLE-NOSED DOLPHINS; INDIAN RIVER LAGOON; GULF-OF-MEXICO; GIARDIA-DUODENALIS GENOTYPES; UNITED-STATES; RED TIDE; TURSIOPS-TRUNCATUS; KARENIA-BREVIS; HUMAN HEALTH	Background Florida's waters are a reservoir for a host of pathogens and toxins. Many of these microorganisms cause water-related diseases in people that are reportable to the Florida Department of Health. Our objective in this review was to ascertain which water-related pathogens and toxins of public health importance have been found in animal populations in Florida over the last twenty years. Methods Nineteen databases were searched, including PubMed and Web of Science Core Collection, using keywords and search terms for the waterborne diseases, water-related vector-borne diseases, and water-based toxins reportable to the Florida Department of Health. For inclusion, peer-reviewed journal articles were to be written in English, published between January 1, 1999 and December 31, 2019, and contain primary research findings documenting at least one of the water-related pathogens or toxins of interest in an animal population within Florida during this same time frame. Results Of over eight thousand initial search results, 65 studies were included for final analysis. The most common animal types implicated in the diseases of interest included marine mammals, fish and shellfish, wild birds, and livestock. Toxins or pathogens most often associated with these animals included toxin-producer Karenia brevis, vibriosis, Escherichia coli, and Salmonellosis. Discussion/conclusion Findings from this review elucidate the water-related disease-causing pathogens and toxins which have been reported within animal populations in recent Florida history. As most of these diseases are zoonotic, our results suggest a One Health approach is necessary to support and maintain healthy water systems throughout the state of Florida for the protection of both human and animal populations.	[Jenkins, Meg; Ahmed, Sabrina; Barnes, Amber N.] Univ North Florida, Dept Publ Hlth, Jacksonville, FL 32224 USA	State University System of Florida; University of North Florida	Barnes, AN (corresponding author), Univ North Florida, Dept Publ Hlth, Jacksonville, FL 32224 USA.	amber.barnes@unf.edu	Barnes, Amber/AAC-5251-2022	Jenkins, Meg/0000-0003-4965-2512	Environmental Center of the University of North Florida	Environmental Center of the University of North Florida	This study was funded by a seed grant from the Environmental Center of the University of North Florida to ANB. https://www.unf.edu/ecenter/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JP, 2009, HARMFUL ALGAE, V8, P343, DOI 10.1016/j.hal.2008.07.005; Allison AB, 2005, AVIAN DIS, V49, P292, DOI 10.1637/7278-091304R; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P1277; [Anonymous], 2014, QUESTIONS ANSWERS; [Anonymous], DIS REP INF HLTH CAR; [Anonymous], 2010, CLIM GLANC STAT TIM; [Anonymous], 2018, ILLN SYMPT; [Anonymous], 2009, SUSTAINING GLOBAL SU; Backer LC, 2013, TOXINS, V5, P1597, DOI 10.3390/toxins5091597; Baker CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217445; Bartram J., 2004, WATERBORNE ZOONOSES; Bingham AM, 2014, AM J TROP MED HYG, V91, P685, DOI 10.4269/ajtmh.14-0081; Blackmore CGM, 2003, AM J TROP MED HYG, V69, P141, DOI 10.4269/ajtmh.2003.69.141; Bogomolni AL, 2008, DIS AQUAT ORGAN, V81, P13, DOI 10.3354/dao01936; Borisova T., 2019, EDIS, V2019, P8; Bossart GD, 2011, VET PATHOL, V48, P676, DOI 10.1177/0300985810388525; Brankston G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196573; Buck JD, 2006, J WILDLIFE DIS, V42, P536, DOI 10.7589/0090-3558-42.3.536; Caffarena RD, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00562; Caminade C, 2019, ANN NY ACAD SCI, V1436, P157, DOI 10.1111/nyas.13950; Capper A, 2013, HARMFUL ALGAE, V28, P1, DOI 10.1016/j.hal.2013.04.009; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P414; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P426; Charles-Smith LE, 2009, CHELONIAN CONSERV BI, V8, P213, DOI 10.2744/CCB-0771.1; Chatfield J, 2013, J ZOO WILDLIFE MED, V44, P404, DOI 10.1638/2012-0258R2.1; Coffey LL, 2006, EMERG INFECT DIS, V12, P1873; Conrad CC, 2017, FOODBORNE PATHOG DIS, V14, P59, DOI 10.1089/fpd.2016.2185; Deeds JR, 2008, T AM FISH SOC, V137, P1317, DOI 10.1577/T07-204.1; Eisenberg JNS, 2007, ENVIRON HEALTH PERSP, V115, P1216, DOI 10.1289/ehp.9806; Ellison RK, 2001, J FOOD PROTECT, V64, P682, DOI 10.4315/0362-028X-64.5.682; Estep LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057879; Fang L, 2019, J APPL MICROBIOL, V126, P1265, DOI 10.1111/jam.14199; Fayer R, 2003, PARASITOL RES, V89, P141, DOI 10.1007/s00436-002-0734-0; Fayer R, 2007, VET PARASITOL, V145, P260, DOI 10.1016/j.vetpar.2006.12.009; Fire SE, 2008, MAR ECOL PROG SER, V368, P283, DOI 10.3354/meps07643; Fire SE, 2008, MAR MAMMAL SCI, V24, P831, DOI 10.1111/j.1748-7692.2008.00221.x; Fire SE, 2020, AQUAT TOXICOL, V218, DOI 10.1016/j.aquatox.2019.105371; Fisheries Economies of the United States, 2016, NOAA FISH; Fleming LE, 2011, HARMFUL ALGAE, V10, P224, DOI 10.1016/j.hal.2010.08.006; Gerhold RW, 2013, ZOONOSES PUBLIC HLTH, V60, P189, DOI 10.1111/j.1863-2378.2012.01522.x; Gibbs SEJ, 2006, VECTOR-BORNE ZOONOT, V6, P261, DOI 10.1089/vbz.2006.6.261; Godsey MS, 2005, VECTOR-BORNE ZOONOT, V5, P82, DOI 10.1089/vbz.2005.5.82; Gramling C., 2018, FRESHWATER SALTWATER; Greger M, 2007, BIOSECUR BIOTERROR, V5, P301, DOI 10.1089/bsp.2007.0028; Greig Thomas W., 2007, Aquatic Mammals, V33, P185, DOI 10.1578/AM.33.2.2007.185; Grigione MM, 2014, URBAN ECOSYST, V17, P1, DOI 10.1007/s11252-013-0302-7; Hasler B, 2013, CURR TOP MICROBIOL, V365, P127, DOI 10.1007/82_2012_239; Hardison DR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198358; Hernandez SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164402; Hudson CR, 2000, J CLIN MICROBIOL, V38, P1860, DOI 10.1128/JCM.38.5.1860-1865.2000; Huffman Jessica N., 2018, Journal of Parasitology Research, P3048795, DOI 10.1155/2018/3048795; Hughes-Hanks JM, 2005, J PARASITOL, V91, P1225, DOI 10.1645/GE-545R.1; Jacobson ER, 2005, J WILDLIFE DIS, V41, P96, DOI 10.7589/0090-3558-41.1.96; Kemp KM, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01035-17; Kirkpatrick B, 2004, HARMFUL ALGAE, V3, P99, DOI 10.1016/j.hal.2003.08.005; Komar N, 2001, ANN NY ACAD SCI, V951, P58; Krystosik A, 2020, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00405; Landolfi JA, 2010, J VET DIAGN INVEST, V22, P37, DOI 10.1177/104063871002200106; Landsberg JH, 2006, ENVIRON HEALTH PERSP, V114, P1502, DOI 10.1289/ehp.8998; Leisnham PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091655; Martony M, 2018, J AQUAT ANIM HEALTH, V30, P325, DOI 10.1002/aah.10043; McFarland K, 2015, TOXICON, V97, P46, DOI 10.1016/j.toxicon.2015.02.005; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Montgomery MP, 2018, MMWR-MORBID MORTAL W, V67, P1032, DOI 10.15585/mmwr.mm6737a3; Morris PJ, 2011, VET MICROBIOL, V148, P440, DOI 10.1016/j.vetmic.2010.08.025; Murphy HM, 2017, HYDROGEOL J, V25, P981, DOI 10.1007/s10040-017-1543-y; Naar JP, 2007, TOXICON, V50, P707, DOI 10.1016/j.toxicon.2007.06.005; Nam DH, 2010, AQUAT TOXICOL, V99, P351, DOI 10.1016/j.aquatox.2010.05.014; Nemeth NM, 2009, J WILDLIFE DIS, V45, P817, DOI 10.7589/0090-3558-45.3.817; O'Haire M, 2010, J VET BEHAV, V5, P226, DOI 10.1016/j.jveb.2010.02.002; Pecl GT, 2017, SCIENCE, V355, DOI 10.1126/science.aai9214; Perrault JR, 2016, AQUAT TOXICOL, V180, P131, DOI 10.1016/j.aquatox.2016.09.020; Pierce RH, 2008, ECOTOXICOLOGY, V17, P623, DOI 10.1007/s10646-008-0241-x; Poli MA, 2000, TOXICON, V38, P981, DOI 10.1016/S0041-0101(99)00191-9; Rabinowitz P, 2013, ANNU REV PUBL HEALTH, V34, P189, DOI 10.1146/annurev-publhealth-031912-114426; Radke EG, 2015, AM J TROP MED HYG, V93, P425, DOI 10.4269/ajtmh.14-0400; Raza A, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8070108; Research, 2020, RES FLORIDA VISITOR; Riley DG, 2008, J FOOD PROTECT, V71, P807, DOI 10.4315/0362-028X-71.4.807; Riley DG, 2003, J FOOD PROTECT, V66, P1778, DOI 10.4315/0362-028X-66.10.1778; Rios LMV, 2009, MED VET ENTOMOL, V23, P357, DOI 10.1111/j.1365-2915.2009.00821.x; Rolton A, 2018, AQUAT TOXICOL, V202, P153, DOI 10.1016/j.aquatox.2018.07.007; Sabshin SJ, 2012, JAVMA-J AM VET MED A, V241, P331, DOI 10.2460/javma.241.3.331; Sapp SGH, 2016, EMERG INFECT DIS, V22, P2128, DOI 10.3201/eid2212.160467; Schaefer AM, 2009, ECOHEALTH, V6, P33, DOI 10.1007/s10393-009-0221-5; Schaefer Adam M., 2009, Aquatic Mammals, V35, P163, DOI 10.1578/AM.35.2.2009.163; Shaman J, 2007, T ROY SOC TROP MED H, V101, P469, DOI 10.1016/j.trstmh.2006.11.007; Staley C, 2013, ENVIRON MICROBIOL, V15, P623, DOI 10.1111/1462-2920.12045; Steele CM, 2005, J WILDLIFE DIS, V41, P735, DOI 10.7589/0090-3558-41.4.735; Stull JW, 2015, CAN MED ASSOC J, V187, P736, DOI 10.1503/cmaj.141020; Stull JW, 2015, VET CLIN N AM-SMALL, V45, P377, DOI 10.1016/j.cvsm.2014.11.007; Trainer VL, 1999, AQUAT TOXICOL, V46, P139, DOI 10.1016/S0166-445X(98)00125-8; Trout JM, 2007, VET PARASITOL, V147, P205, DOI 10.1016/j.vetpar.2007.05.014; Trout JM, 2006, VET PARASITOL, V140, P217, DOI 10.1016/j.vetpar.2006.03.025; Trout JM, 2004, VET PARASITOL, V124, P179, DOI 10.1016/j.vetpar.2004.07.010; Trout JM, 2005, VET PARASITOL, V130, P177, DOI 10.1016/j.vetpar.2005.03.032; Tupler T, 2012, JAVMA-J AM VET MED A, V241, P338, DOI 10.2460/javma.241.3.338; Twiner MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042974; Twiner MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017394; Tyrrel SF, 2003, J APPL MICROBIOL, V94, p87S; Unger NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104577; United States Census Bureau QuickFacts: Florida [Internet, 2019, QUICKFACTS FLOR; van Deventer M, 2012, BOT MAR, V55, P31, DOI [10.1515/BOT.2011.122, 10.1515/bot.2011.122]; Van Dolah FM, 2003, N P TOX ENV, P247; Vilarino N, 2018, TOXINS, V10, DOI 10.3390/toxins10080324; Vorbach BS, 2017, J WILDLIFE DIS, V53, P930, DOI 10.7589/2017-01-012; Walsh CJ, 2015, AQUAT TOXICOL, V161, P73, DOI 10.1016/j.aquatox.2015.01.019; Waltzek TB, 2012, ZOONOSES PUBLIC HLTH, V59, P521, DOI 10.1111/j.1863-2378.2012.01492.x; Wetzel DL, 2010, SCI TOTAL ENVIRON, V408, P6124, DOI 10.1016/j.scitotenv.2010.08.043; World Health Organization, 1988, ENV MAN VECT CONTR T; World Health Organization Food and Agriculture Organization of the United Nations World Organisation for Animal Health, 2019, TAK MULT ON HLTH APP; Wright JG, 2008, JAVMA-J AM VET MED A, V232, P1863, DOI 10.2460/javma.232.12.1863; Wyrosdick Heidi M, 2017, Vet Parasitol Reg Stud Reports, V10, P20, DOI 10.1016/j.vprsr.2017.07.002	113	1	1	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255025	10.1371/journal.pone.0255025	http://dx.doi.org/10.1371/journal.pone.0255025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324547	gold, Green Published			2022-12-26	WOS:000685248200094
J	Rangel-Chavez, CP; Galan-Vasquez, E; Pescador-Tapia, A; Delaye, L; Martinez-Antonio, A				Rangel-Chavez, Cynthia Paola; Galan-Vasquez, Edgardo; Pescador-Tapia, Azucena; Delaye, Luis; Martinez-Antonio, Agustino			RNA polymerases in strict endosymbiont bacteria with extreme genome reduction show distinct erosions that might result in limited and differential promoter recognition	PLOS ONE			English	Article							ALPHA-SUBUNIT; TRANSCRIPTION ACTIVATION; CRYSTAL-STRUCTURE; TERMINAL DOMAINS; CLUSPRO SERVER; FUNCTIONAL MAP; PROTEIN; BINDING; COMPLEXES; SELECTION	Strict endosymbiont bacteria present high degree genome reduction, retain smaller proteins, and in some instances, lack complete functional domains compared to free-living counterparts. Until now, the mechanisms underlying these genetic reductions are not well understood. In this study, the conservation of RNA polymerases, the essential machinery for gene expression, is analyzed in endosymbiont bacteria with extreme genome reductions. We analyzed the RNA polymerase subunits to identify and define domains, subdomains, and specific amino acids involved in precise biological functions known in Escherichia coli. We also perform phylogenetic analysis and three-dimensional models over four lineages of endosymbiotic proteobacteria with the smallest genomes known to date: Candidatus Hodgkinia cicadicola, Candidatus Tremblaya phenacola, Candidatus Tremblaya Princeps, Candidatus Nasuia deltocephalinicola, and Candidatus Carsonella ruddii. We found that some Hodgkinia strains do not encode for the RNA polymerase alpha subunit. The rest encode genes for alpha, beta, beta', and sigma subunits to form the RNA polymerase. However, 16% shorter, on average, respect their orthologous in E. coli. In the alpha subunit, the amino-terminal domain is the most conserved. Regarding the beta and beta' subunits, both the catalytic core and the assembly domains are the most conserved. However, they showed compensatory amino acid substitutions to adapt to changes in the sigma subunit. Precisely, the most erosive diversity occurs within the sigma subunit. We identified broad amino acid substitution even in those recognizing and binding to the -10-box promoter element. In an overall conceptual image, the RNA polymerase from Candidatus Nasuia conserved the highest similarity with Escherichia coli RNA polymerase and their sigma(70). It might be recognizing the two main promoter elements (-10 and -35) and the two promoter accessory elements (-10 extended and UP-element). In Candidatus Carsonella, the RNA polymerase could recognize all the promoter elements except the -10-box extended. In Candidatus Tremblaya and Hodgkinia, due to the alpha carboxyl-terminal domain absence, they might not recognize the UP-promoter element. We also identified the lack of the beta flap-tip helix domain in most Hodgkinia's that suggests the inability to bind the -35-box promoter element.	[Rangel-Chavez, Cynthia Paola; Pescador-Tapia, Azucena; Martinez-Antonio, Agustino] Natl Polytech Inst, Ctr Res & Adv Studies, Genet Engn Dept, Biol Engn Lab, Irapuato, Mexico; [Galan-Vasquez, Edgardo] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Dept Ingn Sistemas Comp & Automatizac, Mexico City, DF, Mexico; [Delaye, Luis] Natl Polytech Inst, Ctr Res & Adv Studies, Genet Engn Dept, Evolutionary Genom Lab, Irapuato, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico	Martinez-Antonio, A (corresponding author), Natl Polytech Inst, Ctr Res & Adv Studies, Genet Engn Dept, Biol Engn Lab, Irapuato, Mexico.	agustino.martinez@cinvestav.mx	Martínez-Antonio, Agustino/GQQ-2363-2022; Galán-Vásquez, Edgardo/AFP-3050-2022	Martínez-Antonio, Agustino/0000-0003-2231-5014; Galán-Vásquez, Edgardo/0000-0002-9165-1241	CONACYT, Mexico [380338]	CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	CPR-C has a Ph.D. fellowship (380338) from CONACYT. Mexico. Thank Rafael Montiel for guiding the selective pressure analyses and Diego Andres Lopez Castro and Paola Isabel Angulo-Bejarano for reading the manuscript.	[Anonymous], PYMOL MOL GRAPHICS S; Bae B, 2013, P NATL ACAD SCI USA, V110, P19772, DOI 10.1073/pnas.1314576110; Belyaeva TA, 1998, J MOL BIOL, V277, P789, DOI 10.1006/jmbi.1998.1666; Bertoni G, 1998, EMBO J, V17, P5120, DOI 10.1093/emboj/17.17.5120; BLATTER EE, 1994, CELL, V78, P889, DOI 10.1016/S0092-8674(94)90682-3; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; BUSBY S, 1994, CELL, V79, P743, DOI 10.1016/0092-8674(94)90063-9; Camarero JA, 2002, P NATL ACAD SCI USA, V99, P8536, DOI 10.1073/pnas.132033899; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cathleen LChan., 1996, STRUCTURE, V4, P235; Clark MA, 2001, J BACTERIOL, V183, P1853, DOI 10.1128/JB.183.6.1853-1861.2001; Cramer P, 2001, SCIENCE, V292, P1863, DOI 10.1126/science.1059493; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; EBRIGHT RH, 1995, CURR OPIN GENET DEV, V5, P197, DOI 10.1016/0959-437X(95)80008-5; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Eleftherianos I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00046; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Galan-Vasquez E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146901; GENTRY DR, 1989, J BACTERIOL, V171, P1271, DOI 10.1128/jb.171.3.1271-1277.1989; Geszvain K, 2004, J MOL BIOL, V343, P569, DOI 10.1016/j.jmb.2004.08.063; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAYWARD RS, 1991, J MOL BIOL, V221, P23, DOI 10.1016/0022-2836(91)80197-3; Hirata A, 2009, CURR OPIN STRUC BIOL, V19, P724, DOI 10.1016/j.sbi.2009.10.006; Huerta AM, 2006, PLOS GENET, V2, P1740, DOI 10.1371/journal.pgen.0020185; Husnik F, 2013, CELL, V153, P1567, DOI 10.1016/j.cell.2013.05.040; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; KENNEY TJ, 1989, P NATL ACAD SCI USA, V86, P9109, DOI 10.1073/pnas.86.23.9109; KIMURA M, 1994, J MOL BIOL, V242, P107, DOI 10.1006/jmbi.1994.1562; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804; LESLEY SA, 1989, BIOCHEMISTRY-US, V28, P7728, DOI 10.1021/bi00445a031; Lim K, 2012, MOL BIOL EVOL, V29, P2937, DOI 10.1093/molbev/mss101; Lukasik P, 2018, P NATL ACAD SCI USA, V115, pE226, DOI 10.1073/pnas.1712321115; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; McLeod SM, 2002, J MOL BIOL, V316, P517, DOI 10.1006/jmbi.2001.5391; Moran NA, 2005, J BACTERIOL, V187, P4229, DOI 10.1128/JB.187.12.4229-4237.2005; Moran NA, 2014, ANNU REV MICROBIOL, V68, P195, DOI 10.1146/annurev-micro-091213-112901; Murakami K, 1997, P NATL ACAD SCI USA, V94, P11274, DOI 10.1073/pnas.94.21.11274; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nelson WC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00713; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ptashne M, 2005, TRENDS BIOCHEM SCI, V30, P275, DOI 10.1016/j.tibs.2005.04.003; Rangel-Chavez C, 2017, MOL BIOSYST, V13, P665, DOI 10.1039/c6mb00789a; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Ross W, 2001, GENE DEV, V15, P491, DOI 10.1101/gad.870001; Sheveleva EV, 2002, NUCLEIC ACIDS RES, V30, P1247, DOI 10.1093/nar/30.5.1247; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; Sloan DB, 2012, MOL BIOL EVOL, V29, P3781, DOI 10.1093/molbev/mss180; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; Tamames J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-181; Vajda S, 2017, PROTEINS, V85, P435, DOI 10.1002/prot.25219; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WALDBURGER C, 1990, J MOL BIOL, V215, P267, DOI 10.1016/S0022-2836(05)80345-6; Xiong P, 2017, J MOL BIOL, V429, P426, DOI 10.1016/j.jmb.2016.11.022; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Yueh C, 2017, J MOL BIOL, V429, P372, DOI 10.1016/j.jmb.2016.10.019; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	73	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0239350	10.1371/journal.pone.0239350	http://dx.doi.org/10.1371/journal.pone.0239350			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324516	Green Published, gold			2022-12-26	WOS:000685248200091
J	Zhang, YK; Khullar, D; Wang, F; Steel, P; Wu, YY; Orlander, D; Weiner, M; Kaushal, R				Zhang, Yongkang; Khullar, Dhruv; Wang, Fei; Steel, Peter; Wu, Yiyuan; Orlander, Duncan; Weiner, Mark; Kaushal, Rainu			Socioeconomic variation in characteristics, outcomes, and healthcare utilization of COVID-19 patients in New York City	PLOS ONE			English	Article							SOCIAL DETERMINANTS; RACIAL DISPARITIES; ACCESS; CONSEQUENCES; COMMUNITIES; RACE	Objectives There is limited evidence on how clinical outcomes differ by socioeconomic conditions among patients with coronavirus disease 2019 (COVID-19). Most studies focused on COVID-19 patients from a single hospital. Results based on patients from multiple health systems have not been reported. The objective of this study is to examine variation in patient characteristics, outcomes, and healthcare utilization by neighborhood social conditions among COVID-19 patients. Methods We extracted electronic health record data for 23,300 community dwelling COVID-19 patients in New York City between March 1(st) and June 11(th), 2020 from all care settings, including hospitalized patients, patients who presented to the emergency department without hospitalization, and patients with ambulatory visits only. Zip Code Tabulation Area-level social conditions were measured by the Social Deprivation Index (SDI). Using logistic regressions and Cox proportional-hazards models, we examined the association between SDI quintiles and hospitalization and death, controlling for race, ethnicity, and other patient characteristics. Results Among 23,300 community dwelling COVID-19 patients, 60.7% were from neighborhoods with disadvantaged social conditions (top SDI quintile), although these neighborhoods only account for 34% of overall population. Compared to socially advantaged patients (bottom SDI quintile), socially disadvantaged patients (top SDI quintile) were older (median age 55 vs. 53, P<0.001), more likely to be black (23.1% vs. 6.4%, P<0.001) or Hispanic (25.4% vs. 8.5%, P<0.001), and more likely to have chronic conditions (e.g., diabetes: 21.9% vs. 10.5%, P<0.001). Logistic and Cox regressions showed that patients with disadvantaged social conditions had higher risk for hospitalization (odds ratio: 1.68; 95% confidence interval [CI]: [1.46, 1.94]; P<0.001) and mortality (hazard ratio: 1.91; 95% CI: [1.35, 2.70]; P<0.001), adjusting for other patient characteristics. Conclusion Substantial socioeconomic disparities in health outcomes exist among COVID-19 patients in NYC. Disadvantaged neighborhood social conditions were associated with higher risk for hospitalization, severity of disease, and death.	[Zhang, Yongkang; Khullar, Dhruv; Wang, Fei; Wu, Yiyuan; Orlander, Duncan; Weiner, Mark; Kaushal, Rainu] Weill Cornell Med Coll, Dept Populat Hlth Sci, New York, NY 10065 USA; [Khullar, Dhruv; Kaushal, Rainu] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Khullar, Dhruv; Kaushal, Rainu] NewYork Presbyterian Hosp, New York, NY USA; [Steel, Peter] Weill Cornell Med, Dept Emergency Med, New York, NY USA; [Kaushal, Rainu] Weill Cornell Med Coll, Dept Pediat, New York, NY USA	Cornell University; Cornell University; NewYork-Presbyterian Hospital; Cornell University; Cornell University	Zhang, YK (corresponding author), Weill Cornell Med Coll, Dept Populat Hlth Sci, New York, NY 10065 USA.	yoz2009@med.cornell.edu			Patient-Centered Outcomes Research Institute [PCORI/HSD-1604-35187]; National Institute on Aging [K99AG064030]	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study is funded by the COVID-19-Related Project Enhancement to the grant PCORI/HSD-1604-35187 ("Identifying and Predicting Patients with Preventable High Utilization", PI: Dr. Rainu Kaushal) from the Patient-Centered Outcomes Research Institute. Dr. Yongkang Zhang is supported by a grant from the National Institute on Aging (Grant no. K99AG064030). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrams EM, 2020, LANCET RESP MED, V8, P659, DOI 10.1016/S2213-2600(20)30234-4; Adhikari S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16938; Alamian A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-224; Alley DE, 2016, NEW ENGL J MED, V374, P8, DOI 10.1056/NEJMp1512532; Almagro M., DETERMINANTS DIFFERE; Argenziano MG, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1996; Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598; Barry Vaughn, 2021, MMWR Morb Mortal Wkly Rep, V70, P818, DOI 10.15585/mmwr.mm7022e1; Bassett MT, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003402; Benda NC, 2020, AM J PUBLIC HEALTH, V110, P1123, DOI 10.2105/AJPH.2020.305784; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolanos CG, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246765; Butler DC, 2013, HEALTH SERV RES, V48, P539, DOI 10.1111/j.1475-6773.2012.01449.x; Chronic Conditions Data Warehouse, 2018, COND CAT; Cockerham WC, 2017, AM J PREV MED, V52, pS5, DOI 10.1016/j.amepre.2016.09.010; Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2; Donnelly JP, 2021, JAMA-J AM MED ASSOC, V325, P304, DOI 10.1001/jama.2020.21465; Egede LE, 2006, J GEN INTERN MED, V21, P667, DOI 10.1111/j.1525-1497.2006.0512.x; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Gu T, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25197; Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8; Hughes MM, 2021, MMWR-MORBID MORTAL W, V70, P431, DOI 10.15585/mmwr.mm7012e1; INSIGHT Clinical Research Network, INSIGHT CLIN RES NET; Joseph NP, 2020, RADIOLOGY, V297, pE303, DOI 10.1148/radiol.2020202602; Karmakar M, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.36462; Kaushal R, 2014, J AM MED INFORM ASSN, V21, P587, DOI 10.1136/amiajnl-2014-002764; Kawachi I, 2005, HEALTH AFFAIR, V24, P343, DOI 10.1377/hlthaff.24.2.343; Liaw W, 2018, J AM BOARD FAM MED, V31, P342, DOI 10.3122/jabfm.2018.03.170421; Mahmud MS, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06346; Mandl RCW, 2013, HUM BRAIN MAPP, V34, P2353, DOI 10.1002/hbm.22075; McCaffery KJ, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp30342012; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Misa NY, 2021, AM J EMERG MED, V45, P451, DOI 10.1016/j.ajem.2020.09.053; Moore JT, 2020, MMWR-MORBID MORTAL W, V69, P1122, DOI 10.15585/mmwr.mm6933e1; Morales DX, 2021, J RACIAL ETHN HEALTH, V8, P1300, DOI 10.1007/s40615-020-00892-7; Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z; National Academies of Sciences E Medicine., 2017, ACCOUNTING SOCIAL RI; Nicklett EJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-684; Norton JM, 2016, J AM SOC NEPHROL, V27, P2576, DOI 10.1681/ASN.2016010027; NYC Health, COVID 19 DAT 2020; NYC Health, SCH NON BUS CLOS 202; Paremoer L, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n129; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Robert Graham Center, SOC DEPR IND SDI; Ryvicker M, 2012, SOC SCI MED, V75, P914, DOI 10.1016/j.socscimed.2012.04.029; Saab FG, 2021, J GEN INTERN MED, V36, P1017, DOI 10.1007/s11606-020-06494-7; Shah GLH, 2020, J PUBLIC HEALTH MAN, V26, P317, DOI 10.1097/PHH.0000000000001200; Singu S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00406; United States Census Bureau, TIGER LIN SHAP 2020; US Census Bureau, AM COMMUNITY SURVEY; Viswanath K, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10862-1; Wadhera RK, 2020, JAMA-J AM MED ASSOC, V323, P2192, DOI 10.1001/jama.2020.7197; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Zhang YK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235064; Zhang YK, 2020, MED CARE, V58, P586, DOI 10.1097/MLR.0000000000001337	59	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255171	10.1371/journal.pone.0255171	http://dx.doi.org/10.1371/journal.pone.0255171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324574	Green Published, gold			2022-12-26	WOS:000685248200052
J	Condemi, S; Mazieres, S; Faux, P; Costedoat, C; Ruiz-Linares, A; Bailly, P; Chiaroni, J				Condemi, Silvana; Mazieres, Stephane; Faux, Pierre; Costedoat, Caroline; Ruiz-Linares, Andres; Bailly, Pascal; Chiaroni, Jacques			Blood groups of Neandertals and Denisova decrypted	PLOS ONE			English	Article							SEQUENCE VARIATION; GENOME SEQUENCE; HISTORY; FUT2; POLYMORPHISM; EVOLUTION; ANCESTRY; VARIANT; GENES; CAVE	Blood group systems were the first phenotypic markers used in anthropology to decipher the origin of populations, their migratory movements, and their admixture. The recent emergence of new technologies based on the decoding of nucleic acids from an individual's entire genome has relegated them to their primary application, blood transfusion. Thus, despite the finer mapping of the modern human genome in relation to Neanderthal and Denisova populations, little is known about red cell blood groups in these archaic populations. Here we analyze the available high-quality sequences of three Neanderthals and one Denisovan individuals for 7 blood group systems that are used today in transfusion (ABO including H/Se, Rh (Rhesus), Kell, Duffy, Kidd, MNS, Diego). We show that Neanderthal and Denisova were polymorphic for ABO and shared blood group alleles recurrent in modern Sub-Saharan populations. Furthermore, we found ABO-related alleles currently preventing from viral gut infection and Neanderthal RHD and RHCE alleles nowadays associated with a high risk of hemolytic disease of the fetus and newborn. Such a common blood group pattern across time and space is coherent with a Neanderthal population of low genetic diversity exposed to low reproductive success and with their inevitable demise. Lastly, we connect a Neanderthal RHD allele to two present-day Aboriginal Australian and Papuan, suggesting that a segment of archaic genome was introgressed in this gene in non-Eurasian populations. While contributing to both the origin and late evolutionary history of Neanderthal and Denisova, our results further illustrate that blood group systems are a relevant piece of the puzzle helping to decipher it.	[Condemi, Silvana; Mazieres, Stephane; Faux, Pierre; Costedoat, Caroline; Ruiz-Linares, Andres; Bailly, Pascal; Chiaroni, Jacques] Aix Marseille Univ, CNRS, EFS, ADES UMR 7268, Marseille, France; [Ruiz-Linares, Andres] UCL, Dept Genet Evolut & Environm, London, England; [Ruiz-Linares, Andres] UCL, UCL Genet Inst, London, England; [Ruiz-Linares, Andres] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai, Peoples R China; [Ruiz-Linares, Andres] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Shanghai, Peoples R China; [Ruiz-Linares, Andres] Fudan Univ, Human Phenome Inst, Shanghai, Peoples R China; [Bailly, Pascal; Chiaroni, Jacques] Etablissement Francais Sang PACA Corse, Biol Grps Sanguins, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; University of London; University College London; University of London; University College London; Fudan University; Fudan University; Fudan University	Condemi, S; Chiaroni, J (corresponding author), Aix Marseille Univ, CNRS, EFS, ADES UMR 7268, Marseille, France.; Chiaroni, J (corresponding author), Etablissement Francais Sang PACA Corse, Biol Grps Sanguins, Marseille, France.	silvana.condemi@univ-amu.fr; jacques.chiaroni@efs.sante.fr	Condemi, Silvana/ABE-2701-2021; Mazieres, Stephane/G-1702-2010; Chiaroni, Jacques/ABA-2944-2021	Condemi, Silvana/0000-0002-6516-0879; Mazieres, Stephane/0000-0003-1266-4659; Chiaroni, Jacques/0000-0002-3133-8990				Anstee DJ, 2010, BLOOD, V115, P4635, DOI 10.1182/blood-2010-01-261859; Bar-Yosef O, 1993, LITHIC ASSEMBLAGES U; Barreiro LB, 2020, HUM GENET, V139, P723, DOI 10.1007/s00439-020-02167-x; Begat C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132211; Bergstrom A, 2020, SCIENCE, V367, P1339, DOI 10.1126/science.aay5012; Bocquet-Appel JP, 2013, CURR ANTHROPOL, V54, pS202, DOI 10.1086/673725; Bokelmann L, 2019, P NATL ACAD SCI USA, V116, P15610, DOI 10.1073/pnas.1903984116; Carritt B, 1997, HUM MOL GENET, V6, P843, DOI 10.1093/hmg/6.6.843; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Choin J, 2021, NATURE, V592, P583, DOI 10.1038/s41586-021-03236-5; Clarkson C, 2017, NATURE, V547, P306, DOI 10.1038/nature22968; Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Degioanni A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216742; Deleers M, 2020, VOX SANG, V115, P451, DOI 10.1111/vox.12905; Denomme GA, 2005, TRANSFUSION, V45, P1554, DOI 10.1111/j.1537-2995.2005.00586.x; Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108; Fumagalli M, 2009, GENOME RES, V19, P199, DOI 10.1101/gr.082768.108; Gouy A, 2020, MOL BIOL EVOL, V37, P1420, DOI 10.1093/molbev/msz306; Groucutt HS, 2018, NAT ECOL EVOL, V2, P800, DOI 10.1038/s41559-018-0518-2; Gunther T, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008302; Jakobsen MA, 2014, TRANSFUSION, V54, P2463, DOI 10.1111/trf.12673; JAROLIM P, 1992, BLOOD, V80, P1592; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; Kitano T, 2012, MOL BIOL EVOL, V29, P1791, DOI 10.1093/molbev/mss021; Koda Y, 2003, HUM GENET, V113, P534, DOI 10.1007/s00439-003-1013-6; Kolobova KA, 2020, P NATL ACAD SCI USA, V117, P2879, DOI 10.1073/pnas.1918047117; Lalueza-Fox C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-342; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Mafessoni F, 2020, P NATL ACAD SCI USA, V117, P15132, DOI 10.1073/pnas.2004944117; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Moller M, 2016, BLOOD ADV, V1, P240, DOI 10.1182/bloodadvances.2016001867; MOORES P, 1994, VOX SANG, V66, P225, DOI 10.1111/j.1423-0410.1994.tb00314.x; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Nordgren J, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030226; Posth C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16046; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Rees JS, 2020, TRENDS GENET, V36, P415, DOI 10.1016/j.tig.2020.03.006; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reid M., 2012, BLOOD GROUP ANTIGEN, P758; Rios L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38571-1; Rogers AR, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay5483; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sawyer S, 2015, P NATL ACAD SCI USA, V112, P15696, DOI 10.1073/pnas.1519905112; Schoeman EM, 2019, TRANSFUSION, V59, P768, DOI 10.1111/trf.15047; Segurel L, 2013, BIOESSAYS, V35, P862, DOI 10.1002/bies.201300030; Slatkin M, 2016, P NATL ACAD SCI USA, V113, P6380, DOI 10.1073/pnas.1524306113; Sousa V, 2013, NAT REV GENET, V14, P404, DOI 10.1038/nrg3446; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tournamille C, 2004, IMMUNOGENETICS, V55, P682, DOI 10.1007/s00251-003-0633-2; Trinkaus E, 2018, P NATL ACAD SCI USA, V115, P11941, DOI 10.1073/pnas.1814989115; Van Blerkom LM, 2003, YEARB PHYS ANTHROPOL, V46, P14, DOI 10.1002/ajpa.10384; van der Poel WHM, 2000, EMERG INFECT DIS, V6, P36, DOI 10.3201/eid0601.000106; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Wagner FF, 2000, BLOOD, V95, P3662; Wagner FF, 2014, TRANSFUS MED HEMOTH, V41, P357, DOI 10.1159/000366176; Wall JD, 2019, NATURE, V576, P106, DOI 10.1038/s41586-019-1793-z; YAMAMOTO F, 1990, J BIOL CHEM, V265, P19257; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yip SP, 2002, ANN HUM GENET, V66, P1, DOI 10.1017/S0003480001008995	61	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254175	10.1371/journal.pone.0254175	http://dx.doi.org/10.1371/journal.pone.0254175			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CM	34320013	gold, Green Published, Green Submitted			2022-12-26	WOS:000685247800042
J	Allabadi, H; Alkaiyat, A; Zahdeh, T; Assadi, A; Ghanayim, A; Hasan, S; Abu Al Haj, D; Allabadi, L; Haj-Yahia, S; Schindler, C; Kwiatkowski, M; Zemp, E; Probst-Hensch, N				Allabadi, Hala; Alkaiyat, Abdulsalam; Zahdeh, Tamer; Assadi, Alaa; Ghanayim, Aya; Hasan, Shaden; Abu Al Haj, Dalia; Allabadi, Liana; Haj-Yahia, Salim; Schindler, Christian; Kwiatkowski, Marek; Zemp, Elisabeth; Probst-Hensch, Nicole			Posttraumatic stress disorder predicts poor health-related quality of life in cardiac patients in Palestine	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; DEPRESSION; SURVIVORS; RISK; COMORBIDITY; PREVALENCE; MORTALITY; SYMPTOMS; SURGERY	Background The longitudinal association of posttraumatic stress disorder (PTSD) with health-related quality of life (HRQL) in cardiac patients' remains poorly studied, particularly in conflict-affected settings. Materials and methods For this cohort study, we used baseline and one-year follow-up data collected from patients 30 to 80 years old consecutively admitted with a cardiac diagnosis to four major hospitals in Nablus, Palestine. All subjects were screened for PTSD and HRQL using the PTSD Checklist Specific and the HeartQoL questionnaire. We used a generalized structural equation model (GSEM) to examine the independent predictive association of PTSD at baseline with HRQL at follow-up. We also examined the mediating roles of depression, anxiety, and stress at baseline. Results The prevalence of moderate-to-high PTSD symptoms among 1022 patients at baseline was 27 center dot 0%. Patients with PTSD symptoms reported an approximate 20 center dot 0% lower HRQL at follow-up. The PTSD and HRQL relationship was largely mediated by depressive and anxiety symptoms. It was not materially altered by adjustment for socio-demographic, clinical, and lifestyle factors. Discussion Our findings suggest that individuals with a combination of PTSD and depression, or anxiety are potentially faced with poor HRQL as a longer-term outcome of their cardiac disease. In Palestine, psychological disorders are often stigmatized; however, integration of mental health care with cardiac care may offer an entry door for addressing psychological problems in the population. Further studies need to assess the effective mental health interventions for improving quality of life in cardiac patients.	[Allabadi, Hala; Alkaiyat, Abdulsalam; Schindler, Christian; Kwiatkowski, Marek; Zemp, Elisabeth; Probst-Hensch, Nicole] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Allabadi, Hala; Alkaiyat, Abdulsalam; Schindler, Christian; Kwiatkowski, Marek; Zemp, Elisabeth; Probst-Hensch, Nicole] Univ Basel, Basel, Switzerland; [Allabadi, Hala; Alkaiyat, Abdulsalam; Zahdeh, Tamer; Assadi, Alaa; Ghanayim, Aya; Hasan, Shaden; Abu Al Haj, Dalia] An Najah Natl Univ, Fac Med & Hlth Sci, Nablus, Palestine; [Allabadi, Liana] Arab Amer Univ, Fac Grad Studies, Ramallah, Palestine; [Haj-Yahia, Salim] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Haj-Yahia, Salim] Glasgow Univ, Inst Cardiovasc & Med Sci, 126 Univ Pl, Glasgow, Lanark, Scotland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; An Najah National University; Arab American University; University of Bristol; University of Glasgow	Probst-Hensch, N (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.; Probst-Hensch, N (corresponding author), Univ Basel, Basel, Switzerland.	nicole.probst@swisstph.ch			Swiss Government Excellence Fellowship for Foreign Scholars (ESKAS); Freiwillige Akademische Gesellschaft, Basel, Switzerland	Swiss Government Excellence Fellowship for Foreign Scholars (ESKAS); Freiwillige Akademische Gesellschaft, Basel, Switzerland	The study was funded by a Swiss Government Excellence Fellowship for Foreign Scholars (ESKAS) for the PhD student, HA, working on the project and by the Freiwillige Akademische Gesellschaft, Basel, Switzerland. The funders of the project took no part in the design of the study, data collection and analysis,	AbuRuz ME, 2018, J MULTIDISCIP HEALTH, V11, P367, DOI 10.2147/JMDH.S170327; Allabadi H, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6561-3; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bosworth HB, 1999, MED CARE, V37, P1226, DOI 10.1097/00005650-199912000-00006; Carney RM, 2008, AM J MED, V121, P20, DOI 10.1016/j.amjmed.2008.09.010; Cohen BE, 2009, ARCH GEN PSYCHIAT, V66, P1214, DOI 10.1001/archgenpsychiatry.2009.149; Danielsson FB, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0507-0; Dugani SB, 2020, ANGIOLOGY, V71, P17, DOI 10.1177/0003319719849737; Edmondson D, 2013, AM HEART J, V166, P806, DOI 10.1016/j.ahj.2013.07.031; Edmondson D, 2011, J PSYCHIATR RES, V45, P1621, DOI 10.1016/j.jpsychires.2011.07.004; Gamper G, 2004, CRIT CARE MED, V32, P378, DOI 10.1097/01.CCM.0000108880.97967.C0; Gander ML, 2006, EUR J CARDIOV PREV R, V13, P165, DOI 10.1097/01.hjr.0000214606.60995.46; Ginzburg K, 2003, J CLIN PSYCHIAT, V64, P1217, DOI 10.4088/JCP.v64n1012; Goldfinger JZ, 2014, J STROKE CEREBROVASC, V23, P1099, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.019; Gudmundsdottir B, 2004, DEPRESS ANXIETY, V20, P187, DOI 10.1002/da.20037; Guzelhan Yalcin, 2020, Arch Med Sci Atheroscler Dis, V5, pe27, DOI 10.5114/amsad.2020.94376; Johansson I, 2021, CIRCULATION, V143, P2129, DOI 10.1161/CIRCULATIONAHA.120.050850; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Lisy K, 2018, INT J EVID-BASED HEA, V16, P154, DOI 10.1097/XEB.0000000000000138; Liu L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145103; Lovebird SH L, 1995, MANUAL DEPRESSION AN, V2nd; Middel B, 2014, J CARDIOVASC NURS, V29, P544, DOI 10.1097/JCN.0b013e3182a102ae; Nygaard E, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-76; Oldridge N., 2012, HEARTQOL HEARTQOL; Pietrzak RH, 2011, PSYCHOSOM MED, V73, P697, DOI 10.1097/PSY.0b013e3182303775; ROTH GA, 2017, J AM COLL CARDIOL, V70, P1, DOI [DOI 10.1016/J.JACC.2017.04.052, DOI 10.1016/j.jacc.2017.04.052]; Rytwinski NK, 2013, J TRAUMA STRESS, V26, P299, DOI 10.1002/jts.21814; Shemesh E, 2001, GEN HOSP PSYCHIAT, V23, P215, DOI 10.1016/S0163-8343(01)00150-5; Sobel Richard M, 2005, Curr Psychiatry Rep, V7, P206, DOI 10.1007/s11920-005-0055-y; Stafford L, 2007, J PSYCHOSOM RES, V62, P401, DOI 10.1016/j.jpsychores.2006.12.009; Stoll C, 2000, J THORAC CARDIOV SUR, V120, P505, DOI 10.1067/mtc.2000.108162; Teixeira C, 2021, CHEST, V160, P157, DOI 10.1016/j.chest.2021.02.034; The American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4, P463; Tsai KY, 2007, J PSYCHIATR RES, V41, P90, DOI 10.1016/j.jpsychires.2005.10.004; Wiedemar L, 2008, HEART LUNG, V37, P113, DOI 10.1016/j.hrtlng.2007.03.005; Yuan K, 2021, MOL PSYCHIATR, V26, P4982, DOI 10.1038/s41380-021-01036-x	37	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255077	10.1371/journal.pone.0255077	http://dx.doi.org/10.1371/journal.pone.0255077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314470	Green Published, gold			2022-12-26	WOS:000685225200009
J	Hou, CX; Jiang, HY				Hou, Chunxia; Jiang, Huiyuan			Methodology of emergency medical logistics for multiple epidemic areas in public health emergency	PLOS ONE			English	Article							ALLOCATION; MODEL; NETWORK; DEMAND	Coronavirus disease 2019(COVID-19) has brought great disasters to humanity, and its influence continues to intensify. In response to the public health emergencies, prompt relief supplies are key to reduce the damage. This paper presents a method of emergency medical logistics to quick response to emergency epidemics. The methodology includes two recursive mechanisms: (1) the time-varying forecasting of medical relief demand according to a modified susceptible-exposed-infected- Asymptomatic- recovered (SEIAR) epidemic diffusion model, (2) the relief supplies distribution based on a multi-objective dynamic stochastic programming model. Specially, the distribution model addresses a hypothetical network of emergency medical logistics with considering emergency medical reserve centers (EMRCs), epidemic areas and e-commerce warehousing centers as the rescue points. Numerical studies are conducted. The results show that with the cooperation of different epidemic areas and e-commerce warehousing centers, the total cost is 6% lower than without considering cooperation of different epidemic areas, and 9.7% lower than without considering cooperation of e-commerce warehousing centers. Particularly, the total cost is 20% lower than without considering any cooperation. This study demonstrates the importance of cooperation in epidemic prevention, and provides the government with a new idea of emergency relief supplies dispatching, that the rescue efficiency can be improved by mutual rescue between epidemic areas in public health emergency.	[Hou, Chunxia; Jiang, Huiyuan] Wuhan Univ Technol, Sch Transportat & Logist Engn, Wuhan, Hubei, Peoples R China	Wuhan University of Technology	Hou, CX (corresponding author), Wuhan Univ Technol, Sch Transportat & Logist Engn, Wuhan, Hubei, Peoples R China.	570611532@qq.com						Akbarpour M, 2020, TRANSPORT RES E-LOG, V136, DOI 10.1016/j.tre.2020.101867; Arino J, 2008, J THEOR BIOL, V253, P118, DOI 10.1016/j.jtbi.2008.02.026; Buyuktahtakm IE, 2018, EUR J OPER RES, V265, P1046, DOI 10.1016/j.ejor.2017.08.037; Du Lijing, 2015, MULTIOBJECTIVE OPTIM; [葛洪磊 Ge Honglei], 2014, [系统工程理论与实践, Systems Engineering-Theory & Practice], V34, P3034; Govindan K, 2020, TRANSPORT RES E-LOG, V138, DOI 10.1016/j.tre.2020.101967; Haiyan Wang, 2009, International Journal of Mathematics in Operational Research, V1, P76, DOI 10.1504/IJMOR.2009.022876; He YX, 2015, TRANSPORT RES E-LOG, V79, P178, DOI 10.1016/j.tre.2015.04.007; [刘明 Liu Ming], 2020, [系统工程理论与实践, Systems Engineering-Theory & Practice], V40, P437; Liu Tian-hu, 2010, Computer Engineering and Applications, V46, P13, DOI 10.3778/j.issn.1002-8331.2010.29.004; Mete HO, 2010, INT J PROD ECON, V126, P76, DOI 10.1016/j.ijpe.2009.10.004; Ruan JH, 2015, INFORM SCIENCES, V303, P15, DOI 10.1016/j.ins.2015.01.002; Sheu JB, 2007, TRANSPORT RES E-LOG, V43, P687, DOI 10.1016/j.tre.2006.04.004; Sheu JB, 2014, TRANSPORT RES B-METH, V67, P284, DOI 10.1016/j.trb.2014.05.011; [苏兆品 SU Zhaopin], 2008, [系统工程理论与实践, Systems Engineering-Theory & Practice], V28, P118; Wang Hai-jun, 2012, Industrial Engineering and Management, V17, P16; Wang Y, 2021, KNOWL-BASED SYST, V223, DOI 10.1016/j.knosys.2021.107041; Wang Y, 2020, TRANSPORT RES E-LOG, V143, DOI 10.1016/j.tre.2020.102118; Wang Y, 2020, J CLEAN PROD, V258, DOI 10.1016/j.jclepro.2020.120590; Wang Y, 2017, J CLEAN PROD, V144, P203, DOI 10.1016/j.jclepro.2017.01.001; [王永奇 Wang Yongqi], 2017, [计算机工程与应用, Computer Engineering and Application], V53, P230; World Health Organization, WHO DIR GEN OP REM M; Xiang YS, 2016, ANN OPER RES, V236, P177, DOI 10.1007/s10479-014-1716-1; Yang B., 2013, J SYST MANAG, V4, P518, DOI [10.3969/j.issn.1005-2542.2013.04.012, DOI 10.3969/J.ISSN.1005-2542.2013.04.012]; Yarmand H, 2014, EUR J OPER RES, V233, P208, DOI 10.1016/j.ejor.2013.08.027; [詹沙磊 Zhan Shalei], 2013, [系统工程理论与实践, Systems Engineering-Theory & Practice], V33, P159; Zhang QX, 2015, THESIS U ELECT SCI T; Zhao Jian-you, 2020, Journal of Traffic and Transportation Engineering, V20, P168, DOI 10.19818/j.cnki.1671-1637.2020.03.016; [朱莉 Zhu Li], 2014, [系统科学与数学, Journal of Systems Science and Mathematical Sciences], V34, P663	29	0	0	26	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0253978	10.1371/journal.pone.0253978	http://dx.doi.org/10.1371/journal.pone.0253978			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310606	Green Published, gold			2022-12-26	WOS:000685224500014
J	Chrustek, A; Dombrowska-Pali, A; Olszewska-Slonina, D				Chrustek, Agnieszka; Dombrowska-Pali, Agnieszka; Olszewska-Slonina, Dorota			Analysis of the composition and antioxidant status of breast milk in women giving birth prematurely and on time	PLOS ONE			English	Article							FULL-TERM INFANTS; PRETERM; MOTHERS; LACTATION; CORTISOL	Background Breastfeeding with mother's milk is the best form of nutrition not only for newborn babies, but especially for premature babies, due to the health benefits of taking human food. Objectives The aim of the study was to examine the basic composition, cortisol concentration and antioxidant status of breast milk samples from women giving birth before 37 weeks of pregnancy and comparing it with milk samples from women giving birth after 37 weeks of pregnancy. Methods The material for the study was milk taken from women giving birth before and after 37 weeks of pregnancy. The basic composition of breast milk was determined using a MIRIS analyzer, cortisol concentration in samples by an enzyme-linked immunosorbent test and their total antioxidant status was assessed by DPPH and FRAP methods. Results It has been shown that the concentration of cortisol in samples of human milk in the group of women giving birth before 37 weeks was 13.95 ng / ml [4,71-86,84], while in the group of women giving birth after week 37 of pregnancy-10.31 ng / ml [2.35-39-02] (p = 0.014), while% inhibition of DPPH was 65.46% and 58.30%, respectively (p = 0.014). Conclusions Milk from women giving birth prematurely is qualitatively different from the milk of women giving birth on time. The total antioxidant status of preterm milk is higher than term milk, which promotes the development of premature babies. Higher cortisol levels in samples from women giving birth before 37 weeks of pregnancy may stimulate the digestive system.	[Chrustek, Agnieszka; Olszewska-Slonina, Dorota] Nicolaus Copernicus Univ Torun, L Rydygier Coll Med Bydgoszcz, Fac Pharm, Dept Pathobiochem & Clin Chem, Torun, Poland; [Dombrowska-Pali, Agnieszka] Nicolaus Copernicus Univ Torun, Coll Med Bydgoszcz, Fac Hlth Sci, Dept Perinatol Gynecol & Gynecol Oncol, Torun, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University	Chrustek, A (corresponding author), Nicolaus Copernicus Univ Torun, L Rydygier Coll Med Bydgoszcz, Fac Pharm, Dept Pathobiochem & Clin Chem, Torun, Poland.	agnieszka.chrustek@gmail.com	Olszewska-Słonina, Dorota M/E-2282-2014	Olszewska-Słonina, Dorota M/0000-0001-9742-451X; Dombrowska-Pali, Agnieszka/0000-0003-0785-8977; Chrustek, Agnieszka/0000-0003-2921-8399				Abuhandan M, 2015, IRAN J PEDIATR, V25, DOI 10.5812/ijp.2363; Agostoni C, 2009, J PEDIATR GASTR NUTR, V49, P112, DOI 10.1097/MPG.0b013e31819f1e05; Arslanoglu S, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00076; Atanassova M., 2011, J U CHEM TECHNOL MET, V46, P81; Bauer J, 2011, CLIN NUTR, V30, P215, DOI 10.1016/j.clnu.2010.08.003; BEIJERS RJW, 1992, EARLY HUM DEV, V29, P351, DOI 10.1016/0378-3782(92)90191-I; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; Feldman-Winter L, 2012, J HUM LACT, V28, P116, DOI 10.1177/0890334412442826; Freeze J, 2018, PROCEEDINGS OF THE 51ST ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES (HICSS), P913; Friel JK, 2011, PEDIATR RES, V69, P160, DOI 10.1203/PDR.0b013e3182042a07; Friel JK, 2002, PEDIATR RES, V51, P612, DOI 10.1203/00006450-200205000-00012; Gidrewicz DA, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-216; Gila-Diaz A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061307; GIULIANO AR, 1994, J NUTR BIOCHEM, V5, P551, DOI 10.1016/0955-2863(94)90054-X; Groer M W, 1994, J Perinat Neonatal Nurs, V7, P42; Hart S, 2004, INFANT BEHAV DEV, V27, P101, DOI 10.1016/j.infbeh.2003.06.002; Hinde K, 2015, BEHAV ECOL, V26, P269, DOI 10.1093/beheco/aru186; Horta B.L., 2013, LONG TERM EFFECTS BR; Horta BL., 2013, SHORT TERM EFFECTS B, V49; Hsu YC, 2014, PEDIATR NEONATOL, V55, P449, DOI 10.1016/j.pedneo.2014.03.002; Huysman MWA, 2000, PEDIATR RES, V48, P629, DOI 10.1203/00006450-200011000-00013; L'Abbe MR, 2000, J PEDIATR GASTR NUTR, V31, P270, DOI 10.1097/00005176-200009000-00013; Maly J, 2019, ARCH DIS CHILD-FETAL, V104, pF50, DOI 10.1136/archdischild-2016-312572; Ors R, 2013, J PEDIATR NEONATAL I, V2, P35, DOI 10.7363/020116; Quiles JL, 2006, FREE RADICAL RES, V40, P199, DOI 10.1080/10715760500404805; van der Voorn B, 2016, J NUTR, V146, P2174, DOI 10.3945/jn.116.236349; Wang W, 2014, INT CONF INSTR MEAS, P6, DOI 10.1109/IMCCC.2014.10; WHO, 2003, GLOB STRAT INF YOUNG; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Xavier AAO, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111654	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255252	10.1371/journal.pone.0255252	http://dx.doi.org/10.1371/journal.pone.0255252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297788	Green Published, gold			2022-12-26	WOS:000678128300005
J	Crossey, BP; Atherton, G; Cross, L				Crossey, Benjamin Philip; Atherton, Gray; Cross, Liam			Lost in the crowd: Imagining walking in synchrony with a crowd increases affiliation and deindividuation	PLOS ONE			English	Article							MENTAL PRACTICE; INTERPERSONAL SYNCHRONY; MOTOR IMAGERY; BEHAVIOR; SELF	Moving in time with others-interpersonal coordination-increases affiliation, helping behaviours and gives rise to a host of other prosocial outcomes. Recent research suggests that merely imagining coordination may lead to similar social effects. In the present study, participants were asked to imagine walking with a crowd in a coordinated (versus uncoordinated) way to explore the effects of imagined coordination on individuals' perceptions of themselves and the crowd. Imagined coordination led to greater levels of deindividuation and affiliation. That is, participants were less likely to report seeing themselves as unique individuals, instead viewing themselves as a part of a group (deindividuation) and more likely to report a sense of emotional closeness (affiliation) with the imagined group. Deindividuation partially mediated the effect of imagined coordination on affiliation. This work establishes that imagined synchrony can be employed online to foster prosocial attitudes towards groups of people, and that a process of deindividuation might mediate this effect.	[Crossey, Benjamin Philip] Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland; [Atherton, Gray; Cross, Liam] Edge Hill Univ, Dept Psychol, Liverpool, Merseyside, England	Queens University Belfast; Edge Hill University; University of Liverpool	Cross, L (corresponding author), Edge Hill Univ, Dept Psychol, Liverpool, Merseyside, England.	drliamcross@gmail.com		Atherton, Gray/0000-0002-3954-9127; cross, liam/0000-0002-5122-1650				Afrouzeh M, 2015, J SPORT MED PHYS FIT, V55, P30; [Anonymous], 2012, HEAD NECK PATHOL, V6, P135; Atherton G ., 2021, PSYCHOL STUD; Atherton G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216585; Beilenhoff U, 2007, ENDOSCOPY, V39, P175, DOI 10.1055/s-2006-945181; BIRD EI, 1984, PERCEPT MOTOR SKILL, V59, P899, DOI 10.2466/pms.1984.59.3.899; CANNAVAL.FJ, 1970, J PERS SOC PSYCHOL, V16, P141, DOI 10.1037/h0029837; CLARK LV, 1960, RES QUART, V31, P560, DOI 10.1080/10671188.1960.10613109; COFFMAN DD, 1990, J RES MUSIC EDUC, V38, P187, DOI 10.2307/3345182; Cohen EEA, 2010, BIOL LETTERS, V6, P106, DOI 10.1098/rsbl.2009.0670; Crisp RJ, 2012, ADV EXP SOC PSYCHOL, V46, P125, DOI 10.1016/B978-0-12-394281-4.00003-9; Crisp RJ, 2010, AM PSYCHOL, V65, P133, DOI 10.1037/a0018437; Crisp RJ, 2009, AM PSYCHOL, V64, P231, DOI 10.1037/a0014718; Cross L., 2019, OPEN PSYCHOL, V1, P273, DOI DOI 10.1515/PSYCH-2018-0018; Cross L., 2021, SCI REPORTS, V11, P1; Cross L, 2020, ACTA PSYCHOL, V206, DOI 10.1016/j.actpsy.2020.103062; Cross L, 2020, J SOC PSYCHOL, V160, P248, DOI 10.1080/00224545.2019.1623161; Cross L, 2021, CURR PSYCHOL, V40, P3393, DOI 10.1007/s12144-019-00283-0; Cross L, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01798; Crossey B. P., 2018, THESIS; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Durkheim E, 1965, ELEMENTARY FORMS REL; Fadiga L, 2004, J CLIN NEUROPHYSIOL, V21, P157, DOI 10.1097/00004691-200405000-00004; Good A, 2017, BASIC APPL SOC PSYCH, V39, P231, DOI 10.1080/01973533.2017.1337015; Guillot A., 2008, INT REV SPORT EXER P, V1, P31, DOI [10.1080/17509840701823139, DOI 10.1080/17509840701823139]; Guillot A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143331; Hardwick RM, 2018, NEUROSCI BIOBEHAV R, V94, P31, DOI 10.1016/j.neubiorev.2018.08.003; Herrera E, 2018, ETHNOMUSICOLOGY, V62, P470, DOI 10.5406/ethnomusicology.62.3.0470; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Hutter RRC, 2013, SOC PSYCHOL-GERMANY, V44, P239, DOI 10.1027/1864-9335/a000108; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Karremans JC, 2005, PERS SOC PSYCHOL B, V31, P1315, DOI 10.1177/0146167205274892; Kilintari M, 2016, BRAIN RES, V1646, P249, DOI 10.1016/j.brainres.2016.06.009; Kuhnen U, 2000, EUR J SOC PSYCHOL, V30, P799; Lakens D, 2011, SOC COGNITION, V29, P1, DOI 10.1521/soco.2011.29.1.1; LATANE B, 1969, AM SCI, V57, P244; Le Bon Gustave, 1895, CROWD STUDY POPULAR; McNeill W. H., 1995, KEEPING TOGETHER TIM; Mogan R, 2017, J EXP SOC PSYCHOL, V72, P13, DOI 10.1016/j.jesp.2017.03.009; Pearce E, 2016, PSYCHOL MUSIC, V44, P1255, DOI 10.1177/0305735616636208; Pilgramm S, 2016, HUM BRAIN MAPP, V37, P81, DOI 10.1002/hbm.23015; Reddish P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071182; Reicher S. D., 1995, EUROPEAN REV SOCIAL, V6, P161, DOI DOI 10.1080/14792779443000049; Rennung M, 2016, Z PSYCHOL, V224, P168, DOI 10.1027/2151-2604/a000252; SUINN RM, 1972, BEHAV THER, V3, P519, DOI 10.1016/S0005-7894(72)80191-6; Turner J.C., 1987, REDISCOVERING SOCIAL; Utz S, 2004, SELF IDENTITY, V3, P177, DOI 10.1080/13576500444000001; Vandell R., 1943, J HUM MOVEMENT STUD, V14, P31, DOI [10.1080/00221309.1943.10544442, DOI 10.1080/00221309.1943.10544442]; Vesper C, 2014, NEUROPSYCHOLOGIA, V55, P115, DOI 10.1016/j.neuropsychologia.2013.05.024; Vicaria IM, 2016, J NONVERBAL BEHAV, V40, P335, DOI 10.1007/s10919-016-0238-8; Wiltermuth S, 2012, SOC INFLUENCE, V7, P78, DOI 10.1080/15534510.2012.658653; Wiltermuth SS, 2012, J EXP SOC PSYCHOL, V48, P453, DOI 10.1016/j.jesp.2011.10.007; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Woolhouse MH, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00167; Woolhouse MH, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00965	55	0	0	11	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254017	10.1371/journal.pone.0254017	http://dx.doi.org/10.1371/journal.pone.0254017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TQ2PW	34297728	Green Published, gold			2022-12-26	WOS:000678128300065
J	Miura, K; Katsumata, Y; Kawakami, T; Ikura, H; Ryuzaki, T; Shiraishi, Y; Fukui, S; Kawakami, M; Kohno, T; Sato, K; Fukuda, K				Miura, Kotaro; Katsumata, Yoshinori; Kawakami, Takashi; Ikura, Hidehiko; Ryuzaki, Toshinobu; Shiraishi, Yasuyuki; Fukui, Shogo; Kawakami, Michiyuki; Kohno, Takashi; Sato, Kazuki; Fukuda, Keiichi			Exercise tolerance and quality of life in hemodynamically partially improved patients with chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty	PLOS ONE			English	Article							RIGHT-VENTRICULAR FUNCTION; FOLLOW-UP; PROGNOSIS; ENDARTERECTOMY	The efficacy of extensive balloon pulmonary angioplasty (BPA) beyond hemodynamic improvement in chronic thromboembolic pulmonary hypertension (CTEPH) patients has been verified. However, the relationship between extensive BPA in CTEPH patients after partial hemodynamic improvement and exercise tolerance or quality of life (QOL) remains unclear. We prospectively enrolled 22 CTEPH patients (66 +/- 10 years, females: 59%) when their mean pulmonary artery pressure initially decreased to <30 mmHg during BPA sessions. Hemodynamic and echocardiographic data, cardiopulmonary exercise testing, and QOL scores using the 36-item short form questionnaire (SF-36) were evaluated at enrollment (entry), just after the final BPA session (finish), and at the 6-month follow-up (follow-up). We analyzed whether extensive BPA improves exercise capacity and QOL scores over time. Moreover, the clinical characteristics leading to improvement were elucidated. The peak oxygen uptake (VO2) showed significant improvement at entry, finish, and follow-up (17.3 +/- 5.5, 18.4 +/- 5.9, and 18.9 +/- 5.3 mL/kg/min, respectively; P<0.001). Regarding the QOL, the physical component summary (PCS) scores significantly improved (32 +/- 11, 38 +/- 13, and 43 +/- 13, respectively; P<0.001), but the mental component summary scores remained unchanged. Linear regression analysis revealed that age and a low peak VO2 at entry were predictors of improvement in peak VO2, while low PCS scores and low TAPSE at entry were predictors of improvement in PCS scores. In conclusion, extensive BPA led to improved exercise tolerance and physical QOL scores, even in CTEPH patients with partially improved hemodynamics.	[Miura, Kotaro; Katsumata, Yoshinori; Kawakami, Takashi; Ikura, Hidehiko; Ryuzaki, Toshinobu; Shiraishi, Yasuyuki; Fukuda, Keiichi] Keio Univ, Dept Cardiol, Sch Med, Tokyo, Japan; [Miura, Kotaro; Katsumata, Yoshinori; Ikura, Hidehiko; Ryuzaki, Toshinobu; Shiraishi, Yasuyuki; Sato, Kazuki] Keio Univ, Inst Integrated Sports Med, Sch Med, Tokyo, Japan; [Fukui, Shogo; Kawakami, Michiyuki] Keio Univ Hosp, Dept Rehabil Med, Tokyo, Japan; [Kohno, Takashi] Kyorin Univ, Dept Cardiovasc Med, Sch Med, Mitaka, Tokyo, Japan	Keio University; Keio University; Keio University; Kyorin University	Katsumata, Y (corresponding author), Keio Univ, Dept Cardiol, Sch Med, Tokyo, Japan.; Katsumata, Y (corresponding author), Keio Univ, Inst Integrated Sports Med, Sch Med, Tokyo, Japan.	goodcentury21@gmail.com	Kawakami, Michiyuki/AAY-6325-2020	Miura, Kotaro/0000-0002-0351-6008				Andreassen AK, 2013, HEART, V99, P1415, DOI 10.1136/heartjnl-2012-303549; Aoki T, 2016, CIRC J, V80, P2227, DOI 10.1253/circj.CJ-16-0254; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Cenedese E, 2006, EUR RESPIR J, V28, P808, DOI 10.1183/09031936.06.00130405; CLARK AL, 1992, J AM COLL CARDIOL, V20, P1326, DOI 10.1016/0735-1097(92)90244-H; Darocha S, 2017, CIRC J, V81, P552, DOI 10.1253/circj.CJ-16-1075; Delcroix M, 2016, CIRCULATION, V133, P859, DOI 10.1161/CIRCULATIONAHA.115.016522; Feinstein JA, 2001, CIRCULATION, V103, P10; Francis DP, 2000, EUR HEART J, V21, P154, DOI 10.1053/euhj.1999.1863; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Fukui S, 2015, INT J CARDIOL, V180, P66, DOI 10.1016/j.ijcard.2014.11.187; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Gaskill SE, 2001, MED SCI SPORT EXER, V33, P1841, DOI 10.1097/00005768-200111000-00007; Hoeper MM, 2014, LANCET RESP MED, V2, P573, DOI 10.1016/S2213-2600(14)70089-X; Hoeper MM, 2006, CIRCULATION, V113, P2011, DOI 10.1161/CIRCULATIONAHA.105.602565; Jais X, 2008, J AM COLL CARDIOL, V52, P2127, DOI 10.1016/j.jacc.2008.08.059; Kataoka M, 2012, CIRC-CARDIOVASC INTE, V5, P756, DOI 10.1161/CIRCINTERVENTIONS.112.971390; Kawakami T, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003318; Kimura M, 2017, CAN J CARDIOL, V33, P463, DOI 10.1016/j.cjca.2016.12.003; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Madani M, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0105-2017; Madani M, 2016, ANN AM THORAC SOC, V13, pS240, DOI 10.1513/AnnalsATS.201601-014AS; Mathai SC, 2016, EUR RESPIR J, V48, P526, DOI 10.1183/13993003.01626-2015; McCabe C, 2013, CHEST, V144, P522, DOI 10.1378/chest.12-2443; Mizoguchi H, 2012, CIRC-CARDIOVASC INTE, V5, P748, DOI 10.1161/CIRCINTERVENTIONS.112.971077; Moriyama H, 2018, INT J CARDIOVAS IMAG, V34, P875, DOI 10.1007/s10554-017-1296-7; Nishimura R, 2013, CIRC J, V77, P2110, DOI 10.1253/circj.CJ-12-1391; Piazza G, 2011, NEW ENGL J MED, V364, P351, DOI 10.1056/NEJMra0910203; Pilla CB, 2008, PEDIATR CARDIOL, V29, P409, DOI 10.1007/s00246-007-9145-4; Rehman MB, 2018, EUR HEART J-CARD IMG, V19, P185, DOI 10.1093/ehjci/jex002; RIEDEL M, 1982, CHEST, V81, P151, DOI 10.1378/chest.81.2.151; Shinkura Y, 2018, EUROINTERVENTION, V13, P2060, DOI 10.4244/EIJ-D-17-00157; Simonneau G, 2015, EUR RESPIR J, V45, P1293, DOI 10.1183/09031936.00087114; Sugimura K, 2012, CIRC J, V76, P485, DOI 10.1253/circj.CJ-11-1217; Suntharalingam J, 2008, CHEST, V134, P229, DOI 10.1378/chest.07-2681; Takei M, 2019, HEART VESSELS, V34, P868, DOI 10.1007/s00380-018-1306-2; Tamada N, 2018, JACC-CARDIOVASC INTE, V11, P1114, DOI 10.1016/j.jcin.2018.02.030; Wang H, 2019, HEART LUNG CIRC, V28, P1655, DOI 10.1016/j.hlc.2018.09.002	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255180	10.1371/journal.pone.0255180	http://dx.doi.org/10.1371/journal.pone.0255180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297758	gold, Green Published			2022-12-26	WOS:000678128300048
J	Yun, U; Lee, SA; Choi, WA; Kang, SW; Seo, GH; Lee, JH; Park, G; Lee, S; Choi, YC; Park, HJ				Yun, UnKyu; Lee, Seung-Ah; Choi, Won Ah; Kang, Seong-Woong; Seo, Go Hun; Lee, Jung Hwan; Park, Goeun; Lee, Sujee; Choi, Young-Chul; Park, Hyung Jun			Clinical and genetic spectra in patients with dystrophinopathy in Korea: A single-center study	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; DMD GENE; STANDARDS; DELETIONS; DATABASE; PRODUCT; CDNA	Dystrophinopathy is a group of inherited phenotypes arising from pathogenic variants in DMD. We evaluated the clinical and genetic characteristics of Korean patients with genetically confirmed dystrophinopathy. We retrospectively reviewed medical records (January 2004-September 2020) from the myopathy database maintained at the study hospital and found 227 patients from 218 unrelated families with dystrophinopathy. Clinical phenotypes included 120 (53%) Duchenne muscular dystrophy (DMD) cases, 20 (9%) intermediate phenotype muscular dystrophy (IMD) cases, 65 (29%) Becker muscular dystrophy (BMD) cases, 18 (8%) undetermined phenotypes, and 4 (2%) symptomatic carriers. The median ages at symptom onset and diagnosis were 5.0 years (interquartile range [IQR]: 3.8-8.0) and 12.0 years (IQR: 7.0-21.0), respectively. Total manual muscle test (MMT) scores decreased annually in patients with DMD, IMD, and BMD. Overall, when age increased by 1 year, total MMT scores decreased on average by -1.978, -1.681, and -1.303 in patients with DMD (p<0.001), IMD (p<0.001), and BMD (p<0.001), respectively. Exonic deletion and duplication were reported in 147 (67%) and 31 (14%) of the 218 unrelated probands, respectively. A total of 37 different small sequence variants were found in 40 (18%) of the 218 probands. The reading frame rule was applicable to 142 (94%) of the 151 probands. The present results highlight the long-term natural history and genetic spectrum of dystrophinopathy in a large-scale Korean cohort.	[Yun, UnKyu] Bucheon Sejong Hosp, Dept Neurol, Bucheon, South Korea; [Lee, Seung-Ah; Choi, Young-Chul; Park, Hyung Jun] Yonsei Univ, Gangnam Severance Hosp, Rehabil Inst Neuromuscular Dis, Dept Neurol,Coll Med, Seoul, South Korea; [Choi, Won Ah; Kang, Seong-Woong] Yonsei Univ, Gangnam Severance Hosp, Rehabil Inst Neuromuscular Dis, Dept Rehabil,Coll Med, Seoul, South Korea; [Seo, Go Hun] 3billion Inc, Div Med Genet, Seoul, South Korea; [Lee, Jung Hwan] Catholic Univ Korea, Coll Med, Dept Neurol, Seoul St Marys Hosp, Seoul, South Korea; [Park, Goeun; Lee, Sujee] Yonsei Univ, Biostat Collaborat Unit, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Catholic University of Korea; Seoul St. Mary's Hospital; Yonsei University; Yonsei University Health System	Park, HJ (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Rehabil Inst Neuromuscular Dis, Dept Neurol,Coll Med, Seoul, South Korea.	hjpark316@yuhs.ac		Choi, Young-Chul/0000-0001-5525-6861; Park, Hyung Jun/0000-0003-4165-8901; Kang, Seong-Woong/0000-0002-7279-3893	Yonsei University College of Medicine [3-20200127]	Yonsei University College of Medicine(General Electric)	This study was supported by a new faculty research seed money grant of Yonsei University College of Medicine for 2020 (3-20200127). The funder provided support in the form of salaries for authors [S.A.L., W.A.C., S.W.K., G.P, S. L. Y.C.C. and H.J.P], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; BUSHBY KMD, 1992, J INHERIT METAB DIS, V15, P551, DOI 10.1007/BF01799614; Cho A, 2017, MUSCLE NERVE, V55, P727, DOI 10.1002/mus.25396; Clemens PR, 2020, JAMA NEUROL, V77, P982, DOI 10.1001/jamaneurol.2020.1264; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; Frank DE, 2020, NEUROLOGY, V94, pE2270, DOI 10.1212/WNL.0000000000009233; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ishikawa Y, 2011, NEUROMUSCULAR DISORD, V21, P47, DOI 10.1016/j.nmd.2010.09.006; Juan-Mateu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135189; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUNKEL LM, 1989, CLIN CHEM, V35, pB21; Lee SH, 2015, J CLIN NEUROL, V11, P248, DOI 10.3988/jcn.2015.11.3.248; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Na SJ, 2013, J CLIN NEUROSCI, V20, P1099, DOI 10.1016/j.jocn.2012.09.021; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sejerson T, 2009, ADV EXP MED BIOL, V652, P13, DOI 10.1007/978-90-481-2813-6_2; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; Vengalil S, 2017, J CLIN NEUROL, V13, P91, DOI 10.3988/jcn.2017.13.1.91; Wagner KR, 2021, MUSCLE NERVE, V64, P285, DOI 10.1002/mus.27347; WINNARD AV, 1995, AM J HUM GENET, V56, P158; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255011	10.1371/journal.pone.0255011	http://dx.doi.org/10.1371/journal.pone.0255011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297739	Green Published, gold			2022-12-26	WOS:000678128300004
J	Hermena, EW; Juma, EJ; AlJassmi, M				Hermena, Ehab W.; Juma, Eida J.; AlJassmi, Maryam			Parafoveal processing of orthographic, morphological, and semantic information during reading Arabic: A boundary paradigm investigation	PLOS ONE			English	Article							SIMILARITY EFFECTS OCCUR; EYE-MOVEMENT CONTROL; PLAUSIBILITY PREVIEW BENEFIT; VISUAL WORD RECOGNITION; INTEGRATING INFORMATION; PHONOLOGICAL CODES; PRINTED WORD; ENGLISH; MODEL; DECOMPOSITION	Evidence shows that skilled readers extract information about upcoming words in the parafovea. Using the boundary paradigm, we investigated native Arabic readers' processing of orthographic, morphological, and semantic information available parafoveally. Target words were embedded in frame sentences, and prior to readers fixating them, one of the following previews were made available: (a) Identity preview; (b) Preview that shared the pattern morpheme with the target; (c) Preview that shared the root morpheme with the target; (d) Preview that was a synonym with the target word; (e) Preview with two of the root letters were transposed thus creating a new root, while preserving all letter identities of the target; (f) Preview with two of the root letters were transposed thus creating a pronounceable pseudo root, while also preserving all letter identities of the target; and (g) Previews that was unrelated to the target word and shared no information with it. The results showed that identity, root-preserving, and synonymous preview conditions yielded preview benefit. On the other hand, no benefit was obtained from the pattern-preserving previews, and significant disruption to processing was obtained from the previews that contained transposed root letters, particularly when this letter transposition created a new real root. The results thus reflect Arabic readers' dependance on morphological and semantic information, and suggest that these levels of representation are accessed as early as orthographic information. Implications for theory- and model-building, and the need to accommodate early morphological and semantic processing activities in more comprehensive models are further discussed.	[Hermena, Ehab W.; Juma, Eida J.; AlJassmi, Maryam] Zayed Univ, Coll Nat & Hlth Sci, Dept Psychol, Cognit & Neurosci Res Lab, Dubai, U Arab Emirates	Zayed University	Hermena, EW (corresponding author), Zayed Univ, Coll Nat & Hlth Sci, Dept Psychol, Cognit & Neurosci Res Lab, Dubai, U Arab Emirates.	Ehab.Hermena@zu.ac.ae	Hermena, Ehab W./ABF-8078-2021	Hermena, Ehab W./0000-0002-3338-7980	Zayed University, UAE [RIF R17035]	Zayed University, UAE	EWH was awarded grant RIF R17035 from Zayed University, UAE, https://www.zu.ac.ae/main/en/index.aspx The university had no role in the study design, data collection, decision to publish or preparing the manuscript.	Abu-Rabia S, 2001, READ WRIT, V14, P39, DOI 10.1023/A:1008147606320; Altarriba J, 2001, PERCEPT PSYCHOPHYS, V63, P875, DOI 10.3758/BF03194444; Andrews S, 2019, LANG LINGUIST COMPAS, V13, DOI 10.1111/lnc3.12344; Ashby J, 2006, J EXP PSYCHOL LEARN, V32, P416, DOI 10.1037/0278-7393.32.2.416; BAILEY IL, 1980, AM J OPTOM PHYS OPT, V57, P378; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bertram Raymond, 2007, P391, DOI 10.1016/B978-008044980-7/50019-7; Boudelaa S, 2005, LANG COGNITIVE PROC, V20, P207, DOI 10.1080/01690960444000106; Boudelaa S, 2004, BRAIN LANG, V90, P106, DOI 10.1016/S0093-934X(03)00424-3; Boudelaa S, 2001, COGNITION, V81, P65, DOI 10.1016/S0010-0277(01)00119-6; Boudelaa S., 2000, P SWAP WORKSH SPOK W, VVol. 1, P23; Boudelaa S., 2014, HDB ARABIC LITERACY, P31, DOI [10.1007/978-94-017-8545-7_2, DOI 10.1007/978-94-017-8545-7_2]; Boudelaa S, 2019, J EXP PSYCHOL HUMAN, V45, P729, DOI 10.1037/xhp0000621; Boudelaa S, 2015, LANG COGN NEUROSCI, V30, P955, DOI 10.1080/23273798.2015.1048258; Boudelaa S, 2011, LANG COGNITIVE PROC, V26, P624, DOI 10.1080/01690965.2010.521022; Boudelaa S, 2010, BEHAV RES METHODS, V42, P481, DOI 10.3758/BRM.42.2.481; Boudelaa S, 2010, J COGNITIVE NEUROSCI, V22, P998, DOI 10.1162/jocn.2009.21273; Brysbaert M, 2001, MEM COGNITION, V29, P765, DOI 10.3758/BF03200479; Brysbaert M, 2019, J MEM LANG, V109, DOI 10.1016/j.jml.2019.104047; Christianson K, 2005, J EXP PSYCHOL LEARN, V31, P1327, DOI 10.1037/0278-7393.31.6.1327; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Davis C.J., 1999, THESIS U NEW S WALES; Davis CJ, 2004, J EXP PSYCHOL HUMAN, V30, P923, DOI 10.1037/0096-1523.30.5.923; Davis CJ, 2010, PSYCHOL REV, V117, P713, DOI 10.1037/a0019738; Davis CJ, 2006, J EXP PSYCHOL HUMAN, V32, P535, DOI 10.1037/0096-1523.32.3.535; Deutsch A, 2000, LANG COGNITIVE PROC, V15, P487, DOI 10.1080/01690960050119670; Deutsch A, 1998, J EXP PSYCHOL LEARN, V24, P1238, DOI 10.1037/0278-7393.24.5.1238; Deutsch A, 2005, LANG COGNITIVE PROC, V20, P341, DOI 10.1080/01690960444000115; Deutsch A, 2003, PSYCHON B REV, V10, P415, DOI 10.3758/BF03196500; Deutsch A, 2018, Q J EXP PSYCHOL, V71, P85, DOI 10.1080/17470218.2016.1250788; Dunabeitia JA, 2007, COGNITION, V105, P691, DOI 10.1016/j.cognition.2006.12.001; Fitzsimmons G, 2011, PSYCHON B REV, V18, P736, DOI 10.3758/s13423-011-0105-x; Frost R, 2005, J EXP PSYCHOL LEARN, V31, P1293, DOI 10.1037/0278-7393.31.6.1293; Frost R, 1997, J EXP PSYCHOL LEARN, V23, P829, DOI 10.1037/0278-7393.23.4.829; Frost R, 2000, J EXP PSYCHOL LEARN, V26, P751, DOI 10.1037/0278-7393.26.3.751; Frost R, 1998, PSYCHOL BULL, V123, P71, DOI 10.1037/0033-2909.123.1.71; Frost R, 2000, MEM COGNITION, V28, P1277, DOI 10.3758/BF03211828; Frost R., 2009, CHILDREN LEARN READ, P235, DOI DOI 10.4324/9780203838006; Frost R, 2012, BEHAV BRAIN SCI, V35, P263, DOI 10.1017/S0140525X11001841; Grainger J, 2004, TRENDS COGN SCI, V8, P58, DOI 10.1016/j.tics.2003.11.006; Gwilliams L, 2015, BRAIN LANG, V147, P1, DOI 10.1016/j.bandl.2015.04.006; Harm MW, 2004, PSYCHOL REV, V111, P662, DOI 10.1037/0033-295X.111.3.662; HENDERSON JM, 1995, J EXP PSYCHOL HUMAN, V21, P82, DOI 10.1037/0096-1523.21.1.82; Hermena EW, 2020, LANG LINGUIST COMPAS, V14, DOI 10.1111/lnc3.12400; Hermena EW, 2019, J EXP PSYCHOL LEARN, V45, P934, DOI 10.1037/xlm0000626; Hermena EW, 2017, J EXP PSYCHOL LEARN, V43, P451, DOI 10.1037/xlm0000319; Hermena EW, 2016, J EXP PSYCHOL HUMAN, V42, P2021, DOI 10.1037/xhp0000294; Hermena EW, 2015, J EXP PSYCHOL HUMAN, V41, P494, DOI 10.1037/xhp0000032; Hohenstein S, 2014, J EXP PSYCHOL LEARN, V40, P166, DOI 10.1037/a0033670; Hohenstein S, 2010, J EXP PSYCHOL LEARN, V36, P1150, DOI 10.1037/a0020233; Holes Clive, 2004, MODERN ARABIC STRUCT; Hy?n? J., 2011, OXFORD HDB EYE MOVEM, P819, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0045; Hyona J, 2005, SCAND J PSYCHOL, V46, P475, DOI 10.1111/j.1467-9450.2005.00479.x; Ibrahim R, 2005, J PSYCHOLINGUIST RES, V34, P51, DOI 10.1007/s10936-005-3631-8; Johnson RL, 2007, J EXP PSYCHOL HUMAN, V33, P209, DOI 10.1037/0096-1523.33.1.209; Johnson RL, 2012, J EXP PSYCHOL HUMAN, V38, P191, DOI 10.1037/a0025983; Juhasz BJ, 2008, J EXP PSYCHOL HUMAN, V34, P1560, DOI 10.1037/a0012319; Kambe G, 2004, PERCEPT PSYCHOPHYS, V66, P279, DOI 10.3758/BF03194879; Kinoshita S, 2009, J EXP PSYCHOL LEARN, V35, P1, DOI 10.1037/a0014277; Ktori M, 2014, J COGN PSYCHOL, V26, P491, DOI 10.1080/20445911.2014.922092; Laubrock J, 2012, BEHAV BRAIN SCI, V35, P292, DOI 10.1017/S0140525X12000209; Lo S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01171; MATIN E, 1974, PSYCHOL BULL, V81, P899, DOI 10.1037/h0037368; Miellet S, 2004, BRAIN LANG, V90, P299, DOI 10.1016/S0093-934X(03)00442-5; Mountaj N, 2015, INT J PSYCHOPHYSIOL, V95, P46, DOI 10.1016/j.ijpsycho.2014.12.009; Pagan A, 2016, J EXP PSYCHOL LEARN, V42, P411, DOI 10.1037/xlm0000175; Paterson KB, 2015, PSYCHON B REV, V22, P1443, DOI 10.3758/s13423-015-0809-4; Perea M, 2004, J MEM LANG, V51, P231, DOI 10.1016/j.jml.2004.05.005; Perea M., 2003, MASKED PRIMING STATE, P97, DOI DOI 10.4324/9780203502846; Perea M, 2008, LANG COGNITIVE PROC, V23, P69, DOI 10.1080/01690960701578146; Perea M, 2006, EXP PSYCHOL, V53, P308, DOI 10.1027/1618-3169.53.4.308; Perea M, 2006, Q J EXP PSYCHOL, V59, P1600, DOI 10.1080/17470210500298880; Perea M, 2011, Q J EXP PSYCHOL, V64, P902, DOI 10.1080/17470218.2010.512088; Perea M, 2010, PSYCHON B REV, V17, P375, DOI 10.3758/PBR.17.3.375; Perea M, 2008, EXP PSYCHOL, V55, P384, DOI 10.1027/1618-3169.55.6.384; POLLATSEK A, 1992, J EXP PSYCHOL HUMAN, V18, P148, DOI 10.1037/0096-1523.18.1.148; Prunet JF, 2000, LINGUIST INQ, V31, P609, DOI 10.1162/002438900554497; R Core Team, 2020, R LANG ENV STAT COMP; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1981, Q J EXP PSYCHOL-A, V33, P351, DOI 10.1080/14640748108400798; Rayner K, 2006, PSYCHOL SCI, V17, P192, DOI 10.1111/j.1467-9280.2006.01684.x; RAYNER K, 1978, J EXP PSYCHOL HUMAN, V4, P529, DOI 10.1037/0096-1523.4.4.529; RAYNER K, 1986, CAN J PSYCHOL, V40, P473, DOI 10.1037/h0080111; RAYNER K, 1975, COGNITIVE PSYCHOL, V7, P65, DOI 10.1016/0010-0285(75)90005-5; RAYNER K, 1982, PERCEPT PSYCHOPHYS, V31, P537, DOI 10.3758/BF03204186; Rayner K, 2014, J EXP PSYCHOL HUMAN, V40, P1617, DOI 10.1037/a0036763; Rayner K, 2014, PSYCHON B REV, V21, P1067, DOI 10.3758/s13423-014-0582-9; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reichle E.D., 2020, COMPUTATIONAL MODELS; Reingold EM, 2012, COGNITIVE PSYCHOL, V65, P177, DOI 10.1016/j.cogpsych.2012.03.001; Saiegh-Haddad E, 2018, J LEARN DISABIL-US, V51, P454, DOI 10.1177/0022219417720460; Schmidtke D, 2018, J EXP PSYCHOL LEARN, V44, P421, DOI 10.1037/xlm0000442; Schoonbaert S, 2004, LANG COGNITIVE PROC, V19, P333, DOI 10.1080/01690960344000198; Schotter ER, 2018, PSYCHOL LEARN MOTIV, V68, P263, DOI 10.1016/bs.plm.2018.08.011; Schotter ER, 2016, J EXP PSYCHOL LEARN, V42, P1839, DOI 10.1037/xlm0000281; Schotter ER, 2015, J MEM LANG, V83, P118, DOI 10.1016/j.jml.2015.04.005; Schotter ER, 2013, J MEM LANG, V69, P619, DOI 10.1016/j.jml.2013.09.002; Schotter ER, 2012, ATTEN PERCEPT PSYCHO, V74, P5, DOI 10.3758/s13414-011-0219-2; Schulz E., 2004, STUDENT GRAMMAR MODE; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; Shimron J., 2006, READING HEBREW LANGU; STRAIN E, 1995, J EXP PSYCHOL LEARN, V21, P1140, DOI 10.1037/0278-7393.21.5.1140; Taft M, 2004, Q J EXP PSYCHOL-A, V57, P745, DOI 10.1080/02724980343000477; VANORDEN GC, 1990, PSYCHOL REV, V97, P488, DOI 10.1037/0033-295X.97.4.488; Velan H, 2007, PSYCHON B REV, V14, P913, DOI 10.3758/BF03194121; Velan H, 2013, J EXP PSYCHOL HUMAN, V39, P1143, DOI 10.1037/a0031075; Velan H, 2009, J MEM LANG, V61, P285, DOI 10.1016/j.jml.2009.05.003; Veldre A, 2020, COGNITION, V197, DOI 10.1016/j.cognition.2020.104184; Veldre A, 2018, Q J EXP PSYCHOL, V71, P64, DOI 10.1080/17470218.2016.1247894; Veldre A, 2017, PSYCHON B REV, V24, P519, DOI 10.3758/s13423-016-1120-8; Veldre A, 2016, J EXP PSYCHOL HUMAN, V42, P939, DOI 10.1037/xhp0000200; Veldre A, 2016, J EXP PSYCHOL LEARN, V42, P837, DOI 10.1037/xlm0000212; von der Malsburg T, 2017, J MEM LANG, V94, P119, DOI 10.1016/j.jml.2016.10.003; Whitney C, 2001, PSYCHON B REV, V8, P221, DOI 10.3758/BF03196158; Whitney C, 2008, LANG COGNITIVE PROC, V23, P824, DOI 10.1080/01690960701828202; Whitney C, 2008, LANG COGNITIVE PROC, V23, P143, DOI 10.1080/01690960701579771; Yan M, 2009, PSYCHON B REV, V16, P561, DOI 10.3758/PBR.16.3.561; Yang JM, 2014, VIS COGN, V22, P193, DOI 10.1080/13506285.2014.890689; Yang JM, 2012, READ WRIT, V25, P1031, DOI 10.1007/s11145-010-9281-8	120	2	2	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0254745	10.1371/journal.pone.0254745	http://dx.doi.org/10.1371/journal.pone.0254745			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TT3IC	34339439	gold, Green Published			2022-12-26	WOS:000680243400035
J	Zhang, HL; Zhao, B; Han, W; Sun, YB; Yang, P; Chen, YJ; Ni, D; Zhang, J; Yin, DM				Zhang, Hai-Long; Zhao, Bing; Han, Wei; Sun, Yi-Bei; Yang, Pin; Chen, Yongjun; Ni, Duan; Zhang, Jian; Yin, Dong-Min			Acetylation of calmodulin regulates synaptic plasticity and fear learning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; HISTONE ACETYLATION; NMDA RECEPTORS; INDUCED LTP; PHOSPHORYLATION; KINASE; MECHANISMS; CAMKII; MEMORY; ACTIVATION	Synaptic plasticity is critical for brain function, including learning and memory. It is regulated by gene transcription and protein synthesis as well as posttranslational modifications at synapses. Although protein acetylation has been shown to be involved in the regulation of synaptic plasticity, this was mainly for histone protein acetylation. To investigate whether acetylation of nonhistone proteins is important for synaptic plasticity, we analyzed mouse brain acetylome and found that calmodulin (CaM), a ubiquitous Ca2+ sensor, was acetylated on three lysine residues, which were conserved across species. NMDA receptor-dependent long-term potentiation (LTP) is considered the most compelling form of synaptic plasticity. During LTP induction, activation of NMDA receptor triggers Ca2+ influx, and the Ca2+ binds with CaM and activates calcium/calmodulin-dependent protein kinase II alpha (CaMKII alpha), which is essential for LTP induction. By using home-generated and site-specific antibodies against acetylated CaM, we show that CaM acetylation is upregulated by neural activities in an NMDA receptor-dependent manner. Moreover, mutation of acetyllysines in CaM1 proteins disrupts synaptic plasticity and fear learning in a mouse model. We further demonstrate that acetylation of CaM reduces the binding free energy and increases the binding affinity toward CaMKII alpha, a protein kinase pivotal to synaptic plasticity and learning. Taken together, our results demonstrate importance of CaM acetylation in regulating synaptic plasticity and learning.	[Zhang, Hai-Long; Zhao, Bing; Han, Wei; Sun, Yi-Bei; Yang, Pin; Yin, Dong-Min] East China Normal Univ, Sch Life Sci, Minist Educ & Shanghai, Key Lab Brain Funct Genom, Shanghai, Peoples R China; [Zhang, Hai-Long] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, Suzhou, Peoples R China; [Zhang, Hai-Long] Soochow Univ, Inst Neurosci, Suzhou, Peoples R China; [Chen, Yongjun] Guangzhou Univ Chinese Med, Med Coll Acu Moxi & Rehabil, Guangzhou, Peoples R China; [Ni, Duan; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med SJTU SM, Dept Pharm, Key Lab Cell Differentiat & Apoptosis Chinese,Min, Shanghai, Peoples R China; [Ni, Duan; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med SJTU SM, Fundamental Res Ctr, Renji Hosp, Shanghai, Peoples R China	East China Normal University; Soochow University - China; Soochow University - China; Guangzhou University of Chinese Medicine; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yin, DM (corresponding author), East China Normal Univ, Sch Life Sci, Minist Educ & Shanghai, Key Lab Brain Funct Genom, Shanghai, Peoples R China.	dmyin@brain.ecnu.edu.cn	Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X; Yin, Dongmin/0000-0001-9329-050X; Ni, Duan/0000-0002-3902-2843; Zhang, Hai-Long/0000-0002-8720-2734				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BIBER A, 1984, EXP BRAIN RES, V56, P323; Biever A, 2019, CURR OPIN NEUROBIOL, V57, P141, DOI 10.1016/j.conb.2019.02.008; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CHEUNG WY, 1980, SCIENCE, V207, P19, DOI 10.1126/science.6243188; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Coba MP, 2019, CURR OPIN STRUC BIOL, V54, P86, DOI 10.1016/j.sbi.2019.01.003; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Grunwald ME, 1999, P NATL ACAD SCI USA, V96, P13444, DOI 10.1073/pnas.96.23.13444; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hansen BK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09024-0; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kim WB, 2017, NEURON, V95, P1129, DOI 10.1016/j.neuron.2017.08.004; Kitchen P, 2020, CELL, V181, P784, DOI 10.1016/j.cell.2020.03.037; KLEE CB, 1980, ANNU REV BIOCHEM, V49, P489, DOI 10.1146/annurev.bi.49.070180.002421; Kouvaros S, 2016, HIPPOCAMPUS, V26, P1542, DOI 10.1002/hipo.22655; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Marks CR, 2018, MOL PHARMACOL, V94, P1352, DOI 10.1124/mol.118.113142; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; MEANS AR, 1980, NATURE, V285, P73, DOI 10.1038/285073a0; Mielcarek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080849; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Narita T, 2019, NAT REV MOL CELL BIO, V20, P156, DOI 10.1038/s41580-018-0081-3; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Parra V, 2017, J MOL CELL CARDIOL, V103, P121, DOI 10.1016/j.yjmcc.2016.12.006; PATTON BL, 1993, MOL BIOL CELL, V4, P159, DOI 10.1091/mbc.4.2.159; Penn AC, 2017, NATURE, V549, P384, DOI 10.1038/nature23658; Perfitt TL, 2020, J NEUROSCI, V40, P2000, DOI 10.1523/JNEUROSCI.0893-19.2020; Quinn JJ, 2005, HIPPOCAMPUS, V15, P665, DOI 10.1002/hipo.20088; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Saito K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009935; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shonesy BC, 2014, PROG MOL BIOL TRANSL, V122, P61, DOI 10.1016/B978-0-12-420170-5.00003-9; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Swaminathan PD, 2012, CIRC RES, V110, P1661, DOI 10.1161/CIRCRESAHA.111.243956; Takemoto K, 2017, NAT BIOTECHNOL, V35, P38, DOI 10.1038/nbt.3710; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wang G, 2017, CELL REP, V20, P1335, DOI 10.1016/j.celrep.2017.07.030; WATTERSON DM, 1980, J BIOL CHEM, V255, P962; West PJ, 2014, EPILEPSIA, V55, P214, DOI 10.1111/epi.12524; Wu D, 2017, NATURE, V544, P316, DOI 10.1038/nature21720; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yao X, 2018, DEV CELL, V45, P526, DOI 10.1016/j.devcel.2018.04.021; Yu Y, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.594332; Zhang HL, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101044; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	76	4	4	4	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101034	10.1016/j.jbc.2021.101034	http://dx.doi.org/10.1016/j.jbc.2021.101034			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	34339735	gold, Green Published			2022-12-26	WOS:000706361700008
J	Oppong, D; Panpipat, W; Chaijan, M				Oppong, David; Panpipat, Worawan; Chaijan, Manat			Chemical, physical, and functional properties of Thai indigenous brown rice flours	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; PHYSICOCHEMICAL PROPERTIES; STARCH DIGESTIBILITY; PHENOLIC-COMPOUNDS; PASTING PROPERTIES; SWEET-POTATO; WHEAT-FLOUR; FT-IR; WATER; EXTRACTION	Thai indigenous brown rice flours from Nakhon Si Thammarat, Thailand, namely Khai Mod Rin (KMRF) and Noui Khuea (NKRF), were assessed for quality aspects in comparison with brown Jasmine rice flour (JMRF) and commercial rice flour (CMRF) from Chai Nat 1 variety. All the rice flours had different chemical composition, physical characteristic, and techno-functionality. The KMRF, NKRF, and JMRF were classified as a low amylose type (19.56-21.25% dw). All rice flours had low total extractable phenolic content (0.1-0.3 mg GAE/g dw) with some DPPH? scavenging activity (38.87-46.77%). The variations in the bulk density (1.36-1.83 g/cm(3)), water absorption capacity (0.71-1.17 g/g), solubility (6.93-13.67%), oil absorption capacity (1.39-2.49 g/g), and swelling power (5.71-6.84 g/g) were noticeable. The least gelation concentration ranged from 4.0 to 8.0% where KMRF was easier to form gel than JMRF, and NKRF/CMRF. The foam capacity of the flours was relatively low (1.30-2.60%). The pasting properties differed among rice flours and the lowest pasting temperature was observed in CMRF. Overall, the chemical, physical, functional, and pasting qualities of flours were substantially influenced by rice variety. The findings offered fundamental information on Thai indigenous rice flour that can be used in food preparations for specific uses.	[Oppong, David; Panpipat, Worawan; Chaijan, Manat] Walailak Univ, Sch Agr Technol & Food Ind, Food Technol & Innovat Res Ctr Excellence, Thasala, Nakhon Si Thamm, Thailand	Walailak University	Chaijan, M (corresponding author), Walailak Univ, Sch Agr Technol & Food Ind, Food Technol & Innovat Res Ctr Excellence, Thasala, Nakhon Si Thamm, Thailand.	cmanat@wu.ac.th			Walailak University, Thailand [MOE 57 19 00/144/2562]; Walailak University, Thailand	Walailak University, Thailand; Walailak University, Thailand	This research was funded by Walailak University, Thailand through the Ph.D. Scholarship for Outstanding International Students, grant number [MOE 57 19 00/144/2562]. This research was also financially supported by the new strategic research project (P2P), Walailak University, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi FF., 2017, INNOV TECHNOL AGR, V1, P32; Akubor P.I., 2012, INT J BIOSCI, V2, P19; Anugrahati NA, 2017, AGRITECH, V37, P77, DOI 10.22146/agritech.10669; Aoac, 1997, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; Appiah F., 2011, Agriculture and Biology Journal of North America, V2, P773, DOI 10.5251/abjna.2011.2.5.773.779; Balindong JL, 2018, J CEREAL SCI, V79, P35, DOI 10.1016/j.jcs.2017.09.008; Banchuen J., 2010, Songklanakarin Journal of Science and Technology, V32, P219; Baxter G, 2004, J CEREAL SCI, V40, P205, DOI 10.1016/j.jcs.2004.07.004; Baxter G, 2014, J CEREAL SCI, V60, P414, DOI 10.1016/j.jcs.2014.05.002; Baxter G, 2010, CEREAL CHEM, V87, P250, DOI 10.1094/CCHEM-87-3-0250; Blazek J, 2008, CARBOHYD POLYM, V71, P380, DOI 10.1016/j.carbpol.2007.06.010; Bryngelsson S, 2002, J AGR FOOD CHEM, V50, P1890, DOI 10.1021/jf011222z; Chaijan M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237844; Chaiwanichsiri S., 2012, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V3, P150; Ciulu M, 2018, MOLECULES, V23, DOI 10.3390/molecules23112890; Devi G. N., 2015, J RICE RES, V8, P23; Ekanayake EWMDS., 2018, NUTR FOOD SCI INT J, V6; Ellepola SW, 2005, INT J BIOL MACROMOL, V37, P12, DOI 10.1016/j.ijbiomac.2005.07.008; Falade KO, 2015, FOOD HYDROCOLLOID, V44, P478, DOI 10.1016/j.foodhyd.2014.10.005; Flores-Morales A, 2012, CARBOHYD POLYM, V87, P61, DOI 10.1016/j.carbpol.2011.07.011; Gonzalez-Perez S, 2009, WOODHEAD PUBL FOOD S, P383, DOI 10.1533/9781845695873.383; Goufo P, 2014, FOOD SCI NUTR, V2, P75, DOI 10.1002/fsn3.86; Goula AM, 2008, DRY TECHNOL, V26, P726, DOI 10.1080/07373930802046377; Hsu RJC, 2015, J CEREAL SCI, V61, P1, DOI 10.1016/j.jcs.2014.03.002; Islam M. Z., 2012, The Agriculturists, V10, P20; Iwe M. O., 2016, Cogent Food & Agriculture, V2, DOI 10.1080/23311932.2016.1142409; Jamal S., 2016, P PAK ACAD SCI, V53, P47; Jang SJ, 2009, J AGR FOOD CHEM, V57, P858, DOI 10.1021/jf803113c; Jideani IA, 2011, J FOOD SCI TECH MYS, V48, P251, DOI 10.1007/s13197-010-0208-9; Joshi AU, 2015, LWT-FOOD SCI TECHNOL, V60, P325, DOI 10.1016/j.lwt.2014.08.038; Ju ZY, 2001, J FOOD SCI, V66, P229, DOI 10.1111/j.1365-2621.2001.tb11322.x; JULIANO BO, 1992, CEREAL FOOD WORLD, V37, P772; Kaur M, 2017, RICE SCI, V24, P349, DOI 10.1016/j.rsci.2017.08.002; Klunklin W, 2018, INT J FOOD SCI TECH, V53, P1962, DOI 10.1111/ijfs.13785; Kraithong S, 2018, J CEREAL SCI, V79, P259, DOI 10.1016/j.jcs.2017.10.015; Lai VMF, 2007, FOOD CHEM, V101, P1205, DOI 10.1016/j.foodchem.2006.03.024; Limsuwanmanee J, 2014, LWT-FOOD SCI TECHNOL, V57, P718, DOI 10.1016/j.lwt.2014.01.042; Lohumi S, 2014, J AGR FOOD CHEM, V62, P9246, DOI 10.1021/jf500574m; Maisuthisakul P, 2014, INT J FOOD PROP, V17, P855, DOI 10.1080/10942912.2012.685677; Mpofu A, 2006, J AGR FOOD CHEM, V54, P1265, DOI 10.1021/jf052683d; Muntana N, 2010, Pak J Biol Sci, V13, P170, DOI 10.3923/pjbs.2010.170.174; Navaratne SB., 2013, EUR INT J SCI TECHNO, V2, P1; Ofoedu CE, 2021, PEERJ, V9, DOI 10.7717/peerj.10968; Oko A O, 2010, INT J BIOTECHNOL BIO, V6, P949; Osundahunsi OF, 2003, J AGR FOOD CHEM, V51, P2232, DOI 10.1021/jf0260139; Pongjanta J, 2016, FUNCT FOODS HEALTH D, V6, P133; Puncha-arnon S, 2013, CARBOHYD POLYM, V91, P85, DOI 10.1016/j.carbpol.2012.08.006; Qin KeXin, 2014, Journal of Northeast Agricultural University (English Edition), V21, P60; Rao RSP, 2004, FOOD CHEM, V84, P527, DOI 10.1016/S0308-8146(03)00274-7; Ravichanthiran K, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7060071; Rosniyana A., 2016, Journal of Tropical Agriculture and Food Science, V44, P147; Saleh ASM, 2019, COMPR REV FOOD SCI F, V18, P1070, DOI 10.1111/1541-4337.12449; Sapna I, 2019, J FOOD SCI TECH MYS, V56, P273, DOI 10.1007/s13197-018-3487-1; SHAHIDI F, 1992, CRIT REV FOOD SCI, V32, P67, DOI 10.1080/10408399209527581; Sompong R, 2011, FOOD CHEM, V124, P132, DOI 10.1016/j.foodchem.2010.05.115; Suliman M. A., 2006, PAK J NUTR, V5, P589; Sungpud C, 2020, INT FOOD RES J, V27, P111; Suresh Chandra, 2013, African Journal of Agricultural Research, V8, P4849; Tabilo-Munizaga G, 2005, J FOOD ENG, V67, P147, DOI 10.1016/j.jfoodeng.2004.05.062; Thomas R., 2013, International Food Research Journal, V20, P1345; Thomas R, 2014, FOOD SCI TECHNOL RES, V20, P469, DOI 10.3136/fstr.20.469; Ti HH, 2015, RSC ADV, V5, P101507, DOI 10.1039/c5ra15963f; Tsakama M., 2010, AFRI J FOOD SCI TECH, V1, P90; Walter M, 2011, BRAZ ARCH BIOL TECHN, V54, P371, DOI 10.1590/S1516-89132011000200020; Yadav BS, 2014, LWT-FOOD SCI TECHNOL, V57, P352, DOI 10.1016/j.lwt.2013.12.042; Ye LX, 2016, J CEREAL SCI, V70, P270, DOI 10.1016/j.jcs.2016.07.007; Ye LX, 2016, INT J FOOD ENG, V12, P537, DOI 10.1515/ijfe-2015-0346; Yuan TZ, 2021, FOOD CHEM, V344, DOI 10.1016/j.foodchem.2020.128616; Zhang YF, 2019, FOOD HYDROCOLLOID, V91, P136, DOI 10.1016/j.foodhyd.2019.01.015; Zhao GH, 2018, LWT-FOOD SCI TECHNOL, V87, P450, DOI 10.1016/j.lwt.2017.09.016	70	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255694	10.1371/journal.pone.0255694	http://dx.doi.org/10.1371/journal.pone.0255694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343208	gold, Green Published			2022-12-26	WOS:000685264200004
J	Yuan, SK; Zhang, PT; Wen, LQ; Jia, SK; Wu, YF; Zhang, ZL; Guan, LZ; Yu, ZQ; Zhao, L				Yuan, Shukai; Zhang, Peitao; Wen, Liqi; Jia, Shikai; Wu, Yufan; Zhang, Zhenlei; Guan, Lizhao; Yu, Zhengquan; Zhao, Li			miR-22 promotes stem cell traits via activating Wnt/beta-catenin signaling in cutaneous squamous cell carcinoma	ONCOGENE			English	Article							COMPREHENSIVE CLINICOPATHOLOGICAL CLASSIFICATION; TUMOR-INITIATING CELLS; TGF-BETA; CANCER; SUPPRESSOR; TARGETS	Emerging evidence suggests that the cancer stem cells (CSCs) are key culprits of cancer metastasis and drug resistance. Understanding mechanisms regulating the critical oncogenic pathways and CSCs function could reveal new diagnostic and therapeutic strategies. We now report that miR-22, a miRNA critical for hair follicle stem/progenitor cell differentiation, promotes tumor initiation, progression, and metastasis by maintaining Wnt/beta-catenin signaling and CSCs function. Mechanistically, we find that miR-22 facilitates beta-catenin stabilization through directly repressing citrullinase PAD2. Moreover, miR-22 also relieves DKK1-mediated repression of Wnt/beta-catenin signaling by targeting a FosB-DDK1 transcriptional axis. miR-22 knockout mice showed attenuated Wnt/beta-catenin activity and Lgr5(+) CSCs penetrance, resulting in reduced occurrence, progression, and metastasis of chemically induced cutaneous squamous cell carcinoma (cSCC). Clinically, miR-22 is abundantly expressed in human cSCC. Its expression is even further elevated in the CSCs proportion, which negatively correlates with PAD2 and FosB expression. Inhibition of miR-22 markedly suppressed cSCC progression and increased chemotherapy sensitivity in vitro and in xenograft mice. Together, our results revealed a novel miR-22-WNT-CSCs regulatory mechanism in cSCC and highlight the important clinical application prospects of miR-22, a common target molecule for Wnt/beta-catenin signaling and CSCs, for patient stratification and therapeutic intervention.	[Yuan, Shukai; Wen, Liqi; Jia, Shikai; Wu, Yufan; Zhang, Zhenlei; Guan, Lizhao; Zhao, Li] Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Sch Basic Med Sci,Dept Biochem & Mol Biol, Natl Clin Res Ctr Canc,Key Lab Canc Prevent & The, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Zhang, Peitao] Tianjin Med Univ Gen Hosp, Dept Nucl Med, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Yu, Zhengquan] China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, 2 Yuanmingyuan West Rd, Beijing 100094, Peoples R China	Tianjin Medical University; Tianjin Medical University; China Agricultural University	Zhao, L (corresponding author), Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Sch Basic Med Sci,Dept Biochem & Mol Biol, Natl Clin Res Ctr Canc,Key Lab Canc Prevent & The, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	shzhaoli@tmu.edu.cn			National Natural Science Foundation of China [81872235, 81702710]; Tianjin Municipal Science and Technology Commission [17JCQNJC11200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission	This research work was supported by grants from the National Natural Science Foundation of China (81872235 to LZ, 81702710 to SY) and The Tianjin Municipal Science and Technology Commission (17JCQNJC11200 to SY).	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Cammareri P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12493; Cassarino DS, 2006, J CUTAN PATHOL, V33, P191, DOI 10.1111/j.0303-6987.2006.00516_1.x; Cassarino DS, 2006, J CUTAN PATHOL, V33, P261, DOI 10.1111/j.0303-6987.2006.00516.x; da Silva-Diz V, 2016, CANCER RES, V76, P1245, DOI 10.1158/0008-5472.CAN-15-1631; Garcia-Sancha N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092181; Ge YJ, 2016, NAT CELL BIOL, V18, P111, DOI 10.1038/ncb3275; Goldie SJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092201; Han MZ, 2020, BRAIN, V143, P512, DOI 10.1093/brain/awz406; Hussein NA, 2017, J CANCER RES CLIN, V143, P83, DOI 10.1007/s00432-016-2248-7; Jafarzadeh-Samani Z, 2017, CHIN CLIN ONCOL, V6, DOI 10.21037/cco.2017.03.01; Jian Z, 2017, J INVEST DERMATOL, V137, P31, DOI 10.1016/j.jid.2016.07.033; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Latil M, 2017, CELL STEM CELL, V20, P191, DOI 10.1016/j.stem.2016.10.018; Li S, 2018, ONCOGENE, V37, P884, DOI 10.1038/onc.2017.381; Lohcharoenkal W, 2016, J INVEST DERMATOL, V136, P2485, DOI 10.1016/j.jid.2016.06.630; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mizrahi A, 2018, ONCOGENE, V37, P218, DOI 10.1038/onc.2017.315; Ordonez-Moran P, 2015, CANCER CELL, V28, P815, DOI 10.1016/j.ccell.2015.11.001; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Patel GK, 2012, J INVEST DERMATOL, V132, P401, DOI 10.1038/jid.2011.317; Qu Y, 2018, NAT CHEM BIOL, V14, P94, DOI [10.1038/NCHEMBIO.2510, 10.1038/nchembio.2510]; Que SKT, 2018, J AM ACAD DERMATOL, V78, P237, DOI 10.1016/j.jaad.2017.08.059; Ra SH, 2011, MODERN PATHOL, V24, P963, DOI 10.1038/modpathol.2011.39; Riemondy K, 2015, ELIFE, V4, DOI 10.7554/eLife.07004; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Sanchez-Danes A, 2018, NATURE, V562, P434, DOI 10.1038/s41586-018-0603-3; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Shao YX, 2019, CLIN LAB, V65, P491, DOI 10.7754/Clin.Lab.2018.180825; Sherwood V, 2016, J INVEST DERMATOL, V136, P1760, DOI 10.1016/j.jid.2016.05.108; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Sun RF, 2019, FASEB J, V33, P5411, DOI 10.1096/fj.201801798RR; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Wang DP, 2019, ONCOL LETT, V17, P3355, DOI 10.3892/ol.2019.10011; Wang X, 2014, BIOCHEM BIOPH RES CO, V445, P175, DOI 10.1016/j.bbrc.2014.01.160; Yuan SK, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005253	39	9	9	2	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 30	2021	40	39					5799	5813		10.1038/s41388-021-01973-5	http://dx.doi.org/10.1038/s41388-021-01973-5		AUG 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UZ8WB	34345013	Green Published, hybrid			2022-12-26	WOS:000681523500003
J	Du, SC; Yang, Z; Lu, XF; Yousuf, S; Zhao, M; Li, WX; Miao, J; Wang, XZ; Yu, H; Zhu, XY; Chen, H; Shi, LS; Xu, E; Xia, XF; Guan, WX				Du, Shangce; Yang, Zhi; Lu, Xiaofeng; Yousuf, Suhail; Zhao, Min; Li, Wenxi; Miao, Ji; Wang, Xingzhou; Yu, Heng; Zhu, Xinya; Chen, Hong; Shi, Linseng; Xu, En; Xia, Xuefeng; Guan, Wenxian			Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBP beta-mediated PDGFB autocrine and paracrine signaling	ONCOGENE			English	Article							TUMOR ANGIOGENESIS; MOLECULAR PATHWAYS; SURVIVAL; DETACHMENT; AUTOPHAGY; GROWTH; AXIS	Anoikis is a type of programmed cell death induced by loss of anchorage to the extracellular matrix (ECM). Anoikis resistance (AR) is crucial for the survival of metastatic cancer cells in blood, lymphatic circulation and distant organs. Compared to ordinary cancer cells, anoikis resistant cancer cells undergo various cellular and molecular alterations, probably characterizing the cells with unique features not limited to anoikis resistance. However, the molecular mechanisms connecting anoikis resistance to other metastatic properties are still poorly understood. Here, the biological interaction between anoikis resistance and angiogenesis as well as their involvement into peritoneal metastasis of gastric cancer (GC) were investigated in vitro and in vivo. The prognostic value of key components involved in this interaction was evaluated in the GC cohort. Compared to ordinary GC cells, GC(AR) cells exhibited stronger metastatic and pro-angiogenic traits corresponding to elevated PDGFB secretion. Mechanistically, transcription factor C/EBP beta facilitated PDGFB transcription by directly binding to and interacting with PDGFB promoter elements, subsequently increasing PDGFB secretion. Secreted PDGFB promoted the survival of detached GC cells through a C/EBP beta-dependent self-feedback loop. Moreover, secreted PDGFB promoted angiogenesis in metastases via activation of the MAPK/ERK signaling pathway in vascular endothelial cells. Both C/EBP beta activation level and PDGFB expression were significantly elevated in GC and correlated with metastatic progression and poor prognosis of patients with GC. Overall, interaction between GC(AR) cells and vascular endothelial cells promotes angiogenesis and peritoneal metastasis of GC based on C/EBP beta-mediated PDGFB autocrine and paracrine signaling. C/EBP beta-PDGFB-PDGFR beta-MAPK axis promises to be potential prognostic biomarkers and therapeutic targets for peritoneal metastasis of GC.	[Du, Shangce; Yang, Zhi; Lu, Xiaofeng; Zhao, Min; Yu, Heng; Zhu, Xinya; Chen, Hong; Shi, Linseng; Guan, Wenxian] Nanjing Med Univ, Dept Gastrointestinal Surg, Drum Tower Clin Med Coll, Nanjing, Peoples R China; [Du, Shangce; Yang, Zhi; Lu, Xiaofeng; Miao, Ji; Wang, Xingzhou; Xu, En; Xia, Xuefeng; Guan, Wenxian] Nanjing Univ, Dept Gastrointestinal Surg, Nanjing Drum Tower Hosp, Affiliated Hosp,Med Sch, Nanjing, Peoples R China; [Yousuf, Suhail] Heidelberg Univ Hosp, Dept Surg, Heidelberg, Germany; [Li, Wenxi] Heidelberg Univ, Fac Med, Heidelberg, Germany	Nanjing Medical University; Nanjing University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Guan, WX (corresponding author), Nanjing Med Univ, Dept Gastrointestinal Surg, Drum Tower Clin Med Coll, Nanjing, Peoples R China.; Xu, E; Xia, XF; Guan, WX (corresponding author), Nanjing Univ, Dept Gastrointestinal Surg, Nanjing Drum Tower Hosp, Affiliated Hosp,Med Sch, Nanjing, Peoples R China.	657416504@qq.com; danielxuefeng@hotmail.com; 15850502391@163.com						Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Avivar-Valderas A, 2013, ONCOGENE, V32, P4932, DOI 10.1038/onc.2012.512; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chen N, 2013, AUTOPHAGY, V9, P1214, DOI 10.4161/auto.24870; Chen X, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.11.019; Cheng P, 2019, MOL THER-NUCL ACIDS, V18, P155, DOI 10.1016/j.omtn.2019.08.013; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; Du SC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0953-7; Eddy RJ, 2017, TRENDS CELL BIOL, V27, P595, DOI 10.1016/j.tcb.2017.03.003; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Haemmerle M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00411-z; Hong SH, 2013, GASTRIC CANCER, V16, P290, DOI 10.1007/s10120-012-0182-1; Hosaka K, 2016, P NATL ACAD SCI USA, V113, pE5618, DOI 10.1073/pnas.1608384113; Hosaka K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3129; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jin K, 2017, J PATHOL, V241, P567, DOI 10.1002/path.4871; Jin LT, 2018, MOL CELL, V69, P87, DOI 10.1016/j.molcel.2017.11.025; Jitariu AA, 2018, CRIT REV ONCOL HEMAT, V131, P46, DOI 10.1016/j.critrevonc.2018.08.002; Kastana P, 2019, METHODS MOL BIOL, V1952, P219, DOI 10.1007/978-1-4939-9133-4_18; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Kirsch M, 2004, CANC TREAT, V117, P285; Kitadai Yasuhiko, 2011, Cancers (Basel), V3, P4245, DOI 10.3390/cancers3044245; Kuczynski EA, 2019, NAT REV CLIN ONCOL, V16, P469, DOI 10.1038/s41571-019-0181-9; La Porta S, 2018, J CLIN INVEST, V128, P834, DOI 10.1172/JCI94674; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu TR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05982-z; Liu Y, 2016, CANCER CELL, V30, P668, DOI 10.1016/j.ccell.2016.09.011; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Ma WH, 2018, THERANOSTICS, V8, P5744, DOI 10.7150/thno.28898; Mazzone M, 2019, ANNU REV PHYSIOL, V81, P535, DOI 10.1146/annurev-physiol-020518-114721; McLean MIH, 2014, NAT REV GASTRO HEPAT, V11, P664, DOI 10.1038/nrgastro.2014.143; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pontes-Quero S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09875-7; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shah MA, 2015, J CLIN ONCOL, V33, P1760, DOI 10.1200/JCO.2014.60.1799; Shen XF, 2018, J ALLERGY CLIN IMMUN, V141, P1929, DOI 10.1016/j.jaci.2018.01.005; Strilic B, 2017, CANCER CELL, V32, P282, DOI 10.1016/j.ccell.2017.07.001; Tamura A, 2017, BLOOD, V130, P1809, DOI 10.1182/blood-2017-03-772962; Thomassen I, 2014, INT J CANCER, V134, P622, DOI 10.1002/ijc.28373; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang SY, 2013, GUT, V62, P496, DOI 10.1136/gutjnl-2011-301522; Wang SH, 2019, J PATHOL, V248, P204, DOI 10.1002/path.5246; Wang XH, 2019, CLIN CANCER RES, V25, P3128, DOI 10.1158/1078-0432.CCR-18-2804; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Xu Yong Zhong, 2013, Methods Mol Biol, V977, P79, DOI 10.1007/978-1-62703-284-1_7; Xue Y, 2012, NAT MED, V18, P100, DOI 10.1038/nm.2575; Yonemura Yutaka, 2003, Surg Oncol Clin N Am, V12, P635, DOI 10.1016/S1055-3207(03)00035-8; Zabielska-Koczywas K, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1114-4; Zhang Y, 2004, J BIOL CHEM, V279, P48342, DOI 10.1074/jbc.M407953200; Zhang YY, 2012, BIOCHEM BIOPH RES CO, V419, P550, DOI 10.1016/j.bbrc.2012.02.058	58	10	10	1	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 23	2021	40	38					5764	5779		10.1038/s41388-021-01988-y	http://dx.doi.org/10.1038/s41388-021-01988-y		AUG 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UU4CG	34341514				2022-12-26	WOS:000680382100002
J	Ducrot, C; Bourque, MJ; Delmas, CVL; Racine, AS; Bello, DG; Delignat-Lavaud, B; Lycas, MD; Fallon, A; Michaud-Tardif, C; Nanni, SB; Herborg, F; Gether, U; Nanci, A; Takahashi, H; Parent, M; Trudeau, LE				Ducrot, Charles; Bourque, Marie-Josee; Delmas, Constantin V. L.; Racine, Anne-Sophie; Guadarrama Bello, Dainelys; Delignat-Lavaud, Benoit; Domenic Lycas, Matthew; Fallon, Aurelie; Michaud-Tardif, Charlotte; Burke Nanni, Samuel; Herborg, Freja; Gether, Ulrik; Nanci, Antonio; Takahashi, Hideto; Parent, Martin; Trudeau, Louis-Eric			Dopaminergic neurons establish a distinctive axonal arbor with a majority of non-synaptic terminals	FASEB JOURNAL			English	Article						active zone; axon terminals; dopamine; exocytosis; synapse; volume transmission	PRESYNAPTIC ACTIVE ZONES; GLUTAMATE CORELEASE; ULTRASTRUCTURAL-LOCALIZATION; TYROSINE-HYDROXYLASE; NEUROLIGIN 1; RELEASE; SYNAPSES; INNERVATION; TRANSMISSION; EXPRESSION	Chemical neurotransmission typically occurs through synapses. Previous ultrastructural examinations of monoamine neuron axon terminals often failed to identify a pre- and postsynaptic coupling, leading to the concept of "volume" transmission. Whether this results from intrinsic properties of these neurons remains undefined. We find that dopaminergic neurons in vitro establish a distinctive axonal arbor compared to glutamatergic or GABAergic neurons in both size and propensity of terminals to avoid direct contact with target neurons. While most dopaminergic varicosities are active and contain exocytosis proteins like synaptotagmin 1, only similar to 20% of these are synaptic. The active zone protein bassoon was found to be enriched in dopaminergic terminals that are in proximity to a target cell. Finally, we found that the proteins neurexin-1 alpha(SS4-) and neuroligin-1(A+B) play a critical role in the formation of synapses by dopamine (DA) neurons. Our findings suggest that DA neurons are endowed with a distinctive developmental connectivity program.	[Ducrot, Charles; Bourque, Marie-Josee; Racine, Anne-Sophie; Delignat-Lavaud, Benoit; Michaud-Tardif, Charlotte; Burke Nanni, Samuel; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Physiol & Pharmacol, Montreal, PQ H3C 3J7, Canada; [Ducrot, Charles; Bourque, Marie-Josee; Racine, Anne-Sophie; Delignat-Lavaud, Benoit; Michaud-Tardif, Charlotte; Burke Nanni, Samuel; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Neurosci, Montreal, PQ, Canada; [Ducrot, Charles; Bourque, Marie-Josee; Racine, Anne-Sophie; Delignat-Lavaud, Benoit; Michaud-Tardif, Charlotte; Burke Nanni, Samuel; Trudeau, Louis-Eric] CNS Res Grp GRSNC, Montreal, PQ, Canada; [Delmas, Constantin V. L.; Parent, Martin] Univ Laval, CERVO Brain Res Ctr, Fac Med, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Guadarrama Bello, Dainelys; Nanci, Antonio] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci, Copenhagen, Denmark; [Domenic Lycas, Matthew; Herborg, Freja; Gether, Ulrik] Univ Montreal, Fac Med Dent, Dept Stomatol, Montreal, PQ, Canada; [Fallon, Aurelie; Takahashi, Hideto] Inst Rech Clin Montreal, Synapse Dev, Montreal, PQ, Canada; [Fallon, Aurelie; Takahashi, Hideto] Inst Rech Clin Montreal, Plast Res Unit, Montreal, PQ, Canada; [Fallon, Aurelie; Takahashi, Hideto] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Fallon, Aurelie; Takahashi, Hideto] McGill Univ, Integrated Program Neurosci, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Laval University; University of Copenhagen; Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Trudeau, LE (corresponding author), Univ Montreal, Fac Med, Dept Physiol & Pharmacol, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca		Delignat-Lavaud, Benoit/0000-0003-4680-9115; Ducrot, Charles/0000-0002-5451-1610; Gether, Ulrik/0000-0002-0020-3807; Nanci, Antonio/0000-0003-0616-843X	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR) [MOP106556, MOP153068, PJT159588]; Lundbeckfonden (Lundbeck Foundation) [2018-792, 2017-4331, 2016-3154]; Krembil Foundation; Fondation Brain Canada (Brain Canada); Parkinson Canada; Henry and Berenice Kaufmann Foundation	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Lundbeckfonden (Lundbeck Foundation); Krembil Foundation; Fondation Brain Canada (Brain Canada); Parkinson Canada; Henry and Berenice Kaufmann Foundation	Gouvernement du Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: MOP106556, MOP153068 and PJT159588; Lundbeckfonden (Lundbeck Foundation), Grant/Award Number: 2018-792, 2017-4331, 2016-3154, 2017-4331 and 2016-3154; Krembil Foundation; Fondation Brain Canada (Brain Canada); Henry and Berenice Kaufmann Foundation; Parkinson Canada	AGNATI LF, 1995, NEUROSCIENCE, V69, P711, DOI 10.1016/0306-4522(95)00308-6; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Barrow SL, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-17; Bello DG, 2017, ACTA BIOMATER, V60, P339, DOI 10.1016/j.actbio.2017.07.022; Berube-Carriere N, 2012, EUR J NEUROSCI, V35, P527, DOI 10.1111/j.1460-9568.2012.07992.x; Berube-Carriere N, 2009, J COMP NEUROL, V517, P873, DOI 10.1002/cne.22194; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Budreck EC, 2013, P NATL ACAD SCI USA, V110, P725, DOI 10.1073/pnas.1214718110; Caille I, 1996, BRAIN RES, V730, P17, DOI 10.1016/0006-8993(96)00424-6; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; COUTEAUX R, 1963, PROC R SOC SER B-BIO, V158, P457, DOI 10.1098/rspb.1963.0058; Craig AM, 1996, J NEUROSCI, V16, P3166; Dal Bo G, 2008, NEUROSCIENCE, V156, P59, DOI 10.1016/j.neuroscience.2008.07.032; Dal Bo G, 2004, J NEUROCHEM, V88, P1398, DOI 10.1046/j.1471-4159.2003.02277.x; Daniel JA, 2009, J NEUROSCI, V29, P14670, DOI 10.1523/JNEUROSCI.1349-09.2009; Descarries L, 2000, PROG BRAIN RES, V125, P27; Descarries L, 1996, J COMP NEUROL, V375, P167; DESCARRIES L, 1975, BRAIN RES, V100, P563, DOI 10.1016/0006-8993(75)90158-4; Descarries L, 2008, BRAIN RES REV, V58, P290, DOI 10.1016/j.brainresrev.2007.10.005; Devine MJ, 2018, NAT REV NEUROSCI, V19, P63, DOI 10.1038/nrn.2017.170; Eid L, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00111; El Beheiry M, 2013, NAT METHODS, V10, P689, DOI 10.1038/nmeth.2566; El Mestikawy S, 2011, NAT REV NEUROSCI, V12, P204, DOI 10.1038/nrn2969; Espinosa Felipe, 2015, Front Synaptic Neurosci, V7, P11, DOI 10.3389/fnsyn.2015.00011; Fasano Caroline, 2008, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0321s44; Fortin GM, 2019, FASEB J, V33, P400, DOI 10.1096/fj.201800713RR; Fortin GM, 2012, J NEUROSCI, V32, P17477, DOI 10.1523/JNEUROSCI.1939-12.2012; Giguere N, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008352; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gonzalez-Hernandez T, 2001, EUR J NEUROSCI, V13, P57, DOI 10.1046/j.1460-9568.2001.01371.x; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; GRAY EG, 1959, J ANAT, V93, P420; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Kwon HB, 2012, NAT NEUROSCI, V15, P1667, DOI 10.1038/nn.3256; Li XP, 2013, BRAIN STRUCT FUNCT, V218, P1159, DOI 10.1007/s00429-012-0452-z; Li YM, 2018, NAT METHODS, V15, P367, DOI 10.1038/nmeth.4661; Liu CL, 2018, CELL, V172, P706, DOI 10.1016/j.cell.2018.01.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Perez-Lopez JL, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00070; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; Mendez JA, 2008, J NEUROSCI, V28, P6309, DOI 10.1523/JNEUROSCI.1331-08.2008; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Naito Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep42548; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Pacelli C, 2015, CURR BIOL, V25, P2349, DOI 10.1016/j.cub.2015.07.050; Parent M, 2006, J NEURAL TRANSM-SUPP, P85; Pereira DB, 2016, NAT NEUROSCI, V19, P578, DOI 10.1038/nn.4252; Pfeffer M., 2020, SYNAPTIC SUPRA SYNAP, DOI [10.1101/2020.02.18.952978, DOI 10.1101/2020.02.18.952978]; Rahbek-Clemmensen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00790-3; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; Robinson BG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04728-z; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; SESACK SR, 1994, J NEUROSCI, V14, P88; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; Silm K, 2019, NEURON, V102, P786, DOI 10.1016/j.neuron.2019.03.031; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tritsch NX, 2016, NAT REV NEUROSCI, V17, P139, DOI 10.1038/nrn.2015.21; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Trudeau LE, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00113; Trudeau LE, 2014, PROG BRAIN RES, V211, P141, DOI 10.1016/B978-0-444-63425-2.00006-4; Uchigashima M, 2016, P NATL ACAD SCI USA, V113, P4206, DOI 10.1073/pnas.1514074113; UMBRIACO D, 1994, J COMP NEUROL, V348, P351, DOI 10.1002/cne.903480304; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Wang SSH, 2016, NEURON, V91, P777, DOI 10.1016/j.neuron.2016.07.005; Wang YN, 2014, OPT EXPRESS, V22, P15982, DOI 10.1364/OE.22.015982; Zhang SL, 2015, NAT NEUROSCI, V18, P386, DOI 10.1038/nn.3945	82	6	6	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21791	10.1096/fj.202100201RR	http://dx.doi.org/10.1096/fj.202100201RR			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34320240	Green Submitted			2022-12-26	WOS:000678975300024
J	Ahmad, U; Ashraf, M; Al-Zubaidi, A; Ali, A; Saleem, S				Ahmad, Uzma; Ashraf, Muhammad; Al-Zubaidi, A.; Ali, Aamir; Saleem, Salman			Effects of temperature dependent viscosity and thermal conductivity on natural convection flow along a curved surface in the presence of exothermic catalytic chemical reaction	PLOS ONE			English	Article							BOUNDARY-LAYERS DRIVEN; VARIABLE VISCOSITY; VISCOUS-FLUID; MICROPOLAR FLUID; TRUNCATED CONE	The natural convection boundary layer flow of a viscous incompressible fluid with temperature dependent viscosity and thermal conductivity in the presence of exothermic catalytic chemical reaction along a curved surface has been investigated. The governing non dimensional form of equations is solved numerically by using finite difference scheme. The numerical results of velocity profile, temperature distribution and mass concentration as well as for skin friction, heat transfer rate and mass transfer rate are presented graphically and in tabular form for various values of dimensionless parameters those are generated in flow model during dimensionalization. From the obtained results, it is concluded that the exothermic catalytic chemical reactions is associated with temperature dependent viscosity and thermal conductivity. Further, it is concluded that the body shape parameter also plays an important quantitative role for change in velocity profile, temperature field and mass concentration behavior in the presence of exothermic catalytic chemical reaction.	[Ahmad, Uzma; Ashraf, Muhammad] Univ Sargodha, Dept Math, Fac Sci, Sargodha, Pakistan; [Ali, Aamir] COMSATS Univ Islamabad, Dept Math, Attock, Pakistan; [Al-Zubaidi, A.; Saleem, Salman] King Khalid Univ, Dept Math, Coll Sci, Abha, Saudi Arabia	University of Sargodha; COMSATS University Islamabad (CUI); King Khalid University	Ali, A (corresponding author), COMSATS Univ Islamabad, Dept Math, Attock, Pakistan.	aamir_ali@cuiatk.edu.pk		Ali, Aamir/0000-0002-6876-693X; saleem, Salman/0000-0001-6217-3626	Deanship of Scientific Research at King Khalid University [RGP.1/46/42]	Deanship of Scientific Research at King Khalid University	The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this work through research groups program under Grant No. RGP.1/46/42.	Ahmad U, 2020, THERM SCI, V24, pS1, DOI 10.2298/TSCI20S1001A; Anantha KK., 2020, J THERM ANAL CALORIM, V140, P1; Anantha KK., 2020, HEAT T, P1; Ashraf M, 2019, COMPUT THERM SCI, V11, P339, DOI 10.1615/ComputThermalScien.2019026521; Carey, 1978, P 6 INT HEAT TRANSF, V2, P211; Chaudhary MA, 1996, J ENG MATH, V30, P403, DOI 10.1007/BF00049243; CHAUDHARY MA, 1994, J ENG MATH, V28, P145, DOI 10.1007/BF00127583; Hossain A, 2001, INT J THERM SCI, V40, P437; Hossain MA, 2002, Z ANGEW MATH PHYS, V53, P48, DOI 10.1007/s00033-002-8141-z; Hossain MA, 2000, ACTA MECH, V140, P171, DOI 10.1007/BF01182509; Hossain MA, 2001, INT J NUMER METHOD H, V11, P494, DOI 10.1108/09615530110399459; Hossain MA., 2020, INT J FLUID MECH RES, V29; Keimanesh R, 2017, TEH VJESN, V24, P371, DOI 10.17559/TV-20150517072748; Kumar K.A., 2019, APPL MATH SCI COMPUT, P325, DOI DOI 10.1007/978-3-030-01123-9_32; Kumar KA, 2020, J THERM ANAL CALORIM, V139, P3661, DOI 10.1007/s10973-019-08694-8; Kumar KA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51242-5; Magyari E, 2002, Z ANGEW MATH MECH, V82, P142, DOI 10.1002/1521-4001(200202)82:2<142::AID-ZAMM142>3.0.CO;2-4; Mahanti N. C., 2009, Journal of Applied Fluid Mechanics, V2, P23; Makanda G, 2017, P 4 INT C FLUID FLOW; MERKIN JH, 1994, Q J MECH APPL MATH, V47, P405, DOI 10.1093/qjmam/47.3.405; Modather M, 2012, LAT AM APPL RES, V42, P121; Molla MM, 2005, J NAV ARCHIT MAR ENG, V2, P53; Molla MM, 2005, HEAT MASS TRANSFER, V41, P594, DOI 10.1007/s00231-004-0576-7; Muhammad A, 2016, INT J NUMER METHOD H, V26, P1580, DOI 10.1108/HFF-08-2014-0265; POP I, 1993, Z ANGEW MATH MECH, V73, pT534; Rahman MM, 2008, NONLINEAR ANAL-MODEL, V13, P513, DOI 10.15388/NA.2008.13.4.14555; Ramadevi B, 2019, PRAMANA-J PHYS, V93, DOI 10.1007/s12043-019-1847-7; Thohura S, 2014, PROCEDIA ENGINEER, V90, P497, DOI 10.1016/j.proeng.2014.11.763; Tlili I, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63708-y; Uddin Z., 2009, MATH PHYS COMPUT MOD, V13, P15; Umavathi JC, 2016, INT J NUMER METHOD H, V26, P18, DOI 10.1108/HFF-12-2014-0385; Ramudu ACV, 2020, HEAT TRANSF, V49, P5020, DOI 10.1002/htj.21865	32	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0252485	10.1371/journal.pone.0252485	http://dx.doi.org/10.1371/journal.pone.0252485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324502	gold, Green Published			2022-12-26	WOS:000685248200037
J	Gebrekidan, K; Hall, H; Plummer, V; Fooladi, E				Gebrekidan, Kahsu; Hall, Helen; Plummer, Virginia; Fooladi, Ensieh			Exclusive breastfeeding continuation and associated factors among employed women in North Ethiopia: A cross-sectional study	PLOS ONE			English	Article							WORKING MOTHERS; BARRIERS	Background Exclusive Breastfeeding (EBF) can prevent up to 13% of under-five mortality in developing countries. In Sub-Saharan Africa the rate of EBF at six months remains very low at 36%. Different types of factors such as maternal, family and work-related factors are responsible for the low rate of EBF among employed women. This study aimed to assess the prevalence of EBF continuation and associated factors among employed women in North Ethiopia. Materials and methods A community-based, cross-sectional study was conducted in two towns of Tigray region, North Ethiopia. Employed women who had children between six months and two years were surveyed using multistage, convenience sampling. Women filled in a paper based validated questionnaire adopted from the Breastfeeding and Employment Study toolkit (BESt). The questions were grouped into four parts of sociodemographic characteristics, maternal characteristics, family support and work-related factors. Factors associated with EBF continuation as a binary outcome (yes/no) were determined using multivariable logistic regression. Results Four-hundred and forty-nine women participated in this study with a mean (SD) age 30.4 (4.2) years. Two hundred and fifty-four (56.4%) participants exclusively breastfed their children for six months or more. The main reason for discontinuation of EBF was the requirement of women to return to paid employment (31.5%). Four-hundred and forty (98.2%) participants believed that breastfeeding has benefits either to the infant or to the mother. Three hundred and seventy-one (82.8%) of the participants received support from their family at home to assist with EBF, most commonly from their husbands and mothers. Having family support (adjusted odds ratio [AOR] = 2.1, 95%, CI 1.2-3.6; P = 0.005), having frequent breaks at work (AOR = 2.6, 95% CI, 1.4-4.8; P = 0.002) and the possibility of buying or borrowing required equipment for expressing breast milk (AOR = 1.7, 95% CI, 1.0-3.0; P = 0.033) were statistically associated with an increased chance of EBF. Conclusion Although returning to work was reported by the study participants as the main reason for discontinuation of EBF, families and managers' support play significant roles in EBF continuation, which in the absence of six-month's maternity leave for employed women in Ethiopia would be of benefit to both mothers and children.	[Gebrekidan, Kahsu; Hall, Helen; Plummer, Virginia] Monash Univ, Monash Nursing & Midwifery, Frankston, Vic, Australia; [Gebrekidan, Kahsu] Mekelle Univ, Coll Hlth Sci, Sch Nursing, Mekelle, Ethiopia; [Plummer, Virginia] Federat Univ Australia, Sch Hlth, Berwick, Australia; [Fooladi, Ensieh] Monash Univ, Monash Nursing & Midwifery, Clayton, Vic, Australia	Monash University; Mekelle University; Federation University Australia; Monash University	Gebrekidan, K (corresponding author), Monash Univ, Monash Nursing & Midwifery, Frankston, Vic, Australia.; Gebrekidan, K (corresponding author), Mekelle Univ, Coll Hlth Sci, Sch Nursing, Mekelle, Ethiopia.	kahsu.gebrekidan@monash.edu		Gebrekidan, Kahsu Geberekirstos/0000-0002-0933-1805				Abou-ElWafa HS, 2019, FAM PRACT, V36, P568, DOI 10.1093/fampra/cmy120; Aikawa T, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1253, DOI 10.1177/1010539511419647; Altamimi E, 2017, WORKPLACE HEALTH SAF, V65, P210, DOI 10.1177/2165079916665395; Atabay E, 2015, J HUM LACT, V31, P81, DOI 10.1177/0890334414554806; Bai DL, 2015, MATERN CHILD HLTH J, V19, P990, DOI 10.1007/s10995-014-1596-7; Chale LE, 2016, BMC NURS, V15, DOI 10.1186/s12912-016-0192-0; Chekol DA, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0118-9; Dagher RK, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0965-1; Dukuzumuremyi JPC, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-020-00313-9; Dun-Dery EJ, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0083-8; Hamze L, 2019, MIDWIFERY, V74, P68, DOI 10.1016/j.midw.2019.03.009; Johnston ML, 2007, JOGNN-J OBST GYN NEO, V36, P9, DOI [10.1111/j.1552-6909.2006.00109.x, 10.1111/J.1552-6909.2006.00109.x]; Kebede T, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-019-0250-9; Khasawneh W, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-020-00303-x; Olson B FI, 2017, BREASTFEEDING EMPLOY; Omer-Salim A, 2015, MIDWIFERY, V31, P473, DOI 10.1016/j.midw.2014.12.008; Osibogun OO, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0182-9; Ratnasari D, 2017, ASIA PAC J CLIN NUTR, V26, pS31, DOI 10.6133/apjcn.062017.s8; Sulaiman Z, 2016, J ADV NURS, V72, P825, DOI 10.1111/jan.12884; Tadesse F, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7345-5; Tangsuksan P, 2020, PAC RIM INT J NURS R, V24, P54; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Yalcin SS, 2016, PAEDIATR PERINAT EP, V30, P439, DOI 10.1111/ppe.12305	23	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0252445	10.1371/journal.pone.0252445	http://dx.doi.org/10.1371/journal.pone.0252445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324499	Green Submitted, gold, Green Published			2022-12-26	WOS:000685248200088
J	Marquioni, VM; de Aguiar, MAM				Marquioni, Vitor M.; de Aguiar, Marcus A. M.			Modeling neutral viral mutations in the spread of SARS-CoV-2 epidemics	PLOS ONE			English	Article							DYNAMICS	Although traditional models of epidemic spreading focus on the number of infected, susceptible and recovered individuals, a lot of attention has been devoted to integrate epidemic models with population genetics. Here we develop an individual-based model for epidemic spreading on networks in which viruses are explicitly represented by finite chains of nucleotides that can mutate inside the host. Under the hypothesis of neutral evolution we compute analytically the average pairwise genetic distance between all infecting viruses over time. We also derive a mean-field version of this equation that can be added directly to compartmental models such as SIR or SEIR to estimate the genetic evolution. We compare our results with the inferred genetic evolution of SARS-CoV-2 at the beginning of the epidemic in China and found good agreement with the analytical solution of our model. Finally, using genetic distance as a proxy for different strains, we use numerical simulations to show that the lower the connectivity between communities, e.g., cities, the higher the probability of reinfection.	[Marquioni, Vitor M.; de Aguiar, Marcus A. M.] Univ Estadual Campinas UNICAMP, Inst Fis Gleb Wataghin, Campinas, SP, Brazil	Universidade Estadual de Campinas	de Aguiar, MAM (corresponding author), Univ Estadual Campinas UNICAMP, Inst Fis Gleb Wataghin, Campinas, SP, Brazil.	aguiar@ifi.unicamp.br		M. Marquioni, Vitor/0000-0002-8904-0230	Sao Paulo Research Foundation (FAPESP) [2019/13341-7, 2019/20271-5, 2016/01343-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301082/2019-7]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Sao Paulo Research Foundation (FAPESP -https://fapesp.br/), grants 2019/13341-7 (VMM), 2019/20271-5 and 2016/01343-7 (MAMA), and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq -https://www.gov.br/cnpq/ptbr), grant 301082/2019-7 (MAMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1988, J ROY STAT SOC A STA, V151, P66, DOI 10.2307/2982185; Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Bar-Yam, 2013, ARXIV PREPRINT ARXIV; Buckee C, 2007, P ROY SOC B-BIOL SCI, V274, P1715, DOI 10.1098/rspb.2007.0415; Buckee CO, 2004, P NATL ACAD SCI USA, V101, P10839, DOI 10.1073/pnas.0402000101; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Cobey S, 2020, SCIENCE, V368, P713, DOI 10.1126/science.abb5659; Costa CLN, 2018, PHYSICA A, V510, P1, DOI 10.1016/j.physa.2018.05.150; de Aguiar MAM, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.047102; de Aguiar MAM, 2017, J PHYS A-MATH THEOR, V50, DOI 10.1088/1751-8121/aa5701; De Maio N, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005130; Dickison M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066109; Duffy S, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000003; Forster P, 2020, P NATL ACAD SCI USA, V117, P9241, DOI 10.1073/pnas.2004999117; Froissart R, 2010, PHILOS T R SOC B, V365, P1907, DOI 10.1098/rstb.2010.0068; Gandy A., 2020, 12 IMP COLL LOND; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Gordo I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004876; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Hawley DM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001570; He X, 2020, NATL SCI REV; Ivorra B, 2020, COMMUN NONLINEAR SCI, V88, DOI 10.1016/j.cnsns.2020.105303; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Korobeinikov A, 2009, B MATH BIOL, V71, P75, DOI 10.1007/s11538-008-9352-z; Kucharski AJ, 2016, J MATH BIOL, V72, P1, DOI 10.1007/s00285-015-0873-4; Kupferschmidt K, 2020, SCIENCE, V367, P1176, DOI 10.1126/science.367.6483.1176; KUZNETSOV YA, 1994, J MATH BIOL, V32, P109, DOI 10.1007/BF00163027; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630; Marquioni VM, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109999; Murray J D, 2007, MATH BIOL; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Research W., 2020, WOLFR DAT REP, DOI [10.24097/wolfram.03304.data, DOI 10.24097/WOLFRAM.03304.DATA]; Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019; Saumell-Mendiola A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026106; Scabini F S., 2020, SOCIAL INTERACTION L; SLATKIN M, 1991, GENETICS, V129, P555; Sung W.-K., 2009, ALGORITHMS BIOINFORM; Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5; Tillett RL, 2021, LANCET INFECT DIS, V21, P52, DOI 10.1016/S1473-3099(20)30764-7; To Kelvin Kai-Wang, 2021, Clin Infect Dis, V73, pe2946, DOI 10.1093/cid/ciaa1275; van Dorp L, 2020, INFECT GENET EVOL, V83, DOI 10.1016/j.meegid.2020.104351; VASCONCELOS G, 2020, MEDRXIV, DOI DOI 10.7717/PEERJ.9421; Volz EM, 2012, GENETICS, V190, P187, DOI 10.1534/genetics.111.134627; Volz EM, 2009, GENETICS, V183, P1421, DOI 10.1534/genetics.109.106021; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Williams BJM, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008606; Wolfram Research, 2020, EP DAT NOV COR COVID, DOI [10.24097/wolfram.04123.data, DOI 10.24097/WOLFRAM.04123.DATA]; Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1080/10408398.2020.1828813, 10.1038/s41591-020-0822-7]; Zhao ZM, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-21; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	55	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255438	10.1371/journal.pone.0255438	http://dx.doi.org/10.1371/journal.pone.0255438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324605	gold, Green Published, Green Submitted			2022-12-26	WOS:000685248200086
J	Moustafa, R; Albouni, T; Aziz, G				Moustafa, Rania; Albouni, Taissir; Aziz, Ghassan			The role of procalcitonin and presepsin in the septic febrile neutropenia in acute leukemia patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; DIAGNOSTIC-VALUE; SEPSIS; CD14	Background The source of bacterial infection in neutropenic acute leukemia patients is detected in about 20-30% of cases. Bacterial cultures may require a long incubation period and risk false-positive and false- negative results. Therefore, biomarkers distinguishing septic febrile neutropenia from other etiologies in acute leukemia patients play the important role in patient assessment and treatment planning. This study aims to determine the role of procalcitonin (PCT) and presepsin (PSPN) in infectious complication in comparison to C-reactive protein (CRP) on the first and third day at the onset of febrile neutropenia in patients with acute leukemia. Methods Between June 2018 and February 2019, 60 acute leukemia patients with febrile neutropenia receiving chemotherapy. The 41 acute myeloid leukemia patients and 19 acute lymphoblastic leukemia patients were recruited in this study. Their ages ranged from 14 to 65 years. PCT and PSPN were measured and were compared to CRP at the onset of febrile neutropenia and after 48 hours. 20 patients had a fever of unknown origin (FUO) and 40 patients had a bacterial infection. Findings Our results showed that the values of these markers were higher in patients with infection than patients without. The area under the curve (AUC) of PCT were 0.931 and 0.813 on day one and three respectively, which was the best in determination of infection. The cut-off values of PCT were 1.27 and 1.23 ng/mL and the cut off values of PSPN were 1.75 and 2.9 mu g/L in the successive days, their clinical sensitivities were high. PCT and PSPN were capable of distinguishing the cause of febrile neutropenia from the onset of infection and predicting its complications (p<0.05). The PSPN level couldn't differentiate gram-positive or gram-negative bacterial infection. Significant differences were found between the mean values of the PSPN during the successive days in all patients and patients with bacteremia. This study illustrated a weak positive correlation between PCT and Sequential Organ Failure Assessment (SOFA) score, the negligible correlation between CRP and SOFA score and no significant correlation between PSPN and SOFA score. Interpretation PCT is an accurate biomarker in identifying infection in acute leukemia patients, its concentration is associated with the severity of bacterial sepsis. PSPN is superior to PCT for follow-up of patients.	[Moustafa, Rania; Albouni, Taissir] Damascus Univ, Dept Lab Med, Fac Med, Damascus, Syria; [Aziz, Ghassan] Damascus Univ, Dept Internal Med Hematol, Fac Med, Damascus, Syria		Moustafa, R (corresponding author), Damascus Univ, Dept Lab Med, Fac Med, Damascus, Syria.	raniakedmzl@gmail.com			Damascus University, Ministry of Higher Education, Syria	Damascus University, Ministry of Higher Education, Syria	This study was supported by Damascus University, Ministry of Higher Education, Syria. The funder provided support in the form of salaries for authors (T.A and G.A) and paid for the laboratory materials needed for the study. But it had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah T. H., 2015, Life Science Journal, V12, P134; Abhijit Chaudhury, 2013, Journal of Clinical and Scientific Research, V2, P216; Aust C, 2013, SCAND J INFECT DIS, V45, P285, DOI 10.3109/00365548.2012.735372; Bamba Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206089; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; Chan T, 2011, EXPERT REV MOL DIAGN, V11, P487, DOI 10.1586/ERM.11.26; Cornillon J, 2011, J INFECTION, V63, P93, DOI 10.1016/j.jinf.2011.05.010; Durnas B, 2016, ONCOTARGETS THER, V9, P469, DOI 10.2147/OTT.S95600; Ebihara Y, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22147; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Koh H, 2016, J INFECT CHEMOTHER, V22, P466, DOI 10.1016/j.jiac.2016.04.002; Koizumi Y, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2116-8; Korpelainen S, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/9805609; Lambden S, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2663-7; Leli C, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/701480; Limongi D, 2016, ASIAN PAC J TROP BIO, V6, P516, DOI 10.1016/j.apjtb.2016.04.005; Memar MY, 2019, BIOMED PHARMACOTHER, V111, P649, DOI 10.1016/j.biopha.2018.12.124; Mu YJ, 2016, INT J CLIN EXP MED, V9, P3173; Nagata T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129159; National Comprehensive Cancer Network, 2018, NCCN CLIN PRACTICE G; Onyenekwu CP, 2017, COCHRANE DB SYST REV; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Qu JY, 2015, INDIAN J MED RES, V141, P315; Qu ZG, 2017, SRP ARK CELOK LEK, V145, P382, DOI 10.2298/SARH160811066Q; RINTALA E, 1992, EUR J CLIN MICROBIOL, V11, P973, DOI 10.1007/BF01967785; Sharma A., 2005, J POSTGRAD MED, V51, P42; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Vanska M., 2015, PUBLICATIONS U E FIN, V279; Vijayan AL, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-017-0246-8; Wilson BJ, 2018, CLIN J ONCOL NURS, V22, P157, DOI 10.1188/18.CJON.157-168; Yap C.Y., 2014, PROC SINGAP HEALTHC, V23; Yunus I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206527; Zhang X, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1032-4	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0253842	10.1371/journal.pone.0253842	http://dx.doi.org/10.1371/journal.pone.0253842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324506	gold, Green Published			2022-12-26	WOS:000685248200047
J	Povoa, LV; Ribeiro, CHC; da Silva, IT				Venezian Povoa, Lucas; Ribeiro, Carlos Henrique Costa; da Silva, Israel Tojal			Machine learning predicts treatment sensitivity in multiple myeloma based on molecular and clinical information coupled with drug response	PLOS ONE			English	Article							RISK STRATIFICATION; POOR-PROGNOSIS; EXPRESSION; GIHCG; HETEROGENEITY	Providing treatment sensitivity stratification at the time of cancer diagnosis allows better allocation of patients to alternative treatment options. Despite many clinical and biological risk markers having been associated with variable survival in cancer, assessing the interplay of these markers through Machine Learning (ML) algorithms still remains to be fully explored. Here, we present a Multi Learning Training approach (MuLT) combining supervised, unsupervised and self-supervised learning algorithms, to examine the predictive value of heterogeneous treatment outcomes for Multiple Myeloma (MM). We show that gene expression values improve the treatment sensitivity prediction and recapitulates genetic abnormalities detected by Fluorescence in situ hybridization (FISH) testing. MuLT performance was assessed by cross-validation experiments, in which it predicted treatment sensitivity with 68.70% of AUC. Finally, simulations showed numerical evidences that in average 17.07% of patients could get better response to a different treatment at the first line.	[Venezian Povoa, Lucas; Ribeiro, Carlos Henrique Costa] Aeronaut Inst Technol ITA, Bioengn Lab, Sao Jose Dos Campos, Brazil; [Venezian Povoa, Lucas; Ribeiro, Carlos Henrique Costa] Aeronaut Inst Technol ITA, Comp Sci Div, Sao Jose Dos Campos, Brazil; [Venezian Povoa, Lucas; da Silva, Israel Tojal] Int Res & Educ Ctr, AC Camargo Canc Ctr ACCCC, Sao Paulo, Brazil; [Venezian Povoa, Lucas] Fed Inst Educ Sci & Technol Sao Paulo IFPS, Jacarei, Brazil		da Silva, IT (corresponding author), Int Res & Educ Ctr, AC Camargo Canc Ctr ACCCC, Sao Paulo, Brazil.	itojal@accamargo.org.br	Silva, Israel T/N-3858-2014; Ribeiro, Carlos/E-2641-2013; Venezian Povoa, Lucas/B-1480-2016	Silva, Israel T/0000-0002-4687-1499; Ribeiro, Carlos/0000-0002-5760-8426; Venezian Povoa, Lucas/0000-0003-4002-4122	A.C. Camargo Cancer Center [ACCCC-ITA-LVP:201803]; CNPq [303093/2016-1]; FAPESP [15/19324-6]	A.C. Camargo Cancer Center; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	LVP thanks the financial support by A.C. Camargo Cancer Center (research grant no. ACCCC-ITA-LVP:201803). CHCR thanks the financial support by CNPq (research grant no. 303093/2016-1). ITS thanks the financial support by FAPESP (research grant no. 15/19324-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binder M, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.83; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Chiu YC, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-018-0460-9; Chng WJ, 2014, LEUKEMIA, V28, P269, DOI 10.1038/leu.2013.247; Guo HX, 2017, EXPERT SYST APPL, V73, P220, DOI 10.1016/j.eswa.2016.12.035; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Haykin S., 2009, NEURAL NETWORKS LEAR, V3rd; Hollander M., 1973, NONPARAMETRIC STAT M; Huang C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34753-5; Jiang XH, 2019, ONCOTARGETS THER, V12, P1059, DOI 10.2147/OTT.S192290; Kassambara A, 2012, HAEMATOL-HEMATOL J, V97, P622, DOI 10.3324/haematol.2011.046821; Ke Guolin, 2017, ADV NEURAL INFORM PR, P3146; Keats JJ, 2012, BLOOD, V120, P1067, DOI 10.1182/blood-2012-01-405985; Kohler M, 2018, CANCER-AM CANCER SOC, V124, P2075, DOI 10.1002/cncr.31243; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Kuiper R, 2012, LEUKEMIA, V26, P2406, DOI 10.1038/leu.2012.127; Kumar SK, 2011, BLOOD, V118, P4359, DOI 10.1182/blood-2011-03-342089; Le GN, 2019, MOL OMICS, V15, P7, DOI 10.1039/c8mo00193f; LeCun Y., 2015, DEEP LEARNING NATURE, V521, P436, DOI [DOI 10.1038/NATURE14539, 10.1038/nature14539]; Lin H, 2002, MODELING SURVIVAL DA, V44, P85; Liu GZ, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.711; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i14, DOI 10.18637/JSS.V008.I18, 10.18637/jss.v008.i18]; Mason MJea, 2019, MULTIPLE MYELOMA DRE, DOI [10.1101/737122, DOI 10.1101/737122]; Multiple Myeloma Research Foundation, 2019, MMRF RES GAT; Multiple Myeloma Research Foundation, 2017, MULT MYEL DREAM CHAL; Nishimura KK, 2020, BLOOD ADV, V4, P422, DOI 10.1182/bloodadvances.2019000524; Platt JC, 2000, ADV NEUR IN, P61; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Rossi D, 2010, CANCER-AM CANCER SOC, V116, P2188, DOI 10.1002/cncr.24959; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Segges P, 2011, GENET RES INT, V2011, DOI 10.4061/2011/798089; Turki T, 2019, COMPUT BIOL MED, V107, P302, DOI 10.1016/j.compbiomed.2018.12.017; Ubels J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05348-5; Vanderlooy S, 2008, MACH LEARN, V72, P247, DOI 10.1007/s10994-008-5070-x; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Venezian Povoa L, 2018, MMWEBBOT CRAWLER MMR; Vincent Pascal, 2008, P INT C MACH LEARN, P1096, DOI 10.1145/1390156.1390294; Walker BA, 2014, LEUKEMIA, V28, P384, DOI 10.1038/leu.2013.199; Xiao SY, 2020, ONCOTARGETS THER, V13, P11607, DOI 10.2147/OTT.S271966; Yu W, 2014, J KOREAN STAT SOC, V43, P161, DOI 10.1016/j.jkss.2013.05.003; Zhang XL, 2019, J CANCER, V10, P672, DOI 10.7150/jca.28525	45	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254596	10.1371/journal.pone.0254596	http://dx.doi.org/10.1371/journal.pone.0254596			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320000	Green Published, gold			2022-12-26	WOS:000685247800013
J	Bousbia, A; Boudalia, S; Gueroui, Y; Hadded, K; Bouzaoui, A; Kiboub, D; Symeon, G				Bousbia, Aissam; Boudalia, Sofiane; Gueroui, Yassine; Hadded, Kamel; Bouzaoui, Abdelkader; Kiboub, Dounia; Symeon, George			Use of multivariate analysis as a tool in the morphological characterization of the main indigenous bovine ecotypes in northeastern Algeria	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; CATTLE; SIZE; COWS; POPULATIONS; TRAITS	Sustainability in livestock farming requires monitoring of autochthonous breeds which are well adapted to the local environment. The morphometric measurements seem to be the first approach which can provide useful information on the suitability of animal genetic resources for selection. In this work, thirteen morphometric variables were used for the phenotypic characterization of 130 adult autochthones cattle randomly selected from 30 local farms in Guelma. There were cases from four commonly accepted and traditional ecotypes: Guelmois, Cheurfa, Setifien and Fawn. The results showed several and significant positive correlations between the different variables. Correlations were analyzed using Varimax orthogonal rotation PCA and three factors were extracted, which explain more than 75% of the total variation in the four ecotypes. Stepwise discriminant analysis showed that 6 of the 13 variables had discriminatory power to define the phenotypic profile of the ecotypes. Canonical discriminant analysis indicated that the Setifien ecotype is separate from the other three ecotypes. Mahalanobis distances were significant between the different ecotypes except for the distance between the Guelmois and Fawn ecotypes. The cross-validation procedure assigned 91.42% of the Setifien animals to their genetic group, while the percentages of animals assigned to the Cheurfa, Guelmois and Fawn ecotypes were 80.00%, 65.71% and 53.33% respectively. The multivariate approach has proven to be effective in differentiating the four ecotypes, with clear morphological differences from the Setifien ecotype that may benefit from a genetic improvement program for more sustainable genetic resources preservation.	[Bousbia, Aissam; Boudalia, Sofiane; Gueroui, Yassine; Hadded, Kamel; Bouzaoui, Abdelkader; Kiboub, Dounia] Univ 8 Mai 1945 Guelma, Fac Sci Nat & Vie Sci Terre & Univers, Guelma 1945, Algeria; [Bousbia, Aissam; Boudalia, Sofiane] Univ 8 Mai 1945 Guelma, Lab Biol Eau & Environm, Guelma, Algeria; [Symeon, George] HAO DEMETER, Paralimni Giannitsa, Greece	Universite 8 Mai 1945 de Guelma; Universite 8 Mai 1945 de Guelma	Boudalia, S (corresponding author), Univ 8 Mai 1945 Guelma, Fac Sci Nat & Vie Sci Terre & Univers, Guelma 1945, Algeria.; Boudalia, S (corresponding author), Univ 8 Mai 1945 Guelma, Lab Biol Eau & Environm, Guelma, Algeria.	boudalia.sofiane@univ-guelma.dz	BOUSBIA, Aissam/L-4309-2018	BOUSBIA, Aissam/0000-0002-0514-4834	Algerian Ministry of Higher Education and Scientific Research; Directorate General for Scientific Research and Technological Development (DGRSDT); ARIMNet2-BOVISOL (Coordination of Agricultural Research in the Mediterranean; EC [618127]	Algerian Ministry of Higher Education and Scientific Research; Directorate General for Scientific Research and Technological Development (DGRSDT); ARIMNet2-BOVISOL (Coordination of Agricultural Research in the Mediterranean; EC(European CommissionEuropean Commission Joint Research Centre)	This work is funded by the Algerian Ministry of Higher Education and Scientific Research and Scientific Research and from the Directorate General for Scientific Research and Technological Development (DGRSDT: http://www.dgrsdt.dz/v1/) and supported by the ARIMNet2-BOVISOL (Coordination of Agricultural Research in the Mediterranean. EC FP7 project N degrees 618127; www.arimnet2.net)-BOVISOL (Breeding and management practices of indigenous bovine breeds: Solutions towards a sustainable future) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Riofrio EL, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11120221; Alhajeri BH, 2019, LIVEST SCI, V230, DOI 10.1016/j.livsci.2019.103824; Altarriba J, 2006, ANIM RES, V55, P55, DOI 10.1051/animres:2005042; Asamoah-Boaheng M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1669-8; Aziz MMA, 2013, EMIR J FOOD AGR, V25, P723, DOI 10.9755/ejfa.v25i9.15827; Bernard A., 1919, ANN GEOGRAPHIE, P147; Boudalia S, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12239891; Boujenane I, 2015, IRAN J APPL ANIM SCI, V5, P293; Bousbia A., 2010, Livestock Research for Rural Development, V22, P121; Boushaba N, 2019, ANIMAL, V13, P8, DOI [10.1017/s1751731118001179, 10.1017/S1751731118001179]; Silva-Jarquin JC, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9070459; CARPENTER JA, 1978, J ANIM SCI, V46, P370, DOI 10.2527/jas1978.462370x; Ribeiro ELD, 2016, TROP ANIM HEALTH PRO, V48, P1305, DOI 10.1007/s11250-016-1109-3; Djaout A., 2017, Genetics and Biodiversity Journal, V1, P1; Dossa LH, 2007, SMALL RUMINANT RES, V73, P150, DOI 10.1016/j.smallrumres.2007.01.003; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Everitt B. S., 2001, CLUSTER ANAL; Fantazi K., 2017, Genetics and Biodiversity Journal, V1, P20; FAO, 2012, FAO ANIM PROD HLTH G, V11; FAO, 2007, GLOB PLAN ACT AN GEN; Feliachi K, 2003, RAPPORT NATL RESSOUR; Harek D, 2015, J CAMEL PRACT RES, V22, P1, DOI 10.5958/2277-8934.2015.00001.6; Hilal B., 2016, Animal Genetic Resources, V59, P55; Hoffmann I., 2010, ANIMAL GENETIC RESOU, V47, P1, DOI [10.1017/S2078633610001050, DOI 10.1017/S2078633610001050]; Hoffmann I, 2011, LIVEST SCI, V139, P69, DOI 10.1016/j.livsci.2011.03.016; Houessou SO, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222756; Johnson R, 1982, APPL MULTIVARIATE ST; Kugonza DR, 2011, ANIM GENET RES, V48, P13, DOI DOI 10.1017/S2078633611000038; Martin G, 2020, AGR SYST, V181, DOI 10.1016/j.agsy.2020.102821; Martins C.E.N., 2009, Arch. zootec., V58, P425, DOI 10.4321/s0004-05922009000300011; Mavule BS, 2013, SMALL RUMINANT RES, V111, P23, DOI 10.1016/j.smallrumres.2012.09.008; Mwacharo JM, 2006, TROP ANIM HEALTH PRO, V38, P65, DOI 10.1007/s11250-006-4266-y; Okpeku M., 2011, Acta Agriculturae Slovenica, V98, P101, DOI 10.2478/v10014-011-0026-4; Popoola M. A., 2018, Slovak Journal of Animal Science, V51, P45; Pundir RK, 2011, ASIAN AUSTRAL J ANIM, V24, P449, DOI 10.5713/ajas.2011.10341; Rahal O, 2021, ANIM BIOTECHNOL, V32, P699, DOI 10.1080/10495398.2020.1746321; Rastija T., 2004, ACTA AGR SLOVECIA S1, V1, P195; Sadek MH, 2006, J ANIM BREED GENET, V123, P369, DOI 10.1111/j.1439-0388.2006.00618.x; Salako A. E., 2006, Int. J. Morphol., V24, P571, DOI 10.4067/S0717-95022006000500009; Saleem M., 2013, Animal Genetic Resources, P83; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Terefe E, 2015, TROP ANIM HEALTH PRO, V47, P485, DOI 10.1007/s11250-014-0746-7; Tolenkhomba T.C., 2012, INT MULTIDISCIP RES, V2, P77; Traore A, 2016, ARCH ANIM BREED, V59, P337, DOI 10.5194/aab-59-337-2016; Vanvanhossou SFU, 2018, COGENT FOOD AGR, V4, DOI 10.1080/23311932.2018.1549767; Wainwright W, 2019, LIVEST SCI, V224, P1, DOI 10.1016/j.livsci.2019.03.016; Yakubu A, 2010, ACTA AGR SCAND A-AN, V60, P74, DOI 10.1080/09064702.2010.502242; Yakubu A., 2009, Trakia Journal of Sciences, V7, P67; Yakubu A., 2011, ACTA AGR SLOVENCIA, V96, P75	49	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255153	10.1371/journal.pone.0255153	http://dx.doi.org/10.1371/journal.pone.0255153			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310659	Green Published, gold			2022-12-26	WOS:000685224500034
J	Youngquist, MB; Boone, MD				Youngquist, Melissa B.; Boone, Michelle D.			Larval development and survival of pond-breeding anurans in an agricultural landscape impacted more by phytoplankton than surrounding habitat	PLOS ONE			English	Article							INSECTICIDE CARBARYL; TERRESTRIAL GROWTH; AQUATIC EXPOSURE; ACRIS-CREPITANS; JUVENILE FROGS; CRICKET FROG; LAND-USE; WATER; METAMORPHOSIS; CONSERVATION	The destruction of freshwater habitat is a major contributor to biodiversity loss in aquatic ecosystems. However, created or restored wetlands could partially mitigate aquatic biodiversity loss by increasing the amount of available habitat across a landscape. We investigated the impact of surrounding terrestrial habitat and water quality variables on suitability for two species of pond-breeding amphibians (bullfrogs [Lithobates catesbeianus] and Blanchard's cricket frogs [Acris blanchardi]) in created permanent wetlands located on an agricultural landscape. We examined tadpole growth and survival in field enclosures placed in ponds surrounded by agricultural, forested, or grassland habitats. We also evaluated the potential for carryover effects of the aquatic environment on terrestrial growth and overwinter survival of cricket frog metamorphs. We found that habitat adjacent to ponds did not predict tadpole growth or survival. Rather, phytoplankton abundance, which showed high variability among ponds within habitat type, was the only predictor of tadpole growth. Cricket frogs emerged larger and earlier from ponds with higher phytoplankton abundance; bullfrogs were also larger and at a more advanced developmental stage in ponds with higher levels of phytoplankton. Overwinter survival of cricket frogs was explained by size at metamorphosis and there were no apparent carryover effects of land use or pond-of-origin on overwinter growth and survival. Our results demonstrate that created ponds in human-dominated landscapes can provide suitable habitat for some anurans, independent of the adjacent terrestrial habitat.	[Youngquist, Melissa B.; Boone, Michelle D.] Miami Univ, Dept Biol, Oxford, OH 45056 USA; [Youngquist, Melissa B.] John G Shedd Aquarium, Daniel P Haerther Ctr Conservat Res, Chicago, IL USA	University System of Ohio; Miami University	Boone, MD (corresponding author), Miami Univ, Dept Biol, Oxford, OH 45056 USA.	boonemd@miamioh.edu		Youngquist, Melissa/0000-0003-2721-1871	ASG (Amphibian Specialist Group)/ARMI Seed Grant	ASG (Amphibian Specialist Group)/ARMI Seed Grant	Funding from ASG (Amphibian Specialist Group)/ARMI Seed Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade CM, 2010, J HERPETOL, V44, P591, DOI 10.1670/09-140.1; Babbitt KJ, 2009, WETLANDS, V29, P294, DOI 10.1672/07-228.1; Balcombe CK, 2005, HYDROBIOLOGIA, V541, P175, DOI 10.1007/s10750-004-5706-1; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; BERVEN KA, 1988, OECOLOGIA, V75, P67, DOI 10.1007/BF00378815; Biek R, 2002, CONSERV BIOL, V16, P728, DOI 10.1046/j.1523-1739.2002.00433.x; Boone MD, 2005, J HERPETOL, V39, P416, DOI 10.1670/187-04A.1; Boone MD, 2008, CONSERV BIOL, V22, P172, DOI 10.1111/j.1523-1739.2007.00817.x; Boone MD, 2007, ECOL APPL, V17, P291, DOI 10.1890/1051-0761(2007)017[0291:MSIACE]2.0.CO;2; Campbell Deborah A., 2002, Wetlands Ecology and Management, V10, P41, DOI 10.1023/A:1014335618914; Carfagno GLF, 2011, HERPETOLOGICA, V67, P386, DOI 10.1655/HERPETOLOGICA-D-10-00041.1; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chelgren ND, 2006, ECOL APPL, V16, P250, DOI 10.1890/04-0329; Dahl T., 1990, WETLANDS LOSSES US 1; Dahl T.E., 2011, STATUS TRENDS WETLAN, P1; Di Minin E, 2011, ECOGRAPHY, V34, P162, DOI 10.1111/j.1600-0587.2010.06263.x; Distel CA, 2010, FUNCT ECOL, V24, P1342, DOI 10.1111/j.1365-2435.2010.01749.x; Distel CA, 2009, ENVIRON TOXICOL CHEM, V28, P1963, DOI 10.1897/09-026.1; Dodds WK, 2008, BIOSCIENCE, V58, P837, DOI 10.1641/B580909; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Earl JE, 2011, FRESHWATER BIOL, V56, P2473, DOI 10.1111/j.1365-2427.2011.02672.x; Fraterrigo JM, 2008, ECOSYSTEMS, V11, P1021, DOI 10.1007/s10021-008-9176-6; Global Invasive Species Database (GISD), 2015, SPEC PROF LITH CAT SPEC PROF LITH CAT; Gosner K. L., 1960, Herpetologica, V16, P183; GRAY RH, 1983, COPEIA, P300; Gray RH, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P441; Guerry AD, 2002, CONSERV BIOL, V16, P745, DOI 10.1046/j.1523-1739.2002.00557.x; Hazell D, 2004, BIOL CONSERV, V119, P61, DOI 10.1016/j.biocon.2003.10.022; Hossler K, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00009.1; James SM, 2011, J HERPETOL, V45, P186, DOI 10.1670/10-032.1; JOHNSON LM, 1991, FRESHWATER BIOL, V25, P51, DOI 10.1111/j.1365-2427.1991.tb00472.x; KATS LB, 1988, ECOLOGY, V69, P1865, DOI 10.2307/1941163; Knoll LB, 2003, LIMNOL OCEANOGR, V48, P608, DOI 10.4319/lo.2003.48.2.0608; Knoll LB, 2014, FRESHWATER BIOL, V59, P2342, DOI 10.1111/fwb.12438; Knutson MG, 2004, ECOL APPL, V14, P669, DOI 10.1890/02-5305; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Loman J, 2006, J APPL ECOL, V43, P690, DOI 10.1111/j.1365-2664.2006.01172.x; Miller JJ, 2015, CAN J SOIL SCI, V95, P139, DOI 10.4141/CJSS-2014-082; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Peterman WE, 2014, ANIM CONSERV, V17, P275, DOI 10.1111/acv.12090; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Porej D., 2003, CD975762010 CD975762010; Porej Deni, 2005, Wetlands Ecology and Management, V13, P445, DOI 10.1007/s11273-004-0522-y; PUCKETT LJ, 1995, ENVIRON SCI TECHNOL, V29, pA408, DOI 10.1021/es00009a001; Puglis HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039590; R Core Team, 2020, R LANG ENV STAT COMP; Reichenberger S, 2007, SCI TOTAL ENVIRON, V384, P1, DOI 10.1016/j.scitotenv.2007.04.046; Rowland FE, 2015, OIKOS, V124, P1648, DOI 10.1111/oik.02106; Ruibal M, 2012, AMPHIBIA-REPTILIA, V33, P355, DOI 10.1163/15685381-00002838; Sacerdote AB, 2009, WETLANDS, V29, P1202, DOI 10.1672/08-235.1; Schiesari L, 2009, FRESHWATER BIOL, V54, P572, DOI 10.1111/j.1365-2427.2008.02134.x; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; Shulse CD, 2010, WETLANDS, V30, P915, DOI 10.1007/s13157-010-0069-z; Smith GR, 2006, AQUAT ECOL, V40, P125, DOI 10.1007/s10452-005-9015-1; Smith SV, 2002, SCI TOTAL ENVIRON, V299, P21, DOI 10.1016/S0048-9697(02)00222-X; Stoler AB, 2011, OIKOS, V120, P862, DOI 10.1111/j.1600-0706.2010.18625.x; USDA-FSA-APFO: United States Department of Agriculture Farm Service Agency Aerial Photography Field Office, 1994, DIG ORTH MOAS BUTL C DIG ORTH MOAS BUTL C; USDA-FSA-APFO: United States Department of Agriculture Farm Service Agency Aerial Photography Field Office, 2000, DIG ORTH MOAS BUTL C DIG ORTH MOAS BUTL C; Williams BK, 2008, OECOLOGIA, V155, P377, DOI 10.1007/s00442-007-0920-y; Williams BK., 2008, THESIS U MISSOURI CO THESIS U MISSOURI CO; Youngquist MB, 2017, LANDSCAPE ECOL, V32, P147, DOI 10.1007/s10980-016-0438-y; Youngquist MB, 2014, BIOL CONSERV, V175, P148, DOI 10.1016/j.biocon.2014.04.028; Zak D, 2018, ENVIRON SCI TECHNOL, V52, P6508, DOI 10.1021/acs.est.8b01036	64	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255058	10.1371/journal.pone.0255058	http://dx.doi.org/10.1371/journal.pone.0255058			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310637	gold, Green Published			2022-12-26	WOS:000685224500002
J	Takagi, S; Sasaki, Y; Koike, S; Takemoto, A; Seto, Y; Haraguchi, M; Ukaji, T; Kawaguchi, T; Sugawara, M; Saito, M; Funauchi, Y; Ae, K; Matsumoto, S; Fujita, N; Katayama, R				Takagi, Satoshi; Sasaki, Yuki; Koike, Sumie; Takemoto, Ai; Seto, Yosuke; Haraguchi, Mizuki; Ukaji, Takao; Kawaguchi, Tokuichi; Sugawara, Minoru; Saito, Masanori; Funauchi, Yuki; Ae, Keisuke; Matsumoto, Seiichi; Fujita, Naoya; Katayama, Ryohei			Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis	ONCOGENE			English	Article							OSTEOGENIC-SARCOMA; CANCER; CHEMOTHERAPY; LPA(1); AGGRUS/PODOPLANIN; ANTAGONIST; MECHANISMS	Osteosarcoma is the most common primary malignant bone cancer, with high rates of pulmonary metastasis. Osteosarcoma patients with pulmonary metastasis have worse prognosis than those with localized disease, leading to dramatically reduced survival rates. Therefore, understanding the biological characteristics of metastatic osteosarcoma and the molecular mechanisms of invasion and metastasis of osteosarcoma cells will lead to the development of innovative therapeutic intervention for advanced osteosarcoma. Here, we identified that osteosarcoma cells commonly exhibit high platelet activation-inducing characteristics, and molecules released from activated platelets promote the invasiveness of osteosarcoma cells. Given that heat-denatured platelet releasate maintained the ability to promote osteosarcoma invasion, we focused on heat-tolerant molecules, such as lipid mediators in the platelet releasate. Osteosarcoma-induced platelet activation leads to abundant lysophosphatidic acid (LPA) release. Exposure to LPA or platelet releasate induced morphological changes and increased invasiveness of osteosarcoma cells. By analyzing publicly available transcriptome datasets and our in-house osteosarcoma patient-derived xenograft tumors, we found that LPA receptor 1 (LPAR1) is notably upregulated in osteosarcoma. LPAR1 gene KO in osteosarcoma cells abolished the platelet-mediated osteosarcoma invasion in vitro and the formation of early pulmonary metastatic foci in experimental pulmonary metastasis models. Of note, the pharmacological inhibition of LPAR1 by the orally available LPAR1 antagonist, ONO-7300243, prevented pulmonary metastasis of osteosarcoma in the mouse models. These results indicate that the LPA-LPAR1 axis is essential for the osteosarcoma invasion and metastasis, and targeting LPAR1 would be a promising therapeutic intervention for advanced osteosarcoma.	[Takagi, Satoshi; Sasaki, Yuki; Koike, Sumie; Takemoto, Ai; Seto, Yosuke; Haraguchi, Mizuki; Ukaji, Takao; Katayama, Ryohei] Japanese Fdn Canc Res, Canc Chemotherapy Ctr, Div Expt Chemotherapy, Tokyo, Japan; [Kawaguchi, Tokuichi; Sugawara, Minoru] Japanese Fdn Canc Res, Canc Precis Med Ctr, Project Dev Genom Based Canc Med, Tokyo, Japan; [Saito, Masanori; Funauchi, Yuki; Ae, Keisuke] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Orthoped Oncol, Tokyo, Japan; [Matsumoto, Seiichi] Japanese Fdn Canc Res, Canc Inst Hosp, Tarcoma Ctr, Tokyo, Japan; [Fujita, Naoya] Japanese Fdn Canc Res, Canc Chemotherapy Ctr, Tokyo, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research	Katayama, R (corresponding author), Japanese Fdn Canc Res, Canc Chemotherapy Ctr, Div Expt Chemotherapy, Tokyo, Japan.	ryohei.katayama@jfcr.or.jp	Saito, Masanori/GRR-1714-2022; Katayama, Ryohei/K-8537-2014	Katayama, Ryohei/0000-0001-7394-895X; Fujita, Naoya/0000-0002-9631-9264; Saito, Masanori/0000-0002-4139-4013	MEXT/JSPS KAKENHI [JP18H06187, JP19K22572, JP17H06327, JP19H03524, JP20K21554]; Acceleration Transformative Research for Medical Innovation (ACT-M) from Japan Agency for Medical Research and Development (AMED) [JP20im0210110]; Nippon Foundation; Tokyo Biochemical Research Foundation; Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development (AMED) [JP21cm0106286, JP21cm0106205, JP21cm0106203]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Acceleration Transformative Research for Medical Innovation (ACT-M) from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Nippon Foundation(Nippon Foundation); Tokyo Biochemical Research Foundation; Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	We thank Mr. Yuki Shimizu, Ms. Miho Takami, Ms. Tomoko Oh-Hara, and Ms. Harumi Shibata from JFCR for technical assistance. This study was supported in part by MEXT/JSPS KAKENHI grant number JP18H06187 (to S Takagi), JP19K22572 (to S Takagi), JP17H06327 (to N Fujita), JP19H03524 (to R Katayama), and JP20K21554 (to R Katayama). This study was also supported in part by the Project for Cancer Research and Therapeutic Evolution (P-CREATE) grant number JP21cm0106286 (to S Takagi), JP21cm0106205 (to N Fujita) and JP21cm0106203 (to R Katayama), the Acceleration Transformative Research for Medical Innovation (ACT-M) grant number JP20im0210110 (to N Fujita) from the Japan Agency for Medical Research and Development (AMED), the grant from Nippon Foundation (to N Fujita), and Grant-inAid from the Tokyo Biochemical Research Foundation (to S Takagi).	Aljubran AH, 2009, ANN ONCOL, V20, P1136, DOI 10.1093/annonc/mdn731; Allanore Y, 2018, ARTHRITIS RHEUMATOL, V70, P1634, DOI 10.1002/art.40547; Anderson RL, 2019, NAT REV CLIN ONCOL, V16, P185, DOI 10.1038/s41571-018-0134-8; Aoki J, 2004, SEMIN CELL DEV BIOL, V15, P477, DOI 10.1016/j.semcdb.2004.05.001; Bacci G, 2001, EUR J CANCER, V37, P2030, DOI 10.1016/S0959-8049(01)00229-5; Baeyens AAL, 2020, ANNU REV IMMUNOL, V38, P759, DOI 10.1146/annurev-immunol-081519-083952; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Bousquet M, 2016, ANN ONCOL, V27, P738, DOI 10.1093/annonc/mdw009; Briccoli A, 2010, SURG ONCOL, V19, P193, DOI 10.1016/j.suronc.2009.05.002; Buergy D, 2012, INT J CANCER, V130, P2747, DOI 10.1002/ijc.27441; Casali PG, 2018, ANN ONCOL, V29, P79, DOI 10.1093/annonc/mdy310; Castelino FV, 2011, ARTHRITIS RHEUM-US, V63, P1405, DOI 10.1002/art.30262; Chatterjee M, 2020, J THROMB HAEMOST, V18, P543, DOI 10.1111/jth.14721; Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C; Durnali AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152621; Franco AT, 2015, BLOOD, V126, P582, DOI 10.1182/blood-2014-08-531582; Fujita N, 2012, J BIOCHEM, V152, P407, DOI 10.1093/jb/mvs108; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Haemmerle M, 2018, CANCER CELL, V33, P965, DOI 10.1016/j.ccell.2018.03.002; Iwano S, 2018, SCIENCE, V359, P935, DOI 10.1126/science.aaq1067; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Kansara M, 2014, NAT REV CANCER, V14, P722, DOI 10.1038/nrc3838; Kempf-Bielack B, 2005, J CLIN ONCOL, V23, P559, DOI 10.1200/JCO.2005.04.063; Knowlden S, 2014, J IMMUNOL, V192, P851, DOI 10.4049/jimmunol.1302831; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Leblanc R, 2018, BRIT J PHARMACOL, V175, P3100, DOI 10.1111/bph.14362; MEYERS PA, 1993, J CLIN ONCOL, V11, P449, DOI 10.1200/JCO.1993.11.3.449; Nagahashi M, 2018, CANCER SCI, V109, P3671, DOI 10.1111/cas.13802; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; O'Donnell VB, 2014, CIRC RES, V114, P1185, DOI 10.1161/CIRCRESAHA.114.301597; Ohashi T, 2015, EXP DERMATOL, V24, P698, DOI 10.1111/exd.12752; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Overall CM, 2006, BRIT J CANCER, V94, P941, DOI 10.1038/sj.bjc.6603043; Palmer SM, 2018, CHEST, V154, P1061, DOI 10.1016/j.chest.2018.08.1058; Pradere JP, 2007, J AM SOC NEPHROL, V18, P3110, DOI 10.1681/ASN.2007020196; Riaz A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020215; Ribi S, 2015, ONCOTARGET, V6, P7727, DOI 10.18632/oncotarget.3115; Ritter J, 2010, ANN ONCOL, V21, P320, DOI 10.1093/annonc/mdq276; ROSEN G, 1979, CANCER-AM CANCER SOC, V43, P2163, DOI 10.1002/1097-0142(197906)43:6<2163::AID-CNCR2820430602>3.0.CO;2-S; Salah S, 2014, MOL CLIN ONCOL, V2, P811, DOI 10.3892/mco.2014.325; Sano T, 2002, J BIOL CHEM, V277, P21197, DOI 10.1074/jbc.M201289200; Stone RL, 2012, NEW ENGL J MED, V366, P610, DOI 10.1056/NEJMoa1110352; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Takagi S, 2018, CLIN CANCER RES, V24, P2430, DOI 10.1158/1078-0432.CCR-17-2003; Takagi S, 2014, CANCER SCI, V105, P983, DOI 10.1111/cas.12464; Takagi S, 2014, INT J CANCER, V134, P2605, DOI 10.1002/ijc.28602; Takagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073609; Takemoto A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42186; Xiang HJ, 2020, J CANCER, V11, P3519, DOI 10.7150/jca.41841; Zhang B, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-020-1576-0	51	5	5	2	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 9	2021	40	36					5548	5558		10.1038/s41388-021-01956-6	http://dx.doi.org/10.1038/s41388-021-01956-6		JUL 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UO7MC	34302117	Green Published, hybrid			2022-12-26	WOS:000676064800003
J	Diszhazi, G; Magyar, ZE; Lisztes, E; Toth-Molnar, E; Nanasi, PP; Vennekens, R; Toth, BI; Almassy, J				Diszhazi, Gyula; Magyar, Zsuzsanna E.; Lisztes, Erika; Toth-Molnar, Edit; Nanasi, Peter P.; Vennekens, Rudi; Toth, Balazs, I; Almassy, Janos			TRPM4 links calcium signaling to membrane potential in pancreatic acinar cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE; RYANODINE-RECEPTORS; CYTOSOLIC CALCIUM; WAVE-PROPAGATION; CHANNEL TRPM4; OSCILLATIONS; CA-2+; ENTRY; ACETYLCHOLINE; ACTIVATION	Transient receptor potential cation channel subfamily M member 4 (TRPM4) is a Ca2+-activated nonselective cation channel that mediates membrane depolarization. Although, a current with the hallmarks of a TRPM4-mediated current has been previously reported in pancreatic acinar cells (PACs), the role of TRPM4 in the regulation of acinar cell function has not yet been explored. In the present study, we identify this TRPM4 current and describe its role in context of Ca2+ signaling of PACs using pharmacological tools and TRPM4-deficient mice. We found a significant Ca2+-activated cation current in PACs that was sensitive to the TRPM4 inhibitors 9-phenanthrol and 4-chloro-2-[[2-(2-chlorophenoxy)acetyl]amino]benzoic acid (CBA). We demonstrated that the CBA-sensitive current was responsible for a Ca2+-dependent depolarization of PACs from a resting membrane potential of -44.4 +/- 2.9 to -27.7 +/- 3 mV. Furthermore, we showed that Ca2+ influx was higher in the TRPM4 KO-and CBA-treated PACs than in control cells. As hormone-induced repetitive Ca2+ transients partially rely on Ca2+ influx in PACs, the role of TRPM4 was also assessed on Ca2+ oscillations elicited by physiologically relevant concentrations of the cholecystokinin analog cerulein. These data show that the amplitude of Ca2+ signals was significantly higher in TRPM4 KO than in control PACs. Our results suggest that PACs are depolarized by TRPM4 currents to an extent that results in a significant reduction of the inward driving force for Ca2+. In conclusion, TRPM4 links intracellular Ca2+ signaling to membrane potential as a negative feedback regulator of Ca2+ entry in PACs.	[Diszhazi, Gyula; Magyar, Zsuzsanna E.; Lisztes, Erika; Nanasi, Peter P.; Toth, Balazs, I; Almassy, Janos] Univ Debrecen, Fac Med, Dept Physiol, Debrecen, Hungary; [Toth-Molnar, Edit] Univ Szeged, Dept Ophthalmol, Szeged, Hungary; [Vennekens, Rudi] Katholieke Univ Leuven, VIB Ctr Brain & Dis Res, Fac Med, Lab Ion Channel Res,Dept Cellular & Mol Med,TRP R, Leuven, Belgium	University of Debrecen; Szeged University; Flanders Institute for Biotechnology (VIB); KU Leuven	Almassy, J (corresponding author), Univ Debrecen, Fac Med, Dept Physiol, Debrecen, Hungary.	almassy.janos@med.unideb.hu	vennekens, rudi/AHD-0495-2022	Vennekens, Rudi/0000-0002-2564-5150; Toth, Balazs Istvan/0000-0002-4103-4333	Lajos Szodoray Scholarship of the Faculty of Medicine, University of Debrecen; New National Excellence Program of the Ministry for Innovation and Technology [UNKP-20-5-DE-422]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; FWO-Vlaanderen; KU Leuven BOF	Lajos Szodoray Scholarship of the Faculty of Medicine, University of Debrecen; New National Excellence Program of the Ministry for Innovation and Technology; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); FWO-Vlaanderen(FWO); KU Leuven BOF	J. A. is a recipient of the Lajos Szodoray Scholarship of the Faculty of Medicine, University of Debrecen. B. I. T. was supported by the New National Excellence Program of the Ministry for Innovation and Technology (UNKP-20-5-DE-422) and the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. R. V. is supported by grants from the FWO-Vlaanderen and KU Leuven BOF (TRPLe: TRP Research Platform Leuven).	[Anonymous], 2015, PANCREAPEDIA EXOCRIN, DOI DOI 10.3998/PANC.2015.24; Burris SK, 2015, BRIT J PHARMACOL, V172, P2459, DOI 10.1111/bph.13077; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; Criddle DN, 2009, AM J PHYSIOL-GASTR L, V297, pG1085, DOI 10.1152/ajpgi.00119.2009; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Edelstein Arthur D, 2014, J Biol Methods, V1; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Gerasimenko JV, 2014, J PHYSIOL-LONDON, V592, P269, DOI 10.1113/jphysiol.2013.261784; Gerasimenko JV, 2013, P NATL ACAD SCI USA, V110, P13186, DOI 10.1073/pnas.1300910110; Gerasimenko JV, 2009, P NATL ACAD SCI USA, V106, P10758, DOI 10.1073/pnas.0904818106; Geyer N, 2015, CELL CALCIUM, V58, P160, DOI 10.1016/j.ceca.2015.03.009; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Ito K, 1997, EMBO J, V16, P242, DOI 10.1093/emboj/16.2.242; IWATSUKI N, 1977, J PHYSIOL-LONDON, V269, P723, DOI 10.1113/jphysiol.1977.sp011925; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; Kim MS, 2009, GASTROENTEROLOGY, V137, P1509, DOI 10.1053/j.gastro.2009.07.042; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Markovics A, 2019, J CELL MOL MED, V23, P6203, DOI 10.1111/jcmm.14505; MARUYAMA Y, 1993, EMBO J, V12, P3017, DOI 10.1002/j.1460-2075.1993.tb05970.x; MARUYAMA Y, 1982, NATURE, V300, P61, DOI 10.1038/300061a0; MCCANDLESS M, 1981, J PHYSIOL-LONDON, V318, P57; Mignen O, 2008, J PHYSIOL-LONDON, V586, P185, DOI 10.1113/jphysiol.2007.146258; Mogami H, 1997, CELL, V88, P49, DOI 10.1016/S0092-8674(00)81857-7; NATHANSON MH, 1992, J BIOL CHEM, V267, P18118; NATHANSON MH, 1994, J BIOL CHEM, V269, P4693; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Orabi AI, 2010, AM J PHYSIOL-GASTR L, V299, pG196, DOI 10.1152/ajpgi.00498.2009; OSIPCHUK YV, 1990, EMBO J, V9, P697, DOI 10.1002/j.1460-2075.1990.tb08162.x; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Ozhathil LC, 2018, BRIT J PHARMACOL, V175, P2504, DOI 10.1111/bph.14220; Pace RW, 2007, J PHYSIOL-LONDON, V582, P113, DOI 10.1113/jphysiol.2007.133660; Park JY, 2008, BIOCHEM BIOPH RES CO, V368, P677, DOI 10.1016/j.bbrc.2008.01.153; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; PETERSEN OH, 1991, CELL CALCIUM, V12, P135, DOI 10.1016/0143-4160(91)90015-7; PETERSEN OH, 1983, PFLUG ARCH EUR J PHY, V396, P82, DOI 10.1007/BF00584703; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PRALONG WF, 1988, FEBS LETT, V242, P79, DOI 10.1016/0014-5793(88)80989-X; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Shuttleworth TJ, 1996, BIOCHEM J, V316, P819, DOI 10.1042/bj3160819; Shuttleworth TJ, 1996, J BIOL CHEM, V271, P21720, DOI 10.1074/jbc.271.36.21720; SJODIN L, 1991, J PHYSIOL-LONDON, V444, P763; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; STREB H, 1985, J BIOL CHEM, V260, P7309; TEPIKIN AV, 1992, J BIOL CHEM, V267, P3569; TEPIKIN AV, 1992, J BIOL CHEM, V267, P14073; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; TOESCU EC, 1992, EMBO J, V11, P1623, DOI 10.1002/j.1460-2075.1992.tb05208.x; TSUNODA Y, 1990, AM J PHYSIOL, V258, pC147, DOI 10.1152/ajpcell.1990.258.1.C147; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; WARD JB, 1995, LANCET, V346, P1016, DOI 10.1016/S0140-6736(95)91695-4; Wen L, 2015, GASTROENTEROLOGY, V149, P481, DOI 10.1053/j.gastro.2015.04.015; Won JH, 2007, AM J PHYSIOL-GASTR L, V293, pG1166, DOI 10.1152/ajpgi.00352.2007; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; YULE DI, 1988, FEBS LETT, V239, P358, DOI 10.1016/0014-5793(88)80951-7; Yule DI, 1997, J BIOL CHEM, V272, P9093; YULE DI, 1991, CELL CALCIUM, V12, P145, DOI 10.1016/0143-4160(91)90016-8	63	7	7	5	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101015	10.1016/j.jbc.2021.101015	http://dx.doi.org/10.1016/j.jbc.2021.101015			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34329682	Green Published, Green Accepted, gold			2022-12-26	WOS:000706408900003
J	Dultz, G; Srikakulam, SK; Konetschnik, M; Shimakami, T; Doncheva, NT; Dietz, J; Sarrazin, C; Biondi, RM; Zeuzem, S; Tampe, R; Kalinina, OV; Welsch, C				Dultz, Georg; Srikakulam, Sanjay K.; Konetschnik, Michael; Shimakami, Tetsuro; Doncheva, Nadezhda T.; Dietz, Julia; Sarrazin, Christoph; Biondi, Ricardo M.; Zeuzem, Stefan; Tampe, Robert; Kalinina, Olga, V; Welsch, Christoph			Epistatic interactions promote persistence of NS3-Q80K in HCV infection by compensating for protein folding instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN; INHIBITORS; HELICASE; FITNESS; REPLICATION; RESISTANCE; SIMEPREVIR; STABILITY; SEQUENCE; NETWORKS	The Q80K polymorphism in the NS3-4A protease of the hepatitis C virus is associated with treatment failure of direct acting antiviral agents. This polymorphism is highly prevalent in genotype 1a infections and stably transmitted between hosts. Here, we investigated the underlying molecular mechanisms of evolutionarily conserved coevolving amino acids in NS3-Q80K and revealed potential implications of epistatic interactions in immune escape and variants persistence. Using purified protein, we characterized the impact of epistatic amino acid substitutions on the physicochemical properties and peptide cleavage kinetics of the NS3-Q80K protease. We found that Q80K destabilized the protease protein fold (p < 0.0001). Although NS3-Q80K showed reduced peptide substrate turnover (p < 0.0002), replicative fitness in an H77S.3 cell culture model of infection was not significantly inferior to the WT virus. Epistatic substitutions at residues 91 and 174 in NS3Q80K stabilized the protein fold (p < 0.0001) and leveraged the WT protease stability. However, changes in protease stability inversely correlated with enzymatic activity. In infectious cell culture, these secondary substitutions were not associated with a gain of replicative fitness in NS3-Q80K variants. Using molecular dynamics, we observed that the total number of residue contacts in NS3-Q80K mutants correlated with protein folding stability. Changes in the number of contacts reflected the compensatory effect on protein folding instability by epistatic substitutions. In summary, epistatic substitutions in NS3-Q80K contribute to viral fitness by mechanisms not directly related to RNA replication. By compensating for protein-folding instability, epistatic interactions likely protect NS3-Q80K variants from immune cell recognition.	[Dultz, Georg; Konetschnik, Michael; Dietz, Julia; Sarrazin, Christoph; Zeuzem, Stefan; Welsch, Christoph] Goethe Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany; [Srikakulam, Sanjay K.; Kalinina, Olga, V] Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res Saarland HIPS, Saarland Univ Campus, Saarbrucken, Germany; [Srikakulam, Sanjay K.] Saarland Univ, Grad Sch Comp Sci, Saarbrucken, Germany; [Srikakulam, Sanjay K.] Saarland Univ, Interdisciplinary Grad Sch Nat Prod Res, Saarbrucken, Germany; [Shimakami, Tetsuro] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Doncheva, Nadezhda T.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, Copenhagen, Denmark; [Biondi, Ricardo M.] Max Planck Gesell, Mol Targeting, Partner Inst, Inst Invest Biomed Buenos Aires IBioBA,CONICET, Buenos Aires, DF, Argentina; [Zeuzem, Stefan; Welsch, Christoph] Univ Hosp Frankfurt, Univ Ctr Infect Dis, Frankfurt, Germany; [Tampe, Robert] Goethe Univ Frankfurt, Bioctr, Inst Biochem, Frankfurt, Germany; [Kalinina, Olga, V] Saarland Univ, Med Fac, Homburg, Germany; [Kalinina, Olga, V] Saarland Informat Campus, Ctr Bioinformat, Saarbrucken, Germany; [Sarrazin, Christoph] St Josef Hosp Wiesbaden, Internal Med 2, Wiesbaden, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Saarland University; Saarland University; Kanazawa University; Novo Nordisk Foundation; University of Copenhagen; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Universitatsklinikum des Saarlandes	Welsch, C (corresponding author), Goethe Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany.; Welsch, C (corresponding author), Univ Hosp Frankfurt, Univ Ctr Infect Dis, Frankfurt, Germany.	christoph.welsch@kgu.de	Tampe, Robert/H-2953-2015	Tampe, Robert/0000-0002-0403-2160; Dultz, Georg/0000-0003-0775-0907; Doncheva, Nadezhda T./0000-0002-8806-6850; Srikakulam, Sanjay Kumar/0000-0002-1752-5060; Biondi, Ricardo/0000-0002-8873-7167	German Research Foundation grant entitled "Molecular escape mechanisms due to patterns of resistance-associated amino acid variants in the hepatitis C virus NS3 protease" [WE 4388/6-1]; Deutscher Akademischer Austauschdienst-Japan Society for the Promotion of Science Joint Research Program grant entitled "Molecular mechanisms for hep-atitis C virus NS3 variant selection" [PPP 57155496]; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of the State of Hessen; Research Center for Translational Medicine and Pharmacology TMP; Else Kroner-Fresenius Foundation, ResearchTraining Group Translational Research Innovation-Pharma TRIP; DZIF German Center for Infection Research grant entitled "Geno-& phenotypic NS3, NS5A and NS5B inhibitor resistance analysis" [TTU 05.902]	German Research Foundation grant entitled "Molecular escape mechanisms due to patterns of resistance-associated amino acid variants in the hepatitis C virus NS3 protease"; Deutscher Akademischer Austauschdienst-Japan Society for the Promotion of Science Joint Research Program grant entitled "Molecular mechanisms for hep-atitis C virus NS3 variant selection"; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of the State of Hessen; Research Center for Translational Medicine and Pharmacology TMP; Else Kroner-Fresenius Foundation, ResearchTraining Group Translational Research Innovation-Pharma TRIP; DZIF German Center for Infection Research grant entitled "Geno-& phenotypic NS3, NS5A and NS5B inhibitor resistance analysis"	C. W. was supported by the German Research Foundation grant entitled "Molecular escape mechanisms due to patterns of resistance-associated amino acid variants in the hepatitis C virus NS3 protease" (WE 4388/6-1) . T. S. and C. W. acknowledge support by the Deutscher Akademischer Austauschdienst-Japan Society for the Promotion of Science Joint Research Program grant entitled "Molecular mechanisms for hep-atitis C virus NS3 variant selection" (PPP 57155496) . C. W. and S. Z. acknowledge support by the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of the State of Hessen, Research Center for Translational Medicine and Pharmacology TMP, and the Else Kroner-Fresenius Foundation, ResearchTraining Group Translational Research Innovation-Pharma TRIP. C. S. was supported by a DZIF German Center for Infection Research grant entitled "Geno-& phenotypic NS3, NS5A and NS5B inhibitor resistance analysis" (TTU 05.902) .	Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Bigman LS, 2020, CURR OPIN STRUC BIOL, V60, P50, DOI 10.1016/j.sbi.2019.11.005; Bigman LS, 2018, J PHYS CHEM B, V122, P11450, DOI 10.1021/acs.jpcb.8b07379; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dietz J, 2018, GASTROENTEROLOGY, V154, P976, DOI 10.1053/j.gastro.2017.11.007; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Doncheva NT, 2019, J MOL BIOL, V431, P2354, DOI 10.1016/j.jmb.2019.04.034; Doncheva NT, 2011, TRENDS BIOCHEM SCI, V36, P179, DOI 10.1016/j.tibs.2011.01.002; Dultz G, 2020, J BIOL CHEM, V295, P13862, DOI 10.1074/jbc.RA120.013898; Engler OB, 2004, VACCINE, V23, P58, DOI 10.1016/j.vaccine.2004.05.009; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Gotte M., 2017, HDB ANTIMICROBIAL RE, V1st; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guedj J, 2010, J THEOR BIOL, V267, P330, DOI 10.1016/j.jtbi.2010.08.036; Harrington PR, 2018, HEPATOLOGY, V67, P2430, DOI 10.1002/hep.29693; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Klein EY, 2018, MSPHERE, V3, DOI 10.1128/mSphereDirect.00554-17; Lenz O, 2015, J HEPATOL, V62, P1008, DOI 10.1016/j.jhep.2014.11.032; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Martin-Garcia F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121114; McCloskey RM, 2015, J INFECT DIS, V211, P1288, DOI 10.1093/infdis/jiu613; McGivern DR, 2015, J VIROL, V89, P5362, DOI 10.1128/JVI.03188-14; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miton CM, 2020, METHOD ENZYMOL, V643, P243, DOI 10.1016/bs.mie.2020.07.012; Murai K, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02601-17, 10.1128/aac.02601-17]; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peres-da-Silva A, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11080691; Pham LV, 2019, J HEPATOL, V70, P388, DOI 10.1016/j.jhep.2018.10.031; Raab M, 2018, ACS CHEM BIOL, V13, P1921, DOI 10.1021/acschembio.7b01078; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Sarrazin C, 2015, ANTIVIR RES, V116, P10, DOI 10.1016/j.antiviral.2015.01.003; Scheiblhofer S, 2017, EXPERT REV VACCINES, V16, P479, DOI 10.1080/14760584.2017.1306441; Schmidt J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003042; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sheldon J, 2014, J VIROL, V88, P12098, DOI 10.1128/JVI.01860-14; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Soderholm J, 2006, GUT, V55, P266, DOI 10.1136/gut.2005.072231; Taremi SS, 1998, PROTEIN SCI, V7, P2143, DOI 10.1002/pro.5560071011; Vallet S, 2005, J MED VIROL, V75, P528, DOI 10.1002/jmv.20302; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; VanderWeele TJ, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1517; Verbinnen T, 2015, ANTIMICROB AGENTS CH, V59, P7548, DOI 10.1128/AAC.01444-15; Welsch C, 2015, J HEPATOL, V62, P779, DOI 10.1016/j.jhep.2014.11.009; Welsch C, 2012, GASTROENTEROLOGY, V142, P654, DOI 10.1053/j.gastro.2011.11.035; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2006, J BIOL CHEM, V281, P8205, DOI 10.1074/jbc.M510246200; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104; Zerihun MB, 2017, BIOCHEM SOC T, V45, P1253, DOI 10.1042/BST20170063	62	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101031	10.1016/j.jbc.2021.101031	http://dx.doi.org/10.1016/j.jbc.2021.101031			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34339738	Green Published, gold			2022-12-26	WOS:000704369100015
J	Solomon, S; Akeju, O; Odumade, OA; Ambachew, R; Gebreyohannes, Z; Van Wickle, K; Abayneh, M; Metaferia, G; Carvalho, MJ; Thomson, K; Sands, K; Walsh, TR; Milton, R; Goddard, FGB; Bekele, D; Chan, GCJ				Solomon, Semaria; Akeju, Oluwasefunmi; Odumade, Oludare A.; Ambachew, Rozina; Gebreyohannes, Zenebe; Van Wickle, Kimi; Abayneh, Mahlet; Metaferia, Gesit; Carvalho, Maria J.; Thomson, Kathryn; Sands, Kirsty; Walsh, Timothy R.; Milton, Rebecca; Goddard, Frederick G. B.; Bekele, Delayehu; Chan, Grace J.			Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis	PLOS ONE			English	Article							INTRAPARTUM ANTIBIOTIC EXPOSURE; BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; NEONATAL SEPSIS; ASSOCIATION; EPIDEMIOLOGY; PATHOGENS; ERA	Introduction Newborn sepsis accounts for more than a third of neonatal deaths globally and one in five neonatal deaths in Ethiopia. The first-line treatment recommended by WHO is the combination of gentamicin with ampicillin or benzylpenicillin. Gram-negative bacteria (GNB) are increasingly resistant to previously effective antibiotics. Objectives Our goal was to estimate the prevalence of antibiotic-resistant gram-negative bacteremia and identify risk factors for antibiotic resistance, among newborns with GNB sepsis. Methods At a tertiary hospital in Ethiopia, we enrolled a cohort pregnant women and their newborns, between March and December 2017. Newborns who were followed up until 60 days of life for clinical signs of sepsis. Among the newborns with clinical signs of sepsis, blood samples were cultured; bacterial species were identified and tested for antibiotic susceptibility. We described the prevalence of antibiotic resistance, identified newborn, maternal, and environmental factors associated with multidrug resistance (MDR), and combined resistance to ampicillin and gentamicin (AmpGen), using multivariable regression. Results Of the 119 newborns with gram-negative bacteremia, 80 (67%) were born preterm and 82 (70%) had early-onset sepsis. The most prevalent gram-negative species were Klebsiella pneumoniae 94 (79%) followed by Escherichia coli 10 (8%). Ampicillin resistance was found in 113 cases (95%), cefotaxime 104 (87%), gentamicin 101 (85%), AmpGen 101 (85%), piperacillin-tazobactam 47 (39%), amikacin 10 (8.4%), and Imipenem 1 (0.8%). Prevalence of MDR was 88% (n = 105). Low birthweight and late-onset sepsis (LOS) were associated with higher risks of AmpGen-resistant infections. All-cause mortality was higher among newborns treated with ineffective antibiotics. Conclusion There was significant resistance to current first-line antibiotics and cephalosporins. Additional data are needed from primary care and community settings. Amikacin and piperacillin-tazobactam had lower rates of resistance; however, context-specific assessments of their potential adverse effects, their local availability, and cost-effectiveness would be necessary before selecting a new first-line regimen to help guide clinical decision-making.	[Solomon, Semaria; Ambachew, Rozina; Gebreyohannes, Zenebe; Abayneh, Mahlet; Metaferia, Gesit; Bekele, Delayehu; Chan, Grace J.] St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia; [Akeju, Oluwasefunmi; Van Wickle, Kimi; Goddard, Frederick G. B.; Bekele, Delayehu; Chan, Grace J.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Odumade, Oludare A.; Chan, Grace J.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA; [Carvalho, Maria J.; Thomson, Kathryn; Sands, Kirsty; Walsh, Timothy R.; Milton, Rebecca] Cardiff Univ, Div Infect & Immun, Cardiff, Wales; [Carvalho, Maria J.] Univ Aveiro, Inst Biomed, Dept Med Sci, Aveiro, Portugal; [Sands, Kirsty] Univ Oxford, Dept Zool, Oxford, England; [Walsh, Timothy R.] Univ Oxford, Ineos Oxford Inst Antimicrobial Res, Dept Zool, Oxford, England; [Milton, Rebecca] Cardiff Univ, Ctr Trials Res, Cardiff, Wales	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard Medical School; Cardiff University; Universidade de Aveiro; University of Oxford; University of Oxford; Cardiff University	Chan, GCJ (corresponding author), St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia.; Chan, GCJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.; Chan, GCJ (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Boston, MA 02115 USA.	grace.chan@hsph.harvard.edu		Bekele, Delayehu/0000-0002-9243-2622; Carvalho, Maria J/0000-0001-6819-927X; Van Wickle, Kimi/0000-0003-4446-9970; Milton, Rebecca/0000-0001-5985-3866	Bill & Melinda Gates Foundation [OPP1119772]; Boston Children's Global Health Program	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Boston Children's Global Health Program	This study was funded by the Bill & Melinda Gates Foundation https://www.gatesfoundation.org/OPP1119772 (TRW GJC). GJC and OAO received funding from the Boston Children's Global Health Program https://www.childrenshospital.org/globalhealth.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almohammady MN, 2020, J TAIBAH UNIV MED SC, V15, P39, DOI 10.1016/j.jtumed.2019.12.005; [Anonymous], 2020, WORLD HLTH ORG, DOI DOI 10.1080/09639284.2021.1971095; Ashkenazi-Hoffnung L, 2011, CLIN PEDIATR, V50, P827, DOI 10.1177/0009922811406260; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Bromiker R, 2013, NEONATOLOGY, V103, P48, DOI 10.1159/000342215; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Camacho-Gonzalez A, 2013, PEDIATR CLIN N AM, V60, P367, DOI 10.1016/j.pcl.2012.12.003; Chan GJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001502; Chen D., 2018, COOUTBREAK ST37 NOVE, P334169; Chong E, 2013, J PERINATOL, V33, P529, DOI 10.1038/jp.2012.169; Collins A, 2018, ARCH DIS CHILD-FETAL, V103, pF391, DOI 10.1136/archdischild-2017-313595; Crichton H, 2018, SAMJ S AFR MED J, V108, P99, DOI [10.7196/SAMJ.2018.v108i2.12601, 10.7196/samj.2018.v108i2.12601, 10.7196/SAMJ.2017.v108i2.12601]; Dagnew Mulat, 2013, BMC Res Notes, V6, P283, DOI 10.1186/1756-0500-6-283; Dramowski A, 2015, PAEDIATR INT CHILD H, V35, P265, DOI 10.1179/2046905515Y.0000000029; Enweronu-Laryea C C, 2007, East Afr Med J, V84, P136; Exner M, 2017, GMS HYG INFECT CONTR, V12, DOI 10.3205/dgkh000290; Fletcher S, 2015, ENVIRON HEALTH PREV, V20, P243, DOI 10.1007/s12199-015-0468-0; Flidel-Rimon O, 2006, SCAND J INFECT DIS, V38, P36, DOI 10.1080/00365540500372879; Fottrell E, 2015, ARCH DIS CHILD-FETAL, V100, pF439, DOI 10.1136/archdischild-2014-307636; Frenk S, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9100705; Fuchs A, 2016, WHO REV; Garces AL, 2017, ACTA PAEDIATR, V106, P904, DOI 10.1111/apa.13805; Geyesus T, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0892-y; Glasgow TS, 2005, PEDIATRICS, V116, P696, DOI 10.1542/peds.2004-2421; Goldman JA., 2011, FLUOROQUINOLONE USE, P1; Hyde TB, 2002, PEDIATRICS, V110, P690, DOI 10.1542/peds.110.4.690; Ipek MS, 2019, J PEDIAT INF DIS-GER, V14, P103, DOI 10.1055/s-0038-1675582; Kabwe M, 2016, PEDIATR INFECT DIS J, V35, pE191, DOI 10.1097/INF.0000000000001154; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Liang L, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00277; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Liu C, 2020, VIRULENCE, V11, P1215, DOI 10.1080/21505594.2020.1809322; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mahajan G, 2013, ANTIMICROB AGENTS CH, V57, P5315, DOI 10.1128/AAC.01059-13; Meletis G, 2016, THER ADV INFECT DIS, V3, P15, DOI 10.1177/2049936115621709; Mercer BM, 1999, AM J OBSTET GYNECOL, V181, P816, DOI 10.1016/S0002-9378(99)70307-8; Mohsen L, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0225-9; Munita JM, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0016-2015; Najafi M, 2003, RES PHEN MICR INF DI; Negussie Adugna, 2015, Int J Biol Med Res, V6, P4709; Okomo U, 2019, LANCET INFECT DIS, V19, P1219, DOI 10.1016/S1473-3099(19)30414-1; Peters L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215666; Pokhrel B, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1176-x; Raymond B, 2019, EVOL APPL, V12, P1079, DOI 10.1111/eva.12808; Sands K, 2021, NAT MICROBIOL, V6, P512, DOI 10.1038/s41564-021-00870-7; Schrag SJ, 2006, PEDIATRICS, V118, P570, DOI 10.1542/peds.2005-3083; Senok AC, 2012, EMERGENCE SPREAD ANT; Sewunet T, 2021, JAC-ANTIMICROB RESIS, V3, DOI 10.1093/jacamr/dlab001; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Sorsa A, 2019, ETHIOP J HEALTH SCI, V29, P333, DOI 10.4314/ejhs.v29i3.5; Sorsa A, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0486-6; Vaidya Varsha K, 2011, J Lab Physicians, V3, P37, DOI 10.4103/0974-2727.78563; Williams PCM, 2020, J PAEDIATR CHILD H, V56, P864, DOI 10.1111/jpc.14883; Woldu MA., 2017, INT J CONT PEDIAT, V1, P135; Worku Fikru, 2018, Interdiscip Perspect Infect Dis, V2018, P4323769, DOI 10.1155/2018/4323769; World Health Organization, 2015, GLOB ACT PLAN ANT RE; World Health Organization, 2013, GUIDELINES MANAGEMEN; Yan J. J., 2015, New Microbes and New Infections, V5, P1, DOI 10.1016/j.nmni.2015.01.002; Yismaw Gizachew, 2010, Ethiop Med J, V48, P293; Yusef D, 2018, PEDIATR NEONATOL, V59, P35, DOI 10.1016/j.pedneo.2017.06.001; Zhong XS, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-1702-5	61	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255410	10.1371/journal.pone.0255410	http://dx.doi.org/10.1371/journal.pone.0255410			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343185	gold, Green Published, Green Accepted			2022-12-26	WOS:000685264200002
J	Ni, JM; Ni, AP				Ni, Jieming; Ni, Anping			Histone deacetylase inhibitor induced pVHL-independent degradation of HIF-1 alpha and hierarchical quality control of pVHL via chaperone system	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; EPITHELIAL OVARIAN-CANCER; SIGNALING PATHWAY; GLUT-1 EXPRESSION; TUMOR-GROWTH; ANGIOGENESIS; PROTEIN; CELLS; HIF-1; GENE	The mortality rate of ovarian cancer is increasing and the role of hypoxia inducible factor-1 alpha (HIF-1 alpha) in tumor progression has been confirmed. von Hippel-Lindau tumor suppressor protein (pVHL) binds HIF-1 alpha and mediates proteasome degradation of HIF-1 alpha. Besides, histone deacetylase inhibitor (HDACi) mitigates tumor growth via targeting HIF-1 alpha, whereas underlying mechanism still requires investigation. In this research, we exposed ovarian cancer cell lines OV-90 and SKOV-3 to escalating concentrations of HDACi LBH589. As a result, cell viability was significantly suppressed and expression of HIF-1 alpha was remarkably reduced along with decreased levels of signal molecules, including phosphoinositide 3-kinase (PI3K) and glycogen synthase kinase 3 beta (GSK3 beta) (P = 0.000). Interestingly, pVHL was expressed in a notably declining tendency (P = 0.000). Chaperone heat shock protein-70 (HSP70) was expressed in an ascending manner, whereas expression of chaperonin TCP-1 alpha was reduced clearly (P = 0.000). Besides, co-inhibition of pVHL plus HDAC did not contribute to a remarkable difference in HIF-1 alpha expression as compared with single HDAC inhibition. Furthermore, both cell lines were transfected with plasmids of VHL plus VHL binding protein-1 (VBP-1). Consequently, the expression of HIF-1 alpha as well as lactate dehydrogenase-A (LDHA) was remarkably decreased (P = 0.000). These findings indicate HDACi may repress expression of HIF-1 alpha via inhibiting PI3K and GSK3 beta and promote degradation of HIF-1 alpha via HSP70, independent of pVHL. Additionally, a sophisticated network of HDAC and chaperones may involve in pVHL quality control.	[Ni, Jieming; Ni, Anping] Chinese Acad Med Sci & Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Ni, AP (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Beijing, Peoples R China.	nianping1960@163.com						Al-Sharaky DR, 2016, J CLIN DIAGN RES, V10, pEC20, DOI 10.7860/JCDR/2016/19576.7805; Andreev E, 2016, SCI REP-UK, V6, DOI 10.1038/srep20508; Banks CAS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32009-w; Beaufort CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103988; Bohonowych JES, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-520; Brandon AD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67533-1; Brophy S, 2009, INT J CANCER, V125, P2778, DOI 10.1002/ijc.24693; Calcinotto A, 2012, CANCER RES, V72, P2746, DOI 10.1158/0008-5472.CAN-11-1272; Campbell EJ, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5503-x; Cassavaugh JM, 2011, J CELL BIOCHEM, V112, P3882, DOI 10.1002/jcb.23321; Chen L, 2020, THERANOSTICS, V10, P3562, DOI 10.7150/thno.39944; Chen SY, 2015, CELL CYCLE, V14, P2520, DOI 10.1080/15384101.2015.1055426; Courtnay R, 2015, MOL BIOL REP, V42, P841, DOI 10.1007/s11033-015-3858-x; Cui XG, 2017, ONCOTARGET, V8, P24840, DOI 10.18632/oncotarget.15266; Daponte A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-335; Dela Cruz M, 2017, ONCOTARGET, V8, P20543, DOI 10.18632/oncotarget.16129; Duan LY, 2020, J OVARIAN RES, V13, DOI 10.1186/s13048-020-00646-3; Endo H, 2020, INT IMMUNOL, V32, P175, DOI 10.1093/intimm/dxz074; Englert-Golon M, 2017, ONCOL LETT, V14, P3401, DOI 10.3892/ol.2017.6590; Farooq M, 2013, ASIAN PAC J CANCER P, V14, P915, DOI 10.7314/APJCP.2013.14.2.915; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Filatova A, 2016, CANCER RES, V76, P5845, DOI 10.1158/0008-5472.CAN-15-2630; Ganapathy-Kanniappan S, 2017, BBA-REV CANCER, V1868, P212, DOI 10.1016/j.bbcan.2017.04.002; Garrett LA, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0267-2; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Hansen WJ, 2002, MOL CELL BIOL, V22, P1947, DOI 10.1128/MCB.22.6.1947-1960.2002; Iaconelli J, 2017, ACS CHEM BIOL, V12, P2139, DOI 10.1021/acschembio.6b01014; Ji F, 2013, INT J ONCOL, V42, P1578, DOI 10.3892/ijo.2013.1878; Jiang YG, 2007, INT J UROL, V14, P1034, DOI 10.1111/j.1442-2042.2007.01866.x; Jin Y, 2014, TUMOR BIOL, V35, P8149, DOI 10.1007/s13277-014-2059-x; Kataria Nalin, 2019, Cell Physiol Biochem, V53, P480, DOI 10.33594/000000152; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Kim JA, 2018, FEBS J, V285, P115, DOI 10.1111/febs.14322; Kim OH, 2020, INT J ONCOL, V56, P1509, DOI 10.3892/ijo.2020.5018; Ko YS, 2016, APMIS, V124, P748, DOI 10.1111/apm.12569; Langdon S P, 2001, Methods Mol Med, V39, P155, DOI 10.1385/1-59259-071-3:155; Li LN, 2015, PHARMACOL THERAPEUT, V150, P33, DOI 10.1016/j.pharmthera.2015.01.004; Liu M, 2007, J BIOL CHEM, V282, P17581, DOI 10.1074/jbc.M702206200; Liu SH, 2020, CANCER MANAG RES, V12, P6195, DOI 10.2147/CMAR.S254784; Liu XX, 2020, ADV SCI, V7, DOI 10.1002/advs.201902040; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Luo ZY, 2018, THERANOSTICS, V8, P3584, DOI 10.7150/thno.25409; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Matulonis U, 2015, CANCER CHEMOTH PHARM, V76, P417, DOI 10.1007/s00280-015-2813-9; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Osada R, 2007, HUM PATHOL, V38, P1310, DOI 10.1016/j.humpath.2007.02.010; Parmakhtiar B, 2019, MOL CANCER RES, V17, P1675, DOI 10.1158/1541-7786.MCR-18-1109; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Sadlecki P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/616850; Saieva L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113832; Schoepflin ZR, 2016, J BONE MINER RES, V31, P1287, DOI 10.1002/jbmr.2787; Song CL, 2016, ONCOGENE, V35, P631, DOI 10.1038/onc.2015.121; Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15; Talekar M, 2014, EXPERT OPIN BIOL TH, V14, P1145, DOI 10.1517/14712598.2014.912270; Taylor SE, 2020, GYNECOL ONCOL, V156, P32, DOI 10.1016/j.ygyno.2019.10.029; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Webb PM, 2017, BEST PRACT RES CL OB, V41, P3, DOI 10.1016/j.bpobgyn.2016.08.006; Wu X, 2020, BRIT J HAEMATOL, V190, P52, DOI 10.1111/bjh.16503; Yang YZ, 2013, J CELL BIOCHEM, V114, P967, DOI 10.1002/jcb.24438; Yao ZG, 2017, J NEUROPATH EXP NEUR, V76, P1000, DOI 10.1093/jnen/nlx088; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Zhao P, 2015, ONCOTARGET, V6, P31901, DOI 10.18632/oncotarget.5043; Zhao Y, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0648-1; Zhou J, 2004, J BIOL CHEM, V279, P13506, DOI 10.1074/jbc.M310164200	67	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0248019	10.1371/journal.pone.0248019	http://dx.doi.org/10.1371/journal.pone.0248019			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329303	gold, Green Published			2022-12-26	WOS:000685248600032
J	Bsteh, G; Assar, H; Hegen, H; Heschl, B; Leutmezer, F; Di Pauli, F; Gradl, C; Traxler, G; Zulehner, G; Rommer, P; Wipfler, P; Guger, M; Enzinger, C; Berger, T				Bsteh, Gabriel; Assar, Hamid; Hegen, Harald; Heschl, Bettina; Leutmezer, Fritz; Di Pauli, Franziska; Gradl, Christiane; Traxler, Gerhard; Zulehner, Gudrun; Rommer, Paulus; Wipfler, Peter; Guger, Michael; Enzinger, Christian; Berger, Thomas		AUT-MuSC investigators	COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry	PLOS ONE			English	Article								Background The COVID-19 pandemic challenges neurologists in counselling patients with multiple sclerosis (pwMS) regarding their risk by SARS-CoV-2 and in guiding disease-modifying treatment (DMT). Objective To characterize the prevalence and outcome of COVID-19 in pwMS specifically associated with different DMT in a nationwide population-based study. Methods We included patients aged >= 18 years with a confirmed diagnosis of MS and a diagnosis of COVID-19 established between January 1, 2020 and December 31, 2020. We classified COVID-19 course as either mild, severe or fatal. Impact of DMT and specifically immunosuppressants (alemtuzumab, cladribine, fingolimod, ocrelizumab or rituximab) on COVID-19 outcome was determined by multivariable models, adjusted for a-priori-risk. Results Of 126 MS patients with COVID-19 (mean age 43.2 years [SD 13.4], 71% female), 86.5% had a mild course, 9.5% a severe course and 3.2% died from COVID-19. A-priori-risk significantly predicted COVID-19 severity (R-2 0.814; p<0.001) and mortality (R-2 0.664; p<0.001). Adjusting for this a-priori-risk, neither exposure to any DMT nor exposure to specific immunosuppressive DMT were significantly associated with COVID-19 severity (odds ratio [OR] 1.6; p = 0.667 and OR 1.9; p = 0.426) or mortality (OR 0.5; p = 0.711 and 2.1; 0.233) when compared to no DMT. Conclusions In a population-based MS cohort, COVID-19 outcome was not associated with exposure to DMT and immunosuppressive DMT when accounting for other already known risk factors. This provides reassuring evidence that COVID-19 risk can be individually anticipated in MS and-except for a very small proportion of high-risk patients-treatment decisions should be primarily focused on treating MS rather than the pandemic.	[Bsteh, Gabriel; Leutmezer, Fritz; Zulehner, Gudrun; Rommer, Paulus; Berger, Thomas; AUT-MuSC investigators] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Assar, Hamid] Kepler Univ Hosp, Dept Neurol, Linz, Austria; [Hegen, Harald; Di Pauli, Franziska] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Heschl, Bettina; Enzinger, Christian] Med Univ Graz, Dept Neurol, Graz, Austria; [Gradl, Christiane] Med Univ St Polten, Dept Neurol, St Polten, Austria; [Traxler, Gerhard; Guger, Michael] Kepler Univ Hosp GmbH, Dept Neurol 2, Med Campus 3, Linz, Austria; [Wipfler, Peter] Paracelsus Med Univ Salzburg, Dept Neurol, Salzburg, Austria	Medical University of Vienna; Kepler University Hospital; Medical University of Innsbruck; Medical University of Graz; Paracelsus Private Medical University	Bsteh, G (corresponding author), Med Univ Vienna, Dept Neurol, Vienna, Austria.	gabriel.bsteh@meduniwien.ac.at	Berger, Thomas U/HGA-3594-2022	Wipfler, Peter/0000-0003-4982-4855				Agentur fur Gesundheit und Ernahrungssicherheit (AGES), 2020, AGES DASHB COVID 19; Amor S, 2020, ANN NEUROL, V87, P794, DOI 10.1002/ana.25770; Asamer EM, 2016, AUST J STAT, V45, P3, DOI 10.17713/ajs.v45i2.97; Baker D, 2020, CLIN EXP IMMUNOL, V202, P149, DOI 10.1111/cei.13495; Berger JR, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000761; Brownlee W, 2020, NEUROLOGY, V94, P949, DOI 10.1212/WNL.0000000000009507; Bsteh G, 2021, EUR J NEUROL, V28, P3369, DOI 10.1111/ene.14555; Bsteh G, 2017, J NEUROL SCI, V376, P71, DOI 10.1016/j.jns.2017.03.002; Capasso N, 2020, J CLIN MED, V9, DOI 10.3390/jcm9124066; Council National Research (CNR), 2010, PREVENTION TREATMENT, DOI [10.17226/12955, DOI 10.17226/12955]; Evangelou N, 2021, J NEUROL NEUROSUR PS, V92, P107, DOI [10.1136/jnnp-2020-324449, 10.13039/501100000381]; Grebenciucova E, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0800-8; Hamer M, 2020, BRAIN BEHAV IMMUN, V87, P184, DOI 10.1016/j.bbi.2020.05.059; Kovvuru S, 2021, J NEUROL SCI, V420, DOI 10.1016/j.jns.2020.117230; Loonstra FC, 2020, MULT SCLER J, V26, P1256, DOI 10.1177/1352458520942198; Louapre C, 2020, JAMA NEUROL, V77, P1079, DOI 10.1001/jamaneurol.2020.2581; Maillart E, 2020, MULT SCLER RELAT DIS, V46, DOI 10.1016/j.msard.2020.102482; Manacorda T, 2021, J HEALTH SERV RES PO, V26, P189, DOI 10.1177/1355819620975069; Mateen FJ, 2020, J NEUROL, V267, P3467, DOI 10.1007/s00415-020-10045-9; Minden SL, 2004, NEUROREHABILITATION, V19, P55; Mohn N, 2020, J CLIN MED, V9, DOI 10.3390/jcm9124067; Parrotta E, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000835; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Salhofer-Polanyi S, 2017, NEUROEPIDEMIOLOGY, V49, P40, DOI 10.1159/000479696; Sharifian-Dorche M, 2021, MULT SCLER RELAT DIS, V50, DOI 10.1016/j.msard.2021.102800; Sormani MP, 2021, ANN NEUROL, V89, P780, DOI 10.1002/ana.26028; Sormani MP, 2020, LANCET NEUROL, V19, P481, DOI 10.1016/S1474-4422(20)30147-2; Talaat F, 2020, MULT SCLER RELAT DIS, V46, DOI 10.1016/j.msard.2020.102580; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Tian JB, 2020, LANCET ONCOL, V21, P893, DOI 10.1016/S1470-2045(20)30309-0; Wang ZL, 2020, CLIN INFECT DIS, V71, P769, DOI 10.1093/cid/ciaa272; World Health Organization, 2021, NOV COR 2019 NCOV SI; Zavascki AP, 2020, NEW ENGL J MED, V382, P1859, DOI 10.1056/NEJMc2005203; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	34	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255316	10.1371/journal.pone.0255316	http://dx.doi.org/10.1371/journal.pone.0255316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314457	Green Published, gold			2022-12-26	WOS:000685225200017
J	Janaka, SK; Clark, NM; Evans, DT; Mou, HH; Farzan, M; Connor, JP				Janaka, Sanath Kumar; Clark, Natasha M.; Evans, David T.; Mou, Huihui; Farzan, Michael; Connor, Joseph P.			Predicting the efficacy of COVID-19 convalescent plasma donor units with the Lumit Dx anti-receptor binding domain assay	PLOS ONE			English	Article								Background The novel coronavirus SARS-CoV2 that causes COVID-19 has resulted in the death of more than 2.5 million people, but no cure exists. Although passive immunization with COVID-19 convalescent plasma (CCP) provides a safe and viable therapeutic option, the selection of optimal units for therapy in a timely fashion remains a barrier. Study design and methods Since virus neutralization is a necessary characteristic of plasma that can benefit recipients, the neutralizing titers of plasma samples were measured using a retroviral-pseudotype assay. Binding antibody titers to the spike (S) protein were also determined by a clinically available serological assay (Ortho-Vitros total IG), and an in-house ELISA. The results of these assays were compared to a measurement of antibodies directed to the receptor binding domain (RBD) of the SARS-CoV2 S protein (Promega Lumit Dx). Results All measures of antibodies were highly variable, but correlated, to different degrees, with each other. However, the anti-RBD antibodies correlated with viral neutralizing titers to a greater extent than the other antibody assays. Discussion Our observations support the use of an anti-RBD assay such as the Lumit Dx assay, as an optimal predictor of the neutralization capability of CCP.	[Janaka, Sanath Kumar; Clark, Natasha M.; Evans, David T.; Connor, Joseph P.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA; [Evans, David T.] Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Mou, Huihui; Farzan, Michael] Scripps Res Inst, Jupiter, FL USA	University of Wisconsin System; University of Wisconsin Madison; Scripps Research Institute	Connor, JP (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA.	jconnor@UWHealth.org		Clark, Natasha/0000-0002-3152-892X; Connor, Joseph/0000-0002-1799-8335	Research and Development funds; University of Wisconsin Department of Pathology and Laboratory Medicine; University of Wisconsin Carbone Cancer Center (UWCCC); NIH/NCI [P30 CA014520-UW]	Research and Development funds; University of Wisconsin Department of Pathology and Laboratory Medicine; University of Wisconsin Carbone Cancer Center (UWCCC); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by Research and Development funds provided to Joseph Connor, MD by the University of Wisconsin Department of Pathology and Laboratory Medicine. Parts of this study were supported by the University of Wisconsin Carbone Cancer Center (UWCCC) through the use of its shared services (BioBank). These shared services are supported in part by NIH/NCI P30 CA014520-UW Comprehensive Cancer Center Support.	Agarwal A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3939; Janaka Sanath Kumar, 2021, medRxiv, DOI 10.1101/2021.02.25.21252463; Joyner M. J, 2020, MEDRXIV, DOI [https://doi.org/10.1101/2020.08.12.20169359, DOI 10.1101/2020.08.12.20169359, 10.1101/2020.08.12.20169359]; Katz LM, 2021, NEW ENGL J MED, V384, P666, DOI 10.1056/NEJMe2035678; Klein Sabra, 2020, medRxiv, DOI [10.1172/JCI142004, 10.1101/2020.06.26.20139063]; Ko JH, 2020, J CLIN MED, V9, DOI 10.3390/jcm9072268; Li L, 2020, JAMA-J AM MED ASSOC, V324, P519, DOI 10.1001/jama.2020.13216; Li L, 2020, TRANSFUSION, V60, P1765, DOI 10.1111/trf.15918; Libster R, 2021, NEW ENGL J MED, V384, P610, DOI 10.1056/NEJMoa2033700; Liu STH, 2020, NAT MED, V26, P1708, DOI 10.1038/s41591-020-1088-9; Muecksch Frauke, 2020, medRxiv, DOI 10.1101/2020.08.05.20169128; Papenburg J., 2021, EVALUATION COMMERCIA, DOI [10.1101/2021.01.23.21250325, DOI 10.1101/2021.01.23.21250325]; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Routhu N. K., 2020, PREPRINT, DOI [10.1101/2020.06.27.175166, DOI 10.1101/2020.06.27.175166]; Salazar Eric, 2020, bioRxiv, DOI 10.1101/2020.06.08.138990; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Wang K, 2020, CLIN INFECT DIS, V71, P2079, DOI 10.1093/cid/ciaa538; Weidner L, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104540; Wu F, 2020, JAMA INTERN MED, V180, P1356, DOI 10.1001/jamainternmed.2020.4616; Zhang Lizhou, 2020, bioRxiv, DOI 10.1101/2020.06.12.148726; Zost SJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-0998-x, 10.1101/2020.05.12.091462]	21	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0253551	10.1371/journal.pone.0253551	http://dx.doi.org/10.1371/journal.pone.0253551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310603	gold, Green Published, Green Submitted			2022-12-26	WOS:000685224500004
J	Park, SM; An, JH; Lee, JH; Kim, KB; Chae, HK; Oh, YI; Song, WJ; Youn, HY				Park, Su-Min; An, Ju-Hyun; Lee, Jeong-Hwa; Kim, Kyung-Bo; Chae, Hyung-Kyu; Oh, Ye-In; Song, Woo-Jin; Youn, Hwa-Young			Extracellular vesicles derived from DFO-preconditioned canine AT-MSCs reprogram macrophages into M2 phase	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; EXOSOMES; HYPOXIA; INFLAMMATION; EXPRESSION; SECRETION	Background Mesenchymal stem/stromal cells (MSCs) are effective therapeutic agents that ameliorate inflammation through paracrine effect; in this regard, extracellular vesicles (EVs) have been frequently studied. To improve the secretion of anti-inflammatory factors from MSCs, preconditioning with hypoxia or hypoxia-mimetic agents has been attempted and the molecular changes in preconditioned MSC-derived EVs explored. In this study, we aimed to investigate the increase of hypoxia-inducible factor 1-alpha (HIF-1 alpha)/cyclooxygenase-2 (COX-2) in deferoxamine (DFO)-preconditioned canine MSC (MSCDFO) and whether these molecular changes were reflected on EVs. Furthermore, we focused on MSCDFO derived EVs (EVDFO) could affect macrophage polarization via the transfer function of EVs. Results In MSCDFO, accumulation of HIF-1 alpha were increased and production of COX-2 were activated. Also, Inside of EVDFO were enriched with COX-2 protein. To evaluate the transferring effect of EVs to macrophage, the canine macrophage cell line, DH82, was treated with EVs after lipopolysaccharide (LPS) stimulation. Polarization changes of DH82 were evaluated with quantitative real-time PCR and immunofluorescence analyses. When LPS-induced DH82 was treated with EVDFO, phosphorylation of signal transducer and transcription3 (p-STAT3), which is one of key factor of inducing M2 phase, expression was increased in DH82. Furthermore, treated with EVDFO in LPS-induced DH82, the expression of M1 markers were reduced, otherwise, M2 surface markers were enhanced. Comparing with EVDFO and EVnon. Conclusion DFO preconditioning in MSCs activated the HIF-1 alpha/COX-2 signaling pathway; Transferring COX-2 through EVDFO could effectively reprogram macrophage into M2 phase by promoting the phosphorylation of STAT3.	[Park, Su-Min; An, Ju-Hyun; Lee, Jeong-Hwa; Kim, Kyung-Bo; Chae, Hyung-Kyu; Oh, Ye-In; Youn, Hwa-Young] Seoul Natl Univ, Coll Vet Med, Lab Vet Internal Med, Dept Vet Clin Sci, Seoul, South Korea; [Song, Woo-Jin] Jeju Natl Univ, Coll Vet Med, Lab Vet Internal Med, Jeju, South Korea	Seoul National University (SNU); Jeju National University	Youn, HY (corresponding author), Seoul Natl Univ, Coll Vet Med, Lab Vet Internal Med, Dept Vet Clin Sci, Seoul, South Korea.; Song, WJ (corresponding author), Jeju Natl Univ, Coll Vet Med, Lab Vet Internal Med, Jeju, South Korea.	ssong@jejunu.ac.kr; hyyoun@snu.ac.kr		Song, Woo-Jin/0000-0002-9195-551X; -Lee, Jeong-Hwa/0000-0003-1716-8152	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2019R1A6A1A10072987]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education in the form of funds granted to WJS [2019R1A6A1A10072987].	Baek G, 2019, STEM CELL TRANSL MED, V8, P880, DOI 10.1002/sctm.18-0226; Basciano L, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-12; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Cui GH, 2018, FASEB J, V32, P654, DOI 10.1096/fj.201700600R; Ding JN, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9742765; Fujisawa K, 2018, STEM CELLS, V36, P1226, DOI 10.1002/stem.2826; Genua M, 2016, INFLAMM BOWEL DIS, V22, P2390, DOI 10.1097/MIB.0000000000000896; Han KH, 2016, CELL BIOL INT, V40, P27, DOI 10.1002/cbin.10519; Han Y, 2019, CANCER LETT, V440, P116, DOI 10.1016/j.canlet.2018.10.011; Haneklaus M, 2013, J INTERN MED, V274, P215, DOI 10.1111/joim.12099; Heo JS, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/7921760; Hessvik NP, 2018, CELL MOL LIFE SCI, V75, P193, DOI 10.1007/s00018-017-2595-9; Hollander L, 2016, CANCER RES, V76, P3884, DOI 10.1158/0008-5472.CAN-15-1524; Hong PY, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1358-y; Huang P, 2014, CYTOTHERAPY, V16, P1336, DOI 10.1016/j.jcyt.2014.05.007; Jansen FH, 2009, MOL CELL PROTEOMICS, V8, P1192, DOI 10.1074/mcp.M800443-MCP200; Jin LY, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1999-8; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Kusuma GD, 2017, STEM CELLS DEV, V26, P617, DOI 10.1089/scd.2016.0349; Lai RC, 2015, SEMIN CELL DEV BIOL, V40, P82, DOI 10.1016/j.semcdb.2015.03.001; Lankford KL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190358; Lee JJ, 2010, CARCINOGENESIS, V31, P427, DOI 10.1093/carcin/bgp326; Liu QL, 2020, STEM CELLS DEV, V29, P1073, DOI 10.1089/scd.2020.0035; Lo Sicco C, 2017, STEM CELL TRANSL MED, V6, P1018, DOI 10.1002/sctm.16-0363; Luo C, 2011, MED HYPOTHESES, V77, P174, DOI 10.1016/j.mehy.2011.04.002; Nakamura R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8847; Park SM, 2020, VET IMMUNOL IMMUNOP, V219, DOI 10.1016/j.vetimm.2019.109973; Pezzi A, 2017, J CELL BIOCHEM, V118, P3072, DOI 10.1002/jcb.25953; Phinney DG, 2017, STEM CELLS, V35, P851, DOI 10.1002/stem.2575; Riau AK, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01368; Roberts J., 2019, MACROPHAGE ACTIVATIO; Samadi P, 2020, CURR STEM CELL RES T; Sargent A, 2016, CURR STEM CELL REP, V2, P168, DOI 10.1007/s40778-016-0044-6; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shiraishi D, 2012, BIOCHEM BIOPH RES CO, V425, P304, DOI 10.1016/j.bbrc.2012.07.086; Sterzenbach U, 2017, MOL THER, V25, P1269, DOI 10.1016/j.ymthe.2017.03.030; Sun Y, 2013, CELL RES, V23, P1270, DOI 10.1038/cr.2013.116; WANG GL, 1993, BLOOD, V82, P3610; Willis GR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092534; Yang HM, 2018, RES VET SCI, V119, P19, DOI 10.1016/j.rvsc.2018.05.011; Yu X, 2018, CELL BIOL INT, V42, P1321, DOI 10.1002/cbin.11017; Zagorska A, 2004, ACTA BIOCHIM POL, V51, P563, DOI 10.18388/abp.2004_3545; Zhao H, 2018, DIABETES, V67, P235, DOI 10.2337/db17-0356	44	3	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254657	10.1371/journal.pone.0254657	http://dx.doi.org/10.1371/journal.pone.0254657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310627	Green Published, gold			2022-12-26	WOS:000685224500053
J	Sasaki, N; Morimoto, S; Suda, C; Shimizu, S; Ichihara, A				Sasaki, Nobukazu; Morimoto, Satoshi; Suda, Chikahito; Shimizu, Satoru; Ichihara, Atsuhiro			Urinary soluble (pro)renin receptor excretion is associated with urine pH in humans	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; CONTRIBUTES; METABOLISM; PRORENIN; FUSION	The (pro)renin receptor [(P)RR] binds to renin and its precursor prorenin to activate the tissue renin-angiotensin system. It is cleaved to generate soluble (P)RR and M8-9, a residual hydrophobic truncated protein. The (pro)renin receptor also functions as an intracellular accessory protein of vacuolar-type H+-ATPase, which plays an essential role in controlling the intracellular vesicular acid environment. Thus, in the kidney, (P)RR may play a role in transporting H+ to urine in the collecting duct. Although blood soluble (P)RR has been recognized as a biomarker reflecting the status of the tissue renin-angiotensin system and/or tissue (P)RR, the significance of urinary soluble (P)RR excretion has not been determined. Therefore, this study aimed to investigate the characteristics of urinary soluble (P)RR excretion. Urinary soluble (P)RR excretion was measured, and its association with background factors was investigated in 441 patients. Relationships between changes in urine pH due to vitamin C treatment, which reduce urine pH, and urinary soluble (P)RR excretion were investigated in 10 healthy volunteers. Urinary soluble (P)RR excretion was 1.46 (0.44-2.92) ng/gCre. Urine pH showed a significantly positive association with urinary soluble (P)RR excretion, independent of other factors. Changes in urine pH and urinary soluble (P)RR excretion due to vitamin C treatment were significantly and positively correlated (rho = 0.8182, p = 0.0038). These data showed an association between urinary soluble (P)RR excretion and urine pH in humans, suggesting that (P)RR in the kidney might play a role in urine pH regulation.	[Sasaki, Nobukazu; Morimoto, Satoshi; Suda, Chikahito; Ichihara, Atsuhiro] Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Tokyo, Japan; [Shimizu, Satoru] Tokyo Womans Christian Univ, Sch Arts & Sci, Tokyo, Japan	Tokyo Women's Medical University	Morimoto, S (corresponding author), Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Tokyo, Japan.	morimoto.satoshi@twmu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [19 K 08497]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (19 K 08497 to S. M.). https://www.mext.go.jp/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2009, HYPERTENSION, V54, P261, DOI 10.1161/HYPERTENSIONAHA.109.128645; Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Bayer MJ, 2003, J CELL BIOL, V162, P211, DOI 10.1083/jcb.200212004; Cousin C, 2009, HYPERTENSION, V53, P1077, DOI 10.1161/HYPERTENSIONAHA.108.127258; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Enomoto M, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00003; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gonzalez AA, 2011, HYPERTENSION, V57, P859, DOI 10.1161/HYPERTENSIONAHA.110.167957; Hamada K, 2013, CLIN EXP NEPHROL, V17, P848, DOI 10.1007/s10157-013-0803-y; Hirao J, 2020, HYPERTENS RES, V43, P1079, DOI 10.1038/s41440-020-0450-0; Ichihara A, 2019, NAT REV NEPHROL, V15, P693, DOI 10.1038/s41581-019-0160-5; Kanda A, 2015, J BIOL CHEM, V290, P9690, DOI 10.1074/jbc.M114.626713; Kinouchi K, 2010, CIRC RES, V107, P30, DOI 10.1161/CIRCRESAHA.110.224667; Maruyama Nobuhiro, 2013, Front Biosci (Elite Ed), V5, P583; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Morimoto S, 2014, HYPERTENS RES, V37, P642, DOI 10.1038/hr.2014.46; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Peters J, 2017, PFLUG ARCH EUR J PHY, V469, P1245, DOI 10.1007/s00424-017-2005-z; Ramser J, 2005, HUM MOL GENET, V14, P1019, DOI 10.1093/hmg/ddi094; Rothenberger F, 2007, J AM SOC NEPHROL, V18, P2085, DOI 10.1681/ASN.2006070753; Seki Y, 2018, J ENDOCR SOC, V2, P252, DOI 10.1210/js.2017-00447; Suzuki F, 2003, J BIOL CHEM, V278, P22217, DOI 10.1074/jbc.M302579200; Umemura S, 2019, HYPERTENS RES, V42, P1235, DOI 10.1038/s41440-019-0284-9; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Watanabe N, 2012, HYPERTENSION, V60, P1250, DOI 10.1161/HYPERTENSIONAHA.112.197418; Winter C, 2011, AM J PHYSIOL-CELL PH, V301, pC1251, DOI 10.1152/ajpcell.00076.2011; Yamashita K, 2019, HYPERTENS RES, V42, P1951, DOI 10.1038/s41440-019-0312-9	30	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254688	10.1371/journal.pone.0254688	http://dx.doi.org/10.1371/journal.pone.0254688			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310595	gold, Green Published			2022-12-26	WOS:000685224500012
J	Habib, KA; Neogi, AK; Rahman, M; Oh, J; Lee, YH; Kim, CG				Habib, Kazi Ahsan; Neogi, Amit Kumer; Rahman, Muntasir; Oh, Jina; Lee, Youn-Ho; Kim, Choong-Gon			DNA barcoding of brackish and marine water fishes and shellfishes of Sundarbans, the world's largest mangrove ecosystem	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; CRAB SCYLLA-SERRATA; DIVERSITY; BANGLADESH; PHYLOGENY; TELEOSTEI; EVOLUTION; PATTERNS; GENE	The present study aims to apply a DNA barcoding tool through amplifying two mitochondrial candidate genes i.e., COI and 16S rRNA for accurate identification of fish, aquatic molluscs and crustaceans of Sundarbans mangrove wetland, to build a reference library of fish and shellfishes of this unique ecosystems. A total of 185 mitochondrial COI barcode sequences and 59 partial sequences of the 16S rRNA gene were obtained from 120 genera, 65 families and 21 orders of fish, crustaceans and molluscs. The collected samples were first identified by examining morphometric characteristics and then assessed by DNA barcoding. The COI and 16S rRNA sequences of fishes and crustaceans were clearly discriminated among genera in their phylogenies. The average Kimura two-parameter (K2P) distances of COI barcode sequences within species, genera, and families of fishes are 1.57 +/- 0.06%, 15.16 +/- 0.23%, and 17.79 +/- 0.02%, respectively, and for 16S rRNA sequences, these values are 1.74 +/-.8%, 0.97 +/-.8%, and 4.29 +/- 1.3%, respectively. The minimum and maximum K2P distance based divergences in COI sequences of fishes are 0.19% and 36.27%, respectively. In crustaceans, the K2P distances within genera, families, and orders are 1.4 +/- 0.03%, 17.73 +/- 0.15%, and 22.81 +/- 0.02%, respectively and the minimum and maximum divergences are 0.2% and 33.93%, respectively. Additionally, the present study resolves the misidentification of the mud crab species of the Sundarbans as Scylla olivacea which was previously stated as Scylla serrata. In case of molluscs, values of interspecific divergence ranges from 17.43% to 66.3% in the barcoded species. The present study describes the development of a molecular and morphometric cross-referenced inventory of fish and shellfish of the Sundarbans. This inventory will be useful in future biodiversity studies and in forming future conservation plan.	[Habib, Kazi Ahsan] Sher e Bangla Agr Univ, Fac Fisheries, Dept Fisheries Biol & Genet Aquaculture & Marine, Dhaka, Bangladesh; [Habib, Kazi Ahsan; Neogi, Amit Kumer] Sher e Bangla Agr Univ, Dept Fisheries Biol & Genet, Aquat Bioresource Res Lab, Dhaka, Bangladesh; [Rahman, Muntasir] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Oh, Jina; Lee, Youn-Ho; Kim, Choong-Gon] Korea Inst Ocean Sci & Technol KIOST, Marine Biol & Biol Oceanog Div, Busan, South Korea	Sher-e-Bangla Agricultural University (SAU); Sher-e-Bangla Agricultural University (SAU); Wayne State University; Korea Institute of Ocean Science & Technology (KIOST)	Habib, KA (corresponding author), Sher e Bangla Agr Univ, Fac Fisheries, Dept Fisheries Biol & Genet Aquaculture & Marine, Dhaka, Bangladesh.	ahsan.sau@gmail.com		Habib, Kazi Ahsan/0000-0002-8989-5175; KIM, Choong-Gon/0000-0003-4907-5540	Yeosu Korea Foundation	Yeosu Korea Foundation	The author(s) received funding for this work from the Yeosu project funded by Expo 2012 Yeosu Korea Foundation in 2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz Abdul, 2015, Diversity-Basel, V7, P242, DOI 10.3390/d7030242; Balasubramanian R., 2015, MARINE FAUNAL DIVERS, P485, DOI 10.1016/b978-0-12-801948-1.00029-x; Begum ZNT., 2007, ENCY FLORA FAUNA BAN, VV-24; Bernacsek, 2001, TECHNICAL REPORT; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Chakraborty A, 2006, HYDROBIOLOGIA, V563, P501, DOI 10.1007/s10750-006-0105-4; Chakraborty C, 2014, APPL MICROBIOL BIOT, V98, P3425, DOI 10.1007/s00253-014-5550-9; Chakraborty M, 2014, GENE, V537, P20, DOI 10.1016/j.gene.2013.12.047; Chaudhuri A.B., 1994, MANGROVES SUNDARBANS; Dey A., 2006, HDB MANGROVE ASS MOL; Falk, 2008, GEOGRAPHISCHE RUNDSC, V4, P12; FAO, 2007, 153 FAO; Fischer W., 1978, FAO SPECIES IDENTIFI, V1-7; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forest Department, 2010, INT RES MAN PLANTS S; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Guo C, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3785-4; Habib Kazi Ahsan, 2020, Journal of Threatened Taxa, V12, P15154, DOI 10.11609/jott.4893.12.1.15154-15172; Hebert P.D., 2003, P ROYAL SOC LONDON S, V270, P313, DOI [10.1098/rspb.2002.2218, DOI 10.1093/molbev/msy096]; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hernandez M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211717; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hoq, 2010, COMPILATION NATL REG, P122; Hossain MAM, 2019, FOOD ADDIT CONTAM A, V36, P493, DOI 10.1080/19440049.2019.1580389; Hussain Z, 1994, MANGROVES SUNDARBANS, V2; Islam, 2006, ASIATIC SOC BANGLADE; Ismail M., 1990, ECOSYSTEMS WORLD; Istiak Syed M., 2018, Bangladesh Journal of Zoology, V46, P263, DOI 10.3329/bjz.v46i2.39066; IUCN, 2013, IUCN RED LIST THREAT; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kauffman JB, 2016, WETL ECOL MANAG, V24, P203, DOI 10.1007/s11273-015-9453-z; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Lee Y-H., 2018, AQUATIC BIODIVERSITY; Li JB, 2008, MOL PHYLOGENET EVOL, V47, P472, DOI 10.1016/j.ympev.2007.09.012; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Lv JZ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-93; MacDicken KG, 2015, FOREST ECOL MANAG, V352, P3, DOI 10.1016/j.foreco.2015.02.006; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Palumbi Stephen R., 1996, P205; Paul Alok K., 2018, AACL Bioflux, V11, P701; Rahman AKA., 2007, ENCY FLORA FAUNA BAN, VV17; Rajanna, 2015, ECOLOGICAL BENEFITS, V4297, P85; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Rao DV., 2007, MANGROVE ICHTHYOFAUN; Rasmussen RS, 2008, COMPR REV FOOD SCI F, V7, P280, DOI 10.1111/j.1541-4337.2008.00046.x; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Salam MA, 2016, 7 BIENN FISH C RES F, P118; Schindel DE, 2011, ZOOKEYS, P87, DOI 10.3897/zookeys.152.2473; Schneider S, 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Talwar PK., 1984, COMMERCIAL SEA FISHE; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vidya Pradhan, 2015, International Journal of Current Microbiology and Applied Sciences, V4, P127; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Xing BP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198109; Yoo HS, 2006, MOL CELLS, V22, P323; Zheng LM, 2014, ACTA OCEANOL SIN, V33, P55, DOI 10.1007/s13131-014-0415-8	67	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255110	10.1371/journal.pone.0255110	http://dx.doi.org/10.1371/journal.pone.0255110			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339426	Green Published, gold			2022-12-26	WOS:000680243400031
J	Sato, K; Watamura, N; Fujioka, R; Mihira, N; Sekiguchi, M; Nagata, K; Ohshima, T; Saito, T; Saido, TC; Sasaguri, H				Sato, Kaori; Watamura, Naoto; Fujioka, Ryo; Mihira, Naomi; Sekiguchi, Misaki; Nagata, Kenichi; Ohshima, Toshio; Saito, Takashi; Saido, Takaomi C.; Sasaguri, Hiroki			A third-generation mouse model of Alzheimer's disease shows early and increased cored plaque pathology composed of wild-type human amyloid beta peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; TRANSMEMBRANE DOMAIN; PRECURSOR PROTEIN; APP; DEPOSITION; CLEAVAGE; MUTATION; BRAIN; HYPOTHESIS; MECHANISM	We previously developed single App knock-in mouse models of Alzheimer's disease (AD) harboring the Swedish and Beyreuther/Iberian mutations with or without the Arctic mutation (AppNL-G-F and AppNL-F mice, respectively). These models showed AP pathology, neuroinflammation, and cognitive impairment in an age-dependent manner. The former model exhibits extensive pathology as early as 6 months, but is unsuitable for investigating AP metabolism and clearance because the Arctic mutation renders AP resistant to proteolytic degradation and prone to aggregation. In particular, it is inapplicable to preclinical immunotherapy studies due to its discrete affinity for anti-AP antibodies. The latter model may take as long as 18 months for the pathology to become prominent, which leaves an unfulfilled need for an Alzheimer's disease animal model that is both swift to show pathology and useful for antibody therapy. We thus utilized mutant Psen1 knock-in mice into which a pathogenic mutation (P117L) had been introduced to generate a new model that exhibits early deposition of wild-type human AP by crossbreeding the AppNL-F line with the Psen1P117L/WT line. We show that the effects of the pathogenic mutations in the App and Psen1 genes are additive or synergistic. This new third-generation mouse model showed more cored plaque pathology and neuroinflammation than AppNL-G-F mice and will help accelerate the development of disease-modifying therapies to treat preclinical AD.	[Sato, Kaori; Watamura, Naoto; Fujioka, Ryo; Mihira, Naomi; Sekiguchi, Misaki; Saido, Takaomi C.; Sasaguri, Hiroki] RIKEN Ctr Brain Sci, Lab Proteolyt Neurosci, Wako, Saitama, Japan; [Sato, Kaori; Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Lab Mol Brain Sci, Shinjuku Ku, Tokyo, Japan; [Nagata, Kenichi] Nagoya Univ, Grad Sch Med, Dept Funct Anat & Neurosci, Nagoya, Aichi, Japan; [Saito, Takashi] Nagoya City Univ, Grad Sch Med Sci, Inst Brain Sci, Dept Neurocognit Sci, Nagoya, Aichi, Japan	RIKEN; Waseda University; Nagoya University; Nagoya City University	Saido, TC; Sasaguri, H (corresponding author), RIKEN Ctr Brain Sci, Lab Proteolyt Neurosci, Wako, Saitama, Japan.	takaomi.saido@riken.jp; hiroki.sasaguri@riken.jp	; Saido, Takaomi/N-5472-2015; Saito, Takashi/G-2563-2015	Nagata, Kenichi/0000-0001-8377-7197; Saido, Takaomi/0000-0003-1970-6903; Watamura, Naoto/0000-0001-7971-7378; Saito, Takashi/0000-0002-9659-9251	AMED [JP20dm0207001]; JSPS KAKENHI [JP18K07402]	AMED; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by AMED under Grant Number JP20dm0207001 (Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS)) (T. C. S.) and JSPS KAKENHI Grant Number JP18K07402 (H. S.).	Boon BDC, 2020, ACTA NEUROPATHOL, V140, P811, DOI 10.1007/s00401-020-02198-8; Chen WT, 2020, CELL, V182, P976, DOI 10.1016/j.cell.2020.06.038; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Enya M, 1999, AM J PATHOL, V154, P271, DOI 10.1016/S0002-9440(10)65273-X; Flood DG, 2002, NEUROBIOL AGING, V23, P335, DOI 10.1016/S0197-4580(01)00330-X; Fukumoto H, 1996, AM J PATHOL, V148, P259; Gamache J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10428-1; Hashimoto S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10278-x; Hashimoto S, 2018, J BIOL CHEM, V293, P3118, DOI 10.1074/jbc.M117.811315; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; Hongo N, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00307; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jun H, 2020, NEURON, V107, P1095, DOI 10.1016/j.neuron.2020.06.023; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kwart D, 2019, NEURON, V104, P256, DOI 10.1016/j.neuron.2019.07.010; Lewcock JW, 2020, NEURON, V108, P801, DOI 10.1016/j.neuron.2020.09.029; Li HM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-28; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Masuda A, 2016, NEUROBIOL LEARN MEM, V135, P73, DOI 10.1016/j.nlm.2016.07.001; Morishima-Kawashima M, 2000, AM J PATHOL, V157, P2093, DOI 10.1016/S0002-9440(10)64847-X; Nalivaeva NN, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00235, 10.3389/fnagi.2014.00235]; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nortley R, 2019, SCIENCE, V365, P250, DOI 10.1126/science.aav9518; Podlesny-Drabiniok A, 2020, TRENDS NEUROSCI, V43, P965, DOI 10.1016/j.tins.2020.10.002; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Qin Q, 2021, MECH AGEING DEV, V195, DOI 10.1016/j.mad.2021.111438; Ruiz-Riquelme A, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01187-6; Saido TC, 2006, NEUROSCI RES, V54, P235, DOI 10.1016/j.neures.2005.12.015; SAIDO TC, 1994, J BIOL CHEM, V269, P15253; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Saito T, 2019, J BIOL CHEM, V294, P12754, DOI 10.1074/jbc.RA119.009487; Saito T, 2016, J NEUROSCI, V36, P9933, DOI 10.1523/JNEUROSCI.1907-16.2016; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sasaguri H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05262-w; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Sato K, 2004, EUR J MED CHEM, V39, P573, DOI 10.1016/j.ejmech.2004.02.013; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shimojo M, 2008, J BIOL CHEM, V283, P16488, DOI 10.1074/jbc.M801279200; Shirotani K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43535-6; Sobue A, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-020-01099-x; Sutoko S, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102198; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6; Uruno A, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00467-19	50	7	7	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101004	10.1016/j.jbc.2021.101004	http://dx.doi.org/10.1016/j.jbc.2021.101004			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34329683	Green Published, gold			2022-12-26	WOS:000706418900011
J	Young, EH; Pan, S; Yap, AG; Reveles, KR; Bhakta, K				Young, Eric H.; Pan, Samantha; Yap, Alex G.; Reveles, Kelly R.; Bhakta, Kajal			Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016	PLOS ONE			English	Article							DRUG-DRUG INTERACTIONS; INTERVENTIONS; RISK; PRESCRIPTIONS; CRITERIA; EVENTS; HEALTH	Background/objectives With an aging population suffering from increased prevalence of chronic conditions in the United States (U.S.), a large portion of these patients are on multiple medications. High-risk medications can increase the risk for drug-drug interactions and medication nonadherence. This study aims to describe the prevalence of polypharmacy and high-risk medication prescribing in U.S. physician offices. Methods This was a cross-sectional study of the Centers for Disease Control and Prevention's National Ambulatory Medical Care Survey from 2009 to 2016. All patients over 65 years old were included. Polypharmacy was categorized as no polypharmacy (< 2 medications), minor polypharmacy (2-3 medications), moderate polypharmacy (4-5 medications), and major polypharmacy (>5 medications). Medications were further categorized into high-risk medication categories (anticholinergics, cardiovascular agents, central nervous system (CNS) medications, pain medications, and other). Comparisons between the degrees of polypharmacy were performed utilizing chi-square or Wilcoxon rank-sum tests with JMP Pro 14(R) (SAS Institute, Cary, NC). Results Over 2 billion patient visits were included. Overall, Polypharmacy was common (65.1%): minor polypharmacy (16.2%), moderate polypharmacy (12.1%), and major polypharmacy (36.8%). Patients with major polypharmacy were older compared to those with moderate or minor polypharmacy (75 vs. 73 years, respectively) and were most frequently prescribed pain medications (477.3 per 1,000 total visits). NSAIDs were the most frequently prescribed, with 232.4 per 1,000 total visits resulting in one high-risk NSAID prescription, while 21.9 per 1,000 total visits resulted in two or more high-risk NSAIDs. Conclusion Most patients over 65 years experienced some degree of polypharmacy, with many experiencing major polypharmacy. This indicates an increased need for expanded pharmacist roles through medication therapy management and safety monitoring in this patient population.	[Young, Eric H.; Pan, Samantha; Yap, Alex G.; Reveles, Kelly R.; Bhakta, Kajal] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Young, Eric H.; Pan, Samantha; Yap, Alex G.; Reveles, Kelly R.; Bhakta, Kajal] UT Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio	Bhakta, K (corresponding author), Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA.; Bhakta, K (corresponding author), UT Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA.	bhaktak2@uthscsa.edu						Baruth JM, 2020, HOSP PRACT, V48, P56, DOI 10.1080/21548331.2019.1706995; Bergman-Evans B, 2020, GERIATR NURS, V41, P956, DOI 10.1016/j.gerinurse.2020.07.002; Chan M, 2001, INTERN MED J, V31, P199, DOI 10.1046/j.1445-5994.2001.00044.x; Chivapricha W, 2021, DRUGS-REAL WOR OUTC, V8, P39, DOI 10.1007/s40801-020-00214-7; Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0; Dagli Rushabh J, 2014, J Int Oral Health, V6, pi; de Gage SB, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5205; Doan J, 2013, ANN PHARMACOTHER, V47, P324, DOI 10.1345/aph.1R621; Farrell B, 2018, CAN PHARM J, V151, P395, DOI 10.1177/1715163518804276; Fick DM, 2019, J AM GERIATR SOC, V67, P674, DOI 10.1111/jgs.15767; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Hudhra K, 2016, J EVAL CLIN PRACT, V22, P189, DOI 10.1111/jep.12452; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Kini V, 2018, JAMA-J AM MED ASSOC, V320, P2461, DOI 10.1001/jama.2018.19271; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; Oscanoa TJ, 2017, EUR J CLIN PHARMACOL, V73, P759, DOI 10.1007/s00228-017-2225-3; Pilotto A, 2003, DRUG AGING, V20, P701, DOI 10.2165/00002512-200320090-00006; Spence MM, 2013, ANN PHARMACOTHER, V47, P993, DOI 10.1345/aph.1R735; Tannenbaum C, 2014, JAMA INTERN MED, V174, P890, DOI 10.1001/jamainternmed.2014.949; Vicens C, 2014, BRIT J PSYCHIAT, V204, P471, DOI 10.1192/bjp.bp.113.134650; Waite LJ, 2004, POPUL DEV REV, V30, P3; Weddle SC, 2017, J MANAG CARE SPEC PH, V23, P520, DOI 10.18553/jmcp.2017.23.5.520; Wongrakpanich S, 2018, AGING DIS, V9, P143, DOI 10.14336/AD.2017.0306; Wright RM, 2009, J AM GERIATR SOC, V57, P243, DOI 10.1111/j.1532-5415.2008.02127.x; Zhang NQ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00326; Zhao Y, 2009, J CLIN NURS, V18, P2444, DOI 10.1111/j.1365-2702.2009.02835.x	27	10	10	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255642	10.1371/journal.pone.0255642	http://dx.doi.org/10.1371/journal.pone.0255642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343225	gold, Green Published			2022-12-26	WOS:000685264200032
J	Zhang, ZY; Jia, HJ; Wang, YH; Du, BS; Zhong, JT				Zhang, Zheying; Jia, Huijie; Wang, Yuhang; Du, Baoshun; Zhong, Jiateng			Association of MACC1 expression with lymphatic metastasis in colorectal cancer: A nested case-control study	PLOS ONE			English	Article							GENE-EXPRESSION; BIOMARKER; PREDICTS; DATABASE; GROWTH	MACC1 gene is a newly discovered gene and plays an important role in the metastasis of colorectal cancer (CRC). The objective of this study was to investigate whether MACC1 is an independent factor associated with lymphatic metastasis in CRC patients. We analyzed the association between MACC1 expression and lymphatic metastasis in a nested case-control study including 99 cases and 198 matched controls in CRC patients, assessed from August 2001 to March 2015. Cases were defined as lymphatic metastasis and non-lymphatic metastasis according to AJCC TNM stages; for each case, two age-matched control without lymphatic and distant metastasis was randomly selected from the study participants. Demographic, variables about metastasis and MACC1 expression were collected. In multivariate analysis, the OR (95% CI) of MACC1 expression was 1.5 (1.1 to 2.0) in patients with lymphatic metastasis versus non-lymphatic metastasis after adjusting all variables. After adjustment for all variables and age stratification, MACC1 expression was found to be an independent risk factor for lymph node metastasis in the middle-aged group (OR 2.1, 95%CI 1.1-4.0). A nonlinear relationship between MACC1 expression and 64-75 age group was observed. The probability of metastasis slightly increased with the MACC1 level lower than turning point 1.4. At the same time, the probability of lymphatic metastasis was obviously increased even after adjusting all variables when MACC1 level higher than 1.4 (OR 11.2, 95% CI 1.5-81.5; p = 0.017) in the middle age group. The expression of MACC1 was not associated with lymphatic metastasis in populations younger than 64 or older than 75. The results demonstrates that increased MACC1 level in 64-75 age group might be associated with lymphatic metastasis in CRC patients.	[Zhang, Zheying; Jia, Huijie; Wang, Yuhang; Zhong, Jiateng] Xinxiang Med Univ, Dept Pathol, Xinxiang 453003, Henan, Peoples R China; [Du, Baoshun] Xinxiang Cent Hosp, Dept Neurosurg 2, Xinxiang 453003, Henan, Peoples R China	Xinxiang Medical University	Zhong, JT (corresponding author), Xinxiang Med Univ, Dept Pathol, Xinxiang 453003, Henan, Peoples R China.	jtzhong@xxmu.edu.cn			National Natural Science Foundation of China [81802470, U1804173]; Doctoral Scientific Research Foundation of Xinxiang Medical University [XYBSKYZZ201632]; Department of Science and Technology of Henan Province [192102310362]; Medical Science and Technology of Henan Province [LHGJ20190452]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Scientific Research Foundation of Xinxiang Medical University; Department of Science and Technology of Henan Province; Medical Science and Technology of Henan Province	This work is supported by National Natural Science Foundation of China (Grant No.81802470,U1804173). The Doctoral Scientific Research Foundation of Xinxiang Medical University (Grant No. XYBSKYZZ201632), the Department of Science and Technology of Henan Province (Grant No. 192102310362) and Medical Science and Technology of Henan Province (Grant No. LHGJ20190452). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chandrasinghe P, 2017, ONCOGENE, V36, P1474, DOI 10.1038/onc.2016.322; Cremolini C, 2015, NAT REV CLIN ONCOL, V12, P607, DOI 10.1038/nrclinonc.2015.129; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Govindarajan A, 2008, CLIN COLORECTAL CANC, V7, P240, DOI 10.3816/CCC.2008.n.031; Gu Y, 2016, J PATHOL, V239, P60, DOI 10.1002/path.4697; Jeong H, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9207153; Juneja M., 2014, NOVEL INSIGHTS MACC1; Li H, 2017, ONCOL LETT, V14, P3899, DOI 10.3892/ol.2017.6670; Li ZH, 2018, CANCER LETT, V432, P237, DOI 10.1016/j.canlet.2018.04.035; Lin AF, 2019, J CELL MOL MED, V23, P1598, DOI 10.1111/jcmm.13989; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rohr UP, 2017, ANN ONCOL, V28, P1869, DOI 10.1093/annonc/mdx207; Stein U, 2010, J MOL MED, V88, P11, DOI 10.1007/s00109-009-0537-1; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tang J, 2016, EUR REV MED PHARMACO, V20, P2825; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Wang JK, 2017, MOL MED REP, V16, P8747, DOI 10.3892/mmr.2017.7721; Willaert W, 2014, CANCER TREAT REV, V40, P405, DOI 10.1016/j.ctrv.2013.09.013; Xie QP, 2016, J ZHEJIANG UNIV-SC B, V17, P361, DOI 10.1631/jzus.B1500236; Yang J, 2018, PROTEIN CELL, V9, P474, DOI 10.1007/s13238-018-0543-6; Yang S, 2017, NUCLEIC ACIDS RES, V45, pD389, DOI 10.1093/nar/gkw868; Yuan L, 2015, CANCER LETT, V359, P136, DOI 10.1016/j.canlet.2015.01.003	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255489	10.1371/journal.pone.0255489	http://dx.doi.org/10.1371/journal.pone.0255489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343214	gold, Green Published			2022-12-26	WOS:000685264200029
J	Heitmann, ASB; Zanjani, AAH; Klenow, MB; Mularski, A; Sonder, SL; Lund, FW; Boye, TL; Dias, C; Bendix, PM; Simonsen, AC; Khandelia, H; Nylandsted, J				Heitmann, Anne Sofie Busk; Zanjani, Ali Asghar Hakami; Klenow, Martin Berg; Mularski, Anna; Sonder, Stine Lauritzen; Lund, Frederik Wendelboe; Boye, Theresa Louise; Dias, Catarina; Bendix, Poul Martin; Simonsen, Adam Cohen; Khandelia, Himanshu; Nylandsted, Jesper			Phenothiazines alter plasma membrane properties and sensitize cancer cells to injury by inhibiting annexin-mediated repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-BILAYER; CHARMM; GUI; TRIFLUOPERAZINE; PHOSPHATIDYLCHOLINE; PHARMACOKINETICS; PROCHLORPERAZINE; SIMULATIONS; CALCIUM; GROMACS	Repair of damaged plasma membrane in eukaryotic cells is largely dependent on the binding of annexin repair proteins to phospholipids. Changing the biophysical properties of the plasma membrane may provide means to compromise annexinmediated repair and sensitize cells to injury. Since, cancer cells experience heightened membrane stress and are more dependent on efficient plasma membrane repair, inhibiting repair may provide approaches to sensitize cancer cells to plasma membrane damage and cell death. Here, we show that derivatives of phenothiazines, which have widespread use in the fields of psychiatry and allergy treatment, strongly sensitize cancer cells to mechanical-, chemical-, and heat-induced injury by inhibiting annexin-mediated plasma membrane repair. Using a combination of cell biology, biophysics, and computer simulations, we show that trifluoperazine acts by thinning the membrane bilayer, making it more fragile and prone to ruptures. Secondly, it decreases annexin binding by compromising the lateral diffusion of phosphatidylserine, inhibiting the ability of annexins to curve and shape membranes, which is essential for their function in plasma membrane repair. Our results reveal a novel avenue to target cancer cells by compromising plasma membrane repair in combination with noninvasive approaches that induce membrane injuries.	[Heitmann, Anne Sofie Busk; Sonder, Stine Lauritzen; Boye, Theresa Louise; Dias, Catarina; Nylandsted, Jesper] Danish Canc Soc, Membrane Integr, Res Ctr, Copenhagen, Denmark; [Zanjani, Ali Asghar Hakami; Klenow, Martin Berg; Mularski, Anna; Lund, Frederik Wendelboe; Simonsen, Adam Cohen; Khandelia, Himanshu] Univ Southern Denmark, PHYLIFE Phys Life Sci, Dept Phys Chem & Pharm, Odense M, Denmark; [Bendix, Poul Martin] Univ Copenhagen, Fac Hlth Sci, Niels Bohr Inst, Copenhagen, Denmark; [Nylandsted, Jesper] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark	Danish Cancer Society; University of Southern Denmark; University of Copenhagen; Niels Bohr Institute; University of Copenhagen	Nylandsted, J (corresponding author), Danish Canc Soc, Membrane Integr, Res Ctr, Copenhagen, Denmark.; Nylandsted, J (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark.	jnl@cancer.dk	Nylandsted, Jesper/ABE-7192-2021	Hakami Zanjani, Ali Asghar/0000-0002-0206-9074; Khandelia, Himanshu/0000-0001-9913-6394; Simonsen, Adam Cohen/0000-0003-1937-8524; Nylandsted, Jesper/0000-0001-6474-5093; Boye, Theresa Louise/0000-0001-6260-6954; Berg Klenow, Martin/0000-0002-2045-8583; Lauritzen Sonder, Stine/0000-0001-5551-4461; Dias, Catarina/0000-0002-1746-4384	Novo Nordisk Foundation Interdisciplinary Synergy Grant [NNF18OC0034936]; Danish Council for Independent Research Natural Sciences [9040-00252B]; Scientific Committee Danish Cancer Society [R90-A5847-14-S2]; PRACE project [2016153468]; PRACE aisbl; Novo Nordisk Foundation	Novo Nordisk Foundation Interdisciplinary Synergy Grant; Danish Council for Independent Research Natural Sciences(Det Frie Forskningsrad (DFF)); Scientific Committee Danish Cancer Society; PRACE project; PRACE aisbl; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This study was supported by the Novo Nordisk Foundation Interdisciplinary Synergy Grant (NNF18OC0034936), the Danish Council for Independent Research Natural Sciences (9040-00252B), and Scientific Committee Danish Cancer Society (R90-A5847-14-S2). The simulations were carried out on the Danish e-Infrastructure Cooperation National HPC Center, on ABACUS 2.0 at the University of Southern Denmark, SDU, and on computing resources on the Swiss cluster Piz Daint as part of a PRACE project (grant number 2016153468). We also acknowledge that the results of this research have been achieved using the DECI resource Kay based in Ireland at ICHEC with support from the PRACE aisbl. Part of the computations was carried out on the ROBUST resource for Biomolecular simulations with support from the Novo Nordisk Foundation.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Anand A, 2019, MOL CANCER THER, V18, P1602, DOI 10.1158/1535-7163.MCT-18-1406; Andrews NW, 2014, TRENDS CELL BIOL, V24, P734, DOI 10.1016/j.tcb.2014.07.008; Bendix PM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9041029; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BLACKWOOD RA, 1995, J LEUKOCYTE BIOL, V58, P114, DOI 10.1002/jlb.58.1.114; Bouter A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1270; Boye TL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28481-z; Boye TL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01743-6; Braga C, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2013227; Broniec A, 2007, LANGMUIR, V23, P694, DOI 10.1021/la061628b; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chamoun-Emanuelli AM, 2013, ANTIMICROB AGENTS CH, V57, P2571, DOI 10.1128/AAC.02593-12; Deng SS, 2013, ONCOL LETT, V5, P107, DOI 10.3892/ol.2012.959; Doktorova M, 2019, BIOPHYS J, V116, P487, DOI 10.1016/j.bpj.2018.12.016; Dornier E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06351-6; Drucker P, 2013, J BIOL CHEM, V288, P24764, DOI 10.1074/jbc.M113.474023; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; Ellegaard AM, 2016, EBIOMEDICINE, V9, P130, DOI 10.1016/j.ebiom.2016.06.013; Erejuwa OO, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/931251; Feng ZZ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1046-3; Florentsen CD, 2021, SOFT MATTER, V17, P308, DOI 10.1039/d0sm00241k; FRENZEL J, 1978, BIOCHIM BIOPHYS ACTA, V507, P185, DOI 10.1016/0005-2736(78)90415-7; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Grek CL, 2010, CURR OPIN PHARMACOL, V10, P362, DOI 10.1016/j.coph.2010.05.003; Hakobyan D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185440; Hendrich AB, 2001, BBA-BIOMEMBRANES, V1510, P414, DOI 10.1016/S0005-2736(00)00373-4; Izadifar Z, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020460; Jaiswal JK, 2015, CELL CYCLE, V14, P502, DOI 10.1080/15384101.2014.995495; Jaiswal JK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4795; Jaszczyszyn A, 2012, PHARMACOL REP, V64, P16, DOI 10.1016/S1734-1140(12)70726-0; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kok HP, 2020, INT J HYPERTHER, V37, P711, DOI 10.1080/02656736.2020.1779357; Kopec W, 2013, FEBS J, V280, P2785, DOI 10.1111/febs.12286; Lauritzen SP, 2015, SEMIN CELL DEV BIOL, V45, P32, DOI 10.1016/j.semcdb.2015.10.028; Lee J, 2019, J CHEM THEORY COMPUT, V15, P775, DOI 10.1021/acs.jctc.8b01066; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Li AM, 2020, FEBS OPEN BIO, V10, P2097, DOI 10.1002/2211-5463.12960; Liu L, 1997, ARCH BIOCHEM BIOPHYS, V342, P322, DOI 10.1006/abbi.1997.0140; Liu XY, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0392-y; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; Michalak K, 2006, CURR DRUG TARGETS, V7, P1095, DOI 10.2174/138945006778226570; Morgan RJ, 2001, CANCER CHEMOTH PHARM, V47, P327, DOI 10.1007/s002800000232; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; NAHATA MC, 1992, J CLIN PHARM THER, V17, P121, DOI 10.1111/j.1365-2710.1992.tb01279.x; Ohlow MJ, 2011, DRUG DISCOV TODAY, V16, P119, DOI 10.1016/j.drudis.2011.01.001; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Perez-Isidoro R, 2020, CHEM PHYS LIPIDS, V229, DOI 10.1016/j.chemphyslip.2020.104913; Petersen NHT, 2013, CANCER CELL, V24, P379, DOI 10.1016/j.ccr.2013.08.003; Pezeshkian W, 2016, SOFT MATTER, V12, P5164, DOI 10.1039/c6sm00464d; Pezeshkian W, 2017, FEBS OPEN BIO, V7, P1638, DOI 10.1002/2211-5463.12321; Pulkoski-Gross A, 2015, MOL PHARMACOL, V87, P501, DOI 10.1124/mol.114.096941; Qi HB, 2015, ONCOL LETT, V10, P1947, DOI 10.3892/ol.2015.3498; Shao CH, 2006, J BIOL CHEM, V281, P31689, DOI 10.1074/jbc.M604502200; Sonder SL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43143-4; Stewart MP, 2018, CHEM REV, V118, P7409, DOI 10.1021/acs.chemrev.7b00678; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Tang SKY, 2017, SCIENCE, V356, P1022, DOI 10.1126/science.aam6496; Wesolowska O., 2011, MOL MEMBR BIOL, V28, P103, DOI DOI 10.3109/09687688.2010.533706; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Zhelev Z, 2004, CANCER CHEMOTH PHARM, V53, P267, DOI 10.1007/s00280-003-0738-1	69	3	3	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							101012	10.1016/j.jbc.2021.101012	http://dx.doi.org/10.1016/j.jbc.2021.101012			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34324830	Green Published, gold			2022-12-26	WOS:000690868100004
J	Fatima, I; Barman, S; Uppada, J; Chauhan, S; Rauth, S; Rachagani, S; Ponnusamy, MP; Smith, L; Talmon, G; Singh, AB; Batra, SK; Dhawan, P				Fatima, Iram; Barman, Susmita; Uppada, JayaPrakash; Chauhan, Shailender; Rauth, Sanchita; Rachagani, Satyanarayana; Ponnusamy, Moorthy Palanimuthu; Smith, Lynette; Talmon, Geoffrey; Singh, Amar B.; Batra, Surinder K.; Dhawan, Punita			MASTL regulates EGFR signaling to impact pancreatic cancer progression	ONCOGENE			English	Article							NUCLEAR-ENVELOPE BREAKDOWN; GREATWALL KINASE; CELL; GALECTIN-3; RECEPTOR; PROTEIN; EXPRESSION; PHOSPHORYLATION; GEMCITABINE; ACTIVATION	Pancreatic cancer (PC) remains a major cause of cancer-related deaths primarily due to its inherent potential of therapy resistance. Checkpoint inhibitors have emerged as promising anti-cancer agents when used in combination with conventional anti-cancer therapies. Recent studies have highlighted a critical role of the Greatwall kinase (microtubule-associated serine/threonine-protein kinase-like (MASTL)) in promoting oncogenic malignancy and resistance to anti-cancer therapies; however, its role in PC remains unknown. Based on a comprehensive investigation involving PC patient samples, murine models of PC progression (Kras;PdxCre-KC and Kras;p53;PdxCre-KPC), and loss and gain of function studies, we report a previously undescribed critical role of MASTL in promoting cancer malignancy and therapy resistance. Mechanistically, MASTL promotes PC by modulating the epidermal growth factor receptor protein stability and, thereupon, kinase signaling. We further demonstrate that combinatorial therapy targeting MASTL promotes the efficacy of the cell-killing effects of Gemcitabine using both genetic and pharmacological inhibitions. Taken together, this study identifies a key role of MASTL in promoting PC progression and its utility as a novel target in promoting sensitivity to the anti-PC therapies.	[Fatima, Iram; Barman, Susmita; Rauth, Sanchita; Rachagani, Satyanarayana; Ponnusamy, Moorthy Palanimuthu; Singh, Amar B.; Batra, Surinder K.; Dhawan, Punita] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Uppada, JayaPrakash] Univ Alabama, Alabama Life Res Inst, Coll Community Hlth Sci, Tuscaloosa, AL USA; [Chauhan, Shailender] Univ Arizona, Cellular & Mol Med, Canc Ctr UAHS, Tucson, AZ USA; [Smith, Lynette] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE USA; [Talmon, Geoffrey] Univ Nebraska Med Ctr, Dept Pathl, Omaha, NE USA; [Singh, Amar B.; Dhawan, Punita] VA Nebraska Western Iowa Hlth Care Syst, Omaha, NE 69101 USA; [Batra, Surinder K.; Dhawan, Punita] Univ Nebraska Med Ctr, Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Alabama System; University of Alabama Tuscaloosa; University of Arizona; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center	Dhawan, P (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Dhawan, P (corresponding author), VA Nebraska Western Iowa Hlth Care Syst, Omaha, NE 69101 USA.; Dhawan, P (corresponding author), Univ Nebraska Med Ctr, Buffett Canc Ctr, Omaha, NE 68198 USA.	punita.dhawan@unmc.edu	Barman, Susmita/AAY-8311-2021; Chauhan, Shailender Singh/AAM-5269-2020	Chauhan, Shailender Singh/0000-0002-1975-2734; Barman, Susmita/0000-0002-0491-8498	VA merit [BX002086, DK124095, BX002761]; NIH/NCI [CA250383, CA216746]; Nebraska Research Initiative (NRI); NCI [P30 CA36727, NIH-1P50 CA 127297-01A2]	VA merit(US Department of Veterans Affairs); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Nebraska Research Initiative (NRI); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by BX002086 (VA merit), CA250383 (NIH/NCI), CA216746 (NIH/NCI), and Nebraska Research Initiative (NRI) to PD and DK124095 and BX002761 (VA merit) to ABS. We also acknowledge NCI Cancer Center Support Grant P30 CA36727, NIH-1P50 CA 127297-01A2 for tissue arrays obtained.	Alvarez-Fernandez M, 2018, CELL DEATH DIFFER, V25, P828, DOI 10.1038/s41418-017-0024-0; Alvarez-Fernandez M, 2014, BIOESSAYS, V36, P757, DOI 10.1002/bies.201400040; Alvarez-Fernandez M, 2013, P NATL ACAD SCI USA, V110, P17374, DOI 10.1073/pnas.1310745110; Ammarah U, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23246-0; Anania MC, 2015, ONCOTARGET, V6, P34629, DOI 10.18632/oncotarget.5282; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Barman S, 2018, J NUTR BIOCHEM, V54, P113, DOI 10.1016/j.jnutbio.2017.11.008; Cabrera M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136878; Castilho PV, 2009, MOL BIOL CELL, V20, P4777, DOI 10.1091/mbc.E09-07-0643; Chang WA, 2017, ONCOL LETT, V14, P5077, DOI 10.3892/ol.2017.6882; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Cruz JJ, 2007, ANN ONCOL, V18, P421, DOI 10.1093/annonc/mdl175; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; El Ayachi I, 2019, CANCER RES, V79, P982, DOI 10.1158/0008-5472.CAN-18-1069; Fatima I, 2020, CANCER MED-US, V9, P6322, DOI 10.1002/cam4.3141; Fatima I, 2019, CANCERS, V11, DOI 10.3390/cancers11122039; Fatima Iram, 2018, PLoS One, V13, pe0197796, DOI 10.1371/journal.pone.0197796; Furukawa Y, 2000, J BIOL CHEM, V275, P21661, DOI 10.1074/jbc.M906893199; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Gowrikumar S, 2019, ONCOGENE, V38, P6566, DOI 10.1038/s41388-019-0864-9; Heinemann V, 2002, SEMIN ONCOL, V29, P9, DOI 10.1053/sonc.2002.37372; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Kleespies A, 2006, DRUG RESIST UPDATE, V9, P1, DOI 10.1016/j.drup.2006.02.002; Kucinska M, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0371-1; Kuo HY, 2016, GLYCOBIOLOGY, V26, P155, DOI 10.1093/glycob/cwv088; Lambert A, 2019, THER ADV MED ONCOL, V11, DOI 10.1177/1758835919875568; Li J, 2019, COMPUT STRUCT BIOTEC, V17, P498, DOI 10.1016/j.csbj.2019.03.016; Li PP, 2016, CELL, V167, P973, DOI 10.1016/j.cell.2016.10.025; Liu W, 2012, J INVEST DERMATOL, V132, P2828, DOI 10.1038/jid.2012.211; Lorca T, 2013, ONCOGENE, V32, P537, DOI 10.1038/onc.2012.79; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Martinez-Bosch N, 2014, CANCER RES, V74, P3512, DOI 10.1158/0008-5472.CAN-13-3013; Marzec K, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00162; Mizrahi JD, 2020, LANCET, V395, P2008, DOI 10.1016/S0140-6736(20)30974-0; Navas C, 2012, CANCER CELL, V22, P318, DOI 10.1016/j.ccr.2012.08.001; Nedaeinia R, 2014, CURR DRUG TARGETS, V15, P1293, DOI 10.2174/1389450115666141125123003; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Oberstein PE, 2013, THER ADV GASTROENTER, V6, P321, DOI 10.1177/1756283X13478680; Ocasio CA, 2016, ONCOTARGET, V7, P71182, DOI 10.18632/oncotarget.11511; Oliveira-Cunha Melissa, 2011, Cancers (Basel), V3, P1513, DOI 10.3390/cancers3021513; Orozco CA, 2018, P NATL ACAD SCI USA, V115, pE3769, DOI 10.1073/pnas.1722434115; Oyanadel C, 2018, MOL BIOL CELL, V29, P557, DOI 10.1091/mbc.E16-05-0301; Piyush T, 2017, CELL DEATH DIFFER, V24, P1937, DOI 10.1038/cdd.2017.119; Pryczynicz A, 2008, ANTICANCER RES, V28, P1399; RCore Team, 2020, R LANG ENV STAT COMP; Ren DP, 2017, J BIOL CHEM, V292, P10026, DOI 10.1074/jbc.M117.778233; Reshi I, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00366-18; Rogers S, 2018, ONCOGENE, V37, P4518, DOI 10.1038/s41388-018-0295-z; Roth Marc T, 2020, F1000Res, V9, DOI 10.12688/f1000research.21981.1; Ruess DA, 2017, DRUG AGING, V34, P331, DOI 10.1007/s40266-017-0453-y; Sun XJ, 2017, ONCOL LETT, V14, P7283, DOI 10.3892/ol.2017.7155; Torres MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080580; Uppada SB, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0848-3; Vera J, 2015, ELIFE, V4, DOI 10.7554/eLife.10115; Voets E, 2012, MOL CELL BIOL, V32, P1334, DOI 10.1128/MCB.00213-12; Voets E, 2010, CELL CYCLE, V9, P3591, DOI 10.4161/cc.9.17.12832; Wang L, 2014, ONCOTARGET, V5, P11479, DOI 10.18632/oncotarget.2565; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Yao YL, 2019, CARBOHYD POLYM, V204, P111, DOI 10.1016/j.carbpol.2018.10.008; Yoon YN, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4600-6; Zaffaroni N, 2001, EUR J CANCER, V37, P1953, DOI 10.1016/S0959-8049(01)00227-1	61	4	4	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 23	2021	40	38					5691	5704		10.1038/s41388-021-01951-x	http://dx.doi.org/10.1038/s41388-021-01951-x		JUL 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UU4CG	34331012	Green Accepted			2022-12-26	WOS:000679620500004
J	Li, X; Qian, KQ; Han, WW				Li, Xiao; Qian, Keqing; Han, Weiwei			Prediction of hyaluronic acid target on sucrase-isomaltase (SI) with reverse docking and molecular dynamics simulations for inhibitors binding to SI	PLOS ONE			English	Article							AURICULARIA-AURICULA; SUBSTRATE; INJURY; IONS	Auricularia cornea (E.) polysaccharide is an important component of A. cornea Ehrenb, a white mutant strain of Auricularia with biological activities, such as enhancement of human immune function and cancer prevention. The hyaluronic acids (HAs) are important components of the A. cornea polysaccharide and have extremely high medicinal value. In this study, we used HA to search the target protein sucrase-isomaltase (SI). In addition, we also performed molecular dynamics (MD) simulations to explore the binding of three inhibitors (HA, acarbose and kotalanol) to SI. The MD simulations indicated that the binding of the three inhibitors may induce the partial disappearance of alpha helix in residues 530-580. Hence, the hydrogen bond for Gly570-Asn572, which was near the catalytic base Asp471 in SI, was broken during the binding of the three inhibitors. We reveal a new inhibitor for SI and provide reasonable theoretical clues for inhibitor binding to SI.	[Li, Xiao; Qian, Keqing] Jilin Agr Univ, Chinese Minist Educ Edible & Med Fungi, Engn Res Ctr, Changchun, Jilin, Peoples R China; [Han, Weiwei] Jilin Univ, Sch Life Sci, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun, Peoples R China	Jilin Agricultural University; Jilin University	Han, WW (corresponding author), Jilin Univ, Sch Life Sci, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun, Peoples R China.	weiweihan@jlu.edu.cn			Overseas Cooperation Project of Jilin Province [20200801069GH]; Open Project of State Key Laboratory for Supramolecular Structure and Materials [SKLSSM202010]	Overseas Cooperation Project of Jilin Province; Open Project of State Key Laboratory for Supramolecular Structure and Materials	The sponsors of Weiwei Han provided funding: the Overseas Cooperation Project of Jilin Province [grant number 20200801069GH] and Open Project of State Key Laboratory for Supramolecular Structure and Materials [grant number SKLSSM202010], and the study design.	Boateng HA, 2020, J CHEM THEORY COMPUT, V16, P7, DOI 10.1021/acs.jctc.9b00648; Daina A, 2019, NUCLEIC ACIDS RES, V47, pW357, DOI 10.1093/nar/gkz382; Dong LY, 2018, ECOTOX ENVIRON SAFE, V166, P390, DOI 10.1016/j.ecoenv.2018.09.097; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Heenan PR, 2018, J CHEM PHYS, V148, DOI 10.1063/1.5009108; Heo S, 2007, J NANOSCI NANOTECHNO, V7, P1518, DOI 10.1166/jnn.2007.335; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hou RL, 2019, FOOD FUNCT, V10, P1017, DOI 10.1039/c8fo01624k; Li CC, 2021, J BIOMOL STRUCT DYN, V39, P1887, DOI 10.1080/07391102.2020.1737232; Li Z, 2019, J CHEM PHYS, V151, DOI 10.1063/1.5132543; Li ZC, 2019, J COMPUT BIOL, V26, P1020, DOI 10.1089/cmb.2019.0013; Liu T, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/6416941; Lu LX, 2017, J MICROBIOL, V55, P792, DOI 10.1007/s12275-017-7241-6; Martonak R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.075503; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mutanabbi Abdula, 2015, MED CHEM RES; Neuman MG, 2015, J PHARM PHARM SCI, V18, P53, DOI 10.18433/J3K89D; Nguyen NT, 2020, J CHEM INF MODEL, V60, P204, DOI 10.1021/acs.jcim.9b00778; Papalia R, 2017, J Biol Regul Homeost Agents, V31, P103; Quigley D, 2004, J CHEM PHYS, V120, P11432, DOI 10.1063/1.1755657; Saha MR, 2018, J ETHNOPHARMACOL, V210, P275, DOI 10.1016/j.jep.2017.08.036; Salwowska NM, 2016, J COSMET DERMATOL-US, V15, P520, DOI 10.1111/jocd.12237; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Tambi R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38401-w; University BF., 2018, MYCOSYSTEMA; Wang D, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01039; Xu SQ, 2016, FOOD FUNCT, V7, P3868, DOI 10.1039/c6fo00686h; Yuan GL, 2018, J INEQUAL APPL, DOI 10.1186/s13660-018-1703-1; Zhang JC, 2017, INT J MED MUSHROOMS, V19, P155, DOI 10.1615/IntJMedMushrooms.v19.i2.70; Zhu JX, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062167	30	1	1	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255351	10.1371/journal.pone.0255351	http://dx.doi.org/10.1371/journal.pone.0255351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329325	Green Published, gold			2022-12-26	WOS:000685248600040
J	Jauharee, AR; Capello, M; Simier, M; Forget, F; Adam, MS; Dagorn, L				Jauharee, Ahmed Riyaz; Capello, Manuela; Simier, Monique; Forget, Fabien; Adam, Mohamed Shiham; Dagorn, Laurent			Tuna behaviour at anchored FADs inferred from Local Ecological Knowledge (LEK) of pole-and-line tuna fishers in the Maldives	PLOS ONE			English	Article							YELLOWFIN THUNNUS-ALBACARES; AGGREGATING DEVICES FADS; PURSE-SEINE FISHERY; VERTICAL MOVEMENTS; TROPICAL TUNA; ASSOCIATIVE BEHAVIOR; HAWAIIAN-ISLANDS; OBESUS; OCEAN; CONSERVATION	The Maldives tuna fishery landings in 2018 were 148, 000 t and accounted for nearly a quarter of the global pole-and-line tuna catch. This fishery partially relies on a network of 55 anchored fish aggregating devices (AFADs) deployed around the archipelago. About one-third of the total pole-and-line tuna catch is harvested at AFADs. Although the AFAD fishery has existed for 35 years, knowledge on the behaviour of tuna in the AFAD array is still limited, precluding the development of science-based fishery management. In this study, local ecological knowledge (LEK) of fishers was used to improve our understanding of tuna behaviour, through personal interviews of 54 pole-and-line fishers from different parts of the archipelago. Interview results suggest that during the northeast monsoon tuna are more abundant on the eastern side of the Maldives, while during the southwest monsoon they are more abundant on the western side of the Maldives. Most fishers believed that tuna tend to stay at the AFADs for 3 to 6 days and remain within 2 miles from the AFADs when they are associated. Fishers believe that strong currents is the main factor for tuna departure from AFADs, though high sea surface temperatures and stormy conditions were also thought to contribute to departures. Moderate currents are believed to be a favourable condition to form aggregations at the AFADs while other factors such as suitable temperature, prey and attractants enhance this aggregation. Fishers also believe that there are multiple schools segregated according to size and species at AFADs and that catchability is higher at dawn and in the late afternoon when the tuna occur shallower in the water column. This study is an important step towards engaging the Maldivian tuna fishers into a science-based fishery management.	[Jauharee, Ahmed Riyaz] Maldives Marine Res Inst, Minist Fisheries Marine Resources & Agr, Male, Maldives; [Jauharee, Ahmed Riyaz; Capello, Manuela; Simier, Monique; Forget, Fabien; Dagorn, Laurent] Univ Montpellier, MARBEC, CNRS, Ifremer,IRD, Sete, France; [Adam, Mohamed Shiham] Int Pole & Line Fdn, Reading, Berks, England	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Jauharee, AR (corresponding author), Maldives Marine Res Inst, Minist Fisheries Marine Resources & Agr, Male, Maldives.; Jauharee, AR (corresponding author), Univ Montpellier, MARBEC, CNRS, Ifremer,IRD, Sete, France.	arjauharee@gmail.com	Capello, Manuela/G-7360-2016; Dagorn, Laurent/K-1002-2016	Capello, Manuela/0000-0002-9206-011X; Dagorn, Laurent/0000-0003-3896-8589; Adam, M. Shiham/0000-0001-7443-1901; Simier, Monique/0000-0002-8436-5925	International Pole & Line Foundation (IPNLF)	International Pole & Line Foundation (IPNLF)	This study was fully funded by the International Pole & Line Foundation (IPNLF).	Adam M. S., 2003, IOTC P, V6, P202; Adam MS., 1999, UNPUB; Ahusan M, 2018, MALDIVES NATL REPORT, P1; Anderson R. Charles, 2005, Journal of Cetacean Research and Management, V7, P119; Anderson RC., 1990, EXPLORATORY FISHING; Anderson RC., 1998, MALDIVES MARINE RES, DOI [10.1016/b978-0-408-70700-8.50018, DOI 10.1016/B978-0-408-70700-8.50018]; Azzurro E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024885; Baidai Y, 2020, FISH RES, V229, DOI 10.1016/j.fishres.2020.105613; Baird IG, 2005, ENVIRON MANAGE, V36, P439, DOI 10.1007/s00267-005-3093-7; Brehmer P, 2019, THALASSAS, V35, P177, DOI 10.1007/s41208-018-0107-9; Brill RW, 1999, MAR BIOL, V133, P395, DOI 10.1007/s002270050478; Capello M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36415; Cayre P, 1993, AQUAT LIVING RESOUR, V6, P1, DOI 10.1051/alr:1993001; Dagorn L, 2000, MAR BIOL, V136, P361, DOI 10.1007/s002270050694; Dagorn L, 2007, MAR BIOL, V151, P595, DOI 10.1007/s00227-006-0511-1; Dagorn L, 2013, FISH FISH, V14, P391, DOI 10.1111/j.1467-2979.2012.00478.x; Doray M, 2006, FISH RES, V82, P162, DOI 10.1016/j.fishres.2006.06.025; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Filmalter J, 2015, MAR ECOL PROG SER, V539, P207, DOI 10.3354/meps11514; Forget FG, 2015, CAN J FISH AQUAT SCI, V72, P1398, DOI 10.1139/cjfas-2014-0458; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; FreuEn P., 1999, DYNAMICS PELAGIC FIS; Girard C, 2004, ANIM BEHAV, V67, P319, DOI 10.1016/j.anbehav.2003.07.007; Govinden R, 2013, AQUAT LIVING RESOUR, V26, P69, DOI 10.1051/alr/2012022; Graham BS, 2007, MAR BIOL, V150, P647, DOI 10.1007/s00227-006-0360-y; Hall M., 1992, 7 SOM HYP MECH GOV A; HOLLAND KN, 1990, FISH B-NOAA, V88, P493; IOTC, 2014, COLL FISH AGGR DEV M; Jaquemet S, 2011, FISH RES, V107, P283, DOI 10.1016/j.fishres.2010.11.011; KINGSFORD MJ, 1993, B MAR SCI, V53, P393; Lavides MN, 2009, ENVIRON CONSERV, V36, P235, DOI 10.1017/S0376892909990385; LEBRETON JD, 1991, EURO CH ENV, V2, P85; Lopez J, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3075-3; Lopez J, 2014, FISH RES, V155, P127, DOI 10.1016/j.fishres.2014.02.033; Mackinson S, 2001, ENVIRON MANAGE, V27, P533, DOI 10.1007/s002670010168; Macusi ED, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00188; Marsac Francis, 2000, IFREMER Actes de Colloques, V28, P537; Menard F, 2000, ICES J MAR SCI, V57, P525, DOI 10.1006/jmsc.2000.0717; Miller KI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177391; Moreno G, 2007, AQUAT LIVING RESOUR, V20, P367, DOI 10.1051/alr:2008014; Moreno G, 2007, CAN J FISH AQUAT SCI, V64, P1517, DOI 10.1139/F07-113; Musyl MK, 2003, FISH OCEANOGR, V12, P152, DOI 10.1046/j.1365-2419.2003.00229.x; Naeem A., 1994, BOBP, P18; Nakamae A, 1991, S ART REEFS FISH AGG; Ohta I, 2005, MAR BIOL, V146, P581, DOI 10.1007/s00227-004-1456-x; Parodi JC, 2014, ANN VASC SURG, V28, P536, DOI 10.1016/j.avsg.2014.01.003; Perez G., 2020, MOV ECOL, P1, DOI [10.1186/s40462-019-0184-2, DOI 10.1186/S40462-019-0184-2]; Poizat G, 1997, ENVIRON BIOL FISH, V50, P435, DOI 10.1023/A:1007317423165; R Core Team, 2021, R LANGUAGE ENV STAT; Robert M, 2013, MAR ECOL PROG SER, V484, P239, DOI 10.3354/meps10303; Rodriguez-Tress P, 2017, MAR ECOL PROG SER, V570, P213, DOI 10.3354/meps12101; ROMESBURG HC, 1985, COMPUT GEOSCI, V11, P19, DOI 10.1016/0098-3004(85)90036-6; Ruddle K., 2013, Asian Fisheries Science, V26, P79; Schaefer KM, 2013, MAR BIOL, V160, P3005, DOI 10.1007/s00227-013-2290-9; Schaefer KM, 2010, MAR BIOL, V157, P2625, DOI 10.1007/s00227-010-1524-3; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Sempo G, 2013, J APPL ECOL, V50, P1081, DOI 10.1111/1365-2664.12140; Silvano RAM, 2012, NEOTROP ICHTHYOL, V10, P133, DOI 10.1590/S1679-62252012000100013; Soria M, 2009, ANIM BEHAV, V78, P1441, DOI 10.1016/j.anbehav.2009.09.025; Taylor RB, 2011, BIOL CONSERV, V144, P3038, DOI 10.1016/j.biocon.2011.09.009; Valbo-Jorgensen J., 2000, ENVIRON DEV SUSTAIN, V2, P253, DOI DOI 10.1023/A:1011418225338	61	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254617	10.1371/journal.pone.0254617	http://dx.doi.org/10.1371/journal.pone.0254617			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324529	Green Published, gold, Green Submitted			2022-12-26	WOS:000685248200072
J	Moyano, LM; Montano, SM; Barreto, PV; Reto, N; Larrauri, L; Mori, N; Cornejo-Olivas, M; Guevara-Silva, E; Urizar, F; Najar, E; Gamboa, R; Azabache, C; Ticse, RH; Bolivar-Herrada, L; Doud, A; Martinez, P; Miranda, JJ; Zunt, JR; Garcia, HH				Moyano, Luz M.; Montano, Silvia M.; Vilchez Barreto, Percy; Reto, Narcisa; Larrauri, Luis; Mori, Nicanor; Cornejo-Olivas, Mario; Guevara-Silva, Erik; Urizar, Fernando; Najar, Enrique; Gamboa, Ricardo; Azabache, Cintya; Herrer Ticse, Raquel; Bolivar-Herrada, Lucia; Doud, Alex; Martinez, Peggy; Miranda, J. Jaime; Zunt, Joseph R.; Garcia, Hector H.		Cysticercosis Working Grp	Prevalence of stroke survival in rural communities living in northern Peru	PLOS ONE			English	Article							RISK-FACTORS; LATIN-AMERICA; NIGER DELTA; EPIDEMIOLOGY; HYPERTENSION; POPULATION	Background and purpose Stroke is the leading cause of neurological impairment in the South American Andean region. However, the epidemiology of stroke in the region has been poorly characterized. Methods We conducted a staged three-phase population-based study applying a validated eight-question neurological survey in 80 rural villages in Tumbes, northern Peru, then confirmed presence or absence of stroke through a neurologist's examination to estimate the prevalence of stroke. Results Our survey covered 90% of the population (22,278/24,854 individuals, mean age 30 +/- 21.28, 48.45% females), and prevalence of stroke was 7.05/1,000 inhabitants. After direct standardization to WHO's world standard population, adjusted prevalence of stroke was 6.94/1,000 inhabitants. Participants aged >= 85 years had higher stroke prevalence (>50/1000 inhabitants) compared to other stratified ages, and some unusual cases of stroke were found among individuals aged 25-34 years. The lowest age reported for a first stroke event was 16.8 years. High blood pressure (aPR 4.2 [2.7-6.4], p>0.001), and sedentary lifestyle (aPR 1.6 [1.0-2.6], p = 0.045) were more prevalent in people with stroke. Conclusions The age-standardized prevalence of stroke in this rural coastal Peruvian population was slightly higher than previously reported in studies from surrounding rural South American settings, but lower than in rural African and Asian regions. The death rate from stroke was much higher than in industrialized and middle-income countries.	[Moyano, Luz M.; Vilchez Barreto, Percy; Reto, Narcisa; Cornejo-Olivas, Mario; Urizar, Fernando; Gamboa, Ricardo; Azabache, Cintya; Herrer Ticse, Raquel; Bolivar-Herrada, Lucia; Miranda, J. Jaime; Garcia, Hector H.] Univ Peruana Cayetano Heredia, Ctr Global Hlth, Cysticercosis Eliminat Program, Tumbes, Peru; [Montano, Silvia M.] Univ Nacl Mayor San Marcos, Inst Med Trop Daniel Alcides Carrion, Secc Epidemiol, Lima, Peru; [Larrauri, Luis; Guevara-Silva, Erik] Inst Nacl Ciencias Neurol, Ctr Basico Invest Demencia & Enfermedades Desmiel, Lima, Peru; [Mori, Nicanor] Hosp Nacl Daniel Alcides Carrion, Dept Med, Lima, Peru; [Cornejo-Olivas, Mario] Inst Nacl Ciencias Neurol, Neurogenet Res Ctr MC, Lima, Peru; [Najar, Enrique; Zunt, Joseph R.] Hosp Nacl Cayetano Heredia, Dept Med, Lima, Peru; [Doud, Alex] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Doud, Alex] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Doud, Alex] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Doud, Alex] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Martinez, Peggy] Inst Nacl Nino, Dept Pediat, Lima, Peru; [Miranda, J. Jaime] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Moyano, Luz M.] Univ Nacl Tumbes, Escuela Med Humana, Tumbes, Peru; [Garcia, Hector H.] Univ Peruana Cayetano Heredia, Sch Sci, Dept Microbiol, Lima, Peru; [Garcia, Hector H.] Inst Ciencias Neurol Lima, Cysticercosis Unit, Ctr Basico Invest Examenes Auxiliares Parasitosis, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Nacional Mayor de San Marcos; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Universidad Peruana Cayetano Heredia; Universidad Nacional de Tumbes; Universidad Peruana Cayetano Heredia	Moyano, LM (corresponding author), Univ Peruana Cayetano Heredia, Ctr Global Hlth, Cysticercosis Eliminat Program, Tumbes, Peru.	luz.moyano.v@upch.pe	Zunt, Joseph/ABD-2886-2021; Cornejo-Olivas, Mario/F-9744-2017	RETO OTERO, NARCISA ELIZABETH/0000-0002-8107-1657; Cornejo-Olivas, Mario/0000-0001-6313-5680; Mori, Nicanor/0000-0002-2270-1663; moyano, luz maria/0000-0002-5878-5782	NIH [D43 TW009345]; FIC-NIH Research Training Grant from the Fogarty International Center [D43 TW009137]; FIC-NIH [D43 TW001140]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FIC-NIH Research Training Grant from the Fogarty International Center; FIC-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project was supported by NIH Research Training Grant #D43 TW009345, and by FIC-NIH Research Training Grant #D43 TW009137 from the Fogarty International Center. LM, PV, FU and RG were partially supported by FIC-NIH training grant D43 TW001140.	Advani R, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0398-5; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; [Anonymous], 2009, NUTR REV, V67, P114, DOI 10.1111/j.1753-4887.2008.00136.x; Atalla M, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00298; Auditeau E, 2018, J ETHNOPHARMACOL, V215, P184, DOI 10.1016/j.jep.2018.01.003; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bonita R, 2003, LANCET NEUROL, V2, P592, DOI 10.1016/S1474-4422(03)00524-6; Brutto OHDel., 2004, REV, V39, P301; Camargo ECS, 2005, NEUROIMAG CLIN N AM, V15, P283, DOI 10.1016/j.nic.2005.07.002; Cantu-Brito C, 2011, STROKE, V42, P601, DOI 10.1161/STROKEAHA.110.592592; Carhuallanqui R., 2011, REV MED HERED, V21, P197, DOI [10.20453/rmh.v21i4.1114, DOI 10.20453/RMH.V21I4.1114]; Del Brutto OH, 2004, NEUROLOGY, V63, P1974, DOI 10.1212/01.WNL.0000145293.04832.78; Del Brutto OH, 2014, INT J STROKE, V9, P367, DOI 10.1111/ijs.12030; Del Brutto VJ, 2018, INT J GERIATR PSYCH, V33, P325, DOI 10.1002/gps.4747; Dempsey PC, 2018, HYPERTENSION, V72, P1037, DOI 10.1161/HYPERTENSIONAHA.118.11190; Enwereji KO, 2014, VASC HEALTH RISK MAN, V10, P375, DOI 10.2147/VHRM.S57623; Ezejimofor MC, 2017, J NEUROL SCI, V372, P262, DOI 10.1016/j.jns.2016.11.059; Feigin VL, 2005, LANCET, V365, P2160, DOI 10.1016/S0140-6736(05)66755-4; Fennema-Notestine C, 2016, NEUROIMAGE-CLIN, V12, P737, DOI 10.1016/j.nicl.2016.10.001; Health R., 2018, RURAL REMOTE HEALTH, V18; Heart Association A, 2018, CHOL MAN GUID WWW HE; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Khedr EM, 2013, NEUROEPIDEMIOLOGY, V40, P288, DOI 10.1159/000346270; Kjeldsen SE, 2018, PHARMACOL RES, V129, P95, DOI 10.1016/j.phrs.2017.11.003; Lavados PM, 2007, LANCET NEUROL, V6, P362, DOI 10.1016/S1474-4422(07)70003-0; Mazetti P., 2014, PREVALENCE STROKE HI, P562; Medina MT., 2007, PREVALENCIA ENFERMED, V44, P460; Nicoletti A, 2000, STROKE, V31, P882, DOI 10.1161/01.STR.31.4.882; O'Donnell M, 2010, NEUROEPIDEMIOLOGY, V35, P36, DOI 10.1159/000306058; Okamoto K, 2003, STROKE, V34, P2107, DOI 10.1161/01.STR.0000091270.29127.1E; Onwuchekwa AC, 2014, J STROKE CEREBROVASC, V23, P505, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.010; Panamericana OS, 2007, SAL AM 2007, VII, P812; Pikija S, 2012, NEUROEPIDEMIOLOGY, V38, P164, DOI 10.1159/000336114; Pradilla Ardila G., 2002, REV MED CHILE SCIELO, P191; Ramirez D, 2008, PERFIL SOCIODEMOGRAF; Saposnik G, 2003, STROKE, V34, P2103, DOI 10.1161/01.STR.0000088063.74250.DB; Shehata M., 2019, INNOVAIT ED INSPIR G, V12, P252, DOI [10.1177/1755738019829780, DOI 10.1177/1755738019829780]; Touboul PJ, 2007, INT J CARDIOVAS IMAG, V23, P557, DOI 10.1007/s10554-006-9197-1; Vigo-ramos J., 2008, MED EXP, V25, P05; Wang WZ, 2017, CIRCULATION, V135, P759, DOI 10.1161/CIRCULATIONAHA.116.025250; WHO, 2006, PROTECTING GROUNDWAT, P1; Xing LY, 2020, INT J STROKE, V15, P399, DOI 10.1177/1747493019851280	42	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254440	10.1371/journal.pone.0254440	http://dx.doi.org/10.1371/journal.pone.0254440			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324513	gold, Green Published, Green Accepted			2022-12-26	WOS:000685248200008
J	Rahman, T; Hasnain, MDG; Islam, A				Rahman, Tabassum; Hasnain, M. D. Golam; Islam, Asad			Food insecurity and mental health of women during COVID-19: Evidence from a developing country	PLOS ONE			English	Article							PSYCHOLOGICAL IMPACT; VIRUS DISEASE; STRESS; SECURITY; DISORDERS; DEPRESSION; INFLUENZA; CASSAVA; STIGMA	Background This study examines the association between food insecurity and mental health of women during the COVID-19 pandemic in a resource poor setting. Materials and methods Data were collected at two time-points (wave 1 and 2) from 2402 women, one per household, participating in a larger study during extended COVID-19 lockdown in the rural areas of the southwest region of Bangladesh. The primary outcome of the analyses is the association between food insecurity, measured using the Food Insecurity Experience Scale (FIES), and stress level, measured using the Perceived Stress Scale (PSS), for women during the lockdown. General awareness about COVID-19 and attitude towards prescribed preventive measures were also measured since COVID-19 health concerns could exacerbate food insecurity. Results An individual-level evaluation of the effect of wave 2 FIES score on PSS score showed that worsening of the food security status increasing the stress level of the participants (95% CI: 1.61; 2.13; p-value: <0.001). Additionally, a significant negative association was observed between the PSS score and change in food security status between the two waves (Coefficient: -1.15, 95% CI: -1.30; -0.99, p-value: <0.001), indicating that deterioration in food security status over the pandemic period increasing the stress level. At the village level, the results showed a similar pattern. General awareness around ways coronavirus spreads was high, yet there were misperceptions at a higher level. Maintaining hand hygiene, wearing face masks outside the home, and going outside only when necessary were widely practised. Fewer respondents could maintain a 1.5-metre distance from others in the outside and maintained cough and sneeze etiquette. Conclusion The results indicate a higher stress level, a potential contributor to poor mental health, as food insecurity deteriorated. Policy initiatives in ameliorating immediate food insecurity during crises, improving long-term wellbeing, and expanding the reach of mental health support are warranted.	[Rahman, Tabassum; Hasnain, M. D. Golam] Univ Newcastle, Sch Med & Publ Hlth, Coll Hlth, Med & Wellbeing, Newcastle, NSW, Australia; [Islam, Asad] Monash Univ, Ctr Dev Econ & Sustainabil, Dept Econ, Melbourne, Vic, Australia	University of Newcastle; Monash University	Rahman, T (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Coll Hlth, Med & Wellbeing, Newcastle, NSW, Australia.	Tabassum.Rahman@uon.edu.au		Islam, Asadul/0000-0002-0928-0454; Rahman, Tabassum/0000-0003-4323-3392	Monash University Faculty Research Group Grant	Monash University Faculty Research Group Grant	AI has been funded by Monash University Faculty Research Group Grant. TR and MGH collaborated in this research work with AI. The funders did not have any input into any aspect of this manuscript.	Abate G. T., 2020, ESSP Working Paper - Ethiopia Strategy Support Program, DOI 10.2499/p15738coll2.133766; Abi-Habib M., 2020, NEW YORK TIMES; Ahmed F., 2020, FOOD POLICY; Ahmed T, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/16473; Alders R, 2014, ECOHEALTH, V11, P63, DOI 10.1007/s10393-013-0867-x; Ayeb-Karlsson S, 2016, SUSTAIN SCI, V11, P679, DOI 10.1007/s11625-016-0379-z; Bahn K, 2020, GENDER WORK ORGAN, V27, P695, DOI 10.1111/gwao.12459; Ballard TJ., 2013, FOOD INSECURITY EXPE; Bangladesh W., CORONAVIRUS DIS COVI; Barrett CB, 2020, NAT FOOD, V1, P319, DOI 10.1038/s43016-020-0085-y; Barrett Christopher B., 2013, FOOD SECURITY SOCIOP; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Bruening M, 2012, AM J PUBLIC HEALTH, V102, P520, DOI 10.2105/AJPH.2011.300390; Ceballos F, 2020, WORLD DEV, V136, DOI 10.1016/j.worlddev.2020.105069; Cheung Edith, 2003, Food and Nutrition Bulletin, V24, P247; Cheung EYL, 2015, INTERVENTION, V13, P70, DOI 10.1097/WTF.0000000000000079; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Chua SE, 2004, CAN J PSYCHIAT, V49, P385, DOI 10.1177/070674370404900607; Cohen S, 1994, PERCEIVED STRESS SCA; Cohen S, 2016, PERSPECT PSYCHOL SCI, V11, P456, DOI 10.1177/1745691616646305; Cowling BJ, 2010, J INFECT DIS, V202, P867, DOI 10.1086/655811; Dajaan D.S., 2018, INT J COMMUNITY MED, V5, P2205, DOI [10.18203/2394-6040.ijcmph20182146, DOI 10.18203/2394-6040.IJCMPH20182146]; Ebaidalla E.M., 2019, WIDER WORKING PAPER; Ebrahim SH, 2020, LANCET PLANET HEALTH, V4, pE379, DOI 10.1016/S2542-5196(20)30175-3; Elsahoryi N, 2020, CLIN NUTR ESPEN, V40, P171, DOI 10.1016/j.clnesp.2020.09.026; Fan S, 2020, PREVENTING GLOBAL FO; FAO, 2017, FOOD SEC NUTR CONFL; Food and Agriculture Organization, 2020, The state of food security and nutrition in the world 2020: transforming food systems for affordable healthy diets, DOI 10.4060/ca9692en; Frongillo EA, 2019, J NUTR, V149, P330, DOI 10.1093/jn/nxy261; Frontieres MS., COR 2021; Galvao J, 2021, LANCET INFECT DIS, V21, pE114, DOI 10.1016/S1473-3099(20)30721-0; Glauber J., 2020, COVID 19 GLOBAL FOOD, P66, DOI [10.2499/p15738coll2.133762_14, DOI 10.2499/P15738COLL2.133762, 10.2499/p15738coll2.133762]; Hadley C, 2006, AM J HUM BIOL, V18, P359, DOI 10.1002/ajhb.20505; Hamadani JD, 2020, LANCET GLOB HEALTH, V8, pE1380, DOI 10.1016/S2214-109X(20)30366-1; Haque Monoarul, 2015, J Family Reprod Health, V9, P35; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Ho RC, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-81; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Hosain GMM, 2007, PUBLIC HEALTH, V121, P18, DOI 10.1016/j.puhe.2006.06.018; Hossain MD, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0216-9; Hossain M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-775; Huang J, 2016, PUBLIC HEALTH NUTR, V19, P511, DOI 10.1017/S1368980015001603; Institute of Epidemiology DCaR, COR INF 2021; Islam A, 2021, SOC SCI MED, V278, DOI 10.1016/j.socscimed.2021.113966; Islam M.N., 2020, HELL J PSYCHOL, V17, P15, DOI [10.26262/hjp.v17i1.7844, DOI 10.26262/HJP.V17I1.7844]; Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573; James PB, 2019, TROP MED INT HEALTH, V24, P671, DOI 10.1111/tmi.13226; Jones AD, 2017, AM J PREV MED, V53, P264, DOI 10.1016/j.amepre.2017.04.008; Juran L, 2015, GEOGR REV, V105, P601, DOI 10.1111/j.1931-0846.2015.12089.x; Kabeer N, 2010, IDS BULL-I DEV STUD, V41, P79, DOI 10.1111/j.1759-5436.2010.00126.x; Kalansooriya C. W., 2014, INT J MULTIDISCIPLIN, V1, P41, DOI DOI 10.4038/ijms.v1i1.31; Kansiime MK, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105199; Kelly JD, 2018, AM J TROP MED HYG, V98, P1484, DOI 10.4269/ajtmh.17-0820; Kuberan Anjana, 2015, J Nat Sci Biol Med, V6, pS69, DOI 10.4103/0976-9668.166090; Laborde D., 2020, POVERTY FOOD INSECUR; LAZARUS RS, 1993, ANNU REV PSYCHOL, V44, P1, DOI 10.1146/annurev.ps.44.020193.000245; Legg JP, 1999, CROP PROT, V18, P627, DOI 10.1016/S0261-2194(99)00062-9; Lukwa AT., 2020, BMC PUBLIC HEALTH, V20, P1, DOI [10.1186/s12889-019-7969-5, DOI 10.1186/S12889-019-7969-5]; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Mariam E, 2020, DAILY STAR; Martin MS, 2016, PUBLIC HEALTH, V132, P86, DOI 10.1016/j.puhe.2015.11.014; McAuliffe Shane, 2020, BMJ Nutr Prev Health, V3, P93, DOI 10.1136/bmjnph-2020-000100; Mozumder MK, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1482-0; Mtika MM, 2001, HUM ORGAN, V60, P178, DOI 10.17730/humo.60.2.cnlpmfrrg8hay9xh; Mucci N, 2016, NEUROPSYCH DIS TREAT, V12, P983, DOI 10.2147/NDT.S98525; Naylor RL, 2010, POPUL DEV REV, V36, P693, DOI 10.1111/j.1728-4457.2010.00354.x; Olff M, 1999, PSYCHIAT RES, V85, P7, DOI 10.1016/S0165-1781(98)00139-5; Organization WH, COR 2020; Organization WH, GUID PREV ADDR SOC S; Patel V, 2006, BRIT J PSYCHIAT, V189, P547, DOI 10.1192/bjp.bp.106.022558; Pereira M, 2020, PUBLIC HEALTH NUTR, V23, P3236, DOI [10.1017/S1368980020003493, 10.1017/S1368980020003493[Opensinanewwindow]]; Perez- Escamilla R, 2012, J APPL RES CHILD INF, V3, P9; PRUDENCIO YC, 1994, FOOD POLICY, V19, P57, DOI 10.1016/0306-9192(94)90008-6; Rabbi SE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-89; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Rahman A, 2019, LANCET, V393, P1733, DOI 10.1016/S0140-6736(18)32343-2; Rahman T, 2020, INCOME LOSS WELLBEIN; Ravallion M., 2020, APR, V15; Ravallion M, 2020, EC POVERTY 2020; Rosegrant MW, 2000, FOOD POLICY, V25, P243, DOI 10.1016/S0306-9192(00)00004-X; Schmeer KK, 2015, PUBLIC HEALTH NUTR, V18, P2915, DOI 10.1017/S1368980014003000; Schuler SR, 2010, DEV PRACT, V20, P840, DOI 10.1080/09614524.2010.508108; Seino K, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-29; Shah J., 2020, PROTHOM ALO; Siwatu G., 2020, IMPACT COVID 19 NIGE; Smith MD, 2017, WORLD DEV, V93, P402, DOI 10.1016/j.worlddev.2017.01.006; Sparling TM, 2020, PUBLIC HEALTH NUTR, V23, P660, DOI 10.1017/S1368980019003495; Stain HJ, 2011, SOC SCI MED, V73, P1593, DOI 10.1016/j.socscimed.2011.09.016; Stangl AL, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1271-3; Stanturf JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137208; Sulser T, 2020, COVID 19 RELATED TRA; Swinnen J, 2020, EUROCHOICES, V19, P26, DOI 10.1111/1746-692X.12288; Tran DS, 2007, EPILEPSY BEHAV, V10, P565, DOI 10.1016/j.yebeh.2007.02.018; Verpoorten M, 2013, FOOD POLICY, V39, P51, DOI 10.1016/j.foodpol.2012.12.006; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Weiser SD, 2011, AM J CLIN NUTR, V94, p1729S, DOI 10.3945/ajcn.111.012070; World Bank, 2008, GLOBAL ECONOMIC PROSPECTS: TECHNOLOGY DIFFUSION IN THE DEVELOPING WORLD, P1, DOI 10.1596/978-0-8213-7365-1; Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X	98	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255392	10.1371/journal.pone.0255392	http://dx.doi.org/10.1371/journal.pone.0255392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324606	gold, Green Published			2022-12-26	WOS:000685248200082
J	Sugihara, K; Takai, Y; Kawasaki, R; Nitta, K; Katai, M; Kitaoka, Y; Yokoyama, Y; Omodaka, K; Naito, T; Yamashita, T; Mizoue, S; Iwase, A; Nakazawa, T; Tanito, M				Sugihara, Kazunobu; Takai, Yasuyuki; Kawasaki, Ryo; Nitta, Koji; Katai, Maki; Kitaoka, Yasushi; Yokoyama, Yu; Omodaka, Kazuko; Naito, Tomoko; Yamashita, Takehiro; Mizoue, Shiro; Iwase, Aiko; Nakazawa, Toru; Tanito, Masaki			Comparisons between retinal vessel calibers and various optic disc morphologic parameters with different optic disc appearances: The Glaucoma Stereo Analysis Study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NERVE-FIBER LAYER; VISUAL-FIELD DEFECTS; OCULAR BLOOD-FLOW; COHERENCE TOMOGRAPHY; TENSION GLAUCOMA; VASCULAR CALIBER; EYES; DIAMETER; POPULATION	The Glaucoma Stereo Analysis Study (GSAS) is a multicenter collaborative study of the characteristics of glaucomatous optic disc morphology using a stereo fundus camera. This study evaluated the retinal vessel calibers and correlations using GSAS fundus photographs between retinal vessels and 38 optic nerve head (ONH) morphologic parameters comprehensively. In all 240 eyes, the mean central retinal arteriolar equivalent (CRAE) and central retinal venular equivalent (CRVE) were 138.4 and 216.5 mu m, respectively; the CRAE correlated with age, visual field scores and 19 ONH parameters and CRVE correlated with age, intraocular pressure, visual field scores and 11 ONH parameters. Among the different optic disc appearances including focal ischemia (FI) (n = 53, 22%), generalized enlargement (GE) (n = 53, 22%), myopic glaucoma (MY) (n = 112, 47%), and senile sclerosis (SS) (n = 22, 9%), the CRAE did not differ significantly; CRVE was significantly narrower in SS than in FI and MY. In FI, GE, MY, and SS disc types, CRAE correlated with 3, 14, 9, and 2 ONH parameters, respectively, and CRVE corelated with 9, 0, 12, and 6 ONH parameters, respectively. We confirmed previous observations on the effect of retinal vessel narrowing on glaucomatous changes in the ONH and visual field. The associations between retinal vessel caliber and ONH morphologic parameters vary among different optic disc appearances, suggesting different effects of vascular changes in each disc type.				tanito-oph@umin.ac.jp	Kawasaki, Ryo/B-7266-2009	Kawasaki, Ryo/0000-0002-7492-6303				Aizawa N, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-113; Amerasinghe N, 2008, INVEST OPHTH VIS SCI, V49, P5397, DOI 10.1167/iovs.08-2142; Asakawa K, 2013, J GLAUCOMA, V22, P698, DOI 10.1097/IJG.0b013e318264be18; Broadway DC, 1998, AM J OPHTHALMOL, V125, P593, DOI 10.1016/S0002-9394(98)00002-6; Broadway DC, 1999, SURV OPHTHALMOL, V43, pS223, DOI 10.1016/S0039-6257(99)00007-7; Broadway DC, 1998, BRIT J OPHTHALMOL, V82, P862, DOI 10.1136/bjo.82.8.862; Chang M, 2011, AM J OPHTHALMOL, V151, P100, DOI 10.1016/j.ajo.2010.07.025; Cheng CSM, 2016, CLIN OPHTHALMOL, V10, DOI 10.2147/OPTH.S96529; Chiba N, 2011, CLIN OPHTHALMOL, V5, P1549, DOI 10.2147/OPTH.S22097; De Leon JMS, 2015, GRAEF ARCH CLIN EXP, V253, P583, DOI 10.1007/s00417-014-2895-9; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; Garhofer G, 2010, ACTA OPHTHALMOL, V88, P717, DOI 10.1111/j.1755-3768.2009.01587.x; GLOSTER J, 1974, BRIT J OPHTHALMOL, V58, P850, DOI 10.1136/bjo.58.10.850; GRAHAM SL, 1995, OPHTHALMOLOGY, V102, P61; Hall JK, 2001, AM J OPHTHALMOL, V132, P855, DOI 10.1016/S0002-9394(01)01200-4; Hosseinaee Z, 2018, TRANSL VIS SCI TECHN, V7, DOI 10.1167/tvst.7.4.18; Hughes AD, 2008, J HYPERTENS, V26, P1703, DOI 10.1097/HJH.0b013e328304b072; Hugo J, 2020, J GLAUCOMA, V29, P271, DOI 10.1097/IJG.0000000000001452; Ishida K, 1998, J GLAUCOMA, V7, P372; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P1599; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P1604; JONAS JB, 1989, AM J OPHTHALMOL, V107, P137, DOI 10.1016/0002-9394(89)90212-2; Kawasaki R, 2013, OPHTHALMOLOGY, V120, P84, DOI 10.1016/j.ophtha.2012.07.007; Kitaoka Y, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/8941489; Kitaoka Y, 2016, GRAEF ARCH CLIN EXP, V254, P523, DOI 10.1007/s00417-015-3239-0; KITAZAWA Y, 1986, OPHTHALMOLOGY, V93, P853; Kiuchi Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45049-7; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Koseki N, 2008, OPHTHALMOLOGY, V115, P2049, DOI 10.1016/j.ophtha.2008.05.015; Lee KE, 2007, INVEST OPHTH VIS SCI, V48, P63, DOI 10.1167/iovs.05-1203; Li X, 2013, INVEST OPHTH VIS SCI, V54, P3650, DOI 10.1167/iovs.12-11126; Liew G, 2008, ARCH OPHTHALMOL-CHIC, V126, P1404, DOI 10.1001/archopht.126.10.1404; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Mayama C, 2013, JPN J OPHTHALMOL, V57, P133, DOI 10.1007/s10384-012-0220-x; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Mitchell P, 2005, OPHTHALMOLOGY, V112, P245, DOI 10.1016/j.ophtha.2004.08.015; Nakazawa T, 2010, JPN J OPHTHALMOL, V54, P291, DOI 10.1007/s10384-010-0816-y; NATHANSON JA, 1995, INVEST OPHTH VIS SCI, V36, P1774; Nicolela MT, 2003, OPHTHALMOLOGY, V110, P2178, DOI 10.1016/S0161-6420(03)00801-7; Nicolela MT, 1996, OPHTHALMOLOGY, V103, P1670, DOI 10.1016/S0161-6420(96)30448-X; Nicolela MT, 1996, OPHTHALMOLOGY, V103, P640, DOI 10.1016/S0161-6420(96)30640-4; Omodaka K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190012; Omodaka K, 2015, JPN J OPHTHALMOL, V59, P223, DOI 10.1007/s10384-015-0379-z; Omodaka K, 2010, CLIN OPHTHALMOL, V4, P629; Papastathopoulos KI, 1999, BRIT J OPHTHALMOL, V83, P285, DOI 10.1136/bjo.83.3.285; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Pellegrini E, 2014, BIOMED OPT EXPRESS, V5, P4329, DOI 10.1364/BOE.5.004329; PHELPS CD, 1985, INVEST OPHTH VIS SCI, V26, P1105; Rankin SJA, 1996, J GLAUCOMA, V5, P22; Rong X, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1211-1; SHIN DH, 1991, OPHTHALMOLOGY, V98, P1087; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Takada N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160226; Takai Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179663; Tanito M, 2019, ACTA OPHTHALMOL, V97, pE42, DOI 10.1111/aos.13816; Tanito M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169858; Tanito M, 2014, JPN J OPHTHALMOL, V58, P56, DOI 10.1007/s10384-013-0280-6; Tham YC, 2013, INVEST OPHTH VIS SCI, V54, P7309, DOI 10.1167/iovs.13-12796; Tobe LA, 2015, BRIT J OPHTHALMOL, V99, P609, DOI 10.1136/bjophthalmol-2014-305780; Wang SA, 2007, CLIN EXP OPHTHALMOL, V35, P800, DOI 10.1111/j.1442-9071.2007.01627.x; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wolfs RCW, 1999, OPHTHALMOLOGY, V106, P1597, DOI 10.1016/S0161-6420(99)90458-X; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Yabana T, 2017, JPN J OPHTHALMOL, V61, P378, DOI 10.1007/s10384-017-0523-z; Yamamoto S, 2014, OPHTHALMOLOGY, V121, P1558, DOI 10.1016/j.ophtha.2014.03.003; Yamazaki Y, 1997, AM J OPHTHALMOL, V124, P287, DOI 10.1016/S0002-9394(14)70820-7; Yap ZL, 2017, J GLAUCOMA, V26, P367, DOI 10.1097/IJG.0000000000000622; Yokoyama Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099138; Yokoyama Y, 2011, CLIN OPHTHALMOL, V5, P1721, DOI 10.2147/OPTH.S23204; Zheng YF, 2009, INVEST OPHTH VIS SCI, V50, P4091, DOI 10.1167/iovs.09-3444	72	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0250245	10.1371/journal.pone.0250245	http://dx.doi.org/10.1371/journal.pone.0250245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324508	Green Published, gold			2022-12-26	WOS:000685248200014
J	Briggs, N; Gormally, MV; Li, FY; Browning, SL; Treggiari, MM; Morrison, A; Laurent-Rolle, M; Deng, YH; Hendrickson, JE; Tormey, CA; Desruisseaux, MS				Briggs, Neima; Gormally, Michael V.; Li, Fangyong; Browning, Sabrina L.; Treggiari, Miriam M.; Morrison, Alyssa; Laurent-Rolle, Maudry; Deng, Yanhong; Hendrickson, Jeanne E.; Tormey, Christopher A.; Desruisseaux, Mahalia S.			Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19	PLOS ONE			English	Article								Background Limited therapeutic options exist for coronavirus disease 2019 (COVID-19). COVID-19 convalescent plasma (CCP) is a potential therapeutic, but there is limited data for patients with moderate-to-severe disease. Research question What are outcomes associated with administration of CCP in patients with moderate-to-severe COVID-19 infection? Study design and methods We conducted a propensity score-matched analysis of patients with moderate-to-severe COVID-19. The primary endpoints were in-hospital mortality. Secondary endpoints were number of days alive and ventilator-free at 30 days; length of hospital stay; and change in WHO scores from CCP administration (or index date) to discharge. Of 151 patients who received CCP, 132 had complete follow-up data. Patients were transfused after a median of 6 hospital days; thus, we investigated the effect of convalescent plasma before and after this timepoint with 77 early (within 6 days) and 55 late (after 6 days) recipients. Among 3,217 inpatients who did not receive CCP, 2,551 were available for matching. Results Early CCP recipients, of whom 31 (40%) were on mechanical ventilation, had lower 14-day (15% vs 23%) and 30-day (38% vs 49%) mortality compared to a matched unexposed cohort, with nearly 50% lower likelihood of in-hospital mortality (HR 0.52, [95% CI 0.28-0.96]; P = 0.036). Early plasma recipients had more days alive and ventilator-free at 30 days (+3.3 days, [95% CI 0.2 to 6.3 days]; P = 0.04) and improved WHO scores at 7 days (-0.8, [95% CI: -1.2 to -0.4]; P = 0.0003) and hospital discharge (-0.9, [95% CI: -1.5 to -0.3]; P = 0.004) compared to the matched unexposed cohort. No clinical differences were observed in late plasma recipients. Interpretation Early administration of CCP improves outcomes in patients with moderate-to-severe COVID-19, while improvement was not observed with late CCP administration. The importance of timing of administration should be addressed in specifically designed trials.	[Briggs, Neima; Gormally, Michael V.] Yale Sch Med, Dept Med, New Haven, CT USA; [Li, Fangyong; Deng, Yanhong] Yale Univ, Yale Ctr Analyt Sci, New Haven, CT USA; [Browning, Sabrina L.] Yale Sch Med, Dept Med, Sect Hematol, New Haven, CT USA; [Browning, Sabrina L.] Yale Canc Ctr, New Haven, CT USA; [Treggiari, Miriam M.] Yale Sch Med, Dept Anesthesiol, New Haven, CT USA; [Morrison, Alyssa] Yale Sch Med, New Haven, CT USA; [Laurent-Rolle, Maudry; Desruisseaux, Mahalia S.] Yale Sch Med, Dept Med, Infect Dis Sect, New Haven, CT 06504 USA; [Hendrickson, Jeanne E.; Tormey, Christopher A.] Yale Sch Med, Dept Lab Med, New Haven, CT USA; [Hendrickson, Jeanne E.] Yale Sch Med, Dept Pediat, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Desruisseaux, MS (corresponding author), Yale Sch Med, Dept Med, Infect Dis Sect, New Haven, CT 06504 USA.	Mahalia.desruisseaux@yale.edu	Desruisseaux, Mahalia S/GOK-0005-2022	Briggs, Neima/0000-0002-5583-7057; Gormally, Michael/0000-0002-0414-4234; Browning, Sabrina/0000-0002-9812-0654; Desruisseaux, Mahalia/0000-0003-2060-412X	Federal funds from the US Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority [75A50120C00096]; Yale University Dean's Diversity Initiative Faculty Excellence award; National Center for Advancing Translational Science (NCATS) [UL1 TR000142]; National Institutes of Health [UL1 TR000142]; National Heart, Lung, and Blood Institute (NHLBI) [T32 HL007974]	Federal funds from the US Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority; Yale University Dean's Diversity Initiative Faculty Excellence award; National Center for Advancing Translational Science (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project has been funded in whole or in part with Federal funds from the US Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority under Contract No. 75A50120C00096. This publication was also made possible by the Yale University Dean's Diversity Initiative Faculty Excellence award (to MSD); the CTSA Grant Number UL1 TR000142 (to FL, YD) from the National Center for Advancing Translational Science (NCATS) and the National Institutes of Health; the Immunohematology/Transfusion Medicine Research Training Grant Number T32 HL007974 (to MLR) from the National Heart, Lung, and Blood Institute (NHLBI); the DeLuca Center for Innovation in Hematology Research at Yale Cancer Center and The Frederick A. Deluca Foundation (to SLB); the Bernard Forget Scholarship in the Section of Hematology and Yale Cancer Center (to SLB).	Agarwal A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3939; Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Cevik M, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3862; Cheng Y, 2005, EUR J CLIN MICROBIOL, V24, P44, DOI 10.1007/s10096-004-1271-9; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Duan Kai, 2020, Proc Natl Acad Sci U S A, V117, P9490, DOI 10.1073/pnas.2004168117; Gharbharan A, 2020, CONVALESCENT PLASMA, DOI 10.1101/2020.07.01.20139857; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Hung IEN, 2013, CHEST, V144, P464, DOI 10.1378/chest.12-2907; Joyner Michael J, 2020, medRxiv, DOI 10.1101/2020.08.12.20169359; Li L, 2020, JAMA-J AM MED ASSOC, V324, P460, DOI 10.1001/jama.2020.10044; Libster R, 2021, NEW ENGL J MED, V384, P610, DOI 10.1056/NEJMoa2033700; Libster R, 2020, PREVENTION SEVERE CO, DOI [10.1101/2020.11.20.20234013, DOI 10.1101/2020.11.20.20234013]; Liu STH, 2020, NAT MED, V26, P1708, DOI 10.1038/s41591-020-1088-9; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Nahid P, 2019, AM J RESP CRIT CARE, V200, pE93, DOI 10.1164/rccm.201909-1874ST; Perotti C, 2020, HAEMATOLOGICA, V105, P2834, DOI 10.3324/haematol.2020.261784; Rojas M, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102554; Salazar E, 2020, AM J PATHOL, V190, P1680, DOI 10.1016/j.ajpath.2020.05.014; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Simonovich VA, 2021, NEW ENGL J MED, V384, P619, DOI 10.1056/NEJMoa2031304; Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wu F, 2020, NATURE, V580, pE7; Zeng QL, 2020, J INFECT DIS, V222, P38, DOI 10.1093/infdis/jiaa228; Zhang B, 2020, CHEST, V158, pE9, DOI 10.1016/j.chest.2020.03.039; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	30	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254453	10.1371/journal.pone.0254453	http://dx.doi.org/10.1371/journal.pone.0254453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320004	Green Submitted, Green Published, gold			2022-12-26	WOS:000685247800041
J	Chen, TR; Juan, SH; Huang, YW; Lin, YC; Lo, WC				Chen, Teng-Ruei; Juan, Sheng-Hung; Huang, Yu-Wei; Lin, Yen-Cheng; Lo, Wei-Cheng			A secondary structure-based position-specific scoring matrix applied to the improvement in protein secondary structure prediction	PLOS ONE			English	Article							CIRCULAR PERMUTATION; FOLD RECOGNITION; DATABASE SEARCH; ACCURACY; SERVER; ALIGNMENT; PROFILES; GENERATION; NETWORKS; TERTIARY	Protein secondary structure prediction (SSP) has a variety of applications; however, there has been relatively limited improvement in accuracy for years. With a vision of moving forward all related fields, we aimed to make a fundamental advance in SSP. There have been many admirable efforts made to improve the machine learning algorithm for SSP. This work thus took a step back by manipulating the input features. A secondary structure element-based position-specific scoring matrix (SSE-PSSM) is proposed, based on which a new set of machine learning features can be established. The feasibility of this new PSSM was evaluated by rigid independent tests with training and testing datasets sharing <25% sequence identities. In all experiments, the proposed PSSM outperformed the traditional amino acid PSSM. This new PSSM can be easily combined with the amino acid PSSM, and the improvement in accuracy was remarkable. Preliminary tests made by combining the SSE-PSSM and well-known SSP methods showed 2.0% and 5.2% average improvements in three- and eight-state SSP accuracies, respectively. If this PSSM can be integrated into state-of-the-art SSP methods, the overall accuracy of SSP may break the current restriction and eventually bring benefit to all research and applications where secondary structure prediction plays a vital role during development. To facilitate the application and integration of the SSE-PSSM with modern SSP methods, we have established a web server and standalone programs for generating SSE-PSSM available at http://10.life.nctu.edu.tw/SSEPSSM.	[Chen, Teng-Ruei; Juan, Sheng-Hung; Huang, Yu-Wei; Lo, Wei-Cheng] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Chen, Teng-Ruei; Juan, Sheng-Hung; Huang, Yu-Wei; Lo, Wei-Cheng] Natl Yang Ming Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Lin, Yen-Cheng; Lo, Wei-Cheng] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Lin, Yen-Cheng; Lo, Wei-Cheng] Natl Yang Ming Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Lo, Wei-Cheng] Natl Yang Ming Chiao Tung Univ, Ctr Bioinformat Res, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lo, WC (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.; Lo, WC (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.; Lo, WC (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.; Lo, WC (corresponding author), Natl Yang Ming Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.; Lo, WC (corresponding author), Natl Yang Ming Chiao Tung Univ, Ctr Bioinformat Res, Hsinchu, Taiwan.	WadeLo@nctu.edu.tw		Lo, Wei-Cheng/0000-0001-8865-5113; Chen, Teng-Ruei/0000-0001-8995-334X	Ministry of Science and Technology (MOST), Taiwan [NSC 101-2311-B-009-006-MY2]	Ministry of Science and Technology (MOST), Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by the Ministry of Science and Technology (MOST), Taiwan (https://www.most.gov.tw/?l=en) with grant number NSC 101-2311-B-009-006-MY2 to WCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambrosi C, 2010, J BIOL CHEM, V285, P24420, DOI 10.1074/jbc.M110.115444; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bondugula R, 2007, PROTEINS, V66, P664, DOI 10.1002/prot.21177; Chen TR, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254555; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Deng X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-436; Donate LE, 1996, PROTEIN SCI, V5, P2600, DOI 10.1002/pro.5560051223; Dor O, 2007, PROTEINS, V66, P838, DOI 10.1002/prot.21298; Dorn M, 2014, COMPUT BIOL CHEM, V53, P251, DOI 10.1016/j.compbiolchem.2014.10.001; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fang C, 2018, PROTEINS, V86, P592, DOI 10.1002/prot.25487; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Fiser A, 2010, METHODS MOL BIOL, V673, P73, DOI 10.1007/978-1-60761-842-3_6; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Gebhard LG, 2006, J MOL BIOL, V358, P280, DOI 10.1016/j.jmb.2006.01.095; Guo J, 2004, PROTEINS, V54, P738, DOI 10.1002/prot.10634; Heffernan R, 2018, J COMPUT CHEM, V39, P2210, DOI 10.1002/jcc.25534; Heffernan R, 2017, BIOINFORMATICS, V33, P2842, DOI 10.1093/bioinformatics/btx218; Heffernan R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11476; Heinemann U, 1995, PROG BIOPHYS MOL BIO, V64, P121, DOI 10.1016/0079-6107(95)00013-5; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hu XZ, 2007, P NATL ACAD SCI USA, V104, P17668, DOI 10.1073/pnas.0707977104; Huang TT, 2015, NUCLEIC ACIDS RES, V43, pW338, DOI 10.1093/nar/gkv454; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Juan SH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235153; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Julenius K, 2007, GLYCOBIOLOGY, V17, P868, DOI 10.1093/glycob/cwm050; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kearns MJ., 1990, COMPUTATIONAL COMPLE, Vxvi, P165; Kifer I, 2008, PROTEINS, V73, P380, DOI 10.1002/prot.22073; Kim H, 2003, PROTEIN ENG, V16, P553, DOI 10.1093/protein/gzg072; Klausen MS, 2019, PROTEINS, V87, P520, DOI 10.1002/prot.25674; Lee YZ, 2017, METHODS MOL BIOL, V1495, P259, DOI 10.1007/978-1-4939-6451-2_17; Lee YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043820; Li Z., 2016, PROTEIN SECONDARY ST, P2560; Li ZX, 2013, ANNU REV BIOPHYS, V42, P315, DOI 10.1146/annurev-biophys-083012-130315; Lin K, 2005, BIOINFORMATICS, V21, P152, DOI 10.1093/bioinformatics/bth487; Lo WC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r11; Lo WC, 2012, NUCLEIC ACIDS RES, V40, pW232, DOI 10.1093/nar/gks529; Lo WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031791; Lo WC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-307; LUGER K, 1989, SCIENCE, V243, P206, DOI 10.1126/science.2643160; Lyons J, 2016, J THEOR BIOL, V393, P67, DOI 10.1016/j.jtbi.2015.12.018; Madhusudhan MS, 2006, PROTEIN ENG DES SEL, V19, P129, DOI 10.1093/protein/gzj005; Magnan CN, 2014, BIOINFORMATICS, V30, P2592, DOI 10.1093/bioinformatics/btu352; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; McDonnell AV, 2006, PROTEINS, V63, P976, DOI 10.1002/prot.20942; Michalsky E, 2003, PROTEIN ENG, V16, P979, DOI 10.1093/protein/gzg119; Mirabello C, 2013, BIOINFORMATICS, V29, P2056, DOI 10.1093/bioinformatics/btt344; Montgomerie S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-301; Moult J, 1997, PROTEINS, P2; NALINI V, 1994, J MOL BIOL, V236, P1250, DOI 10.1016/0022-2836(94)90025-6; Nelson DL., 2004, AMINO ACIDS PEPTIDES, V4th ed, P75; PAULING L, 1951, P NATL ACAD SCI USA, V37, P729, DOI 10.1073/pnas.37.11.729; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; PDB, RED PROT DAT BANK; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Przybylski D, 2004, J MOL BIOL, V341, P255, DOI 10.1016/j.jmb.2004.05.041; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; ROST B, 1994, J MOL BIOL, V235, P13, DOI 10.1016/S0022-2836(05)80007-5; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; ROST B, 1993, P NATL ACAD SCI USA, V90, P7558, DOI 10.1073/pnas.90.16.7558; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Steinegger M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04964-5; Torrisi M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48786-x; Vakser IA, 2014, BIOPHYS J, V107, P1785, DOI 10.1016/j.bpj.2014.08.033; Wang S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18962; Wang ZY, 2011, PROTEOMICS, V11, P3786, DOI 10.1002/pmic.201100196; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Ward JJ, 2003, BIOINFORMATICS, V19, P1650, DOI 10.1093/bioinformatics/btg223; Won KJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-357; Wright G, 1998, PROTEIN SCI, V7, P1280, DOI 10.1002/pro.5560070602; Wu KP, 2004, NUCLEIC ACIDS RES, V32, P5059, DOI 10.1093/nar/gkh836; Xiong P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6330; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yang JM, 2006, NUCLEIC ACIDS RES, V34, P3646, DOI 10.1093/nar/gkl395; Yang YD, 2018, BRIEF BIOINFORM, V19, P482, DOI 10.1093/bib/bbw129; Yaseen A, 2014, J CHEM INF MODEL, V54, P992, DOI 10.1021/ci400647u; Zemla A, 1999, PROTEINS, V34, P220, DOI 10.1002/(SICI)1097-0134(19990201)34:2<220::AID-PROT7>3.0.CO;2-K; Zhang BZ, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2280-5; Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799, DOI 10.1080/073911012010525022; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101; Zhou J, 2014, INT CONF MACH LEARN, P71, DOI 10.1109/ICMLC.2014.7009094; Zhou JY, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2067-8	94	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0255076	10.1371/journal.pone.0255076	http://dx.doi.org/10.1371/journal.pone.0255076			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320027	gold, Green Published			2022-12-26	WOS:000685247800031
J	Marcus, A; Davis, TL; Rittmann, BE; DiBaise, JK; Carnero, EA; Corbin, K; Smith, SR; Krajmalnik-Brown, R				Marcus, Andrew; Davis, Taylor L.; Rittmann, Bruce E.; DiBaise, John K.; Carnero, Elvis A.; Corbin, Karen; Smith, Steven R.; Krajmalnik-Brown, Rosa			Developing a model for estimating the activity of colonic microbes after intestinal surgeries	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GUT-MICROBIOTA; SMALL-BOWEL; ABSORPTION; DEGRADATION; CARBOHYDRATE; FERMENTATION	Background The large intestine provides a compensatory role in energy recovery when surgical interventions such as extensive small intestinal resections or bypass operations lower the efficiency of nutrient absorption in the upper gastrointestinal (GI) tract. While microorganisms in the colon are known to play vital roles in recovering energy, their contributions remain to be qualified and quantified in the small intestine resection. Objective We develop a mathematical model that links nutrient absorption in the upper and lower GI tract in two steps. Methods First, we describe the effects of small intestine resection on the ileocecal output (ICO), which enters the colon and provides food for microbes. Second, we describe energy recovered by the colon's microorganisms via short-chain fatty acid (SCFA) production. We obtain model parameters by performing a least-squares regression analysis on clinical data for subjects with normal physiology and those who had undergone small intestine resection. Results For subjects with their intestines intact, our model provided a metabolizable energy value that aligns well with the traditional Atwater coefficients. With removal of the small intestine, physiological absorption became less efficient, and the metabolizable energy decreased. In parallel, the inefficiencies in physiological absorption by the small intestine are partly compensated by production of short-chain fatty acids (SCFA) from proteins and carbohydrates by microorganisms in the colon. The colon recovered more than half of the gross energy intake when the entire small intestine was removed. Meanwhile, the quality of energy absorbed changed, because microbe-derived SCFAs, not the original components of food, become the dominant form of absorbed energy. Conclusion The mathematical model developed here provides an important framework for describing the effect of clinical interventions on the colon's microorganisms.	[Marcus, Andrew; Davis, Taylor L.; Rittmann, Bruce E.] Arizona State Univ, Biodesign Swette Ctr Environm Biotechnol, Tempe, AZ USA; [Marcus, Andrew; Krajmalnik-Brown, Rosa] Arizona State Univ, Biodesign Ctr Hlth Microbiomes, Tempe, AZ USA; [DiBaise, John K.] Mayo Clin, Div Gastroenterol, Scottsdale, AZ USA; [Carnero, Elvis A.; Corbin, Karen; Smith, Steven R.] AdventHlth, Translat Res Inst, Orlando, FL USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix; Adventist Health Services; AdventHealth	Marcus, A (corresponding author), Arizona State Univ, Biodesign Swette Ctr Environm Biotechnol, Tempe, AZ USA.; Marcus, A; Krajmalnik-Brown, R (corresponding author), Arizona State Univ, Biodesign Ctr Hlth Microbiomes, Tempe, AZ USA.	the.andrew@asu.edu; Dr.Rosy@asu.edu	Smith, Steven/HDM-9496-2022	Marcus, Andrew/0000-0003-3442-6088; Smith, Steven/0000-0002-5098-8147; Corbin, Karen/0000-0003-2065-0003	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01DK105829, R01DK090379]	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Numbers R01DK105829 and R01DK090379.	Bax ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061252; BORGSTROM B, 1957, J CLIN INVEST, V36, P1521, DOI 10.1172/JCI103549; CHACKO A, 1988, GUT, V29, P809, DOI 10.1136/gut.29.6.809; Corbin KD, 2020, CONT CLIN TRIAL COMM, V19, DOI 10.1016/j.conctc.2020.100646; Cremer J, 2017, P NATL ACAD SCI USA, V114, P6438, DOI 10.1073/pnas.1619598114; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Davis TL, 2021, J NUTR, V151, P445, DOI 10.1093/jn/nxaa321; DAWSON AM, 1964, P SOC EXP BIOL MED, V117, P97, DOI 10.3181/00379727-117-29505; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Dinan TG, 2017, PSYCHOSOM MED, V79, P920, DOI 10.1097/PSY.0000000000000519; Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Geurts L, 2014, BENEF MICROBES, V5, P3, DOI 10.3920/BM2012.0065; Gupta A, 2020, NAT REV GASTRO HEPAT, V17, P655, DOI 10.1038/s41575-020-0341-5; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; HIGHAM SE, 1992, BRIT J NUTR, V67, P115, DOI 10.1079/BJN19920013; Hollister EB, 2014, GASTROENTEROLOGY, V146, P1449, DOI 10.1053/j.gastro.2014.01.052; Hounnou G, 2002, SURG RADIOL ANAT, V24, P290, DOI 10.1007/s00276-002-0057-y; Ilhan ZE, 2020, NPJ BIOFILMS MICROME, V6, DOI 10.1038/s41522-020-0122-5; Ilhan ZE, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00047-17; Kettle H, 2015, ENVIRON MICROBIOL, V17, P1615, DOI 10.1111/1462-2920.12599; Kumar M, 2019, NAT MICROBIOL, V4, P1253, DOI 10.1038/s41564-019-0491-9; Lien KA, 1996, AM J CLIN NUTR, V63, P584, DOI 10.1093/ajcn/63.4.584; Livesey Geoffrey, 1995, American Journal of Clinical Nutrition, V62, p1135S, DOI 10.1093/ajcn/62.5.1135S; McLaughlin J., 2009, SURGERY, DOI [10.1016/j.mpsur.2009.04.009, DOI 10.1016/J.MPSUR.2009.04.009]; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Moorthy AS, 2014, J BIOSCI BIOENG, V117, P478, DOI 10.1016/j.jbiosc.2013.09.015; Munoz-Tamayo R, 2010, J THEOR BIOL, V266, P189, DOI 10.1016/j.jtbi.2010.05.040; Nordgaard I, 1996, AM J CLIN NUTR, V64, P222, DOI 10.1093/ajcn/64.2.222; Prachand VN, 2009, WORLD J SURG, V33, P1989, DOI 10.1007/s00268-009-0101-8; Ramsay IR, 2001, BIODEGRADATION, V12, P247, DOI 10.1023/A:1013116728817; Remer T, 2001, EUR J NUTR, V40, P214, DOI 10.1007/s394-001-8348-1; Rittmann B.E., 2020, ENV BIOTECHNOLOGY PR, VSecond; RUPPIN H, 1980, GASTROENTEROLOGY, V78, P1500; SOERGEL KH, 1994, CLIN INVESTIGATOR, V72, P742; STEPHEN AM, 1983, GASTROENTEROLOGY, V85, P589; Thomas DM, 2010, AM J CLIN NUTR, V92, P1326, DOI 10.3945/ajcn.2010.29687; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009; Vavilin VA, 2008, WASTE MANAGE, V28, P939, DOI 10.1016/j.wasman.2007.03.028; Weale AR, 2005, POSTGRAD MED J, V81, P178, DOI 10.1136/pgmj.2004.023846; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	45	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0253542	10.1371/journal.pone.0253542	http://dx.doi.org/10.1371/journal.pone.0253542			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34319981	gold, Green Published			2022-12-26	WOS:000685247800024
J	Gong, QQ; Wang, X; Dou, ZL; Zhang, KY; Liu, XG; Gao, JG; Sun, XY				Gong, Qian-qian; Wang, Xiao; Dou, Zhi-lin; Zhang, Ke-yi; Liu, Xiang-guo; Gao, Jian-gang; Sun, Xiao-yang			A novel mouse line with epididymal initial segment-specific expression of Cre recombinase driven by the endogenous Lcn9 promoter	PLOS ONE			English	Article							EVOLUTION; MODEL; MICE	Spermatozoa released from testes undergo a maturation process and acquire the capacity to fertilize ova through epididymal transit. The epididymis is divided into four regions, each with unique morphology, gene profile, luminal microenvironment and distinct function. To study the functions of relevant genes in the epididymal initial segment (IS), a novel IS-specific mouse model, Lcn9-Cre knock-in (KI) mouse line was generated via CRISPR/Cas9 technology. The TAG stop codon was replaced by a 2A-NLS-Cre cassette, resulting in the co-expression of Lcn9 and Cre recombinase. IS-specific Cre expression was first observed from postnatal day 17. Using the Rosa26(tdTomato) reporter mice, the Cre-mediated DNA recombination was detected exclusively in principal cells. The epididymal IS-specific Cre activity in vivo was further confirmed using Lcn9-Cre mice crossed with a mouse strain carrying Tsc1 floxed alleles (Tsc1(flox/+)). Cre expression did not affect either normal development or male fecundity. Different from any epididymis-specific Cre mice reported previously, the novel Lcn9-Cre mouse line can be used to introduce entire IS-specific conditional gene editing for gene functional study.	[Gong, Qian-qian; Wang, Xiao; Dou, Zhi-lin; Zhang, Ke-yi; Liu, Xiang-guo; Gao, Jian-gang; Sun, Xiao-yang] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cell & Dev Biol, Qingdao, Peoples R China	Shandong University	Sun, XY (corresponding author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cell & Dev Biol, Qingdao, Peoples R China.	sunxy70@sdu.edu.cn		Sun, Xiao-yang/0000-0002-4014-1268	National Key Research and Developmental Program of China [2018YFC1003602]; Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology [SDKLACDB-2019005, SDKLACDB-2019018]	National Key Research and Developmental Program of China; Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology	This study was supported by the National Key Research and Developmental Program of China (2018YFC1003602) and Shandong Provincial Key Laboratory of Animal Cell and Developmental Biology (SDKLACDB-2019005, SDKLACDB-2019018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0032-1; Banan M, 2020, J BIOTECHNOL, V308, P1, DOI 10.1016/j.jbiotec.2019.11.010; Beirowski B, 2017, P NATL ACAD SCI USA, V114, pE4261, DOI 10.1073/pnas.1620761114; Bjorkgren I, 2016, MOL CELL ENDOCRINOL, V427, P143, DOI 10.1016/j.mce.2016.03.013; Bjorkgren I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038457; Breton S, 2016, ASIAN J ANDROL, V18, P3, DOI 10.4103/1008-682X.165946; Charkoftaki G, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-019-0191-9; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Domeniconi RF, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.138768; Elbashir S, 2021, ANDROLOGIA, V53, DOI 10.1111/and.13721; Glenn G, 2013, METHOD ENZYMOL, V529, P47, DOI 10.1016/B978-0-12-418687-3.00005-7; Hinton BT, 1998, J REPROD FERTIL, P47; James ER, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155377; Johnston DS, 2007, ASIAN J ANDROL, V9, P522, DOI 10.1111/j.1745-7262.2007.00317.x; Jones RC, 1998, J REPROD FERTIL, P163; Joseph A, 2011, BIOL REPROD, V84, P207, DOI 10.1095/biolreprod.110.087353; Kathrins M, 2017, FERTIL STERIL, V108, P45, DOI 10.1016/j.fertnstert.2017.05.023; Krutskikh A, 2011, ENDOCRINOLOGY, V152, P689, DOI 10.1210/en.2010-0768; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Legare C, 2020, ANDROLOGY-US, V8, P625, DOI 10.1111/andr.12745; Li MQ, 2019, CELL METAB, V30, P508, DOI 10.1016/j.cmet.2019.05.018; Li XQ, 2012, ACTA BIOCH BIOPH SIN, V44, P876, DOI 10.1093/abbs/gms072; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Nakata H, 2019, J ANAT, V235, P271, DOI 10.1111/joa.13006; Pathak UI, 2020, UROL CLIN N AM, V47, P129, DOI 10.1016/j.ucl.2019.12.001; Penttinen J, 2003, MOL ENDOCRINOL, V17, P2138, DOI 10.1210/me.2003-0008; Rinaldi VD, 2020, ELIFE, V9, DOI 10.7554/eLife.55474; Sullivan R, 2019, ANDROLOGY-US, V7, P748, DOI 10.1111/andr.12633; Sullivan R, 2016, HUM REPROD UPDATE, V22, P574, DOI 10.1093/humupd/dmw015; Suzuki K, 2004, GENE, V339, P49, DOI 10.1016/j.gene.2004.06.027; Turner TT, 2003, REPRODUCTION, V125, P871, DOI 10.1530/reprod/125.6.871; Turunen HT, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092403; Wang HQ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4971; Wen ZZ, 2021, BIOCHEM BIOPH RES CO, V548, P7, DOI 10.1016/j.bbrc.2021.02.052; Weng TT, 2019, J CLIN INVEST, V129, P1984, DOI 10.1172/JCI122106; Wijayarathna R, 2017, ANDROLOGY-US, V5, P578, DOI 10.1111/andr.12337; Xia YZ, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gky1169; Xie SS, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104034; Xu J, 2017, MOL REPROD DEV, V84, P257, DOI 10.1002/mrd.22772; Yeung CH, 1998, J REPROD FERTIL, P137; Zhou W, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00059	41	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254802	10.1371/journal.pone.0254802	http://dx.doi.org/10.1371/journal.pone.0254802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310634	Green Published, gold			2022-12-26	WOS:000685224500010
J	Sakae, K; Nagano, K; Furuhashi, M; Hasegawa, Y				Sakae, Kotaro; Nagano, Keiji; Furuhashi, Miyuna; Hasegawa, Yoshiaki			Diversity analysis of genes encoding Mfa1 fimbrial components in Porphyromonas gingivalis strains	PLOS ONE			English	Article							FIMA GENOTYPES; GENOME SEQUENCE; RAG LOCUS; PROTEIN; IDENTIFICATION; PATHOGENICITY; LOCALIZATION; PREVALENCE; MEMBRANE; DOMAIN	Porphyromonas gingivalis, a gram-negative anaerobic bacterium, is associated with the development of periodontal disease. The genetic diversity in virulence factors, such as adhesive fimbriae, among its strains affects the bacterial pathogenicity. P. gingivalis generally expresses two distinct types of fimbriae, FimA and Mfa1. Although the genetic diversity of fimA, encoding the major FimA fimbrilin protein, has been characterized, the genes encoding the Mfa1 fimbrial components, including the Mfa1 to Mfa5 proteins, have not been fully studied. We, therefore, analyzed their genotypes in 12 uncharacterized and 62 known strains of P. gingivalis (74 strains in total). The mfa1 genotype was primarily classified into two genotypes, 53 and 70. Additionally, we found that genotype 70 could be further divided into two subtypes (70A and 70B). The diversity of mfa2 to mfa4 was consistent with the mfa1 genotype, although no subtype in genotype 70 was observed. Protein structure modeling showed high homology between the genotypes in Mfa1 to Mfa4. The mfa5 gene was classified into five genotypes (A to E) independent of other genotypes. Moreover, genotype A was further divided into two subtypes (A1 and A2). Surprisingly, some strains had two mfa5 genes, and the 2(nd) mfa5 exclusively occurred in genotype E. The Mfa5 protein in all genotypes showed a homologous C-terminal half, including the conserved C-terminal domain recognized by the type IX secretion system. Furthermore, the von Willebrand factor domain at the N-terminal was detected only in genotypes A to C. The mfa1 genotypes partially correlated with the ragA and ragB genotypes (located immediately downstream of the mfa gene cluster) but not with the fimA genotypes.	[Sakae, Kotaro; Hasegawa, Yoshiaki] Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Nagoya, Aichi, Japan; [Sakae, Kotaro] Aichi Gakuin Univ, Sch Dent, Dept Endodont, Nagoya, Aichi, Japan; [Nagano, Keiji] Hlth Sci Univ Hokkaido, Div Microbiol, Dept Oral Biol, Sch Dent, Hokkaido, Japan; [Furuhashi, Miyuna] Aichi Gakuin Univ, Sch Dent, Dept Pediat Dent, Nagoya, Aichi, Japan	Aichi Gakuin University; Aichi Gakuin University; Health Sciences University of Hokkaido; Aichi Gakuin University	Nagano, K (corresponding author), Hlth Sci Univ Hokkaido, Div Microbiol, Dept Oral Biol, Sch Dent, Hokkaido, Japan.	knagano@hoku-iryo-u.ac.jp		Nagano, Keiji/0000-0003-3587-7606				Amano A, 1999, J CLIN MICROBIOL, V37, P1426, DOI 10.1128/JCM.37.5.1426-1430.1999; Beikler T, 2005, J PERIODONTAL RES, V40, P193, DOI 10.1111/j.1600-0765.2005.00783.x; Beikler T, 2003, EUR J ORAL SCI, V111, P390, DOI 10.1034/j.1600-0722.2003.00065.x; Brooks W, 1997, INFECT IMMUN, V65, P3753, DOI 10.1128/IAI.65.9.3753-3758.1997; Curtis MA, 1999, J PERIODONTAL RES, V34, P400, DOI 10.1111/j.1600-0765.1999.tb02273.x; Enersen M., 2011, J ORAL MICROBIOL, V3, P8487, DOI [10.3402/jom.v3i0.8487, DOI 10.3402/J0M.V3I0.8487]; Enersen M, 2008, J CLIN MICROBIOL, V46, P31, DOI 10.1128/JCM.00986-07; Fujiwara-Takahashi K, 2020, J ORAL MICROBIOL, V12, DOI 10.1080/20002297.2020.1775333; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hall LMC, 2005, INFECT IMMUN, V73, P4253, DOI 10.1128/IAI.73.7.4253-4262.2005; Hall M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20067-z; Hasegawa Y, 2016, J DENT RES, V95, P1291, DOI 10.1177/0022034516655083; Hasegawa Y, 2013, MOL ORAL MICROBIOL, V28, P467, DOI 10.1111/omi.12040; Hasegawa Y, 2014, J ORAL BIOSCI, V56, P86, DOI 10.1016/j.job.2014.04.002; Hasegawa Y, 2009, MICROBIOL-SGM, V155, P3333, DOI 10.1099/mic.0.028928-0; Heidler TV, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01621-w; Hutcherson JA, 2015, MOL ORAL MICROBIOL, V30, P242, DOI 10.1111/omi.12089; Ikai R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139454; Jackman SD, 2017, GENOME RES, V27, P768, DOI 10.1101/gr.214346.116; Kloppsteck P, 2016, SCI REP-UK, V6, DOI 10.1038/srep22945; Kuboniwa M, 2010, PERIODONTOL 2000, V54, P136, DOI 10.1111/j.1600-0757.2010.00352.x; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lasica AM, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00215; LEE JY, 1991, INFECT IMMUN, V59, P383, DOI 10.1128/IAI.59.1.383-389.1991; Madej M, 2020, NAT MICROBIOL, V5, P1016, DOI 10.1038/s41564-020-0716-y; Moon JH, 2013, J MED MICROBIOL, V62, P1290, DOI 10.1099/jmm.0.054247-0; Nagano K, 2015, J DENT RES, V94, P1143, DOI 10.1177/0022034515588275; Nagano K, 2013, MOL ORAL MICROBIOL, V28, P392, DOI 10.1111/omi.12032; Nagano K, 2010, J DENT RES, V89, P903, DOI 10.1177/0022034510370089; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Nagano K, 2018, PEERJ, V6, DOI 10.7717/peerj.5581; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nishiyama SI, 2007, MICROBIOL-SGM, V153, P1916, DOI 10.1099/mic.0.2006/005561-0; OGAWA T, 1991, ORAL MICROBIOL IMMUN, V6, P332, DOI 10.1111/j.1399-302X.1991.tb00504.x; Puig-Silla M, 2012, MED ORAL PATOL ORAL, V17, pE1047, DOI 10.4317/medoral.17009; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200; Shibata S, 2020, NAT MICROBIOL, V5, P830, DOI 10.1038/s41564-020-0705-1; Shoji M, 2020, MICROBIOL IMMUNOL, V64, P643, DOI 10.1111/1348-0421.12838; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Suzuki M, 1988, Shigaku, V75, P1229; Xu QP, 2016, CELL, V165, P690, DOI 10.1016/j.cell.2016.03.016; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1281, DOI 10.1107/S1744309110006548; Yoshimura F, 2009, J PERIODONTAL RES, V44, P1, DOI 10.1111/j.1600-0765.2008.01135.x; YOSHIMURA F, 1984, J BACTERIOL, V160, P949, DOI 10.1128/JB.160.3.949-957.1984; Zhao L, 2007, J PERIODONTAL RES, V42, P511, DOI 10.1111/j.1600-0765.2007.00975.x	48	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255111	10.1371/journal.pone.0255111	http://dx.doi.org/10.1371/journal.pone.0255111			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310632	Green Published, gold			2022-12-26	WOS:000685224500033
J	Ensley, R; Hansen, RD; Morales-Aguilar, C; Thompson, J				Ensley, Ross; Hansen, Richard D.; Morales-Aguilar, Carlos; Thompson, Josie			Geomorphology of the Mirador-Calakmul Karst Basin: A GIS-based approach to hydrogeologic mapping	PLOS ONE			English	Article							YUCATAN PENINSULA; QUINTANA-ROO; GROUNDWATER; INSIGHTS; MEXICO; PETEN; HYDROLOGY; AMERICA; STATE; IDENTIFICATION	This paper classifies the karst landscapes of the Peten Plateau and defines the Mirador-Calakmul Karst Basin by illustrating the distribution of its karst hydrologic features. Archaeological and spatial research of the Mirador-Calakmul area of Guatemala and Mexico has shown it to be a karst basin with geopolitical implications. Current research characterizes the karst landscapes of the Peten Plateau, maps the distribution of karst hydrologic features, and delineates the basin in geomorphological terms. To further this aim, multiple forms of remote sensing data including orthophotographs, a satellite Digital Elevation Model, satellite multispectral images, and Light Detection and Ranging (LiDAR) data have been integrated to interpret the karst features in the study area. Outcrop study and thin section analysis of the upper Buena Vista Formation document that the dominant lithologies are a shallow water algal boundstone interbedded with terrestrial caliche. Karst landforms have been mapped over the Peten Plateau and we identify five karst landscapes, the largest of which is a fluviokarst landscape dominated by karst valleys. We further map karst hydrologic features including seasonal swamps, dolines, intermittent lakes, intermittent streams, solution-enhanced fractures, and springs all of which are characteristic of drainage basins. Boundaries of the karst basin are mapped from multiple lines of evidence including distribution of the karst valleys, a line of springs along the western boundary of the fluviokarst landscape, and a surface drainage analysis. We capture and classify hydrologic data points and develop a regional groundwater map that indicates subsurface flow from east to west within the basin. A drainage map illustrates the extensive system of karst valleys, boundaries, and inferred groundwater flow paths of the Mirador-Calakmul Karst Basin. It was within this geomorphological setting that the ancient Maya developed an extensive civilization during the Middle and Late Preclassic periods (1000 BCE-150 CE).	[Ensley, Ross] Terra Geo Solut, Houston, TX 77058 USA; [Hansen, Richard D.] Univ Utah, Dept Anthropol Univ, Salt Lake City, UT 84112 USA; [Morales-Aguilar, Carlos] Univ Paris 1 Pantheon Sorbonne, Lab Archeol Amer UMR 809 CNRS, Paris, France; [Thompson, Josie] Mirador Conservat Fund, Redwood City, CA USA	Utah System of Higher Education; University of Utah	Ensley, R (corresponding author), Terra Geo Solut, Houston, TX 77058 USA.	rensley42@gmail.com		Morales-Aguilar, Carlos/0000-0002-7713-5849; Ensley, Ross/0000-0002-7732-1115	Foundation for Anthropological Research & Environmental Studies (FARES); FARES-Guatemala; Global Conservation Foundation; Mammel Foundation; Global Heritage Fund; Pettit Foundation; Rosalinde and Arthur Gilbert Foundation; Mirador Conservation Fund; Nacional Agro Industrial, S.A.; Wolf Creek Foundation; Morgan Family Foundation; Jay I. Kislak Foundation; Selz Foundation; Asociacion de Amigos del Patrimonio Natural y Cultural de Guatemala; Fundaselva Guatemala; National Geographic Society [SP 0815]; U.S. Department of the Interior International Affairs Program; Victoria Earl-Mion Trust; FARES; National Geographic Society; Eagle Mapping	Foundation for Anthropological Research & Environmental Studies (FARES); FARES-Guatemala; Global Conservation Foundation; Mammel Foundation; Global Heritage Fund; Pettit Foundation; Rosalinde and Arthur Gilbert Foundation; Mirador Conservation Fund; Nacional Agro Industrial, S.A.; Wolf Creek Foundation; Morgan Family Foundation; Jay I. Kislak Foundation; Selz Foundation; Asociacion de Amigos del Patrimonio Natural y Cultural de Guatemala; Fundaselva Guatemala; National Geographic Society(National Geographic Society); U.S. Department of the Interior International Affairs Program; Victoria Earl-Mion Trust; FARES; National Geographic Society(National Geographic Society); Eagle Mapping	Funding for the research noted in this paper was provided by the Foundation for Anthropological Research & Environmental Studies (FARES; RH; https://www.fares-foundation.org/), FARES-Guatemala (RH), Global Conservation Foundation (RH; https://globalconservation.org/), Mammel Foundation (RH), Global Heritage Fund (RH; https://globalheritagefund.org/), Pettit Foundation (RH), Rosalinde and Arthur Gilbert Foundation (RH; https://www.thegilbertfoundation.org/), Mirador Conservation Fund (JT), Nacional Agro Industrial, S.A. (RH; https://www.facebook.com/NAISAGT/), Wolf Creek Foundation (RH; http://www.wolfcreekfoundation.com/), Morgan Family Foundation (RH; https://morganfamilyfdn.org/), Jay I. Kislak Foundation (RH; https://www.kislak.com/), the Selz Foundation (RH), Asociacio ' n de Amigos del Patrimonio Natural y Cultural de Guatemala (RH; http://apanacguate.org/), Fundaselva Guatemala (RH; https://fundaselva.org/), National Geographic Society (RH, Grant #SP 0815; https://www.nationalgeographic.org/), the U.S. Department of the Interior International Affairs Program (RH), and the Victoria Earl-Mion Trust (RH). The LiDAR data were acquired with funding provided by FARES (RH), the Mirador Conservation Fund (RH), the National Geographic Society (RH), and Eagle Mapping (RH and JT; https://www.eaglemapping.com/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS REW, 1981, AM ANTIQUITY, V46, P301, DOI 10.2307/280210; Adams Richard E. W., 1999, RIO AZUL ANCIENT MAY; Adams Richard E.W., 1991, PREHISTORIC MESOAMER; Aguilar Y, 2016, J CAVE KARST STUD, V78, P51, DOI 10.4311/2015ES0124; Akpinar E., 2011, AGUADAS SIGNIFICANT; Sanchez-Sanchez JA, 2015, REV MEX CIENC GEOL, V32, P62; BAKER VR, 1973, WATER RESOUR RES, V9, P695, DOI 10.1029/WR009i003p00695; Bauer-Gottwein P, 2011, HYDROGEOL J, V19, P507, DOI 10.1007/s10040-010-0699-5; Beach T, 2015, QUATERNARY SCI REV, V124, P1, DOI 10.1016/j.quascirev.2015.05.028; Beach T, 2018, INCONSTANT LANDSCAPE: THE MAYA KINGDOM OF EL ZOTZ, GUATEMALA, P163, DOI 10.5876/9781607327646.c007; Beach T, 2015, TIKAL: PALEOECOLOGY OF AN ANCIENT MAYA CITY, P258; Bestelmeyer BT., 2000, RAP BULL BIOL ASSESM, V16, P84; Bishop WF., 1980, J PET GEOL, V3, P3, DOI [10.1111/j.1747-5457.1980.tb01003.x, DOI 10.1111/J.1747-5457.1980.TB01003.X]; Blair RJ., 2013, INTEGRATED SURFACE W; Blair RJ., 2009, GROUNDWATER ASSESSME; Blair RJ, 2012, CARBONATE EVAPORITE, V27, P123, DOI 10.1007/s13146-012-0094-5; Bondesan A., 1992, International Journal of Speleology, V21, P1; Boucher S, 2012, ESTUD CULT MAYA, V39, P99; Braswell Geoff E., 2004, TERMINAL CLASSIC MAY, P162; Braswell Geoffrey E., 2013, INDIANA, V30, P149, DOI DOI 10.18441/IND.V30I0.149-171; Castanet C, 2019, CONTRIBUCION A UNPUB, P13; Chiba T., 2008, TECHNICAL COMMISSION, V37, P1071; Cook D., 2019, PROYECTO ARQUEOLOGIC, P317; Currens JC, 2001, GEOTECHNICAL AND ENVIRONMENTAL APPLICATIONS OF KARST GEOLOGY AND HYDROLOGY, P209; Dahlin B. H., 1980, MIRADOR PETEN GUATEM, P37; Dahlin Bruce H., 1994, GEOARCHAEOLOGY, V9, P203, DOI DOI 10.1002/GEA.3340090303; Darras T, 2015, HYDROL EARTH SYST SC, V19, P4397, DOI 10.5194/hess-19-4397-2015; Day M., 2013, TREATISE GEOMORPHOLO, P157, DOI [DOI 10.1016/B978-0-12-374739-6.00108-1, 10.1016/B978-0-12-374739-6.00108-1]; Day M.J., 2002, EVOLUTION KARST PREK, P235; Day M.J., 2007, CENTRAL AM GEOLOGY R, V1, P155; Deike GH., 1989, KARST HYDROLOGY CONC, P259; DENGO CA, 2007, CENTRAL AM GEOLOGY R, P895; Dominguez M del R., 1996, 9 S INV ARQ GUAT 199, P147; Dominguez M del R., 2012, 25 S INV ARQ GUAT 20, P850; Doyle JA., 2012, 25 S INV ARQ GUAT 20, P816; Drusch M, 2012, REMOTE SENS ENVIRON, V120, P25, DOI 10.1016/j.rse.2011.11.026; Dunning N., 1998, CULT AGR, V20, P87, DOI [10.1525/cag.1998.20.2-3.87, DOI 10.1525/CAG.1998.20.2-3.87]; Dunning NP, 2010, LANDSCAPES AND SOCIETIES: SELECTED CASES, P369, DOI 10.1007/978-90-481-9413-1_23; ELLINS KK, 1990, J HYDROL, V115, P319, DOI 10.1016/0022-1694(90)90212-G; Ensley R, 2018, MES C NOV 16 17 2018; ESA, 2018, **NON-TRADITIONAL**; ESTEBAN M., 1983, AAPG BULL, V33, P1; European Space Agency (ESA), 2017, SENTINEL; European Space Agency (ESA), 2019, SENTINEL; Florea LJ., 2018, ANCIENT OCEANS OROGE, V51, P95; Folan Higgins W.J., 2015, ARCHAEOLOGY BIOARCHA, P51; Folan WJ, 2009, ESTUD CULT MAYA, V34, P11; Folan William J, 2001, ANCIENT MESOAM, V12, P293, DOI DOI 10.1017/S0956536101122017; Folan WJ, 2000, POPULATION DEV ENV Y, P2; Force E, 2008, UNPUB; Ford D.C., 2007, KARST HYDROGEOLOGY G, DOI DOI 10.1002/9781118684986.CH6; Fragoso-Servon P, 2014, REV MEX CIENC GEOL, V31, P127; Franco A.JC., 1995, ENERGY MINERAL POTEN, P105; Freidel D, 2018, MAYA STUD, P363; García Gil Gerardo, 2002, Invest. Geog, P7; Garrison T., 2015, TEMPLE NIGHT SUN ROY, P12; Garrison TG, 2019, J ANTHROPOL ARCHAEOL, V53, P133, DOI 10.1016/j.jaa.2018.11.005; Gates G., 1999, NATURALEZA CULTURA C, P31; Gates GR., 1992, PROGRAMA MANEJO RESE, P22; Gerstenhauer A., 1960, Z GEOMORPHOL S, V2, P22; Gilli E, 2015, KARSTOLOGY KARSTS CA; Gondwe BRN, 2012, HYDROGEOL J, V20, P1407, DOI 10.1007/s10040-012-0877-8; Gondwe BRN, 2010, J HYDROL, V389, P1, DOI 10.1016/j.jhydrol.2010.04.044; Gonzalez-Herrera R, 2002, HYDROGEOL J, V10, P539, DOI 10.1007/s10040-002-0216-6; Graham Ian., 1967, MIDDLE AM RES I PUBL, V33; GRIMES KG, 1994, ENVIRON GEOL, V23, P134, DOI 10.1007/BF00766987; Gunn J., 1995, GEOARCHAEOLOGY, V10, P3, DOI [10.1002/gea.3340100103, DOI 10.1002/GEA.3340100103]; Gunn J. D., 2014, ARCHEOLOGICAL PAPERS, V24, P101, DOI DOI 10.1111/APAA.12032; Gunn JD., 1992, PROGRAMA MANEJO RESE, P34; Gunn JD, 2019, HOLOCENE AND ANTHROPOCENE ENVIRONMENTAL HISTORY OF MEXICO: A PALEOECOLOGICAL APPROACH ON MESOAMERICA, P209, DOI 10.1007/978-3-030-31719-5_11; Halihan T, 1998, J HYDROL, V204, P24, DOI 10.1016/S0022-1694(97)00104-2; Hansen RD., 1993, 6 S INV ARQ GUAT 199, P100; Hansen RD, 2018, MAYA STUD, P147; Hansen RD, 2017, STUD HUM ECOL ADAPT, P305, DOI 10.1007/978-3-319-48402-0_12; Hansen RD, 2016, PENN MUSEUM INT RES, V7, P329; Hansen Richard D., 1994, 7 S INVESTIGACIONES, P311; Hansen Richard D., 1991, ANCIENT MESOAM, V2, P225, DOI DOI 10.1017/S0956536100000547; Haq B. U., 1988, SOC ECON PALEONT MIN, V42, P71, DOI DOI 10.2110/PEC.88.01.0071; Heilprin Angelo, 1891, P ACAD NAT SCI PHILA, V43, P136; Heraud-Pina M-A., 1996, KARST YUCATAN PAYS M, P282, DOI [10.4000/books.pub.1527, DOI 10.4000/BOOKS.PUB.1527]; Hess J.W., 1989, KARST HYDROLOGY CONC, P15; Hofierka J, 2018, GEOMORPHOLOGY, V308, P265, DOI 10.1016/j.geomorph.2018.02.004; Homoya MA., 1982, P INDIANA ACAD SCI, V92, P383; Instituto Nacional de Estadistica y Geografia (INEGI), 2018, RED GEOD NAC PAS VER; Instituto Nacional de Estadistica y Geografia (INEGI), 2015, GUIA MET RED GEOD VE; Isphording Wayne C., 1975, T GULF COAST ASS GEO, V25, P231; James K. H., 2007, CENTRAL AM GEOLOGY R, P277, DOI DOI 10.1201/9780203947043.CH11; James KH, 2009, GEOL SOC SPEC PUBL, V328, P127, DOI 10.1144/SP328.4; JAXA, 2018, ALOS GLOB DIG SURF M; Jennings J.N., 1985, KARST GEOMORPHOLOGY, P293; Jennings JN., 1963, BONNER GEOGRAPHISCHE, V32; Jones WK., 1997, KARST HYDROLOGY ATLA; Jones WK, 2019, ENCY CAVES, P609; King DT., 2003, GULF COAST ASS GEOL, V53, P384; Kominz MA, 2008, BASIN RES, V20, P211, DOI 10.1111/j.1365-2117.2008.00354.x; Kueny JA, 2002, J CAVE KARST STUD, V64, P165; LARA ME, 1993, AAPG BULL, V77, P1041; LaRocque A, 2019, J ARCHAEOL SCI-REP, V23, P80, DOI 10.1016/j.jasrep.2018.10.020; Lauderdale R.W., 1979, GULF COAST ASS GEOL, V29, P275; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; LOPEZRAMOS E, 1975, OCEAN BASIN MARGIN, V3, P257, DOI DOI 10.1007/978-1-4684-8535-6_7; Lugo-Hubp J.J., 1992, REV MEXICANA CIENCIA, V10, P143; Luzzadder-Beach S, 2017, GEOARCHAEOLOGY, V32, P90, DOI 10.1002/gea.21587; Magee KS., 2011, SEGMENTATION OBJECT; Marcus J., 2012, ANCIENT MAYA MEXICO, P88, DOI [10.4324/9781315728667-13, DOI 10.4324/9781315728667-13]; Marshall JS, 2007, CENTRAL AM GEOLOGY R, V1, P1; Martin S, 1995, ARCHAEOLOGY, V48, P41; Martin S., 2008, CHRONICLE MAYA KINGS, P240, DOI [10.1108/rr.2001.15.3.55.194, DOI 10.1108/RR.2001.15.3.55.194]; McCormack T, 2017, J HYDROL-REG STUD, V10, P1, DOI 10.1016/j.ejrh.2016.12.083; MCDONALD RC, 1975, GEOL SOC AM BULL, V86, P255, DOI 10.1130/0016-7606(1975)86<255:OOHEIT>2.0.CO;2; McDonald RC., 1979, Z GEOMORPHOL, V32, P35; McDonald RC, 2011, PHYS GEOGR, V32, P195, DOI 10.2747/0272-3646.32.3.195; Mejia HE., 2006, INVESTIGACI N UNPUB, P350; Mejia HE., 2005, INVESTIGACION UNPUB, P145; Miller DJ., 2003, CAINOZIC RES, P189; Monroe W, 1970, GLOSSARY KARST TERMI, DOI [10.3133/wsp1899K, DOI 10.3133/WSP1899K]; Monroe WH, 1980, US GEOL SURV PROF PA, V1159, P1, DOI [10.3133/pp1159, DOI 10.3133/PP1159]; Morales-Aguilar C., 2015, INVESTIGACIONE UNPUB, P350; Morales-Aguilar C., 2010, INVESTIGACIONES ARQU, P269; Naughton O, 2012, J HYDROL, V470, P82, DOI 10.1016/j.jhydrol.2012.08.012; Nielson G., 2012, ARCHAEOLOGICAL LEGAC, P241; Paylor RL, 2001, GEOTECHNICAL AND ENVIRONMENTAL APPLICATIONS OF KARST GEOLOGY AND HYDROLOGY, P229; Perry E, 2009, J HYDROL, V367, P27, DOI 10.1016/j.jhydrol.2008.12.026; Perry EC, 2019, BOL SOC GEOL MEX, V71, P741, DOI [10.18268/bsgm2019v71n3a7, 10.18268/BSGM2019v71n3a7]; Peterson A.C., 1983, US GEOLOGICAL SURVEY, V760, P1; Pindell J.L., 2001, PETROLEUM SYSTEMS DE, P193, DOI DOI 10.5724/GCS.01.21.0193; Pindell JL, 2009, GEOL SOC SPEC PUBL, V328, P1, DOI 10.1144/SP328.1; POPE KO, 1989, J FIELD ARCHAEOL, V16, P87, DOI 10.1179/jfa.1989.16.1.87; Price TD, 2018, LAT AM ANTIQ, V29, P439, DOI 10.1017/laq.2018.31; Quinlan JF, 1989, KARST HYDROLOGY CONC, P65, DOI [10.1007/978-1- 4615-7317-3_ 3, DOI 10.1007/978-1-4615-7317-3_3]; Quinlan JF., 1989, KARST HYDROLOGY CONC; Quintana O., 2003, 16 S INV ARQ GUAT 20, P381; Quintana O., 2001, CIUDADES MAYAS NORES, V59; Ray JA, 2001, GEOTECHNICAL AND ENVIRONMENTAL APPLICATIONS OF KARST GEOLOGY AND HYDROLOGY, P235; Ray JA., 2005, IDENTIFICATION PRIOR; Ray JA., 2000, KENTUCKY GEOL SURV M, V22, P2, DOI [10.13023/kgs.mc22.12, DOI 10.13023/KGS.MC22.12]; Ray JA., 1998, KENTUCKY GEOL SURV M, V224, P2, DOI [10.13023/kgs.mc17.11, DOI 10.13023/KGS.MC17.11]; Ray JA., 2006, LITTLE RIVER KARST W; Ray JA., 1998, KENTUCKY GEOL SURV M, V226, P2, DOI [10.13023/kgs.mc19.11, DOI 10.13023/KGS.MC19.11]; Reents-Budet Dorie, 2011, 24 S INV ARQ GUAT MU, P832; ROSENFELD J, 2002, B SOC GEOL MEX, V55, P30; Rosenfeld JH., 2003, CIRCUM GULF MEXICO C, P13; Rosenfeld JH., 2003, CIRCUMGULF MEXICO CA, P340; Rugel K, 2019, J HYDROL-REG STUD, V23, DOI 10.1016/j.ejrh.2019.100603; Sanchez Rivera B, 2020, CALAKMUL MOSAICO NAT; Scholes France V., 1968, MAYA CHONTAL INDIANS, V2nd; Schreiner Thomas, 2002, ANCIENT MESOAM, V13, P273, DOI DOI 10.1017/S0956536102132093; Sentinel, 2020, SENTINEL WEBSITE; Siemens A., 1978, PREHISPANIC MAYA AGR; Sluijs A, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001615; Smith JH, 2002, ASS MEX CAVE STUD B, V9, P77; Solleiro-Rebolledo E., 2015, SOILS SEDIMENTS ARCH, P233; Sprajc I., 2010, MEXICON, V32, P148; Sprajc I., 2008, PARIS MONOGR AM ARCH, V19, P339; SWEETING MM, 1973, KARST LANDFORMS, P362; Takaku J., 2014, INT ARCH PHOTOGRAMM, V40, P243, DOI [DOI 10.5194/ISPRSARCHIVES-XL-4-243-2014, 10.5194/isprs-archives-XL-4-243-2014, DOI 10.5194/ISPRS-ARCHIVES-XL-4-243-2014, 10.5194/isprsarchives-XL-4-243-2014]; Takaku J, 2016, ISPRS ANN PHOTO REM, V3, P25, DOI 10.5194/isprsannals-III-4-25-2016; Taylor C. J., 2008, Eleventh Multidisciplinary Conference on Sinkholes and the Engineering and Environmental Impacts of Karst, Tallahassee, Florida, USA, 22-26 September 2008, P146; Taylor CJ., 2005, US GEOLOGICAL SURVEY, P103; Taylor CJ., 2008, US GEOL SURV DATA SE, V339, P1; Taylor CJ, 2008, FIELD TECHNIQUES EST, V4-D2, P71; Taylor CJ., 1997, US GEOL SURV WATER R, V96-4254, P1, DOI [10.3133/wri964254, DOI 10.3133/WRI964254]; Tec Pool F., 2011, 24 S INV ARQ GUAT 20, P796; Titmus Gene L., 2002, 15 S INVESTIGACIONES, P188; Turner BL, 2012, P NATL ACAD SCI USA, V109, P13908, DOI 10.1073/pnas.1210106109; TURNER BL, 2004, INTEGRATED LAND CHAN, P1; Velazquez L., 1986, ING HIDRAULICA MEXIC, V1, P21; Verdin K., 2017, HYDROLOGIC DERIVATIV; Verdin K., 2017, US GEOL SURV DATA SE, V1053, P16, DOI [10.3133/ds1053, DOI 10.3133/DS1053]; Villasuso M.J., 2000, POPULATION DEV ENV Y, P120; Vinson G.L., 1962, B AM ASS PET GEOL, V46, P425, DOI [DOI 10.1306/BC743835-16BE-11D7-8645000102C1865D, 10.1306/BC743835-16BE-11D7-8645000102C1865D]; Wadell H., 1938, INSCRIPTIONS PETEN, P336; Wahl D, 2007, HOLOCENE, V17, P813, DOI 10.1177/0959683607080522; Wahl D, 2016, GLOBAL PLANET CHANGE, V138, P70, DOI 10.1016/j.gloplacha.2015.09.011; Wahl D, 2014, QUATERNARY SCI REV, V103, P19, DOI 10.1016/j.quascirev.2014.08.004; Walker JD, 2013, GEOL SOC AM BULL, V125, P259, DOI 10.1130/B30712.1; Weide A.E., 1985, GEOLOGY HYDROGEOLOGY, P1; Weidie AE., 1978, GEOLOGY HYDROGEOLOGY, P3; West RC, 1964, HDB MIDDLE AM INDIAN, P33; West RC., 1962, FIELD TRIP PENINSULA, P58; White W.B., 1999, KARST MODELING, V5, P11; White W.B., 1988, GEOMORPHOLOGY HYDROL; WHITE WB, 1995, AM SCI, V83, P450; WHITE WB, 1970, GEOGR REV, V60, P88, DOI 10.2307/213346; WHITE WB, 1966, WATER RESOUR RES, V2, P549, DOI 10.1029/WR002i003p00549; White WB, 2002, ENG GEOL, V65, P85, DOI 10.1016/S0013-7952(01)00116-8; White WB., 2018, CAVES KARST GREENBRI, P45, DOI [10.1007/978-3-319-65801-8_4, DOI 10.1007/978-3-319-65801-8_4]; Wilson E.M., 1980, YUCATAN WORLD APART, P5; Woods JC., 1994, 7 S INV ARQ GUAT 199, P295; Yan JH, 2012, CHEM GEOL, V304, P1, DOI 10.1016/j.chemgeo.2012.02.003; Zhou J, 2009, SEDIMENT GEOL, V222, P207, DOI 10.1016/j.sedgeo.2009.09.003	191	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255496	10.1371/journal.pone.0255496	http://dx.doi.org/10.1371/journal.pone.0255496			48	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TT3IC	34339460	Green Published, gold			2022-12-26	WOS:000680243400005
J	Seol, HY; Shrestha, P; Muth, JF; Wi, CI; Sohn, S; Ryu, E; Park, M; Ihrke, K; Moon, S; King, K; Wheeler, P; Borah, B; Moriarty, J; Rosedahl, J; Liu, HF; McWilliams, DB; Juhn, YJ				Seol, Hee Yun; Shrestha, Pragya; Muth, Joy Fladager; Wi, Chung-Il; Sohn, Sunghwan; Ryu, Euijung; Park, Miguel; Ihrke, Kathy; Moon, Sungrim; King, Katherine; Wheeler, Philip; Borah, Bijan; Moriarty, James; Rosedahl, Jordan; Liu, Hongfang; McWilliams, Deborah B.; Juhn, Young J.			Artificial intelligence-assisted clinical decision support for childhood asthma management: A randomized clinical trial	PLOS ONE			English	Article							KIDS TRACK; POPULATION; HEALTH; ROCHESTER; EPIDEMIOLOGY; PREVALENCE; ALGORITHM; RESIDENTS; DIAGNOSIS; OUTCOMES	Rationale Clinical decision support (CDS) tools leveraging electronic health records (EHRs) have been an approach for addressing challenges in asthma care but remain under-studied through clinical trials. Objectives To assess the effectiveness and efficiency of Asthma-Guidance and Prediction System (A-GPS), an Artificial Intelligence (AI)-assisted CDS tool, in optimizing asthma management through a randomized clinical trial (RCT). Methods This was a single-center pragmatic RCT with a stratified randomization design conducted for one year in the primary care pediatric practice of the Mayo Clinic, MN. Children (<18 years) diagnosed with asthma receiving care at the study site were enrolled along with their 42 primary care providers. Study subjects were stratified into three strata (based on asthma severity, asthma care status, and asthma diagnosis) and were blinded to the assigned groups. Measurements Intervention was a quarterly A-GPS report to clinicians including relevant clinical information for asthma management from EHRs and machine learning-based prediction for risk of asthma exacerbation (AE). Primary endpoint was the occurrence of AE within 1 year and secondary outcomes included time required for clinicians to review EHRs for asthma management. Main results Out of 555 participants invited to the study, 184 consented for the study and were randomized (90 in intervention and 94 in control group). Median age of 184 participants was 8.5 years. While the proportion of children with AE in both groups decreased from the baseline (P = 0.042), there was no difference in AE frequency between the two groups (12% for the intervention group vs. 15% for the control group, Odds Ratio: 0.82; 95%CI 0.374-1.96; P = 0.626) during the study period. For the secondary end points, A-GPS intervention, however, significantly reduced time for reviewing EHRs for asthma management of each participant (median: 3.5 min, IQR: 2-5), compared to usual care without A-GPS (median: 11.3 min, IQR: 6.3-15); p<0.001). Mean health care costs with 95%CI of children during the trial (compared to before the trial) in the intervention group were lower than those in the control group (-$1,036 [-$2177, $44] for the intervention group vs. +$80 [-$841, $1000] for the control group), though there was no significant difference (p = 0.12). Among those who experienced the first AE during the study period (n = 25), those in the intervention group had timelier follow up by the clinical care team compared to those in the control group but no significant difference was found (HR = 1.93; 95% CI: 0.82-1.45, P = 0.10). There was no difference in the proportion of duration when patients had well-controlled asthma during the study period between the intervention and the control groups. Conclusions While A-GPS-based intervention showed similar reduction in AE events to usual care, it might reduce clinicians' burden for EHRs review resulting in efficient asthma management. A larger RCT is needed for further studying the findings.	[Seol, Hee Yun; Shrestha, Pragya; Wi, Chung-Il; Ihrke, Kathy; Wheeler, Philip; Juhn, Young J.] Mayo Clin, Precis Populat Sci Lab, Rochester, MN 55902 USA; [Seol, Hee Yun] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan, South Korea; [Shrestha, Pragya; Muth, Joy Fladager; Wi, Chung-Il; Ihrke, Kathy; McWilliams, Deborah B.; Juhn, Young J.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55902 USA; [Sohn, Sunghwan; Moon, Sungrim; Liu, Hongfang] Mayo Clin, Dept Artificial Intelligence & Informat, Rochester, MN USA; [Ryu, Euijung; King, Katherine] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Park, Miguel] Mayo Clin, Div Allerg Dis, Rochester, MN USA; [Borah, Bijan] Mayo Clin, Dept Hlth Serv Res, Rochester, MN USA; [Moriarty, James; Rosedahl, Jordan] Mayo Clin, Kern Ctr Sci Hlth Care Delivery, Rochester, MN USA	Mayo Clinic; Pusan National University; Pusan National University Hospital; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Juhn, YJ (corresponding author), Mayo Clin, Precis Populat Sci Lab, Rochester, MN 55902 USA.; Juhn, YJ (corresponding author), Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55902 USA.	juhn.young@mayo.edu			Innovative Methods to Improve Asthma Disease Management Program, Genentech; National Institute of Health (NIH) [R01 HL126667, R21AI142702]; NIH T32 Training Grant [GM008685-22]	Innovative Methods to Improve Asthma Disease Management Program, Genentech; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32 Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Innovative Methods to Improve Asthma Disease Management Program, Genentech, and National Institute of Health (NIH)-funded R01 grant (R01 HL126667) and R21 grant (R21AI142702). Dr. Shrestha is supported by NIH T32 Training Grant (GM008685-22) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2020, JAMA-J AM MED ASSOC, V323, P1043, DOI 10.1001/jama.2020.1039; Assurance NCfQ, 2016, TECHNICAL SPECIFICAT, V2; Bauer BA, 1997, CHEST, V111, P303, DOI 10.1378/chest.111.2.303; BEARD CM, 1992, J CLIN EPIDEMIOL, V45, P1013; Bell LM, 2010, PEDIATRICS, V125, pE770, DOI 10.1542/peds.2009-1385; Bisgaard H, 2007, PEDIATR PULM, V42, P723, DOI 10.1002/ppul.20644; Busse WW, 2012, J ALLERGY CLIN IMMUN, V129, pS1, DOI 10.1016/j.jaci.2011.12.985; Cajigal S, 2017, J ALLER CL IMM-PRACT, V5, P121, DOI 10.1016/j.jaip.2016.06.025; Center for Devices and Radiological Health, 2020, FADAF SOFTW MED DEV FADAF SOFTW MED DEV, VFDA-2016-D-2483; Ducharme FM, 2015, CAN RESPIR J, V22, P135, DOI 10.1155/2015/101572; Dzau VJ, 2017, JAMA-J AM MED ASSOC, V317, P1461, DOI 10.1001/jama.2017.1964; Findley S, 2011, HEALTH PROMOT PRACT, V12, p52S, DOI 10.1177/1524839911404231; Gardner RL, 2019, J AM MED INFORM ASSN, V26, P106, DOI 10.1093/jamia/ocy145; Gorin AA, 2018, OBESITY, V26, P499, DOI 10.1002/oby.22098; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Holmgren AJ, 2021, JAMA INTERN MED, V181, P251, DOI 10.1001/jamainternmed.2020.7071; HUNT LW, 1993, JAMA-J AM MED ASSOC, V269, P1947, DOI 10.1001/jama.269.15.1947; Jackson SE, 2015, JAMA INTERN MED, V175, P385, DOI 10.1001/jamainternmed.2014.7554; Juhn YJ, 2005, J ALLERGY CLIN IMMUN, V116, P510, DOI 10.1016/j.jaci.2005.05.043; Juhn YJ, 2005, SOC SCI MED, V60, P2453, DOI 10.1016/j.socscimed.2004.11.034; Juhn Y, 2011, PRIM CARE RESP J, V20, P79, DOI 10.4104/pcrj.2010.00076; Juhn YJ, 2014, J ALLERGY CLIN IMMUN, V134, P247, DOI 10.1016/j.jaci.2014.04.024; Juhn YJ, 2010, J ALLERGY CLIN IMMUN, V125, P838, DOI 10.1016/j.jaci.2009.12.998; Katheryn Courville PD, 2018, 2018 CLIN INF C 2018 2018 CLIN INF C 2018; Kaur H, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0593-9; Komorowski M, 2018, NAT MED, V24, P1716, DOI 10.1038/s41591-018-0213-5; Lee MS, 2018, JAMA INTERN MED, V178, P782, DOI 10.1001/jamainternmed.2018.0738; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Lindgren P, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0184-2; Linzer M, 2015, J GEN INTERN MED, V30, P1584, DOI 10.1007/s11606-015-3341-3; Martin-Sanchez F, 2014, Yearb Med Inform, V9, P14, DOI 10.15265/IY-2014-0020; McCowan C, 2001, MED INFORM INTERNET, V26, P191, DOI 10.1080/14639230110067890; Molis WE, 2008, ALLERGY, V63, P1529, DOI 10.1111/j.1398-9995.2008.01749.x; Murphy KR, 2009, J ALLERGY CLIN IMMUN, V123, P833, DOI 10.1016/j.jaci.2009.01.058; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Sbihi H, 2017, AM J RESP CRIT CARE, V195, P607, DOI 10.1164/rccm.201601-0164OC; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Seol HY, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2019-000524; Seol HY, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00113; Shiffman RN, 2000, PEDIATRICS, V105, P767, DOI 10.1542/peds.105.4.767; Silverstein MD, 1997, J ALLERGY CLIN IMMUN, V99, P466, DOI 10.1016/S0091-6749(97)70072-1; SILVERSTEIN MD, 1994, NEW ENGL J MED, V331, P1537, DOI 10.1056/NEJM199412083312301; St Sauver JL, 2012, INT J EPIDEMIOL, V41, P1614, DOI 10.1093/ije/dys195; St Sauver JL, 2012, MAYO CLIN PROC, V87, P151, DOI 10.1016/j.mayocp.2011.11.009; Visscher SL, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2327-8; WHITE E, 1991, AM J PREV MED, V7, P319, DOI 10.1016/S0749-3797(18)30905-X; Wi CI, 2017, AM J RESP CRIT CARE, V196, P430, DOI 10.1164/rccm.201610-2006OC; Wijnberge M, 2020, JAMA-J AM MED ASSOC, V323, P1052, DOI 10.1001/jama.2020.0592; Wu ST, 2014, J AM MED INFORM ASSN, V21, P876, DOI 10.1136/amiajnl-2013-002463; Wu ST, 2013, ANN ALLERG ASTHMA IM, V111, P364, DOI 10.1016/j.anai.2013.07.022; Yawn BP, 1999, J ALLERGY CLIN IMMUN, V103, P54, DOI 10.1016/S0091-6749(99)70525-7; Yawn BP, 2002, J PEDIATR-US, V140, P576, DOI 10.1067/mpd.2002.123764; Yoo KH, 2007, J ALLERGY CLIN IMMUN, V120, P1468, DOI 10.1016/j.jaci.2007.09.008; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888; Zeiger RS, 2011, J ALLERGY CLIN IMMUN, V128, P983, DOI 10.1016/j.jaci.2011.08.010; Zhong WJ, 2015, J PRIM CARE COMMUNIT, V6, P2, DOI 10.1177/2150131914540916	56	7	7	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255261	10.1371/journal.pone.0255261	http://dx.doi.org/10.1371/journal.pone.0255261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TT3IC	34339438	Green Published, gold			2022-12-26	WOS:000680243400047
J	Teramoto, T; Koyasu, T; Adachi, N; Kawasaki, M; Moriya, T; Numata, T; Senda, T; Kakuta, Y				Teramoto, Takamasa; Koyasu, Takeshi; Adachi, Naruhiko; Kawasaki, Masato; Moriya, Toshio; Numata, Tomoyuki; Senda, Toshiya; Kakuta, Yoshimitsu			Minimal protein-only RNase P structure reveals insights into tRNA precursor recognition and catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX; DOMAIN; VALIDATION; MATURATION; MECHANISM; PROVIDES; TOOLS; MODEL	Ribonuclease P (RNase P) is an endoribonuclease that catalyzes the processing of the 5' leader sequence of precursor tRNA (pre-tRNA). Ribonucleoprotein RNase P and protein only RNase P (PRORP) in eukaryotes have been extensively studied, but the mechanism by which a prokaryotic nuclease recognizes and cleaves pre-tRNA is unclear. To gain insights into this mechanism, we studied homologs of Aquifex RNase P (HARPs), thought to be enzymes of approximately 23 kDa comprising only this nuclease domain. We determined the cryo-EM structure of Aq880, the first identified HARP enzyme. The structure unexpectedly revealed that Aq880 consists of both the nuclease and protruding helical (PrH) domains. Aq880 monomers assemble into a dimer via the PrH domain. Six dimers form a dodecamer with a left-handed one-turn superhelical structure. The structure also revealed that the active site of Aq880 is analogous to that of eukaryotic PRORPs. The pre-tRNA docking model demonstrated that 5' processing of pre-tRNAs is achieved by two adjacent dimers within the dodecamer. One dimer is responsible for catalysis, and the PrH domains of the other dimer are responsible for pre-tRNA elbow recognition. Our study suggests that HARPs measure an invariant distance from the pre-tRNA elbow to cleave the 5' leader sequence, which is analogous to the mechanism of eukaryotic PRORPs and the ribonucleoprotein RNase P. Collectively, these findings shed light on how different types of RNase P enzymes utilize the same pre-tRNA processing.	[Teramoto, Takamasa; Koyasu, Takeshi; Kakuta, Yoshimitsu] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Lab Biophys Chem,Nishi Ku, Fukuoka, Japan; [Adachi, Naruhiko; Kawasaki, Masato; Moriya, Toshio; Senda, Toshiya] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Struct Biol Res Ctr, Tsukuba, Ibaraki, Japan; [Kawasaki, Masato; Senda, Toshiya] Grad Univ Adv Studies Soken Dai, Sch High Energy Accelerator Sci, Dept Mat Struct Sci, Tsukuba, Ibaraki, Japan; [Numata, Tomoyuki] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Lab Biochem,Nishi Ku, Fukuoka, Japan	Kyushu University; High Energy Accelerator Research Organization (KEK); Graduate University for Advanced Studies - Japan; Kyushu University	Teramoto, T; Kakuta, Y (corresponding author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Lab Biophys Chem,Nishi Ku, Fukuoka, Japan.	teramotot@agr.kyushu-u.ac.jp; kakuta@agr.kyushu-u.ac.jp		Senda, Toshiya/0000-0002-5153-928X; Kawasaki, Masato/0000-0002-8319-2102; Teramoto, Takamasa/0000-0003-1555-5394; Moriya, Toshio/0000-0001-7226-5487	JSPS KAKENHI [21K06032]; Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from the Japan Agency for Medical Research and Development (AMED) [JP21am0101071, 3051]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Grant-in-aid for scientific research by JSPS KAKENHI (grant number 21K06032) and the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from the Japan Agency for Medical Research and Development (AMED) (grant number JP21am0101071) (supporting no. 3051).	Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daniels CJ, 2019, RNA, V25, P286, DOI 10.1261/rna.068379.118; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feyh R, 2021, ELIFE, V10, DOI 10.7554/eLife.70160; Gobert A, 2019, IUBMB LIFE, V71, P1117, DOI 10.1002/iub.2062; Gobert A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2358; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Itoh Y, 2013, SCIENCE, V340, P75, DOI 10.1126/science.1229521; Karasik A, 2016, J MOL BIOL, V428, P26, DOI 10.1016/j.jmb.2015.11.025; Lan PF, 2018, SCIENCE, V362, P657, DOI 10.1126/science.aat6678; Lechner M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-522; Li FZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09878; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Matelska D, 2017, NUCLEIC ACIDS RES, V45, P6995, DOI 10.1093/nar/gkx494; Mukherjee A, 2017, ENVIRON MICROBIOL, V19, P2831, DOI 10.1111/1462-2920.13808; Nickel AI, 2017, P NATL ACAD SCI USA, V114, P11121, DOI 10.1073/pnas.1707862114; Pellegrini O, 2012, STRUCTURE, V20, P1769, DOI 10.1016/j.str.2012.08.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinker F, 2017, J BIOL CHEM, V292, P13904, DOI 10.1074/jbc.M117.782078; Reinhard L, 2015, NUCLEIC ACIDS RES, V43, P5664, DOI 10.1093/nar/gkv481; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Schaffer AE, 2019, ANNU REV GENOM HUM G, V20, P359, DOI 10.1146/annurev-genom-083118-015334; Schwarz TS, 2019, IUBMB LIFE, V71, P1109, DOI 10.1002/iub.2122; Teramoto T, 2020, NUCLEIC ACIDS RES, V48, P11815, DOI 10.1093/nar/gkaa627; Wan FT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10496-3; Wu J, 2018, CELL, V175, P1393, DOI 10.1016/j.cell.2018.10.003; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Zhang JW, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020018; Zhang JW, 2013, NATURE, V500, P363, DOI 10.1038/nature12440; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	36	4	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101028	10.1016/j.jbc.2021.101028	http://dx.doi.org/10.1016/j.jbc.2021.101028			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34339732	gold, Green Published			2022-12-26	WOS:000706408900008
J	Yamaguchi, K; Itakura, M; Kitazawa, R; Lim, SY; Nagata, K; Shibata, T; Akagawa, M; Uchida, K				Yamaguchi, Kosuke; Itakura, Masanori; Kitazawa, Roma; Lim, Sei-Young; Nagata, Koji; Shibata, Takahiro; Akagawa, Mitsugu; Uchida, Koji			Oxidative deamination of lysine residues by polyphenols generates an equilibrium of aldehyde and 2-piperidinol products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSYL OXIDASE; GREEN TEA; IDENTIFICATION; SEMIALDEHYDES; COMPLEXES; MECHANISM; PROTEINS; EPITOPES	Polyphenols, especially catechol-type polyphenols, exhibit lysyl oxidase-like activity and mediate oxidative deamination of lysine residues in proteins. Previous studies have shown that polyphenol-mediated oxidative deamination of lysine residues can be associated with altered electrical properties of proteins and increased crossreactivity with natural immunoglobulin M antibodies. This interaction suggested that oxidized proteins could act as innate antigens and elicit an innate immune response. However, the structural basis for oxidatively deaminated lysine residues remains unclear. In the present study, to establish the chemistry of lysine oxidation, we characterized oxidation products obtained via incubation of the lysine analog N-biotinyl-5-aminopentylamine with eggshell membranes containing lysyl oxidase and identified a unique six-membered ring 2-piperidinol derivative equilibrated with a ring-open product (aldehyde) as the major product. By monitoring these aldehyde-2-piperidinol products, we evaluated the lysyl oxidase-like activity of polyphenols. We also observed that this reaction was mediated by some polyphenols, especially o-diphenolic-type polyphenols, in the presence of copper ions. Interestingly, the natural immunoglobulin M monoclonal antibody recognized these aldehyde-2-piperidinol products as an innate epitope. These findings establish the existence of a dynamic equilibrium of oxidized lysine and provide important insights into the chemopreventive function of dietary polyphenols for chronic diseases.	[Yamaguchi, Kosuke; Itakura, Masanori; Kitazawa, Roma; Lim, Sei-Young; Nagata, Koji; Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Shibata, Takahiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan; [Akagawa, Mitsugu] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka, Japan; [Uchida, Koji] Japan Agcy Med Res & Dev, CREST, Tokyo, Japan	University of Tokyo; Nagoya University; Osaka Metropolitan University; Japan Science & Technology Agency (JST)	Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.; Uchida, K (corresponding author), Japan Agcy Med Res & Dev, CREST, Tokyo, Japan.	a-uchida@g.ecc.u-tokyo.ac.jp	Shibata, Takahiro/I-6872-2014	Shibata, Takahiro/0000-0003-3194-607X; Nagata, Koji/0000-0002-4704-0603	Ministry of Education, Sciences, Sports, Technology, Japan [JP17H06170];  [JP20gm0910013]	Ministry of Education, Sciences, Sports, Technology, Japan; 	This study was supported in part by a Grant-in-aid for Scientific Research (S) (no. JP17H06170) (to K. U.) from the Ministry of Education, Sciences, Sports, Technology, Japan. This research was also supported by AMED-CREST from AMED (JP20gm0910013) (to K. U.).	Akagawa M, 2005, J AGR FOOD CHEM, V53, P8019, DOI 10.1021/jf050843f; Akagawa M, 2001, EUR J BIOCHEM, V268, P1953, DOI 10.1046/j.1432-1327.2001.02068.x; Akagawa M, 1999, BBA-PROTEIN STRUCT M, V1434, P151, DOI 10.1016/S0167-4838(99)00169-7; Akagawa M, 2016, BIOSCI BIOTECH BIOCH, V80, P13, DOI 10.1080/09168451.2015.1062715; Akagawa M, 2006, CHEM RES TOXICOL, V19, P1059, DOI 10.1021/tx060026p; Binder CJ, 2016, NAT REV IMMUNOL, V16, P485, DOI 10.1038/nri.2016.63; Charron CL, 2018, AUST J CHEM, V71, P697, DOI 10.1071/CH18198; Furuhashi M, 2017, BIOCHEMISTRY-US, V56, P4701, DOI 10.1021/acs.biochem.7b00409; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; HARRIS ED, 1980, SCIENCE, V208, P55, DOI 10.1126/science.6102412; Hatasa Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153002; Hawkins CL, 2019, J BIOL CHEM, V294, P19683, DOI 10.1074/jbc.REV119.006217; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Ishii T, 2010, BIOORGAN MED CHEM, V18, P4892, DOI 10.1016/j.bmc.2010.06.021; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kaveri SV, 2012, J IMMUNOL, V188, P939, DOI 10.4049/jimmunol.1102107; Kijewska M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28798-9; Levine RL, 2002, FREE RADICAL BIO MED, V32, P790, DOI 10.1016/S0891-5849(02)00765-7; Lin H, 2017, FREE RADICAL BIO MED, V104, P20, DOI 10.1016/j.freeradbiomed.2017.01.006; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Lutz HU, 2007, J AUTOIMMUN, V29, P287, DOI 10.1016/j.jaut.2007.07.007; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; Schmelzer CEH, 2020, IUBMB LIFE, V72, P842, DOI 10.1002/iub.2213; SHAH MA, 1992, BIOCHIM BIOPHYS ACTA, V1159, P311, DOI 10.1016/0167-4838(92)90061-H; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; STAHMANN MA, 1977, BIOPOLYMERS, V16, P1299, DOI 10.1002/bip.1977.360160610; SUZUKI S, 1988, INORG CHEM, V27, P591, DOI 10.1021/ic00277a001	27	1	1	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101035	10.1016/j.jbc.2021.101035	http://dx.doi.org/10.1016/j.jbc.2021.101035			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34339739	Green Published, gold			2022-12-26	WOS:000704369100005
J	Cho, SE; Park, CA; Na, KS; Chung, C; Ma, HJ; Kang, CK; Kang, SG				Cho, Seo-Eun; Park, Chan-A; Na, Kyoung-Sae; Chung, ChiHye; Ma, Hyo-Jin; Kang, Chang-Ki; Kang, Seung-Gul			Left-right asymmetric and smaller right habenula volume in major depressive disorder on high-resolution 7-T magnetic resonance imaging	PLOS ONE			English	Article							LATERAL HABENULA; UNIPOLAR DEPRESSION; CONNECTIVITY; METAANALYSIS; RELAXATION; SEROTONIN; RESPONSES; CORTEX; MRI; ANTIDEPRESSANT	The habenula (Hb) has been hypothesized to play an essential role in major depressive disorder (MDD) as it is considered to be an important node between fronto-limbic areas and midbrain monoaminergic structures based on animal studies. In this study, we aimed to investigate the differences in volume and T1 value of the Hb between patients with MDD and healthy control (HC) subjects. Analysis for the Hb volumes was performed using high-resolution 7-T magnetic resonance (MR) image data from 33 MDD patients and 36 healthy subjects. Two researchers blinded to the clinical data manually delineated the habenular nuclei and Hb volume, and T1 values were calculated based on overlapping voxels. We compared the Hb volume and T1 value between the MDD and HC groups and compared the volume and T1 values between the left and right Hbs in each group. Compared to HC subjects, MDD patients had a smaller right Hb volume; however, there was no significant volume difference in the left Hb between groups. In the MDD group, the right Hb was smaller in volume and lower in T1 value than the left Hb. The present findings suggest a smaller right Hb volume and left-right asymmetry of Hb volume in MDD. Future high-resolution 7-T MR imaging studies with larger sample sizes will be needed to derive a more definitive conclusion.	[Cho, Seo-Eun; Na, Kyoung-Sae; Ma, Hyo-Jin; Kang, Seung-Gul] Gachon Univ, Coll Med, Gil Med Ctr, Dept Psychiat, Incheon, South Korea; [Park, Chan-A] Gachon Univ, Biomed Engn Res Ctr, Incheon, South Korea; [Chung, ChiHye] Konkuk Univ, Dept Biol Sci, Seoul, South Korea; [Kang, Chang-Ki] Gachon Univ, Coll Hlth Sci, Dept Radiol Sci, Incheon, South Korea	Gachon University; Gachon University; Konkuk University; Gachon University	Kang, SG (corresponding author), Gachon Univ, Coll Med, Gil Med Ctr, Dept Psychiat, Incheon, South Korea.; Kang, CK (corresponding author), Gachon Univ, Coll Hlth Sci, Dept Radiol Sci, Incheon, South Korea.	ckkang@gachon.ac.kr; kangsg@gachon.ac.kr		Kang, Seung-Gul/0000-0003-4933-0433	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C2665]; National Research Foundation of Korea (NRF) - Korean government (MSIT) [NRF-2020R1A2C1007527]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) - Korean government (MSIT)	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI17C2665). This work was also supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT), grant number NRF-2020R1A2C1007527. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada-Galleguillos P, 2017, BRAIN STRUCT FUNCT, V222, P1087, DOI 10.1007/s00429-016-1231-z; Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; [Anonymous], 2012, MRI BASICS BASICS; Arnone D, 2013, MOL PSYCHIATR, V18, P1265, DOI 10.1038/mp.2012.150; Arnone D, 2012, EUR NEUROPSYCHOPHARM, V22, P1, DOI 10.1016/j.euroneuro.2011.05.003; Arnone D, 2016, HUM BRAIN MAPP, V37, P1393, DOI 10.1002/hbm.23108; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Bazin PL, 2014, NEUROIMAGE, V93, P201, DOI 10.1016/j.neuroimage.2013.03.077; Botteron KN, 2002, BIOL PSYCHIAT, V51, P342, DOI 10.1016/S0006-3223(01)01280-X; BOTTOMLEY PA, 1987, MED PHYS, V14, P1, DOI 10.1118/1.596111; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Browne CA, 2018, FRONT SYNAPTIC NEURO, V10, DOI 10.3389/fnsyn.2018.00046; Busner Joan, 2007, Psychiatry (Edgmont), V4, P28; Caan MWA, 2019, HUM BRAIN MAPP, V40, P1786, DOI 10.1002/hbm.24490; Carceller-Sindreu M, 2015, EUR NEUROPSYCHOPHARM, V25, P2015, DOI 10.1016/j.euroneuro.2015.08.009; Carlson PJ, 2013, BIOL PSYCHIAT, V73, P1213, DOI 10.1016/j.biopsych.2013.02.008; Dreosti E, 2014, CURR BIOL, V24, P440, DOI 10.1016/j.cub.2014.01.016; Dudek KA, 2021, EUR J NEUROSCI, V53, P183, DOI 10.1111/ejn.14547; Fakhoury M, 2017, NEUROSCI BIOBEHAV R, V83, P721, DOI 10.1016/j.neubiorev.2017.02.010; First M, 2015, ENCY CLIN PSYCHOL IN, P1, DOI DOI 10.1002/9781118625392.WBECP351; First MB WJ., 2016, SCID 5 SPQ STRUCTURE; Furman DJ, 2016, SOC COGN AFFECT NEUR, V11, P843, DOI 10.1093/scan/nsw019; Geisler S, 2008, CNS SPECTRUMS, V13, P484, DOI 10.1017/S1092852900016710; Goldman M, 2001, J MAGN RESON, V149, P160, DOI 10.1006/jmre.2000.2239; Gordon N, 2016, BEHAV BRAIN RES, V296, P141, DOI 10.1016/j.bbr.2015.09.013; Gosnell SN, 2019, J AFFECT DISORDERS, V242, P211, DOI 10.1016/j.jad.2018.08.026; Hahn HM, 1986, J KOREAN NEUROPSYCHI, V25, P487; Haro JM, 2003, ACTA PSYCHIAT SCAND, V107, P16, DOI 10.1034/j.1600-0447.107.s416.5.x; Hecht D, 2010, NEUROSCI RES, V68, P77, DOI 10.1016/j.neures.2010.06.013; Hetu S, 2016, HUM BRAIN MAPP, V37, P2602, DOI 10.1002/hbm.23194; Hodes GE, 2019, BIOL PSYCHIAT, V86, P421, DOI 10.1016/j.biopsych.2019.04.028; Husken U, 2014, CURR BIOL, V24, P2217, DOI 10.1016/j.cub.2014.08.006; Ide JS, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00025; Jaworska N, 2016, J AFFECT DISORDERS, V190, P726, DOI 10.1016/j.jad.2015.10.064; Kang SG, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062148; Kim JW, 2016, NEUROIMAGE, V130, P145, DOI 10.1016/j.neuroimage.2016.01.048; KRISHNAN KRR, 1991, J NEUROPSYCH CLIN N, V3, P387; Laube C, 2020, DEV COGN NEUROS-NETH, V42, DOI 10.1016/j.dcn.2020.100753; Lawson RP, 2013, NEUROIMAGE, V64, P722, DOI 10.1016/j.neuroimage.2012.08.076; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Luan SX, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1229; Lutti A, 2014, NEUROIMAGE, V93, P176, DOI 10.1016/j.neuroimage.2013.06.005; Manas-Ojeda A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165819; MATHURDEVRE R, 1984, BRIT J RADIOL, V57, P955, DOI 10.1259/0007-1285-57-683-955; McEwen B. S., 2002, European Psychiatry, V17, P318, DOI 10.1016/S0924-9338(02)00650-8; Metere R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169265; Metzger M, 2021, EUR J NEUROSCI, V53, P65, DOI 10.1111/ejn.14647; Namboodiri VMK, 2016, CURR BIOL, V26, pR873, DOI 10.1016/j.cub.2016.08.051; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pantel J, 2000, HIPPOCAMPUS, V10, P752, DOI 10.1002/1098-1063(2000)10:6<752::AID-HIPO1012>3.0.CO;2-Y; 이중서, 2005, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V44, P456; Pezzoli S, 2018, NEUROSCI BIOBEHAV R, V84, P162, DOI 10.1016/j.neubiorev.2017.11.005; Raman MR, 2017, MAGN RESON MED, V77, P774, DOI 10.1002/mrm.26140; Ranft K, 2010, PSYCHOL MED, V40, P557, DOI 10.1017/S0033291709990821; Ribolsi M, 2009, REV NEUROSCIENCE, V20, P61; Riederer P, 2012, J NEURAL TRANSM, V119, P953, DOI 10.1007/s00702-012-0775-1; Roiser JP, 2009, BIOL PSYCHIAT, V66, P441, DOI 10.1016/j.biopsych.2009.05.002; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Sacchet MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02062-y; Savitz JB, 2011, BIOL PSYCHIAT, V69, P336, DOI 10.1016/j.biopsych.2010.09.027; Schmidt FM, 2017, EUR ARCH PSY CLIN N, V267, P107, DOI 10.1007/s00406-016-0675-8; Seo JS, 2018, MOL PSYCHIATR, V23, P1113, DOI 10.1038/mp.2017.96; Strotmann B, 2014, J MAGN RESON IMAGING, V39, P1018, DOI 10.1002/jmri.24252; Tata DA, 2010, PHYSIOL BEHAV, V99, P186, DOI 10.1016/j.physbeh.2009.09.008; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; WIRTSHAFTER D, 1994, BRAIN RES, V633, P21, DOI 10.1016/0006-8993(94)91517-2; Wise T, 2014, NEUROPSYCH DIS TREAT, V10, P1509, DOI 10.2147/NDT.S50156; Yang LM, 2008, BEHAV BRAIN RES, V188, P84, DOI 10.1016/j.bbr.2007.10.022; Young LT, 2002, J PSYCHIATR NEUROSCI, V27, P8	71	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255459	10.1371/journal.pone.0255459	http://dx.doi.org/10.1371/journal.pone.0255459			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343199	gold, Green Published			2022-12-26	WOS:000685264200009
J	Josia, C; Mashingaidze, K; Amelework, AB; Kondwakwenda, A; Musvosvi, C; Sibiya, J				Josia, Chimwemwe; Mashingaidze, Kingstone; Amelework, Assefa B.; Kondwakwenda, Aleck; Musvosvi, Cousin; Sibiya, Julia			SNP-based assessment of genetic purity and diversity in maize hybrid breeding	PLOS ONE			English	Article							RFLP; CORN	Assessment of genetic purity of parental inbred lines and their resultant F-1 hybrids is an essential quality control check in maize hybrid breeding, variety release and seed production. In this study, genetic purity, parent-offspring relationship and diversity among the inbred lines were assessed using 92 single-nucleotide polymorphism (SNP) markers. A total of 188 maize genotypes, comprising of 26 inbred lines, four doubled haploid (DH) lines and 158 single-cross maize hybrids were investigated in this study using Kompetitive Allele Specific Polymerase Chain Reaction (KASP) genotyping assays. The bi-allelic data was analyzed for genetic purity and diversity parameters using GenAlex software. The SNP markers were highly polymorphic and 90% had polymorphic information content (PIC) values of > 0.3. Pairwise genetic distances among the lines ranged from 0.05 to 0.56, indicating a high level of dissimilarity among the inbred lines. A maximum genetic distance of (0.56) was observed between inbred lines CKDHL0089 and CML443 while the lowest (0.05) was between I-42 and I-40. The majority (67%) of the inbred lines studied were genetically pure with residual heterozygosity of <5%, while only 33% had heterozygosity levels of >5%. Inbred lines, which were not pure, require purification through further inbreeding. Cluster analysis partitioned the lines into three distinct genetic clusters with the potential to contribute new beneficial alleles to the maize breeding program. Out of the 68 hybrids (43%) that passed the parent-offspring test, seven hybrids namely; SCHP29, SCHP95, SCHP94, SCHP134, SCHP44, SCHP114 and SCHP126, were selected as potential candidates for further evaluation and release due to their outstanding yield performance.	[Josia, Chimwemwe; Kondwakwenda, Aleck; Musvosvi, Cousin; Sibiya, Julia] Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, Pietermaritzburg, South Africa; [Mashingaidze, Kingstone] Agr Res Council Grain Crops Inst ARC GCI, Potchefstroom, South Africa; [Amelework, Assefa B.] Agr Res Council Vegetable & Ornamental Plants ARC, Pretoria, South Africa	University of Kwazulu Natal	Kondwakwenda, A (corresponding author), Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, Pietermaritzburg, South Africa.	alekondwa@gmail.com	Assefa, Amelework/GPG-3605-2022; Musvosvi, Cousin/AAM-9762-2021	Musvosvi, Cousin/0000-0002-8483-0479; Kondwakwenda, Aleck/0000-0001-6786-3175	Alliance for a Green Revolution in Africa (AGRA) [2014PASS013]	Alliance for a Green Revolution in Africa (AGRA)	This work was funded by the Alliance for a Green Revolution in Africa (AGRA) under the grant number 2014PASS013. Prof JS received the grant. The sponsors did not play any role in designing, data collection or any towards the development of this manuscript.	Abakemal D, 2015, EUPHYTICA, V204, P49, DOI 10.1007/s10681-014-1332-9; Adeyemo O, 2014, PLANT GENET RESOUR-C, V12, P67, DOI 10.1017/S1479262113000294; Adu GB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214810; Chang MT., 2009, DOUBLED HAPLOIDS MOL, P127; Chen JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157236; Daniel I. O., 2012, American Journal of Experimental Agriculture, V2, P597; Dao A, 2013, THESIS U GHANA; Dao A, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0127-2; Ertiro BT, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4173-9; Ertiro BT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2180-2; Garcia AAF, 2004, GENET MOL BIOL, V27, P579, DOI 10.1590/S1415-47572004000400019; Geiger HH, 2009, MAYDICA, V54, P485; Gowda M., 2017, QUALITY ASSURANCE QU; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hao ZF, 2011, J INTEGR PLANT BIOL, V53, P641, DOI 10.1111/j.1744-7909.2011.01051.x; Ipsilandis C. G., 2005, Asian Journal of Plant Sciences, V4, P75; Labate JA, 2003, CROP SCI, V43, P80, DOI 10.2135/cropsci2003.0080; LANDER ES, 1989, GENETICS, V121, P185; Moreira JN, 2010, HORTIC BRAS, V28, P406, DOI 10.1590/S0102-05362010000400005; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nyombayire A, 2016, MAYDICA, V61; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrier X, DARWIN SOFTWARE DISS; Salgado Kalinka Carla Padovani de Carvalho, 2006, Rev. bras. sementes, V28, P169, DOI 10.1590/S0101-31222006000100024; Semagn K, 2006, AFR J BIOTECHNOL, V5, P2540; Semagn K, 2012, THEOR APPL GENET, V125, P1487, DOI 10.1007/s00122-012-1928-1; Shiferaw B, 2011, FOOD SECUR, V3, P307, DOI 10.1007/s12571-011-0140-5; Warburton ML, 2010, CROP SCI, V50, P467, DOI 10.2135/cropsci2009.02.0089; Yang XH, 2011, GENETICA, V139, P1045, DOI 10.1007/s10709-011-9606-9	29	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0249505	10.1371/journal.pone.0249505	http://dx.doi.org/10.1371/journal.pone.0249505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343170	Green Published, gold, Green Submitted			2022-12-26	WOS:000685264200033
J	Spitzer, MWH; Musslick, S				Spitzer, Markus Wolfgang Hermann; Musslick, Sebastian			Academic performance of K-12 students in an online-learning environment for mathematics increased during the shutdown of schools in wake of the COVID-19 pandemic	PLOS ONE			English	Article							COLLEGE-STUDENTS; ACHIEVEMENT; ACQUISITION; INCENTIVES; KNOWLEDGE; TRACKING; GROWTH; GAP	The shutdown of schools in response to the rapid spread of COVID-19 poses risks to the education of young children, including a widening education gap. In the present article, we investigate how school closures in 2020 influenced the performance of German students in a curriculum-based online learning software for mathematics. We analyzed data from more than 2,500 K-12 students who computed over 124,000 mathematical problem sets before and during the shutdown, and found that students' performance increased during the shutdown of schools in 2020 relative to the year before. Our analyses also revealed that low-achieving students showed greater improvements in performance than high-achieving students, suggesting a narrowing gap in performance between low- and high-achieving students. We conclude that online learning environments may be effective in preventing educational losses associated with current and future shutdowns of schools.	[Spitzer, Markus Wolfgang Hermann] Albert Ludwigs Univ Freiburg, Freiburg, Germany; [Musslick, Sebastian] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	University of Freiburg; Princeton University	Spitzer, MWH (corresponding author), Albert Ludwigs Univ Freiburg, Freiburg, Germany.	Markus.spitzer@psychologie.uni-freiburg.de			John Templeton Foundation [61434]	John Templeton Foundation	Initials of the authors who received each award: SM Grant numbers awarded to each author: 61434 The full name of each funder: John Templeton Foundation URL of each funder website: templeton.org The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrist J, 2002, AM ECON REV, V92, P1535, DOI 10.1257/000282802762024629; Atkeson A., 2020, WHAT WILL BE EC IMPA, DOI [10.3386/w26867, DOI 10.3386/W26867]; Azevedo JP., 2020, SIMULATING POTENTIAL; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bodovski K, 2007, ELEM SCHOOL J, V108, P115, DOI 10.1086/525550; BREHM JW, 1989, ANNU REV PSYCHOL, V40, P109, DOI 10.1146/annurev.ps.40.020189.000545; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Cheema Ritu, 2020, Am J Perinatol, DOI 10.1055/s-0040-1714277; Clarke AJ, 2013, J ATMOS OCEAN TECH, V30, P151, DOI 10.1175/JTECH-D-12-00067.1; Clotfelter CT, 2005, ECON EDUC REV, V24, P377, DOI 10.1016/j.econedurev.2004.06.008; Cohen GL, 2006, SCIENCE, V313, P1307, DOI 10.1126/science.1128317; Couzin-Frankel J, 2020, SCIENCE, V369, P241, DOI 10.1126/science.369.6501.241; Cullen JB, 2013, J ECON PERSPECT, V27, P133, DOI 10.1257/jep.27.2.133; De Corte E, 2011, EDUC PSYCHOL HANDB, P155; De Paola M, 2012, J HUM CAPITAL, V6, P56, DOI 10.1086/664795; Doumen S, 2014, EDUC PSYCHOL-UK, V34, P385, DOI 10.1080/01443410.2013.785063; Duflo E, 2011, AM ECON REV, V101, P1739, DOI 10.1257/aer.101.5.1739; Engzell P., 2020, LEARNING INEQUALITY, P1, DOI [10.1073/pnas.2017308117, DOI 10.1073/PNAS.2017308117]; Engzell P, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022376118; Eskreis-Winkler L, 2016, J PERS SOC PSYCHOL, V111, P728, DOI 10.1037/pspp0000074; Figlio DN, 2002, J URBAN ECON, V51, P497, DOI 10.1006/juec.2001.2255; Frost C, 2000, J R STAT SOC A STAT, V163, P173, DOI 10.1111/1467-985X.00164; Goldhaber D, 2015, EDUC RESEARCHER, V44, P293, DOI 10.3102/0013189X15592622; Gonzalez T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239490; Grewenig E., 2020, COVID 19 ED INEQUALI; Husky MM, 2020, COMPR PSYCHIAT, V102, DOI 10.1016/j.comppsych.2020.152191; Jaeger MM, 2020, RES SOC STRAT MOBIL, V68, DOI 10.1016/j.rssm.2020.100524; Jez SJ, 2015, EDUC URBAN SOC, V47, P284, DOI 10.1177/0013124513495275; Kalogrides D, 2013, EDUC RESEARCHER, V42, P304, DOI 10.3102/0013189X13495087; Kalogrides D, 2013, SOCIOL EDUC, V86, P103, DOI 10.1177/0038040712456555; Kendall MG., 1973, ADV THEORY STAT, V2; Kitsantas A, 2009, METACOGN LEARN, V4, P97, DOI 10.1007/s11409-008-9028-y; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lahmers AG, 2000, J COLL STUDENT DEV, V41, P544; Leuven E, 2010, J EUR ECON ASSOC, V8, P1243, DOI 10.1111/j.1542-4774.2010.tb00554.x; Maloney EA, 2012, TRENDS COGN SCI, V16, P404, DOI [10.1016/j.tics.2012.06.008, 10.1016/j.tics.2012.08.011]; Marelli S, 2021, J NEUROL, V268, P8, DOI 10.1007/s00415-020-10056-6; Means B., 2010, EVALUATION EVIDENCE; Morgan PL, 2011, J LEARN DISABIL-US, V44, P472, DOI 10.1177/0022219411414010; Muis KR, 2007, EDUC PSYCHOL-US, V42, P173, DOI 10.1080/00461520701416306; Musslick S., 2015, REINFORCEMENT LEARNI; Otto B, 2017, LEARN INDIVID DIFFER, V55, P75, DOI 10.1016/j.lindif.2017.03.005; Penno JF, 2002, J EDUC PSYCHOL, V94, P23, DOI 10.1037//0022-0663.94.1.23; Pereda N, 2020, CHILD ADOL PSYCH MEN, V14, DOI 10.1186/s13034-020-00347-1; Protopapas A, 2011, J LEARN DISABIL-US, V44, P402, DOI 10.1177/0022219411417568; Ran H, 2021, J EDUC COMPUT RES, V59, P119, DOI 10.1177/0735633120952063; RICKER WE, 1973, J FISH RES BOARD CAN, V30, P409, DOI 10.1139/f73-072; Ritchie SJ, 2013, PSYCHOL SCI, V24, P1301, DOI 10.1177/0956797612466268; Shea P, 2014, COMPUT EDUC, V75, P103, DOI 10.1016/j.compedu.2014.02.009; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Spitzer MWH, 2022, EUR J PSYCHOL EDUC, V37, P39, DOI 10.1007/s10212-021-00546-0; STANOVICH KE, 1986, READ RES QUART, V21, P360, DOI 10.1598/RRQ.21.4.1; Stella M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222870; UNESCO, 2020, ED DISR REC SCH CLUS, DOI [10.1016/j.ajpath.2020.07.001, DOI 10.1016/J.AJPATH.2020.07.001]; WALBERG HJ, 1983, AM EDUC RES J, V20, P359, DOI 10.2307/1162605; Wo&beta;mann L., 2020, CORONAVIRUS CRISIS C; Woessmann L., 2009, CESIFO DICE REPORT, V7, P26	57	23	23	8	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255629	10.1371/journal.pone.0255629	http://dx.doi.org/10.1371/journal.pone.0255629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6IR	34343221	Green Published, gold			2022-12-26	WOS:000685264200034
J	Kanda, M; Shimizu, D; Nakamura, S; Sawaki, K; Umeda, S; Miwa, T; Tanaka, H; Inokawa, Y; Hattori, N; Hayashi, M; Tanaka, C; Nakayama, G; Iguchi, Y; Katsuno, M; Kodera, Y				Kanda, Mitsuro; Shimizu, Dai; Nakamura, Shunsuke; Sawaki, Koichi; Umeda, Shinichi; Miwa, Takashi; Tanaka, Haruyoshi; Inokawa, Yoshikuni; Hattori, Norifumi; Hayashi, Masamichi; Tanaka, Chie; Nakayama, Goro; Iguchi, Yohei; Katsuno, Masahisa; Kodera, Yasuhiro			Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells	ONCOGENE			English	Article							PERITONEAL METASTASIS; PROLIFERATION; RECEPTORS; SMOKING; GENES	Here, we evaluated the therapeutic potential of antibodies (Abs) targeting cholinergic receptor nicotinic beta 2 subunit (CHRNB2) in gastric cancer. To investigate the effects of these Abs on malignant phenotypes in vitro and in mouse xenograft models, we generated gene knockouts through genome editing, performed RNA interference-mediated knockdown of gene expression, and ectopically expressed CHRNB2 in gastric cancer cells. The effects of anti-CHRNB2 Abs on the proliferation of cancer cells were evaluated both in vitro and in vivo. We determined the effects of Chrnb2 deficiency on mice and the clinical significance of CHRNB2 expression in gastric cancer clinical specimens. Knockdown of CHRNB2 attenuated gastric cancer cell proliferation, whereas forced overexpression of CHRNB2 increased cell proliferation. Knockout of CHRNB2 significantly influenced cell survival and functions associated with metastasis. The effects of polyclonal Abs targeting the C- and N-termini of CHRNB2 guided the development of anti-CHRNB2 monoclonal Abs that inhibited the growth of gastric cancer cells in vitro and in vivo. Pathway analysis revealed that CHRNB2 interfered with signaling through the PI3K-AKT and JAK-STAT pathways. Chrnb2-deficient mice exhibited normal reproduction, organ functions, and motor functions. CHRNB2 regulates multiple oncological phenotypes associated with metastasis, and blockade of CHRNB2 expression using specific Abs shows promise for controlling metastasis in gastric cancer.	[Kanda, Mitsuro; Shimizu, Dai; Nakamura, Shunsuke; Sawaki, Koichi; Umeda, Shinichi; Miwa, Takashi; Tanaka, Haruyoshi; Inokawa, Yoshikuni; Hattori, Norifumi; Hayashi, Masamichi; Tanaka, Chie; Nakayama, Goro; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi, Japan; [Iguchi, Yohei; Katsuno, Masahisa] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Kanda, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi, Japan.	m-kanda@med.nagoya-u.ac.jp	Kanda, Mitsuro/M-4891-2014; Hayashi, Masamichi/P-9743-2015	Kanda, Mitsuro/0000-0001-5464-3819; Hayashi, Masamichi/0000-0001-6875-2303; Tanaka, Haruyoshi/0000-0003-0079-8422	Japan Agency for Medical Research and Development [20H03750, 17lm0203005j0001]; Center for Advanced Medicine and Clinical Research at Nagoya University; Japan Research Foundation for Clinical Pharmacology; Foundation for Promotion of Cancer Research; Kobayashi Foundation for Cancer Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Center for Advanced Medicine and Clinical Research at Nagoya University; Japan Research Foundation for Clinical Pharmacology; Foundation for Promotion of Cancer Research; Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Mochida Memorial Foundation for Medical and Pharmaceutical Research	We thank Edanz Group (https://en-author-services.edanz.com/ac) and the SPRINGER NATURE English Language Editing service (https://authorservices.springernature.com/language-editing/) for editing a draft of this manuscript. This work was supported by a Grant-in-Aid for Scientific Research (B, 20H03750), the Japan Agency for Medical Research and Development (17lm0203005j0001, 2017); the Center for Advanced Medicine and Clinical Research at Nagoya University (2018); a grant (2018) from the Japan Research Foundation for Clinical Pharmacology, Foundation for Promotion of Cancer Research, Kobayashi Foundation for Cancer Research; and the Mochida Memorial Foundation for Medical and Pharmaceutical Research.	Ambrosi P, 2013, RECENT PAT ANTI-CANC, V8, P38; Bang YJ, 2010, LANCET, V376, P1302; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Calcagno DQ, 2013, WORLD J GASTROENTERO, V19, P1182, DOI 10.3748/wjg.v19.i8.1182; Chen JW, 2019, SURG ONCOL, V31, P46, DOI 10.1016/j.suronc.2019.09.003; Chen ZH, 2015, INT J CLIN EXP MED, V8, P9063; Cheng WL, 2020, J CANCER, V11, P1125, DOI 10.7150/jca.36359; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Ehringer MA, 2007, AM J MED GENET B, V144B, P596, DOI 10.1002/ajmg.b.30464; Gao JF, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0072-1; Ibrahim SM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35254-1; Janjigian YY, 2013, J SURG ONCOL, V107, P237, DOI 10.1002/jso.23263; Kanda M, 2020, MOL THER-NUCL ACIDS, V22, P791, DOI 10.1016/j.omtn.2020.10.001; Kanda M, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01251-0; Kanda M, 2020, GASTRIC CANCER, V23, P203, DOI 10.1007/s10120-019-00995-z; Kanda M, 2018, ONCOGENE, V37, P5355, DOI 10.1038/s41388-018-0335-8; Kanda M, 2018, ANN SURG, V267, P495, DOI 10.1097/SLA.0000000000002096; Kanda M, 2016, INT J CANCER, V138, P721, DOI 10.1002/ijc.29803; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Miwa T, 2021, BRIT J CANCER, V124, P1449, DOI 10.1038/s41416-021-01271-7; Muro K, 2016, LANCET ONCOL, V17, P717, DOI 10.1016/S1470-2045(16)00175-3; Pedersen JE, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-018-1341-8; Perkins KA, 2009, CANCER EPIDEM BIOMAR, V18, P2608, DOI 10.1158/1055-9965.EPI-09-0166; Razzak Mina, 2014, Nat Rev Clin Oncol, V11, P499, DOI 10.1038/nrclinonc.2014.138; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Shen Lin, 2013, Lancet Oncol, V14, pe535, DOI 10.1016/S1470-2045(13)70436-4; Shitara K, 2018, LANCET, V392, P123, DOI 10.1016/S0140-6736(18)31257-1; Smyth EC, 2020, LANCET, V396, P635, DOI 10.1016/S0140-6736(20)31288-5; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Thrift AP, 2020, CLIN GASTROENTEROL H, V18, P534, DOI 10.1016/j.cgh.2019.07.045; Umeda S, 2020, INT J CANCER, V146, P2865, DOI 10.1002/ijc.32705; Vandamme N, 2020, CANCER RES, V80, P2983, DOI 10.1158/0008-5472.CAN-19-2373; Velazquez EJ, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01198-8; Wadhwa R, 2013, NAT REV CLIN ONCOL, V10, P643, DOI 10.1038/nrclinonc.2013.170; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Zahavi D, 2020, ANTIBODIES, V9, DOI 10.3390/antib9030034; Zhang ZW, 2019, J CANCER, V10, P3860, DOI 10.7150/jca.31291; Zhao Rongqing, 2020, Antib Ther, V3, P63, DOI 10.1093/abt/tbaa004	39	4	4	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 9	2021	40	36					5495	5504		10.1038/s41388-021-01945-9	http://dx.doi.org/10.1038/s41388-021-01945-9		JUL 2021	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UO7MC	34331011				2022-12-26	WOS:000679620500001
J	Mackay-Smith, A; Dornon, MK; Lucier, R; Okimoto, A; de Sousa, FM; Rodriguero, M; Confalonieri, V; Lanteri, AA; Sequeira, AS				Mackay-Smith, Ava; Dornon, Mary Kate; Lucier, Rosalind; Okimoto, Anna; Mendonca de Sousa, Flavia; Rodriguero, Marcela; Confalonieri, Viviana; Lanteri, Analia A.; Sequeira, Andrea S.			Host-specific gene expression as a tool for introduction success in Naupactus parthenogenetic weevils	PLOS ONE			English	Article							SPIDER-MITE; PLANT; COLEOPTERA; TRANSCRIPTOME; ADAPTATION; EVOLUTION; INSECTS; CURCULIONIDAE; RESISTANCE; METABOLISM	Food resource access can mediate establishment success in invasive species, and generalist herbivorous insects are thought to rely on mechanisms of transcriptional plasticity to respond to dietary variation. While asexually reproducing invasives typically have low genetic variation, the twofold reproductive capacity of asexual organisms is a marked advantage for colonization. We studied host-related transcriptional acclimation in parthenogenetic, invasive, and polyphagous weevils: Naupactus cervinus and N. leucoloma. We analyzed patterns of gene expression in three gene categories that can mediate weevil-host plant interactions through identification of suitable host plants, short-term acclimation to host plant defenses, and long-term adaptation to host plant defenses and their pathogens. This approach employed comparative transcriptomic methods to investigate differentially expressed host detection, detoxification, immune defense genes, and pathway-level gene set enrichment. Our results show that weevil gene expression responses can be host plant-specific, and that elements of that response can be maintained in the offspring. Some host plant groups, such as legumes, appear to be more taxing as they elicit a complex gene expression response which is both strong in intensity and specific in identity. However, the weevil response to taxing host plants shares many differentially expressed genes with other stressful situations, such as host plant cultivation conditions and transition to novel host, suggesting that there is an evolutionarily favorable shared gene expression regime for responding to different types of stressful situations. Modulating gene expression in the absence of other avenues for phenotypic adaptation may be an important mechanism of successful colonization for these introduced insects.	[Mackay-Smith, Ava; Dornon, Mary Kate; Lucier, Rosalind; Okimoto, Anna; Mendonca de Sousa, Flavia; Sequeira, Andrea S.] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA; [Rodriguero, Marcela; Confalonieri, Viviana] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Lanteri, Analia A.] Univ La Plata, Fac Ciencias Nat & Museo, La Plata, Argentina	Wellesley College; University of Buenos Aires; National University of La Plata; Museo La Plata	Sequeira, AS (corresponding author), Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA.	asequeir@wellesley.edu		Mackay-Smith, Ava/0000-0003-0404-0563; Confalonieri, Viviana Andrea/0000-0003-4499-9816; Okimoto, Annalisa/0000-0002-7761-8867	Wellesley College	Wellesley College	This study was funded by an internal fellowships through Wellesley College (A.S.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2002, AM NAT, V159, P553, DOI 10.1086/339463; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Azaiez A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5247-z; Baker H. G., 1965, The genetics of colonizing species., P147; Banerjee AK, 2019, NEOBIOTA, P77, DOI 10.3897/neobiota.49.33723; Bansal R, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4281-6; Barthel A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0897; Birnbaum SSL., 2019, T GENERATIONAL TRANS, DOI [10.1101/541904v1, DOI 10.1101/541904V1]; Birnbaum SSL, 2020, TRENDS ECOL EVOL, V35, P259, DOI 10.1016/j.tree.2019.10.014; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; C.Robin, 2020, bioRxiv, DOI 10.1101/2020.02.17.951962; Cahenzli F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2856; Celorio-Mancera MD, 2013, MOL ECOL, V22, P4884, DOI 10.1111/mec.12440; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Christodoulides N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176956; Dean JM, 2014, INT J MOL SCI, V15, P1466, DOI 10.3390/ijms15011466; del Rio MG, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10030059; Dermauw W, 2013, P NATL ACAD SCI USA, V110, pE113, DOI 10.1073/pnas.1213214110; Ding TB, 2013, PESTIC BIOCHEM PHYS, V106, P28, DOI 10.1016/j.pestbp.2013.03.009; Dowle M, 2019, **DATA OBJECT**; Frenzel M, 2003, ECOGRAPHY, V26, P723, DOI 10.1111/j.0906-7590.2003.03649.x; Gassmann AJ, 2009, PEST MANAG SCI, V65, P1174, DOI 10.1002/ps.1844; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hafer N, 2011, BIOL LETTERS, V7, P755, DOI 10.1098/rsbl.2011.0139; Hardwick S., 1996, EFFECTS WHITEFRINGED; Hardy NB, 2018, EVOL APPL, V11, P739, DOI 10.1111/eva.12579; Heckel DG, 2014, ANNU PLANT REV, V47, P77, DOI 10.1002/9781118472507.ch3; Hettmansperger TP., 2010, ROBUST NONPARAMETRIC, V2nd; Hocking RR., 1985, ANAL LINEAR MODELS, V1st; Isserlin R., 2014, F1000RES, V3; Jia SZ, 2020, ECOL EVOL, V10, P9682, DOI 10.1002/ece3.6574; Jr FEH, 2020, **DATA OBJECT**; Kassambara A., 2020, **DATA OBJECT**; Kloke JD, 2012, R J, V4, P57, DOI 10.32614/rj-2012-014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lanteri A., 2002, NEOTROP ENTOMOL, V31; Lanteri AA, 2013, NEOTROP ENTOMOL, V42, P325, DOI 10.1007/s13744-013-0127-3; LANTERI AA, 1995, COLEOPTS BULL, V49, P206; LANTERI AA, 1995, ANN ENTOMOL SOC AM, V88, P722, DOI 10.1093/aesa/88.6.722; Lanteri AA, 2017, SYST ENTOMOL, V42, P429, DOI 10.1111/syen.12223; Lee KA, 2004, TRENDS ECOL EVOL, V19, P523, DOI 10.1016/j.tree.2004.07.012; Letourneau DK, 2001, J APPL ECOL, V38, P557, DOI 10.1046/j.1365-2664.2001.00611.x; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JY, 2016, PLANT BIOTECHNOL J, V14, P1956, DOI 10.1111/pbi.12554; Li SS, 2021, COMP BIOCHEM PHYS D, V37, DOI 10.1016/j.cbd.2020.100755; Logan David P., 2008, Journal of Insect Science (Tucson), V8, P1, DOI 10.1673/031.008.5101; Lv XM, 2015, CHEM CENT J, V9, DOI 10.1186/s13065-015-0145-9; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Marvaldi AE, 2002, SYST BIOL, V51, P761, DOI 10.1080/10635150290102465; Meijer K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125607; Mitchell AE, 2007, J AGR FOOD CHEM, V55, P6154, DOI 10.1021/jf070344+; Muller C, 2017, MOL ECOL, V26, P6370, DOI 10.1111/mec.14349; Nasvall K, 2021, MOL ECOL, V30, P499, DOI 10.1111/mec.15745; Neuwirth E., 2014, **DATA OBJECT**; Normark BB, 2011, GENETICA, V139, P551, DOI 10.1007/s10709-010-9513-5; Ohgushi T, 1996, OECOLOGIA, V106, P345, DOI 10.1007/BF00334562; Otasek D, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1758-4; Peel AD, 2008, PHILOS T R SOC B, V363, P1539, DOI 10.1098/rstb.2007.2244; Pineda A, 2010, TRENDS PLANT SCI, V15, P507, DOI 10.1016/j.tplants.2010.05.007; Preite V, 2015, MOL ECOL, V24, P4406, DOI 10.1111/mec.13329; R Core Team, 2021, R LANGUAGE ENV STAT; Reimand J., 2017, BIOINFORMATICS, DOI [10.1101/232835, DOI 10.1101/232835]; Richards CL, 2012, ECOL LETT, V15, P1016, DOI 10.1111/j.1461-0248.2012.01824.x; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rodriguero MS, 2016, ECOL EVOL, V6, P5431, DOI 10.1002/ece3.2180; RStudio, OP SOURC PROF SOFTW; Schoville SD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20154-1; Simon JC, 2015, BRIEF FUNCT GENOMICS, V14, P413, DOI 10.1093/bfgp/elv015; SITES RW, 1988, FLA ENTOMOL, V71, P657, DOI 10.2307/3495025; Smilanich AM, 2011, J CHEM ECOL, V37, P239, DOI 10.1007/s10886-011-9924-5; Snell-Rood EC., 2017, ENCY ANIMAL BEHAV, VSecond, P290; Snoeck S, 2018, G3-GENES GENOM GENET, V8, P3865, DOI 10.1534/g3.118.200585; STANLEYSAMUELSON DW, 1988, ARCH INSECT BIOCHEM, V9, P1, DOI 10.1002/arch.940090102; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JS, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180208; SUOMALAINEN E, 1962, ANNU REV ENTOMOL, V7, P349, DOI 10.1146/annurev.en.07.010162.002025; TARRANT CA, 1989, FLA ENTOMOL, V72, P117, DOI 10.2307/3494976; Tobin Patrick C, 2018, F1000Res, V7, DOI 10.12688/f1000research.15414.1; van Dijk JP, 2012, J AGR FOOD CHEM, V60, P2090, DOI 10.1021/jf204696w; VEPSALAINEN K, 1979, AM ZOOL, V19, P739; Vogel H, 2014, ANNU PLANT REV, V47, P197, DOI 10.1002/9781118472507.ch6; Vogelweith F, 2011, FUNCT ECOL, V25, P1241, DOI 10.1111/j.1365-2435.2011.01911.x; Wang SX, 2017, SCI REP-UK, V7, DOI [10.1038/s41598-017-04692-8, 10.1038/s41598-017-10970-2]; Warnes GR, 2020, **DATA OBJECT**; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Wickham H, 2007, J STAT SOFTW, V21, P1; Wickham SMB, 2014, **DATA OBJECT**; Wink M, 2013, S AFR J BOT, V89, P164, DOI 10.1016/j.sajb.2013.06.006; Wybouw N, 2015, MOL ECOL, V24, P4647, DOI 10.1111/mec.13330; Yoon SA, 2019, OECOLOGIA, V191, P141, DOI 10.1007/s00442-019-04480-3; Zhu F, 2016, SCI REP-UK, V6, DOI 10.1038/srep20421	94	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0248202	10.1371/journal.pone.0248202	http://dx.doi.org/10.1371/journal.pone.0248202			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329290	Green Published, gold			2022-12-26	WOS:000685248600019
J	Shin, N; Saitoh, TM; Nasahara, KN				Shin, Nagai; Saitoh, Taku M.; Nasahara, Kenlo Nishida			How did the characteristics of the growing season change during the past 100 years at a steep river basin in Japan?	PLOS ONE			English	Article							TO-YEAR VARIATION; PHENOLOGICAL MODELS; CLIMATE-CHANGE; LEAF-FALL; TEMPERATURE; DATES; SURFACE; TRENDS; INDEX; POPULATIONS	The effects of climate change on plant phenological events such as flowering, leaf flush, and leaf fall may be greater in steep river basins than at the horizontal scale of countries and continents. This possibility is due to the effect of temperature on plant phenology and the difference between vertical and horizontal gradients in temperature sensitivities. We calculated the dates of the start (SGS) and end of the growing season (EGS) in a steep river basin located in a mountainous region of central Japan over a century timescale by using a degree-day phenological model based on long-term, continuous, in situ observations. We assessed the generality and representativeness of the modelled SGS and EGS dates by using phenological events, live camera images taken at multiple points in the basin, and satellite observations made at a fine spatial resolution. The sensitivity of the modelled SGS and EGS dates to elevation changed from 3.29 days (100 m)(-1) (-5.48 days degrees C-1) and -2.89 days (100 m)(-1) (4.81 days degrees C-1), respectively, in 1900 to 2.85 days (100 m)(-1) (-4.75 days degrees C-1) and -2.84 day (100 m)(-1) (4.73 day degrees C-1) in 2019. The long-term trend of the sensitivity of the modelled SGS date to elevation was -0.0037 day year(-1) per 100 m, but the analogous trend in the case of the modelled EGS date was not significant. Despite the need for further studies to improve the generality and representativeness of the model, the development of degree-day phenology models in multiple, steep river basins will deepen our ecological understanding of the sensitivity of plant phenology to climate change.	[Shin, Nagai] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res Inst Global Change, Earth Surface Syst Res Ctr, Kanazawa Ku, Yokohama, Kanagawa, Japan; [Shin, Nagai; Saitoh, Taku M.] Gifu Univ, River Basin Res Ctr, Gifu, Japan; [Nasahara, Kenlo Nishida] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Gifu University; University of Tsukuba	Shin, N (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res Inst Global Change, Earth Surface Syst Res Ctr, Kanazawa Ku, Yokohama, Kanagawa, Japan.; Shin, N (corresponding author), Gifu Univ, River Basin Res Ctr, Gifu, Japan.	nagais@jamstec.go.jp	Nagai, Shin/G-9902-2011	Nagai, Shin/0000-0003-0957-920X	KAKENHI from the Japan Society for the Promotion of Science [19H03301]	KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	KAKENHI grant (19H03301) from the Japan Society for the Promotion of Science https://www.jsps.go.jp/english/e-grants/index.html.	Akiyama T., 2009, J INTEGR FIELD SCI, V6, P1; Amano T, 2010, P ROY SOC B-BIOL SCI, V277, P2451, DOI 10.1098/rspb.2010.0291; Archetti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057373; Babalova D, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10051497; Basler D, 2016, AGR FOREST METEOROL, V217, P10, DOI 10.1016/j.agrformet.2015.11.007; Chuine I, 2016, GLOBAL CHANGE BIOL, V22, P3444, DOI 10.1111/gcb.13383; Dantec CF, 2014, INT J BIOMETEOROL, V58, P1853, DOI 10.1007/s00484-014-0787-7; Delpierre N, 2009, AGR FOREST METEOROL, V149, P938, DOI 10.1016/j.agrformet.2008.11.014; Doi H, 2008, GLOBAL ECOL BIOGEOGR, V17, P556, DOI 10.1111/j.1466-8238.2008.00398.x; Doi H, 2010, GLOBAL CHANGE BIOL, V16, P373, DOI 10.1111/j.1365-2486.2009.01993.x; Fujimoto S., 2007, Journal of the Japanese Forest Society, V89, P253, DOI 10.4005/jjfs.89.253; Fukuda N., 2012, J JPN AGR SYSTEMS SO, V28, P115; Gao MD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11035-w; Gauzere J, 2020, EVOL LETT, V4, P109, DOI 10.1002/evl3.160; Geospatial Information Authority of Japan, GSI MAPS, P2021; Gill AL, 2015, ANN BOT-LONDON, V116, P875, DOI 10.1093/aob/mcv055; Guyon D, 2011, REMOTE SENS ENVIRON, V115, P615, DOI 10.1016/j.rse.2010.10.006; Hadano M, 2013, ECOL EVOL, V3, P1798, DOI 10.1002/ece3.575; Henneken R, 2013, AGR FOREST METEOROL, V168, P177, DOI 10.1016/j.agrformet.2012.09.001; Ide R, 2013, ECOL INFORM, V16, P25, DOI 10.1016/j.ecoinf.2013.04.003; Inoue T, 2014, ECOL INFORM, V22, P58, DOI 10.1016/j.ecoinf.2014.05.009; Ishihara M., 2008, J JPN AGR SYSTEMS SO, V24, P113; Jochner S, 2016, INT J BIOMETEOROL, V60, P1551, DOI 10.1007/s00484-016-1146-7; Jochner SC, 2012, INT J BIOMETEOROL, V56, P387, DOI 10.1007/s00484-011-0444-3; Kobayashi M., 2000, B IIDA CITY MUS, V10, P81; Kobayashi M., 2000, B IIDA CITY MUS, V10, P65; Kopp CW, 2020, INT J BIOMETEOROL, V64, P873, DOI 10.1007/s00484-020-01877-1; Lang WG, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11131546; Li LH, 2019, SCI TOTAL ENVIRON, V678, P21, DOI 10.1016/j.scitotenv.2019.04.399; Lukasova V, 2019, FORESTS, V10, DOI 10.3390/f10010060; Matsumoto K, 2010, INT J CLIMATOL, V30, P1280, DOI 10.1002/joc.1969; Ministry of Land, 2020, INFR TRANSP TOUR JAP; Miura T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52076-x; Motohka T, 2010, REMOTE SENS-BASEL, V2, P2369, DOI 10.3390/rs2102369; Muraoka H, 2009, J PLANT RES, V122, P3, DOI 10.1007/s10265-008-0188-2; Nagai S., 2018, J REMOTE SENS SOC JP, V38, P99; Nagai S, 2020, POLAR SCI, V25, DOI 10.1016/j.polar.2020.100534; Nagai S, 2020, INT J BIOMETEOROL, V64, P2205, DOI 10.1007/s00484-020-02004-w; Nagai S, 2020, INT J BIOMETEOROL, V64, P1743, DOI 10.1007/s00484-020-01953-6; Nagai S, 2018, ECOL RES, V33, P1091, DOI 10.1007/s11284-018-1633-x; Nagai S, 2015, INT J BIOMETEOROL, V59, P47, DOI 10.1007/s00484-014-0822-8; Nagai S, 2014, INT J REMOTE SENS, V35, P3520, DOI 10.1080/01431161.2014.907937; Nagai S, 2013, SOLA, V9, P106, DOI 10.2151/sola.2013-024; Nagai S, 2011, PLANT ECOL DIVERS, V4, P79, DOI 10.1080/17550874.2011.579188; Nasahara KN, 2008, AGR FOREST METEOROL, V148, P1136, DOI 10.1016/j.agrformet.2008.02.011; Nasahara KN, 2015, ECOL RES, V30, P211, DOI 10.1007/s11284-014-1239-x; Nigrelli G, 2018, THEOR APPL CLIMATOL, V131, P1479, DOI 10.1007/s00704-017-2066-0; Ohtsuka T, 2005, AGR FOREST METEOROL, V134, P27, DOI 10.1016/j.agrformet.2005.11.005; Park CK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174390; Piao SL, 2011, AGR FOREST METEOROL, V151, P1599, DOI 10.1016/j.agrformet.2011.06.016; Richardson AD, 2007, OECOLOGIA, V152, P323, DOI 10.1007/s00442-006-0657-z; Richardson AD, 2019, APPL PLANT SCI, V7, DOI 10.1002/aps3.1228; Saitoh TM, 2015, ECOL RES, V30, P267, DOI 10.1007/s11284-014-1229-z; Schaefer D, 2009, CLIM PAST, V5, P13, DOI 10.5194/cp-5-13-2009; Schuster C, 2014, INT J BIOMETEOROL, V58, P485, DOI 10.1007/s00484-013-0709-0; Schwartz MD., 2003, PHENOLOGY INTEGRATIV; Silva SJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197325; St Peter J, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10101612; Suzuki K., 2018, JPN J MOUNTAIN RES, V1, P1; Tadaki Yoshiya, 1994, Japanese Journal of Ecology (Sendai), V44, P305; Takahashi K, 2014, LANDSC ECOL ENG, V10, P349, DOI 10.1007/s11355-014-0250-2; Thayyen RJ., 2005, BULL GLACIOL RES, V22, P31; The 21st Century COE Program, 2006, ANN REP 21 CENT COE, P441; Ueno K, 2013, J GEOGR-TOKYO, V122, P638, DOI 10.5026/jgeography.122.638; Vitasse Y, 2009, AGR FOREST METEOROL, V149, P735, DOI 10.1016/j.agrformet.2008.10.019; Vrieling A, 2018, REMOTE SENS ENVIRON, V215, P517, DOI 10.1016/j.rse.2018.03.014; Wingate L, 2015, BIOGEOSCIENCES, V12, P5995, DOI 10.5194/bg-12-5995-2015; Xie YY, 2018, AGR FOREST METEOROL, V250, P127, DOI 10.1016/j.agrformet.2017.12.259; Yu R, 2016, INT J BIOMETEOROL, V60, P335, DOI 10.1007/s00484-015-1031-9; Zhu WQ, 2019, INT J BIOMETEOROL, V63, P639, DOI 10.1007/s00484-017-1426-x; Ziello C, 2009, CLIM RES, V39, P227, DOI 10.3354/cr00822	71	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255078	10.1371/journal.pone.0255078	http://dx.doi.org/10.1371/journal.pone.0255078			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34330144	Green Published, gold			2022-12-26	WOS:000685248600038
J	Wagner, BK; Relling, AE; Kieffer, JD; Parker, AJ				Wagner, Brooklyn K.; Relling, Alejandro E.; Kieffer, Justin D.; Parker, Anthony J.			Brief communication: Plasma cortisol concentration is affected by lactation, but not intra-nasal oxytocin treatment, in beef cows	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; STRESS HYPORESPONSIVENESS; BRAIN OXYTOCIN; HPA AXIS; RESPONSES; CORTICOSTERONE; BEHAVIOR; SYSTEM	In mammals, including sheep and mice, lactation attenuates the hypothalamo-pituitary-adrenal axis and plasma cortisol concentration. Oxytocin, one neuropeptide present in the blood during lactation, may contribute to such stress attenuation. Providing oxytocin intra-nasally increases plasma oxytocin concentration in cattle and can be used in non-lactating cows to mirror plasma oxytocin concentration of lactating cows. Therefore, our hypothesis was that there would be no difference in plasma cortisol between non-lactating beef cows intra-nasally administered oxytocin and lactating beef cows intra-nasally treated with saline. Twenty Bos taurus cows were randomly allocated by lactational status to one of four treatments, in a 2x2 factorial arrangement: 1) Non-lactating, saline (NL-S; n = 5); 2) Non-lactating, oxytocin (NL-OXT; n = 5); 3) Lactating, saline (L-S; n = 5); and 4) Lactating, oxytocin (L-OXT; n = 5). Two hours pre-treatment, cows were catheterized, moved to their appropriate chute and baseline blood samples were collected at -60, -45, -30, and 0 minutes before treatments were administered. Directly following the 0-minute sample, cows were administered their intra-nasal treatment via a mucosal atomization device. Subsequently, blood was collected at 2, 4, 6, 8, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, and 120 minutes. Non-lactating cows had greater (P = 0.02) plasma cortisol concentration compared with lactating cows. There was no lactation by treatment interactions for either plasma cortisol (P = 0.55) or oxytocin (P = 0.89) concentration. Although a treatment by time interaction was identified for oxytocin (P < 0.0001), there was no main effect of lactation on plasma oxytocin concentration (P = 0.34). Similar oxytocin and dissimilar cortisol concentration in lactating and non-lactating cows indicate that oxytocin alone cannot be responsible for reduced plasma cortisol in lactating ruminants. Further investigations are needed to elucidate alternative mechanisms that may be involved in the stress hypo-responsive condition of lactating mammals.	[Wagner, Brooklyn K.] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA; [Wagner, Brooklyn K.; Relling, Alejandro E.; Parker, Anthony J.] Ohio State Univ, Dept Anim Sci, Wooster, OH 44691 USA; [Kieffer, Justin D.] Ohio State Univ, Dept Anim Sci, Columbus, OH 43210 USA	University of North Carolina; North Carolina State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Parker, AJ (corresponding author), Ohio State Univ, Dept Anim Sci, Wooster, OH 44691 USA.	parker.1203@osu.edu	Parker, Anthony Joseph/K-7949-2019	Parker, Anthony Joseph/0000-0001-6370-6623; Wagner, Brooklyn/0000-0002-8197-5437				BREMEL RD, 1978, J DAIRY SCI, V61, P1103, DOI 10.3168/jds.S0022-0302(78)83693-5; BRUCKMAIER RM, 1994, J DAIRY RES, V61, P323, DOI 10.1017/S0022029900030740; Carson DS, 2016, BIOL PSYCHIAT, V79, pE53, DOI 10.1016/j.biopsych.2015.08.031; Cook CJ, 1997, J DAIRY RES, V64, P327, DOI 10.1017/S0022029997002240; Ditzen B, 2009, BIOL PSYCHIAT, V65, P728, DOI 10.1016/j.biopsych.2008.10.011; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Lochhead JJ, 2012, ADV DRUG DELIVER REV, V64, P614, DOI 10.1016/j.addr.2011.11.002; Neumann ID, 2000, NEUROSCIENCE, V95, P567; Neumann ID, 2000, J NEUROENDOCRINOL, V12, P235; Parker KJ, 2005, PSYCHONEUROENDOCRINO, V30, P924, DOI 10.1016/j.psyneuen.2005.04.002; Petersson M, 2005, MATURITAS, V51, P426, DOI 10.1016/j.maturitas.2004.10.005; Ralph CR, 2016, DOMEST ANIM ENDOCRIN, V55, P66, DOI 10.1016/j.domaniend.2015.11.003; Rault JL, 2013, PHYSIOL BEHAV, V112, P40, DOI 10.1016/j.physbeh.2013.02.007; Slattery DA, 2008, J PHYSIOL-LONDON, V586, P377, DOI 10.1113/jphysiol.2007.145896; Tilbrook AJ, 2006, ENDOCRINOLOGY, V147, P3501, DOI 10.1210/en.2005-1632; Torner L, 2002, STRESS, V5, P249, DOI 10.1080/1025389021000048638; Toufexis DJ, 1999, J NEUROENDOCRINOL, V11, P757; Verkerk GA, 1998, ANIM WELFARE, V7, P77; Wagner BK, 2020, DOMEST ANIM ENDOCRIN, V71, DOI 10.1016/j.domaniend.2019.106387; Wagner BK, 2020, DOMEST ANIM ENDOCRIN, V70, DOI 10.1016/j.domaniend.2019.07.007; Windle RJ, 1997, ENDOCRINOLOGY, V138, P2829, DOI 10.1210/en.138.7.2829	21	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0249323	10.1371/journal.pone.0249323	http://dx.doi.org/10.1371/journal.pone.0249323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329295	Green Published, gold			2022-12-26	WOS:000685248600005
J	Talukdar, S; Thanachartwet, V; Desakorn, V; Chamnanchanunt, S; Sahassananda, D; Vangveeravong, M; Kalayanarooj, S; Wattanathum, A				Talukdar, Sutopa; Thanachartwet, Vipa; Desakorn, Varunee; Chamnanchanunt, Supat; Sahassananda, Duangjai; Vangveeravong, Mukda; Kalayanarooj, Siripen; Wattanathum, Anan			Predictors of plasma leakage among dengue patients in Thailand: A plasma-leak score analysis	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; INFECTION; VIRUS; ASSOCIATION; BIOMARKER	Delayed plasma leakage recognition could lead to improper fluid administration resulting in dengue shock syndrome, subsequently, multi-organ failure, and death. This prospective observational study was conducted in Bangkok, Thailand, between March 2018 and February 2020 to determine predictors of plasma leakage and develop a plasma leakage predictive score among dengue patients aged >= 15 years. Of 667 confirmed dengue patients, 318 (47.7%) developed plasma leakage, and 349 (52.3%) had no plasma leakage. Multivariate analysis showed three independent factors associated with plasma leakage, including body mass index >= 25.0 kg/m(2) (odds ratio [OR] = 1.784; 95% confidence interval [CI] = 1.040-3.057; P = 0.035), platelet count <100,000/mm(3) on fever days 3 to 4 (OR = 2.151; 95% CI = 1.269-3.647; P = 0.004), and aspartate aminotransferase or alanine aminotransferase >= 100 U/l on fever days 3 to 4 (OR = 2.189; 95% CI = 1.231-3.891; P = 0.008). Because these three parameters had evidence of equality, each independent factor was weighted to give a score of 1 with a total plasma-leak score of 3. Higher scores were associated with increased plasma leakage occurrence, with ORs of 2.017 (95% CI = 1.052-3.869; P = 0.035) for score 1, 6.158 (95% CI = 2.914-13.015; P <0.001) for score 2, and 6.300 (95% CI = 2.419-16.407; P <0.001) for score 3. The area under the receiver operating characteristics curves for predicting plasma leakage was good (0.677 [95% CI = 0.616-0.739]). Patients with a plasma-leak score >= 1 had high sensitivity (88.8%), and those with a plasma-leak score of 3 had high specificity (93.4%) for plasma leakage occurrence. This simple and easily accessible clinical score might help physicians provide early and timely appropriate clinical dengue management in endemic areas.	[Talukdar, Sutopa; Thanachartwet, Vipa; Desakorn, Varunee; Chamnanchanunt, Supat] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Sahassananda, Duangjai] Mahidol Univ, Fac Trop Med, Informat Technol Unit, Bangkok, Thailand; [Vangveeravong, Mukda; Kalayanarooj, Siripen] Minist Publ Hlth, Queen Sirikit Natl Inst Child Hlth, Dept Med Serv, Bangkok, Thailand; [Wattanathum, Anan] Phramongkutklao Hosp, Pulm & Crit Care Div, Dept Med, Bangkok, Thailand	Mahidol University; Mahidol University; Ministry of Public Health - Thailand; Phramongkutklao Hospital	Thanachartwet, V (corresponding author), Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand.	vipa.tha@mahidol.edu		Desakorn, Varunee/0000-0002-6184-072X	Faculty of Tropical Medicine, Mahidol University in Bangkok, Thailand	Faculty of Tropical Medicine, Mahidol University in Bangkok, Thailand	This study was supported by the Faculty of Tropical Medicine, Mahidol University in Bangkok, Thailand. The funding organizations had no role in the study design, data collection, data analysis, decision to publish or writing of the manuscript.	Aung KLL, 2013, SE ASIAN J TROP MED, V44, P602; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Bur R, 2016, UNIVERSA MED, V35, P213, DOI 10.18051/UnivMed.2016.v35.213-221; Chumpu R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226945; Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7; da Silva NS, 2018, ACTA TROP, V177, P25, DOI 10.1016/j.actatropica.2017.09.025; Gallagher P, 2020, J INFECTION, V81, P10, DOI 10.1016/j.jinf.2020.04.039; Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317; Kalayanarooj Siripen, 2011, Trop Med Health, V39, P83, DOI 10.2149/tmh.2011-S10; Korevaar Daniel A, 2014, Evid Based Med, V19, P47, DOI 10.1136/eb-2013-101637; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lee IK, 2020, J MICROBIOL IMMUNOL, V53, P69, DOI 10.1016/j.jmii.2017.12.005; Lee IK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154772; Lin CF, 2001, J MED VIROL, V63, P143, DOI 10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L; Mallhi TH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1141-3; Marianneau P, 1999, J VIROL, V73, P5201, DOI 10.1128/JVI.73.6.5201-5206.1999; Trang NTH, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1498-y; Pang JX, 2017, SCI REP-UK, V7, DOI 10.1038/srep39872; Pang JX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001641; Putnak JR, 2008, AM J TROP MED HYG, V79, P115, DOI 10.4269/ajtmh.2008.79.115; Reynes JM, 2003, J CLIN MICROBIOL, V41, P3864, DOI 10.1128/JCM.41.8.3864-3867.2003; Sangkaew S, 2021, LANCET INFECT DIS, V21, P1014, DOI 10.1016/S1473-3099(20)30601-0; Soundravally R, 2008, PLATELETS, V19, P447, DOI 10.1080/09537100802155284; St John AL, 2013, NAT REV MICROBIOL, V11, P420, DOI 10.1038/nrmicro3030; Suwarto S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1671-3; Tan VPK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200698; Tantawichien T, 2012, PAEDIATR INT CHILD H, V32, P22, DOI 10.1179/2046904712Z.00000000049; Tee H P, 2009, Med J Malaysia, V64, P316; Temprasertrudee S., 2016, OPEN FORUM INFECT DI, V3, P592, DOI [10.1093/ofid/ofw172.455, DOI 10.1093/OFID/OFW172.455]; Thanachartwet V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004961; Thomas L, 2010, J CLIN VIROL, V48, P96, DOI 10.1016/j.jcv.2010.03.008; Tissera H, 2017, J INFECT DIS, V216, P1112, DOI 10.1093/infdis/jix447; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Vorndam V, 2002, AM J TROP MED HYG, V66, P208, DOI 10.4269/ajtmh.2002.66.208; Wang WH, 2020, J MICROBIOL IMMUNOL, V53, P963, DOI 10.1016/j.jmii.2020.03.007; Woon YL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004575; World Health Organization, 2012, GLOB STRAT DENG PREV; World Health Organization ROfS-EA, 2011, COMPR GUID PREV CONT; Zulkipli MS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006263	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255358	10.1371/journal.pone.0255358	http://dx.doi.org/10.1371/journal.pone.0255358			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324559	Green Published, gold			2022-12-26	WOS:000685248200035
J	Heuveline, P				Heuveline, Patrick			The Mean Unfulfilled Lifespan (MUL): A new indicator of the impact of mortality shocks on the individual lifespan, with application to mortality reversals induced by COVID-19	PLOS ONE			English	Article							EXPECTANCY	Declines in period life expectancy at birth (PLEB) provide seemingly intuitive indicators of the impact of a cause of death on the individual lifespan. Derived under the assumption that future mortality conditions will remain indefinitely those observed during a reference period, however, their intuitive interpretation becomes problematic when period conditions reflect a temporary mortality "shock", resulting from a natural disaster or the diffusion of a new epidemic in the population for instance. Rather than to make assumptions about future mortality, I propose measuring the difference between a period average age at death and the average expected age at death of the same individuals (death cohort): the Mean Unfulfilled Lifespan (MUL). For fine-grained tracking of the mortality impact of an epidemic, I also provide an empirical shortcut to MUL estimation for small areas or short periods. For illustration, quarterly MUL values in 2020 are derived from estimates of COVID-19 deaths that might substantially underestimate overall mortality change in affected populations. These results nonetheless illustrate how MUL tracks the mortality impact of the pandemic in several national and sub-national populations. Using a seven-day rolling window, the empirical shortcut suggests MUL peaked at 6.43 years in Lombardy, 8.91 years in New Jersey, and 6.24 years in Mexico City for instance. Sensitivity analyses are presented, but in the case of COVID-19, the main uncertainty remains the potential gap between reported COVID-19 deaths and actual increases in the number of deaths induced by the pandemic in some of the most affected countries. Using actual number of deaths rather than reported COVID-19 deaths may increase seven-day MUL from 6.24 to 8.96 years in Mexico City and from 2.67 to 5.49 years in Lima for instance. In Guayas (Ecuador), MUL is estimated to have reached 12.7 years for the entire month of April 2020.	[Heuveline, Patrick] Univ Calif Los Angeles UCLA, Calif Ctr Populat Res CCPR, Los Angeles, CA 15419 USA	University of California System; University of California Los Angeles	Heuveline, P (corresponding author), Univ Calif Los Angeles UCLA, Calif Ctr Populat Res CCPR, Los Angeles, CA 15419 USA.	heuveline@soc.ucla.edu		Heuveline, Patrick/0000-0001-9503-901X	research environment of the California Center for Population Research at UCLA (CCPR; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [P2C-HD041022]	research environment of the California Center for Population Research at UCLA (CCPR; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The author received no specific funding for this work, but benefited from the research environment of the California Center for Population Research at UCLA (CCPR), which receives core support (P2C-HD041022) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto JM., 2020, QUANTIFYING IMPACTS, DOI [10.1101/2021.03.02.21252772, DOI 10.1101/2021.03.02.21252772]; Ahmad FB, 2021, JAMA-J AM MED ASSOC, V325, P1829, DOI 10.1001/jama.2021.5469; Aragon TJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-116; Arias E., 2020, NATL VITAL STAT REPO, V69; Associacao Nacional dos Registradores de Pessoas Naturais (ARPENBRESIL), ESP COVID 19; Beltran-Sanchez H, 2008, DEMOGR RES, V19, P1323, DOI 10.4054/DemRes.2008.19.35; CDC, CDC WOND; Centers for Disease Control and Prevention, PROV COVID 19 DEATH; DEMPSEY M, 1947, AM REV TUBERC PULM, V56, P157; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; El Instituto Nacional de Estadastica e Informatica (INEI), PER SIT PERSP MORT S; Ghislandi S., 2020, NEWS FRONT ESTIMATIO; Goldstein JR, 2006, POP STUD-J DEMOG, V60, P257, DOI 10.1080/00324720600895876; Goldstein JR, 2020, P NATL ACAD SCI USA, V117, P22035, DOI 10.1073/pnas.2006392117; Guilmoto, 2020, COVID 19 DEATH RATES, DOI DOI 10.1101/2020.05.17.20097410; Hanlon Peter, 2020, Wellcome Open Res, V5, P75, DOI 10.12688/wellcomeopenres.15849.1; Heuveline P, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-042934; Ho JY, 2017, DEMOGRAPHY, V54, P1175, DOI 10.1007/s13524-017-0565-3; Ho T, 2017, DEMOGR RES, V37, P1445, DOI [10.4054/DemRes.2017.37.45, 10.4054/demres.2017.37.45]; Instituto Nacional de Estadistica y Geografia (INEGI), POBLACION; Istituto Nazionale di Statistica (Istat), LIFE TABLES; Karlinsky Ariel, 2021, medRxiv, DOI 10.1101/2021.01.27.21250604; KEYFITZ N, 1977, DEMOGRAPHY, V14, P411, DOI 10.2307/2060587; Kontis V, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1112-0; MARLOW AK, 1995, J EPIDEMIOL COMMUN H, V49, P320, DOI 10.1136/jech.49.3.320; Mitra AK, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124392; Modig K, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035932; National Institute for Public Health and the Environment, WEEKL COR SARS COV 2; O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0; OECD, 2021, POT YEARS LIF LOST I, DOI [10.1787/193a2829-en, DOI 10.1787/193A2829-EN]; Ohnishi A, 2020, PROG THEOR EXP PHYS, V2020, DOI 10.1093/ptep/ptaa148; Partida Bush VG., 2018, PROYECCIONES POBLACI; Arolas HPI, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83040-3; Preston S., 2000, DEMOGRAPHY MEASURING; Ramis H., 1993, GRONDHOG DAY; Riffe T., COVERAGE DB DATABASE; Sahoo U., 2020, IMPACT COVID 19 ATTR, DOI [10.1101/2020.07.06.20147009, DOI 10.1101/2020.07.06.20147009]; Trias-Llimos S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241952; United Nations. Department of Economic and Social Affairs Population Dynamics, WORLD POPULATION PRO; United States Census Bureau, EXPL CENS DAT; Wetzler HP., 2020, MANY YEARS LIFE LOST, DOI [10.1101/2020.06.08.20050559, DOI 10.1101/2020.06.08.20050559]	42	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0254925	10.1371/journal.pone.0254925	http://dx.doi.org/10.1371/journal.pone.0254925			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TU	34314459	Green Published, gold			2022-12-26	WOS:000685225200024
J	Popovic, N; Vujosevic, S; Radunovic, M; Radunovic, M; Popovic, T				Popovic, Natasa; Vujosevic, Stela; Radunovic, Miroslav; Radunovic, Miodrag; Popovic, Tomo			TREND database: Retinal images of healthy young subjects visualized by a portable digital non-mydriatic fundus camera	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; CARDIOVASCULAR EVENTS; FRACTAL DIMENSION; RISK; HYPERTENSION	Topological characterization of the Retinal microvascular nEtwork visualized by portable fuNDus camera (TREND) is a database comprising of 72 color digital retinal images collected from the students of the Faculty of Medicine at the University of Montenegro, in the period from February 18(th) to March 11(th) 2020. The database also includes binarized images of manually segmented microvascular networks associated with each raw image. The participant demographic characteristics, health status, and social habits information such as age, sex, body mass index, smoking history, alcohol use, as well as previous medical history was collected. As proof of the concept, a smaller set of 10 color digital fundus images from healthy older participants is also included. Comparison of the microvascular parameters of these two sets of images demonstrate that digital fundus images recorded with a hand-held portable camera are able to capture the changes in patterns of microvascular network associated with aging. The raw images from the TREND database provide a standard that defines normal retinal anatomy and microvascular network geometry in young healthy people in Montenegro as it is seen with the digital hand-held portable non-mydriatic MiiS HORUS Scope DEC 200.This knowledge could facilitate the application of this technology at the primary level of health care for large scale telematic screening for complications of chronic diseases, such as hypertensive and diabetic retinopathy. In addition, it could aid in the development of new methods for early detection of age-related changes in the retina, systemic chronic diseases, as well as eye-specific diseases. The associated manually segmented images of the microvascular networks provide the standard that can be used for development of automatic software for image quality assessment, segmentation of microvascular network, and for computer-aided detection of pathological changes in retina. The TREND database is freely available at https://doi.org/10.5281/zenodo.4521043.	[Popovic, Natasa; Radunovic, Miroslav; Radunovic, Miodrag] Univ Montenegro, Fac Med, Podgorica, Montenegro; [Vujosevic, Stela] IRCCS MultiMed, Eye Clin, Milan, Italy; [Popovic, Tomo] Univ Donja Gorica, Fac Informat Syst & Technol, Podgorica, Montenegro	University of Montenegro; IRCCS Multimedica; University of Donja Gorica	Popovic, N (corresponding author), Univ Montenegro, Fac Med, Podgorica, Montenegro.	npopovic@ucg.ac.me	Popovic, Tomo/V-1550-2017; Popovic, Natasa/V-1717-2017	Popovic, Tomo/0000-0001-5245-3691; Popovic, Natasa/0000-0002-9769-1543; Vujosevic, Stela/0000-0001-6773-9967	Ministry of Science of Montenegro [01-781/2]	Ministry of Science of Montenegro	The research is funded by the scientific research project DEMONSTRATE, through the grant awarded by the Ministry of Science of Montenegro, Grant Agreement No. 01-781/2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownrigg JRW, 2016, LANCET DIABETES ENDO, V4, P588, DOI 10.1016/S2213-8587(16)30057-2; DeBuc DC, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.570412; Cheung CY, 2012, AM J OPHTHALMOL, V154, P663, DOI 10.1016/j.ajo.2012.04.016; Cheung CY, 2011, J HYPERTENS, V29, P1380, DOI 10.1097/HJH.0b013e328347266c; De Maeseneer Jan M, 2004, Ann Fam Med, V2 Suppl 2, pS17, DOI 10.1370/afm.148; Decenciere E, 2014, IMAGE ANAL STEREOL, V33, P231, DOI 10.5566/ias.1155; Fleming AD, 2006, INVEST OPHTH VIS SCI, V47, P1120, DOI 10.1167/iovs.05-1155; Franceschi C, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00061; Hall JE, 2020, GUYTON HALL TXB MED; Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3; Jin K, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0484-5; Kauppi T, 2021, P BRIT MACH VIS C 20; Kramer CK, 2011, DIABETES CARE, V34, P1238, DOI 10.2337/dc11-0079; Li M, 2017, AM J OPHTHALMOL, V174, P56, DOI 10.1016/j.ajo.2016.10.018; Lin Y, 2019, INVEST OPHTH VIS SCI, V60, P685, DOI 10.1167/iovs.18-25864; Liu GD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16675-w; Manresa JM, 2020, ATEN PRIM, V52, P410, DOI 10.1016/j.aprim.2019.06.005; Odstrcilik J, 2013, IET IMAGE PROCESS, V7, P373, DOI 10.1049/iet-ipr.2012.0455; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Popovic N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52659-8; Popovic N, 2019, MICROCIRCULATION, V26, DOI 10.1111/micc.12531; Popovic N, 2018, DATA BRIEF, V18, P470, DOI 10.1016/j.dib.2018.03.041; Popovic N, 2018, MICROVASC RES, V118, P36, DOI 10.1016/j.mvr.2018.02.006; Refractive Errors | National Eye Institute, 2021, REFR ERR; Rim TH, 2020, J NEURO-OPHTHALMOL, V40, P44, DOI 10.1097/WNO.0000000000000888; S3-Leitlinie Extracranielle Carotisstenose, 2010, GEFASSCHIRURGIE, V17, P495; Sehgel NL, 2015, HYPERTENSION, V65, P370, DOI 10.1161/HYPERTENSIONAHA.114.04456; Sevik U, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.4.046006; Van Craenendonck T, 2021, ACTA OPHTHALMOL, V99, pE368, DOI 10.1111/aos.14598; Vazquez Dorrego X M, 2016, Arch Soc Esp Oftalmol, V91, P513, DOI 10.1016/j.oftal.2016.05.001; Vujosevic S, 2020, LANCET DIABETES ENDO, V8, P337, DOI 10.1016/S2213-8587(19)30411-5; Vujosevic S, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/3627465; Wang SZ, 2016, IEEE T MED IMAGING, V35, P1046, DOI 10.1109/TMI.2015.2506902; Yogesan K, 2000, TELEMED J, V6, P219, DOI 10.1089/107830200415153; Zhu PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106551; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	36	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254918	10.1371/journal.pone.0254918	http://dx.doi.org/10.1371/journal.pone.0254918			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297749	Green Published, gold			2022-12-26	WOS:000678128300001
J	Thalinger, B; Putz, Y; Traugott, M				Thalinger, Bettina; Putz, Yannick; Traugott, Michael			Endpoint PCR coupled with capillary electrophoresis (celPCR) provides sensitive and quantitative measures of environmental DNA in singleplex and multiplex reactions	PLOS ONE			English	Article							REAL-TIME PCR; PISCIVOROUS BIRDS; DIGITAL PCR; IDENTIFICATION; EDNA; QUANTIFICATION; BIODIVERSITY; TOOLS	The use of sensitive methods is key for the detection of target taxa from trace amounts of environmental DNA (eDNA) in a sample. In this context, digital PCR (dPCR) enables direct quantification and is commonly perceived as more sensitive than endpoint PCR. However, endpoint PCR coupled with capillary electrophoresis (celPCR) potentially embodies a viable alternative as it quantitatively measures signal strength after PCR in Relative Fluorescence Units (RFU). Provided comparable levels of sensitivity are reached, celPCR permits the development of cost-efficient multiplex reactions, enabling the simultaneous detection of several target taxa. Here, we compared the sensitivity of singleplex and multiplex celPCR to dPCR for species-specific primer pairs amplifying mitochondrial DNA (COI) of fish species occurring in European freshwaters by analyzing dilution series of tissue extracts as well as field-collected water samples. Both singleplex and multiplex celPCR and dPCR displayed comparable sensitivity with reliable positive amplifications starting at two to 10 target DNA copies per mu l extract. celPCR was suitable for quantifying target DNA and direct inference of copy numbers from RFU was possible after accounting for primer effects in linear mixed-effects models and calibration via dPCR. Furthermore, multiplex celPCR and dPCR were successfully used for the detection and quantification of fish-eDNA in field-collected water samples, confirming the results of the dilution series experiment and exemplifying the high sensitivity of the two approaches. The possibility of detection and quantification via multiplex celPCR is appealing for the cost-efficient screening of high sample numbers. The present results confirm the sensitivity of this approach thus enabling its application for future eDNA-based monitoring efforts.	[Thalinger, Bettina; Putz, Yannick; Traugott, Michael] Univ Innsbruck, Dept Zool, Innsbruck, Austria; [Thalinger, Bettina] Univ Guelph, Ctr Biodivers Genom, Guelph, ON, Canada; [Thalinger, Bettina] Univ Guelph, Coll Biol Sci, Dept Integrat Biol, Guelph, ON, Canada; [Traugott, Michael] Sinsoma GmbH, Lannes 6, Vols, Austria	University of Innsbruck; University of Guelph; University of Guelph	Thalinger, B (corresponding author), Univ Innsbruck, Dept Zool, Innsbruck, Austria.; Thalinger, B (corresponding author), Univ Guelph, Ctr Biodivers Genom, Guelph, ON, Canada.; Thalinger, B (corresponding author), Univ Guelph, Coll Biol Sci, Dept Integrat Biol, Guelph, ON, Canada.	bettina.thalinger@gmail.com	Thalinger, Bettina/AAF-3956-2019	Thalinger, Bettina/0000-0001-9315-8648; Putz, Yannick/0000-0001-5569-954X	Austria Research Promotion Agency (FFG) [853219]; University of Innsbruck	Austria Research Promotion Agency (FFG); University of Innsbruck	This research was funded by the Austria Research Promotion Agency (FFG; project number 853219 awarded to MT). The funder provided support in the form of budget for research materials and salary for BT but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of BT is articulated in the `author contributions' section. The commercial affiliation of MT did not play a role in this study, and Sinsoma GmbH did not provide any financial support in the form of salaries or material; this affiliation was only added to guarantee maximum transparency. This open access publication was co-funded by the University of Innsbruck.	Agersnap S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179261; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; Baker CS, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00133; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beckmann A, 1998, J CHROMATOGR B, V710, P75, DOI 10.1016/S0378-4347(98)00135-2; Bio-Rad, 2016, RAR MUT DET BEST PRA; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Boothroyd M, 2016, AQUAT CONSERV, V26, P1107, DOI 10.1002/aqc.2617; Burns MJ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-31; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; BUTLER JM, 1994, J CHROMATOGR B, V658, P271, DOI 10.1016/0378-4347(94)00238-X; Chatterjee N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042063; CHEVET E, 1995, NUCLEIC ACIDS RES, V23, P3343, DOI 10.1093/nar/23.16.3343; Cilleros K, 2019, MOL ECOL RESOUR, V19, P27, DOI 10.1111/1755-0998.12900; Clusa L, 2018, AQUAT CONSERV, V28, P619, DOI 10.1002/aqc.2890; Deiner K, 2017, MOL ECOL, V26, P5872, DOI 10.1111/mec.14350; Deprez Liesbet, 2016, Biomol Detect Quantif, V9, P29, DOI 10.1016/j.bdq.2016.08.002; Doi H, 2015, ENVIRON SCI TECHNOL, V49, P5601, DOI 10.1021/acs.est.5b00253; Doi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122763; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Handley LL., 2019, ENV DNA, V1, P26, DOI [10.1002/edn3.5, DOI 10.1002/EDN3.5]; Harper LR, 2019, HYDROBIOLOGIA, V826, P25, DOI 10.1007/s10750-018-3750-5; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hunter ME, 2017, MOL ECOL RESOUR, V17, P221, DOI 10.1111/1755-0998.12619; Juen A, 2006, SOIL BIOL BIOCHEM, V38, P1872, DOI 10.1016/j.soilbio.2005.11.034; Kelly RA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42799-2; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Kiselinova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085999; Klymus K.E., 2020, ENV DNA, V2, P271, DOI [10.1002/edn3.29, DOI 10.1002/EDN3.29]; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; MacDonald AJ, 2017, MOL ECOL RESOUR, V17, P708, DOI 10.1111/1755-0998.12618; Masseret E, 2010, ENV MICROBIOL REP, V2, P715, DOI 10.1111/j.1758-2229.2010.00164.x; Mauvisseau Q, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50571-9; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Oehm J, 2017, ECOL EVOL, V7, P1984, DOI 10.1002/ece3.2790; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; R Core Team, 2020, R LANG ENV STAT COMP; Rees HC, 2014, ECOL EVOL, V4, P4023, DOI 10.1002/ece3.1272; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Rennstam Rubbmark O, 2019, MOL ECOL RESOUR, V19, P388, DOI 10.1111/1755-0998.12974; Schmelzle MC, 2016, MOL ECOL RESOUR, V16, P895, DOI 10.1111/1755-0998.12501; Sepulveda AJ, 2020, TRENDS ECOL EVOL, V35, P668, DOI 10.1016/j.tree.2020.03.011; Sint D, 2019, MOL ECOL, V28, P336, DOI 10.1111/mec.14839; Sint D, 2012, METHODS ECOL EVOL, V3, P898, DOI 10.1111/j.2041-210X.2012.00215.x; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Thalinger B., 2021, ENV DNA, V3, P305, DOI [10.1002/edn3.171, DOI 10.1002/EDN3.171]; Thalinger B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51398-0; Thalinger B, 2018, ECOL EVOL, V8, P8985, DOI 10.1002/ece3.4421; Thalinger B, 2016, MOL ECOL RESOUR, V16, P123, DOI 10.1111/1755-0998.12436; Turner CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114329; Whale Alexandra S, 2016, Biomol Detect Quantif, V10, P15; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilcox T.M., 2020, ENV DNA, V2, P544, DOI [10.1002/edn3.80, DOI 10.1002/EDN3.80]; Wilcox TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142008; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951	62	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254356	10.1371/journal.pone.0254356	http://dx.doi.org/10.1371/journal.pone.0254356			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297715	Green Published, Green Submitted, gold			2022-12-26	WOS:000678128300026
J	Ferrieres, J; Banks, V; Pillas, D; Giorgianni, F; Gantzer, L; Lekens, B; Ricci, L; Dova-Boivin, M; Chauny, JV; Villa, G; Desamericq, G				Ferrieres, Jean; Banks, Victoria; Pillas, Demetris; Giorgianni, Francesco; Gantzer, Laurene; Lekens, Beranger; Ricci, Lea; Dova-Boivin, Margaux; Chauny, Jean-Vannak; Villa, Guillermo; Desamericq, Gaelle			Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study	PLOS ONE			English	Article							HIGH-CARDIOVASCULAR-RISK; PREVALENCE; DISEASE; POPULATION; DIAGNOSIS; MANAGEMENT; MORTALITY; GUIDANCE; THERAPY; SOCIETY	Background and aims Untreated Familial Hypercholesterolemia (FH) leads to premature morbidity and mortality. In France, its epidemiology and management are understudied in ambulatory care. We described the clinical profile, pharmacological management, and clinical outcomes in a French sample of FH patients. Methods This was a retrospective longitudinal study on patients from The Health Improvement Network (THIN(R)) database in France, between October 2016-June 2019. Patients >= 18 years, with probable/definite FH based on the Dutch Lipid Clinic Network (DLCN) criteria were included. Baseline characteristics, lipid profile, lipid-lowering therapy (LLT), low-density lipoprotein-cholesterol (LDL-C) goal achievement; and disease management at 6-month of follow-up were analyzed. Results 116 patients with probable (n = 70)/definite (n = 46) FH were included (mean age:57.8 +/- 14.0 years; 56.0% women; 9.5% with personal history of cardiovascular events); 90 patients had data available at follow-up. At baseline, 77.6% of patients had LDL-C>190 mg/dL, 27.6% were not receiving LLTs, 37.9% received statins alone, 20.7% statins with other LLTs, and 7.7% other LLTs. High-intensity statins were prescribed to 11.2% of patients, 30.2% received moderate-intensity statins, and 8.6% low-intensity statins. Only 6.0% of patients achieved LDL-C goal. At 6-month of follow-up, statins discontinuation and switching were 22.7% and 2.3%, respectively. None of the patients received proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors at baseline nor follow-up. Conclusions Despite the existence of effective LLTs, FH patients are suboptimally-treated, do not achieve LDL-C goal, and exhibit worsened pharmacological management over time. Future studies with longer follow-up periods and assessment of factors affecting LDL-C management, including lifestyle and diet, are needed.	[Ferrieres, Jean] Toulouse Rangueil Univ Hosp, Dept Cardiol, Toulouse, France; [Ferrieres, Jean] Toulouse Rangueil Univ Hosp, INSERM, UMR 1295, Toulouse, France; [Banks, Victoria; Pillas, Demetris; Giorgianni, Francesco] Amgen UK Ltd, Uxbridge, Middx, England; [Gantzer, Laurene; Lekens, Beranger] GERS SAS, Boulogne, France; [Ricci, Lea; Dova-Boivin, Margaux; Chauny, Jean-Vannak; Desamericq, Gaelle] Amgen France SAS, Boulogne, France; [Villa, Guillermo] Amgen Europe GmbH, Rotkreuz, Switzerland	CHU de Toulouse; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Amgen; Amgen Limited; Amgen; AMGEN Europe	Ferrieres, J (corresponding author), Toulouse Rangueil Univ Hosp, Dept Cardiol, Toulouse, France.; Ferrieres, J (corresponding author), Toulouse Rangueil Univ Hosp, INSERM, UMR 1295, Toulouse, France.	jean.ferrieres@univ-tlse3.fr	Ferrieres, Jean/S-7993-2016	Ferrieres, Jean/0000-0001-6144-1297; Banks, Victoria/0000-0002-0087-7641	Amgen	Amgen(Amgen)	This study was funded by Amgen.	Akioyamen LE, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016461; Allard MD, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-65; Alonso R, 2020, VASC HEALTH RISK MAN, V16, P11, DOI 10.2147/VHRM.S192401; Beheshti SO, 2020, J AM COLL CARDIOL, V75, P2553, DOI 10.1016/j.jacc.2020.03.057; Beliard S, 2018, ATHEROSCLEROSIS, V277, P334, DOI 10.1016/j.atherosclerosis.2018.08.010; Beliard S, 2016, J CLIN LIPIDOL, V10, P1129, DOI 10.1016/j.jacl.2016.06.007; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; Benner JS, 2004, PHARMACOECONOMICS, V22, P13, DOI 10.2165/00019053-200422003-00003; Berard E, 2019, CAN J CARDIOL, V35, P744, DOI 10.1016/j.cjca.2019.02.013; Bianconi V, 2020, TRENDS CARDIOVASC ME; Catapano AL, 2016, ATHEROSCLEROSIS, V252, P1, DOI 10.1016/j.atherosclerosis.2016.07.007; Civeira F, 2008, AM J CARDIOL, V102, P1187, DOI 10.1016/j.amjcard.2008.06.056; Claassen L, 2010, J HEALTH PSYCHOL, V15, P33, DOI 10.1177/1359105309345170; De Backer G, 2015, ATHEROSCLEROSIS, V241, P169, DOI 10.1016/j.atherosclerosis.2015.04.809; Farnier M, 2013, PRESSE MED, V42, P930, DOI 10.1016/j.lpm.2013.01.053; Ferrieres J, 2018, Ann Cardiol Angeiol (Paris), V67, P1, DOI 10.1016/j.ancard.2017.04.015; Ferrieres J, 2016, EUR HEART J, V37, P11; Ferrieres J, 2019, ARCH CARDIOVASC DIS, V112, P75, DOI 10.1016/j.acvd.2018.11.007; Galema-Boers JMH, 2014, EUR J CLIN PHARMACOL, V70, P391, DOI 10.1007/s00228-013-1640-3; Gidding SS, 2015, CIRCULATION, V132, P2167, DOI 10.1161/CIR.0000000000000297; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Goldberg AC, 2011, J CLIN LIPIDOL, V5, pS1, DOI 10.1016/j.jacl.2011.04.003; Green P, 2016, J EVAL CLIN PRACT, V22, P341, DOI 10.1111/jep.12481; Guglielmi V, 2016, INT J CARDIOL, V223, P701, DOI 10.1016/j.ijcard.2016.08.269; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Hu PW, 2020, CIRCULATION, V141, P1742, DOI 10.1161/CIRCULATIONAHA.119.044795; Huijgen Roeland, 2008, Expert Rev Cardiovasc Ther, V6, P567, DOI 10.1586/14779072.6.4.567; Khera AV, 2016, J AM COLL CARDIOL, V67, P2578, DOI 10.1016/j.jacc.2016.03.520; Kim YS, 2002, PHARMACOEPIDEM DR S, V11, P593, DOI 10.1002/pds.730; Kirke AB, 2015, HEART LUNG CIRC, V24, P250, DOI 10.1016/j.hlc.2014.09.011; Kruse G, 2017, VALUE HEALTH, V20, pA606, DOI 10.1016/j.jval.2017.08.1176; Kuiper JG, 2017, CLIN THER, V39, P819, DOI 10.1016/j.clinthera.2017.03.001; Mach F, 2019, ATHEROSCLEROSIS, V290, P140, DOI [10.1016/j.atherosclerosis.2019.08.014, 10.1093/eurheartj/ehz455]; Mata N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-94; McGowan MP, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013225; Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; de Isla LP, 2017, CIRCULATION, V135, P2133, DOI 10.1161/CIRCULATIONAHA.116.024541; de Isla LP, 2016, ARTERIOSCL THROM VAS, V36, P2004, DOI 10.1161/ATVBAHA.116.307514; Rabes JP, 2018, CURR OPIN LIPIDOL, V29, P65, DOI 10.1097/MOL.0000000000000496; Seguro F, 2018, CLIN CARDIOL, V41, P385, DOI 10.1002/clc.22881; Seguro F, 2015, ARCH CARDIOVASC DIS, V108, P511, DOI 10.1016/j.acvd.2015.04.003; Stock J, 2019, ATHEROSCLEROSIS, V290, P138, DOI 10.1016/j.atherosclerosis.2019.09.015; Umans-Eckenhausen MAW, 2001, LANCET, V357, P165, DOI 10.1016/S0140-6736(00)03587-X; Vallejo-Vaz AJ, 2018, ATHEROSCLEROSIS, V277, P234, DOI 10.1016/j.atherosclerosis.2018.08.051; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; Villa G, 2017, EUR HEART J-QUAL CAR, V3, P274, DOI 10.1093/ehjqcco/qcx011; Vinogradova Y, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3305; Weng SF, 2015, ATHEROSCLEROSIS, V238, P336, DOI 10.1016/j.atherosclerosis.2014.12.034; Wilemon KA, 2020, JAMA CARDIOL, V5, P217, DOI 10.1001/jamacardio.2019.5173	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255345	10.1371/journal.pone.0255345	http://dx.doi.org/10.1371/journal.pone.0255345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339471	Green Published, gold			2022-12-26	WOS:000680243400057
J	Seidu, AA; Ahinkorah, BO; Kissah-Korsah, K; Agbaglo, E; Dadzie, LK; Ameyaw, EK; Budu, E; Hagan, JE				Seidu, Abdul-Aziz; Ahinkorah, Bright Opoku; Kissah-Korsah, Kwaku; Agbaglo, Ebenezer; Dadzie, Louis Kobina; Ameyaw, Edward Kwabena; Budu, Eugene; Hagan, John Elvis, Jr.			A multilevel analysis of individual and contextual factors associated with the practice of safe disposal of children's faeces in sub-Saharan Africa	PLOS ONE			English	Article							SANITATION; HYGIENE; DIARRHEA; WATER; MANAGEMENT; DISEASE; IMPACT; CARE	Background Over the years, sanitation programs over the world have focused more on household sanitation, with limited attention towards the disposal of children's stools. This lack of attention could be due to the misconception that children's stools are harmless. The current study examined the individual and contextual predictors of safe disposal of children's faeces among women in sub-Saharan Africa (SSA). Methods The study used secondary data involving 128,096 mother-child pairs of under-five children from the current Demographic and Health Surveys (DHS) in 15 sub-Saharan African countries from 2015 to 2018. Multilevel logistic analysis was used to assess the individual and contextual factors associated with the practice of safe disposal of children's faeces. We presented the results as adjusted odds ratios (aOR) at a statistical significance of p< 0.05. Results The results show that 58.73% (57.79-59.68) of childbearing women in the 15 countries in SSA included in our study safely disposed off their children's stools. This varied from as high as 85.90% (84.57-87.14) in Rwanda to as low as 26.38% (24.01-28.91) in Chad. At the individual level, the practice of safe disposal of children's stools was more likely to occur among children aged 1, compared to those aged 0 [aOR = 1.74; 95% CI: 1.68-1.80] and those with diarrhoea compared to those without diarrhoea [aOR = 1.17, 95% CI: 1.13-1.21]. Mothers with primary level of education [aOR = 1.42, 95% CI: 1.30-1.5], those aged 35-39 [aOR = 1.20, 95% CI: 1.12-1.28], and those exposed to radio [aOR = 1.23, 95% CI: 1.20-1.27] were more likely to practice safe disposal of children's stools. Conversely, the odds of safe disposal of children's stool were lower among mothers who were married [aOR = 0.74, 95% CI: 0.69-0.80] and those who belonged to the Traditional African Religion [aOR = 0.64, 95% CI: 0.51-0.80]. With the contextual factors, women with improved water [aOR = 1.13, 95% CI: 1.10-1.16] and improved toilet facility [aOR = 5.75 95% CI: 5.55-5.95] had higher odds of safe disposal of children's stool. On the other hand, mothers who lived in households with 5 or more children [aOR = 0.89, 95% CI: 0.86-0.93], those in rural areas [aOR = 0.86, 95% CI: 0.82-0.89], and those who lived in Central Africa [aOR = 0.19, 95% CI: 0.18-0.21] were less likely to practice safe disposal of children's stools. Conclusion The findings indicate that between- and within-country contextual variations and commonalities need to be acknowledged in designing interventions to enhance safe disposal of children's faeces. Audio-visual education on safe faecal disposal among rural women and large households can help enhance safe disposal. In light of the strong association between safe stool disposal and improved latrine use in SSA, governments need to develop feasible and cost-effective strategies to increase the number of households with access to improved toilet facilities.	[Seidu, Abdul-Aziz; Kissah-Korsah, Kwaku; Dadzie, Louis Kobina; Budu, Eugene] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana; [Seidu, Abdul-Aziz] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Ahinkorah, Bright Opoku; Ameyaw, Edward Kwabena] Univ Technol Sydney, Fac Hlth, Australian Ctr Publ & Populat Hlth Res, Sydney, NSW, Australia; [Agbaglo, Ebenezer] Univ Cape Coast, Dept English, Cape Coast, Ghana; [Hagan, John Elvis, Jr.] Bielefeld Univ, Fac Psychol & Sport Sci, Neurocognit & Actio Biomechan Res Grp, Bielefeld, Germany; [Hagan, John Elvis, Jr.] Univ Cape Coast, Dept Hlth Phys Educ & Recreat, Cape Coast, Ghana	University of Cape Coast; James Cook University; University of Technology Sydney; University of Cape Coast; University of Bielefeld; University of Cape Coast	Seidu, AA (corresponding author), Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana.; Seidu, AA (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia.	abdul-aziz.seidu@stu.ucc.edu.gh		Hagan Jnr., Dr. John Elvis/0000-0003-3530-6133; Seidu, Abdul-Aziz/0000-0001-9734-9054; Ameyaw, Edward Kwabena/0000-0002-6617-237X				Aliyu Alhaji A, 2019, Niger Med J, V60, P198, DOI 10.4103/nmj.NMJ_3_19; Aluko OO, 2017, BMC PUBLIC HEALTH, V17, DOI [10.1186/s12889-017-4078-1, 10.1186/s12889-017-4078-1`]; [Anonymous], 2018, COR QUESTL DRINK WAT; Austin PC, 2017, INT STAT REV, V85, P185, DOI 10.1111/insr.12214; Azage M, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0090-z; Bauza V, 2019, AM J TROP MED HYG, V100, P1013, DOI 10.4269/ajtmh.18-0840; Bawankule R, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3948-2; Begum HA, 2013, ASIA-PAC J PUBLIC HE, V25, P345, DOI 10.1177/1010539511420132; Brown J, 2013, ARCH DIS CHILD, V98, P629, DOI 10.1136/archdischild-2011-301528; Carlson MDA, 2009, J PALLIAT MED, V12, P77, DOI 10.1089/jpm.2008.9690; Cooke ML, 2010, S AFR J CLIN NUTR, pS42; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; CURTIS V, 1995, SOC SCI MED, V41, P383, DOI 10.1016/0277-9536(94)00341-P; Demberere T, 2016, PHYS CHEM EARTH, V92, P119, DOI 10.1016/j.pce.2015.09.013; Freeman MC, 2017, INT J HYG ENVIR HEAL, V220, P928, DOI 10.1016/j.ijheh.2017.05.007; Gelman A., 2007, DATA ANAL USING REGR; Gil A., 2004, CHILDRENS FECES DISP; Halder AK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-545; Hatt LE, 2006, SOC SCI MED, V62, P375, DOI 10.1016/j.socscimed.2005.06.007; Hutton G, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060536; Islam M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195218; Jain N., 2011, GETTING AFRICA MEET; Majorin F, 2019, T ROY SOC TROP MED H, V113, P263, DOI 10.1093/trstmh/try142; Majorin F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089551; Merlo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153778; Miller-Petrie MK, 2016, AM J TROP MED HYG, V94, P456, DOI 10.4269/ajtmh.15-0423; Modebe IA., 2015, URJMMS, V3; Mwambete K D, 2010, Tanzan J Health Res, V12, P47; Nel ED, 2010, S AFR J CLIN NUTR, pS15; Nkoka O, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08725-2; Phaswana-Mafuya Nancy, 2005, Afr Health Sci, V5, P21; Pickering AJ, 2015, LANCET GLOB HEALTH, V3, pE701, DOI 10.1016/S2214-109X(15)00144-8; Ps Preeti, 2016, J Prev Med Public Health, V49, P323; Robinson A., 2009, SUSTAINABILITY EQUIT; Sahiledengle B, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08945-6; Sahiledengle B, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7325-9; Seidu AA, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10155-7; Seidu AA, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2792-7; Siziya S, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-8; Solanke BL, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2074-9; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; United Nations-Water Decade Programme on Advocacy and Communication and WSSCC, HUMAN RIGHT WAT SAN; Vyas S, 2018, J DEV STUD, V54, P2119, DOI 10.1080/00220388.2018.1469742; WHO, 2019, FACT SHE DRINK WAT; WHO, 2020, FACT SHE SAN REV 20; WHO, 2018, GUID SAN HLTH; WHO/UNICEF, 2017, PROGR DRINKING WATER; Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331; World Bank Unicef., 2014, CHILD FEC DISP MAL; World Bank Unicef., CHILD FEC DISP ZAMB; WSP UNICEF, 2014, 1 2 CHILD FEC DISP B, P1	51	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0254774	10.1371/journal.pone.0254774	http://dx.doi.org/10.1371/journal.pone.0254774			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339451	Green Published, Green Accepted, gold			2022-12-26	WOS:000680243400055
J	Alter, BJ; Anderson, NP; Gillman, AG; Yin, Q; Jeong, JH; Wasan, AD				Alter, Benedict J.; Anderson, Nathan P.; Gillman, Andrea G.; Yin, Qing; Jeong, Jong-Hyeon; Wasan, Ajay D.			Hierarchical clustering by patient-reported pain distribution alone identifies distinct chronic pain subgroups differing by pain intensity, quality, and clinical outcomes	PLOS ONE			English	Article							PERIPHERAL NEUROPATHIC PAIN; PHYSICAL FUNCTION; FIBROMYALGIA; SYSTEM; VALIDITY; COMORBIDITY; RELIABILITY; PAINDETECT; REVISIONS; DRAWINGS	Background In clinical practice, the bodily distribution of chronic pain is often used in conjunction with other signs and symptoms to support a diagnosis or treatment plan. For example, the diagnosis of fibromyalgia involves tallying the areas of pain that a patient reports using a drawn body map. It remains unclear whether patterns of pain distribution independently inform aspects of the pain experience and influence patient outcomes. The objective of the current study was to evaluate the clinical relevance of patterns of pain distribution using an algorithmic approach agnostic to diagnosis or patient-reported facets of the pain experience. Methods and findings A large cohort of patients (N = 21,658) completed pain body maps and a multi-dimensional pain assessment. Using hierarchical clustering of patients by body map selection alone, nine distinct subgroups emerged with different patterns of body region selection. Clinician review of cluster body maps recapitulated some clinically-relevant patterns of pain distribution, such as low back pain with radiation below the knee and widespread pain, as well as some unique patterns. Demographic and medical characteristics, pain intensity, pain impact, and neuropathic pain quality all varied significantly across cluster subgroups. Multivariate modeling demonstrated that cluster membership independently predicted pain intensity and neuropathic pain quality. In a subset of patients who completed 3-month follow-up questionnaires (N = 7,138), cluster membership independently predicted the likelihood of improvement in pain, physical function, and a positive overall impression of change related to multidisciplinary pain care. Conclusions This study reports a novel method of grouping patients by pain distribution using an algorithmic approach. Pain distribution subgroup was significantly associated with differences in pain intensity, impact, and clinically relevant outcomes. In the future, algorithmic clustering by pain distribution may be an important facet in chronic pain biosignatures developed for the personalization of pain management.	[Alter, Benedict J.; Anderson, Nathan P.; Gillman, Andrea G.; Wasan, Ajay D.] Univ Pittsburgh, Dept Anesthesiol & Perioperat Med, Pittsburgh, PA 15260 USA; [Yin, Qing; Jeong, Jong-Hyeon] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA USA; [Wasan, Ajay D.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Alter, BJ (corresponding author), Univ Pittsburgh, Dept Anesthesiol & Perioperat Med, Pittsburgh, PA 15260 USA.	alterbj@upmc.edu	Alter, Benedict/ABD-8516-2021	Alter, Benedict/0000-0002-0171-3411; Anderson, Nathan/0000-0002-5035-1402; Wasan, Ajay D./0000-0002-6394-6077; Yin, Qing/0000-0002-8875-5488	University of Pittsburgh School of Medicine; International Anesthesia Research Society Mentored Research Award	University of Pittsburgh School of Medicine(University of Pittsburgh); International Anesthesia Research Society Mentored Research Award	This study was supported by the University of Pittsburgh School of Medicine (https://www.medschool.pitt.edu/) funds awarded to ADW and the International Anesthesia Research Society Mentored Research Award (BJA; https://iars.org/iars-mentored-research-award/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; Arnold LM, 2019, J PAIN, V20, P611, DOI 10.1016/j.jpain.2018.10.008; Backryd E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192623; Baron R, 2017, PAIN, V158, P261, DOI 10.1097/j.pain.0000000000000753; Basu N, 2018, ARTHRITIS RHEUMATOL, V70, P1000, DOI 10.1002/art.40451; Boudreau SA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34950-2; Boudreau SA, 2016, CLIN J PAIN, V32, P139, DOI 10.1097/AJP.0000000000000230; Brummett CM, 2015, ARTHRITIS RHEUMATOL, V67, P1386, DOI 10.1002/art.39051; Brummett CM, 2013, ANESTHESIOLOGY, V119, P1434, DOI 10.1097/ALN.0b013e3182a8eb1f; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen SP, 2013, REGION ANESTH PAIN M, V38, P175, DOI 10.1097/AAP.0b013e31828ea086; Cook KF, 2016, J CLIN EPIDEMIOL, V73, P89, DOI 10.1016/j.jclinepi.2015.08.038; Cramer E, 2018, J PAIN, V19, pS53, DOI [10.1016/j.jpain.2017.12.128, DOI 10.1016/J.JPAIN.2017.12.128]; Davis KD, 2020, NAT REV NEUROL, V16, P381, DOI 10.1038/s41582-020-0362-2; Demant DT, 2014, PAIN, V155, P2263, DOI 10.1016/j.pain.2014.08.014; Di Carlo M, 2020, J RHEUMATOL, V47, P1198, DOI 10.3899/jrheum.190906; Docampo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074873; Dressler AM, 2019, J PAIN RES, V12, P491, DOI 10.2147/JPR.S184023; Ellingsen DM, 2021, PAIN, V162, P1352, DOI 10.1097/j.pain.0000000000002134; Fillingim RB, 2016, J PAIN, V17, pT10, DOI 10.1016/j.jpain.2015.08.010; Finnerup NB, 2016, PAIN, V157, P1599, DOI 10.1097/j.pain.0000000000000492; Flanagin A, 2021, JAMA-J AM MED ASSOC, V325, P1049, DOI 10.1001/jama.2021.2104; Freeman R, 2014, PAIN, V155, P367, DOI 10.1016/j.pain.2013.10.023; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Freynhagen R, 2016, CURR MED RES OPIN, V32, P1033, DOI 10.1185/03007995.2016.1157460; Fries JF, 2014, J RHEUMATOL, V41, P153, DOI 10.3899/jrheum.130813; Gillman A, 2020, PAIN MED, V21, P978, DOI 10.1093/pm/pnz294; Hauser W, 2021, ARTHRIT CARE RES, V73, P617, DOI 10.1002/acr.24202; HAMERS L, 1989, INFORM PROCESS MANAG, V25, P315, DOI 10.1016/0306-4573(89)90048-4; Hays RD, 2009, QUAL LIFE RES, V18, P873, DOI 10.1007/s11136-009-9496-9; Heres EK, 2018, PAIN MED, V19, P910, DOI 10.1093/pm/pnx079; Hoskin TL, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1532-0; dos Reis FJJ, 2016, PAIN PRACT, V16, P24, DOI 10.1111/papr.12262; Johnson K, 2015, J PAIN, V16, pS8, DOI 10.1016/j.jpain.2015.01.042; Katz J., 2011, HDB PAIN ASSESSMENT, V3, P45; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Kent ML, 2017, J PAIN, V18, P479, DOI 10.1016/j.jpain.2017.02.421; Korwisi B, 2021, PAIN, V162, P2087, DOI 10.1097/j.pain.0000000000002208; Kosek E, 2016, PAIN, V157, P1382, DOI 10.1097/j.pain.0000000000000507; MARGOLIS RB, 1986, PAIN, V24, P57, DOI 10.1016/0304-3959(86)90026-6; Morales-Espinoza EM, 2016, PAIN, V157, P818, DOI 10.1097/j.pain.0000000000000440; Patel KV, 2021, PAIN REP, V6, DOI 10.1097/PR9.0000000000000784; Patel KV, 2018, PAIN, V159, P2245, DOI 10.1097/j.pain.0000000000001324; R Core Team, 2020, R LANG ENV STAT COMP; Riley WT, 2010, QUAL LIFE RES, V19, P1311, DOI 10.1007/s11136-010-9694-5; Salaffi F, 2017, RHEUMATOL INT, V37, P2035, DOI 10.1007/s00296-017-3792-4; Scherrer KH, 2021, PAIN REP, V6, DOI 10.1097/PR9.0000000000000880; Sehgal N, 2021, PAIN MED, V22, P596, DOI 10.1093/pm/pnaa375; Shaballout N, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/14569; Steingrimsdottir OA, 2020, PAIN, V161, P2255, DOI 10.1097/j.pain.0000000000001899; Sturgeon JA, 2015, PAIN, V156, P2627, DOI 10.1097/j.pain.0000000000000313; Sturgeon JA, 2015, J PAIN, V16, P291, DOI 10.1016/j.jpain.2014.12.004; TANIMOTO TT, 1958, IBM INTERNAL REPORT; Tracey I, 2019, NEURON, V101, P783, DOI 10.1016/j.neuron.2019.02.019; Turk DC, 2003, PAIN, V106, P337, DOI 10.1016/j.pain.2003.08.001; Vincent A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0463-7; Wasan AD, 2020, J PAIN, V21, P858, DOI 10.1016/j.jpain.2019.11.013; Wolfe F, 2016, SEMIN ARTHRITIS RHEU, V46, P319, DOI 10.1016/j.semarthrit.2016.08.012	61	3	3	9	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2021	16	8							e0254862	10.1371/journal.pone.0254862	http://dx.doi.org/10.1371/journal.pone.0254862			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6IY	34347793	Green Published, gold			2022-12-26	WOS:000685264900058
J	Ludwig, CA; Vail, D; Rajeshuni, NA; Al-Moujahed, A; Rosenblatt, T; Callaway, NF; Pasricha, MV; Ji, MRH; Moshfeghi, DM				Ludwig, Cassie A.; Vail, Daniel; Rajeshuni, Nitya A.; Al-Moujahed, Ahmad; Rosenblatt, Tatiana; Callaway, Natalia F.; Veerappan Pasricha, Malini; Ji, Marco H.; Moshfeghi, Darius M.			Statins and the progression of age-related macular degeneration in the United States	PLOS ONE			English	Article							5-YEAR INCIDENCE; RISK; ASSOCIATION; DISEASE; CROSS	Purpose To study the effect of statin exposure on the progression from non-exudative to exudative age-related macular degeneration (AMD). Methods Retrospective cohort study of commercially insured patients diagnosed with non-exudative AMD (n = 231,888) from 2007 to 2015. Time-to-event analysis of the association between exposure to lipid-lowering medications and time from non-exudative AMD to exudative AMD diagnosis was conducted. Outcome measures included progression to exudative AMD, indicated by diagnosis codes for exudative AMD or procedural codes for intravitreal injections. Results In the year before and after first AMD diagnosis, 11,330 patients were continuously prescribed lipid-lowering medications and 31,627 patients did not take any lipid-lowering medication. Of those taking statins, 21 (1.6%) patients were on very-high-dose lipophilic statins, 644 (47.6%) on high-dose lipophilic statins, and 689 (50.9%) on low-dose lipophilic statins. We found no statistically significant relationship between exposure to low (HR 0.89, 95% CI 0.83 to 1.38) or high-dose lipophilic statins (HR 1.12, 95% CI 0.86 to 1.45) and progression to exudative AMD. No patients taking very-high-dose lipophilic statins converted from non-exudative to exudative AMD, though this difference was not statistically significant due to the subgroup size (p = .23, log-rank test). Conclusions No statistically significant relationship was found between statin exposure and risk of AMD progression. Interestingly, no patients taking very-high-dose lipophilic statins progressed to exudative AMD, a finding that warrants further exploration.	[Ludwig, Cassie A.; Vail, Daniel; Rajeshuni, Nitya A.; Al-Moujahed, Ahmad; Rosenblatt, Tatiana; Callaway, Natalia F.; Veerappan Pasricha, Malini; Ji, Marco H.; Moshfeghi, Darius M.] Stanford Univ, Byers Eye Inst, Dept Ophthalmol, Palo Alto, CA 94304 USA; [Ludwig, Cassie A.] Harvard Med Sch, Massachusetts Eye & Ear, Retina Serv, Dept Ophthalmol, Boston, MA 02115 USA	Stanford University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Moshfeghi, DM (corresponding author), Stanford Univ, Byers Eye Inst, Dept Ophthalmol, Palo Alto, CA 94304 USA.	dariusm@stanford.edu	Ji, Marco H./Q-3807-2017	Ji, Marco H./0000-0002-7033-7763; Moshfeghi, Darius Mohammad/0000-0003-2254-292X	Research to Prevent Blindness, Inc.; NEI [P30-EY026877]; Society of Heed Fellows; Michels Fellowship Foundation; Heed Ophthalmic Foundation	Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Society of Heed Fellows; Michels Fellowship Foundation; Heed Ophthalmic Foundation	Our financial support was as follows: DMM: Research to Prevent Blindness, Inc., NEI P30-EY026877 CAL: The Heed Fellowship awarded through the Society of Heed Fellows NFC: Heed Ophthalmic Foundation and Michels Fellowship Foundation Darius M. Moshfeghi is a co-founder with equity and serves on the board of directors of Linc, Inc a company that has developed a novel statin molecule that among other things may be targeted for AMD. Additionally, Darius M. Moshfeghi has the following conflicts of interest: 1800 Contacts (board of directors, equity), Akceso Advisors AG (evaluation of DME market), Akebia (scientific advisory board for ROP), Alcon (data safety monitoring board for HAWK/HARRIER), Aldeyra Therapeutics (Site PI: ADX-2191-PVR-001 GUARD), Allegro (scientific advisory board), Apellis (Site PI: APL2-303 DERBY), Bayer Pharma AG (ROP imaging committee), CMEOutfitters.com (CME consultant), Cole Eye Institute (CME consultant), Congruence medical solutions (consultant), dSentz, Inc. (founder, board of directors, equity), Genentech (PROPER grant 2019), Grand Legend Technology, LTD (equity), Iconic Therapeutics (steering committee, unpaid), Irenix (scientific advisory board, unpaid), Northwell Health (grand rounds), Novartis Pharmaceuticals (data safety monitoring board for HAWK/HARRIER, KITE/KESTREL, China nAMD/DME, pediatric advisory board), Ocular Surgery News (consultant), Pr3vent (founder, board of directors, equity), Praxis UNS, Inc. (consultant), Prime Medical Education (CME consultant), Promisight, Inc. (founder, board of directors, equity), Pykus (scientific advisory board, equity), Regeneron (CME consultant, ROP steering committee, PI for ROP trial), Retina Technologies LLC (advisor, consultant), Retina Today/Pentavision (consultant), Shapiro Law Group (ROP expert witness), SLACK, Inc. (CME CoverLetter_Revisions consultant), University of Miami (CME consultant), VersI, Inc. (founder, equity), Vindico (CME consultant), Visunex (scientific advisory board, equity. None of the other authors have any conflicts of interest to report. The above funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Holou SN, 2015, OPHTHALMOLOGY, V122, P2490, DOI 10.1016/j.ophtha.2015.08.028; Behnke V, 2020, CELL MOL LIFE SCI, V77, P781, DOI 10.1007/s00018-019-03419-4; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; Curcio CA, 2010, J LIPID RES, V51, P451, DOI 10.1194/jlr.R002238; Fong CW, 2014, EUR J MED CHEM, V85, P661, DOI 10.1016/j.ejmech.2014.08.037; Fong DS, 2010, AM J OPHTHALMOL, V149, P955, DOI 10.1016/j.ajo.2009.12.037; Friedman E, 2004, BRIT J OPHTHALMOL, V88, P161, DOI 10.1136/bjo.2003.036277; Gehlbach P, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006927.pub5; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Guymer RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083759; Hall NF, 2001, BRIT MED J, V323, P375, DOI 10.1136/bmj.323.7309.375; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein R, 2003, ARCH OPHTHALMOL-CHIC, V121, P1151, DOI 10.1001/archopht.121.8.1151; Klein R, 2007, AM J OPHTHALMOL, V144, P1, DOI 10.1016/j.ajo.2007.02.047; Ma L, 2015, SCI REP-UK, V5, DOI 10.1038/srep18280; Maguire MG, 2009, OPHTHALMOLOGY, V116, P2381, DOI 10.1016/j.ophtha.2009.06.055; McCarty CA, 2001, MED J AUSTRALIA, V175, P340, DOI 10.5694/j.1326-5377.2001.tb143604.x; Menendez ME, 2014, CLIN ORTHOP RELAT R, V472, P2878, DOI 10.1007/s11999-014-3686-7; Mitchell P, 2018, LANCET, V392, P1147, DOI 10.1016/S0140-6736(18)31550-2; Miyaki K, 2009, CURR EYE RES, V34, P10, DOI 10.1080/02713680802579196; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Peponis V, 2010, CLIN OPHTHALMOL, V4, P865; Rozing MP, 2020, PROG RETIN EYE RES, V76, DOI 10.1016/j.preteyeres.2019.100825; Shalev V, 2011, OPHTHAL EPIDEMIOL, V18, P83, DOI 10.3109/09286586.2011.560746; Smeeth L., 2006, AM J OPHTHALMOL, V141, P238, DOI [10.1016/j.ajo.2005.11.029, DOI 10.1016/J.AJO.2005.11.029]; Smith M.K., 2009, ISSUES CULTURAL TOUR; Terai N, 2011, ACTA OPHTHALMOL, V89, pE500, DOI 10.1111/j.1755-3768.2011.02154.x; Tsao SW, 2013, DRUG AGING, V30, P205, DOI 10.1007/s40266-013-0061-4; Tsujinaka H, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00401; Vail D, 2019, AM J OPHTHALMOL, V207, P378, DOI 10.1016/j.ajo.2019.05.029; van Leeuwen EM, 2018, PROG RETIN EYE RES, V67, P56, DOI 10.1016/j.preteyeres.2018.04.006; VanderBeek BL, 2013, RETINA-J RET VIT DIS, V33, P414, DOI 10.1097/IAE.0b013e318276e0cf; Vavvas DG, 2016, EBIOMEDICINE, V5, P198, DOI 10.1016/j.ebiom.2016.01.033; Waugh N, 2018, HEALTH TECHNOL ASSES, V22, P1, DOI 10.3310/hta22270; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Wu TH, 2010, J NEUROCHEM, V114, P1734, DOI 10.1111/j.1471-4159.2010.06884.x	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2021	16	8							e0252878	10.1371/journal.pone.0252878	http://dx.doi.org/10.1371/journal.pone.0252878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IY	34347799	Green Published, gold			2022-12-26	WOS:000685264900044
J	Hacker, V; Reiter, GS; Schranz, M; Told, R; Reumuller, A; Hofer, D; Steiner, I; Schmidt-Erfurth, U; Sacu, S				Hacker, Valentin; Reiter, Gregor Sebastian; Schranz, Markus; Told, Reinhard; Reumueller, Adrian; Hofer, Dominik; Steiner, Irene; Schmidt-Erfurth, Ursula; Sacu, Stefan			Impact of large choroidal vessels on choriocapillaris flow deficit analyses in optical coherence tomography angiography	PLOS ONE			English	Article								Purpose To investigate the impact of large choroidal vessels (LCV) on Choriocapillaris (CC) flow deficit (FD) analyses with swept-source optical coherence tomography angiography (SS-OCTA) Design Prospective, cross-sectional study. Methods Macular 6x6mm SS-OCTA scans were obtained from intermediate age-related macular degeneration (iAMD) and healthy eyes. Images were captured and processed according to most common standards and analyzed for percentage of flow-deficits (FD%) within four 1x1mm squares at the corners of each image. Choroidal thickness (CT), iris color and refraction error were considered as potential influential factors for LCV visibility. A linear mixed model and logistic regression models were calculated for statistical evaluation. Results Sixty-nine iAMD and 49 age-matched healthy eyes were enrolled. LCV were visible in at least one sector in 52% of iAMD and 47% of healthy eyes. Within the iAMD group FD% were significantly lower in areas containing LCV (p = 0.0029). Increasing CT resulted in an odds ratio decrease of LCV (OR: 0.94, p<0.0001). Below a CT value of <= 118 mu m LCV could be expected with a sensitivity of 86% and a specificity of 85%. Conclusions LCV can significantly affect CC FD analyses of SS-OCTA images. Their visibility is negatively associated with CT. The impact of LCV should be taken into account when performing CC FD assessments, especially in patients where reduced CT is to be expected and inclusion of affected areas should be considered carefully.	[Hacker, Valentin; Schranz, Markus; Told, Reinhard; Reumueller, Adrian; Schmidt-Erfurth, Ursula; Sacu, Stefan] Med Univ Vienna, Dept Ophthalmol & Optomet, Vienna Clin Trial Ctr VTC, Vienna, Austria; [Reiter, Gregor Sebastian; Schmidt-Erfurth, Ursula] Med Univ Vienna, Dept Ophthalmol & Optomet, Vienna Reading Ctr, Christian Doppler Lab Ophthalm Image Anal, Vienna, Austria; [Hofer, Dominik; Schmidt-Erfurth, Ursula] Med Univ Vienna, Dept Ophthalmol & Optomet, Vienna Reading Ctr VRC, Vienna, Austria; [Steiner, Irene] Med Univ Vienna, Sect Med Stat, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Sacu, S (corresponding author), Med Univ Vienna, Dept Ophthalmol & Optomet, Vienna Clin Trial Ctr VTC, Vienna, Austria.	Stefan.sacu@meduniwien.ac.at	Schranz, Markus/HHS-9483-2022	Schranz, Markus/0000-0002-2630-1368; Hacker, Valentin/0000-0003-0046-5804; Told, Reinhard/0000-0003-2046-7081; Reiter, Gregor/0000-0001-7661-4015				Alagorie AR, 2019, AM J OPHTHALMOL, V205, P132, DOI 10.1016/j.ajo.2019.04.037; BERNSTEIN M. H., 1965, INVEST OPHTHAL MOL, V4, P1016; Borrelli E, 2018, AM J OPHTHALMOL, V196, P34, DOI 10.1016/j.ajo.2018.08.014; Borrelli E, 2017, INVEST OPHTH VIS SCI, V58, P4792, DOI 10.1167/iovs.17-22360; Byon I, 2019, AM J OPHTHALMOL, V208, P397, DOI 10.1016/j.ajo.2019.08.026; Chu ZD, 2020, AM J OPHTHALMOL, V213, P161, DOI 10.1016/j.ajo.2020.02.003; Chu ZD, 2019, AM J OPHTHALMOL, V208, P111, DOI 10.1016/j.ajo.2019.07.003; Chu ZD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34826-5; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Genders TSS, 2012, RADIOLOGY, V265, P910, DOI 10.1148/radiol.12120509; Hwang S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57211-2; KREBS W, 1988, ARCH OPHTHALMOL-CHIC, V106, P1615, DOI 10.1001/archopht.1988.01060140783055; Manjunath V, 2010, AM J OPHTHALMOL, V150, P325, DOI 10.1016/j.ajo.2010.04.018; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Mehta N, 2019, AM J OPHTHALMOL, V205, P54, DOI 10.1016/j.ajo.2019.03.008; Mrejen S, 2013, SURV OPHTHALMOL, V58, P387, DOI 10.1016/j.survophthal.2012.12.001; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; Phansalkar Neerad, 2011, 2011 International Conference on Communications and Signal Processing (ICCSP), P218, DOI 10.1109/ICCSP.2011.5739305; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Sadda SR, 2018, OPHTHALMOLOGY, V125, P537, DOI 10.1016/j.ophtha.2017.09.028; Sezer T, 2016, TURK OFTALMOL DERG, V46, P30, DOI 10.4274/tjo.10693; Spaide RF, 2016, AM J OPHTHALMOL, V170, P58, DOI 10.1016/j.ajo.2016.07.023; Uji A, 2017, JAMA OPHTHALMOL, V135, P1197, DOI 10.1001/jamaophthalmol.2017.3904; Wood A, 2011, AM J OPHTHALMOL, V152, P1030, DOI 10.1016/j.ajo.2011.05.021; Xiong SY, 2020, AM J OPHTHALMOL, V213, P46, DOI 10.1016/j.ajo.2020.01.003; Zhang QQ, 2018, QUANT IMAG MED SURG, V8, P658, DOI 10.21037/qims.2018.08.10; Zhang QQ, 2018, INVEST OPHTH VIS SCI, V59, P203, DOI 10.1167/iovs.17-22953; Zheng F, 2019, AM J OPHTHALMOL, V200, P110, DOI 10.1016/j.ajo.2018.12.025	28	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0254955	10.1371/journal.pone.0254955	http://dx.doi.org/10.1371/journal.pone.0254955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343177	gold, Green Published			2022-12-26	WOS:000685264200022
J	Shrestha, G; Thakur, RK; Singh, R; Mulmi, R; Shrestha, A; Pradhan, PMS				Shrestha, Gambhir; Thakur, Rahul Kumar; Singh, Rajshree; Mulmi, Rashmi; Shrestha, Abha; Pradhan, Pranil Man Singh			Cancer burden in Nepal, 1990-2017: An analysis of the Global Burden of Disease study	PLOS ONE			English	Article							CHANGING TRENDS; CERVICAL-CANCER; RISK-FACTORS; LIFE-STYLE; MORTALITY; WOMEN	Introduction Cancer is the second leading cause of death and a major public health problem in the world. This study reports the trend and burden of cancer from 1990 to 2017 along with its risk factors in Nepal. Methods This study used the database of the Institute of Health Metrics and Evaluation's Global Burden of Diseases on cancer from Nepal to describe the most recent data available (2017) and trends by age, gender, and year from 1990 to 2017. The data are described as incidence, prevalence, disability-adjusted life years (DALY), and percentage change. Results In 2017, the age-standardized cancer incidence and mortality rates were 101.8/100,000 and 86.6/100,000 respectively in Nepal. Cancer contributed to 10% of total deaths and 5.6% of total DALYs in Nepal. The most common cancers were the breast, lung, cervical, stomach and oral cavity cancers. The number of new cancer cases and deaths in Nepal have increased from 1990 to 2017 by 92% and 95% respectively. On the other hand, age-standardized incidence and mortality rates decreased by 5% and 7% respectively. The leading risk factors of cancer were tobacco use, dietary factors, unsafe sex, air pollution, drug use, and physical inactivity. Conclusions This study highlighted the burden of cancer in Nepal, contributing to a significant number of new cancer cases, deaths and DALY. A comprehensive approach including prevention, early diagnosis and treatment, and rehabilitation should be urgently taken to reduce the burden of cancer.	[Shrestha, Gambhir; Pradhan, Pranil Man Singh] Tribhuvan Univ, Inst Med, Dept Community Med, Maharajgunj Med Campus, Kathmandu, Maharajgunj, Nepal; [Thakur, Rahul Kumar] Albert Einstein Coll Med, Jacobi Med Ctr, Dept Internal Med, Bronx, NY 10451 USA; [Singh, Rajshree] Mercy Catholic Med Ctr, Dept Diagnost Radiol, Philadelphia, PA USA; [Mulmi, Rashmi] BP Koirala Mem Canc Hosp, Dept Canc Prevent Control & Res, Bharatpur, Chitwan, Nepal; [Shrestha, Abha] Kathmandu Univ, Sch Med Sci, Dept Community Med, Kavre, Dhulikhel, Nepal	Tribhuvan University; Institute of Medicine (IoM) - Nepal; Jacobi Medical Center; Yeshiva University; Albert Einstein College of Medicine; Kathmandu University	Shrestha, G (corresponding author), Tribhuvan Univ, Inst Med, Dept Community Med, Maharajgunj Med Campus, Kathmandu, Maharajgunj, Nepal.	gamvir.stha@gmail.com	Shrestha, Abha/AAF-2476-2021	Singh, Rajshree/0000-0003-1054-4485; Shrestha, Gambhir/0000-0002-9975-9804; Thakur, Rahul Kumar/0000-0003-1740-5939				[Anonymous], 2020, IND METD REG LIST; Ansari Shamshul, 2016, BMC Res Notes, V9, P59, DOI 10.1186/s13104-016-1867-z; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Binu V, 2007, ASIAN PAC J CANCER P, V8, P183; Blazer DG., 2006, IMPACT SOCIAL CULTUR; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chalkidou K, 2014, LANCET ONCOL, V15, pE119, DOI 10.1016/S1470-2045(13)70547-3; Chang CP, 2020, INT J CANCER, V147, P866, DOI 10.1002/ijc.32823; Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P571, DOI 10.1007/s00038-014-0553-y; Family Health Division, 2010, NAT GUID CERV CANC S; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Fitzmaurice C, 2018, JAMA ONCOL, V4, P1553, DOI 10.1001/jamaoncol.2018.2706; Gamage SMK, 2018, CRIT REV ONCOL HEMAT, V126, P121, DOI 10.1016/j.critrevonc.2018.03.025; GBD, 2017, GLOBAL BURDEN DIS ST; Giri M, 2018, BIOMED REP, V8, P325, DOI 10.3892/br.2018.1057; Gupta N, 2016, NEPAL J EPIDEMIOL, V6, P613, DOI 10.3126/nje.v6i4.17255; Gyenwali D, 2013, ASIAN PAC J CANCER P, V14, P4373, DOI 10.7314/APJCP.2013.14.7.4373; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kagawa-Singer M, 2010, CA-CANCER J CLIN, V60, P12, DOI 10.3322/caac.20051; Kansakar P, 2012, ASIAN PAC J CANCER P, V13, P3209, DOI 10.7314/APJCP.2012.13.7.3209; Keum N, 2019, NAT REV GASTRO HEPAT, V16, P713, DOI 10.1038/s41575-019-0189-8; Khatiwoda SR, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00160; Kyu HH, 2018, LANCET, V392, P1859, DOI 10.1016/s0140-6736(18)32335-3; Liber AC, 2015, TOB CONTROL, V24, pE137, DOI 10.1136/tobaccocontrol-2013-051184; Ministry of Health and Population, NAT ANT COMM CAMP ST; Ministry of Health and Population, 2020, MED TREATM DEPR CIT; Ministry of Health and Population World Health Organization, 2016, NAT IMM PROGR UPD; Nepal Development Research Institute, 2020, TAX TOB NEP WHAT CAN; Nepal Health Research Council Ministry of Health and Population Monitoring Evaluation and Operational Research, 2019, NEP MARK OV NEP COUN; NHRC, NAT FACTSH ENGL; Office of the Surgeon General United States, 2012, PREV TOB UYOUTH YO; Piya MK, 2012, SOUTH ASIAN J CANCER, V1, P5, DOI 10.4103/2278-330X.96490; Poudel KK, 2017, NEPAL J EPIDEMIOL, V7, P659, DOI 10.3126/nje.v7i1.17759; Poudel Krishna Kanta, 2016, Asian Pac J Cancer Prev, V17, P2171; Pun Chin Bahadur, 2015, Asian Pac J Cancer Prev, V16, P8659; Raspanti GA, 2016, ENVIRON RES, V147, P141, DOI 10.1016/j.envres.2016.02.008; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Sadeghi Mostafa, 2016, Asian Pac J Cancer Prev, V17, P4251; Shammas MA, 2011, CURR OPIN CLIN NUTR, V14, P28, DOI 10.1097/MCO.0b013e32834121b1; Sherpa ATL, 2010, CANCER CAUSE CONTROL, V21, P323, DOI 10.1007/s10552-009-9467-z; Shrestha G., 2020, IJS GLOB HEAL, V3, pE30; Shrestha G, 2019, J NEPAL MED ASSOC, V57, P144, DOI 10.31729/jnma.4192; Singh Y, 2010, ASIAN PAC J CANCER P, V11, P615; Taitt HE, 2018, AM J MENS HEALTH, V12, P1807, DOI 10.1177/1557988318798279; Torre LA, 2017, CANCER EPIDEM BIOMAR, V26, P444, DOI 10.1158/1055-9965.EPI-16-0858; World Health Organization, UN INT CANC CONTR NE; World Health Organization (WHO), UN INT CANC CONTR NE	50	1	1	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255499	10.1371/journal.pone.0255499	http://dx.doi.org/10.1371/journal.pone.0255499			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343216	gold, Green Published			2022-12-26	WOS:000685264200015
J	He, XT; Gao, F; Hou, JJ; Li, TJ; Tan, J; Wang, CY; Liu, XY; Wang, MQ; Liu, H; Chen, YQ; Yu, ZY; Yang, M				He, Xueting; Gao, Fei; Hou, Jiaojiao; Li, Tingjie; Tan, Jiang; Wang, Chunyu; Liu, Xiaoyan; Wang, Maoqi; Liu, Hui; Chen, Yuqin; Yu, Zhuoyuan; Yang, Mei			Metformin inhibits MAPK signaling and rescues pancreatic aquaporin 7 expression to induce insulin secretion in type 2 diabetes mellitus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET BETA-CELLS; GLYCEROL KINASE; P38 MAPK; RAT; APOPTOSIS; GLUCOSE; PROTEIN; MODEL; GENE; JNK	Metformin is the first-line antidiabetic agent for type 2 diabetes mellitus (T2DM) treatment. Although accumulated evidence has shed light on the consequences of metformin action, the precise mechanisms of its action, especially in the pancreas, are not fully understood. Aquaporin 7 (AQP7) acts as a critical regulator of intraislet glycerol content, which is necessary for insulin production and secretion. The aim of this study was to investigate the effects of different doses of metformin on AQP7 expression and explore the possible mechanism of its protective effects in the pancreatic islets. We used an in vivo model of high-fat diet in streptozocin-induced diabetic rats and an in vitro model of rat pancreatic beta-cells (INS1 cells) damaged by hyperglycemia and hyperlipidemia. Our data showed that AQP7 expression levels were decreased, whereas p38 and JNK mitogen-activated protein kinases (MAPKs) were activated in vivo and in vitro in response to hyperglycemia and hyperlipidemia. T2DM rats treated with metformin demonstrated a reduction in blood glucose levels and increased regeneration of pancreatic beta-cells. In addition, metformin upregulated AQP7 expression as well as inhibited activation of p38 and JNK MAPKs both in vivo and in vitro. Overexpression of AQP7 increased glycerol influx into INS-1 cells, whereas inhibition of AQP7 reduced glycerol influx, thereby decreasing subsequent insulin secretion. Our findings demonstrate a new mechanism by which metformin suppresses the p38 and JNK pathways, thereby upregulating pancreatic AQP7 expression and promoting glycerol influx into pancreatic beta Psi-cells and subsequent insulin secretion in T2DM.	[He, Xueting; Hou, Jiaojiao; Li, Tingjie; Tan, Jiang; Wang, Chunyu; Liu, Xiaoyan; Wang, Maoqi; Liu, Hui; Yang, Mei] Chongqing Med Univ, Coll Basic Med, Dept Anat, Chongqing, Peoples R China; [Gao, Fei; Yu, Zhuoyuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, Chongqing, Peoples R China; [Chen, Yuqin] Chongqing Med Univ, Coll Basic Med, Inst Neurosci, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Yang, M (corresponding author), Chongqing Med Univ, Coll Basic Med, Dept Anat, Chongqing, Peoples R China.	yangmei503@cqmu.edu.cn	Liu, XiaoYan/GQA-7216-2022		National Natural Science Foundation of China [81971230, 81671312, 81672893]; Science and technology research project of Chongqing Education Commission [KJQN201800428]; Senior Young-middle-aged Medical Talents Program of Chongqing Health Committee [204216qn]; Chongqing Science and Health Joint Project [2020GDRC007]; Reserve Talents Program for academic Leaders of the First Affiliated Hospital of Chongqing Medical University [XKTS070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technology research project of Chongqing Education Commission; Senior Young-middle-aged Medical Talents Program of Chongqing Health Committee; Chongqing Science and Health Joint Project; Reserve Talents Program for academic Leaders of the First Affiliated Hospital of Chongqing Medical University	Funding from the National Natural Science Foundation of China (81971230 and 81671312), Science and technology research project of Chongqing Education Commission (KJQN201800428) to M. Y.; National Natural Science Foundation of China (81672893), Senior Young-middle-aged Medical Talents Program of Chongqing Health Committee (No.204216qn), Chongqing Science and Health Joint Project (2020GDRC007) and Reserve Talents Program for academic Leaders of the First Affiliated Hospital of Chongqing Medical University (No.XKTS070) to F. G.	Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Baidwan S, 2017, APOPTOSIS, V22, P1380, DOI 10.1007/s10495-017-1409-8; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Dai YL, 2015, INT J BIOL SCI, V11, P1272, DOI 10.7150/ijbs.12108; de Gonzalo-Calvo D, 2016, SCI REP-UK, V6, DOI 10.1038/srep37354; Galant D, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020021; Goldsworthy M, 2016, DIABETES, V65, P1434, DOI 10.2337/db15-1276; Grether-Beck S, 2012, J INVEST DERMATOL, V132, P1561, DOI 10.1038/jid.2012.42; Guo LX, 2017, EUR J PHARM SCI, V110, P70, DOI 10.1016/j.ejps.2017.03.038; Hansen JS, 2016, METABOLISM, V65, P1731, DOI 10.1016/j.metabol.2016.09.004; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Kong CS, 2011, J NUTR BIOCHEM, V22, P276, DOI 10.1016/j.jnutbio.2010.02.005; Lawrence MC, 2015, MOL ENDOCRINOL, V29, P274, DOI 10.1210/me.2014-1066; Li FX, 2015, WORLD J GASTROENTERO, V21, P4547, DOI 10.3748/wjg.v21.i15.4547; Li QX, 2019, FOOD SCI NUTR, V7, P1695, DOI 10.1002/fsn3.1006; Li WB, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03218-x; Li ZH, 2018, MOL CELL PROTEOMICS, V17, P2119, DOI 10.1074/mcp.RA118.000698; Makeeva N, 2006, BIOCHEM J, V393, P129, DOI 10.1042/BJ20050814; Mansor LS, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-136; Matsumura K, 2007, MOL CELL BIOL, V27, P6026, DOI 10.1128/MCB.00384-07; Matthaei S, 2000, ENDOCR REV, V21, P585, DOI 10.1210/er.21.6.585; Miyauchi T, 2015, FEBS LETT, V589, P608, DOI 10.1016/j.febslet.2015.01.025; Moon JS, 2017, J DIABETES COMPLICAT, V31, P21, DOI 10.1016/j.jdiacomp.2016.09.001; Noel RJ, 1997, J BIOL CHEM, V272, P18621, DOI 10.1074/jbc.272.30.18621; Prudente S, 2007, DIABETES, V56, P1468, DOI 10.2337/db06-1389; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Rodriguez A, 2011, CELL CYCLE, V10, P1548, DOI 10.4161/cc.10.10.15672; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Sidarala V, 2016, RECENT PATENTS ENDOC, V10, P76, DOI 10.2174/1872214810666161020154905; Skelly RH, 2001, DIABETES, V50, P1791, DOI 10.2337/diabetes.50.8.1791; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Tan YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17741; Tang XL, 2014, INDIAN J MED RES, V140, P744; Tian JY, 2006, CHINESE MED J-PEKING, V119, P574, DOI 10.1097/00029330-200604010-00010; Veroux M, 2019, BMC SURG, V18, DOI 10.1186/s12893-018-0452-x; Wang CY, 2015, BIOCHEM BIOPH RES CO, V460, P205, DOI 10.1016/j.bbrc.2015.03.009; Wei XY, 2015, J MOL HISTOL, V46, P273, DOI 10.1007/s10735-015-9618-3; Yang GD, 2007, J BIOL CHEM, V282, P16567, DOI 10.1074/jbc.M700605200; Yang X, 2017, BBA-MOL BASIS DIS, V1863, P1984, DOI 10.1016/j.bbadis.2016.09.019; Zhang EM, 2019, CELL METAB, V29, P64, DOI 10.1016/j.cmet.2018.09.008; Zhang XJ, 2015, VASC PHARMACOL, V73, P86, DOI 10.1016/j.vph.2015.04.003	43	7	8	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							101002	10.1016/j.jbc.2021.101002	http://dx.doi.org/10.1016/j.jbc.2021.101002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34303707	gold, Green Published			2022-12-26	WOS:000690868100002
J	Kunimi, H; Lee, D; Ibuki, M; Katada, Y; Negishi, K; Tsubota, K; Kurihara, T				Kunimi, Hiromitsu; Lee, Deokho; Ibuki, Mari; Katada, Yusaku; Negishi, Kazuno; Tsubota, Kazuo; Kurihara, Toshihide			Inhibition of the HIF-1 alpha/BNIP3 pathway has a retinal neuroprotective effect	FASEB JOURNAL			English	Article						BNIP3; HIF; inner retinal degeneration; neuroprotection; retinal ischemia	GANGLION-CELL DEATH; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; INTRAOCULAR-PRESSURE; AUTOPHAGY; BNIP3; APOPTOSIS; ISCHEMIA; SURVIVAL; PROTEIN; CONTRIBUTES	Retinal ischemia is a leading cause of irreversible blindness worldwide. Inner retinal dysfunction including loss of retinal ganglion cells is encountered in a number of retinal ischemic disorders. We previously reported administration of two different hypoxia-inducible factor (HIF) inhibitors exerted neuroprotective effects in a murine model of retinal ischemia/reperfusion (I/R) which mimics these disorders, as inner retinal degeneration could be involved in pathological HIF induction. However, this notion needs further investigation. Therefore, in this study, we attempted to use retina-specific Hif-1 alpha conditional knockout (cKO) mice to uncover this notion more clearly under the same condition. Hif-1 alpha cKO mice showed inner retinal neurodegeneration to a lesser extent than control mice. Hif-1 alpha depletion in a murine 661W retinal cell line reduced cell death under pseudohypoxic and hypoxic conditions. Among hypoxia-related genes, the expression of BCL2 19 kDa protein-interacting protein 3 (Bnip3) was substantially upregulated in the inner retinal layer after retinal I/R. In this regard, we further examined Bnip3 depletion in retinal neurons in vitro and in vivo and found the similar neuroprotective effects. Our results support the notion that the HIF-1 alpha/BNIP3 pathway may have a critical role in inner retinal neurodegeneration, which can be linked with the development of new promising therapeutics for inner retinal ischemic disorders.	[Kunimi, Hiromitsu; Lee, Deokho; Ibuki, Mari; Katada, Yusaku; Kurihara, Toshihide] Keio Univ, Sch Med, Lab Photobiol, Shinanomachi, Japan; [Kunimi, Hiromitsu; Lee, Deokho; Ibuki, Mari; Katada, Yusaku; Negishi, Kazuno; Tsubota, Kazuo; Kurihara, Toshihide] Keio Univ, Sch Med, Dept Ophthalmol, Shinanomachi, Japan; [Tsubota, Kazuo] Tsubota Lab Inc, Tokyo, Japan	Keio University; Keio University	Tsubota, K (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Dept Chair,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.; Kurihara, T (corresponding author), Keio Univ, Sch Med, Lab Photobiol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tsubota@z3.keio.jp; kurihara@z8.keio.jp		Lee, Deokho/0000-0002-5992-9039; Kurihara, Toshihide/0000-0002-5457-2720	KAKENHI [15K10881, 18K09424, 20K22692]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grants--in--Aid for Scientific Research (KAKENHI), Grant/Award Number: 15K10881, 18K09424 and 20K22692	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Agarwal N, 2013, INVEST OPHTH VIS SCI, V54, P7884, DOI 10.1167/iovs.13-13292; Barteczek P, 2017, J CEREBR BLOOD F MET, V37, P291, DOI 10.1177/0271678X15624933; Boatright JH, 2013, MOL VIS, V19, P1848; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Decuypere Jean-Paul, 2012, Cells, V1, P284, DOI 10.3390/cells1030284; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Feng CC, 2016, GROWTH FACTORS, V34, P73, DOI 10.1080/08977194.2016.1191480; Gorbunova AS, 2020, CANCERS, V12, DOI 10.3390/cancers12113390; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Hartsock MJ, 2016, JOVE-J VIS EXP, DOI 10.3791/54065; Hung SSC, 2016, INVEST OPHTH VIS SCI, V57, P3470, DOI 10.1167/iovs.16-19316; Ji JZ, 2005, VISION RES, V45, P169, DOI 10.1016/j.visres.2004.08.008; Katada Y, 2019, PEERJ, V7, DOI 10.7717/peerj.6317; Kim BJ, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-21; Kunimi H, 2019, PEERJ, V7, DOI 10.7717/peerj.7849; Kunimi H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133171; Kurihara T, 2018, KEIJO J MED, V67, P1, DOI 10.2302/kjm.2017-0002-IR; Kurihara T, 2016, ELIFE, V5, DOI 10.7554/eLife.14319; Kurihara T, 2010, DEVELOPMENT, V137, P1563, DOI 10.1242/dev.049015; Lee D, 2021, PEERJ, V9, DOI 10.7717/peerj.11665; Lee D, 2022, KEIJO J MED, V71, P1, DOI [10.2302/kjm.2021-0004-IR, 10.2302/kjm.2021-0004-IR)]; Lee D, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14030223; Lee D, 2020, JOVE-J VIS EXP, DOI 10.3791/61865; Lee JW, 2004, EXP MOL MED, V36, P1, DOI 10.1038/emm.2004.1; Li Y, 2007, J BIOL CHEM, V282, P35803, DOI 10.1074/jbc.M705231200; Lin KH, 2015, CELL PHYSIOL BIOCHEM, V36, P334, DOI 10.1159/000374076; Liu SP, 2020, NUTR METAB, V17, DOI 10.1186/s12986-020-0432-x; Liu W, 2019, INVEST OPHTH VIS SCI, V60, P965, DOI 10.1167/iovs.18-26216; McKinnon SJ, 2009, EXP EYE RES, V88, P816, DOI 10.1016/j.exer.2008.12.002; Mendonca HR, 2018, BRAIN RES, V1700, P126, DOI 10.1016/j.brainres.2018.07.018; Muranishi Y, 2011, J NEUROSCI, V31, P16792, DOI 10.1523/JNEUROSCI.3109-11.2011; Nangia-Makker P, 2007, J BIOENERG BIOMEMBR, V39, P79, DOI 10.1007/s10863-006-9063-9; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Park SW, 2011, INVEST OPHTH VIS SCI, V52, P2837, DOI 10.1167/iovs.09-5010; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Salminen A, 2013, PROG NEUROBIOL, V106, P33, DOI 10.1016/j.pneurobio.2013.06.002; Samardzija M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52508-8; Sayyad Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17241-0; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Shao YX, 2019, INT J ONCOL, V54, P348, DOI 10.3892/ijo.2018.4603; Shelby SJ, 2015, EXP EYE RES, V137, P84, DOI 10.1016/j.exer.2015.06.016; Singh C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129398; Smedowski A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05910; Sowter HM, 2001, CANCER RES, V61, P6669; Sun L, 2014, FUTURE ONCOL, V10, P1387, DOI [10.2217/FON.14.70, 10.2217/fon.14.70]; Tezel G, 2004, ARCH OPHTHALMOL-CHIC, V122, P1348, DOI 10.1001/archopht.122.9.1348; Tual-Chalot S, 2013, JOVE-J VIS EXP, DOI 10.3791/50546; Uehara F, 2001, INVEST OPHTH VIS SCI, V42, P2164; Vidal-Sanz M, 2001, SURV OPHTHALMOL, V45, pS261, DOI 10.1016/S0039-6257(01)00205-3; Walls KC, 2009, J NEUROPATH EXP NEUR, V68, P1326, DOI 10.1097/NEN.0b013e3181c3b9be; Wang Y, 2015, BRAIN RES BULL, V117, P1, DOI 10.1016/j.brainresbull.2015.06.001; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Xue J, 2017, FEBS J, V284, P97, DOI 10.1111/febs.13955; Yang L, 2019, PEERJ, V7, DOI 10.7717/peerj.7165; Yang RY, 2003, CELL MOL LIFE SCI, V60, P267, DOI 10.1007/s000180300022; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhang XN, 2013, AUTOPHAGY, V9, P1321, DOI 10.4161/auto.25132; Zhao XR, 2018, MED SCI MONITOR, V24, P8722, DOI 10.12659/MSM.913384	65	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21829	10.1096/fj.202100572R	http://dx.doi.org/10.1096/fj.202100572R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314069				2022-12-26	WOS:000678975300014
J	Cabot, D; Brun, S; Paco, N; Ginesta, MM; Gendrau-Sanclemente, N; Abuasaker, B; Ruiz-Farina, T; Barcelo, C; Cuatrecasas, M; Bosch, M; Rentero, C; Pons, G; Estanyol, JM; Capella, G; Jaumot, M; Agell, N				Cabot, Debora; Brun, Sonia; Paco, Noelia; Ginesta, Mireia M.; Gendrau-Sanclemente, Nuria; Abuasaker, Baraa; Ruiz-Farina, Triana; Barcelo, Carles; Cuatrecasas, Miriam; Bosch, Marta; Rentero, Carles; Pons, Gabriel; Estanyol, Josep M.; Capella, Gabriel; Jaumot, Montserrat; Agell, Neus			KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer	ONCOGENE			English	Article							K-RAS; ONCOGENIC KRAS; ALPHA-CATENIN; CALMODULIN; EXPRESSION; PROTEINS; IDENTIFICATION; ASSOCIATION; PROMOTES; MODELS	Oncogenic mutations of KRAS are found in the most aggressive human tumors, including colorectal cancer. It has been suggested that oncogenic KRAS phosphorylation at Ser181 modulates its activity and favors cell transformation. Using nonphosphorylatable (S181A), phosphomimetic (S181D), and phospho-/dephosphorylatable (S181) oncogenic KRAS mutants, we analyzed the role of this phosphorylation to the maintenance of tumorigenic properties of colorectal cancer cells. Our data show that the presence of phospho-/dephosphorylatable oncogenic KRAS is required for preserving the epithelial organization of colorectal cancer cells in 3D cultures, and for supporting subcutaneous tumor growth in mice. Interestingly, gene expression differed according to the phosphorylation status of KRAS. In DLD-1 cells, CTNNA1 was only expressed in phospho-/dephosphorylatable oncogenic KRAS-expressing cells, correlating with cell polarization. Moreover, lack of oncogenic KRAS phosphorylation leads to changes in expression of genes related to cell invasion, such as SERPINE1, PRSS1,2,3, and NEO1, and expression of phosphomimetic oncogenic KRAS resulted in diminished expression of genes involved in enterocyte differentiation, such as HNF4G. Finally, the analysis, in a public data set of human colorectal cancer, of the gene expression signatures associated with phosphomimetic and nonphosphorylatable oncogenic KRAS suggests that this post-translational modification regulates tumor progression in patients.	[Cabot, Debora; Brun, Sonia; Paco, Noelia; Gendrau-Sanclemente, Nuria; Abuasaker, Baraa; Ruiz-Farina, Triana; Barcelo, Carles; Bosch, Marta; Rentero, Carles; Estanyol, Josep M.; Jaumot, Montserrat; Agell, Neus] Univ Barcelona, Fac Med & Ciencies Salut, Dept Biomed, Barcelona, Spain; [Cabot, Debora; Brun, Sonia; Paco, Noelia; Abuasaker, Baraa; Barcelo, Carles; Cuatrecasas, Miriam; Bosch, Marta; Rentero, Carles; Jaumot, Montserrat; Agell, Neus] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Ginesta, Mireia M.; Capella, Gabriel] Catalan Inst Oncol, Hosp Llobregat, Hereditary Canc Program, ICO IDIBELL,Translat Res Lab, Barcelona, Spain; [Ginesta, Mireia M.; Capella, Gabriel] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain; [Cuatrecasas, Miriam] Univ Barcelona, Dept Fonaments Clin, Fac Med & Ciencies Salut, Barcelona, Spain; [Cuatrecasas, Miriam] Hosp Clin Barcelona, Pathol Dept, Barcelona, Spain; [Cuatrecasas, Miriam] Hosp Clin Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Cuatrecasas, Miriam] Hosp Clin Barcelona, Tumor Bank Biobank, Barcelona, Spain; [Pons, Gabriel] Univ Barcelona, Fac Med & Ciencies Salut, Dept Ciencies Fisiol, Barcelona, Spain; [Pons, Gabriel] Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Estanyol, Josep M.] Univ Barcelona, Prote Unit, CCiT UB, Barcelona, Spain; [Gendrau-Sanclemente, Nuria] Hosp Duran & Reynals, Catalan Inst Oncol, Inst Invest Biomed Bellvitge IDIBELL, Program Canc Therapeut Resistance ProCURE, Barcelona, Spain; [Barcelo, Carles] Inst Invest Sanitaria Illes Balears IdISBa, Palma De Mallorca, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Institut Investigacio Sanitaria Illes Balears (IdISBa)	Jaumot, M; Agell, N (corresponding author), Univ Barcelona, Fac Med & Ciencies Salut, Dept Biomed, Barcelona, Spain.; Jaumot, M; Agell, N (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	mjaumot@ub.edu; neusagell@ub.edu	Rentero Alfonso, Carles/L-4430-2017; BARCELO, PhD, CARLES/K-4299-2014	Rentero Alfonso, Carles/0000-0003-4684-0278; Gendrau, Nuria/0000-0002-7761-3695; Bosch, Marta/0000-0003-3934-6781; Estanyol Ullate, Josep M/0000-0001-8621-0057; BARCELO, PhD, CARLES/0000-0003-2551-2136; Brun, Sonia/0000-0002-2056-3180; Agell, Neus/0000-0002-1205-6074; Jaumot, Montserrat/0000-0003-2864-357X; Morell Ginesta, Mireia/0000-0002-1708-0110	Ministerio de Economia y Competitividad; FEDER funds-a way to build Europe [SAF2016-76239-R, PID2019-105483RB-I00, SAF2015-68016-R]; CIBERONC; Government of Catalonia [2017SGR1282, SLT002/16/0037]; Instituto de Salud Carlos III [PI17/01304]; FPU fellowship from Ministerio de Educacion, Cultura y Deporte; Generalitat de Catalunya; University of Barcelona; Serra Hunter Program (Generalitat de Catalunya)	Ministerio de Economia y Competitividad(Spanish Government); FEDER funds-a way to build Europe; CIBERONC; Government of Catalonia(Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FPU fellowship from Ministerio de Educacion, Cultura y Deporte; Generalitat de Catalunya(Generalitat de Catalunya); University of Barcelona; Serra Hunter Program (Generalitat de Catalunya)(Generalitat de Catalunya)	We thank the personnel of the Advanced Microscopy Unit of CCiT-UB (Campus Clinic) for help in setting up image acquisition and analysis. This work was supported by grants from the Ministerio de Economia y Competitividad and co funded by FEDER funds-a way to build Europe- (SAF2016-76239-R and PID2019-105483RB-I00 to NA, SAF2015-68016-R to GC), CIBERONC and the Government of Catalonia (grants 2017SGR1282 and PERIS SLT002/16/0037), and from Instituto de Salud Carlos III (grant PI17/01304 to MC); a FPU fellowship from Ministerio de Educacion, Cultura y Deporte for DC, a FI fellowship from Generalitat de Catalunya for NP, and a Predoc-UB from University of Barcelona to BA; CR is supported by the Serra Hunter Program (Generalitat de Catalunya).	Alvarez-Moya B, 2010, ONCOGENE, V29, P5911, DOI 10.1038/onc.2010.298; Barcelo C, 2014, GASTROENTEROLOGY, V147, P882, DOI 10.1053/j.gastro.2014.06.041; Barcelo C, 2014, CANCER RES, V74, P1190, DOI 10.1158/0008-5472.CAN-13-1750; Barcelo C, 2013, J CELL SCI, V126, P4553, DOI 10.1242/jcs.123737; Berg KCG, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0691-y; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brookes MJ, 2006, GUT, V55, P1449, DOI 10.1136/gut.2006.094060; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chaturvedi V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40886-y; Compton CC, 2003, MODERN PATHOL, V16, P376, DOI 10.1097/01.MP.0000062859.46942.93; Cortazar AR, 2018, CANCER RES, V78, P6320, DOI 10.1158/0008-5472.CAN-18-1669; Elia AEH, 2015, MOL CELL, V60, P280, DOI 10.1016/j.molcel.2015.09.011; Garrido E, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006552; Gogarten SM, 2012, BIOINFORMATICS, V28, P3329, DOI 10.1093/bioinformatics/bts610; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Hou ZL, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0922-x; Hu DG, 2016, DRUG METAB REV, V48, P47, DOI 10.3109/03602532.2015.1131292; Humphries BA, 2019, MOL CANCER RES, V17, P1142, DOI 10.1158/1541-7786.MCR-18-0836; Inder KL, 2009, J BIOL CHEM, V284, P28410, DOI 10.1074/jbc.M109.001537; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee SK, 2018, EMBO REP, V19, DOI 10.15252/embr.201846060; Li SJ, 2018, BIOMED PHARMACOTHER, V105, P83, DOI 10.1016/j.biopha.2018.05.119; Lindeboom RGH, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20188227; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; Maher DM, 2011, MOL CANCER RES, V9, P531, DOI 10.1158/1541-7786.MCR-10-0443; Maiden SL, 2011, J CELL BIOL, V195, P543, DOI 10.1083/jcb.201103106; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Mouradov D, 2014, CANCER RES, V74, P3238, DOI 10.1158/0008-5472.CAN-14-0013; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roman-Fernandez A, 2016, TRAFFIC, V17, P1244, DOI 10.1111/tra.12417; Santiago L, 2017, AM J CANCER RES, V7, P1389; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Shibata H, 2007, P NATL ACAD SCI USA, V104, P18199, DOI 10.1073/pnas.0705730104; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Short SP, 2017, J CLIN INVEST, V127, P4462, DOI 10.1172/JCI77217; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vartanian S, 2013, J BIOL CHEM, V288, P2403, DOI 10.1074/jbc.M112.394130; Villalonga P, 2002, J BIOL CHEM, V277, P37929, DOI 10.1074/jbc.M202245200; Villalonga P, 2001, MOL CELL BIOL, V21, P7345, DOI 10.1128/MCB.21.21.7345-7354.2001; Wang Jingyu, 2018, Oncotarget, V9, P18018, DOI 10.18632/oncotarget.22933; Wang MT, 2015, CELL, V163, P1237, DOI 10.1016/j.cell.2015.10.041; Yamamoto H, 2003, J PATHOL, V199, P176, DOI 10.1002/path.1277; Yang MH, 2012, P NATL ACAD SCI USA, V109, P10843, DOI 10.1073/pnas.1201487109; Yin N, 2019, CANCER CELL, V36, P156, DOI 10.1016/j.ccell.2019.07.002	50	0	0	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 23	2021	40	38					5730	5740		10.1038/s41388-021-01967-3	http://dx.doi.org/10.1038/s41388-021-01967-3		JUL 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UU4CG	34333552	Green Accepted			2022-12-26	WOS:000679771600002
J	Dewau, R; Angaw, DA; Kassa, GM; Dagnew, B; Yeshaw, Y; Muche, A; Feleke, DG; Molla, E; Yehuala, ED; Tadesse, SE; Yalew, M; Fentaw, Z; Asfaw, AH; Andargie, A; Chanie, MG; Ayele, WM; Hassen, AM; Damtie, Y; Hussein, FM; Asfaw, ZA; Addisu, E; Adane, B; Ayele, FY; Kefale, B; Zerga, AA; Mekonnen, TC; Necho, M; Ebrahim, OA; Adane, M; Ayele, TA				Dewau, Reta; Angaw, Dessie Abebaw; Kassa, Getahun Molla; Dagnew, Baye; Yeshaw, Yigizie; Muche, Amare; Feleke, Dejen Getaneh; Molla, Eshetie; Yehuala, Enyew Dagnew; Tadesse, Sisay Eshete; Yalew, Melaku; Fentaw, Zinabu; Asfaw, Ahmed Hussien; Andargie, Assefa; Chanie, Muluken Genetu; Ayele, Wolde Melese; Hassen, Anissa Mohammed; Damtie, Yitayish; Hussein, Foziya Mohammed; Asfaw, Zinet Abegaz; Addisu, Elsabeth; Adane, Bezawit; Ayele, Fanos Yeshanew; Kefale, Bereket; Zerga, Aregash Abebayehu; Mekonnen, Tefera Chane; Necho, Mogesie; Ebrahim, Oumer Abdulkadir; Adane, Metadel; Ayele, Tadesse Awoke			Urban-rural disparities in institutional delivery among women in East Africa: A decomposition analysis	PLOS ONE			English	Article								Background Though institutional delivery plays a significant role in maternal and child health, there is substantial evidence that the majority of rural women have lower health facility delivery than urban women. So, identifying the drivers of these disparities will help policy-makers and programmers with the reduction of maternal and child death. Methods The study used the data on a nationwide representative sample from the most recent rounds of the Demographic and Health Survey (DHS) of four East African countries. A Blinder-Oaxaca decomposition analysis and its extensions was conducted to see the urban-rural differences in institutional delivery into two components: one that is explained by residence difference in the level of the determinants (covariate effects), and the other components was explained by differences in the effect of the covariates on the outcome (coefficient effects). Results The findings showed that institutional delivery rates were 21.00% in Ethiopia, 62.61% in Kenya, 65.29% in Tanzania and 74.64% in Uganda. The urban-rural difference in institutional delivery was higher in the case of Ethiopia (61%), Kenya (32%) and Tanzania (30.3%), while the gap was relatively lower in the case of Uganda (19.2%). Findings of the Blinder-Oaxaca decomposition and its extension showed that the covariate effect was dominant in all study countries. The results were robust to the different decomposition weighting schemes. The frequency of antenatal care, wealth and parity inequality between urban and rural households explains most of the institutional delivery gap. Conclusions The urban-rural institutional delivery disparities were high in study countries. By identifying the underlying factors behind the urban-rural institutional birth disparities, the findings of this study help in designing effective intervention measures targeted at reducing residential inequalities and improving population health outcomes. Future interventions to encourage institutional deliveries to rural women of these countries should therefore emphasize increasing rural women's income, access to health care facilities to increase the frequency of antenatal care utilization.	[Dewau, Reta; Muche, Amare; Fentaw, Zinabu; Andargie, Assefa; Ayele, Wolde Melese; Hassen, Anissa Mohammed; Adane, Bezawit] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Dessie, Ethiopia; [Angaw, Dessie Abebaw; Kassa, Getahun Molla; Ayele, Tadesse Awoke] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Dagnew, Baye; Yeshaw, Yigizie] Univ Gondar, Sch Med, Dept Physiol, Coll Med & Hlth Sci, Gondar, Ethiopia; [Feleke, Dejen Getaneh] Debretabor Univ, Dept Neonatal Nursing, Coll Med & Hlth Sci, Debretabor, Ethiopia; [Molla, Eshetie] Debretabor Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Debretabor, Ethiopia; [Yehuala, Enyew Dagnew] Debretabor Univ, Dept Midwifery, Coll Med & Hlth Sci, Debretabor, Ethiopia; [Tadesse, Sisay Eshete; Asfaw, Ahmed Hussien; Hussein, Foziya Mohammed; Ayele, Fanos Yeshanew; Zerga, Aregash Abebayehu; Mekonnen, Tefera Chane] Wollo Univ, Sch Publ Hlth, Dept Publ Hlth Nutr, Coll Med & Hlth Sci, Dessie, Ethiopia; [Yalew, Melaku; Damtie, Yitayish; Asfaw, Zinet Abegaz; Addisu, Elsabeth; Kefale, Bereket] Wollo Univ, Sch Publ Hlth, Dept Reprod & Family Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia; [Chanie, Muluken Genetu] Wollo Univ, Sch Publ Hlth, Dept Hlth Syst & Policy, Coll Med & Hlth Sci, Dessie, Ethiopia; [Necho, Mogesie] Wollo Univ, Dept Psychiat, Coll Med & Hlth Sci, Dessie, Ethiopia; [Ebrahim, Oumer Abdulkadir] Samara Univ, Dept Publ Hlth, Coll Hlth Sci, Assayta, Russia; [Adane, Metadel] Wollo Univ, Dept Environm Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia	University of Gondar; University of Gondar	Dewau, R (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Dessie, Ethiopia.	retadewau30@gmail.com	Mohammed, Anissa/GNP-7326-2022; muche, amare/GNW-4693-2022; Hussien, Foziya Mohammed/CAF-3288-2022; Mekonnen, Tefera Chane/AAC-8002-2021; Fentaw, Zinabu/ABB-7298-2021; Dewau, Reta/AAA-4202-2022; ayele, fanos/AAA-5299-2022; Adane, Metadel/AFQ-9478-2022; Dagnew, Baye/AAL-9572-2020	Mohammed, Anissa/0000-0002-1580-4269; Hussien, Foziya Mohammed/0000-0003-0583-5405; Dewau, Reta/0000-0001-6531-2468; Adane, Metadel/0000-0002-7039-4768; Dagnew, Baye/0000-0002-2397-5930; Genetu Chanie, MULUKEN/0000-0001-7059-1449; Kassa, Getahun Molla/0000-0002-9926-7797; Yeshaw, Yigizie/0000-0003-4587-7925; Getaneh Feleke, Dejen/0000-0002-0816-1744; Fentaw, Zinabu/0000-0002-4577-868X; Kefale Abitew, Bereket/0000-0003-1795-9886				Ali B, 2020, J BIOSOC SCI, V52, P198, DOI 10.1017/S0021932019000385; Alkema L, 2019, TRENDS MATERNAL MORT; Amporfu E, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1025-z; Amsalu Gashaw, 2015, BMC Research Notes, V8, P22, DOI 10.1186/s13104-014-0965-z; Arba MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151082; Assefa M, 2020, NURS OPEN, V7, P186, DOI 10.1002/nop2.378; Atuhaire S., 2020, OBSTET GYNECOL INT J, V11, P77, DOI [DOI 10.15406/OGIJ.2020.11.00492, 10.15406/ogij.2020.11.00492]; Cameron L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217386; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chernet Ayele Gebeyehu, 2019, J Reprod Infertil, V20, P102; COTTON J, 1988, REV ECON STAT, V70, P236, DOI 10.2307/1928307; Croft TN, 2018, GUIDE DHS STAT; Ethiopia CSA (CSA) [Ethiopia] and I, 2017, ETH DEM HLTH SURV 2 ETH DEM HLTH SURV 2; Gedilu T., 2018, J NURS CARE, V7, P2167, DOI [10.4172/2167-1168.1000449, DOI 10.4172/2167-1168.1000449]; Gitobu CM, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1708-2; Goli S, 2018, J BIOSOC SCI, V50, P749, DOI 10.1017/S0021932017000530; Goli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058573; Huda TM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211113; Ifa M., 2019, SCI J PUBLIC HEAL, V7, P38, DOI [10.11648/j.sjph.20190702.12, DOI 10.11648/J.SJPH.20190702.12]; Joseph G, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0192-2; Kebede A, 2016, INT J WOMENS HEALTH, V8, P463, DOI 10.2147/IJWH.S109498; Kenya National Bureau of Statistics Ministry of Health/Kenya National AIDS Control Council Kenya Medical Research Institute National Council for Population Development ICF International, 2014, KENYA DEMOGRAPHIC HL; Mazalale J, 2015, TROP MED INT HEALTH, V20, P617, DOI 10.1111/tmi.12473; Ministry of Health Ethiopia PMNCH WHO World Bank AHPSR Participants in the Ethiopia multistakeholder policy review, 2015, SUCC FACT WOM CHILDR; Noh JW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213987; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Powers DA, 2011, STATA J, V11, P556, DOI 10.1177/1536867X1101100404; REIMERS CW, 1983, REV ECON STAT, V65, P570, DOI 10.2307/1935925; Sadik W, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0782-x; Siraneh Y., 2018, J COMPLEMENT MED ALT, V8, P1, DOI [10.19080/JCMAH.2018.08.555736, DOI 10.19080/JCMAH.2018.08.555736]; Sudan Central Bureau of Statistics (CBS), 2016, MULT IND CLUST SURV, P2016; Teferra AS, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-74; UBOS ICF, 2018, UGANDA DEMOGRAPHIC H; Van Malderen C, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-3; WHO, 2019, WORLD HLTH STAT 2019; Yaya S, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001341; Yoseph M, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05121-9; Yun M-S., 2008, J ECON SOC MEAS, V33, P27, DOI [10.3233/jem-2008-0296, DOI 10.3233/JEM-2008-0296, 10.3233/JEM-2008-0296]; Yun MS, 2004, ECON LETT, V82, P275, DOI 10.1016/j.econlet.2003.09.008	39	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255094	10.1371/journal.pone.0255094	http://dx.doi.org/10.1371/journal.pone.0255094			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CU	34329310	Green Published, gold			2022-12-26	WOS:000685248600004
J	Jiao, WJ; Jia, XW; Liu, YT; Jiang, Q; Sun, ZY				Jiao, Wenjiang; Jia, Xingwu; Liu, Yuetong; Jiang, Qun; Sun, Ziyi			Single image mixed dehazing method based on numerical iterative model and DehazeNet	PLOS ONE			English	Article							OBJECT DETECTION	As one of the most common adverse weather phenomena, haze has caused detrimental effects on many computer vision systems. To eliminate the effect of haze, in the field of image processing, image dehazing has been studied intensively, and many advanced dehazing algorithms have been proposed. Physical model-based and deep learning-based methods are two competitive methods for single image dehazing, but it is still a challenging problem to achieve fidelity and effectively dehazing simultaneously in real hazy scenes. In this work, a mixed iterative model is proposed, which combines a physical model-based method with a learning-based method to restore high-quality clear images, and it has good performance in maintaining natural attributes and completely removing haze. Unlike previous studies, we first divide the image into different regions according to the density of haze to accurately calculate the atmospheric light for restoring haze-free images. Then, dark channel prior and DehazeNet are used to jointly estimate the transmission to promote the final clear haze-free image that is more similar to the real scene. Finally, a numerical iterative strategy is employed to further optimize the atmospheric light and transmission. Extensive experiments demonstrate that our method outperforms existing state-of-the-art methods on synthetic datasets and real-world datasets. Moreover, to indicate the universality of the proposed method, we further apply it to the remote sensing datasets, which can also produce visually satisfactory results.	[Jiao, Wenjiang] Shandong Univ, Sch Software, Jinan, Peoples R China; [Jia, Xingwu] Shandong Prov Publ Secur Dept, Vehicle Management Off, Jinan, Peoples R China; [Liu, Yuetong; Jiang, Qun; Sun, Ziyi] Shandong Univ Finance & Econ, Sch Comp Sci & Technol, Jinan, Peoples R China	Shandong University; Shandong University of Finance & Economics	Sun, ZY (corresponding author), Shandong Univ Finance & Econ, Sch Comp Sci & Technol, Jinan, Peoples R China.	sunziyi@mail.sdufe.edu.cn			National Natural Science Foundation of China [61972227, 61902217, U1909210]; Natural Science Foundation of Shandong Province [ZR2019MF051, ZR2020MF037, ZR2019BF043]; Primary Research and Development Plan of Shandong Province [2019GGX101007]; Fostering Project of Dominant Discipline and Talent Team of Shandong Province Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Primary Research and Development Plan of Shandong Province; Fostering Project of Dominant Discipline and Talent Team of Shandong Province Higher Education Institutions	This work was supported in part by the National Natural Science Foundation of China under Grant 61972227, 61902217, U1909210, in part by the Natural Science Foundation of Shandong Province under Grant ZR2019MF051, ZR2020MF037, ZR2019BF043, in part by the Primary Research and Development Plan of Shandong Province under Grant 2019GGX101007 and in part by the Fostering Project of Dominant Discipline and Talent Team of Shandong Province Higher Education Institutions.	Berman D, 2016, PROC CVPR IEEE, P1674, DOI 10.1109/CVPR.2016.185; Cai BL, 2016, IEEE T IMAGE PROCESS, V25, P5187, DOI 10.1109/TIP.2016.2598681; Cheng G, 2017, P IEEE, V105, P1865, DOI 10.1109/JPROC.2017.2675998; Cheng G, 2016, ISPRS J PHOTOGRAMM, V117, P11, DOI 10.1016/j.isprsjprs.2016.03.014; Cheng G, 2014, ISPRS J PHOTOGRAMM, V98, P119, DOI 10.1016/j.isprsjprs.2014.10.002; Dong H, 2020, PROC CVPR IEEE, P2154, DOI 10.1109/CVPR42600.2020.00223; Engin D, 2018, IEEE COMPUT SOC CONF, P938, DOI 10.1109/CVPRW.2018.00127; Fattal R, 2014, ACM T GRAPHIC, V34, DOI 10.1145/2651362; Fattal R, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360671; Fourure Damien, 2017, ARXIV170707958; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gibson KB, 2012, IEEE T IMAGE PROCESS, V21, P662, DOI 10.1109/TIP.2011.2166968; Goodfellow I., 2013, INT C MACH LEARN, P1319, DOI DOI 10.5555/3042817.3043084; Gu ZQ, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11243008; He KM, 2011, IEEE T PATTERN ANAL, V33, P2341, DOI 10.1109/TPAMI.2010.168; He KM, 2013, IEEE T PATTERN ANAL, V35, P1397, DOI 10.1109/TPAMI.2012.213; Hong M, 2020, PROC CVPR IEEE, P3459, DOI 10.1109/CVPR42600.2020.00352; Hu AN, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12244162; Jiang H, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10060945; Jiang H, 2018, REMOTE SENS LETT, V9, P627, DOI 10.1080/2150704X.2018.1456701; Li BY, 2019, IEEE T IMAGE PROCESS, V28, P492, DOI 10.1109/TIP.2018.2867951; Li BY, 2017, IEEE I CONF COMP VIS, P4780, DOI 10.1109/ICCV.2017.511; Li RD, 2018, PROC CVPR IEEE, P8202, DOI 10.1109/CVPR.2018.00856; Liu Q, 2018, IEEE T IMAGE PROCESS, V27, P5178, DOI 10.1109/TIP.2018.2849928; Liu XH, 2019, IEEE I CONF COMP VIS, P7313, DOI 10.1109/ICCV.2019.00741; Long J, 2014, IEEE GEOSCI REMOTE S, V11, P59, DOI 10.1109/LGRS.2013.2245857; Long Y, 2017, IEEE T GEOSCI REMOTE, V55, P2486, DOI 10.1109/TGRS.2016.2645610; Meng GF, 2013, IEEE I CONF COMP VIS, P617, DOI 10.1109/ICCV.2013.82; Narasimhan SG, 2002, INT J COMPUT VISION, V48, P233, DOI 10.1023/A:1016328200723; Pan XX, 2015, IEEE SIGNAL PROC LET, V22, P1806, DOI 10.1109/LSP.2015.2432466; Qu YY, 2019, PROC CVPR IEEE, P8152, DOI 10.1109/CVPR.2019.00835; Ren WQ, 2018, PROC CVPR IEEE, P3253, DOI 10.1109/CVPR.2018.00343; Ren WQ, 2016, LECT NOTES COMPUT SC, V9906, P154, DOI 10.1007/978-3-319-46475-6_10; Ronneberger O., 2015, P INT C MED IM COM, P234, DOI DOI 10.1007/978-3-319-24574-4_28; Shao YJ, 2020, PROC CVPR IEEE, P2805, DOI 10.1109/CVPR42600.2020.00288; Song T, 2020, INT J COMPUT VISION, V128, P799, DOI 10.1007/s11263-020-01294-2; Song YF, 2018, IEEE T MULTIMEDIA, V20, P1548, DOI 10.1109/TMM.2017.2771472; Sun Z., 2020, COMPUT VIS IMAGE UND, V203, P103; Tan RT, 2008, PROC CVPR IEEE, P2347, DOI 10.1109/cvpr.2008.4587643; Wang P, 2019, IEEE T CONSUM ELECTR, V65, P47, DOI 10.1109/TCE.2018.2884794; Xia GS, 2018, PROC CVPR IEEE, P3974, DOI 10.1109/CVPR.2018.00418; Xiao ZF, 2015, INT J REMOTE SENS, V36, P618, DOI 10.1080/01431161.2014.999881; Zhang H, 2018, PROC CVPR IEEE, P3194, DOI 10.1109/CVPR.2018.00337; Zhang J, 2020, IEEE T IMAGE PROCESS, V29, P72, DOI 10.1109/TIP.2019.2922837; Zhang YF, 2017, IEEE IMAGE PROC, P3205; Zhang YF, 2020, IEEE T CIRC SYST VID, V30, P3544, DOI 10.1109/TCSVT.2019.2939853; Zhu QS, 2015, IEEE T IMAGE PROCESS, V24, P3522, DOI 10.1109/TIP.2015.2446191	47	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0254664	10.1371/journal.pone.0254664	http://dx.doi.org/10.1371/journal.pone.0254664			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329312	gold, Green Published			2022-12-26	WOS:000685248600051
J	Miraglia, JL; Monteiro, CN; Romagnolo, AG; Gomes, RX; Mangueira, CP; Rosseto-Welter, EA; Souza, JG; dos Santos, MD; dos Santos, RN; Carvalho, KI; Bonfim, D				Miraglia, Joao Luiz; Nascimento Monteiro, Camila; Giannecchini Romagnolo, Alexandre; Xavier Gomes, Rafaela; Pitangueiras Mangueira, Cristovao; Aparecida Rosseto-Welter, Eliane; Gabriel Souza, Juliana; da Gloria dos Santos, Marina; Nogueira dos Santos, Ranier; I. Carvalho, Karina; Bonfim, Daiana			A seroprevalence survey of anti-SARS-CoV-2 antibodies among individuals 18 years of age or older living in a vulnerable region of the city of Sao Paulo, Brazil	PLOS ONE			English	Article							HEALTH	A second wave of COVID-19 has demonstrated how challenging it will be to achieve sustained control of the disease, even with vaccination underway in many countries. Therefore, it remains relevant to keep improving our understanding of the distribution of COVID-19, especially of asymptomatic individuals, among different populations, and particularly in vulnerable regions. Hence, this population-based serosurvey had the objective of estimating the prevalence of individuals 18 years of age or older infected by SARS-CoV-2, and the proportion of asymptomatic individuals, among a vulnerable population living in an urban setting. This was a cross-sectional single-stage cluster sampling serosurvey conducted between September and December of 2019, in a vulnerable region of the city of Sao Paulo, Brazil. Families covered by three public primary healthcare units represented the selected clusters. After study inclusion, participants were asked about signs and symptoms related to COVID-19, and had collected 10 mL of blood for serology testing. A total of 272 individuals from 185 families were included in the study, out of the 400 eligible individuals for inclusion, resulting in a non-response rate of 32%. The post stratified prevalence of individuals infected by SARS-CoV-2 was 45.2% (95% CI: 39.4-51.0%), with a proportion of asymptomatic cases of 30.2% (95% CI: 23.3-38.0%). This population-based serosurvey identified a greater prevalence of infected individuals by SARS-CoV-2 compared to data from the beginning of the pandemic, and from a recent citywide serosurvey, with a similar proportion of asymptomatic individuals. It demonstrated the value of primary healthcare services for disease surveillance activities, and the importance of more focused serosurveys, especially in vulnerable locations, and the need to evaluate new surveillance strategies to take into account asymptomatic cases.				joao.miraglia@einstein.br	Carvalho, Karina IL/J-6789-2012	Carvalho, Karina IL/0000-0002-7763-8139; Xavier Gomes, Rafaela/0000-0002-9072-0137; Miraglia, Joao Luiz/0000-0002-4788-6254				Abedi V, 2021, J RACIAL ETHN HEALTH, V8, P732, DOI [10.1007/s40615-020-00833-4, 10.1101/2020.04.26.20079756]; [Anonymous], 2020, LANCET, V395, P1461, DOI 10.1016/S0140-6736(20)31095-3; Barrozo LV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232074; Cavalcante JR, 2020, EPIDEMIOL SERV SAUDE, V29, DOI [10.5123/s1679-49742020000400010, 10.5123/S1679-49742020000400010]; Deckert A, 2021, TRIALS, V22, DOI 10.1186/s13063-020-04982-z; del Rio C, 2021, JAMA-J AM MED ASSOC, V325, P1389, DOI 10.1001/jama.2021.3760; Diaz RS, 2021, BRAZ J INFECT DIS, V25, DOI 10.1016/j.bjid.2020.101537; Eckerle I, 2020, LANCET, V396, P514, DOI 10.1016/S0140-6736(20)31482-3; Fontanet A, 2021, LANCET, V397, P952, DOI 10.1016/S0140-6736(21)00370-6; Forni G, 2021, CELL DEATH DIFFER, V28, P626, DOI 10.1038/s41418-020-00720-9; de Souza CDF, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa145; Gandhi M, 2020, NEW ENGL J MED, V382, P2158, DOI 10.1056/NEJMe2009758; Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Horta BL, 2020, REV PANAM SALUD PUBL, V44, P1, DOI 10.26633/RPSP.2020.135; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Macinko J, 2015, NEW ENGL J MED, V372, P2177, DOI 10.1056/NEJMp1501140; Massuda A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000829; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; R Core Team, 2020, R LANG ENV STAT COMP; Rostami A, 2021, CLIN MICROBIOL INFEC, V27, P331, DOI 10.1016/j.cmi.2020.10.020; Secretaria Municipa de Saude-Sao Paulo, FLUX AT COV 19, P2021; Secretaria Municipa de Saude-Sao Paulo, 2021, AR ABR UN BAS SAUD M; Secretaria Municipal da Saude de, 2021, SAO PAUL COVID 19 AC; Secretaria Municipal da Saude de Sao Paulo, 2020, B DIAR COV 19; Shental N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5961; Thevarajan I, 2020, MED J AUSTRALIA, V213, P134, DOI 10.5694/mja2.50698; Van Rossum G, 2009, PYTHON 3 REFERENCE M, DOI DOI 10.5555/1593511; WHO, 2020, COR; WHO Regional Office for Europe, 2013, GUID COND SER SUPP M; World Health Organization, 2020, GEN TIM WHOS RESP CO; Yanes-Lane M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241536	33	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255412	10.1371/journal.pone.0255412	http://dx.doi.org/10.1371/journal.pone.0255412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324603	Green Published, gold			2022-12-26	WOS:000685248200017
J	Perez-Arancibia, R; Ordonez, JL; Rivas, A; Pihan, P; Sagredo, A; Ahumada, U; Barriga, A; Seguel, I; Cardenas, C; Vidal, RL; Hetz, C; Delporte, C				Perez-Arancibia, Rodrigo; Ordonez, Jose Luis; Rivas, Alexis; Pihan, Philippe; Sagredo, Alfredo; Ahumada, Ulises; Barriga, Andres; Seguel, Ivette; Cardenas, Cesar; Vidal, Rene L.; Hetz, Claudio; Delporte, Carla			A phenolic-rich extract from Ugni molinae berries reduces abnormal protein aggregation in a cellular model of Huntington's disease	PLOS ONE			English	Article							BETA-AMYLOID AGGREGATION; MOUSE MODEL; POLYPHENOLS; AUTOPHAGY; OLIGOMERIZATION; PROTEOSTASIS; ACTIVATION; MECHANISMS; SENESCENCE; QUERCETIN	Accumulation of misfolded proteins in the brain is a common hallmark of most age-related neurodegenerative diseases. Previous studies from our group identified the presence of anti-inflammatory and antioxidant compounds in leaves derived from the Chilean berry Ugni molinae (murtilla), in addition to show a potent anti-aggregation activity in models of Alzheimer ' s disease. However, possible beneficial effects of berry extracts of murtilla was not investigated. Here we evaluated the efficacy of fruit extracts from different genotypes of Chilean-native U. molinae on reducing protein aggregation using cellular models of Huntington ' s disease and assess the correlation with their chemical composition. Berry extraction was performed by exhaustive maceration with increasing-polarity solvents. An unbiased automatic microscopy platform was used for cytotoxicity and protein aggregation studies in HEK293 cells using polyglutamine-EGFP fusion proteins, followed by secondary validation using biochemical assays. Phenolic-rich extracts from murtilla berries of the 19-1 genotype (ETE 19-1) significantly reduced polyglutamine peptide aggregation levels, correlating with the modulation in the expression levels of autophagy-related proteins. Using LC-MS and molecular network analysis we correlated the presence of flavonoids, phenolic acids, and ellagitannins with the protective effects of ETE 19-1 effects on protein aggregation. Overall, our results indicate the presence of bioactive components in ethanolic extracts from U. molinae berries that reduce the load of protein aggregates in living cells.	[Perez-Arancibia, Rodrigo; Ordonez, Jose Luis; Seguel, Ivette; Delporte, Carla] Univ Chile, Fac Ciencias Quim & Farmaceut, Lab Prod Nat, Dept Quim Farmacol & Toxicol, Santiago, Chile; [Perez-Arancibia, Rodrigo; Rivas, Alexis; Pihan, Philippe; Sagredo, Alfredo; Vidal, Rene L.; Hetz, Claudio] Univ Chile, Fac Med, Inst Neurociencia Biomed BNI, Santiago, Chile; [Perez-Arancibia, Rodrigo; Rivas, Alexis; Pihan, Philippe; Sagredo, Alfredo; Ahumada, Ulises; Cardenas, Cesar; Vidal, Rene L.; Hetz, Claudio] Ctr FONDAP Gerociencia Salud Mental & Metab, Santiago, Chile; [Perez-Arancibia, Rodrigo; Ahumada, Ulises; Cardenas, Cesar; Vidal, Rene L.] Univ Mayor, Fac Ciencias, Ctr Biol Integrat, Santiago, Chile; [Ordonez, Jose Luis] Univ Chile, Lab Quim Inorgan & Analit, Dept Quim Inorgan & Analit, Santiago, Chile; [Rivas, Alexis; Pihan, Philippe; Sagredo, Alfredo; Hetz, Claudio] Univ Chile, Programa Biol & Celular Mol, Inst Ciencias Biomed, Santiago, Chile; [Barriga, Andres] Univ Chile, Unidad Espectrometria Masas, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Cardenas, Cesar] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Cardenas, Cesar; Hetz, Claudio] Buck Inst Res Aging, Novato, CA 94945 USA	Universidad de Chile; Universidad de Chile; Universidad Mayor; Universidad de Chile; Universidad de Chile; Universidad de Chile; University of California System; University of California Santa Barbara; Buck Institute for Research on Aging	Delporte, C (corresponding author), Univ Chile, Fac Ciencias Quim & Farmaceut, Lab Prod Nat, Dept Quim Farmacol & Toxicol, Santiago, Chile.; Hetz, C (corresponding author), Univ Chile, Fac Med, Inst Neurociencia Biomed BNI, Santiago, Chile.; Hetz, C (corresponding author), Ctr FONDAP Gerociencia Salud Mental & Metab, Santiago, Chile.; Hetz, C (corresponding author), Univ Chile, Programa Biol & Celular Mol, Inst Ciencias Biomed, Santiago, Chile.; Hetz, C (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	chetz@uchile.cl; cdelpor@uchile.cl	Vidal, Rene Luis/S-7154-2019; Pérez-Arancibia, Rodrigo/ABD-5275-2021; Pérez-Arancibia, Rodrigo/ABE-7554-2021; Hetz, Claudio/ABD-7514-2021	Pérez-Arancibia, Rodrigo/0000-0002-7180-8547; vidal, rene/0000-0002-4305-7387	ANID-Chile (Agencia Nacional de Investigacion y Desarrollo) [21150769, 21150851]; FONDECYT [1140549, 1191003, 1180186, 3190738, 3210294, 1200255, 1130155]; FUNDACION COPEC-UC grant [2013.R.40]; FONDEQUIP [EQM120164]; Millennium Institute [P09-015-F]; ANID/FONDAP program [15150012]; FONDEF [ID11E1007, ID16I10223]; CONICYT-Brazil [441921/2016-7]; Michael J Fox Foundation for Parkinson's Research [9277]; European Commission RD MSCA-RISE [734749]; U.S. Air Force Office of Scientific Research [FA9550-16-1-0384]; US Office of Naval Research-Global (ONR-G) [N62909-16-1-2003]	ANID-Chile (Agencia Nacional de Investigacion y Desarrollo); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FUNDACION COPEC-UC grant; FONDEQUIP; Millennium Institute(Takeda Pharmaceutical Company Ltd); ANID/FONDAP program; FONDEF; CONICYT-Brazil; Michael J Fox Foundation for Parkinson's Research; European Commission RD MSCA-RISE; U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US Office of Naval Research-Global (ONR-G)(Office of Naval Research)	This work was financially supported by ANID-Chile (Agencia Nacional de Investigacion y Desarrollo -www.ANID.cl) grants for Doctoral studies No 21150769 (RPA) and No 21150851 (JLO), FONDECYT 1130155 (CDV), FUNDACION COPEC-UC grant 2013.R.40 (AR), FONDEQUIP EQM120164 (CH), and Millennium Institute P09-015-F (RLV/CH). We also thank the support from ANID/FONDAP program 15150012 (RLV/CH), FONDECYT 1191003 (RLV), FONDECYT 1180186 (CH), FONDECYT 3190738 (AS), FONDECYT 3210294 (PP), FONDECYT 1200255 (CC), FONDECYT 1140549, FONDEF ID16I10223, FONDEF ID11E1007, CONICYT-Brazil 441921/2016-7, Michael J Fox Foundation for Parkinson's Research -Target Validation grant 9277 (www.michaeljfox.org/) (CH), European Commission R&D MSCA-RISE 734749 (ec.europa.eu) (CH). In addition, we would like to thank the support from the U.S. Air Force Office of Scientific Research FA9550-16-1-0384, US Office of Naval Research-Global (ONR-G) N62909-16-1-2003 (CH).	Ashrafizadeh M, 2020, PHYTOTHER RES, V34, P911, DOI 10.1002/ptr.6577; Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Boncler M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180022; Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000; Cordeiro LM, 2020, FOOD CHEM TOXICOL, V141, DOI 10.1016/j.fct.2020.111323; Croce KR, 2019, NEUROBIOL DIS, V122, P16, DOI 10.1016/j.nbd.2018.08.010; Das S, 2016, FOOD FUNCT, V7, P1138, DOI [10.1039/c5fo01281c, 10.1039/C5FO01281C]; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Di Prospero NA, 2005, NAT REV GENET, V6, P756, DOI 10.1038/nrg1690; Dufey E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15694-y; Fuentes-Retamal S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020407; Grabska-Kobylecka I, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051531; Grujicic D, 2020, MUTAT RES-GEN TOX EN, V852, DOI 10.1016/j.mrgentox.2020.503168; Hanaki M, 2016, BIOORGAN MED CHEM, V24, P304, DOI 10.1016/j.bmc.2015.12.021; Hetz C, 2021, CELL, V184, P1545, DOI 10.1016/j.cell.2021.02.007; Hwang HV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190374; Illarioshkin SN, 2018, BIOCHEMISTRY-MOSCOW+, V83, P1030, DOI 10.1134/S0006297918090043; Jara-Moreno D, 2020, CURR PHARM DESIGN, V26, P1365, DOI 10.2174/1381612826666200113160840; Jara-Moreno D, 2018, J ALZHEIMERS DIS, V66, P1175, DOI 10.3233/JAD-180174; Javed H, 2019, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01555; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Kirkland JL, 2020, J INTERN MED, V288, P518, DOI 10.1111/joim.13141; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koch W, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051039; Koli R, 2010, J AGR FOOD CHEM, V58, P3927, DOI 10.1021/jf9024823; Le L, 2019, PHYTOMEDICINE, V53, P193, DOI 10.1016/j.phymed.2018.09.005; Lieberman AP, 2019, ANNU REV PATHOL-MECH, V14, P1, DOI 10.1146/annurev-pathmechdis-012418-012857; de Dicastillo CL, 2017, FOOD RES INT, V102, P119, DOI 10.1016/j.foodres.2017.09.073; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Musi N, 2018, AGING CELL, V17, DOI 10.1111/acel.12840; Nabavi SF, 2018, BIOTECHNOL ADV, V36, P1768, DOI 10.1016/j.biotechadv.2017.12.001; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Pedro AC, 2016, FOOD CHEM, V191, P12, DOI 10.1016/j.foodchem.2015.02.045; Pena-Cerda M, 2017, FOOD CHEM, V215, P219, DOI 10.1016/j.foodchem.2016.07.159; Pierzynowska K, 2018, NEUROMOL MED, V20, P112, DOI 10.1007/s12017-018-8482-1; Regitz C, 2014, MOL NUTR FOOD RES, V58, P1931, DOI 10.1002/mnfr.201400014; Robbins PD, 2021, ANNU REV PHARMACOL, V61, P779, DOI 10.1146/annurev-pharmtox-050120-105018; Seguel I., 2015, MURTILLA BERRY SILVE, V2015, P2; Shao Z, 2021, OSTEOARTHR CARTILAGE, V29, P413, DOI 10.1016/j.joca.2020.11.006; Soto C, 2018, NAT NEUROSCI, V21, P1332, DOI 10.1038/s41593-018-0235-9; Sun X, 2020, FOOD FUNCT, V11, P1334, DOI [10.1039/c9fo02131k, 10.1039/C9FO02131K]; Tsai YH, 2019, AM J CHINESE MED, V47, P841, DOI 10.1142/S0192415X19500447; Ueda T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03115-y; Valionyte E, 2020, J MOL BIOL, V432, P2673, DOI 10.1016/j.jmb.2019.11.012; Wang J, 2008, J NEUROSCI, V28, P6388, DOI 10.1523/JNEUROSCI.0364-08.2008; Wang J, 2010, TRANSL NEUROSCI, V1, P95, DOI 10.2478/v10134-010-0022-y; Wang L, 2019, FOOD CHEM TOXICOL, V124, P239, DOI 10.1016/j.fct.2018.12.001; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Wang SW, 2012, NEUROTOXICOLOGY, V33, P482, DOI 10.1016/j.neuro.2012.03.003; Wyrepkowski CC, 2014, MOLECULES, V19, P16039, DOI 10.3390/molecules191016039; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang PS, 2019, NAT NEUROSCI, V22, P719, DOI 10.1038/s41593-019-0372-9	53	5	5	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254834	10.1371/journal.pone.0254834	http://dx.doi.org/10.1371/journal.pone.0254834			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324551	gold, Green Published			2022-12-26	WOS:000685248200023
J	Guo, XD; Tong, JB; Chen, PY; Fan, WH				Guo, Xudong; Tong, Junbo; Chen, Peiyu; Fan, Wenhui			The suppression effect of emotional contagion in the COVID-19 pandemic: A multi-layer hybrid modelling and simulation approach	PLOS ONE			English	Article							CHINA; SEIR	The entire world has suffered a lot since the outbreak of the novel coronavirus (COVID-19) in 2019, so simulation models of COVID-19 dynamics are urgently needed to understand and control the pandemic better. Meanwhile, emotional contagion, the spread of vigilance or panic, serves as a negative feedback to the epidemic, but few existing models take it into consideration. In this study, we proposed an innovative multi-layer hybrid modelling and simulation approach to simulate disease transmission and emotional contagion together. In each layer, we used a hybrid simulation method combining agent-based modelling (ABM) with system dynamics modelling (SDM), keeping spatial heterogeneity while reducing computation costs. We designed a new emotion dynamics model IWAN (indifferent, worried, afraid and numb) to simulate emotional contagion inside a community during an epidemic. Our model was well fit to the data of China, the UK and the US during the COVID-19 pandemic. If there weren't emotional contagion, our experiments showed that the confirmed cases would increase rapidly, for instance, the total confirmed cases during simulation in Guangzhou, China would grow from 334 to 2096, which increased by 528%. We compared the calibrated emotional contagion parameters of different countries and found that the suppression effect of emotional contagion in China is relatively more visible than that in the US and the UK. Due to the experiment results, the proposed multi-layer network model with hybrid simulation is valid and can be applied to the quantitative analysis of the epidemic trends and the suppression effect of emotional contagion in different countries. Our model can be modified for further research to study other social factors and intervention policies in the COVID-19 pandemic or future epidemics.	[Guo, Xudong; Tong, Junbo; Chen, Peiyu; Fan, Wenhui] Tsinghua Univ, Dept Automat, Beijing, Peoples R China	Tsinghua University	Guo, XD (corresponding author), Tsinghua Univ, Dept Automat, Beijing, Peoples R China.	gxd20@mails.tsinghua.edu.cn	Guo, Xudong/CAG-5824-2022	Tong, Junbo/0000-0002-7433-0788; Guo, Xudong/0000-0002-9607-2679				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; [Anonymous], 2020, OFF UK GOV WEBS DAT; [Anonymous], 2021, NATL BUREAU STAT PEO; Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Chen GH, 2015, PHYSICA A, V417, P345, DOI 10.1016/j.physa.2014.09.055; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Cuevas E, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103827; Fast SM, 2014, THESIS MIT MASSACHUS; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Grieshober L, 2014, SOC NETW ANAL MIN, V4, DOI 10.1007/s13278-014-0183-7; Kasereka S, 2014, 2014 4TH INTERNATIONAL SYMPOSIUM ISKO-MAGHREB: CONCEPTS AND TOOLS FOR KNOWLEDGE MANAGEMENT (ISKO-MAGHREB); Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; LI MY, 1995, MATH BIOSCI, V125, P155, DOI 10.1016/0025-5564(95)92756-5; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Lindzey G., 1968, HDB SOCIAL PSYCHOL; Mahmud M.S., 2020, J APPL LIFE SCI INT, V23, P20, DOI [DOI 10.9734/JALSI/2020/V23I330150, 10.9734/jalsi/2020/v23i330150]; Mrvar A, 2016, COMPLEX ADAPT SYST M, V4, DOI 10.1186/s40294-016-0017-8; Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50; Pharmaceutical Technology,, 2020, WHO DECL COV OUTBR P; Stavrova O, 2015, J RES PERS, V58, P1, DOI 10.1016/j.jrp.2015.06.005; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; United States Census Bureau, 2019, 2019 NAT STAT POP ES; USAFACTS,, 2020, US COR CAS DEATHS; Wang Y, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002794; Xiong X, 2018, PHYSICA A, V490, P185, DOI 10.1016/j.physa.2017.08.025; Yang ZF, 2020, J THORAC DIS, V12, P165, DOI 10.21037/jtd.2020.02.64; Yu B, 2010, LECT NOTES COMPUT SC, V6007, P199; Zanette DH, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041908; Zavascki AP, 2020, NEW ENGL J MED, V382, P1859, DOI 10.1056/NEJMc2005203; Zeng RX, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50770-4	30	2	2	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0253579	10.1371/journal.pone.0253579	http://dx.doi.org/10.1371/journal.pone.0253579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320025	gold, Green Published			2022-12-26	WOS:000685247800034
J	Espin, LX; Asp, AJ; Trevathan, JK; Ludwig, KA; Lujan, JL				Espin, Leonardo X.; Asp, Anders J.; Trevathan, James K.; Ludwig, Kip A.; Lujan, J. Luis			Integral methods for automatic quantification of fast-scan-cyclic-voltammetry detected neurotransmitters	PLOS ONE			English	Article							EXTRACELLULAR DOPAMINE; BRAIN; RELEASE	Modern techniques for estimating basal levels of electroactive neurotransmitters rely on the measurement of oxidative charges. This requires time integration of oxidation currents at certain intervals. Unfortunately, the selection of integration intervals relies on ad-hoc visual identification of peaks on the oxidation currents, which introduces sources of error and precludes the development of automated procedures necessary for analysis and quantification of neurotransmitter levels in large data sets. In an effort to improve charge quantification techniques, here we present novel methods for automatic selection of integration boundaries. Our results show that these methods allow quantification of oxidation reactions both in vitro and in vivo and of multiple analytes in vitro.	[Espin, Leonardo X.; Ludwig, Kip A.; Lujan, J. Luis] Dept Neurol Surg, Rochester, MN 55905 USA; [Asp, Anders J.; Trevathan, James K.] Mayo Clin, Grad Sch Biomed Sci, Rochester, MN 55905 USA; [Lujan, J. Luis] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Lujan, JL (corresponding author), Dept Neurol Surg, Rochester, MN 55905 USA.; Lujan, JL (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA.	lujan.luis@mayo.edu		Espin, Leonardo/0000-0002-2671-2458; Ludwig, Kip/0000-0003-4889-1941	National Institutes of Health [R01 NS084975]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health grant R01 NS084975 awarded to J. Luis Lujan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.nih.gov/.	Atcherley CW, 2015, CHEM COMMUN, V51, P2235, DOI 10.1039/c4cc06165a; Atcherley CW, 2013, LANGMUIR, V29, P14885, DOI 10.1021/la402686s; Burrell MH, 2015, ACS CHEM NEUROSCI, V6, P1802, DOI 10.1021/acschemneuro.5b00120; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; JACKSON BP, 1995, ANAL CHEM, V67, P1115, DOI 10.1021/ac00102a015; Jang DP, 2012, ANALYST, V137, P1428, DOI 10.1039/c2an15912k; KAWAGOE KT, 1993, J ELECTROANAL CHEM, V359, P193, DOI 10.1016/0022-0728(93)80409-B; Lee KH, 2017, SCI REP-UK, V7, DOI 10.1038/srep46675; Logman MJ, 2000, J NEUROSCI METH, V95, P95, DOI 10.1016/S0165-0270(99)00155-7; Lu Y, 1998, J NEUROCHEM, V70, P584; Nawab S.H., 1996, SIGNALS SYSTEMS, V2; Oh Y, 2016, ANAL CHEM, V88, P10962, DOI 10.1021/acs.analchem.6b02605; Park J, 2011, J NEUROCHEM, V119, P932, DOI 10.1111/j.1471-4159.2011.07494.x; Phillips PEM, 2003, METH MOLEC MED, V79, P443; Robinson DL, 2003, CLIN CHEM, V49, P1763, DOI 10.1373/49.10.1763; Robinson DL, 2008, CHEM REV, V108, P2554, DOI 10.1021/cr068081q; Takmakov P, 2010, ANAL CHEM, V82, P9892, DOI 10.1021/ac102399n; WIEDEMANN DJ, 1991, ANAL CHEM, V63, P2965, DOI 10.1021/ac00024a030; WIGHTMAN RM, 1988, NEUROSCIENCE, V25, P513, DOI 10.1016/0306-4522(88)90255-2; WIPF DO, 1989, J ELECTROANAL CHEM, V269, P15, DOI 10.1016/0022-0728(89)80100-7	21	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254594	10.1371/journal.pone.0254594	http://dx.doi.org/10.1371/journal.pone.0254594			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310610	Green Published, gold, Green Submitted			2022-12-26	WOS:000685224500023
J	Malina, RM; Coelho-e-Silva, MJ; Martinho, DV; Sousa-e-Siva, P; Figueiredo, AJ; Cumming, SP; Kralik, M; Koziel, SM				Malina, Robert M.; Coelho-e-Silva, Manuel J.; Martinho, Diogo V.; Sousa-e-Siva, Paulo; Figueiredo, Antonio J.; Cumming, Sean P.; Kralik, Miroslav; Koziel, Slawomir M.			Observed and predicted ages at peak height velocity in soccer players	PLOS ONE			English	Article							MATURITY OFFSET; PHYSICAL PERFORMANCE; LONGITUDINAL SAMPLE; BIOLOGICAL MATURITY; SOMATIC MATURITY; MUSCLE STRENGTH; MATURATION; VALIDATION; FITNESS; ANTHROPOMETRY	The purpose of the study was to evaluate predicted maturity offset (time before age at PHV) and age at PHV (chronological age [CA] minus maturity offset) in a longitudinal sample of 58 under-13 club level soccer players in central Portugal for whom ages at PHV were estimated with the SITAR model. Two maturity offset prediction equations were applied: the original equation which requires CA sitting height, estimated leg length, height and weight, and a modified equation which requires CA and height. Predicted maturity offset increased, on average, with CA at prediction throughout the age range considered, while variation in predicted maturity offset and ages at PHV within CA groups was considerably reduced compared to variation in observed ages at offset and at PHV. Predicted maturity offset and ages at PHV were consistently later than observed maturity offset and age at PHV among early maturing players, and earlier than observed in late maturing players. Both predicted offset and ages at PHV with the two equations were, on average, later than observed among players maturing on time. Intra-individual variation in predicted ages at PHV with each equation was considerable. The results for soccer players were consistent with similar studies in the general population and two recent longitudinal studies of soccer players. The results question the utility of predicted maturity offset and age at PHV as valid indicators of maturity timing and status.	[Malina, Robert M.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA; [Malina, Robert M.] Univ Louisville, Sch Publ Hlth & Informat Sci, Louisville, KY 40292 USA; [Coelho-e-Silva, Manuel J.; Martinho, Diogo V.; Sousa-e-Siva, Paulo; Figueiredo, Antonio J.] Univ Coimbra, FCDEF, Coimbra, Portugal; [Coelho-e-Silva, Manuel J.; Martinho, Diogo V.; Sousa-e-Siva, Paulo; Figueiredo, Antonio J.] Univ Coimbra, CIDAF Uiddtp 04213 2020, Coimbra, Portugal; [Cumming, Sean P.] Univ Bath, Dept Hlth, Bath, Avon, England; [Kralik, Miroslav] Masaryk Univ, Fac Sci, Dept Anthropol, Brno, Czech Republic; [Koziel, Slawomir M.] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Anthropol, Wroclaw, Poland	University of Texas System; University of Texas Austin; University of Louisville; Universidade de Coimbra; Universidade de Coimbra; University of Bath; Masaryk University Brno; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Coelho-e-Silva, MJ (corresponding author), Univ Coimbra, FCDEF, Coimbra, Portugal.; Coelho-e-Silva, MJ (corresponding author), Univ Coimbra, CIDAF Uiddtp 04213 2020, Coimbra, Portugal.	mjcesilva@hotmail.com	Králík, Miroslav/D-4702-2013; Coelho-e-Silva, Manuel/V-1645-2017	Králík, Miroslav/0000-0002-2077-4068; Martinho, Diogo/0000-0003-0825-4032; Moura Relvas de Sousa e Silva, Paulo/0000-0001-8642-5947; Figueiredo, Antonio/0000-0001-6956-0514; Coelho-e-Silva, Manuel/0000-0003-4512-7331	PAFID [289/2005]; Technology Agency of the Czech Republic [TL01000394]; Portuguese Foundation for Science and Technology (FCT) [uid/dtp/04213/2020]; FCT [SFRH/BD/121441/2016, SFRH/BD/138608/2018]	PAFID; Technology Agency of the Czech Republic; Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by PAFID 289/2005 to MJCeS and the Technology Agency of the Czech Republic TL01000394, 2018-2021, title: Poc tacov podpora pro analyzu a predikci rustu avvyvoje d tete to MK. MJCeS, AJF, DVM and PSeS are integrated members of CIDAF research unit (uid/dtp/04213/2020) supported by the Portuguese Foundation for Science and Technology (FCT). DM and PSeS are granted by the FCT (SFRH/BD/121441/2016; SFRH/BD/138608/2018).	Abbott S, 2021, J SCI MED SPORT, V24, P397, DOI 10.1016/j.jsams.2020.10.003; Agostinete RR, 2020, MED SCI SPORT EXER, V52, P2673, DOI 10.1249/MSS.0000000000002420; Teunissen JW, 2020, ANN HUM BIOL, V47, P409, DOI 10.1080/03014460.2020.1783360; Asadi A, 2020, J MATERN-FETAL NEO M, V33, P1958, DOI 10.1080/14767058.2018.1530756; Balyi I., 2004, WINDOWS OPPORTUNITY, P1; Balyi I., 2005, CANADIAN SPORT LIFE; Borges PH, 2018, J HUM KINET, V64, P160, DOI 10.1515/hukin-2017-0190; Brownstein CG, 2018, PEDIATR EXERC SCI, V30, P500, DOI 10.1123/pes.2017-0240; Buchheit M, 2013, J SPORT SCI, V31, P1332, DOI 10.1080/02640414.2013.781662; Campa F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234711; Cao Z., 2018, IAPVBS INDIVIDUAL AG; Cole T., 2020, SITAR: Super Imposition by Translation and Rotation Growth Curve Analysis. R package version 1.1.2; Cole TJ, 2010, INT J EPIDEMIOL, V39, P1558, DOI 10.1093/ije/dyq115; CORNBLEET PJ, 1979, CLIN CHEM, V25, P432; Cripps AJ, 2016, PEDIATR EXERC SCI, V28, P535, DOI 10.1123/pes.2015-0238; Deprez D, 2015, J SPORT SCI, V33, P243, DOI 10.1080/02640414.2014.934707; Deprez DN, 2015, J STRENGTH COND RES, V29, P1692, DOI 10.1519/JSC.0000000000000806; Doncaster G, 2018, PEDIATR EXERC SCI, V30, P216, DOI 10.1123/pes.2017-0185; Eveleth P.B., 1976, WORLDWIDE VARIATION, V8; Eveleth PB, 1990, WORLDWIDE VARIATION; Figueiredo AJ, 2009, ANN HUM BIOL, V36, P60, DOI 10.1080/03014460802570584; Franco-Marquez F, 2015, INT J SPORTS MED, V36, P906, DOI 10.1055/s-0035-1548890; Fransen J, 2018, PEDIATR EXERC SCI, V30, P296, DOI 10.1123/pes.2017-0009; Gibson NV, 2018, SCI MED FOOTBALL, V2, P281, DOI 10.1080/24733938.2018.1461235; Gibson NV, 2018, SCI MED FOOTBALL, V2, P288, DOI 10.1080/24733938.2018.1470664; Goncalves RR, 2011, ANN RES SPORT PHYS A, V1, P71, DOI [10.14195/2182-7087_1_4, DOI 10.14195/2182-7087_1_4]; Hammami R, 2016, PEDIATR EXERC SCI, V28, P521, DOI 10.1123/pes.2015-0231; Hammami R, 2016, J STRENGTH COND RES, V30, P3278, DOI 10.1519/JSC.0000000000001425; Harriss DJ, 2019, INT J SPORTS MED, V40, P813, DOI 10.1055/a-1015-3123; Camacho JDH, 2018, REV ESP NUTR HUM DIE, V22, P219, DOI 10.14306/renhyd.22.3.468; ivkovic M., 2019, FACTA U SERIES PHYS, V17, P125; Jakovljevic S, 2016, INT J MORPHOL, V34, P637, DOI 10.4067/S0717-95022016000200035; John C, 2019, GAIT POSTURE, V68, P18, DOI 10.1016/j.gaitpost.2018.10.036; Koziel SM, 2018, SPORTS MED, V48, P221, DOI 10.1007/s40279-017-0750-y; Krolo A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010294; Laas MM, 2020, SCI MED FOOTBALL, V4, P203, DOI 10.1080/24733938.2020.1737329; Lloyd RS, 2020, J SPORT REHABIL, V29, P760, DOI 10.1123/jsr.2019-0077; Lloyd RS, 2015, J SPORT SCI, V33, P11, DOI 10.1080/02640414.2014.918642; Lopez-Plaza D, 2017, J SPORT SCI, V35, P1083, DOI 10.1080/02640414.2016.1210817; Lovell T, 2017, SCI MED FOOTBALL, P1, DOI [DOI 10.1080/24733938.2017.1420208, 10.1080/24733938.2017.1420208]; Lovell TWJ, 2018, SCI MED FOOTBALL, V2, P58, DOI 10.1080/24733938.2017.1395062; Machado D. R., 2009, REVISTA BRASILEIRA C, V11, P14; Maia J., 2017, J HUM KINET, V60, P113, DOI [10.1515/hukin-2017-0094, DOI 10.1515/hukin-2017-0094]; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; MALINA RM, 1987, AM J PHYS ANTHROPOL, V72, P89, DOI 10.1002/ajpa.1330720111; Malina RM., AGE PEAK HEIGHT VELO; Malina RM, 2006, MED SCI SPORT EXER, V38, P1342, DOI 10.1249/01.mss.0000227321.61964.09; Malina RM, 2021, AM J HUM BIOL, V33, DOI 10.1002/ajhb.23551; Malina RM, 2019, SPORTS MED, V49, P1671, DOI 10.1007/s40279-019-01166-x; Malina RM, 2016, PEDIATR EXERC SCI, V28, P439, DOI 10.1123/pes.2015-0090; Malina RM, 2015, BRIT J SPORT MED, V49, P852, DOI 10.1136/bjsports-2015-094623; Malina RM, 2014, J SPORT SCI, V32, P1374, DOI 10.1080/02640414.2014.889846; Malina RM, 2014, RES Q EXERCISE SPORT, V85, P157, DOI 10.1080/02701367.2014.897592; Malina RM, 2014, J SPORT SCI, V32, P424, DOI 10.1080/02640414.2013.828850; Malina RM, 2012, J SPORT SCI, V30, P1705, DOI 10.1080/02640414.2011.639382; Gil SM, 2014, J SPORT SCI, V32, P1931, DOI 10.1080/02640414.2014.964290; MARTORELL R, 1988, HUM BIOL, V60, P205; Matthys SPJ, 2013, J SPORT SCI, V31, P325, DOI 10.1080/02640414.2012.733819; Mendez-Villanueva A, 2010, PEDIATR EXERC SCI, V22, P497, DOI 10.1123/pes.22.4.497; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Moore SA, 2015, MED SCI SPORT EXER, V47, P1755, DOI 10.1249/MSS.0000000000000588; Moran J, 2017, J SPORT SCI, V35, P1041, DOI 10.1080/02640414.2016.1209306; Moran J, 2017, INT J SPORTS MED, V38, P1, DOI 10.1055/s-0042-111439; Moreira A, 2013, PEDIATR EXERC SCI, V25, P186, DOI 10.1123/pes.25.2.186; Morris RO, 2020, J STRENGTH COND RES, V34, P2947, DOI 10.1519/JSC.0000000000002673; Myburgh GK, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0198-8; Parr J, 2020, ANN HUM BIOL, V47, P400, DOI 10.1080/03014460.2020.1782989; Pena-Gonzalez I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219355; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2020, R LANG ENV STAT COMP; Read PJ, 2018, J ATHL TRAINING, V53, P372, DOI 10.4085/1062-6050-493-16; Read PJ, 2018, PEDIATR EXERC SCI, V30, P168, DOI 10.1123/pes.2017-0081; Read PJ, 2017, INT J SPORTS MED, V38, P902, DOI 10.1055/s-0043-114009; Rodriguez-Rosell D, 2016, INT J SPORT PHYSIOL, V11, P240, DOI 10.1123/ijspp.2015-0176; Seabra A, 2012, JOINT BONE SPINE, V79, P403, DOI 10.1016/j.jbspin.2011.09.003; Till K, 2015, J STRENGTH COND RES, V29, P730, DOI 10.1519/JSC.0000000000000672; Till K, 2013, J SCI MED SPORT, V16, P438, DOI 10.1016/j.jsams.2012.09.002; Towlson C, 2021, J SPORT HEALTH SCI, V10, P403, DOI 10.1016/j.jshs.2020.09.003; Trecoci A., 2019, RES SPORTS MED, V33, P1232; Valente-dos-Santos J, 2012, PEDIATR EXERC SCI, V24, P603, DOI 10.1123/pes.24.4.603; Zago M, 2020, J BIOMECH, V99, DOI 10.1016/j.jbiomech.2019.109523; Zuber C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01088	82	7	7	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254659	10.1371/journal.pone.0254659	http://dx.doi.org/10.1371/journal.pone.0254659			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310636	Green Published, gold			2022-12-26	WOS:000685224500052
J	Wasti, S; Sah, N; Lee, CN; Jha, R; Mishra, B				Wasti, Sanjeev; Sah, Nirvay; Lee, Chin N.; Jha, Rajesh; Mishra, Birendra			Dietary supplementation of alpha-lipoic acid mitigates the negative effects of heat stress in broilers	PLOS ONE			English	Article							GROWTH-PERFORMANCE; ANTIOXIDANT DEFENSE; HEALTH	Heat stress accounts for substantial economic loss in the poultry industry by altering the health and performance of chickens. Alpha-lipoic acid (ALA) is a water and fat-soluble antioxidant which is readily absorbed from the intestine resulting in maximum bioavailability. Moreover, ALA acts as a coenzyme in glucose metabolism and helps generate other antioxidants. Considering these benefits, we hypothesized that dietary supplementation of ALA would help mitigate heat stress in poultry. A total of 72 Day-old broiler chicks were randomly assigned into three treatment groups: no heat stress (NHS), heat stress with basal diet (HS), and heat stress with alpha-lipoic acid (HS+ALA); each treatment group had 6 replicate pens with 4 birds in each pen (n = 24/group). The allocated birds were raised under standard husbandry practices for 3 weeks. After 21 d, birds in the HS and HS+ALA groups were exposed to heat stress (33 degrees C for 8 hours during the day) for 3 weeks, while the NHS group was reared under normal conditions (22-24 degrees C). The HS+ALA group received a basal finisher diet fortified with ALA (500 mg/kg) during the treatment period (22 to 42 d), while other birds were provided with the basal finisher diet. Weekly body weight and feed intake were recorded. The cecum digesta for volatile fatty acids (VFAs) analysis and 16S rRNA sequencing for the gut microbiota analysis; and the ileum tissue samples for histological and gene expression analyses were collected on d 42. Exposure to heat stress decreased (P<0.05) average daily gain (ADG) and final body weight (FBW) in the HS group compared to the NHS group, the supplementation of ALA improved (P<0.05) ADG and FBW in heat-stressed birds. Furthermore, birds in the HS+ALA group had increased (P<0.05) expression of HSP90, PRDX1, GPX3, SOD2, OCLN, and MUC2 genes and higher (P<0.05) concentrations of major VFAs (acetate, propionate, and butyrate). The dietary ALA supplementation also improved the villus height and villus height to crypt depth ratio in the HS+ALA group. The microbial diversity analysis revealed significant abundance (P<0.05) of beneficial bacteria Lactobacillus and Peptostreptococcaceae in the cecum of the ALA group. These results indicate that dietary ALA supplementation effectively mitigates the negative effects of heat stress in broilers by improving the expression of heat-shock, tight-junction, antioxidants, and immune-related genes in the intestine, improving villus structures, increasing concentration of major VFAs, and enriching the beneficial microbiota.	[Wasti, Sanjeev; Sah, Nirvay; Lee, Chin N.; Jha, Rajesh; Mishra, Birendra] Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Mishra, B (corresponding author), Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA.	bmishra@hawaii.edu	Wasti, Sanjeev/AAY-3787-2021; Sah, Nirvay/AAW-1917-2021; Jha, Rajesh/G-4760-2014	Wasti, Sanjeev/0000-0003-0393-6229; Sah, Nirvay/0000-0002-2788-3646; Jha, Rajesh/0000-0002-2891-8353; Mishra, Birendra/0000-0002-8786-3700	CTAHR University of Hawaii at Manoa; USDA [2052R]	CTAHR University of Hawaii at Manoa; USDA(United States Department of Agriculture (USDA))	This work was supported by a Start-up grant from CTAHR University of Hawaii at Manoa, and USDA Multistate (2052R) to B.M.	Bilska A, 2005, PHARMACOL REP, V57, P570; Burkholder KM, 2008, POULTRY SCI, V87, P1734, DOI 10.3382/ps.2008-00107; El-Senousey HK, 2018, POULTRY SCI, V97, P30, DOI 10.3382/ps/pex298; Flees J, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00919; GRIFFIN HD, 1994, INT J BIOCHEM, V26, P19, DOI 10.1016/0020-711X(94)90190-2; Guo ZY, 2014, BRIT POULTRY SCI, V55, P635, DOI 10.1080/00071668.2014.958057; He J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00903; Jha R, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10101863; Jha R, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00048; Kisuse J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01345; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lambert GP, 2009, J ANIM SCI, V87, pE101, DOI 10.2527/jas.2008-1339; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Leng YX, 2016, SCI REP-UK, V6, DOI 10.1038/srep22814; Li WJ, 2019, ASIAN AUSTRAL J ANIM, V32, P1914, DOI 10.5713/ajas.18.0939; Lin H, 2006, WORLD POULTRY SCI J, V62, P71, DOI 10.1079/WPS200585; Martin R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41738-5; Mishra B, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00060; Montagne L, 2004, NUTR REV, V62, P105, DOI [10.1301/nr.2004.mar.105-114, 10.1111/j.1753-4887.2004.tb00031.x]; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; NRC, 1994, NUTR REQ POULTR; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Pearce SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070215; Rivera LR, 2011, CELL TISSUE RES, V344, P111, DOI 10.1007/s00441-010-1126-x; Sah N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35203-y; Saleh AA, 2019, J ANIM PHYSIOL AN N, V103, P1810, DOI 10.1111/jpn.13206; Saleh AA, 2020, BIOL TRACE ELEM RES, V195, P506, DOI 10.1007/s12011-019-01861-w; Sharma MK, 2020, J APPL POULTRY RES, V29, P362, DOI 10.1016/j.japr.2019.12.001; Shimamoto S, 2020, METABOLITES, V10, DOI 10.3390/metabo10050189; Singh AK., 2019, OVO POSTHATCH NUTR P; Sohaib M, 2018, J ANIM PHYSIOL AN N, V102, P33, DOI 10.1111/jpn.12693; Sohail MU, 2012, POULTRY SCI, V91, P2235, DOI 10.3382/ps.2012-02182; Spalding MD, 2010, MICROBIOL MOL BIOL R, V74, P200, DOI 10.1128/MMBR.00008-10; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Surai PF, 2018, WORLD POULTRY SCI J, V74, P185, DOI 10.1017/S0043933918000284; Surai P.F., 2016, J ANIM RES NUTR, V1, P8, DOI [10.21767/2572-5459.100008, DOI 10.21767/2572-5459.100008]; Varasteh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138975; Wasti S, 2021, J ANIM SCI BIOTECHNO, V12, DOI 10.1186/s40104-021-00571-5; Wasti S, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10081266; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Xie JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102204; Xin JG, 2014, APPL MICROBIOL BIOT, V98, P6817, DOI 10.1007/s00253-014-5752-1; Yi D, 2016, ANIM FEED SCI TECH, V220, P83, DOI 10.1016/j.anifeedsci.2016.07.014	44	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254936	10.1371/journal.pone.0254936	http://dx.doi.org/10.1371/journal.pone.0254936			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310622	Green Published, gold			2022-12-26	WOS:000685224500030
J	Meis-Pinheiro, U; Lopez-Segui, F; Walsh, S; Ussi, A; Santaeugenia, S; Garcia-Navarro, JA; San-Jose, A; Andreu, AL; Campins, M; Almirante, B				Meis-Pinheiro, Uxio; Lopez-Segui, Francesc; Walsh, Sandra; Ussi, Anton; Santaeugenia, Sebastia; Augusto Garcia-Navarro, Jose; San-Jose, Antonio; Andreu, Antoni L.; Campins, Magda; Almirante, Benito			Clinical characteristics of COVID-19 in older adults. A retrospective study in long-term nursing homes in Catalonia	PLOS ONE			English	Article							SARS-COV-2	The natural history of COVID-19 and predictors of mortality in older adults need to be investigated to inform clinical operations and healthcare policy planning. A retrospective study took place in 80 long-term nursing homes in Catalonia, Spain collecting data from March 1st to May 31st, 2020. Demographic and clinical data from 2,092 RT-PCR confirmed cases of SARS-CoV-2 infection were registered, including structural characteristics of the facilities. Descriptive statistics to describe the demographic, clinical, and molecular characteristics of our sample were prepared, both overall and by their symptomatology was performed and an analysis of statistically significant bivariate differences and constructions of a logistic regression model were carried out to assess the relationship between variables. The incidence of the infection was 28%. 71% of the residents showed symptoms. Five major symptoms included: fever, dyspnea, dry cough, asthenia and diarrhea. Fever and dyspnea were by far the most frequent (50% and 28%, respectively). The presentation was predominantly acute and symptomatology persisted from days to weeks (mean 9.1 days, SD = 10,9). 16% of residents had confirmed pneumonia and 22% required hospitalization. The accumulated mortality rate was 21.75% (86% concentrated during the first 28 days at onset). A multivariate logistic regression analysis showed a positive predictive value for mortality for some variables such as age, pneumonia, fever, dyspnea, stupor refusal to oral intake and dementia (p<0.01 for all variables). Results suggest that density in the nursing homes did not account for differences in the incidence of the infection within the facilities. This study provides insights into the natural history of the disease in older adults with high dependency living in long-term nursing homes during the first pandemic wave of March-May 2020 in the region of Catalonia, and suggests that some comorbidities and symptoms have a strong predictive value for mortality.	[Meis-Pinheiro, Uxio; Andreu, Antoni L.] Assoc Catalana Recursos Assistencials, Barcelona, Spain; [Lopez-Segui, Francesc] Ctr Recerca Econ Salut CRES UPF, Barcelona, Spain; [Walsh, Sandra] Univ Pompeu Fabra, Inst Biol Evolut UPF, CSIC, Barcelona, Spain; [Ussi, Anton; Andreu, Antoni L.] EATRIS, European Infrastruct Translat Med, Amsterdam, Netherlands; [Santaeugenia, Sebastia] Univ Vic, Cent Univ Catalonia UVIC UCC, Ctr Hlth & Social Care Res CESS Univ, Cent Catalonia Chronic Res Grp C3RG, Vic, Spain; [Santaeugenia, Sebastia] Generalitat Catalunya, Minist Hlth, Chron Care Program, Barcelona, Spain; [Augusto Garcia-Navarro, Jose] Spanish Soc Geriatr & Gerontol, Barcelona, Spain; [San-Jose, Antonio] Hosp Univ Vall dHebron, Geriatr Unit, Barcelona, Spain; [Campins, Magda] Hosp Univ Vail dHebron, Prevent Med & Epidemiol Dept, Barcelona, Spain; [Almirante, Benito] Hosp Univ Vall dHebron, Infect Dis Dept, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; Vrije Universiteit Amsterdam; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron	Almirante, B (corresponding author), Hosp Univ Vall dHebron, Infect Dis Dept, Barcelona, Spain.	balmirante@vhebron.net		Santaeugenia Gonzalez, Sebastia J/0000-0002-2725-4065; Almirante, Benito/0000-0002-1189-2361				Amblas-Novellas J, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01587-8; Amer Geriatrics Soc, 2020, J AM GERIATR SOC, V68, P908, DOI 10.1111/jgs.16477; Amer Geriatrics Soc, 2020, J AM GERIATR SOC, V68, P1131, DOI 10.1111/jgs.16510; [Anonymous], 2020, PAIN MED, VXXX, pXXX; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Bazant MZ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018995118; Borras-Bermejo B, 2020, EMERG INFECT DIS, V26, P2281, DOI 10.3201/eid2609.202603; Byambasuren Oyungerel, 2020, J Assoc Med Microbiol Infect Dis Can, V5, P223, DOI 10.3138/jammi-2020-0030; Carlson C, 2015, MED CLIN N AM, V99, P263, DOI 10.1016/j.mcna.2014.11.003; Crotty F, 2020, INTERN MED J, V50, P1033, DOI 10.1111/imj.14966; D'Adamo H, 2020, J AM GERIATR SOC, V68, P912, DOI 10.1111/jgs.16445; De Georgeo MR, 2021, J MICROBIOL IMMUNOL, V54, P4, DOI 10.1016/j.jmii.2020.07.009; De Vito A, 2021, EUR REV MED PHARMACO, V25, P523, DOI 10.26355/eurrev_202101_24424; De Vito A, 2020, EUR REV MED PHARMACO, V24, P7861, DOI 10.26355/eurrev_202007_22291; De Vito A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248009; Eurosurveillance Editorial Team, 2020, EURO SURVEILL, V25; Figliozzi S, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13362; Fisman DN, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.15957; Geremia N, 2020, INFECT DIS CLIN PRAC, V28, pE30, DOI 10.1097/IPC.0000000000000952; Guarneri C, 2021, LANCET INFECT DIS, V21, P24, DOI 10.1016/S1473-3099(20)30402-3; Guo Y, 2020, AGE AGEING, V49, P706, DOI 10.1093/ageing/afaa145; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; Hand J, 2018, EMERG INFECT DIS, V24, P1964, DOI 10.3201/eid2410.180862; Hao XJ, 2020, NATURE, V584, P420, DOI 10.1038/s41586-020-2554-8; Harapan H, 2020, J INFECT PUBLIC HEAL, V13, P667, DOI 10.1016/j.jiph.2020.03.019; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Lansbury LE, 2017, INFLUENZA OTHER RESP, V11, P356, DOI 10.1111/irv.12464; McMichael TM, 2020, NEW ENGL J MED, V382, P2005, DOI 10.1056/NEJMoa2005412; Panagiotou OA, 2021, JAMA INTERN MED, V181, P439, DOI 10.1001/jamainternmed.2020.7968; Parikh S, 2020, JAMA-J AM MED ASSOC, V324, P1101, DOI 10.1001/jama.2020.14984; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Sacco G, 2020, GERIATR PSYCHOL NEUR, V18, P135, DOI 10.1684/pnv.2020.0863; Senn N, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00078; Serra-Prat M, 2019, J AGING RES CLIN PRA, V8, P39; Shahid Z, 2020, J AM GERIATR SOC, V68, P926, DOI 10.1111/jgs.16472; Tarazona-Santabalbina Francisco Jose, 2020, Rev Esp Geriatr Gerontol, V55, P191, DOI 10.1016/j.regg.2020.04.001; Unger JP, 2021, INT J HEALTH SERV, V51, P37, DOI 10.1177/0020731420946590; Vaira LA, 2020, LARYNGOSCOPE, V130, P1787, DOI [10.1002/lary.28753, 10.1002/lary.28692]; Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1560, DOI 10.1002/hed.26269; Wang J, 2020, ENVIRON POLLUT, V266, DOI 10.1016/j.envpol.2020.115099; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zinellu A, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13427	43	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255141	10.1371/journal.pone.0255141	http://dx.doi.org/10.1371/journal.pone.0255141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TQ2PW	34297774	gold, Green Published			2022-12-26	WOS:000678128300054
J	Mant, M; Aslemand, A; Prine, A; Holland, AJ				Mant, Madeleine; Aslemand, Asal; Prine, Andrew; Jaagumagi Holland, Alyson			University students' perspectives, planned uptake, and hesitancy regarding the COVID-19 vaccine: A multi-methods study	PLOS ONE			English	Article							HEALTH BELIEF MODEL; INFLUENZA VACCINATION; COLLEGE-STUDENTS; ACCEPTABILITY; INTENTION; PARENTS	Purpose To investigate university students' willingness to receive a COVID-19 vaccine when it becomes available to them. Method A multi-methods approach was used-online convenience sample surveys and semi-structured interviews-of young adults attending a large Canadian public university. Two survey samples were collected (June 20-July 28, 2020 and September 22-October 17, 2020). Semi-structured interviews were conducted following each survey, interviewing 20 students in each round. Results In June 77.8% of surveyed students (n = 483) were willing to get the COVID-19 vaccine; in September 79.6% were willing (n = 1269). Multinomial and binary logistic regression analyses found that increasing perception of the severity of COVID-19 predicted the likelihood that a respondent was willing to get the COVID-19 vaccine in both surveys. In the latter survey students who indicated they would be encouraged to get the COVID-19 vaccine if their doctor/pharmacist recommended it were 76 times more likely to be willing to get the vaccine than those who would not be encouraged by medical advice. Interviews revealed concerns about the speed of the vaccine roll out, safety, and efficacy. Conclusions The majority of university students intend to get the COVID-19 vaccine, but there are nuanced concerns about efficacy and safety that must be taken into account by public health authorities as the vaccine becomes available to this group. Ensuring that family doctors, pharmacists, and other front-line healthcare workers have consistent and clear information regarding the benefits of vaccination will be critical to encouraging uptake among young adults.	[Mant, Madeleine] Univ Toronto Mississauga, Dept Anthropol, Mississauga, ON, Canada; [Aslemand, Asal] Univ Toronto Mississauga, Dept Math & Computat Sci, Mississauga, ON, Canada; [Prine, Andrew] Groves Mem Community Hosp, Fergus, ON, Canada; [Jaagumagi Holland, Alyson] McMaster Univ, Fac Med, Dept Family Med, Hamilton, ON, Canada	University of Toronto; University Toronto Mississauga; University of Toronto; University Toronto Mississauga; McMaster University	Mant, M (corresponding author), Univ Toronto Mississauga, Dept Anthropol, Mississauga, ON, Canada.	maddy.mant@utoronto.ca		Mant, Madeleine/0000-0002-5370-9959	University of Toronto COVID-19 Action Initiative	University of Toronto COVID-19 Action Initiative	MM: This study was funded by the University of Toronto COVID-19 Action Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalkhail MS, 2017, J INFECT PUBLIC HEAL, V10, P644, DOI 10.1016/j.jiph.2017.05.001; Akis S, 2011, EUR J PEDIATR, V170, P1165, DOI 10.1007/s00431-011-1425-6; Alhalaseh L, 2020, VACCINE, V38, P7372, DOI 10.1016/j.vaccine.2020.09.002; Barello S, 2020, EUR J EPIDEMIOL, V35, P781, DOI 10.1007/s10654-020-00670-z; Bedford H, 2007, VACCINE, V25, P7818, DOI 10.1016/j.vaccine.2007.08.057; Bednarczyk RA, 2015, VACCINE, V33, P1659, DOI 10.1016/j.vaccine.2015.02.033; Bell S, 2020, VACCINE, V38, P7789, DOI 10.1016/j.vaccine.2020.10.027; Bergeron SL, 2005, EMERG INFECT DIS, V11, P732, DOI 10.3201/eid1105.040512; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Calina D, 2020, INT J MOL MED, V46, P3, DOI 10.3892/ijmm.2020.4596; Cohen J.E., 1988, STAT POWER ANAL BEHA; Faasse K, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.551004; Glowacki Laura, 2020, CBC NEWS; Goldman RD, 2020, VACCINE, V38, P7668, DOI 10.1016/j.vaccine.2020.09.084; Government of Canada, 2020, IMPROVEMENTS INFLUEN; Government of New Brunswick, 2012, DEP ED EARL CHILDH D; Government of Ontario, 2021, COVID 19 VACC ONT; Government of Ontario, 2019, VACC CHILDR SCH; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Grech Victor, 2020, Early Hum Dev, P105258, DOI 10.1016/j.earlhumdev.2020.105258; Guarino, 2013, APPL MULTIVARIATE RE; Gust DA, 2008, PEDIATRICS, V122, P718, DOI 10.1542/peds.2007-0538; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Janz NK, 2002, HLTH BEHAV HLTH ED T, P45, DOI DOI 10.1177/109019819101800409; Mercadante AR, 2021, RES SOC ADMIN PHARM, V17, P1596, DOI 10.1016/j.sapharm.2020.12.012; News Global., 2020, COR TRUD SAYS IND CO; Poehling KA, 2012, J AM COLL HEALTH, V60, P541, DOI 10.1080/07448481.2012.700973; Ramsey MA, 2011, VACCINE, V29, P7599, DOI 10.1016/j.vaccine.2011.07.130; Reiter PL, 2020, VACCINE, V38, P6500, DOI 10.1016/j.vaccine.2020.08.043; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Rubin GJ, 2011, VACCINE, V29, P2421, DOI 10.1016/j.vaccine.2011.01.035; Ryan KA, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02604; Sandler K, 2020, J AM COLL HEALTH, V68, P593, DOI 10.1080/07448481.2019.1583660; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Schmid P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170550; Seanehia J, 2017, VACCINE, V35, P2676, DOI 10.1016/j.vaccine.2017.03.086; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; Shim E, 2012, J R SOC INTERFACE, V9, P2234, DOI 10.1098/rsif.2012.0115; Torun SD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-596; Vermandere H, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0211-7; Wagner AL, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0900-2; WHO, 2021, VACC EFF COV 19 VACC; Wong MCS, 2021, VACCINE, V39, P1148, DOI 10.1016/j.vaccine.2020.12.083; World Health Organization, 2021, VACC EUR COMM WORLD; World Health Organization. World Health Organization, 2021, WEEKLY EPIDEMIOLOGIC; Zhang Z, 2018, PRACTICAL STAT POWER	47	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255447	10.1371/journal.pone.0255447	http://dx.doi.org/10.1371/journal.pone.0255447			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6IR	34343202	Green Published, gold			2022-12-26	WOS:000685264200026
J	Campbell, SM; Anderson, SL; Brym, ZT; Pearson, BJ				Campbell, Sean M.; Anderson, Steven L.; Brym, Zachary T.; Pearson, Brian J.			Evaluation of substrate composition and exogenous hormone application on vegetative propagule rooting success of essential oil hemp (Cannabis sativa L.)	PLOS ONE			English	Article							PROPAGATION	To support the rapidly expanding industrial hemp industry, a commercial supply of high-quality starter plants with low genetic variability from nurseries will be key to consistent and efficient cultivation efforts. Rooting success was evaluated across four propagation medias, five rooting hormones, and eight commercially available high-cannabidiol (CBD) essential oil hemp cultivars. Cuttings were placed in a climate-controlled room and assessed for rooting success 12 days after cloning. Rooting success was determined by quantifying total root number, cumulative total root length, and total root mass. Propagation media had the greatest effect on rooting success (13-80%). Rockwool had the highest rooting success resulting in 10-fold increases in rooting traits over the next highest scoring medium (Berger BM6). Hormone applications significantly improved (15- to 18-fold) rooting success compared to no hormone application, while non-statistical differences were observed across auxin hormone concentrations and application methods. Genetic variation in rooting response was observed between cultivars with 'Cherry Wine' outperforming all other cultivars with an approximate 20% increase in rooting success over the next highest rooting cultivar, 'Wife'. Although the ideal combination was not specifically identified in this study, findings provide insight into how rooting hormone application and medium selection impact vegetative propagule rooting success of essential oil hemp.	[Campbell, Sean M.; Anderson, Steven L.; Pearson, Brian J.] Univ Florida, Inst Food & Agr Sci, Mid Florida Res & Educ Ctr, Dept Environm Hort, Apopka, FL 32703 USA; [Brym, Zachary T.] Univ Florida, Inst Food & Agr Sci, Trop Res & Educ Ctr, Dept Agron, Homestead, FL 33031 USA; [Campbell, Sean M.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of California System; University of California Davis	Pearson, BJ (corresponding author), Univ Florida, Inst Food & Agr Sci, Mid Florida Res & Educ Ctr, Dept Environm Hort, Apopka, FL 32703 USA.	bpearson@ufl.edu		Anderson, Steven/0000-0001-5153-3083; Campbell, Sean/0000-0002-8512-8091	Green Roads, LLC; UF/IFAS Office of the Dean and Research; Roseville Farm's UF/IFAS Florida Industrial Hemp Endowment contribution	Green Roads, LLC; UF/IFAS Office of the Dean and Research; Roseville Farm's UF/IFAS Florida Industrial Hemp Endowment contribution	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This project was made possible by financial support from Green Roads, LLC and the UF/IFAS Office of the Dean and Research. Green Point Research, Green Roads LLC, and ANO Colorado LLC donated the cultivars used in this research. Steven Anderson was funded by Roseville Farm's UF/IFAS Florida Industrial Hemp Endowment contribution.	Allaire SE, 2005, CAN J SOIL SCI, V85, P67, DOI 10.4141/S04-026; Amaducci S, 2015, IND CROP PROD, V68, P2, DOI 10.1016/j.indcrop.2014.06.041; Amaducci S, 2008, PLANT SOIL, V313, P227, DOI 10.1007/s11104-008-9695-0; Ball V., 1998, BALL REDBOOK BALL PU; Berry J., 1984, ROOTING HORMONE FORM; Blazich F., 1988, ADV PLANT SCI SERIES; Blythe Eugene K., 2007, Journal of Environmental Horticulture, V25, P166; Bonaminio V., 1983, COMP IBA QUICK DIPS; Campbell LG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213434; Caplan D, 2018, CAN J PLANT SCI, V98, P1126, DOI 10.1139/cjps-2018-0038; Chong Calvin, 1992, Journal of Environmental Horticulture, V10, P245; Clarke RC, 2013, CANNABIS: EVOLUTION AND ETHNOBOTANY, P1; Clarke RC, 2016, CRIT REV PLANT SCI, V35, P293, DOI 10.1080/07352689.2016.1267498; Da Silva F., 1994, INT S GROW MED PLANT INT S GROW MED PLANT, V401; de Andres EF, 2004, AGROFOREST SYST, V63, P7, DOI 10.1023/B:AGFO.0000049428.12140.af; DORRELL DG, 1974, CAN J PLANT SCI, V54, P197, DOI 10.4141/cjps74-029; Fehr W.R., 1991, PRINCIPLES CULTIVAR; Gordon I., 1992, COMBINED P INT PLANT; Haile G, 2011, J ARID ENVIRON, V75, P873, DOI 10.1016/j.jaridenv.2011.04.007; Hartmann HT., 2014, HARTMANN KESTERS PRI, V8, P922; HINESLEY LE, 1981, CAN J FOREST RES, V11, P316; Huang J., 2013, UF IFAS B UF IFAS B; Loach K, 1985, ROOTING CUTTINGS REL; Macdonald B., 1986, PRACTICAL WOODY PLAN, VI; Mandolino G, 2004, EUPHYTICA, V140, P107, DOI 10.1007/s10681-004-4759-6; Munoz-Gutierrez L, 2009, NEW FOREST, V38, P187, DOI 10.1007/s11056-009-9139-6; Potter DJ, 2014, DRUG TEST ANAL, V6, P31, DOI 10.1002/dta.1531; Preece JE, 2003, HORTSCIENCE, V38, P1015, DOI 10.21273/HORTSCI.38.5.1015; RAM HYM, 1982, THEOR APPL GENET, V62, P369, DOI 10.1007/BF00275107; Raviv M., 2002, HYDROPONIC PRODUCTIO, P25; Sabalka D., 1987, COMBINED P INT PLANT COMBINED P INT PLANT; Salentijn EMJ, 2015, IND CROP PROD, V68, P32, DOI 10.1016/j.indcrop.2014.08.011; Small E., 2002, Trends in new crops and new uses. Proceedings of the Fifth National Symposium, Atlanta, Georgia, USA, 10-13 November, 2001, P284; Small E, 2016, CANNABIS COMPLETE GU; Smith DL, 1992, ROCKWOOL HORTICULTUR; Statista, TOT US CANN CBD CONS TOT US CANN CBD CONS; Statista, SAL HEMP BAS PROD US SAL HEMP BAS PROD US; TILT KM, 1987, HORTSCIENCE, V22, P245	38	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0249160	10.1371/journal.pone.0249160	http://dx.doi.org/10.1371/journal.pone.0249160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324510	gold, Green Submitted, Green Published			2022-12-26	WOS:000685248200056
J	Lee, KY; Lee, J; Park, YY; Oh, ST				Lee, Kil-yong; Lee, Jaeim; Park, Youn Young; Oh, Seong Taek			Routine antibiotics may not be needed to treat uncomplicated right diverticulitis: A retrospective cohort study	PLOS ONE			English	Article							COMPLICATED DIVERTICULITIS; COLONIC DIVERTICULITIS; TOMOGRAPHY; MANAGEMENT	We aimed to investigate whether antibiotic administration is necessary for patients with uncomplicated right colonic diverticulitis. Data from patients diagnosed with uncomplicated right colonic diverticulitis, who received inpatient treatment at a single center between January 2019 and January 2021, were retrospectively examined. The patients were divided into two groups according to whether antibiotics were administered. The patients were matched between groups using propensity score matching in a 1:1 ratio using logistic regression with the nearest-neighbor method. The primary study outcome was the length of hospital stay, and the secondary outcomes were time to the introduction of sips of water and a soft diet. The study included 138 patients who received antibiotics and 59 who did not. After propensity score matching, 55 patients were assigned to each treatment group. There was no significant difference between the two groups in terms of age (p = 0.772), sex (p>0.999), body mass index (p = 0.121), prehospital symptom duration (p = 0.727), initial body temperature (p = 0.661), white blood cell count (p = 0.688), or C-reactive protein level (p = 0.337). There was also no statistically significant difference in the length of hospital stay between the no antibiotic and antibiotic groups (3.1 +/- 0.7 days vs. 3.0 +/- 1.0 days, p = 0.584). Additionally, no significant difference was observed between the no antibiotic and antibiotic groups with respect to time to sips of water (2.1 +/- 0.7 days vs. 1.8 +/- 0.9 days, p = 0.100) and time to the introduction of a soft diet (2.4 +/- 0.8 days vs. 2.1 +/- 0.9 days, p = 0.125). The findings suggest that routine antibiotics may be not required for treating patients with uncomplicated right colonic diverticulitis.	[Lee, Kil-yong; Lee, Jaeim; Park, Youn Young; Oh, Seong Taek] Catholic Univ Korea, Div Coloproctol, Dept Surg, Coll Med,Uijeongbu St Marys Hosp, Seoul, South Korea	Catholic University of Korea	Lee, J (corresponding author), Catholic Univ Korea, Div Coloproctol, Dept Surg, Coll Med,Uijeongbu St Marys Hosp, Seoul, South Korea.	lji96@catholic.ac.kr	Park, Youn Young/GYU-4948-2022	Park, Youn Young/0000-0001-7724-1492; Lee, Jaeim/0000-0002-4074-3904				Brochmann ND, 2016, COLORECTAL DIS, V18, P1101, DOI 10.1111/codi.13355; Chabok A, 2012, BRIT J SURG, V99, P532, DOI 10.1002/bjs.8688; Daniels L, 2017, BRIT J SURG, V104, P52, DOI 10.1002/bjs.10309; DORINGER E, 1992, CRIT REV DIAGN IMAG, V33, P421; Ferrer OE, 2016, TECH COLOPROCTOL, V20, P309, DOI 10.1007/s10151-016-1464-0; Floch MH, 2006, J CLIN GASTROENTEROL, V40, pS121, DOI 10.1097/01.mcg.0000225502.29498.ba; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hjern F, 2007, SCAND J GASTROENTERO, V42, P41, DOI 10.1080/00365520600780650; Ho DE, 2011, J STAT SOFTW, V42; HULNICK DH, 1984, RADIOLOGY, V152, P491, DOI 10.1148/radiology.152.2.6739821; Kaiser AM, 2005, AM J GASTROENTEROL, V100, P910, DOI 10.1111/j.1572-0241.2005.41154.x; Kim JY, 2019, INT J COLORECTAL DIS, V34, P1413, DOI 10.1007/s00384-019-03343-w; Kollef MH, 2003, AM J MED, V115, P582, DOI 10.1016/j.amjmed.2003.09.002; Lee KY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60397-5; Manabe N, 2015, DIS COLON RECTUM, V58, P1174, DOI 10.1097/DCR.0000000000000488; Nagata N, 2019, DIGESTION, V99, P1, DOI 10.1159/000495282; Sartelli M, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00313-4; Soh NYT, 2018, INT J COLORECTAL DIS, V33, P525, DOI 10.1007/s00384-018-3007-9; Tursi A, 2008, DIGEST DIS SCI, V53, P2474, DOI 10.1007/s10620-007-0161-2; van Dijk ST, 2018, AM J GASTROENTEROL, V113, P1045, DOI 10.1038/s41395-018-0030-y; Vedantam G, 2003, CURR OPIN MICROBIOL, V6, P457, DOI 10.1016/j.mib.2003.09.006	21	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255384	10.1371/journal.pone.0255384	http://dx.doi.org/10.1371/journal.pone.0255384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324608	gold, Green Published			2022-12-26	WOS:000685248200099
J	Adu, BG; Akromah, R; Amoah, S; Nyadanu, D; Yeboah, A; Aboagye, LM; Amoah, RA; Owusu, EG				Adu, Bright Gyamfi; Akromah, Richard; Amoah, Stephen; Nyadanu, Daniel; Yeboah, Alex; Aboagye, Lawrence Missah; Amoah, Richard Adu; Owusu, Eva Gyamfuaa			High-density DArT-based SilicoDArT and SNP markers for genetic diversity and population structure studies in cassava (Manihot esculenta Crantz)	PLOS ONE			English	Article							ARRAYS TECHNOLOGY DART; SSR; GERMPLASM; CLONES; BANKS	Cassava (Manihot esculenta Crantz) is an important industrial and staple crop due to its high starch content, low input requirement, and resilience which makes it an ideal crop for sustainable agricultural systems and marginal lands in the tropics. However, the lack of genomic information on local genetic resources has impeded efficient conservation and improvement of the crop and the exploration of its full agronomic and breeding potential. This work was carried out to obtain information on population structure and extent of genetic variability among some local landraces conserved at the Plant Genetic Resources Research Institute, Ghana and exotic cassava accessions with Diversity Array Technology based SilicoDArT and SNP markers to infer how the relatedness in the genetic materials can be used to enhance germplasm curation and future breeding efforts. A total of 10521 SilicoDArT and 10808 SNP markers were used with varying polymorphic information content (PIC) values. The average PIC was 0.36 and 0.28 for the SilicoDArT and SNPs respectively. Population structure and average linkage hierarchical clustering based on SNPs revealed two distinct subpopulations and a large number of admixtures. Both DArT platforms identified 22 landraces as potential duplicates based on Gower's genetic dissimilarity. The expected heterozygosity which defines the genetic variation within each subpopulation was 0.008 for subpop1 which were mainly landraces and 0.391 for subpop2 indicating the homogeneous and admixture nature of the two subpopulations. Further analysis upon removal of the duplicates increased the expected heterozygosity of subpop1 from 0.008 to 0.357. A mantel test indicated strong interdependence (r = 0.970; P < 0.001) between SilicoDArT and DArTSeq SNP genotypic data suggesting both marker platforms as a robust system for genomic studies in cassava. These findings provide important information for efficient ex-situ conservation of cassava, future heterosis breeding, and marker-assisted selection (MAS) to enhance cassava improvement.	[Adu, Bright Gyamfi; Aboagye, Lawrence Missah; Amoah, Richard Adu] Plant Genet Resources Res Inst, Council Sci & Ind Res, Bunso, Ghana; [Akromah, Richard; Amoah, Stephen] Kwame Nkrumah Univ Sci & Technol, Dept Crop & Soil Sci, Kumasi, Ghana; [Nyadanu, Daniel] Cocoa Res Inst, New Tafo Akim, Ghana; [Yeboah, Alex] Savanna Agr Res Inst, Council Sci & Ind Res, Tamale, Ghana; [Owusu, Eva Gyamfuaa] Kwame Nkrumah Univ Sci & Technol, Dept Stat & Actuarial Sci, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Adu, BG (corresponding author), Plant Genet Resources Res Inst, Council Sci & Ind Res, Bunso, Ghana.	adubright1992@gmail.com	Adu Amoah, Richard/AAZ-3098-2021	Adu Amoah, Richard/0000-0001-5094-4964; Adu, Bright/0000-0002-0667-7042; Yeboah, Alex/0000-0002-7519-0094	Alliance for Green Revolution Africa (AGRA) through the IMCDA programme at KNUST (2018)	Alliance for Green Revolution Africa (AGRA) through the IMCDA programme at KNUST (2018)	The authors thank Fuseini Mohammed and Edwin Appiah Moses in the extraction of DNA, data management and the anonymous reviewers for their insightful suggestions. The support from Alliance for Green Revolution Africa (AGRA) through the IMCDA programme at KNUST (2018) is also highly acknowledged.	Adjebeng-Danquah J., 2016, Journal of Crop Science and Biotechnology, V19, P99, DOI 10.1007/s12892-015-0095-8; Adjebeng-Danquah J, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2019.e03154; Adu B.G., 2020, ECOLOGICAL GENETICS, V17, DOI [10.1016/j.egg.2020.100068, DOI 10.1016/J.EGG.2020.100068]; Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Agre AP, 2017, GENET RESOUR CROP EV, V64, P307, DOI 10.1007/s10722-015-0352-1; Agre A.P., 2015, INT J CURR RES BIOSC, V2, P1; Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Akinwale M. G., 2011, British Biotechnology Journal, V1, P68; Alam M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203465; Ampong MG, 2004, RELEASED CASSAVA VAR, P1, DOI [10.1148/radiol.2332031487, DOI 10.1148/RADIOL.2332031487]; Asante IK, 2003, EUPHYTICA, V131, P113, DOI 10.1023/A:1023056313776; Asare PA, 2011, AFR J BIOTECHNOL, V10, P13900; Balagopalan C., 2001, BIOL PRODUCTION UTIL, P301, DOI [10.1006/dbio.2001.0162, DOI 10.1006/DBIO.2001.0162]; Baloch FS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167821; Benesi IRM, 2008, EUPHYTICA, V160, P59, DOI 10.1007/s10681-007-9589-x; Boonchanawiwat A, 2016, J AGR SCI-CAMBRIDGE, V154, P1209, DOI 10.1017/S0021859615001057; Ceballos H, 2013, CROP SCI, V53, P2342, DOI 10.2135/cropsci2013.02.0123; Cruz VMV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064062; Dierig D, 2009, HANDB PLANT BREED, V4, P507, DOI 10.1007/978-0-387-77594-4_18; Dorado G, 2015, REFERENCE MODULE BIO; Duminil J, 2009, PLANT BIOSYST, V143, P528, DOI 10.1080/11263500902722964; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Egea LA, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00098; El-Sharkawy Mabrouk A., 2007, Braz. J. Plant Physiol., V19, P257, DOI 10.1590/S1677-04202007000400003; Eltaher S, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00076; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2014, FAO STAT FAOSTAT; Ferguson ME, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224763; Fregene M, 2000, THEOR APPL GENET, V100, P678, DOI 10.1007/s001220051339; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hampton JO, 2004, J APPL ECOL, V41, P735, DOI 10.1111/j.0021-8901.2004.00936.x; Hayward AC, 2015, METHODS MOL BIOL, V1245, P13, DOI 10.1007/978-1-4939-1966-6_2; Heller-Uszynska K, 2011, MOL BREEDING, V28, P37, DOI 10.1007/s11032-010-9460-y; Huang SM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-717; Hurtado P., 2008, Plant Genetic Resources: Characterization and Utilization, V6, P208, DOI 10.1017/S1479262108994181; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Kawuki RS, 2009, MOL BREEDING, V23, P669, DOI 10.1007/s11032-009-9264-0; Kilian A, 2003, P INT C WAK DOUBL HE, P443; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Kizito EB, 2007, GENETICA, V130, P301, DOI 10.1007/s10709-006-9107-4; Kyamanywa S., 2011, ENHANCING FOOD SECUR, P1; Luo ZN, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00184; Mace ES, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-26; Maechler M, 2013, R PACKAGE; Mantello CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102665; Ministry of Food and Agriculture (MOFA, 2019, CAT CROP VAR REL REG, P58; Mondini L., 2009, Diversity, V1, P19; Nadjiam D., 2016, Agricultural Sciences, V7, P479, DOI 10.4236/as.2016.77049; Noerwijati K., 2013, Journal of Agricultural and Biological Science, V8, P317; Ocampo C, 1992, P 1 INT SCI M CIAT C, P81; Okogbenin E, 2003, J AGRON CROP SCI, V189, P376, DOI 10.1046/j.1439-037X.2003.00050.x; Oksanen J, 2013, VEGAN COMMUNITY ECOL; Olukolu B.A., 2012, GENET RESOUR CROP EV, V59, P347, DOI [10.1007/s10722-011-9686%26%23x2013%3B5, DOI 10.1007/s10722-011-9686-5]; Peterson G. W., 2014, Diversity, V6, P665, DOI 10.3390/d6040665; Pinton F, 2001, GENET SEL EVOL, V33, pS491, DOI 10.1186/BF03500896; Pritchard JK, 2010, DOCUMENTATION STRUCT; Rabbi IY, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.09.0094; Rabbi IY, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0273-1; Raman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101673; Sadiki M., 2006, VARIETY NAMES ENTRY, DOI [10.1021/la061160c, DOI 10.1021/LA061160C]; Sam J., 2009, W AFRICA AGR PRODUCT; Sanchez-Sevilla JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144960; Schouten HJ, 2012, MOL BREEDING, V29, P645, DOI 10.1007/s11032-011-9579-5; Simko I, 2012, PLANT SCI, V184, P54, DOI 10.1016/j.plantsci.2011.12.009; Srinivasan M., 2015, GENET RES INT, V2015, P431487, DOI [10.1155/2015/431487, DOI 10.1155/2015/431487]; Suzuki R., 2015, PVCLUST HIERARCHICAL; Swaminathan MS, 2009, SCIENCE, V325, P517, DOI 10.1126/science.1177070; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Ortiz AHT, 2019, BRAZ ARCH BIOL TECHN, V62, DOI 10.1590/1678-4324-2019180556; Ortiz AHT, 2016, PLANT MOL BIOL REP, V34, P1153, DOI 10.1007/s11105-016-0995-x; Tinker NA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-39; Volk GM, 2004, J AM SOC HORTIC SCI, V129, P559, DOI 10.21273/JASHS.129.4.0559; Wang B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177456; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xia L, 2005, THEOR APPL GENET, V110, P1092, DOI 10.1007/s00122-005-1937-4; Zhao WL, 2011, COMM COM INF SC, V137, P46, DOI 10.1111/j.1439-0523.2010.01805.x	78	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255290	10.1371/journal.pone.0255290	http://dx.doi.org/10.1371/journal.pone.0255290			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314448	Green Published, gold			2022-12-26	WOS:000685225200003
J	Alballa, T; Boone, EL; Ma, LS; Snyder, A; Moeller, FG				Alballa, Tmader; Boone, Edward L.; Ma, Liangsuo; Snyder, Andrew; Moeller, F. Gerard			Exploring the relationship between white matter integrity, cocaine use and GAD polymorphisms using Bayesian Model Averaging	PLOS ONE			English	Article							MEAN DIFFUSIVITY; ANISOTROPY; ADDICTION; DURATION; PRIORS; MAPS	Past investigations utilizing diffusion tensor imaging (DTI) have demonstrated that cocaine use disorder (CUD) yields white matter changes, primarily in the corpus callosum. By applying Bayesian model averaging using multiple linear regression in DTI, we demonstrate there may exist relationships between the impaired white matter and glutamic acid decarboxylase (GAD) polymorphisms. This work explored the two-way and three-way interactions between GAD1(a) (SNP: rs1978340) and GAD1(b) (SNP: rs769390) polymorphisms and years of cocaine use (YCU). GAD1(a) was associated with more frontal white matter changes on its own but GAD1(b) was associated with more midbrain and cerebellar changes as well as a greater increase in white matter changes in the context of chronic cocaine use. The three-way interaction GAD1(a)|GAD1(b)|YCU appeared to be roughly an average of the polymorphism two-way interactions GAD1(a)|YCU and GAD1(b)|YCU. The three-way interaction demonstrated multiple regions including corpus callosum which featured fewer significant voxel changes, perhaps suggesting a small protective effect of having both polymorphisms on corpus callosum and cerebellar peduncle.	[Alballa, Tmader; Boone, Edward L.] Virginia Commonwealth Univ, Dept Stat Sci & Operat Res, Richmond, VA 23284 USA; [Ma, Liangsuo] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Boone, Edward L.; Ma, Liangsuo; Moeller, F. Gerard] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA USA; [Alballa, Tmader] Princess Nourah Bint Abdulrahman Univ, Coll Sci, Math Sci Dept, Riyadh, Saudi Arabia; [Moeller, F. Gerard] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Moeller, F. Gerard] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA; [Snyder, Andrew; Moeller, F. Gerard] Virginia Commonwealth Univ, Ctr Clin Translat Res, C Kenneth & Dianne Wright, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Princess Nourah bint Abdulrahman University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Alballa, T (corresponding author), Virginia Commonwealth Univ, Dept Stat Sci & Operat Res, Richmond, VA 23284 USA.; Alballa, T (corresponding author), Princess Nourah Bint Abdulrahman Univ, Coll Sci, Math Sci Dept, Riyadh, Saudi Arabia.	tmader.alballa@gmail.com		Alballa, Tmader/0000-0002-0776-2652	Wright Center for Clinical and Translational Research Grant: Virginia Commonwealth University, Richmond, Virginia, United States [UL1TR002649]	Wright Center for Clinical and Translational Research Grant: Virginia Commonwealth University, Richmond, Virginia, United States	This study was supported by Wright Center for Clinical and Translational Research Grant: UL1TR002649, Virginia Commonwealth University, Richmond, Virginia, United States.	Azadeh S, 2016, I S BIOMED IMAGING, P824, DOI 10.1109/ISBI.2016.7493393; Azadeh S, 2016, NEUROIMAGE, V125, P813, DOI 10.1016/j.neuroimage.2015.10.033; Baladandayuthapani V, 2010, J AM STAT ASSOC, V105, P1358, DOI 10.1198/jasa.2010.ap09250; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bell RP, 2011, DRUG ALCOHOL DEPEN, V114, P159, DOI 10.1016/j.drugalcdep.2010.10.001; Berger J. O., 1985, STAT DECISION THEORY, P74, DOI DOI 10.1007/978-1-4757-4286-2_3; Brooks SP, 1998, J ROY STAT SOC D-STA, V47, P69, DOI 10.1111/1467-9884.00117; Fernandez C, 2001, J ECONOMETRICS, V100, P381, DOI 10.1016/S0304-4076(00)00076-2; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Hasan KM, 2006, MAGN RESON MED, V56, P130, DOI 10.1002/mrm.20935; Hasan KM, 2003, MAGNET RESON MED, V50, P589, DOI 10.1002/mrm.10552; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Lane SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011591; Lee AH, 2011, J STAT COMPUT SIM, V81, P1111, DOI 10.1080/00949651003702135; Lim KO, 2008, DRUG ALCOHOL DEPEN, V92, P164, DOI 10.1016/j.drugalcdep.2007.07.019; Lim KO, 2002, BIOL PSYCHIAT, V51, P890, DOI 10.1016/S0006-3223(01)01355-5; Ma LS, 2017, DRUG ALCOHOL DEPEN, V173, P39, DOI 10.1016/j.drugalcdep.2016.12.016; Ma LS, 2009, DRUG ALCOHOL DEPEN, V104, P262, DOI 10.1016/j.drugalcdep.2009.05.020; MADIGAN D, 1995, INT STAT REV, V63, P215, DOI 10.2307/1403615; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Moeller FG, 2005, NEUROPSYCHOPHARMACOL, V30, P610, DOI 10.1038/sj.npp.1300617; Mori S., 2005, MRI ATLAS HUMAN WHIT; Morris JS, 2008, BIOMETRICS, V64, P479, DOI 10.1111/j.1541-0420.2007.00895.x; Narayana PA, 2014, PSYCHIAT RES-NEUROIM, V221, P220, DOI 10.1016/j.pscychresns.2014.01.005; Narayana PA, 2009, PSYCHIAT RES-NEUROIM, V171, P242, DOI 10.1016/j.pscychresns.2008.04.004; Oosterhuis BE, 2008, AM J MED GENET B, V147B, P793, DOI 10.1002/ajmg.b.30716; Romero MJ, 2010, PSYCHIAT RES-NEUROIM, V181, P57, DOI 10.1016/j.pscychresns.2009.07.004; Seber G. A. F., 2012, LINEAR REGRESSION AN, V329; Sim ME, 2007, NEUROPSYCHOPHARMACOL, V32, P2229, DOI 10.1038/sj.npp.1301346; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; TAYLOR DG, 1985, PHYS MED BIOL, V30, P345, DOI 10.1088/0031-9155/30/4/009; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Williams J., 1997, BIOMETRICS RES DEP; Zeugner S, 2015, J STAT SOFTW, V68, P1	39	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254776	10.1371/journal.pone.0254776	http://dx.doi.org/10.1371/journal.pone.0254776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310624	Green Published, gold			2022-12-26	WOS:000685224500054
J	Ramaiya, SD; Lee, HH; Xiao, YJ; Shahbani, NS; Zakaria, MH; Bujang, JS				Ramaiya, Shiamala Devi; Lee, Huei Hong; Xiao, Yong Jun; Shahbani, Nur Shahirah; Zakaria, Muta Harah; Bujang, Japar Sidik			Organic cultivation practices enhanced antioxidant activities and secondary metabolites in giant granadilla (Passiflora quadrangularis L.)	PLOS ONE			English	Article							BIOACTIVE COMPOUNDS; FERTILIZATION; STABILITY; NUTRIENTS; CAPACITY; LEAVES; FRUITS	Passiflora quadrangularis L. belongs to the family Passifloraceae which bears larger fruit with edible juicy mesocarp and pulp known as a good source of phytochemicals. Cultivation and plant management practices are known to influence the phytochemical compositions of agricultural produce. This study aimed to examine the influence of the cultivation practices on the antioxidant activities and secondary metabolites of the organically and conventionally grown P. quadrangularis. Findings revealed organically treated P. quadrangularis plants showed enhancement in their antioxidant properties and secondary metabolites profiles. Among the plant parts, leaves of P. quadrangularis grown organically possessed higher antioxidant activities compared to the conventional in all assays evaluated. The antioxidant activities in the edible parts of the P. quadrangularis fruit have also been enhanced through organic cultivation with significantly higher total phenolic content and DPPH in mesocarp, and the pulp showed higher total flavonoid content, DPPH and FRAP. This observation is supported by a higher level of vitamins and secondary metabolites in the samples. The secondary metabolites profile showed mesocarps were phenolic rich, the pulps were flavonoids rich while leaves showed good composition of phenolics, flavonoids and terpenoids with outstanding antioxidant activities. The common secondary metabolites for organically produced P. quadrangularis in different plant parts include 2-isopropyl-3-methoxycinnamic acid (mesocarp and pulp), myricetin isomers (pulp and leaves), and malvidin-3-O-arabinoside isomers (pulp and leaves). This study confirmed that organic cultivated P. quadrangularis possessed higher antioxidant activities contributed by its vitamins and secondary metabolites.	[Ramaiya, Shiamala Devi; Shahbani, Nur Shahirah] Univ Putra Malaysia Bintulu Campus, Fac Agr Sci & Forestry, Dept Crop Sci, Sarawak, Malaysia; [Lee, Huei Hong; Xiao, Yong Jun] Waters Pacific Pte Ltd, Int Food & Water Res Ctr, Singapore, Singapore; [Zakaria, Muta Harah] Univ Putra Malaysia, Fac Agr, Dept Aquaculture, Serdang, Selangor Darul, Malaysia; [Bujang, Japar Sidik] Univ Putra Malaysia, Fac Biol Sci, Dept Biol, Serdang, Selangor Darul, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Ramaiya, SD (corresponding author), Univ Putra Malaysia Bintulu Campus, Fac Agr Sci & Forestry, Dept Crop Sci, Sarawak, Malaysia.	shiamala@upm.edu.my	Zakaria, Muta Harah/A-7129-2017	Zakaria, Muta Harah/0000-0001-9077-367X; ramaiya, shiamala/0000-0002-7281-6020	Universiti Putra Malaysia [GP-IPM/2018/9671100, 6300811]	Universiti Putra Malaysia	This study was funded by Universiti Putra Malaysia under GP-IPM/2018/9671100 and grant 6300811. In-kind contribution was received from the International Food and Water Research Centre, Waters Corporation in the form of manpower, analytical instrument, software, consumables and technical consultancy required for the metabolites profiling study.	Agronet, 2018, RED INFORM COMUNICAC; Aguilera A, 2020, J SOIL SCI PLANT NUT, V20, P715, DOI 10.1007/s42729-019-00159-z; Aina OE, 2019, APPL ECOL ENV RES, V17, P3681, DOI 10.15666/aeer/1702_36813694; Anjos R, 2020, FOOD CHEM, V328, DOI 10.1016/j.foodchem.2020.126833; AOAC, 2000, OFFICIAL METHOD ANAL, V17; Bender D.A., 2003, NUTR BIOCH VITAMINS; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Chiavaroli A, 2020, PROCESSES, V8, DOI 10.3390/pr8091034; Commisso M, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301007; Costa GM, 2013, J LIQ CHROMATOGR R T, V36, P1697, DOI 10.1080/10826076.2012.695316; Demarque DP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58046-y; Dumas Y, 2003, J SCI FOOD AGR, V83, P369, DOI 10.1002/jsfa.1370; Echeverry SM, 2018, REV BRAS FARMACOGN, V28, P610, DOI 10.1016/j.bjp.2018.06.005; El-Moniem MNA., 2012, J SAUDI SOC AGR SCI, V11, P135; Farag MA, 2016, ANAL BIOANAL CHEM, V408, P3125, DOI 10.1007/s00216-016-9376-4; Fonseca LRD., 2020, SCI WORLD J; Gazola AC, 2018, BIOMED PHARMACOTHER, V100, P374, DOI 10.1016/j.biopha.2018.02.002; Genovese MI, 2008, FOOD SCI TECHNOL INT, V14, P207, DOI 10.1177/1082013208092151; Ghosson H, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0329-0; Hassan A., 2012, MED AROMAT PLANT SCI, V6, P105; Ingale A. G., 2010, African Journal of Plant Science, V4, P417; Janzantti NS, 2012, LWT-FOOD SCI TECHNOL, V46, P511, DOI 10.1016/j.lwt.2011.11.016; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kapoulas N, 2011, AFR J BIOTECHNOL, V10, P15938, DOI 10.5897/AJB11.904; Li Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204570; Ortega AMM, 2019, BIOACTIVE COMPOUNDS: HEALTH BENEFITS AND POTENTIAL APPLICATIONS, P247, DOI 10.1016/B978-0-12-814774-0.00013-X; McCullagh M, 2021, TALANTA, V221, DOI 10.1016/j.talanta.2020.121311; Medina S, 2017, FOOD CHEM, V229, P1, DOI 10.1016/j.foodchem.2017.02.049; Mitran T, 2018, PEDOSPHERE, V28, P823, DOI 10.1016/S1002-0160(17)60423-5; Mozner Z, 2012, ECOL INDIC, V16, P58, DOI 10.1016/j.ecolind.2011.06.034; Olermo NC., 2017, ASIA PAC J MULTIDISC, V5; Onofrei V, 2017, ACTA POL PHARM, V74, P611; Pertuzatti PB, 2015, LWT-FOOD SCI TECHNOL, V64, P259, DOI 10.1016/j.lwt.2015.05.031; Premamali M., 2019, Sustainable Agriculture Research, V8, P57, DOI 10.5539/sar.v8n3p57; Sakalem ME, 2012, REV BRAS FARMACOGN, V22, P1219, DOI 10.1590/S0102-695X2012005000108; Sarker U, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91157-8; Sarker U, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02780-y; Sarker U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71714-3; Sarker U, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.559876; Sarker U, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02700-0; Sarker U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71727-y; Sarker U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60252-7; Sarker U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59848-w; Sarker U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57687-3; Sarker U, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34944-0; Sarker U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206388; Sarker U, 2019, J SCI FOOD AGR, V99, P2275, DOI 10.1002/jsfa.9423; Sarker U, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30897-6; Sarker U, 2018, APPL BIOCHEM BIOTECH, V186, P999, DOI 10.1007/s12010-018-2784-5; Sarker U, 2018, FOOD CHEM, V252, P72, DOI 10.1016/j.foodchem.2018.01.097; Saupi N, 2019, FOOD RES, P231, DOI [DOI 10.26656/FR.2017.3(3).233, 10.26656/fr.2017.3(3).233]; Shang LR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240559; Sharma P., 2012, J BOT, V2012, P26, DOI [10.1155/2012/217037, DOI 10.1155/2012/217037]; Teodoro AJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3765986; Timsina J, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8100214; Vallverdu-Queralt A, 2011, FOOD CHEM, V126, P1700, DOI 10.1016/j.foodchem.2010.12.061; Veberic R, 2016, HORTICULTURAE, V2, DOI 10.3390/horticulturae2030008; Wezel A, 2014, AGRON SUSTAIN DEV, V34, P1, DOI 10.1007/s13593-013-0180-7; You J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01092; Zeinab AS., 2013, J SAUDI SOC AGR, V14, P91; Zhang QF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112572; Zhao XY, 2018, BIORESOURCE TECHNOL, V267, P378, DOI 10.1016/j.biortech.2018.07.060	63	3	3	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255059	10.1371/journal.pone.0255059	http://dx.doi.org/10.1371/journal.pone.0255059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310644	gold, Green Published			2022-12-26	WOS:000685224500013
J	Roehe, MA; Kluger, DS; Schroeder, SCY; Schliephake, LM; Boelte, J; Jacobsen, T; Schubotz, RI				Roehe, Marlen A.; Kluger, Daniel S.; Schroeder, Svea C. Y.; Schliephake, Lena M.; Boelte, Jens; Jacobsen, Thomas; Schubotz, Ricarda I.			Early alpha/beta oscillations reflect the formation of face-related expectations in the brain	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; SEX-DIFFERENCES; TOP-DOWN; IDENTITY; MODULATION; DYNAMICS; BETA	Although statistical regularities in the environment often go explicitly unnoticed, traces of implicit learning are evident in our neural activity. Recent perspectives have offered evidence that both pre-stimulus oscillations and peri-stimulus event-related potentials are reliable biomarkers of implicit expectations arising from statistical learning. What remains ambiguous, however, is the origination and development of these implicit expectations. To address this lack of knowledge and determine the temporal constraints of expectation formation, pre-stimulus increases in alpha/beta power were investigated alongside a reduction in the N170 and a suppression in peri-/post-stimulus gamma power. Electroencephalography was acquired from naive participants who engaged in a gender classification task. Participants were uninformed, that eight face images were sorted into four reoccurring pairs which were pseudorandomly hidden amongst randomly occurring face images. We found a reduced N170 for statistically expected images at left parietal and temporo-parietal electrodes. Furthermore, enhanced gamma power following the presentation of random images emphasized the bottom-up processing of these arbitrary occurrences. In contrast, enhanced alpha/beta power was evident pre-stimulus for expected relative to random faces. A particularly interesting finding was the early onset of alpha/beta power enhancement which peaked immediately after the depiction of the predictive face. Hence, our findings propose an approximate timeframe throughout which consistent traces of enhanced alpha/beta power illustrate the early prioritisation of top-down processes to facilitate the development of implicitly cued face-related expectations.	[Roehe, Marlen A.; Schroeder, Svea C. Y.; Schliephake, Lena M.; Boelte, Jens; Schubotz, Ricarda I.] Univ Munster, Dept Psychol, Munster, Germany; [Roehe, Marlen A.; Kluger, Daniel S.; Schroeder, Svea C. Y.; Boelte, Jens; Schubotz, Ricarda I.] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Munster, Germany; [Kluger, Daniel S.] Univ Munster, Inst Biomagnetism & Biosignal Anal, Munster, Germany; [Jacobsen, Thomas] Univ Fed Armed Forces Hamburg, Helmut Schmidt Univ, Expt Psychol Unit, Hamburg, Germany	University of Munster; University of Munster; University of Munster; Helmut Schmidt University	Roehe, MA (corresponding author), Univ Munster, Dept Psychol, Munster, Germany.; Roehe, MA (corresponding author), Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Munster, Germany.	marlen.roehe@uni-muenster.de	Jacobsen, Thomas/B-5796-2011	Jacobsen, Thomas/0000-0002-1523-3996; Kluger, Daniel/0000-0002-0691-794X; Bolte, Jens/0000-0002-8128-0520				Arnal LH, 2011, NAT NEUROSCI, V14, P797, DOI 10.1038/nn.2810; Bastos AM, 2015, NEURON, V85, P390, DOI 10.1016/j.neuron.2014.12.018; Bauer M, 2014, J NEUROSCI, V34, P16117, DOI 10.1523/JNEUROSCI.3474-13.2014; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Brodski-Guerniero A, 2017, J NEUROSCI, V37, P8273, DOI 10.1523/JNEUROSCI.0614-17.2017; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Caharel S, 2009, NEUROPSYCHOLOGIA, V47, P639, DOI 10.1016/j.neuropsychologia.2008.11.016; Campanella S, 2000, PSYCHOPHYSIOLOGY, V37, P796, DOI 10.1017/S0048577200991728; Cao LY, 2017, NEUROIMAGE, V147, P895, DOI 10.1016/j.neuroimage.2016.11.001; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Cohen MX, 2014, ISS CLIN COGN NEUROP, P203; Cohen MX, 2014, ISS CLIN COGN NEUROP, P73; de Cheveigne A, 2019, NEURON, V102, P280, DOI 10.1016/j.neuron.2019.02.039; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gao CJ, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13336; Godard O, 2013, NEUROSCI RES, V76, P58, DOI 10.1016/j.neures.2013.03.005; Gordon N, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000233; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Griffiths BJ, 2019, ELIFE, V8, DOI 10.7554/eLife.49562; Jemel B, 2010, J COGNITIVE NEUROSCI, V22, P2289, DOI 10.1162/jocn.2009.21320; Johnston P, 2017, BIOL PSYCHOL, V125, P45, DOI 10.1016/j.biopsycho.2017.02.004; Johnston P, 2016, CORTEX, V85, P54, DOI 10.1016/j.cortex.2016.10.002; Kaiser J, 2005, NEUROREPORT, V16, P207, DOI 10.1097/00001756-200502280-00001; Klimesch W, 2011, BRAIN RES, V1408, P52, DOI 10.1016/j.brainres.2011.06.003; Kluger DS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218311; Kropotov JD, 2016, FUNCTIONAL NEUROMARKERS FOR PSYCHIATRY: APPLICATIONS FOR DIAGNOSIS AND TREATMENT, P137, DOI 10.1016/B978-0-12-410513-3.00011-5; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Martinovic J, 2011, INT J PSYCHOPHYSIOL, V79, P32, DOI 10.1016/j.ijpsycho.2010.07.004; Mayer A, 2016, CEREB CORTEX, V26, P3146, DOI 10.1093/cercor/bhv146; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Proverbio AM, 2012, NEUROPSYCHOLOGIA, V50, P2325, DOI 10.1016/j.neuropsychologia.2012.05.036; Proverbio AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011242; Ran GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114011; Rossion B., 2012, OXFORD HDB ERP COMPO, P115, DOI [10.1093/oxfordhb/9780195374148.013.0064, DOI 10.1093/OXFORDHB/9780195374148.013.0064]; Shen C, 2017, CORTEX, V86, P55, DOI 10.1016/j.cortex.2016.10.010; Smout CA, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006812; Spaak E, 2016, CEREB CORTEX, V26, P4327, DOI 10.1093/cercor/bhv210; Taylor J, 2016, BIOL PSYCHOL, V118, P136, DOI 10.1016/j.biopsycho.2016.05.011; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; Turk-Browne NB, 2010, J NEUROSCI, V30, P11177, DOI 10.1523/JNEUROSCI.0858-10.2010; van Pelt S, 2016, SOC COGN AFFECT NEUR, V11, P973, DOI 10.1093/scan/nsw017; Zheng CG, 2015, NEURON, V85, P236, DOI 10.1016/j.neuron.2014.12.067	44	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255116	10.1371/journal.pone.0255116	http://dx.doi.org/10.1371/journal.pone.0255116			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TN	34310657	gold, Green Published			2022-12-26	WOS:000685224500040
J	Weaver, DT; McElvany, BD; Gopalakrishnan, V; Card, KJ; Crozier, D; Dhawan, A; Dinh, MN; Dolson, E; Farrokhian, N; Hitomi, M; Ho, E; Jagdish, T; King, ES; Cadnum, JL; Donskey, CJ; Krishnan, N; Kuzmin, G; Li, J; Maltas, J; Mo, JH; Pelesko, J; Scarborough, JA; Sedor, G; Tian, EZ; An, GC; Diehl, SA; Scott, JG				Weaver, Davis T.; McElvany, Benjamin D.; Gopalakrishnan, Vishhvaan; Card, Kyle J.; Crozier, Dena; Dhawan, Andrew; Dinh, Mina N.; Dolson, Emily; Farrokhian, Nathan; Hitomi, Masahiro; Ho, Emily; Jagdish, Tanush; King, Eshan S.; Cadnum, Jennifer L.; Donskey, Curtis J.; Krishnan, Nikhil; Kuzmin, Gleb; Li, Ju; Maltas, Jeff; Mo, Jinhan; Pelesko, Julia; Scarborough, Jessica A.; Sedor, Geoff; Tian, Enze; An, Gary C.; Diehl, Sean A.; Scott, Jacob G.			UV decontamination of personal protective equipment with idle laboratory biosafety cabinets during the COVID-19 pandemic	PLOS ONE			English	Article								Personal protective equipment (PPE) is crucially important to the safety of both patients and medical personnel, particularly in the event of an infectious pandemic. As the incidence of Coronavirus Disease 2019 (COVID-19) increases exponentially in the United States and many parts of the world, healthcare provider demand for these necessities is currently outpacing supply. In the midst of the current pandemic, there has been a concerted effort to identify viable ways to conserve PPE, including decontamination after use. In this study, we outline a procedure by which PPE may be decontaminated using ultraviolet (UV) radiation in biosafety cabinets (BSCs), a common element of many academic, public health, and hospital laboratories. According to the literature, effective decontamination of N95 respirator masks or surgical masks requires UV-C doses of greater than 1 Jcm(-2), which was achieved after 4.3 hours per side when placing the N95 at the bottom of the BSCs tested in this study. We then demonstrated complete inactivation of the human coronavirus NL63 on N95 mask material after 15 minutes of UV-C exposure at 61 cm (232 mu Wcm(-2)). Our results provide support to healthcare organizations looking for methods to extend their reserves of PPE.	[Weaver, Davis T.; Gopalakrishnan, Vishhvaan; Card, Kyle J.; Crozier, Dena; Dhawan, Andrew; Dinh, Mina N.; Dolson, Emily; Farrokhian, Nathan; Hitomi, Masahiro; Ho, Emily; King, Eshan S.; Krishnan, Nikhil; Kuzmin, Gleb; Pelesko, Julia; Scarborough, Jessica A.; Sedor, Geoff; Scott, Jacob G.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA; [Weaver, Davis T.; Gopalakrishnan, Vishhvaan; Card, Kyle J.; Crozier, Dena; Dhawan, Andrew; Dinh, Mina N.; Dolson, Emily; Farrokhian, Nathan; Hitomi, Masahiro; Ho, Emily; King, Eshan S.; Krishnan, Nikhil; Kuzmin, Gleb; Pelesko, Julia; Scarborough, Jessica A.; Sedor, Geoff; Scott, Jacob G.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; [McElvany, Benjamin D.; An, Gary C.; Diehl, Sean A.] Univ Vermont, Med Ctr, Burlington, VT 05405 USA; [Dhawan, Andrew] Cleveland Clin, Div Neurol, Cleveland, OH 44106 USA; [Jagdish, Tanush] Harvard Univ, Dana Farber Canc Inst, Boston, MA 02115 USA; [Maltas, Jeff] Univ Michigan, Ann Arbor, MI 48109 USA; [Mo, Jinhan] Tsinghua Univ, Beijing, Peoples R China; [Li, Ju; Tian, Enze] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Card, Kyle J.] Michigan State Univ, E Lansing, MI 48824 USA; [Cadnum, Jennifer L.; Donskey, Curtis J.] Louis Stokes Cleveland VA, Cleveland, OH USA	Cleveland Clinic Foundation; Case Western Reserve University; University of Vermont; University of Vermont Medical Center; Cleveland Clinic Foundation; Harvard University; Dana-Farber Cancer Institute; University of Michigan System; University of Michigan; Tsinghua University; Massachusetts Institute of Technology (MIT); Michigan State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Scott, JG (corresponding author), Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA.; Scott, JG (corresponding author), Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA.; Diehl, SA (corresponding author), Univ Vermont, Med Ctr, Burlington, VT 05405 USA.	Sean.Diehl@med.uvm.edu; scottj10@ccf.org	Tian, Enze/AAX-1415-2020; Tian, Enze/HHY-7956-2022; Dolson, Emily/A-8944-2019; Mo, Jinhan/A-7424-2008	Tian, Enze/0000-0001-6410-5360; Tian, Enze/0000-0001-6410-5360; Dolson, Emily/0000-0001-8616-4898; Mo, Jinhan/0000-0002-3178-6507; Dhawan, Andrew/0000-0002-5027-1277; Dinh, Mina/0000-0002-4026-5105; Ho, Emily/0000-0002-7083-7880; Weaver, Davis/0000-0003-3086-497X; McElvany, Benjamin/0000-0002-0226-7222; Crozier, Dena/0000-0002-1841-0011; Farrokhian, Nathan/0000-0001-8731-4464; Gopalakrishnan, Vishhvaan/0000-0002-0532-7710; Card, Kyle/0000-0002-0462-2777				[Anonymous], COVID 19 DECONTAMINA; Bergman MS, 2010, J ENG FIBER FABR, V5, P33; Dolson E, 2020, DATA ANAL USE UV C R, DOI [10.5281/zenodo.3724005, DOI 10.5281/ZENODO.3724005]; DUNN CG, 1948, J APPL PHYS, V19, P605, DOI 10.1063/1.1698179; Fisher EM, 2011, J APPL MICROBIOL, V110, P287, DOI 10.1111/j.1365-2672.2010.04881.x; Griffiths D. J., 1999, INTRO ELECTRODYNAMIC; Harnish, 2019, HHSF223201400158C AP; Jones D, TIMELY UV C LAMP REP; Kowalski W, 2009, ULTRAVIOLET GERMICIDAL IRRADIATION HANDBOOK, P1, DOI 10.1007/978-3-642-01999-9; Lindsley WG, 2015, J OCCUP ENVIRON HYG, V12, P509, DOI 10.1080/15459624.2015.1018518; Lore MB, 2012, ANN OCCUP HYG, V56, P92, DOI 10.1093/annhyg/mer054; Lowe, 2020, N95 FILTERING FACEPI, DOI 10.11604/pamj.supp.2020.35.2.22794; Mamahlodi MT, 2019, J PUBLIC HEALTH AFR, V10, P61, DOI 10.4081/jphia.2019.742; MEULEMANS CCE, 1987, OZONE-SCI ENG, V9, P299; Mills D, 2018, AM J INFECT CONTROL, V46, pE49, DOI 10.1016/j.ajic.2018.02.018; National Institute for Occupational Safety and Health (NIOSH), 1996, NIOSH GUID SEL US PA; REED L. J., 1938, AMER JOUR HYG, V27, P493; She R. C, 2003, BUILD AT HOME UV C D, P12916; Sureka CS, 2017, RAD BIOL MED PHYS; Tseng CC, 2007, J OCCUP ENVIRON HYG, V4, P400, DOI 10.1080/15459620701329012; Viscusi DJ, 2009, ANN OCCUP HYG, V53, P815, DOI 10.1093/annhyg/mep070; Vo E, 2009, APPL ENVIRON MICROB, V75, P7303, DOI 10.1128/AEM.00799-09; WorldHealthOrganization, 2020, SHORT PERS PROT EQ E	23	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0241734	10.1371/journal.pone.0241734	http://dx.doi.org/10.1371/journal.pone.0241734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310599	gold, Green Published			2022-12-26	WOS:000685224500016
J	Yoon, HJ; Kim, HR; Song, CM; Lee, JY; Ahn, YH; Tae, K				Yoon, Hyung-Joon; Kim, Hee Ryung; Song, Chang Myeon; Lee, Ji Young; Ahn, You Hern; Tae, Kyung			Aggravation of Reflux Finding Score (RFS) after thyroidectomy	PLOS ONE			English	Article							LARYNGOPHARYNGEAL REFLUX; LARYNGEAL NERVE; VOICE OUTCOMES; RELIABILITY; SUPERIOR; VALIDITY	Laryngopharyngeal reflux (LPR) has been suggested as a possible cause of post-thyroidectomy syndrome. However, the pathophysiology and relationship between thyroidectomy and LPR have not been well investigated. We aimed to evaluate the correlation between thyroidectomy and LPR by assessing changes in LPR-related symptoms and laryngoscopic findings before and after thyroidectomy. Ninety-five patients who underwent thyroidectomy with or without central neck dissection were included. The reflux finding score (RFS) and reflux symptom index (RSI) were investigated one day before surgery and two, four, six, and twelve months after surgery. The RFS scores increased significantly after thyroidectomy and decreased to the preoperative level 12 months after surgery. The RSI scores increased after surgery and decreased gradually by 12 months postoperatively, although it was not statistically significant. The RSI and RFS scores improved with the administration of proton pump inhibitors. In conclusion, LPR-related laryngoscopic findings were exacerbated after uncomplicated thyroidectomy. Further studies using pH-monitoring and esophageal manometry are required to investigate the possible deterioration of LPR itself and the UES pressure after thyroidectomy.	[Yoon, Hyung-Joon; Kim, Hee Ryung; Song, Chang Myeon; Tae, Kyung] Hanyang Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Lee, Ji Young] Hanyang Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Ahn, You Hern] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Hanyang University; Hanyang University; Hanyang University	Tae, K (corresponding author), Hanyang Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	kytae@hanyang.ac.kr		Tae, Kyung/0000-0002-0382-2072; Song, Chang Myeon/0000-0001-5267-0135				Belafsky PC, 2001, LARYNGOSCOPE, V111, P1313, DOI 10.1097/00005537-200108000-00001; Belafsky PC, 2002, J VOICE, V16, P274, DOI 10.1016/S0892-1997(02)00097-8; Chandrasekhar SS, 2013, OTOLARYNG HEAD NECK, V148, pS1, DOI 10.1177/0194599813487301; Cusimano A, 2016, EUR ARCH OTO-RHINO-L, V273, P197, DOI 10.1007/s00405-014-3474-8; Fiorentino E, 2011, EUR ARCH OTO-RHINO-L, V268, P715, DOI 10.1007/s00405-010-1394-9; Holler T, 2014, J OTOLARYNGOL-HEAD N, V43, DOI 10.1186/s40463-014-0028-4; Hong KH, 1997, J VOICE, V11, P23; Jin BJ, 2008, LARYNGOSCOPE, V118, P938, DOI 10.1097/MLG.0b013e3181651c3a; KOUFMAN JA, 1991, LARYNGOSCOPE, V101, P1; Lechien JR, 2019, LARYNGOSCOPE, V129, P1174, DOI 10.1002/lary.27591; LENNQUIST S, 1987, SURGERY, V102, P999; Lombardi CP, 2009, SURGERY, V146, P1174, DOI 10.1016/j.surg.2009.09.010; Pereira JA, 2003, SURGERY, V133, P318, DOI 10.1067/msy.2003.58; Scerrino G, 2013, OTOLARYNG HEAD NECK, V148, P926, DOI 10.1177/0194599813482299; Schreiber S, 2009, EUR ARCH OTO-RHINO-L, V266, P17, DOI 10.1007/s00405-008-0770-1; Shaker R, 2014, LARYNGOSCOPE, V124, P2268, DOI 10.1002/lary.24735; Shin KS, 2010, CLIN OTOLARYNGOL, V35, P25, DOI 10.1111/j.1749-4486.2009.02072.x; Song CM, 2020, ORAL ONCOL, V107, DOI 10.1016/j.oraloncology.2020.104748; Sung ES, 2018, EUR ARCH OTO-RHINO-L, V275, P3049, DOI 10.1007/s00405-018-5145-7; Tae K, 2011, CLIN EXP OTORHINOLAR, V4, P101, DOI 10.3342/ceo.2011.4.2.101; Tedla M, 2016, EUR ARCH OTO-RHINO-L, V273, P4543, DOI 10.1007/s00405-016-4163-6; Zawawi Faisal, 2013, ISRN Otolaryngol, V2013, P135978, DOI 10.1155/2013/135978	22	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254235	10.1371/journal.pone.0254235	http://dx.doi.org/10.1371/journal.pone.0254235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310631	Green Published, gold			2022-12-26	WOS:000685224500029
J	Huang, CC; Liang, CM; Yang, TI; Chen, JL; Wang, WK				Huang, Chi-Chun; Liang, Chih-Ming; Yang, Ting-, I; Chen, Jiann-Long; Wang, Wei-Kuang			Shift of bacterial communities in heavy metal-contaminated agricultural land during a remediation process	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MICROBIAL COMMUNITIES; SOIL MICROBIOME; HEALTH-RISKS; DIVERSITY; SEDIMENTS; ABUNDANCE; PATTERNS; DATABASE; AREAS	Anthropogenic activities accompanied by heavy metal waste threaten the environment. Heavy metal pollution alters the soil microbial community composition, and the microorganisms that adapt to this stress increase in abundance. The remediation process of contaminated soil not only reduces the concentration of heavy metals but also alters the bacterial communities. High-throughput 16S rDNA sequencing techniques were applied to understand the changes in soil microbial communities. Using the remediation approach of the soil mixing, the concentrations of heavy metals in the contaminated areas were diluted and the soil environment was changed. The change of soil environment as a disturbance contributed to the alteration of microbial diversity of the remediated areas. The pH and heavy metals (Cr, Cu, Ni, and Zn) were the most influential factors driving the changes in community structure. The bacterial community structure was significantly different among sample areas. The decrease of heavy metals in soil may be the important factors that changed the microbial composition. This study provides the better understanding of the changes in composition of microbial communities affected by the remediation process in heavy metal-contaminated soil.	[Huang, Chi-Chun] Endem Species Res Inst, Nantou, Taiwan; [Liang, Chih-Ming; Yang, Ting-, I; Chen, Jiann-Long; Wang, Wei-Kuang] Feng Chia Univ, Dept Environm Engn & Sci, Taichung, Taiwan	Feng Chia University	Wang, WK (corresponding author), Feng Chia Univ, Dept Environm Engn & Sci, Taichung, Taiwan.	wkwang@fcu.edu.tw		Wang, Weikuang/0000-0003-4068-0429	Ministry of Science and Technology, Taiwan [MOST 109-2221-E-035-034]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Ministry of Science and Technology, Taiwan (MOST 109-2221-E-035-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also no authors received a salary from the funder.	Ager D, 2010, ENVIRON MICROBIOL, V12, P670, DOI 10.1111/j.1462-2920.2009.02107.x; Ali H, 2019, J CHEM-NY, V2019, DOI 10.1155/2019/6730305; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2011, Prescrire Int, V20, P43; [Anonymous], 1991, MONOGRAPH, V17, P1; Azarbad H, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu003; Baath E, 1998, APPL ENVIRON MICROB, V64, P238; Balaban N, 2019, WATER-SUI, V11, DOI 10.3390/w11102128; Berg J, 2012, APPL ENVIRON MICROB, V78, P7438, DOI 10.1128/AEM.01071-12; Bourceret A, 2016, MICROB ECOL, V71, P711, DOI 10.1007/s00248-015-0682-8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chellaiah ER, 2018, APPL WATER SCI, V8, DOI 10.1007/s13201-018-0796-5; Cheng BY, 2013, PADDY WATER ENVIRON, V11, P343, DOI 10.1007/s10333-012-0325-3; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cui H, 2018, ECOTOX ENVIRON SAFE, V166, P259, DOI 10.1016/j.ecoenv.2018.09.096; Das S, 2013, GEOMICROBIOL J, V30, P635, DOI 10.1080/01490451.2012.746407; David M, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0475-x; Delgado-Baquerizo M, 2018, SCIENCE, V359, P320, DOI 10.1126/science.aap9516; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dubey A, 2019, BIODIVERS CONSERV, V28, P2405, DOI 10.1007/s10531-019-01760-5; Fatimawali, 2020, INT J MICROBIOL, V2020, DOI 10.1155/2020/1858732; Feng G, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1152-5; Fernandes CC, 2018, BRAZ J MICROBIOL, V49, P489, DOI 10.1016/j.bjm.2017.12.006; Frossard A, 2017, SOIL BIOL BIOCHEM, V105, P162, DOI 10.1016/j.soilbio.2016.11.016; Giller KE, 1998, SOIL BIOL BIOCHEM, V30, P1389, DOI 10.1016/S0038-0717(97)00270-8; Golebiewski M, 2014, MICROB ECOL, V67, P635, DOI 10.1007/s00248-013-0344-7; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hemme CL, 2010, ISME J, V4, P660, DOI 10.1038/ismej.2009.154; Hsu MJ, 2006, ENVIRON POLLUT, V143, P327, DOI 10.1016/j.envpol.2005.11.023; Tran HT, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5875-y; Igiri BE, 2018, J TOXICOL-US, V2018, DOI 10.1155/2018/2568038; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Khudur LS, 2018, ENVIRON POLLUT, V243, P94, DOI 10.1016/j.envpol.2018.08.040; Li XQ, 2017, ENVIRON POLLUT, V231, P908, DOI 10.1016/j.envpol.2017.08.057; McBride M, 1997, EUR J SOIL SCI, V48, P337, DOI 10.1111/j.1365-2389.1997.tb00554.x; Rai PK, 2019, ENVIRON INT, V125, P365, DOI 10.1016/j.envint.2019.01.067; Remenar M, 2017, BIOLOGIA, V72, P971, DOI 10.1515/biolog-2017-0117; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sandrin TR, 2003, ENVIRON HEALTH PERSP, V111, P1093, DOI 10.1289/ehp.5840; Schloss PD, 2016, MBIO, V7, DOI 10.1128/mBio.00201-16; Song JW, 2018, ENVIRON POLLUT, V243, P510, DOI 10.1016/j.envpol.2018.09.011; Song L, 2020, PEERJ, V8, DOI 10.7717/peerj.10302; Spain AM, 2009, ISME J, V3, P992, DOI 10.1038/ismej.2009.43; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Tao JM, 2017, APPL MICROBIOL BIOT, V101, P1289, DOI 10.1007/s00253-016-7938-1; Violante A, 2010, J SOIL SCI PLANT NUT, V10, P268, DOI 10.4067/S0718-95162010000100005; Wang YL, 2020, SCI REP-UK, V10, DOI [10.1038/s41598-020-60384-w, 10.1038/s41598-020-67389-5]; Wu WC, 2017, SCI TOTAL ENVIRON, V601, P57, DOI 10.1016/j.scitotenv.2017.05.165; Wu ZX, 2018, APPL SOIL ECOL, V125, P192, DOI 10.1016/j.apsoil.2018.01.011; Xiao SQ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01867; Xiao SN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09509-y; Xiong JB, 2014, APPL ENVIRON MICROB, V80, P1919, DOI 10.1128/AEM.03731-13; Xiong JB, 2012, ENVIRON MICROBIOL, V14, P2457, DOI 10.1111/j.1462-2920.2012.02799.x; YANG HY, 2020, SUSTAINABILITY-BASEL, V12, DOI DOI 10.3390/SU122310066; Yang Y, 2018, ENVIRON POLLUT, V238, P263, DOI 10.1016/j.envpol.2018.02.059; Zeng QC, 2019, SCI TOTAL ENVIRON, V680, P124, DOI 10.1016/j.scitotenv.2019.04.184; Zeng XY, 2020, SCI TOTAL ENVIRON, V723, DOI 10.1016/j.scitotenv.2020.138081; Zhang GL, 2017, CHEMOSPHERE, V184, P278, DOI 10.1016/j.chemosphere.2017.05.155; Zhang XM, 2018, ENVIRON MICROBIOL, V20, P3862, DOI 10.1111/1462-2920.14407; 2018, AM J GASTROENTEROL, V113	61	13	13	18	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255137	10.1371/journal.pone.0255137	http://dx.doi.org/10.1371/journal.pone.0255137			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297781	gold, Green Published			2022-12-26	WOS:000678128300010
J	Joshi, S; Thoday-Kennedy, E; Daetwyler, HD; Hayden, M; Spangenberg, G; Kant, S				Joshi, Sameer; Thoday-Kennedy, Emily; Daetwyler, Hans D.; Hayden, Matthew; Spangenberg, German; Kant, Surya			High-throughput phenotyping to dissect genotypic differences in safflower for drought tolerance	PLOS ONE			English	Article							CARTHAMUS-TINCTORIUS L.; WATER-USE EFFICIENCY; SEED YIELD; PHYSIOLOGICAL TRAITS; OIL CONTENT; CROP; STRESS; GROWTH; PRODUCTIVITY; IRRIGATION	Drought is one of the most severe and unpredictable abiotic stresses, occurring at any growth stage and affecting crop yields worldwide. Therefore, it is essential to develop drought tolerant varieties to ensure sustainable crop production in an ever-changing climate. High-throughput digital phenotyping technologies in tandem with robust screening methods enable precise and faster selection of genotypes for breeding. To investigate the use of digital imaging to reliably phenotype for drought tolerance, a genetically diverse safflower population was screened under different drought stresses at Agriculture Victoria's high-throughput, automated phenotyping platform, Plant Phenomics Victoria, Horsham. In the first experiment, four treatments, control (90% field capacity; FC), 40% FC at initial branching, 40% FC at flowering and 50% FC at initial branching and flowering, were applied to assess the performance of four safflower genotypes. Based on these results, drought stress using 50% FC at initial branching and flowering stages was chosen to further screen 200 diverse safflower genotypes. Measured plant traits and dry biomass showed high correlations with derived digital traits including estimated shoot biomass, convex hull area, caliper length and minimum area rectangle, indicating the viability of using digital traits as proxy measures for plant growth. Estimated shoot biomass showed close association having moderately high correlation with drought indices yield index, stress tolerance index, geometric mean productivity, and mean productivity. Diverse genotypes were classified into four clusters of drought tolerance based on their performance (seed yield and digitally estimated shoot biomass) under stress. Overall, results show that rapid and precise image-based, high-throughput phenotyping in controlled environments can be used to effectively differentiate response to drought stress in a large numbers of safflower genotypes.	[Joshi, Sameer; Thoday-Kennedy, Emily; Kant, Surya] Agr Victoria, Grains Innovat Pk, Horsham, Vic, Australia; [Daetwyler, Hans D.; Hayden, Matthew; Spangenberg, German] AgriBio, Agr Victoria, Ctr AgriBiosci, Bundoora, Vic, Australia; [Daetwyler, Hans D.; Hayden, Matthew; Spangenberg, German] La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic, Australia; [Kant, Surya] Univ Melbourne, Fac Vet & Agr Sci, Ctr Agr Innovat, Sch Agr & Food, Melbourne, Vic, Australia	La Trobe University; La Trobe University; University of Melbourne	Kant, S (corresponding author), Agr Victoria, Grains Innovat Pk, Horsham, Vic, Australia.; Kant, S (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Ctr Agr Innovat, Sch Agr & Food, Melbourne, Vic, Australia.	surya.kant@agriculture.vic.gov.au		Kant, Surya/0000-0001-6178-7036; Hayden, Matthew/0000-0003-3117-5500; Joshi, Sameer/0000-0002-9047-8221	Australian Government Cooperative Research Centre Project [CRC-P54024]; Agriculture Victoria; Grains Research AMP; Development Corporation	Australian Government Cooperative Research Centre Project; Agriculture Victoria; Grains Research AMP; Development Corporation(Grains R&D Corp)	All authors were awarded funding from the Australian Government Cooperative Research Centre Project (CRC-P54024). Agriculture Victoria and the Grains Research & Development Corporation provided infrastructure funding for the establishment of the Plant Phenomics Victoria, Horsham facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolhasani K., 2006, Journal of Science and Technology of Agriculture and Natural Resources, V10, P407; Amini H, 2013, INT J PLANT PROD, V7, P597; Anjani K, 2017, IND CROP PROD, V104, P7, DOI 10.1016/j.indcrop.2017.04.011; [Anonymous], 2018, INDIAN J NEPHROL SS1, V28, P28; [Anonymous], 1995, EVOLUTION CROP PLANT; Asgarpanah J, 2013, CHIN J INTEGR MED, V19, P153, DOI 10.1007/s11655-013-1354-5; Bahrami F, 2014, AGRON J, V106, P1219, DOI 10.2134/agronj13.0387; Banerjee BP, 2020, J EXP BOT, V71, P4604, DOI 10.1093/jxb/eraa143; Bar-Tal A, 2008, AGRON J, V100, P1499, DOI 10.2134/agronj2007.0353; Bassil ES, 2002, AGR WATER MANAGE, V54, P67, DOI 10.1016/S0378-3774(01)00148-2; Baye A, 2020, COGENT FOOD AGR, V6, DOI 10.1080/23311932.2020.1752603; Belide S, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-12; Bergman JW, 2005, CROP SCI, V45, P801, DOI 10.2135/cropsci2005.0801; Beyyavas V, 2011, AFR J BIOTECHNOL, V10, P527; Bortolheiro FPAP, 2017, AN ACAD BRAS CIENC, V89, P3051, DOI 10.1590/0001-3765201720170475; BOUSLAMA M, 1984, CROP SCI, V24, P933, DOI 10.2135/cropsci1984.0011183X002400050026x; Cai JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157102; Calkins H, 2017, J ARRYTHM, V33, P369, DOI 10.1016/j.joa.2017.08.001; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Chinnusamy V, 2005, USE GENETIC ENG MOLE, P47; Clark RT, 2011, PLANT PHYSIOL, V156, P455, DOI 10.1104/pp.110.169102; Dabi A., 2016, INT J NAT RES ECO MA, V1, P9, DOI DOI 10.11648/J.IJNREM.20160104.11; Dajue L, 1996, SAFFLOWER CARTHAMUS; Delshad Elahe, 2018, Electron Physician, V10, P6672, DOI 10.19082/6672; Dias PMB, 2011, THEOR APPL GENET, V122, P429, DOI 10.1007/s00122-010-1458-7; Duan LF, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-44; El-Lattief E. A. A., 2012, Asian Journal of Crop Science, V4, P72, DOI 10.3923/ajcs.2012.72.79; Emongor V., 2010, Asian Journal of Plant Sciences, V9, P299; Esendal A, 2008, 7 INT SAFFL C; Eslam BP, 2011, J AGR SCI TECH-IRAN, V13, P327; Fahlgren N, 2015, CURR OPIN PLANT BIOL, V24, P93, DOI 10.1016/j.pbi.2015.02.006; FAO, 2018, FAO STAT DAT; Fernandex G, 1992, P 4 INT S AD VEG OTH; FERNANDEZ GCJ, 1993, ADAPTATION OF FOOD CROPS TO TEMPERATURE AND WATER STRESS, P257; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; Galeano E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221571; Gavuzzi P, 1997, CAN J PLANT SCI, V77, P523, DOI 10.4141/P96-130; Golzarian MR, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-2; Gregersen PL, 2013, PLANT MOL BIOL, V82, P603, DOI 10.1007/s11103-013-0013-8; Hairmansis A, 2014, RICE, V7, DOI 10.1186/s12284-014-0016-3; Hassani SMR, 2020, MOL BIOL REP, V47, P2123, DOI 10.1007/s11033-020-05312-x; Homolova L, 2013, ECOL COMPLEX, V15, P1, DOI 10.1016/j.ecocom.2013.06.003; Hoyos-Villegas V, 2014, CROP SCI, V54, P1756, DOI 10.2135/cropsci2013.08.0540; Hussain MI, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-015-0344-8; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Janni M, 2019, PLANT PHENOMICS, V2019, DOI 10.34133/2019/6168209; Joshan Y, 2019, PLANT SOIL ENVIRON, V65, P563, DOI 10.17221/591/2019-PSE; Kar G, 2007, AGR WATER MANAGE, V87, P73, DOI 10.1016/j.agwat.2006.06.002; Katz E, 2000, ACTA HORTIC, P93, DOI 10.17660/ActaHortic.2000.535.9; Kendal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072296; Khalili M, 2014, NOT BOT HORTI AGROBO, V42, P214; Kim James Y., 2020, Journal of Biosystems Engineering, V45, P43, DOI 10.1007/s42853-020-00043-0; Klukas C, 2014, PLANT PHYSIOL, V165, P506, DOI 10.1104/pp.113.233932; KNOWLES PF, 1969, ECON BOT, V23, P324, DOI 10.1007/BF02860678; Krisnawati A, 2015, ENRGY PROCED, V65, P14, DOI 10.1016/j.egypro.2015.01.023; La Bella S, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9080468; Limpens J, 2012, NEW PHYTOL, V195, P408, DOI 10.1111/j.1469-8137.2012.04157.x; Louhaichi M, 2018, AGROFOREST SYST, V92, P1341, DOI 10.1007/s10457-017-0079-4; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Machewad G. M., 2012, Journal of Food Processing and Technology, V3, P172; Marchin RM, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01715; Meka P. K., 2007, Journal of Oleo Science, V56, P9; Mokhtassi Bidgoli A, 2006, EUPHYTICA, V148, P261, DOI 10.1007/s10681-005-9019-x; Munns R, 2010, J EXP BOT, V61, P3499, DOI 10.1093/jxb/erq199; Nguyen GN, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01372; Nguyen GN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207788; Pennisi E, 2008, SCIENCE, V320, P171, DOI 10.1126/science.320.5873.171; Pour-Aboughadareh A, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9090522; Pourdad S. S., 2008, Acta Agronomica Hungarica, V56, P203, DOI 10.1556/AAgr.56.2008.2.9; Rahaman MM, 2017, J INTEGR BIOINFORMAT, V14, DOI 10.1515/jib-2017-0028; Ray DK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217148; Razzaq H, 2017, J SOIL SCI PLANT NUT, V17, P662, DOI 10.4067/S0718-95162017000300009; Reynolds MP, 2016, GLOB FOOD SECUR-AGR, V8, P9, DOI 10.1016/j.gfs.2016.02.002; Richards RA, 2006, AGR WATER MANAGE, V80, P197, DOI 10.1016/j.agwat.2005.07.013; Richards RA, 2010, FUNCT PLANT BIOL, V37, P85, DOI 10.1071/FP09219; ROSIELLE AA, 1981, CROP SCI, V21, P943, DOI 10.2135/cropsci1981.0011183X002100060033x; Sharifmoghaddas M. R., 2009, Advances in Environmental Biology, V3, P233; Sheshshayee MS, 2005, J EXP BOT, V56, P3033, DOI 10.1093/jxb/eri300; Singh S, 2016, AGR WATER MANAGE, V177, P432, DOI 10.1016/j.agwat.2016.08.023; Singh V, 2016, BREEDING OILSEED CROPS FOR SUSTAINABLE PRODUCTION: OPPORTUNITIES AND CONSTRAINTS, P149, DOI 10.1016/B978-0-12-801309-0.00007-0; Stewart EL, 2014, PHYTOPATHOLOGY, V104, P985, DOI 10.1094/PHYTO-11-13-0328-R; Strasil Z, 2002, ROST VYROBA, V48, P307; Talebi R., 2009, General and Applied Plant Physiology, V35, P64; Tharakan PJ, 2005, CAN J FOREST RES, V35, P421, DOI 10.1139/X04-195; Verelst W, 2013, MOL PLANT, V6, P311, DOI 10.1093/mp/sss098; Walter A, 2007, NEW PHYTOL, V174, P447, DOI 10.1111/j.1469-8137.2007.02002.x; Walter A, 2012, ANN BOT-LONDON, V110, P1271, DOI 10.1093/aob/mcs026; Wood CC, 2018, PLANT BIOTECHNOL J, V16, P1788, DOI 10.1111/pbi.12915; Wouters J, 2010, STUD CONSERV, V55, P186, DOI 10.1179/sic.2010.55.3.186; Yeilaghi H, 2012, FOOD CHEM, V130, P618, DOI 10.1016/j.foodchem.2011.07.085; Zareie S., 2013, Australian Journal of Crop Science, V7, P1032; Zemour K, 2019, COSMETICS-BASEL, V6, DOI 10.3390/cosmetics6030055	93	3	3	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254908	10.1371/journal.pone.0254908	http://dx.doi.org/10.1371/journal.pone.0254908			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297757	Green Published, gold			2022-12-26	WOS:000678128300012
J	Wu, ZJ				Wu, Zhijun			Social distancing is a social dilemma game played by every individual against his/her population	PLOS ONE			English	Article							PUBLIC-GOODS GAME; EVOLUTIONARY GAMES; DYNAMICS; COOPERATION; VACCINATION; EQUILIBRIA; PATTERNS	Since the outbreak of the global COVID-19 pandemic, social distancing has been known to everyone and recommended almost everywhere everyday. Social distancing has been and will be one of the most effective measures and sometimes, the only available one for fighting epidemics and saving lives. However, it has not been so clear how social distancing should be practiced or managed, especially when it comes to regulating everyone's otherwise normal social activities. The debate on how to implement social distancing often leads to a heated political argument, while research on the subject is lacking. This paper is to provide a theoretical basis for the understanding of the scientific nature of social distancing by considering it as a social dilemma game played by every individual against his/her population. From this perspective, every individual needs to make a decision on how to engage in social distancing, or risk being trapped into a dilemma either exposing to deadly diseases or getting no access to necessary social activities. As the players of the game, the individual's decisions depend on the population's actions and vice versa, and an optimal strategy can be found when the game reaches an equilibrium. The paper shows how an optimal strategy can be determined for a population with either closely related or completely separated social activities and with either single or multiple social groups, and how the collective behaviors of social distancing can be simulated by following every individual's actions as the distancing game progresses. The simulation results for populations of varying sizes and complexities are presented, which not only justify the choices of the strategies based on the theoretical analysis, but also demonstrate the convergence of the individual actions to an optimal distancing strategy in silico and possibly in natura as well, if every individual makes rational distancing decisions.	[Wu, Zhijun] Iowa State Univ, Grad Program Bioinformat & Computat Biol, Ames, IA 50011 USA; [Wu, Zhijun] Iowa State Univ, Dept Math, Ames, IA 50011 USA	Iowa State University; Iowa State University	Wu, ZJ (corresponding author), Iowa State Univ, Grad Program Bioinformat & Computat Biol, Ames, IA 50011 USA.; Wu, ZJ (corresponding author), Iowa State Univ, Dept Math, Ames, IA 50011 USA.	zhijun@iastate.edu			Simons Foundation; Mathematics and Physical Sciences Collaboration Grants for Mathematicians [586065]	Simons Foundation; Mathematics and Physical Sciences Collaboration Grants for Mathematicians	ZW receives support from the Simons Foundation on this work through the Mathematics and Physical Sciences Collaboration Grants for Mathematicians (Award Number: 586065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5446-1; [Anonymous], 1995, EVOLUTIONARY GAME TH; [Anonymous], 2020, GUID SOC DIST EV UK; Arefin MR, 2020, PHYS REV E, V102, DOI 10.1103/PhysRevE.102.032120; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Bazant MZ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018995118; Benzell SG, 2020, P NATL ACAD SCI USA, V117, P14642, DOI 10.1073/pnas.2008025117; Bomze IM, 1997, J GLOBAL OPTIM, V10, P143, DOI 10.1023/A:1008230200610; Bomze IM, 2002, SIAM REV, V44, P394, DOI 10.1137/S00361445003756; Bonaccorsi G, 2020, P NATL ACAD SCI USA, V117, P15530, DOI 10.1073/pnas.2007658117; Bondy J.A., 2008, GRAPH THEORY; Britton T, 2020, SCIENCE, V369, P846, DOI 10.1126/science.abc6810; Broom M, 2019, B MATH BIOL, V81, P4643, DOI 10.1007/s11538-018-00545-1; Caley P, 2008, J R SOC INTERFACE, V5, P631, DOI 10.1098/rsif.2007.1197; CAMERON K, 1989, DISCRETE APPL MATH, V24, P97, DOI 10.1016/0166-218X(92)90275-F; CANNINGS C, 1988, J THEOR BIOL, V132, P409, DOI 10.1016/S0022-5193(88)80081-X; Chakradhar S, 2020, STAT NEWS; Chicago U, 2020, SOC DIST; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Cressman R, 2014, P NATL ACAD SCI USA, V111, P10810, DOI 10.1073/pnas.1400823111; Cressman R, 2012, J THEOR BIOL, V299, P144, DOI 10.1016/j.jtbi.2011.07.030; Durrett R, 1997, J THEOR BIOL, V185, P165, DOI 10.1006/jtbi.1996.0292; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Faherty LJ, 2019, PREV MED REP, V14, DOI 10.1016/j.pmedr.2019.100871; Fenichel EP, 2013, J HEALTH ECON, V32, P440, DOI 10.1016/j.jhealeco.2013.01.002; Giraldeau L.A., 2000, MG BEH ECOL; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Guttal V, 2010, P NATL ACAD SCI USA, V107, P16172, DOI 10.1073/pnas.1006874107; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Hofbauer J, 2003, B AM MATH SOC, V40, P479, DOI 10.1090/S0273-0979-03-00988-1; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Huang YY, 2015, MATH BIOSCI ENG, V12, P503, DOI 10.3934/mbe.2015.12.503; Islam N, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2743; Kabir KMA, 2021, CHAOS SOLITON FRACT, V146, DOI 10.1016/j.chaos.2021.110918; Kabir KMA, 2019, CHAOS SOLITON FRACT, V119, P180, DOI 10.1016/j.chaos.2018.12.023; Karatayev VA, 2020, P NATL ACAD SCI USA, V117, P24575, DOI 10.1073/pnas.2014385117; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Krause J, 2002, LIVING GROUPS; Krivan V, 2018, J THEOR BIOL, V455, P232, DOI 10.1016/j.jtbi.2018.07.003; Kuga K, 2021, P ROY SOC A-MATH PHY, V477, DOI 10.1098/rspa.2020.0769; Lim W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232652; Long N. J., 2020, Medicine Anthropology Theory, V7, P247, DOI 10.17157/mat.7.2.791; Lozin, 2006, RUTCOR RES REPORT RR, V3; Mann CC., 2020, PANDEMICS LEAVE US F; Maynard Smith J., 1982, pi; Metcalf CJE, 2020, SCIENCE, V369, P368, DOI 10.1126/science.abd1668; Miller G., 2020, SCIENCE, DOI [10.1126/science.abb7506, DOI 10.1126/SCIENCE.ABB7506]; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; PARDALOS PM, 1991, LINEAR ALGEBRA APPL, V152, P69, DOI 10.1016/0024-3795(91)90267-Z; Pearce K., 2020, WHAT IS SOCIAL DISTA; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Reluga TC, 2013, B MATH BIOL, V75, P1961, DOI 10.1007/s11538-013-9879-5; Reluga TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000793; Roth D., 2011, SOCIAL DISTANCING PA; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sumpter DJT, 2010, COLLECTIVE ANIMAL BEHAVIOR, P1; Tanimoto J., 2015, FUNDAMENTALS EVOLUTI; Tanimoto J, 2021, SOCIOPHYSICS APPROAC; Thunstrom L, 2020, J BENEFIT-COST ANAL, V11, P179, DOI 10.1017/bca.2020.12; Valdez LD, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036108; VICKERS GT, 1988, J THEOR BIOL, V132, P387, DOI 10.1016/S0022-5193(88)80080-8; VICKERS GT, 1988, J THEOR BIOL, V131, P273, DOI 10.1016/S0022-5193(88)80225-X; Wang M, 2016, B MATH BIOL, V78, P531, DOI 10.1007/s11538-016-0153-5; Wang M, 2019, J BIOL DYNAM, V13, P74, DOI 10.1080/17513758.2018.1508762; Wang Q, 2018, APPL MATH COMPUT, V328, P162, DOI 10.1016/j.amc.2018.01.045; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Weill JA, 2020, P NATL ACAD SCI USA, V117, P19658, DOI 10.1073/pnas.2009412117; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Wu ZJ, 2021, CSIAM T APPL MATH, V2, P56, DOI 10.4208/csiam-am.2020-0031; Yan YP, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2008814118	78	0	0	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255543	10.1371/journal.pone.0255543	http://dx.doi.org/10.1371/journal.pone.0255543			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339481	gold, Green Published			2022-12-26	WOS:000680243400056
J	Yamazaki, S; Ueno, Y; Hosoki, R; Saito, T; Idehara, T; Yamaguchi, Y; Otani, C; Ogawa, Y; Harata, M; Hoshina, H				Yamazaki, Shota; Ueno, Yuya; Hosoki, Ryosuke; Saito, Takanori; Idehara, Toshitaka; Yamaguchi, Yuusuke; Otani, Chiko; Ogawa, Yuichi; Harata, Masahiko; Hoshina, Hiromichi			THz irradiation inhibits cell division by affecting actin dynamics	PLOS ONE			English	Article							F-ACTIN; TERAHERTZ RADIATION; REPAIR; POLYMERIZATION; LOCALIZATION; SPECTROSCOPY; EXPRESSION; DAMAGE; RING	Biological phenomena induced by terahertz (THz) irradiation are described in recent reports, but underlying mechanisms, structural and dynamical change of specific molecules are still unclear. In this paper, we performed time-lapse morphological analysis of human cells and found that THz irradiation halts cell division at cytokinesis. At the end of cytokinesis, the contractile ring, which consists of filamentous actin (F-actin), needs to disappear; however, it remained for 1 hour under THz irradiation. Induction of the functional structures of F-actin was also observed in interphase cells. Similar phenomena were also observed under chemical treatment (jasplakinolide), indicating that THz irradiation assists actin polymerization. We previously reported that THz irradiation enhances the polymerization of purified actin in vitro; our current work shows that it increases cytoplasmic F-actin in vivo. Thus, we identified one of the key biomechanisms affected by THz waves.	[Yamazaki, Shota; Otani, Chiko; Hoshina, Hiromichi] RIKEN Ctr Adv Photon, Terahertz Sensing & Imaging Res Team, Sendai, Miyagi, Japan; [Ueno, Yuya; Hosoki, Ryosuke; Saito, Takanori; Harata, Masahiko] Tohoku Univ, Grad Sch Agr Sci, Mol Biol Lab, Sendai, Miyagi, Japan; [Idehara, Toshitaka; Yamaguchi, Yuusuke] Univ Fukui FIRUF, Res Ctr Dev Far Infrared Region, Bunkyo Ku, Fukui, Japan; [Ogawa, Yuichi] Kyoto Univ, Grad Sch Agr, Lab Biosensing Engn, Sakyo Ku, Kyoto, Japan	RIKEN; Tohoku University; Kyoto University	Yamazaki, S; Hoshina, H (corresponding author), RIKEN Ctr Adv Photon, Terahertz Sensing & Imaging Res Team, Sendai, Miyagi, Japan.; Harata, M (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Mol Biol Lab, Sendai, Miyagi, Japan.	shota.yamazaki.fc@riken.jp; masahiko.harata.b6@tohoku.ac.jp; hoshina@riken.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [JP19K15812, JP20H05378, JP21H02151, JP20K21261, JP21H04746]; JSPS Core-to-Core Program (Advanced Research Networks) entitled "Establishment of international agricultural immunology research-core for a quantum improvement in food safety, the RIKEN-AIST Joint Research Fund (Semi-full research); RIKEN-AIST Joint Research Fund; Cooperative Research Program of Research Center for Development of Far-Infrared Region University of Fukui [R02FIRDM022A, R03FIRDG018A]; JSPS [JPJSBP120202501]; CAS [JPJSBP120202501]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Core-to-Core Program (Advanced Research Networks) entitled "Establishment of international agricultural immunology research-core for a quantum improvement in food safety, the RIKEN-AIST Joint Research Fund (Semi-full research); RIKEN-AIST Joint Research Fund; Cooperative Research Program of Research Center for Development of Far-Infrared Region University of Fukui; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CAS(Chinese Academy of Sciences)	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers JP19K15812, JP20H05378, JP21H02151, JP20K21261, JP21H04746, the JSPS Core-to-Core Program (Advanced Research Networks) entitled "Establishment of international agricultural immunology research-core for a quantum improvement in food safety, the RIKEN-AIST Joint Research Fund (Semi-full research), the Cooperative Research Program of Research Center for Development of Far-Infrared Region University of Fukui (R02FIRDM022A, R03FIRDG018A) and the Japan-Czech Republic Research Cooperative Program between JSPS and CAS grant number JPJSBP120202501. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov BS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01184; Alexandrov BS, 2011, BIOMED OPT EXPRESS, V2, P2679, DOI 10.1364/BOE.2.002679; ALTANKOV G, 1993, J CELL BIOL, V120, P1449, DOI 10.1083/jcb.120.6.1449; Bezanilla M, 2015, J CELL BIOL, V209, P329, DOI 10.1083/jcb.201502062; Bock J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015806; Boreham DR, 1997, BIOCHEM CELL BIOL, V75, P393, DOI 10.1139/bcb-75-4-393; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Caridi CP, 2019, NAT CELL BIOL, V21, P1068, DOI 10.1038/s41556-019-0379-1; Dean P, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/37/374008; Eisemann T, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4007-4; Giordani M, 2020, IEEE COMMUN MAG, V58, P55, DOI 10.1109/MCOM.001.1900411; Group CB., 1994, SINGLE PARTICLE TRAC, V127, P963; Guillet JP, 2014, J INFRARED MILLIM TE, V35, P382, DOI 10.1007/s10762-014-0057-0; Habauzit D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109435; HENRIQUES FC, 1947, AM J PATHOL, V23, P531; Idehara T, 2015, J INFRARED MILLIM TE, V36, P613, DOI 10.1007/s10762-015-0150-z; Jamshed MA, 2020, IEEE J ELECTROMAG RF, V4, P24, DOI 10.1109/JERM.2019.2917766; KAWAMURA M, 1972, J BIOCHEM-TOKYO, V72, P179, DOI 10.1093/oxfordjournals.jbchem.a129884; Kim KH, 2013, SCI REP-UK, V3, DOI [10.1038/srep02017, 10.1038/srep02296]; Koenig S, 2013, NAT PHOTONICS, V7, P977, DOI [10.1038/NPHOTON.2013.275, 10.1038/nphoton.2013.275]; Korenstein-Ilan A, 2008, RADIAT RES, V170, P224, DOI 10.1667/RR0944.1; Leitgeb N, 2016, SCENIHR SCI COMMITTE SCENIHR SCI COMMITTE; Lien JM, 2016, ACM T GRAPHIC, V35, DOI [10.1145/2897824.2925953, 10.1145/9999997.9999999]; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Milo R., 2015, GARLAND SCI, DOI [10.1201/9780429258770, DOI 10.1201/9780429258770]; Mittleman DM, 2017, J APPL PHYS, V122, DOI 10.1063/1.5007683; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; MORI E., 2008, THERM MED, V24, P39, DOI [10.3191/thermalmed.24.39, DOI 10.3191/THERMALMED.24.39]; Mourad A, 2020, ELECTRONICS-SWITZ, V9, DOI 10.3390/electronics9020351; Munzarova AF., 2013, VESTNIK NSU PHYS SER, V8, P117; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Nagatsuma T, 2019, P 24 OPTOELECTRON CO, P1; Nibali VC, 2014, J AM CHEM SOC, V136, P12800, DOI 10.1021/ja504441h; O'Connell CB, 2001, CURR BIOL, V11, P702, DOI 10.1016/S0960-9822(01)00181-6; O'Hara JF, 2019, TECHNOLOGIES, V7, DOI 10.3390/technologies7020043; Olshevskaya JS., 2010, VESTNIK NSU SER PHYS, V5, P177; Pearce John A., 2010, Critical Reviews in Biomedical Engineering, V38, P1, DOI 10.1615/CritRevBiomedEng.v38.i1.20; Peiponen K.E., 2012, TERAHERTZ SPECTROSC, V171, P29, DOI [10.1007/978-3-642-29564-5, DOI 10.1007/978-3-642-29564-5]; Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999; Pinto IM, 2012, DEV CELL, V22, P1247, DOI 10.1016/j.devcel.2012.04.015; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Romanenko S, 2019, BIOPHYS J, V116, P2331, DOI 10.1016/j.bpj.2019.04.021; Roti JLR, 2010, INT J HYPERTHER, V26, P67, DOI 10.3109/02656730903417947; Saad W, 2020, IEEE NETWORK, V34, P134, DOI 10.1109/MNET.001.1900287; SENDEROWICZ AMJ, 1995, J NATL CANCER I, V87, P46, DOI 10.1093/jnci/87.1.46; Small JV, 1998, BBA-MOL CELL RES, V1404, P271, DOI 10.1016/S0167-4889(98)00080-9; Titova LV, 2013, BIOMED OPT EXPRESS, V4, P559, DOI 10.1364/BOE.4.000559; Tsubouchi M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75337-6; Ueno Y, 2008, ANAL SCI, V24, P185, DOI 10.2116/analsci.24.185; Vallenius T, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130001; White KN, 2017, J NAT PROD, V80, P740, DOI 10.1021/acs.jnatprod.6b00970; Wilmink GJ, 2009, J INVEST DERMATOL, V129, P205, DOI 10.1038/jid.2008.175; Xu Y, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4934504; Yamamoto N, 2016, J PHYS CHEM B, V120, P4743, DOI 10.1021/acs.jpcb.6b01491; Yamazaki S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65955-5; Yamazaki S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28245-9; Yamazaki S, 2016, HISTOCHEM CELL BIOL, V145, P389, DOI 10.1007/s00418-016-1416-9	57	6	6	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0248381	10.1371/journal.pone.0248381	http://dx.doi.org/10.1371/journal.pone.0248381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339441	Green Submitted, Green Published, gold			2022-12-26	WOS:000680243400046
J	Zhao, JL; Li, YF; Li, JM; Huang, YB; Wu, JX				Zhao, Jianlong; Li, Yanfeng; Li, Junmei; Huang, Youbo; Wu, Jinxiang			Experimental study on the backdraft phenomenon of solid fuel	PLOS ONE			English	Article							TEMPERATURE; FIRES	In this study, a series of small-scale experiments were conducted to investigate the backdraft phenomenon in a compartment (1.1 x 0.4 x 0.75 m) with woodblocks as fuel. This research focused on the effects of compartment window woodblock areas on backdraft time, with a video recording of the experimental phenomena. Thermocouples and a gas analyzer were used to measure the temperature and the concentration of gas components in the compartment, respectively. There was no additional heat source or ignition source pre-set in the compartment at the beginning of the experiments; the experimental processes only depended on the heat released from the burning or smoldering of woodblocks. When compartment ventilation improved, smoldering of woodblocks became intense, and backdraft occurred. The results show that backdraft time is shorten with increases of compartment window and woodblock areas, and opening the upper window of a compartment could avoid the backdraft phenomenon. The results help to understand the backdraft phenomenon of solid fuel and, more importantly, could help firefighters adopt reasonable fire-fighting strategies for restraining backdraft occurrence.	[Zhao, Jianlong; Li, Yanfeng; Li, Junmei] Beijing Univ Technol, Beijing Key Lab Green Built Environm & Energy Eff, Beijing, Peoples R China; [Huang, Youbo] Chongqing Univ Sci Technol, Coll Safety Engn, Chongqing, Peoples R China; [Wu, Jinxiang] Hebei Univ Technol, Sch Energy & Environm Engn, Tianjin, Peoples R China	Beijing University of Technology; Chongqing University of Science & Technology; Hebei University of Technology	Zhao, JL; Li, YF (corresponding author), Beijing Univ Technol, Beijing Key Lab Green Built Environm & Energy Eff, Beijing, Peoples R China.	jlzhao2019@sina.com; liyanfeng@bjut.edu.cn		Zhao, Jianlong/0000-0003-1098-7868				[Anonymous], 1979, DICT FIR TERM DICT FIR TERM; Ashok SG, 2021, FIRE SAFETY J, V121, DOI 10.1016/j.firesaf.2020.103270; Bukowski RW., 1996, FIRE ENG J; Burklin RW., 1980, FIRE TERMS GUIDE THE; Chen AP, 2011, J LOSS PREVENT PROC, V24, P632, DOI 10.1016/j.jlp.2011.05.001; Chitty RA., 1994, SURVEY BACKDRAFT, V5; CROFT WM, 1980, FIRE SAFETY J, V3, P3, DOI 10.1016/0379-7112(80)90003-X; Drysdale DD., 2011, INTRO FIRE DYNAMICS, V3rd ed., DOI DOI 10.1002/9781119975465; Fleischmann C., 1994, FIRE SAF SCI, DOI [10.3801/iafss.fss.4-253, DOI 10.3801/IAFSS.FSS.4-253]; Fleischmann C.M., 1993, FIRE TECHNOL, V29, P298, DOI [10.1007/BF01052526, DOI 10.1007/BF01052526]; Fleischmann C.M., 1994, FIRE SAFETY SCI, P337, DOI DOI 10.3801/IAFSS.FSS.4-337; Fleischmann CM, 1999, FIRE SAFETY J, V33, P21, DOI 10.1016/S0379-7112(98)00046-0; Fleischmann CM., 1992, P 12 JOINT PAN M UJN P 12 JOINT PAN M UJN; Fleischmann CM., 1993, THESIS U CALIFORNIA THESIS U CALIFORNIA; Gong J, 2006, CHINESE SCI BULL, V51, P364, DOI 10.1007/s11434-006-0364-5; Gottuk DT., 1999, FIRE SAF J, DOI [10.1016/S0379-7112%2899%2900033-8, DOI 10.1016/S0379-7112%2899%2900033-8]; Ha Suim, 2019, [Fire Science and Engineering, 한국화재소방학회 논문지], V33, P30, DOI 10.7731/KIFSE.2019.33.1.030; Ha Suim, 2019, [Fire Science and Engineering, 한국화재소방학회 논문지], V33, P48, DOI 10.7731/KIFSE.2019.33.5.048; Hu LH, 2010, INT J HEAT MASS TRAN, V53, P2844, DOI 10.1016/j.ijheatmasstransfer.2010.02.013; Hu LH, 2005, TUNN UNDERGR SP TECH, V20, P223, DOI 10.1016/j.tust.2004.08.007; Ko MW., 2016, J KOREAN SOC SAF, DOI [10.14346/jkosos.2016.31.4.1, DOI 10.14346/JKOSOS.2016.31.4.1]; Krol A, 2020, ENERGIES, V13, DOI 10.3390/en13071854; Mao J, 2011, FIRE SAFETY J, V46, P164, DOI 10.1016/j.firesaf.2011.01.005; Mei F., 2017, APPL THERM ENG; Myilsamy D, 2019, J MECH SCI TECHNOL, V33, P2189, DOI 10.1007/s12206-019-0421-z; Myilsamy Dinesh, 2017, [Fire Science and Engineering, 한국화재소방학회 논문지], V31, P35, DOI 10.7731/KIFSE.2017.31.4.035; Park JW, 2017, J MECH SCI TECHNOL, V31, P985, DOI 10.1007/s12206-017-0151-z; Shi CL, 2021, TUNN UNDERGR SP TECH, V109, DOI 10.1016/j.tust.2020.103784; Tang F, 2018, INT J THERM SCI, V127, P329, DOI 10.1016/j.ijthermalsci.2018.02.001; Tinaburri A, 2006, WIT TRANS ENG SCI, V53, P279, DOI 10.2495/HT060281; Tsai LC, 2013, PROCESS SAF ENVIRON, V91, P202, DOI 10.1016/j.psep.2012.05.007; Weng W., 2002, PROG NAT SCI-MATER, V12; Weng WG., 2003, COMBUST FLAME, DOI [10.1016/S0010-2180%2802%2900521-7, DOI 10.1016/S0010-2180%2802%2900521-7]; Weng WG., 2003, J LOSS PREV PROCESS, DOI [10.1016/S0950-4230%2802%2900088-8, DOI 10.1016/S0950-4230%2802%2900088-8]; Wu CL, 2020, FIRE TECHNOL, V56, P937, DOI 10.1007/s10694-019-00914-9; Wu CL, 2017, FIRE SAFETY J, V91, P320, DOI 10.1016/j.firesaf.2017.04.003; Wu JX, 2011, PROCEDIA ENVIRON SCI, V11, P1542, DOI 10.1016/j.proenv.2011.12.232	37	1	1	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255572	10.1371/journal.pone.0255572	http://dx.doi.org/10.1371/journal.pone.0255572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339466	gold, Green Published			2022-12-26	WOS:000680243400007
J	Shi, S; Ma, B; Sun, FD; Qu, C; An, HL				Shi, Sai; Ma, Biao; Sun, Fude; Qu, Chang; An, Hailong			Theaflavin binds to a druggable pocket of TMEM16A channel and inhibits lung adenocarcinoma cell viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNELS; SWISS-MODEL; CONTRIBUTES	As a calcium-activated chloride channel regulated by the intracellular Ca2+ concentration and membrane potential, TMEM16A has attracted considerable attention and has been proposed as a novel anticancer drug target. We have previously reported that the pocket above the ion conductance pore could be a nonselective inhibitor-binding pocket. However, whether this pocket is druggable remains unexplored. In this study, we performed virtual screening to target the presumed inhibitor binding pocket and identified a highly effective TMEM16A inhibitor, theaflavin (TF: a tea polyphenol in black tea). Molecular dynamics simulations revealed that theaflavin adopts a "wedge insertion mode" to block the ion conduction pore and induces pore closure. Moreover, the binding mode showed that the TF pedestal plays an important role in pore blockade, and R515, R535, T539, K603, E623, and E633 were determined to be most likely to interact directly with the pedestal. Mutagenesis experiment results corroborated the mechanism through which TF binds to this pocket. Combined with the quantitative calculation results, our data indicated that the three hydroxyl groups on the pedestal may be the most crucial pharmacophores for TMEM16A inhibition by TF. Finally, antitumor experiments revealed that TF could target TMEM16A to inhibit the proliferation and migration of LA795 cells, indicating the potential therapeutic effect of TF on the growth of lung adenocarcinoma with high TMEM16A expression. The successful application of drug screening strategies based on this binding pocket highlights new directions for discovering superior modulators and contributes to the development of novel therapeutics for lung adenocarcinoma.	[Shi, Sai; Ma, Biao; Qu, Chang; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin, Peoples R China; [Shi, Sai; Ma, Biao; Qu, Chang; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Electromagnet Field & Elect Apparat Relia, Tianjin, Peoples R China; [Shi, Sai; Ma, Biao; Sun, Fude; Qu, Chang; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Mol Biophys, Tianjin, Peoples R China	Hebei University of Technology; Hebei University of Technology; Hebei University of Technology	An, HL (corresponding author), Hebei Univ Technol, Sch Sci, Inst Biophys, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin, Peoples R China.; An, HL (corresponding author), Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Electromagnet Field & Elect Apparat Relia, Tianjin, Peoples R China.; An, HL (corresponding author), Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Mol Biophys, Tianjin, Peoples R China.	hailong_an@163.com			National Natural Science Foundation of China [81830061]; Natural Science Foundation of Tianjin of China [19JCYBJC28300]; Natural Science Foundation of Hebei Province of China [H2020202005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin of China(Natural Science Foundation of Tianjin); Natural Science Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province)	This work was supported by the National Natural Science Foundation of China (Grant No. 81830061 to H. A.), the Natural Science Foundation of Tianjin of China (Grant No. 19JCYBJC28300 to H. A.), the Natural Science Foundation of Hebei Province of China (Grant No. H2020202005 to H. A.).	Ben Chorin A, 2020, PROTEIN SCI, V29, P258, DOI 10.1002/pro.3779; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bushell KSR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11753-1; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Case D. A., 2016, AMBER 2016; Cosconati S, 2010, EXPERT OPIN DRUG DIS, V5, P597, DOI 10.1517/17460441.2010.484460; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Luis JAD, 2021, MINI-REV MED CHEM, V21, P2655, DOI 10.2174/1389557520666200730161549; Falzone ME, 2019, ELIFE, V8, DOI 10.7554/eLife.43229; Fraga CG, 2019, FOOD FUNCT, V10, P514, DOI [10.1039/C8FO01997E, 10.1039/c8fo01997e]; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guo S, 2020, PHARMACOL RES, V155, DOI 10.1016/j.phrs.2020.104721; Guo S, 2019, J CELL PHYSIOL, V234, P8698, DOI 10.1002/jcp.27529; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ji QS, 2019, J CELL PHYSIOL, V234, P7856, DOI 10.1002/jcp.27865; Jia LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136584; Joung IS, 2009, J PHYS CHEM B, V113, P13279, DOI 10.1021/jp902584c; Kalienkova V, 2019, ELIFE, V8, DOI 10.7554/eLife.44364; Liu F, 2015, ONCOTARGET, V6, P11585, DOI 10.18632/oncotarget.3412; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Oh U, 2016, PFLUG ARCH EUR J PHY, V468, P443, DOI 10.1007/s00424-016-1790-0; Paulino C, 2017, NATURE, V552, P421, DOI 10.1038/nature24652; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shi S, 2020, ARCH BIOCHEM BIOPHYS, V695, DOI 10.1016/j.abb.2020.108650; Shi S, 2020, COMPUT STRUCT BIOTEC, V18, P714, DOI 10.1016/j.csbj.2020.03.015; Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Studer G, 2014, BIOINFORMATICS, V30, pI505, DOI 10.1093/bioinformatics/btu457; Sui YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115443; Tan QY, 2019, J AGR FOOD CHEM, V67, P159, DOI 10.1021/acs.jafc.8b05369; Tao WQ, 2016, J PHARMACEUT BIOMED, V131, P140, DOI 10.1016/j.jpba.2016.08.020; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wu YY, 2011, J ZHEJIANG UNIV-SC B, V12, P744, DOI 10.1631/jzus.B1100041; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang X, 2017, BRIT J PHARMACOL, V174, P2334, DOI 10.1111/bph.13841	42	6	6	5	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101016	10.1016/j.jbc.2021.101016	http://dx.doi.org/10.1016/j.jbc.2021.101016			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34329684	Green Published, gold			2022-12-26	WOS:000706408900005
J	Chiodi, V; Domenici, MR; Biagini, T; De Simone, R; Tartaglione, AM; Di Rosa, M; Lo Re, O; Mazza, T; Micale, V; Vinciguerra, M				Chiodi, Valentina; Domenici, Maria Rosaria; Biagini, Tommaso; De Simone, Roberta; Tartaglione, Anna Maria; Di Rosa, Michelino; Lo Re, Oriana; Mazza, Tommaso; Micale, Vincenzo; Vinciguerra, Manlio			Systemic depletion of histone macroH2A1.1 boosts hippocampal synaptic plasticity and social behavior in mice	FASEB JOURNAL			English	Article						epigenetics; hippocampus; 1; social behavior	LONG-TERM POTENTIATION; MOUSE MODEL; CONDITIONED FEAR; LTP; MECHANISMS; DEPRESSION; RATS; MODULATION; EXPRESSION; AMYGDALA	Gene expression and epigenetic processes in several brain regions regulate physiological processes such as cognitive functions and social behavior. MacroH2A1.1 is a ubiquitous variant of histone H2A that regulates cell stemness and differentiation in various organs. Whether macroH2A1.1 has a modulatory role in emotional behavior is unknown. Here, we employed macroH2A1.1 knock-out ((-/-)) mice to perform a comprehensive battery of behavioral tests, and an assessment of hippocampal synaptic plasticity (long-term potentiation) accompanied by whole hippocampus RNA sequencing. MacroH2A1.1(-/-) mice exhibit a stunningly enhancement both of sociability and of active stress-coping behavior, reflected by the increased social behavior in social activity tests and higher mobility time in the forced swim test, respectively. They also display an increased hippocampal synaptic plasticity, accompanied by significant neurotransmission transcriptional networks changes. These results suggest that systemic depletion of histone macroH2A1.1 supports an epigenetic control necessary for hippocampal function and social behavior.	[Chiodi, Valentina; Domenici, Maria Rosaria; De Simone, Roberta; Micale, Vincenzo] Ist Super Sanita, Natl Ctr Drug Res & Evaluat, Rome, Italy; [Biagini, Tommaso; Mazza, Tommaso] IRCCS Casa Sollievo Sofferenza, Bioinformat Unit, San Giovanni Rotondo, Italy; [Tartaglione, Anna Maria] Ist Super Sanita, Ctr Behav Sci & Mental Hlth, Rome, Italy; [Di Rosa, Michelino; Micale, Vincenzo] Univ Catania, Sch Med, Dept Biomed & Biotechnol Sci, Biol Tower, Catania, Italy; [Lo Re, Oriana; Vinciguerra, Manlio] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic; [Vinciguerra, Manlio] Med Univ Varna, ERA Chair Translat Stem Cell Biol, Varna, Bulgaria; [Vinciguerra, Manlio] Univ Coll London UCL, Div Med, London, England	Istituto Superiore di Sanita (ISS); IRCCS Casa Sollievo Della Sofferenza; Istituto Superiore di Sanita (ISS); University of Catania; St Anne's University Hospital Brno (FNUSA-ICRC); Medical University Varna; University of London; University College London	Micale, V (corresponding author), Univ Catania, Sch Med, Dept Biomed & Biotechnol Sci, Biol Tower, Catania, Italy.; Vinciguerra, M (corresponding author), St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic.	vincenzomicale@inwind.it; manlio.vinciguerra@fnusa.cz	Vinciguerra, Manlio/N-1309-2015; Mazza, Tommaso/I-4531-2019; Lo Re, Oriana/ACC-4425-2022; Tartaglione, Anna Maria/K-4844-2018; Biagini, Tommaso/K-3044-2016	Vinciguerra, Manlio/0000-0002-1768-3894; Mazza, Tommaso/0000-0003-0434-8533; Lo Re, Oriana/0000-0002-4798-6802; Tartaglione, Anna Maria/0000-0002-9761-8098; Biagini, Tommaso/0000-0002-4539-028X	European Regional Development Fund-Project MAGNET [CZ.02.1.01/0.0/0.0/15_003/0000492]; Ministry of Health of the Czech Republic [NV18-03-00058]; European Commission Horizon 2020 Framework Program [856871-TRANSTEM]; University of Catania	European Regional Development Fund-Project MAGNET; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); European Commission Horizon 2020 Framework Program; University of Catania	This research was funded by the European Regional Development Fund-Project MAGNET (No. CZ.02.1.01/0.0/0.0/15_003/0000492), by the Ministry of Health of the Czech Republic, grant nr. NV18-03-00058, and by the European Commission Horizon 2020 Framework Program (Project 856871-TRANSTEM), and by a Starting Grant 2020, University of Catania (to VM)	Akbarian S, 2001, NEUROBIOL DIS, V8, P784, DOI 10.1006/nbdi.2001.0420; Alexander GM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10300; Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Barak B, 2016, NAT NEUROSCI, V19, P647, DOI 10.1038/nn.4276; Bereshchenko O, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0724-z; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borghesan M, 2016, CANCER RES, V76, P594, DOI 10.1158/0008-5472.CAN-15-1336; Buschbeck M, 2017, NAT REV MOL CELL BIO, V18, P299, DOI 10.1038/nrm.2016.166; Campbell SL, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0396-6; Chalkiadaki K, 2019, NEUROPHARMACOLOGY, V144, P193, DOI 10.1016/j.neuropharm.2018.10.026; Chilton JK, 2017, DEV NEUROBIOL, V77, P861, DOI 10.1002/dneu.22477; Commons KG, 2017, ACS CHEM NEUROSCI, V8, P955, DOI 10.1021/acschemneuro.7b00042; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; De Filippis B, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00086; De Filippis D, 2014, EUR J PHARMACOL, V725, P64, DOI 10.1016/j.ejphar.2013.12.021; Diogenes MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P1823, DOI 10.1038/npp.2011.64; Direnberger S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2035; Drago F, 2001, EUR NEUROPSYCHOPHARM, V11, P209, DOI 10.1016/S0924-977X(01)00084-0; Fernandez AP, 2008, P NATL ACAD SCI USA, V105, P12581, DOI 10.1073/pnas.0803174105; Ferrante A, 2018, NEUROBIOL DIS, V110, P1, DOI 10.1016/j.nbd.2017.10.013; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gerlai R, 2001, BEHAV BRAIN RES, V125, P269, DOI 10.1016/S0166-4328(01)00296-0; Giallongo S, 2021, ANTIOXID REDOX SIGN, V34, P335, DOI 10.1089/ars.2019.7983; Glerup S, 2016, MOL PSYCHIATR, V21, P1740, DOI 10.1038/mp.2016.108; Gu YH, 2002, J NEUROSCI, V22, P2753, DOI 10.1523/JNEUROSCI.22-07-02753.2002; Guttula Satya Vani, 2012, Int J Alzheimers Dis, V2012, P649456, DOI 10.1155/2012/649456; Hazane F, 2009, NEUROTOX RES, V15, P311, DOI 10.1007/s12640-009-9035-z; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Hofelmann D, 2013, BRAIN RES, V1527, P47, DOI 10.1016/j.brainres.2013.06.011; Hu Y, 2011, P NATL ACAD SCI USA, V108, P17141, DOI 10.1073/pnas.1104409108; Kalman E, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.775; Laviola G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188907; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lo Re O, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120367; Lundbye CJ, 2018, J PHYSIOL-LONDON, V596, P5017, DOI 10.1113/JP276304; Macri S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13257; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Meira T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06501-w; Melnikova T, 2006, NEUROSCIENCE, V141, P1149, DOI 10.1016/j.neuroscience.2006.05.001; Micale V, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00207; Micale V, 2013, CELL TISSUE RES, V354, P309, DOI 10.1007/s00441-013-1692-9; Mizuno S, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.595607; Monday HR, 2018, ANNU REV NEUROSCI, V41, P299, DOI 10.1146/annurev-neuro-080317-062155; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Nguyen PV, 2000, J NEUROPHYSIOL, V84, P2484, DOI 10.1152/jn.2000.84.5.2484; Okuyama T, 2016, SCIENCE, V353, P1536, DOI 10.1126/science.aaf7003; Oliva A, 2020, NATURE, V587, P264, DOI 10.1038/s41586-020-2758-y; Pamplona FA, 2011, J PSYCHIATR RES, V45, P354, DOI 10.1016/j.jpsychires.2010.06.015; Pazienza V, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0098-9; Perche PY, 2000, CURR BIOL, V10, P1531, DOI 10.1016/S0960-9822(00)00832-0; Rao RP, 2019, CELL REP, V27, P3460, DOI 10.1016/j.celrep.2019.05.081; Rozov AV, 2017, BIOCHEMISTRY-MOSCOW+, V82, P257, DOI 10.1134/S0006297917030038; Sankoorikal GMV, 2006, BIOL PSYCHIAT, V59, P415, DOI 10.1016/j.biopsych.2005.07.026; Serrano Mercedes, 2018, Handb Clin Neurol, V155, P227, DOI 10.1016/B978-0-444-64189-2.00015-9; Smit-Rigter LA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00169; Stark T, 2019, NEUROPHARMACOLOGY, V146, P212, DOI 10.1016/j.neuropharm.2018.11.035; Terzian AL, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00049; Terzian ALB, 2014, EUR J NEUROSCI, V40, P2293, DOI 10.1111/ejn.12561; Tzakis N, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00233; Uttl L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00703; van der Kooij MA, 2012, NEUROSCI BIOBEHAV R, V36, P1763, DOI 10.1016/j.neubiorev.2011.10.006; Wegener S, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0398-17.2018; Yen YC, 2012, NEUROBIOL LEARN MEM, V98, P56, DOI 10.1016/j.nlm.2012.04.009; Zoratto F, 2018, BEHAV BRAIN RES, V347, P37, DOI 10.1016/j.bbr.2018.02.033; Zoratto F, 2018, NEUROPHARMACOLOGY, V143, P250, DOI 10.1016/j.neuropharm.2018.09.010; Zovkic IB, 2014, NATURE, V515, P582, DOI 10.1038/nature13707	67	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21793	10.1096/fj.202100569R	http://dx.doi.org/10.1096/fj.202100569R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34320234				2022-12-26	WOS:000678975300025
J	Piper, IM; Struyvenberg, SA; Valgardson, JD; Johnson, DA; Gao, M; Johnston, K; Svendsen, JE; Kodama, HM; Hvorecny, KL; Antos, JM; Amacher, JF				Piper, Isabel M.; Struyvenberg, Sarah A.; Valgardson, Jordan D.; Johnson, D. Alex; Gao, Melody; Johnston, Katherine; Svendsen, Justin E.; Kodama, Hanna M.; Hvorecny, Kelli L.; Antos, John M.; Amacher, Jeanine F.			Sequence variation in the beta 7-beta 8 loop of bacterial class A sortase enzymes alters substrate selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; SURFACE-PROTEINS; EVOLUTIONARY CONSERVATION; SORTING SIGNAL; CELL-WALL; SPECIFICITY; TRANSPEPTIDASE; ALIGNMENT; RECOGNITION; LIGATION	Gram-positive bacteria contain sortase enzymes on their cell surfaces that catalyze transpeptidation reactions critical for proper cellular function. In vitro, sortases are used in sortase-mediated ligation (SML) reactions for a variety of protein engineering applications. Historically, sortase A from Staphylococcus aureus (saSrtA) has been the enzyme of choice to catalyze SML reactions. However, the stringent specificity of saSrtA for the LPXTG sequence motif limits its uses. Here, we describe the impact on substrate selectivity of a structur-ally conserved loop with a high degree of sequence variability in all classes of sortases. We investigate the contribution of this beta 7-beta 8 loop by designing and testing chimeric sortase enzymes. Our chimeras utilize natural sequence variation of class A sortases from eight species engineered into the SrtA sequence from Streptococcus pneumoniae. While some of these chimeric enzymes mimic the activity and selectivity of the WT protein from which the loop sequence was derived (e.g., that of saSrtA), others results in chimeric Streptococcus pneumoniae SrtA enzymes that are able to accommodate a range of residues in the final position of the substrate motif (LPXTX). Using mutagenesis, structural comparisons, and sequence analyses, we identify three interactions facilitated by beta 7-beta 8 loop residues that appear to be broadly conserved or converged upon in class A sortase enzymes. These studies provide the foundation for a deeper understanding of sortase target selectivity and can expand the sortase toolbox for future SML applications.	[Piper, Isabel M.; Struyvenberg, Sarah A.; Valgardson, Jordan D.; Johnson, D. Alex; Gao, Melody; Johnston, Katherine; Svendsen, Justin E.; Kodama, Hanna M.; Antos, John M.; Amacher, Jeanine F.] Western Washington Univ, Dept Chem, Bellingham, WA 98225 USA; [Hvorecny, Kelli L.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Valgardson, Jordan D.] Stanford Univ, Dept Chem Syst Biol, Palo Alto, CA 94304 USA	Western Washington University; University of Washington; University of Washington Seattle; Stanford University	Antos, JM; Amacher, JF (corresponding author), Western Washington Univ, Dept Chem, Bellingham, WA 98225 USA.	antosj@wwu.edu; amachej@wwu.edu		Svendsen, Justin/0000-0002-5873-5339; Gao, Melody/0000-0003-2902-7517; Johnson, David/0000-0001-5675-685X	NSF [CHE-1904711]; Cottrell Scholar Award from the Research Corporation for Science Advancement; NIAID, National Institutes of Health [F32AI145111]; Elwha Undergraduate Summer Research Award; Joseph and Karen Morse Student Research in Chemistry Fellowship	NSF(National Science Foundation (NSF)); Cottrell Scholar Award from the Research Corporation for Science Advancement; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Elwha Undergraduate Summer Research Award; Joseph and Karen Morse Student Research in Chemistry Fellowship	J. F. A. was funded by NSF CHE-1904711 and J. M. A. was funded by a Cottrell Scholar Award from the Research Corporation for Science Advancement. K. L. H. was supported by the NIAID, National Institutes of Health, Award Number F32AI145111. In addition, I. M. P. received an Elwha Undergraduate Summer Research Award and D. A. J. received a Joseph and Karen Morse Student Research in Chemistry Fellowship to fund summer research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antos JM, 2016, CURR OPIN STRUC BIOL, V38, P111, DOI 10.1016/j.sbi.2016.05.021; Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Bennett NR, 2019, BIOMACROMOLECULES, V20, P4370, DOI 10.1021/acs.biomac.9b01049; Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bradshaw WJ, 2015, FEBS J, V282, P2097, DOI 10.1111/febs.13288; Chan AH, 2015, J BIOL CHEM, V290, P25461, DOI 10.1074/jbc.M115.670984; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Clancy KW, 2010, BIOPOLYMERS, V94, P385, DOI 10.1002/bip.21472; Coordinators NR., 2017, NUCLEIC ACIDS RES, V45, pD12, DOI 10.1093/nar/gkw1071; Di Girolamo S, 2019, BIOCHEM J, V476, P665, DOI 10.1042/BCJ20180885; Dorr BM, 2014, P NATL ACAD SCI USA, V111, P13343, DOI 10.1073/pnas.1411179111; Freund C, 2021, CHEMBIOCHEM, V22, P1347, DOI 10.1002/cbic.202000745; Guimaraes CP, 2013, NAT PROTOC, V8, P1787, DOI 10.1038/nprot.2013.101; Hess GT, 2013, ACS SYNTH BIOL, V2, P490, DOI 10.1021/sb400019s; Jacobitz AW, 2017, ADV PROTEIN CHEM STR, V109, P223, DOI 10.1016/bs.apcsb.2017.04.008; Johanning K, 1998, J BIOL CHEM, V273, P22672, DOI 10.1074/jbc.273.35.22672; Kang CY, 2020, J BIOL CHEM, V295, P3734, DOI 10.1074/jbc.RA119.011322; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Kruger RG, 2004, ANAL BIOCHEM, V326, P42, DOI 10.1016/j.ab.2003.10.023; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Li J, 2020, J BIOL CHEM, V295, P2664, DOI 10.1074/jbc.RA119.012039; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Nikghalb KD, 2018, CHEMBIOCHEM, V19, P185, DOI 10.1002/cbic.201700517; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Piotukh K, 2011, J AM CHEM SOC, V133, P17536, DOI 10.1021/ja205630g; Podracky CJ, 2021, NAT CHEM BIOL, V17, P317, DOI 10.1038/s41589-020-00706-1; Popp MW, 2009, J BIOL CHEM, V284, P3593, DOI 10.1074/jbc.M807172200; Pritz S, 2007, J ORG CHEM, V72, P3909, DOI 10.1021/jo062331l; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Raeeszadeh-Sarmazdeh M, 2015, COLLOID SURFACE B, V128, P457, DOI 10.1016/j.colsurfb.2015.02.044; Schmohl L, 2017, BIOORGAN MED CHEM, V25, P5002, DOI 10.1016/j.bmc.2017.06.033; Schmohl L, 2017, J PEPT SCI, V23, P631, DOI 10.1002/psc.2980; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Valgardson J, 2019, PROTEIN SCI, V28, P2127, DOI 10.1002/pro.3741; Wojcik M, 2020, PROTEINS, V88, P1394, DOI 10.1002/prot.25958; Wuethrich I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109883; Zou Z, 2020, BIOCONJUGATE CHEM, V31, P2476, DOI 10.1021/acs.bioconjchem.0c00486	50	4	4	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100981	10.1016/j.jbc.2021.100981	http://dx.doi.org/10.1016/j.jbc.2021.100981			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34302812	gold, Green Published			2022-12-26	WOS:000690868100011
J	Liu, ZY; Wang, AQ; Pu, YY; Li, ZW; Xue, RD; Zhang, C; Xiang, X; Jian-Yu, E; Bu, ZD; Bai, F; Ji, JF				Liu, Ziyang; Wang, Anqiang; Pu, Yingying; Li, Zhongwu; Xue, Ruidong; Zhang, Chong; Xiang, Xiao; Jian-Yu, E.; Bu, Zhaode; Bai, Fan; Ji, Jiafu			Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach	ONCOGENE			English	Article							STEM-CELLS; TUMOR; CANCER; METASTASIS; METHIONINE; MUTATIONS; CARCINOMA; DIFFERENTIATION; HETEROGENEITY; TRANSITION	Hepatoid adenocarcinoma of the stomach (HAS), a rare subtype of gastric cancer (GC), has a low incidence but a high mortality rate. Little is known about the molecular features of HAS. Here we applied whole-exome sequencing (WES) on 58 tumours and the matched normal controls from 54 HAS patients, transcriptome sequencing on 30 HAS tumours, and single-cell RNA sequencing (scRNA-seq) on one HAS tumour. Our results reveal that the adenocarcinomatous component and hepatocellular-like component of the same HAS tumour originate monoclonally, and HAS is likely to initiate from pluripotent precursor cells. HAS has high stemness and high methionine cycle activity compared to classical GC. Two genes in the methionine cycle, MAT2A, and AHCY are potential targets for HAS treatments. We provide the first integrative genomic profiles of HAS, which may facilitate its diagnosis, prognosis, and treatment.	[Liu, Ziyang; Pu, Yingying; Xue, Ruidong; Zhang, Chong; Bai, Fan] Peking Univ, Biomed Pioneering Innovat Ctr BIOPIC, Sch Life Sci, Beijing, Peoples R China; [Wang, Anqiang; Bu, Zhaode; Ji, Jiafu] Peking Univ, Dept Gastrointestinal Surg, Canc Hosp & Inst, Minist Educ,Lab Carcinogenesis & Translat Res, Beijing, Peoples R China; [Pu, Yingying] Wuhan Univ, Frontier Sci Ctr Immunol & Metab, Sch Med, Med Res Inst, Wuhan, Peoples R China; [Pu, Yingying] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China; [Pu, Yingying] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ KLOBM, Key Lab Oral Biomed, Wuhan, Peoples R China; [Li, Zhongwu] Peking Univ, Dept Pathol, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China; [Xue, Ruidong] Peking Univ First Hosp, Translat Canc Res Ctr, Beijing, Peoples R China; [Xiang, Xiao] Peking Univ Peoples Hosp, Beijing Key Surg Basic Res Lab Liver Cirrhosis &, Dept Hepatobilliary Surg, Beijing, Peoples R China; [Jian-Yu, E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ji, Jiafu] Peking Univ, Dept Biobank, Minist Educ, Key Lab Carcinogenesis & Translat Res,Canc Hosp &, Beijing, Peoples R China	Peking University; Peking University; Wuhan University; Wuhan University; Wuhan University; Peking University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Peking University	Bai, F (corresponding author), Peking Univ, Biomed Pioneering Innovat Ctr BIOPIC, Sch Life Sci, Beijing, Peoples R China.; Bu, ZD; Ji, JF (corresponding author), Peking Univ, Dept Gastrointestinal Surg, Canc Hosp & Inst, Minist Educ,Lab Carcinogenesis & Translat Res, Beijing, Peoples R China.; Ji, JF (corresponding author), Peking Univ, Dept Biobank, Minist Educ, Key Lab Carcinogenesis & Translat Res,Canc Hosp &, Beijing, Peoples R China.	buzhaode@cjcrcn.org; jijiafu@hsc.pku.edu.cn		Bu, Zhaode/0000-0001-8728-9676; Liu, Ziyang/0000-0002-3067-9523; E, Jian-Yu/0000-0002-6175-6974; Xue, Ruidong/0000-0002-5743-805X; Zhang, Chong/0000-0001-5072-5219	National Science and Technology Major Project [2018ZX10302205, 2019YFC1315702]; Guangdong Province Key Research and Development Program [2019B020226002]; Peking University Clinical Scientist Program [BMU2019LCKXJ011]; National Science Foundation for Young Scientists of China [81802735]; Beijing Youth Talent Plan [QML20191101]; 'San Ming' Project of Shenzhen city, China [SZSM201612051]; Beijing Municipal Science and Technology Commission NOVA Program [2010B033]	National Science and Technology Major Project; Guangdong Province Key Research and Development Program; Peking University Clinical Scientist Program; National Science Foundation for Young Scientists of China; Beijing Youth Talent Plan; 'San Ming' Project of Shenzhen city, China; Beijing Municipal Science and Technology Commission NOVA Program	This work was financially supported by the National Science and Technology Major Project (2018ZX10302205, 2019YFC1315702), the Guangdong Province Key Research and Development Program (2019B020226002) to F. Bai; Peking University Clinical Scientist Program (BMU2019LCKXJ011); National Science Foundation for Young Scientists of China (No. 81802735); Beijing Youth Talent Plan (No. QML20191101); 'San Ming' Project of Shenzhen city, China (No. SZSM201612051) and Beijing Municipal Science and Technology Commission NOVA Program (2010B033).	Akazawa Y, 2018, HUM PATHOL, V78, P79, DOI 10.1016/j.humpath.2018.04.022; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Apte RS, 2019, CELL, V176, P1248, DOI 10.1016/j.cell.2019.01.021; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, 2017, Cell, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Christenser S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12594-8; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Comoglio PM, 2018, NAT REV CANCER, V18, P341, DOI 10.1038/s41568-018-0002-y; DeLaForest A, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00044; Ding X, 2019, BRAIN RES, V1717, P117, DOI 10.1016/j.brainres.2019.03.035; Favero F, 2015, ANN ONCOL, V26, P64, DOI 10.1093/annonc/mdu479; Fu DJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13847-2; Gao Q, 2019, CELL, V179, P561, DOI 10.1016/j.cell.2019.08.052; Gao X, 2019, NATURE, V572, P397, DOI 10.1038/s41586-019-1437-3; Gaude E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13041; Gibbons DL, 2018, DEV DYNAM, V247, P555, DOI 10.1002/dvdy.24485; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Harvey A, 2019, STEM CELL REP, V13, P573, DOI 10.1016/j.stemcr.2019.09.003; ISHIKURA H, 1986, CANCER, V58, P119, DOI 10.1002/1097-0142(19860701)58:1<119::AID-CNCR2820580121>3.0.CO;2-U; Jiang H, 2020, P NATL ACAD SCI USA, V117, P4770, DOI 10.1073/pnas.1914937117; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Khemlina G, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0712-x; Kim E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09780-z; Kim JE, 2009, MODERN PATHOL, V22, P1312, DOI 10.1038/modpathol.2009.98; Kim KM, 2014, ASIA-PAC J CLIN ONCO, V10, P297, DOI 10.1111/ajco.12263; Kim S, 2018, NAT METHODS, V15, P591, DOI 10.1038/s41592-018-0051-x; Komninou D, 2006, NUTR CANCER, V54, P202, DOI 10.1207/s15327914nc5402_6; Krebs AM, 2017, NAT CELL BIOL, V19, P518, DOI 10.1038/ncb3513; Lan SW, 2019, LUNG CANCER, V132, P154, DOI 10.1016/j.lungcan.2019.04.025; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin L, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1362-2; Liu PY, 2012, CARCINOGENESIS, V33, P1270, DOI 10.1093/carcin/bgs148; Liu XW, 2010, AM J SURG PATHOL, V34, P1465, DOI 10.1097/PAS.0b013e3181f0a873; Malta TM, 2018, CELL, V173, P338, DOI 10.1016/j.cell.2018.03.034; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Newman AM, 2019, NAT BIOTECHNOL, V37, P773, DOI 10.1038/s41587-019-0114-2; Pastushenko I, 2019, TRENDS CELL BIOL, V29, P212, DOI 10.1016/j.tcb.2018.12.001; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Qing T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04221-7; Reid MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07868-6; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/nmeth.2883, 10.1038/NMETH.2883]; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Scholnick SB, 2003, GENE CHROMOSOME CANC, V38, P281, DOI 10.1002/gcc.10279; Shafiei S, 2019, EXP MOL PATHOL, V108, P164, DOI 10.1016/j.yexmp.2019.04.015; Shiraki N, 2014, CELL METAB, V19, P780, DOI 10.1016/j.cmet.2014.03.017; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Su JS, 2013, WORLD J GASTROENTERO, V19, P321, DOI 10.3748/wjg.v19.i3.321; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Tschaharganeh DF, 2014, CELL, V158, P579, DOI 10.1016/j.cell.2014.05.051; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang Q, 2017, CELL STEM CELL, V20, P70, DOI 10.1016/j.stem.2016.10.002; Wang YK, 2019, GASTRIC CANCER, V22, P1183, DOI 10.1007/s10120-019-00965-5; Wang ZX, 2019, NAT MED, V25, P825, DOI 10.1038/s41591-019-0423-5; Xu W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.27; Xue RD, 2019, CANCER CELL, V35, P932, DOI 10.1016/j.ccell.2019.04.007; Yonemura Y, 2002, EXP ONCOL, V24, P89; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang P, 2019, CELL REP, V27, P1934, DOI 10.1016/j.celrep.2019.04.052; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035	70	4	4	9	38	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 23	2021	40	38					5705	5717		10.1038/s41388-021-01976-2	http://dx.doi.org/10.1038/s41388-021-01976-2		JUL 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UU4CG	34326469				2022-12-26	WOS:000679262800001
J	Adams, AM; Khan, A; Roy, AS; Hassan, MT; Mridha, MK; Ahmed, NU; Mustaphi, P; Chowdhury, I; Khondker, R; Hyder, Z				Adams, A. M.; Khan, A.; Roy, A. S.; Hassan, Md. T.; Mridha, M. K.; Ahmed, N. U.; Mustaphi, P.; Chowdhury, I.; Khondker, R.; Hyder, Z.			Growth dynamics among adolescent girls in Bangladesh: Evidence from nationally representative data spanning 2011-2014	PLOS ONE			English	Article							EARLY-LIFE; UNDERNUTRITION; NUTRITION; CHILDREN; INTERVENTIONS; DETERMINANTS; MALNUTRITION; DISEASE; FAMINE; RISK	Background Adolescence is the last opportunity to reverse any growth faltering accumulated from fetal life through childhood and it is considered a crucial period to optimize human development. In Bangladesh, a growing double burden of underweight and obesity in adolescents is recognized, yet limited data exists on how, when, and where to intervene. This study assesses the dynamics of growth among adolescent girls in Bangladesh, providing insight about critical junctures where faltering occurs and where immediate interventions are warranted. Methods We pooled data from Bangladesh's Food Security and Nutrition Surveillance Project collected between 2011 and 2014 to document the age dynamics of weight and linear growth. 20,572 adolescent girls were measured for height and 19,345 for weight. We constructed growth curves for height, weight, stunting, and underweight. We also stratified growth dynamics by wealth quintile to assess socioeconomic inequities in adolescent trajectories. Results Height-for-age z-score (HAZ) in Bangladeshi girls deteriorates throughout adolescence and especially during the early years. Mean HAZ decreases by 0.20 standard deviations (sd) per year in early adolescence (10-14 years) vs 0.06 sd/year during late adolescence (15-19 years), while stunting increases by 16 percentage points (pp) vs 6.7 pp, respectively. Conversely, BMI-for-age z-score (BAZ) increases by 0.13 sd/year in early adolescence vs 0.02 sd/year in late adolescence, and underweight decreases by 12.8 pp vs 3.2 pp. Adolescent girls in all socioeconomic groups show a similar pattern of HAZ and BAZ dynamics, but the curve for the richest quintile stays above that of the poorest across all ages. Conclusions Trends and levels of stunting and underweight among adolescent girls in Bangladesh are worrisome, suggesting substantial linear growth faltering in early adolescence, with improving weight-for-age occurring only as linear growth slows and stops. Given the rising burden of non-communicable diseases (NCDs) in Bangladesh and emerging evidence of the link between stunting and later chronic diseases, greater attention to adolescent growth and development is needed. Our findings suggest that, to address stunting, interventions in early adolescence would have the greatest benefits. School-based interventions could be a way to target this population.	[Adams, A. M.; Roy, A. S.] McGill Univ, Dept Family Med, Fac Med & Hlth Sci, Montreal, PQ, Canada; [Adams, A. M.; Hassan, Md. T.; Mridha, M. K.] BRAC Univ, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Khan, A.] Uppsala Univ, Dept Econ, Uppsala, Sweden; [Ahmed, N. U.] Shornokishori Network Fdn, Dhaka, Bangladesh; [Mustaphi, P.; Chowdhury, I.] UNICEF Bangladesh Country Off, Dhaka, Bangladesh; [Khondker, R.] Global Alliance Improved Nutr GAIN, Dhaka, Bangladesh; [Hyder, Z.] World Bank Grp Cambodia, Phnom Penh, Cambodia	McGill University; Bangladesh Rural Advancement Committee BRAC; BRAC University; Uppsala University	Adams, AM (corresponding author), McGill Univ, Dept Family Med, Fac Med & Hlth Sci, Montreal, PQ, Canada.; Adams, AM (corresponding author), BRAC Univ, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	alayne.adams@gmail.com	Mridha, Malay Kanti/AAJ-5539-2020	Mridha, Malay Kanti/0000-0001-9226-457X; Adams, Alayne/0000-0002-0961-9825; HASAN, MD TANVIR/0000-0002-5806-060X; Khan, Akib/0000-0002-9180-392X	World Bank Group Bangladesh; UNICEF Bangladesh	World Bank Group Bangladesh; UNICEF Bangladesh	MM received funding from The World Bank Group Bangladesh to support data analysis and knowledge translation associated with broader partnership activities. ZH, a senior health specialist with the The World Bank Group Cambodia, was involved in the conception of the study and the preparation of the manuscript. https://www.worldbank.org/en/home AA was supported by UNICEF Bangladesh as a consultant advisor to this study. PM and IA from the UNICEF office were involved in the conception of the study and the preparation of the manuscript. https://www.unicef.org/bangladesh/en.	Ahmed A., 2013, **DATA OBJECT**, DOI [10.7910/DVN/OR6MHT, DOI 10.7910/DVN/OR6MHT]; Beal T., 2018, ADOLESCENT NUTR BANG, DOI [10.13140/RG.2.2.11189.22246, DOI 10.13140/RG.2.2.11189.22246]; Berhe K, 2019, BMC NUTR, V5, DOI 10.1186/s40795-019-0309-4; Bhutta ZA, 2017, ANN NY ACAD SCI, V1393, P61, DOI 10.1111/nyas.13352; Biswas T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181080; Bosch AM, 2008, J HEALTH POPUL NUTR, V26, P189; Christian P, 2018, ANN NUTR METAB, V72, P316, DOI 10.1159/000488865; CIA, 2014, MOTH MEAN AG 1 BIRTH; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; GOLDEN MHN, 1994, EUR J CLIN NUTR, V48, pS58; Gupta MD., 2014, STATE WORLD POPULATI; Headey D, 2017, GLOB FOOD SECUR-AGR, V13, P12, DOI 10.1016/j.gfs.2017.02.003; Hossain M, 2018, PUBLIC HEALTH NUTR, V21, P1800, DOI 10.1017/S136898001700427X; International Food Policy Research Institute (IFPRI), 2016, **DATA OBJECT**, DOI [10.7910/DVN/BXSYEL, DOI 10.7910/DVN/BXSYEL]; James P, 2015, STAT FOOD SEC NUTR B; James P, 2012, STAT FOOD SEC NUTR B; James P, 2014, STAT FOOD SEC NUTR B; James P, 2013, STAT FOOD SEC NUTR B; Krishna A, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26523; Maehara M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221273; Martins VJB, 2011, INT J ENV RES PUB HE, V8, P1817, DOI 10.3390/ijerph8061817; MARTORELL R, 1994, EUR J CLIN NUTR, V48, pS45; Melaku YA, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0093-9; Ministry of Health and Family Welfare, COMPR NAT NUTR SURV; Ministry of Health and Family Welfare, 2011, OP PLAN NATL NUTR SE; Ministry of Health and Family Welfare, 2015, NAT NUTR POL 2015; Mridha MalayKanti., 2019, HLTH NUTR POPULATION; Muhammad HFL, 2018, ACTA MED INDONES, V50, P159; Organization WH, 2018, NONCOMMUNICABLE DIS; Portrait F, 2011, SOC SCI MED, V73, P711, DOI 10.1016/j.socscimed.2011.04.005; Rah JH, 2008, J NUTR, V138, P1505, DOI 10.1093/jn/138.8.1505; Rogol AD, 2000, AM J CLIN NUTR, V72, p521S, DOI 10.1093/ajcn/72.2.521S; Salam RA, 2016, J ADOLESCENT HEALTH, V59, pS29, DOI 10.1016/j.jadohealth.2016.06.022; Sawaya AL, 2005, MATERN CHILD NUTR, V1, P155, DOI 10.1111/j.1740-8709.2005.00033.x; Sawaya AL, 2009, NESTLE NUTR WORKS SE, V63, P95, DOI 10.1159/000209975; Stein AD, 2005, MATERN CHILD NUTR, V1, P177, DOI 10.1111/j.1740-8709.2005.00021.x; Svastha o Paribara Kalyaa Mantranalaa Jana Svasthya Pushi Pratishhana (Bangladesh), 2017, 2 NAT PLAN ACT NUTR; UNESCO Institute for Statistics, 2020, ED TOT NET ATT RAT L; UNICEF, 2011, AD AG OPP; United Nations Children's Fund, 2014, END CHILD MARR PROGR; Wells JCK, 2018, EUR J CLIN NUTR, V72, P688, DOI 10.1038/s41430-018-0142-x; WHO, 2015, GLOB SCH BAS STUD HL; WHO, 2020, BANGL STAT SUMM 2002; Xin XL, 2019, EUR J NUTR, V58, P391, DOI 10.1007/s00394-017-1603-z; Ziegelh Z., 2014, FOOD PRICES HOUSEHOL	47	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255273	10.1371/journal.pone.0255273	http://dx.doi.org/10.1371/journal.pone.0255273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324581	gold, Green Published			2022-12-26	WOS:000685248200079
J	Carle, RD; Fleishman, AB; Varela, T; Angulo, PM; De Rodt, G; Hodum, P; Colodro, V; Lopez, V; Gutierrez-Guzman, H				Carle, Ryan David; Fleishman, Abram B.; Varela, Tiare; Manriquez Angulo, Pablo; De Rodt, Guillermo; Hodum, Peter; Colodro, Valentina; Lopez, Veronica; Gutierrez-Guzman, Hector			Introduced and native vertebrates in pink-footed shearwater (Ardenna creatopus) breeding colonies in Chile	PLOS ONE			English	Article							JUAN-FERNANDEZ ISLANDS; ROBINSON-CRUSOE ISLAND; CALONECTRIS-DIOMEDEA; SEABIRDS; CONSERVATION; MOONLIGHT; ERADICATION; PREDATION; MOCHA; CATS	Biodiversity conservation planning requires accurate, current information about species status and threats. Although introduced mammals are the greatest threat to seabirds globally, data on introduced species is lacking for many seabird breeding islands. To inform conservation planning, we used trail cameras to document the presence, relative abundance, and seasonal and diel attendance of introduced and native vertebrates within pink-footed shearwater (Ardenna creatopus) breeding colonies on Isla Mocha (five colonies, 2015-2020) and Isla Robinson Crusoe (Juan Fernandez Archipelago), Chile (one colony, 2019-2020). The most commonly detected species were pink-footed shearwaters and introduced rats (Rattus spp.) on Isla Mocha, and European rabbits (Oryctolagus cuniculus) and pink-footed shearwaters on Isla Robinson Crusoe. Introduced mammals observed, in order of greatest catch-per-unit-effort, were rats, cats (Felis catus), dogs (Canis lupus familiaris), and European hares (Lepus europaeus) on Isla Mocha and European rabbits, cats, cattle (Bos taurus), rats, dogs, mice (Mus musculus), and southern coati (Nasua nasua) on Isla Robinson Crusoe. Especially noteworthy results for pink-footed shearwater conservation were the presence of cats during all monitoring months in shearwater colonies on both islands, that catch-per-unit-effort of rabbits was greater than shearwaters on Isla Robinson Crusoe, and that rats were the most observed vertebrates after shearwaters on Isla Mocha. Pink-footed shearwaters were regularly present on the islands from October through May. Presence and relative catch-per-unit-effort of pink-footed shearwaters qualitatively matched the species' known breeding phenology. The regular presence and temporal overlap with shearwaters of cats, rats, rabbits, and cattle within shearwater colonies, coupled with the irregular presence of dogs, coati, hares, and mice, indicated a serious conservation threat for pink-footed shearwaters and other native insular fauna and flora. Finally, our study provides a widely applicable model for analysis of multi-year trail camera data collected with unstandardized settings.	[Carle, Ryan David; Varela, Tiare; Manriquez Angulo, Pablo; De Rodt, Guillermo; Hodum, Peter; Colodro, Valentina; Lopez, Veronica; Gutierrez-Guzman, Hector] Oikonos Ecosyst Knowledge, Robinson Crusoe Isl, Valparaiso Regi, Chile; [Fleishman, Abram B.] Conservat Metr Inc, Santa Cruz, CA USA; [Hodum, Peter] Univ Puget Sound, Tacoma, WA USA		Carle, RD (corresponding author), Oikonos Ecosyst Knowledge, Robinson Crusoe Isl, Valparaiso Regi, Chile.	ryan@oikonos.org		Carle, Ryan/0000-0002-8213-4306	National Fish and Wildlife Foundation [0115.19.055334]; Idea Wild	National Fish and Wildlife Foundation; Idea Wild	Funding for this project came from the National Fish and Wildlife Foundation (grant number 0115.19.055334; https://www.nfwf.org/), Idea Wild (https://ideawild.org/), and a generous donation from an anonymous donor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors [RC, AF, TV, PMA, GDR, PH, VC, VL, HGG) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. One of the authors, AF, is employed by a commercial company, Conservation Metrics, Inc, which was contracted by the nonprofit Oikonos (using funds from the aforementioned funders) to analyze data for this study.	Anderson A., 2002, 50 YEARS FIELD ESSAY, V25, P239; Angel A, 2009, BIOL INVASIONS, V11, P1743, DOI 10.1007/s10530-008-9401-4; BirdLife International, 2017, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2017-1.RLTS.T22698195A112079183.en, DOI 10.2305/IUCN.UK.2017-1.RLTS.T22698195A112079183.EN]; Bonino N, 2010, FOLIA ZOOL, V59, P9; Bonnaud E, 2011, BIOL INVASIONS, V13, P581, DOI 10.1007/s10530-010-9851-3; Bourgeois K, 2008, CR BIOL, V331, P88, DOI 10.1016/j.crvi.2007.10.008; BOURNE W R P, 1992, Oryx, V26, P43; Bowkett AE, 2008, AFR J ECOL, V46, P479, DOI 10.1111/j.1365-2028.2007.00881.x; Brodier S, 2011, ANIM CONSERV, V14, P459, DOI 10.1111/j.1469-1795.2011.00455.x; Brooke M, 2004, ALBATROSSES PETRELS; BROOKE MD, 1987, CONDOR, V89, P581; Brownlie KC., EMU, V2020, P1; Campbell R, 2017, LAT AM ANTIQ, V28, P495, DOI 10.1017/laq.2017.42; Campbell R, 2015, QUATERN INT, V373, P117, DOI 10.1016/j.quaint.2014.11.060; Caravaggi A, 2019, IBIS, V161, P648, DOI 10.1111/ibi.12664; Carle RD., 2019, CONDOR, V121, P1; Carle Ryan D., 2016, Revista Chilena de Ornitologia, V22, P184; Clinchy M, 2013, FUNCT ECOL, V27, P56, DOI 10.1111/1365-2435.12007; Colodro V, 2009, THESIS U MAYOR; COLWELL RK, 1989, IBIS, V131, P548, DOI 10.1111/j.1474-919X.1989.tb04790.x; COSEWIC, 2016, COSEWIC ASS STAT REP; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Dias MP, 2019, BIOL CONSERV, V237, P525, DOI 10.1016/j.biocon.2019.06.033; Dirnbock T, 2003, CONSERV BIOL, V17, P1650, DOI 10.1111/j.1523-1739.2003.00173.x; Felis JJ, 2019, ENDANGER SPECIES RES, V39, P269, DOI 10.3354/esr00969; FITZGERALD BM, 1986, NEW ZEAL J ECOL, V9, P71; Flux J.E.C., 1990, P61; Gantchoff MG, 2015, MAMM BIOL, V80, P54, DOI 10.1016/j.mambio.2014.10.001; Garcia P.F., 2020, EUR BIOPHYS J BIOPHY, P1; Granadeiro JP, 1998, ANIM BEHAV, V56, P1169, DOI 10.1006/anbe.1998.0827; Guicking D., 1999, WORLD BIRDWATCH, P20; Guicking Daniela, 1999, Boletin Chileno de Ornitologia, V6, P33; Hahn Ingo, 2002, Cotinga, V17, P66; Hahn I, 2016, VERTEBR ZOOL, V66, P397; Hinojosa Saez A., 2007, PLAN NACL CONSERVACI; Holmes ND, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212128; HUTTERER R, 1994, Z SAUGETIERKD, V59, P27; IUCN SSC Amphibian Specialist Group, 2019, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2019-1.RLTS.T8375A79809055.en, DOI 10.2305/IUCN.UK.2019-1.RLTS.T8375A79809055.EN]; Jimenez Jaime E., 2010, P140; Jones HP, 2008, CONSERV BIOL, V22, P16, DOI 10.1111/j.1523-1739.2007.00859.x; Jones HP, 2010, ECOL APPL, V20, P2075, DOI 10.1890/10-0118.1; Keitt Bradford S., 2004, Marine Ornithology, V32, P173; Keitt BS, 2003, ANIM CONSERV, V6, P307, DOI 10.1017/S1367943003003378; Keitt BS, 2002, ANIM CONSERV, V5, P217, DOI 10.1017/S1367943002002263; KLOMP NI, 1990, ORNIS SCAND, V21, P270, DOI 10.2307/3676391; Le Corre M, 2008, NATURE, V451, P134, DOI 10.1038/451134a; Mann Wilcke GW., 1975, B MUS NAC HIST NAT C, V34, P207; McChesney GJ, 1998, COLON WATERBIRD, V21, P335, DOI 10.2307/1521646; Monteiro LR, 1996, BIOL CONSERV, V78, P319, DOI 10.1016/S0006-3207(96)00037-7; Morosinotto C, 2013, J AVIAN BIOL, V44, P427, DOI 10.1111/j.1600-048X.2013.00084.x; Mougeot F, 2000, J AVIAN BIOL, V31, P376, DOI 10.1034/j.1600-048X.2000.310314.x; Munoz D. V., 2011, THESIS; Murphy R. C., 1936, OCEANIC BIRDS S AM S; Nicholson E, 2006, CONSERV BIOL, V20, P871, DOI 10.1111/j.1523-1739.2006.00369.x; Pagad S, 2018, SCI DATA, V5, DOI 10.1038/sdata.2017.202; Pefaur J. E., 1980, B MUSEO NACL HIST NA, V37, P103; Powell Christopher, 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P35; R Core Team, 2020, R LANG ENV STAT COMP; Roach N., 2016, IUCN RED LIST THREAT, V2016, DOI [10.2305/IUCN.UK.2016-2.RLTS.T15090A78321512.en, DOI 10.2305/IUCN.UK.2016-2.RLTS.T15090A78321512.EN]; Rodriguez A, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00094; Rubolini D, 2015, ETHOLOGY, V121, P284, DOI 10.1111/eth.12338; Spatz DR, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603080; Spatz DR, 2014, CONSERV BIOL, V28, P1282, DOI 10.1111/cobi.12279; Torres D., 1971, B U CHILE, V112, P26; Wanless RM, 2007, BIOLOGY LETT, V3, P241, DOI 10.1098/rsbl.2007.0120; WESTER L, 1991, J HIST GEOGR, V17, P18, DOI 10.1016/0305-7488(91)90003-E; Whitworth DL, 2013, BIOL CONSERV, V162, P52, DOI 10.1016/j.biocon.2013.03.026	68	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254416	10.1371/journal.pone.0254416	http://dx.doi.org/10.1371/journal.pone.0254416			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324511	gold, Green Published			2022-12-26	WOS:000685248200046
J	Welander, F; Holmberg, H; Dimeny, E; Jansson, U; Sjalander, A				Welander, Frida; Holmberg, Henrik; Dimeny, Emoke; Jansson, Ulf; Sjalander, Anders			Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome-A retrospective observational study	PLOS ONE			English	Article							THROMBOTIC COMPLICATIONS; EVENTS; COHORT; RISK	Background Nephrotic syndrome (NS) is associated with increased risk of venous thromboembolism (VTE). Guidelines suggest prophylactic anticoagulants to patients with high risk of thrombosis and low risk of bleeding, but the evidence behind this is poor. This study aims to investigate the effectiveness and risks of prophylactic anticoagulants (PAC) and investigate risk factors for VTE and bleeding in NS. Methods A retrospective medical records study including adults with NS, biopsy proven glomerular disease in the county of Vasternorrland, Sweden. Outcomes were VTE, bleeding and death. Patients divided into PAC- and no PAC group were compared using Fisher's exact test. Patient time was divided into serum/plasma(S/P)-albumin intervals (<20g/L and >= 20g/L) and VTE- and bleeding rates were calculated. Results In 95 included NS patients (PAC = 40, no PAC = 55), 7 VTE (7.4%) and 17 bleedings (18%) were found. Outcomes didn't differ significantly between the PAC and no PAC group. Time with S/P-albumin <20g/L conferred higher rates/100 years of VTE (IRR 21.7 (95%CI 4.5-116.5)) and bleeding (IRR 5.0 (1.4-14.7)), compared to time with S/P-albumin>20g/L. Conclusion Duration of severe hypoalbuminemia (S/P-albumin <20g/L) in NS is a risk factor for both VTE and bleeding. There is a need for randomized controlled studies regarding the benefit of PAC in NS as well as risk factors of thrombosis and bleeding in NS.	[Welander, Frida] Umea Univ, Dept Publ Hlth & Clin Med, Dept Res & Dev Sundsvall, Umea, Sweden; [Holmberg, Henrik; Dimeny, Emoke; Sjalander, Anders] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Jansson, Ulf] Hosp Sundsvall, Dept Lab Med, Sundsvall, Vasternorrland, Sweden	Umea University; Umea University	Welander, F (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Dept Res & Dev Sundsvall, Umea, Sweden.	frida.welander@umu.se		Holmberg, Henrik/0000-0001-6206-3099; Welander, Frida/0000-0003-1111-7215	Unit for Research and Development, Region Vasternorrland [LVNFOU938547]; Umea university	Unit for Research and Development, Region Vasternorrland; Umea university	Support for this study was provided by Unit for Research and Development, Region Vasternorrland grant number LVNFOU938547, www.rvn.se (FW) and Agreement regarding research and education of doctors, Umea university (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRASSY K, 1980, KLIN WOCHENSCHR, V58, P1029, DOI 10.1007/BF01476873; Beck L, 2013, AM J KIDNEY DIS, V62, P403, DOI 10.1053/j.ajkd.2013.06.002; BELLOMO R, 1993, NEPHRON, V63, P249, DOI 10.1159/000187205; Bjork J, 2011, SCAND J CLIN LAB INV, V71, P232, DOI 10.3109/00365513.2011.557086; Dean AG SK., OPENEPI OPEN SOURCE; DEGUCHI F, 1989, NEPHRON, V51, P377, DOI 10.1159/000185326; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Glassock RJ, 2007, J AM SOC NEPHROL, V18, P2221, DOI 10.1681/ASN.2006111300; Gordon-Cappitelli J, 2020, CLIN J AM SOC NEPHRO, V15, P123, DOI 10.2215/CJN.05250419; Gyamlani G, 2017, NEPHROL DIAL TRANSPL, V32, P157, DOI 10.1093/ndt/gfw227; JACKSON CA, 1982, BRIT J HAEMATOL, V52, P69, DOI 10.1111/j.1365-2141.1982.tb03862.x; Kelddal S, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1336-8; Lee T, 2014, KIDNEY INT, V85, P1412, DOI 10.1038/ki.2013.476; Lin R, 2020, KIDNEY INT REP, V5, P435, DOI 10.1016/j.ekir.2019.12.001; Lionaki S, 2012, CLIN J AM SOC NEPHRO, V7, P43, DOI 10.2215/CJN.04250511; LLACH F, 1985, KIDNEY INT, V28, P429, DOI 10.1038/ki.1985.149; Mahmoodi BK, 2008, CIRCULATION, V117, P224, DOI 10.1161/CIRCULATIONAHA.107.716951; Medjeral-Thomas N, 2014, CLIN J AM SOC NEPHRO, V9, P478, DOI 10.2215/CJN.07190713; Orth SR, 1998, NEW ENGL J MED, V338, P1202, DOI 10.1056/NEJM199804233381707; Petrauskiene V, 2005, DIABETOLOGIA, V48, P1017, DOI 10.1007/s00125-005-1715-5; Ribic C, 2016, HEMATOL-AM SOC HEMAT, P188, DOI 10.1182/asheducation-2016.1.188; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; ROSTOKER G, 1995, NEPHRON, V69, P20, DOI 10.1159/000188355; SARASIN FP, 1994, KIDNEY INT, V45, P578, DOI 10.1038/ki.1994.75; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; Singhal R, 2006, THROMB RES, V118, P397, DOI 10.1016/j.thromres.2005.03.030; Sjaelander A, 2008, J INTERN MED, V263, P52, DOI 10.1111/j.1365-2796.2007.01878.x; VIGANODANGELO S, 1987, ANN INTERN MED, V107, P42, DOI 10.7326/0003-4819-107-1-42; Wein L, 2007, ARCH INTERN MED, V167, P1476, DOI 10.1001/archinte.167.14.1476; Yang MQ, 2019, MED SCI MONITOR, V25, P2179, DOI 10.12659/MSM.912466; YOSHIDA N, 1978, BLOOD, V52, P969; Zou Peimei, 2018, Chinese Medical Sciences Journal, V33, P91, DOI 10.24920/11809	33	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0255009	10.1371/journal.pone.0255009	http://dx.doi.org/10.1371/journal.pone.0255009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34319998	Green Published, gold			2022-12-26	WOS:000685247800018
J	Fan, XY; Wang, YT; Jiang, TH; Liu, T; Jin, YL; Du, KL; Niu, YL; Zhang, CX; Liu, ZY; Lei, YL; Bu, YQ				Fan, Xiaoyan; Wang, Yitao; Jiang, Tinghui; Liu, Tao; Jin, Yuelei; Du, Kailong; Niu, Yulong; Zhang, Chunxue; Liu, Zhongyu; Lei, Yunlong; Bu, Youquan			B-Myb accelerates colorectal cancer progression through reciprocal feed-forward transactivation of E2F2	ONCOGENE			English	Article							TRANSCRIPTION FACTORS; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; CELL; PROLIFERATION; CONTRIBUTES; OVEREXPRESSION; ACTIVATION; CYCLIN-D1; FAMILY	B-Myb is an important transcription factor that plays a critical role in gene expression regulation and tumorigenesis. However, its functional implication in colorectal cancer remains elusive. In this study, we found that B-Myb was significantly upregulated at both mRNA and protein levels in colorectal cancer samples compared to non-tumor counterparts. B-Myb overexpression accelerated cell proliferation, cell cycle progression and cell motility in colorectal cancer cells, and promoted tumor growth in orthotopic nude mouse models in vivo. In contrast, B-Myb depletion inhibited these malignant phenotypes. Mechanistic investigations revealed that E2F2 was a novel transcriptional target of B-Myb and is essential to B-Myb-induced malignant phenotypes. Notably, B-Myb and E2F2 exhibited positive expression correlation, and interacted with each other in colorectal cancer cells. In addition to their autoregulatory mechanisms, B-Myb and E2F2 can also directly transactivate each other, thus constituting consolidated reciprocal feed-forward transactivation loops. Moreover, both B-Myb and E2F2 are required for the activation of ERK and AKT signaling pathways in colorectal cancer cells. Taken together, our data clarified a critical role for B-Myb in colorectal cancer and unraveled an exquisite mutual collaboration and reciprocal cross regulation between B-Myb and E2F2 that contribute to the malignant progression of human colorectal cancer.	[Fan, Xiaoyan; Wang, Yitao; Jiang, Tinghui; Liu, Tao; Jin, Yuelei; Du, Kailong; Zhang, Chunxue; Lei, Yunlong; Bu, Youquan] Chongqing Med Univ, Dept Biochem & Mol Biol, Coll Basic Med Sci, Chongqing 400016, Peoples R China; [Wang, Yitao; Jin, Yuelei; Niu, Yulong; Liu, Zhongyu; Lei, Yunlong; Bu, Youquan] Chongqing Med Univ, Canc Res Ctr, Mol Med, Chongqing 400016, Peoples R China; [Fan, Xiaoyan] Taizhou Univ, Taizhou Univ Hosp, Dermopath Res Inst, Taizhou, Peoples R China	Chongqing Medical University; Chongqing Medical University; Taizhou University	Lei, YL; Bu, YQ (corresponding author), Chongqing Med Univ, Dept Biochem & Mol Biol, Coll Basic Med Sci, Chongqing 400016, Peoples R China.; Lei, YL; Bu, YQ (corresponding author), Chongqing Med Univ, Canc Res Ctr, Mol Med, Chongqing 400016, Peoples R China.	leiyunlong@126.com; buyqcn@cqmu.edu.cn	Niu, Yulong/GQI-0688-2022	Niu, Yulong/0000-0002-1361-6272; yi tao, wang/0000-0002-1516-4548; Lei, Yunlong/0000-0002-7918-0221	National Natural Science Foundation of China [81672301, 81872014]; Basic Sciences and Advanced Technology Key Project of CQ CSTC [cstc2017jcyjBX0069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Sciences and Advanced Technology Key Project of CQ CSTC	This work was supported in part by grants-in-aid from the National Natural Science Foundation of China (No. 81672301 to YB and no. 81872014 to YL), the Basic Sciences and Advanced Technology Key Project of CQ CSTC (No. cstc2017jcyjBX0069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Prof. David P. Molloy for checking the language of our manuscript.	Bayley R, 2020, BBA-REV CANCER, V1874, DOI 10.1016/j.bbcan.2020.188407; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Calvisi DF, 2011, HEPATOLOGY, V53, P1226, DOI 10.1002/hep.24174; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Cooper CS, 2006, LUNG CANCER, V54, P155, DOI 10.1016/j.lungcan.2006.07.005; Fan XY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051479; Feng XF, 2017, ONCOTARGET, V8, P63605, DOI 10.18632/oncotarget.18868; Frau M, 2011, J HEPATOL, V55, P111, DOI 10.1016/j.jhep.2010.10.031; Huang CL, 2007, CLIN CANCER RES, V13, P6938, DOI 10.1158/1078-0432.CCR-07-1539; Ji Y, 2013, INT J BIOCHEM CELL B, V45, P645, DOI 10.1016/j.biocel.2012.12.002; Jiang M, 2016, MOL CELL BIOL, V36, P2945, DOI 10.1128/MCB.00370-16; Jin YL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18060860; Joaquin M, 2003, CELL MOL LIFE SCI, V60, P2389, DOI 10.1007/s00018-003-3037-4; Kent LN, 2019, NAT REV CANCER, V19, P326, DOI 10.1038/s41568-019-0143-7; Kheirelseid EAH, 2013, J GASTROINTEST ONCOL, V4, P144, DOI 10.3978/j.issn.2078-6891.2013.010; Mega S, 2005, DIS ESOPHAGUS, V18, P109, DOI 10.1111/j.1442-2050.2005.00463.x; Miller KD, 2019, CA-CANCER J CLIN, V69, P363, DOI 10.3322/caac.21565; Mowla SN, 2014, AGING CELL, V13, P773, DOI 10.1111/acel.12242; Musa J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.244; Nientiedt M, 2021, J CANCER RES CLIN, V147, P129, DOI 10.1007/s00432-020-03392-7; NOMURA N, 1988, NUCLEIC ACIDS RES, V16, P11075, DOI 10.1093/nar/16.23.11075; O'Connell MJ, 2010, J CLIN ONCOL, V28, P3937, DOI 10.1200/JCO.2010.28.9538; Papetti M, 2011, AM J PHYSIOL-GASTR L, V301, pG508, DOI 10.1152/ajpgi.00066.2011; Reimer D, 2006, ANN NY ACAD SCI, V1091, P270, DOI 10.1196/annals.1378.073; Ren F, 2015, AM J CANCER RES, V5, P1542; SALA A, 1992, P NATL ACAD SCI USA, V89, P10415, DOI 10.1073/pnas.89.21.10415; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Scheijen B, 2004, J BIOL CHEM, V279, P10476, DOI 10.1074/jbc.M313682200; Sharma N, 2006, J BIOL CHEM, V281, P36124, DOI 10.1074/jbc.M604152200; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Thorner AR, 2009, ONCOGENE, V28, P742, DOI 10.1038/onc.2008.430; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; Toscani A, 1997, NATURE, V386, P713, DOI 10.1038/386713a0; Wang YT, 2015, BBA-GENE REGUL MECH, V1849, P1133, DOI 10.1016/j.bbagrm.2015.07.002; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Xanthoulis A, 2014, APPL IMMUNOHISTO M M, V22, P471, DOI 10.1097/PAI.0b013e3182598198; Xanthoulis A, 2013, WORLD J GASTROENTERO, V19, P3189, DOI 10.3748/wjg.v19.i21.3189; Zhou J, 2019, THERANOSTICS, V9, P5577, DOI 10.7150/thno.34663	39	5	5	2	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 16	2021	40	37					5613	5625		10.1038/s41388-021-01961-9	http://dx.doi.org/10.1038/s41388-021-01961-9		JUL 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UR2PS	34316028	hybrid, Green Published			2022-12-26	WOS:000677949900001
J	Seto-Tetsuo, F; Arioka, M; Miura, K; Inoue, T; Igawa, K; Tomooka, K; Takahashi-Yanaga, F; Sasaguri, T				Seto-Tetsuo, Fumi; Arioka, Masaki; Miura, Koichi; Inoue, Takeru; Igawa, Kazunobu; Tomooka, Katsuhiko; Takahashi-Yanaga, Fumi; Sasaguri, Toshiyuki			DIF-1 inhibits growth and metastasis of triple-negative breast cancer through AMPK-mediated inhibition of the mTORC1-S6K signaling pathway	ONCOGENE			English	Article							DIFFERENTIATION-INDUCING FACTOR; FACTOR-I; MESENCHYMAL TRANSITION; CYCLIN D1; PHOSPHORYLATION SITES; MTOR; EXPRESSION; MUTATIONS; SNAIL; P53	We have previously reported that the differentiation-inducing factor-1 (DIF-1), a compound identified in Dictyostelium discoideum, suppresses the growth of MCF-7 breast cancer cells by inactivating p70 ribosomal protein S6 kinase (p70(S6K)). Therefore, we first examined whether the same mechanism operates in other breast cancer cells, especially triple-negative breast cancer (TNBC), the most aggressive and refractory phenotype of breast cancer. We also investigated the mechanism by which DIF-1 suppresses p70(S6K) by focusing on the AMPK-mTORC1 system. We found that DIF-1 induces phosphorylation of AMPK and Raptor and dephosphorylation of p70(S6K) in multiple TNBC cell lines. Next, we examined whether AMPK-mediated inhibition of p70(S6K) leads to the suppression of proliferation and migration/infiltration of TNBC cells. DIF-1 significantly reduced the expression levels of cyclin D1 by suppressing the translation of STAT3 and strongly suppressed the expression levels of Snail, which led to the suppression of growth and motility, respectively. Finally, we investigated whether DIF-1 exerts anticancer effects on TNBC in vivo. Intragastric administration of DIF-1 suppressed tumor growth and spontaneous lung metastasis of 4T1-Luc cells injected into the mammary fat pad of BALB/c mice. DIF-1 is expected to lead to the development of anticancer drugs, including anti-TNBC, by a novel mechanism.	[Seto-Tetsuo, Fumi; Arioka, Masaki; Miura, Koichi; Inoue, Takeru; Sasaguri, Toshiyuki] Kyushu Univ, Fac Med Sci, Dept Clin Pharmacol, Fukuoka, Japan; [Igawa, Kazunobu; Tomooka, Katsuhiko] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Japan; [Takahashi-Yanaga, Fumi] Univ Occupat & Environm Hlth, Sch Med, Dept Pharmacol, Kitakyushu, Fukuoka, Japan	Kyushu University; Kyushu University; University of Occupational & Environmental Health - Japan	Arioka, M; Sasaguri, T (corresponding author), Kyushu Univ, Fac Med Sci, Dept Clin Pharmacol, Fukuoka, Japan.	arioka.masaki.118@m.kyushu-u.ac.jp; sasaguri.toshiyuki.922@m.kyushu-u.ac.jp		Tetsuo, Fumi/0000-0002-6443-9827	JSPS KAKENHI [JP17K15581, JP20K07292, JP20K22709]; Fukuoka Foundation for Sound Health Cancer Research Fund; Kaibara Morikazu Medical Science Promotion Foundation; Society for Women's Health Science Research	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fukuoka Foundation for Sound Health Cancer Research Fund; Kaibara Morikazu Medical Science Promotion Foundation(Kaibara Morikazu Medical Science Promotion Foundation); Society for Women's Health Science Research	We appreciate the technical support provided by the Research Support Center at the Graduate School of Medical Sciences of Kyushu University. This study was supported by JSPS KAKENHI Grant Numbers JP17K15581, JP20K07292, JP20K22709, by Fukuoka Foundation for Sound Health Cancer Research Fund to MA, by Kaibara Morikazu Medical Science Promotion Foundation to MA, and by Society for Women's Health Science Research to FTY.	Agarwal S, 2016, MOL CANCER RES, V14, P66, DOI 10.1158/1541-7786.MCR-15-0159; Agarwal S, 2015, J BIOL CHEM, V290, P27473, DOI 10.1074/jbc.M115.665133; Arioka M, 2017, BIOCHEM PHARMACOL, V138, P31, DOI 10.1016/j.bcp.2017.05.004; Ban HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162568; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Blanco MJ, 2002, ONCOGENE, V21, P3241, DOI 10.1038/sj.onc.1205416; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Burgstaller S, 2009, AMINO ACIDS, V36, P297, DOI 10.1007/s00726-008-0066-1; Campbell K, 2016, DEVELOPMENT, V143, P4291, DOI 10.1242/dev.139071; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen L, 2014, BREAST CANCER RES TR, V147, P609, DOI 10.1007/s10549-014-3112-6; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Casas SD, 2019, CUREUS, V11, DOI 10.7759/cureus.4963; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Faria J, 2019, J MAMMARY GLAND BIOL, V24, P111, DOI 10.1007/s10911-019-09429-z; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Figueiredo VC, 2017, CELL MOL LIFE SCI, V74, P2537, DOI 10.1007/s00018-017-2481-5; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Handa N, 2011, ACTA CRYSTALLOGR D, V67, P480, DOI 10.1107/S0907444911010201; He JC, 2019, BREAST CANCER RES TR, V178, P263, DOI 10.1007/s10549-019-05380-z; Hiraga T, 2004, CLIN CANCER RES, V10, P4559, DOI 10.1158/1078-0432.CCR-03-0325; Howlader NR, 2020, BREAST CANCER RES TR, V182, P739, DOI 10.1007/s10549-020-05738-8; Hua H, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0754-1; Hui L, 2006, ONCOGENE, V25, P7305, DOI 10.1038/sj.onc.1209735; Iriki T, 2017, LUNG CANCER, V106, P22, DOI 10.1016/j.lungcan.2017.01.003; Jhaveri K, 2016, CLIN BREAST CANCER, V16, P113, DOI 10.1016/j.clbc.2015.11.006; Jingushi K, 2013, J PHARMACOL SCI, V121, P103, DOI 10.1254/jphs.12204FP; Jingushi K, 2012, BIOCHEM PHARMACOL, V83, P47, DOI 10.1016/j.bcp.2011.10.001; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kubokura N, 2015, J PHARMACOL SCI, V127, P446, DOI 10.1016/j.jphs.2015.03.005; Lee JS, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1202-4; Liu QS, 2013, CANCER RES, V73, P2574, DOI 10.1158/0008-5472.CAN-12-1702; Ma JH, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-0527-z; Matsuda T, 2010, J PHARMACOL SCI, V112, P320, DOI 10.1254/jphs.09348FP; Mori J, 2005, EXP CELL RES, V310, P426, DOI 10.1016/j.yexcr.2005.07.024; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Nakamura K, 2017, J EPIDEMIOL, V27, pS58, DOI 10.1016/j.je.2016.12.009; Parajuli P, 2001, CANCER RES, V61, P8227; Pastushenko I, 2019, TRENDS CELL BIOL, V29, P212, DOI 10.1016/j.tcb.2018.12.001; Peart O, 2017, RADIOL TECHNOL, V88, p519M; Pon YL, 2008, CANCER RES, V68, P6524, DOI 10.1158/0008-5472.CAN-07-6302; Rosner M, 2010, AMINO ACIDS, V38, P223, DOI 10.1007/s00726-008-0230-7; Sabbatinelli J, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01523; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schaffer BE, 2015, CELL METAB, V22, P907, DOI 10.1016/j.cmet.2015.09.009; Shimizu K, 2004, CANCER RES, V64, P2568, DOI 10.1158/0008-5472.CAN-03-3551; Son H, 2010, TOX RESEARCH, V26, P245, DOI 10.5487/TR.2010.26.4.245; Stevens KN, 2013, CANCER RES, V73, P2025, DOI 10.1158/0008-5472.CAN-12-1699; Sugden C, 2015, MOL BIOL CELL, V26, P805, DOI 10.1091/mbc.E14-08-1319; Takahashi-Yanaga F, 2006, J BIOL CHEM, V281, P38489, DOI 10.1074/jbc.M605205200; Takahashi-Yanaga F, 2014, BIOCHEM PHARMACOL, V89, P340, DOI 10.1016/j.bcp.2014.03.006; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Tetsuo F, 2019, CANCER SCI, V110, P3761, DOI 10.1111/cas.14204; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Yao H, 2017, ONCOTARGET, V8, P1913, DOI 10.18632/oncotarget.12284; Yin L, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-01296-5; Yunokawa M, 2012, CANCER SCI, V103, P1665, DOI 10.1111/j.1349-7006.2012.02359.x; Zhang A, 2013, ONCOL LETT, V6, P339, DOI 10.3892/ol.2013.1385	63	4	4	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 16	2021	40	37					5579	5589		10.1038/s41388-021-01958-4	http://dx.doi.org/10.1038/s41388-021-01958-4		JUL 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UR2PS	34304250				2022-12-26	WOS:000677232000001
J	Lin, J; Lee, SL; Russell, AM; Huang, RF; Batt, MA; Chang, SS; Ferrante, A; Verdino, P				Lin, Joanne; Lee, Stacey L.; Russell, Anna M.; Huang, Rong Fong; Batt, Micheal A.; Chang, Shawn S.; Ferrante, Andrea; Verdino, Petra			A structure-based engineering approach to abrogate pre-existing antibody binding to biotherapeutics	PLOS ONE			English	Article							IMPACT; AUTOANTIBODIES; ANTAGONIST; EXPRESSION; RESIDUES; PRODUCT	Development of biotherapeutics is hampered by the inherent risk of immunogenicity, which requires extensive clinical assessment and possible re-engineering efforts for mitigation. The focus in the pre-clinical phase is to determine the likelihood of developing treatment-emergent anti-drug antibodies (TE-ADA) and presence of pre-existing ADA in drug-naive individuals as risk-profiling strategies. Pre-existing ADAs are routinely identified during clinical immunogenicity assessment, but their origin and impact on drug safety and efficacy have not been fully elucidated. One specific class of pre-existing ADAs has been described, which targets neoepitopes of antibody fragments, including Fabs, VH, or VHH domains in isolation from their IgG context. With the increasing number of antibody fragments and other small binding scaffolds entering the clinic, a widely applicable method to mitigate pre-existing reactivity against these molecules is desirable. Here is described a structure-based engineering approach to abrogate pre-existing ADA reactivity to the C-terminal neoepitope of VH(H)s. On the basis of 3D structures, small modifications applicable to any VH(H) are devised that would not impact developability or antigen binding. In-silico B cell epitope mapping algorithms were used to rank the modified VHH variants by antigenicity; however, the limited discriminating capacity of the computational methods prompted an experimental evaluation of the engineered molecules. The results identified numerous modifications capable of reducing pre-existing ADA binding. The most efficient consisted of the addition of two proline residues at the VHH C-terminus, which led to no detectable pre-existing ADA reactivity while maintaining favorable developability characteristics. The method described, and the modifications identified thereby, may provide a broadly applicable solution to mitigate immunogenicity risk of antibody-fragments in the clinic and increase safety and efficacy of this promising new class of biotherapeutics.	[Lin, Joanne; Lee, Stacey L.; Russell, Anna M.; Huang, Rong Fong; Batt, Micheal A.; Chang, Shawn S.; Ferrante, Andrea; Verdino, Petra] Eli Lilly & Co, Lilly Biotechnol Ctr, San Diego, CA 92121 USA	Eli Lilly	Verdino, P (corresponding author), Eli Lilly & Co, Lilly Biotechnol Ctr, San Diego, CA 92121 USA.	verdino_petra@lilly.com			Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	At the time of this manuscript preparation, all authors were employees of Eli Lilly and Company. Eli Lilly and Company, as funding organization, provided support in the form of salaries for authors (JL, SLL, AMR, FH, MB, SSC, AF, PV), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2006, W TREK OCLC W MAGAZI, V2, P2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brezski RJ, 2011, THESCIENTIFICWORLDJO, V11, P1153, DOI 10.1100/tsw.2011.107; Brezski RJ, 2009, P NATL ACAD SCI USA, V106, P17864, DOI 10.1073/pnas.0904174106; Cordy JC, 2015, CLIN EXP IMMUNOL, V182, P139, DOI 10.1111/cei.12680; Duggan S, 2018, DRUGS, V78, P1639, DOI 10.1007/s40265-018-0989-0; Falkenburg WJJ, 2017, J IMMUNOL, V198, P82, DOI 10.4049/jimmunol.1601096; Gorovits B, 2016, AAPS J, V18, P311, DOI 10.1208/s12248-016-9878-1; Holland MC, 2013, J CLIN IMMUNOL, V33, P1192, DOI 10.1007/s10875-013-9915-0; Huang T, 2018, J BIOL CHEM, V293, P906, DOI 10.1074/jbc.RA117.000165; Jawa V, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01301; Jovcevska I, 2020, BIODRUGS, V34, P11, DOI 10.1007/s40259-019-00392-z; KABAT EA, 1971, ANN NY ACAD SCI, V190, P382, DOI 10.1111/j.1749-6632.1971.tb13550.x; Kaplon H, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2019.1703531; Kim HS, 2016, MABS-AUSTIN, V8, P1536, DOI 10.1080/19420862.2016.1219006; LESK AM, 1988, NATURE, V335, P188, DOI 10.1038/335188a0; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Raddrizzani L, 1999, EUR J IMMUNOL, V29, P660, DOI 10.1002/(SICI)1521-4141(199902)29:02<660::AID-IMMU660>3.0.CO;2-I; Rajendra Y, 2015, BIOTECHNOL LETT, V37, P2379, DOI 10.1007/s10529-015-1938-6; Rajendra Y, 2015, BIOTECHNOL BIOENG, V112, P977, DOI 10.1002/bit.25514; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Tian C, 2020, J CHEM THEORY COMPUT, V16, P528, DOI 10.1021/acs.jctc.9b00591; van Schie KA, 2015, MABS-AUSTIN, V7, P662, DOI 10.1080/19420862.2015.1048411; Verdino P, 2018, CURR OPIN CHEM ENG, V19, P107, DOI 10.1016/j.coche.2018.01.004; Wen Y, 2021, J PHARM SCI-US, V110, P1025, DOI 10.1016/j.xphs.2020.12.003; Xue L, 2013, AAPS J, V15, P852, DOI 10.1208/s12248-013-9492-4	26	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254944	10.1371/journal.pone.0254944	http://dx.doi.org/10.1371/journal.pone.0254944			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297759	Green Published, gold			2022-12-26	WOS:000678128300042
J	Wei, CR; Zhao, WQ; Fan, RQ; Meng, YY; Yang, YM; Wang, XD; Foroud, NA; Liu, DQ; Yu, XM				Wei, Chunru; Zhao, Weiquan; Fan, Runqiao; Meng, Yuyu; Yang, Yiming; Wang, Xiaodong; Foroud, Nora A.; Liu, Daqun; Yu, Xiumei			Genome-wide survey of the F-box/Kelch (FBK) members and molecular identification of a novel FBK gene TaAFR in wheat	PLOS ONE			English	Article							BOX PROTEINS; KELCH; EVOLUTION; FAMILY; EXPRESSION; INDUCTION; TOLERANCE; ENCODES; RICE	F-box proteins play critical roles in plant responses to biotic/abiotic stresses. In the present study, a total of 68 wheat F-box/Kelch (TaFBK) genes, unevenly distributed across 21 chromosomes and encoding 74 proteins, were identified in EnsemblPlants. Protein sequences were compared with those of Arabidopsis and three cereal species by phylogenetic and domain analyses, where the wheat sequences were resolved into 6 clades. In silico analysis of a digital PCR dataset revealed that TaFBKs were expressed at multiple developmental stages and tissues, and in response to drought and/or heat stresses. The TaFBK19 gene, a homolog of the Attenuated Far-Red Response (AFR) genes in other plant species, and hence named TaAFR, was selected for further analysis. Reverse-transcription quantitative real-time PCR (RT-qPCR) was carried out to determine tissue-specific, hormone and stress (abiotic/biotic) responsive expression patterns. Of interest, TaAFR was expressed most abundantly in the leaves, and its expression in response to leaf rust variants suggests a potential role in compatible vs incompatible rust responses. The protein was predicted to localize in cytosol, but it was shown experimentally to localize in both the cytosol and the nucleus of tobacco. A series of protein interaction studies, starting with a yeast-2-hybrid (Y2H) library screen (wheat leaf infected with incompatible leaf rust pathogens), led to the identification of three TaAFR interacting proteins. Skp1/ASK1-like protein (Skp1) was found to interact with the F-box domain of TaAFR, while ADP-ribosylation factor 2-like isoform X1 (ARL2) and phenylalanine ammonia-lyase (PAL) were shown to interact with its Kelch domain. The data presented herein provides a solid foundation from which the function and metabolic network of TaAFR and other wheat FBKs can be further explored.	[Wei, Chunru; Fan, Runqiao; Meng, Yuyu; Yang, Yiming; Yu, Xiumei] Hebei Agr Univ, Coll Life Sci, Key Lab Hebei Prov Plant Physiol & Mol Pathol, Baoding, Hebei, Peoples R China; [Zhao, Weiquan; Wang, Xiaodong; Liu, Daqun; Yu, Xiumei] Hebei Agr Univ, Technol Innovat Ctr Biol Control Crop Dis & Insec, Baoding, Hebei, Peoples R China; [Foroud, Nora A.] Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada	Hebei Agricultural University; Hebei Agricultural University; Agriculture & Agri Food Canada	Yu, XM (corresponding author), Hebei Agr Univ, Coll Life Sci, Key Lab Hebei Prov Plant Physiol & Mol Pathol, Baoding, Hebei, Peoples R China.; Yu, XM (corresponding author), Hebei Agr Univ, Technol Innovat Ctr Biol Control Crop Dis & Insec, Baoding, Hebei, Peoples R China.	yuxiumei@hebau.edu.cn	; Wang, Xiaodong/GVS-5446-2022	Yu, Xiumei/0000-0002-8011-4926; Foroud, Nora A/0000-0001-8677-4784; Wang, Xiaodong/0000-0002-4304-5482	Postgraduate Innovation Funding Project of Hebei Province [CXZZBS2021046]; Natural Science Foundation of Hebei Province [C2020204050, C2021204008]; Scientific and Technological Research Projects of Higher Education of Hebei Province [ZD2019086]; Provincial Supporting Program of Hebei for the Returned Oversea Scholars [C20190180]	Postgraduate Innovation Funding Project of Hebei Province; Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Scientific and Technological Research Projects of Higher Education of Hebei Province; Provincial Supporting Program of Hebei for the Returned Oversea Scholars	CW was supported by the Postgraduate Innovation Funding Project of Hebei Province (CXZZBS2021046). XY received supports from the Natural Science Foundation of Hebei Province (C2020204050) and Scientific and Technological Research Projects of Higher Education of Hebei Province (ZD2019086). XW was supported by Natural Science Foundation of Hebei Province (C2021204008) and Provincial Supporting Program of Hebei for the Returned Oversea Scholars (C20190180). All of the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Au WC, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008597; BEFFA RS, 1993, P NATL ACAD SCI USA, V90, P8792, DOI 10.1073/pnas.90.19.8792; Bianchet C, 2019, J PLANT PHYSIOL, V232, P12, DOI 10.1016/j.jplph.2018.10.025; Binjubair FA, 2020, CHEMMEDCHEM, V15, P1294, DOI 10.1002/cmdc.202000250; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cao Y., 2016, J SHANXI AGR SCI, V44, P723; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Curtis RHC, 2013, MOL PLANT MICROBE IN, V26, P36, DOI 10.1094/MPMI-05-12-0135-FI; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; El Beji IH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133295; Guan C, 2020, PLANT CELL REP, V39, P1623, DOI 10.1007/s00299-020-02589-x; Hong MJ, 2020, MOL BIOL REP, V47, P1129, DOI 10.1007/s11033-019-05210-x; Hong MJ, 2012, MOL BIOL REP, V39, P9681, DOI 10.1007/s11033-012-1833-3; Hong SH, 2017, PROTOPLASMA, V254, P327, DOI 10.1007/s00709-016-0948-0; Hou XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112375; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jia FJ, 2013, MOL GENET GENOMICS, V288, P559, DOI 10.1007/s00438-013-0769-1; Jia YY, 2012, MOL BIOL REP, V39, P2337, DOI 10.1007/s11033-011-0984-y; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kim YY, 2017, PLANT CELL PHYSIOL, V58, P574, DOI 10.1093/pcp/pcx003; Koralewski TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018055; [李风童 Li Fengtong], 2012, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V32, P130; Li HY, 2020, PLANT PHYSIOL BIOCH, V155, P535, DOI 10.1016/j.plaphy.2020.06.040; Li YQ, 2021, PEERJ, V9, DOI 10.7717/peerj.10963; Lim J, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01365; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu ZS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0511-8; Ma Nan, 2019, Sheng Wu Gong Cheng Xue Bao, V35, P1686, DOI 10.13345/j.cjb.190055; McElver J, 2000, PLANT CELL, V12, P1379, DOI 10.1105/tpc.12.8.1379; Nguyen KM, 2020, ADV EXP MED BIOL, V1217, P111, DOI 10.1007/978-981-15-1025-0_8; Paquis S, 2011, MOL BIOL REP, V38, P3327, DOI 10.1007/s11033-010-0438-y; Schiavon CR, 2019, MOL BIOL CELL, V30, P1198, DOI 10.1091/mbc.E18-12-0804; Schumann N, 2011, PLANT PHYSIOL, V155, P835, DOI 10.1104/pp.110.166579; Shao T, 2012, THEOR APPL GENET, V125, P381, DOI 10.1007/s00122-012-1840-8; Takahara M, 2013, PLANT CELL PHYSIOL, V54, P433, DOI 10.1093/pcp/pct022; Thiel H, 2012, MOL PLANT MICROBE IN, V25, P1058, DOI 10.1094/MPMI-03-12-0057-R; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; ul Hassan MN, 2015, RSC ADV, V5, P42808, DOI 10.1039/c5ra01875g; Ullah F, 2021, J INTEGR PLANT BIOL, V63, P451, DOI 10.1111/jipb.13042; Wang Q, 2019, GENES-BASEL, V10, DOI 10.3390/genes10090701; Watzlich D, 2013, EMBO REP, V14, P465, DOI 10.1038/embor.2013.37; Wei CR, 2020, PHYSIOL MOL PLANT P, V112, DOI 10.1016/j.pmpp.2020.101564; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Yu XM, 2013, PLANT MOL BIOL REP, V31, P314, DOI 10.1007/s11105-012-0504-9; Zhang XB, 2015, PLANT PHYSIOL, V167, P337, DOI 10.1104/pp.114.249136; Zhang XB, 2013, PLANT CELL, V25, P4994, DOI 10.1105/tpc.113.119644; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929; Zhu L, 2019, METHODS MOL BIOL, V2026, P29, DOI 10.1007/978-1-4939-9612-4_3	52	2	2	10	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2021	16	7							e0250479	10.1371/journal.pone.0250479	http://dx.doi.org/10.1371/journal.pone.0250479			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2OO	34293801	Green Submitted, Green Published, gold			2022-12-26	WOS:000678124900032
J	Pommerenke, C; Rand, U; Uphoff, CC; Nagel, S; Zaborski, M; Hauer, V; Kaufmann, M; Meyer, C; Denkmann, SA; Riese, P; Eschke, K; Kim, Y; Safranko, ZM; Kurolt, IC; Markotic, A; Cicin-Sain, L; Steenpass, L				Pommerenke, Claudia; Rand, Ulfert; Uphoff, Cord C.; Nagel, Stefan; Zaborski, Margarete; Hauer, Vivien; Kaufmann, Maren; Meyer, Corinna; Denkmann, Sabine A.; Riese, Peggy; Eschke, Kathrin; Kim, Yeonsu; Safranko, Zeljka Macak; Kurolt, Ivan-Christian; Markotic, Alemka; Cicin-Sain, Luka; Steenpass, Laura			Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies	PLOS ONE			English	Article							CORONAVIRUS; ACE2; VARIANTS; LEUKEMIA; RECEPTOR; ENTRY	The SARS-CoV-2 pandemic is a major global threat that sparked global research efforts. Pre-clinical and biochemical SARS-CoV-2 studies firstly rely on cell culture experiments where the importance of choosing an appropriate cell culture model is often underestimated. We here present a bottom-up approach to identify suitable permissive cancer cell lines for drug screening and virus research. Human cancer cell lines were screened for the SARS-CoV-2 cellular entry factors ACE2 and TMPRSS2 based on RNA-seq data of the Cancer Cell Line Encyclopedia (CCLE). However, experimentally testing permissiveness towards SARS-CoV-2 infection, we found limited correlation between receptor expression and permissiveness. This underlines that permissiveness of cells towards viral infection is determined not only by the presence of entry receptors but is defined by the availability of cellular resources, intrinsic immunity, and apoptosis. Aside from established cell culture infection models CACO-2 and CALU-3, three highly permissive human cell lines, colon cancer cell lines CL-14 and CL-40 and the breast cancer cell line CAL-51 and several low permissive cell lines were identified. Cell lines were characterised in more detail offering a broader choice of non-overexpression in vitro infection models to the scientific community. For some cell lines a truncated ACE2 mRNA and missense variants in TMPRSS2 might hint at disturbed host susceptibility towards viral entry.	[Pommerenke, Claudia] German Collect Microorganisms & Cell Cultures, Leibniz Inst DSMZ, Dept Bioinformat & Databases, Braunschweig, Germany; [Rand, Ulfert; Riese, Peggy; Eschke, Kathrin; Kim, Yeonsu; Cicin-Sain, Luka] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Uphoff, Cord C.; Nagel, Stefan; Zaborski, Margarete; Hauer, Vivien; Kaufmann, Maren; Meyer, Corinna; Denkmann, Sabine A.; Steenpass, Laura] German Collect Microorganisms & Cell Cultures, Leibniz Inst DSMZ, Dept Human & Anim Cell Lines, Braunschweig, Germany; [Safranko, Zeljka Macak; Kurolt, Ivan-Christian; Markotic, Alemka] Dr Fran Mihaljev Univ, Hosp Infect Dis, Zagreb, Croatia; [Cicin-Sain, Luka] Helmholtz Ctr Infect Res, Ctr Individualized Infect Med, Hannover, Germany; [Cicin-Sain, Luka] Med Sch Hannover, Hannover, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Helmholtz Association; Helmholtz-Center for Infection Research; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School	Pommerenke, C (corresponding author), German Collect Microorganisms & Cell Cultures, Leibniz Inst DSMZ, Dept Bioinformat & Databases, Braunschweig, Germany.	claudia.pommerenke@dsmz.de			Helmholtz Gemeinschaft (EU) [PIE-0008]; German Ministry of Science and Education (BMBF) [01KI20140A]	Helmholtz Gemeinschaft (EU); German Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Helmholtz Gemeinschaft (EU partnership grant PIE-0008) and the German Ministry of Science and Education (BMBF grant 01KI20140A) to Luka Cicin-Sain.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Bertoglio F., SARS COV 2 NEUTRALIZ; Bojkova D., SARS COV 2 SARS COV, DOI [10.1101/2020.04.03.024257v1, DOI 10.1101/2020.04.03.024257V1]; Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Cao YH, 2020, J MED VIROL, V92, P1449, DOI 10.1002/jmv.25822; Chaudhry MZ., SARS COV 2 QUASISPEC, DOI [10.1101/2020.08.10.241414v1, DOI 10.1101/2020.08.10.241414V1]; Cheung KS, 2020, GASTROENTEROLOGY, V159, P81, DOI 10.1053/j.gastro.2020.03.065; Cohen JI, 2021, CLIN INFECT DIS, V73, pE4223, DOI 10.1093/cid/ciaa1866; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Daly JL, 2020, SCIENCE, V370, P861, DOI 10.1126/science.abd3072; Dirks Wilhelm G, 2013, Methods Mol Biol, V946, P27, DOI 10.1007/978-1-62703-128-8_3; Fears AC, 2020, EMERG INFECT DIS, V26, P2168, DOI 10.3201/eid2609.201806; Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301; Gordon CJ, 2020, J BIOL CHEM, V295, P6785, DOI 10.1074/jbc.RA120.013679; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, NATURE, V585, P588, DOI 10.1038/s41586-020-2575-3; Hou Y, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01673-z; Howley P. M., 2020, FIELDS VIROLOGY EMER; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Kanieff M, 2010, EUROSURVEILLANCE, V15, P14; Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669; Lavezzo E, 2020, NATURE, V584, P425, DOI 10.1038/s41586-020-2488-1; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lukassen S, 2020, EMBO J, V39, DOI 10.15252/embj.20105114; MacLeod RAF, 2008, CURR MED CHEM, V15, P339, DOI 10.2174/092986708783497319; McCallum M, 2021, CELL, V184, P2332, DOI [10.1101/2021.01.14.426475, 10.1016/j.cell.2021.03.028]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mulligan MJ, 2020, NATURE, V586, P589, DOI 10.1038/s41586-020-2639-4; Ng KW, 2020, NAT GENET, V52, P1294, DOI 10.1038/s41588-020-00732-8; Nikolai LA, 2020, INT J INFECT DIS, V100, P112, DOI 10.1016/j.ijid.2020.08.076; Ogando NS, 2020, J GEN VIROL, V101, P925, DOI 10.1099/jgv.0.001453; Onabajo OO, 2020, NAT GENET, V52, P1283, DOI 10.1038/s41588-020-00731-9; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]; Qi FR, 2020, BIOCHEM BIOPH RES CO, V526, P135, DOI 10.1016/j.bbrc.2020.03.044; Quentmeier H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44491-x; Quentmeier H, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-3; Rehman SU, 2020, CLIN SCI, V134, P1143, DOI 10.1042/CS20200419; Robinson JT, 2017, CANCER RES, V77, pE31, DOI 10.1158/0008-5472.CAN-17-0337; Sasaki M, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009233; Sheahan TP, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb5883; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Singh M, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108175; Smith JC, 2020, DEV CELL, V53, P514, DOI 10.1016/j.devcel.2020.05.012; Standl F, 2021, LANCET INFECT DIS, V21, pE77, DOI [10.1016/S1473-3099(20)30648-4, 10.1016/S1473-3099(20)30484-9]; Sungnak W, 2020, NAT MED, V26, P681, DOI 10.1038/s41591-020-0868-6; Tang S, 2020, ENVIRON INT, V144, DOI 10.1016/j.envint.2020.106039; Tu YF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072657; Uphoff CC, 2002, IN VITRO CELL DEV-AN, V38, P79; Uphoff CC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210404; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang K, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00426-x; Wang P, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03252-9; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wei J, 2021, CELL, V184, P76, DOI 10.1016/j.cell.2020.10.028; Zhou GY, 2020, INT J BIOL SCI, V16, P1718, DOI 10.7150/ijbs.45123; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737; Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0	66	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255622	10.1371/journal.pone.0255622	http://dx.doi.org/10.1371/journal.pone.0255622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339474	gold, Green Published			2022-12-26	WOS:000680243400052
J	Schaub, C; Lee, P; Racho-Jansen, A; Giovinazzo, J; Terra, N; Raper, J; Thomson, R				Schaub, Charles; Lee, Penny; Racho-Jansen, Alisha; Giovinazzo, Joseph; Terra, Nada; Raper, Jayne; Thomson, Russell			Coiled-coil binding of the leucine zipper domains of APOL1 is necessary for the open cation channel conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOME LYTIC FACTOR; HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-L; KIDNEY-DISEASE; INNATE IMMUNITY; RISK VARIANTS; PROTEIN; BRUCEI; MEMBRANE; SERUM	Apolipoprotein L-I (APOL1) is a channel-forming effector of innate immunity. The common human APOL1 variant G0 provides protection against infection with certain Trypano-soma and Leishmania parasite species, but it cannot protect against the trypanosomes responsible for human African trypanosomiasis. Human APOL1 variants G1 and G2 protect against human-infective trypanosomes but also confer a higher risk of developing chronic kidney disease. Trypanosome-killing activity is dependent on the ability of APOL1 to insert into membranes at acidic pH and form pH-gated cation channels. We previously mapped the channel's pore-lining region to the C-terminal domain (residues 332-398) and identified a membrane-insertion domain (MID, residues 177-228) that facilitates acidic pH-dependent membrane insertion. In this article, we further investigate structural determinants of cation channel formation by APOL1. Using a combination of site-directed mutagenesis and targeted chemical modification, our data indicate that the C-terminal heptad-repeat sequence (residues 368-395) is a bona fide leucine zipper domain (ZIP) that is required for cation channel formation as well as lysis of trypanosomes and mammalian cells. Using protein-wide cysteine-scanning mutagenesis, coupled with the substituted cysteine accessibility method, we determined that, in the open channel state, both the N-terminal domain and the C-terminal ZIP domain are exposed on the intralumenal/extracellular side of the membrane and provide evidence that each APOL1 monomer contributes four transmembrane domains to the open cation channel conformation. Based on these data, we propose an oligomeric topology model in which the open APOL1 cation channel is assembled from the coiled-coil as-sociation of C-terminal ZIP domains.	[Schaub, Charles; Lee, Penny; Racho-Jansen, Alisha; Giovinazzo, Joseph; Terra, Nada; Raper, Jayne; Thomson, Russell] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Schaub, Charles; Raper, Jayne] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10021 USA; [Schaub, Charles] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Lee, Penny] CUNY, John Jay Coll, New York, NY 10021 USA; [Giovinazzo, Joseph] Univ Colorado, Sch Med, Aurora, CO USA; [Terra, Nada] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Vanderbilt University; City University of New York (CUNY) System; University of Colorado System; University of Colorado Anschutz Medical Campus; Icahn School of Medicine at Mount Sinai	Raper, J; Thomson, R (corresponding author), CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA.; Raper, J (corresponding author), CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10021 USA.	raper@genectr.hunter.cuny.edu; rthomson@genectr.hunter.cuny.edu		Terra, Nada/0000-0003-2181-695X; Schaub, Charles/0000-0002-3251-3455; Raper, Jayne/0000-0002-8723-9748	NSF [IOS-1249166]	NSF(National Science Foundation (NSF))	J. R. received fund NSF IOS-1249166.	Akabas MH, 2015, ADV EXP MED BIOL, V869, P25, DOI 10.1007/978-1-4939-2845-3_3; Beckerman P, 2017, NAT MED, V23, P429, DOI 10.1038/nm.4287; Bruno J, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.013943; Chun J, 2019, P NATL ACAD SCI USA, V116, P3712, DOI 10.1073/pnas.1820414116; Cooper A, 2017, ELIFE, V6, DOI [10.7554/eLife.25461, 10.7554/elife.25461]; Currier RB, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006855; Datta S, 2020, J AM SOC NEPHROL, V31, P2083, DOI 10.1681/ASN.2020010079; DeJesus E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003317; Duchateau PN, 2001, J LIPID RES, V42, P620; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; Dummer PD, 2015, SEMIN NEPHROL, V35, P222, DOI 10.1016/j.semnephrol.2015.04.008; Friedman DJ, 2021, J AM SOC NEPHROL, V32, P1, DOI 10.1681/ASN.2020111629; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Giovinazzo JA, 2020, ELIFE, V9, DOI 10.7554/eLife.51185; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Gupta N, 2020, J AM SOC NEPHROL, V31, P2065, DOI 10.1681/ASN.2019080830; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; HU JC, 1993, PROTEIN SCI, V2, P1072, DOI 10.1002/pro.5560020701; Jha A, 2020, FEBS J, V287, P2000, DOI 10.1111/febs.15133; Johnstone DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051546; Lan XQ, 2014, AM J PHYSIOL-RENAL, V307, pF326, DOI 10.1152/ajprenal.00647.2013; Lannon H, 2019, KIDNEY INT, V96, P1303, DOI 10.1016/j.kint.2019.07.010; Lecordier L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000685; Madhavan SM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92581; Molina-Portela MP, 2008, J EXP MED, V205, P1721, DOI 10.1084/jem.20071463; Molina-Portela MD, 2005, MOL BIOCHEM PARASIT, V144, P218, DOI 10.1016/j.molbiopara.2005.08.018; Mony L, 2020, P NATL ACAD SCI USA, V117, P20898, DOI 10.1073/pnas.2010032117; Musset B, 2011, NATURE, V480, P273, DOI 10.1038/nature10557; Nichols B, 2015, KIDNEY INT, V87, P332, DOI 10.1038/ki.2014.270; O'Toole JF, 2018, J AM SOC NEPHROL, V29, P869, DOI 10.1681/ASN.2016121322; Olabisi OA, 2016, P NATL ACAD SCI USA, V113, P830, DOI 10.1073/pnas.1522913113; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Oshaben KM, 2012, BIOCHEMISTRY-US, V51, P9581, DOI 10.1021/bi301132k; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Raper J, 1999, INFECT IMMUN, V67, P1910; RIFKIN MR, 1984, EXP PARASITOL, V58, P81, DOI 10.1016/0014-4894(84)90023-7; Samanovic M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000276; Scales SJ, 2020, J AM SOC NEPHROL, V31, P2044, DOI 10.1681/ASN.2019080829; Schaub C, 2020, J BIOL CHEM, V295, P13138, DOI 10.1074/jbc.RA120.014201; Shah SS, 2019, J AM SOC NEPHROL, V30, P2355, DOI 10.1681/ASN.2019020114; Sharma AK, 2016, FEBS J, V283, P1846, DOI 10.1111/febs.13706; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; Smith EE, 2009, GENOME RES, V19, P850, DOI 10.1101/gr.085647.108; Spencer RK, 2017, BIOCHEMISTRY-US, V56, P5300, DOI 10.1021/acs.biochem.7b00756; Stephens NA, 2011, EUKARYOT CELL, V10, P1023, DOI 10.1128/EC.05112-11; Thomson R, 2015, P NATL ACAD SCI USA, V112, P2894, DOI 10.1073/pnas.1421953112; Thomson R, 2014, P NATL ACAD SCI USA, V111, pE2130, DOI 10.1073/pnas.1400699111; Thomson R, 2009, P NATL ACAD SCI USA, V106, P19509, DOI 10.1073/pnas.0905669106; Ultsch M, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02387-5; Uzureau P, 2013, NATURE, V501, P430, DOI 10.1038/nature12516; Uzureau S, 2020, CELL REP, V30, P3821, DOI 10.1016/j.celrep.2020.02.064; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Vanhollebeke B, 2006, NEW ENGL J MED, V355, P2752, DOI 10.1056/NEJMoa063265; Vanwalleghem G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9078; Verdi J, 2020, CELL HOST MICROBE, V28, P79, DOI 10.1016/j.chom.2020.04.012; Verdi J, 2020, METHODS MOL BIOL, V2116, P463, DOI 10.1007/978-1-0716-0294-2_28	59	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101009	10.1016/j.jbc.2021.101009	http://dx.doi.org/10.1016/j.jbc.2021.101009			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34331942	gold, Green Published			2022-12-26	WOS:000706418900013
J	Suresh, P; Miller, WT; London, E				Suresh, Pavana; Miller, W. Todd; London, Erwin			Phospholipid exchange shows insulin receptor activity is supported by both the propensity to form wide bilayers and ordered raft domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; DETERGENT-RESISTANT MEMBRANES; THERMOTROPIC PHASE-BEHAVIOR; LIPID RAFTS; MODEL MEMBRANES; COORDINATED ACTION; CHOLESTEROL; CAVEOLAE; CELLS; PHOSPHATIDYLCHOLINES	Insulin receptor (IR) is a membrane tyrosine kinase that mediates the response of cells to insulin. IR activity has been shown to be modulated by changes in plasma membrane lipid composition, but the properties and structural determinants of lipids mediating IR activity are poorly understood. Here, using efficient methyl-alpha-cyclodextrin mediated lipid exchange, we studied the effect of altering plasma membrane outer leaflet phospholipid composition upon the activity of IR in mammalian cells. After substitution of endogenous lipids with lipids having an ability to form liquid ordered (Lo) domains (sphingomyelins) or liquid disordered (Ld) domains (unsaturated phosphatidylcholines (PCs)), we found that the propensity of lipids to form ordered domains is required for high IR activity. Additional substitution experiments using a series of saturated PCs showed that IR activity increased substantially with increasing acyl chain length, which increases both bilayer width and the propensity to form ordered domains. Incorporating purified IR into alkyl maltoside micelles with increasing hydrocarbon lengths also increased IR activity, but more modestly than by increasing lipid acyl chain length in cells. These results suggest that the ability to form Lo domains as well as wide bilayer width contributes to increased IR activity. Inhibition of phosphatases showed that some of the lipid dependence of IR activity upon lipid structure reflected protection from phosphatases by lipids that support Lo domain formation. These results are consistent with a model in which a combination of bilayer width and ordered domain formation modulates IR activity via IR conformation and accessibility to phosphatases.	[Suresh, Pavana; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Miller, W. Todd] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Miller, W. Todd] Dept Vet Affairs Med Ctr, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Erwin.london@stonybrook.edu		Suresh, Pavana/0000-0003-1597-6818	NIH [GM 122493]; Department of Veterans Affairs Merit Review Grant [BX002292]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Grant(US Department of Veterans Affairs)	This work was supported by NIH grant GM 122493 (to E. L.) and Department of Veterans Affairs Merit Review Grant BX002292 (to W. T. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amoui M, 2001, J ENDOCRINOL, V171, P153, DOI 10.1677/joe.0.1710153; Arsov Z, 2018, CHEM PHYS LIPIDS, V213, P102, DOI 10.1016/j.chemphyslip.2018.03.003; Asante-Appiah E, 2003, AM J PHYSIOL-ENDOC M, V284, pE663, DOI 10.1152/ajpendo.00462.2002; BARON CB, 1984, J LIQ CHROMATOGR, V7, P2793, DOI 10.1080/01483918408067046; Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1, DOI 10.1152/ajpendo.2002.282.1.E1; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Caselli A, 2002, BIOCHEM BIOPH RES CO, V296, P692, DOI 10.1016/S0006-291X(02)00928-2; Cheng A, 2002, EUR J BIOCHEM, V269, P1050, DOI 10.1046/j.0014-2956.2002.02756.x; Cheng HT, 2009, J BIOL CHEM, V284, P6079, DOI 10.1074/jbc.M806077200; Delle Bovi RJ, 2019, BBA-BIOMEMBRANES, V1861, P819, DOI 10.1016/j.bbamem.2019.01.009; Delle Bovi RJ, 2017, ANAL BIOCHEM, V536, P69, DOI 10.1016/j.ab.2017.08.011; Diaz-Rohrer BB, 2014, P NATL ACAD SCI USA, V111, P8500, DOI 10.1073/pnas.1404582111; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Heberle FA, 2020, P NATL ACAD SCI USA, V117, P19943, DOI 10.1073/pnas.2002200117; Heberle FA, 2013, J AM CHEM SOC, V135, P6853, DOI 10.1021/ja3113615; Hissa B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082988; Karlsson M, 2004, EUR J BIOCHEM, V271, P2471, DOI 10.1111/j.1432-1033.2004.04177.x; Khatibzadeh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057147; Kim J, 2015, LIPIDS, V50, P721, DOI 10.1007/s11745-015-4007-y; Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9; Krishnakumar SS, 2007, J MOL BIOL, V374, P671, DOI 10.1016/j.jmb.2007.09.037; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levental I, 2020, TRENDS CELL BIOL, V30, P341, DOI 10.1016/j.tcb.2020.01.009; LEWIS RNAH, 1987, BIOCHEMISTRY-US, V26, P6118, DOI 10.1021/bi00393a026; LEWIS RNAH, 1988, BIOCHEMISTRY-US, V27, P880, DOI 10.1021/bi00403a007; Li GT, 2020, J LIPID RES, V61, P758, DOI 10.1194/jlr.RA119000565; Li GT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223572; Li GT, 2016, P NATL ACAD SCI USA, V113, P14025, DOI 10.1073/pnas.1610705113; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lin CY, 2015, BBA-BIOMEMBRANES, V1848, P886, DOI 10.1016/j.bbamem.2014.12.019; Lin QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087903; Lin QQ, 2013, J BIOL CHEM, V288, P1340, DOI 10.1074/jbc.M112.415596; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; MCINTOSH TJ, 1992, BIOCHEMISTRY-US, V31, P2012, DOI 10.1021/bi00122a017; Mihailescu M, 2011, BIOPHYS J, V100, P1455, DOI 10.1016/j.bpj.2011.01.035; Oliver RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062488; Oshikawa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010189; Park JW, 2013, HEPATOLOGY, V57, P525, DOI 10.1002/hep.26015; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Sanchez-Wandelmer J, 2009, BBA-BIOMEMBRANES, V1788, P1731, DOI 10.1016/j.bbamem.2009.05.002; Stone MB, 2017, ELIFE, V6, DOI 10.7554/eLife.19891; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; Symons JL, 2021, SOFT MATTER, V17, P288, DOI 10.1039/d0sm00404a; Tada K, 2009, BBA-BIOMEMBRANES, V1788, P1056, DOI 10.1016/j.bbamem.2009.02.008; Uchikawa E, 2019, ELIFE, V8, DOI 10.7554/eLife.48630; Vainio S, 2005, BIOCHEM J, V391, P465, DOI 10.1042/BJ20050460; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; Varshney P, 2016, IMMUNOLOGY, V149, P13, DOI 10.1111/imm.12617; Wang Q, 2018, BIOPHYS J, V115, P664, DOI 10.1016/j.bpj.2018.07.011; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200; Zhang L, 2019, FRONT CHEM SCI ENG, V13, P98, DOI 10.1007/s11705-018-1775-y	61	4	4	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101010	10.1016/j.jbc.2021.101010	http://dx.doi.org/10.1016/j.jbc.2021.101010			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34324831	Green Published, gold			2022-12-26	WOS:000706408900012
J	Zhang, F; Li, P; Liu, S; Yang, MQ; Zeng, SS; Deng, JJ; Chen, DY; Yi, YM; Liu, H				Zhang, Fan; Li, Pan; Liu, Shuang; Yang, Mingqiang; Zeng, Shanshan; Deng, Junjian; Chen, Danyang; Yi, Yanmei; Liu, Hao			beta-Catenin-CCL2 feedback loop mediates crosstalk between cancer cells and macrophages that regulates breast cancer stem cells	ONCOGENE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; BETA-CATENIN; CHEMOATTRACTANT PROTEIN-1; CCL2; ACTIVATION; EXPRESSION; COMPLEX; TRANSACTIVATION; POLARIZATION; FIBROBLASTS	Breast cancer is the most frequently diagnosed cancer among women worldwide. Though advances in diagnosis and treatment have prolonged overall survival (OS) for patients with breast cancer, metastasis remains the major obstacles to improved survival for breast cancer patients. The existence of breast cancer stem cells (BCSCs) is a major reason underlying cancer metastasis and recurrence. Therefore, understanding the molecular pathways sustaining BCSC properties and targeting BCSCs will ultimately improve breast cancer treatments. In this study, we found that activation of beta-Catenin directly regulated CCL2 expression at the transcriptional level, and in turn promoted macrophages infiltration and M2 polarization. Moreover, macrophages co-cultured with breast cancer cells showed a significant increase in CCL2 expression and promoted beta-Catenin-induced BCSCs properties, whereas depletion of CCL2 by adding neutralizing antibodies suppressed BSCSs properties. In addition, we found that beta-Catenin-mediated CCL2 secretion recruited macrophages into tumor microenvironment and promoted breast cancer growth and metastasis in vivo. Clinically, we observed a significant positive correlation between beta-Catenin, CCL2 and CD163 expression, and increased expression of beta-Catenin, CCL2 and CD163 predicted poor prognosis in breast cancer. Furthermore, pharmacological inhibition of CCR2 and beta-Catenin synergistically suppressed BCSC properties and breast cancer growth. Collectively, our findings suggested that beta-Catenin-mediated CCL2 secretion forms a paracrine feedback loop between breast cancer cells and macrophages, which in turn promotes BCSC properties and supports breast cancer growth and metastasis. Targeting beta-Catenin/CCL2 signaling might be an effective strategy for breast cancer therapy.	[Zhang, Fan] Wuhan Univ, Renmin Hosp, Dept Pharm, Wuhan, Hubei, Peoples R China; [Li, Pan; Liu, Shuang; Yang, Mingqiang; Zeng, Shanshan; Chen, Danyang; Liu, Hao] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Guangzhou Key Lab Translat Med Malignant Tumor Tr, Guangzhou, Guangdong, Peoples R China; [Deng, Junjian] Wuhan Univ, Renmin Hosp, Dept Canc Ctr, Wuhan, Hubei, Peoples R China; [Yi, Yanmei] Guangdong Med Univ, Sch Basic Med, Zhanjiang, Guangdong, Peoples R China	Wuhan University; Guangzhou Medical University; Wuhan University; Guangdong Medical University	Chen, DY; Liu, H (corresponding author), Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Guangzhou Key Lab Translat Med Malignant Tumor Tr, Guangzhou, Guangdong, Peoples R China.; Yi, YM (corresponding author), Guangdong Med Univ, Sch Basic Med, Zhanjiang, Guangdong, Peoples R China.	cdy026@126.com; yiymei@gdmu.edu.cn; haoliu2020@163.com		Liu, Hao/0000-0001-6338-4003; Chen, Danyang/0000-0002-7894-9457	National Natural Science Foundation of China [81702819, 81772825, 81972194]; Guangdong Natural Science Funds [2017A030313500, 2019A1515010113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds	This work was supported by the National Natural Science Foundation of China (81702819, 81772825, 81972194), grants from Guangdong Natural Science Funds (2017A030313500, 2019A1515010113).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amini-Nik S, 2014, J CLIN INVEST, V124, P2599, DOI 10.1172/JCI62059; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; [Anonymous], 2019, CA-CANCER J CLIN, DOI [DOI 10.3322/CAAC.21551, DOI 10.3322/caac.21551]; Bai XP, 2018, CANCER TREAT REV, V69, P152, DOI 10.1016/j.ctrv.2018.07.004; Batlle E, 2017, NAT MED, V23, P1124, DOI 10.1038/nm.4409; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Brown JM, 2017, CLIN CANCER RES, V23, P3241, DOI 10.1158/1078-0432.CCR-16-3122; Chen CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06152-x; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Chen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022818; Daly C, 2003, MICROCIRCULATION, V10, P247, DOI 10.1038/sj.mn.7800190; Dehnel N, 2017, CURR OPIN PHARMACOL, V35, P12, DOI 10.1016/j.coph.2017.04.007; Ellsworth RE, 2017, SEMIN CELL DEV BIOL, V64, P65, DOI 10.1016/j.semcdb.2016.08.025; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Gilles C, 2003, CANCER RES, V63, P2658; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hamburg-Shields E, 2015, J PATHOL, V235, P686, DOI 10.1002/path.4481; Hsu DSS, 2014, CANCER CELL, V26, P534, DOI 10.1016/j.ccell.2014.09.002; Jamiyan T, 2020, VIRCHOWS ARCH, V477, P767, DOI 10.1007/s00428-020-02855-z; Jang GB, 2015, CANCER RES, V75, P1691, DOI 10.1158/0008-5472.CAN-14-2041; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; KOELWYN GJ, 2017, NAT REV CANCER, V17, P620, DOI DOI 10.1038/NRC.2017.78; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Liu M, 2018, CELL PHYSIOL BIOCHEM, V51, P1679, DOI 10.1159/000495673; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mestdagt M, 2006, INT J CANCER, V118, P35, DOI 10.1002/ijc.21291; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Obeid E, 2013, INT J ONCOL, V43, P5, DOI 10.3892/ijo.2013.1938; Ou BC, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1906-5; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Raggi C, 2016, ONCOGENE, V35, P671, DOI 10.1038/onc.2015.132; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Sarode P, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6105; Schade B, 2013, CANCER RES, V73, P4474, DOI 10.1158/0008-5472.CAN-12-3925; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Tsuyada A, 2012, CANCER RES, V72, P2768, DOI 10.1158/0008-5472.CAN-11-3567; Ueno T, 2000, CLIN CANCER RES, V6, P3282; van Zoelen MAD, 2011, MOL IMMUNOL, V48, P1468, DOI 10.1016/j.molimm.2011.04.001; Waks AG, 2019, JAMA-J AM MED ASSOC, V321, P288, DOI 10.1001/jama.2018.19323; Watson AL, 2013, CANCER DISCOV, V3, P674, DOI 10.1158/2159-8290.CD-13-0081; Webster S, 2020, SUPPORT CARE CANCER, V28, P1041, DOI 10.1007/s00520-019-05218-w; Williams CB, 2016, NPJ BREAST CANCER, V2, DOI 10.1038/npjbcancer.2015.25; Yang J, 2013, STEM CELLS, V31, P248, DOI 10.1002/stem.1281; Yang Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0818-0; Yao M, 2016, MODERN PATHOL, V29, P810, DOI 10.1038/modpathol.2016.78; Ye YC, 2019, CANCER RES, V79, P4160, DOI 10.1158/0008-5472.CAN-18-1691; Yoshimura T, 2018, CELL MOL IMMUNOL, V15, P335, DOI 10.1038/cmi.2017.135; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhang F, 2015, PROTEOMICS, V15, P773, DOI 10.1002/pmic.201300494; Zhao SJ, 2018, ONCOGENE, V37, P1049, DOI 10.1038/onc.2017.403	61	9	10	3	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 30	2021	40	39					5854	5865		10.1038/s41388-021-01986-0	http://dx.doi.org/10.1038/s41388-021-01986-0		AUG 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UZ8WB	34345015				2022-12-26	WOS:000681523500005
J	Yan, Y; Narayan, A; Cho, S; Cheng, ZQ; Liu, JO; Zhu, H; Wang, GN; Wharram, B; Lisok, A; Brummet, M; Saeki, H; Huang, T; Gabrielson, K; Gabrielson, E; Cope, L; Kanaan, YM; Afsari, A; Naab, T; Yfantis, HG; Ambs, S; Pomper, MG; Sukumar, S; Merino, VF				Yan, Yu; Narayan, Athira; Cho, Soonweng; Cheng, Zhiqiang; Liu, Jun O.; Zhu, Heng; Wang, Guannan; Wharram, Bryan; Lisok, Ala; Brummet, Mary; Saeki, Harumi; Huang, Tao; Gabrielson, Kathleen; Gabrielson, Edward; Cope, Leslie; Kanaan, Yasmine M.; Afsari, Ali; Naab, Tammey; Yfantis, Harris G.; Ambs, Stefan; Pomper, Martin G.; Sukumar, Saraswati; Merino, Vanessa F.			CRY beta B2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer	ONCOGENE			English	Article							AFRICAN-AMERICAN; TRANSLATION; CELLS; DRUG; OVEREXPRESSION; STABILIZATION; PHENOTYPE; REGIONS; MODEL	Expression of beta-crystallin B2 (CRY beta B2) is elevated in African American (AA) breast tumors. The underlying mechanisms of CRY beta B2-induced malignancy and the association of CRY beta B2 protein expression with survival have not yet been described. Here, we report that the expression of CRY beta B2 in breast cancer cells increases stemness, growth, and metastasis. Transcriptomics data revealed that CRY beta B2 upregulates genes that are functionally associated with unfolded protein response, oxidative phosphorylation, and DNA repair, while down-regulating genes related to apoptosis. CRY beta B2 in tumors promotes de-differentiation, an increase in mesenchymal markers and cancer-associated fibroblasts, and enlargement of nucleoli. Proteome microarrays identified a direct interaction between CRY beta B2 and the nucleolar protein, nucleolin. CRY beta B2 induces nucleolin, leading to the activation of AKT and EGFR signaling. CRISPR studies revealed a dependency on nucleolin for the pro-tumorigenic effects of CRY beta B2. Triple-negative breast cancer (TNBC) xenografts with upregulated CRY beta B2 are distinctively sensitive to the nucleolin aptamer, AS-1411. Lastly, in AA patients, higher levels of nucleolar CRY beta B2 in primary TNBC correlates with decreased survival. In summary, CRY beta B2 is upregulated in breast tumors of AA patients and induces oncogenic alterations consistent with an aggressive cancer phenotype. CRY beta B2 increases sensitivity to nucleolin inhibitors and may promote breast cancer disparity.	[Yan, Yu; Narayan, Athira; Wharram, Bryan; Lisok, Ala; Brummet, Mary; Pomper, Martin G.; Merino, Vanessa F.] Johns Hopkins Univ, Dept Radiol & Radiol Sci, Sch Med, Baltimore, MD 21218 USA; [Yan, Yu; Huang, Tao] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Breast & Thyroid Surg, Wuhan, Peoples R China; [Yan, Yu; Cho, Soonweng; Liu, Jun O.; Wang, Guannan; Gabrielson, Kathleen; Cope, Leslie; Pomper, Martin G.; Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Cheng, Zhiqiang; Liu, Jun O.; Zhu, Heng; Pomper, Martin G.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Saeki, Harumi; Gabrielson, Kathleen] Johns Hopkins Univ, Dept Mol & Comparat Pathobiol, Sch Med, Baltimore, MD USA; [Saeki, Harumi; Gabrielson, Kathleen; Gabrielson, Edward] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Kanaan, Yasmine M.] Howard Univ, Coll Med, Dept Microbiol, Washington, DC USA; [Afsari, Ali; Naab, Tammey] Howard Univ, Coll Med, Dept Pathol, Washington, DC USA; [Yfantis, Harris G.] Baltimore Vet Affairs Med Ctr, Pathol & Lab Med, Baltimore, MD USA; [Ambs, Stefan] NCI, Mol Epidemiol Sect, Lab Human Carcinogenesis, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Huazhong University of Science & Technology; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard University; Howard University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Merino, VF (corresponding author), Johns Hopkins Univ, Dept Radiol & Radiol Sci, Sch Med, Baltimore, MD 21218 USA.; Sukumar, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.	saras@jhmi.edu; vmerino1@jhmi.edu	Cheng, Zhiqiang/F-5016-2016	Cheng, Zhiqiang/0000-0002-4371-0104; Yan, Yu/0000-0003-2309-9464	DOD BCRP Center of Excellence Grant [W81XWH-04-1-0595]; DOD BCRP [W81XWH-15-1-0017]; Division of Nuclear Medicine and Molecular Imaging	DOD BCRP Center of Excellence Grant; DOD BCRP(United States Department of Defense); Division of Nuclear Medicine and Molecular Imaging	This work was funded by the DOD BCRP Center of Excellence Grant W81XWH-04-1-0595 to S.S, DOD BCRP, W81XWH-15-1-0017 to V.M and the Division of Nuclear Medicine and Molecular Imaging.	Abdelmohsen K, 2011, NUCLEIC ACIDS RES, V39, P8513, DOI 10.1093/nar/gkr488; Alvandi F, 2014, ONCOLOGIST, V19, P94, DOI 10.1634/theoncologist.2013-0077; Anders F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175451; Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Barrow MA, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1191-3; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; BUGLER B, 1982, EUR J BIOCHEM, V128, P475; Carotenuto P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091090; Chen CY, 2000, GENE DEV, V14, P1236; Chen Z, 2016, SAUDI MED J, V37, P1312, DOI 10.15537/smj.2016.12.15972; Cho B, 2021, JAMA ONCOL, V7, P1016, DOI 10.1001/jamaoncol.2021.1254; Churpek JE, 2015, BREAST CANCER RES TR, V149, P31, DOI 10.1007/s10549-014-3195-0; Dawson PJ, 1996, AM J PATHOL, V148, P313; Derenzini M, 1998, AM J PATHOL, V152, P1291; DERENZINI M, 1989, ACTA CYTOL, V33, P491; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Di Segni A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002310; Dietze EC, 2015, NAT REV CANCER, V15, P248, DOI 10.1038/nrc3896; Field LA, 2012, CANCER-AM CANCER SOC, V118, P1334, DOI 10.1002/cncr.26405; Fonseca NA, 2015, BIOMATERIALS, V69, P76, DOI 10.1016/j.biomaterials.2015.08.007; Foss CA, 2019, MOL IMAGING BIOL, V21, P473, DOI 10.1007/s11307-018-1228-5; Gao Q, 2014, BIOCHEM BIOPH RES CO, V453, P37, DOI 10.1016/j.bbrc.2014.09.049; Gieniec KA, 2019, BRIT J CANCER, V121, P293, DOI 10.1038/s41416-019-0509-3; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jovov B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030168; Konishi H, 2011, P NATL ACAD SCI USA, V108, P17773, DOI 10.1073/pnas.1110969108; Li L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18222-z; Liedtke T, 2007, MOL CELL PROTEOMICS, V6, P895, DOI 10.1074/mcp.M600245-MCP200; Lv YR, 2014, MOL CELL BIOL, V34, P4513, DOI 10.1128/MCB.00524-14; Mahotka C, 2018, LEUKEMIA, V32, P1865, DOI 10.1038/s41375-018-0090-4; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Menashe I, 2009, J NATL CANCER I, V101, P993, DOI 10.1093/jnci/djp176; Merino VF, 2016, CANCER RES, V76, P2013, DOI 10.1158/0008-5472.CAN-15-1619; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Otake Y, 2007, BLOOD, V109, P3069, DOI 10.1182/blood-2006-08-043257; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Paulucci DJ, 2017, ONCOTARGET, V8, P5196, DOI 10.18632/oncotarget.14122; Pomper MG, 2009, CELL RES, V19, P370, DOI 10.1038/cr.2008.329; Rosenberg JE, 2014, INVEST NEW DRUG, V32, P178, DOI 10.1007/s10637-013-0045-6; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Shin SH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06606-2; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sturtz LA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-62; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tu Zhigang, 2012, Small GTPases, V3, P163, DOI 10.4161/sgtp.19884; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Xie QP, 2016, ONCOTARGET, V7, P16636, DOI 10.18632/oncotarget.7674; Yakhni M, 2019, AM J CANCER RES, V9, P1043; Yang A, 2011, J BIOL CHEM, V286, P43370, DOI 10.1074/jbc.M111.225185; Yang YG, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0547-5; Zeng Sulin, 2018, Cancer Transl Med, V4, P70, DOI 10.4103/ctm.ctm_22_18	52	4	4	2	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 23	2021	40	38					5752	5763		10.1038/s41388-021-01975-3	http://dx.doi.org/10.1038/s41388-021-01975-3		AUG 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UU4CG	34341513				2022-12-26	WOS:000680382100001
J	dos Santos, C; Rafacho, A; Ferreira, SM; Vettorazzi, JF; Araujo, TD; Goncalves, LM; Ruhrmann, S; Bacos, K; Ling, CR; Boschero, AC; dos Santos, GJ				dos Santos, Cristiane; Rafacho, Alex; Ferreira, Sandra Mara; Vettorazzi, Jean Franciesco; dos Reis Araujo, Thiago; Mateus Goncalves, Luciana; Ruhrmann, Sabrina; Bacos, Karl; Ling, Charlotte; Boschero, Antonio Carlos; Jorge dos Santos, Gustavo			Excess of glucocorticoids during late gestation impairs the recovery of offspring's beta-cell function after a postnatal injury	FASEB JOURNAL			English	Article						beta-cell regeneration; glucocorticoid; Hnf4-alpha; low birth weight; offspring	STREPTOZOTOCIN; RAT; REGENERATION; GROWTH; EXPOSURE; PROLIFERATION; CONVERSION; GLUCOSE; OBESITY; MICE	Since prenatal glucocorticoids (GC) excess increases the risk of metabolic dysfunctions in the offspring and its effect on beta-cell recovery capacity remains unknown we investigated these aspects in offspring from mice treated with dexamethasone (DEX) in the late pregnancy. Half of the pups were treated with streptozotocin (STZ) on the sixth postnatal day (PN). Functional and molecular analyses were performed in male offspring on PN25 and PN225. Prenatal DEX treatment resulted in low birth weight. At PN25, both the STZ-treated offspring developed hyperglycemia and had lower beta-cell mass, in parallel with higher a-cell mass and glucose intolerance, with no impact of prenatal DEX on such parameters. At PN225, the beta-cell mass was partially recovered in the STZ-treated mice, but they remained glucose-intolerant, irrespective of being insulin sensitive. Prenatal exposition to DEX predisposed adult offspring to sustained hyperglycemia and perturbed islet function (lower insulin and higher glucagon response to glucose) in parallel with exacerbated glucose intolerance. beta-cell-specific knockdown of the Hnf4 alpha in mice from the DS group resulted in exacerbated glucose intolerance. We conclude that high GC exposure during the prenatal period exacerbates the metabolic dysfunctions in adult life of mice exposed to STZ early in life, resulting in a lesser ability to recover the islets' function over time. This study alerts to the importance of proper management of exogenous GCs during pregnancy and a healthy postnatal lifestyle since the combination of adverse factors during the prenatal and postnatal period accentuates the predisposition to metabolic disorders in adult life.	[dos Santos, Cristiane; Ferreira, Sandra Mara; Vettorazzi, Jean Franciesco; dos Reis Araujo, Thiago; Mateus Goncalves, Luciana; Boschero, Antonio Carlos] Campinas State Univ UNICAMP, Dept Struct & Funct Biol, Lab Endocrine Pancreas & Metab LAPEM, Inst Biol, Campinas, Brazil; [Rafacho, Alex; Jorge dos Santos, Gustavo] Fed Univ Santa Catarina UFSC, Ctr Biol Sci, Dept Physiol Sci, Lab Invest Chron Dis LIDoC, BR-88040900 Florianopolis, SC, Brazil; [Ruhrmann, Sabrina; Bacos, Karl; Ling, Charlotte] Scania Univ Hosp, Lund Univ Diabet Ctr, Dept Clin Sci Malmo, Epigenet & Diabet Unit, Malmo, Sweden	Universidade de Sao Paulo; Universidade Estadual de Campinas; Lund University	dos Santos, GJ (corresponding author), Fed Univ Santa Catarina UFSC, Ctr Biol Sci, Dept Physiol Sci, Lab Invest Chron Dis LIDoC, BR-88040900 Florianopolis, SC, Brazil.	gustavo.js@ufsc.br	Santos, Gustavo/L-6419-2013; Rafacho, Alex/O-8609-2016	Santos, Gustavo/0000-0001-9135-7184; Rafacho, Alex/0000-0002-8637-6097; VETTORAZZI, JEAN/0000-0002-6411-2947	Sao Paulo Research Foundation (FAPESP) [2015/12611-0, 2016/23140-0, 2019/10543-8]; Santa Catarina Research Foundation [2017TR1760]; National Counsel of Technological and Scientific Development - CNPq [420602/2018-6, 304388/2020-3]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Santa Catarina Research Foundation; National Counsel of Technological and Scientific Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by grants from the Sao Paulo Research Foundation (FAPESP grants 2015/12611--0, 2016/23140--0, and 2019/10543--8), Santa Catarina Research Foundation (2017TR1760) and, National Counsel of Technological and Scientific Development --CNPq (420602/2018--6 and 304388/2020--3)	Aguayo-Mazzucato C, 2018, CELL METAB, V27, P57, DOI 10.1016/j.cmet.2017.08.007; Bacos K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11089; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; BARKER DJP, 1989, LANCET, V2, P577; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Blondeau B, 2001, AM J PHYSIOL-ENDOC M, V281, pE592, DOI 10.1152/ajpendo.2001.281.3.E592; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Chen YT, 2020, DIABETES, V69, P1662, DOI 10.2337/db20-0009; Chera S, 2014, NATURE, V514, P503, DOI 10.1038/nature13633; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; de Vries A, 2007, J CLIN INVEST, V117, P1058, DOI 10.1172/JCI30982; dos Santos C, 2021, J NUTR BIOCHEM, V90, DOI 10.1016/j.jnutbio.2020.108572; Feng AL, 2017, DIABETOLOGIA, V60, P1033, DOI 10.1007/s00125-017-4239-x; Franko KL, 2010, J ENDOCRINOL, V204, P319, DOI 10.1677/JOE-09-0390; Godfrey Keith M, 2016, Nestle Nutr Inst Workshop Ser, V85, P71, DOI 10.1159/000439488; Goyal D, 2019, J ENDOCRINOL, V242, pT105, DOI 10.1530/JOE-19-0009; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Karlsson L, 2017, CLIN ENDOCRINOL, V87, P651, DOI 10.1111/cen.13441; Kataoka M, 2013, BIOCHEM BIOPH RES CO, V430, P1103, DOI 10.1016/j.bbrc.2012.12.030; King R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030605; Korchynska S, 2020, EMBO J, V39, DOI 10.15252/embj.2018100882; Li L, 2004, DIABETES, V53, P608, DOI 10.2337/diabetes.53.3.608; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Lundy BL, 1999, INFANT BEHAV DEV, V22, P119, DOI 10.1016/S0163-6383(99)80009-5; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P391, DOI 10.1038/nrendo.2014.73; Movassat J, 1999, DIABETOLOGIA, V42, P1098, DOI 10.1007/s001250051277; Muller TD, 2019, MOL METAB, V30, P72, DOI 10.1016/j.molmet.2019.09.010; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; Ozanne SE, 2004, CLIN SCI, V106, P141, DOI 10.1042/CS20030278; Pantaleao LC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10642-1; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; PORTHA B, 1974, DIABETES, V23, P889, DOI 10.2337/diab.23.11.889; Protzek AOP, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/983453; RAKIETEN N, 1963, CANCER CHEMOTH REP, P91; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Riveline JP, 2020, J CLIN ENDOCR METAB, V105, pE191, DOI 10.1210/clinem/dgz145; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Sandovici I, 2011, P NATL ACAD SCI USA, V108, P5449, DOI 10.1073/pnas.1019007108; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Valtat B, 2011, DIABETOLOGIA, V54, P350, DOI 10.1007/s00125-010-1898-2; WANG RN, 1994, DIABETOLOGIA, V37, P1088; Wang RN, 1996, DIABETOLOGIA, V39, P548, DOI 10.1007/BF00403301; Wang ZY, 1998, DIABETES, V47, P50, DOI 10.2337/diabetes.47.1.50; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	48	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21828	10.1096/fj.202100841R	http://dx.doi.org/10.1096/fj.202100841R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34325494				2022-12-26	WOS:000678975300013
J	Gan, ST; Teo, CJ; Manirasa, S; Wong, WC; Wong, CK				Gan, Siou Ting; Teo, Chin Jit; Manirasa, Shobana; Wong, Wei Chee; Wong, Choo Kien			Assessment of genetic diversity and population structure of oil palm (Elaeis guineensis Jacq.) field genebank: A step towards molecular-assisted germplasm conservation	PLOS ONE			English	Article							CORE COLLECTIONS; EST DATABASE; ACCESSIONS; SOFTWARE; DISTANCE; MARKERS; WORLDS	Oil palm (Elaeis guineensis) germplasm is exclusively maintained as ex situ living collections in the field for genetic conservation and evaluation. However, this is not for long term and the maintenance of field genebanks is expensive and challenging. Large area of land is required and the germplasms are exposed to extreme weather conditions and casualty from pests and diseases. By using 107 SSR markers, this study aimed to examine the genetic diversity and relatedness of 186 palms from a Nigerian-based oil palm germplasm and to identify core collection for conservation. On average, 8.67 alleles per SSR locus were scored with average effective number of alleles per population ranging from 1.96 to 3.34 and private alleles were detected in all populations. Mean expected heterozygosity was 0.576 ranging from 0.437 to 0.661 and the Wright's fixation index calculated was -0.110. Overall moderate genetic differentiation among populations was detected (mean pairwise population F-ST = 0.120, gene flow Nm = 1.117 and Nei's genetic distance = 0.466) and this was further confirmed by AMOVA analysis. UPGMA dendogram and Bayesian structure analysis concomitantly clustered the 12 populations into eight genetic groups. The best core collection assembled by Core Hunter ver. 3.2.1 consisted of 58 palms accounting for 31.2% of the original population, which was a smaller core set than using PowerCore 1.0. This core set attained perfect allelic coverage with good representation, high genetic distance between entries, and maintained genetic diversity and structure of the germplasm. This study reported the first molecular characterization and validation of core collections for oil palm field genebank. The established core collection via molecular approach, which captures maximum genetic diversity with minimum redundancy, would allow effective use of genetic resources for introgression and for sustainable oil palm germplasm conservation. The way forward to efficiently conserve the field genebanks into next generation without losing their diversity was further discussed.				ganst@aarsb.com.my			Advanced Agriecological Research Sdn. Bhd. (AAR)	Advanced Agriecological Research Sdn. Bhd. (AAR)	The research is funded by Advanced Agriecological Research Sdn. Bhd. (AAR). AAR is an associate company of Boustead Plantations Berhad and Kuala Lumpur Kepong Berhad. The funder provided support in the form of salaries for authors STG, CJT, SM, WCW and CKW and played a role in decision to publish. However, the funder did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The funder had granted permission to publish the article.	Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Arias D, 2015, PLANT GENET RESOUR-C, V13, P256, DOI 10.1017/S1479262114001026; Bakoume C, 2015, GENET RESOUR CROP EV, V62, P349, DOI 10.1007/s10722-014-0156-8; Barcelos E, 2002, PESQUI AGROPECU BRAS, V37, P1105, DOI 10.1590/S0100-204X2002000800008; Barcelos E, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00190; Billotte N, 2005, THEOR APPL GENET, V110, P754, DOI 10.1007/s00122-004-1901-8; Billotte N, 2001, GENOME, V44, P413, DOI 10.1139/g01-017; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Cardona CCC, 2018, BRAGANTIA, V77, P546, DOI 10.1590/1678-4499.2017385; Choudhury DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113094; Cochard B, 2009, TREE GENET GENOMES, V5, P493, DOI 10.1007/s11295-009-0203-3; Cooper R. M., 2011, Planter, V87, P515; Corley R., 2016, OIL PALM, V5th; Corley RHV, 2009, ENVIRON SCI POLICY, V12, P134, DOI 10.1016/j.envsci.2008.10.011; De Beukelaer H, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2209-z; De Beukelaer H, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-312; Diez CM, 2012, CROP SCI, V52, P211, DOI 10.2135/cropsci2011.02.0110; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Frankel O.H., 1984, CROP GENETIC RESOURC, P249; Garcia-Lor A, 2017, ANN APPL BIOL, V171, P327, DOI 10.1111/aab.12376; GOODMAN MM, 1983, MAYDICA, V28, P169; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; Guzman LF, 2017, FRONT PLANT SCI, V8, P1, DOI 10.3389/fpls.2017.00243; Hartley C. W. S., 1988, OIL PALM ELAEIS GUIN, V3rd; Hayati A, 2004, THEOR APPL GENET, V108, P1274, DOI 10.1007/s00122-003-1545-0; Hintum T. J. L. van, 2000, IPGRI Technical Bulletin; Reyes-Valdes MH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193346; Ihase L. O., 2014, African Journal of Biotechnology, V13, P1529; Ithnin M, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0505-7; Jackson TA, 2019, J OIL PALM RES, V31, P331, DOI 10.21894/jopr.2019.0046; Jaligot E, 2011, ANN BOT-LONDON, V108, P1453, DOI 10.1093/aob/mcq266; Jansen J, 2007, THEOR APPL GENET, V114, P421, DOI 10.1007/s00122-006-0433-9; Jeong S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181420; Kim KW, 2007, BIOINFORMATICS, V23, P2155, DOI 10.1093/bioinformatics/btm313; Krishnan RR, 2014, CROP SCI, V54, P1070, DOI 10.2135/cropsci2013.09.0600; Kumar S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01554; Kushairi A., 2010, INT SEM ADV OIL PALM; Liang W, 2015, PLANT MOL BIOL REP, V33, P458, DOI 10.1007/s11105-014-0754-9; Liu FM, 2019, GENES-BASEL, V10, DOI 10.3390/genes10040281; Liu M, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.600249; Maizura I, 2006, GENET RESOUR CROP EV, V53, P187, DOI 10.1007/s10722-004-4004-0; Mohd Isa ZA, 1999, PORIM SERIES 1 PORIM, V15; Moretzsohn MC, 2002, EUPHYTICA, V124, P35, DOI 10.1023/A:1015606304653; Natawijaya A., 2019, BIODIVERSITAS, V20, P3365, DOI [10.13057/biodiv/d200501, DOI 10.13057/biodiv/d200501]; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nugroho Y. A., 2019, IOP Conference Series: Earth and Environmental Science, V293, DOI 10.1088/1755-1315/293/1/012041; Odong TL, 2013, THEOR APPL GENET, V126, P289, DOI 10.1007/s00122-012-1971-y; Odong TL, 2011, CROP SCI, V51, P2401, DOI 10.2135/cropsci2011.02.0095; Ong PW, 2015, GENET MOL RES, V14, P12205, DOI 10.4238/2015.October.9.9; Paterson RRM, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010024; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2000, GENETICS, V155, P945; Rajanaidu, 1980, INT S CONS INP LIF S, P25; Rajanaidu N., 1994, PORIM OIL PALM GENEB; Rosenquist E. A., 1986, Workshop Proceedings of the Palm Oil Research Institute of Malaysia, P27; Schlottfeldt S, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0836-3; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; Singh R, 2007, ASIA-PAC J MOL BIOL, V15, P121; Singh R, 2008, BIOLOGIA, V63, P227, DOI 10.2478/s11756-008-0041-z; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Singh R, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-114; Soh AC, 2011, J OIL PALM RES, V23, P935; Taamalli W., 2008, Journal of Agronomy, V7, P176; Thachuk C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-243; Ting NC, 2010, J GENET, V89, P135, DOI 10.1007/s12041-010-0053-7; Weckx S, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00722; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; WRIGHT S, 1978, EVOLUTION GENETICS P, V4, P91; Xia W, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00130; Xu Y, 2010, MOLECULAR PLANT BREEDING, P1, DOI [10.1079/9781845933920.0001, 10.1079/9781845933920.0000]; YATIM Z, 2012, J OIL PALM RES, V24, P1368; Yonezawa K., 1995, P35	73	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255418	10.1371/journal.pone.0255418	http://dx.doi.org/10.1371/journal.pone.0255418			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324602	Green Published, gold			2022-12-26	WOS:000685248200013
J	Patuelli, A; Caldarelli, G; Lattanzi, N; Saracco, F				Patuelli, Alessia; Caldarelli, Guido; Lattanzi, Nicola; Saracco, Fabio			Firms' challenges and social responsibilities during Covid-19: A Twitter analysis	PLOS ONE			English	Article							EXAMINING PUBLIC REACTIONS; STAKEHOLDER ENGAGEMENT; CSR COMMUNICATION; STRATEGIES; IMPACT; MEDIA; SUSTAINABILITY; LEGITIMACY	This paper offers insights on the major issues and challenges firms face in the Covid-19 pandemic and their concerns for Corporate Social Responsibility (CSR) themes. To do so, we investigate large Italian firms' discussions on Twitter in the first nine months of the pandemic. Specifically, we ask: How is firms' Twitter discussion developing during the Covid-19 pandemic? Which CSR dimensions and topics do firms discuss? To what extent do they resonate with the public? We downloaded Twitter posts by the accounts of large Italian firms, and we built the bipartite network of accounts and hashtags. Using an entropy-based null model as a benchmark, we projected the information contained in the network into the accounts layers, identifying a network of accounts. We find that the network is composed of 13 communities and accounts at the core of the network focus on environmental sustainability, digital innovation, and safety. Firms' ownership type does not seem to influence the conversation. While the relevance of CSR hashtags and stakeholder engagement is relatively small, peculiarities arise in some communities. Overall, our paper highlights the contribution of online social networks and complex networks methods for management and strategy research, showing the role of online social media in understanding firms' issues, challenges, and responsibilities, with common narratives naturally emerging from data.	[Patuelli, Alessia; Caldarelli, Guido; Lattanzi, Nicola; Saracco, Fabio] IMT Sch Adv Studies, Lucca, Italy; [Caldarelli, Guido] Univ Ca Foscari, DSMN, Venice, Ve, Italy; [Caldarelli, Guido] Univ Ca Foscari, ECLT, Venice, Ve, Italy; [Caldarelli, Guido] CNR Inst Complex Syst, Unit Sapienza, Rome, Italy	IMT School for Advanced Studies Lucca; Universita Ca Foscari Venezia; Universita Ca Foscari Venezia; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Patuelli, A (corresponding author), IMT Sch Adv Studies, Lucca, Italy.	alessia.patuelli@imtlucca.it	LATTANZI, NICOLA/ABD-4189-2021; Caldarelli, Guido/AAB-8206-2022; Saracco, Fabio/O-5295-2015	LATTANZI, NICOLA/0000-0001-9653-4805; Saracco, Fabio/0000-0003-0812-5927	EU grant "Humane-AI-net" [952026]; EU project SoBigData++ [871042]; PAI (Progetto di Attivita Integrata) project TOFFEe - IMT School or Advanced Studies Lucca	EU grant "Humane-AI-net"; EU project SoBigData++; PAI (Progetto di Attivita Integrata) project TOFFEe - IMT School or Advanced Studies Lucca	GC acknowledges support from the EU grant "Humane-AI-net" (Grant nr. 952026). GC and FS acknowledge support from EU project SoBigData++ (Grant nr. 871042); PAI (Progetto di Attivita Integrata) project TOFFEe, funded by IMT School or Advanced Studies Lucca.	Amorelli MF, 2021, CORP SOC RESP ENV MA, V28, P537, DOI 10.1002/csr.2079; [Anonymous], 2019, ANN REPORT EUROPEAN; Axenbeck J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249583; Bartik AW, 2020, P NATL ACAD SCI USA, V117, P17656, DOI 10.1073/pnas.2006991117; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Brown N., 1998, ACCOUNTING BUSINESS, V29, P21, DOI DOI 10.1080/00014788.1998.9729564; Caldarelli G., 2020, FLOW ONLINE MISINFOR; Caldarelli G, 2020, COMMUN PHYS-UK, V3, DOI 10.1038/s42005-020-0340-4; Campopiano G, 2015, J BUS ETHICS, V129, P511, DOI 10.1007/s10551-014-2174-z; Carroll A.B., 1999, BUS SOC, V38, P268, DOI DOI 10.1177/000765039903800303; Celestini A., 2020, INFORM DISORDERS ITA; Chae B, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10072231; Choudhury PR, 2018, MACHINE LEARNING PAT; Cimini G, 2019, NAT REV PHYS, V1, P58, DOI 10.1038/s42254-018-0002-6; Cinelli M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73510-5; Crick JM, 2020, IND MARKET MANAG, V88, P206, DOI 10.1016/j.indmarman.2020.05.016; Dahlsrud A, 2008, CORP SOC RESP ENV MA, V15, P1, DOI 10.1002/csr.132; Doan A., MAGELLAN PROJECT PY; Elkington J., 1997, ENV MANAGEMENT READI, V2, P424; Gallotti R, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-00994-6; Gamerschlag R, 2011, REV MANAG SCI, V5, P233, DOI 10.1007/s11846-010-0052-3; Garlaschelli D, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.015101; Ghose A, 2011, IEEE T KNOWL DATA EN, V23, P1498, DOI 10.1109/TKDE.2010.188; Hong YL, 2013, COMPUT STAT DATA AN, V59, P41, DOI 10.1016/j.csda.2012.10.006; Ivanov Dmitry, 2020, International Journal of Integrated Supply Management, V13, P90; Jansen BJ, 2009, J AM SOC INF SCI TEC, V60, P2169, DOI 10.1002/asi.21149; Lopreite M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81333-1; Matt C, 2015, BUS INFORM SYST ENG+, V57, P339, DOI 10.1007/s12599-015-0401-5; McWilliams A, 2001, ACAD MANAGE REV, V26, P117, DOI 10.5465/AMR.2001.4011987; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066117; Qiu S, 2021, INT J HOSP MANAG, V93, DOI 10.1016/j.ijhm.2020.102759; Reilly AH, 2014, BUS HORIZONS, V57, P747, DOI 10.1016/j.bushor.2014.07.008; Rovetta A, 2020, JMIR PUBLIC HLTH SUR, V6, DOI 10.2196/19374; Saracco F, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa6b38; Saracco F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10595; Seven U, 2021, RES INT BUS FINANC, V56, DOI 10.1016/j.ribaf.2020.101349; Sharma A, 2020, J BUS RES, V117, P443, DOI 10.1016/j.jbusres.2020.05.035; Snider J, 2003, J BUS ETHICS, V48, P175, DOI 10.1023/B:BUSI.0000004606.29523.db; Squartini T., 2017, PATTERN DETECTION NE; Squartini T, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/8/083001; Vallarano N, 2021, FAST SCALABLE LIKELI; Wankmuller C., 2020, MIND SOC; Yang KC, 2020, COVID 19 INFODEMIC T; Zimmer M, 2014, ASLIB J INFORM MANAG, V66, P250, DOI 10.1108/AJIM-09-2013-0083	95	7	7	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0254748	10.1371/journal.pone.0254748	http://dx.doi.org/10.1371/journal.pone.0254748			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TU	34314432	gold, Green Published, Green Submitted			2022-12-26	WOS:000685225200023
J	Interlandi, C; Leonardi, F; Spadola, F; Costa, GL				Interlandi, Claudia; Leonardi, Fabio; Spadola, Filippo; Costa, Giovanna Lucrezia			Evaluation of the paw withdrawal latency for the comparison between tramadol and butorphanol administered locally, in the plantar surface of rat, preliminary study	PLOS ONE			English	Article							POSTOPERATIVE PAIN; ANALGESIC EFFICACY; OPIOID RECEPTORS; INFILTRATION; ANESTHETICS; LIDOCAINE; VARIABLES; SITE	The aim of the study was to evaluate the analgesic efficacy of tramadol compared to butorphanol administered locally in ventral surface of the hind paw of rats. Prospective, randomized experimental study; twenty-one adult male Wistar rats were selected. Heart rate (beats minute(-1)), respiratory rate (breaths minute(-1)), and paw withdrawal latency (onset of radiant heat until paw withdrawal/seconds) were measured prior (T-0) and after (T-5, T-10, T-15, T-20) intraplantar injection with saline solution 0,9% (group S), butorphanol 1 mg kg(-1) (group B), and tramadol 1 mg kg(-1) (group T). Shapiro-Wilk normality test and Friedman test were used to analyze the data expressed by median and range. Statistical significance was set at p < 0.05. Statistical analysis of heart rate showed that there were significant differences between groups at different monitoring times. There were no significant differences in respiratory rate after intraplantar injection in any of the treatment groups. The paw withdrawal latency values at T5, T10, and T15 minutes after intraplantar injection in the group B were significantly higher compared to baseline value and to the values of the other groups. The paw withdrawal latency were no significant changes in the measurements of intragroup in S and T. Intraplantar administration of butorphanol provides a good analgesia and significantly increases paw withdrawal latency compared to tramadol. Intraplantar injection of butorphanol could be useful and safe and safe technique to achieve local analgesia for minor surgical procedures in rats.	[Interlandi, Claudia; Spadola, Filippo; Costa, Giovanna Lucrezia] Univ Messina, Dept Vet Sci, Messina, Italy; [Leonardi, Fabio] Univ Parma, Dept Med & Vet Sci, Parma, Italy	University of Messina; University of Parma	Interlandi, C (corresponding author), Univ Messina, Dept Vet Sci, Messina, Italy.	cinterlandi@unime.it	SPADOLA, Filippo F. S./D-5948-2017; Leonardi, Fabio/AAC-2140-2020; Costa, Giovanna Lucrezia/B-7468-2017	SPADOLA, Filippo F. S./0000-0002-6946-4992; Costa, Giovanna Lucrezia/0000-0001-9330-5038; Interlandi, Claudia/0000-0002-5933-4334				Akbay BK, 2010, J ANESTH, V24, P705, DOI 10.1007/s00540-010-0978-2; Bailard NS, 2014, AM J HEALTH-SYST PH, V71, P373, DOI 10.2146/ajhp130336; Beyzadeoglu T, 2012, ACTA ORTHOP TRAUMATO, V46, P201, DOI 10.3944/AOTT.2012.2606; Carnaval TG, 2013, BRAZ ORAL RES, V27, P455, DOI 10.1590/S1806-83242013000600003; Childs JD, 2005, SPINE, V30, P1331, DOI 10.1097/01.brs.0000164099.92112.29; Costa G, 2018, LARGE ANIM REV, V24, P219; Costa GL, 2015, VET ANAESTH ANALG, V42, P220, DOI 10.1111/vaa.12210; Costa GL, 2019, J VET BEHAV, V30, P33, DOI 10.1016/j.jveb.2018.11.003; Oliveira JOD, 2016, J PAIN RES, V9, P797, DOI 10.2147/JPR.S117674; Gercek Arzu, 2004, Agri, V16, P53; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Interlandi C, 2017, LARGE ANIM REV, V23, P51; Interlandi C, 2017, J EXOT PET MED, V26, P290, DOI 10.1053/j.jepm.2017.07.001; Isiordia-Espinoza MA, 2011, MED ORAL PATOL ORAL, V16, pE776, DOI 10.4317/medoral.16854; Kakagia D, 2012, J CUTAN MED SURG, V16, P101, DOI 10.2310/7750.2011.11015; Kaki AM, 2008, ANN SAUDI MED, V28, P165; Kargi E, 2010, UROLOGY, V75, P672, DOI 10.1016/j.urology.2009.06.108; Leonardi F, 2020, EQUINE VET EDUC, V32, P53, DOI 10.1111/eve.13040; Lomas LM, 2007, PSYCHOPHARMACOLOGY, V191, P273, DOI 10.1007/s00213-006-0663-1; Matkap E, 2011, J CLIN ANESTH, V23, P197, DOI 10.1016/j.jclinane.2010.08.010; Mert T, 2007, EUR J PHARMACOL, V558, P68, DOI 10.1016/j.ejphar.2006.11.055; RHIM H, 1994, J NEUROSCI, V14, P7608; Tsang BK, 1998, CAN J ANAESTH, V45, P1019, DOI 10.1007/BF03012311; Vahabi S., 2011, Middle East Journal of Anesthesiology, V21, P9; Wang JTC, 2010, CAN J ANAESTH, V57, P659, DOI 10.1007/s12630-010-9301-9	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254497	10.1371/journal.pone.0254497	http://dx.doi.org/10.1371/journal.pone.0254497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310642	Green Published, gold			2022-12-26	WOS:000685224500046
J	Aziz, F; Malek, S; Ibrahim, KS; Shariff, RER; Ahmad, WAW; Ali, RM; Liu, KT; Selvaraj, G; Kasim, S				Aziz, Firdaus; Malek, Sorayya; Ibrahim, Khairul Shafiq; Raja Shariff, Raja Ezman; Wan Ahmad, Wan Azman; Ali, Rosli Mohd; Liu, Kien Ting; Selvaraj, Gunavathy; Kasim, Sazzli			Short- and long-term mortality prediction after an acute ST-elevation myocardial infarction (STEMI) in Asians: A machine learning approach	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; IN-HOSPITAL MORTALITY; TIMI RISK SCORE; CARDIOGENIC-SHOCK; 30-DAY MORTALITY; BIG DATA; IMPUTATION; REGISTRY; FUTURE	Background Conventional risk score for predicting short and long-term mortality following an ST-segment elevation myocardial infarction (STEMI) is often not population specific. Objective Apply machine learning for the prediction and identification of factors associated with short and long-term mortality in Asian STEMI patients and compare with a conventional risk score. Methods The National Cardiovascular Disease Database for Malaysia registry, of a multi-ethnic, heterogeneous Asian population was used for in-hospital (6299 patients), 30-days (3130 patients), and 1-year (2939 patients) model development. 50 variables were considered. Mortality prediction was analysed using feature selection methods with machine learning algorithms and compared to Thrombolysis in Myocardial Infarction (TIMI) score. Invasive management of varying degrees was selected as important variables that improved mortality prediction. Results Model performance using a complete and reduced variable produced an area under the receiver operating characteristic curve (AUC) from 0.73 to 0.90. The best machine learning model for in-hospital, 30 days, and 1-year outperformed TIMI risk score (AUC = 0.88, 95% CI: 0.846-0.910; vs AUC = 0.81, 95% CI:0.772-0.845, AUC = 0.90, 95% CI: 0.870-0.935; vs AUC = 0.80, 95% CI: 0.746-0.838, AUC = 0.84, 95% CI: 0.798-0.872; vs AUC = 0.76, 95% CI: 0.715-0.802, p < 0.0001 for all). TIMI score underestimates patients' risk of mortality. 90% of non-survival patients are classified as high risk (>50%) by machine learning algorithm compared to 10-30% non-survival patients by TIMI. Common predictors identified for short- and long-term mortality were age, heart rate, Killip class, fasting blood glucose, prior primary PCI or pharmaco-invasive therapy and diuretics. The final algorithm was converted into an online tool with a database for continuous data archiving for algorithm validation. Conclusions In a multi-ethnic population, patients with STEMI were better classified using the machine learning method compared to TIMI scoring. Machine learning allows for the identification of distinct factors in individual Asian populations for better mortality prediction. Ongoing continuous testing and validation will allow for better risk stratification and potentially alter management and outcomes in the future.	[Aziz, Firdaus; Malek, Sorayya] Univ Malaya, Fac Sci, Bioinformat Div, Inst Biol Sci, Kuala Lumpur, Malaysia; [Malek, Sorayya; Ibrahim, Khairul Shafiq; Kasim, Sazzli] Univ Teknol MARA UiTM, Fac Med, Dept Cardiol, Shah Alam, Malaysia; [Ibrahim, Khairul Shafiq; Raja Shariff, Raja Ezman; Kasim, Sazzli] Univ Teknol MARA UiTM, Cardiac Vasc & Lung Res Inst, Shah Alam, Malaysia; [Ibrahim, Khairul Shafiq; Raja Shariff, Raja Ezman; Wan Ahmad, Wan Azman; Liu, Kien Ting; Selvaraj, Gunavathy; Kasim, Sazzli] Natl Heart Assoc Malaysia, Heart House, Kuala Lumpur, Malaysia; [Wan Ahmad, Wan Azman] Univ Malaya, Div Cardiol, Med Ctr, Kuala Lumpur, Malaysia; [Ali, Rosli Mohd] Cardiac Vasc Sentral Kuala Lumpur, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Teknologi MARA; Universiti Teknologi MARA; Universiti Malaya	Malek, S (corresponding author), Univ Malaya, Fac Sci, Bioinformat Div, Inst Biol Sci, Kuala Lumpur, Malaysia.; Kasim, S (corresponding author), Univ Teknol MARA UiTM, Fac Med, Dept Cardiol, Shah Alam, Malaysia.; Kasim, S (corresponding author), Univ Teknol MARA UiTM, Cardiac Vasc & Lung Res Inst, Shah Alam, Malaysia.; Kasim, S (corresponding author), Natl Heart Assoc Malaysia, Heart House, Kuala Lumpur, Malaysia.	sorayya@um.edu.my; sazzlikasim@gmail.com	Aziz, Firdaus/GZK-7398-2022; Malek, Sorayya/B-9830-2010; RAJA SHARIFF, RAJA EZMAN/A-3441-2019	Malek, Sorayya/0000-0001-6450-6404; Ibrahim, Khairul Shafiq/0000-0002-0507-8865; RAJA SHARIFF, RAJA EZMAN/0000-0002-5167-5863; Liu, Kien Ting/0000-0002-2476-8853	University of Malaya [GPF013B-2018]	University of Malaya(Universiti Malaya)	This work was supported by the University of Malaya Internal grant (Project No: GPF013B-2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad WAW, 2013, INT J CARDIOL, V165, P161, DOI 10.1016/j.ijcard.2011.08.015; Azman W, 2011, CVD PREV CONTROL, V6, P81; Bengio Y., 1999, INFERENCE GEN ERROR; Breiman L., 2001, MACH LEARN, V45, P5; Cheng JM, 2016, EUR HEART J-ACUTE CA, V5, P101, DOI 10.1177/2048872615568966; Chimparlee N, 2018, J AM COLL CARDIOL, V71, P246, DOI 10.1016/S0735-1097(18)30787-3; Chopra A, 2017, 2017 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P1684, DOI 10.1109/ICACCI.2017.8126085; Correia LCL, 2014, ARQ BRAS CARDIOL, V103, P98, DOI 10.5935/abc.20140095; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feurer M, 2019, SPRING SER CHALLENGE, P3, DOI 10.1007/978-3-030-05318-5_1; Geisser S., 2017, PREDICTIVE INFERENCE; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; González-Pacheco Héctor, 2012, Arch. Cardiol. Méx., V82, P7; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Han J, 2012, MOR KAUF D, P1; Jafarian A., 2011, 2011 IEEE 11th International Conference on Bioinformatics & Bioengineering, P78, DOI 10.1109/BIBE.2011.19; Johansson S, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0482-9; Kesavaraj G., 2013, P COMM NETW TECHN IC, P1; Kim J, 2017, J AM COLL CARDIOL, V69, P899, DOI 10.1016/j.jacc.2017.01.006; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Kwon JM, 2019, RESUSCITATION, V139, P84, DOI 10.1016/j.resuscitation.2019.04.007; Laufer-Perl M, 2015, CLIN CARDIOL, V38, P145, DOI 10.1002/clc.22363; Lin XH, 2018, MOLECULES, V23, DOI 10.3390/molecules23010052; Mao KZ, 2004, IEEE T SYST MAN CY B, V34, P629, DOI 10.1109/TSMCB.2002.804363; Menard S., 2002, APPL LOGISTIC REGRES; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Peng Y, 2017, AM J CARDIOL, V120, P1077, DOI 10.1016/j.amjcard.2017.06.044; Perez-Riverol Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189875; R Core Team, 2020, R LANG ENV STAT COMP; Rajadurai J., 2017, CLIN PRACTICES GUIDE; Raschka, 2018, MODEL EVALUATION MOD; Selvarajah S, 2013, AM J CARDIOL, V111, P1270, DOI 10.1016/j.amjcard.2013.01.271; Selvarajah S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040249; Shouval R, 2017, INT J CARDIOL, V246, P7, DOI 10.1016/j.ijcard.2017.05.067; Solaro N, 2018, J STAT COMPUT SIM, V88, P3588, DOI 10.1080/00949655.2018.1530773; Thalib L, 2017, ANGIOLOGY, V68, P251, DOI 10.1177/0003319716659179; Timbol AB., 2015, CRIT CARE MED, V43, P28; Trevethan R, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00307; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vapnik V, 1998, NONLINEAR MODELING, P55; Venkatason P, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025734; Vomlel J, 2012, P WUPES, V2012, P204; Wallert J, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0500-y; World Health Organization, 2018, HLTH GLANC AS PAC 20; Yang XQ, 2018, MOL MED REP, V17, P1555, DOI 10.3892/mmr.2017.8044; Zheng YY, 2019, CARDIOL RES PRACT, V2019, DOI 10.1155/2019/5432076; Zuhdi ASM, 2016, SINGAP MED J, V57, P191, DOI 10.11622/smedj.2015145	51	8	9	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0254894	10.1371/journal.pone.0254894	http://dx.doi.org/10.1371/journal.pone.0254894			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339432	Green Published, gold			2022-12-26	WOS:000680243400054
J	Reisner, SL; Silva-Santisteban, A; Salazar, X; Vilela, J; D'Amico, L; Perez-Brumer, A				Reisner, Sari L.; Silva-Santisteban, Alfonso; Salazar, Ximena; Vilela, Jesse; D'Amico, Lynne; Perez-Brumer, Amaya			"Existimos": Health and social needs of transgender men in Lima, Peru	PLOS ONE			English	Article							HIV; WOMEN; EPIDEMIOLOGY; IDENTITY; STRESS; BURDEN; ADULTS; CARE	Background The health of transgender men (trans men)-individuals who identify as men and were assigned a female sex assigned at birth-is overlooked globally. This mixed-methods exploratory study sought to understand the lived experiences, health, and social needs of trans men in Lima, Peru to bring visibility to specific health needs and inform responsive and holistic public health efforts. Methods Between July 2016-January 2017, 46 trans men in Lima, Peru participated in a mixed-methods study. Four focus group discussions were conducted, complemented with 10 one-on-one interviews to explore in-depth issues that arose in groups. Two individuals participated in both a focus group and an interview. All participants completed a brief survey assessing sociodemographic characteristics and experiences with healthcare, mental health, and stigma. Audio files were transcribed verbatim and analyzed using an immersion crystallization approach to identify themes. Results Participants had a mean age of 24 years (range 18-48). Trans men reported a lack of awareness and information among medical providers, avoidance of healthcare due to discrimination and maltreatment, an absence of public services for medical gender affirmation (hormones, surgeries), and unmet mental health needs. Trans men described health as multidimensional and influenced by social, economic, and legal contexts including family, school, employment and work, legal identity recognition, discrimination in public spaces, and peer support. Violence, stigma, and intersecting forms of oppression were described as limiting social and legal recognition of trans identity a central dimension of health. Peer support, often in an online environment, was described as important to resistance and well-being. Conclusions Findings demonstrate that the physical and mental health of trans men, as well as unmet needs for healthcare services, are influenced by a complex set of social, economic, and legal challenges due to the social exclusion of trans people in Peruvian society. Results are a call to action for stakeholders in Peru to guarantee the rights, health, and wellbeing of this community.	[Reisner, Sari L.; D'Amico, Lynne] Fenway Inst, Fenway Hlth, Boston, MA USA; [Reisner, Sari L.] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA USA; [Reisner, Sari L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Reisner, Sari L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Silva-Santisteban, Alfonso; Salazar, Ximena] Univ Peruana Cayetano Heredia, Ctr Interdisciplinary Res Sexual AIDS & Soc, Lima, Peru; [Vilela, Jesse] Sociedad Trans FTM Peru, Lima, Peru; [Perez-Brumer, Amaya] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Fenway Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Universidad Peruana Cayetano Heredia; University of Toronto	Silva-Santisteban, A (corresponding author), Univ Peruana Cayetano Heredia, Ctr Interdisciplinary Res Sexual AIDS & Soc, Lima, Peru.	alfonsoss@upch.pe		Perez-Brumer, Amaya/0000-0003-2441-4358; D'Amico, Lynne/0000-0002-4903-7395; salazar, ximena/0000-0003-4998-8251; Silva-Santisteban, Alfonso/0000-0001-7225-3515	Global Equality Fund [SLMAQM15GR1049]	Global Equality Fund	This study was conducted as part of the activities of project UNICXS funded by the Global Equality Fund. Grant number: SLMAQM15GR1049. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Borkan JM., 1999, DOING QUALITATIVE RE, P179; Carter M.J., 2014, SOCIAL SCI, V3, P242, DOI [10.3390/socsci3020242, DOI 10.3390/SOCSCI3020242]; Cicero EC, 2019, ADV NURS SCI, V42, P123, DOI 10.1097/ANS.0000000000000256; Clark JL, 2020, AIDS BEHAV, V24, P233, DOI 10.1007/s10461-019-02506-8; Divan V, 2016, J INT AIDS SOC, V19, P79, DOI 10.7448/IAS.19.3.20803; Hughto JMW, 2015, SOC SCI MED, V147, P222, DOI 10.1016/j.socscimed.2015.11.010; Johnson M, 2020, PREV MED REP, V17, DOI 10.1016/j.pmedr.2020.101052; Kattari SK, 2020, AM J PREV MED, V58, P506, DOI 10.1016/j.amepre.2019.11.014; Kcomt L, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2020.100608; Kidd KM, 2020, PRIMARY CARE, V47, P273, DOI 10.1016/j.pop.2020.02.006; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; MacCarthy S, 2017, SEX HEALTH, V14, P456, DOI 10.1071/SH17096; Meier M J, 1965, Epilepsia, V6, P263, DOI 10.1111/j.1528-1157.1965.tb03794.x; MEYER IH, 1995, J HEALTH SOC BEHAV, V36, P38, DOI 10.2307/2137286; Miller W L, 1994, Fam Pract Res J, V14, P289; Ministerio de Justicia y Derechos Humanos, 2021, PLAN NAC DER HUM 201; Ministerio de Salud, 2016, NORM TECN SAL AT INT; Pearlin LI, 2010, J GERONTOL B-PSYCHOL, V65, P207, DOI 10.1093/geronb/gbp106; Perez-Brumer A, 2020, Perspect Sex Orienta, P13, DOI 10.1037/0000159-002; Perez-Brumer AG, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21462; Perez-Brumer AG, 2016, GLOB PUBLIC HEALTH, V11, P849, DOI 10.1080/17441692.2016.1181193; Pollock L, 2016, GLOB PUBLIC HEALTH, V11, P981, DOI 10.1080/17441692.2016.1167932; Poteat T, 2016, JAIDS-J ACQ IMM DEF, V72, pS210, DOI 10.1097/QAI.0000000000001087; Reisner SL, 2020, SEX MED-UK, V8, P350, DOI 10.1016/j.esxm.2020.05.006; Reisner SL, 2017, AIDS BEHAV, V21, P3299, DOI 10.1007/s10461-017-1768-8; Reisner SL, 2016, LANCET, V388, P412, DOI 10.1016/S0140-6736(16)00684-X; Restar A, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2020.100595; Romanelli M, 2020, AM J PREV MED, V58, pE123, DOI 10.1016/j.amepre.2019.11.002; Scheim A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003471; Scheim AI, 2020, LANCET PUBLIC HEALTH, V5, pE196, DOI 10.1016/S2468-2667(20)30032-3; Silva-Santisteban A, 2012, AIDS BEHAV, V16, P872, DOI 10.1007/s10461-011-0053-5; Sterling J, 2020, TRANSL ANDROL UROL, V9, pS215, DOI 10.21037/tau.2019.09.28; Villayzan, 2012, ESTUDIO FACTORES QUE; White Hughto Jaclyn M, 2016, Transgend Health, V1, P21; Winter S, 2016, LANCET, V388, P390, DOI 10.1016/S0140-6736(16)00683-8	36	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0254494	10.1371/journal.pone.0254494	http://dx.doi.org/10.1371/journal.pone.0254494			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TT3IC	34339444	Green Published, gold			2022-12-26	WOS:000680243400042
J	Matsuzawa, T; Morita, M; Shimane, A; Otsuka, R; Mei, Y; Irie, F; Yamaguchi, Y; Yanai, K; Yoshikawa, T				Matsuzawa, Takuro; Morita, Masanobu; Shimane, Ai; Otsuka, Rina; Mei, Yu; Irie, Fumitoshi; Yamaguchi, Yu; Yanai, Kazuhiko; Yoshikawa, Takeo			Heparan sulfate promotes differentiation of white adipocytes to maintain insulin sensitivity and glucose homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; CELL-SURFACE; PPAR-GAMMA; ADIPOSE; ADIPOGENESIS; RECEPTOR; TARGET; FAT; ACTIVATION; ENZYME	Heparan sulfate (HS), a highly sulfated linear polysaccharide, is involved in diverse biological functions in various tissues. Although previous studies have suggested a possible contribution of HS to the differentiation of white adipocytes, there has been no direct evidence supporting this. Here, we inhibited the synthesis of HS chains in 3T3-L1 cells using CRISPR-Cas9 technology, resulting in impaired differentiation of adipocytes with attenuated bone morphogenetic protein 4 (BMP4)- fibroblast growth factor 1 (FGF1) signaling pathways. HS reduction resulted in reduced glucose uptake and decreased insulin-dependent intracellular signaling. We then made heterozygous mutant mice for the Ext1 gene, which encodes an enzyme essential for the HS biosynthesis, specifically in the visceral white adipose tissue (Fabp4-Cre(+)::Ext1(flox/WT) mice, hereafter called Ext1(Delta/WT)) to confirm the importance of HS in vivo. The expression levels of transcription factors that control adipocyte differentiation, such as peroxisome proliferator-activated receptor gamma, were reduced in Ext1(Delta/WT) adipocytes, which contained smaller, unilocular lipid droplets, reduced levels of enzymes involved in lipid synthesis, and altered expression of BMP4-FGF1 signaling molecules. Furthermore, we examined the impact of HS reduction in visceral white adipose tissue on systemic glucose homeostasis. We observed that Ext1(Delta/WT) mice showed glucose intolerance because of insulin resistance. Our results demonstrate that HS plays a crucial role in the differentiation of white adipocytes through BMP4-FGF1 signaling pathways, thereby contributing to insulin sensitivity and glucose homeostasis.	[Matsuzawa, Takuro; Shimane, Ai; Otsuka, Rina; Mei, Yu; Yanai, Kazuhiko; Yoshikawa, Takeo] Tohoku Univ, Grad Sch Med, Dept Pharmacol, Sendai, Miyagi, Japan; [Morita, Masanobu] Tohoku Univ, Grad Sch Med, Dept Environm Med & Mol Toxicol, Sendai, Miyagi, Japan; [Irie, Fumitoshi; Yamaguchi, Yu] Sanford Burnham Prebys Med Discovery Inst, Human Genet Program, La Jolla, CA USA	Tohoku University; Tohoku University; Sanford Burnham Prebys Medical Discovery Institute	Yoshikawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Pharmacol, Sendai, Miyagi, Japan.	tyoshikawa@med.tohoku.ac.jp	Yoshikawa, Takeo/U-1823-2019	Yoshikawa, Takeo/0000-0002-7056-6021; Yamaguchi, Yu/0000-0003-0098-281X	Japan Society for the Promotion of Science KAKENHI [JP20J11179]; Nishinomiya Basic Research Fund, Japan; Anzai Diabetes Memorial Research Fund, Japan; National Institutes of Health, USA [R01 AR055670]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nishinomiya Basic Research Fund, Japan; Anzai Diabetes Memorial Research Fund, Japan; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Japan Society for the Promotion of Science KAKENHI grant number JP20J11179 (to T. M.); Nishinomiya Basic Research Fund (to T. M.), Japan; Anzai Diabetes Memorial Research Fund, Japan (to T. Y.); and National Institutes of Health grant R01 AR055670 (to Y. Y.), USA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BOURDON MA, 1987, P NATL ACAD SCI USA, V84, P3194, DOI 10.1073/pnas.84.10.3194; Chang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095045; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Clarke AJ, 2018, J EXP MED, V215, P399, DOI 10.1084/jem.20170771; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fellgett SW, 2015, J CELL SCI, V128, P1408, DOI 10.1242/jcs.164467; Foster MT, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.15; Foster MT, 2011, PHYSIOL BEHAV, V104, P845, DOI 10.1016/j.physbeh.2011.04.064; FROST SC, 1985, J BIOL CHEM, V260, P2646; Garin-Shkolnik T, 2014, DIABETES, V63, P900, DOI 10.2337/db13-0436; Greenall SA, 2016, MABS-AUSTIN, V8, P246, DOI 10.1080/19420862.2015.1122149; Hallakou S, 1997, DIABETES, V46, P1393, DOI 10.2337/diabetes.46.9.1393; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; Harmon AW, 2004, AM J PHYSIOL-ENDOC M, V287, pE758, DOI 10.1152/ajpendo.00581.2003; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hoffmann JM, 2017, CELL REP, V20, P1038, DOI 10.1016/j.celrep.2017.07.020; Hutley LJ, 2011, MOL CELL ENDOCRINOL, V339, P165, DOI 10.1016/j.mce.2011.04.012; Iida T, 2015, GLIA, V63, P1213, DOI 10.1002/glia.22812; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Inubushi T, 2018, J BONE MINER RES, V33, P658, DOI 10.1002/jbmr.3341; Irie F, 2012, P NATL ACAD SCI USA, V109, P5052, DOI 10.1073/pnas.1117881109; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; Lee MJ, 2019, DIABETES, V68, P587, DOI 10.2337/db18-0955; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lubura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037026; Martinez L, 2010, BIOCHEM PHARMACOL, V79, P1300, DOI 10.1016/j.bcp.2009.12.013; Matsumoto Y, 2010, J BIOL CHEM, V285, P19227, DOI 10.1074/jbc.M110.105338; Matsuzawa T, 2018, BIOCHEM BIOPH RES CO, V499, P688, DOI 10.1016/j.bbrc.2018.03.213; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Miller SG, 1996, P NATL ACAD SCI USA, V93, P5507, DOI 10.1073/pnas.93.11.5507; Moens SJB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115662; Moore AF, 2008, DIABETES, V57, P2503, DOI 10.2337/db08-0284; Mullican SE, 2013, MOL ENDOCRINOL, V27, P127, DOI 10.1210/me.2012-1267; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417; Satoh M, 2008, EUR J CLIN INVEST, V38, P97, DOI 10.1111/j.1365-2362.2007.01912.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seip M, 1996, ACTA PAEDIATR, V85, P2, DOI 10.1111/j.1651-2227.1996.tb14262.x; Serafini S, 2017, DIAGN PATHOL, V12, DOI 10.1186/s13000-017-0673-9; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Smith U, 2016, J INTERN MED, V280, P465, DOI 10.1111/joim.12540; Suenaga M, 2013, CYTOKINE, V64, P138, DOI 10.1016/j.cyto.2013.07.011; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Tran TH, 2012, J BIOL CHEM, V287, P32651, DOI 10.1074/jbc.M112.353243; van Wijk XMR, 2014, ANGIOGENESIS, V17, P443, DOI 10.1007/s10456-013-9401-6; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wilsie Larissa C, 2005, Lipids Health Dis, V4, P2, DOI 10.1186/1476-511X-4-2; Yamada Y, 2020, NEUROPHARMACOLOGY, V175, DOI 10.1016/j.neuropharm.2020.108179; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yokoyama M, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2020.129707; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhang P, 2018, CELL, V174, P1450, DOI 10.1016/j.cell.2018.07.002; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	61	4	4	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101006	10.1016/j.jbc.2021.101006	http://dx.doi.org/10.1016/j.jbc.2021.101006			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34310946	Green Published, gold			2022-12-26	WOS:000706418900003
J	Weismiller, HA; Holub, TJ; Krzesinski, BJ; Margittai, M				Weismiller, Hilary A.; Holub, Tyler J.; Krzesinski, Brad J.; Margittai, Martin			A thiol-based intramolecular redox switch in four-repeat tau controls fibril assembly and disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYO-EM STRUCTURES; PROTEIN-TAU; STRUCTURAL-CHARACTERIZATION; HEPARIN-BINDING; DISULFIDE BONDS; SEEDING BARRIER; FILAMENTS; AGGREGATION; MECHANISMS; CYSTEINE-322	Oxidative stress has been implicated in the pathogenesis and progression of several tauopathies, including Alzheimer's dis-ease. The deposition of fibrillar inclusions made of tau protein is one of the pathological hallmarks of these disorders. Although it is becoming increasingly evident that the specific fibril structure may vary from one tauopathy to another and it is recognized that different types of isoforms (three-repeat and four-repeat tau) can be selectively deposited, little is known about the role oxidation may play in aggregation. Four-repeat tau contains two cysteines that can form an intramolecular disulfide bond, resulting in a structurally restrained compact monomer. There is discrepancy as to whether this monomer can aggregate or not. Using isolated four-repeat tau monomers (htau40) with intramolecular disulfide bonds, we demonstrate that these proteins form fibrils. The fibrils are less stable than fibrils formed under reducing conditions but are highly effec-tive in seeding oxidized tau monomers. Conversely, a strong seeding barrier prevents incorporation of reduced tau mono-mers, tau mimics in which the cysteines have been replaced by alanines or serines, and three-repeat tau (htau23), a single-cysteine isoform. The barrier also holds true when seed and monomer types are reversed, indicating that oxidized and reduced tau are incompatible with each other. Surprisingly, fibrils composed of compact tau disaggregate upon reduction, highlighting the importance of the intramolecular disulfide bond for fibril stability. The findings uncover a novel binary redox switch that controls the aggregation and disaggregation of these fibrils and extend the conformational spectrum of tau aggregates.	[Weismiller, Hilary A.; Holub, Tyler J.; Krzesinski, Brad J.; Margittai, Martin] Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA	University of Denver	Margittai, M (corresponding author), Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA.	martin.margittai@du.edu	Margittai, Martin/D-5039-2014	Margittai, Martin/0000-0003-1903-5927	NIH [RF1AG061566]; Ted Puck Endowed Chair position	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ted Puck Endowed Chair position	This work was funded by the NIH grant RF1AG061566 (to M. M.). The work was also supported by the Ted Puck Endowed Chair position (to M. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Arakhamia T, 2020, CELL, V180, P633, DOI 10.1016/j.cell.2020.01.027; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Bhattacharya K, 2001, BIOCHEM BIOPH RES CO, V285, P20, DOI 10.1006/bbrc.2001.5116; Braakman M. J., 2018, ROYAL SOC CHEM, P1, DOI DOI 10.1039/9781788013253-00001; Brunello CA, 2020, CELL MOL LIFE SCI, V77, P1721, DOI 10.1007/s00018-019-03349-1; Cereghetti G, 2018, CELL CYCLE, V17, P1545, DOI 10.1080/15384101.2018.1480220; Crowe A, 2013, J BIOL CHEM, V288, P11024, DOI 10.1074/jbc.M112.436006; Dinkel PD, 2015, BIOCHEMISTRY-US, V54, P4731, DOI 10.1021/acs.biochem.5b00453; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Fichou Y, 2018, P NATL ACAD SCI USA, V115, P13234, DOI 10.1073/pnas.1810058115; Fichou Y, 2018, CHEM COMMUN, V54, P4573, DOI 10.1039/c8cc01355a; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025; Furukawa Y, 2011, J BIOL CHEM, V286, P27236, DOI 10.1074/jbc.M111.248963; Gibbons GS, 2019, JAMA NEUROL, V76, P101, DOI 10.1001/jamaneurol.2018.2505; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Gotz J, 2019, ANNU REV PATHOL-MECH, V14, P239, DOI 10.1146/annurev-pathmechdis-012418-012936; Hou YJ, 2019, NAT REV NEUROL, V15, P565, DOI 10.1038/s41582-019-0244-7; Hughson AG., 2021, STRUCTURE INFECTIOUS, DOI [10.1101/2021.02.14.431014, DOI 10.1101/2021.02.14.431014]; Iadanza MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06761-6; Jacob C, 2004, ORG BIOMOL CHEM, V2, P1953, DOI 10.1039/b406180b; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Lee YM, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03355-3; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2006, METHOD ENZYMOL, V413, P122, DOI 10.1016/S0076-6879(06)13007-4; MCLELLAN T, 1982, ANAL BIOCHEM, V126, P94, DOI 10.1016/0003-2697(82)90113-0; Meyer V, 2014, BIOCHEMISTRY-US, V53, P5804, DOI 10.1021/bi501050g; Meyer V, 2014, ANGEW CHEM INT EDIT, V53, P1590, DOI 10.1002/anie.201308473; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Nachman E, 2020, J BIOL CHEM, V295, P9676, DOI 10.1074/jbc.RA120.013478; Nespovitaya N, 2016, J AM CHEM SOC, V138, P846, DOI 10.1021/jacs.5b08694; Otzen D, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033860; PACE CN, 1988, J BIOL CHEM, V263, P11820; POLAND DC, 1965, BIOPOLYMERS, V3, P379, DOI 10.1002/bip.1965.360030404; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Radamaker L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21126-2; Radamaker L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09032-0; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Sbodio JI, 2019, ANTIOXID REDOX SIGN, V30, P1450, DOI 10.1089/ars.2017.7321; SCHELLMAN JOHN A., 1955, COMPT REND TRAV LAB CARLSBERG SER CHIM, V29, P230; Scheres SHW, 2020, CURR OPIN STRUC BIOL, V64, P17, DOI 10.1016/j.sbi.2020.05.011; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Siddiqua A, 2010, J BIOL CHEM, V285, P37920, DOI 10.1074/jbc.M110.185728; Siddiqua A, 2012, J AM CHEM SOC, V134, P10271, DOI 10.1021/ja303498q; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; Soragni A, 2008, BIOCHEMISTRY-US, V47, P10841, DOI 10.1021/bi8008856; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Strang KH, 2019, LAB INVEST, V99, P912, DOI 10.1038/s41374-019-0197-x; Strang KH, 2018, J BIOL CHEM, V293, P2408, DOI 10.1074/jbc.M117.815357; Swuec P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09133-w; Tonnies E, 2017, J ALZHEIMERS DIS, V57, P1105, DOI 10.3233/JAD-161088; Walker S, 2012, J BIOL CHEM, V287, P9591, DOI 10.1074/jbc.M111.336107; Wang LQ, 2020, NAT STRUCT MOL BIOL, V27, P598, DOI 10.1038/s41594-020-0441-5; Wegmann S, 2013, P NATL ACAD SCI USA, V110, pE313, DOI 10.1073/pnas.1212100110; Weismiller HA, 2018, J BIOL CHEM, V293, P17336, DOI 10.1074/jbc.RA118.005316; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Zhang WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.43584; Zhang WJ, 2020, NATURE, V580, P283, DOI 10.1038/s41586-020-2043-0; Zhao J, 2017, BIOPHYS J, V112, P921, DOI 10.1016/j.bpj.2017.01.024; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691; Zubcic K, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.572308	72	2	2	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101021	10.1016/j.jbc.2021.101021	http://dx.doi.org/10.1016/j.jbc.2021.101021			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34339733	Green Published, gold			2022-12-26	WOS:000706408900004
J	Welch, N; Singh, SS; Kumar, A; Dhruba, SR; Mishra, S; Sekar, J; Bellar, A; Attaway, AH; Chelluboyina, A; Willard, BB; Li, L; Huo, ZG; Karnik, SS; Esser, K; Longworth, MS; Shah, YM; Davuluri, G; Pal, R; Dasarathy, S				Welch, Nicole; Singh, Shashi Shekhar; Kumar, Avinash; Dhruba, Saugato Rahman; Mishra, Saurabh; Sekar, Jinendiran; Bellar, Annette; Attaway, Amy H.; Chelluboyina, Aruna; Willard, Belinda B.; Li, Ling; Huo, Zhiguang; Karnik, Sadashiva S.; Esser, Karyn; Longworth, Michelle S.; Shah, Yatrik M.; Davuluri, Gangarao; Pal, Ranadip; Dasarathy, Srinivasan			Integrated multiomics analysis identifies molecular landscape perturbations during hyperammonemia in skeletal muscle and myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-SEQ EXPERIMENTS; AMMONIA METABOLISM; SYSTEMS BIOLOGY; TRANSCRIPTIONAL REGULATION; EXPRESSION ANALYSIS; SENESCENCE; QUANTIFICATION; GLYCOSYLATION; SARCOPENIA; CIRRHOSIS	Ammonia is a cytotoxic molecule generated during normal cellular functions. Dysregulated ammonia metabolism, which is evident in many chronic diseases such as liver cirrhosis, heart failure, and chronic obstructive pulmonary disease, initiates a hyperammonemic stress response in tissues including skeletal muscle and in myotubes. Perturbations in levels of specific regulatory molecules have been reported, but the global responses to hyperammonemia are unclear. In this study, we used a multiomics approach to vertically integrate unbiased data generated using an assay for transposase-accessible chromatin with high-throughput sequencing, RNA-Seq, and proteomics. We then horizontally integrated these data across different models of hyperammonemia, including myotubes and mouse and human muscle tissues. Changes in chromatin accessibility and/or expression of genes resulted in distinct clusters of temporal molecular changes including transient, persistent, and delayed responses during hyperammonemia in myotubes. Known responses to hyperammonemia, including mitochondrial and oxidative dysfunction, protein homeostasis disruption, and oxidative stress pathway activation, were enriched in our datasets. During hyperammonemia, pathways that impact skeletal muscle structure and function that were consistently enriched were those that contribute to mitochondrial dysfunction, oxidative stress, and senescence. We made several novel observations, including an enrichment in antiapoptotic B-cell leukemia/lymphoma 2 family protein expression, increased calcium flux, and increased protein glycosylation in myotubes and muscle tissue upon hyperammonemia. Critical molecules in these pathways were validated experimentally. Human skeletal muscle from patients with cirrhosis displayed similar responses, establishing translational relevance. These data demonstrate complex molecular interactions during adaptive and maladaptive responses during the cellular stress response to hyperammonemia.	[Welch, Nicole; Singh, Shashi Shekhar; Kumar, Avinash; Mishra, Saurabh; Sekar, Jinendiran; Bellar, Annette; Attaway, Amy H.; Chelluboyina, Aruna; Longworth, Michelle S.; Dasarathy, Srinivasan] Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44106 USA; [Welch, Nicole; Dasarathy, Srinivasan] Cleveland Clin, Dept Gastroenterol & Hepatol, Cleveland, OH 44106 USA; [Dhruba, Saugato Rahman; Pal, Ranadip] Texas Tech Univ, Dept Elect & Comp Engn, Lubbock, TX 79409 USA; [Attaway, Amy H.] Cleveland Clin, Lerner Res Inst, Dept Pulm Med, Cleveland, OH 44106 USA; [Willard, Belinda B.; Li, Ling] Cleveland Clin, Lerner Res Inst, Prote Res Core Serv, Cleveland, OH 44106 USA; [Huo, Zhiguang] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL USA; [Karnik, Sadashiva S.] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA; [Esser, Karyn] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL USA; [Shah, Yatrik M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Shah, Yatrik M.] Univ Michigan, Dept Gastroenterol, Ann Arbor, MI 48109 USA; [Davuluri, Gangarao] Pennington Biomed Res Ctr, Integrated Physiol & Mol Metab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Texas Tech University System; Texas Tech University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; State University System of Florida; University of Florida; Cleveland Clinic Foundation; State University System of Florida; University of Florida; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Dasarathy, S (corresponding author), Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44106 USA.; Dasarathy, S (corresponding author), Cleveland Clin, Dept Gastroenterol & Hepatol, Cleveland, OH 44106 USA.; Pal, R (corresponding author), Texas Tech Univ, Dept Elect & Comp Engn, Lubbock, TX 79409 USA.	Ranadip.pal@ttu.edu; dasaras@ccf.org	CHELLUBOYINA, ARUNA KUMAR/GXG-8165-2022; Sekar, Jinendiran/AEJ-5723-2022; Singh, Shashi Shekhar/AAD-7584-2021; CHELLUBOYINA, ARUNA KUMAR/GZL-7536-2022; longworth, michelle/S-8456-2019	CHELLUBOYINA, ARUNA KUMAR/0000-0001-7201-3810; Sekar, Jinendiran/0000-0002-8044-1628; Singh, Shashi Shekhar/0000-0002-9294-4855; CHELLUBOYINA, ARUNA KUMAR/0000-0001-7201-3810; Dhruba, Saugato Rahman/0000-0001-5947-6757	National Institutes of Health (NIH) [RO1 GM119174, RO1 DK113196, P50 AA024333, RO1 AA021890, 3U01AA026976-03S1, UO1 AA 026976, R56HL141744, UO1 DK061732, 5U01 DK062470-17S2, R21 AR 071046]; Howard and Helen Trevey Endowment; American College of Gastroenterology Clinical Research Award; Velosano grant; Department of Defense [PR150084]; Cure for IBD; NIH [K08 AA028794, 1S10OD023436-01, R21AI153780];  [K12 HL141952];  [R01CA148828];  [R01DK095201];  [R01CA245546]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard and Helen Trevey Endowment; American College of Gastroenterology Clinical Research Award; Velosano grant; Department of Defense(United States Department of Defense); Cure for IBD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; 	S. D. is partially supported by the National Institutes of Health (NIH) RO1 GM119174; RO1 DK113196; P50 AA024333; RO1 AA021890; 3U01AA026976-03S1; UO1 AA 026976; R56HL141744;UO1 DK061732; 5U01 DK062470-17S2; R21 AR 071046 (also G. D. is supported); and the Howard and Helen Trevey Endowment. N. W. is partially supported by the NIH K08 AA028794 and the American College of Gastroenterology Clinical Research Award. The proteomics core is partially supported by the NIH shared instrument grant 1S10OD023436-01. A. H. A. and N. W. were supported by K12 HL141952. M. S. L. was supported by the NIH R21AI153780, Velosano grant, Department of Defense grant no. PR150084, and by Cure for IBD. Y. S. S. was supported by R01CA148828, R01DK095201, and R01CA245546. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adeva MM, 2012, METABOLISM, V61, P1495, DOI 10.1016/j.metabol.2012.07.007; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; BORYS MC, 1994, BIOTECHNOL BIOENG, V43, P505, DOI 10.1002/bit.260430611; Cavalcante RG, 2017, BIOINFORMATICS, V33, P2381, DOI 10.1093/bioinformatics/btx183; Chen G, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00317; Cisek K, 2016, NEPHROL DIAL TRANSPL, V31, P2003, DOI 10.1093/ndt/gfv364; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Dam G, 2013, METAB BRAIN DIS, V28, P217, DOI 10.1007/s11011-013-9377-3; Damink SWMO, 2002, NEUROCHEM INT, V41, P177, DOI 10.1016/S0197-0186(02)00040-2; Dasarathy S, 2018, CURR OPIN CLIN NUTR, V21, P30, DOI 10.1097/MCO.0000000000000426; Dasarathy S, 2017, METAB BRAIN DIS, V32, P529, DOI 10.1007/s11011-016-9938-3; Dasarathy S, 2011, J HEPATOL, V54, P915, DOI 10.1016/j.jhep.2010.08.032; Davuluri G, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00451-18; Davuluri G, 2016, J PHYSIOL-LONDON, V594, P7341, DOI 10.1113/JP272796; Davuluri G, 2016, J HEPATOL, V65, P929, DOI 10.1016/j.jhep.2016.06.004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; GANDA OP, 1976, METABOLISM, V25, P427, DOI 10.1016/0026-0495(76)90075-5; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gorg B, 2015, GLIA, V63, P37, DOI 10.1002/glia.22731; Haider S, 2013, CURR GENOMICS, V14, P91, DOI 10.2174/1389202911314020003; Holecek M, 2019, AMINO ACIDS, V51, P1667, DOI 10.1007/s00726-019-02803-5; Jayakumar AR, 2009, J NEUROCHEM, V109, P252, DOI 10.1111/j.1471-4159.2009.05842.x; Kant S, 2019, J BIOL CHEM, V294, P7231, DOI 10.1074/jbc.RA118.005411; Kappler M, 2017, CLIN ORAL INVEST, V21, P211, DOI 10.1007/s00784-016-1780-9; Kelly RT, 2020, MOL CELL PROTEOMICS, V19, P1739, DOI 10.1074/mcp.R120.002234; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kitajima S, 2017, ONCOTARGET, V8, P114481, DOI 10.18632/oncotarget.23010; Klemann CJHM, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-017-0015-3; Koster J, 2018, BIOINFORMATICS, V34, P3600, DOI 10.1093/bioinformatics/bty350; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kumar A, 2019, FREE RADICAL BIO MED, V145, P284, DOI 10.1016/j.freeradbiomed.2019.09.031; Kumar A, 2017, HEPATOLOGY, V65, P2045, DOI 10.1002/hep.29107; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lau E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02467-3; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li ZJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1642-2; LOCKWOOD AH, 1979, J CLIN INVEST, V63, P449, DOI 10.1172/JCI109322; Love JT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07669-x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Norenberg MD, 2009, METAB BRAIN DIS, V24, P103, DOI 10.1007/s11011-008-9113-6; Orchard P, 2020, CELL SYST, V10, P298, DOI 10.1016/j.cels.2020.02.009; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Qiu J, 2013, P NATL ACAD SCI USA, V110, P18162, DOI 10.1073/pnas.1317049110; Qiu J, 2012, AM J PHYSIOL-ENDOC M, V303, pE983, DOI 10.1152/ajpendo.00183.2012; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Rimland CA, 2021, HEPATOLOGY, V73, P247, DOI 10.1002/hep.31252; Robinson SW, 2014, COMPUT STRUCT BIOTEC, V11, P35, DOI 10.1016/j.csbj.2014.08.007; Sapieha P, 2018, TRENDS CELL BIOL, V28, P595, DOI 10.1016/j.tcb.2018.03.003; Schlotter F, 2018, CIRCULATION, V138, P377, DOI 10.1161/CIRCULATIONAHA.117.032291; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrattenholz A, 2010, METHODS MOL BIOL, V662, P29, DOI 10.1007/978-1-60761-800-3_2; Seliger B, 2009, PROTEOMICS, V9, P1567, DOI 10.1002/pmic.200700288; Singh KD, 2019, J CHEM INF MODEL, V59, P373, DOI 10.1021/acs.jcim.8b00583; Singh Shashi Shekhar, 2021, Cell Physiol Biochem, V55, P91, DOI 10.33594/000000327; Suzuki H, 2002, AM J PHYSIOL-GASTR L, V283, pG986, DOI 10.1152/ajpgi.00482.2001; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsien C, 2015, HEPATOLOGY, V61, P2018, DOI 10.1002/hep.27717; von Zglinicki T, 2021, ANTIOXID REDOX SIGN, V34, P308, DOI 10.1089/ars.2020.8048; Walker V, 2014, ADV CLIN CHEM, V67, P73, DOI 10.1016/bs.acc.2014.09.002; Wang DG, 2008, COMPUT BIOL CHEM, V32, P462, DOI 10.1016/j.compbiolchem.2008.07.014; Wang FG, 2018, MUTAGENESIS, V33, P291, DOI 10.1093/mutage/gey023; Wang RS, 2015, WIRES SYST BIOL MED, V7, P141, DOI 10.1002/wsbm.1297; Wang Y, 2015, MOL CELL, V58, P598, DOI 10.1016/j.molcel.2015.05.005; Welch N, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020659; Yang M, 2000, BIOTECHNOL PROGR, V16, P751, DOI 10.1021/bp000090b; Yuan GC, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1218-y; Zhang B, 2013, GENOME RES, V23, P1522, DOI 10.1101/gr.156539.113; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.414	84	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101023	10.1016/j.jbc.2021.101023	http://dx.doi.org/10.1016/j.jbc.2021.101023			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34343564	gold, Green Published			2022-12-26	WOS:000706408900011
J	Inoue, H; Murase, Y; Todo, Y				Inoue, Hiroyasu; Murase, Yohsuke; Todo, Yasuyuki			Do economic effects of the anti-COVID-19 lockdowns in different regions interact through supply chains?	PLOS ONE			English	Article							SHOCKS; PROPAGATION; NETWORK	To prevent the spread of COVID-19, many cities, states, and countries have 'locked down', restricting economic activities in non-essential sectors. Such lockdowns have substantially shrunk production in most countries. This study examines how the economic effects of lockdowns in different regions interact through supply chains, which are a network of firms for production, by simulating an agent-based model of production using supply-chain data for 1.6 million firms in Japan. We further investigate how the complex network structure affects the interactions between lockdown regions, emphasising the role of upstreamness and loops by decomposing supply-chain flows into potential and circular flow components. We find that a region's upstreamness, intensity of loops, and supplier substitutability in supply chains with other regions largely determine the economic effect of the lockdown in the region. In particular, when a region lifts its lockdown, its economic recovery substantially varies depending on whether it lifts the lockdown alone or together with another region closely linked through supply chains. These results indicate that the economic effect produced by exogenous shocks in a region can affect other regions and therefore this study proposes the need for inter-region policy coordination to reduce economic loss due to lockdowns.	[Inoue, Hiroyasu] Univ Hyogo, Grad Sch Informat Sci, Kobe, Hyogo, Japan; [Murase, Yohsuke] RIKEN, Ctr Computat Sci, Kobe, Hyogo, Japan; [Todo, Yasuyuki] Waseda Univ, Grad Sch Econ, Tokyo, Japan	University of Hyogo; RIKEN; Waseda University	Inoue, H (corresponding author), Univ Hyogo, Grad Sch Informat Sci, Kobe, Hyogo, Japan.	inoue@gsis.u-hyogo.ac.jp		Inoue, Hiroyasu/0000-0003-1639-4801	Japan Society for the Promotion of Science [18K04615, 18H03642]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	H.I., 18K04615, Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/index.html, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Y.T, 18H03642, Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/index.html, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro L, 2019, J POLIT ECON, V127, P508, DOI 10.1086/700935; [Anonymous], 2020, FINANCIAL STABILITY; [Anonymous], 2020, SWEDEN HAS BECOME WO; [Anonymous], 2020, GOV RESP COR DIS 201; [Anonymous], 2015, INP OUTP TABL JAP; [Anonymous], 2018, INT WORKSH MASS MULT; [Anonymous], 2013, JAP STAND IND CLASS; Antras P, 2013, ECONOMETRICA, V81, P2127, DOI 10.3982/ECTA10813; Antras P, 2012, AM ECON REV, V102, P412, DOI 10.1257/aer.102.3.412; Axtell Robert., 2006, GENERATIVE SOCIAL SC; Barabasi A.-L., 2016, NETWORK SCI; Barrot JN, 2016, Q J ECON, V131, P1543, DOI 10.1093/qje/qjw018; Boehm CE, 2019, REV ECON STAT, V101, P60, DOI 10.1162/rest_a_00750; Bonadio Barthelemy, 2020, NBER WORKING PAPER S, V7224; Branger Nicole, 2019, 3476690 SSRN; Carvalho V. M., 2016, SUPPLY CHAIN DISRUPT; Demirel G, 2019, J OPER MANAG, V65, P136, DOI 10.1002/joom.1005; Fally T., 2012, PRODUCTION STAGING M; Fally Thibault, 2017, COASIAN MODEL INT PR; Fu Jiangtao, 2018, RIETI DISCUSSION PAP, V18; Fujiwara Y, 2010, EUR PHYS J B, V77, P565, DOI 10.1140/epjb/e2010-00275-2; Gomez CJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12650-3; Guan DB, 2020, NAT HUM BEHAV, V4, P577, DOI 10.1038/s41562-020-0896-8; Hale T., 2020, OXFORD COVID 19 GOVT; Hallegatte S, 2008, RISK ANAL, V28, P779, DOI 10.1111/j.1539-6924.2008.01046.x; Hunter RF, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002890; Inoue H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239251; Inoue H, 2019, NAT SUSTAIN, V2, P841, DOI 10.1038/s41893-019-0351-x; Inoue H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213648; Kashiwagi Yuzuka, 2018, E1810 WINPEC; Kichikawa Y, 2019, APPL NETW SCI, V4, DOI 10.1007/s41109-019-0202-8; Kremer M, 2007, Q J ECON, V122, P1007, DOI 10.1162/qjec.122.3.1007; LeBaron B, 2008, AM ECON REV, V98, P246, DOI 10.1257/aer.98.2.246; McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796; Ministry of Economy Trade and Industry, 2020, IND ALL IND PROD; Murase Y, 2017, J PHYS CONF SER, V921, DOI 10.1088/1742-6596/921/1/012001; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Sciabolazza VL, 2020, SOC NETWORKS, V61, P181, DOI 10.1016/j.socnet.2019.11.003; Senge P.M., 1980, SYSTEM DYNAMICS TIMS, V14, P209; Taylor JB, 2013, J POLICY MODEL, V35, P463, DOI 10.1016/j.jpolmod.2013.03.010; Valente TW, 2017, P NATL ACAD SCI USA, V114, P9500, DOI 10.1073/pnas.1712473114; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Wasserman S., 2005, MODELS METHODS SOCIA, P192	44	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255031	10.1371/journal.pone.0255031	http://dx.doi.org/10.1371/journal.pone.0255031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CU	34329336	Green Published, gold, Green Submitted			2022-12-26	WOS:000685248600042
J	Lindberg, LD; Scott, RH; Desai, S; Pleasure, ZH				Lindberg, Laura D.; Scott, Rachel H.; Desai, Sheila; Pleasure, Zoe H.			Comparability of estimates and trends in adolescent sexual and contraceptive behaviors from two national surveys: National Survey of Family Growth and the Youth Risk Behavior Survey	PLOS ONE			English	Article							HEALTH; PREVALENCE; SCHOOL	Objective To compare adolescents' reports of sexual and contraceptive behaviors between the National Survey of Family Growth (NSFG) and the Youth Risk Behavior Survey (YRBS). Methods For each survey, we estimated the year- and sex-specific prevalence of sexual and contraceptive behaviors among a comparably defined sample of US respondents ages 15-19 currently attending high school. We used logistic regression to test for changes in prevalence from 2007-2019 and conducted sensitivity analyses to investigate between-survey differences. Results We found differences in both prevalence and trends between the YRBS and NSFG when limited to a comparably defined sample. Compared to the NSFG, adolescents in the YRBS were more likely to report being sexually experienced, less likely to report use of prescription methods for both sexes, and less likely to report condoms among males. Only the YRBS estimated significant declines in sexual experience for both sexes, and significant increases in prescription methods and declines in condom use among males. Differences between surveys in the prevalence of specific contraceptive methods reflected greater combined use of methods in the NSFG. We identified differences in question-wording and other aspects that may influence these differential patterns. Conclusions The NSFG and YRBS produced inconsistent prevalence estimates and trends for sexual and contraceptive behaviors among in-school adolescents. Further efforts to improve these national surveillance systems are critical to inform policy and research efforts that support adolescent sexual and reproductive health and wellbeing.	[Lindberg, Laura D.; Desai, Sheila; Pleasure, Zoe H.] Guttmacher Inst, New York, NY 10038 USA; [Scott, Rachel H.] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	Lindberg, LD (corresponding author), Guttmacher Inst, New York, NY 10038 USA.	llindberg@guttmacher.org		Lindberg, Laura/0000-0003-2660-9407	Susan Thompson Buffett Foundation [576.04]	Susan Thompson Buffett Foundation	This study was made possible by a grant to the Guttmacher Institute from the Susan Thompson Buffett Foundation (grant no. 576.04). The findings and conclusions in this article are those of the authors and do not necessarily reflect the positions and policies of the donor. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PUBL US DAT FIL DOC; [Anonymous], 2018, TABLE 21970 DIGEST E; [Anonymous], 2011, PUBL US DAT FIL DOC; [Anonymous], 2016, PUBL US DAT FIL DOC; [Anonymous], YOUTH RISK BEHAV SUR; [Anonymous], 2018, PUBL US DAT FIL DOC; [Anonymous], 2020, PUBL US DAT FIL DOC; Ansari-Thomas Z, 2020, CONTRACEPTION, V101, P86, DOI 10.1016/j.contraception.2019.11.001; Brener ND, 2004, J ADOLESCENT HEALTH, V35, P91, DOI 10.1016/j.jadohealth.2003.08.013; Brener ND, 2003, J ADOLESCENT HEALTH, V33, P436, DOI 10.1016/S1054-139X(03)00052-1; Brener ND, 1998, J ADOLESCENT HEALTH, V22, P209, DOI 10.1016/S1054-139X(97)00161-4; Brener ND., 2013, MMWR-MORBID MORTAL W, V62; Brick JM, 2013, ANN AM ACAD POLIT SS, V645, P36, DOI 10.1177/0002716212456834; Centers for Disease Control and Prevention, 2018, INT YRBS TREND DAT; Cimpian JR, 2020, ARCH SEX BEHAV, V49, P1097, DOI 10.1007/s10508-020-01661-7; Daugherty J., 2016, NATL HLTH STAT REP, V17, P1; Fendrich M, 2001, J DRUG ISSUES, V31, P615, DOI 10.1177/002204260103100303; Fish JN, 2018, ARCH SEX BEHAV, V47, P1053, DOI 10.1007/s10508-017-0993-6; Foti K, 2011, J SCHOOL HEALTH, V81, P345, DOI 10.1111/j.1746-1561.2011.00601.x; Fricker S, 2010, PUBLIC OPIN QUART, V74, P934, DOI 10.1093/poq/nfq064; Gfroerer J, 2012, P ANN C AM STAT ASS; Griesler PC, 2008, PUBLIC OPIN QUART, V72, P260, DOI 10.1093/poq/nfn016; Johnson TP, 2003, SUBST USE MISUSE, V38, P1447, DOI 10.1081/JA-120023394; KAHN JR, 1988, DEMOGRAPHY, V25, P189, DOI 10.2307/2061288; Kann L, 2002, J ADOLESCENT HEALTH, V31, P327, DOI 10.1016/S1054-139X(02)00343-9; Lindberg Laura D., 2021, CONTRACEPTION X; Martinez G., 2012, NATL HLTH STAT REP, P1; National Academies of Sciences E, 2019, PROM POS AD HLTH BEH; National Center for Health Statistics, 2017, NSFG FEM CAPI REF QU; Office of Disease Prevention and Health Promotion U.S. Department of Health and Human Services, 2020, HLTH PEOPL 2030 FAM; Phillips G, 2020, ARCH SEX BEHAV, V49, P1409, DOI 10.1007/s10508-020-01746-3; Sanders SA, 1999, JAMA-J AM MED ASSOC, V281, P275, DOI 10.1001/jama.281.3.275; Santelli JS, 2000, FAM PLANN PERSPECT, V32, P156, DOI 10.2307/2648232; Tourangeau R., SURVEY MEASUREMENT T; Twenge JM, 2016, ARCH SEX BEHAV, V45, P1713, DOI 10.1007/s10508-016-0769-4; Underwood JM, 2020, J ADOLESCENT HEALTH, V67, P338, DOI 10.1016/j.jadohealth.2020.06.023; Underwood JM, 2020, MMWR-MORBID MORTAL W, V69, P1, DOI 10.15585/mmwr.su6901a1	37	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0253262	10.1371/journal.pone.0253262	http://dx.doi.org/10.1371/journal.pone.0253262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CU	34329323	gold, Green Published, Green Accepted			2022-12-26	WOS:000685248600026
J	Anderson, SL; Pearson, B; Kjelgren, R; Brym, Z				Anderson, Steven L., II; Pearson, Brian; Kjelgren, Roger; Brym, Zachary			Response of essential oil hemp (Cannabis sativa L.) growth, biomass, and cannabinoid profiles to varying fertigation rates	PLOS ONE			English	Article							ORGANIC FERTILIZER; ACID SYNTHASE; MARIJUANA; NITROGEN; STAGE	Five essential oil hemp (Cannabis sativa L.) cultivars (Cherry Blossom, Cherry Blossom (Tuan), Berry Blossom, Cherry Wine, and Cherry Blossom x Trump) were treated with six fertigation treatments to quantify the effects of synthetic fertilizer rates and irrigation electrical conductivity on plant growth, biomass accumulation, and cannabinoid profiles. Irrigation water was injected with a commercial 20-20-20 fertilizer at rates of 0, 50, 150, 300, 450, and 600 ppm nitrogen equating to 0.33 (control), 0.54, 0.96, 1.59, 2.22, and 2.85 dS m(-1), respectively. Plants were grown under artificial lighting (18 hr) to maintain vegetative growth for eight weeks, followed by an eight-week flowering period. High linear relationship between chlorophyll concentrations and SPAD-502 measurements validated the utilization of SPAD meters to rapidly identify nutrient deficiency in essential oil hemp. Cultivars expressed significant variation in plant height and cannabinoid profiles (% dry mass), in concurrence with limited biomass and cannabinoid (g per plant) yield variation. Cherry Blossom was the best performing cultivar and Cherry Wine was the least productive. Variation in plant growth, biomass, and cannabinoid concentrations were affected to a greater extent by fertilizer rates. Optimal fertilizer rates were observed at 50 ppm N, while increased fertilizer rates significantly reduced plant growth, biomass accumulation, and cannabinoid concentrations. Increased fertilizer rates (> 300 ppm N) resulted in compliant THC levels (< 0.3%), although when coupled with biomass reductions resulted in minimal cannabinoid yields. Additionally, CBD concentration demonstrated higher sensitivity to increased fertilizer rates (> 300 ppm N) compared to THC and CBG (> 450 ppm N). The results of this study can serve as a guide when using fertigation methods on essential oil hemp cultivars; although results may differ with cultivar selection, environmental conditions, and management practices.	[Anderson, Steven L., II; Pearson, Brian; Kjelgren, Roger] Univ Florida, Inst Food & Agr Sci, Mid Florida Res & Educ Ctr, Dept Environm Hort, Apopka, FL 32703 USA; [Brym, Zachary] Univ Florida, Inst Food & Agr Sci, Trop Res & Educ Ctr, Dept Agron, Homestead, FL 33031 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Pearson, B (corresponding author), Univ Florida, Inst Food & Agr Sci, Mid Florida Res & Educ Ctr, Dept Environm Hort, Apopka, FL 32703 USA.	bpearson@ufl.edu		Anderson, Steven/0000-0001-5153-3083	Green Roads, LLC; UF/IFAS Office of the Dean and Research - Roseville Farm's UF/IFAS Florida Industrial Hemp Endowment	Green Roads, LLC; UF/IFAS Office of the Dean and Research - Roseville Farm's UF/IFAS Florida Industrial Hemp Endowment	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This project was made possible by financial support from Green Roads, LLC and the UF/IFAS Office of the Dean and Research. Steven Anderson was funded by Roseville Farm's UF/IFAS Florida Industrial Hemp Endowment contribution.	Adesina I, 2020, AGRICULTURE-BASEL, V10, DOI 10.3390/agriculture10040129; ARNON DI, 1974, BIOCHIM BIOPHYS ACTA, V357, P231, DOI 10.1016/0005-2728(74)90063-2; Aubin MP, 2015, CROP FORAGE TURF MAN, V1, DOI 10.2134/cftm2015.0159; Bernstein N, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00736; Berthold EC, 2020, J CANNABIS RES, V2, DOI 10.1186/s42238-020-00050-0; Campbell S., 2019, PROCESS DRYING POSTH, V2019; Caplan D, 2017, HORTSCIENCE, V52, P1796, DOI 10.21273/HORTSCI12401-17; Caplan D, 2017, HORTSCIENCE, V52, P1307, DOI 10.21273/HORTSCI11903-17; COFFMAN CB, 1977, AGRON J, V69, P832, DOI 10.2134/agronj1977.00021962006900050026x; ElSohly MA, 2005, LIFE SCI, V78, P539, DOI 10.1016/j.lfs.2005.09.011; Gao CS, 2018, INT J GENOMICS, V2018, DOI 10.1155/2018/3057272; Grassa CJ, 2021, NEW PHYTOL, V230, P1665, DOI 10.1111/nph.17243; Hanus LO, 2016, NAT PROD REP, V33, P1357, DOI 10.1039/c6np00074f; Hawkesford M, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P135, DOI 10.1016/B978-0-12-384905-2.00006-6; Henry P, 2020, J CANNABIS RES, V2, DOI 10.1186/s42238-020-00036-y; Incrocci L, 2017, HORTICULTURAE, V3, DOI 10.3390/horticulturae3020037; Konica-Minolta, 1989, CHLOROPHYLL METER SP; Laverty KU, 2019, GENOME RES, V29, P146, DOI 10.1101/gr.242594.118; Liu JJ, 2016, PHYSIOL MOL BIOL PLA, V22, P429, DOI 10.1007/s12298-016-0381-z; Livingston SJ, 2020, PLANT J, V101, P37, DOI 10.1111/tpj.14516; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Mahlberg P. G., 2004, Journal of Industrial Hemp, V9, P15, DOI 10.1300/J237v09n01_04; Marks MD, 2009, MOL PLANT, V2, P803, DOI 10.1093/mp/ssp037; MUNNS R, 1995, AUST J PLANT PHYSIOL, V22, P561, DOI 10.1071/PP9950561; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Rupasinghe HPV, 2020, MOLECULES, V25, DOI 10.3390/molecules25184078; Saloner A, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.572293; Saloner A, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01369; Schluttenhofer C, 2017, TRENDS PLANT SCI, V22, P917, DOI 10.1016/j.tplants.2017.08.004; Sirikantaramas S, 2004, J BIOL CHEM, V279, P39767, DOI 10.1074/jbc.M403693200; Small E, 2016, GENET RESOUR CROP EV, V63, P349, DOI 10.1007/s10722-015-0254-2; Tang K, 2017, IND CROP PROD, V107, P427, DOI 10.1016/j.indcrop.2017.06.033; Taura F, 2007, FEBS LETT, V581, P2929, DOI 10.1016/j.febslet.2007.05.043; Toth JA, 2020, GCB BIOENERGY, V12, P213, DOI 10.1111/gcbb.12667; Vera CL, 2004, CAN J PLANT SCI, V84, P939, DOI 10.4141/P04-022; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; WRIGHT RD, 1986, HORTSCIENCE, V21, P227; Yang R, 2020, J AGR FOOD CHEM, V68, P6058, DOI 10.1021/acs.jafc.0c01211	39	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0252985	10.1371/journal.pone.0252985	http://dx.doi.org/10.1371/journal.pone.0252985			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324496	Green Published, gold			2022-12-26	WOS:000685248200059
J	Bin Masud, S; Jenkins, C; Hussey, E; Elkin-Frankston, S; Mach, P; Dhummakupt, E; Aeron, S				Bin Masud, Shoaib; Jenkins, Conor; Hussey, Erika; Elkin-Frankston, Seth; Mach, Phillip; Dhummakupt, Elizabeth; Aeron, Shuchin			Utilizing machine learning with knockoff filtering to extract significant metabolites in Crohn's disease with a publicly available untargeted metabolomics dataset	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; POST-SELECTION INFERENCE; FALSE DISCOVERY RATE; MULTIVARIATE-ANALYSIS; MASS-SPECTROMETRY; STRATEGIES; BIOMARKERS; VALUES	Metabolomic data processing pipelines have been improving in recent years, allowing for greater feature extraction and identification. Lately, machine learning and robust statistical techniques to control false discoveries are being incorporated into metabolomic data analysis. In this paper, we introduce one such recently developed technique called aggregate knockoff filtering to untargeted metabolomic analysis. When applied to a publicly available dataset, aggregate knockoff filtering combined with typical p-value filtering improves the number of significantly changing metabolites by 25% when compared to conventional untargeted metabolomic data processing. By using this method, features that would normally not be extracted under standard processing would be brought to researchers' attention for further analysis.	[Bin Masud, Shoaib; Aeron, Shuchin] Tufts Univ, Dept Elect & Comp Engn, Medford, MA 02155 USA; [Hussey, Erika; Elkin-Frankston, Seth] DEVCOM Soldier Ctr, Natick, MA USA; [Jenkins, Conor; Mach, Phillip; Dhummakupt, Elizabeth] DEVCOM Chem Biol Ctr, Aberdeen, MD 21010 USA	Tufts University	Aeron, S (corresponding author), Tufts Univ, Dept Elect & Comp Engn, Medford, MA 02155 USA.; Dhummakupt, E (corresponding author), DEVCOM Chem Biol Ctr, Aberdeen, MD 21010 USA.	elizabeth.s.dhummakupt.civ@mail.mil; shuchin@ece.tufts.edu		Jenkins, Conor/0000-0002-2333-9184; Dhummakupt, Elizabeth/0000-0003-0116-5598	DEVCOM Soldier Center under the Measuring and Advancing Soldier Tactical Readiness and Effectiveness program	DEVCOM Soldier Center under the Measuring and Advancing Soldier Tactical Readiness and Effectiveness program	This analysis technique was funded by DEVCOM Soldier Center under the Measuring and Advancing Soldier Tactical Readiness and Effectiveness program. This funding was awarded to ESD. EKH and SEF, members of the Soldier Center, provided minor preparation of the manuscript.	Albaum SP, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-30; Antonelli J, 2019, METABOLITES, V9, DOI 10.3390/metabo9070143; Barber RF, 2015, ANN STAT, V43, P2055, DOI 10.1214/15-AOS1337; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennike T, 2014, WORLD J GASTROENTERO, V20, P3231, DOI 10.3748/wjg.v20.i12.3231; Berk R, 2013, ANN STAT, V41, P802, DOI 10.1214/12-AOS1077; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Bunger R, 2016, CRIT CARE MED, V44, P1784, DOI 10.1097/CCM.0000000000001795; Candes E, 2016, ARXIV PREPRINT ARXIV; Ching T, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0387; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Cross AJ, 2014, CANCER-AM CANCER SOC, V120, P3049, DOI 10.1002/cncr.28799; DeFranchis R, 1997, ALIMENT PHARM THER, V11, P845, DOI 10.1046/j.1365-2036.1997.00212.x; Goodwin CR, 2014, ANAL CHEM, V86, P6563, DOI 10.1021/ac5010794; Armitage EG, 2015, ELECTROPHORESIS, V36, P3050, DOI 10.1002/elps.201500352; Gromski PS, 2014, METABOLITES, V4, P433, DOI 10.3390/metabo4020433; Iskandar HN, 2012, TRANSL RES, V159, P313, DOI 10.1016/j.trsl.2012.01.001; Kokla M, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3110-0; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Kuroki F, 1997, DIGEST DIS SCI, V42, P1137, DOI 10.1023/A:1018873217192; Lee T, 2017, GUT, V66, P863, DOI 10.1136/gutjnl-2015-309940; Levan SR, 2019, NAT MICROBIOL, V4, P1851, DOI 10.1038/s41564-019-0498-2; Liu Y, 2018, ARXIV180700202; Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9; Lu Y., 2018, ADV NEURAL INFORM PR, P8676; Makinen VP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100205; Meinshausen N, 2009, J AM STAT ASSOC, V104, P1671, DOI 10.1198/jasa.2009.tm08647; Mendez KM, 2020, METABOLOMICS, V16, DOI 10.1007/s11306-020-1640-0; Nanni P, 2007, RAPID COMMUN MASS SP, V21, P4142, DOI 10.1002/rcm.3323; Nguyen BT, 2020, ARXIV PREPRINT ARXIV; Qin XF, 2012, WORLD J GASTROENTERO, V18, P1708, DOI 10.3748/wjg.v18.i15.1708; Rett BS, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-36; Romano Y., 2019, J AM STAT ASSOC, V115, P1861, DOI [10.1080/01621459.2019.1660174, DOI 10.1080/01621459.2019.1660174]; Sitkin S, 2018, DIGEST DIS SCI, V63, P2480, DOI 10.1007/s10620-018-5182-5; Solakivi T, 2011, SCAND J GASTROENTERO, V46, P299, DOI 10.3109/00365521.2010.533380; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Suzuki K, 2017, NATURE, V546, pE1, DOI 10.1038/nature22084; Thurgate Lauren E, 2019, Inflamm Intest Dis, V4, P97, DOI 10.1159/000501519; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Tibshirani RJ, 2016, J AM STAT ASSOC, V111, P600, DOI 10.1080/01621459.2015.1108848; Tiratterra E, 2018, ANN GASTROENTEROL, V31, P266, DOI 10.20524/aog.2018.0239; Trainor PJ, 2017, METABOLITES, V7, DOI 10.3390/metabo7020030; TRAVIS SPL, 1994, BAILLIERE CLIN GASTR, V8, P203, DOI 10.1016/0950-3528(94)90002-7; Treutler H, 2016, ANAL CHEM, V88, P8082, DOI 10.1021/acs.analchem.6b01569; Turck CW, 2020, METABOLITES, V10, DOI 10.3390/metabo10040128; Vinaixa M, 2012, METABOLITES, V2, P775, DOI 10.3390/metabo2040775; Volkova A., 2019, PREDICTIVE METAGENOM, P779967; WHITEHEAD WE, 1980, DIGEST DIS SCI, V25, P404, DOI 10.1007/BF01395503; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092	51	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255240	10.1371/journal.pone.0255240	http://dx.doi.org/10.1371/journal.pone.0255240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324558	Green Published, gold			2022-12-26	WOS:000685248200022
J	Boudou, M; OhAiseadha, C; Garvey, P; O'Dwyer, J; Hynds, P				Boudou, Martin; OhAiseadha, Coilin; Garvey, Patricia; O'Dwyer, Jean; Hynds, Paul			Breakpoint modelling of temporal associations between non-pharmaceutical interventions and symptomatic COVID-19 incidence in the Republic of Ireland	PLOS ONE			English	Article							REGRESSION	Background To constrain propagation and mitigate the burden of COVID-19, most countries initiated and continue to implement several non-pharmaceutical interventions (NPIs), including national and regional lockdowns. In the Republic of Ireland, the first national lockdown was decreed on 23(rd) of March 2020, followed by a succession of restriction increases and decreases (phases) over the following year. To date, the effects of these interventions remain unclear, and particularly within differing population subsets. The current study sought to assess the impact of individual NPI phases on COVID-19 transmission patterns within delineated population subgroups in the Republic of Ireland. Methods and findings Confirmed, anonymised COVID-19 cases occurring between the 29(th) of February 2020 and 30(th) November 2020 (n = 72,654) were obtained. Segmented modelling via breakpoint regression with multiple turning points was employed to identify structural breaks across sub-populations, including primary/secondary infections, age deciles, urban/commuter/rural areas, patients with underlying health conditions, and socio-demographic profiles. These were subsequently compared with initiation dates of eight overarching NPI phases. Five distinct breakpoints were identified. The first breakpoint, associated with a decrease in the daily COVID-19 incidence, was reported within 14 days of the first set of restrictions in mid-March 2020 for most population sub-groups. Results suggest that moderately strict NPIs were more effective than the strictest Phase 5 (National Lockdown). Divergences were observed across population sub-groups; lagged response times were observed among populations >80 years, residents of rural/ commuter regions, and cases associated with a below-median deprivation score. Conclusions Study findings suggest that many NPIs have been successful in decreasing COVID-19 incidence rates, however the strictest Phase 5 NPI was not. Moreover, NPIs were not equally successful across all sub-populations, with differing response times noted. Future strategies and interventions may need to be increasingly bespoke, based on sub-population profiles and required responses.	[Boudou, Martin; OhAiseadha, Coilin; Garvey, Patricia; O'Dwyer, Jean; Hynds, Paul] Technol Univ Dublin, Environm Sustainabil & Hlth Inst, SpatioTemporal Environm Epidemiol Res STEER Grp, Dublin, Ireland; [OhAiseadha, Coilin] Hlth Serv Execut HSE, Dublin, Ireland; [Garvey, Patricia] Hlth Protect Surveillance Ctr HPSC, Dublin, Ireland; [O'Dwyer, Jean] Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland; [O'Dwyer, Jean; Hynds, Paul] Univ Coll Dublin, Irish Ctr Res Appl Geosci, Dublin, Ireland	University College Cork; University College Dublin	Hynds, P (corresponding author), Technol Univ Dublin, Environm Sustainabil & Hlth Inst, SpatioTemporal Environm Epidemiol Res STEER Grp, Dublin, Ireland.; Hynds, P (corresponding author), Univ Coll Dublin, Irish Ctr Res Appl Geosci, Dublin, Ireland.	hyndsp@tcd.ie	O'Dwyer, Jean/B-2532-2017	O'Dwyer, Jean/0000-0001-7852-4662; Boudou, Martin/0000-0002-2849-3172	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The presented study has been funded by the Science Foundation Ireland as part of its COVID-19 Rapid Response Funding Programme. PH received the research grant.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ambikapathy Bakiya, 2020, JMIR Public Health Surveill, V6, pe19368, DOI 10.2196/19368; Audi A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.567184; Central Statistics Office, 2019, URB RUR LIF IR; Clark A, 2020, LANCET GLOB HEALTH, V8, P1003, DOI 10.1016/S2214-109X(20)30264-3; Department of Health, 2021, LAT UPD COVID 19; Gonzalez-Sanguino C, 2020, BRAIN BEHAV IMMUN, V87, P172, DOI 10.1016/j.bbi.2020.05.040; Haase T., 2012, INTR REF TABL; Heavey L, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.21.2000903; Henning-Smith C, 2020, J AGING SOC POLICY, V32, P396, DOI 10.1080/08959420.2020.1770036; HPSC, 2020, EP COVID 19 IR; HPSC, 2021, COV 19 CAS DEF; Huang Q, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246548; Ibarra-Vega D, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138917; Kennelly B, 2020, HEALTH POLICY TECHN, V9, P419, DOI 10.1016/j.hlpt.2020.08.021; Kim HJ, 2008, J STAT COMPUT SIM, V78, P1087, DOI 10.1080/00949650701528461; Kong Tak-Kwan, 2020, Aging Med (Milton), V3, P102, DOI 10.1002/agm2.12114; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Kuhn M., 2020, R J, V223, P7; Legido-Quigley H, 2020, LANCET, V395, P848, DOI 10.1016/S0140-6736(20)30551-1; Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2; Merow C, 2020, P NATL ACAD SCI USA, V117, P27456, DOI 10.1073/pnas.2008590117; Mueller JT, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2019378118; Muggeo V.M., 2008, R NEWS, V8, P20; Parcha V, 2020, MAYO CLIN PROC, V95, P2633, DOI 10.1016/j.mayocp.2020.08.039; Post RAJ, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10257-2; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517; Santamaria L, 2021, SCI TOTAL ENVIRON, V751, DOI 10.1016/j.scitotenv.2020.142257; Savaris RF, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84092-1; van Gerwen M, 2021, J MED VIROL, V93, P907, DOI 10.1002/jmv.26337; Verelst F, 2020, EUROSURVEILLANCE, V25, P13, DOI 10.2807/1560-7917.ES.2020.25.13.2000323; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wieland T, 2020, SAFETY SCI, V131, DOI 10.1016/j.ssci.2020.104924; World Health Organisation, 2021, COR DIS COVID 19 PAN; World Health Organization, 2020, ARCH WHO TIM COVID 1	37	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255254	10.1371/journal.pone.0255254	http://dx.doi.org/10.1371/journal.pone.0255254			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324566	Green Published, gold			2022-12-26	WOS:000685248200007
J	Hall, JA; Forman, FJ; Bobe, G; Farace, G; Yerramilli, M				Hall, Jean A.; Forman, Franci J.; Bobe, Gerd; Farace, Giosi; Yerramilli, Murthy			The impact of periodontal disease and dental cleaning procedures on serum and urine kidney biomarkers in dogs and cats	PLOS ONE			English	Article							SYMMETRIC DIMETHYLARGININE; RISK-FACTORS; CYSTATIN C; GUIDELINES; CREATININE; AZOTEMIA	The objective of this study was to evaluate the benefits and inherent risks of dental cleaning procedures, based on serum and urine biomarkers for kidney function and tissue damage, in dogs and cats. Thirty-one asymptomatic, mostly older dogs (14 neutered male and 17 ovariohysterectomized female dogs of various breeds between 3 and 14 years old) and cats (19 neutered male and 12 ovariohysterectomized female domestic short hair cats between 2 and 16 years old) diagnosed with periodontal disease on physical exam, and recommended by their veterinarian to have dental cleaning under general anesthesia were evaluated in a prospective study. Serum and urine samples were collected from dogs and cats 1 week before, 6 hours after, and again 1 week after the dental cleaning procedure. Samples were analyzed for biomarkers of kidney function [serum creatinine (Cr), symmetric dimethylarginine (SDMA), and blood urea nitrogen (BUN), and urine for specific gravity (USG) and protein:creatinine (UPC) ratio]. A panel of biomarkers for renal tissue damage was also assessed [serum beta-aminoisobutyric acid (BAIB), and urine cystatin B and clusterin]. Samples collected one week before dental cleaning procedures showed that increased age and severity of dental disease were linked to abnormal kidney function biomarker values (age: elevated SDMA and Cr concentrations and isosthenuric USG values; disease severity: elevated UPC ratios) as well as elevated urine cystatin B and clusterin concentrations. Directly after the dental cleaning procedure, an increased number of cats with elevated SDMA concentrations was observed (specifically in cats with longer duration of dental procedures). Extended duration of dental procedures (>= 60 min) was linked to increased urine cystatin B and clusterin concentrations, whereas shorter duration procedures was linked to decreased urine cystatin B and clusterin. Higher SDMA concentrations persisted in cats one week after the dental cleaning procedures and were linked to elevated UPC ratios one week before cleaning procedures. In conclusion, the results of this study indicate a link between severity of dental disease, renal tissue injury, and impaired renal function. Longer duration dental procedures in cats may carry inherent risks of kidney injury and impaired renal function.	[Hall, Jean A.; Forman, Franci J.] Oregon State Univ, Dept Biomed Sci, Carlson Coll Vet Med, Corvallis, OR 97331 USA; [Bobe, Gerd] Oregon State Univ, Coll Agr Sci, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA; [Bobe, Gerd] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Farace, Giosi; Yerramilli, Murthy] IDEXX Labs Inc, One IDEXX Dr, Westbrook, ME USA	Oregon State University; Oregon State University; Oregon State University	Hall, JA (corresponding author), Oregon State Univ, Dept Biomed Sci, Carlson Coll Vet Med, Corvallis, OR 97331 USA.	Jean.Hall@oregonstate.edu		Hall, Jean/0000-0002-7758-6703	IDEXX Laboratories, Inc., One IDEXX Drive, Westbrook, ME, USA	IDEXX Laboratories, Inc., One IDEXX Drive, Westbrook, ME, USA	Funded by a grant from IDEXX Laboratories, Inc., One IDEXX Drive, Westbrook, ME, USA. www.idexx.com/en/The funding decision makers had no role in study design, data collection and analyses, or preparation of the manuscript. Data is freely available upon request. The funder provided support in the form of salaries for authors [GF, MY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bednarski R, 2011, J AM ANIM HOSP ASSOC, V47, P377, DOI 10.5326/JAAHA-MS-5846; Brown SA, 1997, VET J, V154, P93, DOI 10.1016/S1090-0233(97)80048-2; Chakrabarti S, 2012, J VET INTERN MED, V26, P275, DOI 10.1111/j.1939-1676.2011.00874.x; Cobrin AR, 2013, J SMALL ANIM PRACT, V54, P647, DOI 10.1111/jsap.12150; Conroy M, 2019, VET REC, V184, DOI 10.1136/vr.105100; Davis H, 2013, J AM ANIM HOSP ASSOC, V49, P149, DOI 10.5326/JAAHA-MS-5868; Finch NC, 2016, J VET INTERN MED, V30, P602, DOI 10.1111/jvim.13917; Gengler W, 1995, J Vet Dent, V12, P97; Ghys LFE, 2016, J VET INTERN MED, V30, P1074, DOI 10.1111/jvim.14256; Glickman LT, 2011, PREV VET MED, V99, P193, DOI 10.1016/j.prevetmed.2011.01.011; Gordin E, 2021, RES VET SCI, V134, P12, DOI 10.1016/j.rvsc.2020.11.019; Gordon AM, 2006, VET MED-US, V101, P22; Hall JA, 2016, J VET INTERN MED, V30, P794, DOI 10.1111/jvim.13942; Hall JA, 2014, J VET INTERN MED, V28, P1676, DOI 10.1111/jvim.12445; Hall JA., 2017, J ANIM PHYSL ANIM NU, P1, DOI [10.1111/jpn.12692, DOI 10.1111/JPN.12692]; Hall JA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235480; Hezzell MJ, 2020, VET J, V255, DOI 10.1016/j.tvjl.2019.105420; International Renal Interest Society, 2019, IRIS STAG CKD MOD 20; Jepson RE, 2009, J VET INTERN MED, V23, P806, DOI 10.1111/j.1939-1676.2009.0339.x; KuKanich K, 2021, J FELINE MED SURG, V23, P138, DOI 10.1177/1098612X20935750; Marino CL, 2014, J FELINE MED SURG, V16, P465, DOI 10.1177/1098612X13511446; Maxie MG., 2007, JUBB KENNEDY PALMERS, V2, P425; Monti P, 2012, J SMALL ANIM PRACT, V53, P254, DOI 10.1111/j.1748-5827.2012.01198.x; Nabi SU, 2014, VET WORLD, V7, P403, DOI 10.14202/vetworld.2014.403-407; O'Neill DG, 2013, J VET INTERN MED, V27, P814, DOI 10.1111/jvim.12090; Pavlica Z, 2008, J VET DENT, V25, P97, DOI 10.1177/089875640802500210; Perry R, 2015, J FELINE MED SURG, V17, P45, DOI 10.1177/1098612X14560099; Polzin DJ, 2013, J VET EMERG CRIT CAR, V23, P205, DOI 10.1111/vec.12034; Rodionov RN, 2014, TRENDS PHARMACOL SCI, V35, P31, DOI 10.1016/j.tips.2014.09.005; Tanianskii DA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030524; Thoen ME, 2011, J VET EMERG CRIT CAR, V21, P648, DOI 10.1111/j.1476-4431.2011.00689.x; Trevejo RT, 2018, JAVMA-J AM VET MED A, V252, P710, DOI 10.2460/javma.252.6.710; Yerramilli M, 2016, VET CLIN N AM-SMALL, V46, P961, DOI 10.1016/j.cvsm.2016.06.011; Zanghi BM., 2018, FRONT VET SCI, P5; Zanghi BM, 2018, AM J VET RES, V79, P733, DOI 10.2460/ajvr.79.7.733	35	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255310	10.1371/journal.pone.0255310	http://dx.doi.org/10.1371/journal.pone.0255310			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324590	gold, Green Published			2022-12-26	WOS:000685248200075
J	Kritioti, E; Theodosiou, A; Parpaite, T; Alexandrou, A; Nicolaou, N; Papaevripidou, I; Sejourne, N; Coste, B; Christophidou-Anastasiadou, V; Tanteles, GA; Sismani, C				Kritioti, Evie; Theodosiou, Athina; Parpaite, Thibaud; Alexandrou, Angelos; Nicolaou, Nayia; Papaevripidou, Ioannis; Sejourne, Nina; Coste, Bertrand; Christophidou-Anastasiadou, Violetta; Tanteles, George A.; Sismani, Carolina			Unravelling the genetic causes of multiple malformation syndromes: A whole exome sequencing study of the Cypriot population	PLOS ONE			English	Article							GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY; MOLECULAR-SPECTRUM; INBORN ERROR; PIEZO2 CAUSE; MUTATIONS; ANOMALIES; VARIANTS; GENOMICS; DISEASES; CHANNEL	Multiple malformation syndromes (MMS) belong to a group of genetic disorders characterised by neurodevelopmental anomalies and congenital malformations. Here we explore for the first time the genetic aetiology of MMS using whole-exome sequencing (WES) in undiagnosed patients from the Greek-Cypriot population after prior extensive diagnostics workup including karyotype and array-CGH. A total of 100 individuals (37 affected), from 32 families were recruited and family-based WES was applied to detect causative single-nucleotide variants (SNVs) and indels. A genetic diagnosis was reported for 16 MMS patients (43.2%), with 10/17 (58.8%) of the findings being novel. All autosomal dominant findings occurred de novo. Functional studies were also performed to elucidate the molecular mechanism relevant to the abnormal phenotypes, in cases where the clinical significance of the findings was unclear. The 17 variants identified in our cohort were located in 14 genes (PCNT, UBE3A, KAT6A, SPR, POMGNT1, PIEZO2, PXDN, KDM6A, PHIP, HECW2, TFAP2A, CNOT3, AGTPBP1 and GAMT). This study has highlighted the efficacy of WES through the high detection rate (43.2%) achieved for a challenging category of undiagnosed patients with MMS compared to other conventional diagnostic testing methods (10-20% for array-CGH and similar to 3% for G-banding karyotype analysis). As a result, family-based WES could potentially be considered as a first-tier cost effective diagnostic test for patients with MMS that facilitates better patient management, prognosis and offer accurate recurrence risks to the families.	[Kritioti, Evie; Theodosiou, Athina; Alexandrou, Angelos; Papaevripidou, Ioannis; Sismani, Carolina] Cyprus Inst Neurol & Genet, Dept Cytogenet & Genom, Nicosia, Cyprus; [Kritioti, Evie; Nicolaou, Nayia; Tanteles, George A.] Cyprus Inst Neurol & Genet, Clin Genet Clin, Nicosia, Cyprus; [Kritioti, Evie; Theodosiou, Athina; Tanteles, George A.; Sismani, Carolina] Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Nicosia, Cyprus; [Parpaite, Thibaud; Sejourne, Nina; Coste, Bertrand] Aix Marseille Univ, CNRS, LNC, UMR 7291, Marseille, France; [Christophidou-Anastasiadou, Violetta] Cyprus Inst Neurol & Genet & Archbishop Makarios, Clin Genet Clin, Nicosia, Cyprus	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Sismani, C (corresponding author), Cyprus Inst Neurol & Genet, Dept Cytogenet & Genom, Nicosia, Cyprus.; Sismani, C (corresponding author), Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Nicosia, Cyprus.	csismani@cing.ac.cy		Coste, Bertrand/0000-0002-0163-2494	2017 Telethon Grant; RCB Bank Ltd; Cy-Tera Project [NAYPiDeltaMH/SigmaTATH/0308/31]; European Regional Development Fund; Republic of Cyprus through the Cyprus Research Promotion Foundation (now renamed to Cyprus Research and Innovation Foundation); European Research Council [678610]	2017 Telethon Grant; RCB Bank Ltd; Cy-Tera Project; European Regional Development Fund(European Commission); Republic of Cyprus through the Cyprus Research Promotion Foundation (now renamed to Cyprus Research and Innovation Foundation); European Research Council(European Research Council (ERC)European Commission)	This project was funded by 2017 Telethon Grant (Cyprus), RCB Bank Ltd (Cyprus) and a departmental donation. This work was also supported by the Cy-Tera Project (NAY Pi Delta MH/Sigma TATH/0308/31), which was co-funded by the European Regional Development Fund and the Republic of Cyprus through the Cyprus Research Promotion Foundation (now renamed to Cyprus Research and Innovation Foundation). Thibaud Parpaite, Nina Sejourne and Bertrand Coste received funding from the European Research Council (Grant agreement No. 678610).	Alper SL, 2017, CURR TOP MEMBR, V79, P97, DOI 10.1016/bs.ctm.2017.01.001; BAYSAL E, 1992, BRIT J HAEMATOL, V81, P607, DOI 10.1111/j.1365-2141.1992.tb03000.x; Besenbacher S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006315; Borisovna KO, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1470-2; Chesler AT, 2016, NEW ENGL J MED, V375, P1355, DOI 10.1056/NEJMoa1602812; Comeaux MS, 2013, MOL GENET METAB, V109, P260, DOI 10.1016/j.ymgme.2013.04.006; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dhar SU, 2009, MOL GENET METAB, V96, P38, DOI 10.1016/j.ymgme.2008.10.008; Dill P, 2012, NEUROLOGY, V78, pE29, DOI 10.1212/WNL.0b013e3182452849; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Florez-Paz D, 2016, SCI REP-UK, V6, DOI 10.1038/srep25923; Jiao QG, 2019, CLIN GENET, V96, P140, DOI 10.1111/cge.13548; Kaplanis J, 2019, GENOME RES, V29, P1047, DOI 10.1101/gr.239756.118; Kopanos C, 2019, BIOINFORMATICS, V35, P1978, DOI 10.1093/bioinformatics/bty897; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lukacs V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9329; McMillin MJ, 2014, AM J HUM GENET, V94, P734, DOI 10.1016/j.ajhg.2014.03.015; Mercimek-Mahmutoglu S, 2006, NEUROLOGY, V67, P480, DOI 10.1212/01.wnl.0000234852.43688.bf; Mercimek-Mahmutoglu S, 2014, HUM MUTAT, V35, P462, DOI 10.1002/humu.22511; Meshcheryakova TI, 2015, ANN HUM GENET, V79, P148, DOI 10.1111/ahg.12098; Milunsky JM, 2008, AM J HUM GENET, V82, P1171, DOI 10.1016/j.ajhg.2008.03.005; Moorthie S, 2018, J COMMUN GENET, V9, P387, DOI 10.1007/s12687-018-0384-2; Morris AAM, 2007, J INHERIT METAB DIS, V30, P100, DOI 10.1007/s10545-006-0478-2; Nambot S, 2018, GENET MED, V20, P645, DOI 10.1038/gim.2017.162; Novoradovsky A., 2005, 2005 NSTI Nanotechnology Conference and Trade Show. NSTI Nanotech 2005, P532; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Pedersen BS, 2017, AM J HUM GENET, V100, P406, DOI 10.1016/j.ajhg.2017.01.017; Pfundt R, 2017, GENET MED, V19, P667, DOI 10.1038/gim.2016.163; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Reiber J, 2010, AM J MED GENET A, V152A, P994, DOI 10.1002/ajmg.a.33331; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Schieppati A, 2008, LANCET, V371, P2039, DOI 10.1016/S0140-6736(08)60872-7; Schrider DR, 2011, CURR BIOL, V21, P1051, DOI 10.1016/j.cub.2011.05.013; Segen J., 2006, CONCISE DICT MODERN; Sframeli M, 2017, NEUROMUSCULAR DISORD, V27, P793, DOI 10.1016/j.nmd.2017.06.008; Shashi V, 2014, GENET MED, V16, P176, DOI 10.1038/gim.2013.99; Stockler S, 1996, AM J HUM GENET, V58, P914; Stojanovic JR, 2020, J CHILD NEUROL, V35, P116, DOI 10.1177/0883073819879835; Taberner FJ, 2019, P NATL ACAD SCI USA, V116, P14260, DOI 10.1073/pnas.1905985116; Theodosiou A., 2017, NGS ANAL PIPELINE GU; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vianna GS, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017769; Wang L, 2019, NATURE, V573, P225, DOI 10.1038/s41586-019-1505-8; Woo SH, 2015, NAT NEUROSCI, V18, P1756, DOI 10.1038/nn.4162; Wright CF, 2015, LANCET, V385, P1305, DOI 10.1016/S0140-6736(14)61705-0; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601; Zanardo EA, 2020, J MOL DIAGN, V22, P1041, DOI 10.1016/j.jmoldx.2020.05.007	51	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0253562	10.1371/journal.pone.0253562	http://dx.doi.org/10.1371/journal.pone.0253562			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324503	Green Published, gold			2022-12-26	WOS:000685248200042
J	Neumann, A; Breher, K; Wahl, S				Neumann, Antonia; Breher, Katharina; Wahl, Siegfried			Effects of screen-based retinal light stimulation measured with a novel contrast sensitivity test	PLOS ONE			English	Article							LONGITUDINAL CHROMATIC ABERRATION; EYE GROWTH; REFRACTIVE DEVELOPMENT; GANGLION-CELLS; MYOPIA; DOPAMINE; DEFOCUS; MELANOPSIN; ILLUMINATION; PREVALENCE	Myopia is increasing worldwide hence it exists a pressing demand to find effective myopia control strategies. Previous studies have shown that light, spectral composition, spatial frequencies, and contrasts play a critical role in refractive development. The effects of light on multiple retinal processes include growth regulation, but also visual performance and perception. Changes in subjective visual performance can be examined by contrast sensitivity (CS). This study was conducted to investigate whether retinal light stimulation of different wavelength ranges is able to elicit changes in CS and, therefore, may be used for myopia control purposes. In total, 30 right eyes were stimulated with the light of different wavelength ranges, including dominant wavelengths of similar to 480 nm, similar to 530 nm, similar to 630 nm and polychromatic light via a commercial liquid crystal display (LCD) screen. Stimulation was performed screen full-field and on the optic nerve head only. CS was measured before any stimulation and after each stimulation condition using a novel and time-efficient CS test. Post-stimulation CS changes were analyzed by ANOVA regarding the influencing factors spatial frequency, stimulation wavelength and stimulation location. A priorly conducted verification study on a subset of five participants compared the newly developed CS test to a validated CS test. The novel CS test exhibited good reliability of 0.94 logCS and repeatability of 0.13 logCS with a duration of 92 sec +/- 17 sec. No clinically critical change between pre- and post-stimulation CS was detected (all p>0.05). However, the results showed that post-stimulation CS differed significantly at 18 cpd after stimulation with polychromatic light from short-wavelength light (p<0.0001). Location of illumination (screen full-field vs. optic nerve head) or any interactions with other factors did not reveal significant influences (all p>0.05). To summarize, a novel CS test measures the relationship between retinal light stimulation and CS. However, using retinal illumination via LCD screens to increase CS is inconclusive.	[Neumann, Antonia; Breher, Katharina; Wahl, Siegfried] Eberhard Karls Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany; [Breher, Katharina; Wahl, Siegfried] Carl Zeiss Vis Int GmbH, Aalen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Neumann, A (corresponding author), Eberhard Karls Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany.	antonia.neumann@uni-tuebingen.de		Neumann, Antonia/0000-0002-9259-8681	EberhardKarls-University Tuebingen as part of the German Excellence initiative from the Federal Ministry of Education and Research (BMBF) [ZUK 63]; Deutsche Forschungsgemeinschaft; University of Tuebingen; Carl Zeiss Vision International GmbH	EberhardKarls-University Tuebingen as part of the German Excellence initiative from the Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tuebingen; Carl Zeiss Vision International GmbH	This study was funded by EberhardKarls-University Tuebingen (Grant No. ZUK 63) as part of the German Excellence initiative from the Federal Ministry of Education and Research (BMBF) and by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tuebingen. Carl Zeiss Vision International GmbH provided support in the form of salaries for authors KB and SW. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari P, 2015, INVEST OPHTH VIS SCI, V56, P3838, DOI 10.1167/iovs.14-16233; Allen AE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10113-3; Atchison DA, 2013, OPTOMETRY VISION SCI, V90, P1304, DOI 10.1097/OPX.0000000000000033; Bahmani H, 2019, INVEST OPHTH VIS SCI, V60; Banerjee S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030530; Barkan Y, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00012; BARTMANN M, 1994, VISUAL NEUROSCI, V11, P199, DOI 10.1017/S0952523800001565; Berntsen DA, 2013, INVEST OPHTH VIS SCI, V54, P5761, DOI 10.1167/iovs.13-11904; Bock GR., 2008, MYOPIA CONTROL EYE G, Vvol. 155; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chakraborty R, 2022, J OPTOM, V15, P112, DOI 10.1016/j.optom.2020.12.001; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Davis KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123424; Dietze H., 2015, OPTOMETRISCHE UNTERS; Dong F, 2011, MOL VIS, V17, P2824; Feldkaemper M, 2013, EXP EYE RES, V114, P106, DOI 10.1016/j.exer.2013.02.007; Flitcroft DI, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.11.42; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; Guillon M, 2016, OPTOMETRY VISION SCI, V93, P1093, DOI 10.1097/OPX.0000000000000893; Habtamu E, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.5.13; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Hung LF, 2018, EXP EYE RES, V176, P147, DOI 10.1016/j.exer.2018.07.004; Hwang CK, 2013, J NEUROSCI, V33, P14989, DOI 10.1523/JNEUROSCI.2039-13.2013; IUVONE PM, 1978, SCIENCE, V202, P901, DOI 10.1126/science.30997; Jackson CR, 2014, J NEUROSCI, V34, P4627, DOI 10.1523/JNEUROSCI.4887-13.2014; Jaskulski M, 2020, OPHTHAL PHYSL OPT, V40, P549, DOI 10.1111/opo.12725; Kingdom FAA., 2009, PSYCHOMETRICS PRACTI; Kleiner M, 2007, PERCEPTION, V36, P14; Kraft C, 2019, J OPT SOC AM A, V36, pB77, DOI 10.1364/JOSAA.36.000B77; Kroger RHH, 1996, J COMP PHYSIOL A, V179, P837; KROGER RHH, 1994, VISION RES, V34, P1807, DOI 10.1016/0042-6989(94)90305-0; Landis E, 2018, INVEST OPHTH VIS SCI, V59; Liao HW, 2016, J COMP NEUROL, V524, P2845, DOI 10.1002/cne.23995; Lingham G, 2020, BRIT J OPHTHALMOL, V104, P593, DOI 10.1136/bjophthalmol-2019-314675; Liu R, 2014, INVEST OPHTH VIS SCI, V55, P1901, DOI 10.1167/iovs.13-12276; Liu R, 2011, EXP EYE RES, V92, P447, DOI 10.1016/j.exer.2011.03.003; Long Q, 2009, CUTAN OCUL TOXICOL, V28, P176, DOI 10.3109/15569520903178364; Lu ZL, 2014, VISUAL PSYCHOPHYSICS: FROM LABORATORY TO THEORY, P1; Mather J., 2021, SPECTRAL XYZ COLOR F; McAdams H, 2018, INVEST OPHTH VIS SCI, V59, P5615, DOI 10.1167/iovs.18-25219; Mouland JW, 2017, CURR BIOL, V27, P1633, DOI 10.1016/j.cub.2017.04.039; Naidoo KS, 2019, OPHTHALMOLOGY, V126, P338, DOI 10.1016/j.ophtha.2018.10.029; Norton TT., 2002, PSYCHOPHYSICAL MEASU, Vvol. 362; Peguda R, 2020, OPTOMETRY VISION SCI, V97, P797, DOI 10.1097/OPX.0000000000001573; Qian YF, 2013, J VISION, V13, DOI 10.1167/13.11.16; Radhakrishnan H, 2004, VISION RES, V44, P1869, DOI 10.1016/j.visres.2004.03.007; ROHLER R, 1969, VISION RES, V9, P407, DOI 10.1016/0042-6989(69)90088-1; ROHRER B, 1992, J PHYSIOL-LONDON, V449, P363, DOI 10.1113/jphysiol.1992.sp019090; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Rucker F, 2019, EXP EYE RES, V184, P172, DOI 10.1016/j.exer.2019.04.020; Rucker FJ, 2009, VISION RES, V49, P1775, DOI 10.1016/j.visres.2009.04.014; Rudnicka AR, 2016, BRIT J OPHTHALMOL, V100, P882, DOI 10.1136/bjophthalmol-2015-307724; Saw SM, 2019, INVEST OPHTH VIS SCI, V60, P488, DOI 10.1167/iovs.18-25221; Schaeffel F, 2002, OPHTHALMOLOGE, V99, P120, DOI 10.1007/s00347-001-0591-8; Schilling T, 2020, PROCEEDINGS OF THE 13TH INTERNATIONAL JOINT CONFERENCE ON BIOMEDICAL ENGINEERING SYSTEMS AND TECHNOLOGIES, VOL 5: HEALTHINF, P482, DOI 10.5220/0008972404820489; Schilling T, 2017, BIOMED OPT EXPRESS, V8, P1477, DOI 10.1364/BOE.8.001477; Sengupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024483; Shi Q, 2020, EXP EYE RES, V195, DOI 10.1016/j.exer.2020.108026; Smith EL, 2015, INVEST OPHTH VIS SCI, V56, P6490, DOI 10.1167/iovs.15-17025; Stone RA, 2013, EXP EYE RES, V114, P35, DOI 10.1016/j.exer.2013.01.001; Strang NC, 1999, OPHTHAL PHYSL OPT, V19, P415, DOI 10.1016/S0275-5408(99)00014-9; Strickland R, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.2.13; Taylor CP, 2018, INVEST OPHTH VIS SCI, V59, P4622, DOI 10.1167/iovs.18-24113; Tran N, 2008, VISION RES, V48, P1655, DOI 10.1016/j.visres.2008.03.022; Uhl A., 2020, HDB VASCULAR BIOMETR; Werner A, 2000, VISION RES, V40, P1101, DOI 10.1016/S0042-6989(00)00012-2; WIER CC, 1976, PERCEPT PSYCHOPHYS, V19, P75, DOI 10.3758/BF03199389; Wildsoet CF, 2019, INVEST OPHTH VIS SCI, V60, pM106, DOI 10.1167/iovs.18-25958; Williams Katie, 2019, Community Eye Health, V32, P5; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Zele AJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00529; Zhou XT, 2017, PROG RETIN EYE RES, V61, P60, DOI 10.1016/j.preteyeres.2017.06.003; Zou LL, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/9197631	75	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254877	10.1371/journal.pone.0254877	http://dx.doi.org/10.1371/journal.pone.0254877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324537	Green Published, gold			2022-12-26	WOS:000685248200070
J	Scordo, JM; Aguillon-Duran, GP; Ayala, D; Quirino-Cerrillo, AP; Rodriguez-Reyna, E; Mora-Guzman, F; Caso, JA; Ledezma-Campos, E; Schlesinger, LS; Torrelles, JB; Turner, J; Restrepo, BI				Scordo, Julia M.; Aguillon-Duran, Genesis P.; Ayala, Doris; Quirino-Cerrillo, Ana Paulina; Rodriguez-Reyna, Emine; Mora-Guzman, Francisco; Caso, Jose A.; Ledezma-Campos, Eder; Schlesinger, Larry S.; Torrelles, Jordi B.; Turner, Joanne; Restrepo, Blanca I.			A prospective cross-sectional study of tuberculosis in elderly Hispanics reveals that BCG vaccination at birth is protective whereas diabetes is not a risk factor	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CONVERGING EPIDEMICS; RESEARCH AGENDA; PREVALENCE; LYMPHOCYTE; NEUTROPHIL; INFECTION; IMMUNITY; ADDRESS; CARE	Background Aging increases the risk of tuberculosis (TB) and its adverse outcomes, but most studies are based on secondary analyses, and few are in Hispanics. Diabetes is a risk factor for TB in adults, but its contribution in the elderly is unknown. We aimed to identify the role of diabetes and other risk factors for TB in elderly Hispanics. Methods Cross-sectional study among newly-diagnosed TB patients, recent contacts (ReC), or community controls (CoC) totaling 646 participants, including 183 elderly (>60 years; 43 TB, 80 ReC, 60 CoC) and 463 adults (18 to 50 years; 80 TB, 301 ReC and 82 CoC). Host characteristics associated with TB and latent Mycobacterium tuberculosis infection (LTBI) were identified in the elderly by univariable and confirmed by multivariable logistic regression. Results LTBI was more prevalent among the elderly CoC (55% vs. 23.2% in adults; p<0.001), but not in ReC (elderly 71.3% vs. adult 63.8%); p = 0.213). Risk factors for TB in the elderly included male sex (adj-OR 4.33, 95% CI 1.76, 10.65), smoking (adj-OR 2.55, 95% CI 1.01, 6.45) and low BMI (adj-OR 12.34, 95% CI 4.44, 34.33). Unexpectedly, type 2 diabetes was not associated with TB despite its high prevalence (adj-OR 0.38, 95% CI 0.06, 2.38), and BCG vaccination at birth was protective (adj-OR 0.16, 95% CI 0.06, 0.45). Conclusions We report novel distinctions in TB risk factors in the elderly vs. adults, notably in diabetes and BCG vaccination at birth. Further studies are warranted to address disparities in this vulnerable, understudied population.	[Scordo, Julia M.; Schlesinger, Larry S.; Torrelles, Jordi B.; Turner, Joanne] Texas Biomed Res Inst, Host Pathogen Interact & Populat Hlth Programs, San Antonio, TX USA; [Scordo, Julia M.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Aguillon-Duran, Genesis P.; Rodriguez-Reyna, Emine; Mora-Guzman, Francisco; Ledezma-Campos, Eder] Secretaria Salud Tamaulipas, Matamoros, Tamaulipas, Mexico; [Aguillon-Duran, Genesis P.; Rodriguez-Reyna, Emine; Mora-Guzman, Francisco; Ledezma-Campos, Eder] Secretaria Salud Tamaulipas, Ciudad Victoria, Tamaulipas, Mexico; [Ayala, Doris; Quirino-Cerrillo, Ana Paulina; Restrepo, Blanca I.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Brownsville, TX 78520 USA; [Caso, Jose A.; Restrepo, Blanca I.] Univ Texas Rio Grande Valley, Biol Dept, Edinburg, TX 78539 USA; [Caso, Jose A.] Univ Texas Rio Grande Valley, Sch Med, South Texas Diabet & Obes Inst, Edinburg, TX 78539 USA	Texas Biomedical Research Institute; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley	Restrepo, BI (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Brownsville, TX 78520 USA.; Restrepo, BI (corresponding author), Univ Texas Rio Grande Valley, Biol Dept, Edinburg, TX 78539 USA.	Blanca.i.restrepo@uth.tmc.edu		Restrepo, Blanca I/0000-0002-3743-9098; Quirino Cerrillo, Ana Paulina/0000-0001-8817-554X	National Institute of Aging (NIA) at the National Institutes of Health [P01-AG051428]; National Institute of Health (NIH)/NIA NRSA [T32-AG021890]	National Institute of Aging (NIA) at the National Institutes of Health; National Institute of Health (NIH)/NIA NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Aging (NIA) at the National Institutes of Health [P01-AG051428 to JT, BIR, LSS and JBT] and National Institute of Health (NIH)/NIA NRSA T32-AG021890 to JMS. URL: https://www.nia.nih.gov/research/grants-funding The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbara A, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00228-2018; Abdelbary BE, 2017, EPIDEMIOL INFECT, V145, P3020, DOI 10.1017/S0950268817001911; Al-Rifai RH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187967; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], 2021, NETHERLAND NEWS 0118; Ault R, 2018, EXP GERONTOL, V111, P35, DOI 10.1016/j.exger.2018.06.029; Behr MA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2738; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigelow A, 2017, JNP-J NURSE PRACT, V13, P181, DOI 10.1016/j.nurpra.2016.08.010; Burusie A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239333; Byng-Maddick R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1451-0; CDC, 2016, DIAGN TUB DIS; Cheng J, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-019-0614-9; Critchley JA, 2017, CHEST, V152, P165, DOI 10.1016/j.chest.2017.04.155; Di Gennaro F, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9080489; Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025; Garcia-Goez JF, 2020, J BRAS PNEUMOL, V46, DOI 10.36416/1806-3756/e20200072; Fisher-Hoch SP, 2010, PREV CHRONIC DIS, V7; Giamarellos-Bourboulis EJ, 2020, CELL, V183, P315, DOI 10.1016/j.cell.2020.08.051; Hochberg NS, 2013, CLIN INFECT DIS, V56, P1240, DOI 10.1093/cid/cit027; Ito Tsukasa, 2010, Immun Ageing, V7, P12, DOI 10.1186/1742-4933-7-12; Jackson DA, 2015, AM J INFECT CONTROL, V43, P992, DOI 10.1016/j.ajic.2015.03.035; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jiamsakul A, 2018, INT J TUBERC LUNG D, V22, P179, DOI 10.5588/ijtld.17.0348; de Castro MJ, 2015, CLIN INFECT DIS, V60, P1611, DOI 10.1093/cid/civ144; Kim SJ, 1995, TUBERCLE LUNG DIS, V76, P529, DOI 10.1016/0962-8479(95)90529-4; Komine-Aizawa S, 2010, CLIN VACCINE IMMUNOL, V17, P1500, DOI 10.1128/CVI.00190-10; Li J, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0284-4; Lin CH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029948; Lin YH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/1471-2458-15-3; Moliva Juan I, 2017, Front Immunol, V8, P407, DOI 10.3389/fimmu.2017.00407; Moliva JI, 2015, VACCINE, V33, P5035, DOI 10.1016/j.vaccine.2015.08.033; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Perez-Guzman Carlos, 1999, Chest, V116, P961, DOI 10.1378/chest.116.4.961; Piergallini TJ, 2018, EXP GERONTOL, V105, P32, DOI 10.1016/j.exger.2017.12.021; Ponce-De-Leon A, 2004, DIABETES CARE, V27, P1584, DOI 10.2337/diacare.27.7.1584; Radhakrishnan RK, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133788; Rajagopalan S, 2001, CLIN INFECT DIS, V33, P1034, DOI 10.1086/322671; Rajagopalan S, 2016, CLIN GERIATR MED, V32, P479, DOI 10.1016/j.cger.2016.02.006; Rehm J, 1999, INT J EPIDEMIOL, V28, P219, DOI 10.1093/ije/28.2.219; Restrepo BI, 2021, TUBERCULOSIS, V126, DOI 10.1016/j.tube.2020.102047; Restrepo BI, 2021, HUM IMMUNOL, V82, P124, DOI 10.1016/j.humimm.2020.11.005; Restrepo BI, 2018, TUBERCULOSIS, V113, P10, DOI 10.1016/j.tube.2018.08.007; Restrepo BI, 2013, TUBERCULOSIS, V93, pS10, DOI 10.1016/S1472-9792(13)70004-0; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Ronacher K, 2017, CHEST, V152, P174, DOI 10.1016/j.chest.2017.02.032; Roy A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4643; Russell CD, 2019, J INFECTION, V78, P339, DOI 10.1016/j.jinf.2019.02.006; Stefaniuk P, 2020, CANCER MANAG RES, V12, P2961, DOI 10.2147/CMAR.S245928; TEALE C, 1993, AGE AGEING, V22, P289, DOI 10.1093/ageing/22.4.289; Trauer JM, 2021, THORAX, V76, P1131, DOI 10.1136/thoraxjnl-2020-216794; Vesosky B, 2005, IMMUNOL REV, V205, P229, DOI 10.1111/j.0105-2896.2005.00257.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang J, 2015, BRAZ J INFECT DIS, V19, P125, DOI 10.1016/j.bjid.2014.10.008; Wang W, 2019, CAN J INFECT DIS MED, V2019, DOI 10.1155/2019/3270393; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yin YM, 2017, ARCH MED SCI, V13, P404, DOI 10.5114/aoms.2016.60822	58	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255194	10.1371/journal.pone.0255194	http://dx.doi.org/10.1371/journal.pone.0255194			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324578	Green Published, gold			2022-12-26	WOS:000685248200032
J	Waugh, CM; Scott, A				Waugh, C. M.; Scott, A.			Substantial Achilles adaptation following strength training has no impact on tendon function during walking	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; VISCOELASTIC PROPERTIES; MUSCLE-TENDON; GASTROCNEMIUS-MUSCLE; STIFFNESS; RESISTANCE; TENDINOPATHY; EFFICIENCY; BEHAVIOR; ALTERS	Tendons are responsive to mechanical loading and their properties are often the target of intervention programs. The tendon's mechanical properties, particularly stiffness, also govern its function, therefore changes to these properties could have substantial influence on energy-saving mechanisms during activities utilizing the stretch-shortening cycle. We investigated Achilles tendon (AT) function in vivo during walking with respect to a training intervention that elicited significant increases in AT stiffness. 14 men and women completed 12-weeks of isometric plantarflexor strength training that increased AT stiffness, measured during isometric MVC, by similar to 31%. Before and after the intervention, participants walked shod at their preferred velocity on a fully-instrumented treadmill. Movement kinematics, kinetics and displacement of the gastrocnemius medialis muscle-tendon junction were captured synchronously using 3D motion capture and ultrasound imaging, respectively. A MANOVA test was used to examine changes in AT force, stress, strain, stiffness, Young's modulus, hysteresis and strain energy, measured during walking, before and following strength training. All were non-significant for a main effect of time, therefore no follow-up statistical tests were conducted. Changes in joint kinematics, tendon strain, velocity, work and power and muscle activity during the stance phase were assessed with 1D statistical parametric mapping, all of which also demonstrated a lack of change in response to the intervention. This in vivo examination of tendon function in walking provides an important foundation for investigating the functional consequences of training adaptations. We found substantial increases in AT stiffness did not impact on tendon function during walking. AT stiffness measured during walking, however, was unchanged with training, which suggests that increases in stiffness may not be evident across the whole force-elongation relation, a finding which may help explain previously mixed intervention results and guide future investigations in the functional implications of tendon adaptation.	[Waugh, C. M.; Scott, A.] Univ British Columbia, Dept Phys Therapy, Fac Med, Vancouver, BC, Canada	University of British Columbia	Waugh, CM (corresponding author), Univ British Columbia, Dept Phys Therapy, Fac Med, Vancouver, BC, Canada.	cmwaugh@ubc.ca	Waugh, Charlie/J-3687-2015	Waugh, Charlie/0000-0002-3090-046X	European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant [608765]; Alun Morgan Memorial Research Award in Orthopaedic Physiotherapy from the Physiotherapy Foundation of Canada; National Sciences and Engineering Research Council Discovery Accelerator Supplements Program	European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant; Alun Morgan Memorial Research Award in Orthopaedic Physiotherapy from the Physiotherapy Foundation of Canada; National Sciences and Engineering Research Council Discovery Accelerator Supplements Program	(CW) People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no. 608765. https://cordis.europa.eu/project/id/608765 (AS) Alun Morgan Memorial Research Award in Orthopaedic Physiotherapy from the Physiotherapy Foundation of Canada. https://physiotherapy.ca/2015-alunmorgan-memorial-research-award-orthopaedic-physiotherapy-alex-scott (AS) National Sciences and Engineering Research Council Discovery Accelerator Supplements Program. https://www.nserc-crsng.gc.ca/NSERC-CRSNG/FundingDecisions-DecisionsFinancement/DiscoveryAcceleratorSupplements-SupplementsAccelerationDecouverte/index_eng.asp?Year=2017 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Albracht K, 2013, EUR J APPL PHYSIOL, V113, P1605, DOI 10.1007/s00421-012-2585-4; Altman AR, 2012, GAIT POSTURE, V35, P287, DOI 10.1016/j.gaitpost.2011.09.101; Arampatzis A, 2007, J EXP BIOL, V210, P2743, DOI 10.1242/jeb.003814; Arya S, 2010, J APPL PHYSIOL, V108, P670, DOI 10.1152/japplphysiol.00259.2009; Azizi E, 2009, J PHYSIOL-LONDON, V587, P4309, DOI 10.1113/jphysiol.2009.173690; Batista F, 2008, FOOT ANKLE INT, V29, P498, DOI 10.3113/FAI.2008.0498; BENNETT MB, 1986, J ZOOL, V209, P537, DOI 10.1111/j.1469-7998.1986.tb03609.x; Bojsen-Moller J, 2005, J APPL PHYSIOL, V99, P986, DOI 10.1152/japplphysiol.01305.2004; Brauner T, 2017, MED SCI SPORT EXER, V49, P2001, DOI 10.1249/MSS.0000000000001322; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Cheng VWT, 2007, J MATER SCI, V42, P8957, DOI 10.1007/s10853-007-1653-3; Child S, 2010, AM J SPORT MED, V38, P1885, DOI 10.1177/0363546510366234; COTES JE, 1960, ERGONOMICS, V3, P97, DOI 10.1080/00140136008930473; Couppe C, 2016, J APPL PHYSIOL, V120, P130, DOI 10.1152/japplphysiol.00547.2015; Cronin NJ, 2012, J APPL PHYSIOL, V112, P1054, DOI 10.1152/japplphysiol.01402.2011; Cronin NJ, 2010, CLIN BIOMECH, V25, P476, DOI 10.1016/j.clinbiomech.2010.01.018; Csapo R, 2010, J EXP BIOL, V213, P2582, DOI 10.1242/jeb.044271; Depalle B, 2015, J MECH BEHAV BIOMED, V52, P1, DOI 10.1016/j.jmbbm.2014.07.008; Farris DJ, 2011, J BIOMECH, V44, P822, DOI 10.1016/j.jbiomech.2010.12.015; Finni T, 2013, J APPL PHYSIOL, V114, P515, DOI 10.1152/japplphysiol.01005.2012; Foure A, 2010, J APPL PHYSIOL, V109, P849, DOI 10.1152/japplphysiol.01150.2009; Franchi M, 2013, CONNECT TISSUE RES, V54, P267, DOI 10.3109/03008207.2013.807808; Fukunaga T, 2001, P ROY SOC B-BIOL SCI, V268, P229, DOI 10.1098/rspb.2000.1361; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; Giddings VL, 2000, MED SCI SPORT EXER, V32, P627, DOI 10.1097/00005768-200003000-00012; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Halaki M, 2012, COMPUTATIONAL INTELL; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hirayama K, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00016; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; Karunaratne A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21786-z; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Kharazi M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84847-w; Kongsgaard M, 2010, AM J SPORT MED, V38, P749, DOI 10.1177/0363546509350915; Kubo K, 2002, J PHYSIOL-LONDON, V538, P219, DOI 10.1113/jphysiol.2001.012703; Kubo K, 2002, J APPL PHYSIOL, V92, P595, DOI 10.1152/japplphysiol.00658.2001; Lichtwark GA, 2008, J THEOR BIOL, V252, P662, DOI 10.1016/j.jtbi.2008.01.018; Lichtwark GA, 2007, J BIOMECH, V40, P157, DOI 10.1016/j.jbiomech.2005.10.035; Lichtwark GA, 2007, J BIOMECH, V40, P1768, DOI 10.1016/j.jbiomech.2006.07.025; Lichtwark GA, 2010, J EXP BIOL, V213, P707, DOI 10.1242/jeb.038026; Lichtwark GA, 2005, J EXP BIOL, V208, P4715, DOI 10.1242/jeb.01950; Lichtwark GA, 2013, J APPL PHYSIOL, V114, P518, DOI 10.1152/japplphysiol.01525.2012; LOVEJOY CO, 1988, SCI AM, V259, P118, DOI 10.1038/scientificamerican1188-118; Maganaris CN, 2002, J BIOMECH, V35, P1639, DOI 10.1016/S0021-9290(02)00240-3; Marqueti RC, 2018, FASEB J, V32, P353, DOI 10.1096/fj.201700543R; Mian OS, 2007, ACTA PHYSIOL, V189, P57, DOI 10.1111/j.1748-1716.2006.01634.x; Muraoka T, 2005, J APPL PHYSIOL, V99, P665, DOI 10.1152/japplphysiol.00624.2004; Orselli MIV, 2017, J BIOMECH, V60, P227, DOI 10.1016/j.jbiomech.2017.06.022; Petrovic M, 2018, J APPL PHYSIOL, V124, P1333, DOI 10.1152/japplphysiol.00290.2017; RACK PMH, 1983, J PHYSIOL-LONDON, V344, P503, DOI 10.1113/jphysiol.1983.sp014954; Reeves ND, 2003, MUSCLE NERVE, V28, P74, DOI 10.1002/mus.10392; Roberts TJ, 2002, COMP BIOCHEM PHYS A, V133, P1087, DOI 10.1016/S1095-6433(02)00244-1; Sawicki GS, 2009, J EXP BIOL, V212, P21, DOI 10.1242/jeb.017269; Screen HRC, 2004, P I MECH ENG H, V218, P109, DOI 10.1243/095441104322984004; Takeshita D, 2006, J APPL PHYSIOL, V101, P111, DOI 10.1152/japplphysiol.01084.2005; Uchida TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150378; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Waugh CM, 2018, SCAND J MED SCI SPOR, V28, P436, DOI 10.1111/sms.12930; Waugh CM, 2014, J APPL PHYSIOL, V117, P257, DOI 10.1152/japplphysiol.00325.2014; Werkhausen A, 2019, PEERJ, V7, DOI 10.7717/peerj.6764; Werkhausen A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00794; WILKIE DR, 1949, J PHYSIOL-LONDON, V110, P249, DOI 10.1113/jphysiol.1949.sp004437; WOO SLY, 1982, BIORHEOLOGY, V19, P385; WOOD TO, 1988, AM J SPORT MED, V16, P153, DOI 10.1177/036354658801600211; Wren TAL, 2003, ANN BIOMED ENG, V31, P710, DOI 10.1114/1.1569267; Wu YK, 2010, SCAND J MED SCI SPOR, V20, pE80, DOI 10.1111/j.1600-0838.2009.00908.x; Zelik KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179976	68	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255221	10.1371/journal.pone.0255221	http://dx.doi.org/10.1371/journal.pone.0255221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324575	Green Published, gold			2022-12-26	WOS:000685248200044
J	Franco, S; Abreu, AM; Biscaia, R; Gama, S				Franco, Sara; Abreu, Ana Maria; Biscaia, Rui; Gama, Sandra			Sports ingroup love does not make me like the sponsor's beverage but gets me buying it	PLOS ONE			English	Article							TOP-DOWN; IDENTITY; ATTENTION; EMOTION; SYSTEM; MECHANISMS; KNOWLEDGE; RESPONSES; ATTITUDE; LOYALTY	Previous literature has shown that social identity influences consumer decision-making towards branded products. However, its influence on ones' own sensory perception of an ingroup (or outgroup) associated brand's product (i.e. sponsor) is seldom documented and little understood. Here, we investigate the impact of social identity (i.e. team identification) with a football team on the sensorial experience and willingness to buy a beverage, said to be sponsoring the ingroup or the outgroup team. Ninety subjects participated in one of three sensorial experience conditions (matched identity: ingroup beverage; mismatched identity: outgroup beverage; control: no group preference). Each participant tasted the new sponsoring beverage and answered a questionnaire about their subjective sensorial experience of the beverage. EEG and BVP were synchronously collected throughout. Analyses revealed that team identification does not influence subjective responses and only slightly modulates physiological signals. All participants reported high valence and arousal values while physiological signals consistently translated negative affects across groups, which showed that participants reported to be happy/excited about trying the beverage while their physiological signals showed that they were feeling sad/depressed/angry. Crucially, despite a similar sensorial experience, and similar socially desirable report of the subjective experience, only participants in the matched identity group demonstrate higher willingness to buy, showing that the level of team identification, but not taste or beverage quality, influences willingness to buy the said sponsor's product.	[Franco, Sara; Gama, Sandra] Univ Lisbon, Inst Super Tecn, Dept Comp Engn, Lisbon, Portugal; [Abreu, Ana Maria] Univ Catolica Portuguesa, Inst Hlth Sci, Ctr Interdisciplinary Res Hlth, Lisbon, Portugal; [Biscaia, Rui] Univ Bath, Fac Humanities & Social Sci, Dept Hlth, Bath, Avon, England; [Gama, Sandra] INESC ID, Grp Graph & Interact, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade Catolica Portuguesa; University of Bath; INESC-ID; Universidade de Lisboa	Abreu, AM (corresponding author), Univ Catolica Portuguesa, Inst Hlth Sci, Ctr Interdisciplinary Res Hlth, Lisbon, Portugal.	anamariablom@gmail.com	Biscaia, Rui/O-8001-2014	Biscaia, Rui/0000-0003-2752-4317; Abreu, Ana Maria/0000-0003-4067-0386	FCT -Fundacao para a Ciencia e a Tecnologia, I.P [UIDB/04279/2020]	FCT -Fundacao para a Ciencia e a Tecnologia, I.P(Portuguese Foundation for Science and Technology)	This work was financially supported by National Funds through FCT -Fundacao para a Ciencia e a Tecnologia, I.P., under the project UIDB/04279/2020 to Ana Maria Abreu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CA, 2019, J NEUROSCI RES, V97, P241, DOI 10.1002/jnr.24281; Armstrong G., 1999, FOOTBALL CULTURES ID; Balthazar CF, 2018, LWT-FOOD SCI TECHNOL, V98, P94, DOI 10.1016/j.lwt.2018.08.017; Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Biscaia R, 2018, SPORT MARKET Q, V27, P180; Biscaia R, 2016, SPORT MANAG REV, V19, P157, DOI 10.1016/j.smr.2015.02.001; Biscaia R, 2013, J SPORT MANAGE, V27, P288, DOI 10.1123/jsm.27.4.288; Bodet G, 2011, PSYCHOL MARKET, V28, P781, DOI 10.1002/mar.20412; Bradley M. M., 2007, HDB EMOTION ELICITAT, P29; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brown L, 2011, IEEE ENG MED BIO, P2188, DOI 10.1109/IEMBS.2011.6090412; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Bynion T.-M., 2017, ENCY PERSONALITY IND, P1, DOI [10.1007/978-3-319-28099-8_77-1, DOI 10.1007/978-3-319-28099-8_77-1]; Candidi M, 2010, CEREB CORTEX, V20, P2832, DOI 10.1093/cercor/bhq033; Carreiras C, 2015, BIOSPPY BIOSIGNAL PR; Codispoti M, 2006, BRAIN RES, V1068, P213, DOI 10.1016/j.brainres.2005.11.009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crimmins J, 1996, J ADVERTISING RES, V36, P11; Delia EB, 2015, SPORT MANAG REV, V18, P396, DOI 10.1016/j.smr.2014.10.006; Deliza R, 2005, J SENS STUD, V20, P17, DOI 10.1111/j.1745-459X.2005.050604.x; Di Flumeri G, 2017, IEEE ENG MED BIO, P3228, DOI 10.1109/EMBC.2017.8037544; DONOVAN RJ, 1994, J RETAILING, V70, P283, DOI 10.1016/0022-4359(94)90037-X; DONOVAN RJ, 1982, J RETAILING, V58, P34; Dror IE, 2005, APPL COGNITIVE PSYCH, V19, P799, DOI 10.1002/acp.1130; Gotz O., 2010, HDB PARTIAL LEAST SQ; Gueguen N, 2003, CURRENT PSYCHOL LETT, V2; James J. D., 2002, Sport Marketing Quarterly, V11, P215; Jerritta S., 2011, 2011 Proceedings of IEEE 7th International Colloquium on Signal Processing & its Applications (CSPA 2011), P410, DOI 10.1109/CSPA.2011.5759912; Kaneko D, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19204397; Koelstra S, 2012, IEEE T AFFECT COMPUT, V3, P18, DOI 10.1109/T-AFFC.2011.15; Kuhn S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061569; Kwak DH, 2011, EUR SPORT MANAG Q, V11, P225, DOI 10.1080/16184742.2011.577792; Lakhan P, 2019, IEEE SENS J, V19, P9896, DOI 10.1109/JSEN.2019.2928781; Lang P.J., 1997, INT AFFECTIVE PICTUR, V1, P3, DOI DOI 10.1027/0269-8803/A000147; Liu NH, 2013, SENSORS-BASEL, V13, P10273, DOI 10.3390/s130810273; Lock D, 2017, EUR SPORT MANAG Q, V17, P413, DOI 10.1080/16184742.2017.1306872; Madrigal R, 2001, PSYCHOL MARKET, V18, P145, DOI 10.1002/1520-6793(200102)18:2<145::AID-MAR1003>3.3.CO;2-K; MILLER JN, 1993, ANALYST, V118, P455, DOI 10.1039/an9931800455; Mohanani R, 2020, IEEE T SOFTWARE ENG, V46, P1318, DOI 10.1109/TSE.2018.2877759; Montalan B, 2011, SOIOAFFECTIVE NEUROS, V1, DOI 10.3402/snp.v1i0.5892; MOSKOWITZ HR, 1995, FOOD QUAL PREFER, V6, P157, DOI 10.1016/0950-3293(94)00030-Y; Ngan HMK, 2011, EUR J MARKETING, V45, P551, DOI 10.1108/03090561111111334; Nidal K, 2014, EEG ERP ANAL METHODS; Niemann A, 2008, SPORT SOC, V11, P90, DOI 10.1080/17430430701717822; Norman GR, 2017, ACAD MED, V92, P23, DOI 10.1097/ACM.0000000000001421; Nugroho S.P., 2017, MEDITERRANEAN J SOCI, V8, P306, DOI [10.5901/mjss.2017.v8n1p306, DOI 10.5901/MJSS.2017.V8N1P306]; Obaid M, 2015, LECT NOTES COMPUT SC, V9296, P263, DOI 10.1007/978-3-319-22701-6_19; Ocklenburg S., 2017, LATERALIZED BRAIN NE; OHNHAUS EE, 1975, PAIN, V1, P379, DOI 10.1016/0304-3959(75)90075-5; Oliveira PA, 2014, PSYCHOL SPORT EXERC, V15, P39, DOI 10.1016/j.psychsport.2013.09.008; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Parker HM, 2010, INT J SPORT MARK SPO, V11, P200; Potter R. F., 2012, International Journal of Sport Communication, V5, P348; Richie M, 2018, TEACH LEARN MED, V30, P67, DOI 10.1080/10401334.2017.1332631; Roccas S, 2002, PERS SOC PSYCHOL REV, V6, P88, DOI 10.1207/S15327957PSPR0602_01; Rodgers S, 2003, J ADVERTISING, V32, P67, DOI 10.1080/00913367.2003.10639141; Rousmans S, 2000, CHEM SENSES, V25, P709, DOI 10.1093/chemse/25.6.709; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; SNYDER CR, 1986, J PERS SOC PSYCHOL, V51, P382, DOI 10.1037/0022-3514.51.2.382; Sorenson D, 2005, J FOOD PROD MARK, V11, P57, DOI 10.1300/J038v11n01_04; SPEARS N., 2004, J CURRENT ISSUES RES, V26, P53, DOI [DOI 10.1080/10641734.2004.10505164, 10.1080/10641734.2004.10505164]; Sreedevi S, 2015, PROCEDIA COMPUT SCI, V46, P1724, DOI 10.1016/j.procs.2015.02.117; Stevens S, 2012, INT J SPORT MARK SPO, V13, P220; TAJFEL H, 1982, ANNU REV PSYCHOL, V33, P1, DOI 10.1146/annurev.ps.33.020182.000245; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tashiro N, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1262; Theodorakis ND., 2012, SPORT MARKET Q, V21, P80; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; van de Mortel TF, 2008, AUST J ADV NURS, V25, P40; Verschuere B., 2001, PSYCHOLO BELGICA, V41, P205, DOI [10.5334/pb.981, DOI 10.5334/PB.981]; Wann DL, 2005, J SOC PSYCHOL, V145, P531, DOI 10.3200/SOCP.145.5.531-546; Wann DL., 2001, SPORT FANS PSYCHOL S; WOOLFOLK ME, 1983, PSYCHOL REP, V52, P185, DOI 10.2466/pr0.1983.52.1.185; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	76	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254940	10.1371/journal.pone.0254940	http://dx.doi.org/10.1371/journal.pone.0254940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CM	34319994	Green Published, gold			2022-12-26	WOS:000685247800036
J	Paris, EA; Bahr, JM; Bitterman, P; Basu, S; Abramowicz, JS; Barua, A				Paris, Elizabeth A.; Bahr, Janice M.; Bitterman, Pincas; Basu, Sanjib; Abramowicz, Jacques S.; Barua, Animesh			Incidence of malignant transformation in the oviductal fimbria in laying hens, a preclinical model of spontaneous ovarian cancer	PLOS ONE			English	Article							FALLOPIAN-TUBE; PROTEIN WT1; EARLY-STAGE; PAX GENES; TUMORS; EXPRESSION; P53; CARCINOMA; DIAGNOSIS; CHICKEN	Ovarian high grade serous carcinoma (HGSC) is a lethal form of ovarian cancer (OVCA). In most cases it is detected at late stages as the symptoms are non-specific during early stages. Emerging information suggests that the oviductal fimbria is a site of origin of ovarian HGSC. Currently available tests cannot detect ovarian HGSC at early stage. The lack of a preclinical model with oviductal fimbria that develops spontaneous ovarian HGSC is a significant barrier to developing an early detection test for this disease. The goal of this study was to examine if the oviductal fimbria in hens is a site of origin of HGSC and whether it expresses several putative markers expressed in ovarian HGSC in patients. A total of 135 laying hens (4 years old) were selected from a flock using transvaginal ultrasound (TVUS) imaging, followed by euthanasia and gross examination for the presence of solid masses and ascites. Histological types of carcinomas were determined by hematoxylin and eosin staining. Expression of WT-1, mutant p53, CA-125, PAX2 and Ki67 in normal or malignant fimbriae or ovaries were examined using immunohistochemistry, immunoblotting and gene expression assays. This study detected tumors in oviductal fimbriae in hens and routine staining revealed ovarian HGSC-like microscopic features in these tumors. These tumors showed similarities to ovarian HGSC in patients in expressing several markers. Compared with normal fimbriae, intensities of expression of WT-1, mutant p53, CA-125, and Ki67 were significantly (P<0.05) higher in fimbrial tumors. In contrast, expression of PAX2 decreased gradually as the tumor progressed to late stages. The patterns of expression of these markers were similar to those in ovarian HGSC patients. Thus, tumors of the oviductal fimbria in hens may offer a preclinical model to study different aspects of spontaneous ovarian HGSC in women including its early detection.	[Paris, Elizabeth A.; Barua, Animesh] Rush Univ, Dept Cell & Mol Med, Med Ctr, Chicago, IL 60612 USA; [Bahr, Janice M.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Bitterman, Pincas; Barua, Animesh] Rush Univ, Dept Pathol, Med Ctr, Chicago, IL 60612 USA; [Bitterman, Pincas; Barua, Animesh] Rush Univ, Dept Obstet & Gynecol, Med Ctr, Chicago, IL 60612 USA; [Basu, Sanjib] Rush Univ, Dept Internal Med, Med Ctr, Chicago, IL USA; [Abramowicz, Jacques S.] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA	Rush University; University of Illinois System; University of Illinois Urbana-Champaign; Rush University; Rush University; Rush University; University of Chicago	Barua, A (corresponding author), Rush Univ, Dept Cell & Mol Med, Med Ctr, Chicago, IL 60612 USA.; Barua, A (corresponding author), Rush Univ, Dept Pathol, Med Ctr, Chicago, IL 60612 USA.; Barua, A (corresponding author), Rush Univ, Dept Obstet & Gynecol, Med Ctr, Chicago, IL 60612 USA.	Animesh_Barua@rush.edu		Paris, Elizabeth/0000-0002-7594-2954; Abramowicz, Jacques/0000-0003-4695-5972	NIH [R01 CA210370]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH R01 CA210370 (AB). The funders had no role in study design, data collection and analysis, preparation of manuscript and decision to publish.	Aloni-Grinstein R, 2014, FEBS LETT, V588, P2580, DOI 10.1016/j.febslet.2014.02.011; Barua A, 2007, J ULTRAS MED, V26, P909, DOI 10.7863/jum.2007.26.7.909; Barua A, 2015, ULTRASONIC IMAGING, V37, P224, DOI 10.1177/0161734614553603; Barua A, 2012, TRANSL ONCOL, V5, P260, DOI 10.1593/tlo.12184; Barua A, 2010, J ULTRAS MED, V29, P173, DOI 10.7863/jum.2010.29.2.173; Barua A, 2009, INT J GYNECOL CANCER, V19, P531, DOI 10.1111/IGC.0b013e3181a41613; Capriglione S, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-1026-y; Carmona R, 2001, CELL TISSUE RES, V303, P173, DOI 10.1007/s004410000307; Diniz PM, 2011, CLINICS, V66, P73, DOI 10.1590/S1807-59322011000100013; Dochez V, 2019, J OVARIAN RES, V12, DOI 10.1186/s13048-019-0503-7; Duraisamy S, 2006, GENE, V373, P28, DOI 10.1016/j.gene.2005.12.021; FREDRICKSON TN, 1987, ENVIRON HEALTH PERSP, V73, P35, DOI 10.2307/3430596; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Fujii S., 1981, J FACULTY APPL BIOL, V20, P12; Gadducci A, 2005, GYNECOL ENDOCRINOL, V20, P200, DOI 10.1080/09513590400021201; Hakim AA, 2009, CANCER PREV RES, V2, P114, DOI 10.1158/1940-6207.CAPR-08-0065; Hardy LR, 2018, CANCERS, V10, DOI 10.3390/cancers10080262; Hartkamp J, 2008, BIOCHEM SOC T, V36, P629, DOI 10.1042/BST0360629; Hawkridge AM, 2014, PROTEOM CLIN APPL, V8, P689, DOI 10.1002/prca.201300135; Henderson JT, 2018, JAMA-J AM MED ASSOC, V319, P595, DOI 10.1001/jama.2017.21421; Hwang H, 2004, APPL IMMUNOHISTO M M, V12, P122; Jayson GC, 2014, LANCET, V384, P1376, DOI 10.1016/S0140-6736(13)62146-7; Johnson PA, 2013, NAT REV CANCER, V13, P432, DOI 10.1038/nrc3535; Karnezis AN, 2017, CLIN OBSTET GYNECOL, V60, P789, DOI 10.1097/GRF.0000000000000312; Kastan MB, 2007, CELL, V128, P837, DOI 10.1016/j.cell.2007.02.022; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Kim O, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008808; Lee HJ, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2590910; Leong AS, 2003, MANUAL DIAGNOSTIC CY, V2, P447; Li Caiyun G., 2012, Frontiers in Genetics, V3, P6, DOI 10.3389/fgene.2012.00006; Li LT, 2015, MOL MED REP, V11, P1566, DOI 10.3892/mmr.2014.2914; Maugeri Grazia, 2016, Genes Cancer, V7, P47; Morin PJ, 2016, J PATHOL, V238, P180, DOI 10.1002/path.4663; Ottevanger PB, 2017, SEMIN CANCER BIOL, V44, P67, DOI 10.1016/j.semcancer.2017.04.009; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Prat J, 2018, HUM PATHOL, V80, P11, DOI 10.1016/j.humpath.2018.06.018; Robson EJD, 2006, NAT REV CANCER, V6, P52, DOI 10.1038/nrc1778; Scharnhorst V, 1999, J BIOL CHEM, V274, P23456, DOI 10.1074/jbc.274.33.23456; Schildkraut JM, 1996, OBSTET GYNECOL, V88, P554, DOI 10.1016/0029-7844(96)00226-8; Simmons D., 2008, NATURE ED, V1, P70; Society T.A.C., 2020, CAN OV CANC BE FOUND; Stakleff KDS, 2003, INT J GYNECOL CANCER, V13, P405, DOI 10.1046/j.1525-1438.2003.13317.x; Taube ET, 2016, GYNECOL ONCOL, V140, P494, DOI 10.1016/j.ygyno.2015.12.018; Tong GX, 2007, MODERN PATHOL, V20, P856, DOI 10.1038/modpathol.3800827; Trevino Lindsey S., 2010, Hormones & Cancer, V1, P177, DOI 10.1007/s12672-010-0024-8; Tung CS, 2009, MODERN PATHOL, V22, P1243, DOI 10.1038/modpathol.2009.92; Ueda T, 2015, BBA-MOL BASIS DIS, V1852, P2467, DOI 10.1016/j.bbadis.2015.08.008; Weiland F, 2012, INT J MOL SCI, V13, P10568, DOI 10.3390/ijms130810568; Yang C, 2018, CLIN TRANSL ONCOL, V20, P570, DOI 10.1007/s12094-017-1774-3; Yellapa A, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.041; Yoshimura Y, 2017, ADV EXP MED BIOL, V1001, P33, DOI 10.1007/978-981-10-3975-1_3; Zhai QJ, 2010, APPL IMMUNOHISTO M M, V18, P323, DOI 10.1097/PAI.0b013e3181d712ef; Zhai YL, 2014, 10 BIENN OV CANC RES	53	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255007	10.1371/journal.pone.0255007	http://dx.doi.org/10.1371/journal.pone.0255007			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314463	Green Published, gold			2022-12-26	WOS:000685225200037
J	Wang, BK; Zhang, W; Zhang, G; Kwong, L; Lu, HZ; Tan, JF; Sadek, N; Xiao, M; Zhang, J; Labrie, M; Randell, S; Beroard, A; Sugarman, E; Rebecca, VW; Wei, Z; Lu, YL; Mills, GB; Field, J; Villanueva, J; Xu, XW; Herlyn, M; Guo, W				Wang, Beike; Zhang, Wei; Zhang, Gao; Kwong, Lawrence; Lu, Hezhe; Tan, Jiufeng; Sadek, Norah; Xiao, Min; Zhang, Jie; Labrie, Marilyne; Randell, Sergio; Beroard, Aurelie; Sugarman, Eric; Rebecca, Vito W.; Wei, Zhi; Lu, Yiling; Mills, Gordon B.; Field, Jeffrey; Villanueva, Jessie; Xu, Xiaowei; Herlyn, Meenhard; Guo, Wei			Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma	ONCOGENE			English	Article							GENE COPY NUMBER; MAMMALIAN TARGET; PHASE-II; ADAPTIVE RESISTANCE; PROTEIN EXPRESSION; CONFER RESISTANCE; RAPAMYCIN MTOR; MAPK PATHWAY; CANCER; AKT	Targeting MAPK pathway using a combination of BRAF and MEK inhibitors is an efficient strategy to treat melanoma harboring BRAF-mutation. The development of acquired resistance is inevitable due to the signaling pathway rewiring. Combining western blotting, immunohistochemistry, and reverse phase protein array (RPPA), we aim to understanding the role of the mTORC1 signaling pathway, a center node of intracellular signaling network, in mediating drug resistance of BRAF-mutant melanoma to the combination of BRAF inhibitor (BRAFi) and MEK inhibitor (MEKi) therapy. The mTORC1 signaling pathway is initially suppressed by BRAFi and MEKi combination in melanoma but rebounds overtime after tumors acquire resistance to the combination therapy (CR) as assayed in cultured cells and PDX models. In vitro experiments showed that a subset of CR melanoma cells was sensitive to mTORC1 inhibition. The mTOR inhibitors, rapamycin and NVP-BEZ235, induced cell cycle arrest and apoptosis in CR cell lines. As a proof-of-principle, we demonstrated that rapamycin and NVP-BEZ235 treatment reduced tumor growth in CR xenograft models. Mechanistically, AKT or ERK contributes to the activation of mTORC1 in CR cells, depending on PTEN status of these cells. Our study reveals that mTOR activation is essential for drug resistance of melanoma to MAPK inhibitors, and provides insight into the rewiring of the signaling networks in CR melanoma.	[Wang, Beike; Zhang, Wei; Guo, Wei] Univ Penn, Sch Arts & Sci, Dept Biol, Philadelphia, PA 19104 USA; [Zhang, Gao; Tan, Jiufeng; Sadek, Norah; Xiao, Min; Randell, Sergio; Beroard, Aurelie; Sugarman, Eric; Rebecca, Vito W.; Villanueva, Jessie; Herlyn, Meenhard] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program & Melanoma Res, 3601 Spruce St, Philadelphia, PA 19104 USA; [Kwong, Lawrence] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Lu, Hezhe] Mt Sinai Hosp, Ctr Syst Biol, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Zhang, Jie; Wei, Zhi] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Labrie, Marilyne; Mills, Gordon B.] Oregon Hlth & Sci Univ, Sch Med, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Labrie, Marilyne; Mills, Gordon B.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Lu, Yiling] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Div Canc Med, Houston, TX 77030 USA; [Field, Jeffrey] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Xu, Xiaowei] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Zhang, Gao] Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr, Dept Neurosurg, Durham, NC USA; [Zhang, Gao] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	University of Pennsylvania; The Wistar Institute; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; New Jersey Institute of Technology; Oregon Health & Science University; Oregon Health & Science University; University of Texas System; UTMD Anderson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Duke University; Duke University	Guo, W (corresponding author), Univ Penn, Sch Arts & Sci, Dept Biol, Philadelphia, PA 19104 USA.; Herlyn, M (corresponding author), Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program & Melanoma Res, 3601 Spruce St, Philadelphia, PA 19104 USA.	herlynm@wistar.org; guowei@sas.upenn.edu		Labrie, Marilyne/0000-0003-3957-5533	NIH [R35GM141832, P01 CA114046, P50 CA174523, U54 CA224070]; DoD PRCRP [WX1XWH-16-1-0119 [CA150619]]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD PRCRP	This work was supported by NIH R35GM141832, P01 CA114046, P50 CA174523, U54 CA224070, DoD PRCRP WX1XWH-16-1-0119 [CA150619], and a kind gift from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation to MH and GBM.	Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; Ali M, 2017, BMB REP, V50, P601, DOI 10.5483/BMBRep.2017.50.12.206; Amaral T, 2017, EUR J CANCER, V73, P93, DOI 10.1016/j.ejca.2016.12.012; Atefi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028973; Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012; Boussemart L, 2014, NATURE, V513, P105, DOI 10.1038/nature13572; Carlo MI, 2016, ONCOLOGIST, V21, P787, DOI 10.1634/theoncologist.2016-0145; Corcoran RB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005753; Corcoran RB, 2011, ONCOTARGET, V2, P336; Corcoran RB, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001148; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deng W, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2011.00950.x; Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; El Zaoui I, 2019, INVEST OPHTH VIS SCI, V60, P2764, DOI 10.1167/iovs.18-26508; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Fazio N, 2016, ANTICANCER RES, V36, P713; Gopal YNV, 2014, CANCER RES, V74, P7037, DOI 10.1158/0008-5472.CAN-14-1392; Gopal YNV, 2010, CANCER RES, V70, P8736, DOI 10.1158/0008-5472.CAN-10-0902; Greger JG, 2012, MOL CANCER THER, V11, P909, DOI 10.1158/1535-7163.MCT-11-0989; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Hu-Lieskovan S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4691; Iadevaia V, 2012, BIOCHEM SOC T, V40, P168, DOI 10.1042/BST20110682; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Kappelmann-Fenzl M, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1821-9; Kim LC, 2017, ONCOGENE, V36, P2191, DOI 10.1038/onc.2016.363; Krepler C, 2017, CELL REP, V21, P1953, DOI 10.1016/j.celrep.2017.10.021; Krepler C, 2016, CLIN CANCER RES, V22, P1592, DOI 10.1158/1078-0432.CCR-15-1762; Kumar SM, 2005, AM J PATHOL, V166, P823, DOI 10.1016/S0002-9440(10)62303-6; Kwitkowski VE, 2010, ONCOLOGIST, V15, P428, DOI 10.1634/theoncologist.2009-0178; Kwong LN, 2015, J CLIN INVEST, V125, P1459, DOI 10.1172/JCI78954; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Libutti S, 2015, NEUROENDOCRINOLOGY, V102, P131; Long GV, 2017, NEW ENGL J MED, V377, P1813, DOI 10.1056/NEJMoa1708539; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Long GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6694; LoRusso PM, 2016, J CLIN ONCOL, V34, P3803, DOI 10.1200/JCO.2014.59.0018; Lu HZ, 2017, NATURE, V550, P133, DOI 10.1038/nature24040; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Menzies AM, 2014, LANCET ONCOL, V15, pE371, DOI 10.1016/S1470-2045(14)70072-5; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Moriceau G, 2015, CANCER CELL, V27, P240, DOI 10.1016/j.ccell.2014.11.018; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Penna I, 2016, ONCOTARGET, V7, P3947, DOI 10.18632/oncotarget.6600; Pongas G, 2016, ONCOLOGIST, V21, P1033, DOI 10.1634/theoncologist.2016-0243; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122; Rojo F, 2007, CLIN CANCER RES, V13, P81, DOI 10.1158/1078-0432.CCR-06-1560; Romano G, 2018, CANCER DISCOV, V8, P556, DOI 10.1158/2159-8290.CD-17-0745; Salazar R, 2015, J CLIN ONCOL, V33, P4102; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Shi HB, 2014, CANCER DISCOV, V4, P69, DOI 10.1158/2159-8290.CD-13-0279; Shi HB, 2011, CANCER RES, V71, P5067, DOI 10.1158/0008-5472.CAN-11-0140; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Silva JM, 2014, MOL CANCER RES, V12, P447, DOI 10.1158/1541-7786.MCR-13-0224-T; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Subbiah V, 2018, JCO PRECIS ONCOL, V2, DOI 10.1200/PO.18.00189; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Sweetlove M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00135; Teh JLF, 2018, CANCER DISCOV, V8, P568, DOI 10.1158/2159-8290.CD-17-0699; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Villanueva J, 2013, CELL REP, V4, P1090, DOI 10.1016/j.celrep.2013.08.023; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang J, 2015, PIGM CELL MELANOMA R, V28, P572, DOI 10.1111/pcmr.12390; Welsh SJ, 2016, EUR J CANCER, V62, P76, DOI 10.1016/j.ejca.2016.04.005; Xie XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055096; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Zuo Q, 2018, ONCOGENE, V37, P3275, DOI 10.1038/s41388-018-0205-4	87	13	13	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 16	2021	40	37					5590	5599		10.1038/s41388-021-01911-5	http://dx.doi.org/10.1038/s41388-021-01911-5		JUL 2021	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UR2PS	34304249	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000677232000002
J	Haseda, Y; Munakata, L; Kimura, C; Kinugasa-Katayama, Y; Mori, Y; Suzuki, R; Aoshi, T				Haseda, Yasunari; Munakata, Lisa; Kimura, Chiyo; Kinugasa-Katayama, Yumi; Mori, Yasuko; Suzuki, Ryo; Aoshi, Taiki			Development of combination adjuvant for efficient T cell and antibody response induction against protein antigen	PLOS ONE			English	Article							IDENTICAL-TWINS DISCORDANT; CATIONIC LIPIDS; VACCINE; IMMUNITY; BIODISTRIBUTION; ADSORPTION; MECHANISM; LIPOSOME; FUTURE; CAF09	Most current clinical vaccines work primarily by inducing the production of neutralizing antibodies against pathogens. Vaccine adjuvants that efficiently induce T cell responses to protein antigens need to be developed. In this study, we developed a new combination adjuvant consisting of 1,2-dioleoyl-3-trimethylammonium propane (DOTAP), D35, and an aluminum salt. Among the various combinations tested, the DOTAP/D35/aluminum salt adjuvant induced strong T cell and antibody responses against the model protein antigen with a single immunization. Adjuvant component and model antigen interaction studies in vitro also revealed that the strong mutual interactions among protein antigens and other components were one of the important factors for this efficient immune induction by the novel combination adjuvant. In addition, in vivo imaging of the antigen distribution suggested that the DOTAP component in the combination adjuvant formulation elicited transient antigen accumulation at the draining lymph nodes, possibly by antigen uptake DC migration. These results indicate the potential of the new combination adjuvant as a promising vaccine adjuvant candidate to treat infectious diseases and cancers.	[Haseda, Yasunari] Osaka Univ, Microbial Dis Res Inst, BIKEN Innovat Vaccine Res Alliance Labs, Vaccine Dynam Project, Osaka, Japan; [Munakata, Lisa; Suzuki, Ryo] Teikyo Univ, Fac Pharma Sci, Lab Drug & Gene Delivery Res, Itabashi Ku, Tokyo, Japan; [Kimura, Chiyo; Kinugasa-Katayama, Yumi; Aoshi, Taiki] Osaka Univ, Dept Cellular Immunol, Microbial Dis Res Inst, Osaka, Japan; [Mori, Yasuko] Kobe Univ, Grad Sch Med, Div Clin Virol, Ctr Infect Dis, Kobe, Hyogo, Japan	Osaka University; Teikyo University; Osaka University; Kobe University	Aoshi, T (corresponding author), Osaka Univ, Dept Cellular Immunol, Microbial Dis Res Inst, Osaka, Japan.	aoshi@biken.osaka-u.ac.jp		Suzuki, Ryo/0000-0001-6614-4486	Japan Agency for Medical Research and Development (AMED) [16im0210601h001, 17im0210601h002]; KAKENHI [16K01436]; Research Foundation for Microbial Diseases of Osaka University	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Foundation for Microbial Diseases of Osaka University	This work was supported by the Japan Agency for Medical Research and Development (AMED) [grant numbers 16im0210601h001, 17im0210601h002], KAKENHI (16K01436), and Research Foundation for Microbial Diseases of Osaka University. The Research Foundation for Microbial Diseases of Osaka University had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	ALSHAKHSHIR RH, 1995, VACCINE, V13, P41, DOI 10.1016/0264-410X(95)80009-3; Aoshi T, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/316364; Bengtsson KL, 2011, EXPERT REV VACCINES, V10, P401, DOI [10.1586/erv.11.25, 10.1586/ERV.11.25]; Brewitz A, 2017, IMMUNITY, V46, P205, DOI 10.1016/j.immuni.2017.01.003; Brito LA, 2013, SEMIN IMMUNOL, V25, P130, DOI 10.1016/j.smim.2013.05.007; Chen WS, 2008, CANCER IMMUNOL IMMUN, V57, P517, DOI 10.1007/s00262-007-0390-4; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; de Titta A, 2013, P NATL ACAD SCI USA, V110, P19902, DOI 10.1073/pnas.1313152110; Del Giudice G, 2018, SEMIN IMMUNOL, V39, P14, DOI 10.1016/j.smim.2018.05.001; Didierlaurent AM, 2014, J IMMUNOL, V193, P1920, DOI 10.4049/jimmunol.1400948; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Dupuis M, 1999, VACCINE, V18, P434, DOI 10.1016/S0264-410X(99)00263-7; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Foged C, 2012, EUR J PHARM SCI, V45, P482, DOI 10.1016/j.ejps.2011.08.016; Gandhapudi SK, 2019, J IMMUNOL, V202, P3524, DOI 10.4049/jimmunol.1801634; Gerner MY, 2015, IMMUNITY, V42, P172, DOI 10.1016/j.immuni.2014.12.024; Haegert DG, 2003, CLIN EXP IMMUNOL, V134, P532, DOI 10.1111/j.1365-2249.2003.02327.x; Hanagata N, 2012, INT J NANOMED, V7, P2181, DOI 10.2147/IJN.S30197; Hansen B, 2007, VACCINE, V25, P6618, DOI 10.1016/j.vaccine.2007.06.049; Haseda Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227891; HogenEsch H, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0089-x; Huang M, 2014, INT J PHARMACEUT, V466, P139, DOI 10.1016/j.ijpharm.2014.03.015; Inoue Y, 2008, MOL IMAGING, V7, P21, DOI 10.2310/7290.2008.0003; Jacobs C, 2011, INT J CANCER, V128, P897, DOI 10.1002/ijc.25399; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Korsholm KS, 2014, VACCINE, V32, P3927, DOI 10.1016/j.vaccine.2014.05.050; Liu L, 2018, THERANOSTICS, V8, P3138, DOI 10.7150/thno.21693; Lonez C, 2012, ADV DRUG DELIVER REV, V64, P1749, DOI 10.1016/j.addr.2012.05.009; Lu FJ, 2013, VACCINE, V31, P4362, DOI 10.1016/j.vaccine.2013.07.019; MALHOTRA U, 1992, J IMMUNOL, V149, P1802; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Milicic A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034255; Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011; Mount A, 2013, EXPERT REV VACCINES, V12, P733, DOI 10.1586/14760584.2013.811185; Mutwiri G, 2011, EXPERT REV VACCINES, V10, P95, DOI [10.1586/erv.10.154, 10.1586/ERV.10.154]; O'Hagan DT, 2003, NAT REV DRUG DISCOV, V2, P727, DOI 10.1038/nrd1176; Panagioti E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00276; Pedersen GK, 2018, SEMIN IMMUNOL, V39, P4, DOI 10.1016/j.smim.2018.10.003; Puig M, 2006, NUCLEIC ACIDS RES, V34, P6488, DOI 10.1093/nar/gkl867; Rahimian S, 2015, BIOMATERIALS, V37, P469, DOI 10.1016/j.biomaterials.2014.10.043; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Robinson HL, 2005, NAT MED, V11, pS25, DOI 10.1038/nm1212; Saade F, 2013, VACCINE, V31, P1999, DOI 10.1016/j.vaccine.2012.12.077; Samulowitz U, 2010, OLIGONUCLEOTIDES, V20, P93, DOI 10.1089/oli.2009.0210; Schmidt ST, 2016, J CONTROL RELEASE, V239, P107, DOI 10.1016/j.jconrel.2016.08.034; Segal L, 2015, J APPL TOXICOL, V35, P1564, DOI 10.1002/jat.3130; Shi ST, 2019, VACCINE, V37, P3167, DOI 10.1016/j.vaccine.2019.04.055; Simberg D, 2004, CRIT REV THER DRUG, V21, P257, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i4.10; Somma P, 2007, J LEUKOCYTE BIOL, V81, P696, DOI 10.1189/jlb.0906584; Vasievich EA, 2011, CANCER IMMUNOL IMMUN, V60, P629, DOI 10.1007/s00262-011-0970-1; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Wang BC, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008609; Wang ZF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7833; Watson DS, 2012, VACCINE, V30, P2256, DOI 10.1016/j.vaccine.2012.01.070; Yan WL, 2007, MOL IMMUNOL, V44, P3672, DOI 10.1016/j.molimm.2007.04.009	55	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0254628	10.1371/journal.pone.0254628	http://dx.doi.org/10.1371/journal.pone.0254628			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339430	Green Published, gold			2022-12-26	WOS:000680243400015
J	Yang, HX; Xiong, W; Zhang, XL; Wang, K; Tian, MZ				Yang, Hanxuan; Xiong, Wei; Zhang, Xueliang; Wang, Kai; Tian, Maozai			Penalized homophily latent space models for directed scale-free networks	PLOS ONE			English	Article							P-ASTERISK MODELS; EXPONENTIAL FAMILY MODELS; STOCHASTIC BLOCKMODELS; MAXIMUM-LIKELIHOOD; VARIABLE SELECTION; DISTRIBUTIONS; REGRESSION; GRAPHS	Online social networks like Twitter and Facebook are among the most popular sites on the Internet. Most online social networks involve some specific features, including reciprocity, transitivity and degree heterogeneity. Such networks are so called scale-free networks and have drawn lots of attention in research. The aim of this paper is to develop a novel methodology for directed network embedding within the latent space model (LSM) framework. It is known, the link probability between two individuals may increase as the features of each become similar, which is referred to as homophily attributes. To this end, penalized pair-specific attributes, acting as a distance measure, are introduced to provide with more powerful interpretation and improve link prediction accuracy, named penalized homophily latent space models (PHLSM). The proposed models also involve in-degree heterogeneity of directed scale-free networks by embedding with the popularity scales. We also introduce LASSO-based PHLSM to produce an accurate and sparse model for high-dimensional covariates. We make Bayesian inference using MCMC algorithms. The finite sample performance of the proposed models is evaluated by three benchmark simulation datasets and two real data examples. Our methods are competitive and interpretable, they outperform existing approaches for fitting directed networks.	[Yang, Hanxuan; Xiong, Wei] Univ Int Business & Econ, Sch Stat, Beijing, Peoples R China; [Zhang, Xueliang; Wang, Kai; Tian, Maozai] Xinjiang Med Univ, Dept Med Engn & Technol, Urumqi, Peoples R China; [Tian, Maozai] Renmin Univ China, Sch Stat, Ctr Appl Stat, Beijing, Peoples R China	University of International Business & Economics; Xinjiang Medical University; Renmin University of China	Tian, MZ (corresponding author), Xinjiang Med Univ, Dept Med Engn & Technol, Urumqi, Peoples R China.; Tian, MZ (corresponding author), Renmin Univ China, Sch Stat, Ctr Appl Stat, Beijing, Peoples R China.	mztian@ruc.edu.cn			National Natural Science Foundation of China (NNSFC) [12001101]; Fundamental Research Funds for the Central Universities in UIBE [CXTD10-09, 20YQ18]; National Natural Science Foundation of China [11861042]; China Statistical Research Project [2020LZ25]	National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in UIBE; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Statistical Research Project	The research of WX was supported by National Natural Science Foundation of China (NNSFC) grants No.12001101 and the Fundamental Research Funds for the Central Universities in UIBE (CXTD10-09) and 20YQ18. MT's work was partially supported by the National Natural Science Foundation of China (No.11861042), and the China Statistical Research Project (No.2020LZ25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin A, 2013, SOC NETWORKS, V35, P338, DOI 10.1016/j.socnet.2013.03.005; Bickel P, 2013, ANN STAT, V41, P1922, DOI 10.1214/13-AOS1124; Biswas S, 2012, BIOMETRICS, V68, P587, DOI 10.1111/j.1541-0420.2011.01680.x; Chang XY, 2019, STAT SINICA, V29, P1277, DOI 10.5705/ss.202017.0103; Choi DS, 2012, BIOMETRIKA, V99, P273, DOI 10.1093/biomet/asr053; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; ERDOS P, 1960, B INT STATIST INST, V38, P343; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Fan JQ, 2010, STAT SINICA, V20, P101; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; FAUST K, 1988, SOC NETWORKS, V10, P313, DOI 10.1016/0378-8733(88)90002-0; FRANK O, 1986, J AM STAT ASSOC, V81, P832, DOI 10.2307/2289017; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Genkin A, 2007, TECHNOMETRICS, V49, P291, DOI 10.1198/004017007000000245; Geweke J, 2001, COMPUT STAT DATA AN, V37, P151, DOI 10.1016/S0167-9473(01)00009-3; GEYER CJ, 1992, J R STAT SOC B, V54, P657; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Goodreau SM, 2007, SOC NETWORKS, V29, P231, DOI 10.1016/j.socnet.2006.08.001; Gormley I.C., 2010, STAT METHODOL, V7, P385, DOI [10.1016/j.stamet.2010.01.002, DOI 10.1016/j.stamet.2010.01.002, DOI 10.1016/J.STAMET.2010.01.002]; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Handcock MS, 2007, J ROY STAT SOC A STA, V170, P301, DOI 10.1111/j.1467-985X.2007.00471.x; Hoff PD, 2002, J AM STAT ASSOC, V97, P1090, DOI 10.1198/016214502388618906; HOLLAND PW, 1981, J AM STAT ASSOC, V76, P33, DOI 10.2307/2287037; HOLLAND PW, 1983, SOC NETWORKS, V5, P109, DOI 10.1016/0378-8733(83)90021-7; Hunter DR, 2007, SOC NETWORKS, V29, P216, DOI 10.1016/j.socnet.2006.08.005; Hunter DR, 2006, J COMPUT GRAPH STAT, V15, P565, DOI 10.1198/106186006X133069; Karrer B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016107; Krivitsky PN, 2009, SOC NETWORKS, V31, P204, DOI 10.1016/j.socnet.2009.04.001; McAuley J, 2014, ACM T KNOWL DISCOV D, V8, P73, DOI 10.1145/2556612; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nowicki K, 2001, J AM STAT ASSOC, V96, P1077, DOI 10.1198/016214501753208735; Robins G, 2007, SOC NETWORKS, V29, P192, DOI 10.1016/j.socnet.2006.08.003; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Rohe K, 2016, P NATL ACAD SCI USA, V113, P12679, DOI 10.1073/pnas.1525793113; Sarkar P., 2005, ACM SIGKDD EXPLOR NE, V7, P31, DOI DOI 10.1145/1117454.1117459; Sewell DK, 2016, SOC NETWORKS, V44, P105, DOI 10.1016/j.socnet.2015.07.005; Stephens M, 2000, J ROY STAT SOC B, V62, P795, DOI 10.1111/1467-9868.00265; STRAUSS D, 1990, J AM STAT ASSOC, V85, P204, DOI 10.2307/2289546; Takac L, 2012, P INT SCI C INT WORK; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Duijn MAJ, 2009, SOC NETWORKS, V31, P52, DOI 10.1016/j.socnet.2008.10.003; Wasserman S, 1996, PSYCHOMETRIKA, V61, P401, DOI 10.1007/BF02294547; WASSERMAN S, 1987, SOC NETWORKS, V9, P1, DOI 10.1016/0378-8733(87)90015-3; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; Zou H, 2008, ANN STAT, V36, P1509, DOI 10.1214/009053607000000802	48	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0253873	10.1371/journal.pone.0253873	http://dx.doi.org/10.1371/journal.pone.0253873			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TT3IC	34339437	gold, Green Published			2022-12-26	WOS:000680243400012
J	Zhang, J; Gao, Y; Yang, NN; Dai, EH; Yang, MH; Wang, ZF; Geng, YN				Zhang, Jun; Gao, Yu; Yang, Ningning; Dai, Enhua; Yang, Minghang; Wang, Zhoufeng; Geng, Yani			Ecological risk and source analysis of soil heavy metals pollution in the river irrigation area from Baoji, China	PLOS ONE			English	Article							TOXICITY COEFFICIENT; GEO-ACCUMULATION; SEDIMENTS; ENRICHMENT; INDEX	Due to various human activities, soil quality under different land use patterns is deteriorating all over the world. This deterioration is very complex in the river irrigation area and is caused by multi-point and non-point source pollution and seasonal variation. Therefore, the characteristics and sources of soil metal pollution in river irrigation area of Baoji city were analyzed. The contents of 8 metals were given by ICP-MS, in the soil samples. Statistical methods, geo-accumulation index (I-geo) and potential ecological risk index (RI) were conducted to evaluate the spatial distribution features, sources and ecological risks of metal contamination from the study area soil. Principal component analysis and cluster analysis were used to analyze the pollution sources of metal. The analysis showed that Cd is the most polluted, and human activities represented a great impact on the contents of Zn, Ni, Cu and Cd in soil, Cd post moderate-strong pollution and strong risk, Cd has a maximum Igeo value of 3.17. All rivers were at risk of moderate pollution levels in study. Among them, some rivers had even reached strong pollution level. Pollution caused by human activities was the most significant pollution source of metal in the research area soil.	[Zhang, Jun; Gao, Yu; Yang, Ningning; Dai, Enhua; Yang, Minghang; Geng, Yani] Baoji Univ Arts & Sci, Shaanxi Key Lab Disaster Monitoring & Mech Simula, Baoji, Peoples R China; [Zhang, Jun; Wang, Zhoufeng] Changan Univ, Minist Educ, Key Lab Subsurface Hydrol & Ecol Effect Arid Regi, Xian, Peoples R China	Baoji University of Arts & Sciences; Chang'an University	Geng, YN (corresponding author), Baoji Univ Arts & Sci, Shaanxi Key Lab Disaster Monitoring & Mech Simula, Baoji, Peoples R China.; Wang, ZF (corresponding author), Changan Univ, Minist Educ, Key Lab Subsurface Hydrol & Ecol Effect Arid Regi, Xian, Peoples R China.	284335449@qq.com; gyn1977@126.com			National Natural Science Foundation of China [41771215, 41771084]; Shaanxi Provincial Key Laboratory project of Disaster Monitoring and Mechanism Simulation [20JS012]; Key Laboratory Project of the Ministry of Education of China (Chang 'an University) [300102290504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Key Laboratory project of Disaster Monitoring and Mechanism Simulation; Key Laboratory Project of the Ministry of Education of China (Chang 'an University)	This work was supported by the National Natural Science Foundation of China [grant numbers 41771215, 41771084], funding assisted in data collecting and heavy metal analysis; Shaanxi Provincial Key Laboratory project of Disaster Monitoring and Mechanism Simulation [grant number 20JS012], funding assisted in data collecting; Key Laboratory Project of the Ministry of Education of China (Chang 'an University) [grant number 300102290504], Funding assisted in data collecting and heavy metal analysis.	Aiman U, 2016, CHEMOSPHERE, V144, P2229, DOI 10.1016/j.chemosphere.2015.10.077; Baltas H, 2020, CHEMOSPHERE, V241, DOI 10.1016/j.chemosphere.2019.125015; Nguyen BT, 2020, ENVIRON POLLUT, V256, DOI 10.1016/j.envpol.2019.113412; Chen RH, 2019, SCI TOTAL ENVIRON, V694, DOI 10.1016/j.scitotenv.2019.133819; El Azhari A, 2017, ECOTOX ENVIRON SAFE, V144, P464, DOI 10.1016/j.ecoenv.2017.06.051; Fei XF, 2019, ECOL INDIC, V106, DOI 10.1016/j.ecolind.2019.105508; Fu CP., 2014, ENV SUSTAINABLE DEV, V39, P95; Gao ZX, 2018, INT BIODETER BIODEGR, V128, P94, DOI 10.1016/j.ibiod.2017.01.001; [高志癑 Gao Zhiyue], 2018, [干旱地区农业研究, Agricultural Research in the Arid Areas], V36, P33; Hasan AB, 2013, J GEOCHEM EXPLOR, V125, P130, DOI 10.1016/j.gexplo.2012.12.002; Hou QinYan, 2019, Journal of Agro-Environment Science, V38, P1514; Hu WY, 2018, ENVIRON POLLUT, V237, P650, DOI 10.1016/j.envpol.2018.02.070; Hu XY., 2019, ENV SCI MANAGEMENT, V44, P32; Jiang YX, 2017, CHEMOSPHERE, V168, P1658, DOI 10.1016/j.chemosphere.2016.11.088; Jin GQ, 2019, ECOTOX ENVIRON SAFE, V184, DOI 10.1016/j.ecoenv.2019.109495; Kumar V, 2019, CHEMOSPHERE, V216, P449, DOI 10.1016/j.chemosphere.2018.10.066; Li MY, 2020, CHEMOSPHERE, V244, DOI 10.1016/j.chemosphere.2019.125410; Liang W., 2017, HENAN AGR, P63; Liu J, 2018, ECOTOX ENVIRON SAFE, V164, P261, DOI 10.1016/j.ecoenv.2018.08.030; Liu YX, 2018, CHEMOSPHERE, V194, P562, DOI 10.1016/j.chemosphere.2017.12.002; Ministry of Ecological and Environment of China, 2018, GB156182018 MIN EC E; National environmental protection bureau, 1990, CHIN ENV MON STAT BA CHIN ENV MON STAT BA; Rampley CPN, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.134760; Song Bo, 2018, Huanjing Kexue, V39, P4317, DOI 10.13227/j.hjkx.201712161; Tian WeiHua, 2017, Journal of Environmental Engineering Technology, V7, P684; Wang L.J., 2015, CHIN AGR SCI B, V31, P179, DOI [10.11924/j.issn.1000-6850.2014-1868, DOI 10.11924/J.ISSN.1000-6850.2014-1868]; [王利军 Wang Lijun], 2011, [城市环境与城市生态, Urban Environment and Urban Ecology], V24, P22; Wang LX, 2008, J GEOGR SCI, V18, P353, DOI 10.1007/s11442-008-0353-5; Wang NN, 2018, SCI TOTAL ENVIRON, V610, P167, DOI 10.1016/j.scitotenv.2017.07.268; Wang YZ, 2020, SCI TOTAL ENVIRON, V710, DOI 10.1016/j.scitotenv.2019.134953; Whitehead PG, 2019, SCI TOTAL ENVIRON, V697, DOI 10.1016/j.scitotenv.2019.134090; Wu J, 2020, J HAZARD MATER, V388, DOI 10.1016/j.jhazmat.2019.121766; Wu J, 2018, CHEMOSPHERE, V201, P234, DOI 10.1016/j.chemosphere.2018.02.122; Xu Chen, 2019, Huanjing Kexue, V40, P4914, DOI 10.13227/j.hjkx.201903082; Yan F, 2019, ECOL INDIC, V102, P246, DOI 10.1016/j.ecolind.2019.02.040; Yan F, 2019, SCI TOTAL ENVIRON, V659, P1, DOI 10.1016/j.scitotenv.2018.12.311; Yang QQ, 2018, SCI TOTAL ENVIRON, V642, P690, DOI 10.1016/j.scitotenv.2018.06.068; [易文利 Yi Wenli], 2018, [生态环境学报, Ecology and Environmental Sciences], V27, P2142; Yu Yuan-he, 2018, Huanjing Kexue, V39, P2865, DOI 10.13227/j.hjkx.201708201; Zhang Jun, 2019, Huanjing Kexue, V40, P3774, DOI 10.13227/j.hjkx.201811114; Zhou XY, 2019, ENVIRON POLLUT, V254, DOI 10.1016/j.envpol.2019.112962; Zhu HN, 2012, T NONFERR METAL SOC, V22, P1470, DOI 10.1016/S1003-6326(11)61343-5; Zhuang QF, 2018, CATENA, V170, P386, DOI 10.1016/j.catena.2018.06.037	43	1	1	15	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0253294	10.1371/journal.pone.0253294	http://dx.doi.org/10.1371/journal.pone.0253294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339446	gold, Green Published			2022-12-26	WOS:000680243400033
J	Anzmann, AF; Sniezek, OL; Pado, A; Busa, V; Vaz, FM; Kreimer, SD; DeVine, LR; Cole, RN; Le, A; Kirsch, BJ; Claypool, SM; Vernon, HJ				Anzmann, Arianna F.; Sniezek, Olivia L.; Pado, Alexandra; Busa, Veronica; Vaz, Frederic M.; Kreimer, Simion D.; DeVine, Lauren R.; Cole, Robert N.; Le, Anne; Kirsch, Brian J.; Claypool, Steven M.; Vernon, Hilary J.			Diverse mitochondrial abnormalities in a new cellular model of TAFFAZZIN deficiency are remediated by cardiolipin-interacting small molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHOMBOID PROTEASE PARL; BARTH-SYNDROME; RESPIRATORY-CHAIN; COMPLEX-I; MASS-SPECTROMETRY; DYSFUNCTION; MUTATIONS; MITOPHAGY; APOPTOSIS; AUTOPHAGY	Barth syndrome (BTHS) is an X-linked disorder of mito-chondrial phospholipid metabolism caused by pathogenic variants in TAFFAZIN, which results in abnormal cardiolipin (CL) content in the inner mitochondrial membrane. To identify unappreciated pathways of mitochondrial dysfunction in BTHS, we utilized an unbiased proteomics strategy and iden-tified that complex I (CI) of the mitochondrial respiratory chain and the mitochondrial quality control protease presenilin-associated rhomboid-like protein (PARL) are altered in a new HEK293-based tafazzin-deficiency model. Follow-up studies confirmed decreased steady state levels of specific CI subunits and an assembly factor in the absence of tafazzin; this decrease is in part based on decreased transcription and results in reduced CI assembly and function. PARL, a rhomboid pro-tease associated with the inner mitochondrial membrane with a role in the mitochondrial response to stress, such as mito-chondrial membrane depolarization, is increased in tafazzin-deficient cells. The increased abundance of PARL correlates with augmented processing of a downstream target, phospho-glycerate mutase 5, at baseline and in response to mitochon-drial depolarization. To clarify the relationship between abnormal CL content, CI levels, and increased PARL expres-sion that occurs when tafazzin is missing, we used blue-native PAGE and gene expression analysis to determine that these defects are remediated by SS-31 and bromoenol lactone, pharmacologic agents that bind CL or inhibit CL deacylation, respectively. These findings have the potential to enhance our understanding of the cardiac pathology of BTHS, where defective mitochondrial quality control and CI dysfunction have well-recognized roles in the pathology of diverse forms of cardiac dysfunction.	[Anzmann, Arianna F.; Sniezek, Olivia L.; Pado, Alexandra; Busa, Veronica; Vernon, Hilary J.] Johns Hopkins Univ, Sch Med, Dept Genet Med, Baltimore, MD 21218 USA; [Vaz, Frederic M.] Acad Med Ctr, Dept Clin Chem & Pediat, Amsterdam, Netherlands; [Kreimer, Simion D.; DeVine, Lauren R.; Cole, Robert N.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Mass Spectrometry & Prote Facil, Baltimore, MD 21205 USA; [Le, Anne; Kirsch, Brian J.] Johns Hopkins Univ, Sch Med, Dept Pathol & Oncol, Baltimore, MD USA; [Claypool, Steven M.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; University of Amsterdam; Academic Medical Center Amsterdam; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Vernon, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Genet Med, Baltimore, MD 21218 USA.	hvernon1@jhmi.edu		Anzmann, Arianna/0000-0002-7368-6918; Le, Anne/0000-0002-2958-8149; Pado, Alexandra/0000-0003-2018-0662; Kirsch, Brian/0000-0001-9984-4438; Sniezek, Olivia/0000-0002-6435-2852	Johns Hopkins University School of Medicine Core Coins Program; National Heart, Lung, and Blood Institute of the National Institutes of Health [F31HL147454]	Johns Hopkins University School of Medicine Core Coins Program; National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Proteomics analysis was supported by the Johns Hopkins University School of Medicine Core Coins Program to H. J. V. Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number F31HL147454 to A. F. A. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anzmann AF, 2019, HANDBOOK OF MITOCHONDRIAL DYSFUNCTION, P61; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Birk AV, 2014, BRIT J PHARMACOL, V171, P2017, DOI 10.1111/bph.12468; Chatzispyrou IA, 2018, BBA-MOL BASIS DIS, V1864, P3650, DOI 10.1016/j.bbadis.2018.08.041; Chavez JD, 2020, P NATL ACAD SCI USA, V117, P15363, DOI 10.1073/pnas.2002250117; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Cole LK, 2016, DIABETES, V65, P3289, DOI 10.2337/db16-0114; Dorn GW, 2015, EMBO MOL MED, V7, P865, DOI 10.15252/emmm.201404575; Elgogary A, 2016, P NATL ACAD SCI USA, V113, pE5328, DOI 10.1073/pnas.1611406113; Fassone E, 2011, J MED GENET, V48, P691, DOI 10.1136/jmedgenet-2011-100340; Ferreira C., 1993, GENEREVIEWS R; Galluzzi L, 2016, IMMUNITY, V44, P221, DOI 10.1016/j.immuni.2016.01.020; Gonzalez IL, 2005, AM J MED GENET A, V134A, P409, DOI 10.1002/ajmg.a.30661; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002; Herbrich SM, 2013, J PROTEOME RES, V12, P594, DOI 10.1021/pr300624g; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kammers Kai, 2015, EuPA Open Proteom, V7, P11; Kulik W, 2008, CLIN CHEM, V54, P371, DOI 10.1373/clinchem.2007.095711; Lavandero S, 2015, J CLIN INVEST, V125, P55, DOI 10.1172/JCI73943; Lee E, 2014, AUTOPHAGY, V10, P572, DOI 10.4161/auto.27649; Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505; Lu YW, 2016, HUM MOL GENET, V25, P1754, DOI 10.1093/hmg/ddw046; Lu YW, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00003; Lysyk L, 2020, J MOL BIOL, V432, P5052, DOI 10.1016/j.jmb.2020.04.006; Ma KL, 2020, CELL DEATH DIFFER, V27, P1036, DOI 10.1038/s41418-019-0396-4; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Miliara X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09089-x; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RCore Team, 2020, R LANG ENV STAT COMP; Roberts AE, 2012, AM J MED GENET A, V158A, P2726, DOI 10.1002/ajmg.a.35609; Saric A, 2016, FRONT GENET, V6, DOI 10.3389/fgene.2015.00359; Scheubel RJ, 2002, J AM COLL CARDIOL, V40, P2174, DOI 10.1016/S0735-1097(02)02600-1; Sekine S, 2012, J BIOL CHEM, V287, P34635, DOI 10.1074/jbc.M112.357509; Shi G, 2017, CELL REP, V18, P1458, DOI 10.1016/j.celrep.2017.01.029; Shires SE, 2018, CIRC RES, V122, P649, DOI 10.1161/CIRCRESAHA.118.312655; Spinazzi M, 2016, SEMIN CELL DEV BIOL, V60, P19, DOI 10.1016/j.semcdb.2016.07.034; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461; Tang JX, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113820; Thompson WR, 2016, GENET MED, V18, P1001, DOI 10.1038/gim.2015.204; Nguyen T, 2019, CELL REP, V27, P491, DOI 10.1016/j.celrep.2019.03.036; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Wai T, 2016, EMBO REP, V17, P1844, DOI 10.15252/embr.201642698; Wang B, 2018, CIRC RES, V122, P712, DOI 10.1161/CIRCRESAHA.117.312317; Wu WX, 2016, EMBO J, V35, P1368, DOI 10.15252/embj.201593102; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yang C, 2017, IN VITRO CELL DEV-AN, V53, P248, DOI 10.1007/s11626-016-0105-2; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	58	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101005	10.1016/j.jbc.2021.101005	http://dx.doi.org/10.1016/j.jbc.2021.101005			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34314685	Green Published, gold			2022-12-26	WOS:000706418900008
J	Wang, Y; Yang, J; Ma, HJ; Dong, XC; Xie, GM; Ye, SN; Du, J				Wang, Yan; Yang, Jie; Ma, Huijuan; Dong, Xinchun; Xie, Guangmei; Ye, Songning; Du, Juan			Application of telemedicine in the COVID-19 epidemic: An analysis of Gansu Province in China	PLOS ONE			English	Article								This paper analyzes the application of various telemedicine services in Gansu Province, China during the COVID-19 epidemic, and summarizes the experiences with these services. In addition, the satisfaction levels of patients and doctors with the application of telemedicine in COVID-19 were investigated, the deficiencies of telemedicine in Gansu were determined, and recommendations for modification were proposed. Coronavirus Disease 2019 (COVID-19) has broken out in China, and Gansu Province in Northwest of China has not been spared. To date, there are 91 local COVID-19 cases and 42 imported cases. 109 hospitals were selected as designated hospitals during the COVID-19 outbreak, and most of them were secondary hospitals. However, it was unsatisfactory that the ability of medical services is relatively low in most of secondary hospitals and primary hospitals. Therefore, we helped the secondary hospitals cope with COVID-19 by means of remote consultation, long-distance education, telemedicine question and answer (Q&A). Our practical experience shows that telemedicine can be widely used during the COVID-19 epidemic, especially in developing countries and areas with lagging medical standards.	[Wang, Yan; Ma, Huijuan; Ye, Songning] Gansu Prov Hosp, Dept Telemed Consultat Ctr, Lanzhou, Gansu, Peoples R China; [Yang, Jie; Xie, Guangmei] Gansu Prov Matern & Child care Hosp, Lanzhou, Gansu, Peoples R China; [Dong, Xinchun] Gansu Prov Hosp, Lanzhou, Gansu, Peoples R China; [Du, Juan] Gansu Prov Hosp, Dept Human Resources, Lanzhou, Gansu, Peoples R China		Xie, GM (corresponding author), Gansu Prov Matern & Child care Hosp, Lanzhou, Gansu, Peoples R China.	13893110862@126.com			Scientific Research Projects of Gansu Health Industry [GSWSKY2017-37]	Scientific Research Projects of Gansu Health Industry	This study was supported by Scientific Research Projects of Gansu Health Industry (GSWSKY2017-37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, NEWS CHINA; [Anonymous], 2015, CHINA ACAD J ELECT P, V4, P59; Asia & Pacific, 2020, TRAVEL BAN GOES EFFE; Cai H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158026; Cao G.W, 2020, ZHONGHUA LIU XING BI, V41, P1; Chen PJ, 2020, J SPORT HEALTH SCI, V9, P103, DOI 10.1016/j.jshs.2020.02.001; Kamsu-Foguem B., 2014, RECHERCHE EUROPEENNE, V3, P117, DOI 10.1016/j.eurtel.2014.08.001; Khaliq R., CHINA PROLONGS SCH C; Klaassen B, 2016, INT J MED INFORM, V93, P57, DOI 10.1016/j.ijmedinf.2016.06.004; Suzuki T, 2020, HEALTH POLICY TECHN, V9, P13, DOI 10.1016/j.hlpt.2020.01.006; Whitten P, 2010, APPL CLIN INFORM, V1, P132, DOI 10.4338/ACI-2009-12-R-0020; World Health Organization, STAT 2 M INT HLTH RE; World Health Organization, WHO DIR GEN OP REM M; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3	14	3	3	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2021	16	8							e0249872	10.1371/journal.pone.0249872	http://dx.doi.org/10.1371/journal.pone.0249872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IY	34347779	gold, Green Published			2022-12-26	WOS:000685264900061
J	Dohi, N; Yamaguchi, M; Hase, R; Suzuki, R; Wakabayashi, Y; Nishiyama, R; Saito, S; Ishikawa, T				Dohi, Naoki; Yamaguchi, Momoka; Hase, Reina; Suzuki, Ryosuke; Wakabayashi, Yumeto; Nishiyama, Ryota; Saito, Shin-ya; Ishikawa, Tomohisa			Quantitative real-time measurement of endothelin-1-induced contraction in single non-activated hepatic stellate cells	PLOS ONE			English	Article							RECEPTOR CROSS-TALK; RAT; CHANNELS; LIVER; HETEROGENEITY; SENSITIZATION; LOCALIZATION; ACTIVATION; PHYSIOLOGY; BIOLOGY	Although quiescent hepatic stellate cells (HSCs) have been suggested to regulate hepatic blood flow, there is no direct evidence that quiescent HSCs display contractile abilities. Here, we developed a new method to quantitatively measure the contraction of single isolated HSCs and evaluated whether endothelin-1 (ET-1) induced contraction of HSCs in a non-activated state. HSCs isolated from mice were seeded on collagen gel containing fluorescent beads. The beads around a single HSC were observed gravitating toward the cell upon contraction. By recording the movement of each bead by fluorescent microscopy, the real-time contraction of HSCs was quantitatively evaluated. ET-1 induced a slow contraction of non-activated HSCs, which was inhibited by the non-muscle myosin II inhibitor blebbistatin, the calmodulin inhibitor W-7, and the ETA receptor antagonist ambrisentan. ET-1-induced contraction was also largely reduced in Ca2+-free conditions, but sustained contraction still remained. The tonic contraction was further diminished by the Rho-kinase inhibitor H-1152. The mRNA expression of P/Q-type voltage-dependent Ca2+ channels (VDCC), as well as STIM and Orai, constituents of store-operated channels (SOCs), was observed in mouse non-activated HSCs. ET-1-induced contraction was not affected by amlodipine, a VDCC blocker, whereas it was partly reduced by Gd3+ and amiloride, non-selective cation channel blockers. However, neither YM-58483 nor SKF-96365, which inhibit SOCs, had any effects on the contraction. These results suggest that ET-1 leads to Ca2+-influx through cation channels other than SOCs and produces myosin II-mediated contraction of non-activated HSCs via ETA receptors, as well as via mechanisms involving Ca2+-calmodulin and Rho kinase.	[Dohi, Naoki; Yamaguchi, Momoka; Hase, Reina; Suzuki, Ryosuke; Wakabayashi, Yumeto; Nishiyama, Ryota; Saito, Shin-ya; Ishikawa, Tomohisa] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacol, Suruga Ward, Shizuoka, Shizuoka, Japan; [Saito, Shin-ya] Okayama Univ Sci, Fac Vet Med, Imabari, Ehime, Japan	University of Shizuoka; Okayama University of Science	Yamaguchi, M (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmacol, Suruga Ward, Shizuoka, Shizuoka, Japan.	yamamomo@u-shizuoka-ken.ac.jp		Yamaguchi, Momoka/0000-0002-4730-551X	University of Shizuoka; JSPS KAKENHI [JP17H07000, JP19K20186, JP20H04110]	University of Shizuoka; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants for the research projects from University of Shizuoka and by JSPS KAKENHI Grant Number JP17H07000, JP19K20186 and JP20H04110. University of Shizuoka: https://eng.u-shizuoka-ken.ac.jp/JSPS KAKENHI: https://www.jsps.go.jp/jgrantsinaid/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum Irfan, 2018, Journal of Basic and Clinical Physiology and Pharmacology, V29, P227, DOI 10.1515/jbcpp-2017-0071; Evans AM, 1999, BRIT J PHARMACOL, V127, P153, DOI 10.1038/sj.bjp.0702548; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; HOUSSET C, 1993, P NATL ACAD SCI USA, V90, P9266, DOI 10.1073/pnas.90.20.9266; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Kawada N, 1999, BIOCHEM BIOPH RES CO, V266, P296, DOI 10.1006/bbrc.1999.1823; Melton AC, 2006, AM J PHYSIOL-GASTR L, V290, pG7, DOI 10.1152/ajpgi.00337.2005; Moore CC, 2011, WORLD J HEPATOL, V3, P184, DOI 10.4254/wjh.v3.i7.184; Ng LC, 2001, CIRC RES, V89, P923, DOI 10.1161/hh2201.100315; Nimmrich V, 2012, BRIT J PHARMACOL, V167, P741, DOI 10.1111/j.1476-5381.2012.02069.x; Olsen AL, 2011, AM J PHYSIOL-GASTR L, V301, pG110, DOI 10.1152/ajpgi.00412.2010; Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009; Rapoport RM, 2012, J CARDIOVASC PHARM, V60, P483, DOI 10.1097/FJC.0b013e31826f32c1; Rockey DC, 1998, HEPATOLOGY, V27, P472, DOI 10.1002/hep.510270222; ROCKEY DC, 1995, BIOCHEM BIOPH RES CO, V207, P725, DOI 10.1006/bbrc.1995.1247; Rockey DC, 2001, SEMIN LIVER DIS, V21, P337, DOI 10.1055/s-2001-17551; Rocky D, 1997, HEPATOLOGY, V25, P2, DOI 10.1002/hep.510250102; Roth-Eichhorn S, 1999, J HEPATOL, V30, P612, DOI 10.1016/S0168-8278(99)80191-3; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Saiman Y, 2013, AM J PHYSIOL-GASTR L, V305, pG375, DOI 10.1152/ajpgi.00185.2012; SAKAMOTO M, 1993, HEPATOLOGY, V18, P978, DOI 10.1002/hep.1840180432; Senoo H, 2017, ANAT SCI INT, V92, P387, DOI 10.1007/s12565-017-0395-9; Sohara N, 2002, J HEPATOL, V37, P214, DOI 10.1016/S0168-8278(02)00103-4; Sward K, 2000, J PHYSIOL-LONDON, V522, P33, DOI 10.1111/j.1469-7793.2000.0033m.x; Thimgan MS, 1999, AM J PHYSIOL-GASTR L, V277, pG137, DOI 10.1152/ajpgi.1999.277.1.G137; Wake K, 2006, P JPN ACAD B-PHYS, V82, P155, DOI 10.2183/pjab.82.155; Yamaguchi M, 2017, BIOL PHARM BULL, V40, P658, DOI 10.1248/bpb.b16-00947; Yoon S, 2016, J CARDIOVASC PHARM, V67, P212, DOI 10.1097/FJC.0000000000000335; ZHANG JX, 1994, AM J PHYSIOL, V266, pG624, DOI 10.1152/ajpgi.1994.266.4.G624	30	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255656	10.1371/journal.pone.0255656	http://dx.doi.org/10.1371/journal.pone.0255656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343209	Green Published, gold			2022-12-26	WOS:000685264200011
J	Baddar, ZE; Peck, E; Xu, XY				Elhaj Baddar, Zeinah; Peck, Erin; Xu, Xiaoyu			Temporal deposition of copper and zinc in the sediments of metal removal constructed wetlands	PLOS ONE			English	Article							WASTE-WATER TREATMENT; INDUSTRIAL WASTEWATERS; DEVELOPING-COUNTRIES; HEAVY-METALS; POLLUTION; DESIGN	The objective of this study was to explore the effects of time, seasons, and total carbon (TC) on Copper (Cu) and Zinc (Zn) deposition in the surface sediments. This study was performed at the H-02 constructed wetland on the Savannah River Site (Aiken, SC, USA). Covering both warm (April-September) and cool (October-March) seasons, several sediment cores were collected twice a year from the H-02 constructed wetland cells from 2007 to 2013. Total concentrations of Cu and Zn were measured in the sediments. Concentrations of Cu and Zn (mean +/- standard deviation) in the surface sediments over 7 years of operation increased from 6.0 +/- 2.8 and 14.6 +/- 4.5 mg kg(-1) to 139.6 +/- 87.7 and 279.3 +/- 202.9 mg kg(-1) dry weight, respectively. The linear regression model explained the behavior and the variability of Cu deposition in the sediments. On the other hand, using the generalized least squares extension with the linear regression model allowed for unequal variance and thus produced a model that explained the variance properly, and as a result, was more successful in explaining the pattern of Zn deposition. Total carbon significantly affected both Cu (p = 0.047) and Zn (p < 0.001). Time effect on Cu deposition was statistically significant (p = 0.013), whereas Zn was significantly affected by the season (p = 0.009).	[Elhaj Baddar, Zeinah; Peck, Erin; Xu, Xiaoyu] Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29801 USA	United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia	Baddar, ZE (corresponding author), Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29801 USA.	Zeinah.Baddar@uga.edu	Xu, Xiaoyu/AAQ-6143-2021	Xu, Xiaoyu/0000-0003-2337-8949; Elhaj Baddar, Zeinah/0000-0002-1661-9671	National Nuclear Security Administration-Tritium	National Nuclear Security Administration-Tritium	This research was supported by the National Nuclear Security Administration-Tritium	[Anonymous], 2004, 9060A USEPA; [Anonymous], 2008, BIOGEOCHEMISTRY WETL; [Anonymous], 1998, 6020ASW846 USEPA; Ansola G, 2014, SCI TOTAL ENVIRON, V473, P63, DOI 10.1016/j.scitotenv.2013.11.125; Batool A, 2020, ECOTOX ENVIRON SAFE, V189, DOI 10.1016/j.ecoenv.2019.109924; Belabed BE, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5968-5; Ben Salem Z, 2014, ECOL ENG, V69, P25, DOI 10.1016/j.ecoleng.2014.03.072; Calheiros CSC, 2008, BIORESOURCE TECHNOL, V99, P6866, DOI 10.1016/j.biortech.2008.01.043; Cui BS, 2011, ENVIRON POLLUT, V159, P1297, DOI 10.1016/j.envpol.2011.01.024; Di Luca GA, 2011, ECOL ENG, V37, P1267, DOI 10.1016/j.ecoleng.2011.03.003; Du Laing G, 2009, SCI TOTAL ENVIRON, V407, P3972, DOI 10.1016/j.scitotenv.2008.07.025; Du Laing G, 2007, J ENVIRON MONITOR, V9, P449, DOI 10.1039/b618772b; DUNBABIN JS, 1992, SCI TOTAL ENVIRON, V111, P151, DOI 10.1016/0048-9697(92)90353-T; Dzakpasu M, 2015, ENVIRON SCI POLLUT R, V22, P341, DOI 10.1007/s11356-014-3350-5; Everaert G, 2017, ENVIRON SCI TECHNOL, V51, P12764, DOI 10.1021/acs.est.7b02964; Gill LW, 2017, SCI TOTAL ENVIRON, V601, P32, DOI 10.1016/j.scitotenv.2017.05.182; Gorgoglione A, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10113910; Harris S, 2020, WETL ECOL MANAG, V28, P847, DOI 10.1007/s11273-020-09749-6; Kivaisi AK, 2001, ECOL ENG, V16, P545, DOI 10.1016/S0925-8574(00)00113-0; Kosolapov DB, 2004, ENG LIFE SCI, V4, P403, DOI 10.1002/elsc.200420048; Liang Y, 2003, CHEMOSPHERE, V52, P1647, DOI 10.1016/S0045-6535(03)00505-8; Mackintosh TJ, 2017, FRESHW SCI, V36, P138, DOI 10.1086/690674; Marchand L, 2010, ENVIRON POLLUT, V158, P3447, DOI 10.1016/j.envpol.2010.08.018; Mayor DJ, 2010, ENVIRON SCI TECHNOL, V44, P2079, DOI 10.1021/es903073h; Mitsch WJ, 2012, BIOSCIENCE, V62, P237, DOI 10.1525/bio.2012.62.3.5; Nahlik AM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13835; O'Geen AT, 2010, ADV AGRON, V108, P1, DOI 10.1016/S0065-2113(10)08001-6; Pascoe GA, 1996, ARCH ENVIRON CON TOX, V30, P306, DOI 10.1007/BF00212288; R C, 2014, LANG ENV STAT COMP; Rajan RJ, 2019, ENVIRON ENG RES, V24, P181, DOI 10.4491/eer.2018.127; Schneider AR, 2016, ENVIRON POLLUT, V213, P618, DOI 10.1016/j.envpol.2016.03.010; Scholz M, 2007, WETLANDS, V27, P337, DOI 10.1672/0277-5212(2007)27[337:TICWIC]2.0.CO;2; SHINE JP, 1995, ENVIRON SCI TECHNOL, V29, P1781, DOI 10.1021/es00007a014; Symader W, 2000, IAHS-AISH P, P175; US EPA, 2007, 3051ASW846 USEPA; Vymazal J, 2008, ENVIRON POLLUT, V14; Vymazal J, 2014, ECOL ENG, V73, P724, DOI [10.1016/j.ecoleng.2014.09.0, 10.1016/j.ecoleng.2014.09.034]; Walker DJ, 2002, ECOL ENG, V18, P407, DOI 10.1016/S0925-8574(01)00101-X; Wu HM, 2015, BIORESOURCE TECHNOL, V175, P594, DOI 10.1016/j.biortech.2014.10.068; Xu XY, 2019, ECOL ENG, V133, P32, DOI 10.1016/j.ecoleng.2019.04.020; Xu XY, 2018, J ENVIRON MANAGE, V218, P245, DOI 10.1016/j.jenvman.2018.04.014; Zhang DQ, 2014, J ENVIRON MANAGE, V141, P116, DOI 10.1016/j.jenvman.2014.03.015; Zuur Alain F., 2009, P1	43	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255527	10.1371/journal.pone.0255527	http://dx.doi.org/10.1371/journal.pone.0255527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343201	gold, Green Published			2022-12-26	WOS:000685264200023
J	Trastoy, B; Du, JJ; Li, C; Garcia-Alija, M; Klontz, EH; Roberts, BR; Donahue, TC; Wang, LX; Sundberg, EJ; Guerin, ME				Trastoy, Beatriz; Du, Jonathan J.; Li, Chao; Garcia-Alija, Mikel; Klontz, Erik H.; Roberts, Blaine R.; Donahue, Thomas C.; Wang, Lai-Xi; Sundberg, Eric J.; Guerin, Marcelo E.			GH18 endo-beta-N-acetylglucosaminidases use distinct mechanisms to process hybrid-type N-linked glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; TRANSGLYCOSYLATION ACTIVITY; PLANT POLYSACCHARIDES; GLYCOSYLATION; SPECIFICITY; BACTEROIDES; FERMENTATION; ANTIBODIES; INSIGHTS; STARCH	N-glycosylation is one of the most abundant post-translational modifications of proteins, essential for many physiological processes, including protein folding, protein stability, oligomerization and aggregation, and molecular recognition events. Defects in the N-glycosylation pathway cause diseases that are classified as congenital disorders of glycosylation. The ability to manipulate protein N-glycosylation is critical not only to our fundamental understanding of biology but also for the development of new drugs for a wide range of human diseases. Chemoenzymatic synthesis using engineered endo-beta-N-acetylglucosaminidases (ENGases) has been used extensively to modulate the chemistry of N-glycosylated proteins. However, defining the molecular mechanisms by which ENGases specifically recognize and process N-glycans remains a major challenge. Here we present the X-ray crystal structure of the ENGase EndoBT-3987 from Bacteroides thetaiotaomicron in complex with a hybrid-type glycan product. In combination with alanine scanning mutagenesis, molecular docking calculations and enzymatic activity measurements conducted on a chemically engineered monoclonal antibody substrate unveil two mechanisms for hybrid-type recognition and processing by paradigmatic ENGases. Altogether, the experimental data provide pivotal insight into the molecular mechanism of substrate recognition and specificity for GH18 ENGases and further advance our understanding of chemoenzymatic synthesis and remodeling of homogeneous N-glycan glycoproteins.	[Trastoy, Beatriz; Garcia-Alija, Mikel; Guerin, Marcelo E.] Ctr Cooperat Res Biosci CIC bioGUNE, Struct Biol Unit, Struct Glycobiol Lab, Basque Res & Technol Alliance BRTA, Bizkaia, Derio, Spain; [Trastoy, Beatriz; Garcia-Alija, Mikel; Guerin, Marcelo E.] IIS Biocruces Bizkaia, Struct Glycobiol Lab, Baracaldo, Bizkaia, Spain; [Du, Jonathan J.; Roberts, Blaine R.; Sundberg, Eric J.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Li, Chao; Donahue, Thomas C.; Wang, Lai-Xi] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Klontz, Erik H.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Klontz, Erik H.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Guerin, Marcelo E.] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	CIC bioGUNE; Emory University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Basque Foundation for Science	Trastoy, B; Guerin, ME (corresponding author), Ctr Cooperat Res Biosci CIC bioGUNE, Struct Biol Unit, Struct Glycobiol Lab, Basque Res & Technol Alliance BRTA, Bizkaia, Derio, Spain.; Trastoy, B; Guerin, ME (corresponding author), IIS Biocruces Bizkaia, Struct Glycobiol Lab, Baracaldo, Bizkaia, Spain.; Sundberg, EJ (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.; Guerin, ME (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao, Spain.	beatriz.trastoy@gmail.com; eric.sundberg@emory.edu; mrcguerin@gmail.com	Du, Jonathan/AAW-5098-2021; Trastoy, Beatriz/F-3692-2016; Li, Chao/E-5253-2013	Du, Jonathan/0000-0002-7750-4413; Trastoy, Beatriz/0000-0002-2178-732X; Li, Chao/0000-0002-8090-2017	MINECO/FEDER EU [BFU2016-77427-C2-2-R, BFU2017-92223-EXP, PID2019-105649RB-I00]; Severo Ochoa Excellence Accreditation [SEV-2016-0644]; Basque Government [KK-2019/00076]; NIH [R01AI149297, R01GM080374]; European Union Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant [844905]; La Caixa Foundation [100010434, LCF/BQ/DR19/11740011]	MINECO/FEDER EU(Spanish Government); Severo Ochoa Excellence Accreditation; Basque Government(Basque Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant; La Caixa Foundation(La Caixa Foundation)	This work was supported by the MINECO/FEDER EU contracts BFU2016-77427-C2-2-R, BFU2017-92223-EXP, PID2019-105649RB-I00 and Severo Ochoa Excellence Accreditation SEV-2016-0644; the Basque Government contract KK-2019/00076 (to M. E. G.) and NIH R01AI149297 (to E. J. S., M. E. G., L.-X. W.), and R01GM080374 (to L.-X. W.). This project was supported by the European Union Horizon 2020 Research and Innovation Program under the Marie SklodowskaCurie grant agreement No. 844905 (to B. T.) and from La Caixa Foundation (ID 100010434) grant LCF/BQ/DR19/11740011 (to M. G.-A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Chacko BK, 2011, J BIOL CHEM, V286, P38738, DOI 10.1074/jbc.M111.247981; Chen L, 2014, ACTA CRYSTALLOGR D, V70, P932, DOI 10.1107/S1399004713033841; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Della JN, 1996, J BACTERIOL, V178, P7180; Du JJ, 2020, GLYCOBIOLOGY, V30, P268, DOI 10.1093/glycob/cwz042; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fadel F, 2015, ACTA CRYSTALLOGR D, V71, P1455, DOI 10.1107/S139900471500783X; Fairbanks AJ, 2017, CHEM SOC REV, V46, P5128, DOI 10.1039/c6cs00897f; Fairbanks AJ, 2013, PURE APPL CHEM, V85, P1847, DOI 10.1351/PAC-CON-12-09-10; Forster SC, 2019, NAT BIOTECHNOL, V37, P186, DOI 10.1038/s41587-018-0009-7; Fujita K, 2001, BIOSCI BIOTECH BIOCH, V65, P1542, DOI 10.1271/bbb.65.1542; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Jitonnom J, 2011, BIOCHEMISTRY-US, V50, P4697, DOI 10.1021/bi101362g; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klontz EH, 2019, ACS CENTRAL SCI, V5, P524, DOI 10.1021/acscentsci.8b00917; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; KUMAR R, 1990, P NATL ACAD SCI USA, V87, P9948, DOI 10.1073/pnas.87.24.9948; Lapebie P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10068-5; Lee KH, 2018, MABS-AUSTIN, V10, P380, DOI 10.1080/19420862.2018.1433976; Li C, 2018, CHEM REV, V118, P8359, DOI 10.1021/acs.chemrev.8b00238; Li TZ, 2016, J BIOL CHEM, V291, P16508, DOI 10.1074/jbc.M116.738765; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mackenzie LF, 1998, J AM CHEM SOC, V120, P5583, DOI 10.1021/ja980833d; Majewska NI, 2020, ANNU REV CHEM BIOMOL, V11, P311, DOI 10.1146/annurev-chembioeng-102419-010001; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mastrangeli R, 2020, TRENDS BIOTECHNOL, V38, P1154, DOI 10.1016/j.tibtech.2020.05.009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Noguchi M, 2009, J ORG CHEM, V74, P2210, DOI 10.1021/jo8024708; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; Parry S, 2006, GLYCOBIOLOGY, V16, P623, DOI 10.1093/glycob/cwj110; Peanne R, 2018, EUR J MED GENET, V61, P643, DOI 10.1016/j.ejmg.2017.10.012; Pereira NA, 2018, MABS-AUSTIN, V10, P693, DOI 10.1080/19420862.2018.1466767; Petrescu AJ, 2006, CURR OPIN STRUC BIOL, V16, P600, DOI 10.1016/j.sbi.2006.08.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quast I, 2017, CELL MOL LIFE SCI, V74, P837, DOI 10.1007/s00018-016-2366-z; Reily C, 2019, NAT REV NEPHROL, V15, P346, DOI 10.1038/s41581-019-0129-4; Rymen D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003989; SALYERS AA, 1977, APPL ENVIRON MICROB, V34, P529, DOI 10.1128/AEM.34.5.529-533.1977; SALYERS AA, 1977, APPL ENVIRON MICROB, V33, P319, DOI 10.1128/AEM.33.2.319-322.1977; Seki H, 2019, J BIOL CHEM, V294, P17143, DOI 10.1074/jbc.RA119.010842; Sjogren J, 2020, GLYCOBIOLOGY, V30, P254, DOI 10.1093/glycob/cwz085; Stanley P, 2017, ESSENTIALS GLYCOBIOL, P99; Tamura K, 2021, CURR OPIN STRUC BIOL, V68, P26, DOI 10.1016/j.sbi.2020.11.001; Trastoy B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14754-7; Trastoy B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04300-x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Wang LX, 2011, TRENDS GLYCOSCI GLYC, V23, P33, DOI 10.4052/tigg.23.33; White A, 1997, CURR OPIN STRUC BIOL, V7, P645, DOI 10.1016/S0959-440X(97)80073-5; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu H, 2006, ANGEW CHEM INT EDIT, V45, P3938, DOI 10.1002/anie.200600572; Zhang XY, 2016, J MOL BIOL, V428, P3183, DOI 10.1016/j.jmb.2016.02.030	68	1	1	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							101011	10.1016/j.jbc.2021.101011	http://dx.doi.org/10.1016/j.jbc.2021.101011			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34324829	Green Published, gold			2022-12-26	WOS:000690868100014
J	Zhang, SY; Guo, XM; Liu, XF; Zhong, ZX; Yang, SL; Wang, HH				Zhang, Shaoyang; Guo, Xueming; Liu, Xiufeng; Zhong, Zhixiong; Yang, Shulan; Wang, Haihe			Adaptor SH3BGRL promotes breast cancer metastasis through PFN1 degradation by translational STUB1 upregulation	ONCOGENE			English	Article							KAPPA-B; CELL MOTILITY; PROFILIN; PROTEIN; PROLIFERATION; SUPPRESSION; INHIBITION; BIOMARKER	Metastatic recurrence is still a major challenge in breast cancer treatment, but the underlying mechanisms remain unclear. Here, we report that a small adaptor protein, SH3BGRL, is upregulated in the majority of breast cancer patients, especially elevated in those with metastatic relapse, indicating it as a marker for the poor prognosis of breast cancer. Physiologically, SH3BGRL can multifunctionally promote breast cancer cell tumorigenicity, migration, invasiveness, and efficient lung colonization in nude mice. Mechanistically, SH3BGRL downregulates the acting-binding protein profilin 1 (PFN1) by accelerating the translation of the PFN1 E3 ligase, STUB1 via SH3BGRL interaction with ribosomal proteins, or/and enhancing the interaction of PFN1 with STUB1 to accelerate PFN1 degradation. Loss of PFN1 consequently contributes to downstream multiple activations of AKT, NF-B-k, and WNT signaling pathways. In contrast, the forced expression of compensatory PFN1 in SH3BGRL-high cells efficiently neutralizes SH3BGRL-induced metastasis and tumorigenesis with PTEN upregulation and PI3K-AKT signaling inactivation. Clinical analysis validates that SH3BGRL expression is negatively correlated with PFN1 and PTEN levels, but positively to the activations of AKT, NF-B-k, and WNT signaling pathways in breast patient tissues. Our results thus suggest that SH3BGRL is a valuable prognostic factor and a potential therapeutic target for preventing breast cancer progression and metastasis.	[Zhang, Shaoyang; Liu, Xiufeng; Yang, Shulan] Sun Yat Sen Univ, Affiliated Hosp 1, Translat Med Ctr, Guangzhou, Peoples R China; [Zhang, Shaoyang; Wang, Haihe] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou, Peoples R China; [Guo, Xueming; Zhong, Zhixiong] Meizhou City Peoples Hosp, Ctr Hlth Examinat, Guangzhou, Guangdong, Peoples R China; [Guo, Xueming; Zhong, Zhixiong] Guangdong Prov Key Lab Precis Med & Clin Translat, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Yang, SL (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Translat Med Ctr, Guangzhou, Peoples R China.; Wang, HH (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou, Peoples R China.	yangshl3@mail.sysu.edu.cn; wanghaih@mail.sysu.edu.cn		Yang, Shu-Lan/0000-0002-6864-2195; Zhong, Zhixiong/0000-0002-3200-3105; , Haihe/0000-0002-9302-2334; Guo, Xuemin/0000-0003-2929-7461	National Science Foundation of China [81672704]; Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translation Research of Hakka Population [2018B030322003KF02]; Natural Science Foundation of Guangdong Province [2021A1515010999]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translation Research of Hakka Population; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by National Science Foundation of China (No. 81672704), the Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translation Research of Hakka Population (2018B030322003KF02), and Natural Science Foundation of Guangdong Province (No. 2021A1515010999) to WH.	Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Bae YH, 2010, P NATL ACAD SCI USA, V107, P21547, DOI 10.1073/pnas.1002309107; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; Cesareni G, 2002, FEBS LETT, V513, P38, DOI 10.1016/S0014-5793(01)03307-5; Choi YN, 2014, BIOCHEM BIOPH RES CO, V446, P1060, DOI 10.1016/j.bbrc.2014.03.061; Das T, 2009, J CELL PHYSIOL, V218, P436, DOI 10.1002/jcp.21618; Ding Z, 2014, ONCOGENE, V33, P2065, DOI 10.1038/onc.2013.166; Egeo A, 1998, BIOCHEM BIOPH RES CO, V247, P302, DOI 10.1006/bbrc.1998.8763; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Li H, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01577-z; Loibl S, 2021, LANCET, V397, P1750, DOI 10.1016/S0140-6736(20)32381-3; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Majid SM, 2006, ONCOGENE, V25, P756, DOI 10.1038/sj.onc.1209107; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Lino MAM, 2014, J PROTEOMICS, V111, P198, DOI 10.1016/j.jprot.2014.04.019; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tong F, 2016, DEV GENES EVOL, V226, P287, DOI 10.1007/s00427-016-0552-5; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Waks Adrienne G, 2019, JAMA, V321, P288, DOI 10.1001/jama.2018.19323; Wang H, 2016, ONCOGENE, V35, P3303, DOI 10.1038/onc.2015.391; Werner CJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-8; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Wu N, 2006, PROTEOMICS, V6, P6095, DOI 10.1002/pmic.200500321; Xu LM, 2018, LEUKEMIA LYMPHOMA, V59, P918, DOI 10.1080/10428194.2017.1344843; Yarmola EG, 2006, TRENDS BIOCHEM SCI, V31, P197, DOI 10.1016/j.tibs.2006.02.006; Yin L, 2005, PROTEINS, V61, P213, DOI 10.1002/prot.20523; Zoidakis J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009449; Zou L, 2010, J CELL PHYSIOL, V223, P623, DOI 10.1002/jcp.22058	41	2	2	4	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 23	2021	40	38					5677	5690		10.1038/s41388-021-01970-8	http://dx.doi.org/10.1038/s41388-021-01970-8		JUL 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UU4CG	34331014				2022-12-26	WOS:000679620500003
J	Lee, CM; Juarez, M; Rae, G; Jones, L; Rodriguez, RM; Davis, JA; Boysen-Osborn, M; Kashima, KJ; Krane, NK; Kman, N; Langsfeld, JM; Harries, AJ				Lee, Carmen M.; Juarez, Marianne; Rae, Guenevere; Jones, Lee; Rodriguez, Robert M.; Davis, John A.; Boysen-Osborn, Megan; Kashima, Kathleen J.; Krane, N. Kevin; Kman, Nicholas; Langsfeld, Jodi M.; Harries, Aaron J.			Anxiety, PTSD, and stressors in medical students during the initial peak of the COVID-19 pandemic	PLOS ONE			English	Article							MENTAL-HEALTH; IMPACT	Purpose To assess psychological effects of the initial peak phase of the COVID-19 pandemic on United States (US) medical students in clinical training to anticipate sequelae and prepare for future outbreaks. Methods Authors emailed a cross-sectional survey in April-May, 2020 to students in clinical training years at six US medical schools which included validated General Anxiety Disorder (GAD-7) and Primary Care-PTSD (PC-PTSD-5) screening tools, and asked students about pandemic-related stress and specific concerns. Authors used quantitative and thematic analysis to present results. Results Of 2511 eligible students, 741 responded (29.5%). Most students (84.1%) reported at least "somewhat" increased levels of stress and anxiety related to the pandemic. On the GAD-7, 34.3% showed mild, 16.1% moderate, and 9.5% severe anxiety symptoms, with 39.6% demonstrating no/minimal symptoms. One quarter (25.4%) screened positive for PTSD risk symptoms. Top concerns of students chosen from a pre-populated list included inadequate COVID-19 testing, undiagnosed or asymptomatic spread and racial or other disparities in the pandemic. In thematic analysis, students' reactions to removal from clinical learning included: understanding the need to conserve PPE (32.2%), a desire to help (27.7%), worry over infectious risk to others (25.4%) and self (21.2%), and lost learning opportunities (22.5%). Female students were significantly more likely to report anxiety and PTSD risk symptoms. Asian students had a greater risk of moderate anxiety and those underrepresented in medicine (UIM) had greater risk of moderate and severe anxiety symptoms compared to white students. Conclusions During the initial peak phase of COVID-19, over 60% of US medical students screened positive for pandemic-related anxiety and one quarter were at risk for PTSD. Female and UIM students were significantly more affected. Medical schools should consider broad support of students, and targeted outreach to female and UIM students.	[Lee, Carmen M.; Juarez, Marianne; Jones, Lee; Rodriguez, Robert M.; Davis, John A.; Harries, Aaron J.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Rae, Guenevere; Krane, N. Kevin] Tulane Univ, Sch Med, New Orleans, LA 70118 USA; [Boysen-Osborn, Megan] Univ Calif Irvine, Sch Med, Orange, CA 92668 USA; [Kashima, Kathleen J.] Univ Illinois, Coll Med, Chicago, IL USA; [Kman, Nicholas] Ohio State Coll Med, Columbus, OH USA; [Langsfeld, Jodi M.] Donald & Barbara Zucker Sch Med Hofstra Northwell, Hempstead, NY USA	University of California System; University of California San Francisco; Tulane University; University of California System; University of California Irvine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Ohio; Ohio State University	Lee, CM (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.	carmen.lee2@ucsf.edu		Lee, Carmen/0000-0002-5502-2552; Davis, John/0000-0002-0252-8402; Rodriguez, Robert/0000-0003-1354-1773				Abbas M, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02293-0; Abdulghani HM, 2020, PSYCHOL RES BEHAV MA, V13, P871, DOI 10.2147/PRBM.S276938; Al-Rabiaah A, 2020, J INFECT PUBLIC HEAL, V13, P687, DOI 10.1016/j.jiph.2020.01.005; Association of American Medical Colleges, 2004, DIVERSITY INCLUSION; Association of American Medical Colleges, 2020, INT GUID MED STUD PA; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]; Debowska Agata, 2020, Psychol Med, P1, DOI 10.1017/S003329172000392X; DePierro J, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.113024; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Essangri H, 2021, AM J TROP MED HYG, V104, P95, DOI 10.4269/ajtmh.20-1302; Halperin SJ, 2021, J MED EDUC CURRIC DE, V8, DOI 10.1177/2382120521991150; Harries AJ, 2021, BMC MED EDUC, V21, DOI 10.1186/s12909-020-02462-1; Jacob R, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02075-8; Kahn MJ, 2007, ACAD PSYCHIATR, V31, P200, DOI 10.1176/appi.ap.31.3.200; Khoshaim HB, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.579750; Loh LC, 2006, MALAYS J MED SCI, V13, P30; Lyons Z, 2020, AUSTRALAS PSYCHIATRY, V28, P649, DOI 10.1177/1039856220947945; Moorthy A, 2020, J PUBLIC HEALTH-UK, V42, P486, DOI 10.1093/pubmed/fdaa096; Nakhostin-Ansari Amin, 2020, Iran J Psychiatry, V15, P228, DOI 10.18502/ijps.v15i3.3815; Pandey U, 2021, J OBSTET GYN INDIA, V71, P33, DOI 10.1007/s13224-020-01366-w; Prins A, 2016, J GEN INTERN MED, V31, P1206, DOI 10.1007/s11606-016-3703-5; Quek TTC, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16152735; Rodriguez RM, 2020, ACAD EMERG MED, V27, P700, DOI 10.1111/acem.14065; Saddik B, 2020, RISK MANAG HEALTHC P, V13, P2395, DOI 10.2147/RMHP.S273333; Sheraton M, 2020, PSYCHIAT RES, V292, DOI 10.1016/j.psychres.2020.113360; Shreffler J, 2020, WEST J EMERG MED, V21, P1059, DOI 10.5811/westjem.2020.7.48684; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092	27	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255013	10.1371/journal.pone.0255013	http://dx.doi.org/10.1371/journal.pone.0255013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324555	Green Published, gold			2022-12-26	WOS:000685248200006
J	Danielsen, J; Sandbakk, O; McGhie, D; Ettema, G				Danielsen, Jorgen; Sandbakk, Oyvind; McGhie, David; Ettema, Gertjan			Mechanical energy and propulsion mechanics in roller-skiing double-poling at increasing speeds	PLOS ONE			English	Article							CROSS-COUNTRY SKIERS; INVERTED PENDULUM; RUNNING ECONOMY; WALKING; POWER; WORK; BIOMECHANICS; LOCOMOTION; ENERGETICS; FORCES	Objectives The aim of this study was to examine the effect of speed on mechanical energy fluctuations and propulsion mechanics in the double-poling (DP) technique of cross-country skiing. Methods Kinematics and dynamics were acquired while fourteen male skiers performed roller-skiing DP on a treadmill at increasing speeds (15, 21 and 27 km.h(-1)). Kinetic (E-kin), potential (E-pot), and total (E-body) body mechanical energy and pole power (P-pole) were calculated. Inverse dynamics was used to calculate arm power (P-arm). Trunk+leg power (PT+L) was estimated, as was the power associated with body movements perpendicular to goal-direction (E-body perpendicular to). Results E-kin and E-pot fluctuated out-of-phase throughout the cycle, at first sight indicating that pendulum-like behaviour occurs partly in DP. However, during the swing phase, the increase in E-pot (body heightening) was mainly driven by positive PT+L, while the decrease in E-kin was lost to rolling friction, and during the poling phase, considerable positive P-arm generation occurs. Thus, possible exchange between E-kin and E-pot seem not to occur as directly and passively as in classic pendulum locomotion (walking). During the poling phase, E.body perpendicular to fluctuated out-of-phase with P-pole, indicating a transfer of body energy to P-pole. In this way, power generated by trunk+leg mainly during the swing phase (body heightening) can be used in the poling phase as pole power. At all speeds, negative PT+L occurred during the poling phase, suggesting energy absorption of body energy not transferred to pole power. Thus, DP seem to resemble bouncing ball-like behaviour more than pendulum at faster speeds. Over the cycle, P-arm contribution to P-pole (external power) was 63% at 15 km.h(-1) and 66% at 21 and 27 km.h(-1), with the remainder being PT+L contribution. Conclusions When speed increases in level DP, both power production and absorption by trunk+leg actions increase considerably. This enhanced involvement of the legs at faster speeds is likely a prerequisite for effective generation of pole power at high speeds with very short poling times. However, the relative trunk+leg power contribution did not increase at the speeds studied here.	[Danielsen, Jorgen; Sandbakk, Oyvind; McGhie, David; Ettema, Gertjan] Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, Ctr Elite Sports Res, Fac Med & Hlth Sci, Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Danielsen, J (corresponding author), Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, Ctr Elite Sports Res, Fac Med & Hlth Sci, Trondheim, Norway.	jorgen.danielsen@ntnu.no			Faculty of Medicine at NTNU; Central Norway Regional Health Authority	Faculty of Medicine at NTNU; Central Norway Regional Health Authority	The lab facility was provided by NeXt Move, Norwegian University of Science and Technology (NTNU). NeXt Move is funded by the Faculty of Medicine at NTNU and Central Norway Regional Health Authority. The authors would like to thank Vidar Jakobsen for his assistance by gracefully supplying equipment for measuring poling forces and instruction, Xiangchun Tan (Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway) for all help in the lab, and the participating athletes and their coaches for their cooperation and enthusiasm during the testing sessions.	ALEXANDER RM, 1991, J EXP BIOL, V160, P55; Bisseling RW, 2006, J BIOMECH, V39, P2438, DOI 10.1016/j.jbiomech.2005.07.021; Bojsen-Moller J, 2010, J APPL PHYSIOL, V109, P1895, DOI 10.1152/japplphysiol.00671.2010; Cavagna GA, 2002, J EXP BIOL, V205, P3413; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Dahl C, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00094; Danielsen J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212500; Danielsen J, 2015, MED SCI SPORT EXER, V47, P2586, DOI 10.1249/MSS.0000000000000723; Danielsen J, 2018, HUM MOVEMENT SCI, V57, P83, DOI 10.1016/j.humov.2017.11.010; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Donelan JM, 2002, J BIOMECH, V35, P117, DOI 10.1016/S0021-9290(01)00169-5; Elftman H, 1939, AM J PHYSIOL, V125, P339, DOI 10.1152/ajplegacy.1939.125.2.339; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Hegge AM, 2016, EUR J APPL PHYSIOL, V116, P291, DOI 10.1007/s00421-015-3281-y; Holmberg HC, 2006, MED SCI SPORT EXER, V38, P1853, DOI 10.1249/01.mss.0000230121.83641.d1; Holmberg HC, 2005, MED SCI SPORT EXER, V37, P807, DOI 10.1249/01.MSS.0000162615.47763.C8; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Kuo AD, 2007, HUM MOVEMENT SCI, V26, P617, DOI 10.1016/j.humov.2007.04.003; Lindinger SJ, 2011, EUR J APPL PHYSIOL, V111, P1103, DOI 10.1007/s00421-010-1736-8; Lindinger SJ, 2009, MED SCI SPORT EXER, V41, P210, DOI 10.1249/MSS.0b013e318184f436; Ortega JD, 2005, J APPL PHYSIOL, V99, P2099, DOI 10.1152/japplphysiol.00103.2005; Pellegrini B, 2014, J EXP BIOL, V217, P3910, DOI 10.1242/jeb.106740; Rud B, 2014, SCAND J MED SCI SPOR, V24, P913, DOI 10.1111/sms.12133; Sandbakk O, 2014, INT J SPORT PHYSIOL, V9, P117, DOI [10.1123/ijspp.2013-0373, 10.1123/IJSPP.2013-0373]; Sandbakk O, 2010, EUR J APPL PHYSIOL, V109, P473, DOI 10.1007/s00421-010-1372-3; Schache AG, 2015, J EXP BIOL, V218, P2472, DOI 10.1242/jeb.119156; SCHENAU GJV, 1990, J BIOMECH, V23, P865, DOI 10.1016/0021-9290(90)90352-4; Stoggl TL, 2016, MED SCI SPORT EXER, V48, P1580, DOI 10.1249/MSS.0000000000000943; Stoggl T, 2011, SCAND J MED SCI SPOR, V21, pE393, DOI 10.1111/j.1600-0838.2011.01324.x; Tartaruga MP, 2012, RES Q EXERCISE SPORT, V83, P367; van Hall G, 2003, AM J PHYSIOL-ENDOC M, V284, pE193, DOI 10.1152/ajpendo.00273.2002; VANDENBOGERT A, 1996, P 9 BIENN C CAN SOC; WILLIAMS KR, 1987, J APPL PHYSIOL, V63, P1236, DOI 10.1152/jappl.1987.63.3.1236; Winter D. A, 2009, BIOMECHANICS MOTOR C; WINTER DA, 1979, J APPL PHYSIOL, V46, P79, DOI 10.1152/jappl.1979.46.1.79; Winter DA., 2009, BIOMECHANICS MOTOR C, V4, P154; Zelik KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031143; Zoppirolli C, 2017, SCAND J MED SCI SPOR, V27, P1292, DOI 10.1111/sms.12783; Zoppirolli C, 2015, EUR J APPL PHYSIOL, V115, P969, DOI 10.1007/s00421-014-3078-4	39	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0255202	10.1371/journal.pone.0255202	http://dx.doi.org/10.1371/journal.pone.0255202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320011	gold, Green Published			2022-12-26	WOS:000685247800022
J	Huang, SB; Deng, WG; Wang, P; Yan, Y; Xie, CB; Cao, XL; Chen, M; Zhang, CL; Shi, DB; Dong, YX; Cheng, P; Xu, HL; Zhu, WK; Hu, ZC; Tang, B; Zhu, JY				Huang, Shaobin; Deng, Wuguo; Wang, Peng; Yan, Yue; Xie, Chuanbo; Cao, Xiaoling; Chen, Miao; Zhang, Changlin; Shi, Dingbo; Dong, Yunxian; Cheng, Pu; Xu, Hailin; Zhu, Wenkai; Hu, Zhicheng; Tang, Bing; Zhu, Jiayuan			Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-alpha-Pix to Rac1 to activate the MAPK pathway	ONCOGENE			English	Article							STAGE-III MELANOMA; METASTATIC MELANOMA; KINDLIN-2 PROMOTES; CANCER CELLS; BRAF; INHIBITION; VEMURAFENIB; RESISTANCE; SURVIVAL; MORTALITY	We identified fermitin family member 2 (FERMT2, also known as kindlin-2) as a potential target in A375 cell line by siRNA library screening. Drugs that target mutant BRAF kinase lack durable efficacy in the treatment of melanoma because of acquired resistance, thus the identification of novel therapeutic targets is needed. Immunohistochemistry was used to identify kindlin-2 expression in melanoma samples. The interaction between kindlin-2 and Rac1 or p-Rac/Cdc42 guanine nucleotide exchange factor 6 (alpha-Pix) was investigated. Finally, the tumor suppressive role of kindlin-2 was validated in vitro and in vivo. Analysis of clinical samples and Oncomine data showed that higher levels of kindlin-2 predicted a more advanced T stage and M stage and facilitated metastasis and recurrence. Kindlin-2 knockdown significantly inhibited melanoma growth and migration, whereas kindlin-2 overexpression had the inverse effects. Further study showed that kindlin-2 could specifically bind to p-alpha-Pix(S13) and Rac1 to induce a switch from the inactive Rac1-GDP conformation to the active Rac1-GTP conformation and then stimulate the downstream MAPK pathway. Moreover, we revealed that a Rac1 inhibitor suppressed melanoma growth and metastasis and the combination of the Rac1 inhibitor and vemurafenib resulted in a better therapeutic outcome than monotherapy in melanoma with high kindlin-2 expression and BRAF mutation. Our results demonstrated that kindlin-2 promoted melanoma progression, which was attributed to specific binding to p-alpha-Pix(S13) and Rac1 to stimulate the downstream MAPK pathway. Thus, kindlin-2 could be a potential therapeutic target for treating melanoma.	[Huang, Shaobin; Wang, Peng; Cao, Xiaoling; Dong, Yunxian; Cheng, Pu; Xu, Hailin; Hu, Zhicheng; Tang, Bing; Zhu, Jiayuan] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China; [Huang, Shaobin; Deng, Wuguo; Yan, Yue; Xie, Chuanbo; Chen, Miao; Zhang, Changlin; Shi, Dingbo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China; [Huang, Shaobin] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Peoples R China; [Zhu, Wenkai] Portland State Univ, Dept Chem, Portland, OR 97207 USA	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Portland State University	Hu, ZC; Tang, B; Zhu, JY (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China.	huzhch5@mail.sysu.edu.cn; tangbing@mail.sysu.edu.cn; zhujiay@mail.sysu.edu.cn			National Natural Science Foundation of China [81702761, 81772925, 81871565]; Natural Science Foundation of Guangdong Province [2016A03031100, 2015A030313018]; Science and Technology Planning Project of Guangdong Province [2016B090916001]; Sun Yat-sen University Clinical Research 5010 Program [2013001, 2018003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Sun Yat-sen University Clinical Research 5010 Program	This work was supported in part by the National Natural Science Foundation of China (81702761, 81772925, 81871565), the Natural Science Foundation of Guangdong Province (2016A03031100, 2015A030313018), the Science and Technology Planning Project of Guangdong Province (2016B090916001), the Sun Yat-sen University Clinical Research 5010 Program (2013001, 2018003).	Amin M.B., 2017, AJCC CANC STAGING MA, V8; Balch C, 1992, RADIOTHERAPY MELANOM; Barbaric J, 2016, EUR J CANCER, V55, P47, DOI 10.1016/j.ejca.2015.11.019; Bottcher RT, 2017, J CELL BIOL, V216, P3785, DOI 10.1083/jcb.201701176; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Casado-Medrano V, 2018, BIOCHEM SOC T, V46, P1003, DOI 10.1042/BST20170519; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ducreux M, 2019, THER ADV MED ONCOL, V11, DOI 10.1177/1758835919856494; Dudnik E, 2019, CLIN LUNG CANCER, V20, P278, DOI 10.1016/j.cllc.2019.03.007; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8; Falini B, 2019, HEMATOL ONCOL, V37, P30, DOI 10.1002/hon.2594; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; Feng JH, 2016, MOL CANCER THER, V15, P1163, DOI 10.1158/1535-7163.MCT-15-0973; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Guo L, 2018, J CELL BIOL, V217, P1431, DOI 10.1083/jcb.201612177; Guy GP, 2015, MMWR-MORBID MORTAL W, V64, P591; Haga Raquel B, 2016, Small GTPases, V7, P207; Halaban R, 2015, CLIN THER, V37, P682, DOI 10.1016/j.clinthera.2014.10.027; Hong M, 2019, CANCER MANAG RES, V11, P369, DOI 10.2147/CMAR.S186236; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; HUHN J, 2019, INT MICROBIOL; Joly MM, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0868-8; Kim G, 2014, CLIN CANCER RES, V20, P4994, DOI 10.1158/1078-0432.CCR-14-0776; KNIPPLER CM, 2019, ENDOCR RELAT CANC; Lin J, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0603-4; Long GV, 2017, ANN ONCOL, V28, P1631, DOI 10.1093/annonc/mdx176; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066275; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Margiotta A, 2017, BBA-MOL CELL RES, V1864, P367, DOI 10.1016/j.bbamcr.2016.11.020; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ou YW, 2016, ONCOTARGET, V7, P74872, DOI 10.18632/oncotarget.12439; Pedini F, 2019, MOL ONCOL, V13, P1836, DOI 10.1002/1878-0261.12506; Peng JX, 2019, ONCOL REP, V41, P224, DOI 10.3892/or.2018.6838; Pluskota E, 2017, J PHYSIOL-LONDON, V595, P6443, DOI 10.1113/JP274380; Qi LH, 2016, SCI CHINA LIFE SCI, V59, P1123, DOI 10.1007/s11427-016-0025-0; Qin Y, 2013, PIGM CELL MELANOMA R, V26, P97, DOI 10.1111/pcmr.12031; Robert C, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw435.37; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sandru A, 2014, J Med Life, V7, P572; Shen ZL, 2013, J SURG ONCOL, V108, P106, DOI 10.1002/jso.23353; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Sossey-Alaoui K, 2017, CANCER RES, V77, P5129, DOI 10.1158/0008-5472.CAN-16-2337; Spagnolo F, 2015, ONCOTARGETS THER, V8, P157, DOI 10.2147/OTT.S39096; Sullivan RJ, 2019, NAT MED, V25, P929, DOI 10.1038/s41591-019-0474-7; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Wang P, 2018, INT J BIOCHEM CELL B, V105, P41, DOI 10.1016/j.biocel.2018.09.022; Wang P, 2017, SCI CHINA LIFE SCI, V60, P1214, DOI 10.1007/s11427-016-9044-5; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Wei CY, 2019, AGING-US, V11, P6273, DOI 10.18632/aging.102187; Wiebe CB, 2003, J PERIODONTOL, V74, P25, DOI 10.1902/jop.2003.74.1.25; Wu CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8531; Yang JR, 2016, GENE, V576, P571, DOI 10.1016/j.gene.2015.11.005; Yasuda-Yamahara M, 2018, MATRIX BIOL, V68-69, P263, DOI 10.1016/j.matbio.2018.01.003; Yoshida N, 2017, CANCER LETT, V390, P103, DOI 10.1016/j.canlet.2017.01.008; Zhou K, 2018, LAB INVEST, V98, P989, DOI 10.1038/s41374-018-0071-2	58	4	4	2	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 16	2021	40	37					5626	5638		10.1038/s41388-021-01954-8	http://dx.doi.org/10.1038/s41388-021-01954-8		JUL 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UR2PS	34321603	Green Published, hybrid			2022-12-26	WOS:000678443300002
J	Manukhova, TI; Evtushenko, EA; Ksenofontov, AL; Arutyunyan, AM; Kovalenko, AO; Nikitin, NA; Karpova, OV				Manukhova, Tatiana I.; Evtushenko, Ekaterina A.; Ksenofontov, Alexander L.; Arutyunyan, Alexander M.; Kovalenko, Angelina O.; Nikitin, Nikolai A.; Karpova, Olga V.			Thermal remodelling of Alternanthera mosaic virus virions and virus-like particles into protein spherical particles	PLOS ONE			English	Article							MODIFIED PLANT-VIRUS; POTATO-VIRUS; COAT PROTEIN; X RNA; TRANSITION; COMPLEXES	The present work addresses the thermal remodelling of flexible plant viruses with a helical structure and virus-like particles (VLPs). Here, for the first time, the possibility of filamentous Alternanthera mosaic virus (AltMV) virions' thermal transition into structurally modified spherical particles (SP) has been demonstrated. The work has established differences in formation conditions of SP from virions (SPV) and VLPs (SPVLP) that are in accordance with structural data (on AltMV virions and VLPs). SP originate from AltMV virions through an intermediate stage. However, the same intermediate stage was not detected during AltMV VLPs' structural remodelling. According to the biochemical analysis, AltMV SPV consist of protein and do not include RNA. The structural characterisation of AltMV SPV/VLP by circular dichroism, intrinsic fluorescence spectroscopy and thioflavin T fluorescence assay has been performed. AltMV SPV/VLP adsorption properties and the availability of chemically reactive surface amino acids have been analysed. The revealed characteristics of AltMV SPV/VLP indicate that they could be applied as protein platforms for target molecules presentation and for the design of functionally active complexes.	[Manukhova, Tatiana I.; Evtushenko, Ekaterina A.; Kovalenko, Angelina O.; Nikitin, Nikolai A.; Karpova, Olga V.] Lomonosov Moscow State Univ, Dept Virol, Fac Biol, Moscow, Russia; [Ksenofontov, Alexander L.; Arutyunyan, Alexander M.] Lomonosov Moscow State Univ, Belozersky Inst Physico Chem Biol, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University	Evtushenko, EA (corresponding author), Lomonosov Moscow State Univ, Dept Virol, Fac Biol, Moscow, Russia.	trifonova.katerina@gmail.com	Kovalenko, Angelina/ABF-8211-2020; Nikitin, Nikolai/D-6520-2013; Karpova, Olga V/H-2475-2013	Kovalenko, Angelina/0000-0001-9786-7652; Nikitin, Nikolai/0000-0001-9626-2336; Karpova, Olga V/0000-0002-0605-9033; Manukhova, Tatyana/0000-0001-9498-1257	Russian Foundation for Basic Research grant [20-3470023]	Russian Foundation for Basic Research grant(Russian Foundation for Basic Research (RFBR))	The work was funded by Russian Foundation for Basic Research grant. 20-3470023, https://www.rfbr.ru/rffi/eng.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderibigbe BA, 2017, MOLECULES, V22, DOI 10.3390/molecules22081370; Atabekov J, 2011, J GEN VIROL, V92, P453, DOI 10.1099/vir.0.024356-0; Bruckman MA, 2013, J MATER CHEM B, V1, P1482, DOI 10.1039/c3tb00461a; Dobrov EN, 2014, J BIOMOL STRUCT DYN, V32, P701, DOI 10.1080/07391102.2013.788983; Donchenko EK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183824; FRAENK.H, 1961, VIROLOGY, V14, P54, DOI 10.1016/0042-6822(61)90131-3; Geering ADW, 1999, ARCH VIROL, V144, P577, DOI 10.1007/s007050050526; Ivanov PA, 2011, VIRUS GENES, V42, P268, DOI 10.1007/s11262-010-0556-6; Karpova OV, 2006, MOL BIOL+, V40, P703; Karpova O, 2012, J GEN VIROL, V93, P400, DOI 10.1099/vir.0.036293-0; Ksenofontov AL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216905; Ksenofontov AL, 2016, J BIOMOL STRUCT DYN, V34, P250, DOI 10.1080/07391102.2015.1022604; Maduray K, 2021, BIOL TRACE ELEM RES, V199, P3159, DOI 10.1007/s12011-020-02414-2; MIROSHNICHENKO NA, 1988, FEBS LETT, V234, P65, DOI 10.1016/0014-5793(88)81304-8; Mukhamedzhanova Anna A, 2011, Open Virol J, V5, P136, DOI 10.2174/1874357901105010136; Murray AA, 2018, MOL PHARMACEUT, V15, P3700, DOI 10.1021/acs.molpharmaceut.8b00316; Nanda JS, 2014, METHOD ENZYMOL, V536, P79, DOI 10.1016/B978-0-12-420070-8.00007-6; Nikitin NA, 2018, DATA BRIEF, V21, P1504, DOI 10.1016/j.dib.2018.10.102; Nikitin NA, 2018, DATA BRIEF, V21, P742, DOI 10.1016/j.dib.2018.10.030; Nikitin NA, 2018, REGUL TOXICOL PHARM, V97, P127, DOI 10.1016/j.yrtph.2018.06.010; Nikitin NA, 2011, POLYM SCI SER A+, V53, P1026, DOI 10.1134/S0965545X11110083; Nikitin N, 2016, FEBS LETT, V590, P1543, DOI 10.1002/1873-3468.12184; Rodriguez-Galvan A, 2017, J NANOSCI NANOTECHNO, V17, P4740, DOI 10.1166/jnn.2017.13714; Semenyuk PI, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1522, DOI 10.1134/S0006297916120130; Shah S., 2012, P 6 INT C GOLD SCI T; Trifonova E.A., 2017, MOSC U BIOL SCI B, V4, P179, DOI [10.3103/S0096392517040125, DOI 10.3103/S0096392517040125]; Trifonova E, 2014, J BIOMOL STRUCT DYN, V32, P1193, DOI 10.1080/07391102.2013.816868; Trifonova EA, 2017, ANTIVIR RES, V144, P27, DOI 10.1016/j.antiviral.2017.05.006; Wang D, 2013, FOOD SCI BIOTECHNOL, V22, P1359, DOI 10.1007/s10068-013-0223-5	29	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0255378	10.1371/journal.pone.0255378	http://dx.doi.org/10.1371/journal.pone.0255378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320024	Green Published, gold			2022-12-26	WOS:000685247800007
J	Nuhu, H; Hashim, S; Saleh, MA; Sanusi, MSM; Alomari, AH; Jamal, MH; Abdullah, RA; Hassan, SA				Nuhu, Habila; Hashim, Suhairul; Aziz Saleh, Muneer; Syazwan Mohd Sanusi, Mohamad; Hussein Alomari, Ahmad; Jamal, Mohamad Hidayat; Abdullah, Rini Asnida; Hassan, Sitti Asmah			Soil gas radon and soil permeability assessment: Mapping radon risk areas in Perak State, Malaysia	PLOS ONE			English	Article							INDOOR RADON; EUROPEAN ATLAS; DOSE-RATE; REGRESSION; METHODOLOGY; EXPOSURE; REGION; RN-222	In this study geogenic radon potential (GRP) mapping was carried out on the bases of field radon in soil gas concentration and soil gas permeability measurements by considering the corresponding geological formations. The spatial pattern of soil gas radon concentration, soil permeability, and GRP and the relationship between geological formations and these parameters was studied by performing detailed spatial analysis. The radon activity concentration in soil gas ranged from 0.11 to 434.5 kBq m(-3) with a mean of 18.96 kBq m(-3), and a standard deviation was 55.38 kBq m(-3). The soil gas permeability ranged from 5.2x10(-14) to 5.2x10(-12) m(2), with a mean of 5.65x10(-13) m(2). The GRP values were computed from the Rn-222 activity concentration and soil gas permeability data. The range of GRP values was from 0.04 to 154.08. Locations on igneous granite rock geology were characterized by higher soil radon gas activity and higher GRP, making them radon-prone areas according to international standards. The other study locations fall between the low to medium risk, except for areas with high soil permeability, which are not internationally classified as radon prone. A GRP map was created displaying radon-prone areas for the study location using Kriging/Cokriging, based on in situ and predicted measured values. The GRP map assists in human health risk assessment and risk reduction since it indicates the potential of the source of radon and can serve as a vital tool for radon combat planning.	[Nuhu, Habila; Hashim, Suhairul; Syazwan Mohd Sanusi, Mohamad] Univ Teknol Malaysia, Dept Phys, Fac Sci, Skudai, Johor, Malaysia; [Nuhu, Habila] Plateau State Polytech Barkin Ladi Jos, Dept Sci, Bukuru, Plateau State, Nigeria; [Hashim, Suhairul] Univ Teknol Malaysia, Ibnu Sina Inst Sci & Ind Res ISISIR, Skudai, Johor, Malaysia; [Aziz Saleh, Muneer] Univ Teknol Malaysia, Nucl Engn Programme, Skudai, Johor, Malaysia; [Hussein Alomari, Ahmad] Energy & Minerals Regulatory Commiss EMRC, Amman, Jordan; [Jamal, Mohamad Hidayat; Abdullah, Rini Asnida; Hassan, Sitti Asmah] Univ Teknol Malaysia, Fac Engn, Skudai, Johor, Malaysia	Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia	Nuhu, H (corresponding author), Univ Teknol Malaysia, Dept Phys, Fac Sci, Skudai, Johor, Malaysia.; Nuhu, H (corresponding author), Plateau State Polytech Barkin Ladi Jos, Dept Sci, Bukuru, Plateau State, Nigeria.	nuhuhabila@gmail.com	Hashim, Suhairul/K-6357-2012; Hassan, Sitti Asmah/AAG-5781-2021; MOHD SANUSI, MOHAMAD SYAZWAN/U-9938-2018	Hashim, Suhairul/0000-0001-8758-4288; Nuhu, Habila/0000-0002-9380-0490; MOHD SANUSI, MOHAMAD SYAZWAN/0000-0002-1792-8142	Ministry of Higher Education Malaysia; Universiti Teknologi Malaysia through UTMSHINE Signature Grant [07G82, 07G85, 07G90, 07G91]; Intech Scientific Sdn. Bhd. [R.J130000.7617.4C403]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); Universiti Teknologi Malaysia through UTMSHINE Signature Grant; Intech Scientific Sdn. Bhd.	We acknowledged the financial support from the Ministry of Higher Education Malaysia and Universiti Teknologi Malaysia through UTMSHINE Signature Grant (No. 07G82, 07G85, 07G90 and 07G91). This study was also partially funded by a contract research DTD grant from Intech Scientific Sdn. Bhd. (R.J130000.7617.4C403)	Abdul Razab Mohammad Khairul Azhar, 2017, Materials Science Forum, V888, P471, DOI 10.4028/www.scientific.net/MSF.888.471; Abdul Razab Mohammad Khairul Azhar, 2017, Materials Science Forum, V888, P466, DOI 10.4028/www.scientific.net/MSF.888.466; Ahmad N., 2015, NATURAL RADIOACTIVIT; Ahmad N, 2017, J RADIAT RES APPL SC, V10, P327, DOI 10.1016/j.jrras.2017.08.001; Almayahi B, 2011, P INT C CHEM BIOL; Almayahi BA, 2013, RADIAT PHYS CHEM, V90, P11, DOI 10.1016/j.radphyschem.2013.04.028; Almayahi BA, 2012, ADV BIOMED ENG, V6, P593; Alonso H, 2019, SCI TOTAL ENVIRON, V664, P449, DOI 10.1016/j.scitotenv.2019.01.411; Andersen CE, 2001, SCI TOTAL ENVIRON, V272, P231, DOI 10.1016/S0048-9697(01)00697-0; [Anonymous], 1991, Ann ICRP, V21, P1; [Anonymous], 2015, DURRIDGE CO SOIL GAS; [Anonymous], 1988, DIRECTOR GEN GEOLOGI; [Anonymous], 1986, PRINCIPLES GEOGRAPHI; [Anonymous], 2010, EQUIPMENT IN SITU PE; [Anonymous], 1989, DIRECTOR NATL MAPPIN; Appleton JD, 2011, SCI TOTAL ENVIRON, V409, P1572, DOI 10.1016/j.scitotenv.2011.01.023; Appleton JD, 2010, J ENVIRON RADIOACTIV, V101, P799, DOI 10.1016/j.jenvrad.2009.06.002; Arnedo MA, 2017, J ENVIRON RADIOACTIV, V166, P242, DOI 10.1016/j.jenvrad.2016.07.010; Barnet I, 2008, RADIAT PROT DOSIM, V130, P81, DOI 10.1093/rpd/ncn107; Barnet I, 2011, ENVIRON EARTH SCI, V63, P551, DOI 10.1007/s12665-010-0722-0; Bossew P., 2014, LECT N EARTH SYST SC, P527, DOI DOI 10.1007/978-3-642-32408-6_115; Burghele B, 2019, SCI TOTAL ENVIRON, V669, P887, DOI 10.1016/j.scitotenv.2019.02.342; Burrough PA., 1998, PRINCIPLES GEOGRAPHI; Castelluccio M., 2014, GEOCHEMICAL EXPLORAT, V148, P56; Ciotoli G, 2017, J ENVIRON RADIOACTIV, V166, P355, DOI 10.1016/j.jenvrad.2016.05.010; Devore JL, 2016, PROBABILITY STAT ENG; Elio J, 2018, ENVIRON INT, V114, P69, DOI 10.1016/j.envint.2018.02.025; Garcia-Talavera M, 2013, J RADIOL PROT, V33, P605, DOI 10.1088/0952-4746/33/3/605; Giustini F, 2019, SCI TOTAL ENVIRON, V661, P449, DOI 10.1016/j.scitotenv.2019.01.146; Hutchison C.S., 2009, GEOLOGY PENINSULAR M; Ielsch G, 2010, J ENVIRON RADIOACTIV, V101, P813, DOI 10.1016/j.jenvrad.2010.04.006; Johner HU, 2001, SCI TOTAL ENVIRON, V272, P337, DOI 10.1016/S0048-9697(01)00712-4; Kemski J, 2009, ENVIRON GEOL, V56, P1269, DOI 10.1007/s00254-008-1226-z; Lara E, 2015, RADIAT PROT DOSIM, V167, P126, DOI 10.1093/rpd/ncv228; Metcalfe I, 2013, J ASIAN EARTH SCI, V76, P195, DOI 10.1016/j.jseaes.2012.12.011; Neznal M, 2005, ANN GEOPHYS-ITALY, V48, P175; Neznal M., 2004, CZECH REPUBLIC 1 94, P1; Neznal M, 2014, RADIAT PROT DOSIM, V160, P214, DOI 10.1093/rpd/ncu088; Nursama HA., 2013, MAL EARTH SCI RES, V2, P122; Omar M, 2006, RADIAT PROT DOSIM, V121, P456, DOI [10.1093/rpd/ncl060, 10.1093/rpd/nc1060]; Pasztor L, 2016, SCI TOTAL ENVIRON, V544, P883, DOI 10.1016/j.scitotenv.2015.11.175; Petoussi-Henss N., 2010, Annals of the ICRP, V40, DOI 10.1016/j.icrp.2011.10.001; RENDU JMM, 1979, J INT ASS MATH GEOL, V11, P407, DOI 10.1007/BF01029297; Saleh MA, 2020, MALAYS J FUNDAM APPL, V16, P324; Szabo KZ, 2014, J ENVIRON RADIOACTIV, V129, P107, DOI 10.1016/j.jenvrad.2013.12.009; UNSCEAR, 2006, EFFECTS IONIZING RAD, VII, P1; WHO, 2011, GUID DRINK WAT QUAL, V1; Zahariman A, 2018, INT J CURR SCI ENG T, P269; Zeeb H, 2009, WHO HANDBOOK ON INDOOR RADON: A PUBLIC HEALTH PERSPECTIVE, P1	49	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254099	10.1371/journal.pone.0254099	http://dx.doi.org/10.1371/journal.pone.0254099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320010	gold, Green Published			2022-12-26	WOS:000685247800044
J	Hoek, JM; Field, SM; de Vries, YA; Linde, M; Pittelkow, MM; Muradchanian, J; van Ravenzwaaij, D				Hoek, Joyce M.; Field, Sarahanne M.; de Vries, Ymkje Anna; Linde, Maximilian; Pittelkow, Merle-Marie; Muradchanian, Jasmine; van Ravenzwaaij, Don			Rethinking remdesivir for COVID-19: A Bayesian reanalysis of trial findings	PLOS ONE			English	Article								Background Following testing in clinical trials, the use of remdesivir for treatment of COVID-19 has been authorized for use in parts of the world, including the USA and Europe. Early authorizations were largely based on results from two clinical trials. A third study published by Wang et al. was underpowered and deemed inconclusive. Although regulators have shown an interest in interpreting the Wang et al. study, under a frequentist framework it is difficult to determine if the non-significant finding was caused by a lack of power or by the absence of an effect. Bayesian hypothesis testing does allow for quantification of evidence in favor of the absence of an effect. Findings Results of our Bayesian reanalysis of the three trials show ambiguous evidence for the primary outcome of clinical improvement and moderate evidence against the secondary outcome of decreased mortality rate. Additional analyses of three studies published after initial marketing approval support these findings. Conclusions We recommend that regulatory bodies take all available evidence into account for endorsement decisions. A Bayesian approach can be beneficial, in particular in case of statistically non-significant results. This is especially pressing when limited clinical efficacy data is available.	[Hoek, Joyce M.; Field, Sarahanne M.; de Vries, Ymkje Anna; Linde, Maximilian; Pittelkow, Merle-Marie; Muradchanian, Jasmine; van Ravenzwaaij, Don] Univ Groningen, Behav & Social Sci, Groningen, Netherlands	University of Groningen	Hoek, JM (corresponding author), Univ Groningen, Behav & Social Sci, Groningen, Netherlands.	j.m.hoek@rug.nl	; Field, Sarahanne/H-9004-2017	Linde, Maximilian/0000-0001-8421-090X; Hoek, Joyce/0000-0003-3003-3199; Muradchanian, Jasmine/0000-0002-2914-9197; Field, Sarahanne/0000-0001-7874-1261	Dutch scientific organization VIDI fellowship [016. Vidi.188.001]	Dutch scientific organization VIDI fellowship	This research was supported by a Dutch scientific organization VIDI fellowship grant (016. Vidi.188.001, http://www.nwo.nl) to DvR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; CSSE Johns Hopkins University, 2021, COVID 19 DASHB CTR S; EMA, 2020, 1 COVID 19 TREATM RE; EMA, 2020, EMA STARTS ROLL REV; EMA, 2020, VEKL EPAR PUBL ASS R; Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; GUNEL E, 1974, BIOMETRIKA, V61, P545; Ibrahim JG., 2014, BAYESIAN SURVIVAL AN; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Linde M., 2019, **DATA OBJECT**; Morey R.D., 2018, BAYESFACTOR COMPUTAT; PMDA, 2020, SPEC APPR EM REMD CO; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Spinner CD, 2020, JAMA-J AM MED ASSOC, V324, P1048, DOI 10.1001/jama.2020.16349; U.S. Food and Drug Administration, 2020, FACT SHEET HLTH CAR; van Ravenzwaaij D, 2021, ADV METH PRACT PSYCH, V4, DOI 10.1177/2515245920972624; van Ravenzwaaij D, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0699-7; Wagenmakers E.J, 2014, BAYESIAN COGNITIVE M, DOI DOI 10.1017/CBO9781139087759; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255093	10.1371/journal.pone.0255093	http://dx.doi.org/10.1371/journal.pone.0255093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297766	Green Published, Green Submitted, gold			2022-12-26	WOS:000678128300002
J	Matsuo, T; Ishii, A; Ishida, R; Minami, T; Yoshikawa, T				Matsuo, Takashi; Ishii, Akira; Ishida, Rika; Minami, Takayuki; Yoshikawa, Takahiro			Neural correlates of the improvement of cognitive performance resulting from enhanced sense of competence: A magnetoencephalography study	PLOS ONE			English	Article							WORKING-MEMORY; ACHIEVEMENT-MOTIVATION; ACADEMIC MOTIVATION; EXECUTIVE FUNCTIONS; STROOP TASK; SYNCHRONIZATION; INTERFERENCE; LOCALIZATION; OSCILLATIONS; ACTIVATION	The alterations in neural activity related to the improvement of cognitive performance, which would be leading to better academic performance, remain poorly understood. In the present study, we assessed neural activity related to the improvement of task performance resulting from academic rewards. Twenty healthy male volunteers participated in this study. All participants performed four sessions of a 1-back-Stroop task under both target and control conditions. An image indicating that the task performance of each participant was above average and categorized as being at almost the highest level was presented immediately after each session under the target condition, whereas a control image did not indicate task performance. Neural activity during the 1-back-Stroop task was recorded by magnetoencephalography. The correction rate of the 1-back-Stroop task in the final session relative to that in the first under the target condition was increased compared with the control condition. Correlation analysis revealed that the decreases in alpha band power in right Brodmann's area (BA) 47 and left BA 7 were positively associated with the increased correction rate caused by the target condition. These findings are expected to contribute to a better understanding of the neural mechanisms underlying the improvement of cognitive performance.	[Matsuo, Takashi; Ishii, Akira; Ishida, Rika; Minami, Takayuki; Yoshikawa, Takahiro] Osaka City Univ, Grad Sch Med, Dept Sports Med, Osaka, Osaka, Japan	Osaka Metropolitan University	Ishii, A (corresponding author), Osaka City Univ, Grad Sch Med, Dept Sports Med, Osaka, Osaka, Japan.	a.ishii@med.osaka-cu.ac.jp		Matsuo, Takashi/0000-0002-7786-9375	JSPS KAKENHI [16H03248]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant No. 16H03248 (AI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal H, 2010, INT J BUSINESS MANAG, V5, P80, DOI DOI 10.5539/IJBM.V5N4P80; Alkozei A, 2016, SLEEP, V39, P1671, DOI 10.5665/sleep.6090; Almalki Sultan A, 2019, Open Access Maced J Med Sci, V7, P1374, DOI 10.3889/oamjms.2019.319; Banfield J., 2014, CONT ISS ED RES, V7, P291, DOI [DOI 10.19030/CIER.V7I4.8843, 10.19030/cier.v7i4.8843]; Beilenhoff U, 2007, ENDOSCOPY, V39, P175, DOI 10.1055/s-2006-945181; Best JR, 2011, LEARN INDIVID DIFFER, V21, P327, DOI 10.1016/j.lindif.2011.01.007; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Covington MV, 2000, ANNU REV PSYCHOL, V51, P171, DOI 10.1146/annurev.psych.51.1.171; da Silva PHR, 2020, BRAIN STRUCT FUNCT, V225, P2553, DOI 10.1007/s00429-020-02143-1; Dalal SS, 2008, NEUROIMAGE, V40, P1686, DOI 10.1016/j.neuroimage.2008.01.023; David O, 2006, NEUROIMAGE, V31, P1580, DOI 10.1016/j.neuroimage.2006.02.034; Deci EL, 1996, LEARN INDIVID DIFFER, V8, P165, DOI 10.1016/S1041-6080(96)90013-8; Di Domenico SI, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00145; FORTIER MS, 1995, CONTEMP EDUC PSYCHOL, V20, P257, DOI 10.1006/ceps.1995.1017; Goodman S, 2011, S AFR J PSYCHOL, V41, P373, DOI 10.1177/008124631104100311; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; Hayden BY, 2008, NEURON, V60, P19, DOI 10.1016/j.neuron.2008.09.012; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Ishii A, 2018, EXP BRAIN RES, V236, P1735, DOI 10.1007/s00221-018-5260-0; Ishii A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16439-6; Kapa LL, 2017, J SPEECH LANG HEAR R, V60, P2170, DOI 10.1044/2017_JSLHR-L-16-0027; Kausler DH, 1990, HDB PSYCHOL AGING, P171; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Koca F., 2016, J INT ED LEADERSHIP, V6, P1; Lague-Beauvais M, 2013, NEUROIMAGE, V64, P485, DOI 10.1016/j.neuroimage.2012.09.042; MACLEOD CM, 1992, J EXP PSYCHOL GEN, V121, P12, DOI 10.1037/0096-3445.121.1.12; Maehr M.L., 1984, MOTIVATION ED STUDEN, P115; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Mizuno K, 2008, NEUROIMAGE, V42, P369, DOI 10.1016/j.neuroimage.2008.04.253; Murayama K, 2010, P NATL ACAD SCI USA, V107, P20911, DOI 10.1073/pnas.1013305107; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PIEDMONT RL, 1988, J RES PERS, V22, P177, DOI 10.1016/0092-6566(88)90013-X; Ryan RM, 2000, CONTEMP EDUC PSYCHOL, V25, P54, DOI 10.1006/ceps.1999.1020; Schmidt H, 2009, HUM BRAIN MAPP, V30, P3609, DOI 10.1002/hbm.20783; Sekihara K, 2008, SER BIOMED ENG, P1; Shaul S, 2014, READ WRIT, V27, P749, DOI 10.1007/s11145-013-9470-3; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Takeuchi H, 2014, BRAIN STRUCT FUNCT, V219, P71, DOI 10.1007/s00429-012-0485-3; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Ueno S, 2012, NEUROSCI LETT, V515, P141, DOI 10.1016/j.neulet.2012.03.031; VALLERAND RJ, 1992, EDUC PSYCHOL MEAS, V52, P1003, DOI 10.1177/0013164492052004025; van Dam A, 2011, WORK STRESS, V25, P257, DOI 10.1080/02678373.2011.613648; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Wang H, 2019, BRAIN COGNITION, V132, P1, DOI 10.1016/j.bandc.2019.01.002; Yokosawa K, 2016, IEEE ENG MED BIO, P4539, DOI 10.1109/EMBC.2016.7591737; Zysset S, 2007, NEUROBIOL AGING, V28, P937, DOI 10.1016/j.neurobiolaging.2006.05.008	50	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255272	10.1371/journal.pone.0255272	http://dx.doi.org/10.1371/journal.pone.0255272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297767	gold, Green Published			2022-12-26	WOS:000678128300041
J	Mamo, H; Dagnaw, A; Sharew, NT; Brhane, K; Kotiso, KS				Mamo, Hana; Dagnaw, Abinet; Sharew, Nigussie Tadesse; Brhane, Kalayu; Kotiso, Kehabtimer Shiferaw			Prevalence of short interpregnancy interval and its associated factors among pregnant women in Debre Berhan town, Ethiopia	PLOS ONE			English	Article								Background Short inter-pregnancy interval is an interval of <24 months between the dates of birth of the preceding child and the conception date of the current pregnancy. Despite its direct effects on the perinatal and maternal outcomes, there is a paucity of evidence on its prevalence and determinant factors, particularly in Ethiopia. Therefore, this study assessed the prevalence and associated factors of short inter-pregnancy interval among pregnant women in Debre Berhan town, Northern Ethiopia. Methods A community based cross-sectional study was conducted among a randomly selected 496 pregnant women in Debre Berhan town from February 9 to March 9, 2020. The data were collected by using an interviewer-administered questionnaire and analyzed using STATA (14.2) statistical software. To identify the predictors of short inter-pregnancy interval, multivariable binary logistic regression was fitted and findings are presented using adjusted odds ratio (AOR) with 95% confidence interval (CI). Result The overall prevalence of short inter-pregnancy interval (<24 months) among pregnant women was 205 (40.9%). Being over 30 years of age at first birth (AOR = 3.50; 95% CI: 2.12-6.01), non-use of modern contraceptive (AOR = 2.51; 95% CI: 1.23-3.71), duration of breastfeeding for less than 12 months (AOR = 2.62; 95% CI: 1.32-5.23), parity above four (AOR = 0.31; 95% CI: 0.05-0.81), and unintended pregnancy (AOR = 5.42; 95% CI: 3.34-9.22) were independently associated factors with short inter-pregnancy interval. Conclusion Despite the public health interventions being tried in the country, the prevalence of short inter-pregnancy interval in this study is high. Therefore, it implies that increasing contraceptive use and encouraging optimal breastfeeding might help in the efforts made to avert the problem.	[Mamo, Hana] Wachemo Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Hosaena, Ethiopia; [Dagnaw, Abinet; Sharew, Nigussie Tadesse; Brhane, Kalayu] Debre Berhan Univ, Dept Publ Hlth, Coll Hlth Sci, Debre Berhan, Ethiopia; [Brhane, Kalayu] Curtin Univ, Sch Publ Hlth, Perth, Australia; [Kotiso, Kehabtimer Shiferaw] Wolaita Sodo Univ, Sch Med, Coll Hlth Sci & Med, Wolaita Sodo, Ethiopia	Curtin University	Kotiso, KS (corresponding author), Wolaita Sodo Univ, Sch Med, Coll Hlth Sci & Med, Wolaita Sodo, Ethiopia.	kehabtimershfrw@gmail.com	Sharew, Nigussie Tadesse/AAD-5597-2022; Kotiso, Kehabtimer Shiferaw/ABB-4913-2021; Mekuria, Abinet/AAV-1831-2021; Mruts, Kalayu Brhane/AAI-8335-2020	Sharew, Nigussie Tadesse/0000-0002-6443-6992; Kotiso, Kehabtimer Shiferaw/0000-0002-4195-0243; Mekuria, Abinet/0000-0002-3892-1572; Mruts, Kalayu Brhane/0000-0001-5655-5636	Debre Berhan University	Debre Berhan University	Debre Berhan University (www.dbu.edu.et) funded this study. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests:	Aman Yesuf AY, 2016, J HLTH MED NURSING, P31; Anikwe CC., 2018, OJOG, V8, P1364; Ashfaq M, 2017, PAK J MED HEALTH SCI, V11, P582; Bassey G., 2016, SAHEL MED J, V19, P180, DOI [10.4103/1118-8561.196357, DOI 10.4103/1118-8561.196357]; BelaYnew W., 2015, World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS), V4, P12; Conde-Agudelo A, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3482; de Jonge HCC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0427-6; Gemmill A, 2013, OBSTET GYNECOL, V122, P64, DOI 10.1097/AOG.0b013e3182955e58; Klima CS, 1998, J NURSE-MIDWIFERY, V43, P483, DOI 10.1016/S0091-2182(98)00063-9; Labbok MH., 2018, GLOB LIB WOMENS MED; Mahande MJ, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0929-5; Mardiana O, 2019, Med J Malaysia, V74, P151; Shree R, 2018, J MATERN-FETAL NEO M, V31, P3014, DOI 10.1080/14767058.2017.1362384; Smith GCS, 2003, BRIT MED J, V327, P313, DOI 10.1136/bmj.327.7410.313; Tian Y., 2020, EFFECT INTERPREGNANC; World H, 2007, REP WHO TECHN CONS B REP WHO TECHN CONS B	16	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255613	10.1371/journal.pone.0255613	http://dx.doi.org/10.1371/journal.pone.0255613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339456	gold, Green Published, Green Submitted			2022-12-26	WOS:000680243400010
J	Kondo, K; Izumi, M; Inabe, K; Yoshida, K; Imashimizu, M; Suzuki, T; Hisabori, T				Kondo, Kumiko; Izumi, Masayuki; Inabe, Kosuke; Yoshida, Keisuke; Imashimizu, Mari; Suzuki, Toshiharu; Hisabori, Toru			The phototroph-specific beta-hairpin structure of the gamma subunit of FoF1-ATP synthase is important for efficient ATP synthesis of cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON MOTIVE FORCE; ELECTRON-TRANSPORT; ESCHERICHIA-COLI; ROTARY MOTOR; C-RING; PHOTOSYNTHESIS; STOICHIOMETRY; CHLOROPLASTS; HOMEOSTASIS; ACTIVATION	The F(o)F(1)synthase produces ATP from ADP and inorganic phosphate. The gamma subunit of FoF1 ATP synthase in photosynthetic organisms, which is the rotor subunit of this enzyme, contains a characteristic beta-hairpin structure. This structure is formed from an insertion sequence that has been conserved only in phototrophs. Using recombinant subcomplexes, we previously demonstrated that this region plays an essential role in the regulation of ATP hydrolysis activity, thereby functioning in controlling intracellular ATP levels in response to changes in the light environment. However, the role of this region in ATP synthesis has long remained an open question because its analysis requires the preparation of the whole FoF1 complex and a transmembrane proton-motive force. In this study, we successfully prepared proteoliposomes containing the entire FoF1 ATP synthase from a cyanobacterium, Synechocystis sp. PCC 6803, and measured ATP synthesis/hydrolysis and proton-translocating activities. The relatively simple genetic manipulation of Synechocystis enabled the biochemical investigation of the role of the beta-hairpin structure of FoF1 ATP synthase and its activities. We further performed physiological analyses of Synechocystis mutant strains lacking the beta-hairpin structure, which provided novel insights into the regulatory mechanisms of FoF1 ATP synthase in cyanobacteria via the phototroph-specific region of the gamma subunit. Our results indicated that this structure critically contributes to ATP synthesis and suppresses ATP hydrolysis.	[Kondo, Kumiko; Izumi, Masayuki; Inabe, Kosuke; Yoshida, Keisuke; Imashimizu, Mari; Suzuki, Toshiharu; Hisabori, Toru] Tokyo Inst Technol, Lab Chem & Life Sci, Midori Ku, Yokohama, Kanagawa, Japan; [Inabe, Kosuke] Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan	Tokyo Institute of Technology; Kobe University	Hisabori, T (corresponding author), Tokyo Inst Technol, Lab Chem & Life Sci, Midori Ku, Yokohama, Kanagawa, Japan.	thisabor@res.titech.ac.jp	Hisabori, Toru/E-5205-2014; Yoshida, Keisuke/E-5231-2014	Hisabori, Toru/0000-0003-2046-0277; Yoshida, Keisuke/0000-0001-6542-6254	JSPS KAKENHI [16H06556]; Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials	This study was supported by JSPS KAKENHI Grant Number 16H06556 (to T. H.) and by Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials.	Akiyama K, 2019, BIOCHEM J, V476, P1771, DOI 10.1042/BCJ20190242; Arisaka S, 2019, ALGAL RES, V41, DOI 10.1016/j.algal.2019.101565; Armbruster U, 2017, CURR OPIN PLANT BIOL, V37, P56, DOI 10.1016/j.pbi.2017.03.012; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Doello S, 2021, CURR BIOL, V31, P1606, DOI 10.1016/j.cub.2021.01.065; Doello S, 2018, PLANT PHYSIOL, V177, P594, DOI 10.1104/pp.18.00297; Falcon LI, 2010, ISME J, V4, P777, DOI 10.1038/ismej.2010.2; Fischer S, 1999, FEBS LETT, V457, P327, DOI 10.1016/S0014-5793(99)01060-1; Fujikawa M, 2012, J BIOL CHEM, V287, P18781, DOI 10.1074/jbc.M112.345793; Hahn A, 2018, SCIENCE, V360, P620, DOI 10.1126/science.aat4318; Hisabori T, 2013, ANTIOXID REDOX SIGN, V19, P1846, DOI 10.1089/ars.2012.5044; Imashimizu M, 2011, J BIOL CHEM, V286, P26595, DOI 10.1074/jbc.M111.234138; Inabe K, 2019, J BIOL CHEM, V294, P10094, DOI 10.1074/jbc.RA118.007131; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; JUNESCH U, 1987, BIOCHIM BIOPHYS ACTA, V893, P275, DOI 10.1016/0005-2728(87)90049-1; Junge W, 2015, ANNU REV BIOCHEM, V84, P631, DOI 10.1146/annurev-biochem-060614-034124; Kondo K, 2018, BBA-BIOENERGETICS, V1859, P319, DOI 10.1016/j.bbabio.2018.02.004; Konno H, 2012, PLANT CELL PHYSIOL, V53, P626, DOI 10.1093/pcp/pcs018; Konno H, 2011, J BIOL CHEM, V286, P13423, DOI 10.1074/jbc.M110.155986; KRAMER DM, 1990, PHOTOSYNTH RES, V26, P213, DOI 10.1007/BF00033134; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; KRAMER DM, 1989, BIOCHIM BIOPHYS ACTA, V976, P28, DOI 10.1016/S0005-2728(89)80186-0; Kuhlbrandt W, 2019, ANNU REV BIOCHEM, V88, P515, DOI 10.1146/annurev-biochem-013118-110903; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Luan GD, 2019, BIOTECHNOL ADV, V37, P771, DOI 10.1016/j.biotechadv.2019.04.005; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Muller DJ, 2001, FEBS LETT, V504, P219, DOI 10.1016/S0014-5793(01)02708-9; Murakami S, 2018, BIOCHEM J, V475, P2925, DOI 10.1042/BCJ20180481; Nakamura J, 2013, BIOSCIENCE REP, V33, P735, DOI 10.1042/BSR20130078; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Shikanai T, 2017, MOL PLANT, V10, P20, DOI 10.1016/j.molp.2016.08.004; Soga N, 2017, P NATL ACAD SCI USA, V114, P4960, DOI 10.1073/pnas.1700801114; Soga N, 2011, FEBS J, V278, P2647, DOI 10.1111/j.1742-4658.2011.08191.x; Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Suhai T, 2008, BBA-BIOMEMBRANES, V1778, P1131, DOI 10.1016/j.bbamem.2007.12.017; Sunamura EI, 2010, PLANT CELL PHYSIOL, V51, P855, DOI 10.1093/pcp/pcq061; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; Tikhonov AN, 2013, PHOTOSYNTH RES, V116, P511, DOI 10.1007/s11120-013-9845-y; Usukura E, 2012, J BIOL CHEM, V287, P1884, DOI 10.1074/jbc.M111.305938; Watanabe R, 2015, BIOPHYS J, V108, P1144, DOI 10.1016/j.bpj.2015.01.017; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Yang JH, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01221-8; Yoshida K, 2013, PLANT CELL PHYSIOL, V54, P875, DOI 10.1093/pcp/pct037; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	53	1	1	4	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101027	10.1016/j.jbc.2021.101027	http://dx.doi.org/10.1016/j.jbc.2021.101027			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34339736	gold, Green Published			2022-12-26	WOS:000706408900015
J	Kondo, T; Kichijo, M; Maruta, A; Nakaya, M; Takenaka, S; Arakawa, T; Fushinobu, S; Sakamoto, T				Kondo, Tatsuya; Kichijo, Miyu; Maruta, Akiho; Nakaya, Makoto; Takenaka, Shigeo; Arakawa, Takatoshi; Fushinobu, Shinya; Sakamoto, Tatsuji			Structural and functional analysis of gum arabic L-rhamnose-alpha-1,4-D-glucuronate lyase establishes a novel polysaccharide lyase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTITUTION POSITIONS; FUSARIUM-OXYSPORUM; CRYSTAL-STRUCTURE; ARABINOGALACTAN; ENZYMES; LARCH; EXO-BETA-1,3-D-GALACTANASE; RHAMNOGALACTURONAN; CLASSIFICATION; IDENTIFICATION	Gum arabic (GA) is widely used as an emulsion stabilizer and coating in several industrial applications, such as foods and pharmaceuticals. GA contains a complex carbohydrate moiety, and the nonreducing ends of the side chains are often capped with L-rhamnose; thus, enzymes that can remove these caps are promising tools for the structural analysis of the carbohydrates comprising GA. In this study, GA-specific L-rhamnose-alpha-1,4-D- glucuronate lyase from the fungus Fusarium oxysporum 12S (FoRham1) was cloned and characterized. FoRham1 showed the highest amino acid sequence similarity with enzymes belonging to the glycoside hydrolase family 145; however, the catalytic residue on the posterior pocket of the fl-propeller fold protein was not conserved. The catalytic residues of FoRham1 were instead conserved with ulvan lyases belonging to polysaccharide lyase family 24. Kinetic analysis showed that FoRham1 has the highest catalytic efficiency for the substrate alpha-L-rhamnose-(1-4)-D-glucuronic acid. The crystal structures of ligand-free and alpha-L-rhamnose-(1-4)-D-glucuronic acid -bound FoRham1 were determined, and the active site was identified on the anterior side of the fl-propeller. The three-dimensional structure of the active site and mutagenesis analysis revealed the detailed catalytic mechanism of FoRham1. Our findings offer a new enzymatic tool for the further analysis of the GA carbohydrate structure and for elucidating its physiological functions in plants. Based on these results, we renamed glycoside hydrolase family 145 as a new polysaccharide lyase family 42, in which FoRham1 is included.	[Kondo, Tatsuya; Kichijo, Miyu; Maruta, Akiho; Sakamoto, Tatsuji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Org Res Promot, Osaka, Japan; [Nakaya, Makoto] Osaka Prefecture Univ, Ctr Res & Dev Bioresources, Org Res Promot, Osaka, Japan; [Nakaya, Makoto] Otemae Coll Nutr & Confectionery, Dept Nutr, Osaka, Japan; [Takenaka, Shigeo] Osaka Prefecture Univ, Grad Sch Comprehens Rehabil, Osaka, Japan; [Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Tokyo, Japan; [Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Collaborat Res Inst Innovat Microbiol, Tokyo, Japan; [Kondo, Tatsuya] Kyoto Univ, Res Inst Sustainable Humanosphere RISH, Uji, Kyoto 6110011, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; University of Tokyo; University of Tokyo; Kyoto University	Sakamoto, T (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Org Res Promot, Osaka, Japan.	sakamoto@biochem.osakafu-u.ac.jp	Nakaya, Makoto/F-6731-2015	Nakaya, Makoto/0000-0002-5890-2272	Osaka Prefecture University [4020101]	Osaka Prefecture University	Funding was provided by Osaka Prefecture University (grant No 4020101). The funder had no role in the study design; data collection, analysis, or interpretation; manuscript writing; or the decision to submit the article for publication.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bazin HG, 1998, CARBOHYD RES, V309, P135, DOI 10.1016/S0008-6215(98)00118-9; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Garron ML, 2014, CURR OPIN STRUC BIOL, V28, P87, DOI 10.1016/j.sbi.2014.07.012; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Haque A, 2005, BIOSCI BIOTECH BIOCH, V69, P2170, DOI 10.1271/bbb.69.2170; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Ishida T, 2009, J BIOL CHEM, V284, P10100, DOI 10.1074/jbc.M808122200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KNOX JP, 1995, FASEB J, V9, P1004, DOI 10.1096/fasebj.9.11.7544308; KOGA H, 1988, PHYSIOL MOL PLANT P, V32, P395, DOI 10.1016/S0885-5765(88)80033-X; Kondo K, 2011, INT J BIOL MACROMOL, V48, P256, DOI 10.1016/j.ijbiomac.2010.11.009; Kondo T, 2021, FEBS J, V288, P4918, DOI 10.1111/febs.15795; Kondo T, 2020, APPL MICROBIOL BIOT, V104, P1135, DOI 10.1007/s00253-019-10299-y; Konishi T, 2008, CARBOHYD RES, V343, P1191, DOI 10.1016/j.carres.2008.03.004; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Maruta A, 2017, ENZYME MICROB TECH, V103, P25, DOI 10.1016/j.enzmictec.2017.04.006; Matsumoto S, 2017, ENZYME MICROB TECH, V98, P76, DOI 10.1016/j.enzmictec.2016.12.008; Munoz-Munoz J, 2017, J BIOL CHEM, V292, P13271, DOI 10.1074/jbc.M117.794578; Munoz-Munoz J, 2017, P NATL ACAD SCI USA, V114, P4936, DOI 10.1073/pnas.1701130114; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nie SP, 2013, FOOD HYDROCOLLOID, V31, P42, DOI 10.1016/j.foodhyd.2012.09.014; Okawa M, 2013, APPL MICROBIOL BIOT, V97, P9685, DOI 10.1007/s00253-013-4759-3; Panteloglou AG, 2010, FOOD CHEM, V122, P972, DOI 10.1016/j.foodchem.2010.02.037; Poidevin L, 2013, APPL ENVIRON MICROB, V79, P4220, DOI 10.1128/AEM.00327-13; Ponder GR, 1997, CARBOHYD POLYM, V34, P251, DOI 10.1016/S0144-8617(97)00099-4; Qin LX, 2017, PLANT J, V89, P957, DOI 10.1111/tpj.13434; Rojas AL, 2004, J MOL BIOL, V343, P1281, DOI 10.1016/j.jmb.2004.09.012; Sakamoto T, 2007, APPL ENVIRON MICROB, V73, P3109, DOI 10.1128/AEM.02101-06; Sakamoto T, 2011, APPL MICROBIOL BIOT, V90, P1701, DOI 10.1007/s00253-011-3219-1; Sakamoto T, 2010, APPL MICROBIOL BIOT, V86, P1115, DOI 10.1007/s00253-009-2344-6; Singh A, 2016, CAN J CHEM, V94, P927, DOI 10.1139/cjc-2015-0606; Sogabe Y, 2011, ACTA CRYSTALLOGR D, V67, P415, DOI 10.1107/S0907444911006299; STREET CA, 1983, TALANTA, V30, P887, DOI 10.1016/0039-9140(83)80206-9; Suzuki K, 2014, PROTEINS, V82, P2857, DOI 10.1002/prot.24649; Takeda K, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01692-19; Ulaganathan T, 2018, J BIOL CHEM, V293, P4026, DOI 10.1074/jbc.RA117.001642; Ulaganathan T, 2017, ACS CHEM BIOL, V12, P1269, DOI 10.1021/acschembio.7b00126; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vuillemin ME, 2019, FOOD HYDROCOLLOID, V96, P463, DOI 10.1016/j.foodhyd.2019.05.048; Wende FJ, 2017, CARBOHYD POLYM, V157, P1525, DOI 10.1016/j.carbpol.2016.11.029; Wende FJ, 2016, CARBOHYD POLYM, V136, P1348, DOI 10.1016/j.carbpol.2015.09.112; Xu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048742	46	1	1	4	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101001	10.1016/j.jbc.2021.101001	http://dx.doi.org/10.1016/j.jbc.2021.101001			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34303708	gold, Green Published			2022-12-26	WOS:000706418900014
J	Safari, MS; King, MR; Brangwynne, CP; Petry, S				Safari, Mohammad S.; King, Matthew R.; Brangwynne, Clifford P.; Petry, Sabine			Interaction of spindle assembly factor TPX2 with importins-alpha/beta inhibits protein phase separation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE NUCLEATION; BINDING; RAN; CENTROSOME; RECEPTORS; TARGET; FUS	The microtubule-based mitotic spindle is responsible for equally partitioning the genome during each cell division, and its assembly is executed via several microtubule nucleation pathways. Targeting Protein for XKlp2 (TPX2) stimulates the branching microtubule nucleation pathway, where new microtubules are nucleated from preexisting ones within mitotic or meiotic spindles. TPX2, like other spindle assembly factors, is sequestered by binding to nuclear importins-alpha/beta until the onset of mitosis, yet the molecular nature of this regulation remains unclear. Here we demonstrate that TPX2 interacts with importins-alpha/beta with nanomolar affinity in a 1:1:1 mono dispersed trimer. We also identify a new nuclear localization sequence in TPX2 that contributes to its high-affinity interaction with importin-alpha. In addition, we establish that TPX2 interacts with importin-beta via dispersed, weak interactions. We show that interactions of both importin-alpha and -beta with TPX2 inhibit its ability to undergo phase separation, which was recently shown to enhance the kinetics of branching microtubule nucleation. In summary, our study informs how importins regulate TPX2 to facilitate spindle assembly, and provides novel insight into the functional regulation of protein phase separation.	[Safari, Mohammad S.; King, Matthew R.; Petry, Sabine] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Brangwynne, Clifford P.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Brangwynne, Clifford P.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University	Petry, S (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	spetry@princeton.edu		King, Matthew/0000-0002-8533-3589	NIGMS, National Institutes of Health [T32GM007388]; NIGMS, National Institutes of Health; Pew Scholars Program in the Biomedical Sciences; David and Lucile Packard Foundation	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pew Scholars Program in the Biomedical Sciences; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was supported by PhD training grant T32GM007388 by NIGMS, National Institutes of Health (to M. R. K.), as well as the New Innovator Award of NIGMS, National Institutes of Health (DP2), the Pew Scholars Program in the Biomedical Sciences, and the David and Lucile Packard Foundation (all to S. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfaro-Aco R, 2020, ELIFE, V9, DOI 10.7554/eLife.49797; Alfaro-Aco R, 2017, J CELL BIOL, V216, P983, DOI 10.1083/jcb.201607060; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/nphys3532, 10.1038/NPHYS3532]; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Cavazza T, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00082; Chang CC, 2017, J CELL BIOL, V216, P3453, DOI 10.1083/jcb.201705168; Christie M, 2016, J MOL BIOL, V428, P2060, DOI 10.1016/j.jmb.2015.10.023; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Das RK, 2013, P NATL ACAD SCI USA, V110, P13392, DOI 10.1073/pnas.1304749110; Decker F, 2018, ELIFE, V7, DOI 10.7554/eLife.31149; Eibes S, 2018, CURR BIOL, V28, P121, DOI 10.1016/j.cub.2017.11.046; Forbes DJ, 2015, CURR OPIN CELL BIOL, V35, P78, DOI 10.1016/j.ceb.2015.04.012; Frisken BJ, 2001, APPL OPTICS, V40, P4087, DOI 10.1364/AO.40.004087; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Guo L, 2018, CELL, V173, P677, DOI 10.1016/j.cell.2018.03.002; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Heald R, 2015, J CELL BIOL, V211, P1103, DOI 10.1083/jcb.201510015; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; King MR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14087-0; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Miyatake H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115995; Monterroso B, 2019, EMBO REP, V20, DOI 10.15252/embr.201845946; Mothilal M, SPR NONLINEAR KINETI; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Pan WC, 2007, BIOPHYS J, V92, P267, DOI 10.1529/biophysj.106.094854; Pan WC, 2010, J PHYS CHEM B, V114, P7620, DOI 10.1021/jp100617w; Petry S, 2016, ANNU REV BIOCHEM, V85, P659, DOI 10.1146/annurev-biochem-060815-014528; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Roostalu J, 2015, NAT CELL BIOL, V17, P1422, DOI 10.1038/ncb3241; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Thawani A, 2019, ELIFE, V8, DOI 10.7554/eLife.43890; Thawani A, 2018, NAT CELL BIOL, V20, P575, DOI 10.1038/s41556-018-0091-6; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; Verma V, 2019, J CELL BIOL, V218, P2829, DOI 10.1083/jcb.201904114; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Woodruff JB, 2017, CELL, V169, P1066, DOI 10.1016/j.cell.2017.05.028; Wuhr M, 2015, CURR BIOL, V25, P2663, DOI 10.1016/j.cub.2015.08.047; Yoshizawa T, 2018, CELL, V173, P693, DOI 10.1016/j.cell.2018.03.003; Zhang R, 2017, ELIFE, V6, DOI 10.7554/eLife.30959	51	4	4	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100998	10.1016/j.jbc.2021.100998	http://dx.doi.org/10.1016/j.jbc.2021.100998			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34302807	Green Published, gold			2022-12-26	WOS:000706418900010
J	Song, SY; Baek, S				Song, Suyong; Baek, Stephen			Body shape matters: Evidence from machine learning on body shape-income relationship	PLOS ONE			English	Article							LABOR-MARKET OUTCOMES; MEASUREMENT ERROR; MODELS; OBESITY; HEIGHT; ATTRACTIVENESS; EARNINGS; STATURE; BEAUTY	The association between physical appearance and income has been of central interest in social science. However, most previous studies often measured physical appearance using classical proxies from subjective opinions based on surveys. In this study, we use novel data, called CAESAR, which contains three-dimensional (3D) whole-body scans to mitigate possible reporting and measurement errors. We demonstrate the existence of significant nonclassical reporting errors in the reported heights and weights by comparing them with measured counterparts, and show that these discrete measurements are too sparse to provide a complete description of the body shape. Instead, we use a graphical autoencoder to obtain intrinsic features, consisting of human body shapes directly from 3D scans and estimate the relationship between body shapes and family income. We also take into account a possible issue of endogenous body shapes using proxy variables and control functions. The estimation results reveal a statistically significant relationship between physical appearance and family income and that these associations differ across genders. This supports the hypothesis on the physical attractiveness premium in labor market outcomes and its heterogeneity across genders.	[Song, Suyong] Univ Iowa, Dept Econ & Finance, Iowa City, IA 52240 USA; [Baek, Stephen] Univ Iowa, Dept Ind & Syst Engn, Iowa City, IA 52240 USA	University of Iowa; University of Iowa	Song, SY (corresponding author), Univ Iowa, Dept Econ & Finance, Iowa City, IA 52240 USA.	suyong-song@uiowa.edu	Baek, Stephen/GXH-9181-2022; Baek, Stephen/A-6316-2016	Baek, Stephen/0000-0002-4758-4539				Baek SY, 2012, COMPUT AIDED DESIGN, V44, P56, DOI 10.1016/j.cad.2010.12.006; Baek SY, 2013, THESIS SEOUL NATL U THESIS SEOUL NATL U; Bockerman P, 2013, LABOUR ECON, V24, P86, DOI 10.1016/j.labeco.2013.06.003; Bollinger CR, 1998, J LABOR ECON, V16, P576, DOI 10.1086/209899; BOURLARD H, 1988, BIOL CYBERN, V59, P291, DOI 10.1007/BF00332918; Case A, 2008, J POLIT ECON, V116, P499, DOI 10.1086/589524; Cawley J, 2004, J HUM RESOUR, V39, P451, DOI 10.2307/3559022; Cawley J, 2015, J HEALTH ECON, V43, P244, DOI 10.1016/j.jhealeco.2015.03.001; Chiappori PA, 2012, J POLIT ECON, V120, P659, DOI 10.1086/667941; Courtemanche C, 2015, ECON HUM BIOL, V19, P275, DOI 10.1016/j.ehb.2015.04.003; Deaton A, 2009, ECON HUM BIOL, V7, P133, DOI 10.1016/j.ehb.2009.06.001; Freifeld O, 2012, LECT NOTES COMPUT SC, V7572, P1, DOI 10.1007/978-3-642-33718-5_1; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Hoberg G, 2016, J POLIT ECON, V124, P1423, DOI 10.1086/688176; Hu Y, 2018, PSYCHOL SCI, V29, P1969, DOI 10.1177/0956797618799300; Hu Y, 2008, ECONOMETRICA, V76, P195, DOI 10.1111/j.0012-9682.2008.00823.x; Hu YY, 2015, J ECONOMETRICS, V185, P392, DOI 10.1016/j.jeconom.2014.11.004; Kan KH, 2012, J APPL ECONOMET, V27, P666, DOI 10.1002/jae.1209; Kim KI, 2022, ECONOMET REV, V41, P448, DOI 10.1080/07474938.2021.1960752; Kim KI, 2016, J ECONOMETRICS, V190, P267, DOI 10.1016/j.jeconom.2015.06.016; Lindqvist E, 2012, REV ECON STAT, V94, P1191, DOI 10.1162/REST_a_00239; Liu TC., 2018, INT J HUMAN FACTORS, V6, P81, DOI [10.1504/IJHFMS.2018.091359, DOI 10.1504/IJHFMS.2018.091359]; Lundborg P, 2014, J HUM RESOUR, V49, P141; Mobius MM, 2006, AM ECON REV, V96, P222, DOI 10.1257/000282806776157515; Murillo AL, 2019, OBESITY, V27, P489, DOI 10.1002/oby.22387; Ng BK, 2019, AM J CLIN NUTR, V110, P1316, DOI 10.1093/ajcn/nqz218; Persico N, 2004, J POLIT ECON, V112, P1019, DOI 10.1086/422566; Piel M., 2017, THESIS U CALIFORNIA THESIS U CALIFORNIA; Rooth DO, 2009, J HUM RESOUR, V44, P710, DOI 10.1353/jhr.2009.0027; Scholz JK, 2015, REV ECON STAT, V97, P14, DOI 10.1162/REST_a_00435; Song SY, 2015, QUANT ECON, V6, P749, DOI 10.3982/QE275; Song S, 2015, J ECONOMETRICS, V185, P95, DOI 10.1016/j.jeconom.2014.10.007; Sun JJ, 2017, OBESITY, V25, P1795, DOI 10.1002/oby.21957; Thaler A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192152; US Department of Health and Human Services Centers for Disease Control, BOD MASS IND CONS PR BOD MASS IND CONS PR; Wada R, 2010, ECON HUM BIOL, V8, P242, DOI 10.1016/j.ehb.2010.02.001; Wang QY, 2019, IEEE ENG MED BIO, P1729, DOI 10.1109/EMBC.2019.8857092	37	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0254785	10.1371/journal.pone.0254785	http://dx.doi.org/10.1371/journal.pone.0254785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CU	34329322	Green Published, gold			2022-12-26	WOS:000685248600052
J	Chesnel, MJ; Healy, M; McNeill, J				Chesnel, Mary Jo; Healy, Maria; McNeill, Jenny			The experiences of trained breastfeeding support providers that influence how breastfeeding support is practised: A protocol for a qualitative evidence synthesis	PLOS ONE			English	Article							INTERVENTIONS; DURATION; MOTHERS	Background Many women stop breastfeeding before they intend to as they cannot overcome breastfeeding difficulties. Breastfeeding support, as an evidence-based intervention by trained lay or professional breastfeeding support providers, can prevent early unintended cessation. Yet some women report dissatisfaction with support and reluctantly stop breastfeeding despite receiving this intervention. Understanding the experiences which shape how support is provided can inform effective implementation of breastfeeding support interventions. This review aims to synthesise experiences of trained breastfeeding support providers in high income settings and how these may influence their breastfeeding support practices. Methods A qualitative systematic review of trained breastfeeding supporters' experiences of supporting women to breastfeed, as part of a generic healthcare role or focused breastfeeding support role, will be conducted. A systematic search will be performed of the databases: Cumulative Index to Nursing and Allied Health Literature (CINAHL +), MEDLINE ALL, Maternity and Infant Care, EMBASE, APA PsycINFO, Web of Science and Scopus. Title and abstract screening using eligibility criteria will be conducted using Covidence software. Eligible papers will be agreed by the review team following full text screening and reported using PRISMA guidelines. CASP and COREQ tools will assess study methodological quality and quality of reporting. Data will be extracted using a bespoke form and coded, using Excel software for data management. Analysis will involve the three stages of thematic synthesis: initial free coding, development of descriptive and subsequent analytical themes. Confidence in findings will be assessed using the CERQual framework. Discussion This review is the first to date to synthesise qualitative evidence on experiences which influence how trained lay and professional providers support women with breastfeeding. Findings will enable deeper understanding of the underpinning mechanisms of breastfeeding support provision and inform the development of tailored interventions to improve breastfeeding rates. Systematic review registration PROSPERO registration number:				mchesnel01@qub.ac.uk		Chesnel, Mary Jo/0000-0002-0285-0063	Department of the Economy (Northern Ireland)	Department of the Economy (Northern Ireland)	This review is funded as part of the Department of the Economy (Northern Ireland) funding of Doctoral training for the first author MJ Chesnel. The funder had no role in the design of this study protocol, decision to publish or production of the protocol manuscript. They will have no role in data collection, analysis, decision to publish or preparation of the subsequent review manuscript.	Alianmoghaddam N, 2017, WOMEN BIRTH, V30, pE281, DOI 10.1016/j.wombi.2017.05.005; Antenes G., 2011, SYSTEMATIC REV SUPPO, DOI [10.1136/ebm-2011-100058, DOI 10.1136/EBM-2011-100058]; Bai YK, 2019, J HUM LACT, V35, P478, DOI 10.1177/0890334419850822; Beake S, 2012, MATERN CHILD NUTR, V8, P141, DOI 10.1111/j.1740-8709.2011.00381.x; Blixt I, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0247-4; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brockway M, 2017, J HUM LACT, V33, P486, DOI 10.1177/0890334417707957; Brown A, 2017, J HUM NUTR DIET, V30, P759, DOI 10.1111/jhn.12496; Brown A, 2014, J ADV NURS, V70, P587, DOI 10.1111/jan.12219; Brown CRL, 2014, CAN J PUBLIC HEALTH, V105, pE179, DOI 10.17269/cjph.105.4244; Burns E, 2016, MATERN CHILD NUTR, V12, P111, DOI 10.1111/mcn.12179; Chetwynd EM, 2019, J HUM LACT, V35, P424, DOI 10.1177/0890334419851482; Colvin CJ, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0691-8; Dagher RK, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0965-1; Almeida Jordana Moreira de, 2015, Rev. paul. pediatr., V33, P355, DOI 10.1016/j.rpped.2014.10.002; Galipeau R, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12607; Hannula L, 2008, J CLIN NURS, V17, P1132, DOI 10.1111/j.1365-2702.2007.02239.x; Haroon S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S20; Hoddinott P, 2011, MATERN CHILD NUTR, V7, P221, DOI 10.1111/j.1740-8709.2011.00336.x; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Hunt L, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12279; Jolly K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8287; Kaunonen M, 2012, J CLIN NURS, V21, P1943, DOI 10.1111/j.1365-2702.2012.04071.x; Leeming D, 2015, MATERN CHILD NUTR, V11, P687, DOI 10.1111/mcn.12033; Lewin S, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0688-3; Lewin S, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0689-2; McInnes RJ, 2008, J ADV NURS, V62, P407, DOI 10.1111/j.1365-2648.2008.04618.x; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Munthe-Kaas H, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-017-0690-9; Noyes J, 2018, J CLIN EPIDEMIOL, V97, P35, DOI 10.1016/j.jclinepi.2017.09.025; Nursing and Midwifery Council, 2019, STAND PROF MIDW; ONU, 2015, TRANSF OUR WORLD 203; Patnode CD, 2016, JAMA-J AM MED ASSOC, V316, P1694, DOI 10.1001/jama.2016.8882; Ranch MM, 2019, NURS RES PRACT, V2019, DOI 10.1155/2019/8731705; Renfrew Mary J, 2012, Cochrane Database Syst Rev, pCD001141, DOI 10.1002/14651858.CD001141.pub4; Schmied V, 2011, BIRTH-ISS PERINAT C, V38, P49, DOI 10.1111/j.1523-536X.2010.00446.x; Sinha B, 2015, ACTA PAEDIATR, V104, P114, DOI 10.1111/apa.13127; Skouteris H, 2017, BREASTFEED MED, V12, P604, DOI 10.1089/bfm.2017.0065; Swerts M, 2016, MIDWIFERY, V37, P32, DOI 10.1016/j.midw.2016.02.016; Taylor AM, 2019, MIDWIFERY, V75, P16, DOI 10.1016/j.midw.2019.04.004; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Thomson G., 2013, EUROPEAN MEDICAL J G, V2013, P15; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO, 2003, GLOB STRAT INF YOUNG; World Health Organisation, 2014, GLOB NUTR TARG 2025	46	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254445	10.1371/journal.pone.0254445	http://dx.doi.org/10.1371/journal.pone.0254445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324535	Green Published, gold			2022-12-26	WOS:000685248200015
J	Kim, SJ; Kwon, OD; Lee, EJ; Ock, SM; Kim, KS				Kim, Seung Jae; Kwon, Oh Deog; Lee, Eung-Joon; Ock, Sun Myeong; Kim, Kyung-Soo			Impact of a family history of cardiovascular disease on prevalence, awareness, treatment, control of dyslipidemia, and healthy behaviors: Findings from the Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							RISK FACTOR; CORONARY; ADULTS; STROKE; WOMEN	Background Family history (FH) is one of important risk factors for cardiovascular disease (CVD). However, little is known about its impact on dyslipidemia prevalence and management status. Thus, we aimed to investigate the impact of FH of CVD on dyslipidemia prevalence, awareness, treatment, control, and healthy behaviors in Korean adults. Methods We conducted a cross-sectional study using representative data from the Korea National Health and Nutrition Examination Survey (KNHANES) 2014-2018. A total of 22,024 participants aged >= 19 years without histories of CVDs were classified into two groups according to the presence of FH of CVD (with FH, n = 3,778; without FH, n = 18,246). FH of CVD was defined as having a first-degree relative with ischemic heart disease or stroke. Multivariate logistic regression analyses were performed to evaluate the association between FH of CVD and dyslipidemia prevalence, awareness, treatment, control, and healthy behaviors (weight control, non-smoking, non-risky drinking, sufficient physical activity, and undergoing health screening). Results FH of CVD was significantly associated with a higher dyslipidemia prevalence (adjusted odds ratio [aOR] 1.34, 95% confidence interval [CI] 1.18-1.51), better awareness (aOR 1.54, 95%CI 1.19-2.00), and treatment rates (aOR 1.34, 95%CI 1.12-1.60), but not control. Having an FH of CVD was not predictive of any healthy behaviors in dyslipidemia patients. For non-dyslipidemia patients, FH of CVD even showed significant association with smoking (aOR 1.18, 95%CI 1.02-1.36), and risky drinking (aOR 1.20, 95%CI 1.03-1.40) while it was predictive of receiving health screening (aOR 1.14, 95% CI 1.02-1.27). Conclusions Having an FH of CVD might positively trigger dyslipidemia patients to start pharmacological intervention, but not non-pharmacological interventions. Therefore, physicians should make more efforts to educate and promote the importance of non-pharmacological behavioral modification in dyslipidemia patients with an FH of CVD.	[Kim, Seung Jae; Kim, Kyung-Soo] Catholic Univ Korea, Seoul St Marys Hosp, Dept Family Med, Coll Med, Seoul, South Korea; [Kim, Seung Jae] Catholic Univ Korea, Seoul St Marys Hosp, Int Healthcare Ctr, Coll Med, Seoul, South Korea; [Kwon, Oh Deog] Movinci Clin, Seoul, South Korea; [Lee, Eung-Joon] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Ock, Sun Myeong] Catholic Univ Korea, Yeouido St Marys Hosp, Dept Family Med, Coll Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea	Kim, KS (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Family Med, Coll Med, Seoul, South Korea.	kskim@catholic.ac.kr		Kim, Seung Jae/0000-0001-8885-7137				Allen JK, 1998, AM HEART J, V135, P428, DOI 10.1016/S0002-8703(98)70318-7; Andersson Per, 2009, Central European Journal of Public Health, V17, P3; Arnett DK, 2019, J AM COLL CARDIOL, V74, P1376, DOI 10.1016/j.jacc.2019.03.009; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Choi JC, 2009, J NEUROL SCI, V284, P29, DOI 10.1016/j.jns.2009.03.015; Elis A, 2008, EUR J CARDIOV PREV R, V15, P325, DOI 10.1097/HJR.0b013e3282f50ed8; GRECH ED, 1992, EUR HEART J, V13, P1311, DOI 10.1093/oxfordjournals.eurheartj.a060059; Grundy SM, 2019, CIRCULATION, V139, pE1082, DOI 10.1161/CIR.0000000000000625; Health NIo, 2001, ATP 3 GUID AT A GLAN; Imes CC, 2014, J CARDIOVASC NURS, V29, P108, DOI 10.1097/JCN.0b013e31827db5eb; Kim Y, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014002; Kip KE, 2002, AM J PREV MED, V22, P258, DOI 10.1016/S0749-3797(02)00416-6; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Lee YH, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000650; Liao DP, 1997, STROKE, V28, P1908, DOI 10.1161/01.STR.28.10.1908; Mach F, 2019, ATHEROSCLEROSIS, V290, P140, DOI [10.1016/j.atherosclerosis.2019.08.014, 10.1093/eurheartj/ehz455]; Mahase E, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5368; McDonald M, 2009, J GERONTOL A-BIOL, V64, P256, DOI 10.1093/gerona/gln016; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Pan L, 2016, ATHEROSCLEROSIS, V248, P2, DOI 10.1016/j.atherosclerosis.2016.02.006; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Rhee Eun-Jung, 2019, J Lipid Atheroscler, V8, P78, DOI 10.12997/jla.2019.8.2.78; RONCAGLIONI MC, 1992, CIRCULATION, V85, P2065, DOI 10.1161/01.CIR.85.6.2065; ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Shin S, 2021, EUR J PREV CARDIOL, V28, P864, DOI 10.1177/2047487320905722; Slattery ML, 2009, J HEALTH CARE POOR U, V20, P678, DOI 10.1353/hpu.0.0191; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Thanavaro JL, 2006, APPL NURS RES, V19, P149, DOI 10.1016/j.apnr.2005.07.006; Valerio L, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004260; Zhang FL, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0453-2	34	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254907	10.1371/journal.pone.0254907	http://dx.doi.org/10.1371/journal.pone.0254907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324532	gold, Green Published			2022-12-26	WOS:000685248200065
J	Masota, NE; Vogg, G; Ohlsen, K; Holzgrabe, U				Masota, Nelson E.; Vogg, Gerd; Ohlsen, Knut; Holzgrabe, Ulrike			Reproducibility challenges in the search for antibacterial compounds from nature	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; IN-VITRO; MEDICINAL-PLANTS; HERBAL EXTRACTS; COMBRETACEAE; BIOASSAY; BACTERIA; STRAINS; LEAVES	Background Reproducibility of reported antibacterial activities of plant extracts has long remained questionable. Although plant-related factors should be well considered in serious pharmacognostic research, they are often not addressed in many research papers. Here we highlight the challenges in reproducing antibacterial activities of plant extracts. Methods Plants with reported antibacterial activities of interest were obtained from a literature review. Antibacterial activities against Escherichia coli and Klebsiella pneumoniae were tested using extracts' solutions in 10% DMSO and acetone. Compositions of working solutions from both solvents were established using LC-MS analysis. Moreover, the availability of details likely to affect reproducibility was evaluated in articles which reported antibacterial activities of studied plants. Results Inhibition of bacterial growth at MIC of 256-1024 mu g/mL was observed in only 15.4% of identical plant species. These values were 4-16-fold higher than those reported earlier. Further, 18.2% of related plant species had MICs of 128-256 mu g/mL. Besides, 29.2% and 95.8% of the extracts were soluble to sparingly soluble in 10% DMSO and acetone, respectively. Extracts' solutions in both solvents showed similar qualitative compositions, with differing quantities of corresponding phytochemicals. Details regarding seasons and growth state at collection were missing in 65% and 95% of evaluated articles, respectively. Likewise, solvents used to dissolve the extracts were lacking in 30% of the articles, whereas 40% of them used unidentified bacterial isolates. Conclusion Reproducibility of previously reported activities from plants' extracts is a multi-factorial aspect. Thus, collective approaches are necessary in addressing the highlighted challenges.	[Masota, Nelson E.; Holzgrabe, Ulrike] Univ Wurzburg, Inst Pharm & Food Chem, Wurzburg, Germany; [Masota, Nelson E.] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dar Es Salaam, Tanzania; [Vogg, Gerd] Univ Wurzburg, Bot Garden, Wurzburg, Germany; [Ohlsen, Knut] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany	University of Wurzburg; Muhimbili University of Health & Allied Sciences; University of Wurzburg; University of Wurzburg	Holzgrabe, U (corresponding author), Univ Wurzburg, Inst Pharm & Food Chem, Wurzburg, Germany.	ulrike.holzgrabe@uni-wuerzburg.de		Masota, Nelson/0000-0001-7375-7803	German Academic Exchange Service (DAAD) [57381412]; Open Access Publication Fund of the University of Wuerzburg	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Open Access Publication Fund of the University of Wuerzburg	The study was supported by funding from the German Academic Exchange Service (DAAD) (www.daad.de) offered to N.E.M. through research grants for Doctoral programmes in Germany, 2018/2019 (57381412). This publication was also supported by the Open Access Publication Fund of the University of Wuerzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al AlSheikh HM, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9080480; Amjad Khalil, 2005, Asian Journal of Plant Sciences, V4, P544; Anand U, 2019, METABOLITES, V9, DOI 10.3390/metabo9110258; Arif T, 2009, J ETHNOPHARMACOL, V123, P177, DOI 10.1016/j.jep.2009.02.040; Balouiri M, 2016, J PHARM ANAL, V6, P71, DOI 10.1016/j.jpha.2015.11.005; Basile A, 2000, FITOTERAPIA, V71, pS110, DOI 10.1016/S0367-326X(00)00185-4; Calvert MB, 2018, BEILSTEIN J ORG CHEM, V14, P2607, DOI 10.3762/bjoc.14.239; Castro I, 2019, J NAT PROD, V82, P3233, DOI 10.1021/acs.jnatprod.9b00149; Cock I. E., 2011, Pharmacognosy Communications, V1, P52, DOI 10.5530/pc.2011.1.3; Di L, 2006, DRUG DISCOV TODAY, V11, P446, DOI 10.1016/j.drudis.2006.03.004; Dildar Ahmed, 2012, International Journal of Phytomedicine, V4, P326; Djeussi DE, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0978-8; Elisha IL, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1597-3; Eloff JN, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2519-3; Eloff JN, 2005, AFR J BIOTECHNOL, V4, P1161; Gbedema SY, 2010, PHARMACOGN RES, V2, P63, DOI 10.4103/0974-8490.62948; Genilloud O, 2019, CURR OPIN MICROBIOL, V51, P81, DOI 10.1016/j.mib.2019.10.012; HARBORNE J B, 1973, P278; Hassan A, 2009, J MED PLANTS RES, V3, P20; Hasselmann C, 2003, CLIN MICROBIOL INFEC, V9; Hoffman PS, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9050213; Karaman I, 2003, J ETHNOPHARMACOL, V85, P231, DOI 10.1016/S0378-8741(03)00006-0; Karuppiah Ponmurugan, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P597, DOI 10.1016/S2221-1691(12)60104-X; Khan R, 2009, MOLECULES, V14, P586, DOI 10.3390/molecules14020586; Klimm FS, 2020, EUR J ENTOMOL, V117, P101, DOI 10.14411/eje.2020.011; Korukluoglu M, 2010, J FOOD PROCESS PRES, V34, P383, DOI 10.1111/j.1745-4549.2008.00318.x; Kuete V, 2007, S AFR J BOT, V73, P347, DOI 10.1016/j.sajb.2007.01.004; Lai B., 2012, Journal of Medicinal Plants Research, V6, P1846; Limsuwan S, 2009, PHARM BIOL, V47, P683, DOI 10.1080/13880200902930415; Madureira AM, 2012, PHARM BIOL, V50, P481, DOI 10.3109/13880209.2011.615841; Mannino AM, 2017, J BIOL RES, V90, DOI [10.4081/jbr.2017.6578, DOI 10.4081/JBR.2017.6578]; Masota NE, 2020, ARCH PHARM, V353, DOI 10.1002/ardp.202000147; McDowell LL, 2019, SLAS DISCOV, V24, P440, DOI 10.1177/2472555218818786; Najeeb Ullah, 2016, Asian Pacific Journal of Tropical Disease, V6, P660, DOI 10.1016/S2222-1808(16)61106-4; Njume C, 2011, J HEALTH POPUL NUTR, V29, P438; Noundou XS, 2014, J ETHNOPHARMACOL, V151, P1023, DOI 10.1016/j.jep.2013.12.002; Orhan I, 2009, NAT PROD RES, V23, P514, DOI 10.1080/14786410802163743; Osadebe PO, 2010, ASIAN PAC J TROP MED, V3, P196, DOI 10.1016/S1995-7645(10)60008-9; Panghal M, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-21; Rao K, 2010, APPL BIOCHEM BIOTECH, V162, P871, DOI 10.1007/s12010-009-8900-9; Rguez S., 2019, INT J PLANT SCI HORT, V1, P7, DOI [10.36811/ijpsh.2019.110002, DOI 10.36811/IJPSH.2019.110002]; Sahin F, 2003, J ETHNOPHARMACOL, V87, P61, DOI 10.1016/S0378-8741(03)00110-7; Shah NR, 2020, EUR FOOD RES TECHNOL, V246, P723, DOI 10.1007/s00217-020-03438-7; Simoes M, 2009, NAT PROD REP, V26, P746, DOI 10.1039/b821648g; Singh M, 2008, J ETHNOPHARMACOL, V115, P327, DOI 10.1016/j.jep.2007.09.018; Stefanovic OD, 2012, ACTA POL PHARM, V69, P457; Teinkela JEM, 2016, PHARM BIOL, V54, P1086, DOI 10.3109/13880209.2015.1103273; Ustun O, 2016, PHARMACOGN MAG, V12, pS82, DOI 10.4103/0973-1296.176125; Uzun E, 2004, J ETHNOPHARMACOL, V95, P287, DOI 10.1016/j.jep.2004.07.013; Voukeng Igor K, 2017, BMC Res Notes, V10, P321, DOI 10.1186/s13104-017-2665-y; Voukeng Igor K, 2012, BMC Res Notes, V5, P299, DOI 10.1186/1756-0500-5-299; Weinsteinet, 2018, METHODS DILUTION ANT, V1; Wilson B, 2005, J ETHNOPHARMACOL, V99, P147, DOI 10.1016/j.jep.2005.02.004; Zhu CF, 2019, J AGR FOOD CHEM, V67, P14143, DOI 10.1021/acs.jafc.9b03577	54	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255437	10.1371/journal.pone.0255437	http://dx.doi.org/10.1371/journal.pone.0255437			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324599	Green Published, gold			2022-12-26	WOS:000685248200089
J	Fallara, G; Gedeborg, R; Bill-Axelson, A; Garmo, H; Stattin, P				Fallara, Giuseppe; Gedeborg, Rolf; Bill-Axelson, Anna; Garmo, Hans; Stattin, Par			A drug comorbidity index to predict mortality in men with castration resistant prostate cancer	PLOS ONE			English	Article							REGISTER; HISTORY; DEATH; TIME	Background The Charlson Comorbidity Index is a poor predictor of mortality in men with castration resistant prostate cancer (CRPC). To improve this prediction, we created a comorbidity index based on filled prescriptions intended to be used in registry-based studies. Materials and methods In a population-based cohort of men with CPRC a drug comorbidity index (DCI-CRPC) was calculated based on prescriptions filled during a 365-day period before the date of CRPC diagnosis to predict mortality. Five risk categories for men with CRPC were defined based on PSA kinetics. Mortality rates were described by Kaplan-Meier curves. The predictive ability of the DCI-CRPC was compared in univariable models to that of the original DCI, derived from men in the general population, and to that of the Charlson Comorbidity Index. Results In 1,885 men with CRPC the median overall survival ranged from 3.0 years (95% confidence interval [CI] 2.8 to 3.4) in the first tertile of the DCI-CRPC, to 1.0 year (95% CI 0.9 to 1.1) in the third tertile of the DCI-CRPC. The index had higher discriminative ability (C-index 0.667) than the Charlson Comorbidity Index (C-index 0.508). The discriminative ability of the DCI-CRPC was highest in the subgroup with least aggressive cancer (C-index 0.651) and lowest in men with most aggressive cancer (C-index 0.618). The performance of the DCI-CRPC was comparable to that of the original DCI. Conclusion Our newly created comorbidity index using filled prescriptions predicted death in men with CRPC better than the Charlson Comorbidity Index.	[Fallara, Giuseppe] IRCCS Osped San Raffaele, Div Expt Oncol, Unit Urol URI, Milan, Italy; [Fallara, Giuseppe] Univ Vita Salute San Raffaele, Milan, Italy; [Fallara, Giuseppe; Gedeborg, Rolf; Bill-Axelson, Anna; Garmo, Hans; Stattin, Par] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Garmo, Hans] Uppsala Univ Hosp, Reg Canc Ctr, Uppsala Orebro, Uppsala, Sweden	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Uppsala University; Uppsala University; Uppsala University Hospital	Fallara, G (corresponding author), IRCCS Osped San Raffaele, Div Expt Oncol, Unit Urol URI, Milan, Italy.; Fallara, G (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.; Fallara, G (corresponding author), Uppsala Univ, Dept Surg Sci, Uppsala, Sweden.	fallara.giuseppe@hsr.it	Gedeborg, Rolf/AAV-6702-2020	Gedeborg, Rolf/0000-0002-8850-7863; Fallara, Giuseppe/0000-0001-7872-2650	Swedish Cancer Society [20190030]; Swedish Research Council [2017-00847]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This project (PS) received research support from the Swedish Cancer Society (20190030) (https://www.cancerfonden.se/) and the Swedish Research Council (2017-00847) (https://www.vr.se/english.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen PC, 2011, J CLIN ONCOL, V29, P1335, DOI 10.1200/JCO.2010.31.2330; Aronsky D, 2005, AM J MED QUAL, V20, P319, DOI 10.1177/1062860605280358; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Cazzaniga W, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00051; Enblad AP., 2020, SCAND J UROL, V54, P1; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Gedeborg R, 2021, EPIDEMIOLOGY, V32, P607, DOI 10.1097/EDE.0000000000001358; Gedeborg R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241439; Goyal J, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.02.015; Howard LE, 2017, BJU INT, V120, pE80, DOI 10.1111/bju.13856; Khoshkar Y., 2020, MORTALITY MEN CASTRA; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Paner GP, 2018, EUR UROL, V73, P560, DOI 10.1016/j.eururo.2017.12.018; Pratt NL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021122; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Sylvestre E, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0586-x; Van Hemelrijck M, 2016, BJU INT, V117, P507, DOI 10.1111/bju.13059; Van Hemelrijck M, 2013, INT J EPIDEMIOL, V42, P956, DOI 10.1093/ije/dys068; van Soest RJ, 2016, EUR UROL FOCUS, V2, P480, DOI 10.1016/j.euf.2016.12.006; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Wallerstedt SM, 2016, BASIC CLIN PHARMACOL, V119, P464, DOI 10.1111/bcpt.12613; West TA, 2014, EUR J CANCER, V50, P1916, DOI 10.1016/j.ejca.2014.04.004; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Whitney CA, 2019, PROSTATE CANCER P D, V22, P252, DOI 10.1038/s41391-018-0095-0; Zist A, 2015, RADIOL ONCOL, V49, P402, DOI 10.1515/raon-2015-0038	27	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0255239	10.1371/journal.pone.0255239	http://dx.doi.org/10.1371/journal.pone.0255239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320037	Green Published, gold			2022-12-26	WOS:000685247800033
J	Lu, M; Parel, JM; Miller, D				Lu, Min; Parel, Jean-Marie; Miller, Darlene			Interactions between staphylococcal enterotoxins A and D and superantigen-like proteins 1 and 5 for predicting methicillin and multidrug resistance profiles among Staphylococcus aureus ocular isolates	PLOS ONE			English	Article							VIRULENCE FACTORS; GENE PROFILES; EPIDEMIOLOGY; INFECTION; STRAINS; TRENDS	Background Methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant (MDR) S. aureus strains are well recognized as posing substantial problems in treating ocular infections. S. aureus has a vast array of virulence factors, including superantigens and enterotoxins. Their interactions and ability to signal antibiotics resistance have not been explored. Objectives To predict the relationship between superantigens and methicillin and multidrug resistance among S. aureus ocular isolates. Methods We used a DNA microarray to characterize the enterotoxin and superantigen gene profiles of 98 S. aureus isolates collected from common ocular sources. The outcomes contained phenotypic and genotypic expressions of MRSA. We also included the MDR status as an outcome, categorized as resistance to three or more drugs, including oxacillin, penicillin, erythromycin, clindamycin, moxifloxacin, tetracycline, trimethoprim-sulfamethoxazole and gentamicin. We identified gene profiles that predicted each outcome through a classification analysis utilizing Random Forest machine learning techniques. Findings Our machine learning models predicted the outcomes accurately utilizing 67 enterotoxin and superantigen genes. Strong correlates predicting the genotypic expression of MRSA were enterotoxins A, D, J and R and superantigen-like proteins 1, 3, 7 and 10. Among these virulence factors, enterotoxin D and superantigen-like proteins 1, 5 and 10 were also significantly informative for predicting both MDR and MRSA in terms of phenotypic expression. Strong interactions were identified including enterotoxins A (entA) interacting with superantigen-like protein 1 (set6-var1_11), and enterotoxin D (entD) interacting with superantigen-like protein 5 (ssl05/set3_probe 1): MRSA and MDR S. aureus are associated with the presence of both entA and set6-var1_11, or both entD and ssl05/set3_probe 1, while the absence of these genes in pairs indicates non-multidrug-resistant and methicillin-susceptible S. aureus. Conclusions MRSA and MDR S. aureus show a different spectrum of ocular pathology than their non-resistant counterparts. When assessing the role of enterotoxins in predicting antibiotics resistance, it is critical to consider both main effects and interactions.	[Lu, Min] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Parel, Jean-Marie] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol,Ophthalm Biophys Ctr, Miami, FL 33136 USA; [Miller, Darlene] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol,Ocular Microbiol Lab, Miami, FL 33136 USA; [Miller, Darlene] McKnight Vis Res Ctr, Miami, FL USA	University of Miami; Bascom Palmer Eye Institute; University of Miami; Bascom Palmer Eye Institute; University of Miami	Miller, D (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol,Ocular Microbiol Lab, Miami, FL 33136 USA.	dmiller@med.miami.edu	Lu, Min/AAX-1605-2021	Lu, Min/0000-0002-1386-1315; Miller, Darlene/0000-0002-4756-2030	NIH Center Core Grant [P30EY014801]; Research to Prevent Blindness	NIH Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	Funding in part by a NIH Center Core Grant P30EY014801 (institutional) and a Research to Prevent Blindness Unrestricted Grant (institutional).	Abolghait SK, 2020, INT J FOOD MICROBIOL, V328, DOI 10.1016/j.ijfoodmicro.2020.108669; Algammal AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72264-4; Algammal AM, 2020, TOXINS, V12, DOI 10.3390/toxins12060383; Algammal AM, 2020, AMB EXPRESS, V10, DOI 10.1186/s13568-020-01037-z; Algammal AM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9050362; Algammal AM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030238; Argudin MA, 2010, TOXINS, V2, P1751, DOI 10.3390/toxins2071751; Assimacopoulos AP, 2009, CLIN INFECT DIS, V48, P612, DOI 10.1086/597009; Baba-Moussa L, 2008, J HOSP INFECT, V68, P32, DOI 10.1016/j.jhin.2007.10.010; Bachert C, 2010, J ALLERGY CLIN IMMUN, V126, P962, DOI 10.1016/j.jaci.2010.07.007; Bispo PJM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00204; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Coates-Brown R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02753; Collery MM, 2009, J MED MICROBIOL, V58, P13, DOI 10.1099/jmm.0.005215-0; El-Sayed ME, 2019, REV MED VET-TOULOUSE, V170, P80; Enany ME, 2018, PAK J PHARM SCI, V31, P1865; Fang XY, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4930-2; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Freidlin J, 2007, AM J OPHTHALMOL, V144, P313, DOI 10.1016/j.ajo.2007.03.032; Goldstein A, 2015, J COMPUT GRAPH STAT, V24, P44, DOI 10.1080/10618600.2014.907095; Hastie T., 2009, UNSUPERVISED LEARNIN; Hsiao CH, 2012, OPHTHALMOLOGY, V119, P522, DOI 10.1016/j.ophtha.2011.08.038; Ishwaran H, 2019, STAT MED, V38, P558, DOI 10.1002/sim.7803; Kogalur Udaya B, 2021, CRAN; Kolawole DO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068721; Liu CL, 2015, J MICROBIOL IMMUNOL, V48, P490, DOI 10.1016/j.jmii.2014.03.003; Lu M, 2021, BIOMETRICS, V77, P23, DOI 10.1111/biom.13391; Lu M, 2018, J THORAC CARDIOV SUR, V155, P1130, DOI 10.1016/j.jtcvs.2017.08.056; Molnar C, 2020, LULU COM; Mutters NT, 2016, DIAGN MICR INFEC DIS, V86, P417, DOI 10.1016/j.diagmicrobio.2016.08.016; Omidpanah Adam, 2020, CRAN; Ong J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006587; Otto M, 2011, NAT MED, V17, P169, DOI 10.1038/nm0211-169; Peterson JC, 2019, INFECT DRUG RESIST, V12, P831, DOI 10.2147/IDR.S190245; Rice TW, 2009, DIS ESOPHAGUS, V22, P1, DOI 10.1111/j.1442-2050.2008.00901.x; Ronco T, 2018, VET MICROBIOL, V215, P35, DOI 10.1016/j.vetmic.2018.01.003; Rutar T, 2005, AM J OPHTHALMOL, V140, P740, DOI 10.1016/j.ajo.2005.03.076; Sabouni Farah, 2014, Osong Public Health Res Perspect, V5, P96, DOI 10.1016/j.phrp.2014.03.002; Sato K, 2015, CAN J OPHTHALMOL, V50, pE97, DOI 10.1016/j.jcjo.2015.05.006; Schlievert PM, 2009, J INFECT DIS, V200, P676, DOI 10.1086/605333; Schulte RH, 2019, CLIN MED RES, V17, P72, DOI 10.3121/cmr.2019.1503; Shanmuganathan VA, 2005, EYE, V19, P284, DOI 10.1038/sj.eye.6701465; Sina H, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-188; Sola C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030487; Solomon R, 2011, J CATARACT REFR SURG, V37, P1343, DOI 10.1016/j.jcrs.2011.05.006; Speiser JL, 2019, EXPERT SYST APPL, V134, P93, DOI 10.1016/j.eswa.2019.05.028; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; van Trijp MJCA, 2010, DIAGN MICR INFEC DIS, V66, P222, DOI 10.1016/j.diagmicrobio.2009.08.021; Williamson BD, 2021, BIOMETRICS, V77, P9, DOI 10.1111/biom.13392; Xu S, 2017, 2017 IEEE 2ND INTERNATIONAL CONFERENCE ON BIG DATA ANALYSIS (ICBDA), P233, DOI 10.1109/ICBDA.2017.8078813; Xu SG, 2007, J MICROBIOL, V45, P441; Zhang YN, 2012, MOL VIS, V18, P974	52	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254519	10.1371/journal.pone.0254519	http://dx.doi.org/10.1371/journal.pone.0254519			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320020	Green Published, gold			2022-12-26	WOS:000685247800001
J	Spradling, TA; Place, AC; Campbell, AL; Demastes, JW				Spradling, Theresa A.; Place, Alexandra C.; Campbell, Ashley L.; Demastes, James W.			Mitochondrial genome of Geomydoecus aurei, a pocket-gopher louse	PLOS ONE			English	Article							RNA PUNCTUATION MODEL; HUMAN-BODY LOUSE; DISPARATE RATES; CHEWING LICE; EVOLUTION; DNA; PHTHIRAPTERA; REPLICATION; COPHYLOGENY; SEQUENCES	Parasitic lice demonstrate an unusual array of mitochondrial genome architectures and gene arrangements. We characterized the mitochondrial genome of Geomydoecus aurei, a chewing louse (Phthiraptera: Trichodectidae) found on pocket gophers (Rodentia: Geomyidae) using reads from both Illumina and Oxford Nanopore sequencing coupled with PCR, cloning, and Sanger sequencing to verify structure and arrangement for each chromosome. The genome consisted of 12 circular mitochondrial chromosomes ranging in size from 1,318 to 2,088 nucleotides (nt). Total genome size was 19,015 nt. All 37 genes typical of metazoans (2 rRNA genes, 22 tRNA genes, and 13 protein-coding genes) were present. An average of 26% of each chromosome was composed of non-gene sequences. Within the non-gene region of each chromosome, there was a 79-nt nucleotide sequence that was identical among chromosomes and a conserved sequence with secondary structure that was always followed by a poly-T region. We hypothesize that these regions may be important in the initiation of transcription and DNA replication, respectively. The G. aurei genome shares 8 derived gene clusters with other chewing lice of mammals, but in G. aurei, genes on several chromosomes are not contiguous.	[Spradling, Theresa A.; Place, Alexandra C.; Campbell, Ashley L.; Demastes, James W.] Univ Northern Iowa, Dept Biol, Cedar Falls, IA 50614 USA; [Campbell, Ashley L.] Des Moines Univ, Coll Osteopath Med, Des Moines, IA USA	University of Northern Iowa	Spradling, TA (corresponding author), Univ Northern Iowa, Dept Biol, Cedar Falls, IA 50614 USA.	theresa.spradling@uni.edu			National Science Foundation [DEB 1445708]; Collaborative Research Centre 992 Medical Epigenetics (DFG) [SFB 992/1 2012]; German Federal Ministry of Education and Research (BMBF) [031 A538A/A538C RBC, 031L0101B/031L0101C de.NBI-epi, 031L0106 de. STAIR]	National Science Foundation(National Science Foundation (NSF)); Collaborative Research Centre 992 Medical Epigenetics (DFG); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Portions of this work were funded by National Science Foundation Grant DEB 1445708 to TAS and JWD. The Galaxy server that was used for some calculations is in part funded by Collaborative Research Centre 992 Medical Epigenetics (DFG grant SFB 992/1 2012) and German Federal Ministry of Education and Research (BMBF grants 031 A538A/A538C RBC, 031L0101B/031L0101C de.NBI-epi, 031L0106 de. STAIR (de.NBI)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AQUADRO CF, 1983, GENETICS, V103, P287; Baldwin-Brown JG, 2021, G3-GENES GENOM GENET, V11, DOI 10.1093/g3journal/jkab009; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8; Cameron SL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-394; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Demastes JW, 2019, MOL ECOL, V28, P703, DOI 10.1111/mec.14997; Demastes JW, 2012, J PARASITOL, V98, P262, DOI 10.1645/GE-2904.1; Donath A, 2019, NUCLEIC ACIDS RES, V47, P10543, DOI 10.1093/nar/gkz833; Dong WG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-751; Dong WG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-44; Fu YT, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04381-y; Hafner DJ, 2019, ECOL EVOL, V9, P7410, DOI 10.1002/ece3.5183; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; Herd KE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1843-3; Jiang HW, 2013, GENOME BIOL EVOL, V5, P1298, DOI 10.1093/gbe/evt094; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Light JE, 2018, J PARASITOL, V104, P89, DOI 10.1645/17-130; Light JE, 2007, MOL PHYLOGENET EVOL, V45, P997, DOI 10.1016/j.ympev.2007.09.001; Mattei E, 2015, NUCLEIC ACIDS RES, V43, pW493, DOI 10.1093/nar/gkv489; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; PELISSIER P, 1995, CURR GENET, V27, P409, DOI 10.1007/BF00311209; Pietan LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162248; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; Shao RF, 2017, GENOME BIOL EVOL, V9, P431, DOI 10.1093/gbe/evx007; Shao RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep17389; Shao RF, 2012, GENOME BIOL EVOL, V4, P1088, DOI 10.1093/gbe/evs088; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Song F, 2019, SYST BIOL, V68, P430, DOI 10.1093/sysbio/syy062; Song SD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-144; Stewart JB, 2009, GENE, V445, P49, DOI 10.1016/j.gene.2009.06.006; Sweet AD, 2020, PEERJ, V8, DOI 10.7717/peerj.8759	42	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0254138	10.1371/journal.pone.0254138	http://dx.doi.org/10.1371/journal.pone.0254138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314423	Green Published, gold			2022-12-26	WOS:000685225200039
J	Kim, H; Seo, P; Choi, JW; Kim, KH				Kim, Hyun; Seo, Pukyeong; Choi, Jeong Woo; Kim, Kyung Hwan			Emotional arousal due to video stimuli reduces local and inter-regional synchronization of oscillatory cortical activities in alpha- and beta-bands	PLOS ONE			English	Article							EEG PHASE SYNCHRONIZATION; MIRROR NEURON DYSFUNCTION; IMAGE MOTION; BRAIN; MECHANISMS; DESYNCHRONIZATION; PERCEPTION; ACTIVATION; ATTENTION; OTHERS	The purpose of current study is to reveal spatiotemporal features of oscillatory EEG activities in response to emotional arousal induced by emotional video stimuli, and to find the characteristics of cortical activities showing significant difference according to arousal levels. The EEGs recorded during watching affective video clips were transformed to cortical current density time-series, and then, cluster-based permutation test was applied to determine the spatiotemporal origins of alpha- and beta-band activities showing significant difference between high and low arousal levels. We found stronger desynchronization of alpha-band activities due to higher arousal in visual areas, which may be due to stronger activation for sensory information processing for the highly arousing video stimuli. In precentral and superior parietal regions, the stronger desynchronization in alpha-and low beta-bands was observed for the high arousal stimuli. This is expected to reflect enhanced mirror neuron system activities, which is involved in understanding the intention of other's action. Similar changes according to arousal level were found also in inter-regional phase synchronization in alpha- and beta-bands.	[Kim, Hyun; Seo, Pukyeong; Choi, Jeong Woo; Kim, Kyung Hwan] Yonsei Univ, Coll Hlth Sci, Dept Biomed Engn, Wonju, South Korea; [Choi, Jeong Woo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA	Yonsei University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kim, KH (corresponding author), Yonsei Univ, Coll Hlth Sci, Dept Biomed Engn, Wonju, South Korea.	khkim0604@yonsei.ac.kr		Kim, Hyun/0000-0002-7265-8640; Choi, Jeong Woo/0000-0001-5824-8859	Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [2017M3C7A1029485]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A01056743]	Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (2017M3C7A1029485); This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A01056743).	Aftanas L, 2005, INT J NEUROSCI, V115, P893, DOI 10.1080/00207450590897969; Aftanas L I, 2004, Neurosci Behav Physiol, V34, P859, DOI 10.1023/B:NEAB.0000038139.39812.eb; Aftanas LI, 2002, INT J PSYCHOPHYSIOL, V44, P67, DOI 10.1016/S0167-8760(01)00194-5; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cannon EN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092002; Cho PS, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02071; Costa T, 2006, NEUROSCI LETT, V406, P159, DOI 10.1016/j.neulet.2006.06.039; Cuthbert BN, 1996, PSYCHOPHYSIOLOGY, V33, P103, DOI 10.1111/j.1469-8986.1996.tb02114.x; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; De Cesarei A, 2011, PSYCHOPHYSIOLOGY, V48, P1397, DOI 10.1111/j.1469-8986.2011.01204.x; de Pesters A, 2016, NEUROIMAGE, V134, P122, DOI 10.1016/j.neuroimage.2016.03.074; Enticott PG, 2008, NEUROPSYCHOLOGIA, V46, P2851, DOI 10.1016/j.neuropsychologia.2008.04.022; Fell J, 1996, BIOL CYBERN, V75, P85, DOI 10.1007/BF00238742; Festante F, 2018, DEV COGN NEUROS-NETH, V30, P142, DOI 10.1016/j.dcn.2018.02.010; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Guntekin B, 2014, NEUROPSYCHOLOGIA, V58, P33, DOI 10.1016/j.neuropsychologia.2014.03.014; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Hanjalic A, 2005, IEEE T MULTIMEDIA, V7, P143, DOI 10.1109/TMM.2004.840618; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Hanslmayr S, 2011, BRAIN RES REV, V67, P331, DOI 10.1016/j.brainresrev.2011.04.002; Helfrich RF, 2017, P NATL ACAD SCI USA, V114, P9457, DOI 10.1073/pnas.1705965114; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Kilner JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004925; Klein A, 2005, NEUROIMAGE, V24, P261, DOI 10.1016/j.neuroimage.2004.09.016; Koelstra S, 2012, IEEE T AFFECT COMPUT, V3, P18, DOI 10.1109/T-AFFC.2011.15; Koelstra S, 2010, LECT NOTES ARTIF INT, V6334, P89, DOI 10.1007/978-3-642-15314-3_9; Kybic J, 2005, IEEE T MED IMAGING, V24, P12, DOI 10.1109/TMI.2004.837363; Liu YL, 2012, J NEUROSCI, V32, P14563, DOI 10.1523/JNEUROSCI.3109-12.2012; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Meng XX, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00616; Milston SI, 2013, NEUROPSYCHOLOGIA, V51, P1103, DOI 10.1016/j.neuropsychologia.2013.02.020; Morris JD, 1995, J ADVERTISING RES, V35, P63; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Puzzo I, 2011, NEUROIMAGE, V57, P1358, DOI 10.1016/j.neuroimage.2011.05.071; Ravaja N, 2004, J BROADCAST ELECTRON, V48, P108, DOI 10.1207/s15506878jobem4801_6; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Schubring D, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13386; Simons RF, 2003, MEDIA PSYCHOL, V5, P283, DOI 10.1207/S1532785XMEP0503_03; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Uusberg A, 2013, INT J PSYCHOPHYSIOL, V89, P26, DOI 10.1016/j.ijpsycho.2013.04.020; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Vindiola MM, 2014, J NEUROSCI METH, V226, P1, DOI 10.1016/j.jneumeth.2014.01.025; Williams JHG, 2006, NEUROPSYCHOLOGIA, V44, P610, DOI 10.1016/j.neuropsychologia.2005.06.010; Woodruff CC, 2016, INT J PSYCHOPHYSIOL, V99, P18, DOI 10.1016/j.ijpsycho.2015.11.005	53	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255032	10.1371/journal.pone.0255032	http://dx.doi.org/10.1371/journal.pone.0255032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TQ2PW	34297738	Green Published, gold			2022-12-26	WOS:000678128300040
J	Gong, ZL; Song, WL; Gu, MJ; Zhou, XM; Tian, CW				Gong, Zonglin; Song, Wenlei; Gu, Minjun; Zhou, Xiaoming; Tian, Changwei			Association between serum iron concentrations and cognitive impairment in older adults aged 60 years and older: A dose-response analysis of National Health and Nutrition Examination Survey	PLOS ONE			English	Article							BRAIN IRON; ALZHEIMERS-DISEASE; DEMENTIA; DECLINE; COPPER; LEVEL; ACCUMULATION; METAANALYSIS; PERFORMANCE; PREVALENCE	Epidemiological evidence on peripheral iron and cognitive impairment in older adults is sparse and limited. Results on serum iron and cognitive impairment in older adults from the National Health and Nutrition Examination Survey have not been reported. Data on serum iron and cognitive impairment from individuals >= 60 years of age were obtained from the 2011-2014 NHANES (N = 3,131). Serum iron concentrations were determined with DcX800 method. Cognitive impairment was assessed with four cognitive tests: the Digit Symbol Substitution Test (DSST), the Animal Fluency (AF), the Consortium to Establish a Registry for Alzheimer's Disease Delayed Recall (CERAD-DR) and Word Learning (CERAD-WL) tests. Logistic regression and restricted cubic splines were adopted to explore the dose-response relationship between serum iron concentrations and cognitive impairment. Comparing the highest to lowest tertile of serum iron concentrations, the multivariate-adjusted odds ratios of scoring low on the DSST were 0.70 (0.49-1.00), 0.88 (0.65-1.20) for CERAD-WL, 0.65 (0.48-0.88) for CERAD-DR, and 0.78 (0.53-1.15) for AF. Stratified analyses by sex showed that the above-mentioned associations were mainly found in men; however, the interaction with sex was not significant. Dose-response analysis showed that relationships between serum iron and cognitive impairment evaluated by DSST and CERAD-DR were linear, respectively.	[Gong, Zonglin; Song, Wenlei; Zhou, Xiaoming; Tian, Changwei] Kunshan Ctr Dis Control & Prevent, Dept Integrated Serv, Kunshan, Jiangsu, Peoples R China; [Gu, Minjun] Kunshan Ctr Dis Control & Prevent, Dept Dis Control, Kunshan, Jiangsu, Peoples R China		Tian, CW (corresponding author), Kunshan Ctr Dis Control & Prevent, Dept Integrated Serv, Kunshan, Jiangsu, Peoples R China.	tiancwcdc@126.com			Kunshan Special Fund for Social Development and Science Technology	Kunshan Special Fund for Social Development and Science Technology	Zonglin Gong receives support from Kunshan Special Fund for Social Development and Science & Technology (No.KS1545). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayton S, 2017, JAMA NEUROL, V74, P122, DOI 10.1001/jamaneurol.2016.4406; Bailey RL, 2020, AM J CLIN NUTR, V112, P1547, DOI 10.1093/ajcn/nqaa239; Cardoso BR, 2021, EUR J NUTR, V60, P1153, DOI 10.1007/s00394-020-02384-0; Cherbuin N, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00004; da Silva VK, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0232-5; da Silva VK, 2018, BRAIN RES BULL, V139, P1, DOI 10.1016/j.brainresbull.2018.01.014; Daugherty AM, 2015, J NEUROSCI, V35, P6731, DOI 10.1523/JNEUROSCI.4717-14.2015; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Gao LL, 2017, MOL MED REP, V16, P8209, DOI 10.3892/mmr.2017.7668; Gong ZL, 2022, BIOL TRACE ELEM RES, V200, P1495, DOI 10.1007/s12011-021-02765-4; Hare D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00034; Hosking DE, 2018, THER ADV CHRONIC DIS, V9, P241, DOI 10.1177/2040622318788485; Kim Y, 2020, MOL ASPECTS MED, V75, DOI 10.1016/j.mam.2020.100867; Li HY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020533; Li SY, 2019, J ALZHEIMERS DIS, V72, P1145, DOI 10.3233/JAD-190263; Mainous AG, 2005, FAM MED, V37, P36; Min JY, 2016, J ALZHEIMERS DIS, V52, P705, DOI 10.3233/JAD-151095; Miyajima H, 2003, BIOMETALS, V16, P205, DOI 10.1023/A:1020775101654; Molz P, 2021, EUR J NUTR, V60, P3679, DOI 10.1007/s00394-021-02541-z; Owens DK, 2020, JAMA-J AM MED ASSOC, V323, P757, DOI 10.1001/jama.2020.0435; Peeri NC, 2021, EUR J NUTR, V60, P465, DOI 10.1007/s00394-020-02267-4; Pino JMV, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00145; Pirpamer L, 2016, NEUROBIOL AGING, V43, P149, DOI 10.1016/j.neurobiolaging.2016.04.002; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Puig S, 2017, METALLOMICS, V9, P1483, DOI 10.1039/c7mt00116a; Samieri C, 2018, JAMA-J AM MED ASSOC, V320, P657, DOI 10.1001/jama.2018.11499; Schiepers OJG, 2010, J GERONTOL A-BIOL, V65, P1312, DOI 10.1093/gerona/glq149; Schroder N, 2013, J ALZHEIMERS DIS, V34, P797, DOI 10.3233/JAD-121996; Spence H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240697; Squitti R, 2014, J ALZHEIMERS DIS, V38, P809, DOI 10.3233/JAD-131247; Uberti VH, 2020, MOL NEUROBIOL, V57, P1044, DOI 10.1007/s12035-019-01794-4; van Wijngaarden E, 2011, NEUROTOXICOLOGY, V32, P110, DOI 10.1016/j.neuro.2010.11.002; Varikasuvu SR, 2019, BIOL TRACE ELEM RES, V189, P361, DOI 10.1007/s12011-018-1492-x; Ventriglia M, 2015, J ALZHEIMERS DIS, V46, P75, DOI 10.3233/JAD-141296; Vlasak T, 2019, SCI TOTAL ENVIRON, V668, P678, DOI 10.1016/j.scitotenv.2019.03.052; von Haehling S, 2015, NAT REV CARDIOL, V12, P659, DOI 10.1038/nrcardio.2015.109; Ward A, 2012, ALZHEIMERS DEMENT, V8, P14, DOI 10.1016/j.jalz.2011.01.002; Xu L, 2018, J ALZHEIMERS DIS, V62, P361, DOI 10.3233/JAD-170811; Zheng W, 2012, PHARMACOL THERAPEUT, V133, P177, DOI 10.1016/j.pharmthera.2011.10.006	40	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255595	10.1371/journal.pone.0255595	http://dx.doi.org/10.1371/journal.pone.0255595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339453	Green Published, gold			2022-12-26	WOS:000680243400028
J	Aggarwal, G; May-Zhang, LS; Yermalitsky, V; Dikalov, S; Voynov, MA; Amarnath, V; Kon, V; Linton, MF; Vickers, KC; Davies, SS				Aggarwal, Geetika; May-Zhang, Linda S.; Yermalitsky, Valery; Dikalov, Sergey; Voynov, Maxim A.; Amarnath, Venkataraman; Kon, Valentina; Linton, MacRae F.; Vickers, Kasey C.; Davies, Sean S.			Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; LIPID-PEROXIDATION; LACTONASE ACTIVITY; GAMMA-KETOALDEHYDES; PON1; ASSOCIATION; SITES; ATHEROSCLEROSIS	Reduced activity of paraoxonase 1 (PON1), a high-density lipoprotein (HDL)-associated enzyme, has been implicated in the development of atherosclerosis. Post-translational modifi- cations of PON1 may represent important mechanisms leading to reduced PON1 activity. Under atherosclerotic conditions, myeloperoxidase (MPO) is known to associate with HDL. MPO generates the oxidants hypochlorous acid and nitrogen dioxide, which can lead to post-translational modification of PON1, including tyrosine modifications that inhibit PON1 activity. Nitrogen dioxide also drives lipid peroxidation, leading to the formation of reactive lipid dicarbonyls such as malondialde-hyde and isolevuglandins, which modify HDL and could inhibit PON1 activity. Because isolevuglandins are more reactive than malondialdehyde, we used in vitro models containing HDL, PON1, and MPO to test the hypothesis that IsoLG formation by MPO and its subsequent modification of HDL contributes to MPO-mediated reductions in PON1 activity. Incubation of MPO with HDL led to modification of HDL proteins, including PON1, by IsoLG. Incubation of HDL with IsoLG reduced PON1 lactonase and antiperoxidation activities. IsoLG modi-fication of recombinant PON1 markedly inhibited its activity, while irreversible IsoLG modification of HDL before adding recombinant PON1 only slightly inhibited the ability of HDL to enhance the catalytic activity of recombinant PON1. Together, these studies support the notion that association of MPO with HDL leads to lower PON1 activity in part via IsoLG-mediated modification of PON1, so that IsoLG modification of PON1 could contribute to increased risk for atherosclerosis, and blocking this modification might prove beneficial to reduce atherosclerosis.	[Aggarwal, Geetika; May-Zhang, Linda S.; Yermalitsky, Valery; Linton, MacRae F.; Davies, Sean S.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; [Dikalov, Sergey; Amarnath, Venkataraman; Davies, Sean S.] Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN 37235 USA; [Voynov, Maxim A.] North Carolina State Univ, Dept Chem, Raleigh, NC USA; [Kon, Valentina] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Linton, MacRae F.; Vickers, Kasey C.] Vanderbilt Univ, Med Ctr, Dept Med, Atherosclerosis Res Unit,Div Cardiovasc Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; University of North Carolina; North Carolina State University; Vanderbilt University; Vanderbilt University	Davies, SS (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA.; Davies, SS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN 37235 USA.	sean.davies@vanderbilt.edu	Aggarwal, Geetika/ABD-8696-2021	Aggarwal, Geetika/0000-0002-1848-5056; Voynov, Maxim/0000-0002-5565-5843; Dikalov, Sergey/0000-0003-2976-6184	NIH/National Heart, Lung, and Blood Institute [PO1 HL116263]	NIH/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a program project grant from the NIH/National Heart, Lung, and Blood Institute (PO1 HL116263). The authors are grateful to Dr Keri Tallman for the synthesis of IsoLG and Dr Dan S. Tawfik (Weizmann Institute of Science, Rehovot, Israel) for kindly providing recombinant paraoxonase 1 plasmid. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggarwal G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147999; Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Amarnath V, 2005, SYNTHETIC COMMUN, V35, P397, DOI 10.1081/SCC-200048945; Atwa ET, 2020, MOL BIOL REP, V47, P4255, DOI 10.1007/s11033-020-05558-5; Aviram M, 2000, CIRCULATION, V101, P2510, DOI 10.1161/01.CIR.101.21.2510; Bajaj P, 2013, PROTEIN SCI, V22, P1799, DOI 10.1002/pro.2380; Bi WZ, 2016, CHEM RES TOXICOL, V29, P1628, DOI 10.1021/acs.chemrestox.6b00141; Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Brame CJ, 1999, J BIOL CHEM, V274, P13139, DOI 10.1074/jbc.274.19.13139; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Connelly PW, 2004, J LIPID RES, V45, P561, DOI 10.1194/jlr.M300464-JLR200; Davies SS, 2006, BIOCHEMISTRY-US, V45, P15756, DOI 10.1021/bi061860g; Dikalov SI, 2018, ANTIOXID REDOX SIGN, V28, P1433, DOI 10.1089/ars.2017.7396; Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Enkisch C, 2009, EUR J ORG CHEM, V2009, P5549, DOI 10.1002/ejoc.200900787; Fuhrman B, 2010, NUTRITION, V26, P359, DOI 10.1016/j.nut.2009.05.003; Gaidukov L, 2005, BIOCHEMISTRY-US, V44, P11843, DOI 10.1021/bi050862i; Gaidukov L, 2007, J LIPID RES, V48, P1637, DOI 10.1194/jlr.D600045-JLR200; Godbole Charuta, 2021, Future Cardiol, V17, P119, DOI 10.2217/fca-2020-0028; Graner M, 2006, J AM COLL CARDIOL, V47, P2429, DOI 10.1016/j.jacc.2006.01.074; Hernandez-Diaz Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005298; Huang JS, 2020, NUTRIENTS, V12, DOI 10.3390/nu12071937; Huang Y, 2013, J CLIN INVEST, V123, P3815, DOI 10.1172/JCI67478; James RW, 2000, CIRCULATION, V101, P2252, DOI 10.1161/01.CIR.101.19.2252; Kato Y, 2016, J CLIN BIOCHEM NUTR, V58, P99, DOI 10.3164/jcbn.15-104; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Khersonsky O, 2006, CHEMBIOCHEM, V7, P49, DOI 10.1002/cbic.200500334; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Kraemer T, 2004, BIOL CHEM, V385, P809, DOI 10.1515/BC.2004.106; Li C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42518-x; Liu T, 2014, EUR J CLIN NUTR, V68, P1029, DOI 10.1038/ejcn.2014.105; Mackness B, 2000, EUR J CLIN INVEST, V30, P4; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; Mackness B, 2006, ARTERIOSCL THROM VAS, V26, P1545, DOI 10.1161/01.ATV.0000222924.62641.aa; Mackness Michael I, 2004, Am J Cardiovasc Drugs, V4, P211, DOI 10.2165/00129784-200404040-00002; May-Zhang LS, 2019, J BIOL CHEM, V294, P19022, DOI 10.1074/jbc.RA119.009424; May-Zhang LS, 2018, J BIOL CHEM, V293, P9176, DOI 10.1074/jbc.RA117.001099; Mohammed CJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8071034; Mont S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24919; Murillo-Gonzalez FE, 2020, CLIN CHIM ACTA, V500, P47, DOI 10.1016/j.cca.2019.09.016; Poliakov E, 2003, FASEB J, V17, P2209, DOI 10.1096/fj.03-0086com; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Tao H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17915-w; Tomas M, 2004, REV ESP CARDIOL, V57, P557, DOI 10.1157/13062921; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Zagol-Ikapite I, 2015, J LIPID RES, V56, P2196, DOI 10.1194/jlr.P063271; Zhang C, 2010, GENE THER, V17, P626, DOI 10.1038/gt.2010.11; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhang RL, 2002, BLOOD, V99, P1802, DOI 10.1182/blood.V99.5.1802.h8001802_1802_1810; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a; Zhao Y, 2012, MOL GENET METAB, V105, P141, DOI 10.1016/j.ymgme.2011.09.018; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	54	5	5	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101019	10.1016/j.jbc.2021.101019	http://dx.doi.org/10.1016/j.jbc.2021.101019			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34331945	gold, Green Published			2022-12-26	WOS:000706408900009
J	Gugushvili, A; Bulczak, G; Zelinska, O; Koltai, J				Gugushvili, Alexi; Bulczak, Grzegorz; Zelinska, Olga; Koltai, Jonathan			Socioeconomic position, social mobility, and health selection effects on allostatic load in the United States	PLOS ONE			English	Article							INTERGENERATIONAL EDUCATIONAL MOBILITY; SELF-RATED HEALTH; EUROPEAN COUNTRIES; FUNDAMENTAL CAUSES; BLOOD-PRESSURE; JOHN-HENRYISM; ADULT HEALTH; LONG ARM; CHILDHOOD; RISK	The contemporaneous association between higher socioeconomic position and better health is well established. Life course research has also demonstrated a lasting effect of childhood socioeconomic conditions on adult health and well-being. Yet, little is known about the separate health effects of intergenerational mobility-moving into a different socioeconomic position than one's parents-among early adults in the United States. Most studies on the health implications of mobility rely on cross-sectional datasets, which makes it impossible to differentiate between health selection and social causation effects. In addition, understanding the effects of social mobility on health at a relatively young age has been hampered by the paucity of health measures that reliably predict disease onset. Analysing 4,713 respondents aged 25 to 32 from the National Longitudinal Study of Adolescent Health's Waves I and IV, we use diagonal reference models to separately identify the effects of socioeconomic origin and destination, as well as social mobility on allostatic load among individuals in the United States. Using a combined measure of educational and occupational attainment, and accounting for individuals' initial health, we demonstrate that in addition to health gradient among the socially immobile, individuals' socioeconomic origin and destination are equally important for multi-system physiological dysregulation. Short-range upward mobility also has a positive and significant association with health. After mitigating health selection concerns in our observational data, this effect is observed only among those reporting poor health before experiencing social mobility. Our findings move towards the reconciliation of two theoretical perspectives, confirming the positive effect of upward mobility as predicted by the "rags to riches" perspective, while not contradicting potential costs associated with more extensive upward mobility experiences as predicted by the dissociative thesis.	[Gugushvili, Alexi] Univ Oslo, Dept Sociol & Human Geog, Oslo, Norway; [Gugushvili, Alexi; Bulczak, Grzegorz; Zelinska, Olga] Polish Acad Sci, Inst Philosophy & Sociol, Warsaw, Poland; [Gugushvili, Alexi] Univ Oxford, Nuffield Coll, Oxford, England; [Koltai, Jonathan] Univ New Hampshire, Dept Sociol, Durham, NH 03824 USA	University of Oslo; Polish Academy of Sciences; Institute of Philosophy & Sociology of the Polish Academy of Sciences; University of Oxford; University System Of New Hampshire; University of New Hampshire	Gugushvili, A (corresponding author), Univ Oslo, Dept Sociol & Human Geog, Oslo, Norway.; Gugushvili, A (corresponding author), Polish Acad Sci, Inst Philosophy & Sociol, Warsaw, Poland.; Gugushvili, A (corresponding author), Univ Oxford, Nuffield Coll, Oxford, England.	alexi.gugushvili@sosgeo.uio.no	Zelinska, Olga/ABH-4934-2020; Bulczak, Grzegorz/GLQ-7648-2022	Zelinska, Olga/0000-0003-0148-1507; Bulczak, Grzegorz/0000-0002-6139-1389; Gugushvili, Alexi/0000-0002-3933-9111	Polish National Science Centre [UMO-2018/31/D/HS6/01877]	Polish National Science Centre	This work was supported by the Polish National Science Centre grant received by AG (Program SONATA14) -https://ncn.gov.pl/-[grant number UMO-2018/31/D/HS6/01877]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Bartley M., 2017, HLTH INEQUALITY INTR; Belsky DW, 2018, P NATL ACAD SCI USA, V115, pE7275, DOI 10.1073/pnas.1801238115; Bernardi F., 2016, ED OCCUPATION SOCIAL; Billingsley S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211977; Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Brody GH, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1042; Brody GH, 2013, PSYCHOL SCI, V24, P1285, DOI 10.1177/0956797612471954; Brownstein N., 2011, NONRESPONSE WAVE 4 N; Campos-Matos I, 2015, SOC SCI MED, V142, P241, DOI 10.1016/j.socscimed.2015.08.035; Caspar Kaiser, 2018, DRM STATA MODULE FIT; Chan TW, 2018, BRIT J SOCIOL, V69, P183, DOI 10.1111/1468-4446.12285; Chen E, 2020, BRAIN BEHAV IMMUN, V88, P661, DOI 10.1016/j.bbi.2020.04.070; Chen E, 2015, CLIN PSYCHOL SCI, V3, P675, DOI 10.1177/2167702614546639; Chetty R, 2017, SCIENCE, V356, P398, DOI 10.1126/science.aal4617; Chetty R, 2014, AM ECON REV, V104, P141, DOI 10.1257/aer.104.5.141; Claussen B, 2005, SOC SCI MED, V61, P2513, DOI 10.1016/j.socscimed.2005.04.045; Davillas A, 2017, J HEALTH ECON, V56, P87, DOI 10.1016/j.jhealeco.2017.09.010; Dennison CR, 2018, J DRUG ISSUES, V48, P205, DOI 10.1177/0022042617746974; Elstad JI, 2003, SOC SCI MED, V57, P1475, DOI 10.1016/S0277-9536(02)00514-2; ERIKSON R, 1984, SOCIOLOGY, V18, P500, DOI 10.1177/0038038584018004003; Erikson R, 2002, J ECON PERSPECT, V16, P31, DOI 10.1257/089533002760278695; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P7, DOI 10.1136/jech.2004.023531; Gaydosh L, 2018, P NATL ACAD SCI USA, V115, P109, DOI 10.1073/pnas.1714616114; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Gruenewald TL, 2012, SOC SCI MED, V74, P75, DOI 10.1016/j.socscimed.2011.09.037; Gugushvili A, 2020, PUBLIC HEALTH, V181, P94, DOI 10.1016/j.puhe.2019.12.009; Gugushvili A, 2019, SOC SCI MED, V222, P294, DOI 10.1016/j.socscimed.2018.12.027; Gugushvili A, 2019, INT J SOC WELF, V28, P16, DOI 10.1111/ijsw.12316; Gugushvili A, 2019, SOC INDIC RES, V141, P413, DOI 10.1007/s11205-017-1834-7; Haas S, 2008, SOC SCI MED, V66, P849, DOI 10.1016/j.socscimed.2007.11.004; Hayward MD, 2004, DEMOGRAPHY, V41, P87, DOI 10.1353/dem.2004.0005; Hill PL, 2013, PERS INDIV DIFFER, V54, P92, DOI 10.1016/j.paid.2012.08.011; Hoffmann R, 2018, ADV LIFE COURSE RES, V36, P23, DOI 10.1016/j.alcr.2018.02.002; Houle JN, 2011, RES SOC STRAT MOBIL, V29, P193, DOI 10.1016/j.rssm.2010.11.001; Hout M, 2018, P NATL ACAD SCI USA, V115, P9527, DOI 10.1073/pnas.1802508115; Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4; Iveson MH, 2017, SOC SCI MED, V188, P11, DOI 10.1016/j.socscimed.2017.06.038; Jackson M, 2018, BRIT J SOCIOL, V69, P1096, DOI 10.1111/1468-4446.12505; Jaime-Castillo AM, 2019, BRIT J SOCIOL, V70, P138, DOI 10.1111/1468-4446.12363; JAMES SA, 1992, AM J EPIDEMIOL, V135, P59, DOI 10.1093/oxfordjournals.aje.a116202; JAMES SA, 1983, J BEHAV MED, V6, P259, DOI 10.1007/BF01315113; James SA., 2019, J HENRYISM STRUCTURA, DOI [10.2105/9780875533049ch08, DOI 10.2105/9780875533049CH08]; Johnson SC, 2017, SOC SCI MED, V192, P66, DOI 10.1016/j.socscimed.2017.09.025; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Koltai J, 2018, SOC SCI MED, V202, P108, DOI 10.1016/j.socscimed.2018.01.019; KRAUSE NM, 1994, MED CARE, V32, P930, DOI 10.1097/00005650-199409000-00004; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lorem G, 2020, SCI REP-UK, V10, DOI [10.1038/s41598-020-61603-0, 10.1038/s41598-020-75260-w]; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M., 2004, STATUS SYNDROME SOCI; McCrory C, 2019, PSYCHONEUROENDOCRINO, V104, P64, DOI 10.1016/j.psyneuen.2019.02.018; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Miller GE, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015698; Miller GE, 2015, P NATL ACAD SCI USA, V112, P10325, DOI 10.1073/pnas.1505063112; Mirowsky J., 2003, ED SOCIAL STATUS HLT; Missinne S, 2015, SOCIOL HEALTH ILL, V37, P823, DOI 10.1111/1467-9566.12225; Nam CB, 2004, POPUL RES POLICY REV, V23, P327, DOI 10.1023/B:POPU.0000040045.51228.34; Newman Katherine., 1999, FALLING GRACE DOWNWA; Nicklett EJ, 2009, AM J EPIDEMIOL, V170, P793, DOI 10.1093/aje/kwp192; Paskov M., 2019, DOES DOWNWARD SOCIAL; Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498; Poulton R, 2002, LANCET, V360, P1640, DOI 10.1016/S0140-6736(02)11602-3; Prag P., 2020, EUR SOC, P1; Prag P, 2019, J EPIDEMIOL COMMUN H, V73, P100, DOI 10.1136/jech-2017-210171; Prag Patrick., 2020, SOCARXIV; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schafer MH, 2013, SOC FORCES, V91, P1007, DOI 10.1093/sf/sos192; Seeman M, 2014, SOC SCI MED, V118, P143, DOI 10.1016/j.socscimed.2014.08.002; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; SOBEL ME, 1981, AM SOCIOL REV, V46, P893, DOI 10.2307/2095086; SOBEL ME, 1985, AM SOCIOL REV, V50, P699, DOI 10.2307/2095383; Song X, 2020, P NATL ACAD SCI USA, V117, P251, DOI 10.1073/pnas.1905094116; Sorokin Pitirim Aleksandrovich, 1927, SOCIAL MOBILITY; Steiber N, 2019, SOC SCI MED, V242, DOI 10.1016/j.socscimed.2019.112603; Surachman A, 2020, PSYCHOSOM MED, V82, P224, DOI 10.1097/PSY.0000000000000752; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tiikkaja S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077975; Timms D, 1998, SOC SCI MED, V46, P1235, DOI 10.1016/S0277-9536(97)10052-1; Torche F., 2016, ED OCCUPATION SOCIAL, P237, DOI [10.4337/9781785360459.00020, DOI 10.4337/9781785360459.00020]; Ueno K, 2013, WORK OCCUPATION, V40, P3, DOI 10.1177/0730888412460532; van der Waal J, 2017, INT J PUBLIC HEALTH, V62, P1029, DOI 10.1007/s00038-017-1018-x; Vie TL, 2014, SOC SCI MED, V117, P1, DOI 10.1016/j.socscimed.2014.07.019; Walsemann KM, 2016, SOC SCI MED, V152, P147, DOI 10.1016/j.socscimed.2016.01.038; Watkins PC, 2003, SOC BEHAV PERSONAL, V31, P431, DOI 10.2224/sbp.2003.31.5.431; Wickrama KAS, 2016, J YOUTH ADOLESCENCE, V45, P271, DOI 10.1007/s10964-015-0397-7; Wickrama K, 2015, HEALTH PSYCHOL, V34, P905, DOI 10.1037/hea0000208; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x; Yang YC, 2017, BIODEMOGR SOC BIOL, V63, P87, DOI 10.1080/19485565.2017.1279536; Zajacova A, 2018, ANNU REV PUBL HEALTH, V39, P273, DOI 10.1146/annurev-publhealth-031816-044628; Zhao YZ, 2017, RES SOC STRAT MOBIL, V48, P54, DOI 10.1016/j.rssm.2017.02.002; Zimmerman FJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6386	92	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2021	16	8							e0254414	10.1371/journal.pone.0254414	http://dx.doi.org/10.1371/journal.pone.0254414			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6IY	34347798	Green Published, gold			2022-12-26	WOS:000685264900068
J	Sabas, I; Miro, A; Piera, J; Catalan, J; Camarero, L; Buchaca, T; Ventura, M				Sabas, Ibor; Miro, Alexandre; Piera, Jaume; Catalan, Jordi; Camarero, Lluis; Buchaca, Teresa; Ventura, Marc			Factors of surface thermal variation in high-mountain lakes of the Pyrenees	PLOS ONE			English	Article							WATER-TEMPERATURE; EPILIMNETIC TEMPERATURE; ZOOPLANKTON COMMUNITIES; INTERANNUAL VARIATION; AIR-TEMPERATURE; CLIMATE-CHANGE; BODY-SIZE; ALTITUDE; VARIABILITY; POPULATIONS	Thermal variables are crucial drivers of biological processes in lakes and ponds. In the current context of climate change, determining which factors better constrain their variation within lake districts become of paramount importance for understanding species distribution and their conservation. In this study, we describe the regional and short-term interannual variability in surface water temperature of high mountain lakes and ponds of the Pyrenees. And, we use mixed regression models to identify key environmental factors and to infer mean and maximum summer temperature, accumulated degree-days, diel temperature ranges and three-days' oscillation. The study is based on 59 lake-temperature series measured from 2001 to 2014. We found that altitude was the primary explicative factor for accumulated degree-days and mean and maximum temperature. In contrast, lake area showed the most relevant effect on the diel temperature range and temperature oscillations, although diel temperature range was also found to decline with altitude. Furthermore, the morphology of the catchment significantly affected accumulated degree-days and maximum and mean water temperatures. The statistical models developed here were applied to upscale spatially the current thermic conditions across the whole set of lakes and ponds of the Pyrenees.	[Sabas, Ibor; Miro, Alexandre; Camarero, Lluis; Buchaca, Teresa; Ventura, Marc] CSIC, Integrat Freshwater Ecol Grp, Ctr Adv Studies Blanes CEAB, Blanes, Catalonia, Spain; [Piera, Jaume] CSIC, Inst Marine Sci, ICM, Dept Phys & Technol Oceanog, Barcelona, Spain; [Catalan, Jordi] CREAF Campus UAB, Edifici C, Cerdanyola Del Valles, Spain; [Catalan, Jordi] CSIC, Campus UAB, Cerdanyola Del Valles, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC)	Sabas, I (corresponding author), CSIC, Integrat Freshwater Ecol Grp, Ctr Adv Studies Blanes CEAB, Blanes, Catalonia, Spain.	iborsabas@gmail.com	Catalan, Jordi/ABD-4402-2021; Piera, Jaume/I-1152-2015; Buchaca, Teresa/L-1679-2014; Miro, Alexandre/K-5758-2017	Catalan, Jordi/0000-0002-2934-4013; Piera, Jaume/0000-0001-5818-9836; Buchaca, Teresa/0000-0001-7933-8992; Ventura, Marc/0000-0003-1401-414X; Miro, Alexandre/0000-0002-7348-1736	Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya; European Social Fund [2015FI_B_01147]; Spanish Government [CGL2010-14841, 427/2011, RTI2018-096217-B-I00]; European Commission LIFE+ project LimnoPirineus [LIFE13 NAT/ES/001210]	Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); European Social Fund(European Social Fund (ESF)); Spanish Government(Spanish GovernmentEuropean Commission); European Commission LIFE+ project LimnoPirineus(European CommissionEuropean Commission Joint Research Centre)	The authors want to aknowledge the Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya and the European Social Fund for the doctoral scholarship FI (2015FI_B_01147) given to the first author, that has allowed this work. The projects provided by the Spanish Government projects; Fundalzoo (CGL2010-14841) and Invasivefish (427/2011) and by the European Commission LIFE+ project LimnoPirineus (LIFE13 NAT/ES/001210), and also the last project of the Spanish Government, FUNBIO (RTI2018-096217B-I00) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti-Panareda A, 2002, J PALEOLIMNOL, V28, P7, DOI 10.1023/A:1020363700397; Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; Balcells E, 1956, B I BIOL APL, V24, P81; Beniston M, 2006, HYDROBIOLOGIA, V562, P3, DOI 10.1007/s10750-005-1802-0; Blenckner T, 2007, GLOBAL CHANGE BIOL, V13, P1314, DOI 10.1111/j.1365-2486.2007.01364.x; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Bunay D, 2017, INTERACCIONES TROFIC, DOI [10.1038/s41598-017-02752-7, DOI 10.1038/S41598-017-02752-7]; Butterwick C, 2005, FRESHWATER BIOL, V50, P291; Casals-Carrasco P, 2009, ADV LIMNOL, V62, P353; Catalan J, 2002, J PALEOLIMNOL, V28, P129, DOI 10.1023/A:1020380104031; Catalan J, 2009, FRESHWATER BIOL, V54, P2419, DOI 10.1111/j.1365-2427.2009.02326.x; Charnov EL, 2003, EVOL ECOL RES, V5, P43; de Mendoza G, 2010, HYDROBIOLOGIA, V648, P51, DOI 10.1007/s10750-010-0261-4; Dokulil MT, 2014, INLAND WATERS, V4, P27, DOI 10.5268/IW-4.1.705; Duarte H, 2012, GLOBAL CHANGE BIOL, V18, P412, DOI 10.1111/j.1365-2486.2011.02518.x; EDINGER JE, 1968, WATER RESOUR RES, V4, P1137, DOI 10.1029/WR004i005p01137; ELLIOTT JM, 1995, FUNCT ECOL, V9, P290, DOI 10.2307/2390576; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Fu PD, 2002, COMPUT ELECTRON AGR, V37, P25, DOI 10.1016/S0168-1699(02)00115-1; GORHAM E, 1989, J GREAT LAKES RES, V15, P233, DOI 10.1016/S0380-1330(89)71479-9; Gudasz C, 2010, NATURE, V466, P478, DOI 10.1038/nature09186; Hansen GJA, 2017, GLOBAL CHANGE BIOL, V23, P1463, DOI 10.1111/gcb.13462; Honsey AE, 2019, CAN J FISH AQUAT SCI, V76, P657, DOI 10.1139/cjfas-2018-0051; Jacobsen D, 1997, FRESHWATER BIOL, V38, P247, DOI 10.1046/j.1365-2427.1997.00210.x; Kettle H, 2004, LIMNOL OCEANOGR, V49, P271, DOI 10.4319/lo.2004.49.1.0271; Korner C, 2004, AMBIO, P11; Livingstone DM, 2003, CLIMATIC CHANGE, V57, P205, DOI 10.1023/A:1022119503144; Livingstone DM, 1999, ARCT ANTARCT ALP RES, V31, P341, DOI 10.2307/1552583; Livinstone DM, 2005, LIMNOL OCEANOGR, V50, P1313, DOI 10.4319/lo.2005.50.4.1313; Maberly SC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15108-z; MacLennan MM, 2015, FRESHWATER BIOL, V60, P1502, DOI 10.1111/fwb.12583; MAGNUSON JJ, 1979, AM ZOOL, V19, P331; Marziali L., 2013, Journal of Entomological and Acarological Research, V45, P73, DOI 10.4081/jear.2013.e14; Masson-Delmotte V., 2018, CONTEXT STRENGTHENIN, DOI DOI 10.1017/CBO9781107415324; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; O'Reilly CM, 2015, GEOPHYS RES LETT, V42, P10773, DOI 10.1002/2015GL066235; Oromi N, 2015, ACTA HERPETOL, V10, P85; Pepin N, 2015, NAT CLIM CHANGE, V5, P424, DOI [10.1038/nclimate2563, 10.1038/NCLIMATE2563]; PILGRIM DH, 1982, J HYDROL, V58, P205, DOI 10.1016/0022-1694(82)90035-X; Pinheiro J, 2020, R PACKAGE VERSION 31; Pla S, 2005, CLIM DYNAM, V24, P263, DOI [10.1007/s00382-004-0482-1, 10.1007/s00382-004-0482-l]; R Core Team, 2020, R LANG ENV STAT COMP; Read JS, 2013, LIMNOL OCEANOGR, V58, P921, DOI 10.4319/lo.2013.58.3.0921; Redmond LE, 2018, WATER RESOUR RES, V54, P2362, DOI 10.1002/2017WR021956; Richter-Boix A, 2015, EVOLUTION, V69, P2210, DOI 10.1111/evo.12711; Rose KC, 2016, LIMNOL OCEANOGR LETT, V1, P44, DOI 10.1002/lol2.10027; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Sharma S, 2008, FRESHWATER BIOL, V53, P897, DOI 10.1111/j.1365-2427.2008.01943.x; Snucins E, 2000, LIMNOL OCEANOGR, V45, P1639, DOI 10.4319/lo.2000.45.7.1639; Sporka F, 2006, BIOLOGIA, V61, pS77, DOI 10.2478/s11756-006-0121-x; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Strong C, 2011, GLOBAL CHANGE BIOL, V17, P2013, DOI 10.1111/j.1365-2486.2011.02391.x; Stuecker MF, 2018, NAT CLIM CHANGE, V8, P1076, DOI 10.1038/s41558-018-0339-y; Symons CC, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0825; Tarrats P, 2018, HOLOCENE, V28, P1685, DOI 10.1177/0959683618788662; Thompson R, 2009, FRESHWATER BIOL, V54, P2433, DOI 10.1111/j.1365-2427.2009.02236.x; Velthuis M, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1651; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilhelm S, 2006, CAN J FISH AQUAT SCI, V63, P2467, DOI 10.1139/F06-140; Winslow LA, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.53; Winslow LA, 2015, GEOPHYS RES LETT, V42, P355, DOI 10.1002/2014GL062325; Woolway RI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152466; Woolway RI, 2015, INLAND WATERS, V5, P311, DOI 10.5268/IW-5.4.854; Woolway RI, 2015, INLAND WATERS, V5, P139, DOI 10.5268/IW-5.2.748; Zuur Alain F., 2009, P1	65	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0254702	10.1371/journal.pone.0254702	http://dx.doi.org/10.1371/journal.pone.0254702			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343195	Green Published, gold			2022-12-26	WOS:000685264200038
J	de ten Ryen, SV; Warnier, G; Gnimassou, O; Belhaj, MR; Benoit, N; Naslain, D; Brook, MS; Smith, K; Wilkinson, DJ; Nielens, H; Atherton, PJ; Francaux, M; Deldicque, L				van Doorslaer de ten Ryen, Sophie; Warnier, Geoffrey; Gnimassou, Olouyomi; Belhaj, Mehdi R.; Benoit, Nicolas; Naslain, Damien; Brook, Matthew S.; Smith, Kenneth; Wilkinson, Daniel J.; Nielens, Henri; Atherton, Philip J.; Francaux, Marc; Deldicque, Louise			Higher strength gain after hypoxic vs normoxic resistance training despite no changes in muscle thickness and fractional protein synthetic rate	FASEB JOURNAL			English	Article						deuterium; hypoxia; muscle thickness; myogenesis; protein synthesis	ACUTE ENVIRONMENTAL HYPOXIA; SATELLITE CELL; HYPERTROPHY; EXERCISE; MYOGENESIS; ADAPTATIONS; INTERVAL; POWER; REST	Acute hypoxia has previously been suggested to potentiate resistance training-induced hypertrophy by activating satellite cell-dependent myogenesis rather than an improvement in protein balance in human. Here, we tested this hypothesis after a 4-week hypoxic vs normoxic resistance training protocol. For that purpose, 19 physically active male subjects were recruited to perform 6 sets of 10 repetitions of a one-leg knee extension exercise at 80% 1-RM 3 times/week for 4 weeks in normoxia (FiO(2): 0.21; n = 9) or in hypoxia (FiO(2): 0.135, n = 10). Blood and skeletal muscle samples were taken before and after the training period. Muscle fractional protein synthetic rate was measured over the whole period by deuterium incorporation into the protein pool and muscle thickness by ultrasound. At the end of the training protocol, the strength gain was higher in the hypoxic vs the normoxic group despite no changes in muscle thickness and in the fractional protein synthetic rate. Only early myogenesis, as assessed by higher MyoD and Myf5 mRNA levels, appeared to be enhanced by hypoxia compared to normoxia. No effects were found on myosin heavy chain expression, markers of oxidative metabolism and lactate transport in the skeletal muscle. Though the present study failed to unravel clearly the mechanisms by which hypoxic resistance training is particularly potent to increase muscle strength, it is important message to keep in mind that this training strategy could be effective for all athletes looking at developing and optimizing their maximal muscle strength.	[van Doorslaer de ten Ryen, Sophie; Warnier, Geoffrey; Gnimassou, Olouyomi; Belhaj, Mehdi R.; Benoit, Nicolas; Naslain, Damien; Francaux, Marc; Deldicque, Louise] UCLouvain, Inst Neurosci, Pl Pierre Coubertin,1 L08 10 01, B-1348 Lovain La Neuve, Belgium; [Brook, Matthew S.; Smith, Kenneth; Wilkinson, Daniel J.; Atherton, Philip J.] Univ Nottingham, Sch Med, Nottingham Biomed Res Ctr BRC, MRC ARUK Ctr Musculoskeletal Ageing Res, Nottingham, England; [Brook, Matthew S.; Smith, Kenneth; Wilkinson, Daniel J.; Atherton, Philip J.] Univ Nottingham, Sch Med, Nottingham Biomed Res Ctr BRC, Natl Inst Hlth Res, Nottingham, England; [Nielens, Henri] UCLouvain, Clin Univ St Luc, Brussels, Belgium; [Gnimassou, Olouyomi] Univ Hubert Koutoukou Maga, Ctr Natl Hosp, Clin Univ Med Phys & Readaptat, Cotonou, Benin; [Belhaj, Mehdi R.] Australian Catholic Univ, Mary MacKillop Inst Hlth, Exercise & Nutr Res Program, Melbourne, Vic, Australia	University of Nottingham; University of Nottingham; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Australian Catholic University	Deldicque, L (corresponding author), UCLouvain, Inst Neurosci, Pl Pierre Coubertin,1 L08 10 01, B-1348 Lovain La Neuve, Belgium.	louise.deldicque@uclouvain.be	Warnier, Geoffrey/AEK-2389-2022	Warnier, Geoffrey/0000-0002-2438-0875	Fonds National de la Recherche Scientifique [J.0050.16]; Sports Ministry of the Brussels-Wallonia Federation; Centre d'Aide a la Performance Sportive	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Sports Ministry of the Brussels-Wallonia Federation; Centre d'Aide a la Performance Sportive	Fonds National de la Recherche Scientifique, Grant/Award Number: J.0050.16; Sports Ministry of the Brussels-Wallonia Federation and the Centre d'Aide a la Performance Sportive	Bazgir B, 2017, CELL J, V18, P473; Britto FA, 2020, FASEB J, V34, P1885, DOI 10.1096/fj.201902244R; Brocherie F, 2015, EUR J APPL PHYSIOL, V115, P891, DOI 10.1007/s00421-014-3070-z; Brook MS, 2015, FASEB J, V29, P4485, DOI 10.1096/fj.15-273755; Chaillou T, 2016, FASEB J, V30, P3929, DOI 10.1096/fj.201600757R; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; D'Hulst G, 2013, ACTA PHYSIOL, V208, P251, DOI 10.1111/apha.12086; de Salles BF, 2009, SPORTS MED, V39, P765, DOI 10.2165/11315230-000000000-00000; Etheridge T, 2011, AM J PHYSIOL-ENDOC M, V301, pE697, DOI 10.1152/ajpendo.00276.2011; Feriche B, 2017, SPORTS MED-OPEN, V3, DOI 10.1186/s40798-017-0078-z; Francaux M., 2013, CELL MOL EXERC PHYSL, V2, pE5; Friedmann B, 2003, PFLUG ARCH EUR J PHY, V446, P742, DOI 10.1007/s00424-003-1133-9; Gnimassou O, 2018, FASEB J, V32, P5272, DOI 10.1096/fj.201800049RR; Ho JY, 2014, J STRENGTH COND RES, V28, P935, DOI 10.1519/JSC.0000000000000289; Inness MWH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00502; Joanisse S, 2015, AM J PHYSIOL-REG I, V309, pR1101, DOI 10.1152/ajpregu.00249.2015; Joanisse S, 2013, FASEB J, V27, P4596, DOI 10.1096/fj.13-229799; Kon M, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12033; Koppo K, 2002, RESP PHYSIOL NEUROBI, V133, P241, DOI 10.1016/S1569-9048(02)00184-2; Kurobe K, 2015, CLIN PHYSIOL FUNCT I, V35, P197, DOI 10.1111/cpf.12147; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Mancinelli R, 2011, J BIOL REG HOMEOS AG, V25, P635; Manimmanakorn A, 2013, EUR J APPL PHYSIOL, V113, P1767, DOI 10.1007/s00421-013-2605-z; Masschelein E, 2014, FASEB J, V28, P1022, DOI 10.1096/fj.13-239863; Mitchell CJ, 2015, J APPL PHYSIOL, V118, P495, DOI 10.1152/japplphysiol.00609.2014; MORITANI T, 1993, J BIOMECH, V26, P95, DOI 10.1016/0021-9290(93)90082-P; Muller W, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-095641; Nguyen DD, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00604; Nishimura A, 2010, INT J SPORT PHYSIOL, V5, P497, DOI 10.1123/ijspp.5.4.497; Olsen S, 2006, J PHYSIOL-LONDON, V573, P525, DOI 10.1113/jphysiol.2006.107359; Paddon-Jones D, 2001, EUR J APPL PHYSIOL, V85, P466, DOI 10.1007/s004210100467; Puype J, 2013, MED SCI SPORT EXER, V45, P2166, DOI 10.1249/MSS.0b013e31829734ae; Ramos-Campo DJ, 2018, EUR J SPORT SCI, V18, P92, DOI 10.1080/17461391.2017.1388850; Richardson RS, 2001, J APPL PHYSIOL, V91, P2679, DOI 10.1152/jappl.2001.91.6.2679; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Scott BR, 2015, SPORTS MED, V45, P313, DOI 10.1007/s40279-014-0288-1; Shamim B, 2018, SPORTS MED, V48, P1329, DOI 10.1007/s40279-018-0883-7; Shepstone TN, 2005, J APPL PHYSIOL, V98, P1768, DOI 10.1152/japplphysiol.01027.2004; Tarnopolsky MA, 2011, MUSCLE NERVE, V43, P717, DOI 10.1002/mus.21945; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilkinson DJ, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12433; Wilson JM, 2012, J STRENGTH COND RES, V26, P1724, DOI 10.1519/JSC.0b013e318234eb6f; Yasuda T, 2016, ONCOTARGET, V7, P33595, DOI 10.18632/oncotarget.9564	44	1	1	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21773	10.1096/fj.202100654RR	http://dx.doi.org/10.1096/fj.202100654RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34324735				2022-12-26	WOS:000678975300031
J	Duckworth, AT; Windgassen, TA; Keck, JL				Duckworth, Alexander T.; Windgassen, Tricia A.; Keck, James L.			Examination of the roles of a conserved motif in the PriA helicase in structure-specific DNA unwinding and processivity	PLOS ONE			English	Article							STALLED REPLICATION FORKS; PHI X174-TYPE PRIMOSOME; MECHANISMS; BINDING	DNA replication complexes (replisomes) frequently encounter barriers that can eject them prematurely from the genome. To avoid the lethality of incomplete DNA replication that arises from these events, bacteria have evolved "DNA replication restart" mechanisms to reload replisomes onto abandoned replication forks. The Escherichia coli PriA DNA helicase orchestrates this process by recognizing and remodeling replication forks and recruiting additional proteins that help to drive replisome reloading. We have identified a conserved sequence motif within a linker region of PriA that docks into a groove on the exterior of the PriA helicase domain. Alterations to the motif reduce the apparent processivity and attenuate structure-specific helicase activity in PriA, implicating the motif as a potential autoregulatory element in replication fork processing. The study also suggests that multiple PriA molecules may function in tandem to enhance DNA unwinding processivity, highlighting an unexpected similarity between PriA and other DNA helicases.	[Duckworth, Alexander T.; Windgassen, Tricia A.; Keck, James L.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53705 USA; [Windgassen, Tricia A.] Codexis Inc, Redwood City, CA USA	University of Wisconsin System; University of Wisconsin Madison	Keck, JL (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53705 USA.	jlkeck@wisc.edu		Keck, James/0000-0002-5961-0220; DUCKWORTH, ALEXANDER/0000-0002-7713-4117	National Institute of General Medical Sciences of the National Institutes of Health [T32GM008349]; National Science Foundation Graduate Research Fellowship [DGE1256259]; National Institutes of Health [GM098885]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number T32GM008349 to ATD, a National Science Foundation Graduate Research Fellowship under Grant No. DGE1256259 to TAW, and National Institutes of Health grant GM098885 to JLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; Cadman CJ, 2005, J BIOL CHEM, V280, P39693, DOI 10.1074/jbc.M508521200; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Eoff RL, 2010, BIOCHEMISTRY-US, V49, P4543, DOI 10.1021/bi100061v; Gupta MK, 2013, P NATL ACAD SCI USA, V110, P7252, DOI 10.1073/pnas.1303890110; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LEE MS, 1987, P NATL ACAD SCI USA, V84, P8345, DOI 10.1073/pnas.84.23.8345; Lin MG, 2020, BIOCHEM J, V477, P3911, DOI 10.1042/BCJ20200269; Liu J, 1999, J BIOL CHEM, V274, P25033, DOI 10.1074/jbc.274.35.25033; Liu J, 1996, J BIOL CHEM, V271, P15656, DOI 10.1074/jbc.271.26.15656; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Mangiameli SM, 2017, ELIFE, V6, DOI 10.7554/eLife.19848; Manhart CM, 2013, J BIOL CHEM, V288, P3989, DOI 10.1074/jbc.M112.435966; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; Nurse P, 1999, J BIOL CHEM, V274, P25026, DOI 10.1074/jbc.274.35.25026; NURSE P, 1991, J BACTERIOL, V173, P6686, DOI 10.1128/jb.173.21.6686-6693.1991; Sandler SJ, 2000, GENETICS, V155, P487; Sasaki K, 2007, EMBO J, V26, P2584, DOI 10.1038/sj.emboj.7601697; Windgassen TA, 2019, J BIOL CHEM, V294, P2801, DOI 10.1074/jbc.RA118.006870; Windgassen TA, 2018, P NATL ACAD SCI USA, V115, pE9075, DOI 10.1073/pnas.1809842115; Windgassen TA, 2018, NUCLEIC ACIDS RES, V46, P504, DOI 10.1093/nar/gkx1203; Windgassen TA, 2016, NUCLEIC ACIDS RES, V44, P9745, DOI 10.1093/nar/gkw690	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255409	10.1371/journal.pone.0255409	http://dx.doi.org/10.1371/journal.pone.0255409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329356	gold, Green Published			2022-12-26	WOS:000685248600002
J	Hopkins, KL; Jaffer, M; Hlongwane, KE; Otwombe, K; Dietrich, J; Cheyip, M; Olivier, J; Doherty, T; Gray, GE				Hopkins, Kathryn L.; Jaffer, Maya; Hlongwane, Khuthadzo E.; Otwombe, Kennedy; Dietrich, Janan; Cheyip, Mireille; Olivier, Jacobus; Doherty, Tanya; Gray, Glenda E.			Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa	PLOS ONE			English	Article							PAPILLOMAVIRUS; PREVENTION; PREVALENCE; INFECTION; DISEASES; HISTORY; WOMEN	Objective A screening centre in Soweto, South Africa (SA), investigated high-risk human papillomavirus (HR-HPV), HIV, cervical cancer risk amongst women. Methods This cross-sectional study (June 2018-March 2019) describes screening results (Roche Linear Array HPV test and Pap smear liquid based cytology) and history of screening (known HIV status, antiretroviral therapy [ART] use, previous Pap smears). Data were stratified by age group (18-29, 30+ years), HIV status, Pap smear results and tested for statistical significance. Results Of 280 women, 20.4% were HIV-positive, 18.2% had abnormal Pap smears, 41.8% had HR-HPV. Of older women, 48.2% (n = 78/162) had never had a Pap smear. Of younger women, 89.0% (n = 105/118) never had a Pap smear, but had significantly more low-grade squamous intraepithelial lesions (LSIL) and other HR-HPV infection than older women (12.7%[n = 15/118] vs 4.9%[n = 8/162], p = 0.0193; and 49.2%[n = 58/118] vs 29.0%[n = 47/162], p = 0.0006; respectively). HIV-positive women had more abnormal cytology results and infection with other HR-HPV types or co-infection with other HR-HPV type(s)/HPV-16 compared to HIV-negative women (35.1%[n = 20/57] vs 13.9%[n = 31/223], p = 0.0002; 56.1%[n = 32/57] vs 32.7%[n = 73/223], p = 0.001; and 12.3%[n = 7/57] vs 4.9%[n = 11/223], p = 0.044; respectively). Of 57 HIV-positive women, 45.6% (n = 26) already knew their HIV status; of which 69.2% were on ART and 34.6% never had a Pap smear. Conclusion South African women have high rates of HIV, Pap smear abnormalities and HR-HPV, with low cervical cancer screening coverage. SA cervical cancer screening policy excludes (undiagnosed) HIV-positive and HIV-negative women <30 years, both populations found to have high prevalence of HR-HPV. HPV-based primary screening from 25 years could improve outcomes.	[Hopkins, Kathryn L.; Jaffer, Maya; Hlongwane, Khuthadzo E.; Otwombe, Kennedy; Dietrich, Janan; Gray, Glenda E.] Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa; [Hopkins, Kathryn L.; Doherty, Tanya] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Dietrich, Janan; Doherty, Tanya] South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa; [Cheyip, Mireille; Olivier, Jacobus] Ctr Dis Control & Prevent, Pretoria, South Africa; [Gray, Glenda E.] South African Med Res Council, Off President, Cape Town, South Africa	University of Witwatersrand; University of Witwatersrand; South African Medical Research Council; South African Medical Research Council	Hopkins, KL (corresponding author), Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa.; Hopkins, KL (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.	HopkinsK@PHRU.co.za		Dietrich, Janan/0000-0002-1949-3138; Hopkins, Kathryn/0000-0003-2809-3686	President's Emergency Plan for AIDS Relief through the CDC [CoAg 1U2GGH001150]; South African Research Council; National Research Foundation	President's Emergency Plan for AIDS Relief through the CDC; South African Research Council; National Research Foundation	This project has been supported by the President's Emergency Plan for AIDS Relief through the CDC under the terms of CoAg 1U2GGH001150. TD and GEG are funded by the South African Research Council and the National Research Foundation. JO and MC were funder technical advisors of the study and provided review of the manuscript as per the cooperative agreement. All authors read and approved the final manuscript.	Adler DdBG., 2013, J CLIN MICROBIOLOGY, V46, P4109; Africa SS, 2015, MIDYEAR POPULATION E; [Anonymous], 2017, S AFR NAT STRAT PLAN; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Botha MH, 2017, SOUTH AFR J GYNAECOL, V9, P8, DOI [10.10520/EJC-9584c6bc7, DOI 10.10520/EJC-9584C6BC7]; Bruni L B-RL., 2016, ICO INFORM CTR HPV C; Council HSR., 2017, S AFRICAN NATL HIV P; De Vuyst H, 2013, VACCINE, V31, pF32, DOI 10.1016/j.vaccine.2012.07.092; Delany-Moretlwe S, 2018, GLOB HEALTH-SCI PRAC, V6, P425, DOI 10.9745/GHSP-D-18-00090; Firnhaber C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053494; Gilkey MB, 2015, PREV MED, V77, P181, DOI 10.1016/j.ypmed.2015.05.024; Hamid H, 2020, DRUGS THER PERSPECT, V36, P466, DOI 10.1007/s40267-020-00766-2; Health SANDo, 2017, PRET 2017; Jorgensen L, 2018, BMJ EVID-BASED MED, V23, P165, DOI 10.1136/bmjebm-2018-111012; Mapanga W, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0874-7; Mbulawa ZZA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190166; Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010; Organization WH, 2013, WHO GUID SCREEN TREA; Patel P, 2018, AIDS, V32, pS5, DOI 10.1097/QAD.0000000000001888; Perkins RB, 2020, J LOW GENIT TRACT DI, V24, P102, DOI 10.1097/LGT.0000000000000525; Richter K, 2013, SAMJ S AFR MED J, V103, P313, DOI 10.7196/SAMJ.6514; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Simelela NP, 2014, SAMJ S AFR MED J, V104, P249, DOI [10.7196/SAMJ.7700, 10.7196/samj.7700]; Simelela N, 2015, CURR HIV-AIDS REP, V12, P256, DOI 10.1007/s11904-015-0259-7; South African National Department of Health, 2015, NAT HIV TEST SERV PO; Tsang SH, 2020, JNCI-J NATL CANCER I, V112, DOI 10.1093/jnci/djaa010; UNAIDS, 2012, UNAIDS GLOB REP AIDS; UNAIDS, 2016, GET FAST TRACK LIFE; Vale DB, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251688; Williamson AL, 2002, IUBMB LIFE, V53, P253, DOI 10.1080/15216540212654; Xu L, 2018, J CLIN VIROL, V98, P37, DOI 10.1016/j.jcv.2017.12.001	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255124	10.1371/journal.pone.0255124	http://dx.doi.org/10.1371/journal.pone.0255124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329334	Green Published, gold			2022-12-26	WOS:000685248600020
J	Jiang, Y; Zhang, CD; Shen, WB; Li, YM; Wang, Y; Han, JJ; Liu, T; Jia, L; Gao, F; Liu, XJ; Chen, M; Yi, GM; Dai, HC; He, J				Jiang, Yue; Zhang, Chengda; Shen, Wenbin; Li, Yiming; Wang, Yun; Han, Jianjun; Liu, Tao; Jia, Li; Gao, Fei; Liu, Xiaojun; Chen, Mi; Yi, Guangming; Dai, Hongchun; He, Jun			Identification of serum prognostic marker miRNAs and construction of microRNA-mRNA networks of esophageal cancer	PLOS ONE			English	Article							EXPRESSION; MIGRATION; INVASION; PATIENT; GROWTH; CELLS; GEO	Esophageal cancer is a common tumor of the digestive system with poor prognosis. This study was to gain a better understanding of the mechanisms involved in esophageal cancer and to identify new prognostic markers. We downloaded the esophageal cancer miRNA expression profile microarray data (GSE113740, GSE112264, GSE122497, GSE113486, and GSE106817) from the GEO database, extracted the esophageal cancer miRNA sequencing data from The Cancer Genome Atlas (TCGA) database, and then used a bioinformatics approach to select common differentially expressed miRNAs (DEMs). Differentially expressed genes (DEGs) were selected by predicting DEM target genes using the miRWalk database and intersecting with differential genes obtained from TCGA database for esophageal cancer. The STRING database was used to obtain protein-protein interaction (PPI) relationships to construct the DEM-DEG network. Furthermore, we selected core genes and core miRNAs associated with esophageal cancer prognosis by performing survival and univariate/multivariate COX analysis on DEMs and DEGs in the network and performed GSEA analysis on core genes alone, and finally the expression of the markers was verified by qPCR in esophageal cancer cell lines Eca109, SKGT-4 and normal esophageal epithelial cells HEEC. Nine DEMs were obtained, of which three were upregulated and six were downregulated, and 326 DEGs were obtained, of which 105 were upregulated and 221 were downregulated. Survival univariate/multivariate COX analysis revealed that five genes, ZBTB16, AQP4, ADCYAP1R1, PDGFD, and VIPR2, and two microRNAs, miR-99a-5p, and miR-508-5p, were related to esophageal cancer prognosis. GSEA analysis showed that the following genes may be involved in esophageal cancer prognosis: ZBTB16 may through the MTOR signaling pathway, AQP4 through the GNRH signaling pathway, ADCYAP1R1 through the PPAR signaling pathway, VIPR2 through the P53 signaling pathway and PDGFD through the PENTOSE-PHOSPHATE signaling pathway.	[Jiang, Yue] Southwest Med Univ, Dept Clin Med, Luzhou, Peoples R China; [Zhang, Chengda; Li, Yiming] Third Hosp Mian Yang, Dept Gastroenterol, Sichuan Mental Hlth Ctr, Mianyang, Sichuan, Peoples R China; [Shen, Wenbin] Third Hosp Mianyang, Dept Oncol, Sichuan Mental Hlth Ctr, Mianyang, Sichuan, Peoples R China; [Wang, Yun; Han, Jianjun; Liu, Tao; Jia, Li; Gao, Fei; Liu, Xiaojun; Chen, Mi; Yi, Guangming; Dai, Hongchun; He, Jun] Chengdu Med Coll, Dept Oncol, Affiliated Hosp 1, Chengdu, Peoples R China; [He, Jun] Third Hosp Mianyang, Sichuan Mental Hlth Ctr, Mianyang, Sichuan, Peoples R China	Southwest Medical University; Chengdu Medical College	He, J (corresponding author), Chengdu Med Coll, Dept Oncol, Affiliated Hosp 1, Chengdu, Peoples R China.; He, J (corresponding author), Third Hosp Mianyang, Sichuan Mental Hlth Ctr, Mianyang, Sichuan, Peoples R China.	he-001jun@163.com			Health Commission of Mianyang City [201937]	Health Commission of Mianyang City	This study was supported by the Health Commission of Mianyang City (grant number 201937).	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Daly JM, 2000, J AM COLL SURGEONS, V190, P562, DOI 10.1016/S1072-7515(00)00238-6; Fischer S, 2008, J MED GENET, V45, P731, DOI 10.1136/jmg.2008.059451; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Fu T, 2020, CANCER BIOMARK, V27, P541, DOI 10.3233/CBM-192389; Grotenhuis BA, 2010, ANN SURG, V252, P823, DOI 10.1097/SLA.0b013e3181fcd730; Guo XC, 2015, ANALYST, V140, P2016, DOI 10.1039/c4an02402h; He J, 2020, CLIN EPIGENETICS, V12, DOI 10.1186/s13148-020-00867-9; Hu GZ, 2020, J COMPUT BIOL, V27, P81, DOI 10.1089/cmb.2019.0217; Hutter C, 2018, CELL, V173, P283, DOI 10.1016/j.cell.2018.03.042; Klima T, 2012, EUR HEART J, V33, P2071, DOI 10.1093/eurheartj/ehr501; Kolde R, 2012, BIOINFORMATICS, V28, P573, DOI 10.1093/bioinformatics/btr709; Kristensen LS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18355-2; Li YB, 2016, FOLIA BIOL-PRAGUE, V62, P131; Lu D, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01098; Madhavan Dharanija, 2013, Frontiers in Genetics, V4, P116, DOI 10.3389/fgene.2013.00116; Mao A-P., 2017, NAT COMMUN, V8, P1, DOI [10.1038/s41467-016-0009-6, DOI 10.1038/S41467-016-0009-6]; Matsumoto S, 2007, ANTICANCER RES, V27, P2409; Meng JC, 2017, ONCOL LETT, V14, P1152, DOI 10.3892/ol.2017.6248; Plaisier CL, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.21; Ramsingh G, 2010, BLOOD, V116, P5316, DOI 10.1182/blood-2010-05-285395; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ru YB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku631; Sandiford OA, 2018, ADV EXP MED BIOL, V1056, P137, DOI 10.1007/978-3-319-74470-4_9; Sarver AL, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5085-z; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheffield NC, 2017, NAT MED, V23, P386, DOI 10.1038/nm.4273; Shi ZZ, 2015, CANCER BIOMARK, V15, P755, DOI 10.3233/CBM-150517; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sudo K, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.4573; Sun C, 2019, J COMPUT BIOL, V26, P1130, DOI 10.1089/cmb.2019.0045; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tutar Y, 2014, CURR PHARM BIOTECHNO, V15, P429, DOI 10.2174/138920101505140828161335; Urabe F, 2019, CLIN CANCER RES, V25, P3016, DOI 10.1158/1078-0432.CCR-18-2849; Usuba W, 2019, CANCER SCI, V110, P408, DOI 10.1111/cas.13856; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Warth A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-161; Wu XH, 2021, TECHNOL CANCER RES T, V20, DOI 10.1177/1533033820985868; Yamamoto Y, 2020, HEPATOL COMMUN, V4, P284, DOI 10.1002/hep4.1451; Yang X, 2018, ONCOTARGETS THER, V11, P1457, DOI 10.2147/OTT.S152238; Yang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14421; Yokoi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06434-4; Yu CQ, 2018, ANN INTERN MED, V168, P489, DOI [10.7326/M17-2000, 10.7326/m17-2000]; Yu HX, 2019, CANCERS, V11, DOI 10.3390/cancers11030415; Zhai RH, 2010, J CLIN ONCOL, V28, P2445, DOI 10.1200/JCO.2009.26.2790; Zhang YF, 2018, J THORAC DIS, V10, P148, DOI 10.21037/jtd.2017.12.27	48	0	0	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255479	10.1371/journal.pone.0255479	http://dx.doi.org/10.1371/journal.pone.0255479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329340	gold, Green Published			2022-12-26	WOS:000685248600050
J	Al-Haddad, C; El Moussawi, Z; Hoyeck, S; Mehanna, CJ; El Salloukh, NA; Ismail, K; Hnaini, M; Boustany, RMN				Al-Haddad, Christiane; El Moussawi, Zeinab; Hoyeck, Stephanie; Mehanna, Carl-Joe; El Salloukh, Nasrine Anais; Ismail, Karine; Hnaini, Mona; Boustany, Rose-Mary N.			Amblyopia risk factors among pediatric patients in a hospital-based setting using photoscreening	PLOS ONE			English	Article							REFRACTIVE ERRORS; SCHOOL-CHILDREN; PREVALENCE; VISION; POPULATION; STRABISMUS; GUIDELINES; STUDENTS; INDIA; EYE	Purpose The aim of our study was to determine the prevalence of amblyopia risk factors in children visiting the American University of Beirut Medical Center (AUBMC) using automated vision screening. Methods This was a hospital-based screening of 1102 children aged between 2 and 6 years. Vision screening was performed using PlusoptiX S12 over 2 years (2018-2020). The need for referral to a pediatric ophthalmologist was based on the amblyopia risk factors set forth by the American Association for Pediatric Ophthalmology and Strabismus. Referred patients underwent a comprehensive eye examination. Results A total of 1102 children were screened, 63 were referred for amblyopia risk factors (5.7%); 37/63 (59%) underwent comprehensive eye examination and 73% were prescribed glasses. Of the non-referred group of children, 6.35% had astigmatism, 6.25% were hyperopic and 3.27% were myopic. The refractive errors observed among the examined patients were distributed as follows: 41% astigmatism, 51% hyperopia, and 8% myopia; amblyopia was not detected. Refractive amblyopia risk factors were associated with the presence of systemic disorders. Bland-Altman plots showed most of the differences to be within limits of agreement. Conclusion Using an automated vision screener in a hospital-based cohort of children aged 2 to 6 years, the rate of refractive amblyopia risk factors was 5.7%. Hyperopia was the most commonly encountered refractive error and children with systemic disorders were at higher risk.	[Al-Haddad, Christiane; El Moussawi, Zeinab; Hoyeck, Stephanie; Mehanna, Carl-Joe; El Salloukh, Nasrine Anais; Ismail, Karine] Amer Univ Beirut, Ophthalmol Dept, Beirut, Lebanon; [Hnaini, Mona; Boustany, Rose-Mary N.] AUBMC Special Kids Clin, Dept Pediat & Adolescent Med, Pediat Neurol Div, Beirut, Lebanon	American University of Beirut	Al-Haddad, C (corresponding author), Amer Univ Beirut, Ophthalmol Dept, Beirut, Lebanon.	ca12@aub.edu.lb		Mehanna, Carl-Joe/0000-0002-6758-7972	Medical Practice Plan (MPP) of the American University of Beirut	Medical Practice Plan (MPP) of the American University of Beirut	This study was funded by the Medical Practice Plan (MPP) of the American University of Beirut awarded to CA (https://www.aub.edu.lb/fm/medicalresearch/Pages/ResearchFunding.aspx).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afsari S, 2013, BRIT J OPHTHALMOL, V97, P1095, DOI 10.1136/bjophthalmol-2012-302637; Aldebasi YH, 2015, MIDDLE EAST AFR J OP, V22, P86, DOI 10.4103/0974-9233.148355; Alrahili NHR, 2017, SAUDI MED J, V38, P804, DOI 10.15537/smj.2017.8.20412; Arnold Robert W, 2013, Binocul Vis Strabolog Q Simms Romano, V28, P20; Azizoglu S, 2011, CLIN EXP OPTOM, V94, P67, DOI 10.1111/j.1444-0938.2010.00563.x; Barton M, 2011, PEDIATRICS, V127, P340, DOI 10.1542/peds.2010-3177; Betaineh HA., 2008, SUDANESE J PUBLIC HL, V3, P186; Chang Duane A, 2015, Hawaii J Med Public Health, V74, P292; Dahlmann-Noor AH, 2009, BRIT J OPHTHALMOL, V93, P342, DOI 10.1136/bjo.2008.138115; Dirani M, 2010, INVEST OPHTH VIS SCI, V51, P1348, DOI 10.1167/iovs.09-3587; Donahue SP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3596; Donahue SP, 2013, J AAPOS, V17, P4, DOI 10.1016/j.jaapos.2012.09.012; Donahue SP, 2003, J AAPOS, V7, P314, DOI 10.1016/S1091-8531(03)00182-4; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; Fu J, 2014, OPHTHAL EPIDEMIOL, V21, P197, DOI 10.3109/09286586.2014.904371; Galvis V, 2018, BRIT J OPHTHALMOL, V102, P1320, DOI 10.1136/bjophthalmol-2018-312149; Galvis V, 2017, ARQ BRAS OFTALMOL, V80, P359, DOI 10.5935/0004-2749.20170088; Ganekal S, 2013, OPHTHAL EPIDEMIOL, V20, P228, DOI 10.3109/09286586.2013.809772; Giordano L, 2009, OPHTHALMOLOGY, V116, P739, DOI 10.1016/j.ophtha.2008.12.030; Gronlund MA, 2006, ACTA OPHTHALMOL SCAN, V84, P169, DOI 10.1111/j.1600-0420.2005.00615.x; Huang D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02246-6; Kirk VG, 2008, ARCH OPHTHALMOL-CHIC, V126, P489, DOI 10.1001/archopht.126.4.489; Lan WZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078003; M K., 1996, CAHIER D TUDE RECHER, V6, P323; Moghaddam AAS, 2012, BRIT J OPHTHALMOL, V96, P83, DOI 10.1136/bjo.2010.190405; O'Donoghue L., 2009, INVESTIGATIVE OPHTHA, V50, P2562; Oscar A, 2014, J PEDIAT OPHTH STRAB, V51, P284, DOI 10.3928/01913913-20140618-01; Pai ASI, 2012, OPHTHALMOLOGY, V119, P138, DOI 10.1016/j.ophtha.2011.06.024; Polling Jan-Roelof, 2012, Optom Vis Sci, V89, pe44; Rajavi Zhale, 2015, J Ophthalmic Vis Res, V10, P408, DOI 10.4103/2008-322X.176909; Rim Tyler Hyungtaek, 2016, Korean J Ophthalmol, V30, P214, DOI 10.3341/kjo.2016.30.3.214; Salcido AA, 2005, J AAPOS, V9, P114, DOI 10.1016/j.jaapos.2003.10.011; Saw SM, 2002, OPHTHALMOLOGY, V109, P2065, DOI 10.1016/S0161-6420(02)01220-4; Schmidt P, 2004, OPHTHALMOLOGY, V111, P637, DOI 10.1016/j.ophtha.2004.01.022; Sharma IP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239117; Sheeladevi S, 2018, CLIN EXP OPTOM, V101, P495, DOI 10.1111/cxo.12689; Steele G, 2003, OPTOMETRY VISION SCI, V80, P573, DOI 10.1097/00006324-200308000-00010; Tidbury LP., 2015, BRIT IRISH ORTHOPTIC, V10, P11; Wallace DK, 2018, OPHTHALMOLOGY, V125, P1961, DOI 10.1016/j.ophtha.2018.05.001; Webber Ann L, 2005, Clin Exp Optom, V88, P365; Ying GS, 2014, OPHTHALMOLOGY, V121, P630, DOI 10.1016/j.ophtha.2013.09.036; Zhang XH, 2018, CLIN EXP OPHTHALMOL, V46, P994, DOI 10.1111/ceo.13330	42	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254831	10.1371/journal.pone.0254831	http://dx.doi.org/10.1371/journal.pone.0254831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324539	gold, Green Published			2022-12-26	WOS:000685248200027
J	Jung, DJ; Lee, HJ; Hong, JS; Kim, DG; Mun, JY; Bae, JW; Yoo, MH; Lee, KY				Jung, Da Jung; Lee, Hyun Ju; Hong, Ji Song; Kim, Dong Gyu; Mun, Jae Yeon; Bae, Jong-Won; Yoo, Myung Hoon; Lee, Kyu-Yup			Prediction of hearing outcomes in chronic otitis media patients underwent tympanoplasty using ossiculoplasty outcome parameter staging or middle ear risk indices	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; RECONSTRUCTION; DISEASE	Purpose Ossiculoplasty outcome parameter staging (OOPS) and middle ear risk index (MERI) are the most commonly used indices for predicting prognosis of patients with chronic otitis media (COM). This study aimed to verify the efficiency of OOPS and MERI scores in predicting outcomes of patients with COM who underwent tympanoplasty. Methods We retrospectively reviewed the data of patients who underwent tympanoplasty (n = 526). OOPS, and MERI scores were collected. Hearing data were measured 1 day preoperatively, and 3 and 12 months postoperatively. Operation success was defined according to the Korean Society of Otology guidelines. Results For calculation of success, the ROC values of MERI were 0.551 at 12 months. ROC values of OOPS were 0.637 at 12 months. There were no significant differences in hearing variables among the three groups according to MERI. There were significantly favorable outcomes in hearing variables in the low-risk group in OOPS. The mean OOPS score was greater in patients with success than those with non-success. Otorrhea, ossicle status, and status of mucosa as variables in both indices were associated with success. The type of mastoidectomy as a variable in OOPS alone was associated with success. Absence of hypertension, presence of ossiculoplasty, and use of incus as ossiculoplasty material were associated with poor success rate. Conclusion Compared with MERI, the OOPS index was more closely associated with the hearing outcomes, which may be due to the extent of inflammation in the OOPS index.	[Jung, Da Jung; Lee, Hyun Ju; Hong, Ji Song; Kim, Dong Gyu; Mun, Jae Yeon; Bae, Jong-Won; Yoo, Myung Hoon; Lee, Kyu-Yup] Kyungpook Natl Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Daegu, South Korea	Kyungpook National University	Lee, KY (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Daegu, South Korea.	kylee@knu.ac.kr			Biomedical Research Institute grant, Kyungpook National University Hospital	Biomedical Research Institute grant, Kyungpook National University Hospital	This work was supported by Biomedical Research Institute grant, Kyungpook National University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, Otolaryngol Head Neck Surg, V113, P186; Becvarovski Z, 2001, LARYNGOSCOPE, V111, P1806, DOI 10.1097/00005537-200110000-00026; BROWNING GG, 1992, CLIN OTOLARYNGOL, V17, P317, DOI 10.1111/j.1365-2273.1992.tb01004.x; Cox MD, 2017, OTOL NEUROTOL, V38, P510, DOI 10.1097/MAO.0000000000001339; Demir UL, 2012, OTOL NEUROTOL, V33, P580, DOI 10.1097/MAO.0b013e31824b774c; Dornhoffer JL, 2001, OTOL NEUROTOL, V22, P299, DOI 10.1097/00129492-200105000-00005; KARTUSH JM, 1994, OTOLARYNG CLIN N AM, V27, P689; Kotzias SA, 2020, BRAZ J OTORHINOLAR, V86, P49, DOI 10.1016/j.bjorl.2018.09.005; Kumar N, 2012, INDIAN J OTOLARYNGOL, V64, P13, DOI 10.1007/s12070-010-0115-4; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P176, DOI 10.1016/S0194-5998(95)70100-1; Onal K, 2005, CLIN OTOLARYNGOL, V30, P115, DOI 10.1111/j.1365-2273.2004.00947.x; Park M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125905; Pinar E, 2008, OTOLARYNG HEAD NECK, V139, P386, DOI 10.1016/j.otohns.2008.05.623; Shishegar M, 2019, EUR ARCH OTO-RHINO-L, V276, P2769, DOI 10.1007/s00405-019-05539-w; Sousa AC, 2017, ACTA OTORRINOLAR ESP, V68, P131, DOI 10.1016/j.otorri.2016.06.006	15	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0252812	10.1371/journal.pone.0252812	http://dx.doi.org/10.1371/journal.pone.0252812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324485	gold, Green Published			2022-12-26	WOS:000685248200001
J	Lannon, E; Sanchez-Saez, F; Bailey, B; Hellman, N; Kinney, K; Williams, A; Nag, S; Kutcher, ME; Goodin, BR; Rao, U; Morris, MC				Lannon, Edward; Sanchez-Saez, Francisco; Bailey, Brooklynn; Hellman, Natalie; Kinney, Kerry; Williams, Amber; Nag, Subodh; Kutcher, Matthew E.; Goodin, Burel R.; Rao, Uma; Morris, Matthew C.			Predicting pain among female survivors of recent interpersonal violence: A proof-of-concept machine-learning approach	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; PHYSICAL HEALTH CONSEQUENCES; PSYCHOMETRIC PROPERTIES; EXECUTIVE FUNCTION; PERSISTENT PAIN; RISK-FACTORS; STRESS; WOMEN; ABUSE; PTSD	Interpersonal violence (IPV) is highly prevalent in the United States and is a major public health problem. The emergence and/or worsening of chronic pain are known sequelae of IPV; however, not all those who experience IPV develop chronic pain. To mitigate its development, it is critical to identify the factors that are associated with increased risk of pain after IPV. This proof-of-concept study used machine-learning strategies to predict pain severity and interference in 47 young women, ages 18 to 30, who experienced an incident of IPV (i.e., physical and/or sexual assault) within three months of their baseline assessment. Young women are more likely than men to experience IPV and to subsequently develop posttraumatic stress disorder (PTSD) and chronic pain. Women completed a comprehensive assessment of theory-driven cognitive and neurobiological predictors of pain severity and pain-related interference (e.g., pain, coping, disability, psychiatric diagnosis/symptoms, PTSD/trauma, executive function, neuroendocrine, and physiological stress response). Gradient boosting machine models were used to predict symptoms of pain severity and pain-related interference across time (Baseline, 1-,3-,6- follow-up assessments). Models showed excellent predictive performance for pain severity and adequate predictive performance for pain-related interference. This proof-of-concept study suggests that machine-learning approaches are a useful tool for identifying predictors of pain development in survivors of recent IPV. Baseline measures of pain, family life impairment, neuropsychological function, and trauma history were of greatest importance in predicting pain and pain-related interference across a 6-month follow-up period. Present findings support the use of machine-learning techniques in larger studies of post-IPV pain development and highlight theory-driven predictors that could inform the development of targeted early intervention programs. However, these results should be replicated in a larger dataset with lower levels of missing data.	[Lannon, Edward; Kinney, Kerry; Morris, Matthew C.] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA; [Lannon, Edward; Hellman, Natalie] Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA; [Lannon, Edward] Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA; [Sanchez-Saez, Francisco] Univ Int La Rioja, Sch Engn & Technol, Logrono, Spain; [Bailey, Brooklynn] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Kinney, Kerry] Univ Illinois, Coll Med, Dept Psychiat, Chicago, IL USA; [Nag, Subodh] Meharry Med Ctr, Dept Neurosci & Pharmacol, Nashville, TN USA; [Kutcher, Matthew E.] Univ Mississippi, Med Ctr, Dept Surg, Jackson, MS 39216 USA; [Goodin, Burel R.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Rao, Uma] Univ Calif Irvine, Dept Psychiat & Human Behav, Dept Pediat, Irvine, CA 92717 USA; [Rao, Uma] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92717 USA; [Rao, Uma] Childrens Hosp Orange Cty, Orange, CA 92668 USA	University of Mississippi; University of Mississippi Medical Center; University of Tulsa; Stanford University; Universidad Internacional de La Rioja (UNIR); University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Meharry Medical College; University of Mississippi; University of Mississippi Medical Center; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Irvine; University of California System; University of California Irvine; Childrens Hospital of Orange County	Lannon, E (corresponding author), Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA.; Lannon, E (corresponding author), Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA.; Lannon, E (corresponding author), Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA.	elannon@stanford.edu	Sanchez-Saez, Francisco/AAF-8781-2019	Sanchez-Saez, Francisco/0000-0002-3011-9884; Hellman, Natalie/0000-0003-4811-2346; Kinney, Kerry/0000-0003-4966-8362	National Institutes of Health [K01 MH101403, U54 MD007593, U54MD007586, R01MH108155, R01MD010757, R01DA040966]; National Institute On Drug Abuse [T32DA035165]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute On Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in part, by grants from the National Institutes of Health (K01 MH101403, U54 MD007593, U54MD007586, R01MH108155, R01MD010757 and R01DA040966) and by the National Institute On Drug Abuse (T32DA035165). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Birmes P, 2005, EUR PSYCHIAT, V20, P145, DOI 10.1016/j.eurpsy.2004.06.033; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Blyth FM, 2007, PAIN, V129, P8, DOI 10.1016/j.pain.2007.03.009; Buhle J, 2010, PAIN, V149, P19, DOI 10.1016/j.pain.2009.10.027; Buskila D, 2007, BEST PRACT RES CL RH, V21, P535, DOI 10.1016/j.berh.2007.02.011; Campbell J, 2002, ARCH INTERN MED, V162, P1157, DOI 10.1001/archinte.162.10.1157; Campbell LK, 2009, J PEDIATR PSYCHOL, V34, P317, DOI 10.1093/jpepsy/jsn080; Casey CY, 2008, PAIN, V134, P69, DOI 10.1016/j.pain.2007.03.032; Chen T., 2015, XGBOOST EXTREME GRAD, V1, P1; Coker AL, 2000, ARCH FAM MED, V9, P451, DOI 10.1001/archfami.9.5.451; Compas B. E., 2000, J CONSULT CLIN PSYCH, V68, P976, DOI 10.1037/0022-006X.68.6.976; COMPAS BE, 1987, J CONSULT CLIN PSYCH, V55, P534, DOI 10.1037/0022-006X.55.4.534; Davis DA, 2005, CLIN J PAIN, V21, P398, DOI 10.1097/01.ajp.0000149795.08746.31; Delis DC, 2001, DELIS KAPLAN EXECUTI; Denk F, 2014, NAT NEUROSCI, V17, P192, DOI 10.1038/nn.3628; Dillon Gina, 2013, Int J Family Med, V2013, P313909, DOI 10.1155/2013/313909; Doove LL, 2014, COMPUT STAT DATA AN, V72, P92, DOI 10.1016/j.csda.2013.10.025; Dozois DJA, 1998, PSYCHOL ASSESSMENT, V10, P83, DOI 10.1037/1040-3590.10.2.83; DWORKIN S F, 1992, Annals of Behavioral Medicine, V14, P3; First MB., 2005, STRUCTURED CLIN INTE; Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303; Fumagalli L, 2013, J R STAT SOC A STAT, V176, P499, DOI 10.1111/j.1467-985X.2012.01051.x; Galatzer-Levy Isaac R, 2018, Chronic Stress (Thousand Oaks), V2, DOI 10.1177/2470547017747553; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Grol-Prokopczyk H, 2017, PAIN, V158, P313, DOI 10.1097/j.pain.0000000000000762; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Heaton RK., 1993, WISCONSIN CARD SORTI, V4, P1; Hocking MC, 2011, J PEDIATR PSYCHOL, V36, P64, DOI 10.1093/jpepsy/jsq056; Humphreys J, 2011, VIOLENCE AGAINST WOM, V17, P1327, DOI 10.1177/1077801211425216; International Diabetes Federation, 2019, IDF DIABETES ATLAS, VNinth; Johnson SU, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01713; Kendall-Tackett K, 2003, WOMEN THER, V26, P45, DOI 10.1300/J015v26n01_03; Kilpatrick DG, 2003, J CONSULT CLIN PSYCH, V71, P692, DOI 10.1037/0022-006X.71.4.692; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Koenen KC, 2017, PSYCHOL MED, V47, P2260, DOI 10.1017/S0033291717000708; Kringel D, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0772-4; Kringel D, 2019, PAIN, V160, P2263, DOI 10.1097/j.pain.0000000000001616; Lotsch J, 2017, BRIT J ANAESTH, V119, P821, DOI 10.1093/bja/aex236; Lotsch J, 2020, PAIN, V161, P114, DOI 10.1097/j.pain.0000000000001693; Lotsch J, 2018, BREAST CANCER RES TR, V171, P399, DOI 10.1007/s10549-018-4841-8; Lotsch J, 2018, PAIN, V159, P623, DOI 10.1097/j.pain.0000000000001118; Ludwig NN, 2018, J PEDIATR PSYCHOL, V43, P1160, DOI 10.1093/jpepsy/jsy057; Marmar CR., 2004, PERITRAUMATIC DISSOC; Martins I, 2010, PAIN, V151, P137, DOI 10.1016/j.pain.2010.06.027; McLean SA, 2012, J PAIN, V13, P736, DOI 10.1016/j.jpain.2012.04.008; Mehta SP, 2015, J ORTHOP SPORT PHYS, V45, P119, DOI 10.2519/jospt.2015.5129; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Moore DJ, 2013, PAIN, V154, P82, DOI 10.1016/j.pain.2012.09.009; Moore DJ, 2012, Q J EXP PSYCHOL, V65, P565, DOI 10.1080/17470218.2011.626865; Morris MC, 2022, J INTERPERS VIOLENCE, V37, pNP11460, DOI 10.1177/0886260520978195; Morris MC, 2017, STRESS, V20, P350, DOI 10.1080/10253890.2017.1340450; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Pacella ML, 2018, ACAD EMERG MED, V25, P844, DOI 10.1111/acem.13406; Pena-Bautista C, 2019, J PROTEOMICS, V200, P144, DOI 10.1016/j.jprot.2019.04.008; Pfister R, 2013, TUTOR QUANT METHODS, V9, P72, DOI 10.20982/tqmp.09.2.p072; Plichta SB, 2004, J INTERPERS VIOLENCE, V19, P1296, DOI 10.1177/0886260504269685; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Romans S, 2008, HARVARD REV PSYCHIAT, V16, P35, DOI 10.1080/10673220801933788; Rosenbloom BN, 2013, J PAIN RES, V6, P39, DOI 10.2147/JPR.S38878; Rush AJ., 2009, HDB PSYCHIAT MEASURE; Sheehan D. V., 1983, HDB PSYCHIAT MEAS, V2, P100; Sieben JM, 2005, PAIN, V117, P162, DOI 10.1016/j.pain.2005.06.002; Sipila R, 2012, BRIT J CANCER, V107, P1459, DOI 10.1038/bjc.2012.445; Sng BL, 2009, ANAESTH INTENS CARE, V37, P748, DOI 10.1177/0310057X0903700513; Sorenson SB, 1996, EVALUATION REV, V20, P123, DOI 10.1177/0193841X9602000201; Spielberger C., 1983, STAI MANUAL; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Strand LI, 2008, EUR J PAIN, V12, P917, DOI 10.1016/j.ejpain.2007.12.013; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; van Buuren S, 2011, J STAT SOFTW, V45, P1; VANDERHEIDE A, 1995, J RHEUMATOL, V22, P1466; West CM, 2004, J INTERPERS VIOLENCE, V19, P1487, DOI 10.1177/0886260504269700; Wilcox RR, 2003, PSYCHOL METHODS, V8, P254, DOI 10.1037/1082-989X.8.3.254; Williams RA, 1998, ARCH PHYS MED REHAB, V79, P366, DOI 10.1016/S0003-9993(98)90135-6; Works T, 2016, HEALTH SOC WORK, V41, P42, DOI 10.1093/hsw/hlv085; Wuest J, 2008, J PAIN, V9, P1049, DOI 10.1016/j.jpain.2008.06.009	84	0	0	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255277	10.1371/journal.pone.0255277	http://dx.doi.org/10.1371/journal.pone.0255277			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324550	gold, Green Published			2022-12-26	WOS:000685248200074
J	Martinez, D; Parilli, C; Rojas, AM; Scartascini, C; Simpser, A				Martinez, Deborah; Parilli, Cristina; Rojas, Ana Maria; Scartascini, Carlos; Simpser, Alberto			Do you have COVID-19? How to increase the use of diagnostic and contact tracing apps	PLOS ONE			English	Article							AVAILABILITY; PRIVACY	Diagnostic and contact tracing apps are a needed weapon to contain contagion during a pandemic. We study how the content of the messages used to promote the apps influence adoption by running a survey experiment on approximately 23,000 Mexican adults. Respondents were randomly assigned to one of three different prompts, or a control condition, before stating their willingness to adopt a diagnostic app and contact tracing app. The prompt emphasizing government efforts to ensure data privacy, which has been one of the most common strategies, reduced willingness to adopt the apps by about 4 pp and 3 pp, respectively. An effective app promotion policy must understand individuals' reservations and be wary of unintended reactions to naive reassurances.	[Martinez, Deborah; Rojas, Ana Maria; Scartascini, Carlos] Res Dept, Inter Amer Dev Bank, Washington, DC USA; [Parilli, Cristina] Inter Amer Dev Bank, Dev Effectiveness Dept, Washington, DC USA; [Simpser, Alberto] ITAM, Dept Polit Sci, Mexico City, DF, Mexico	Inter-American Development Bank; Inter-American Development Bank; Instituto Tecnologico Autonomo de Mexico	Scartascini, C (corresponding author), Res Dept, Inter Amer Dev Bank, Washington, DC USA.	carlossc@iadb.org	Scartascini, Carlos/ABE-4489-2021	Scartascini, Carlos/0000-0001-7031-3983				Aleta A, 2020, NAT HUM BEHAV, V4, P964, DOI 10.1038/s41562-020-0931-9; Amann J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246524; Australian Government Department of Health, 2020, COV APP APP; Balafoutas L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06896-6; Barber G, 2020, WIRED; Blasimme A, 2020, SCIENCE, V370, P760, DOI 10.1126/science.abd9006; Boruchowicz C., 2020, DEFAULT OPTIONS POWE; CARROLL JS, 1978, J EXP SOC PSYCHOL, V14, P88, DOI 10.1016/0022-1031(78)90062-8; Chiu WA, 2020, NAT HUM BEHAV, V4, P1080, DOI 10.1038/s41562-020-00969-7; Choe S., 2020, NEW YORK TIMES; Chong I, 2018, COMPUT SECUR, V78, P143, DOI 10.1016/j.cose.2018.06.005; Cohn A, 2016, CURR OPIN PSYCHOL, V12, P17, DOI 10.1016/j.copsyc.2016.04.019; Coppedge M, 2020, V DEM COUNTRY YEAR C; de la Garza A., 2020, TIME MAGAZINE 1110; Eje Central, 2020, AS PUED TRAM TU LIC; Facebook, 2019, FACEBOOK INVESTOR RE; Farronato Chiara, 2020, HARVARD BUS REV; Garrett PM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244827; Gingerich DW, 2018, IDB WORKING PAPER SE, P927; Gobierno de Mexico, 2020, QUE GOB MX; Hautala Laura, 2020, COVID 19 CONTACT TRA; Hay-Newman L, 2021, WIRED; Ho V., 2018, GUARDIAN 1215; Jennings B, 2007, ETHICS PREVENTION PU, P30; Johnson B., 2020, TECH REV; Kahneman D., 2011, THINKING FAST SLOW; Kahneman D., 2011, THINKING FAST SLOW; Kahneman Daniel, 2012, PROPOSAL DEAL QUESTI; Kelion L, 2020, BBC NEWS 0416; Klonowska K., 2020, COVID 19 PANDEMIC 2; Klosowski T, 2020, NEW YORK TIMES; Latinobarometer, LAB SURV 2021; Martinez D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247454; Martinez-Martin N, 2020, HASTINGS CENT REP, V50, P43, DOI 10.1002/hast.1131; Maryland Department of Health, 2020, MD COV AL APP; McClain C, 2020, PEW RES CTR; Mello MM, 2020, SCIENCE, V368, P951, DOI 10.1126/science.abb9045; Mosseri A., 2018, NEWS FEED FYI BRINGI; Newcomb A., 2018, NBC NEWS; OECD, 2020, TRACK TRACL COV PROT; Parker MJ, 2020, J MED ETHICS, V46, P427, DOI 10.1136/medethics-2020-106314; Payne BK, 2016, J EXP PSYCHOL GEN, V145, P1269, DOI 10.1037/xge0000201; Rajivan P, 2016, INFLUENCE PRIVACY AT; Reuters, 2020, REUTERS 1025; Saw YE, 2021, J MED INTERNET RES, V23, DOI 10.2196/24730; Timberg C., 2020, WASH POST; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; UK National Health Service, 2020, NHS COV 19 APP; Virginia Department of Health, 2020, COV PRIV POL INT; Wikipedia, 2020, COVID 19 APPS; Zhang BB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242652; Zimmermann BM, 2021, J MED INTERNET RES, V23, DOI 10.2196/25525	52	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0253490	10.1371/journal.pone.0253490	http://dx.doi.org/10.1371/journal.pone.0253490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324504	Green Published, gold			2022-12-26	WOS:000685248200080
J	Vasquez, AA; Mohiddin, O; Li, ZY; Bonnici, BL; Gurdziel, K; Ram, JL				Vasquez, Adrian A.; Mohiddin, Obadeh; Li, Zeyu; Bonnici, Brittany L.; Gurdziel, Katherine; Ram, Jeffrey L.			Molecular diet studies of water mites reveal prey biodiversity	PLOS ONE			English	Article							ACARI; HYDRACHNIDIA; BARCODES; DNA; HYDRACHNELLAE; BIOINDICATORS; PARASITENGONA; ASSEMBLAGES; POPULATION	Water mites are diverse aquatic invertebrates that provide potentially important ecosystem and economic services as bioindicators and mosquito biocontrol; however, little is known about water mite digestive physiology, including their diet in nature. Water mites, much like their spider relatives, liquefy their prey upon consumption. This results in the absence of morphologically identifiable prey in water mite mid-gut. Previous studies have reported associations in the field of water mites with presumed prey and laboratory observations of water mites feeding on specific organisms offered for ingestion; however, the present work aims to determine what water mites have ingested in nature based on molecular studies of gut contents from freshly collected organisms from the field. To elucidate water mite prey, we used next-generation sequencing to detect diverse cytochrome oxidase I DNA barcode sequences of putative prey in the guts of 54 specimens comprising two species of Lebertia and a few specimens of Arrenurus (2) and Limnesia (1). To our knowledge this is the first molecular study of the diets of water mites as they feed in nature. While the presence of chironomid DNA confirmed previous observations of midge larvae as part of the diets of Lebertia, we also found the DNA of diverse organisms in all four species of water mites, including the DNA of mosquitoes in 6 specimens of Lebertia and a large number of previously unknown prey, especially from oligochaete worms. These studies thereby reveal a greater diversity of prey and a potentially broader significance than previously appreciated for water mites in aquatic food webs. Molecular studies like this can detect water mite predators of mosquito larvae and add knowledge of water mite predatory contributions to freshwater food webs.	[Vasquez, Adrian A.; Bonnici, Brittany L.] Wayne State Univ, Dept Civil & Environm Engn, Hlth Urban Waters, Detroit, MI 48202 USA; [Vasquez, Adrian A.] Univ Michigan, Cooperat Inst Great Lakes Res, Sch Environm & Sustainabil, Ann Arbor, MI 48109 USA; [Mohiddin, Obadeh; Li, Zeyu; Bonnici, Brittany L.; Ram, Jeffrey L.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Gurdziel, Katherine] Wayne State Univ, Genome Sci Core, Detroit, MI USA	Wayne State University; University of Michigan System; University of Michigan; Wayne State University; Wayne State University	Vasquez, AA (corresponding author), Wayne State Univ, Dept Civil & Environm Engn, Hlth Urban Waters, Detroit, MI 48202 USA.; Vasquez, AA (corresponding author), Univ Michigan, Cooperat Inst Great Lakes Res, Sch Environm & Sustainabil, Ann Arbor, MI 48109 USA.	avasquez@wayne.edu	Li, Zeyu/GXM-4336-2022		National Institute of General Medical Sciences [NIGMS-R25GM-058905, RL5GM118981, TL4GM118983, 1UL1GM118982]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of General Medical Sciences NIGMS-R25GM-058905 Dr. Adrian Amelio Vasquez National Institutes of Health RL5GM118981, TL4GM118983, and 1UL1GM118982 Dr. Adrian Amelio Vasquez Sharon L. Ram Aquatic Sciences Fund, administered by the Community Foundation of Southeast Michigan Dr. Adrian Amelio Vasquez This work was also supported by a donation from Dr. David R. Cook to Wayne State University. Dr. Adrian Amelio Vasquez The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christoffersen Martin Lindsey, 2010, Acta Zoologica Mexicana Nueva Serie, V26, P35; Di Sabatino A, 2008, HYDROBIOLOGIA, V595, P303, DOI 10.1007/s10750-007-9025-1; Erseus C, 2017, MOL PHYLOGENET EVOL, V115, P115, DOI 10.1016/j.ympev.2017.07.016; Failla AJ, 2016, B ENTOMOL RES, V106, P34, DOI 10.1017/S0007485315000486; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gerecke R, 2002, ACARID PHYLOGENY AND EVOLUTION: ADAPTATION IN MITES AND TICKS, P69; Gerecke Reinhard, 2009, Abhandlungen der Senckenberg Gesellschaft fur Naturforschung, V566, P1; Goldschmidt Tom, 2016, Neotropical Biodiversity, V2, P12, DOI 10.1080/23766808.2016.1144359; Goldschmidt T, 2016, LIMNOLOGICA, V59, P63, DOI 10.1016/j.limno.2016.03.007; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hamback PA, 2016, ECOL EVOL, V6, P8431, DOI 10.1002/ece3.2536; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; HIRSCH RM, 1984, WATER RESOUR RES, V20, P727, DOI 10.1029/WR020i006p00727; Kotov AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168711; Lefort M-C., 2020, MOL APPROACH STUDY H, V63, DOI [10.3897/neobiota.63.58640%25JNeoBiota, DOI 10.3897/NEOBIOTA.63.58640%25JNEOBIOTA]; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; MARSHALL J. F., 1938; Martin P, 2015, EXP APPL ACAROL, V67, P373, DOI 10.1007/s10493-015-9956-6; MATVEEV VF, 1990, HYDROBIOLOGIA, V198, P227, DOI 10.1007/BF00048637; Mwango John, 1995, Entomologist, V114, P107; Olmos-Perez L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00321; Perner J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36695; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Pozojevic I., 2018, ACTA BIOLOGICA, V25, P69, DOI [10.18276/ab.2018.25%26%23x2013%3B06, DOI 10.18276/AB.2018.25-06]; Pozojevic I, 2019, EXP APPL ACAROL, V77, P487, DOI 10.1007/s10493-019-00362-8; PROCTOR H, 1989, J N AM BENTHOL SOC, V8, P100, DOI 10.2307/1467406; Proctor HC, 2009, EXP APPL ACAROL, V49, P161, DOI 10.1007/s10493-009-9273-z; Rougerie R, 2011, MOL ECOL, V20, P179, DOI 10.1111/j.1365-294X.2010.04918.x; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Sanchez MI, 2015, J INSECT CONSERV, V19, P433, DOI 10.1007/s10841-015-9764-7; SCHMIDT HW, 1967, OIKOS, V18, P357, DOI 10.2307/3565112; Smith BP, 2002, EXP APPL ACAROL, V27, P257, DOI 10.1023/A:1023328428716; Smith IM, 2010, AQUAT ECOL-SAN DIEGO, P485, DOI 10.1016/B978-0-12-374855-3.00015-7; SMITH IM, 1986, CAN ENTOMOL, V118, P407, DOI 10.4039/Ent118407-5; Strayer DL, 2006, J N AM BENTHOL SOC, V25, P271, DOI 10.1899/0887-3593(2006)25[271:CFFIC]2.0.CO;2; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TENWINKEL EH, 1989, NETH J ZOOL, V39, P246; Trebitz AS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12162; Trekels H, 2019, ECOL LETT, V22, P89, DOI 10.1111/ele.13170; Varney RL, 2010, CURR BIOL, V20, pR466, DOI 10.1016/j.cub.2010.03.043; Vasquez AA, 2017, THESIS WAYNE STATE U; Vasquez AAK B.A., 2020, DIVERSITY, V12, P6; Vasquez AA, 2020, EXP APPL ACAROL, V80, P491, DOI 10.1007/s10493-020-00476-4; Vasquez AA, 2017, INT J ACAROL, V43, P494, DOI 10.1080/01647954.2017.1349178; Walter David Evans, MITES ECOLOGY EVOLUT; Wiecek M, 2013, EXP APPL ACAROL, V61, P147, DOI 10.1007/s10493-013-9692-8; YUEN KK, 1974, BIOMETRIKA, V61, P165, DOI 10.2307/2334299	49	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254598	10.1371/journal.pone.0254598	http://dx.doi.org/10.1371/journal.pone.0254598			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324525	gold, Green Published			2022-12-26	WOS:000685248200071
J	Janssen, TWP; Nieuwenhuis, S; Hoefakker, J; Gligoor, PDD; Bonte, M; van Atteveldt, N				Janssen, Tieme W. P.; Nieuwenhuis, Smiddy; Hoefakker, Jamie; Dreier Gligoor, Patricia D.; Bonte, Milene; van Atteveldt, Nienke			Neural correlates of error-monitoring and mindset: Back to the drawing board?	PLOS ONE			English	Article							ATTENTION; AWARENESS; POTENTIALS; MOTIVATION; COMPONENTS; CHILDREN; P3	The different ways students deal with mistakes is an integral part of mindset theory. While previous error-monitoring studies found supporting neural evidence for mindset-related differences, they may have been confounded by overlapping stimulus processing. We therefore investigated the relationship between mindset and event-related potentials (ERPs) of error-monitoring (response-locked Ne, Pe), with and without overlap correction. In addition, besides behavioral measures of remedial action after errors (post-error slowing and accuracy), we investigated their neural correlates (stimulus-locked N2). Results indicated comparable Ne, but larger Pe amplitudes in fixed-minded students; however, after overlap correction, the Pe results were rendered non-significant. A likely explanation for this overlap was a near-significant effect of mindset on the preceding stimulus P3. Finally, although N2 was larger for trials following errors, mindset was unrelated. The current study shows that the relationship between error-monitoring and mindset is more complex and should be reconsidered. Future studies are advised to explore stimulus processing as well, and if needed, to correct for stimulus overlap. In addition, contextual influences on and individual variation in error-monitoring need more scrutiny, which may contribute to refining mindset theory.	[Janssen, Tieme W. P.; Nieuwenhuis, Smiddy; Hoefakker, Jamie; Dreier Gligoor, Patricia D.; van Atteveldt, Nienke] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Clin Neuro & Dev Psychol, Amsterdam, Netherlands; [Bonte, Milene] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands	Vrije Universiteit Amsterdam; Maastricht University	Janssen, TWP (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Clin Neuro & Dev Psychol, Amsterdam, Netherlands.	twp.janssen@vu.nl	van Atteveldt, Nienke/K-2124-2014; Janssen, Tieme/I-3840-2016	van Atteveldt, Nienke/0000-0002-3387-6151; Hoefakker, Gerrit Jamie/0000-0002-7377-8054; Janssen, Tieme/0000-0001-8375-8762; Bonte, Milene/0000-0002-0203-8913	European Research Council Starting Grant [716736]	European Research Council Starting Grant(European Research Council (ERC))	NvA received an European Research Council Starting Grant (grant number: 716736).	Burgoyne AP, 2020, PSYCHOL SCI, V31, P258, DOI 10.1177/0956797619897588; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099909; De Castella K, 2015, EUR J PSYCHOL EDUC, V30, P245, DOI 10.1007/s10212-015-0244-y; DWECK CS, 1988, PSYCHOL REV, V95, P256, DOI 10.1037/0033-295X.95.2.256; Engle-Friedman M, 2003, J SLEEP RES, V12, P113, DOI 10.1046/j.1365-2869.2003.00351.x; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Gehring WJ, 2018, PERSPECT PSYCHOL SCI, V13, P200, DOI 10.1177/1745691617715310; Gentsch A, 2009, NEUROIMAGE, V47, P2023, DOI 10.1016/j.neuroimage.2009.05.064; Herrmann MJ, 2004, COGNITIVE BRAIN RES, V20, P294, DOI 10.1016/j.cogbrainres.2004.02.013; Ide JS, 2011, NEUROIMAGE, V54, P455, DOI 10.1016/j.neuroimage.2010.07.042; Janssen TWP, 2020, CLIN NEUROPHYSIOL, V131, P2236, DOI 10.1016/j.clinph.2020.06.022; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Lee W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107254; Li CSR, 2008, J COGNITIVE NEUROSCI, V20, P1021, DOI 10.1162/jocn.2008.20071; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Mangels JA, 2006, SOC COGN AFFECT NEUR, V1, P75, DOI 10.1093/scan/nsl013; Miller DI, 2019, TRENDS COGN SCI, V23, P910, DOI 10.1016/j.tics.2019.08.005; Moser JS, 2011, PSYCHOL SCI, V22, P1484, DOI 10.1177/0956797611419520; Myers CA, 2016, SOC COGN AFFECT NEUR, V11, P1521, DOI 10.1093/scan/nsw065; Ng B, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8020020; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; Orr C, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00177; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Richter M, 2016, ADV MOTIV SCI, V3, P149, DOI 10.1016/bs.adms.2016.02.001; Ridderinkhof KR, 2009, PSYCHOPHYSIOLOGY, V46, P531, DOI 10.1111/j.1469-8986.2009.00790.x; Schroder HS, 2017, DEV COGN NEUROS-NETH, V24, P42, DOI 10.1016/j.dcn.2017.01.004; Schroder HS, 2014, BIOL PSYCHOL, V103, P27, DOI 10.1016/j.biopsycho.2014.08.004; Shalgi S, 2009, EUR J NEUROSCI, V29, P1522, DOI 10.1111/j.1460-9568.2009.06690.x; Sisk VF, 2018, PSYCHOL SCI, V29, P549, DOI 10.1177/0956797617739704; Ullsperger M, 2014, PHYSIOL REV, V94, P35, DOI 10.1152/physrev.00041.2012; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; VASEY MW, 1987, PSYCHOPHYSIOLOGY, V24, P479, DOI 10.1111/j.1469-8986.1987.tb00324.x; Vocat R, 2008, NEUROPSYCHOLOGIA, V46, P2545, DOI 10.1016/j.neuropsychologia.2008.04.006; Waller DA, 2021, INT J PSYCHOPHYSIOL, V163, P11, DOI 10.1016/j.ijpsycho.2019.01.004; Wessel JR, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13041; Wessel JR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00088; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x; Yu JL, 2020, CONTEMP EDUC PSYCHOL, V62, DOI 10.1016/j.cedpsych.2020.101901	44	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254322	10.1371/journal.pone.0254322	http://dx.doi.org/10.1371/journal.pone.0254322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CM	34320015	Green Submitted, Green Published, gold			2022-12-26	WOS:000685247800006
J	Ragan, D; Kustan, P; Horvath-Szalai, Z; Szirmay, B; Bugyi, B; Ludany, A; Miseta, A; Nagy, B; Muhl, D				Ragan, Daniel; Kustan, Peter; Horvath-Szalai, Zoltan; Szirmay, Balazs; Bugyi, Beata; Ludany, Andrea; Miseta, Attila; Nagy, Balint; Muhl, Diana			Urinary actin, as a potential marker of sepsis-related acute kidney injury: A pilot study	PLOS ONE			English	Article							SEPTIC SHOCK; EXTRACELLULAR ACTIN; SCAVENGER SYSTEM; GC-GLOBULIN; BIOMARKERS; NORMALIZATION; CREATININE; GELSOLIN; FAILURE; TRENDS	Introduction A major complication of sepsis is the development of acute kidney injury (AKI). Recently, it was shown that intracellular actin released from damaged tissues appears in the urine of patients with multiple organ dysfunction syndrome. Our aims were to measure urinary actin (u-actin) concentrations of septic and control patients and to test if u-actin levels could predict AKI and mortality. Methods Blood and urine samples were collected from septic and sepsis-related AKI patients at three time points (T1-3): T1: within 24 hours after admission; T2: second day morning; T3: third day morning of follow-up. Patients with malignancies needing palliative care, end-stage renal disease or kidney transplantation were excluded. Serum and u-actin levels were determined by quantitative Western blot. Patients were categorized by the Sepsis-3 and KDIGO AKI classifications. Results In our study, 17 septic, 43 sepsis-induced AKI and 24 control patients were enrolled. U-actin levels were higher in septic patients compared with controls during follow-up (p<0.001). At T1, the septic and sepsis-related AKI groups also showed differences (p<0.001), yet this increase was not statistically significant at T2 and T3. We also detected significantly elevated u-actin concentrations in AKI-2 and AKI-3 septic patients compared with AKI-1 septic patients (p<0.05) at T1 and T3, along with a significant increase in AKI-2 septic patients compared with AKI-1 septic patients at T2 (p<0.01). This tendency remained the same when referring u-actin to urine creatinine. Parameters of first-day septic patient samples could discriminate AKI from non-AKI state (AUC ROC, p<0.001): u-actin: 0.876; se-creatinine: 0.875. Derived cut-off value for u-actin was 2.63 mu g/L (sensitivity: 86.0%, specificity: 82.4%). Conclusion U-actin may be a complementary diagnostic biomarker to se-creatinine in sepsis-related AKI while higher u-actin levels also seem to reflect the severity of AKI. Further investigations may elucidate the importance of u-actin release in sepsis-related AKI.	[Ragan, Daniel; Kustan, Peter; Horvath-Szalai, Zoltan; Szirmay, Balazs; Ludany, Andrea; Miseta, Attila] Univ Pecs, Med Sch, Dept Lab Med, Pecs, Hungary; [Ragan, Daniel; Nagy, Balint; Muhl, Diana] Univ Pecs, Med Sch, Dept Anesthesiol & Intens Therapy, Pecs, Hungary; [Horvath-Szalai, Zoltan] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary; [Bugyi, Beata] Univ Pecs, Med Sch, Dept Biophys, Pecs, Hungary	University of Pecs; University of Pecs; University of Pecs; University of Pecs	Ragan, D (corresponding author), Univ Pecs, Med Sch, Dept Lab Med, Pecs, Hungary.; Ragan, D (corresponding author), Univ Pecs, Med Sch, Dept Anesthesiol & Intens Therapy, Pecs, Hungary.	ragandaniel@hotmail.com		Ragan, Daniel/0000-0002-5429-0168; Nagy, Balint/0000-0002-4865-8958	University of Pecs, Medical School, Hungary [KA-2018-17]; University of Pecs [EFOP 3.6.1-16-2016-00004]	University of Pecs, Medical School, Hungary; University of Pecs	The work was financially supported by the University of Pecs, Medical School, Hungary grant (KA-2018-17) and was also supported by the EFOP 3.6.1-16-2016-00004 project (Comprehensive Development for Implementing Smart Specialization Strategies) of the University of Pecs. Balint Nagy was supported by the Thematic Excellence Program 2020-National Excellence Subprogram; Biomedical Engineering Project ("2020-4.1.1-TKP2020") of the University of Pecs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellomo R, 2017, INTENS CARE MED, V43, P816, DOI 10.1007/s00134-017-4755-7; Belsky JB, 2020, BIOMARKERS, V25, P391, DOI 10.1080/1354750X.2020.1771419; Belsky JB, 2016, BIOMARKERS, V21, P180, DOI 10.3109/1354750X.2015.1126646; Conti M, 2009, CLIN CHEM LAB MED, V47, P1553, DOI 10.1515/CCLM.2009.341; Dahl B, 2003, CRIT CARE MED, V31, P152, DOI 10.1097/00003246-200301000-00024; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Endre ZH, 2008, NEPHROLOGY, V13, P91, DOI 10.1111/j.1440-1797.2007.00905.x; Faix JD, 2013, CRIT REV CL LAB SCI, V50, P23, DOI 10.3109/10408363.2013.764490; Gaudry S, 2016, NEW ENGL J MED, V375, P122, DOI 10.1056/NEJMoa1603017; Goldstein SL, 2010, KIDNEY INT, V78, P433, DOI 10.1038/ki.2010.200; HADDAD JG, 1990, P NATL ACAD SCI USA, V87, P1381, DOI 10.1073/pnas.87.4.1381; Horvath-Szalai Z, 2017, CLIN BIOCHEM, V50, P127, DOI 10.1016/j.clinbiochem.2016.10.018; Karkar A, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-0648-y; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Kustan Peter, 2017, EJIFCC, V28, P122; Kustan P, 2016, BIOCHEM MEDICA, V26, P421, DOI 10.11613/BM.2016.044; Kwon O, 2003, AM J KIDNEY DIS, V41, P1074, DOI 10.1016/S0272-6386(03)00206-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003712; LEE WM, 1992, NEW ENGL J MED, V326, P1335; Meier U, 2006, CLIN CHEM, V52, P1247, DOI 10.1373/clinchem.2005.065680; Oh DJ, 2020, RENAL FAILURE, V42, P154, DOI 10.1080/0886022X.2020.1721300; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Ragan D., 2018, CLIN CHEM LAB MED CC, V56, pEA151; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stoller J, 2016, J CRIT CARE, V31, P58, DOI 10.1016/j.jcrc.2015.09.034; Sudakov NP, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1, DOI 10.1134/S0006297917010011; Suhler E, 1997, CRIT CARE MED, V25, P594, DOI 10.1097/00003246-199704000-00007; Szirmay B, 2018, BIOANALYSIS, V10, P377, DOI 10.4155/bio-2017-0228; Tang KWA, 2015, SINGAP MED J, V56, P7, DOI 10.11622/smedj.2015003; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Umbro I, 2016, J INFECTION, V72, P131, DOI 10.1016/j.jinf.2015.11.008; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; WHITEHEAD TP, 1979, CLIN CHEM, V25, P1531; Wu F, 2015, INT J CLIN EXP PATHO, V8, P14409; Zarbock A, 2016, JAMA-J AM MED ASSOC, V315, P2190, DOI 10.1001/jama.2016.5828	39	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255266	10.1371/journal.pone.0255266	http://dx.doi.org/10.1371/journal.pone.0255266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310652	Green Published, gold			2022-12-26	WOS:000685224500047
J	Schmuck, J; Hiebel, N; Rabe, M; Schneider, J; Erim, Y; Morawa, E; Jerg-Bretzke, L; Beschoner, P; Albus, C; Hannemann, J; Weidner, K; Steudte-Schmiedgen, S; Radbruch, L; Brunsch, H; Geiser, F				Schmuck, Jonas; Hiebel, Nina; Rabe, Milena; Schneider, Juliane; Erim, Yesim; Morawa, Eva; Jerg-Bretzke, Lucia; Beschoner, Petra; Albus, Christian; Hannemann, Julian; Weidner, Kerstin; Steudte-Schmiedgen, Susann; Radbruch, Lukas; Brunsch, Holger; Geiser, Franziska			Sense of coherence, social support and religiosity as resources for medical personnel during the COVID-19 pandemic: A web-based survey among 4324 health care workers within the German Network University Medicine	PLOS ONE			English	Article							MENTAL-HEALTH; PSYCHOLOGICAL DISTRESS; LONELINESS; ENRICHD; IMPACT	Introduction The COVID-19 pandemic resulted in severe detrimental effects on the mental well-being of health care workers (HCW). Consequently, there has been a need to identify health-promoting resources in order to mitigate the psychological impact of the pandemic on HCW. Objective Our objective was to investigate the association of sense of coherence (SOC), social support and religiosity with self-reported mental symptoms and increase of subjective burden during the COVID-19 pandemic in HCW. Methods Our sample comprised 4324 HCW of four professions (physicians, nurses, medical technical assistants (MTA) and pastoral workers) who completed an online survey from 20 April to 5 July 2020. Health-promoting resources were assessed using the Sense of Coherence Scale Short Form (SOC-3), the ENRICHD Social Support Inventory (ESSI) and one item on religiosity derived from the Scale of Transpersonal Trust (TPV). Anxiety and depression symptoms were measured with the PHQ-2 and GAD-2. The increase of subjective burden due to the pandemic was assessed as the retrospective difference between burden during the pandemic and before the pandemic. Results In multiple regressions, higher SOC was strongly associated with fewer anxiety and depression symptoms. Higher social support was also related to less severe mental symptoms, but with a smaller effect size, while religiosity showed minimal to no correlation with anxiety or depression. In professional group analysis, SOC was negatively associated with mental symptoms in all groups, while social support only correlated significantly with mental health outcomes in physicians and MTA. In the total sample and among subgroups, an increase of subjective burden was meaningfully associated only with a weaker SOC. Conclusion Perceived social support and especially higher SOC appeared to be beneficial for mental health of HCW during the COVID-19 pandemic. However, the different importance of the resources in the respective occupations requires further research to identify possible reasons.	[Schmuck, Jonas; Hiebel, Nina; Rabe, Milena; Schneider, Juliane; Geiser, Franziska] Univ Hosp Bonn, Fac Med, Dept Psychosomat Med & Psychotherapy, Bonn, Germany; [Erim, Yesim; Morawa, Eva] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Psychosomat Med & Psychotherapy, Erlangen, Germany; [Jerg-Bretzke, Lucia; Beschoner, Petra] Univ Ulm, Ulm Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Ulm, Germany; [Albus, Christian; Hannemann, Julian] Univ Cologne, Univ Hosp Cologne, Dept Psychosomat & Psychotherapy, Cologne, Germany; [Weidner, Kerstin; Steudte-Schmiedgen, Susann] Tech Univ Dresden, Dept Psychotherapy & Psychosomat Med, Fac Med, Dresden, Germany; [Radbruch, Lukas; Brunsch, Holger] Univ Hosp Bonn, Fac Med, Dept Palliat Med, Bonn, Germany; [Schmuck, Jonas] Univ Bonn, Dept Psychol, Bonn, Germany	University of Bonn; University of Erlangen Nuremberg; Ulm University; University of Cologne; Technische Universitat Dresden; University of Bonn; University of Bonn	Schmuck, J (corresponding author), Univ Hosp Bonn, Fac Med, Dept Psychosomat Med & Psychotherapy, Bonn, Germany.; Schmuck, J (corresponding author), Univ Bonn, Dept Psychol, Bonn, Germany.	jonas.schmuck@uni-bonn.de	Geiser, Franziska/J-2351-2019; Steudte-Schmiedgen, Susann/HHZ-4248-2022	Geiser, Franziska/0000-0002-4212-9692; Steudte-Schmiedgen, Susann/0000-0002-1171-7133; Schneider, Juliane Nora/0000-0002-9057-2867	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [348851031]; German Federal Ministry of Education and Research (BMBF), Network University Medicine (NUM) [01KX2021]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF), Network University Medicine (NUM)(Federal Ministry of Education & Research (BMBF))	The study was designed and set up within the research group "Resilience in Religion and Spirituality", speaker Prof. Dr. Cornelia Richter, financially supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) -project number 348851031. Data management and evaluation were performed in the collaborative research project egePan Unimed which is financially supported by the German Federal Ministry of Education and Research (BMBF) as part of the Network University Medicine (NUM) (funding code: 01KX2021) and led by Prof. Dr. Michael Albrecht, Prof. Dr. Jurgen Graf, Prof. Dr. Jochen Schmitt and Dr. Michael von Wagner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Alfano V, 2020, APPL HEALTH ECON HEA, V18, P509, DOI 10.1007/s40258-020-00596-3; Ando M., 2011, HEALTH, V3, P118, DOI [DOI 10.4236/HEALTH.2011.32022, 10.4236/health.2011.32022]; [Anonymous], 2002, Bull World Health Organ, V80, P983; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Antonovsky A., 1987, UNRAVELING MYSTERY H; Bachem R, 2018, EUR J PSYCHOL ASSESS, V34, P206, DOI 10.1027/1015-5759/a000323; Bauerle A, 2020, J PUBLIC HEALTH-UK, V42, P672, DOI 10.1093/pubmed/fdaa106; Batra K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17239096; Belschner W., 1998, TRANSPERSONALE ARBEI; Berkman L, 2001, PSYCHOSOM MED, V63, P747; Bonelli RM, 2013, J RELIG HEALTH, V52, P657, DOI 10.1007/s10943-013-9691-4; Britt TW, 2021, APPL PSYCHOL-INT REV, V70, P120, DOI 10.1111/apps.12304; Cordes A., 2009, KLIN DIAGNOSTIK EVAL, V2, P16; Delacre M, 2019, INT REV SOC PSYCHOL, V32, DOI 10.5334/irsp.198; Eriksson M, 2006, J EPIDEMIOL COMMUN H, V60, P376, DOI 10.1136/jech.2005.041616; Fang XH, 2021, BMC PSYCHIATRY, V21, DOI 10.1186/s12888-020-02998-y; Fava GA, 2017, PSYCHOTHER PSYCHOSOM, V86, P13, DOI 10.1159/000448856; Fernandez RS, 2020, J AFFECT DISORDERS, V277, P75, DOI 10.1016/j.jad.2020.07.133; Ferrell BR, 2020, J PAIN SYMPTOM MANAG, V60, pE7, DOI 10.1016/j.jpainsymman.2020.06.034; Geyer S, 1997, SOC SCI MED, V44, P1771, DOI 10.1016/S0277-9536(96)00286-9; Gomez-Salgado J, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12176855; Gottlieb BH, 2010, J PSYCHOSOM RES, V69, P511, DOI 10.1016/j.jpsychores.2009.10.001; Grey I, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113452; Gruszczynska E., 2006, POL PSYCHOL BULL, V37, P74; Hagerty BM, 1999, NURS RES, V48, P215, DOI 10.1097/00006199-199907000-00004; Hou TY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233831; Jaspal R, 2020, MENT HEALTH RELIG CU, V23, P427, DOI 10.1080/13674676.2020.1784119; Kendel F, 2011, DIAGNOSTICA, V57, P99, DOI 10.1026/0012-1924/a000030; Kikuchi Yoko, 2014, Indian J Occup Environ Med, V18, P32, DOI 10.4103/0019-5278.134959; Kim SC, 2021, NURS OPEN, V8, P900, DOI 10.1002/nop2.697; Kranz D., 2020, PSYCHOL RELIG SPIRIT, DOI [10.1037/rel0000395, DOI 10.1037/REL0000395]; Labrague LJ, 2020, J NURS MANAGE, V28, P1653, DOI 10.1111/jonm.13121; Lakey B, 2011, PSYCHOL REV, V118, P482, DOI 10.1037/a0023477; Lenhard W., 2016, COMPUTATION EFFECT S, DOI 10.13140/RG.2.2.17823.92329; Liu LJ, 2016, J HEALTH PSYCHOL, V21, P750, DOI 10.1177/1359105314536941; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190; Malinauskiene V, 2009, MEDICINA-LITHUANIA, V45, P910, DOI 10.3390/medicina45110117; Morawa E, 2021, J PSYCHOSOM RES, V144, DOI 10.1016/j.jpsychores.2021.110415; Moyers SA, 2020, INT REV SPORT EXER P, DOI 10.1080/1750984X.2020.1846068; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Schafer SK, 2020, PSYCHOTHER PSYCHOSOM, V89, P386, DOI 10.1159/000510752; Schafer SK, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00440; Schmalbach B., 2019, PSYCHOTHER PSYCHOSOM, V70, P86; Schug C, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18073827; Serrano-Ripoll MJ, 2020, J AFFECT DISORDERS, V277, P347, DOI 10.1016/j.jad.2020.08.034; Streb M, 2014, BEHAV COGN PSYCHOTH, V42, P452, DOI 10.1017/S1352465813000337; Theorell T, 2020, PSYCHOTHER PSYCHOSOM, V89, P193, DOI 10.1159/000507765; Phan T, 2020, INFECT GENET EVOL, V79, DOI 10.1016/j.meegid.2020.104211; Vogel I, 2012, CHRONIC ILLN, V8, P296, DOI 10.1177/1742395312445935; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; WHO, 2020, DIS CONS COVID 19 OU; WILLIAMS DR, 1991, SOC SCI MED, V32, P1257, DOI 10.1016/0277-9536(91)90040-J; Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923921; Yu H, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02826-3; Zhang WR, 2020, PSYCHOTHER PSYCHOSOM, V89, P242, DOI 10.1159/000507639	57	13	14	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255211	10.1371/journal.pone.0255211	http://dx.doi.org/10.1371/journal.pone.0255211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TN	34310616	gold, Green Published			2022-12-26	WOS:000685224500007
J	Zeng, Z; Zhao, Y; Chen, QY; Zhu, S; Niu, Y; Ye, Z; Hu, P; Chen, D; Xu, P; Chen, JH; Hu, CJ; Hu, YH; Xu, FY; Tang, J; Wang, F; Han, SB; Huang, MQ; Wang, CY; Zhao, G				Zeng, Zhu; Zhao, Yong; Chen, QingYong; Zhu, Shuai; Niu, Yi; Ye, Zeng; Hu, Ping; Chen, Ding; Xu, Peng; Chen, Jinghuang; Hu, Chaojie; Hu, Yuhang; Xu, Fengyu; Tang, Jiang; Wang, Fan; Han, Shengbo; Huang, Mengqi; Wang, Chunyou; Zhao, Gang			Hypoxic exosomal HIF-1 alpha-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis	ONCOGENE			English	Article							DRUG-RESISTANCE; INDUCIBLE FACTOR-1-ALPHA; MEDIATED TRANSFER; CHEMOTHERAPY; HIF-1-ALPHA; INHIBITION; RNA	Research has indicated that hypoxia profoundly contributes to chemoresistance of pancreatic cancer (PC), while the precise mechanism has not been fully elucidated. In this study, we report a hypoxic exosomal circular RNA (circRNA)-mediated mechanism of conferred chemoresistance in PC cells. Gemcitabine (GEM) resistance was enhanced in normoxic PC cells incubated with exosomes derived from hypoxic PC cells. CircRNA microarray displayed that circZNF91 was remarkably increased in hypoxic exosomes of PC cells compared with normoxic exosomes. Overexpression of circZNF91 obviously stimulated chemoresistance in PC cells, while knockdown of circZNF91 retarded the hypoxic exosome-transmitted chemoresistance. Mechanistically, the hypoxic-induced exosomal circZNF91 transmitted into normoxic PC cells could competitively bind to miR-23b-3p, which deprives the inhibition of miR-23b-3p on expression of deacetylase Sirtuin1 (SIRT1). Consequently, the upregulated SIRT1 enhanced deacetylation-dependent stability of HIF-1 alpha protein, leading to glycolysis and GEM chemoresistance of recipient PC cells. In addition, we revealed that the increased circZNF91 in hypoxic exosome was attributed to the transcriptional regulation by HIF-1 alpha. Coincidently, transmission of hypoxic exosomes into subcutaneous xenografts in nude mice obviously facilitated the chemoresistance of transplanted PC tumor, which could be reversed by depletion of circZNF91 or upregulation of miR-23b-3p. Furthermore, clinical data showed that circZNF91 was significantly upregulated in PC tissues and correlated with overexpression of glycolytic enzymes and short overall survival time. Collectively, exosomal circZNF91 can function as a cargo mediating the signal transmission between hypoxic and normoxic tumor cells to promote GEM chemoresistance of PC and may potentially serve as a therapeutic target.	[Zeng, Zhu; Zhao, Yong; Chen, QingYong; Zhu, Shuai; Ye, Zeng; Hu, Ping; Chen, Ding; Xu, Peng; Chen, Jinghuang; Hu, Chaojie; Hu, Yuhang; Xu, Fengyu; Tang, Jiang; Wang, Fan; Han, Shengbo; Huang, Mengqi; Zhao, Gang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Emergency Surg, Wuhan, Peoples R China; [Niu, Yi] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastrointestinal Surg, Wuhan, Peoples R China; [Wang, Chunyou] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pancreat Surg, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhao, G (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Emergency Surg, Wuhan, Peoples R China.	gangzhao@hust.edu.cn			National Science Foundation Committee of China [81372666, 81672406, 81802450, 81802377]; Clinical Research Physician Program of Tongji Medical College, Huazhong University of Science and Technology	National Science Foundation Committee of China; Clinical Research Physician Program of Tongji Medical College, Huazhong University of Science and Technology	The National Science Foundation Committee of China (Grant Number: 81372666, 81672406 to GZ; 81802450 to SZ; 81802377 to YN); and Clinical Research Physician Program of Tongji Medical College, Huazhong University of Science and Technology to GZ supported this study.	Abraham J, 2015, LEUKEMIA LYMPHOMA, V56, P26, DOI 10.3109/10428194.2014.907890; An Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.123; Bednar F, 2020, CANCER DISCOV, V10, P762, DOI 10.1158/2159-8290.CD-20-0359; Boeckel JN, 2015, CIRC RES, V117, P884, DOI 10.1161/CIRCRESAHA.115.306319; Borji M, 2019, BIOCHEM GENET, V57, P507, DOI 10.1007/s10528-019-09905-5; Cho HS, 2019, GENES-BASEL, V10, DOI 10.3390/genes10121008; Christenson ES, 2020, LANCET ONCOL, V21, pE135, DOI 10.1016/S1470-2045(19)30795-8; da Costa WL, 2020, JAMA ONCOL, V6, P1163, DOI 10.1001/jamaoncol.2020.0562; Ding CY, 2020, CANCER LETT, V479, P1, DOI 10.1016/j.canlet.2020.03.002; Doktorova H, 2015, BIOMED PAP, V159, P166, DOI 10.5507/bp.2015.025; Dong CJ, 2019, ONCOTARGETS THER, V12, P1947, DOI 10.2147/OTT.S186922; Halbrook CJ, 2019, CELL METAB, V29, P1390, DOI 10.1016/j.cmet.2019.02.001; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hosein AN, 2020, NAT REV GASTRO HEPAT, V17, P487, DOI 10.1038/s41575-020-0300-1; Icard P, 2018, DRUG RESIST UPDATE, V38, P1, DOI 10.1016/j.drup.2018.03.001; Jing XM, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1089-9; Joo HY, 2015, BIOCHEM BIOPH RES CO, V462, P294, DOI 10.1016/j.bbrc.2015.04.119; Karasic TB, 2019, JAMA ONCOL, V5, P993, DOI 10.1001/jamaoncol.2019.0684; Klotz R, 2020, LANCET ONCOL, V21, pE295, DOI 10.1016/S1470-2045(20)30179-0; Kristensen LS, 2018, RNA BIOL, V15, P280, DOI 10.1080/15476286.2017.1409931; Lane JS, 2020, CANCERS, V12, DOI 10.3390/cancers12061530; Lin SC, 2011, J CLIN INVEST, V121, P1905, DOI 10.1172/JCI44362; Oon CE, 2015, EUR J PHARMACOL, V757, P59, DOI 10.1016/j.ejphar.2015.03.064; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Paulson AS, 2013, GASTROENTEROLOGY, V144, P1316, DOI 10.1053/j.gastro.2013.01.078; Robey IF, 2005, NEOPLASIA, V7, P324, DOI 10.1593/neo.04430; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shukla SK, 2017, CANCER CELL, V32, P71, DOI 10.1016/j.ccell.2017.06.004; Siegel RL., 2020, CA-CANCER J CLIN, V70; Takahashi K, 2014, FEBS OPEN BIO, V4, P458, DOI 10.1016/j.fob.2014.04.007; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wang JP, 2020, ONCOL LETT, V20, DOI 10.3892/ol.2020.11891; Wang P, 2013, GASTROENTEROLOGY, V145, P1133, DOI 10.1053/j.gastro.2013.07.048; Wang XY, 2020, MOL ONCOL, V14, P539, DOI 10.1002/1878-0261.12629; Warfel NA, 2014, CURR MED CHEM, V21, P3021, DOI 10.2174/0929867321666140414101056; Xu RH, 2005, CANCER RES, V65, P613; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Yokoi K, 2004, CLIN CANCER RES, V10, P2299, DOI 10.1158/1078-0432.CCR-03-0488; Yoon JH, 2012, METHODS, V58, P81, DOI 10.1016/j.ymeth.2012.07.004; Zeng Z, 2019, THERANOSTICS, V9, P5298, DOI 10.7150/thno.34559; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhang JG, 2014, CANCER SCI, V105, P445, DOI 10.1111/cas.12364; Zhou WK, 2019, J CELL BIOCHEM, V120, P19635, DOI 10.1002/jcb.29270	44	34	34	4	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 9	2021	40	36					5505	5517		10.1038/s41388-021-01960-w	http://dx.doi.org/10.1038/s41388-021-01960-w		JUL 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UO7MC	34294845				2022-12-26	WOS:000678017100002
J	Facioli, R; Lojudice, FH; Anauate, AC; Maquigussa, E; Nishiura, JL; Heilberg, IP; Sogayar, MC; Boim, MA				Facioli, Roberta; Lojudice, Fernando Henrique; Anauate, Ana Carolina; Maquigussa, Edgar; Nishiura, Jose Luiz; Heilberg, Ita Pfeferman; Sogayar, Mari Cleide; Boim, Mirian Aparecida			Kidney organoids generated from erythroid progenitors cells of patients with autosomal dominant polycystic kidney disease	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; CYST FORMATION; 2-HIT MODEL; CYSTOGENESIS	Background Kidney organoids have been broadly obtained from commercially available induced pluripotent stem cells (iPSCs); however, it has been a great challenge to efficiently produce renal organoid models from patients with autosomal dominant polycystic kidney disease (ADPKD) that recapitulate both embryogenesis and the mechanisms of cystogenesis. Methods Blood erythroid progenitors (EPs) from two ADPKD patients and one healthy donor (HC) was used as a comparative control to normalize the many technical steps for reprogramming EPs and for the organoids generation. EPs were reprogrammed by an episomal vector into iPSCs, which were differentiated into renal tubular organoids and then stimulated by forskolin to induce cysts formation. Results iPSCs derived from EPs exhibited all characteristics of pluripotency and were able to differentiate into all three germ layers. 3D tubular organoids were generated from single cells after 28 days in Matrigel. HC and ADPKD organoids did not spontaneously form cysts, but upon forskolin stimulation, cysts-like structures were observed in the ADPKD organoids but not in the HC-derived organoids. Conclusion The findings of this study showed that kidney organoids were successfully generated from the blood EP cells of ADPKD patients and a healthy control donor. This approach should contribute as a powerful tool for embryonic kidney development model, which is able to recapitulate the very early pathophysiological mechanisms involved in cytogenesis.	[Facioli, Roberta; Anauate, Ana Carolina; Maquigussa, Edgar; Nishiura, Jose Luiz; Heilberg, Ita Pfeferman; Boim, Mirian Aparecida] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil; [Lojudice, Fernando Henrique; Sogayar, Mari Cleide] Univ Sao Paulo, Sch Med, Cell & Mol Therapy Ctr NUCEL, Sao Paulo, Brazil; [Sogayar, Mari Cleide] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo	Facioli, R (corresponding author), Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil.	facioli.roberta@unifesp.br	Anauate, Ana Carolina/AAA-5420-2020	Anauate, Ana Carolina/0000-0001-6158-3412; heilberg, ita pfeferman/0000-0002-0885-5877	CNPq; CAPES; FAPESP [2015/23345-9, 2016/05311-2]; Fundacao Oswaldo Ramos	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Oswaldo Ramos	This work was supported by funding from CNPq, CAPES, FAPESP (grants 2015/23345-9 to MAB and No. 2016/05311-2 to MCS), and Fundacao Oswaldo Ramos.	Bastos AP, 2011, BRAZ J MED BIOL RES, V44, P606, DOI [10.1590/S0100-879X2011007500068, 10.1590/S0100-879X2011000700001]; Briggs JA, 2013, STEM CELLS, V31, P467, DOI 10.1002/stem.1297; Chebib FT, 2016, AM J KIDNEY DIS, V67, P792, DOI 10.1053/j.ajkd.2015.07.037; Chen Hong Yu, 2016, Curr Protoc Stem Cell Biol, V38, DOI 10.1002/cpsc.12; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Cruz NM, 2017, NAT MATER, V16, P1112, DOI [10.1038/NMAT4994, 10.1038/nmat4994]; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715; Freedman BS, 2013, J AM SOC NEPHROL, V24, P1571, DOI 10.1681/ASN.2012111089; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Lantinga-van Leeuwen IS, 2007, HUM MOL GENET, V16, P3188, DOI 10.1093/hmg/ddm299; Little MH, 2019, GENE DEV, V33, P1319, DOI 10.1101/gad.329573.119; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Nishinakamura R, 2019, NAT REV NEPHROL, V15, P613, DOI 10.1038/s41581-019-0176-x; Pei Y, 1999, J AM SOC NEPHROL, V10, P1524; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Rao MS, 2012, J CELL BIOCHEM, V113, P3061, DOI 10.1002/jcb.24183; Schutgens F, 2016, EUR J PHARMACOL, V790, P12, DOI 10.1016/j.ejphar.2016.06.059; Shimizu T, 2020, BIOCHEM BIOPH RES CO, V529, P1186, DOI 10.1016/j.bbrc.2020.06.141; Taguchi A, 2017, CELL STEM CELL, V21, P730, DOI 10.1016/j.stem.2017.10.011; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takakura A, 2009, HUM MOL GENET, V18, P2523, DOI 10.1093/hmg/ddp147; Tsukiyama T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13398-6; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Watnick TJ, 1998, MOL CELL, V2, P247, DOI 10.1016/S1097-2765(00)80135-5; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	28	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0252156	10.1371/journal.pone.0252156	http://dx.doi.org/10.1371/journal.pone.0252156			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339420	Green Published, gold			2022-12-26	WOS:000680243400051
J	Cavac, E; Ramirez-Tapia, LE; Martin, CT				Cavac, Elvan; Ramirez-Tapia, Luis E.; Martin, Craig T.			High-salt transcription of DNA cotethered with T7 RNA polymerase to beads generates increased yields of highly pure RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO TRANSCRIPTION; DOUBLE-STRANDED-RNA; MESSENGER-RNA; PURIFICATION; MECHANISM; RECOGNITION; BINDING; PROTEIN; ELONGATION; ACTIVATION	High yields of RNA are routinely prepared following the two-step approach of high-yield in vitro transcription using T7 RNA polymerase followed by extensive purification using gel separation or chromatographic methods. We recently demonstrated that in high-yield transcription reactions, as RNA accumulates in solution, T7 RNA polymerase rebinds and extends the encoded RNA (using the RNA as a template), resulting in a product pool contaminated with longer-than desired, (partially) double-stranded impurities. Current purifi- cation methods often fail to fully eliminate these impurities, which, if present in therapeutics, can stimulate the innate immune response with potentially fatal consequences. In this work, we introduce a novel in vitro transcription method that generates high yields of encoded RNA without double-stranded impurities, reducing the need for further purification. Transcription is carried out at high-salt conditions to eliminate RNA product rebinding, while promoter DNA and T7 RNA polymerase are cotethered in close proximity on magnetic beads to drive promoter binding and transcription initiation, resulting in an increase in overall yield and purity of only the encoded RNA. A more complete elimination of double stranded RNA during synthesis will not only reduce overall production costs, but also should ultimately enable therapies and technologies that are currently being hampered by those impurities.	[Cavac, Elvan; Martin, Craig T.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Ramirez-Tapia, Luis E.; Martin, Craig T.] Univ Massachusetts, Grad Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Martin, CT (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.; Martin, CT (corresponding author), Univ Massachusetts, Grad Program Mol & Cellular Biol, Amherst, MA 01003 USA.	cmartin@chem.umass.edu	Martin, Craig/L-3596-2013	Martin, Craig/0000-0003-1029-5239	National Science Foundation [MCB-1516896]; National Institutes of Health [1R01GM134042]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation [MCB-1516896] and by the National Institutes of Health [1R01GM134042]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arnaud-Barbe N, 1998, NUCLEIC ACIDS RES, V26, P3550, DOI 10.1093/nar/26.15.3550; Baiersdorfer M, 2019, MOL THER-NUCL ACIDS, V15, P26, DOI 10.1016/j.omtn.2019.02.018; Bandwar RP, 2002, J MOL BIOL, V324, P63, DOI 10.1016/S0022-2836(02)01034-3; Baumschlager A, 2017, ACS SYNTH BIOL, V6, P2157, DOI 10.1021/acssynbio.7b00169; BROWNLEE GG, 1995, NUCLEIC ACIDS RES, V23, P2641, DOI 10.1093/nar/23.14.2641; Burgess K, 2000, CHEM REV, V100, P2047, DOI 10.1021/cr990045m; CAZENAVE C, 1994, P NATL ACAD SCI USA, V91, P6972, DOI 10.1073/pnas.91.15.6972; CHAPMAN KA, 1987, NUCLEIC ACIDS RES, V15, P5413, DOI 10.1093/nar/15.13.5413; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Davis Robert H., 1995, Current Opinion in Biotechnology, V6, P213, DOI 10.1016/0958-1669(95)80035-2; Easton LE, 2010, RNA, V16, P647, DOI 10.1261/rna.1862210; Esposito EA, 2004, J BIOL CHEM, V279, P44270, DOI 10.1074/jbc.M407688200; Gholamalipour Y, 2018, NUCLEIC ACIDS RES, V46, P9253, DOI 10.1093/nar/gky796; Gong P, 2004, J BIOL CHEM, V279, P44277, DOI 10.1074/jbc.M409118200; GUREVICH VV, 1991, ANAL BIOCHEM, V195, P207, DOI 10.1016/0003-2697(91)90318-N; Hartmann G, 2017, ADV IMMUNOL, V133, P121, DOI 10.1016/bs.ai.2016.11.001; Jia YP, 1997, BIOCHEMISTRY-US, V36, P4223, DOI 10.1021/bi9630467; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; KONARSKA MM, 1989, CELL, V57, P423, DOI 10.1016/0092-8674(89)90917-3; KRUPP G, 1989, NUCLEIC ACIDS RES, V17, P3023, DOI 10.1093/nar/17.8.3023; KRUPP G, 1988, GENE, V72, P75, DOI 10.1016/0378-1119(88)90129-1; Kukarin A, 2003, J BIOL CHEM, V278, P2419, DOI 10.1074/jbc.M210058200; Lebedev AV, 2001, NUCLEOS NUCLEOT NUCL, V20, P1403, DOI 10.1081/NCN-100002565; Lemaire PA, 2008, J MOL BIOL, V381, P351, DOI 10.1016/j.jmb.2008.05.056; Liu XQ, 2009, J BIOL CHEM, V284, P36262, DOI 10.1074/jbc.M109.056820; Lukavsky PJ, 2004, RNA, V10, P889, DOI 10.1261/rna.5264804; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Martins R, 2014, J CHROMATOGR A, V1355, P1, DOI 10.1016/j.chroma.2014.05.075; MCALLISTER WT, 1993, CELL MOL BIOL RES, V39, P385; MCALLISTER WT, 1980, NUCLEIC ACIDS RES, V8, P4821, DOI 10.1093/nar/8.20.4821; McKenna SA, 2007, NAT PROTOC, V2, P3270, DOI 10.1038/nprot.2007.480; MELLITS KH, 1990, NUCLEIC ACIDS RES, V18, P5401, DOI 10.1093/nar/18.18.5401; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Nacheva GA, 2003, EUR J BIOCHEM, V270, P1458, DOI 10.1046/j.1432-1033.2003.03510.x; Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200; OSTRANDER EA, 1990, SCIENCE, V249, P1261, DOI 10.1126/science.2399463; Petrov A, 2013, METHOD ENZYMOL, V530, P315, DOI 10.1016/B978-0-12-420037-1.00017-8; POKROVSKAYA ID, 1994, ANAL BIOCHEM, V220, P420, DOI 10.1006/abio.1994.1360; Ramirez-Tapia LE, 2012, J BIOL CHEM, V287, P37352, DOI 10.1074/jbc.M112.370643; Rong M, 1998, J BIOL CHEM, V273, P10253, DOI 10.1074/jbc.273.17.10253; Sarcar SN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32231-6; SCHENBORN ET, 1985, NUCLEIC ACIDS RES, V13, P6223, DOI 10.1093/nar/13.17.6223; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Sousa R., 2013, ENCY BIOL CHEM, P355; Steitz TA, 2009, CURR OPIN STRUC BIOL, V19, P683, DOI 10.1016/j.sbi.2009.09.001; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tatematsu M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2857; Temiakov D, 2002, J BIOL CHEM, V277, P47035, DOI 10.1074/jbc.M208923200; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P6298, DOI 10.1074/jbc.270.11.6298; Ujvari A, 1996, BIOCHEMISTRY-US, V35, P14574, DOI 10.1021/bi961165g; Ujvari A, 1997, J MOL BIOL, V273, P775, DOI 10.1006/jmbi.1997.1350; Weissman Drew, 2013, Methods Mol Biol, V969, P43, DOI 10.1007/978-1-62703-260-5_3; Yeliseev A, 2017, PROTEIN EXPRES PURIF, V131, P109, DOI 10.1016/j.pep.2016.11.006; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zaher HS, 2004, BIOCHEMISTRY-US, V43, P7873, DOI 10.1021/bi0497300	63	3	3	6	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100999	10.1016/j.jbc.2021.100999	http://dx.doi.org/10.1016/j.jbc.2021.100999			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34303704	Green Published, gold			2022-12-26	WOS:000706418900004
J	Kassas, B; Morgan, SN; Lai, JH; Kropp, JD; Gao, ZF				Kassas, Bachir; Morgan, Stephen N.; Lai, John H.; Kropp, Jaclyn D.; Gao, Zhifeng			Perception versus preference: The role of self-assessed risk measures on individual mitigation behaviors during the COVID-19 pandemic	PLOS ONE			English	Article							FOOD SAFETY; ATTITUDES	In the midst of a global pandemic, prevention methods stand as a crucial first step toward addressing the public health crisis and controlling the spread of the virus. However, slowing the spread of the virus hinges on the public's willingness to follow a combination of mitigation practices to avoid contracting and transmitting the disease. In this study, we investigate the factors related to individuals' risk perceptions associated with COVID-19 as well as their general self-assessed risk preferences. We also provide insights regarding the role of risk perceptions and preferences on mitigation behavior by examining the correlation between these risk measures and both the likelihood of following various mitigation practices and total number of practices followed. Although we find both risk perceptions and preferences to be significantly correlated with mitigation behaviors, risk perceptions are correlated with a larger number of practices. Additionally, we find significant heterogeneity in mitigation behaviors across numerous individual and household characteristics. These results can serve as a benchmark for the design and development of interventions to increase awareness and promote higher adoption of mitigation practices.	[Kassas, Bachir; Lai, John H.; Kropp, Jaclyn D.; Gao, Zhifeng] Univ Florida, Food & Resource Econ Dept, Gainesville, FL 32611 USA; [Morgan, Stephen N.] ERS, USDA, Kansas City, MO USA	State University System of Florida; University of Florida; United States Department of Agriculture (USDA)	Kassas, B (corresponding author), Univ Florida, Food & Resource Econ Dept, Gainesville, FL 32611 USA.	b.kassas@ufl.edu	Gao, Zhifeng/AFD-7759-2022	Kassas, Bachir/0000-0002-3922-471X				[Anonymous], 2007, BE J ECON ANAL POLI; Barron G, 2003, J BEHAV DECIS MAKING, V16, P215, DOI 10.1002/bdm.443; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; CDC, 2020, COR DIS 2019 COVID 1; Charness G, 2013, J ECON BEHAV ORGAN, V87, P43, DOI 10.1016/j.jebo.2012.12.023; Cromartie J., 2019, USDA ERS DOC; Gidengil CA, 2012, AM J PUBLIC HEALTH, V102, P672, DOI 10.2105/AJPH.2011.300407; HAYES DJ, 1995, AM J AGR ECON, V77, P40, DOI 10.2307/1243887; Ito N, 2017, AM J AGR ECON, V99, P55, DOI 10.1093/ajae/aaw078; Lee SWS, 2010, PSYCHOL SCI, V21, P375, DOI 10.1177/0956797609359876; Lusk JL, 2005, AM J AGR ECON, V87, P393, DOI 10.1111/j.1467-8276.2005.00730.x; Machin MA, 2008, ACCIDENT ANAL PREV, V40, P541, DOI 10.1016/j.aap.2007.08.010; MCCLELLAND GH, 1993, J RISK UNCERTAINTY, V7, P95, DOI 10.1007/BF01065317; Pennings JME, 2002, INT J RES MARK, V19, P91, DOI 10.1016/S0167-8116(02)00050-2; Pennings JME, 2000, AM J AGR ECON, V82, P908, DOI 10.1111/0002-9092.00090; PRATT JW, 1964, ECONOMETRICA, V32, P122, DOI 10.2307/1913738; Raifman J., 2021, COVID 19 US STATE PO; Rubinstein H, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1541-8; Schuchat A, 2020, MMWR-MORBID MORTAL W, V69, P551, DOI 10.15585/mmwr.mm6918e2; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; SITKIN SB, 1992, ACAD MANAGE REV, V17, P9, DOI 10.2307/258646; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Tonsor GT, 2009, J AGR ECON, V60, P625, DOI 10.1111/j.1477-9552.2009.00209.x; VISCUSI WK, 1990, J POLIT ECON, V98, P1253, DOI 10.1086/261733; Wagner G. G., 2007, SCHMOLLERS JB, V127, P139, DOI DOI 10.2139/SSRN.1028709; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Weber EU, 1997, MANAGE SCI, V43, P123, DOI 10.1287/mnsc.43.2.123; Yang J, 2011, CAN J AGR ECON, V59, P493, DOI 10.1111/j.1744-7976.2011.01225.x	29	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2021	16	8							e0254756	10.1371/journal.pone.0254756	http://dx.doi.org/10.1371/journal.pone.0254756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6IY	34347778	Green Published, gold			2022-12-26	WOS:000685264900035
J	Zhang, WL; Wang, XP; Ji, XM; Tang, XY; Liu, FF; Liu, SW				Zhang, Weiliang; Wang, Xupeng; Ji, Xiaomin; Tang, Xinyao; Liu, Fengfeng; Liu, Shuwei			Parametric characteristics analysis of three cells in 3D and five-directional annular braided composites	PLOS ONE			English	Article							PROGRESSIVE DAMAGE	On the basis of analyzing the movement law of 3D circular braided yarn, the three-cell model of 3D five-direction circular braiding composite material is established. By analyzing the node position relationship in various cell models, the calculation formulas of braiding angle, cell volume, fiber volume and fiber volume content in various cell models are obtained. It is found that there are four different braiding angles in four internal cells, and the braiding angles in internal cells gradually increase from inside to outside. The braiding angles of upper and lower surface cells are approximately equal. With the increase of the length of the knuckles, the braiding angles of each cell decrease, and the braiding angles of the four inner cells decrease greatly, while the braiding angles of upper and lower surfaces decrease slightly. The results of parametric analysis showed that with the increase of the length of the knuckles and the inner diameter of cells, the mass of cells increased proportionally, while the total fiber volume content of cells decreased. With the increase of braiding yarn number and axial yarn number, the unit cell mass decreases in direct proportion, and the unit cell total fiber volume content increases. Through the research results of this paper, the geometrical characteristics of the cell model under different braided parameters can be obtained, which greatly improves the analysis efficiency.	[Zhang, Weiliang; Wang, Xupeng; Ji, Xiaomin; Tang, Xinyao] Xian Univ Technol, Sch Mech & Precis Instrument Engn, Xian, Peoples R China; [Zhang, Weiliang] Baoji Univ Arts & Sci, Inst Engn Mech, Baoji, Peoples R China; [Wang, Xupeng; Ji, Xiaomin; Liu, Fengfeng; Liu, Shuwei] Xian Univ Technol, Dept Ind Design, Xian, Peoples R China	Xi'an University of Technology; Baoji University of Arts & Sciences; Xi'an University of Technology	Wang, XP; Ji, XM (corresponding author), Xian Univ Technol, Sch Mech & Precis Instrument Engn, Xian, Peoples R China.; Wang, XP; Ji, XM (corresponding author), Xian Univ Technol, Dept Ind Design, Xian, Peoples R China.	wangxupeng@xaut.edu.cn; jixm@xaut.edu.cn			Shaanxi Province Young Outstanding Talents Support Program Project (Program) [106-451420001]; Shaanxi Provincial Education Department of China [21JK0490]	Shaanxi Province Young Outstanding Talents Support Program Project (Program); Shaanxi Provincial Education Department of China	The project supported by Shaanxi Province Young Outstanding Talents Support Program Project (Program No.106-451420001), and supported by Scientific research program funded by Shaanxi Provincial Education Department of China (Program No.21JK0490).	Alpyildiz T, 2012, TEXT RES J, V82, P443, DOI 10.1177/0040517511427969; Chen L, 1999, COMPOS SCI TECHNOL, V59, P391, DOI 10.1016/S0266-3538(98)00079-7; [陈利 Chen Li], 2003, [复合材料学报, Acta Materiae Compositae Sinica], V20, P76; Fang GD, 2009, COMPOS STRUCT, V89, P126, DOI 10.1016/j.compstruct.2008.07.016; Fang GD, 2011, J COMPOS MATER, V45, P2415, DOI 10.1177/0021998311401093; Fang GD, 2011, COMPOS STRUCT, V93, P392, DOI 10.1016/j.compstruct.2010.09.002; Kang HR, 2016, COMPOS STRUCT, V141, P264, DOI 10.1016/j.compstruct.2016.01.050; Li DS., 2007, ACTA AERONAUTICA AST, V28, P1223, DOI [10.1016/S1001-6058(07)-60030-4, DOI 10.1016/S1001-6058(07)-60030-4]; Li L, 2019, THEOR APPL FRACT MEC, V104, DOI 10.1016/j.tafmec.2019.102338; Lu Zi-xing, 2002, Journal of Beijing University of Aeronautics and Astronautics, V28, P563; Lu Zixing, 2006, Journal of Beijing University of Aeronautics and Astronautics, V32, P92; [卢子兴 Lu Zixing], 2004, [复合材料学报, Acta Materiae Compositae Sinica], V21, P1; [马文锁 Ma Wensuo], 2005, [复合材料学报, Acta Materiae Compositae Sinica], V22, P162; Sun XK, 2004, J COMPOS MATER, V38, P791, DOI 10.1177/0021998304042147; Verpoest I, 2005, COMPOS SCI TECHNOL, V65, P2563, DOI 10.1016/j.compscitech.2005.05.031; Wang YB, 2017, 21 INT C COMP MAT XI; Wang YB, 2016, COMPOS STRUCT, V136, P75, DOI 10.1016/j.compstruct.2015.09.036; Xu K, 2008, MAT SCI ENG A-STRUCT, V487, P499, DOI 10.1016/j.msea.2007.10.030; Zhang C, 2017, J MATER SCI, V52, P4658, DOI 10.1007/s10853-016-0709-7; Zhang C, 2013, APPL COMPOS MATER, V20, P803, DOI 10.1007/s10443-012-9309-0; Zhang F, 2010, CHINESE J AERONAUT, V23, P61, DOI 10.1016/S1000-9361(09)60188-6	21	0	0	11	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2021	16	8							e0254691	10.1371/journal.pone.0254691	http://dx.doi.org/10.1371/journal.pone.0254691			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IY	34347792	Green Published, gold			2022-12-26	WOS:000685264900067
J	de Oliveira, AGL; Sudre, AP; do Bomfim, TCB; Santos, HLC				de Oliveira, Amanda Gleyce Lima; Sudre, Adriana Pittella; Bergamo do Bomfim, Teresa Cristina; Santos, Helena Lucia Carneiro			Molecular characterization of Cryptosporidium spp. in dogs and cats in the city of Rio de Janeiro, Brazil, reveals potentially zoonotic species and genotype	PLOS ONE			English	Article							SAO-PAULO; GASTROINTESTINAL PARASITES; GENETIC DIVERSITY; DOMESTIC-ANIMALS; HOUSEHOLD DOGS; PREVALENCE; INFECTION; MUNICIPALITY; WATER; IDENTIFICATION	Intestinal cryptosporidiosis is a diarrheal disease caused by protists of genus Cryptosporidium that infect a wide variety of hosts, primarily vertebrates. Due to the close contact between humans and their companion animals, especially dogs and cats, there is concern about the potential for zoonotic transmission of this enteric protozoan parasite by infected animals. This study aimed to perform a microscopic and molecular diagnosis of Cryptosporidium spp. in fecal samples from domiciled dogs and cats. One hundred and nineteen fecal samples were processed using sugar centrifugal flotation followed by molecular detection of Cryptosporidium spp. DNA using nested PCR. Subtyping of isolates positive for C. parvum was performed by sequence analysis of the 60 kDa glycoprotein gene (GP60). Cryptosporidium oocysts were detected in 7.8% (5/64) and 5.4% (3/55) of the fecal samples from dogs and cats, respectively. Cryptosporidium canis (n = 3) and C. parvum (n = 2) were the main species found in dogs, whereas C. felis (n = 3) was prevalent in cats. Subtype IIaA17G2R2 (potentially zoonotic) was identified in samples positive for C. parvum. Despite the low prevalence of Cryptosporidium observed in the domiciled dogs and cats, the presence of potentially zoonotic C. parvum in dogs evidences a public health concern. Further research is needed to better understand the epidemiology, source, and potential impacts of Cryptosporidium infection in cats and dogs.	[de Oliveira, Amanda Gleyce Lima; Bergamo do Bomfim, Teresa Cristina] Univ Fed Rural Rio De Janeiro, Inst Vet, Dept Parasitol, Rio De Janeiro, Brazil; [Sudre, Adriana Pittella] Univ Fed Fluminense, Inst Biomed, Dept Microbiol & Parasitol, Rio De Janeiro, Brazil; [Santos, Helena Lucia Carneiro] Inst Oswaldo Cruz, Lab Estudos Integrados Protozool, Rio De Janeiro, Brazil	Universidade Federal Rural do Rio de Janeiro (UFRRJ); Universidade Federal Fluminense; Fundacao Oswaldo Cruz	do Bomfim, TCB (corresponding author), Univ Fed Rural Rio De Janeiro, Inst Vet, Dept Parasitol, Rio De Janeiro, Brazil.	tcbb@ufrrj.br		Bomfim, Teresa Cristina Bergamo/0000-0002-6741-0202; Lima de Oliveira, Amanda Gleyce/0000-0002-8599-554X				Abe N, 2002, VET PARASITOL, V108, P185, DOI 10.1016/S0304-4017(02)00204-2; Abinpet, 2015, FAT SET CRESC 7 4 FE; Almeida MS., 2015, ENCICLOP BIOSFERA, V11, P1421; Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; Alves Oslania de Fatima, 2005, Ciencia Animal Brasileira, V6, P127; Ballweber LR, 2009, VET PARASITOL, V160, P306, DOI 10.1016/j.vetpar.2008.11.018; Caccio SM., 2014, EPIDEMIOLOGY HUMAN C, P43, DOI [DOI 10.1007/978-3-7091-1562-6_2, 10.1007/978-3-7091-1562-6_2]; Carpenter C, 1999, EMERG INFECT DIS, V5, P579, DOI 10.3201/eid0504.990425; Carrasco L. P. S., 2016, Revista Brasileira de Medicina Veterinaria, V38, P22; Certad G, 2017, TRENDS PARASITOL, V33, P561, DOI 10.1016/j.pt.2017.02.006; Chernomor O, 2016, SYST BIOL, V65, P997, DOI 10.1093/sysbio/syw037; CURRENT WL, 1991, CLIN MICROBIOL REV, V4, P325, DOI 10.1128/CMR.4.3.325-358.1991; Gizzi ABD, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-23; Ederli Bianca B, 2008, Rev Bras Parasitol Vet, V17 Suppl 1, P260; El-Madawy R. S., 2010, Bulgarian Journal of Veterinary Medicine, V13, P104; Fayer Ronald, 2007, P1, DOI 10.1201/9781420052275.ch1; Fayer R, 2010, VET PARASITOL, V172, P23, DOI 10.1016/j.vetpar.2010.04.028; Feltus DC, 2006, J CLIN MICROBIOL, V44, P4303, DOI 10.1128/JCM.01067-06; Feng YY, 2011, APPL ENVIRON MICROB, V77, P3609, DOI 10.1128/AEM.00146-11; Ferreira AP., 2012, REV BAIANA SAUDE PUB, V36, P328, DOI [10.22278/2318-2660.2012.v36.n2.a461, DOI 10.22278/2318-2660.2012.V36.N2.A461]; Funada MR, 2007, ARQ BRAS MED VET ZOO, V59, P1338, DOI 10.1590/S0102-09352007000500038; Gennari S. M., 1999, Brazilian Journal of Veterinary Research and Animal Science, V36, P87; Gennari SM, 2016, REV BRAS PARASITOL V, V25, P423, DOI [10.1590/S1984-29612016082, 10.1590/s1984-29612016082]; Giangaspero A, 2006, PARASITOL RES, V99, P297, DOI 10.1007/s00436-006-0169-0; Grecca M., 2013, Archives of Veterinary Science, V18, P1; Hajdusek O, 2004, VET PARASITOL, V122, P183, DOI 10.1016/j.vetpar.2004.04.005; Hamnes IS, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-22; Herges GR, 2012, APPL ENVIRON MICROB, V78, P8096, DOI 10.1128/AEM.02105-12; Huber F, 2007, VET PARASITOL, V150, P65, DOI 10.1016/j.vetpar.2007.08.018; Huber F, 2005, VET PARASITOL, V130, P69, DOI 10.1016/j.vetpar.2005.03.012; Itoh N, 2014, VET PARASITOL, V200, P284, DOI 10.1016/j.vetpar.2013.12.030; Jian FC, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-26; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kostopoulou D, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1989-8; Labruna M.B., 2006, Arq. Inst. Biol., V73, P183, DOI 10.1590/1808-1657v73p1832006; Lallo M. A., 2016, Revista Academica: Ciencia Animal, V14, P119; Lallo MA, 2006, REV SAUDE PUBL, V40, P120, DOI 10.1590/S0034-89102006000100019; Lemos FD, 2012, J FELINE MED SURG, V14, P113, DOI 10.1177/1098612X11429221; Li W, 2015, VET PARASITOL, V208, P125, DOI 10.1016/j.vetpar.2015.01.014; Alves MEM, 2018, PARASITOL RES, V117, P3033, DOI 10.1007/s00436-018-5986-4; Meireles MV, 2010, REV BRAS PARASITOL V, V19, P197, DOI 10.1590/S1984-29612010000400002; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Moura AB., 2009, REV CIENC AGROVET, V8, P173; Olabanji Gbemisola Magaret, 2016, Vet Med Int, V2016, P4591238, DOI 10.1155/2016/4591238; Osman M, 2015, VET PARASITOL, V214, P167, DOI 10.1016/j.vetpar.2015.09.015; Pollock KGJ, 2014, EPIDEMIOL INFECT, V142, P56, DOI 10.1017/S0950268813000678; Ragozo A. M. A., 2002, Brazilian Journal of Veterinary Research and Animal Science, V39, P244, DOI 10.1590/S1413-95962002000500005; Rambozzi L, 2007, J FELINE MED SURG, V9, P392, DOI 10.1016/j.jfms.2007.03.005; Robertson ID, 2000, INT J PARASITOL, V30, P1369, DOI 10.1016/S0020-7519(00)00134-X; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosanowski SM, 2018, PARASITOL RES, V117, P1663, DOI 10.1007/s00436-018-5857-z; Samie A., 2013, African Journal of Microbiology Research, V7, P2510; Seva AD, 2010, REV BRAS PARASITOL V, V19, P249; Sheather A. L., 1923, Journal of Comparative Pathology and Therapeutics, V36, P266; Silva A S., 2008, REV FZVA, V15, P191; Silva AS., 2007, PREVALENCIA PARASITI, V33, P27, DOI [10.5902/223658346460, DOI 10.5902/223658346460]; Sotiriadou I, 2013, PARASITE, V20, DOI 10.1051/parasite/2013008; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomaz A, 2007, VET PARASITOL, V150, P291, DOI 10.1016/j.vetpar.2007.09.023; Walsh F, 2009, FAM PROCESS, V48, P462, DOI 10.1111/j.1545-5300.2009.01296.x; Wells DL, 2009, J SOC ISSUES, V65, P523, DOI 10.1111/j.1540-4560.2009.01612.x; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Xiao Lihua, 2007, P119; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Xu HL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1409-5; Yoshiuchi R, 2010, VET PARASITOL, V174, P313, DOI 10.1016/j.vetpar.2010.09.004	67	1	1	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255087	10.1371/journal.pone.0255087	http://dx.doi.org/10.1371/journal.pone.0255087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343188	gold, Green Published			2022-12-26	WOS:000685264200019
J	Yang, F; Andersen, DS; Trabue, S; Kent, AD; Pepple, LM; Gates, RS; Howe, AS				Yang, Fan; Andersen, Daniel S.; Trabue, Steven; Kent, Angela D.; Pepple, Laura M.; Gates, Richard S.; Howe, Adina S.			Microbial assemblages and methanogenesis pathways impact methane production and foaming in manure deep-pit storages	PLOS ONE			English	Article							DISTILLERS DRIED GRAINS; METABOLIZABLE ENERGY; DIETARY FIBER; SWINE; COMMUNITIES; CLOSTRIDIUM; DIGESTIBILITY; FERMENTATION; DEGRADATION; PREDICTION	Foam accumulation in swine manure deep-pits has been linked to explosions and flash fires that pose devastating threats to humans and livestock. It is clear that methane accumulation within these pits is the fuel for the fire; it is not understood what microbial drivers cause the accumulation and stabilization of methane. Here, we conducted a 13-month field study to survey the physical, chemical, and biological changes of pit-manure across 46 farms in Iowa. Our results showed that an increased methane production rate was associated with less digestible feed ingredients, suggesting that diet influences the storage pit's microbiome. Targeted sequencing of the bacterial 16S rRNA and archaeal mcrA genes was used to identify microbial communities' role and influence. We found that microbial communities in foaming and non-foaming manure were significantly different, and that the bacterial communities of foaming manure were more stable than those of non-foaming manure. Foaming manure methanogen communities were enriched with uncharacterized methanogens whose presence strongly correlated with high methane production rates. We also observed strong correlations between feed ration, manure characteristics, and the relative abundance of specific taxa, suggesting that manure foaming is linked to microbial community assemblage driven by efficient free long-chain fatty acid degradation by hydrogenotrophic methanogenesis.	[Yang, Fan; Andersen, Daniel S.; Howe, Adina S.] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA; [Trabue, Steven] USDA ARS, Natl Lab Agr & Environm, Ames, IA USA; [Kent, Angela D.; Pepple, Laura M.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL USA; [Gates, Richard S.] Iowa State Univ, Egg Ind Ctr, Ames, IA USA	Iowa State University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; Iowa State University	Yang, F (corresponding author), Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA.	fan.michelle.yang@gmail.com	Gates, Richard/M-4367-2014	Gates, Richard/0000-0003-2812-1739; Yang, Fan/0000-0002-2442-7098	National Pork Board; Iowa Pork Producers Association [15-136]	National Pork Board; Iowa Pork Producers Association	This project was funded by National Pork Board and Iowa Pork Producers Association (project number: 15-136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MM, 2009, MICROB BIOTECHNOL, V2, P538, DOI 10.1111/j.1751-7915.2009.00100.x; Andersen DS, 2018, T ASABE, V61, P943, DOI 10.13031/trans.12568; Anderson PV, 2012, J ANIM SCI, V90, P1242, DOI 10.2527/jas.2010-3605; Angenent LT, 2016, ENVIRON SCI TECHNOL, V50, P2796, DOI 10.1021/acs.est.5b04847; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2016, FOAM MAN FOAM MAN; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bonder MJ, 2012, BIOINFORMATICS, V28, P2891, DOI 10.1093/bioinformatics/bts552; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cavaleiro AJ, 2016, ENVIRON SCI TECHNOL, V50, P3082, DOI 10.1021/acs.est.5b03204; Chen W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070837; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Conrad R, 2020, PEDOSPHERE, V30, P25, DOI 10.1016/S1002-0160(18)60052-9; Cuiv PO, 2011, J BACTERIOL, V193, P1288, DOI 10.1128/JB.01328-10; Duca FA, 2014, DIABETES OBES METAB, V16, P68, DOI 10.1111/dom.12340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ferry James G., 1993, P304; FRANK GR, 1983, J ANIM SCI, V57, P645, DOI 10.2527/jas1983.573645x; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; GrechMora I, 1996, INT J SYST BACTERIOL, V46, P512, DOI 10.1099/00207713-46-2-512; Hagen LH, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01955-16; Hammond KJ., 2016, J DAIRY SCI, V99, P1, DOI [10.3168/jds.2015-9445, DOI 10.3168/JDS.2015-9445]; Hoff SJ., 2015, MANURE FOAMING ISSUE; Jacobson LD., 2013, BIOL ENG T, V7004, P4764; Jarosz AF, 2014, J PROBL SOLVING, V7, P2, DOI 10.7771/1932-6246.1167; Jha R, 2016, ANIM FEED SCI TECH, V212, P18, DOI 10.1016/j.anifeedsci.2015.12.002; Karakashev D, 2006, APPL ENVIRON MICROB, V72, P5138, DOI 10.1128/AEM.00489-06; Kerr BJ, 2013, J ANIM SCI, V91, P3231, DOI 10.2527/jas.2013-6252; Lay JJ, 1997, WATER RES, V31, P1518, DOI 10.1016/S0043-1354(96)00413-7; Lin PY, 2007, INT J HYDROGEN ENERG, V32, P1728, DOI 10.1016/j.ijhydene.2006.12.009; Marsh TL., 2016, ADV MICROBIOL, V6, P879, DOI [DOI 10.4236/AIM.2016.612083, 10.4236/aim.2016.612083]; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Mechichi T, 1999, INT J SYST BACTERIOL, V49, P1741, DOI 10.1099/00207713-49-4-1741; Oh ST, 2010, PROCESS BIOCHEM, V45, P335, DOI 10.1016/j.procbio.2009.10.006; Pugazhendhi Arivalagan, 2019, Biotechnology Reports, V21, pe00301, DOI 10.1016/j.btre.2018.e00301; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Santos SD, 2014, BRIEF BIOINFORM, V15, P906, DOI 10.1093/bib/bbt051; SCHULZE H, 1994, J ANIM SCI, V72, P2362, DOI 10.2527/1994.7292362x; Shurson J., 2018, WHAT HAVE WE LEARNED; Smil V, 2002, ENZYME MICROB TECH, V30, P305, DOI 10.1016/S0141-0229(01)00504-X; Sousa DZ, 2007, APPL ENVIRON MICROB, V73, P1054, DOI 10.1128/AEM.01723-06; Sousa DZ, 2009, FEMS MICROBIOL ECOL, V68, P257, DOI 10.1111/j.1574-6941.2009.00680.x; Steinberg LM, 2009, APPL ENVIRON MICROB, V75, P4435, DOI 10.1128/AEM.02858-08; Trabue S, 2014, J ENVIRON QUAL, V43, P1176, DOI 10.2134/jeq2013.05.0207; Urriola PE, 2010, J ANIM SCI, V88, P1454, DOI 10.2527/jas.2009-2162; Van Weelden MB, 2016, T ASABE, V59, P923, DOI 10.13031/trans.59.11470; Van Weelden MB, 2016, BIORESOURCE TECHNOL, V202, P84, DOI 10.1016/j.biortech.2015.11.080; Van Weelden MB, 2015, T ASABE, V58, P1299; WANG G, 1984, APPL ENVIRON MICROB, V47, P294, DOI 10.1128/AEM.47.2.294-298.1984; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willis AD, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02407; Yan M, 2015, T ASABE, V58, P1841; Yang SZ, 2014, J MICROBIOL METH, V103, P3, DOI 10.1016/j.mimet.2014.05.006; Yang ZH, 2016, BIORESOURCE TECHNOL, V212, P164, DOI 10.1016/j.biortech.2016.04.046; Zhang P, 2009, WATER RES, V43, P3735, DOI 10.1016/j.watres.2009.05.036; Zhang Y., 2010, SULFUR CONCENTRATION; Zhu XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep14360; Zmora N, 2019, NAT REV GASTRO HEPAT, V16, P35, DOI 10.1038/s41575-018-0061-2	58	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0254730	10.1371/journal.pone.0254730	http://dx.doi.org/10.1371/journal.pone.0254730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343206	Green Published, gold			2022-12-26	WOS:000685264200051
J	Chung, I; Kim, SA; Kim, S; Lee, JO; Park, CY; Lee, J; Kang, J; Lee, JY; Seo, I; Lee, HJ; Han, JA; Kang, MJ; Lim, E; Kim, SJ; Wu, SW; Oh, JY; Chung, JH; Kim, EK; Kim, HS; Shin, MJ				Chung, InHyeok; Kim, Shin Ae; Kim, Seolsong; Lee, Jung Ok; Park, Clara Yongjoo; Lee, Juhee; Kang, Jun; Lee, Jin Young; Seo, Ilhyeok; Lee, Hye Jeong; Han, Jeong Ah; Kang, Min Ju; Lim, Eunice; Kim, Su Jin; Wu, Sang Woo; Oh, Joo Yeon; Chung, Ji Hyung; Kim, Eun-Kyoung; Kim, Hyeon Soo; Shin, Min-Jeong			Biglycan reduces body weight by regulating food intake in mice and improves glucose metabolism through AMPK/AKT dual pathways in skeletal muscle	FASEB JOURNAL			English	Article						AKT; AMPK; biglycan; food intake; glucose uptake; obesity	PROTEIN-KINASE; INSULIN-RESISTANCE; TOLL-LIKE; EXPRESSION; EXERCISE; DECORIN; PROTEOGLYCANS; HEALTH; CONTRACTION; NEURONS	While biglycan (BGN) is suggested to direct diverse signaling cascades, the effects of soluble BGN as a ligand on metabolic traits have not been studied. Herein, we tested the effects of BGN on obesity in high-fat diet (HFD)-induced obese animals and glucose metabolism, with the underlying mechanism responsible for observed effects in vitro. Our results showed that BGN administration (1 mg/kg body weight, intraperitoneally) significantly prevented HFD-induced obesity, and this was mainly attributed to reduced food intake. Also, intracerebroventricular injection of BGN reduced food intake and body weight. The underlying mechanism includes modulation of neuropeptides gene expression involved in appetite in the hypothalamus in vitro and in vivo. In addition, BGN regulates glucose metabolism as shown by improved glucose tolerance in mice as well as AMPK/AKT dual pathway-driven enhanced glucose uptake and GLUT4 translocation in L6 myoblast cells. In conclusion, our results suggest BGN as a potential therapeutic target to treat risk factors for metabolic diseases.	[Chung, InHyeok; Lee, Juhee; Lee, Jin Young; Shin, Min-Jeong] Korea Univ, Interdisciplinary Program Precis Publ Hlth, Seoul 02841, South Korea; [Kim, Shin Ae; Lee, Jung Ok; Seo, Ilhyeok; Lee, Hye Jeong; Han, Jeong Ah; Kang, Min Ju; Kim, Su Jin; Wu, Sang Woo; Oh, Joo Yeon; Kim, Hyeon Soo] Korea Univ, Dept Anat, Coll Med, Seoul 02841, South Korea; [Kim, Seolsong; Kim, Eun-Kyoung] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain & Cognit Sci, Daegu, South Korea; [Park, Clara Yongjoo] Chonnam Natl Univ, Dept Food & Nutr, Gwangju, South Korea; [Kang, Jun; Chung, Ji Hyung] CHA Univ, Dept Biotechnol, Gyeonggi Do, South Korea; [Lim, Eunice] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Kim, Eun-Kyoung] Daegu Gyeongbuk Inst Sci & Technol, Neurometabol Res Ctr, Daegu, South Korea; [Shin, Min-Jeong] Korea Univ, Sch Biosyst & Biomed Sci, Coll Hlth Sci, Seoul, South Korea	Korea University; Korea University; Korea University Medicine (KU Medicine); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Chonnam National University; Pochon Cha University; University of Michigan System; University of Michigan; Daegu Gyeongbuk Institute of Science & Technology (DGIST); Korea University	Shin, MJ (corresponding author), Korea Univ, Interdisciplinary Program Precis Publ Hlth, Seoul 02841, South Korea.; Kim, HS (corresponding author), Korea Univ, Dept Anat, Coll Med, Seoul 02841, South Korea.	anatomykim@korea.ac.kr; mjshin@korea.ac.kr		Lee, Juhee/0000-0002-3223-734X	NRF - Ministry of Science and ICT [NRF-2020R1A2C2005580, NRF-2020R1A2B5B02001468]	NRF - Ministry of Science and ICT	This study was supported by the Basic Science Research Program through the NRF funded by the Ministry of Science and ICT (NRF-2020R1A2C2005580 & NRF-2020R1A2B5B02001468)	Amenta AR, 2011, P NATL ACAD SCI USA, V108, P762, DOI 10.1073/pnas.1013067108; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Berendsen AD, 2011, P NATL ACAD SCI USA, V108, P17022, DOI 10.1073/pnas.1110629108; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801; Carter S, 2019, PFLUG ARCH EUR J PHY, V471, P413, DOI 10.1007/s00424-018-2210-4; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Chanmee T, 2016, J BIOL CHEM, V291, P24105, DOI 10.1074/jbc.M116.751263; Chavez JA, 2008, J BIOL CHEM, V283, P9187, DOI 10.1074/jbc.M708934200; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; ERIKSSON H, 1992, J INTERN MED, V232, P389, DOI 10.1111/j.1365-2796.1992.tb00604.x; FISHER LW, 1983, J BIOL CHEM, V258, P6588; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Hogemann B, 1997, PATHOL RES PRACT, V193, P747; Huang GR, 2012, TRENDS ENDOCRIN MET, V23, P16, DOI 10.1016/j.tem.2011.09.006; Huang XJ, 2018, INT J BIOL SCI, V14, P1483, DOI 10.7150/ijbs.27173; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; Jeon Y, 2016, BIOCHEM BIOPH RES CO, V470, P818, DOI 10.1016/j.bbrc.2016.01.115; Kang L, 2013, DIABETES, V62, P1888, DOI 10.2337/db12-1502; Kang L, 2011, DIABETES, V60, P416, DOI 10.2337/db10-1116; Kim JI, 2016, SCI REP-UK, V6, DOI 10.1038/srep18825; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Kwak SY, 2020, METABOLISM, V105, DOI 10.1016/j.metabol.2020.154171; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Matsuura T, 2001, MATRIX BIOL, V20, P367, DOI 10.1016/S0945-053X(01)00142-1; Moreth K, 2010, J CLIN INVEST, V120, P4251, DOI 10.1172/JCI42213; O'Neill HM, 2013, DIABETES METAB J, V37, P1, DOI 10.4093/dmj.2013.37.1.1; Ojima K, 2014, EUPA OPEN PROTEOM, V5, DOI DOI 10.1016/J.EUPR0T.2014.08.001; Parisuthiman D, 2005, J BONE MINER RES, V20, P1878, DOI 10.1359/JBMR.050612; Park SW, 2006, DIABETES, V55, P1813, DOI 10.2337/db05-1183; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; ROUGHLEY PJ, 1994, MATRIX BIOL, V14, P51, DOI 10.1016/0945-053X(94)90029-9; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Smushkin Galina, 2010, Medicine (Abingdon), V38, P597; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211; Ying Z, 2018, BBA-MOL BASIS DIS, V1864, P3679, DOI 10.1016/j.bbadis.2018.10.002	48	2	2	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21794	10.1096/fj.202002039RR	http://dx.doi.org/10.1096/fj.202002039RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314059	Green Published			2022-12-26	WOS:000678975300003
J	Gajewski, K				Gajewski, Konrad			Multiple drivers of ecological change in Arctic lakes and ponds	PLOS ONE			English	Editorial Material							ELLESMERE-ISLAND; HOLOCENE CLIMATE; SOMERSET ISLAND; ASSEMBLAGES; RESPONSES; CANADA	Griffiths et al. (2017) analyzed several ponds and lakes from the Cape Herschel region of Ellesmere Island in order to " horizontal ellipsis explicitly examine the role of ice cover as the dominant driver of diatom assemblage change horizontal ellipsis ". I reanalyze their data and suggest that their classification scheme, that they propose is due to differences in ice cover seasonality ("warm", "cool", "cold", and "oasis"), is confounded with other morphological and chemical variables that better explain the differences between the groups. The "cold" sites are the deepest (lakes) and differ from the small, shallow ponds that occasionally dry, which would therefore have different diatom assemblages and histories. The "oasis" sites are nutrient enriched and probably have more stable water supplies, thereby enabling an aquatic flora providing habitats for diatoms. A key part of their interpretation is that "warm" sites have responded more rapidly to recent climate change than "cold" or "cool" sites, but their chronologies do not allow for such a conclusion. There is no clear difference between "cool" and "warm" sites, and problems in dating the sequences means inferences about their histories are not supported by data. Their results, which are restricted to the past century, are contradicted by a Holocene sequence from the region.	[Gajewski, Konrad] Univ Ottawa, Dept Geog Environm & Geomat, Lab Paleoclimatol & Climatol, Ottawa, ON, Canada	University of Ottawa	Gajewski, K (corresponding author), Univ Ottawa, Dept Geog Environm & Geomat, Lab Paleoclimatol & Climatol, Ottawa, ON, Canada.	gajewski@uottawa.ca			Natural sciences and engineering research council of Canada (NSERC)	Natural sciences and engineering research council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Natural sciences and engineering research council of Canada (NSERC) http://www.nserc-crsng.gc.ca/index_eng.asp (KG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson DE, 2000, B AM METEOROL SOC, V81, P2621, DOI 10.1175/1520-0477(2000)081<2621:ANDOHA>2.3.CO;2; Atkinson DE, 2002, J CLIMATE, V15, P3601, DOI 10.1175/1520-0442(2002)015<3601:HREOSS>2.0.CO;2; Bergeron JF, 1989, MUSKOX, V37, P76; Blake Jr W, 1978, 781C GEOL SURV CAN P, V78, P119; BLAKE W, 1981, GEOGR ANN A, V63, P201, DOI 10.2307/520833; BLAKE W, 1992, CAN J EARTH SCI, V29, P1958, DOI 10.1139/e92-153; Bouchard G, 2004, J BIOGEOGR, V31, P1955, DOI 10.1111/j.1365-2699.2004.01143.x; Briner JP, 2016, QUATERNARY SCI REV, V147, P340, DOI 10.1016/j.quascirev.2016.02.010; DOUGLAS MSV, 1994, SCIENCE, V266, P416, DOI 10.1126/science.266.5184.416; Elster Josef, 1999, Polar Record, V35, P231; FAHSELT D, 1988, LICHENOLOGIST, V20, P253, DOI 10.1017/S0024282988000295; Finkelstein SA, 2014, J QUATERNARY SCI, V29, P249, DOI 10.1002/jqs.2697; Fisher D, 2012, GLOBAL PLANET CHANGE, V84-85, P3, DOI 10.1016/j.gloplacha.2011.06.005; Gajewski K, 2015, GLOBAL PLANET CHANGE, V128, P14, DOI 10.1016/j.gloplacha.2015.02.003; GAJEWSKI K, 1995, QUATERNARY RES, V44, P228, DOI 10.1006/qres.1995.1067; Griffiths K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172989; HENRY G, 1986, ARCTIC, V39, P78; Henry GHR, 1998, PLANT ECOL, V134, P119, DOI 10.1023/A:1009731615304; Hobbie J.E., 1984, P63; Juggins S, 2007, C2 VERSION 1 5 USER; Koizumi T, 2003, GEOGR REV JAPAN, V78, P270; Labine C, 1994, ECOLOGY POLAR OASIS, P23; Levesque E, 1997, GLOBAL CHANGE BIOL, V3, P125, DOI 10.1111/j.1365-2486.1997.gcb145.x; Levesque E, 1996, ARCTIC ALPINE RES, V28, P156, DOI 10.2307/1551755; Michelutti N, 2013, J PHYCOL, V49, P41, DOI 10.1111/jpy.12024; Oksanen J., 2019, R PACKAGE VERSION; Oswald WW, 2005, HOLOCENE, V15, P758, DOI 10.1191/0959683605hl849rr; Paull TM, 2017, ARCT SCI, V3, P17, DOI 10.1139/as-2016-0013; Peros M, 2010, QUATERNARY RES, V73, P247, DOI 10.1016/j.yqres.2009.11.010; Peros MC, 2008, QUATERNARY SCI REV, V27, P235, DOI 10.1016/j.quascirev.2007.09.002; R Core Team, 2020, R LANG ENV STAT COMP; Raillard M, 2000, ARCT ANTARCT ALP RES, V32, P278, DOI 10.2307/1552526; Rouillard A, 2012, PALAEOGEOGR PALAEOCL, V321, P1, DOI 10.1016/j.palaeo.2012.01.011; Ruhland KM, 2015, J PALEOLIMNOL, V54, P1, DOI 10.1007/s10933-015-9837-3; SCHLEDERMANN P, 1978, ARCTIC, V31, P459; Smol JP, 2007, P NATL ACAD SCI USA, V104, P12395, DOI 10.1073/pnas.0702777104	36	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0254257	10.1371/journal.pone.0254257	http://dx.doi.org/10.1371/journal.pone.0254257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34330143	gold, Green Published			2022-12-26	WOS:000685248600070
J	Marmet, S; Wicki, M; Gmel, G; Gachoud, C; Daeppen, JB; Bertholet, N; Studer, J				Marmet, Simon; Wicki, Matthias; Gmel, Gerhard; Gachoud, Celine; Daeppen, Jean-Bernard; Bertholet, Nicolas; Studer, Joseph			The psychological impact of the COVID-19 crisis is higher among young Swiss men with a lower socioeconomic status: Evidence from a cohort study	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; EVENT SCALE; HEALTH; WORKERS; INDEX	Aims The present study aimed to investigate whether the psychological impact of the COVID-19 crisis varied with regards to young Swiss men's pre-crisis level of education and socioeconomic status and to changes in their work situation due to it. Methods A cohort of 2345 young Swiss men (from 21 out of 26 Swiss cantons; mean age = 29) completed survey-based assessments shortly before (April 2019 to February 2020) and early on during the COVID-19 crisis (May to June 2020). Outcomes measured were psychological outcomes before and during the COVID-19 crisis (depression, perceived stress and sleep quality), and the fear, isolation and psychological trauma induced by it. We investigated associations between these outcomes and their predictors: pre-crisis socioeconomic status (relative financial status, difficulty paying bills, level of education), changes in work situation during the crisis (job loss, partial unemployment, working from home, change in workload) and working in contact with potentially infected people, both inside and outside the healthcare sector. For outcomes measured before and during the crisis, the analyses were adjusted for their pre-crisis levels. Results About 21% of participants changed their employment status (job loss, partial unemployment or lost money if self-employed) and more than 40% worked predominantly from home during the COVID-19 crisis. Participants with a lower relative socioeconomic status already before the crisis experienced a higher psychological impact due to the COVID-19 crisis, compared to participants with an average socioeconomic status (major depression (b = 0.12 [0.03, 0.22]), perceived stress (b = 0.15 [0.05, 0.25]), psychological trauma (b = 0.15 [0.04, 0.26]), fear (b = 0.20 [0.10, 0.30]) and isolation (b = 0.19 [0.08, 0.29])). A higher impact was also felt by participants who lost their job due to the COVID-19 crisis, the partially unemployed, those with an increased workload or those who worked mainly from home (e.g. depression b = 0.25 [0.16, 0.34] for those working 90%+ at home, compared to those not working at home). Conclusions Even in a country like Switzerland, with relatively high social security benefits and universal healthcare, the COVID-19 crisis had a considerable psychological impact, especially among those with a lower socioeconomic status and those who experienced deteriorations in their work situation due to the COVID-19 crisis. Supporting these populations during the crisis may help to prevent an amplification of inequalities in mental health and social status. Such support could help to lower the overall impact of the crisis on the mental well-being of Switzerland's population.	[Marmet, Simon; Wicki, Matthias; Gmel, Gerhard; Gachoud, Celine; Daeppen, Jean-Bernard; Bertholet, Nicolas; Studer, Joseph] Lausanne Univ Hosp, Addict Med, Lausanne, Switzerland; [Marmet, Simon; Wicki, Matthias; Gmel, Gerhard; Gachoud, Celine; Daeppen, Jean-Bernard; Bertholet, Nicolas; Studer, Joseph] Univ Lausanne, Lausanne, Switzerland; [Gmel, Gerhard] Addict Switzerland, Lausanne, Switzerland; [Gmel, Gerhard] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Gmel, Gerhard] Univ West England, Bristol, Avon, England	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of West England	Marmet, S (corresponding author), Lausanne Univ Hosp, Addict Med, Lausanne, Switzerland.; Marmet, S (corresponding author), Univ Lausanne, Lausanne, Switzerland.	simon.marmet@chuv.ch		Wicki, Matthias/0000-0002-4255-5931; Marmet, Simon/0000-0002-9060-8567; Bertholet, Nicolas/0000-0001-5064-6377	Swiss National Science Foundation [FN 33CSC0-122679, FN 33CS30_139467, FN 33CS30_148493, FN 33CS30_177519]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grants FN 33CSC0-122679, FN 33CS30_139467, FN 33CS30_148493 and FN 33CS30_177519 from the Swiss National Science Foundation (www.snf.ch) to GG. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agberotimi SF, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.559819; Ahmed K, 2020, J ENVIRON MANAGE, V274, DOI 10.1016/j.jenvman.2020.111209; AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Anderson G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2149; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401; Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; Bech P, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0529-3; Burstrom B., 2020, SOCIAL DETERMINANTS; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chong MY, 2004, BRIT J PSYCHIAT, V185, P127, DOI 10.1192/bjp.185.2.127; COHEN S, 1988, CLAR SYMP, P31; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; De Quervain D., 2020, SWISS CORONA STRESS, DOI [10.31219/osf.io/jqw6a, DOI 10.31219/OSF.IO/JQW6A]; Federal Office of Public Health, 2020, COVID 19 SCHW; Federal Statistical Office, STAT INC LIV COND HO; Findlay LC, 2020, HEALTH REP, V31, P22, DOI 10.25318/82-003-x202000400003-eng; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Hibell B., 2012, 2011 ESPAD REPORT SU, DOI [10.1111/j.1360-0443.2011.03537.x, DOI 10.1111/J.1360-0443.2011.03537.X]; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Junna L, 2021, ADDICTION, V116, P74, DOI 10.1111/add.15106; Kantamneni N, 2020, J VOCAT BEHAV, V119, DOI 10.1016/j.jvb.2020.103439; Khalatbari-Soltani S, 2020, J EPIDEMIOL COMMUN H, V74, P620, DOI 10.1136/jech-2020-214297; Kohler K, 2020, B 2020 SCHWEIZERISCH; Kuhn U, 2021, EUR SOC, V23, pS942, DOI 10.1080/14616696.2020.1839671; Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190; Marmet S., 2020, PSYCHOL IMPACT COVID; Maunder RG, 2004, PSYCHOSOM MED, V66, P938, DOI 10.1097/01.psy.0000145673.84698.18; Meyer OL, 2014, AM J PUBLIC HEALTH, V104, P1734, DOI 10.2105/AJPH.2014.302003; Muller AE, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113441; Nguyen LH, 2020, LANCET PUBLIC HEALTH, V5, pE475, DOI 10.1016/S2468-2667(20)30164-X; Pietrabissa G, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.02201; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Raker EJ, 2020, P NATL ACAD SCI USA, V117, P12595, DOI 10.1073/pnas.2006706117; Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w; Shanahan L, 2022, PSYCHOL MED, V52, P824, DOI 10.1017/S003329172000241X; Shaukat N, 2020, INT J EMERG MED, V13, DOI 10.1186/s12245-020-00299-5; Sommer I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2227-y; Spiller TR, 2022, PSYCHOL MED, V52, P1395, DOI 10.1017/S0033291720003128; Spoorthy MS, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102119; Swiss Federal Statistical Office, 2021, SCHW GES 2017 TEL SC; Swiss Federal Statistical Office, 2020, BILD 2019; Traunmuller C, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09489-5; UCLouvain, 2020, COVID 19 RES IPSY 20; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; Wanberg CR, 2020, J APPL PSYCHOL, V105, P1382, DOI 10.1037/apl0000831; Weiss Daniel S., 1997, P399; WHO, 2003, SUMM TABL SARS CAS C; Wu P, 2008, ALCOHOL ALCOHOLISM, V43, P706, DOI 10.1093/alcalc/agn073	49	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255050	10.1371/journal.pone.0255050	http://dx.doi.org/10.1371/journal.pone.0255050			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324522	Green Submitted, gold, Green Published			2022-12-26	WOS:000685248200053
J	Suvanto, S; Lehtonen, A; Nevalainen, S; Lehtonen, I; Viiri, H; Strandstrom, M; Peltoniemi, M				Suvanto, Susanne; Lehtonen, Aleksi; Nevalainen, Seppo; Lehtonen, Ilari; Viiri, Heli; Strandstrom, Mikael; Peltoniemi, Mikko			Mapping the probability of forest snow disturbances in Finland	PLOS ONE			English	Article							NORWAY SPRUCE; PICEA-ABIES; NATURAL DISTURBANCES; WIND DAMAGE; SCOTS PINE; MODELS; STANDS; STORM; LOADS; RISK	The changing forest disturbance regimes emphasize the need for improved damage risk information. Here, our aim was to (1) improve the current understanding of snow damage risks by assessing the importance of abiotic factors, particularly the modelled snow load on trees, versus forest properties in predicting the probability of snow damage, (2) produce a snow damage probability map for Finland. We also compared the results for winters with typical snow load conditions and a winter with exceptionally heavy snow loads. To do this, we used damage observations from the Finnish national forest inventory (NFI) to create a statistical snow damage occurrence model, spatial data layers from different sources to use the model to predict the damage probability for the whole country in 16 x 16 m resolution. Snow damage reports from forest owners were used for testing the final map. Our results showed that best results were obtained when both abiotic and forest variables were included in the model. However, in the case of the high snow load winter, the model with only abiotic predictors performed nearly as well as the full model and the ability of the models to identify the snow damaged stands was higher than in other years. The results showed patterns of forest adaptation to high snow loads, as spruce stands in the north were less susceptible to damage than in southern areas and long-term snow load reduced the damage probability. The model and the derived wall-to-wall map were able to discriminate damage from no-damage cases on a good level (AUC > 0.7). The damage probability mapping approach identifies the drivers of snow disturbances across forest landscapes and can be used to spatially estimate the current and future disturbance probabilities in forests, informing practical forestry and decision-making and supporting the adaptation to the changing disturbance regimes.	[Suvanto, Susanne; Lehtonen, Aleksi; Strandstrom, Mikael; Peltoniemi, Mikko] Nat Resources Inst Finland Luke, Helsinki, Finland; [Suvanto, Susanne] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Nevalainen, Seppo] Nat Resources Inst Finland Luke, Joensuu, Finland; [Lehtonen, Ilari] Finnish Meteorol Inst, Helsinki, Finland; [Viiri, Heli] UPM Forest, Tampere, Finland	Natural Resources Institute Finland (Luke); University of Birmingham; Natural Resources Institute Finland (Luke); Finnish Meteorological Institute	Suvanto, S (corresponding author), Nat Resources Inst Finland Luke, Helsinki, Finland.; Suvanto, S (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.	susanne.suvanto@luke.fi		Peltoniemi, Mikko/0000-0003-2028-6969; Viiri, Heli/0000-0003-3952-9481; Suvanto, Susanne/0000-0002-0345-3596; Lehtonen, Aleksi/0000-0003-1388-0388; Lehtonen, Ilari/0000-0001-7317-9580	project SAATYO by Ministry of Agriculture and Forestry of Finland; European Union [895158]; BiodivClim ERANet Cofund (joint BiodivERsA Call on "Biodiversity and Climate Change", 2019-2020); Academy of Finland [344722]; ANR (France) [ANR-20-EBI50005-03]; Federal Ministry of Education and Research (Germany) [16LC2021A]	project SAATYO by Ministry of Agriculture and Forestry of Finland; European Union(European Commission); BiodivClim ERANet Cofund (joint BiodivERsA Call on "Biodiversity and Climate Change", 2019-2020); Academy of Finland(Academy of Finland); ANR (France)(French National Research Agency (ANR)); Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF))	The research was funded from the project SAATYO funded by the Ministry of Agriculture and Forestry of Finland. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 895158. The contribution of Mikko Peltoniemi on the research was also funded through the BiodivClim ERANet Cofund (joint BiodivERsA Call on "Biodiversity and Climate Change", 2019-2020) with national co-funding through Academy of Finland (decision no. 344722), ANR (France, project ANR-20-EBI50005-03), and Federal Ministry of Education and Research (Germany, grant no. 16LC2021A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Diaz-Yanez O, 2019, ECOL MODEL, V408, DOI 10.1016/j.ecolmodel.2019.108741; Diaz-Yanez O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161361; Duperat M, 2020, FORESTS, V11, DOI 10.3390/f11101089; Geburek T, 2008, FLORA, V203, P126, DOI 10.1016/j.flora.2007.01.003; Groenemeijer P., 2015, CASES EXTREME WEATHE; Hijmans RJ, 2017, RASTER GEOGRAPHIC DA; Hlasny T, 2011, FOREST ECOL MANAG, V262, P2151, DOI 10.1016/j.foreco.2011.08.005; Hoffmann L, 2019, ATMOS CHEM PHYS, V19, P3097, DOI 10.5194/acp-19-3097-2019; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Jalkanen A, 2000, FOREST ECOL MANAG, V135, P315, DOI 10.1016/S0378-1127(00)00289-9; Jalkanen R, 1998, EUR J FOREST PATHOL, V28, P373; Klopcic M, 2009, ECOSCIENCE, V16, P48, DOI 10.2980/16-1-3181; Korhonen K.T., 2016, NATL FOREST INVENTOR, P369; Korhonen K.T., 2017, SUOMEN METSAT 2009 2; Lehtonen I, 2016, NAT HAZARD EARTH SYS, V16, P2259, DOI 10.5194/nhess-16-2259-2016; Lehtonen I, 2014, SILVA FENN, V48, DOI 10.14214/sf.1120; Makisara K., 2019, MULTISOURCE NATL FOR; MAKKONEN L, 1995, ATMOS RES, V36, P185, DOI 10.1016/0169-8095(94)00034-B; Mikola P., 1938, FINNISH SUMMARY GERM; Morgenstern K.E., 1996, GEOGRAPHIC VARIATION; Nagel TA, 2017, FOREST ECOL MANAG, V388, P29, DOI 10.1016/j.foreco.2016.07.047; Nykanen Marja-Leena, 1997, Silva Fennica, V31, P193; Pebesma E.J., 2005, R NEWS, V5; Peltola H, 1999, CAN J FOREST RES, V29, P647, DOI 10.1139/cjfr-29-6-647; R Core Team, 2020, R LANG ENV STAT COMP; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schelhaas MJ, 2003, GLOBAL CHANGE BIOL, V9, P1620, DOI 10.1046/j.1365-2486.2003.00684.x; Seidl R, 2017, NAT CLIM CHANGE, V7, P395, DOI [10.1038/NCLIMATE3303, 10.1038/nclimate3303]; Solantie Reijo, 1994, Silva Fennica, V28, P203; Suominen O., 1963, FINNISH SUMMARY ENGL; Suvanto S, 2019, FOREST ECOL MANAG, V453, DOI 10.1016/j.foreco.2019.117619; Suvanto S, 2016, FOREST ECOL MANAG, V381, P17, DOI 10.1016/j.foreco.2016.09.005; SYKE, 2015, METS; Tomppo E, 2011, MANAG FOR ECOSYST, V21, P1; Tomppo E, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11040384; Valinger E, 1997, FOREST ECOL MANAG, V97, P215, DOI 10.1016/S0378-1127(97)00062-5; Valinger E, 1999, ENVIRON MANAGE, V24, P209, DOI 10.1007/s002679900227; Venalainen A, 2020, GLOBAL CHANGE BIOL, V26, P4178, DOI 10.1111/gcb.15183; Wallentin C, 2014, FORESTRY, V87, P229, DOI 10.1093/forestry/cpt046; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zhu JJ, 2006, SILVA FENN, V40, P37, DOI 10.14214/sf.351	41	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254876	10.1371/journal.pone.0254876	http://dx.doi.org/10.1371/journal.pone.0254876			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324530	gold, Green Published, Green Submitted			2022-12-26	WOS:000685248200069
J	Okotto-Okotto, J; Yu, WY; Kwoba, E; Thumbi, SM; Okotto, LG; Wanza, P; da Silva, DTG; Wright, J				Okotto-Okotto, Joseph; Yu, Weiyu; Kwoba, Emmah; Thumbi, Samuel M.; Okotto, Lorna Grace; Wanza, Peggy; Trajano Gomes da Silva, Diogo; Wright, Jim			A mixed methods study to evaluate participatory mapping for rural water safety planning in western Kenya	PLOS ONE			English	Article							RAINWATER HARVESTING SYSTEMS; DRINKING-WATER; QUALITY; INFORMATION; PERCEPTIONS; SANITATION; MANAGEMENT; KISUMU; FOREST; GIS	Water safety planning is an approach to ensure safe drinking-water access through comprehensive risk assessment and water supply management from catchment to consumer. However, its uptake remains low in rural areas. Participatory mapping, the process of map creation for resource management by local communities, has yet to be used for rural water safety planning. In this mixed methods study, to evaluate the validity of participatory mapping outputs for rural water safety planning and assess community understanding of water safety, 140 community members in Siaya County, Kenya, attended ten village-level participatory mapping sessions. They mapped drinking-water sources, ranked their safety and mapped potential contamination hazards. Findings were triangulated against a questionnaire survey of 234 households, conducted in parallel. In contrast to source type ranking for international monitoring, workshop participants ranked rainwater's safety above piped water and identified source types such as broken pipes not explicitly recorded in water source typologies often used for formal monitoring. Participatory mapping also highlighted the overlap between livestock grazing areas and household water sources. These findings were corroborated by the household survey and subsequent participatory meetings. However, comparison with household survey data suggested participatory mapping outputs omitted some water sources and landscape-scale contamination hazards, such as open defecation areas or flood-prone areas. In follow-up visits, participant groups ranked remediation of rainwater harvesting systems as the most acceptable intervention to address hazards. We conclude that participatory mapping can complement other established approaches to rural water safety planning by capturing informally managed source use and facilitating community engagement.	[Okotto-Okotto, Joseph] Victoria Inst Res Environm & Dev VIRED Int, Rabuor, Kisumu, Kenya; [Yu, Weiyu; Wright, Jim] Univ Southampton, Sch Geog & Environm Sci, Southampton, Hants, England; [Kwoba, Emmah; Thumbi, Samuel M.; Wanza, Peggy] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Thumbi, Samuel M.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Thumbi, Samuel M.] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [Okotto, Lorna Grace] Jaramogi Oginga Odinga Univ Sci & Technol, Sch Spatial Planning & Nat Resource Management, Bondo, Kenya; [Trajano Gomes da Silva, Diogo] Univ Brighton, Sch Environm & Technol, Brighton, E Sussex, England	University of Southampton; Kenya Medical Research Institute; Washington State University; University of Nairobi; Jaramogi Oginga Odinga University of Science & Technology; University of Brighton	Wright, J (corresponding author), Univ Southampton, Sch Geog & Environm Sci, Southampton, Hants, England.	J.A.Wright@soton.ac.uk	Parween, Shama/AFQ-4232-2022; Wright, Jim/C-7881-2013	Wright, Jim/0000-0002-8842-2181; Trajano Gomes da Silva, Diogo/0000-0003-1971-2799; Kwoba, Emmah/0000-0002-7839-5845; Yu, Weiyu/0000-0003-4624-2139	Department for International Development [MR/P024920/1]	Department for International Development	JAW, DGS, JOO, SMT. UK Medical Research Council (https://mrc.ukri.org/) & Department for International Development (https://www.gov.uk/government/organisations/foreigncommonwealth-development-office).Grant Ref.: MR/P024920/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, WHOSDEWSH030416; Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; Barrington D, 2013, J WATER SANIT HYG DE, V3, P392, DOI 10.2166/washdev.2013.120; Beverly JL, 2008, CAN J FOREST RES, V38, P289, DOI 10.1139/X07-149; Brown G, 2017, APPL GEOGR, V79, P153, DOI 10.1016/j.apgeog.2016.12.015; Brown G, 2014, APPL GEOGR, V48, P42, DOI 10.1016/j.apgeog.2014.01.008; Chambers Robert, 2006, Electronic Journal on Information Systems in Developing Countries, V25, P1; Clasen Thomas, 2015, Curr Environ Health Rep, V2, P69, DOI 10.1007/s40572-014-0033-9; Cresswell J. W.., 2017, DESIGNING CONDUCTING; Davidson A., 2005, WATER SAFETY PLANS M; DHV Consultants, 1988, RUR DOM WAT SUPPL SA RUR DOM WAT SUPPL SA; Doria MD, 2009, SCI TOTAL ENVIRON, V407, P5455, DOI 10.1016/j.scitotenv.2009.06.031; Felbab-Brown Vanda, 2017, WATER THEFT WATER SM; Ferrero G, 2019, INT J HYG ENVIR HEAL, V222, P615, DOI 10.1016/j.ijheh.2019.01.011; Ferrero G, 2018, WATER-SUI, V10, DOI 10.3390/w10020227; Fisher P, 2007, GEOINFORMATICA, V11, P311, DOI 10.1007/s10707-006-0009-5; Forrester J., 2015, GUIDE USING COMMUNIT; Gaglio B, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0096-x; Glockner H, 2004, ENVIRON URBAN, V16, P185, DOI 10.1177/095624780401600115; Hasan TJ, 2011, WATER SCI TECH-W SUP, V11, P309, DOI 10.2166/ws.2011.051; Kar K., 2003, SUBSIDY SELF RESPECT; Karanja I, 2010, ENVIRON URBAN, V22, P217, DOI 10.1177/0956247809362642; Kenya National Bureau of Statistics, 2013, KEN SIAYA COUNT MULT KEN SIAYA COUNT MULT; Kohlitz JP, 2015, WATER SCI TECH-W SUP, V15, P134, DOI 10.2166/ws.2014.093; Kot M, 2015, ENVIRON REV, V23, P24, DOI 10.1139/er-2014-0030; Lammerink M. P., 1998, Community Development Journal, V33, P342, DOI 10.1093/cdj/33.4.342; Majuru B, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121222; Mapedza E, 2003, APPL GEOGR, V23, P1, DOI 10.1016/S0143-6228(02)00070-X; Meera V, 2006, J WATER SUPPLY RES T, V55, P257, DOI 10.2166/aqua.2006.0010; Odhiambo FO, 2012, INT J EPIDEMIOL, V41, P977, DOI 10.1093/ije/dys108; Okotto-Okotto J, 2018, WETLANDS, V38, P1107, DOI 10.1007/s13157-016-0831-y; Parker A., 2013, Waterlines, V32, P113, DOI 10.3362/1756-3488.2013.013; Price HD, 2018, WATER INT, V43, P591, DOI 10.1080/02508060.2018.1500343; RAIN, 2008, RAIN WAT QUAL GUID G RAIN WAT QUAL GUID G; Ramirez-Gomez SOI, 2013, ELECTR J INF SYS DEV, V58; Rautanen SL, 2014, WATER ALTERN, V7, P160; Rickert B., 2014, WATER SAFETY PLAN FI; Garcia CER, 2009, J ENVIRON MANAGE, V90, P3040, DOI 10.1016/j.jenvman.2009.04.014; Rondi L., 2015, SUSTAINABILITY-BASEL, V7; Sova CA, 2015, SYST PRACT ACT RES, V28, P383, DOI 10.1007/s11213-014-9335-y; StataCorp, 2019, STAT REL 16 STAT SOF; String G, 2016, WATER SCI TECH-W SUP, V16, P1580, DOI 10.2166/ws.2016.073; Tertiary Consulting Engineers Ltd, 2019, WAT SAF PLANN PRACT WAT SAF PLANN PRACT; Thomson P, 2019, SCI TOTAL ENVIRON, V649, P722, DOI 10.1016/j.scitotenv.2018.08.330; Thumbi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120761; Van Koppen B, 2009, IRRIG DRAIN, V58, pS73, DOI 10.1002/ird.486; Verplanke J, 2017, ISPRS INT J GEO-INF, V6, DOI 10.3390/ijgi6080244; WHO, 2012, WAT SAF PLANN SMALL; WHO/UNICEF, 2006, COR QUEST DRINK WAT; WHO / UNICEF, 2019, DRINK WAT NEW JMP LA DRINK WAT NEW JMP LA; Wilson RT, 2007, AGR WATER MANAGE, V90, P1, DOI 10.1016/j.agwat.2007.03.003; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x; Yates TM, 2015, ENVIRON SCI TECHNOL, V49, P5115, DOI 10.1021/acs.est.5b00309	53	0	0	8	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0255286	10.1371/journal.pone.0255286	http://dx.doi.org/10.1371/journal.pone.0255286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CM	34320036	Green Published, gold, Green Accepted			2022-12-26	WOS:000685247800014
J	Rudd, JL; Bartolomeu, T; Dolton, HR; Exeter, OM; Kerry, C; Hawkes, LA; Henderson, SM; Shirley, M; Witt, MJ				Rudd, Jessica L.; Bartolomeu, Tiago; Dolton, Haley R.; Exeter, Owen M.; Kerry, Christopher; Hawkes, Lucy A.; Henderson, Suzanne M.; Shirley, Marcus; Witt, Matthew J.			Basking shark sub-surface behaviour revealed by animal-towed cameras	PLOS ONE			English	Article							BORNE VIDEO; CETORHINUS-MAXIMUS; HUMPBACK WHALES; FEEDING-BEHAVIOR; DIVING BEHAVIOR; SOCIAL-BEHAVIOR; PREY CAPTURE; PATTERNS; WATERS; SEAL	While biologging tags have answered a wealth of ecological questions, the drivers and consequences of movement and activity often remain difficult to ascertain, particularly marine vertebrates which are difficult to observe directly. Basking sharks, the second largest shark species in the world, aggregate in the summer in key foraging sites but despite advances in biologging technologies, little is known about their breeding ecology and sub-surface behaviour. Advances in camera technologies holds potential for filling in these knowledge gaps by providing environmental context and validating behaviours recorded with conventional telemetry. Six basking sharks were tagged at their feeding site in the Sea of Hebrides, Scotland, with towed cameras combined with time-depth recorders and satellite telemetry. Cameras recorded a cumulative 123 hours of video data over an average 64-hour deployment and confirmed the position of the sharks within the water column. Feeding events only occurred within a metre depth and made up 3/4 of the time spent swimming near the surface. Sharks maintained similar tail beat frequencies regardless of whether feeding, swimming near the surface or the seabed, where they spent surprisingly up to 88% of daylight hours. This study reported the first complete breaching event and the first sub-surface putative courtship display, with nose-to-tail chasing, parallel swimming as well as the first observation of grouping behaviour near the seabed. Social groups of sharks are thought to be very short term and sporadic, and may play a role in finding breeding partners, particularly in solitary sharks which may use aggregations as an opportunity to breed. In situ observation of basking sharks at their seasonal aggregation site through animal borne cameras revealed unprecedented insight into the social and environmental context of basking shark behaviour which were previously limited to surface observations.	[Rudd, Jessica L.; Hawkes, Lucy A.; Witt, Matthew J.] Univ Exeter, Coll Life & Environm Sci, Hatherly Labs, Exeter, Devon, England; [Bartolomeu, Tiago] CEiiA, Matosinhos, Portugal; [Dolton, Haley R.; Exeter, Owen M.; Kerry, Christopher; Witt, Matthew J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, England; [Henderson, Suzanne M.] NatureScot, Inverness, Scotland; [Shirley, Marcus] MrROV, Wadebride, Cornwall, England	University of Exeter; University of Exeter	Hawkes, LA (corresponding author), Univ Exeter, Coll Life & Environm Sci, Hatherly Labs, Exeter, Devon, England.	l.hawkes@exeter.ac.uk	Rudd, Jessica/GVT-5188-2022; Witt, Matthew/V-3318-2018	Kerry, Chris/0000-0002-0276-9775; Rudd, Jessica/0000-0003-4512-7999; Dolton, Haley/0000-0001-8550-7289; Witt, Matthew/0000-0002-9498-5378	NatureScot; University of Exeter	NatureScot; University of Exeter	NatureScot and the University of Exeter funded the study. NatureScot is an independent scientific adviser to the Scottish Government. The funder provided support in the form of salaries for authors [S.M.H], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The University of Exeter is a researchintensive university based in the UK. The specific roles of authors are articulated in the `author contributions' section.	Andrzejaczek S, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00229; Austin RA, 2019, J SEA RES, V153, DOI 10.1016/j.seares.2019.101767; BERROW SD, 1994, BIOL ENVIRON, V94B, P101; Boness DJ, 2006, BEHAV ECOL SOCIOBIOL, V61, P119, DOI 10.1007/s00265-006-0242-9; Braun CD, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00025; Carroll G, 2014, J EXP BIOL, V217, P4295, DOI 10.1242/jeb.113076; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Crowe LM, 2018, J FISH BIOL, V92, P1371, DOI 10.1111/jfb.13592; Curtis Tobey H., 2011, Florida Scientist, V74, P253; De Carli RC, 2018, J MAR BIOL ASSOC UK, V98, P1151, DOI 10.1017/S0025315417000327; DEMSKI L S, 1990, Journal of Aquariculture and Aquatic Sciences, V5, P53; Dewar H, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00163; Doherty PD, 2019, MAR BIOL, V166, DOI 10.1007/s00227-019-3565-6; Doherty PD, 2017, BIOL CONSERV, V209, P68, DOI 10.1016/j.biocon.2017.01.018; Doherty PD, 2017, SCI REP-UK, V7, DOI 10.1038/srep42837; Dolton HR, 2020, ENDANGER SPECIES RES, V41, P209, DOI 10.3354/esr01018; Felix F, 2012, AQUAT MAMM, V38, P311, DOI 10.1578/AM.38.3.2012.311; Fossi MC, 2014, MAR ENVIRON RES, V100, P17, DOI 10.1016/j.marenvres.2014.02.002; Francis MP, 2002, MAR BIOL, V140, P831, DOI 10.1007/s00227-001-0744-y; Gore M, 2019, J MAR BIOL ASSOC UK, V99, P681, DOI 10.1017/S0025315418000383; Gore MA, 2008, BIOL LETTERS, V4, P395, DOI 10.1098/rsbl.2008.0147; Gore MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150160; Gradenwitz A., 1908, TECHNICAL WORLD MAGA, V10, P485; Halsey LG, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.216036; Heaslip SG, 2008, DEEP-SEA RES PT I, V55, P1179, DOI 10.1016/j.dsr.2008.05.006; Heaslip SG, 2014, CAN J ZOOL, V92, P309, DOI 10.1139/cjz-2013-0137; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Heithaus MR, 2002, J MAR BIOL ASSOC UK, V82, P1049, DOI 10.1017/S0025315402006689; Herman EYK, 2007, MAR TECHNOL SOC J, V41, P35, DOI 10.4031/002533207787441971; HETTLER WF, 1976, J FISH BIOL, V8, P55, DOI 10.1111/j.1095-8649.1976.tb03907.x; Hooker SK, 2008, MAR TECHNOL SOC J, V42, P65, DOI 10.4031/002533208786829179; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Iosilevskii G, 2012, J THEOR BIOL, V294, P172, DOI 10.1016/j.jtbi.2011.11.008; Jacoby DMP, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0676; Jacoby DMP, 2012, FISH FISH, V13, P399, DOI 10.1111/j.1467-2979.2011.00436.x; JAMES AG, 1989, J EXP MAR BIOL ECOL, V131, P81, DOI 10.1016/0022-0981(89)90001-4; Jewell OJD, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2019.0085; Johnston EM, 2019, J FISH BIOL, V95, P1530, DOI 10.1111/jfb.14163; Johnston EM, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0537; Kane SA, 2015, J EXP BIOL, V218, P212, DOI 10.1242/jeb.108597; Kavanagh AS, 2017, MAR MAMMAL SCI, V33, P313, DOI 10.1111/mms.12374; Kays R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2478; Klimley AP, 2002, ENVIRON BIOL FISH, V63, P117; Klimley AP, 1996, GREAT WHITE SHARKS, P175, DOI 10.1016/B978-012415031-7/50017-3; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Krause D.J., 2015, ANIM BIOTELEM, V3, P1, DOI [10.1186/s40317-015-0059-2, DOI 10.1186/S40317-015-0059-2]; Kuczaj S.A., 2014, ANIM BEHAV COGNITION, V1, P113, DOI [10.12966/abc.05.03.2014, DOI 10.12966/ABC.05.03.2014]; Loyd KAT, 2013, BIOL CONSERV, V160, P183, DOI 10.1016/j.biocon.2013.01.008; Maricato G., 2017, REV BRAS ZOO, V18, DOI [10.34019/2596-3325.2017.v18.24652, DOI 10.34019/2596-3325.2017.V18.24652]; Marshall AD, 2010, J FISH BIOL, V77, P169, DOI 10.1111/j.1095-8649.2010.02669.x; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; MATTHEWS LH, 1950, PHILOS T R SOC B, V234, P247, DOI 10.1098/rstb.1950.0003; Meyers CA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34143-x; Miller PI, 2015, FUNCT ECOL, V29, P1099, DOI 10.1111/1365-2435.12423; Nakamura I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127667; Nakamura I, 2015, J ANIM ECOL, V84, P590, DOI 10.1111/1365-2656.12346; Nakamura I, 2011, MAR ECOL PROG SER, V424, P237, DOI 10.3354/meps08980; Narazaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066043; Nelms SE, 2017, SCI TOTAL ENVIRON, V579, P1399, DOI 10.1016/j.scitotenv.2016.11.137; Ona J, 2019, AQUAT MAMM, V45, P456, DOI 10.1578/AM.45.4.2019.456; Papastamatiou YP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18608-z; Papastamatiou YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127807; Papastamatiou YP., 2018, SHARK RES EMERGING T, V3, P83; Parrish Frank A., 2008, Endangered Species Research, V4, P299, DOI 10.3354/esr00090; Parton KJ, 2019, ENDANGER SPECIES RES, V39, P173, DOI 10.3354/esr00964; Pikesley SK, 2014, J MAR BIOL ASSOC UK, V94, P1401, DOI 10.1017/S0025315414000137; Pratt HL, 2001, ENVIRON BIOL FISH, V60, P157; Queiroz N, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00239; Ratnarajah L, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00109; Rigby CL., 2019, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2019-3.RLTS.T4292A166822294.en, DOI 10.2305/IUCN.UK.2019-3.RLTS.T4292A166822294.EN]; Rudd JL., 2021, SCI REP-UK, V11, P1, DOI [10.1038/s41598-020-79139-8, DOI 10.1038/S41598-020-79139-8]; Rutz C, 2007, SCIENCE, V318, P765, DOI 10.1126/science.1146788; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Segre PS, 2020, ELIFE, V9, DOI 10.7554/eLife.51760; Seminoff JA, 2006, MAR ECOL PROG SER, V322, P269, DOI 10.3354/meps322269; Shepard ELC, 2006, MAR ECOL PROG SER, V328, P205, DOI 10.3354/meps328205; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2008, ADV MAR BIOL, V54, P171, DOI 10.1016/S0065-2881(08)00003-5; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Sims DW, 1999, P ROY SOC B-BIOL SCI, V266, P1437, DOI 10.1098/rspb.1999.0798; Sims DW, 2000, J EXP MAR BIOL ECOL, V249, P65, DOI 10.1016/S0022-0981(00)00183-0; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; Sims DW, 2000, P ROY SOC B-BIOL SCI, V267, P1897, DOI 10.1098/rspb.2000.1227; Skomal GB, 2009, CURR BIOL, V19, P1019, DOI 10.1016/j.cub.2009.04.019; Southhall EJ, 2005, J MAR BIOL ASSOC UK, V85, P1083, DOI 10.1017/S0025315405012129; Speedie CD., 339 SCOTT NAT HER; Stevens GMW, 2018, J FISH BIOL, V93, P344, DOI 10.1111/jfb.13768; Sutton GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144297; Tackaberry JE, 2020, PEERJ, V8, DOI 10.7717/peerj.8538; Takahashi A, 2008, POLAR BIOL, V31, P1291, DOI 10.1007/s00300-008-0502-4; Tavares DC, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00262; Votier SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057376; Watanabe YY, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2376; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Watanabe YY, 2012, J EXP MAR BIOL ECOL, V426, P5, DOI 10.1016/j.jembe.2012.04.021; Wilmers CC, 2015, ECOLOGY, V96, P1741, DOI 10.1890/14-1401.1; Wilson SG, 2004, FISH OCEANOGR, V13, P283, DOI 10.1111/j.1365-2419.2004.00292.x; Wing SR, 2014, MAR ECOL PROG SER, V510, P1, DOI 10.3354/meps10923; Witt MJ, 2010, ANIM BEHAV, V80, P571, DOI 10.1016/j.anbehav.2010.05.022; Witt MJ, 2012, MAR ECOL PROG SER, V459, P121, DOI 10.3354/meps09737; Yoshino K, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.212936	101	1	1	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0253388	10.1371/journal.pone.0253388	http://dx.doi.org/10.1371/journal.pone.0253388			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320007	Green Published, gold			2022-12-26	WOS:000685247800023
J	Cozier, YC; Castro-Webb, N; Hochberg, NS; Rosenberg, L; Albert, MA; Palmer, JR				Cozier, Yvette C.; Castro-Webb, Nelsy; Hochberg, Natasha S.; Rosenberg, Lynn; Albert, Michelle A.; Palmer, Julie R.			Lower serum 25(OH)D levels associated with higher risk of COVID-19 infection in US Black women	PLOS ONE			English	Article							VITAMIN-D; POSTMENOPAUSAL WOMEN; SOCIOECONOMIC-STATUS; 25-HYDROXYVITAMIN D; OBESITY; PREVALENCE; PLASMA; ADULTS; REPRODUCIBILITY; SARCOIDOSIS	Objective Limited evidence suggests that higher levels of serum vitamin D (25(OH)D) protect against SARS-CoV-2 virus (COVID-19) infection. Black women commonly experience 25(OH)D insufficiency and are overrepresented among COVID-19 cases. We conducted a prospective analysis of serum 25(OH)D levels in relation to COVID-19 infection among participants in the Black Women's Health Study. Methods Since 1995, the Black Women's Health Study has followed 59,000 U.S. Black women through biennial mailed or online questionnaires. Over 13,000 study participants provided a blood sample in 2013-2017. 25(OH)D assays were performed in a certified national laboratory shortly after collection of the samples. In 2020, participants who had completed the online version of the 2019 biennial health questionnaire were invited to complete a supplemental online questionnaire assessing their experiences related to the COVID-19 pandemic, including whether they had been tested for COVID-19 infection and the result of the test. We used logistic regression analysis to estimate odds ratios (OR) and 95% confidence intervals (CI) for the association of 25(OH)D level with COVID-19 positivity, adjusting for age, number of people living in the household, neighborhood socioeconomic status, and other potential confounders. Results Among 5,081 eligible participants whose blood sample had been assayed for 25(OH)D, 1,974 reported having had a COVID-19 test in 2020. Relative to women with 25(OH)D levels of 30 ng/mL (75 nmol/l) or more, multivariable-adjusted ORs for COVID-19 infection in women with levels of 20-29 ng/mL (50-72.5 nmol/l) and <20 ng/mL (<50 nmol/l) were, respectively, 1.48 (95% CI 0.95-2.30) and 1.69 (95% CI 1.04-2.72) (p trend 0.02). Conclusion The present results suggest that U.S. Black women with lower levels of 25(OH)D are at increased risk of infection with COVID-19. Further work is needed to confirm these findings and determine the optimal level of 25(OH)D for a beneficial effect.	[Cozier, Yvette C.; Castro-Webb, Nelsy; Rosenberg, Lynn; Palmer, Julie R.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Hochberg, Natasha S.] Boston Univ, Sch Med, Dept Med, Sect Infect Dis, Boston, MA 02118 USA; [Hochberg, Natasha S.] Boston Med Ctr, Ctr Infect Dis, Boston, MA USA; [Albert, Michelle A.] Univ Calif San Francisco, Sch Med, Dept Med,Div Cardiol, Ctr Study Advers & Cardiovasc Dis,NURTURE Ctr, San Francisco, CA 94143 USA	Boston University; Boston University; Boston Medical Center; University of California System; University of California San Francisco	Cozier, YC (corresponding author), Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA.	yvettec@bu.edu		Cozier, Yvette/0000-0003-0625-7256; Hochberg, Natasha/0000-0002-5449-9973	National Cancer Institute [R01-CA058420, U01CA164974]; American Heart Association [12174sc]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association)	Research reported in this publication was supported by the National Cancer Institute (www.cancer.gov) R01-CA058420 (PI: Rosenberg); U01CA164974 (PIs: Palmer, Rosenberg); and the American Heart Association (www.heart.org) 12174sc (PIs: Albert, Cozier). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Alwarawrah Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01055; American Psychological Association. APA Working Group on Stress and Health Disparities, 2017, STRESS HLTH DISPARIT; [Anonymous], DONNA SPIEGELMANS FA; Bailey ZD, 2021, NEW ENGL J MED, V384, P768, DOI 10.1056/NEJMms2025396; Bertrand KA, 2012, BRIT J NUTR, V108, P1889, DOI 10.1017/S0007114511007409; Beydoun MA, 2009, OBESITY, V17, P169, DOI 10.1038/oby.2008.492; Bilezikian JP, 2020, EUR J ENDOCRINOL, V183, pR133, DOI 10.1530/EJE-20-0665; Bouillon R, 2018, BEST PRACT RES CL EN, V32, P669, DOI 10.1016/j.beem.2018.09.014; Burke RR, 2010, SEMIN RESP CRIT CARE, V31, P474, DOI 10.1055/s-0030-1262215; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Centers for Medicare & Medicaid Services, 2017, ACC CAR ORG ACO; Colotta F, 2017, J AUTOIMMUN, V85, P78, DOI 10.1016/j.jaut.2017.07.007; Cozier Y, 2006, ANN EPIDEMIOL, V16, P681, DOI 10.1016/j.annepidem.2005.11.008; Cozier YC, 2016, J URBAN HEALTH, V93, P279, DOI 10.1007/s11524-016-0034-0; Cozier YC, 2011, CHEST, V139, P144, DOI 10.1378/chest.10-0413; D'Avolio A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051359; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Getachew B, 2021, J MED VIROL, V93, P5285, DOI 10.1002/jmv.27075; Glynn SJ, 2019, BREADWINNING MOTHERS; Gu T, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25197; Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI 10.1056/NEJMc2005203; HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649; Hastie CE, 2020, DIABETES METAB SYND, V14, P561, DOI 10.1016/j.dsx.2020.04.050; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Holick MF, 2005, SEMIN DIALYSIS, V18, P266, DOI 10.1111/j.1525-139X.2005.18402.x; HOLICK MF, 1995, AM J CLIN NUTR, V61, p638S, DOI 10.1093/ajcn/61.3.638S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Ilie PC, 2020, AGING CLIN EXP RES, V32, P1195, DOI 10.1007/s40520-020-01570-8; Kalinowski J, 2019, CIRCULATION, V139, P1003, DOI 10.1161/CIRCULATIONAHA.118.037689; Kaufman HW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239252; Kotsopoulos J, 2010, CANCER EPIDEM BIOMAR, V19, P938, DOI 10.1158/1055-9965.EPI-09-1318; Krishnan S, 2007, OBESITY, V15, P1860, DOI 10.1038/oby.2007.220; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; Lukaszuk JM, 2017, OBES SCI PRACT, V3, P99, DOI 10.1002/osp4.85; Martens PJ, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051248; Meltzer DO, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19722; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Rosenberg L, 1995, J Am Med Womens Assoc (1972), V50, P56; Rosner B., 2006, FUNDAMENTALS BIOSTAT; Russell C, 2001, AM J EPIDEMIOL, V154, P845, DOI 10.1093/aje/154.9.845; Sattar N, 2020, CIRCULATION, V142, P4, DOI 10.1161/CIRCULATIONAHA.120.047659; Snowden LR., 2020, J RACIAL ETHN HLTH D; Van Belle TL, 2011, BEST PRACT RES CL EN, V25, P617, DOI 10.1016/j.beem.2011.04.009; Williams DR, 2001, PUBLIC HEALTH REP, V116, P404, DOI 10.1016/S0033-3549(04)50068-7; Williams DR, 1999, ANN NY ACAD SCI, V896, P173, DOI 10.1111/j.1749-6632.1999.tb08114.x; Zadshir A, 2005, ETHNIC DIS, V15, pS97; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	51	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255132	10.1371/journal.pone.0255132	http://dx.doi.org/10.1371/journal.pone.0255132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314458	Green Published, gold			2022-12-26	WOS:000685225200010
J	Heins, N; Pomp, J; Kluger, DS; Vinbrux, S; Trempler, I; Kohler, A; Kornysheva, K; Zentgraf, K; Raab, M; Schubotz, RI				Heins, Nina; Pomp, Jennifer; Kluger, Daniel S.; Vinbrux, Stefan; Trempler, Ima; Kohler, Axel; Kornysheva, Katja; Zentgraf, Karen; Raab, Markus; Schubotz, Ricarda I.			Surmising synchrony of sound and sight: Factors explaining variance of audiovisual integration in hurdling, tap dancing and drumming	PLOS ONE			English	Article							AUDITORY-FEEDBACK; TEMPORAL WINDOW; BRAIN ACTIVITY; PERCEPTION; SPEECH; OSCILLATIONS; SENSITIVITY; SUPPRESSION; PREDICTION; ASYNCHRONY	Auditory and visual percepts are integrated even when they are not perfectly temporally aligned with each other, especially when the visual signal precedes the auditory signal. This window of temporal integration for asynchronous audiovisual stimuli is relatively well examined in the case of speech, while other natural action-induced sounds have been widely neglected. Here, we studied the detection of audiovisual asynchrony in three different whole-body actions with natural action-induced sounds-hurdling, tap dancing and drumming. In Study 1, we examined whether audiovisual asynchrony detection, assessed by a simultaneity judgment task, differs as a function of sound production intentionality. Based on previous findings, we expected that auditory and visual signals should be integrated over a wider temporal window for actions creating sounds intentionally (tap dancing), compared to actions creating sounds incidentally (hurdling). While percentages of perceived synchrony differed in the expected way, we identified two further factors, namely high event density and low rhythmicity, to induce higher synchrony ratings as well. Therefore, we systematically varied event density and rhythmicity in Study 2, this time using drumming stimuli to exert full control over these variables, and the same simultaneity judgment tasks. Results suggest that high event density leads to a bias to integrate rather than segregate auditory and visual signals, even at relatively large asynchronies. Rhythmicity had a similar, albeit weaker effect, when event density was low. Our findings demonstrate that shorter asynchronies and visual-first asynchronies lead to higher synchrony ratings of whole-body action, pointing to clear parallels with audiovisual integration in speech perception. Overconfidence in the naturally expected, that is, synchrony of sound and sight, was stronger for intentional (vs. incidental) sound production and for movements with high (vs. low) rhythmicity, presumably because both encourage predictive processes. In contrast, high event density appears to increase synchronicity judgments simply because it makes the detection of audiovisual asynchrony more difficult. More studies using real-life audiovisual stimuli with varying event densities and rhythmicities are needed to fully uncover the general mechanisms of audiovisual integration.	[Heins, Nina; Pomp, Jennifer; Trempler, Ima; Schubotz, Ricarda I.] Univ Munster, Dept Psychol, Munster, Germany; [Heins, Nina; Pomp, Jennifer; Kluger, Daniel S.; Trempler, Ima; Kohler, Axel; Schubotz, Ricarda I.] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Munster, Germany; [Kluger, Daniel S.] Univ Hosp Muenster, Inst Biomagnetism & Biosignal Anal, Munster, Germany; [Vinbrux, Stefan] Univ Munster, Inst Sport & Exercise Sci Human Performance & Tra, Munster, Germany; [Kornysheva, Katja] Bangor Univ, Bangor Neuroimaging Unit, Sch Psychol, Bangor, Wales; [Zentgraf, Karen] Goethe Univ Frankfurt, Inst Sport Sci, Dept Movement Sci & Training Sports, Frankfurt, Germany; [Raab, Markus] German Sport Univ Cologne, Inst Psychol, Cologne, Germany; [Raab, Markus] London South Bank Univ, Sch Appl Sci, London, England	University of Munster; University of Munster; University of Munster; University of Munster; Bangor University; Goethe University Frankfurt; German Sport University Cologne; London South Bank University	Schubotz, RI (corresponding author), Univ Munster, Dept Psychol, Munster, Germany.; Schubotz, RI (corresponding author), Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Munster, Germany.	rschubotz@uni-muenster.de	Kornysheva, Katja/AAP-7062-2020	Kornysheva, Katja/0000-0002-1562-7880; Kluger, Daniel/0000-0002-0691-794X; Kohler, Axel/0000-0003-0196-973X; Schubotz, Ricarda/0000-0001-5802-6869; Pomp, Jennifer/0000-0002-8577-7948	German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) [SCHU1439/4-2]	German Research Foundation (DFG, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	Author: RIS; Grant number: SCHU1439/4-2; Name of funder: German Research Foundation (DFG, Deutsche Forschungsgemeinschaft); URL: https://www.dfg.de/en/index.jsp.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliu SO, 2009, J COGNITIVE NEUROSCI, V21, P791, DOI 10.1162/jocn.2009.21055; Arai T., 1997, P EUR 5 EUR C SPEECH, V2, P1011; Baess P, 2011, PSYCHOPHYSIOLOGY, V48, P1276, DOI 10.1111/j.1469-8986.2011.01196.x; Blank H, 2018, J NEUROSCI, V38, P6076, DOI 10.1523/JNEUROSCI.3258-17.2018; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; Chen YC, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00445; Cravo AM, 2013, J NEUROSCI, V33, P4002, DOI 10.1523/JNEUROSCI.4675-12.2013; de Lange FP, 2018, TRENDS COGN SCI, V22, P764, DOI 10.1016/j.tics.2018.06.002; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; Eg R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00736; Eg R, 2015, MULTIMED TOOLS APPL, V74, P345, DOI 10.1007/s11042-014-2136-6; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fujisaki W, 2005, EXP BRAIN RES, V166, P455, DOI 10.1007/s00221-005-2385-8; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Grant KW, 2004, SPEECH COMMUN, V44, P43, DOI 10.1016/j.specom.2004.06.004; Grant KW., 2001, P AUD VIS SPEECH PRO, P132; Greenberg S., 2006, LISTENING SPEECH AUD, P411; Hardesty J, 2016, MUME 2016 4 INT WORK; Heins N, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.573970; Heins N, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00483; Henry MJ, 2012, P NATL ACAD SCI USA, V109, P20095, DOI 10.1073/pnas.1213390109; Horvath J, 2012, J COGNITIVE NEUROSCI, V24, P1919, DOI 10.1162/jocn_a_00215; Jicol C, 2018, EXP BRAIN RES, V236, P1869, DOI 10.1007/s00221-018-5269-4; Kaiser J, 2018, EUR J NEUROSCI, V47, P1303, DOI 10.1111/ejn.13931; Kennel C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00069; Keough D, 2009, J ACOUST SOC AM, V126, P837, DOI 10.1121/1.3158600; Kok P, 2012, CEREB CORTEX, V22, P2197, DOI 10.1093/cercor/bhr310; Lartillot O., 2007, P INT C DIG AUD EFF, V2007, P237; Love SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054798; Massaro DW, 1996, J ACOUST SOC AM, V100, P1777, DOI 10.1121/1.417342; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Navarra J, 2005, COGNITIVE BRAIN RES, V25, P499, DOI 10.1016/j.cogbrainres.2005.07.009; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; Noel JP, 2018, EUR J NEUROSCI, V47, P1230, DOI 10.1111/ejn.13911; Noppeney U, 2018, ANN NY ACAD SCI, V1423, P102, DOI 10.1111/nyas.13615; Nour MM, 2015, PSYCHOPATHOLOGY, V48, P217, DOI 10.1159/000437271; Orlandi A, 2020, COGNITION, V205, DOI 10.1016/j.cognition.2020.104446; Petrini K, 2011, NEUROIMAGE, V56, P1480, DOI 10.1016/j.neuroimage.2011.03.009; Petrini K, 2009, EXP BRAIN RES, V198, P339, DOI 10.1007/s00221-009-1817-2; Pfordresher PQ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00914; Schutz M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63132-2; Schwartz JL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003743; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; Stevenson RA, 2013, EXP BRAIN RES, V227, P249, DOI 10.1007/s00221-013-3507-3; Straube B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169131; Su YH, 2018, PSYCHON B REV, V25, P1416, DOI 10.3758/s13423-018-1480-3; Su YH, 2014, COGNITION, V131, P330, DOI 10.1016/j.cognition.2014.02.004; ten Oever S, 2014, NEUROPSYCHOLOGIA, V63, P43, DOI 10.1016/j.neuropsychologia.2014.08.008; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Van der Stoep N, 2019, J COGNITIVE NEUROSCI, V31, P885, DOI 10.1162/jocn_a_01389; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vatakis A, 2006, NEUROSCI LETT, V393, P40, DOI 10.1016/j.neulet.2005.09.032; Vatakis A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00071; Venezia JH, 2016, ATTEN PERCEPT PSYCHO, V78, P583, DOI 10.3758/s13414-015-1026-y; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Zhou HY, 2020, NEUROPSYCHOLOGIA, V140, DOI 10.1016/j.neuropsychologia.2020.107396	56	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2021	16	7							e0253130	10.1371/journal.pone.0253130	http://dx.doi.org/10.1371/journal.pone.0253130			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TQ2OO	34293800	Green Published, Green Accepted, gold			2022-12-26	WOS:000678124900105
J	Akhtar, Z; Chowdhury, F; Rahman, M; Ghosh, PK; Ahmmed, MK; Islam, MA; Mott, JA; Davis, W				Akhtar, Zubair; Chowdhury, Fahmida; Rahman, Mahmudur; Ghosh, Probir Kumar; Ahmmed, Md. Kaousar; Islam, Md Ariful; Mott, Joshua A.; Davis, William			Seasonal influenza during the COVID-19 pandemic in Bangladesh	PLOS ONE			English	Article							SURVEILLANCE	Introduction During the 2019 novel coronavirus infectious disease (COVID-19) pandemic in 2020, limited data from several countries suggested reduced seasonal influenza viruses' circulation. This was due to community mitigation measures implemented to control the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We used sentinel surveillance data to identify changes in the 2020 influenza season compared with previous seasons in Bangladesh. Methods We used hospital-based influenza surveillance (HBIS) data of Bangladesh that are generated year-round and are population-representative severe acute respiratory infection (SARI) data for all age groups from seven public and two private tertiary care level hospitals data from 2016 to 2019. We applied the moving epidemic method (MEM) by using R language (v4.0.3), and MEM web applications (v2.14) on influenza-positive rates of SARI cases collected weekly to estimate an average seasonal influenza curve and establish epidemic thresholds. Results The 2016-2019 average season started on epi week 18 (95% CI: 15-25) and lasted 12.5 weeks (95% CI: 12-14 weeks) until week 30.5. The 2020 influenza season started on epi week 36 and ended at epi week 41, lasting for only five weeks. Therefore, influenza epidemic started 18 weeks later, was 7.5 weeks shorter, and was less intense than the average epidemic of the four previous years. The 2020 influenza season started on the same week when COVID-19 control measures were halted, and 13 weeks after the measures were relaxed. Conclusion Our findings suggest that seasonal influenza circulation in Bangladesh was delayed and less intense in 2020 than in previous years. Community mitigation measures may have contributed to this reduction of seasonal influenza transmission. These findings contribute to a limited but growing body of evidence that influenza seasons were altered globally in 2020.	[Akhtar, Zubair; Chowdhury, Fahmida; Rahman, Mahmudur; Ghosh, Probir Kumar; Ahmmed, Md. Kaousar; Islam, Md Ariful] Icddr B, Programme Emerging Infect, Int Ctr Diarrheal Dis, Dhaka, Bangladesh; [Mott, Joshua A.; Davis, William] Ctrs Dis Control & Prevent, Influenza Div, Reg Influenza Program, Bangkok, Thailand	International Centre for Diarrhoeal Disease Research (ICDDR)	Akhtar, Z (corresponding author), Icddr B, Programme Emerging Infect, Int Ctr Diarrheal Dis, Dhaka, Bangladesh.	zakhtar@icddrb.org		Ghosh, Probir Kumar/0000-0003-1580-5883; Islam, Md. Ariful/0000-0002-0734-5832; Zubair Akhtar, Abu Muhammad/0000-0001-5054-9243	Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta [6 NU51IP000852-05-01]	Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta	This hospital-based influenza surveillance was funded by the Influenza Division of Centers for Disease Control and Prevention (CDC), Atlanta, under the co-operative agreement (6 NU51IP000852-05-01). icddr,b is grateful to the Governments of Bangladesh, Canada, Sweden, and the UK for providing core/unrestricted support. The funders had no conflict of interest with the contents of the manuscript.	Ahmed M, 2018, INFLUENZA OTHER RESP, V12, P65, DOI 10.1111/irv.12490; Cuadrado-Payan E, 2020, LANCET, V395, pE84, DOI 10.1016/S0140-6736(20)31052-7; Huang QS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21157-9; Kuo SC, 2020, EMERG INFECT DIS, V26, P1928, DOI 10.3201/eid2608.201192; Lei H, 2020, J INFECT DIS, V222, P1780, DOI 10.1093/infdis/jiaa570; Olsen SJ, 2020, MMWR-MORBID MORTAL W, V69, P1305, DOI 10.15585/mmwr.mm6937a6; Organization WH, 2020, 4 WHO; Organization WH, 2020, WHO COVID 19 CAS DEF; Soo RJJ, 2020, EMERG INFECT DIS, V26, P1933, DOI 10.3201/eid2608.201229; Sullivan SG, 2020, EUROSURVEILLANCE, V25, DOI 10.2807/1560-7917.ES.2020.25.47.2001847; Suntronwong N, 2020, PATHOG GLOB HEALTH, V114, P225, DOI 10.1080/20477724.2020.1777803; Vega T, 2015, INFLUENZA OTHER RESP, V9, P234, DOI 10.1111/irv.12330; Vega T, 2013, INFLUENZA OTHER RESP, V7, P546, DOI 10.1111/j.1750-2659.2012.00422.x; Zaman RU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008452	14	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255646	10.1371/journal.pone.0255646	http://dx.doi.org/10.1371/journal.pone.0255646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343203	gold, Green Published			2022-12-26	WOS:000685264200024
J	Zhang, JN; Jiang, XY; Yin, J; Dou, SY; Xie, XL; Liu, T; Wang, YJ; Wang, SL; Zhou, X; Zhang, DX; Jiang, HQ				Zhang, Jiuna; Jiang, Xiaoyu; Yin, Jie; Dou, Shiying; Xie, Xiaoli; Liu, Ting; Wang, Yijun; Wang, Shuling; Zhou, Xue; Zhang, Dongxuan; Jiang, Huiqing			RNF141 interacts with KRAS to promote colorectal cancer progression	ONCOGENE			English	Article							K-RAS; HUMAN COLON; PROTEINS; MUTATIONS; GENE; LOCALIZATION; ASSOCIATION; EXPRESSION; LIGASES; GROWTH	RING finger proteins (RNFs) play a critical role in cancer initiation and progression. RNF141 is a member of RNFs family; however, its clinical significance, roles, and mechanism in colorectal cancer (CRC) remain poorly understood. Here, we examined the expression of RNF141 in 64 pairs of CRC and adjacent normal tissues by real-time PCR, Western blot, and immunohistochemical analysis. We found that there was more expression of RNF141 in CRC tissue compared with its adjacent normal tissue and high RNF141 expression associated with T stage. In vivo and in vitro functional experiments were conducted and revealed the oncogenic role of RNF141 in CRC. RNF141 knockdown suppressed proliferation, arrested the cell cycle in the G1 phase, inhibited migration, invasion and HUVEC tube formation but promoted apoptosis, whereas RNF141 overexpression exerted the opposite effects in CRC cells. The subcutaneous xenograft models showed that RNF141 knockdown reduced tumor growth, but its overexpression promoted tumor growth. Mechanistically, liquid chromatography-tandem mass spectrometry indicated RNF141 interacted with KRAS, which was confirmed by Co-immunoprecipitation, Immunofluorescence assay. Further analysis with bimolecular fluorescence complementation (BiFC) and Glutathione-S-transferase (GST) pull-down assays showed that RNF141 could directly bind to KRAS. Importantly, the upregulation of RNF141 increased GTP-bound KRAS, but its knockdown resulted in a reduction accordingly. Next, we demonstrated that RNF141 induced KRAS activation via increasing its enrichment on the plasma membrane not altering total KRAS expression, which was facilitated by the interaction with LYPLA1. Moreover, KRAS silencing partially abolished the effect of RNF141 on cell proliferation and apoptosis. In addition, our findings presented that RNF141 functioned as an oncogene by upregulating KRAS activity in a manner of promoting KRAS enrichment on the plasma membrane in CRC.	[Zhang, Jiuna; Jiang, Xiaoyu; Yin, Jie; Dou, Shiying; Xie, Xiaoli; Liu, Ting; Wang, Yijun; Wang, Shuling; Zhou, Xue; Zhang, Dongxuan; Jiang, Huiqing] Hebei Med Univ, Hosp 2, Hebei Inst Gastroenterol, Dept Gastroenterol,Hebei Key Lab Gastroenterol, Shijiazhuang, Hebei, Peoples R China; [Zhang, Jiuna] Hebei Engn Univ, Affiliated Hosp, Dept Gastroenterol, Handan, Peoples R China	Hebei Medical University	Jiang, HQ (corresponding author), Hebei Med Univ, Hosp 2, Hebei Inst Gastroenterol, Dept Gastroenterol,Hebei Key Lab Gastroenterol, Shijiazhuang, Hebei, Peoples R China.	jianghuiqing1959@sina.com	Wang, Yu/GZL-9655-2022; wang, yixuan/GXW-2866-2022; Wang, Yijun/GXW-1763-2022; Wang, Yixuan/GZK-6559-2022; Wang, Yin/HCI-9352-2022; wang, yi/GVT-8516-2022		National Natural Science Foundation of China [81702324, 81770601, 81602529]; Natural Science Foundation of Hebei Province, China [H2018206176, H2017206141]; Medical Science Research Project of Hebei Province, China [20190510]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province, China(Natural Science Foundation of Hebei Province); Medical Science Research Project of Hebei Province, China	This work was supported by the National Natural Science Foundation of China (81702324, 81770601, and 81602529), Natural Science Foundation of Hebei Province, China (H2018206176 and H2017206141); Medical Science Research Project of Hebei Province, China (20190510).	Adjei AA, 2001, JNCI-J NATL CANCER I, V93, P1062, DOI 10.1093/jnci/93.14.1062; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Baietti MF, 2016, EMBO MOL MED, V8, P288, DOI 10.15252/emmm.201505972; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Castagnola P, 2005, BBA-REV CANCER, V1756, P115, DOI 10.1016/j.bbcan.2005.06.003; Dekker E, 2019, LANCET, V394, P1467, DOI 10.1016/S0140-6736(19)32319-0; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Deng WQ, 2009, GENET MOL BIOL, V32, P594, DOI 10.1590/S1415-47572009005000062; Dohlman HG, 2019, J BIOL CHEM, V294, P18613, DOI 10.1074/jbc.REV119.011068; Donovan S, 2002, BBA-REV CANCER, V1602, P23, DOI 10.1016/S0304-419X(01)00041-5; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; Geng R, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.400; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hobbs GA, 2016, J CELL SCI, V129, P1287, DOI 10.1242/jcs.182873; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Inamura K, 2018, CANCERS, V10, DOI 10.3390/cancers10010026; JACKSON JH, 1994, P NATL ACAD SCI USA, V91, P12730, DOI 10.1073/pnas.91.26.12730; Jaworska AM, 2020, STEM CELLS, V38, P165, DOI 10.1002/stem.3109; Jiang XM, 2015, MOL CELL, V58, P522, DOI 10.1016/j.molcel.2015.03.015; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; KATO K, 1992, P NATL ACAD SCI USA, V89, P6403, DOI 10.1073/pnas.89.14.6403; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Koveitypour Z, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0361-4; Lee DW, 2017, CANCER-AM CANCER SOC, V123, P3513, DOI 10.1002/cncr.30760; Levinson AM, 2017, J AM CHEM SOC, V139, P7632, DOI 10.1021/jacs.7b02988; Lieu CH, 2019, CLIN CANCER RES, V25, P5852, DOI 10.1158/1078-0432.CCR-19-0899; Liu L, 2018, ONCOGENE, V37, P148, DOI 10.1038/onc.2017.313; Martinelli E, 2020, ANN ONCOL, V31, P30, DOI 10.1016/j.annonc.2019.10.007; McCormick F, 2015, CLIN CANCER RES, V21, P1797, DOI 10.1158/1078-0432.CCR-14-2662; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Papke B, 2017, SCIENCE, V355, P1158, DOI 10.1126/science.aam7622; Prior IA, 2001, J CELL SCI, V114, P1603; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Schmick M, 2015, TRENDS CELL BIOL, V25, P190, DOI 10.1016/j.tcb.2015.02.004; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Senft D, 2018, NAT REV CANCER, V18, P69, DOI 10.1038/nrc.2017.105; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Smakman N, 2005, BBA-REV CANCER, V1756, P103, DOI 10.1016/j.bbcan.2005.07.001; Song HX, 2008, BMB REP, V41, P664, DOI 10.5483/BMBRep.2008.41.9.664; Tan ZL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax5576; Tsai FD, 2015, P NATL ACAD SCI USA, V112, P779, DOI 10.1073/pnas.1412811112; Veggiani G, 2019, PHARMACOL THERAPEUT, V199, P139, DOI 10.1016/j.pharmthera.2019.03.003; Venuto S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050510; Wang XW, 2014, GUT LIVER, V8, P487, DOI 10.5009/gnl13133; Wang YX, 2013, J MED CHEM, V56, P5219, DOI 10.1021/jm3017706; Zhu J, 2016, ONCOGENE, V35, P1955, DOI 10.1038/onc.2015.260	51	3	3	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 30	2021	40	39					5829	5842		10.1038/s41388-021-01877-4	http://dx.doi.org/10.1038/s41388-021-01877-4		AUG 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UZ8WB	34345014	hybrid, Green Published			2022-12-26	WOS:000681523500006
J	Dangsagul, W; Ruchusatsawat, K; Tawatsin, A; Changsom, D; Noisumdaeng, P; Putchakarn, S; Phatihattakorn, C; Auewarakul, P; Puthavathana, P				Dangsagul, Worawat; Ruchusatsawat, Kriengsak; Tawatsin, Apiwat; Changsom, Don; Noisumdaeng, Pirom; Putchakarn, Sukontip; Phatihattakorn, Chayawat; Auewarakul, Prasert; Puthavathana, Pilaipan			Zika virus isolation, propagation, and quantification using multiple methods	PLOS ONE			English	Article							MOSQUITO INOCULATION; DENGUE; ASSAY; DIAGNOSTICS; TITRATION; DETECT; PCR	Zika virus (ZIKV) was isolated from the archival urine, serum, and autopsy specimens by intrathoracic inoculation of Toxorhynchitis splendens and followed by three blind sub-passaging in C6/36 mosquito cells. The virus isolates were identified using an immunofluorescence assay and real-time reverse transcription-polymerase chain reaction (real-time RT-PCR). This study analyzed 11 ZIKV isolates. One isolate (0.6%) was obtained from 171 urine samples, eight (8.7%) from 92 serum samples and two from tissues of an abortive fetus. After propagation in C6/36 cells, ZIKV was titrated by plaque and focus forming unit (FFU) assays in Vero cell monolayers, and viral genomes were determined via real-time and digital RT-PCR. Plaque and FFU assay quantitations were comparable, with the amount of infectious viruses averaging 10(6)-10(7) PFU or FFU/ml. Real-time RT-PCR semi-quantified the viral genome numbers, with Ct values varying from 12 to 14. Digital RT-PCR, which precisely determines the numbers of the viral genomes, consistently averaged 10-100 times higher than the number of infectious units. There was good correlation between the results of these titration methods. Therefore, the selection of a method should be based on the objectives of each research studies.	[Dangsagul, Worawat; Puthavathana, Pilaipan] Mahidol Univ, Fac Med Technol, Nakhon Pathom, Thailand; [Ruchusatsawat, Kriengsak; Tawatsin, Apiwat; Changsom, Don; Putchakarn, Sukontip] Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand; [Noisumdaeng, Pirom] Thammasat Univ, Fac Publ Hlth, Pathum Thani, Thailand; [Noisumdaeng, Pirom] Thammasat Univ, Thammasat Univ Res Unit Modern Microbiol & Publ H, Pathum Thani, Thailand; [Phatihattakorn, Chayawat; Auewarakul, Prasert] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok, Thailand	Mahidol University; Ministry of Public Health - Thailand; Thammasat University; Thammasat University; Mahidol University	Puthavathana, P (corresponding author), Mahidol Univ, Fac Med Technol, Nakhon Pathom, Thailand.	pilaipan.put@mahidol.edu		Puthavathana, Pilaipan/0000-0002-5481-9156; Dangsagul, Worawat/0000-0002-6066-5245	National Science and Technology Development Agency, Thailand [P-17-50551]	National Science and Technology Development Agency, Thailand	This study was financially supported by the National Science and Technology Development Agency, Thailand, Grant No. P-17-50551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT ADT, 1986, CURR TOP MICROBIOL, V128, P55; Borisevich V, 2008, J VIROL METHODS, V147, P197, DOI 10.1016/j.jviromet.2007.08.015; Bustin SA, 2005, CLIN SCI, V109, P365, DOI 10.1042/CS20050086; Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99; Choy MM, 2014, METHODS MOL BIOL, V1138, P15, DOI 10.1007/978-1-4939-0348-1_2; Clementi M, 2000, J CLIN MICROBIOL, V38, P2030; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548; Jarman RG, 2011, AM J TROP MED HYG, V84, P218, DOI 10.4269/ajtmh.2011.09-0798; KIMURAKURODA J, 1985, MICROBIOL IMMUNOL, V29, P55, DOI 10.1111/j.1348-0421.1985.tb00802.x; KUNO G, 1985, B WORLD HEALTH ORGAN, V63, P279; Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Oehler E, 2014, EUROSURVEILLANCE, V19, P4; Quan PL, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18041271; ROSEN L, 1981, AM J TROP MED HYG, V30, P177, DOI 10.4269/ajtmh.1981.30.177; ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153; ROUX L, 1991, ADV VIRUS RES, V40, P181; Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7; Sedlak RH, 2013, DIAGN MICR INFEC DIS, V75, P1, DOI 10.1016/j.diagmicrobio.2012.10.009; Sippert E, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11111058; Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018; Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16; Yamamoto K, 2018, MICROBIOL IMMUNOL, V62, P90, DOI 10.1111/1348-0421.12563	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255314	10.1371/journal.pone.0255314	http://dx.doi.org/10.1371/journal.pone.0255314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329309	gold, Green Published			2022-12-26	WOS:000685248600048
J	Utsumi, I; Hascilowicz, T; Omi, S				Utsumi, Isao; Hascilowicz, Tomasz; Omi, Sachiko			Recognition and differentiation of dural puncture click sensation: A subjective and objective prospective study of dural puncture forces using fine-gauge spinal needles	PLOS ONE			English	Article							ANESTHESIA; HEADACHE; DAMAGE	Background We hypothesized that the click perceived when puncturing the dura-arachnoid with fine-gauge spinal needles can be subjectively identified, and investigated whether it may be distinguishable among different needle types. Methods Subjective and objective evaluations were performed. First, physicians punctured the polyamide film or porcine dura mater (n = 70 and n = 20, respectively) with seven types of spinal needles and numerically evaluated the perceived click sensations. Using an 11-point numerical rating scale (from "0" for "no click sensation" to "10" for "the strongest click perceived") data, subjective differentiation among needle types was assessed. Second, in the objective part of the study, total forces elicited by polyamide film or porcine dura mater punctures with each needle were measured using a biomechanical testing device, and load-displacement curves evaluated. Third, the results of subjective and objective evaluations were compared. Results All participants recognized the click and could discriminate among needles of different tip shape. The load-displacement curves for polyamide film and porcine dura mater were similar and needle-specific. The subjective numerical rating scale values corresponded well with the objectively measured changes in total forces (R-2 = 0.862 and R-2 = 0.881 for polyamide film and porcine dura mater, respectively), indicating that an increase in the largest drop in total force value of 0.30 N or 0.21 N would produce an increase of numerical rating scale value of 1 for polyamide film and porcine dura mater, respectively. Conclusions We provide an objective proof of the click sensation felt upon dural puncture using different fine-gauge spinal needles. Click recognition could be used as an additional indicator of successful spinal puncture.	[Utsumi, Isao; Hascilowicz, Tomasz; Omi, Sachiko] Jikei Univ, Dept Anesthesiol, Sch Med, Tokyo, Japan	Jikei University	Utsumi, I (corresponding author), Jikei Univ, Dept Anesthesiol, Sch Med, Tokyo, Japan.	isa049@jikei.ac.jp		UTSUMI, ISAO/0000-0002-9687-5682				Calthorpe N, 2004, ANAESTHESIA, V59, P1231, DOI 10.1111/j.1365-2044.2004.03976.x; Campbell DC, 1996, REGION ANESTH, V21, P582; Cook TM, 2000, ANAESTHESIA, V55, P42, DOI 10.1046/j.1365-2044.2000.01157.x; Fettes PDW, 2009, BRIT J ANAESTH, V102, P739, DOI 10.1093/bja/aep096; FLAATTEN H, 1989, ANAESTHESIA, V44, P147, DOI 10.1111/j.1365-2044.1989.tb11167.x; HART JR, 1951, JAMA-J AM MED ASSOC, V147, P657, DOI 10.1001/jama.1951.73670240021006k; Hoskin MF, 1998, ANAESTH INTENS CARE, V26, P96, DOI 10.1177/0310057X9802600115; Kathirgamanathan A, 2007, ANAESTHESIA, V62, P802, DOI 10.1111/j.1365-2044.2007.05099.x; Krommendijk EJ, 1999, REGION ANESTH PAIN M, V24, P43; Lewis MC, 2000, BRIT J ANAESTH, V85, P238, DOI 10.1093/bja/85.2.238; Mahvash Mohsen, 2009, 2009 IEEE International Conference on Robotics and Automation (ICRA), P3097, DOI 10.1109/ROBOT.2009.5152617; Mori U, 2016, R J, V8, P451; Nath S, 2018, LANCET, V391, P1197, DOI 10.1016/S0140-6736(17)32451-0; Ponde VC, 2019, INDIAN J ANAESTH, V63, P58, DOI 10.4103/ija.IJA_114_18; Puolakka R, 2000, REGION ANESTH PAIN M, V25, P163, DOI 10.1053/rapm.2000.0250163; Rajakulendran Y, 1999, INT J OBSTET ANESTH, V8, P62, DOI 10.1016/S0959-289X(99)80154-X; Rand E., 2016, ANESTH PAIN MED, V6, DOI [10.5812/aapm.36607, DOI 10.5812/AAPM.36607]; Reynolds F, 2001, ANAESTHESIA, V56, P238, DOI 10.1046/j.1365-2044.2001.01422-2.x; Riley ET, 2002, ANESTHESIOLOGY, V97, P574, DOI 10.1097/00000542-200209000-00009; SMITH EA, 1994, ANAESTHESIA, V49, P859, DOI 10.1111/j.1365-2044.1994.tb04258.x; Tsen LC, 2006, EXPERT REV MED DEVIC, V3, P499, DOI 10.1586/17434440.3.4.499; Turnbull DK, 2003, BRIT J ANAESTH, V91, P718, DOI 10.1093/bja/aeg231; Vallejo MC, 2000, ANESTH ANALG, V91, P916, DOI 10.1097/00000539-200010000-00027; WESTBROOK JL, 1994, ANESTH ANALG, V79, P769; Xu H, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006527	25	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0247346	10.1371/journal.pone.0247346	http://dx.doi.org/10.1371/journal.pone.0247346			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329298	Green Published, gold, Green Submitted			2022-12-26	WOS:000685248600007
J	Xu, GP; Rathi, Y; Camprodon, JA; Cao, HQ; Ning, LP				Xu, Guoping; Rathi, Yogesh; Camprodon, Joan A.; Cao, Hanqiang; Ning, Lipeng			Rapid whole-brain electric field mapping in transcranial magnetic stimulation using deep learning	PLOS ONE			English	Article							TISSUE; SEGMENTATION; FOCALITY; TMS	Transcranial magnetic stimulation (TMS) is a non-invasive neurostimulation technique that is increasingly used in the treatment of neuropsychiatric disorders and neuroscience research. Due to the complex structure of the brain and the electrical conductivity variation across subjects, identification of subject-specific brain regions for TMS is important to improve the treatment efficacy and understand the mechanism of treatment response. Numerical computations have been used to estimate the stimulated electric field (E-field) by TMS in brain tissue. But the relative long computation time limits the application of this approach. In this paper, we propose a deep-neural-network based approach to expedite the estimation of whole-brain E-field by using a neural network architecture, named 3D-MSResUnet and multimodal imaging data. The 3D-MSResUnet network integrates the 3D U-net architecture, residual modules and a mechanism to combine multi-scale feature maps. It is trained using a large dataset with finite element method (FEM) based E-field and diffusion magnetic resonance imaging (MRI) based anisotropic volume conductivity or anatomical images. The performance of 3D-MSResUnet is evaluated using several evaluation metrics and different combinations of imaging modalities and coils. The experimental results show that the output E-field of 3D-MSResUnet provides reliable estimation of the E-field estimated by the state-of-the-art FEM method with significant reduction in prediction time to about 0.24 second. Thus, this study demonstrates that neural networks are potentially useful tools to accelerate the prediction of E-field for TMS targeting.	[Xu, Guoping] Wuhan Inst Technol, Sch Comp Sci & Engn, Wuhan, Peoples R China; [Xu, Guoping; Rathi, Yogesh; Ning, Lipeng] Brigham & Womens Hosp, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA; [Rathi, Yogesh; Camprodon, Joan A.; Ning, Lipeng] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Rathi, Yogesh; Camprodon, Joan A.; Ning, Lipeng] Harvard Med Sch, Boston, MA 02115 USA; [Cao, Hanqiang] Huazhong Univ Sci & Technol, Sch Elect Informat & Commun, Wuhan, Hubei, Peoples R China	Wuhan Institute of Technology; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Huazhong University of Science & Technology	Ning, LP (corresponding author), Brigham & Womens Hosp, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA.; Ning, LP (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.; Ning, LP (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	lning@bwh.harvard.edu	Camprodon, Joan Albert/M-9093-2017	Camprodon, Joan Albert/0000-0003-1282-9257; Ning, Lipeng/0000-0003-4992-459X	NIH [R21MH126396, R21MH115280, K01MH117346, R21MH116352, R01MH112737]; Graduate School of Huazhong University of Science and Technology	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate School of Huazhong University of Science and Technology	This work was supported in part by NIH grants R21MH126396 (LN), R21MH115280 (LN and JC), K01MH117346 (LN), R21MH116352 (LN), R01MH112737(JC). XG was supported by Graduate School of Huazhong University of Science and Technology. This study was partially completed while XG visited the Psychiatry Neuroimaging Laboratory at Brigham and Women's Hospital in 2019. No additional external funding was received for this study.	Astrom M, 2012, MED BIOL ENG COMPUT, V50, P23, DOI 10.1007/s11517-011-0842-z; Bakir A.A., 2019, BRAIN HUMAN BODY MOD, P27; Camprodon JA, 2016, JAMA PSYCHIAT, V73, P407, DOI 10.1001/jamapsychiatry.2015.3127; Cicek Ozgun, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P424, DOI 10.1007/978-3-319-46723-8_49; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Daneshzand M, 2021, NEUROIMAGE, V237, DOI 10.1016/j.neuroimage.2021.118097; De Geeter N, 2015, PHYS MED BIOL, V60, P453, DOI 10.1088/0031-9155/60/2/453; Deng ZD, 2013, BRAIN STIMUL, V6, P1, DOI 10.1016/j.brs.2012.02.005; Dou Q, 2017, MED IMAGE ANAL, V41, P40, DOI 10.1016/j.media.2017.05.001; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Gomez LJ, 2021, NEUROIMAGE, V228, DOI 10.1016/j.neuroimage.2020.117696; Gomez LJ, 2020, BRAIN STIMUL, V13, P157, DOI 10.1016/j.brs.2019.09.015; Gullmar D, 2010, NEUROIMAGE, V51, P145, DOI 10.1016/j.neuroimage.2010.02.014; Hannula H., 2017, NAVIGATED TRANSCRANI, P3, DOI [10.1007/978-3-319-54918-7_1, DOI 10.1007/978-3-319-54918-7_1]; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Ilmoniemi RJ, 1999, CRIT REV BIOMED ENG, V27, P241; K?pf, 2019, ADV NEURAL INFORM PR, V32, P8024, DOI DOI 10.5555/3454287.3455008; Laakso I, 2012, PHYS MED BIOL, V57, P7753, DOI 10.1088/0031-9155/57/23/7753; Lee CY, 2015, JMLR WORKSH CONF PRO, V38, P562; Lee EG, 2018, CLIN NEUROPHYSIOL, V129, P1873, DOI 10.1016/j.clinph.2018.04.749; Lee K., ARXIV170600120, P2017; Liu L., ARXIV190803265, P2019; Miranda PC, 2003, IEEE T BIO-MED ENG, V50, P1074, DOI 10.1109/TBME.2003.816079; Nielsen JD, 2018, NEUROIMAGE, V174, P587, DOI 10.1016/j.neuroimage.2018.03.001; Nummenmaa A, 2014, BRAIN STIMUL, V7, P80, DOI 10.1016/j.brs.2013.10.001; Nummenmaa A, 2013, CLIN NEUROPHYSIOL, V124, P1995, DOI 10.1016/j.clinph.2013.04.019; Opitz A, 2011, NEUROIMAGE, V58, P849, DOI 10.1016/j.neuroimage.2011.06.069; Salinas FS, 2009, PHYS MED BIOL, V54, P3631, DOI 10.1088/0031-9155/54/12/002; Saturnino G.B., 2019, BRAIN HUMAN BODY MOD, P3, DOI DOI 10.1007/978-3-030-21293-3_1; Saturnino GB, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab41ba; Saturnino GB, 2019, NEUROIMAGE, V188, P821, DOI 10.1016/j.neuroimage.2018.12.053; Shahid SS, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/036002; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Stenroos M, 2019, NEUROIMAGE, V203, DOI 10.1016/j.neuroimage.2019.116159; Thielscher A, 2004, CLIN NEUROPHYSIOL, V115, P1697, DOI 10.1016/j.clinph.2004.02.019; Thielscher A, 2015, IEEE ENG MED BIO, P222, DOI 10.1109/EMBC.2015.7318340; Tustison N.J., 2009, INSIGHT J, P707, DOI [10.54294/1vixgg, DOI 10.54294/1VIXGG]; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Windhoff M, 2013, HUM BRAIN MAPP, V34, P923, DOI 10.1002/hbm.21479; Yokota T, 2019, BRAIN STIMUL, V12, P1500, DOI 10.1016/j.brs.2019.06.015; Yu LQ, 2017, AAAI CONF ARTIF INTE, P66; Zeng GD, 2017, LECT NOTES COMPUT SC, V10541, P274, DOI 10.1007/978-3-319-67389-9_32; Zhu QK, 2017, IEEE IJCNN, P178, DOI 10.1109/IJCNN.2017.7965852	46	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0254588	10.1371/journal.pone.0254588	http://dx.doi.org/10.1371/journal.pone.0254588			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329328	Green Published, gold			2022-12-26	WOS:000685248600047
J	Zhou, H; Xu, YQ; Ebel, F; Jin, C				Zhou, Hui; Xu, Yueqiang; Ebel, Frank; Jin, Cheng			Galactofuranose (Galf)-containing sugar chain contributes to the hyphal growth, conidiation and virulence of F. oxysporum f.sp. cucumerinum	PLOS ONE			English	Article							UDP-GALACTOPYRANOSE MUTASE; CELL-WALL; ASPERGILLUS-NIDULANS; BIOSYNTHESIS; FUSARIUM; PROTEIN; ROLES; GLYCOSYLATION; GALACTOMANNAN; COLONIZATION	The ascomycete fungus Fusarium oxysporum f.sp. cucumerinum causes vascular wilt diseases in cucumber. However, few genes related to morphogenesis and pathogenicity of this fungal pathogen have been functionally characterized. BLASTp searches of the Aspergillus fumigatus UgmA and galatofuranosyltransferases (Galf-transferases) sequences in the F. oxysporum genome identified two genes encoding putative UDP-galactopyranose mutase (UGM), ugmA and ugmB, and six genes encoding putative Galf-transferase homologs. In this study, the single and double mutants of the ugmA, ugmB and gfsB were obtained. The roles of UGMs and GfsB were investigated by analyzing the phenotypes of the mutants. Our results showed that deletion of the ugmA gene led to a reduced production of galactofuranose-containing sugar chains, reduced growth and impaired conidiation of F. oxysporum f.sp. cucumerinum. Most importantly, the ugmA deletion mutant lost the pathogenicity in cucumber plantlets. Although deletion of the ugmB gene did not cause any visible phenotype, deletion of both ugmA and ugmB genes caused more severe phenotypes as compared with the Delta ugmA, suggesting that UgmA and UgmB are redundant and they can both contribute to synthesis of UDP-Galf. Furthermore, the Delta gfsB exhibited an attenuated virulence although no other phenotype was observed. Our results demonstrate that the galactofuranose (Galf) synthesis contributes to the cell wall integrity, germination, hyphal growth, conidiation and virulence in Fusarium oxysporum f.sp. cucumerinum and an ideal target for the development of new anti-Fusarium agents.	[Zhou, Hui; Xu, Yueqiang; Jin, Cheng] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Xu, Yueqiang; Jin, Cheng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ebel, Frank] LMU, Inst Infect Dis & Zoonoses, Munich, Germany; [Jin, Cheng] Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Munich	Jin, C (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.; Jin, C (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Jin, C (corresponding author), Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Peoples R China.	jinc@im.ac.cn	Ebel, Frank/AAF-2303-2022; Ebel, Frank/AFH-1488-2022	Ebel, Frank/0000-0002-1027-1440; Ebel, Frank/0000-0002-1027-1440; jin, cheng/0000-0002-1514-6374	National Natural Sciences Foundation of China [31630016, 31320103901]; Bagui Scholar Program Fund [2016A24]; Guangxi Zhuang Autonomous Region	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Bagui Scholar Program Fund; Guangxi Zhuang Autonomous Region	This work was supported by the National Natural Sciences Foundation of China (31630016 and 31320103901) and partially supported by Bagui Scholar Program Fund (2016A24) of Guangxi Zhuang Autonomous Region to CJ. the funders play no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz S, 2011, FUNGAL GENET BIOL, V48, P896, DOI 10.1016/j.fgb.2011.06.001; Arentshorst M, 2020, ARCH MICROBIOL, V202, P197, DOI 10.1007/s00203-019-01709-w; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; Damveld RA, 2008, GENETICS, V178, P873, DOI 10.1534/genetics.107.073148; de Oliveira NF, 2019, MED MYCOL, V57, P234, DOI 10.1093/mmy/myx167; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; DELEDERKREMER RM, 1995, GLYCOBIOLOGY, V5, P547, DOI 10.1093/glycob/5.6.547; El-Ganiny AM, 2010, FUNGAL GENET BIOL, V47, P629, DOI 10.1016/j.fgb.2010.03.002; El-Ganiny AM, 2008, FUNGAL GENET BIOL, V45, P1533, DOI 10.1016/j.fgb.2008.09.008; Engel J, 2012, J BIOL CHEM, V287, P44418, DOI 10.1074/jbc.M112.398321; Engel J, 2009, J BIOL CHEM, V284, P33859, DOI 10.1074/jbc.M109.070219; Fang WX, 2010, GLYCOBIOLOGY, V20, P542, DOI 10.1093/glycob/cwp206; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Gow NAR, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0035-2016; GUARRO J, 1995, EUR J CLIN MICROBIOL, V14, P741, DOI 10.1007/BF01690988; JAMES PG, 1992, INFECT IMMUN, V60, P1084, DOI 10.1128/IAI.60.3.1084-1088.1992; Katafuchi Y, 2017, GLYCOBIOLOGY, V27, P568, DOI 10.1093/glycob/cwx028; Komachi Y, 2013, MOL MICROBIOL, V90, P1054, DOI 10.1111/mmi.12416; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; Lee MJ, 2014, J BIOL CHEM, V289, P1243, DOI 10.1074/jbc.M113.522516; Li MH, 2014, FUNGAL GENET BIOL, V65, P1, DOI 10.1016/j.fgb.2014.01.005; Li PQ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00312; Lievens B, 2007, ENVIRON MICROBIOL, V9, P2145, DOI 10.1111/j.1462-2920.2007.01329.x; Liu ShaoHua, 2005, Acta Phytopathologica Sinica, V35, P362; Lopez-Fernandez L, 2015, J PROTEOMICS, V128, P189, DOI 10.1016/j.jprot.2015.07.035; Novelli JF, 2009, DEV BIOL, V335, P340, DOI 10.1016/j.ydbio.2009.09.010; Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07; Oka T, 2018, BIOSCI BIOTECH BIOCH, V82, P183, DOI 10.1080/09168451.2017.1422383; Oka T, 2016, TRENDS GLYCOSCI GLYC, V28, pE39, DOI 10.4052/tigg.1428.1E; Park Joohae, 2014, Fungal Biol Biotechnol, V1, P6, DOI 10.1186/s40694-014-0006-7; Previato JO, 2004, ADV PARASIT, V56, P1, DOI 10.1016/S0065-308X(03)56001-8; Pu XM, 2014, FEMS MICROBIOL LETT, V355, P142, DOI 10.1111/1574-6968.12461; Sarrocco S, 2007, J PLANT PATHOL, V89, P47; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Tam PH, 2009, CURR OPIN CHEM BIOL, V13, P618, DOI 10.1016/j.cbpa.2009.09.012; Tefsen B, 2012, GLYCOBIOLOGY, V22, P456, DOI 10.1093/glycob/cwr144; Wiedemann A, 2016, INT J MED MICROBIOL, V306, P381, DOI 10.1016/j.ijmm.2016.05.002	37	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0250064	10.1371/journal.pone.0250064	http://dx.doi.org/10.1371/journal.pone.0250064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329342	Green Published, gold			2022-12-26	WOS:000685248600036
J	Rackova, L; Kuruczova, D; Jarkovsky, J; Bienertova-Vasku, J				Rackova, Lucie; Kuruczova, Daniela; Jarkovsky, Jiri; Bienertova-Vasku, Julie			Birth weight rather than birth length is associated with childhood behavioural problems in a Czech ELSPAC cohort	PLOS ONE			English	Article							EFFORTFUL CONTROL; FETAL-GROWTH; DIFFICULTIES QUESTIONNAIRE; NEUROBEHAVIORAL OUTCOMES; PSYCHOMETRIC PROPERTIES; EXTERNALIZING PROBLEMS; ETHNIC-DIFFERENCES; PRENATAL STRESS; CHILDREN BORN; STRENGTHS	Many physical and psychological characteristics are influenced by prenatal development. Some studies have located links between low birth parameters and behavioural problems, with the latter in turn associated with educational progress, career success, overall health, and subsequent life events. However, few studies have investigated whether this association also applies to children in the normal birth growth range. This study thus investigates the relationship between normal-range birth length, weight, and behavioural problems at the age of seven. We use data from the Czech part of the European Longitudinal Study of Pregnancy and Childhood (ELSPAC) cohort, which provides comprehensive insight into a post-communist country undergoing a period of economic transition. Childhood behavioural problems were measured in 1,796 children using the Strengths and Difficulties Questionnaire. Associations were modelled using weighted logistic regression. Birth weight was found to be linked to the total difficulties score, hyperactivity, and peer relationship problems subscales in a fully adjusted model while birth length was not significantly associated with any subscale in the fully adjusted model. We thus conclude that normal-range birth weight is associated with behavioural problems. It can therefore be assumed that the odds of behavioural problems and their consequences can be mitigated by preventive programs targeting pregnant women and children with lower but still normal weight.	[Rackova, Lucie; Kuruczova, Daniela; Jarkovsky, Jiri; Bienertova-Vasku, Julie] Masaryk Univ, Res Ctr Tox Cpds Environm RECETOX, Brno, Czech Republic; [Bienertova-Vasku, Julie] Masaryk Univ, Dept Pathol Physiol, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno	Bienertova-Vasku, J (corresponding author), Masaryk Univ, Res Ctr Tox Cpds Environm RECETOX, Brno, Czech Republic.; Bienertova-Vasku, J (corresponding author), Masaryk Univ, Dept Pathol Physiol, Brno, Czech Republic.	julie.dobrovolna@recetox.muni.cz	Ráčková, Lucie/AAZ-2736-2021; Kuruczová, Daniela/ADP-1511-2022; Bienertova Vasku, Julie/G-9763-2017	Ráčková, Lucie/0000-0001-7474-4377; Kuruczová, Daniela/0000-0002-6783-5251; Bienertova Vasku, Julie/0000-0001-5327-808X	RECETOX research infrastructure (Ministry of Education, Youth and Sports of the Czech Republic) [LM2018121]; Horizon 2020 Teaming 2 project [857560]; Ministry of Education, Youth and Sports of the Czech Republic [CZ.02.1.01/0.0/0.0/17_043/0009632, CZ.02.1.01/0.0/0.0/15_003/0000469]	RECETOX research infrastructure (Ministry of Education, Youth and Sports of the Czech Republic); Horizon 2020 Teaming 2 project; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This study has recieved support from RECETOX research infrastructure (Ministry of Education, Youth and Sports of the Czech Republic: LM2018121), Horizon 2020 Teaming 2 project (857560) and the Ministry of Education, Youth and Sports of the Czech Republic (CZ.02.1.01/0.0/0.0/17_043/0009632 and CZ.02.1.01/0.0/0.0/15_003/0000469).	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; [Anonymous], 1989, Paediatr Perinat Epidemiol, V3, P460; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; BARKER DJP, 1988, BRIT MED J, V297, P134, DOI 10.1136/bmj.297.6641.134-b; BARKER DJP, 1986, LANCET, V1, P1077; Barlow J, 2000, J DEV BEHAV PEDIATR, V21, P356, DOI 10.1097/00004703-200010000-00006; Bienertova-Vasku J, 2017, EUR J CLIN NUTR, V71, P1193, DOI 10.1038/ejcn.2016.244; Bonthuis M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042506; Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Brick J M, 1996, Stat Methods Med Res, V5, P215, DOI 10.1177/096228029600500302; CAMPBELL SB, 1995, J CHILD PSYCHOL PSYC, V36, P113, DOI 10.1111/j.1469-7610.1995.tb01657.x; Chatterji P, 2014, ECON HUM BIOL, V15, P187, DOI 10.1016/j.ehb.2014.09.002; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Del Giudice M, 2011, NEUROSCI BIOBEHAV R, V35, P1562, DOI 10.1016/j.neubiorev.2010.11.007; Drooger JC, 2005, ULTRASOUND OBST GYN, V26, P115, DOI 10.1002/uog.1962; Dziadek M, 2005, PERINAT PROGRAM, V289; Eisenberg N, 2005, CHILD DEV, V76, P1055, DOI 10.1111/j.1467-8624.2005.00897.x; Essau CA, 2012, INT J METH PSYCH RES, V21, P232, DOI 10.1002/mpr.1364; Franz AP, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1645; Geva R, 2008, J CHILD PSYCHOL PSYC, V49, P1031, DOI 10.1111/j.1469-7610.2008.01918.x; Glover V, 2012, PHYSIOL BEHAV, V106, P736, DOI 10.1016/j.physbeh.2012.02.011; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Goodfellow SA, 2013, INT J EPIDEMIOL, V42, P1246, DOI 10.1093/ije/dys121; Goodman A, 2009, J AM ACAD CHILD PSY, V48, P400, DOI 10.1097/CHI.0b013e3181985068; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Gupta ND, 2013, ECON HUM BIOL, V11, P42, DOI 10.1016/j.ehb.2011.06.002; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hayes B, 2009, J MATERN-FETAL NEO M, V22, P849, DOI 10.1080/14767050902994507; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Karreman A, 2009, MERRILL PALMER QUART, V55, P111; Kelly YJ, 2001, INT J EPIDEMIOL, V30, P88, DOI 10.1093/ije/30.1.88; Kersten P, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1063-7; Khulan B, 2012, BEST PRACT RES CL EN, V26, P689, DOI 10.1016/j.beem.2012.03.007; Kinare AS, 2010, J ULTRAS MED, V29, P215, DOI 10.7863/jum.2010.29.2.215; Kuruczova D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234074; Lenart P, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2019.0091; Linsell L, 2016, J DEV BEHAV PEDIATR, V37, P88, DOI 10.1097/DBP.0000000000000238; Loukas A, 2006, J EARLY ADOLESCENCE, V26, P432, DOI 10.1177/0272431606291939; MacKinnon N, 2018, BIOL PSYCHIAT, V83, P100, DOI 10.1016/j.biopsych.2017.07.010; Mind Y., 2018, USES SDQ; Mollegaard S, 2020, ECON HUM BIOL, V36, DOI 10.1016/j.ehb.2019.100828; Morris AS, 2009, J APPL DEV PSYCHOL, V30, P695, DOI 10.1016/j.appdev.2009.01.002; Myers SS, 2009, EARLY EDUC DEV, V20, P756, DOI 10.1080/10409280802571244; Nyirenda MJ, 2005, PERINAT PROGRAM, V49; Piler P, 2017, INT J EPIDEMIOL, V46, P1379, DOI 10.1093/ije/dyw091; Poehlmann J, 2010, J CLIN CHILD ADOLESC, V39, P522, DOI 10.1080/15374416.2010.486319; RCore Team, 2020, R LANG ENV STAT COMP; Regional Office for Europe WHO, 1998, EUR LONG STUD PREGN; Regional Office for Europe WHO, 1997, EUR LONG STUD PREGN; Regional Office for Europe WHO, 1999, EUR LONG STUD PREGN; Research Centre for Toxic Compounds in the Environment (RECETOX), TOP ELSPAC STUD; Sallout B, 2003, J Obstet Gynaecol, V23, P555; Schlotz W, 2008, J CHILD PSYCHOL PSYC, V49, P1228, DOI 10.1111/j.1469-7610.2008.01946.x; Schlotz W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096715; Sletner L, 2015, EARLY HUM DEV, V91, P547, DOI 10.1016/j.earlhumdev.2015.07.002; Sobotka T, 2003, EUR J POPUL, V19, P249, DOI 10.1023/A:1024913321935; Stepanikova I, 2020, MATERN CHILD HLTH J, V24, P1193, DOI 10.1007/s10995-020-02978-4; Tore EC, 2018, TWIN RES HUM GENET, V21, P253, DOI 10.1017/thg.2018.13; United Nations Educational and Cultural Organization Paris (France), 1976, DIV STAT ED S INT ST; Valiente C, 2007, SOC DEV, V16, P249, DOI 10.1111/j.1467-9507.2007.00383.x; Van den Bergh BRH, 2020, NEUROSCI BIOBEHAV R, V117, P26, DOI 10.1016/j.neubiorev.2017.07.003; van Os J, 2001, BIOL PSYCHIAT, V50, P593, DOI 10.1016/S0006-3223(01)01085-X; Vaske J, 2013, INFANT CHILD DEV, V22, P235, DOI 10.1002/icd.1782; Viddal KR, 2015, ATTACH HUM DEV, V17, P319, DOI 10.1080/14616734.2014.999098; Villar J, 2014, LANCET DIABETES ENDO, V2, P781, DOI 10.1016/S2213-8587(14)70121-4; Wadhwa PD., 2006, PERINATAL PROGRAMMIN, P29; WHO Expert Committee on Maternal and Child Health & World Health Organization, 1961, WHO TECHNICAL REPORT, V217; Wiles NJ, 2006, AM J EPIDEMIOL, V163, P829, DOI 10.1093/aje/kwj108; Yang S, 2011, PAEDIATR PERINAT EP, V25, P377, DOI 10.1111/j.1365-3016.2011.01193.x	73	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0253607	10.1371/journal.pone.0253607	http://dx.doi.org/10.1371/journal.pone.0253607			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324515	Green Published, gold			2022-12-26	WOS:000685248200030
J	da Costa, FV; Guimaraes, MFM; Messias, MCTB				da Costa, Fernanda Vieira; Guimaraes, Mariana Fernandes Monteiro; Messias, Maria Cristina Teixeira Braga			Gender differences in traditional knowledge of useful plants in a Brazilian community	PLOS ONE			English	Article							ATLANTIC FOREST COAST; CULTURAL TRANSMISSION; MEDICINAL-PLANTS; RESOURCE USE; ETHNOBOTANY; CLASSIFICATION	Genders differ in traditional ecological knowledge (TEK) about plants, but how gender influences TEK sharing is still poorly understood. Here, we examined how gender is associated with the diversity, transmission, and structure of TEK. We tested whether women and men differ in terms of plant knowledge (species richness, alpha-diversity), knowledge heterogeneity (beta-diversity), and in the structure of social-ecological networks they form. The study was carried out in a suburban community in the city of Ouro Preto, Southeastern, Brazil. Using the snow-ball technique, semi-structured interviews, guided tours, and participant observation, we gathered information from 33 women and 33 men in the community. We collected information about their culture, social-economic profiles, and plant knowledge from which we identified 291 plant species in 10 use categories. Overall, our results indicated that the cognition and sharing of ethnobotanical knowledge are structured by gender. Women rated better in their plant knowledge repertory (greater alpha-diversity), while plant knowledge among men was more heterogeneous (greater beta-diversity), suggesting less information sharing among them. We observed that the network among women is more connected, exhibited greater information sharing, with a greater number of central individuals, who likely provide the cohesion and maintenance of TEK in the community. Our findings indicate how social-ecological networks can provide insights and information to unveil social patterns of knowledge transmission. Understanding how TEK is fostered and shared among community members will favor better planning of ethnobotanical studies, as well as inform decision-makers about strategies for the conservation of plant TEK.	[da Costa, Fernanda Vieira; Guimaraes, Mariana Fernandes Monteiro; Messias, Maria Cristina Teixeira Braga] Univ Fed Ouro Preto, Dept Biodiversidade, Programa Posgrad Ecol Biomas Trop Evolucao & Meio, Ouro Preto, MG, Brazil	Universidade Federal de Ouro Preto	Messias, MCTB (corresponding author), Univ Fed Ouro Preto, Dept Biodiversidade, Programa Posgrad Ecol Biomas Trop Evolucao & Meio, Ouro Preto, MG, Brazil.	cristina@ufop.edu.br		Teixeira Braga Messias, Maria Cristina/0000-0003-0300-9038	Postdoctoral Scholarship from Brazilian Coordination for Improvement of Higher Education Personnel (CAPES); Master scholarship from Brazilian National Council for Scientific and Technological Development (CNPq); Federal University of Ouro Preto	Postdoctoral Scholarship from Brazilian Coordination for Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Master scholarship from Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Federal University of Ouro Preto	This study was funded by the Postdoctoral Scholarship from Brazilian Coordination for Improvement of Higher Education Personnel (CAPES) https://www.gov.br/capes/pt-br awarded to FVC, by the Master scholarship from Brazilian National Council for Scientific and Technological Development (CNPq) https://www.gov.br/cnpq/pt-br awarded to MFMG, and by the Federal University of Ouro Preto awarded to MCTBM.	Albuquerque U. P., 2014, METHODS TECHNIQUES E, Vfirst, P1, DOI DOI 10.1007/978-1-4614-8636-7; Albuquerque UP, 2019, ACTA BOT BRAS, V33, P376, DOI 10.1590/0102-33062018abb0331; Albuquerque Ulysses Paulino, 2019, Biological Theory, V14, P73, DOI 10.1007/s13752-019-00316-8; Albuquerque UP., 1998, JARDIN BOTANICO MADR, P56, DOI [10.3989/ajbm.1998.v56.i1.224, DOI 10.3989/AJBM.1998.V56.I1.224]; Albuquerque UP., 2014, METHODS TECHNIQUES E, V1, DOI [10.1007/978-1-4614-8636-7, DOI 10.1007/978-1-4614-8636-7]; Alencar NL, 2014, ECON BOT, V68, P371, DOI 10.1007/s12231-014-9284-5; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; [Anonymous], 2013, GENDERED LIVES COMMU; Bailey K.D., 1994, METHODS SOCIAL RES, V4th; Barbosa KA., 2020, RES SOC DEV, V9, P332985797, DOI [10.33448/rsd-v9i8.5797, DOI 10.33448/RSD-V9I8.5797]; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Begossi A, 2002, HUM ECOL, V30, P281, DOI 10.1023/A:1016564217719; Berkes F., 2000, LINKING SOCIAL ECOLO, DOI [10.1046/j.1524-4725.2000.00021.x, DOI 10.1046/J.1524-4725.2000.00021.X]; Boyd R, 2011, P NATL ACAD SCI USA, V108, P10918, DOI 10.1073/pnas.1100290108; Calvet-Mir L, 2012, ECOL SOC, V17, DOI 10.5751/ES-04682-170129; Camou-Guerrero A, 2008, HUM ECOL, V36, P259, DOI 10.1007/s10745-007-9152-3; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; Di Ciommo Regina Célia, 2007, Ambient. soc., V10, P151, DOI 10.1590/S1414-753X2007000100010; Costa FV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167161; Di Ciommo Regina Célia, 2003, Rev. Estud. Fem., V11, P423; Dormann CF, 2014, METHODS ECOL EVOL, V5, P90, DOI 10.1111/2041-210X.12139; Dormann CF., 2014, VEGAN SNA, V149; Dovie DBK, 2008, APPL GEOGR, V28, P311, DOI 10.1016/j.apgeog.2008.07.002; Elias M, 2015, J RURAL STUD, V38, P27, DOI 10.1016/j.jrurstud.2015.01.006; Eyssartier C, 2008, J ETHNOBIOL ETHNOMED, V4, DOI 10.1186/1746-4269-4-25; Ferreira Junior WS., 2015, EVOLUTIONARY ETHNOBI, P105, DOI DOI 10.1007/978-3-319-19917-7; Hanazaki N, 2000, BIODIVERS CONSERV, V9, P597, DOI 10.1023/A:1008920301824; Heineberg MR, 2019, ACTA BOT BRAS, V33, P254, DOI 10.1590/0102-33062018abb0307; Henrich J, 2011, PHILOS T R SOC B, V366, P1139, DOI 10.1098/rstb.2010.0323; Hoppitt W., 2013, SOCIAL LEARNING INTR, DOI DOI 10.23943/PRINCETON/9780691150703.001.0001/UPSO-9780691150703; Howard P., 2003, WOMEN PLANTS GENDER, P1, DOI [10.1663/0013-0001(2004)058, DOI 10.1663/0013-0001(2004)058]; IBGE. Instituto Brasileiro de Geografia e Estatistica, I BRAS GEOGR EST CIT; KAINER KA, 1992, ECON BOT, V46, P408, DOI 10.1007/BF02866513; Kefi S, 2012, ECOL LETT, V15, P291, DOI 10.1111/j.1461-0248.2011.01732.x; Ladio A. H., 2020, Ethnoscientia, V5, DOI 10.22276/ethnoscientia.v5i1.298; Lopes VL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73563-6; Lozada M, 2006, ECON BOT, V60, P374, DOI 10.1663/0013-0001(2006)60[374:CTOEKI]2.0.CO;2; Luoga EJ, 2000, ECON BOT, V54, P328, DOI 10.1007/BF02864785; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; Mesoudi A, 2006, BEHAV BRAIN SCI, V29, P329, DOI 10.1017/S0140525X06009083; MESSIAS M.C.T.B., 2015, Rev. bras. plantas med., V17, P76, DOI 10.1590/1983-084X/12_139; Moore, 2004, ANTROPOLOGIA FEMINIS; Muller JG, 2015, AMBIO, V44, P67, DOI 10.1007/s13280-014-0517-8; Alves RRN, 2012, ETHNOBIOL CONSERV, V1, DOI [10.15451/ec2012-8-1.2-1-69, 10.15451/ec2012-8-1.7-1-21, 10.15451/ec2012-8-1.1-1-03]; Onnela JP, 2014, SCI REP-UK, V4, DOI 10.1038/srep05604; Peixoto AL, 2013, MANUAL PROCEDIMENTOS; Pfeiffer Jeanine M., 2005, Journal of Ethnobiology, V25, P240, DOI 10.2993/0278-0771(2005)25[240:ACAEVI]2.0.CO;2; Prado Amanda C.C., 2019, Rodriguésia, V70, pe02032017, DOI 10.1590/2175-7860201970019; R Development Core Team, 2017, R LANG STAT COMP; Reyes-Garcia V, 2010, ECON BOT, V64, P235, DOI 10.1007/s12231-010-9124-1; Reyes-Garcia V, 2009, EVOL HUM BEHAV, V30, P274, DOI 10.1016/j.evolhumbehav.2009.02.001; Mello MAR, 2015, OIKOS, V124, P1031, DOI 10.1111/oik.01613; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; Rossato SC, 1999, ECON BOT, V53, P387, DOI 10.1007/BF02866716; Samter W, 2005, COMMUN Q, V53, P265, DOI 10.1080/01463370500100982; SAPADIN LA, 1988, J SOC PERS RELAT, V5, P387, DOI 10.1177/0265407588054001; Schaedel R.P., 2011, URBANIZATION AMERICA, DOI [10.1515/9783110808018, DOI 10.1515/9783110808018]; Soldati GT, 2016, ETHNOBIOL CONSERV, V5, DOI 10.15451/ec2016-6-5.2-1-09; Soldati GT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126389; Stehmann J. R., 1995, Fitoterapia, V66, P515; The Plant List, 2013, PLANT LIST WORK LIST; Tongco M. D. C., 2007, Ethnobotany Research and Applications, V5, P147; Torres-Avilez W, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/8313790; Torres-Avilez W, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/6592363; Torres-Avilez WM, 2017, ETHNOBIOL CONSERV, V6, DOI 10.15451/ec2017-07-6.8-1-6; UNESCO, 2020, WORLD HER CONV HIST; Urriago-Ospina LM, 2021, ENVIRON DEV SUSTAIN, V23, P2092, DOI 10.1007/s10668-020-00665-6; Voeks RA, 2007, SINGAPORE J TROP GEO, V28, P7, DOI 10.1111/j.1467-9493.2006.00273.x; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wood J.T., 1993, J APPLIED COMMUNICAT, V21, P279, DOI [10.1080/00909889309365372, DOI 10.1080/00909889309365372]; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	72	2	2	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0253820	10.1371/journal.pone.0253820	http://dx.doi.org/10.1371/journal.pone.0253820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CM	34320019	gold, Green Published			2022-12-26	WOS:000685247800017
J	Dokmegang, J; Yap, MH; Han, LX; Cavaliere, M; Doursat, R				Dokmegang, Joel; Yap, Moi Hoon; Han, Liangxiu; Cavaliere, Matteo; Doursat, Rene			Computational modelling unveils how epiblast remodelling and positioning rely on trophectoderm morphogenesis during mouse implantation	PLOS ONE			English	Article							APICAL CONSTRICTION; CELL; STIFFNESS; MECHANISM; GROWTH; EMBRYO	Understanding the processes by which the mammalian embryo implants in the maternal uterus is a long-standing challenge in embryology. New insights into this morphogenetic event could be of great importance in helping, for example, to reduce human infertility. During implantation the blastocyst, composed of epiblast, trophectoderm and primitive endoderm, undergoes significant remodelling from an oval ball to an egg cylinder. A main feature of this transformation is symmetry breaking and reshaping of the epiblast into a "cup". Based on previous studies, we hypothesise that this event is the result of mechanical constraints originating from the trophectoderm, which is also significantly transformed during this process. In order to investigate this hypothesis we propose MG# (MechanoGenetic Sharp), an original computational model of biomechanics able to reproduce key cell shape changes and tissue level behaviours in silico. With this model, we simulate epiblast and trophectoderm morphogenesis during implantation. First, our results uphold experimental findings that repulsion at the apical surface of the epiblast is essential to drive lumenogenesis. Then, we provide new theoretical evidence that trophectoderm morphogenesis indeed can dictate the cup shape of the epiblast and fosters its movement towards the uterine tissue. Our results offer novel mechanical insights into mouse peri-implantation and highlight the usefulness of agent-based modelling methods in the study of embryogenesis.	[Dokmegang, Joel; Yap, Moi Hoon; Han, Liangxiu; Cavaliere, Matteo; Doursat, Rene] Manchester Metropolitan Univ, Ctr Adv Computat Sci CfACS, Manchester, Lancs, England; [Doursat, Rene] Natl Ctr Sci Res CNRS, Paris Ile de France ISC PIF, Complex Syst Inst, Paris, France; [Dokmegang, Joel] Northwestern Univ, NSF Simons Ctr Quantitat Biol, Evanston, IL 60201 USA	Manchester Metropolitan University; Centre National de la Recherche Scientifique (CNRS); Northwestern University	Dokmegang, J; Cavaliere, M (corresponding author), Manchester Metropolitan Univ, Ctr Adv Computat Sci CfACS, Manchester, Lancs, England.; Dokmegang, J (corresponding author), Northwestern Univ, NSF Simons Ctr Quantitat Biol, Evanston, IL 60201 USA.	joel.dokmegang-kassap@stu.mmu.ac.uk; m.cavaliere@mmu.ac.uk		Yap, Moi Hoon/0000-0001-7681-4287; Dokmegang, Joel/0000-0001-9953-7913; Han, Prof. Liangxiu/0000-0003-2491-7473	European Union [721537]; NSF-Simons Center for Quantitative Biology at Northwestern University [SFARI 597491-RWC]; National Science Foundation [1764421]	European Union(European Commission); NSF-Simons Center for Quantitative Biology at Northwestern University; National Science Foundation(National Science Foundation (NSF))	This work has received funding from the European Union's Horizon 2020 Research and Innovation Programme ImageInLife under the Marie Sklodowska-Curie grant agreement No. 721537. We are also grateful for the support of the NSF-Simons Center for Quantitative Biology at Northwestern University (awards Simons Foundation/SFARI 597491-RWC and the National Science Foundation 1764421).	Alt S, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2015.0520; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Bedzhov I, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0538; Bedzhov I, 2014, CELL, V156, P1032, DOI 10.1016/j.cell.2014.01.023; Bongiorno T, 2014, J BIOMECH, V47, P2197, DOI 10.1016/j.jbiomech.2013.11.017; Brodland GW, 2015, SEMIN CELL DEV BIOL, V47-48, DOI 10.1016/j.semcdb.2015.07.001; Christodoulou N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11482-5; Christodoulou N, 2018, NAT CELL BIOL, V20, P1278, DOI 10.1038/s41556-018-0211-3; Christodoulou N, 2015, CELL REP, V13, P2189, DOI 10.1016/j.celrep.2015.11.017; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Delile J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13929; Dokmegang J, 2021, BIOINFORMATICS, V37, P2946, DOI 10.1093/bioinformatics/btab201; Duclut C, 2019, P NATL ACAD SCI USA, V116, P19264, DOI 10.1073/pnas.1908481116; Fletcher AG, 2014, BIOPHYS J, V106, P2291, DOI 10.1016/j.bpj.2013.11.4498; Fukui Y, 2019, REPROD MED BIOL, V18, P234, DOI 10.1002/rmb2.12280; Harding MJ, 2014, DEVELOPMENT, V141, P2549, DOI 10.1242/dev.101444; Harrison SE, 2017, SCIENCE, V356, DOI 10.1126/science.aal1810; Heisenberg CP, 2017, MECH DEVELOP, V145, P32, DOI 10.1016/j.mod.2017.03.006; Honda H, 2004, J THEOR BIOL, V226, P439, DOI 10.1016/j.jtbi.2003.10.001; Kaouri K, 2019, J MATH BIOL, V78, P2059, DOI 10.1007/s00285-019-01333-8; Kim YS, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe1640; Kojima Y, 2014, SEMIN CELL DEV BIOL, V34, P65, DOI 10.1016/j.semcdb.2014.06.010; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Micoulet A, 2005, CHEMPHYSCHEM, V6, P663, DOI 10.1002/cphc.200400417; Milde F, 2014, COMPUT PART MECH, V1, P211, DOI 10.1007/s40571-014-0017-4; Newman TJ., 2005, QBIO0504028 ARXIV QBIO0504028 ARXIV; Odenthal T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003267; Ogura Y, 2018, DEV CELL, V46, P162, DOI 10.1016/j.devcel.2018.06.004; Parfitt DE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0542; Pillarisetti A, 2011, CELL REPROGRAM, V13, P371, DOI 10.1089/cell.2011.0028; Sandersius SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015002; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Shahbazi MN, 2017, NATURE, V552, P239, DOI 10.1038/nature24675; Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347; Sharpe J, 2017, DEVELOPMENT, V144, P4214, DOI 10.1242/dev.151274; Sui LY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06497-3; Suzuki M, 2017, DEVELOPMENT, V144, P1307, DOI 10.1242/dev.141952; Thompson D. W., 1917, GROWTH FORM; Van Liedekerke P, 2015, COMPUT PART MECH, V2, P401, DOI 10.1007/s40571-015-0082-3; Villoutreix P, 2016, SCI REP-UK, V6, DOI 10.1038/srep37438; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang X, 2018, BIOPHYS J, V115, P2443, DOI 10.1016/j.bpj.2018.11.008; Weberling A, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108655; Wolpert L, 2015, PRINCIPLES DEV; Zhang SP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08378-9	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254763	10.1371/journal.pone.0254763	http://dx.doi.org/10.1371/journal.pone.0254763			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320001	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000685247800008
J	Siqueira, WL; Canales, MP; Crosara, KTB; Marin, LM; Xiao, YZ				Siqueira, Walter Luiz; Canales, Maria Pia; Crosara, Karla Tonelli Bicalho; Marin, Lina Maria; Xiao, Yizhi			Proteome difference among the salivary proteins adsorbed onto metallic orthodontic brackets and hydroxyapatite discs	PLOS ONE			English	Article							WHITE-SPOT LESIONS; DENTAL PLAQUE; ORAL STREPTOCOCCI; ALPHA-AMYLASE; IDENTIFICATION; ADSORPTION; COMPONENTS; CYSTATINS; ADHERENCE; PELLICLES	The aim of this study was to investigate the atomic composition and the proteome of the salivary proteins adsorbed on the surface of orthodontic metallic bracket. For this, the atomic composition of orthodontic metallic brackets was analyzed with X-ray Photoelectron Spectroscopy (XPS). The acquired bracket pellicle was characterized after brackets were immersed in human whole saliva supernatant for 2 hours at 37 degrees C. Hydroxyapatite (HA) discs were used as a control. Acquired pellicle was harvested from the HA discs (n = 12) and from the metallic brackets (n = 12). Proteomics based on mass spectrometry technology was used for salivary protein identification and characterization. Results showed that most of the proteins adsorbed on the surface of orthodontic metallic brackets and on the HA discs were identified specifically to each group, indicating a small overlapping between the salivary proteins on each study group. A total of 311 proteins present on the HA discs were unique to this group while 253 proteins were unique to metallic brackets, and only 45 proteins were common to the two groups. Even though most proteins were unique to each study group, proteins related to antimicrobial activity, lubrication, and remineralization were present in both groups. These findings demonstrate that the salivary proteins adsorbed on the bracket surface are dependent on the material molecular composition.	[Siqueira, Walter Luiz; Marin, Lina Maria] Univ Saskatchewan, Coll Dent, Saskatoon, SK, Canada; [Canales, Maria Pia; Crosara, Karla Tonelli Bicalho; Xiao, Yizhi] Univ Western Ontario, Schulich Dent & Med, London, ON, Canada	University of Saskatchewan; Western University (University of Western Ontario)	Siqueira, WL (corresponding author), Univ Saskatchewan, Coll Dent, Saskatoon, SK, Canada.	walter.siqueira@usask.ca	Marin, Lina Maria/O-7549-2016; Siqueira, Walter/ABE-4069-2021	Marin, Lina Maria/0000-0003-2108-4656; 	Canadian Institutes of Health Research [106657, 400347]; Canada Foundation for Innovation -Leaders Opportunity Fund [25116]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation -Leaders Opportunity Fund	This study was funded by the grants awarded to WLS by the Canadian Institutes of Health Research (grants 106657 and 400347, http://www.cihr-irsc.gc.ca/e/193.html) and by Canada Foundation for Innovation -Leaders Opportunity Fund (grant 25116, https://www.innovation.ca/about/news/leaders-opportunityfund).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2003, AM J ORTHOD DENTOFAC, V124, P198, DOI 10.1016/S0889-5406(03)00346-9; Ahn SJ, 2002, J DENT RES, V81, P411, DOI 10.1177/154405910208100611; Ahn SJ, 2007, AM J ORTHOD DENTOFAC, V132, P815, DOI 10.1016/j.ajodo.2005.09.034; Baron AC, 1999, ORAL DIS, V5, P234, DOI 10.1111/j.1601-0825.1999.tb00307.x; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BRADWAY SD, 1989, BIOCHEM J, V261, P887, DOI 10.1042/bj2610887; Brandao Gustavo Antonio Martins, 2015, Indian J Dent Res, V26, P148, DOI 10.4103/0970-9290.159143; Bruno LS, 2005, BBA-MOL CELL RES, V1746, P65, DOI 10.1016/j.bbamcr.2005.08.007; Chaudhuri B, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-60; Crosara KTB, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6346954; Dee K.C., 2003, INTRO TISSUE BIOMATE; Edgerton M, 1996, Int J Oral Maxillofac Implants, V11, P443; Edgerton M, 2000, Adv Dent Res, V14, P16; Enaia M, 2011, AM J ORTHOD DENTOFAC, V140, pE17, DOI 10.1016/j.ajodo.2010.12.016; Fournier A, 1998, AM J ORTHOD DENTOFAC, V114, P414, DOI 10.1016/S0889-5406(98)70186-6; Ganeshnarayan K, 2012, J PERIODONTAL RES, V47, P661, DOI 10.1111/j.1600-0765.2012.01481.x; GIBBONS R J, 1970, Archives of Oral Biology, V15, P1397, DOI 10.1016/0003-9969(70)90031-2; GIBBONS RJ, 1973, J PERIODONTOL, V44, P347, DOI 10.1902/jop.1973.44.6.347; Hermas AA, 2005, ELECTROCHIM ACTA, V50, P2001, DOI 10.1016/j.electacta.2004.09.008; Heymann GC, 2013, J ESTHET RESTOR DENT, V25, P85, DOI 10.1111/jerd.12013; JOHNSSON M, 1991, ARCH ORAL BIOL, V36, P631, DOI 10.1016/0003-9969(91)90014-L; KUNIMATSU K, 1990, J PERIODONTAL RES, V25, P69, DOI 10.1111/j.1600-0765.1990.tb00894.x; LAI CH, 1975, INFECT IMMUN, V11, P200, DOI 10.1128/IAI.11.1.200-210.1975; LAMKIN MS, 1993, CRIT REV ORAL BIOL M, V4, P251, DOI 10.1177/10454411930040030101; Lee SJ, 2001, AM J ORTHOD DENTOFAC, V119, P59, DOI 10.1067/mod.2001.110583; Lee YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067919; Lin NJ, 2017, DENT MATER, V33, P667, DOI 10.1016/j.dental.2017.03.003; LISTGARTEN MA, 1975, J PERIODONTOL, V46, P10, DOI 10.1902/jop.1975.46.1.10; LISTGARTEN MA, 1976, J PERIODONTOL, V47, P1, DOI 10.1902/jop.1976.47.1.1; Nikitkova AE, 2013, APPL ENVIRON MICROB, V79, P416, DOI 10.1128/AEM.02581-12; OGAARD B, 1988, AM J ORTHOD DENTOFAC, V94, P123, DOI 10.1016/0889-5406(88)90360-5; Oliveros J.C., 2007, VENNY INTERACTIVE TO; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; ORSTAVIK D, 1974, INFECT IMMUN, V9, P794; Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007; RAJ PA, 1990, J BIOL CHEM, V265, P3898; Rosan B, 2000, MICROBES INFECT, V2, P1599, DOI 10.1016/S1286-4579(00)01316-2; Rosan B., 1985, MOL BASIS ORAL MICOR; SCANNAPIECO FA, 1993, CRIT REV ORAL BIOL M, V4, P301, DOI 10.1177/10454411930040030701; Siqueira WL, 2008, J DENT RES, V87, P445, DOI 10.1177/154405910808700508; Siqueira WL, 2012, J DENT RES, V91, P1110, DOI 10.1177/0022034512462578; Siqueira WL, 2010, J DENT RES, V89, P626, DOI 10.1177/0022034510363384; Siqueira WL, 2007, J PROTEOME RES, V6, P2152, DOI 10.1021/pr060580k; Siqueira WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042204; TABAK LA, 1982, J ORAL PATHOL MED, V11, P1, DOI 10.1111/j.1600-0714.1982.tb00138.x	46	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254909	10.1371/journal.pone.0254909	http://dx.doi.org/10.1371/journal.pone.0254909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34319997	Green Published, gold			2022-12-26	WOS:000685247800009
J	Zhang, M; Han, J; Cao, C; Ma, SW				Zhang, Ming; Han, Jun; Cao, Chen; Ma, Shuangwen			Experimental study on anchorage performance of rockbolts by adding steel aggregates into resin anchoring agents	PLOS ONE			English	Article							LOAD-TRANSFER; ROCK; STRENGTH; BOLTS; GROUT	Pull-out testing was carried out to evaluate the effects of shape, size and concentration of steel aggregates on anchorage performance. Steel grit with particle sizes of 1.5, 2.0, and 2.8 mm and steel shot diameters of 1.4, 2.0, and 2.5 mm were used as steel aggregates and were added into the resin anchoring agent. For each kind of steel aggregate, either 30, 40 or 50 aggregates were used to evaluate the effects of different steel aggregate densities. Anchorage specimens were prepared using phi 20mm rebar bolts and steel sleeves. Compressive and shear strengths of resin containing steel aggregates, the pullout curve, and the circumferential strain of the sleeves were measured, and the energy consumption was calculated. Results show that compressive and shear strengths of resin containing steel grit and steel shot are increased by 8.4%-17.0% compared to pure resin. For the aggregate numbers of 30, 40 and 50, the anchoring force is increased by 7.9%, 7.5% and 6.5%; energy consumption is increased by 19.2%, 15.0% and 18.6%; and the circumferential strain of the specimen is increased by 28.4%, 25.1% and 39.5%, respectively. The effect of aggregate size on anchoring performance is significant; that is, the aggregate sizes of 1.4 similar to 1.5, 2.0 and 2.5 similar to 2.8 mm increase the anchoring force, energy consumption and sleeve circumferential strain by 8.5%, 4.6% and 8.7%, 16.0%, 8.4% and 28.4%, and 17.9%, 23.3% and 51.9%, respectively. The relationships of the anchoring force, energy consumption, and circumferential strain with steel aggregate quantity and size are formulated. Results show that the addition of steel aggregates increases the compressive and shear strengths of the resin, and steel aggregate quantity and size have significant impact on anchoring performance. This paper provides the basis for optimization of resin anchoring agents used in the mining industry. The impact of anchoring agent shear strength and residual shear strength on the anchoring effect were also discussed based on the failure analysis of the anchoring section.	[Zhang, Ming; Han, Jun; Cao, Chen; Ma, Shuangwen] Liaoning Tech Univ, Coll Min, Fuxing, Peoples R China; [Han, Jun] Liaoning Prov Coal Resources Safety Min & Clean U, Fuxing, Peoples R China; [Cao, Chen] Univ Wollongong, EIS, CME, Wollongong, NSW, Australia	Liaoning Technical University; University of Wollongong	Han, J (corresponding author), Liaoning Tech Univ, Coll Min, Fuxing, Peoples R China.; Han, J (corresponding author), Liaoning Prov Coal Resources Safety Min & Clean U, Fuxing, Peoples R China.	hanjun@lntu.edu.cn	han, jun/H-6297-2018	han, jun/0000-0001-7363-8310; Zhang, Ming/0000-0001-8208-0806	National Natural Science Foundation of China [52074145]; Liaoning Province Innovative Talents Support Plan for Colleges and Universities [LR2017030]; Liaoning Revitalization Talents Program [XLYC2002110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Province Innovative Talents Support Plan for Colleges and Universities; Liaoning Revitalization Talents Program	This study was funded by the National Natural Science Foundation of China awarded to JH (Grant Number 52074145), the Liaoning Province Innovative Talents Support Plan for Colleges and Universities awarded to JH, (Grant Number LR2017030) and the Liaoning Revitalization Talents Program awarded to JH (Grant Number XLYC2002110).	Aziz N, 2016, ROCK MECH ROCK ENG, V49, P3189, DOI 10.1007/s00603-016-0973-5; Bagherzadeh A, 2020, CONSTR BUILD MATER, V240, DOI 10.1016/j.conbuildmat.2019.117979; BENMOKRANE B, 1995, INT J ROCK MECH MIN, V32, P633, DOI 10.1016/0148-9062(95)00021-8; [韩军 Han Jun], 2020, [采矿与安全工程学报, Journal of Mining & Safety Engineering], V37, P890; Cao C, 2016, INT J ROCK MECH MIN, V85, P52, DOI 10.1016/j.ijrmms.2015.12.010; Cao C, 2014, INT J ROCK MECH MIN, V72, P16, DOI 10.1016/j.ijrmms.2014.04.026; Cao C, 2013, INT J ROCK MECH MIN, V64, P175, DOI 10.1016/j.ijrmms.2013.08.034; Cao C, 2013, INT J ROCK MECH MIN, V60, P188, DOI 10.1016/j.ijrmms.2012.12.013; Chen C, 2014, INT J MIN SCI TECHNO, V24, P325, DOI 10.1016/j.ijmst.2014.03.006; Chen JH, 2021, INT J COAL SCI TECHN, V8, P64, DOI 10.1007/s40789-020-00388-z; Craig P., 2016, P 16 COAL OP C MIN E, P53; Crompton BR, 2020, J S AFR I MIN METALL, V120, P7, DOI 10.17159/2411-9717/845/2020; Dai LP, 2020, TUNN UNDERGR SP TECH, V102, DOI 10.1016/j.tust.2020.103427; Dalhat MA, 2020, CONSTR BUILD MATER, V236, DOI 10.1016/j.conbuildmat.2019.117585; Debska B, 2020, CONSTR BUILD MATER, V258, DOI 10.1016/j.conbuildmat.2020.119632; Dou LT, 2021, INT J COAL SCI TECHN, V8, P77, DOI 10.1007/s40789-020-00344-x; Feng XW, 2021, CONSTR BUILD MATER, V268, DOI 10.1016/j.conbuildmat.2020.121179; Feng XW, 2019, INT J ROCK MECH MIN, V123, DOI 10.1016/j.ijrmms.2019.104097; Feng XW, 2018, INT J ROCK MECH MIN, V109, P138, DOI 10.1016/j.ijrmms.2018.06.018; Formisano A, 2021, J BRAZ SOC MECH SCI, V43, DOI 10.1007/s40430-021-02987-6; Frith R., 2017, P 17 COAL OP C MIN E, P149; Galvin JM., 2016, GROUND ENG PRINCIPLE, P211, DOI [10.1007/978-3-319-25005-2%5F6, DOI 10.1007/978-3-319-25005-2%5F6]; Han J, 2018, GEOTECH LETT, V8, P92, DOI 10.1680/jgele.17.00106; Han J, 2019, MAG CONCRETE RES, V71, P175, DOI 10.1680/jmacr.17.00329; He X. g, 2001, ENG MECH, V18, P96; Jia JZ, 2020, MATERIALS, V13, DOI 10.3390/ma13010137; [康红普 Kang Hongpu], 2021, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V40, P1; Kilic A, 2008, CEMENT CONCRETE COMP, V30, P290, DOI 10.1016/j.cemconcomp.2007.05.011; Kim H, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9224781; Komurlu E, 2020, INT J GEOSYNTH GROUN, V6, DOI 10.1007/s40891-020-00236-9; Li CX, 2020, MATERIALS, V13, DOI 10.3390/ma13163563; Maepa TG, 2017, J S AFR I MIN METALL, V117, P329, DOI 10.17159/2411-9717/2017/v117n4a3; Miah Md Jihad, 2020, Key Engineering Materials, V833, P228, DOI 10.4028/www.scientific.net/KEM.833.228; Peng R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192470; People's Republic of China Coal Industry Standards, 2011, RES ANCH BOLT 1; Tao W, 2017, INT J MIN SCI TECHNO, V27, P431, DOI 10.1016/j.ijmst.2017.03.009; Teymen A, 2017, CONSTR BUILD MATER, V145, P376, DOI 10.1016/j.conbuildmat.2017.04.046; Tian JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171653; Wang JG, 2019, MATERIALS, V12, DOI 10.3390/ma12101662; Wang J, 2020, INT J COAL SCI TECHN, V7, P704, DOI 10.1007/s40789-020-00327-y; Windsor CR, 1997, INT J ROCK MECH MIN, V34, P919, DOI 10.1016/S1365-1609(97)80004-4; Xu GL, 2020, CONSTR BUILD MATER, V261, DOI 10.1016/j.conbuildmat.2020.120002; Xu QY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234071; Xu XL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227539; Xue DJ, 2020, ROCK MECH ROCK ENG, V53, P1225, DOI 10.1007/s00603-019-01974-7; Xue DJ, 2020, INT J COAL SCI TECHN, P1, DOI DOI 10.1007/S40789-020-00357-6; Xue DJ, 2020, INT J COAL SCI TECHN, V7, P58, DOI 10.1007/s40789-020-00299-z; [尤春安 YOU Chun'an], 2009, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V28, P1976; Zhang L, 2020, FUEL, V262, DOI 10.1016/j.fuel.2019.116635; ZHOU FP, 1995, CEMENT CONCRETE RES, V25, P177, DOI 10.1016/0008-8846(94)00125-I	50	0	0	10	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0255046	10.1371/journal.pone.0255046	http://dx.doi.org/10.1371/journal.pone.0255046			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320008	Green Published, gold			2022-12-26	WOS:000685247800012
J	Kaps, L; Hildebrand, K; Nagel, M; Michel, M; Kremer, WM; Hilscher, M; Galle, PR; Schattenberg, JM; Worns, MA; Labenz, C				Kaps, Leonard; Hildebrand, Katharina; Nagel, Michael; Michel, Maurice; Kremer, Wolfgang Maximilian; Hilscher, Max; Galle, Peter R.; Schattenberg, Jorn M.; Woerns, Marcus-Alexander; Labenz, Christian			Risk factors for poorer health literacy in patients with liver cirrhosis	PLOS ONE			English	Article							HEPATIC-ENCEPHALOPATHY; DISEASE; KNOWLEDGE; ASSOCIATION; DEPRESSION; MANAGEMENT; QUALITY	Background Health literacy is a concept that refers to patients' ability to manage their disease and the health system's ability to guarantee access to services. There is evidence that health literacy impacts the health outcomes of patients with chronic diseases, but detailed information on this topic in patients with liver cirrhosis is scarce. It was the aim of this study to identify risk factors for poorer health literacy in patients with liver cirrhosis. Methods 89 patients with liver cirrhosis were enrolled in this study and health literacy was measured using the Health Literacy Questionnaire (HLQ). Covert hepatic encephalopathy (CHE) was diagnosed clinically according to the West-Haven Criteria (HE grade 1) and the PHES (minimal HE). Depressive symptoms were assessed using the Hamilton Depression Rating Scale (HDRS). Based on the nine subscales of the HLQ, risk factors for poor health literacy were identified using linear regression models. Results Normalized HLQ scores ranged between 65-76%, while appraisal of health information had lowest score (65%) and ability to actively engage with healthcare providers had highest score (76%). Multivariable regression analyses revealed an association of poorer health literacy and liver function as determined by MELD score and complications of liver cirrhosis such as a history of ascites or CHE. Additionally, we identified modifiable or preventable factors such as depressive symptoms, a history of falls, and active smoking as risk factors for poorer health literacy. Conclusion Multiple factors seem to impact on health literacy in patients with liver cirrhosis. Addressing modifiable and preventable factors may improve health literacy.	[Kaps, Leonard; Hildebrand, Katharina; Nagel, Michael; Michel, Maurice; Kremer, Wolfgang Maximilian; Hilscher, Max; Galle, Peter R.; Schattenberg, Jorn M.; Woerns, Marcus-Alexander; Labenz, Christian] Johannes Gutenberg Univ Mainz, Dept Internal Med 1, Univ Med Ctr, Mainz, Germany; [Kaps, Leonard; Hildebrand, Katharina; Nagel, Michael; Michel, Maurice; Kremer, Wolfgang Maximilian; Hilscher, Max; Galle, Peter R.; Woerns, Marcus-Alexander; Labenz, Christian] Johannes Gutenberg Univ Mainz, Cirrhosis Ctr Mainz CCM, Univ Med Ctr, Mainz, Germany; [Kaps, Leonard] Johannes Gutenberg Univ Mainz, Inst Translat Immunol, Univ Med Ctr, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Kaps, L; Labenz, C (corresponding author), Johannes Gutenberg Univ Mainz, Dept Internal Med 1, Univ Med Ctr, Mainz, Germany.; Kaps, L; Labenz, C (corresponding author), Johannes Gutenberg Univ Mainz, Cirrhosis Ctr Mainz CCM, Univ Med Ctr, Mainz, Germany.; Kaps, L (corresponding author), Johannes Gutenberg Univ Mainz, Inst Translat Immunol, Univ Med Ctr, Mainz, Germany.	leonard.kaps@unimedizin-mainz.de; christian.labenz@unimedizin-mainz.de	Galle, Peter R/T-5292-2018; Schattenberg, Jörn M./C-1301-2013; Galle, Peter/ABE-2872-2021	Galle, Peter R/0000-0001-8294-0992; Schattenberg, Jörn M./0000-0002-4224-4703; Galle, Peter/0000-0001-8294-0992; Labenz, Christian/0000-0001-8390-9663; Hildebrand, Katharina/0000-0002-6724-622X; Kaps, Leonard/0000-0002-4782-8003				Baker DW, 1998, J GEN INTERN MED, V13, P791, DOI 10.1046/j.1525-1497.1998.00242.x; Baker DW, 2002, AM J PUBLIC HEALTH, V92, P1278, DOI 10.2105/AJPH.92.8.1278; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bianchi G, 2005, DIGEST LIVER DIS, V37, P593, DOI 10.1016/j.dld.2005.01.020; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Buganza-Torio E, 2019, ALIMENT PHARM THER, V49, P194, DOI 10.1111/apt.15068; Dunn P, 2018, INT J CARDIOL, V273, P249, DOI 10.1016/j.ijcard.2018.08.090; Gazmararian JA, 2003, PATIENT EDUC COUNS, V51, P267, DOI 10.1016/S0738-3991(02)00239-2; Gluud LL, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003044.pub4; Grydgaard MF, 2018, SCAND J GASTROENTERO, V53, P1584, DOI 10.1080/00365521.2018.1545045; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Huber Y, 2019, CLIN GASTROENTEROL H, V17, P2085, DOI 10.1016/j.cgh.2018.12.016; Krause J, 2001, J HEPATOL, V34, P156, DOI 10.1016/S0168-8278(01)80570-5; Kremer Wolfgang M, 2020, Clin Transl Gastroenterol, V11, pe00211, DOI 10.14309/ctg.0000000000000211; Labenz C, 2018, ALIMENT PHARM THER, V48, P313, DOI 10.1111/apt.14824; Labenz C, 2020, ALIMENT PHARM THER, V52, P527, DOI 10.1111/apt.15915; Labenz C, 2020, Z GASTROENTEROL, V58, P49, DOI 10.1055/a-1010-6974; Labenz C, 2019, EUR J INTERN MED, V70, P54, DOI 10.1016/j.ejim.2019.09.004; Laube R, 2018, LIVER INT, V38, P2117, DOI 10.1111/liv.13917; Mullish BH, 2014, ALIMENT PHARM THER, V40, P880, DOI 10.1111/apt.12925; Murphy SL, 2020, DIGEST DIS SCI, V65, P3734, DOI 10.1007/s10620-020-06099-4; Nolte S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172340; Osborne RH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-658; Poureslami I., 2016, HEALTH PROMOT INT, pDAW003; Roman E, 2013, EUR J GASTROEN HEPAT, V25, P77, DOI 10.1097/MEG.0b013e3283589f49; Rudd RE, 2017, STUD HEALTH TECHNOL, V240, P60, DOI 10.3233/978-1-61499-790-0-60; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; Schillinger D, 2004, PATIENT EDUC COUNS, V52, P315, DOI 10.1016/S0738-3991(03)00107-1; Scott TL, 2002, MED CARE, V40, P395, DOI 10.1097/00005650-200205000-00005; Sorensen K, 2015, EUR J PUBLIC HEALTH, V25, P1053, DOI 10.1093/eurpub/ckv043; Taylor DM, 2018, NEPHROL DIAL TRANSPL, V33, P1545, DOI 10.1093/ndt/gfx293; Trivedi HD, 2018, GASTROENTEROL REP, V6, P13, DOI 10.1093/gastro/gox042; Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210; Volk ML, 2013, AM J GASTROENTEROL, V108, P302, DOI 10.1038/ajg.2012.214; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; Wu JR, 2013, J GEN INTERN MED, V28, P1174, DOI 10.1007/s11606-013-2394-4	36	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255349	10.1371/journal.pone.0255349	http://dx.doi.org/10.1371/journal.pone.0255349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TU	34314445	gold, Green Published			2022-12-26	WOS:000685225200035
J	Wongsinhirun, N; Chatjuthamard, P; Treepongkaruna, S; Likitapiwatc, T				Wongsinhirun, Nopparat; Chatjuthamard, Pattanaporn; Treepongkaruna, Sirimon; Likitapiwatc, Tanakorn			Do algorithm traders mitigate insider trading profits?: Evidence from the Thai stock market	PLOS ONE			English	Article							INFORMATION; PRICE; SIZE	This paper asks whether algorithm traders (AT) mitigate insider trading profits in the Thai stock market over the period of 2010-2016. We find that in general it does but not in the case of buy side, big trades nor the executive trades. Our findings suggest that, to some extent, AT can take important role to increase an efficiency in stock market by processing the public information and incorporating it into price at ultra-fast speed. Additional robustness checks based on the instrumental variable approach confirm our findings.	[Wongsinhirun, Nopparat; Chatjuthamard, Pattanaporn; Treepongkaruna, Sirimon] Chulalongkorn Univ, Sasin Sch Management, Bangkok, Thailand; [Chatjuthamard, Pattanaporn] Chulalongkorn Univ, Ctr Excellence Management Res Corp Governance & B, Sasin Sch Management, Bangkok, Thailand; [Treepongkaruna, Sirimon] Univ Western Australia, UWA Business Sch, Crawley, WA, Australia; [Likitapiwatc, Tanakorn] Chulalongkorn Univ, Chula Business Sch, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; University of Western Australia; Chulalongkorn University	Chatjuthamard, P (corresponding author), Chulalongkorn Univ, Sasin Sch Management, Bangkok, Thailand.; Chatjuthamard, P (corresponding author), Chulalongkorn Univ, Ctr Excellence Management Res Corp Governance & B, Sasin Sch Management, Bangkok, Thailand.	pattanaporn.chatjuthamard@sasin.edu		Treepongkaruna, Sirimon/0000-0002-3096-8499; Chatjuthamard, Pattanaporn/0000-0003-1479-1969	Chulalongkorn University under Ratchadapisek Sompoch Endowment Fund through the Center of Excellence in Management Research for Corporate Governance and Behavioral Finance	Chulalongkorn University under Ratchadapisek Sompoch Endowment Fund through the Center of Excellence in Management Research for Corporate Governance and Behavioral Finance	This research is funded by Chulalongkorn University under Ratchadapisek Sompoch Endowment Fund through the Center of Excellence in Management Research for Corporate Governance and Behavioral Finance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboody D, 2000, J FINANC, V55, P2747, DOI 10.1111/0022-1082.00305; Aboody D, 2005, J ACCOUNT RES, V43, P651, DOI 10.1111/j.1475-679X.2005.00185.x; Alldredge DM, 2015, J FINANC ECON, V115, P84, DOI 10.1016/j.jfineco.2014.09.005; AUSUBEL LM, 1990, AM ECON REV, V80, P1022; Baiman S, 1996, J ACCOUNTING RES, V34, P1, DOI 10.2307/2491329; Boehmer E, 2020, J FINANC QUANT ANAL, P1, DOI DOI 10.1017/S0022109020000782; Boehmer E, 2012, ALGORITHMIC TRADING; Brogaard J, 2014, REV FINANC STUD, V27, P2267, DOI 10.1093/rfs/hhu032; Carrion A, 2013, J FINANC MARK, V16, P680, DOI 10.1016/j.finmar.2013.06.005; Chakrabarty B, 2015, ATTENTION EFFECTS HI; Cheng Q, 2006, J ACCOUNTING RES, V44, P815, DOI 10.1111/j.1475-679X.2006.00222.x; Cohen L, 2012, J FINANC, V67, P1009, DOI 10.1111/j.1540-6261.2012.01740.x; Dai LL, 2015, J ACCOUNT RES, V53, P331, DOI 10.1111/1475-679X.12073; Del Brio EB, 2007, ATLANTIC ECON J, V35, P173, DOI 10.1007/s11293-006-9060-8; EASLEY D, 1987, J FINANC ECON, V19, P69, DOI 10.1016/0304-405X(87)90029-8; FAMA EF, 1992, J FINANC, V47, P427, DOI 10.2307/2329112; FINNERTY JE, 1976, J FINANC, V31, P1141, DOI 10.2307/2326279; Fishe RPH, 2004, J FINANC ECON, V71, P461, DOI 10.1016/S0304-405X(03)00188-0; Foucault T, 2016, J FINANC, V71, P335, DOI 10.1111/jofi.12302; Garfinkel JA, 2003, J FINANC QUANT ANAL, V38, P591, DOI 10.2307/4126733; Gregory A., 1997, J BUS FINAN ACCOUNT, V24, P309, DOI [10.1111/1468-5957.00107, DOI 10.1111/1468-5957.00107]; Hendershott T, 2011, J FINANC, V66, P1, DOI 10.1111/j.1540-6261.2010.01624.x; Hirschey N., 2002, DO HIGH FREQUENCY TR; Huang Y, 2019, QUICK INFORMED INSID; JAFFE JF, 1974, J BUS, V47, P410, DOI 10.1086/295655; Jeng LA, 2003, REV ECON STAT, V85, P453, DOI 10.1162/003465303765299936; Jovanovic B., 2016, MIDDLEMEN LIMIT ORDE; KIM O, 1991, J ACCOUNTING RES, V29, P302, DOI 10.2307/2491051; Lakonishok J, 2001, REV FINANC STUD, V14, P79, DOI 10.1093/rfs/14.1.79; LAKONISHOK J, 1994, J FINANC, V49, P1541, DOI 10.2307/2329262; Likitapiwat T, 2016, CHULALONGKORN BUSINE; LIN JC, 1990, J FINANC, V45, P1273, DOI 10.2307/2328724; LORIE JH, 1968, J LAW ECON, V11, P35, DOI 10.1086/466642; Martinez V, 2013, AM FIN ASS M PAP SAN; Massa M, 2015, J FINANC ECON, V118, P268, DOI 10.1016/j.jfineco.2015.08.004; MASSON RT, 1991, J IND ECON, V39, P333, DOI 10.2307/2098435; MEULBROEK LK, 1992, J FINANC, V47, P1661, DOI 10.2307/2328992; O'Hara M, 2019, REV ASSET PRICING ST, V9, P47, DOI 10.1093/rapstu/ray009; Ofek E, 2000, J FINANC, V55, P1367, DOI 10.1111/0022-1082.00250; Piotroski JD, 2005, J ACCOUNT ECON, V39, P55, DOI 10.1016/j.jacceco.2004.01.003; Podolski EJ, 2013, J INT FINANC MARK I, V27, P286, DOI 10.1016/j.intfin.2013.09.001; Ravina E, 2010, REV FINANC STUD, V23, P962, DOI 10.1093/rfs/hhp027; Rozeff MS, 1998, J FINANC, V53, P701, DOI 10.1111/0022-1082.275500; SEYHUN HN, 1986, J FINANC ECON, V16, P189, DOI 10.1016/0304-405X(86)90060-7; SEYHUN HN, 1992, Q J ECON, V107, P1303, DOI 10.2307/2118390; To TY, 2018, J INT FINANC MARK I, V54, P114, DOI 10.1016/j.intfin.2017.05.003; Weller BM, 2018, REV FINANC STUD, V31, P2184, DOI 10.1093/rfs/hhx137; Zhang Sarah., 2012, NEED SPEED EMPIRICAL	48	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255057	10.1371/journal.pone.0255057	http://dx.doi.org/10.1371/journal.pone.0255057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TN	34310623	gold, Green Published			2022-12-26	WOS:000685224500006
J	Guo, LF; Wang, L; Ren, S; Su, N; Wei, K; Sun, XG; Ren, XD; Huang, Q				Guo, Li-fang; Wang, Liu; Ren, Sai; Su, Ning; Wei, Kun; Sun, Xian-Ge; Ren, Xiao-Dong; Huang, Qing			Enrichment of leukocytes in peripheral blood using 3D printed tubes	PLOS ONE			English	Article							FICOLL GRADIENT CENTRIFUGATION; STEM-CELLS	Leukocytes have an essential role in patient clinical trajectories and progression. Traditional methods of leukocyte enrichment have many significant limitations for current applications. It is demonstrated a novel 3D printing leukocyte sorting accumulator that combines with centrifugation to ensure label-free initial leukocyte enrichment based on cell density and size. The internal structure of leukocyte sorting accumulator (revealed here in a new design, leukocyte sorting accumulator-3, upgraded from earlier models), optimizes localization of the buffy coat fraction and the length of the period allocated for a second centrifugation step to deliver a higher recovery of buffy coats than earlier models. Established methodological parameters were evaluated for reliability by calculating leukocyte recovery rates and erythrocyte depletion rates by both pushing and pulling methods of cell displacement. Results indicate that leukocyte sorting accumulator-3 achieves a mean leukocytes recovery fraction of 96.2 +/- 2.38% by the pushing method of layer displacement. By the pulling method, the leukocyte sorting accumulator-3 yield a mean leukocytes recovery fraction of 94.4 +/- 0.8%. New procedures for preliminary enrichment of leukocytes from peripheral blood that avoid cellular damage, as well as avert metabolic and phase cycle intervention, are required as the first step in many modern clinical and basic research assays.	[Guo, Li-fang; Wang, Liu; Ren, Sai; Su, Ning; Wei, Kun; Sun, Xian-Ge; Ren, Xiao-Dong; Huang, Qing] Army Med Ctr, Dept Lab Med, Chongqing, Peoples R China; [Guo, Li-fang; Huang, Qing] Army Med Univ, Southwest Hosp, Dept Lab Med, Chongqing, Peoples R China; [Guo, Li-fang; Huang, Qing] Southwest Univ, Fac Mat & Energy, Inst Clean Energy & Adv Mat, Chongqing, Peoples R China	Army Medical University; Southwest University - China	Huang, Q (corresponding author), Army Med Ctr, Dept Lab Med, Chongqing, Peoples R China.; Huang, Q (corresponding author), Army Med Univ, Southwest Hosp, Dept Lab Med, Chongqing, Peoples R China.; Huang, Q (corresponding author), Southwest Univ, Fac Mat & Energy, Inst Clean Energy & Adv Mat, Chongqing, Peoples R China.	qinghuang@tmmu.edu.cn			National Natural Science Foundation of China [81572066]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The sources of funding for this study is the National Natural Science Foundation of China (face items, project's number: 81572066). The funders had a very important role in microdevices design and project administration.	Al Battah F, 2011, TOXICOL IN VITRO, V25, P1224, DOI 10.1016/j.tiv.2011.05.024; Alidjinou EK, 2017, ACTA DIABETOL, V54, P1025, DOI 10.1007/s00592-017-1041-7; Augustine TN, 2016, MICROSC MICROANAL, V22, P630, DOI 10.1017/S1431927616000854; Brinckmann M, 2009, J MOL CELL CARDIOL, V47, P66, DOI 10.1016/j.yjmcc.2009.03.014; Brodersen LE, 2015, CYTOM PART B-CLIN CY, V88, P125, DOI 10.1002/cyto.b.21199; Cruz RLJ, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00147; Gray BP, 2020, CELL CHEM BIOL, V27, P232, DOI 10.1016/j.chembiol.2019.12.004; Hoettges KF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55579-9; Kambic H E, 1997, Ther Apher, V1, P284, DOI 10.1111/j.1744-9987.1997.tb00151.x; Kamyabi N, 2019, BIOMICROFLUIDICS, V13, DOI 10.1063/1.5111888; Kimijima T, 2018, J ANESTH, V32, P655, DOI 10.1007/s00540-018-2531-7; Konczalla L, 2021, ANN SURG, V273, P299, DOI 10.1097/SLA.0000000000003406; Lee VK, 2017, ANN BIOMED ENG, V45, P115, DOI 10.1007/s10439-016-1613-7; Legocki AT, 2017, JAMA OTOLARYNGOL, V143, P389, DOI 10.1001/jamaoto.2016.3673; Lu Y, 2015, J TRACE ELEM MED BIO, V29, P249, DOI 10.1016/j.jtemb.2014.08.012; Masuda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052918; Miron RJ, 2020, CLIN ORAL INVEST, V24, P2819, DOI 10.1007/s00784-019-03147-w; Najar M, 2014, CYTOTHERAPY, V16, P1220, DOI 10.1016/j.jcyt.2014.05.021; Navas A, 2019, BMC IMMUNOL, V20, DOI 10.1186/s12865-019-0286-z; Obregon F, 2015, J DENT RES, V94, p143S, DOI 10.1177/0022034515588885; Okano H, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9964-7; Olwal CO, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1183-y; Ozer K, 2019, J COSMET DERMATOL-US, V18, P474, DOI 10.1111/jocd.12682; Shiono H, 2016, J SEP SCI, V39, P3062, DOI 10.1002/jssc.201600329; Sun YL, 2019, BIOL OPEN, V8, DOI 10.1242/bio.038885; Sun YX, 2018, BIOMED MICRODEVICES, V20, DOI 10.1007/s10544-018-0323-3; Zheng PF, 2019, MED SCI MONITOR, V25, P7361, DOI 10.12659/MSM.915441	27	1	1	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254615	10.1371/journal.pone.0254615	http://dx.doi.org/10.1371/journal.pone.0254615			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297742	Green Published, gold			2022-12-26	WOS:000678128300059
J	Hadaya, J; Sanaiha, Y; Juillard, C; Benharash, P				Hadaya, Joseph; Sanaiha, Yas; Juillard, Catherine; Benharash, Peyman			Impact of frailty on clinical outcomes and resource use following emergency general surgery in the United States	PLOS ONE			English	Article							RISK-FACTORS; POSTOPERATIVE MORTALITY; PATIENT FRAILTY; MORBIDITY; ASSOCIATION; PREDICTOR; COMPLICATIONS; READMISSIONS; COMORBIDITY; QUALITY	Background Frailty has been recognized as an independent risk factor for inferior outcomes, but its effect on emergency general surgery (EGS) is understudied. Objective The purpose of the present study was to define the impact of frailty on risk-adjusted mortality, non-home discharge, and readmission following EGS operations. Methods Adults undergoing appendectomy, cholecystectomy, small bowel resection, large bowel resection, repair of perforated ulcer, or laparotomy within two days of an urgent admission were identified in the 2016-2017 Nationwide Readmissions Database. Frailty was defined using diagnosis codes corresponding to the Johns Hopkins Adjusted Clinical Groups frailty indicator. Multivariable regression was used to study in-hospital mortality and non-home discharge by operation, and Kaplan Meier analysis to study freedom from unplanned readmission at up to 90-days follow-up. Results Among 655,817 patients, 11.9% were considered frail. Frail patients most commonly underwent large bowel resection (37.3%) and cholecystectomy (29.2%). After adjustment, frail patients had higher mortality rates for all operations compared to nonfrail, including those most commonly performed (11.9% [95% CI 11.4-12.5%] vs 6.0% [95% CI 5.8-6.3%] for large bowel resection; 2.3% [95% CI 2.0-2.6%] vs 0.2% [95% CI 0.2-0.2%] for cholecystectomy). Adjusted non-home discharge rates were higher for frail compared to nonfrail patients following all operations, including large bowel resection (68.1% [95% CI 67.1-69.0%] vs 25.9% [95% CI 25.2-26.5%]) and cholecystectomy (33.7% [95% CI 32.7-34.7%] vs 2.9% [95% CI 2.8-3.0%]). Adjusted hospitalization costs were nearly twice as high for frail patients. On Kaplan-Meier analysis, frail patients had greater unplanned readmissions (log rank P<0.001), with 1 in 4 rehospitalized within 90 days. Conclusions Frail patients have inferior clinical outcomes and greater resource use following EGS, with the greatest absolute differences following complex operations. Simple frailty assessments may inform expectations, identify patients at risk of poor outcomes, and guide the need for more intensive postoperative care.	[Hadaya, Joseph; Sanaiha, Yas; Benharash, Peyman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Div Cardiac Surg, Los Angeles, CA 90095 USA; [Hadaya, Joseph; Sanaiha, Yas; Juillard, Catherine] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Div Gen Surg, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Benharash, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Div Cardiac Surg, Los Angeles, CA 90095 USA.	pbenharash@mednet.ucla.edu						Akinbami F, 2011, AM J SURG, V201, P456, DOI 10.1016/j.amjsurg.2010.11.007; Asemota AO, 2020, J NEUROSURG, V132, P360, DOI 10.3171/2018.8.JNS181875; Augustin T, 2016, SURGERY, V160, P987, DOI 10.1016/j.surg.2016.07.010; Davenport DL, 2006, ANN SURG, V243, P636, DOI 10.1097/01.sla.0000216508.95556.cc; DeWane MP, 2018, J TRAUMA ACUTE CARE, V85, P348, DOI 10.1097/TA.0000000000001939; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Farhat JS, 2012, J TRAUMA ACUTE CARE, V72, P1526, DOI 10.1097/TA.0b013e3182542fab; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gilbert T, 2018, LANCET, V391, P1775, DOI 10.1016/S0140-6736(18)30668-8; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Havens JM, 2016, JAMA SURG, V151, P330, DOI 10.1001/jamasurg.2015.4056; Havens JM, 2015, J TRAUMA ACUTE CARE, V78, P306, DOI 10.1097/TA.0000000000000517; Hedegaard Holly, 2019, Natl Health Stat Report, P1; Iyengar A, 2020, ANN THORAC SURG, V109, P1120, DOI [10.1016/j.athoracsur.2016.10.087, 10.1016/j.athoracsur.2019.10.087]; LaPar DJ, 2010, ANN SURG, V252, P544, DOI 10.1097/SLA.0b013e3181e8fd75; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Matsuyama T, 2013, J ANESTH, V27, P838, DOI 10.1007/s00540-013-1639-z; McIsaac DI, 2017, ANESTH ANALG, V124, P1653, DOI 10.1213/ANE.0000000000001960; McIsaac DI, 2016, JAMA SURG, V151, P538, DOI 10.1001/jamasurg.2015.5085; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Mullen MG, 2017, JAMA SURG, V152, P768, DOI 10.1001/jamasurg.2017.0918; Murphy PB, 2020, J SURG RES, V247, P95, DOI 10.1016/j.jss.2019.10.038; Nieman CL, 2018, LARYNGOSCOPE, V128, P102, DOI 10.1002/lary.26735; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Sankar A, 2015, CURR OPIN CRIT CARE, V21, P328, DOI 10.1097/MCC.0000000000000216; Scott JW, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.0480; Seib CD, 2018, JAMA SURG, V153, P160, DOI 10.1001/jamasurg.2017.4007; Sheils CRDAR, 2016, ACAD SURG C ABSTRACT; Subramaniam S, 2018, J AM COLL SURGEONS, V226, P173, DOI 10.1016/j.jamcollsurg.2017.11.005; Sundaresan S, 2013, ANN THORAC SURG, V95, P472, DOI 10.1016/j.athoracsur.2012.10.001; Tran DTT, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009882; Turrentine FE, 2006, J AM COLL SURGEONS, V203, P865, DOI 10.1016/j.jamcollsurg.2006.08.026; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Walston J, 2018, CLIN GERIATR MED, V34, P25, DOI 10.1016/j.cger.2017.09.004	36	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255122	10.1371/journal.pone.0255122	http://dx.doi.org/10.1371/journal.pone.0255122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297772	Green Published, gold			2022-12-26	WOS:000678128300015
J	Tasakis, RN; Samaras, G; Jamison, A; Lee, M; Paulus, A; Whitehouse, G; Verkoczy, L; Papavasiliou, FN; Diaz, M				Tasakis, Rafail Nikolaos; Samaras, Georgios; Jamison, Anna; Lee, Michelle; Paulus, Alexandra; Whitehouse, Gabrielle; Verkoczy, Laurent; Papavasiliou, F. Nina; Diaz, Marilyn			SARS-CoV-2 variant evolution in the United States: High accumulation of viral mutations over time likely through serial Founder Events and mutational bursts	PLOS ONE			English	Article							REPLICATION	Since the first case of COVID-19 in December 2019 in Wuhan, China, SARS-CoV-2 has spread worldwide and within a year and a half has caused 3.56 million deaths globally. With dramatically increasing infection numbers, and the arrival of new variants with increased infectivity, tracking the evolution of its genome is crucial for effectively controlling the pandemic and informing vaccine platform development. Our study explores evolution of SARS-CoV-2 in a representative cohort of sequences covering the entire genome in the United States, through all of 2020 and early 2021. Strikingly, we detected many accumulating Single Nucleotide Variations (SNVs) encoding amino acid changes in the SARS-CoV-2 genome, with a pattern indicative of RNA editing enzymes as major mutators of SARS-CoV-2 genomes. We report three major variants through October of 2020. These revealed 14 key mutations that were found in various combinations among 14 distinct predominant signatures. These signatures likely represent evolutionary lineages of SARS-CoV-2 in the U.S. and reveal clues to its evolution such as a mutational burst in the summer of 2020 likely leading to a homegrown new variant, and a trend towards higher mutational load among viral isolates, but with occasional mutation loss. The last quartile of 2020 revealed a concerning accumulation of mostly novel low frequency replacement mutations in the Spike protein, and a hypermutable glutamine residue near the putative furin cleavage site. Finally, end of the year data and 2021 revealed the gradual increase to prevalence of known variants of concern, particularly B.1.1.7, that have acquired additional Spike mutations. Overall, our results suggest that predominant viral genomes are dynamically evolving over time, with periods of mutational bursts and unabated mutation accumulation. This high level of existing variation, even at low frequencies and especially in the Spike-encoding region may become problematic when super-spreader events, akin to serial Founder Events in evolution, drive these rare mutations to prominence.	[Tasakis, Rafail Nikolaos; Samaras, Georgios; Papavasiliou, F. Nina] German Canc Res Ctr, Div Immune Divers, Heidelberg, Germany; [Tasakis, Rafail Nikolaos] Heidelberg Univ, Fac Biosci, Heidelberg, Germany; [Samaras, Georgios] Heidelberg Univ, Med Fac Mannheim, Program Translat Med Res, Heidelberg, Germany; [Jamison, Anna; Paulus, Alexandra; Whitehouse, Gabrielle] Nightingale Bamford Sch, New York, NY USA; [Lee, Michelle] Cornell Univ, Ithaca, NY USA; [Verkoczy, Laurent; Diaz, Marilyn] San Diego Biomed Res Inst SDBRI, San Diego, CA 92121 USA; [Diaz, Marilyn] Appl Biomed Sci Inst, San Diego, CA 92127 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Cornell University	Papavasiliou, FN (corresponding author), German Canc Res Ctr, Div Immune Divers, Heidelberg, Germany.; Verkoczy, L; Diaz, M (corresponding author), San Diego Biomed Res Inst SDBRI, San Diego, CA 92121 USA.; Diaz, M (corresponding author), Appl Biomed Sci Inst, San Diego, CA 92127 USA.	lverkoczy@SDBRI.ORG; n.papavasiliou@dkfz-heidelberg.de; mdiaz@SDBRI.ORG		Samaras, Georgios/0000-0002-1538-0048; Tasakis, Rafail Nikolaos/0000-0003-2650-2220; Diaz, Marilyn/0000-0002-3046-2746; Papavasiliou, Nina/0000-0002-5971-7909				Angeletti S, 2020, J MED VIROL, V92, P584, DOI 10.1002/jmv.25719; Arevalo SJ., 2020, ANAL DYNAMICS DISTRI, DOI [10.1101/2020.11.13.381228, DOI 10.1101/2020.11.13.381228]; Arvin AM, 2020, NATURE, V584, P353, DOI 10.1038/s41586-020-2538-8; Bal A, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.3.2100008; Benvenuto D, 2020, J INFECTION, V81, pE24, DOI 10.1016/j.jinf.2020.03.058; Bodenhofer U, 2015, BIOINFORMATICS, V31, P3997, DOI 10.1093/bioinformatics/btv494; Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; Di Giorgio S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb5813; Edwards AM, 2020, GENES-BASEL, V11, DOI 10.3390/genes11080907; Fang SG, 2008, VIROLOGY, V379, P175, DOI 10.1016/j.virol.2008.06.038; Flaherty P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr861; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Gallaher WR, 2020, ARCH VIROL, V165, P2341, DOI 10.1007/s00705-020-04750-z; Galloway SE, 2021, MMWR-MORBID MORTAL W, V70, P95, DOI [10.15585/mmwr.mm7003e2, 10.15585/mmwr.mm7003e2externalicon]; Hassan SS, 2020, BIORXIV, DOI [10.1101/2020.11.06.372227, DOI 10.1101/2020.11.06.372227]; Hoepel W, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf8654; Hou YXJ, 2020, SCIENCE, V370, P1464, DOI 10.1126/science.abe8499; Issa E, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00266-20; Jalili P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16802-8; Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836; Kemp SA, 2021, NATURE, V592, P277, DOI 10.1038/s41586-021-03291-y; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Klein S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19619-7; Klimczak LJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237689; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Laha S, 2020, INFECT GENET EVOL, V85, DOI 10.1016/j.meegid.2020.104445; Lee WS, 2020, NAT MICROBIOL, V5, P1185, DOI 10.1038/s41564-020-00789-5; Libin PJK, 2019, BIOINFORMATICS, V35, P1763, DOI 10.1093/bioinformatics/bty851; Lin JW, 2021, CELL HOST MICROBE, V29, P489, DOI 10.1016/j.chom.2021.01.015; Liu MC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04273-x; Ma YY, 2015, P NATL ACAD SCI USA, V112, P9436, DOI 10.1073/pnas.1508686112; Meyer B, 2020, NUCLEIC ACIDS RES, V48, P1435, DOI 10.1093/nar/gkz1191; Miladi M, 2020, LANDSCAPE SARS COV 2, DOI [10.1101/2020.07.18.204362, DOI 10.1101/2020.07.18.204362]; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Morris SB, 2020, MMWR-MORBID MORTAL W, V69, P1450, DOI 10.15585/mmwr.mm6940e1; Munnink BBO, 2021, SCIENCE, V371, P172, DOI 10.1126/science.abe5901; Naqvi AA, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165878; Network TCHA, 2020, MULT INFL SYNDR CHIL; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; O'Toole Aine, 2021, Wellcome Open Res, V6, P121, DOI 10.12688/wellcomeopenres.16661.1; Ogando NS, 2020, J VIROL, V94, DOI 10.1128/JVI.01246-20; Pater AA., 2021, GENOMICS, DOI [10.1101/2021.01.11.426287, DOI 10.1101/2021.01.11.426287]; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Poulain F, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008718; Provine WB, 2004, GENETICS, V167, P1041; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Saha O, 2020, TEMPORAL LANDSCAPE M, DOI 10.1101/2020.08.20.259721; Schubert K, 2020, NAT STRUCT MOL BIOL, V27, P959, DOI 10.1038/s41594-020-0511-8; Shah M, 2020, COMPUT STRUCT BIOTEC, V18, P3402, DOI 10.1016/j.csbj.2020.11.002; Sharma S, 2017, PEERJ, V5, DOI 10.7717/peerj.4136; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7881; Simmonds P, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00408-20; Slanina H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022310118; Slatkin M, 2012, GENETICS, V191, P171, DOI 10.1534/genetics.112.139022; Stavrou S, 2015, J IMMUNOL, V195, P4565, DOI 10.4049/jimmunol.1501504; Toyoshima Y, 2020, J HUM GENET, V65, P1075, DOI 10.1038/s10038-020-0808-9; Travis JMJ, 2007, MOL BIOL EVOL, V24, P2334, DOI 10.1093/molbev/msm167; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; Verkoczy L, 2014, CURR OPIN HIV AIDS, V9, P224, DOI 10.1097/COH.0000000000000049; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wang LG, 2020, MOL BIOL EVOL, V37, P599, DOI 10.1093/molbev/msz240; Wang R, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12101095; Wang Rui, 2020, Res Sq, DOI 10.21203/rs.3.rs-49671/v1; Wang XX, 2012, J VIROL, V86, P3777, DOI 10.1128/JVI.06594-11; Werner S, 2020, NUCLEIC ACIDS RES, V48, P3734, DOI 10.1093/nar/gkaa113; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Williams TC, 2021, LANCET RESP MED, V9, P333, DOI 10.1016/S2213-2600(21)00075-8; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n359; Yi CY, 2020, CELL MOL IMMUNOL, V17, P621, DOI 10.1038/s41423-020-0458-z; Yoshimoto FK, 2020, PROTEIN J, V39, P198, DOI 10.1007/s10930-020-09901-4; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628	75	15	15	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255169	10.1371/journal.pone.0255169	http://dx.doi.org/10.1371/journal.pone.0255169			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297786	gold, Green Published, Green Submitted			2022-12-26	WOS:000678128300028
J	Chen, YY; Chen, HH; Lo, TC; Chou, P				Chen, Yu-Yen; Chen, Hsin-Hua; Lo, Tzu-Chen; Chou, Pesus			The risk of psoriasis in patients with uveitis: A nationwide population-based cohort study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MEDICAL COMORBIDITY; CLINICAL-FEATURES; ANTERIOR UVEITIS; ARTHRITIS; PREVALENCE; IRIDOCYCLITIS; EPIDEMIOLOGY; ASSOCIATION; CYTOKINES	Objective To evaluate whether the risk of subsequent psoriasis and psoriatic arthritis development is increased in patients with uveitis. Methods In Taiwan's national health insurance research database, we identified 195,125 patients with new-onset uveitis between 2001 and 2013. We randomly selected 390,250 individuals without uveitis who were matched 2:1 to uveitis cases based on age, sex and year of enrolment. The characteristics of the two groups were compared. Using multivariate Cox regression, hazard ratios (HRs) for psoriasis or psoriatic arthritis corresponding to uveitis were computed after adjustment for age, sex, insurance cost and comorbidities. In subgroup analyses, separate HRs for mild psoriasis, severe psoriasis and psoriatic arthritis were calculated. Results The mean age of the study cohort was 50.2 +/- 17.2 years. Hypertension, diabetes, hyperlipidaemia and obesity were more prevalent in the uveitis group (all p < 0.0001). The hazard of psoriasis or psoriatic arthritis development was significantly greater in the uveitis group than in the non-uveitis group (p < 0.0001); this increased risk persisted after adjustment for confounders [adjusted HR = 1.41; 95% confidence interval (CI), 1.33-1.48]. Adjusted HRs showed an increasing trend from mild psoriasis (1.35; 95% CI, 1.28-1.44) to severe psoriasis (1.59; 95% CI, 1.30-1.94) and psoriatic arthritis (1.97; 95% CI, 1.60-2.42). Conclusions This nationwide population-based cohort study revealed that patients with uveitis have an increased risk of subsequent psoriasis or psoriatic arthritis development.	[Chen, Yu-Yen; Chen, Hsin-Hua; Lo, Tzu-Chen; Chou, Pesus] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan; [Chen, Yu-Yen] Taichung Vet Gen Hosp, Dept Ophthalmol, Taichung, Taiwan; [Chen, Yu-Yen; Chen, Hsin-Hua] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Yu-Yen; Chen, Hsin-Hua; Chou, Pesus] Natl Yang Ming Chiao Tung Univ, Community Med Res Ctr, Taipei, Taiwan; [Chen, Yu-Yen; Chen, Hsin-Hua; Chou, Pesus] Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Yu-Yen; Chen, Hsin-Hua] Natl Chung Hsing Univ, Taichung, Taiwan; [Chen, Hsin-Hua] Taichung Vet Gen Hosp, Div Allergy & Rheumatol, Taichung, Taiwan; [Chen, Hsin-Hua] Taichung Vet Gen Hosp, Div Gen Internal Med, Dept Internal Med, Taichung, Taiwan; [Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Hsin-Hua] Tunghai Univ, Dept Ind Engn & Enterprise Informat, Taichung, Taiwan; [Lo, Tzu-Chen] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan	National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Chung Hsing University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; Tunghai University; Taichung Veterans General Hospital	Chen, HH (corresponding author), Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan.; Chen, HH (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Chiao Tung Univ, Community Med Res Ctr, Taipei, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Taipei, Taiwan.; Chen, HH (corresponding author), Natl Chung Hsing Univ, Taichung, Taiwan.; Chen, HH (corresponding author), Taichung Vet Gen Hosp, Div Allergy & Rheumatol, Taichung, Taiwan.; Chen, HH (corresponding author), Taichung Vet Gen Hosp, Div Gen Internal Med, Dept Internal Med, Taichung, Taiwan.; Chen, HH (corresponding author), Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.	shc5555@hotmail.com		Lo, Tzu-Chen/0000-0003-4306-8710	Taichung Veterans General Hospital [TCVGH-1106901B]	Taichung Veterans General Hospital	This work was supported by the Taichung Veterans General Hospital [grant number TCVGH-1106901B].	Abbagani S, 2019, OCUL IMMUNOL INFLAMM, V27, P531, DOI 10.1080/09273948.2017.1414271; Abbouda A, 2017, SEMIN OPHTHALMOL, V32, P715, DOI 10.3109/08820538.2016.1170161; Abu El-Asrar AM, 2011, CLIN IMMUNOL, V139, P177, DOI 10.1016/j.clim.2011.01.014; Aletaha D, 2019, ADV THER, V36, P1672, DOI 10.1007/s12325-019-00964-z; Armstrong AW, 2012, DERMATOLOGY, V225, P121, DOI 10.1159/000342180; Burden-Teh E, 2014, BRIT J DERMATOL, V170, P756, DOI 10.1111/bjd.12731; Chandran NS, 2007, J DERMATOL, V34, P805, DOI 10.1111/j.1346-8138.2007.00390.x; Chen YY, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-042201; Chi CC, 2017, JAMA OPHTHALMOL, V135, P415, DOI 10.1001/jamaophthalmol.2017.0569; Chi CC, 2015, J DERMATOL SCI, V78, P232, DOI 10.1016/j.jdermsci.2015.03.012; Chiu HY, 2015, BRIT J DERMATOL, V173, P146, DOI 10.1111/bjd.13599; Conforti C, 2020, DERMATOL THER, V33, DOI 10.1111/dth.14451; Fraga NAD, 2012, AN BRAS DERMATOL, V87, P877, DOI 10.1590/S0365-05962012000600009; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Egeberg A, 2015, JAMA DERMATOL, V151, P1200, DOI 10.1001/jamadermatol.2015.1986; Fotiadou C, 2019, PSORIASIS-TARGETS TH, V9, P91, DOI 10.2147/PTT.S179182; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gevorgyan O, 2019, RHEUMATOL INT, V39, P1607, DOI 10.1007/s00296-019-04386-6; Ghalamkarpour F, 2020, J DERMATOL TREAT, V31, P27, DOI 10.1080/09546634.2019.1577947; Iijima S, 1996, DERMATOLOGY, V193, P295, DOI 10.1159/000246273; Kilic B, 2013, INT J DERMATOL, V52, P554, DOI 10.1111/j.1365-4632.2011.05424.x; Langley RGB, 2005, ANN RHEUM DIS, V64, P18, DOI 10.1136/ard.2004.033217; Mallbris L, 2006, J AM ACAD DERMATOL, V54, P614, DOI 10.1016/j.jaad.2005.11.1079; Muhammad FY, 2019, J LEUKOCYTE BIOL, V106, P879, DOI 10.1002/JLB.MA0119-030RR; Niccoli L, 2012, INT J RHEUM DIS, V15, P414, DOI 10.1111/j.1756-185X.2012.01736.x; Nien CW, 2018, INVEST OPHTH VIS SCI, V59, P5053, DOI 10.1167/iovs.18-25039; Ooi KGJ, 2006, CLIN MED RES, V4, P294, DOI 10.3121/cmr.4.4.294; Paiva ES, 2000, ANN RHEUM DIS, V59, P67, DOI 10.1136/ard.59.1.67; Radtke MA, 2017, J EUR ACAD DERMATOL, V31, P151, DOI 10.1111/jdv.13813; Rosenbaum JT, 2017, CURR OPIN RHEUMATOL, V29, P298, DOI 10.1097/BOR.0000000000000403; Sampaio-Barros PD, 2013, CLIN EXP RHEUMATOL, V31, P484; Sharma SM, 2017, BEST PRACT RES CL RH, V31, P846, DOI 10.1016/j.berh.2018.08.002; Tanaka R, 2015, GRAEF ARCH CLIN EXP, V253, P1175, DOI 10.1007/s00417-015-2968-4; Tsai TF, 2011, J DERMATOL SCI, V63, P40, DOI 10.1016/j.jdermsci.2011.03.002; Turkcu FM, 2016, INT OPHTHALMOL, V36, P851, DOI 10.1007/s10792-016-0212-9; van Laar JAM, 2006, CLIN MED RES, V4, P248, DOI 10.3121/cmr.4.4.248; Wakefield D, 2016, OCUL IMMUNOL INFLAMM, V24, P450, DOI 10.3109/09273948.2016.1158283; Wan J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5961; Yang TS, 2016, INT J RHEUM DIS, V19, P1002, DOI 10.1111/1756-185X.12744; Yang YW, 2011, BRIT J DERMATOL, V165, P1037, DOI 10.1111/j.1365-2133.2011.10494.x; Yeung H, 2013, JAMA DERMATOL, V149, P1173, DOI 10.1001/jamadermatol.2013.5015	41	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255492	10.1371/journal.pone.0255492	http://dx.doi.org/10.1371/journal.pone.0255492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339476	gold, Green Published			2022-12-26	WOS:000680243400009
J	Signore, PE; Guo, GJ; Wei, ZH; Zhang, WH; Lin, A; del Balzo, U				Signore, Pierre E.; Guo, Guangjie; Wei, Zhihua; Zhang, Weihua; Lin, Al; del Balzo, Ughetta			A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEART-FAILURE; HIF-PROLYL; CARDIAC-FUNCTION; RENAL-DISEASE; FACTOR-I; MYOCARDIAL-INFARCTION; DIABETIC-NEPHROPATHY; GLUCOSE-HOMEOSTASIS; ROXADUSTAT FG-4592	Prolyl hydroxylase (PH) enzymes control the degradation of hypoxia-inducible factor (HIF), a transcription factor known to regulate erythropoiesis, angiogenesis, glucose metabolism, cell proliferation, and apoptosis. HIF-PH inhibitors (HIF-PHIs) correct anemia in patients with renal disease and in animal models of anemia and kidney disease. However, the effects of HIF-PHIs on comorbidities associated with kidney disease remain largely unknown. We evaluated the effects of the HIF-PHI FG-2216 in obese ZSF1 (Ob-ZSF1) rats, an established model of kidney failure with metabolic syndrome. Following unilateral nephrectomy (Nx) at 8 weeks of age, rats were treated with 40 mg/kg FG-2216 or vehicle by oral gavage three times per week for up to 18 weeks. FG-2216 corrected blood hemoglobin levels and improved kidney function and histopathology in Nx-Ob-ZSF1 rats by increasing the glomerular filtration rate, decreasing proteinuria, and reducing peritubular fibrosis, tubular damage, glomerulosclerosis and mesangial expansion. FG-2216 increased renal glucose excretion and decreased body weight, fat pad weight, and serum cholesterol in Nx-Ob-ZSF1 rats. Additionally, FG-2216 corrected hypertension, improved diastolic and systolic heart function, and reduced cardiac hypertrophy and fibrosis. In conclusion, the HIF-PHI FG-2216 improved renal and cardiovascular outcomes, and reduced obesity in a rat model of kidney disease with metabolic syndrome. Thus, in addition to correcting anemia, HIF-PHIs may provide renal and cardiac protection to patients suffering from kidney disease with metabolic syndrome.	[Signore, Pierre E.; Guo, Guangjie; Wei, Zhihua; Zhang, Weihua; Lin, Al; del Balzo, Ughetta] FibroGen Inc, San Francisco, CA 94158 USA	FibroGen	del Balzo, U (corresponding author), FibroGen Inc, San Francisco, CA 94158 USA.	udelbalzo@fibrogen.com	zhang, weihua/GXV-1334-2022		FibroGen, Inc.	FibroGen, Inc.	This research was funded by FibroGen, Inc. P.E.S., G.G., Z. W., W. Z., A.L., and U. d. B. are employees, and/or stock owners of FibroGen Inc. The funder provided support in the form of salaries for authors P.E.S., G.G., Z. W., W. Z., A.L., and U. d. B., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Angeli FS, 2010, J CARD FAIL, V16, P579, DOI 10.1016/j.cardfail.2010.02.008; [Anonymous], 2017, WEB 108; Bao WK, 2010, J CARDIOVASC PHARM, V56, P147, DOI 10.1097/FJC.0b013e3181e2bfef; Barrett TD, 2015, BRIT J PHARMACOL, V172, P4078, DOI 10.1111/bph.13188; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Bilan VP, 2011, J ENDOCRINOL, V210, P293, DOI 10.1530/JOE-11-0122; Bishop T, 2015, CIRC RES, V117, P65, DOI 10.1161/CIRCRESAHA.117.305109; Burmakin M, 2021, ACTA PHYSIOL, V233, DOI 10.1111/apha.13668; Cadenas S, 2010, CARDIOVASC RES, V88, P219, DOI 10.1093/cvr/cvq256; Chan MC, 2016, J BIOL CHEM, V291, P20661, DOI 10.1074/jbc.M116.749291; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Del Vecchio L, 2018, EXPERT OPIN INV DRUG, V27, P613, DOI 10.1080/13543784.2018.1493455; Deng AH, 2010, AM J PHYSIOL-RENAL, V299, pF1365, DOI 10.1152/ajprenal.00153.2010; Evangelista LS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193559; Fang Y, 2013, AM J PHYSIOL-RENAL, V304, pF1274, DOI 10.1152/ajprenal.00287.2012; Fioretto P, 2018, DIABETES OBES METAB, V20, P2532, DOI 10.1111/dom.13413; Flamme I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111838; Fraser SDS, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0189-z; Fukui K, 2019, EUR J PHARMACOL, V859, DOI 10.1016/j.ejphar.2019.172532; Griffin KA, 2007, AM J PHYSIOL-RENAL, V293, pF1605, DOI 10.1152/ajprenal.00511.2006; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Gullion CM, 2006, AM J KIDNEY DIS, V48, P212, DOI 10.1053/j.ajkd.2006.04.083; Gunaratnam L, 2009, J AM SOC NEPHROL, V20, P1877, DOI 10.1681/ASN.2008070804; Gupta N, 2017, AM J KIDNEY DIS, V69, P815, DOI 10.1053/j.ajkd.2016.12.011; Haase VH, 2017, HEMODIAL INT, V21, pS110, DOI 10.1111/hdi.12567; Hamdani N, 2013, CIRC-HEART FAIL, V6, P1239, DOI 10.1161/CIRCHEARTFAILURE.113.000539; Han SP, 2008, DIABETES, V57, P1723, DOI 10.2337/db07-1472; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hung TW, 2013, INDIAN J MED RES, V137, P102; Hwang S, 2017, J BIOL CHEM, V292, P9382, DOI 10.1074/jbc.M117.788562; Jain MR, 2016, DRUG RES, V66, P107, DOI 10.1055/s-0035-1554630; Jelkmann W, 2015, NEPHROL DIAL TRANSPL, V30, P553, DOI 10.1093/ndt/gfu089; Jung F, 2000, CIRC RES, V86, P319, DOI 10.1161/01.RES.86.3.319; Kapitsinou PP, 2012, AM J PHYSIOL-RENAL, V302, pF1172, DOI 10.1152/ajprenal.00667.2011; Katsuno K, 2007, J PHARMACOL EXP THER, V320, P323, DOI 10.1124/jpet.106.110296; Kietzmann T, 1999, BLOOD, V94, P4177, DOI 10.1182/blood.V94.12.4177.424k14_4177_4185; Kimakova P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071519; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Koivunen P, 2016, PHARMACOL RES, V114, P265, DOI 10.1016/j.phrs.2016.11.003; Kovesdy CP, 2017, KIDNEY DIS-BASEL, V3, P33, DOI 10.1159/000452965; Koya D, 2000, FASEB J, V14, P439, DOI 10.1096/fasebj.14.3.439; Kramer HJ, 2006, J AM SOC NEPHROL, V17, P1453, DOI 10.1681/ASN.2005111241; Leite S, 2015, AM J PHYSIOL-HEART C, V309, pH1648, DOI 10.1152/ajpheart.00397.2015; Liu J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050950; Loinard C, 2009, CIRCULATION, V120, P50, DOI 10.1161/CIRCULATIONAHA.108.813303; Manolis Antonis S., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P355, DOI 10.2174/156800605774370326; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; MAUER SM, 1981, AM J MED, V70, P603, DOI 10.1016/0002-9343(81)90582-9; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Mohanan A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/751513; Nangaku M, 2008, NEPHRON EXP NEPHROL, V110, pE1, DOI 10.1159/000148256; Nangaku M, 2006, SEMIN NEPHROL, V26, P261, DOI 10.1016/j.semnephrol.2006.06.001; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Nordquist L, 2015, J AM SOC NEPHROL, V26, P328, DOI 10.1681/ASN.2013090990; Norman JT, 2000, KIDNEY INT, V58, P2351, DOI 10.1046/j.1523-1755.2000.00419.x; ODONNELL MP, 1988, FASEB J, V2, P2339, DOI 10.1096/fasebj.2.8.3282959; Ohtomo S, 2008, NEPHROL DIAL TRANSPL, V23, P1166, DOI 10.1093/ndt/gfm715; Ong SG, 2014, CARDIOVASC RES, V104, P24, DOI 10.1093/cvr/cvu172; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Philipp S., 2013, J CLIN EXP CARDIOLOG, V4, P227; Philipp S, 2006, EUR J HEART FAIL, V8, P347, DOI 10.1016/j.ejheart.2005.10.009; Powell DR, 2014, J PHARMACOL EXP THER, V350, P232, DOI 10.1124/jpet.114.214304; Prabhakar S, 2007, J AM SOC NEPHROL, V18, P2945, DOI 10.1681/ASN.2006080895; Provenzano R, 2016, CLIN J AM SOC NEPHRO, V11, P982, DOI 10.2215/CJN.06890615; Provenzano R, 2016, AM J KIDNEY DIS, V67, P912, DOI 10.1053/j.ajkd.2015.12.020; Prunier F, 2007, AM J PHYSIOL-HEART C, V292, pH522, DOI 10.1152/ajpheart.00357.2006; Rabinowitz MH, 2013, J MED CHEM, V56, P9369, DOI 10.1021/jm400386j; Rahtu-Korpela L, 2016, ARTERIOSCL THROM VAS, V36, P608, DOI 10.1161/ATVBAHA.115.307136; Rahtu-Korpela L, 2014, DIABETES, V63, P3324, DOI 10.2337/db14-0472; Riboulet W., 2013, J EXP APPL ANIM SCI, V1, P125; Rosenberger C, 2008, NEPHROL DIAL TRANSPL, V23, P3472, DOI 10.1093/ndt/gfn276; Saito H, 2019, LAB INVEST, V99, P1217, DOI 10.1038/s41374-019-0239-4; Salah EM, 2018, J CARDIOVASC PHARM, V71, P205, DOI 10.1097/FJC.0000000000000561; Santhanam AVR, 2010, ADV PHARMACOL, V60, P257, DOI [10.1016/S1054-3589(10)60001-4, 10.1016/B978-0-12-385061-4.00009-X]; Schefold JC, 2016, NAT REV NEPHROL, V12, P610, DOI 10.1038/nrneph.2016.113; Schley G, 2011, J AM SOC NEPHROL, V22, P2004, DOI 10.1681/ASN.2010121249; Seeley TW, 2017, HYPOXIA, V5, P1, DOI 10.2147/HP.S130526; Shoji K, 2014, CURR OPIN NEPHROL HY, V23, P161, DOI 10.1097/01.mnh.0000441049.98664.6c; Singh G, 2018, N-S ARCH PHARMACOL, V391, P933, DOI 10.1007/s00210-018-1511-7; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; Stenvinkel P, 2013, J AM SOC NEPHROL, V24, P1727, DOI 10.1681/ASN.2013040330; Stolina M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231234; Strowitzki MJ, 2018, AM J PATHOL, V188, P2826, DOI 10.1016/j.ajpath.2018.08.003; Su Z, 2016, AM J NEPHROL, V44, P339, DOI 10.1159/000449324; Sugahara M, 2020, J AM SOC NEPHROL, V31, P560, DOI 10.1681/ASN.2019060582; Sugahara M, 2017, KIDNEY INT, V92, DOI 10.1016/j.kint.2017.02.035; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Szczech LA, 2008, KIDNEY INT, V74, P791, DOI 10.1038/ki.2008.295; Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Tanaka S, 2018, KIDNEY INT, V94, P912, DOI 10.1016/j.kint.2018.04.025; Tanaka T, 2005, KIDNEY INT, V68, P2714, DOI 10.1111/j.1523-1755.2005.00742.x; Tanaka T, 2005, LAB INVEST, V85, P1292, DOI 10.1038/labinvest.3700328; Tanaka T, 2017, MED MOL MORPHOL, V50, P1, DOI 10.1007/s00795-016-0146-3; Titze S, 2015, NEPHROL DIAL TRANSPL, V30, P441, DOI 10.1093/ndt/gfu294; Tofovic SP, 2000, RENAL FAILURE, V22, P387, DOI 10.1081/JDI-100100882; Toma C, 2007, J MOL CELL CARDIOL, V43, P130, DOI 10.1016/j.yjmcc.2007.05.014; Tuegel C, 2017, HEART, V103, P1848, DOI 10.1136/heartjnl-2016-310794; Ueda K, 2010, J CLIN INVEST, V120, P2016, DOI 10.1172/JCI39896; van der Meer P, 2005, J AM COLL CARDIOL, V46, P125, DOI 10.1016/j.jacc.2005.03.044; van der Meer P, 2004, EUR HEART J, V25, P285, DOI 10.1016/j.ehj.2003.11.017; van Dijk CGM, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.115.002760; Vogler M, 2015, PFLUG ARCH EUR J PHY, V467, P2141, DOI 10.1007/s00424-014-1667-z; Wang ZD, 2012, NEPHROL DIAL TRANSPL, V27, P929, DOI 10.1093/ndt/gfr379; Westenbrink BD, 2010, CARDIOVASC RES, V87, P30, DOI 10.1093/cvr/cvq041; Yang JW, 2018, CLIN EXP NEPHROL, V22, P752, DOI 10.1007/s10157-018-1552-8; Zapata-Morales JR, 2014, J BIOL CHEM, V289, P346, DOI 10.1074/jbc.M113.526814; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang PL, 2008, KIDNEY INT, V73, P608, DOI 10.1038/sj.ki.5002697; Zhang XC, 2007, J CARDIOVASC PHARM, V49, P56, DOI 10.1097/FJC.0b013e31802cb88e	114	2	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255022	10.1371/journal.pone.0255022	http://dx.doi.org/10.1371/journal.pone.0255022			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339435	Green Published, gold			2022-12-26	WOS:000680243400045
J	Smilowitz, NR; Dubner, R; Hellkamp, AS; Widmer, RJ; Reynolds, HR				Smilowitz, Nathaniel R.; Dubner, Rachel; Hellkamp, Anne S.; Widmer, Robert J.; Reynolds, Harmony R.			Variability of discharge medical therapy for secondary prevention among patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) in the United States	PLOS ONE			English	Article							OUTCOMES; HEART	Background Optimal medical therapy after myocardial infarction with nonobstructive coronary arteries (MINOCA; <50% stenosis) is uncertain. We evaluated variability in discharge prescription of angiotensin-converting enzyme inhibitors / angiotensin receptor blockers (ACEI/ARB) and beta-blockers (BB) to MINOCA patients between hospitals to assess physician equipoise about secondary prevention. Methods Patients with MINOCA between 2007-2014 were identified in the NCDR Chest Pain-MI Registry. Those with prior revascularization or missing demographic, angiographic, or medication data were excluded. Analysis was limited to high-volume hospitals with >= 20 MINOCA total discharges. Discharge prescriptions for ACEI/ARB and BB after MINOCA were analyzed for each hospital. Clinical data on left ventricular ejection fraction (LVEF), glomerular filtration rate (GFR), and diabetes mellitus status were extracted to identify other indications for ACEI/ARB or BB. Results Clinical data were available for 17,849 MINOCA patients, of whom 8,752 (49%) had LVEF <40%, GFR <= 60 mL/min, and/or diabetes. 5,913 patients without one of these indications for ACEI/ARB or BB were discharged from 156 high-volume hospitals. At discharge, ACEI/ARB was prescribed to between 16.0% and 88.8% of MINOCA patients (median 45.6%, IQR 38.0%-56.5%) and BB to between 28.0% and 97.5% (median 74.1%, IQR 64.7%-80.0%). Conclusion There is marked variability between hospitals in the proportions of patients receiving ACEI/ARB and BB after hospitalization for MINOCA, suggesting clinical equipoise about the routine use of these agents. Randomized clinical trials are necessary to establish the benefit of ACEI/ARB and BB to improve outcomes after MINOCA.	[Smilowitz, Nathaniel R.; Dubner, Rachel; Reynolds, Harmony R.] New York Univ, Sch Med, Soter Ctr Womens Cardiovasc Res, Leon H Charney Div Cardiol,Dept Med, New York, NY 10003 USA; [Hellkamp, Anne S.] Duke Clin Res Inst, Durham, NC USA; [Widmer, Robert J.] Baylor Scott White Med Ctr, Temple, TX USA	New York University; Duke University; Baylor Health Care System	Reynolds, HR (corresponding author), New York Univ, Sch Med, Soter Ctr Womens Cardiovasc Res, Leon H Charney Div Cardiol,Dept Med, New York, NY 10003 USA.	Harmony.Reynolds@nyulangone.org		Widmer, RJ/0000-0002-3063-5651; Reynolds, Harmony/0000-0003-0284-0655	National Heart, Lung, And Blood Institute of the National Institutes of Health [K23HL150315]	National Heart, Lung, And Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Reynolds has received in kind support for an unrelated research study in MINOCA from Abbott Vascular and from Siemens, and for an unrelated research study in takotsubo syndrome from BioTelemetry Inc. Dr. Smilowitz serves on an advisory board for Abbott Vascular and as a consultant for Medyria. Industry had no role in the funding, study design, data collection and analysis, decision to publish, or preparation of this manuscript. Sponsor/Funding: Dr. Smilowitz is supported, in part, by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number K23HL150315.	Agewall S, 2017, EUR HEART J, V38, P143, DOI 10.1093/eurheartj/ehw149; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Ciliberti G, 2021, INT J CARDIOL, V327, P9, DOI 10.1016/j.ijcard.2020.11.040; Dondo TB, 2017, J AM COLL CARDIOL, V69, P2710, DOI 10.1016/j.jacc.2017.03.578; Lindahl B, 2017, CIRCULATION, V135, P1481, DOI 10.1161/CIRCULATIONAHA.116.026336; Maddox TM, 2010, CIRC-CARDIOVASC QUAL, V3, P632, DOI 10.1161/CIRCOUTCOMES.109.906214; Nordenskjold AM, 2021, AM HEART J, V231, P96, DOI 10.1016/j.ahj.2020.10.059; Paolisso P, 2021, CARDIOVASC DIABETOL, V20, DOI 10.1186/s12933-021-01222-9; Paolisso P, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01606; Pasupathy S, 2015, CIRCULATION, V131, P861, DOI 10.1161/CIRCULATIONAHA.114.011201; Pauly DF, 2011, AM HEART J, V162, P678, DOI 10.1016/j.ahj.2011.07.011; Peterson ED, 2009, CIRC-CARDIOVASC QUAL, V2, P491, DOI 10.1161/CIRCOUTCOMES.108.847145; Reynolds HR, 2021, CIRCULATION, V143, P624, DOI 10.1161/CIRCULATIONAHA.120.052008; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Smilowitz NR, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.003443; Tamis-Holland JE, 2019, CIRCULATION, V139, pE891, DOI 10.1161/CIR.0000000000000670; Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011	18	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255462	10.1371/journal.pone.0255462	http://dx.doi.org/10.1371/journal.pone.0255462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339469	Green Published, gold			2022-12-26	WOS:000680243400043
J	Davis, SE; Roth, JR; Aljabi, Q; Hakim, AR; Savell, KE; Day, JJ; Arrant, AE				Davis, Skylar E.; Roth, Jonathan R.; Aljabi, Qays; Hakim, Ahmad R.; Savell, Katherine E.; Day, Jeremy J.; Arrant, Andrew E.			Delivering progranulin to neuronal lysosomes protects against excitotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; TRAUMATIC BRAIN-INJURY; ACTIVATED MICROGLIA; NEURITE OUTGROWTH; TNF RECEPTORS; HOST-DEFENSE; MOUSE MODEL; AUTOPHAGY; DEMENTIA; DEATH	Loss-of-function mutations in progranulin (GRN) are a major genetic cause of frontotemporal dementia (FTD), possibly due to loss of progranulin's neurotrophic and antiinflammatory effects. Progranulin promotes neuronal growth and protects against excitotoxicity and other forms of injury. It is unclear if these neurotrophic effects are mediated through cellular signaling or through promotion of lysosomal function. Progranulin is a secreted proprotein that may activate neurotrophic signaling through cell-surface receptors. However, progranulin is efficiently trafficked to lysosomes and is necessary for maintaining lysosomal function. To determine which of these mechanisms mediates progranulin's protection against excitotoxicity, we generated lentiviral vectors expressing progranulin (PGRN) or lysosome-targeted progranulin (L-PGRN). L-PGRN was generated by fusing the LAMP-1 transmembrane and cytosolic domains to the C-terminus of progranulin. L-PGRN exhibited no detectable secretion, but was delivered to lysosomes and processed into granulins. PGRN and L-PGRN protected against NMDA excitotoxicity in rat primary cortical neurons, but L-PGRN had more consistent protective effects than PGRN. L-PGRN's protective effects were likely mediated through the autophagy-lysosomal pathway. In control neurons, an excitotoxic dose of NMDA stimulated autophagy, and inhibiting autophagy with 3-methyladenine reduced excitotoxic cell death. L-PGRN blunted the autophagic response to NMDA and occluded the protective effect of 3-methyladenine. This was not due to a general impairment of autophagy, as L-PGRN increased basal autophagy and did not alter autophagy after nutrient starvation. These data show that progranulin's protection against excitotoxicity does not require extracellular progranulin, but is mediated through lysosomes, providing a mechanistic link between progranulin's lysosomal and neurotrophic effects.	[Davis, Skylar E.; Roth, Jonathan R.; Aljabi, Qays; Hakim, Ahmad R.; Arrant, Andrew E.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Davis, Skylar E.; Roth, Jonathan R.; Aljabi, Qays; Hakim, Ahmad R.; Savell, Katherine E.; Day, Jeremy J.; Arrant, Andrew E.] Univ Alabama Birmingham, Alzheimers Dis Ctr, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA; [Savell, Katherine E.; Day, Jeremy J.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Savell, Katherine E.] NIDA, Behav Neurosci Branch, Intramural Res Program, NIH, Baltimore, MD 20852 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Arrant, AE (corresponding author), Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA.; Arrant, AE (corresponding author), Univ Alabama Birmingham, Alzheimers Dis Ctr, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA.	andrewarrant@uabmc.edu		Day, Jeremy/0000-0002-7361-3399	Association for Frontotemporal Degeneration (Basic Science Pilot Grant); National Institute on Aging [F31 AG064868, R00 AG056597, R21 AG068658]; UAB Alzheimer's Disease Center [P20 AG068024]; National Institute on Drug Abuse [F31 DA042514]; National Institute of Mental Health [R01 MH114990]	Association for Frontotemporal Degeneration (Basic Science Pilot Grant); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UAB Alzheimer's Disease Center; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from The Association for Frontotemporal Degeneration (Basic Science Pilot Grant) to A. E. A., from the National Institute on Aging to J. R. R. (F31 AG064868), A. E. A. (R00 AG056597 and R21 AG068658), and the UAB Alzheimer's Disease Center (P20 AG068024), from the National Institute on Drug Abuse to K. E. S. (F31 DA042514), and from the National Institute of Mental Health to J. J. D. (R01 MH114990). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Remaileh M, 2017, SCIENCE, V358, P807, DOI 10.1126/science.aan6298; Almeida MR, 2016, NEUROBIOL AGING, V41, DOI 10.1016/j.neurobiolaging.2016.02.019; Altmann C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0132-1; Altmann C, 2016, NEUROBIOL DIS, V96, P294, DOI 10.1016/j.nbd.2016.09.010; Arrant AE, 2020, ANN CLIN TRANSL NEUR, V7, P2433, DOI 10.1002/acn3.51242; Arrant AE, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0872-6; Arrant AE, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0264-6; Arrant AE, 2018, J NEUROSCI, V38, P2341, DOI 10.1523/JNEUROSCI.3081-17.2018; Arrant AE, 2017, BRAIN, V140, P1447, DOI 10.1093/brain/awx060; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Beel S, 2017, HUM MOL GENET, V26, P2850, DOI 10.1093/hmg/ddx162; Borsello T, 2003, EUR J NEUROSCI, V18, P473, DOI 10.1046/j.1460-9568.2003.02757.x; Butler VJ, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008295; Butler VJ, 2019, BIOCHEMISTRY-US, V58, P2670, DOI 10.1021/acs.biochem.9b00275; Butlers VJ, 2019, J MOL BIOL, V431, P1038, DOI 10.1016/j.jmb.2019.01.027; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Chang MC, 2017, J EXP MED, V214, P2611, DOI 10.1084/jem.20160999; Chen X, 2013, J NEUROSCI, V33, P9202, DOI 10.1523/JNEUROSCI.5336-12.2013; Chen YH, 2018, J MOL MED, V96, P1359, DOI 10.1007/s00109-018-1703-0; Chitramuthu BP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174784; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P581, DOI 10.1001/archneurol.2010.350; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; De Muynck L, 2013, NEUROBIOL AGING, V34, P2541, DOI 10.1016/j.neurobiolaging.2013.04.022; Descloux C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0916-z; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; Finch N, 2011, NEUROLOGY, V76, P467, DOI 10.1212/WNL.0b013e31820a0e3b; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Gao X, 2010, PROTEIN CELL, V1, P552, DOI 10.1007/s13238-010-0067-1; Gass J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-33; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Ginet V, 2014, AUTOPHAGY, V10, P846, DOI 10.4161/auto.28264; Gotzl JK, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0281-5; Gotzl JK, 2014, ACTA NEUROPATHOL, V127, P845, DOI 10.1007/s00401-014-1262-6; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; Guo A, 2010, BRAIN RES, V1366, P1, DOI 10.1016/j.brainres.2010.09.099; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Holler CJ, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0100-17.2017; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Huin V, 2020, BRAIN, V143, P303, DOI 10.1093/brain/awz377; Hyung S, 2019, GLIA, V67, P360, DOI 10.1002/glia.23547; Kanazawa M, 2015, BRAIN, V138, P1932, DOI 10.1093/brain/awv079; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kleinberger G, 2016, NEUROBIOL AGING, V39, DOI 10.1016/j.neurobiolaging.2015.12.014; Klionsky DJ, 2021, AUTOPHAGY, V17, P1, DOI 10.1080/15548627.2020.1797280; Krabbe G, 2017, P NATL ACAD SCI USA, V114, P5029, DOI 10.1073/pnas.1700477114; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Lee CW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0196-6; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Mikulka CR, 2020, P NATL ACAD SCI USA, V117, P9032, DOI 10.1073/pnas.1917675117; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Neill T, 2016, J CELL BIOL, V215, P687, DOI 10.1083/jcb.201603079; Nguyen AD, 2013, TRENDS ENDOCRIN MET, V24, P597, DOI 10.1016/j.tem.2013.08.003; Nicholson AM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11992; Puyal J, 2012, NEUROSCIENTIST, V18, P224, DOI 10.1177/1073858411404948; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Sadasivan S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-21; Salazar DA, 2015, J NEUROSCI, V35, P9315, DOI 10.1523/JNEUROSCI.4808-14.2015; Savell KE, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3348; Savell KE, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0495-18.2019; Schmitz K, 2020, CELL MOL IMMUNOL, V17, P1077, DOI 10.1038/s41423-019-0274-5; Shacka JJ, 2007, NEUROSCI LETT, V414, P57, DOI 10.1016/j.neulet.2006.12.025; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; Sheng JH, 2014, GENE, V542, P141, DOI 10.1016/j.gene.2014.03.041; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Suh HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035115; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tanaka Y, 2017, HUM MOL GENET, V26, P969, DOI 10.1093/hmg/ddx011; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Valdez C, 2020, HUM MOL GENET, V29, P716, DOI 10.1093/hmg/ddz229; Valdez C, 2017, HUM MOL GENET, V26, P4861, DOI 10.1093/hmg/ddx364; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van der Zee J, 2011, BRAIN, V134, P808, DOI 10.1093/brain/awr007; Voskobiynyk Y, 2020, ELIFE, V9, DOI 10.7554/eLife.57354; Wang C, 2018, CURR OPIN NEUROBIOL, V48, P52, DOI 10.1016/j.conb.2017.09.005; Wang WZ, 2011, BRAIN RES, V1389, P61, DOI 10.1016/j.brainres.2011.02.083; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wang Y, 2009, EUR J NEUROSCI, V30, P2258, DOI 10.1111/j.1460-9568.2009.07025.x; Ward ME, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5642; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhang JS, 2020, NATURE, V588, P459, DOI 10.1038/s41586-020-2709-7; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhou XL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212382; Zhou XL, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0205-9; Zhou XL, 2017, ACTA NEUROPATHOL, V134, P151, DOI 10.1007/s00401-017-1719-5; Zhou XL, 2015, J CELL BIOL, V210, P991, DOI 10.1083/jcb.201502029; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	97	5	5	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100993	10.1016/j.jbc.2021.100993	http://dx.doi.org/10.1016/j.jbc.2021.100993			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	34298019	gold, Green Published			2022-12-26	WOS:000706361700009
J	Deguchi, A; Yamamoto, T; Shibata, N; Maru, Y				Deguchi, Atsuko; Yamamoto, Tomoko; Shibata, Noriyuki; Maru, Yoshiro			S100A8 may govern hyper-inflammation in severe COVID-19	FASEB JOURNAL			English	Article						acute respiratory distress syndrome; Coronavirus disease 2019; myeloid-derived suppressor cells; Toll-like receptor	HOMEOSTATIC INFLAMMATION; PROTEINS; CELLS; NEUTROPHILS; ACTIVATION; MIGRATION; RELEASE; MRP14	The coronavirus disease 2019 (COVID-19) pandemic threatens human species with mortality rate of roughly 2%. We can hardly predict the time of herd immunity against and end of COVID-19 with or without success of vaccine. One way to overcome the situation is to define what delineates disease severity and serves as a molecular target. The most successful analogy is found in BCR-ABL in chronic myeloid leukemia, which is the golden biomarker, and simultaneously, the most effective molecular target. We hypothesize that S100 calcium-binding protein A8 (S100A8) is one such molecule. The underlying evidence includes accumulating clinical information that S100A8 is upregulated in severe forms of COVID-19, pathological similarities of the affected lungs between COVID-19 and S100A8-induced acute respiratory distress syndrome (ARDS) model, homeostatic inflammation theory in which S100A8 is an endogenous ligand for endotoxin sensor Toll-like receptor 4/Myeloid differentiation protein-2 (TLR4/MD-2) and mediates hyper-inflammation even after elimination of endotoxin-producing extrinsic pathogens, analogous findings between COVID-19-associated ARDS and pre-metastatic lungs such as S100A8 upregulation, pulmonary recruitment of myeloid cells, increased vascular permeability, and activation coagulation cascade. A successful treatment in an animal COVID-19 model is given with a reagent capable of abrogating interaction between S100A8/S100A9 and TLR4. In this paper, we try to verify our hypothesis that S100A8 governs COVID-19-associated ARDS.	[Deguchi, Atsuko; Maru, Yoshiro] Tokyo Womens Med Univ, Dept Pharmacol, Tokyo, Japan; [Yamamoto, Tomoko; Shibata, Noriyuki] Tokyo Womens Med Univ, Dept Pathol, Div Pathol Neurosci, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University	Maru, Y (corresponding author), Tokyo Womens Med Univ, Dept Pharmacol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	maru.yoshiro@twmu.ac.jp		Deguchi, Atsuko/0000-0001-9647-3539	Japan Society for the Promotion of Science [18K07245, 21K07157, 19K03506]; Smoking Research Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation	Japan Society for the Promotion of Science, Grant/Award Number: 18K07245, 21K07157 and 19K03506; Smoking Research Foundation	ANDERSSON KB, 1988, SCAND J IMMUNOL, V28, P241, DOI 10.1111/j.1365-3083.1988.tb02437.x; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Bruger AM, 2019, CANCER IMMUNOL IMMUN, V68, P631, DOI 10.1007/s00262-018-2170-8; Cappy P, 2020, BLOOD, V136, P1888, DOI 10.1182/blood.2020008230; Chandrashekar D.S., 2020, COMP TRANSCRIPTOME A, DOI [10.1101/2020.06.24.169268, DOI 10.1101/2020.06.24.169268]; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Dash P, 2021, INT J INFECT DIS, V104, P491, DOI 10.1016/j.ijid.2021.01.020; Deguchi, UNPUBLISHED RESULTS; Deguchi A, 2016, ONCOGENE, V35, P1445, DOI 10.1038/onc.2015.211; Dinnon KH, 2020, NATURE, V586, P560, DOI 10.1038/s41586-020-2708-8; Doeing Diana C, 2003, BMC Clin Pathol, V3, P3; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; Elrashdy F, 2021, J BIOMOL STRUCT DYN, V39, P5831, DOI 10.1080/07391102.2020.1790426; FAGERHOL MK, 1980, SCAND J HAEMATOL, V24, P393; FRIEND C, 1978, CANCER RES, V38, P2581; Guo QR, 2021, CELL HOST MICROBE, V29, P222, DOI 10.1016/j.chom.2020.12.016; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hiratsuka S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2856; Hodgson SH, 2021, LANCET INFECT DIS, V21, pE26, DOI 10.1016/S1473-3099(20)30773-8; Hong WQ, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-020-00451-w; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Jiang RD, 2020, CELL, V182, P50, DOI 10.1016/j.cell.2020.05.027; Jreige M, 2020, J NUCL MED, V61, P26, DOI 10.2967/jnumed.119.229575; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P585, DOI 10.1189/jlb.0113014; Li YJ, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI148635; Maru Y., 2021, INFLAMMATION METASTA, V2nd; Maru Y., 2016, INFLAMMATION METASTA, V1st ed; Maru Y, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a036897; Maru Yoshiro, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P337; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134; Miyake K, 2014, CURR OPIN IMMUNOL, V30, P85, DOI 10.1016/j.coi.2014.08.003; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Ortiz-Munoz G, 2020, J CLIN INVEST, V130, P2041, DOI 10.1172/JCI129635; Pan SG, 2020, INT J ONCOL, V56, P101, DOI 10.3892/ijo.2019.4907; Price TH, 1996, BLOOD, V88, P335; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Ravindra NG, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001143; Rawal Gautam, 2018, J Transl Int Med, V6, P74, DOI 10.1515/jtim-2016-0012; Reizine F, 2021, J CLIN IMMUNOL, V41, P515, DOI 10.1007/s10875-020-00920-5; Rodriguez RA, 2009, APPL ENVIRON MICROB, V75, P297, DOI 10.1128/AEM.01150-08; Rosas IO, 2021, NEW ENGL J MED, V384, P1503, DOI 10.1056/NEJMoa2028700; Ruan SY, 2014, CRIT CARE, V18, DOI 10.1186/cc13819; Scott NR, 2020, J CLIN INVEST, V130, P3098, DOI 10.1172/JCI130546; Shah S, 2016, NEURON, V92, P342, DOI 10.1016/j.neuron.2016.10.001; Tian JB, 2020, LANCET ONCOL, V21, P893, DOI 10.1016/S1470-2045(20)30309-0; Tirkos S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-51; Tomita T, 2011, ONCOGENE, V30, P3429, DOI 10.1038/onc.2011.53; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Veras FP, 2020, J EXP MED, V217, DOI 10.1084/jem.20201129; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Whiteside Theresa L, 2018, Contemp Oncol (Pozn), V22, P38, DOI 10.5114/wo.2018.73882; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Yap GLR, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2625-7; Yipp BG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8929; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017	64	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21798	10.1096/fj.202101013	http://dx.doi.org/10.1096/fj.202101013			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34339064	Green Published			2022-12-26	WOS:000691122900056
J	Littler, DR; Mohanty, B; Lowery, SA; Colson, RN; Gully, BS; Perlman, S; Scanlon, MJ; Rossjohn, J				Littler, Dene R.; Mohanty, Biswaranjan; Lowery, Shea A.; Colson, Rhys N.; Gully, Benjamin S.; Perlman, Stanley; Scanlon, Martin J.; Rossjohn, Jamie			Binding of a pyrimidine RNA base-mimic to SARS-CoV-2 nonstructural protein 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONAVIRUS; REPLICATION; NSP9	The coronaviral nonstructural protein 9 (Nsp9) is essential for viral replication; it is the primary substrate of Nsp12's pseudokinase domain within the viral replication transcription complex, an association that also recruits other components during different stages of RNA reproduction. In the unmodified state, Nsp9 forms an obligate homodimer via an essential GxxxG protein-interaction motif, but its ssRNA-binding mechanism remains unknown. Using structural biological techniques, here we show that a base-mimicking compound identified from a small molecule fragment screen engages Nsp9 via a tetrameric Pi-Pi stacking interaction that induces the formation of a parallel trimer-of-dimers. This oligomerization mechanism allows an interchange of "latching" N-termini, the charges of which contribute to a series of electropositive channels that suggests a potential interface for viral RNA. The identified pyrrolo-pyrimidine compound may also serve as a potential starting point for the development of compounds seeking to probe Nsp9's role within SARS-CoV-2 replication.	[Littler, Dene R.; Colson, Rhys N.; Gully, Benjamin S.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Infect & Immun Program, Clayton, Vic, Australia; [Mohanty, Biswaranjan; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic, Australia; [Mohanty, Biswaranjan] Univ Sydney, Sydney Analyt Core Res Facil, Sydney, NSW, Australia; [Mohanty, Biswaranjan; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, ARC Ctr Fragment Based Design, Parkville, Vic, Australia; [Lowery, Shea A.; Perlman, Stanley] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA USA; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff, Wales	Monash University; Monash University; University of Sydney; Monash University; University of Iowa; Cardiff University	Littler, DR; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Infect & Immun Program, Clayton, Vic, Australia.; Scanlon, MJ (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff, Wales.	dene.littler@monash.edu; martin.scanlon@monash.edu; jamie.rossjohn@monash.edu	Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Scanlon, Martin/0000-0002-9230-7506; Gully, Benjamin/0000-0002-8197-0871; Littler, Dene/0000-0001-5904-1905	Australian Research Council Centre of Excellence for Advanced Molecular Imaging; Australian Research Council Centre for Fragment-Based Design	Australian Research Council Centre of Excellence for Advanced Molecular Imaging(Australian Research Council); Australian Research Council Centre for Fragment-Based Design(Australian Research Council)	Funding for the work originated from the Australian Research Council Centre of Excellence for Advanced Molecular Imaging and the Centre for Fragment-Based Design. This research was undertaken in part using the MX2 beamline at the Australian Synchrotron, part of ANSTO, and made use of the Australian Cancer Research Foundation (ACRF) detector. Additionally, we thank Dr Geoffrey Kong of the Monash Molecular Crystallisation Facility for his assistance with crystallographic screening and optimization. We thank A. RiboldiTunnicliffe and R. Williamson for assistance with data collection.	Aragao D, 2018, J SYNCHROTRON RADIAT, V25, P885, DOI 10.1107/S1600577518003120; Banerjee AK, 2020, CELL, V183, P1325, DOI 10.1016/j.cell.2020.10.004; Brockway SM, 2003, J VIROL, V77, P10515, DOI 10.1128/JVI.77.19.10515-10527.2003; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Chen J, 2020, CELL, V182, P1560, DOI 10.1016/j.cell.2020.07.033; Chen JP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00853; Egloff MP, 2004, P NATL ACAD SCI USA, V101, P3792, DOI 10.1073/pnas.0307877101; El-Kamand S, 2022, PROTEINS, V90, P176, DOI 10.1002/prot.26205; Dudas EF, 2021, BIOMOL NMR ASSIGN, V15, P235, DOI 10.1007/s12104-021-10011-0; Fehr AR, 2020, METHODS MOL BIOL, V2099, P53, DOI 10.1007/978-1-0716-0211-9_5; Frieman M, 2012, J VIROL, V86, P884, DOI 10.1128/JVI.05957-11; Glanzer JG, 2016, J ANTIMICROB CHEMOTH, V71, P3432, DOI 10.1093/jac/dkw340; Ivanov KA, 2004, J VIROL, V78, P5619, DOI 10.1128/JVI.78.11.5619-5632.2004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Lehmann KC, 2015, NUCLEIC ACIDS RES, V43, P8416, DOI 10.1093/nar/gkv838; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Littler DR, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101258; Lu D, 2010, P NATL ACAD SCI USA, V107, P633, DOI 10.1073/pnas.0909191107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miknis ZJ, 2009, J VIROL, V83, P3007, DOI 10.1128/JVI.01505-08; Nebl S, 2020, J BIOMOL NMR, V74, P595, DOI 10.1007/s10858-020-00339-5; Ponnusamy R, 2008, J MOL BIOL, V383, P1081, DOI 10.1016/j.jmb.2008.07.071; Sawicki S G, 1995, Adv Exp Med Biol, V380, P499; Slanina H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022310118; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003760; Snijder EJ, 2016, ADV VIRUS RES, V96, P59, DOI 10.1016/bs.aivir.2016.08.008; Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05; Sola I, 2015, ANNU REV VIROL, V2, P265, DOI 10.1146/annurev-virology-100114-055218; Sutton G, 2004, STRUCTURE, V12, P341, DOI 10.1016/j.str.2004.01.016; Taylor A, 2018, METHOD ENZYMOL, V610, P97, DOI 10.1016/bs.mie.2018.09.018; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yan LM, 2021, CELL, V184, P3474, DOI 10.1016/j.cell.2021.05.033; Yan LM, 2021, CELL, V184, P184, DOI 10.1016/j.cell.2020.11.016; Yin WC, 2020, SCIENCE, V368, P1499, DOI 10.1126/science.abc1560; Zeng Z, 2018, J VIROL, V92, DOI 10.1128/JVI.00692-18; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	38	5	5	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101018	10.1016/j.jbc.2021.101018	http://dx.doi.org/10.1016/j.jbc.2021.101018			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34331944	Green Accepted, Green Published, gold			2022-12-26	WOS:000706408900014
J	Kamalov, F; Sulieman, H; Calonge, DS				Kamalov, Firuz; Sulieman, Hana; Santandreu Calonge, David			Machine learning based approach to exam cheating detection	PLOS ONE			English	Article							OUTLIER DETECTION; ACADEMIC INTEGRITY	The COVID-19 pandemic has impelled the majority of schools and universities around the world to switch to remote teaching. One of the greatest challenges in online education is preserving the academic integrity of student assessments. The lack of direct supervision by instructors during final examinations poses a significant risk of academic misconduct. In this paper, we propose a new approach to detecting potential cases of cheating on the final exam using machine learning techniques. We treat the issue of identifying the potential cases of cheating as an outlier detection problem. We use students' continuous assessment results to identify abnormal scores on the final exam. However, unlike a standard outlier detection task in machine learning, the student assessment data requires us to consider its sequential nature. We address this issue by applying recurrent neural networks together with anomaly detection algorithms. Numerical experiments on a range of datasets show that the proposed method achieves a remarkably high level of accuracy in detecting cases of cheating on the exam. We believe that the proposed method would be an effective tool for academics and administrators interested in preserving the academic integrity of course assessments.	[Kamalov, Firuz] Canadian Univ Dubai, Dept Elect Engn, Dubai, U Arab Emirates; [Sulieman, Hana] Amer Univ Sharjah, Dept Math & Stat, Sharjah, U Arab Emirates; [Santandreu Calonge, David] Canadian Univ Dubai, Dept Commun & Media, Dubai, U Arab Emirates	Canadian University Dubai; American University of Sharjah; Canadian University Dubai	Kamalov, F (corresponding author), Canadian Univ Dubai, Dept Elect Engn, Dubai, U Arab Emirates.	firuz@cud.ac.ae	Santandreu Calonge, David/AHE-1864-2022	Santandreu Calonge, David/0000-0003-0101-8758; Sulieman, Hana/0000-0003-4952-8298; Kamalov, Firuz/0000-0003-3946-0920	American University of Sharjah	American University of Sharjah	This work was supported in part by the American University of Sharjah. No additional external funding was received for this study.	Aggarwal CC, 2001, SIGMOD RECORD, V30, P37; Aldowah H, 2019, TELEMAT INFORM, V37, P13, DOI 10.1016/j.tele.2019.01.007; Alexandron G., 2019, P 12 INT CONFERENCEO, V480, P483; Amigud A, 2020, ASSESS EVAL HIGH EDU, V45, P541, DOI 10.1080/02602938.2019.1670780; Awdry R, 2021, ASSESS EVAL HIGH EDU, V46, P220, DOI 10.1080/02602938.2020.1765311; Barnett V., 1994, OUTLIERS STAT DATA, V3; Berman S., 2020, SECURE ONLINE HIGH S; Bollag B., 2020, AL FANAR MEDIA 0526; Breunig MM, 2000, SIGMOD REC, V29, P93, DOI 10.1145/335191.335388; Carnevale D, 1999, CHRON HIGHER EDUC; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chirumamilla A, 2020, ASSESS EVAL HIGH EDU, V45, P940, DOI 10.1080/02602938.2020.1719975; Chollet F, 2016, KERAS, DOI DOI 10.1038/NATURE083580; Cizek G.J., 2016, HDB QUANTITATIVE MET; Connolly C., 2020, NBC BOSTON 0430; Dawson P, 2016, BRIT J EDUC TECHNOL, V47, P592, DOI 10.1111/bjet.12246; Domingues R, 2018, PATTERN RECOGN, V74, P406, DOI 10.1016/j.patcog.2017.09.037; Eaton S. E, 2020, INQUIRY MAJOR ACAD I; Fellner, 2020, SYDNEY MORNING HERAL; Gogoi P, 2011, COMPUT J, V54, P570, DOI 10.1093/comjnl/bxr026; Harmon OR, 2008, J ECON EDUC, V39, P116, DOI 10.3200/JECE.39.2.116-125; Harper R, 2021, HIGH EDUC RES DEV, V40, P263, DOI 10.1080/07294360.2020.1724899; Hernandeza J.A., 2006, P C DATA MINING DMIN, V6, P205; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Joudaki Hossein, 2014, Glob J Health Sci, V7, P194, DOI 10.5539/gjhs.v7n1p194; Kamalov F, 2020, KNOWL-BASED SYST, V207, DOI 10.1016/j.knosys.2020.106368; Kamalov F, 2020, J INF KNOWL MANAG, V19, DOI 10.1142/S0219649220400134; Kamalov F, 2020, NEURAL COMPUT APPL, V32, P17655, DOI 10.1007/s00521-020-04942-3; Kamalov F, 2020, INFORM SCIENCES, V512, P1192, DOI 10.1016/j.ins.2019.10.017; King CG., 2009, J ED ONLINE, V6, P11, DOI 10.1111/j.2042-3306.1989.tb02693.x; Knorr E. M., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining, P219; Lancaster T, 2016, HANDBOOK OF ACADEMIC INTEGRITY, P639, DOI 10.1007/978-981-287-098-8_17; Lanier MM, 2006, J CRIM JUSTICE EDUC, V17, P244, DOI 10.1080/10511250600866166; Leinonen Juho, 2016, P 2016 ACM C INNOVAT, P160; Liu FT, 2008, IEEE DATA MINING, P413, DOI 10.1109/ICDM.2008.17; Macfarlane B, 2014, STUD HIGH EDUC, V39, P339, DOI 10.1080/03075079.2012.709495; Nguyen QP, 2019, IEEE CONF COMM NETW, P91; Ram P., 2018, FRAUD DETECTION DENS; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; Sheinermann M.R, 2020, DAILY PRINCETON 0526; Simon M, 2014, TEST FRAUD, P99; Thabtah F, 2020, INFORM SCIENCES, V513, P429, DOI 10.1016/j.ins.2019.11.004; Ueno M., 2002, P INT C ADV LEARN TE, P436; van Capelleveen G, 2016, INT J ACCOUNT INF SY, V21, P18, DOI 10.1016/j.accinf.2016.04.001; Yu Y, 2019, NEURAL COMPUT, V31, P1235, DOI 10.1162/neco_a_01199	45	10	10	11	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2021	16	8							e0254340	10.1371/journal.pone.0254340	http://dx.doi.org/10.1371/journal.pone.0254340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6IY	34347794	gold, Green Published			2022-12-26	WOS:000685264900047
J	Winitchaikul, T; Sawong, S; Surangkul, D; Srikummool, M; Somran, J; Pekthong, D; Kamonlakorn, K; Nangngam, P; Parhira, S; Srisawang, P				Winitchaikul, Thanwarat; Sawong, Suphunwadee; Surangkul, Damratsamon; Srikummool, Metawee; Somran, Julintorn; Pekthong, Dumrongsak; Kamonlakorn, Kittiya; Nangngam, Pranee; Parhira, Supawadee; Srisawang, Piyarat			Calotropis gigantea stem bark extract induced apoptosis related to ROS and ATP production in colon cancer cells	PLOS ONE			English	Article							EHRLICHS ASCITES-CARCINOMA; FLAVONOID CONTENT; ROOT BARK; 5-FLUOROURACIL; CARDENOLIDES; L.; IDENTIFICATION; MITOCHONDRIA; MECHANISMS; GLYCOSIDES	Conventional chemotherapeutic agents for colorectal cancer (CRC) cause systemic side effects and eventually become less efficacious owing to the development of drug resistance in cancer cells. Therefore, new therapeutic regimens have focused on the use of natural products. The anticancer activity of several parts of Calotropis gigantea has been reported; however, the effects of its stem bark extract on inhibition of cancer cell proliferation have not yet been examined. In this study, the anticancer activity of C. gigantea stem bark extract, both alone and in combination with 5-fluorouracil (5-FU), was evaluated. A crude ethanolic extract was prepared from dry, powdered C. gigantea barks using 95% ethanol. This was then partitioned to obtain dichloromethane (CGDCM), ethyl acetate, and water fractions. Quantitative analysis of the constituent secondary metabolites and calotropin was performed. These fractions exhibited cytotoxicity in HCT116 and HT-29 cells, with CGDCM showing the highest potency in both the cell lines. A combination of CGDCM and 5-FU significantly enhanced the cytotoxic effect. Moreover, the resistance of normal fibroblast, HFF-1, cells to this combination demonstrated its safety in normal cells. The combination significantly enhanced apoptosis through the mitochondria-dependent pathway. Additionally, the combination reduced adenosine triphosphate production and increased the production of reactive oxygen species, demonstrating the mechanisms involved in the induction of apoptosis. Our results suggest that CGDCM is a promising anti-cancer agent and may enhance apoptosis induction by 5-FU in the treatment of CRC, while minimizing toxicity toward healthy cells.	[Winitchaikul, Thanwarat; Sawong, Suphunwadee; Srisawang, Piyarat] Naresuan Univ, Dept Physiol, Fac Med Sci, Phitsanulok, Thailand; [Surangkul, Damratsamon; Srikummool, Metawee] Naresuan Univ, Dept Biochem, Fac Med Sci, Phitsanulok, Thailand; [Somran, Julintorn] Naresuan Univ, Dept Pathol, Fac Med, Phitsanulok, Thailand; [Pekthong, Dumrongsak] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Phitsanulok, Thailand; [Kamonlakorn, Kittiya] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharmaceut Chem & Pharmacognosy, Phitsanulok, Thailand; [Nangngam, Pranee] Naresuan Univ, Dept Biol, Fac Sci, Phitsanulok, Thailand; [Parhira, Supawadee] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Phitsanulok, Thailand	Naresuan University; Naresuan University; Naresuan University; Naresuan University; Naresuan University; Naresuan University; Naresuan University	Srisawang, P (corresponding author), Naresuan Univ, Dept Physiol, Fac Med Sci, Phitsanulok, Thailand.; Parhira, S (corresponding author), Naresuan Univ, Fac Pharmaceut Sci, Dept Pharmaceut Technol, Phitsanulok, Thailand.	supawadeep@nu.ac.th; piyarats@nu.ac.th		Parhira, Supawadee/0000-0002-2077-5888	Thailand Science Research and Innovation [R2564B007]; Department of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand [61063417]	Thailand Science Research and Innovation; Department of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand	SP and PS received grant supported from Thailand Science Research and Innovation, [Grant NO. R2564B007]. TW received the graduate thesis funding from the Department of Physiology, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand [Grant NO. 61063417]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia YM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35083-2; Baba SA, 2015, J TAIBAH UNIV SCI, V9, P449, DOI 10.1016/j.jtusci.2014.11.001; Bianchi G, 2018, CARCINOGENESIS, V39, P1141, DOI 10.1093/carcin/bgy076; Blondy S, 2020, CANCER SCI, V111, P3142, DOI 10.1111/cas.14532; Cai-Xia Y., 2017, AM J ORG CHEM, V7, P13; Chang CL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/984295; Chen SJ, 2020, NUTR CANCER, V72, P209, DOI 10.1080/01635581.2019.1622739; Cheng ZY, 2020, ENVIRON TOXICOL, V35, P911, DOI 10.1002/tox.22927; Davoodi H, 2013, IRAN J PHARM RES, V12, P453; Erkisa M, 2020, BIOCHIMIE, V175, P159, DOI 10.1016/j.biochi.2020.05.010; Focaccetti C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115686; Giampazolias E, 2016, FEBS J, V283, P803, DOI 10.1111/febs.13603; Grada A, 2017, J INVEST DERMATOL, V137, pE11, DOI 10.1016/j.jid.2016.11.020; Habib MR, 2011, ASIAN PAC J TROP MED, V4, P786, DOI 10.1016/S1995-7645(11)60194-6; Habib MR, 2013, PHARMACOL REP, V65, P761, DOI 10.1016/S1734-1140(13)71057-0; Habib MR, 2010, J APPL BIOMED, V8, P47, DOI 10.2478/v10136-009-0007-7; Huang YH, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12451; Khan M, 2015, INT J BIOL SCI, V11, P1100, DOI 10.7150/ijbs.11595; Kharat KR, 2019, IRAN J MED SCI, V44, P483, DOI 10.30476/ijms.2019.44966; Kumar N. S., 2015, Research Journal of Phytochemistry, V9, P137, DOI 10.3923/rjphyto.2015.137.143; Lee J., 2018, CALOTROPIS GIGANTEA; Lee JH, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-018-1008-7; da Silva LAL, 2015, PHARMACOGN MAG, V11, P96, DOI 10.4103/0973-1296.149721; Li B, 2014, ONCOTARGET, V5, P11576, DOI 10.18632/oncotarget.2596; Li HL, 2018, FOOD CHEM TOXICOL, V119, P169, DOI 10.1016/j.fct.2018.04.054; Li XX, 2020, BIOMED PHARMACOTHER, V124, DOI 10.1016/j.biopha.2020.109852; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Luo M, 2018, BIOMED PHARMACOTHER, V106, P593, DOI 10.1016/j.biopha.2018.06.077; Mhaidat NM, 2014, ONCOL LETT, V8, P699, DOI 10.3892/ol.2014.2211; Miura Koh, 2010, Cancers (Basel), V2, P1717, DOI 10.3390/cancers2031717; Mutiah R., 2016, ALCHEMY, V5, P1, DOI DOI 10.18860/AL.V5I1.3690; Mutiah R, 2016, INT J PHARM CHEM RES, V8, P167; Mutiah R, 2017, INT J PHARM PHARM SC, V9, P83; Mutiah Roihatul, 2018, Asian Pac J Cancer Prev, V19, P1457, DOI 10.22034/APJCP.2018.19.6.1457; Ng PL, 2014, J ZHEJIANG UNIV-SC B, V15, P692, DOI 10.1631/jzus.B1300303; Oh SH, 2018, FOOD CHEM TOXICOL, V121, P326, DOI 10.1016/j.fct.2018.09.008; Organization WH, 2020, WHO REP CANC SETT PR; Oven Ustaalioglu BB., 2018, CAPECITABINE CISPLAT, DOI [10.4103/0973-1482.183548, DOI 10.4103/0973-1482.183548]; Parhira S, 2016, J ETHNOPHARMACOL, V194, P930, DOI 10.1016/j.jep.2016.10.070; Parhira S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04748; Park C, 2019, CANCERS, V11, DOI 10.3390/cancers11101494; Park HY, 2014, CHEMBIOCHEM, V15, P872, DOI 10.1002/cbic.201300786; Patel RK, 2015, INT J PHARM PHARM SC, V7; Pederson PJ, 2020, J NAT PROD, V83, P2269, DOI 10.1021/acs.jnatprod.0c00423; Khang PV, 2014, NAT PROD RES, V28, P1191, DOI 10.1080/14786419.2014.909419; Lopez EPF, 2019, ARCH ORAL BIOL, V101, P8, DOI 10.1016/j.archoralbio.2019.02.018; Rascon-Valenzuela LA, 2016, J ETHNOPHARMACOL, V193, P303, DOI 10.1016/j.jep.2016.08.022; Regasini LO, 2009, J CHIL CHEM SOC, V54, P218, DOI 10.4067/S0717-97072009000300004; Satari A, 2019, ADV PHARM BULL, V9, P462, DOI 10.15171/apb.2019.055; Seema Singh, 2013, International Research Journal of Pharmaceutical and Applied Sciences, V3, P1; Shi Y, 2020, J CELL MOL MED, V24, P760, DOI 10.1111/jcmm.14785; Soebagjo HD., 2019, RES J PHARM TECHNOLO, V12, P1307; Song W, 2017, BIOMED PHARMACOTHER, V89, P845, DOI 10.1016/j.biopha.2017.01.062; Sun M, 2017, ONCOTARGET, V8, P32807, DOI 10.18632/oncotarget.16454; Sur S, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0447-y; Tao T, 2019, J CELL PHYSIOL, V234, P3088, DOI 10.1002/jcp.27129; Tatsumi T, 2003, CARDIOVASC RES, V59, P428, DOI 10.1016/S0008-6363(03)00391-2; Tecza Karolina, 2018, Oncotarget, V9, P9114, DOI 10.18632/oncotarget.24148; THAKUR S, 1984, PHYTOCHEMISTRY, V23, P2085, DOI 10.1016/S0031-9422(00)84985-7; Tofighi Z, 2016, RES J PHARMACOGN, V3, P25; Van der Jeught K, 2018, WORLD J GASTROENTERO, V24, P3834, DOI 10.3748/wjg.v24.i34.3834; Van Quaquebeke E, 2005, J MED CHEM, V48, P849, DOI 10.1021/jm049405a; Wang H., 2021, RHEUMATOLOGY, DOI [10.1093/rheumatology/keab018, DOI 10.1093/rheumatology/keab018]; Wang ZN, 2008, MOLECULES, V13, P3033, DOI 10.3390/molecules13123033; You HY, 2013, STEROIDS, V78, P1029, DOI 10.1016/j.steroids.2013.06.002; Zhang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127386; Zhang N, 2008, MOLECULES, V13, P1551, DOI 10.3390/molecules13081551; Zhang P., 2017, CLIN CANCER RES, V36, P1; Zhou LM, 2019, ONCOTARGETS THER, V12, P4047, DOI 10.2147/OTT.S200873	69	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0254392	10.1371/journal.pone.0254392	http://dx.doi.org/10.1371/journal.pone.0254392			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343190	gold, Green Published			2022-12-26	WOS:000685264200021
J	Elder, CT; Filiberto, AC; Su, G; Ladd, Z; Leroy, V; Pruitt, EY; Lu, GY; Jiang, ZH; Sharma, AK; Upchurch, GR				Elder, Craig T.; Filiberto, Amanda C.; Su, Gang; Ladd, Zachary; Leroy, Victoria; Pruitt, Eric Y.; Lu, Guanyi; Jiang, Zhihua; Sharma, Ashish K.; Upchurch, Gilbert R., Jr.			Maresin 1 activates LGR6 signaling to inhibit smooth muscle cell activation and attenuate murine abdominal aortic aneurysm formation	FASEB JOURNAL			English	Article						aorta; aneurysm; efferocytosis; macrophage; maresin; smooth muscle cells; transforming growth factor beta 2	TGF-BETA; APOPTOTIC CELLS; LIPID MEDIATORS; INFLAMMATION; RESOLUTION; RECEPTOR; PROTEOLYSIS; PROTECTS	The specialized pro-resolving lipid mediator maresin 1 (MaR1) is involved in the resolution phase of tissue inflammation. It was hypothesized that exogenous administration of MaR1 would attenuate abdominal aortic aneurysm (AAA) growth in a cytokine-dependent manner via LGR6 receptor signaling and macrophage-dependent efferocytosis of smooth muscle cells (SMCs). AAAs were induced in C57BL/6 wild-type (WT) mice and smooth muscle cell specific TGF-beta 2 receptor knockout (SMC-TGF beta r2(-/-)) mice using a topical elastase AAA model. MaR1 treatment significantly attenuated AAA growth as well as increased aortic SMC alpha-actin and TGF-beta 2 expressions in WT mice, but not SMC-TGF beta r2(-/-) mice, compared to vehicle-treated mice. In vivo inhibition of LGR6 receptors obliterated MaR1-dependent protection in AAA formation and SMC alpha-actin expression. Furthermore, MaR1 upregulated macrophage-dependent efferocytosis of apoptotic SMCs in murine aortic tissue during AAA formation. In vitro studies demonstrate that MaR1-LGR6 interaction upregulates TGF-beta 2 expression and decreases MMP2 activity during crosstalk of macrophage-apoptotic SMCs. In summary, these results demonstrate that MaR1 activates LGR6 receptors to upregulate macrophage-dependent efferocytosis, increases TGF-beta expression, preserves aortic wall remodeling and attenuate AAA formation. Therefore, this study demonstrates the potential of MaR1-LGR6-mediated mitigation of vascular remodeling through increased efferocytosis of apoptotic SMCs via TGF-beta 2 to attenuate AAA formation.	[Elder, Craig T.; Filiberto, Amanda C.; Su, Gang; Ladd, Zachary; Leroy, Victoria; Pruitt, Eric Y.; Lu, Guanyi; Jiang, Zhihua; Sharma, Ashish K.; Upchurch, Gilbert R., Jr.] Univ Florida, Dept Surg, POB 100286, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Upchurch, GR (corresponding author), Univ Florida, Dept Surg, POB 100286, Gainesville, FL 32610 USA.	gib.upchurch@surgery.ufl.edu		Ladd, Zachary/0000-0001-8146-1076; Sharma, Ashish/0000-0002-1234-6039	NIH [R01 HL153341]; American College of Surgeons Resident Research Scholarship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American College of Surgeons Resident Research Scholarship	NIH, Grant/Award Number: R01 HL153341; American College of Surgeons Resident Research Scholarship	Akagi D, 2015, FASEB J, V29, P2504, DOI 10.1096/fj.14-265363; Angelov SN, 2017, ARTERIOSCL THROM VAS, V37, P2102, DOI 10.1161/ATVBAHA.117.309401; [Anonymous], UNDERLYING CAUSE DEA; Arandjelovic S, 2015, NAT IMMUNOL, V16, P907, DOI 10.1038/ni.3253; Bhamidipati CM, 2012, SURGERY, V152, P238, DOI 10.1016/j.surg.2012.02.010; Chen PY, 2020, CELL STEM CELL, V26, P542, DOI 10.1016/j.stem.2020.02.013; Chiang N, 2019, J CLIN INVEST, V129, P5294, DOI 10.1172/JCI129448; Cullen JM, 2019, J VASC SURG, V70, P252, DOI 10.1016/j.jvs.2018.09.057; Dale MA, 2015, ARTERIOSCL THROM VAS, V35, P1746, DOI 10.1161/ATVBAHA.115.305269; Doran AC, 2020, NAT REV IMMUNOL, V20, P254, DOI 10.1038/s41577-019-0240-6; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fashandi AZ., 2017, SURGERY; Francos-Quijorna I, 2017, J NEUROSCI, V37, P11731, DOI 10.1523/JNEUROSCI.1395-17.2017; Gahllo EM, 2014, J CLIN INVEST, V124, P448, DOI 10.1172/JCI69666; Gong J, 2014, BRIT J PHARMACOL, V171, P3539, DOI 10.1111/bph.12714; HARRIS LM, 1991, J VASC SURG, V14, P812, DOI 10.1067/mva.1991.33494; Kojima Y, 2018, CIRCULATION, V137, P750, DOI 10.1161/CIRCULATIONAHA.117.030389; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Laser A, 2012, J SURG RES, V178, P1038, DOI 10.1016/j.jss.2012.04.073; Li W, 2014, J CLIN INVEST, V124, P755, DOI 10.1172/JCI69942; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; LopezCandales A, 1997, AM J PATHOL, V150, P993; Lu GY, 2017, J VASC SURG, V66, P232, DOI 10.1016/j.jvs.2016.07.105; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Meher AK, 2018, ARTERIOSCL THROM VAS, V38, P843, DOI 10.1161/ATVBAHA.117.309897; Nelson JW, 2014, AM J PHYSIOL-CELL PH, V306, pC178, DOI 10.1152/ajpcell.00284.2013; NEWMAN KM, 1994, CIRCULATION, V90, P224; Petri MH, 2018, JACC-BASIC TRANSL SC, V3, P719, DOI 10.1016/j.jacbts.2018.08.005; Pope NH, 2016, FASEB J, V30, P4192, DOI 10.1096/fj.201600144RR; Rowe VL, 2000, J VASC SURG, V31, P567; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2017, MOL ASPECTS MED, V58, P1, DOI 10.1016/j.mam.2017.03.001; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Shah PK, 1997, CIRCULATION, V96, P2115; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Spinosa M, 2018, J VASC SURG, V68, p93S, DOI 10.1016/j.jvs.2018.05.253; Spinosa M, 2018, FASEB J, V32, P6038, DOI 10.1096/fj.201701138RR; Sun QC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9634803; Thompson RW, 1997, CORONARY ARTERY DIS, V8, P623, DOI 10.1097/00019501-199710000-00005; Thompson SG, 2012, BRIT J SURG, V99, P1649, DOI 10.1002/bjs.8897; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Yang P, 2016, SCI REP-UK, V6, DOI 10.1038/srep35444	46	9	9	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21780	10.1096/fj.202100484R	http://dx.doi.org/10.1096/fj.202100484R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34320253	Green Accepted			2022-12-26	WOS:000678975300036
J	Le Coq, J; Navajas, PL; Martin, BR; Alfonso, C; Lietha, D				Le Coq, Johanne; Lopez Navajas, Pilar; Rodrigo Martin, Barbara; Alfonso, Carlos; Lietha, Daniel			A new layer of phosphoinositide-mediated allosteric regulation uncovered for SHIP2	FASEB JOURNAL			English	Article						allosteric regulation; enzyme kinetics; lipid phosphatase; phosphinositides; SHIP2	PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHATASE SHIP2; PROTEIN; CANCER; EXPRESSION; RECEPTOR; ACTIVATION; INHIBIT; BINDING	The Src homology 2 containing inositol 5-phosphatase 2 (SHIP2) is a large multidomain enzyme that catalyzes the dephosphorylation of the phospholipid phosphatidylinositol 3,4,5-triphosphate (PI(3,4,5)P-3) to form PI(3,4)P-2. PI(3,4,5)P-3 is a key lipid second messenger controlling the recruitment of signaling proteins to the plasma membrane, thereby regulating a plethora of cellular events, including proliferation, growth, apoptosis, and cytoskeletal rearrangements. SHIP2, alongside PI3K and PTEN, regulates PI(3,4,5)P-3 levels at the plasma membrane and has been heavily implicated in serious diseases such as cancer and type 2 diabetes; however, many aspects of its regulation mechanism remain elusive. We recently reported an activating effect of the SHIP2 C2 domain and here we describe an additional layer of regulation via the pleckstrin homology-related (PHR) domain. We show a phosphoinositide-induced transition to a high activity state of the enzyme that increases phosphatase activity up to 10-15 fold. We further show that PI(3,4)P-2 directly interacts with the PHR domain to trigger this allosteric activation. Modeling of the PHR-phosphatase-C2 region of SHIP2 on the membrane suggests no major inter-domain interactions with the PHR domain, but close contacts between the two linkers offer a possible path of allosteric communication. Together, our data show that the PHR domain acts as an allosteric module regulating the catalytic activity of SHIP2 in response to specific phosphoinositide levels in the cell membrane.	[Le Coq, Johanne] Spanish Natl Canc Res Ctr CNIO, Struct Biol Programme, Madrid, Spain; [Lopez Navajas, Pilar; Rodrigo Martin, Barbara; Alfonso, Carlos; Lietha, Daniel] CSIC, Ctr Invest Biol Margarita Salas, Struct & Chem Biol, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Lietha, D (corresponding author), CSIC, Ctr Invest Biol Margarita Salas, Struct & Chem Biol, Madrid, Spain.	daniel.lietha@cib.csic.es	Alfonso, Carlos/K-1316-2014; Lietha, Daniel/L-8041-2014; Lietha, Daniel/AAD-1952-2022	Alfonso, Carlos/0000-0001-7165-4800; Lietha, Daniel/0000-0002-6133-6486; Lietha, Daniel/0000-0002-6133-6486	Ministerio de Ciencia, Innovacion y Universidades (MCIU) [RTI2018-099318-B-I00]; Ministerio de Ciencia e Innovacion (MICINN) [PID2019-104544GB-I00]	Ministerio de Ciencia, Innovacion y Universidades (MCIU)(Spanish Government); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Ministerio de Ciencia, Innovacion y Universidades (MCIU), Grant/Award Number: RTI2018-099318-B-I00; Ministerio de Ciencia e Innovacion (MICINN), Grant/Award Number: PID2019-104544GB-I00	[Anonymous], PYMOL MOL GRAPHICS S; Balzano D, 2015, J BIOL CHEM, V290, P24975, DOI 10.1074/jbc.M115.651570; Begley MJ, 2005, CURR OPIN STRUC BIOL, V15, P614, DOI 10.1016/j.sbi.2005.10.016; Brauer H, 2012, CELL SIGNAL, V24, P2095, DOI 10.1016/j.cellsig.2012.07.017; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Ceccarelli DFJ, 2007, J BIOL CHEM, V282, P13864, DOI 10.1074/jbc.M700505200; Clague MJ, 2005, TRAFFIC, V6, P1063, DOI 10.1111/j.1600-0854.2005.00338.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Fu MY, 2013, INT J CLIN EXP PATHO, V6, P2185; Giuriato S, 2002, BIOCHEM BIOPH RES CO, V296, P106, DOI 10.1016/S0006-291X(02)00787-8; Gozzelino L, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00360; Hamilton MJ, 2011, EXP HEMATOL, V39, P2, DOI 10.1016/j.exphem.2010.11.002; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Hawkins PT, 2016, BIOCHEM SOC T, V44, P307, DOI 10.1042/BST20150248; Hoekstra E, 2016, ONCOTARGET, V7, P73525, DOI 10.18632/oncotarget.12321; Kaisaki PJ, 2004, DIABETES, V53, P1900, DOI 10.2337/diabetes.53.7.1900; Kato K, 2012, MOL BIOL CELL, V23, P2593, DOI 10.1091/mbc.E11-11-0958; Kerr WG, 2020, BIOCHEM SOC T, V48, P291, DOI 10.1042/BST20190775; Kuruma S, 2014, WORLD J GASTROENTERO, V20, P17456, DOI 10.3748/wjg.v20.i46.17456; Le Coq J, 2017, ELIFE, V6, DOI 10.7554/eLife.26640; Le Coq J, 2016, PROTEIN J, V35, P225, DOI 10.1007/s10930-016-9665-y; Lee HN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51914-2; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lo TCT, 2009, LEUKEMIA RES, V33, P1562, DOI 10.1016/j.leukres.2009.04.032; Lopez-Suarez A, 2019, METABOLISM, V92, P136, DOI 10.1016/j.metabol.2018.10.013; Luo JM, 2003, LEUKEMIA, V17, P1, DOI 10.1038/sj.leu.2402725; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Ming-Lum A, 2012, FASEB J, V26, P3163, DOI 10.1096/fj.11-201475; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Pauls SD, 2017, EUR J IMMUNOL, V47, P932, DOI 10.1002/eji.201646795; Pesesse X, 2006, ADV ENZYME REGUL, V46, P142, DOI 10.1016/j.advenzreg.2006.01.013; Pirruccello M, 2012, TRENDS BIOCHEM SCI, V37, P134, DOI 10.1016/j.tibs.2012.01.002; Porter CM, 2012, BIOORG CHEM, V43, P44, DOI 10.1016/j.bioorg.2011.11.001; Prasad NK, 2008, TUMOR BIOL, V29, P330, DOI 10.1159/000172970; Sasaki T, 2009, PROG LIPID RES, V48, P307, DOI 10.1016/j.plipres.2009.06.001; Schink KO, 2016, ANNU REV CELL DEV BI, V32, P143, DOI 10.1146/annurev-cellbio-111315-125349; Sherwood AR, 2013, ANAL BIOCHEM, V435, P54, DOI 10.1016/j.ab.2012.10.044; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Srivastava N, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00288; Stelea SD, 2002, BIOPHYS J, V83, P2259, DOI 10.1016/S0006-3495(02)73986-6; STEPHENS L, 1993, EMBO J, V12, P2265, DOI 10.1002/j.1460-2075.1993.tb05880.x; Suwa A, 2010, EXPERT OPIN THER TAR, V14, P727, DOI 10.1517/14728222.2010.492780; Taylor V, 2000, MOL CELL BIOL, V20, P6860, DOI 10.1128/MCB.20.18.6860-6871.2000; Viernes DR, 2014, MED RES REV, V34, P795, DOI 10.1002/med.21305; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang YB, 2018, J BIOL CHEM, V293, P6230, DOI 10.1074/jbc.R117.000582; Yip SC, 2008, BIOCHEM J, V411, P441, DOI 10.1042/BJ20071179; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhou H, 2021, PROTEIN EXPRES PURIF, V180, DOI 10.1016/j.pep.2021.105821; Zhou XJ, 2011, ARCH MED RES, V42, P589, DOI 10.1016/j.arcmed.2011.10.012	53	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21815	10.1096/fj.202100561R	http://dx.doi.org/10.1096/fj.202100561R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314064	Green Published			2022-12-26	WOS:000678975300027
J	Xu, DC; Wu, JW; Chen, JH; Jiang, LL; Chen, J; Bao, WH; Chen, X; Yang, QQ; Zhang, XL; Yao, LY; Su, HB; Liu, JB				Xu, Dacai; Wu, Jiawen; Chen, Jinghong; Jiang, Liling; Chen, Juan; Bao, Wenhao; Chen, Xin; Yang, Qianqian; Zhang, Xiaolan; Yao, Leyi; Su, Huabo; Liu, Jinbao			Cullin 2-RBX1 E3 ligase and USP2 regulate antithrombin ubiquitination and stability	FASEB JOURNAL			English	Article						coagulation; deubiquitinase; neddylation; ubiquitin	THERAPEUTIC TARGETING ANTITHROMBIN; HEMOPHILIA-A; CANCER; COAGULATION; DEGRADATION; INHIBITORS; ENZYME	Hemophilia A and B are congenital bleeding disorders caused by a deficiency in pro-coagulant factor VIII or IX that is treated by downregulation of antithrombin. However, the molecular mechanisms that regulate antithrombin expression remain poorly understood. Here, we identified Cullin 2 and USP2 (ubiquitin-specific peptidase-2) as novel regulators of antithrombin expression that act by modulating antithrombin ubiquitination. Inhibition of the proteasome caused accumulation of antithrombin and its ubiquitinated forms in HepG2 and SMMC7721 cells. Notably, inhibition of neddylation with MLN4924 suppressed both ubiquitination and degradation of antithrombin, which is recapitulated by silencing of the neddylation enzymes, NAE1, UBA3, and UBE2M, with small interfering RNA (siRNA). We identified Cullin 2 as the interaction partner of antithrombin, and siRNA-mediated Cullin 2 knockdown reduced antithrombin ubiquitination and increased antithrombin protein. We further found that USP2 interacted with antithrombin and regulated antithrombin expression, showing that overexpression of USP2 inhibits the ubiquitination and proteasomal clearance of antithrombin, whereas pharmacological inhibition or siRNA-mediated knockdown of USP2 downregulates antithrombin. Collectively, these results suggest that Cullin 2 E3 ubiquitin ligase and USP2 coordinately regulate antithrombin ubiquitination and degradation. Thus, targeting Cullin 2 and USP2 could be a potential strategy for treatment of hemophilia.	[Xu, Dacai; Wu, Jiawen; Chen, Jinghong; Jiang, Liling; Chen, Juan; Bao, Wenhao; Chen, Xin; Yang, Qianqian; Zhang, Xiaolan; Yao, Leyi; Liu, Jinbao] Guangzhou Med Univ, Affiliated Canc Hosp, Sch Basic Med Sci, State Key Lab Resp Dis,Guangzhou Municipal & Guan, Guangzhou, Peoples R China; [Su, Huabo] Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA USA	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; University System of Georgia; Augusta University	Liu, JB (corresponding author), Guangzhou Med Univ, Sch Basic Med Sci, Key Lab Prot Modificat & Degradat, Guangzhou 511436, Guangdong, Peoples R China.	jliu@gzhmu.edu.cn		Xu, Dacai/0000-0002-2566-7077; Su, Huabo/0000-0002-8475-2685; CHEN, XIN/0000-0003-3668-4830	National Funds for developing local Colleges and Universities [B16056001]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2018B030312001]; Science and Technology Program of Guangzhou [201604020001]; Innovative Academic Team of Guangzhou Education System [1201610014]; Department of the Education Guangdong [2017KCXTD027]; National Natural Science Foundation of China (NSFC) [81900365]	National Funds for developing local Colleges and Universities; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province); Science and Technology Program of Guangzhou; Innovative Academic Team of Guangzhou Education System; Department of the Education Guangdong; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Funds for developing local Colleges and Universities, Grant/Award Number: B16056001; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2018B030312001; Science and Technology Program of Guangzhou, Grant/Award Number: 201604020001; Innovative Academic Team of Guangzhou Education System, Grant/Award Number: 1201610014; Research Team of the Department of the Education Guangdong, Grant/Award Number: 2017KCXTD027; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81900365	Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; CHAN TK, 1981, THROMB HAEMOSTASIS, V46, P504; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Chen X, 2017, EUR J PHARMACOL, V815, P147, DOI 10.1016/j.ejphar.2017.09.003; Colombo M, 2010, CHEMMEDCHEM, V5, P552, DOI 10.1002/cmdc.200900409; Davis MI, 2016, J BIOL CHEM, V291, P24628, DOI 10.1074/jbc.M116.738567; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Hermanns T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03148-5; Hernandez-Espinosa D, 2008, LAB INVEST, V88, P306, DOI 10.1038/labinvest.3700717; Liao H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009183; Liao YN, 2018, ONCOGENE, V37, P1896, DOI 10.1038/s41388-017-0069-z; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; Machin N, 2018, J BLOOD MED, V9, P135, DOI 10.2147/JBM.S159297; Mammen EF., 1998, SEMIN THROMB HEMOST, V24, p19; Mistry H, 2013, MOL CANCER THER, V12, P2651, DOI 10.1158/1535-7163.MCT-13-0103-T; Molusky MM, 2012, DIABETES, V61, P1025, DOI 10.2337/db11-0970; Palta S, 2014, INDIAN J ANAESTH, V58, P515, DOI 10.4103/0019-5049.144643; Pasi KJ, 2017, NEW ENGL J MED, V377, P819, DOI [10.1056/NEJMoa1616569, 10.1056/NEJMoa1708483]; Sehgal A, 2015, NAT MED, V21, P492, DOI 10.1038/nm.3847; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Tong X, 2012, J BIOL CHEM, V287, P25280, DOI 10.1074/jbc.M112.340786; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Wang SW, 2016, ONCOTARGET, V7, P46707, DOI 10.18632/oncotarget.8732; Xu JF, 2015, MOL CELL PROTEOMICS, V14, P499, DOI 10.1074/mcp.M114.045211; Zhang SZ, 2020, ADV EXP MED BIOL, V1217, P261, DOI 10.1007/978-981-15-1025-0_16; Zhu HQ, 2017, INT J BIOL SCI, V13, P1489, DOI 10.7150/ijbs.21637	28	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21800	10.1096/fj.202001146RR	http://dx.doi.org/10.1096/fj.202001146RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34324733	Green Accepted, hybrid			2022-12-26	WOS:000678975300048
J	Herzog, R; Morales, A; Mora, S; Araya, J; Escobar, MJ; Palacios, AG; Cofre, R				Herzog, Ruben; Morales, Arturo; Mora, Soraya; Araya, Joaquin; Escobar, Maria-Jose; Palacios, Adrian G.; Cofre, Rodrigo			Scalable and accurate method for neuronal ensemble detection in spiking neural networks	PLOS ONE			English	Article							BUILDING-BLOCKS; CELL-TYPES; CIRCUITS	We propose a novel, scalable, and accurate method for detecting neuronal ensembles from a population of spiking neurons. Our approach offers a simple yet powerful tool to study ensemble activity. It relies on clustering synchronous population activity (population vectors), allows the participation of neurons in different ensembles, has few parameters to tune and is computationally efficient. To validate the performance and generality of our method, we generated synthetic data, where we found that our method accurately detects neuronal ensembles for a wide range of simulation parameters. We found that our method outperforms current alternative methodologies. We used spike trains of retinal ganglion cells obtained from multi-electrode array recordings under a simple ON-OFF light stimulus to test our method. We found a consistent stimuli-evoked ensemble activity intermingled with spontaneously active ensembles and irregular activity. Our results suggest that the early visual system activity could be organized in distinguishable functional ensembles. We provide a Graphic User Interface, which facilitates the use of our method by the scientific community.	[Herzog, Ruben; Araya, Joaquin; Palacios, Adrian G.] Univ Valparaiso, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile; [Morales, Arturo; Escobar, Maria-Jose] Univ Tecn Federico Santa Maria, Dept Elect, Valparaiso, Chile; [Mora, Soraya] Univ San Sebastian, Fac Med & Ciencia, Santiago, Chile; [Mora, Soraya] Fdn Ciencia & Vida, Lab Biol Computac, Santiago, Chile; [Araya, Joaquin] Univ Santo Tomas, Fac Salud, Escuela Tecnol Med, Santiago, Chile; [Cofre, Rodrigo] Univ Valparaiso, Fac Ingn, CIMFAV Ingemat, Valparaiso, Chile	Universidad de Valparaiso; Universidad Tecnica Federico Santa Maria; Universidad San Sebastian; Universidad Santo Tomas; Universidad de Valparaiso	Herzog, R (corresponding author), Univ Valparaiso, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile.	rubenherzog@ug.uchile.cl	Palacios, Adrian G/E-9846-2015; COFRE, RODRIGO/E-2133-2015	Palacios, Adrian G/0000-0003-1532-7527; Morales, Arturo/0000-0002-9635-2865; COFRE, RODRIGO/0000-0002-7498-7122; Escobar, Maria Jose/0000-0003-1563-624X; A. Arriagada, Joaquin Alberto/0000-0002-4698-6149; Mora, Soraya/0000-0002-9794-2218	CONICYT [21180428, 22200156]; Fondecyt Iniciacion [11181072]; AFOSR [FA9550-19-1-0002]; ICM-ANID [P09-022-F]; CINV	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondecyt Iniciacion(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ICM-ANID; CINV	RH is funded by CONICYT scholarship CONICYT-PFCHA/Doctorado Nacional/201821180428. (https://www.anid.cl) AM is funded by CONICYT scholarship CONICYT-PFCHA/Magister Nacional/2020-22200156. (https://www.anid.cl) RC is funded by Fondecyt Iniciacion 2018 Proyecto 11181072. (https://www.anid.cl) MJE and AGP are funded by AFOSR Grant FA9550-19-1-0002 (https://www.afrl.af.mil/AFOSR/).AGP is funded by ICM-ANID #P09-022-F, CINV (http://www.iniciativamilenio.cl/).SM and JA received no funding for developing this work. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bruno AM, 2015, NEURON, V86, P304, DOI 10.1016/j.neuron.2015.03.005; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Carrillo-Reid L, 2020, PLAYING PIANO CORTEX; Carrillo-Reid L, 2020, OXFORD RES ENCY NEUR; Carrillo-Reid L, 2017, ANNU REV BIOPHYS, V46, P271, DOI 10.1146/annurev-biophys-070816-033647; Carrillo-Reid L, 2015, INT J NEURAL SYST, V25, DOI 10.1142/S0129065715500264; Carrillo-Reid L, 2015, J NEUROSCI, V35, P8813, DOI 10.1523/JNEUROSCI.5214-14.2015; Eichenbaum H, 2018, NEUROSCI LETT, V680, P88, DOI 10.1016/j.neulet.2017.04.006; Einevoll GT, 2012, CURR OPIN NEUROBIOL, V22, P11, DOI 10.1016/j.conb.2011.10.001; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Fang WQ, 2017, CELL REP, V21, P381, DOI 10.1016/j.celrep.2017.09.040; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Greschner M, 2011, J PHYSIOL-LONDON, V589, P75, DOI 10.1113/jphysiol.2010.193888; Hamm JP, 2017, NEURON, V94, P153, DOI 10.1016/j.neuron.2017.03.019; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; Hebb Donald O., 1949, ORG BEHAV; Humphries MD, 2011, J NEUROSCI, V31, P2321, DOI 10.1523/JNEUROSCI.2853-10.2011; Humphries MD., 2017, DYNAMICAL NETWORKS F, DOI [10.1101/115485, DOI 10.1101/115485]; Lopes-dos-Santos V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020996; Louis S, 2010, SPR SER COMPUT NEURO, V7, P359, DOI 10.1007/978-1-4419-5675-0_17; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Montijn JS, 2016, J NEUROSCI, V36, P8624, DOI 10.1523/JNEUROSCI.0853-16.2016; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Onken A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005189; Peyrache A, 2010, J COMPUT NEUROSCI, V29, P309, DOI 10.1007/s10827-009-0154-6; Quaglio P, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00041; Real E, 2017, CURR BIOL, V27, P189, DOI 10.1016/j.cub.2016.11.040; Ringach DL, 2009, CURR OPIN NEUROBIOL, V19, P439, DOI 10.1016/j.conb.2009.07.005; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Russo E, 2017, ELIFE, V6, DOI 10.7554/eLife.19428; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; See JZ, 2018, ELIFE, V7, DOI 10.7554/eLife.35587; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Singh A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08828; Stringer C, 2019, SCIENCE, V364, P255, DOI 10.1126/science.aav7893; Tikidji-Hamburyan A., 2014, NAT NEUROSCI, DOI [10.1038/nn.3891 25485757, DOI 10.1038/NN.389125485757]; Torre E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004939; Torre E, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00132; Uhlhaas PJ, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.017.2009; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vlasits AL, 2019, CURR OPIN NEUROBIOL, V56, P8, DOI 10.1016/j.conb.2018.10.011; Watanabe K, 2019, FRONT NEUROINFORM, V13, DOI 10.3389/fninf.2019.00039; Wenzel M, 2019, J NEUROSCI, V39, P8562, DOI 10.1523/JNEUROSCI.3176-18.2019; Wenzel M, 2019, CELL SYST, V8, P467, DOI 10.1016/j.cels.2019.03.007; Yegenoglu A, 2016, LECT NOTES COMPUTER; Yger P, 2018, ELIFE, V7, DOI 10.7554/eLife.34518; Yuste R, 2015, NAT REV NEUROSCI, V16, P487, DOI 10.1038/nrn3962	49	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0251647	10.1371/journal.pone.0251647	http://dx.doi.org/10.1371/journal.pone.0251647			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329314	gold, Green Published			2022-12-26	WOS:000685248600001
J	El Hage, J; Gravitt, P; Ravel, J; Lahrichi, N; Gralla, E				El Hage, Jad; Gravitt, Patti; Ravel, Jacques; Lahrichi, Nadia; Gralla, Erica			Supporting scale-up of COVID-19 RT-PCR testing processes with discrete event simulation	PLOS ONE			English	Article								Testing is critical to mitigating the COVID-19 pandemic, but testing capacity has fallen short of the need in the United States and elsewhere, and long wait times have impeded rapid isolation of cases. Operational challenges such as supply problems and personnel shortages have led to these bottlenecks and inhibited the scale-up of testing to needed levels. This paper uses operational simulations to facilitate rapid scale-up of testing capacity during this public health emergency. Specifically, discrete event simulation models were developed to represent the RT-PCR testing process in a large University of Maryland testing center, which retrofitted high-throughput molecular testing capacity to meet pandemic demands in a partnership with the State of Maryland. The simulation models support analyses that identify process steps which create bottlenecks, and evaluate "what-if" scenarios for process changes that could expand testing capacity. This enables virtual experimentation to understand the trade-offs associated with different interventions that increase testing capacity, allowing the identification of solutions that have high leverage at a feasible and acceptable cost. For example, using a virucidal collection medium which enables safe discarding of swabs at the point of collection removed a time-consuming "deswabbing" step (a primary bottleneck in this laboratory) and nearly doubled the testing capacity. The models are also used to estimate the impact of demand variability on laboratory performance and the minimum equipment and personnel required to meet various target capacities, assisting in scale-up for any laboratories following the same process steps. In sum, the results demonstrate that by using simulation modeling of the operations of SARS-CoV-2 RT-PCR testing, preparedness planners are able to identify high-leverage process changes to increase testing capacity.	[El Hage, Jad; Gralla, Erica] George Washington Univ, Dept Engn Management & Syst Engn, Washington, DC 20052 USA; [Gravitt, Patti] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Ravel, Jacques] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Lahrichi, Nadia] CIRRELT, Dept Math & Ind Engn, Montreal, PQ, Canada; [Lahrichi, Nadia] Polytech Montreal, Montreal, PQ, Canada	George Washington University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Universite de Montreal; Universite de Montreal; Polytechnique Montreal	Gralla, E (corresponding author), George Washington Univ, Dept Engn Management & Syst Engn, Washington, DC 20052 USA.	egralla@gwu.edu		Gralla, Erica/0000-0001-7942-7709	Gordon and Betty Moore Foundation [GBMF9634]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research was funded by the Gordon and Betty Moore Foundation through Grant GBMF9634 to Johns Hopkins University to support the work of the Society for Medical Decision Making COVID-19 Decision Modeling Initiative (https://nursing.jhu.edu/alumni-giving/giving/covid-decision-modeling/smdm-covid-19decision-modeling-grant.html) (EG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, BLOOMBERG COM 0710; Anthes E., NEW YORK TIMES; Araz OM, 2020, HEALTH SYST, V9, P119, DOI 10.1080/20476965.2020.1758000; Bradley DT, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100325; Cleevely M, 2020, OXFORD REV ECON POL, V36, pS14, DOI 10.1093/oxrep/graa029; Currie CSM, 2020, J SIMUL, V14, P83, DOI 10.1080/17477778.2020.1751570; Deckert A, 2020, B WORLD HEALTH ORGAN, V98, P590, DOI 10.2471/BLT.20.257188; Deka S, 2020, J LAB PHYS, V12, P212, DOI 10.1055/s-0040-1721159; Esbin MN, 2020, RNA, V26, P771, DOI 10.1261/rna.076232.120; Flynn EF, 2020, ACAD PEDIATR, V20, P753, DOI 10.1016/j.acap.2020.05.018; Gonella F, 2020, FRONT COMMUN, V5, DOI 10.3389/fcomm.2020.00063; Haley D, 2021, SYSTEMS-BASEL, V9, DOI 10.3390/systems9010013; JHU, JOHNS HOPKINS CORNON; Jonnerby J, 2020, ARXIV200413650PHYSQB; Kasy M, 2020, OXFORD REV ECON POL, V36, pS77, DOI 10.1093/oxrep/graa018; Nyazika TK, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00524-20; Petersen M, 2020, LOS ANGELES TIMES; Sturmberg JP, 2022, INT J HEALTH POLICY, V11, P409, DOI 10.34172/ijhpm.2020.132; The Rockefeller Foundation, 2020, TAK BACK CONTR RES A	19	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255214	10.1371/journal.pone.0255214	http://dx.doi.org/10.1371/journal.pone.0255214			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324577	gold, Green Published			2022-12-26	WOS:000685248200064
J	Gao, X; Tian, JP; Huo, Z; Wu, YB; Li, CX				Gao, Xing; Tian, Junping; Huo, Zheng; Wu, Yanbin; Li, Chenxi			Evaluation of redevelopment priority of abandoned industrial and mining land based on heavy metal pollution	PLOS ONE			English	Article							ECOLOGICAL RISK-ASSESSMENT; HEALTH-RISK; URBAN SOILS; CHINA; CITY; ACCUMULATION	Heavy metal contamination in soil is an important factor affecting the determination of safe redevelopment methods for industrial and mining land. In this paper, the soil environment of a typical mining city in northern China was taken as the research object, 148 surface soil samples were collected and the contents of heavy metals were measured. The health risk classification criteria for heavy metal contamination of soils and the method of priority assessment for redevelopment were used. The results showed that: the risk of potential utilization types of heavy metals in the abandoned industrial and mining land is different. When the utilization type is agricultural land, the soil environmental quality is good as a whole, and a small number of plots are polluted by cadmium (Cd)and mercury (Hg); When the land use type is construction land, the risk of heavy metal pollution comes from chromium (Cr); The priority of development in this study area is as follows: agricultural land > construction land > ecological land.	[Gao, Xing] Hebei Univ Econ & Business, Sch Publ Adm, Shijiazhuang, Hebei, Peoples R China; [Tian, Junping; Wu, Yanbin] Hebei Univ Econ & Business, Hebei Prov Geog Informat Platform Socioecon & Soc, Shijiazhuang, Hebei, Peoples R China; [Huo, Zheng] Hebei Univ Econ & Business, Sch Informat Technol, Shijiazhuang, Hebei, Peoples R China; [Li, Chenxi] Xian Univ Architecture & Technol, Sch Publ Adm, Xian, Peoples R China	Hebei University of Economics & Business; Hebei University of Economics & Business; Hebei University of Economics & Business; Xi'an University of Architecture & Technology	Wu, YB (corresponding author), Hebei Univ Econ & Business, Hebei Prov Geog Informat Platform Socioecon & Soc, Shijiazhuang, Hebei, Peoples R China.; Li, CX (corresponding author), Xian Univ Architecture & Technol, Sch Publ Adm, Xian, Peoples R China.	wuyanbin@heuet.edu.cn; lichenxi@xauat.edu.cn		Li, Chenxi/0000-0002-5019-9949	National Social Science Fund of China [18BGL272]	National Social Science Fund of China	This research is funded by the National Social Science Fund of China (No. 18BGL272).	Baran A, 2018, ENVIRON GEOCHEM HLTH, V40, P435, DOI 10.1007/s10653-017-9924-7; Bardos P, 2020, FRONT ENV SCI-SWITZ, V8, DOI 10.3389/fenvs.2020.00086; Bhuiyan MAH, 2010, J HAZARD MATER, V173, P384, DOI 10.1016/j.jhazmat.2009.08.085; Buscaroli E, 2021, FOOD CONTROL, V126, DOI 10.1016/j.foodcont.2021.108085; Cao SZ, 2016, CHEMOSPHERE, V147, P404, DOI 10.1016/j.chemosphere.2015.12.134; Cao W, 2020, ECOTOX ENVIRON SAFE, V198, DOI 10.1016/j.ecoenv.2020.110646; Cevik F, 2009, ENVIRON MONIT ASSESS, V152, P309, DOI 10.1007/s10661-008-0317-3; Chen XD, 2012, CATENA, V98, P73, DOI 10.1016/j.catena.2012.06.007; Cheng HX, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16203985; Cheng LL, 2017, INT J MIN RECLAM ENV, V31, P212, DOI 10.1080/17480930.2016.1167305; Diami SM, 2016, ENVIRON SCI POLLUT R, V23, P21086, DOI 10.1007/s11356-016-7314-9; Dominguez-Haydar Y, 2019, ECOL INDIC, V103, P182, DOI 10.1016/j.ecolind.2019.04.015; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fashola MO, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111047; Ferronato N, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16061060; He BJ, 2018, HABITAT INT, V82, P83, DOI 10.1016/j.habitatint.2018.10.001; Hofer C, 2010, ENVIRON POLLUT, V158, P1207, DOI 10.1016/j.envpol.2010.01.018; Hu H, 2014, SUSTAINABILITY-BASEL, V6, P5820, DOI 10.3390/su6095820; Hu TH, 2018, ECOL INDIC, V94, P164, DOI 10.1016/j.ecolind.2017.11.006; Huang RJ, 2021, ENVIRON SCI POLLUT R, V28, P25650, DOI 10.1007/s11356-020-12336-0; Kivinen S, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9101705; Li CX, 2019, ENVIRON MONIT ASSESS, V191, DOI 10.1007/s10661-019-7547-4; Li CX, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11051446; Li XL, 2019, CATENA, V182, DOI 10.1016/j.catena.2019.104142; Li ZY, 2014, SCI TOTAL ENVIRON, V468, P843, DOI 10.1016/j.scitotenv.2013.08.090; Luo X, 2021, J CLEAN PROD, V310, DOI 10.1016/j.jclepro.2021.127467; Nogues S, 2016, J URBAN PLAN DEV, V142, DOI 10.1061/(ASCE)UP.1943-5444.0000272; Ogunkunle CO, 2013, POL J ENVIRON STUD, V22, P487; ONU, 2015, TRANSF OUR WORLD 203; Pan LB, 2018, ENVIRON SCI POLLUT R, V25, P1055, DOI 10.1007/s11356-017-0513-1; Rai PK, 2019, ENVIRON INT, V125, P365, DOI 10.1016/j.envint.2019.01.067; Rehman A, 2021, ENVIRON RES, V196, DOI 10.1016/j.envres.2020.110427; Roman-Ochoa Y, 2021, CHEMOSPHERE, V274, DOI 10.1016/j.chemosphere.2021.129792; Saaty TL., 1980, ANAL HIERARCHY PROCE; Santos-Frances F, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080859; Schadek Ute, 2009, Urban Ecosystems, V12, P115, DOI 10.1007/s11252-008-0072-9; Smith P, 2016, GLOBAL CHANGE BIOL, V22, P1008, DOI 10.1111/gcb.13068; Soltanmohammadi H, 2009, ENVIRON GEOL, V58, P877, DOI 10.1007/s00254-008-1563-y; United Nations, 2020, WAQF REL UN SDGS; Whitehead PG, 2019, SCI TOTAL ENVIRON, V697, DOI 10.1016/j.scitotenv.2019.134090; Xiao Q, 2015, ECOTOX ENVIRON SAFE, V120, P377, DOI 10.1016/j.ecoenv.2015.06.019; Zhao DX, 2021, CATENA, V196, DOI 10.1016/j.catena.2020.104938; Zou YC, 2018, WETLANDS, V38, P383, DOI 10.1007/s13157-017-0975-4	52	2	2	9	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255509	10.1371/journal.pone.0255509	http://dx.doi.org/10.1371/journal.pone.0255509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324591	gold, Green Published			2022-12-26	WOS:000685248200029
J	Habibi, M; Taheri, G				Habibi, Mahnaz; Taheri, Golnaz			Topological network based drug repurposing for coronavirus 2019	PLOS ONE			English	Article							COVID-19	The COVID-19 pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has become the current health concern and threat to the entire world. Thus, the world needs the fast recognition of appropriate drugs to restrict the spread of this disease. The global effort started to identify the best drug compounds to treat COVID-19, but going through a series of clinical trials and our lack of information about the details of the virus's performance has slowed down the time to reach this goal. In this work, we try to select the subset of human proteins as candidate sets that can bind to approved drugs. Our method is based on the information on human-virus protein interaction and their effect on the biological processes of the host cells. We also define some informative topological and statistical features for proteins in the protein-protein interaction network. We evaluate our selected sets with two groups of drugs. The first group contains the experimental unapproved treatments for COVID-19, and we show that from 17 drugs in this group, 15 drugs are approved by our selected sets. The second group contains the external clinical trials for COVID-19, and we show that 85% of drugs in this group, target at least one protein of our selected sets. We also study COVID-19 associated protein sets and identify proteins that are essential to disease pathology. For this analysis, we use DAVID tools to show and compare disease-associated genes that are contributed between the COVID-19 comorbidities. Our results for shared genes show significant enrichment for cardiovascular-related, hypertension, diabetes type 2, kidney-related and lung-related diseases. In the last part of this work, we recommend 56 potential effective drugs for further research and investigation for COVID-19 treatment. Materials and implementations are available at: .https://github.com/ MahnazHabibi/Drug-repurposing.	[Habibi, Mahnaz] Islamic Azad Univ, Dept Math, Qazvin Branch, Qazvin, Iran; [Taheri, Golnaz] KTH Royal Inst Technol, Dept Elect Engn & Comp Sci, Stockholm, Sweden; [Taheri, Golnaz] Sci Life Lab, Stockholm, Sweden	Islamic Azad University; Royal Institute of Technology	Habibi, M (corresponding author), Islamic Azad Univ, Dept Math, Qazvin Branch, Qazvin, Iran.	mhabibi@ipm.ir		Habibi, Mahnaz/0000-0002-8969-2706				Alanis-Lobato G, 2017, NUCLEIC ACIDS RES, V45, pD408, DOI 10.1093/nar/gkw985; Alonso-Lopez D, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz005; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Cheng FX, 2019, METHODS MOL BIOL, V1878, P243, DOI 10.1007/978-1-4939-8868-6_15; Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006; Cheng FX, 2017, BRIEF BIOINFORM, V18, P682, DOI 10.1093/bib/bbw051; Durez P, 2022, ACTA CLIN BELG, V77, P233, DOI 10.1080/17843286.2020.1812830; Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1; Galvez Romero JL., 2020, JOU INT MED, V286, P906; Ghandili S, 2020, BLOOD ADV, V4, P5936, DOI 10.1182/bloodadvances.2020002543; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Gysi DM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025581118; Habibi M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88427-w; Hashimoto H, 2021, J DERMATOL, V48, pE122, DOI 10.1111/1346-8138.15696; Hazeldine J, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.680134; Luck K, 2020, NATURE, V580, P402, DOI 10.1038/s41586-020-2188-x; Marchetti M, 2020, ANN HEMATOL, V99, P1701, DOI 10.1007/s00277-020-04138-8; Morales-Ortega A, 2021, J INFECTION, V82, P213, DOI 10.1016/j.jinf.2021.02.002; Patil Ashwini, 2005, Biophysics (Nagoya-shi), V1, P21, DOI 10.2142/biophysics.1.21; Perisic O, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10091346; Quaglino P., 2020, ANTI BRAF ANTIMEK TA, V17, P759; Reznik SE, 2020, PHARMACOL RES, V160, DOI 10.1016/j.phrs.2020.105055; Salgado-Benvindo C, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00900-20; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Serebrovska ZO, 2020, ACTA PHARMACOL SIN, V41, P1539, DOI 10.1038/s41401-020-00554-8; Shah K, 2020, DIABETES METAB SYND, V14, P1143, DOI 10.1016/j.dsx.2020.07.003; Sharma S, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108183; Sheahan TP, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb5883; Smith T., 2020, COVID 19 DRUG THERAP; Taheri G, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S0219720013410084; Tong S, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106114; Villani A, 2020, J AM ACAD DERMATOL, V82, pE205, DOI 10.1016/j.jaad.2020.03.057; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Wuchty S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011796	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255270	10.1371/journal.pone.0255270	http://dx.doi.org/10.1371/journal.pone.0255270			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324563	Green Published, gold			2022-12-26	WOS:000685248200073
J	Karal, MA; Nasrin, T; Ahmed, M; Ahamed, MK; Ahammed, S; Akter, S; Hasan, S; Bin Mahbub, Z				Karal, Mohammad Abu Sayem; Nasrin, Tawfika; Ahmed, Marzuk; Ahamed, Md. Kabir; Ahammed, Shareef; Akter, Salma; Hasan, Sharif; Mahbub, Zaid Bin			A new purification technique to obtain specific size distribution of giant lipid vesicles using dual filtration	PLOS ONE			English	Article							2-INDUCED PORE FORMATION; UNILAMELLAR VESICLES; DELIVERY	A new purification technique is developed for obtaining distribution of giant unilamellar vesicles (GUVs) within a specific range of sizes using dual filtration. The GUVs were prepared using well known natural swelling method. For filtration, different combinations of polycarbonate membranes were implemented in filter holders. In our experiment, the combinations of membranes were selected with corresponding pore sizes-(i) 12 and 10 mu m, (ii) 12 and 8 mu m, and (iii) 10 and 8 mu m. By these filtration arrangements, obtained GUVs size distribution were in the ranges of 6-26 mu m, 5-38 mu m and 5-30 mu m, respectively. In comparison, the size distribution range was much higher for single filtration technique, for example, 6-59 mu m GUVs found for a membrane with 12 mu m pores. Using this technique, the water-soluble fluorescent probe, calcein, can be removed from the suspension of GUVs successfully. The size distributions were analyzed with lognormal distribution. The skewness became smaller (narrow size distribution) when a dual filtration was used instead of single filtration. The mode of the size distribution obtained in dual filtration was also smaller to that of single filtration. By continuing this process of purification for a second time, the GUVs size distribution became even narrower. After using an extra filtration with dual filtration, two different size distributions of GUVs were obtained at a time. This experimental observation suggests that different size specific distributions of GUVs can be obtained easily, even if GUVs are prepared by different other methods.	[Karal, Mohammad Abu Sayem; Nasrin, Tawfika; Ahmed, Marzuk; Ahamed, Md. Kabir; Ahammed, Shareef; Akter, Salma; Hasan, Sharif] Bangladesh Univ Engn & Technol, Dept Phys, Dhaka, Bangladesh; [Mahbub, Zaid Bin] North South Univ, Dept Math & Phys, Dhaka, Bangladesh	Bangladesh University of Engineering & Technology (BUET); North South University (NSU)	Karal, MA (corresponding author), Bangladesh Univ Engn & Technol, Dept Phys, Dhaka, Bangladesh.	asayem221@phy.buet.ac.bd	Bin Mahbub, Zaid/AAY-9607-2020	Bin Mahbub, Zaid/0000-0003-3877-0177; Sayem Karal, Mohammad Abu/0000-0001-5288-2357; Ahamed, Md. Kabir/0000-0001-8245-8397; Ahmed, Marzuk/0000-0003-2322-7657	Ministry of Science and Technology, Bangladesh [39.00.0000.009.06.024.19-12]; Ministry of Education, Bangladesh [37.20.0000.004.033.020.2016]; Information and Communication Technology Division (ICTD), Ministry of Posts, Telecommunications and Information Technology, Bangladesh [56.00.0000.028.33.105.18-05]; Committee for Advanced Studies and Research (CASR), Bangladesh University of Engineering and Technology (BUET), Bangladesh [DAERS/R01/CASR-339th/2021]	Ministry of Science and Technology, Bangladesh; Ministry of Education, Bangladesh; Information and Communication Technology Division (ICTD), Ministry of Posts, Telecommunications and Information Technology, Bangladesh; Committee for Advanced Studies and Research (CASR), Bangladesh University of Engineering and Technology (BUET), Bangladesh	This study was supported by the Ministry of Science and Technology, Bangladesh (No. 39.00.0000.009.06.024.19-12), Ministry of Education, Bangladesh (No. 37.20.0000.004.033.020.2016), Information and Communication Technology Division (ICTD), Ministry of Posts, Telecommunications and Information Technology, Bangladesh (No. 56.00.0000.028.33.105.18-05), and Committee for Advanced Studies and Research (CASR), Bangladesh University of Engineering and Technology (BUET), Bangladesh (No. DAERS/R01/CASR-339th/2021) in the form of funds for MASK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed MK, 2020, EUR BIOPHYS J BIOPHY, V49, P371, DOI 10.1007/s00249-020-01440-1; Ahmed M, 2021, EUR PHYS J E, V44, DOI 10.1140/epje/s10189-021-00071-4; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Baker R.W., 2000, MEMBRANE TECHNOLOGY; Dhand Rajiv, 2004, Respir Care, V49, P666; Edwards DA, 1998, J APPL PHYSIOL, V85, P379, DOI 10.1152/jappl.1998.85.2.379; Evans E, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/095010; Fanti A, 2018, INTEGR BIOL-UK, V10, P6, DOI 10.1039/c7ib00138j; Fayolle D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192975; Islam MZ, 2014, PHYS CHEM CHEM PHYS, V16, P15752, DOI 10.1039/c4cp00717d; Johnson N., 1994, CONTINUOUS UNIVARIAT, V2; Karal MA, 2020, CHEM PHYS LIPIDS, V230, DOI 10.1016/j.chemphyslip.2020.104916; Karal MA, 2020, PHYS REV E, V101, DOI 10.1103/PhysRevE.101.012404; Karal MA, 2019, EUR BIOPHYS J BIOPHY, V48, P731, DOI 10.1007/s00249-019-01398-9; Karal MA, 2019, EUR BIOPHYS J BIOPHY, V48, P349, DOI 10.1007/s00249-019-01363-6; KWOK R, 1981, BIOPHYS J, V35, P637, DOI 10.1016/S0006-3495(81)84817-5; Lian T, 2001, J PHARM SCI-US, V90, P667, DOI 10.1002/jps.1023; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Malam Y, 2009, TRENDS PHARMACOL SCI, V30, P592, DOI 10.1016/j.tips.2009.08.004; Moghal Md Mizanur Rahman, 2020, Biophys Rev, V12, P339, DOI 10.1007/s12551-020-00662-z; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; REEVES JP, 1969, J CELL PHYSIOL, V73, P49, DOI 10.1002/jcp.1040730108; Saha SK, 2020, J PHYS CHEM B, V124, P5588, DOI 10.1021/acs.jpcb.0c03681; Sarkar MK, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251690; Shibly SUA, 2016, BIOPHYS J, V111, P2190, DOI 10.1016/j.bpj.2016.09.043; Shigematsu T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15369; Tamba Y, 2005, BIOCHEMISTRY-US, V44, P15823, DOI 10.1021/bi051684w; Tamba Y, 2011, CHEM PHYS LIPIDS, V164, P351, DOI 10.1016/j.chemphyslip.2011.04.003; Tamba Y, 2010, J PHYS CHEM B, V114, P12018, DOI 10.1021/jp104527y; Tamba Y, 2009, J PHYS CHEM B, V113, P4846, DOI 10.1021/jp8109622; Tanaka T, 2002, BBA-BIOMEMBRANES, V1564, P173, DOI 10.1016/S0005-2736(02)00444-3; Verschraegen CF, 2004, CLIN CANCER RES, V10, P2319, DOI 10.1158/1078-0432.CCR-0929-3; Walde P, 2010, CHEMBIOCHEM, V11, P848, DOI 10.1002/cbic.201000010; Yamashita Y, 2002, LANGMUIR, V18, P9638, DOI 10.1021/la0265124; Yoshida N, 2000, SINGLE MOL, V4, P279, DOI DOI 10.1002/1438-5171(200012)1:4<279::AID-SIM0279>3.0.00; Yu Y, 2009, J AM CHEM SOC, V131, P14158, DOI 10.1021/ja905900h; Zhu TF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005009	38	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254930	10.1371/journal.pone.0254930	http://dx.doi.org/10.1371/journal.pone.0254930			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324548	Green Published, gold			2022-12-26	WOS:000685248200048
J	Park, S; Lee, S; Kim, Y; Lee, Y; Kang, MW; Kim, K; Kim, YC; Han, SS; Lee, H; Lee, JP; Joo, KW; Lim, CS; Kim, YS; Kim, DK				Park, Sehoon; Lee, Soojin; Kim, Yaerim; Lee, Yeonhee; Kang, Min Woo; Kim, Kwangsoo; Kim, Yong Chul; Han, Seung Seok; Lee, Hajeong; Lee, Jung Pyo; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Kim, Dong Ki			Causal linkage between adult height and kidney function: An integrated population-scale observational analysis and Mendelian randomization study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; INSTRUMENTS; SERUM; CREATININE; DISEASE; BIAS; MASS	As adult height is linked to various health outcomes, further investigation of its causal effects on kidney function later in life is warranted. This study involved a cross-sectional observational analysis and summary-level Mendelian randomization (MR) analysis. First, the observational association between height and estimated GFR determined by creatinine (eGFR(creatinine)) or cystatin C (eGFR(cystatinC)) was investigated in 467,182 individuals aged 40-69 using UK Biobank. Second, the genetic instrument for adult height, as reported by the GIANT consortium, was implemented, and summary-level MR of eGFR(creatinine) and CKDcreatinine in a CKDGen genome-wide association study was performed (N = 567,460), with multivariable MR being adjusted for the effects of genetic predisposition on body mass index. To replicate the findings, additional two-sample MR using the summary statistics of eGFR(cystatinC) and CKDcystatinC in UK Biobank was performed (N = 321,405). In observational analysis, adult height was inversely associated with both eGFR(creatinine) (per 1 SD, adjusted beta -1.039, standard error 0.129, P < 0.001) and eGFR(cystatinC) (adjusted beta -1.769, standard error 0.161, P < 0.001) in a multivariable model adjusted for clinicodemographic, anthropometric, metabolic, and social factors. Moreover, multivariable summary-level MR showed that a taller genetically predicted adult height was causally linked to a lower log-eGFR(creatinine) (adjusted beta -0.007, standard error 0.001, P < 0.001) and a higher risk of CKDcreatinine (adjusted beta 0.083, standard error 0.019, P < 0.001). Other pleiotropy-robust sensitivity MR analysis results supported the findings. In addition, similar results were obtained by two-sample MR of eGFR(cystatinC) (adjusted beta -1.303, standard error 0.140, P < 0.001) and CKDcystatinC (adjusted beta 0.153, standard error 0.025, P < 0.001) in UK Biobank. In conclusion, the results of this study suggest that a taller adult height is causally linked to worse kidney function in middle-aged to elderly individuals, independent of the effect of body mass index.	[Park, Sehoon] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Park, Sehoon] Armed Forces Capital Hosp, Dept Internal Med, Seongnam Si, Gyeonggi Do, South Korea; [Lee, Soojin; Lee, Yeonhee] Uijeongbu Eulji Univ, Div Nephrol, Dept Internal Med, Med Ctr, Seongnam Si, Gyeonggi Do, South Korea; [Kim, Yaerim] Keimyung Univ, Dept Internal Med, Sch Med, Daegu, South Korea; [Kang, Min Woo; Kim, Yong Chul; Han, Seung Seok; Lee, Hajeong; Joo, Kwon Wook; Kim, Yon Su; Kim, Dong Ki] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Kwangsoo] Seoul Natl Univ Hosp, Transdisciplinary Dept Med & Adv Technol, Seoul, South Korea; [Han, Seung Seok; Lee, Hajeong; Lee, Jung Pyo; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Kim, Dong Ki] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea; [Lee, Jung Pyo; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Kim, Dong Ki] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Lee, Jung Pyo; Lim, Chun Soo] SMG SNU Boramae Med Ctr, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Keimyung University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, DK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.; Kim, DK (corresponding author), Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea.; Kim, DK (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	dkkim73@gmail.com	Han, Seung Seok/HGD-2825-2022; Kim, Dong Ki/J-5389-2012	Kim, Dong Ki/0000-0002-5195-7852; Kim, Yaerim/0000-0003-1596-1528	SNU RDB Foundation [800-20190571]; Seoul National University, Republic of Korea	SNU RDB Foundation; Seoul National University, Republic of Korea	DKK: This work was supported by a grant from SNU R&DB Foundation (800-20190571) of the Seoul National University, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Bikbov B, 2020, LANCET, V395, P709, DOI 10.1016/S0140-6736(20)30045-3; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; Burgess Stephen, 2019, Wellcome Open Res, V4, P186, DOI 10.12688/wellcomeopenres.15555.1; Burgess S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14156-4; Burgess S, 2015, AM J EPIDEMIOL, V181, P251, DOI 10.1093/aje/kwu283; Burgess S, 2011, INT J EPIDEMIOL, V40, P755, DOI 10.1093/ije/dyr036; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chagnac A, 2000, AM J PHYSIOL-RENAL, V278, pF817, DOI 10.1152/ajprenal.2000.278.5.F817; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Davies NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k601; Denic A, 2018, J AM SOC NEPHROL, V29, P1960, DOI 10.1681/ASN.2017121305; Denic A, 2017, NEW ENGL J MED, V376, P2349, DOI 10.1056/NEJMoa1614329; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kennedy OJ, 2020, AM J KIDNEY DIS, V75, P753, DOI 10.1053/j.ajkd.2019.08.025; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Lai FY, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1175-7; Lees JS, 2019, NAT MED, V25, P1753, DOI 10.1038/s41591-019-0627-8; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Luyckx VA, 2018, B WORLD HEALTH ORGAN, V96, P414, DOI 10.2471/BLT.17.206441; Nelson CP, 2015, NEW ENGL J MED, V372, P1608, DOI 10.1056/NEJMoa1404881; Nuesch E, 2016, INT J EPIDEMIOL, V45, P1927, DOI 10.1093/ije/dyv074; Park S, 2021, J AM SOC NEPHROL, V32, P1484, DOI 10.1681/ASN.2020071086; Park S, 2022, NEPHROL DIAL TRANSPL, V37, P1059, DOI 10.1093/ndt/gfab153; Park S, 2021, AM J CLIN NUTR, V113, P1023, DOI 10.1093/ajcn/nqaa379; Park S, 2020, J AM SOC NEPHROL, V31, P2937, DOI 10.1681/ASN.2020050666; Rees JMB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222362; Sanderson E, 2019, INT J EPIDEMIOL, V48, P713, DOI 10.1093/ije/dyy262; Slob EAW, 2020, GENET EPIDEMIOL, V44, P313, DOI 10.1002/gepi.22295; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Tonneijck L, 2017, J AM SOC NEPHROL, V28, P1023, DOI 10.1681/ASN.2016060666; Tyrrell J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i582; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wuerzner G, 2010, AM J KIDNEY DIS, V56, P303, DOI 10.1053/j.ajkd.2010.03.017; Wuttke M, 2019, NAT GENET, V51, P957, DOI 10.1038/s41588-019-0407-x; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271; Zhao JV, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01594-x; Zhao QY, 2020, ANN STAT, V48, P1742, DOI 10.1214/19-AOS1866	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254649	10.1371/journal.pone.0254649	http://dx.doi.org/10.1371/journal.pone.0254649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324541	Green Published, gold			2022-12-26	WOS:000685248200039
J	Whately, KM; Voronkova, MA; Maskey, A; Gandhi, J; Loskutov, J; Choi, H; Yanardag, S; Chen, DQ; Wen, SJ; Margaryan, NV; Smolkin, MB; Purazo, ML; Hu, GQ; Pugacheva, EN				Whately, Kristina M.; Voronkova, Maria A.; Maskey, Abha; Gandhi, Jasleen; Loskutov, Juergen; Choi, Hyeran; Yanardag, Sila; Chen, Dongquan; Wen, Sijin; Margaryan, Naira, V; Smolkin, Matthew B.; Purazo, Marc L.; Hu, Gangqing; Pugacheva, Elena N.			Nuclear Aurora-A kinase-induced hypoxia signaling drives early dissemination and metastasis in breast cancer: implications for detection of metastatic tumors	ONCOGENE			English	Article							INDUCIBLE FACTOR-1-ALPHA; MESENCHYMAL TRANSITION; DOWN-REGULATION; EXPRESSION; SURVIVAL; ACTIVATION; PROGNOSIS; CARCINOMA; THERAPY	Metastatic breast cancer causes most breast cancer-associated deaths, especially in triple negative breast cancers (TNBC). The metastatic drivers of TNBCs are still poorly understood, and effective treatment non-existent. Here we reveal that the presence of Aurora-A Kinase (AURKA) in the nucleus and metastatic dissemination are molecularly connected through HIF1 (Hypoxia-Inducible Factor-1) signaling. Nuclear AURKA activates transcription of "hypoxia-induced genes" under normoxic conditions (pseudohypoxia) and without upregulation of oxygen-sensitive HIF1A subunit. We uncover that AURKA preferentially binds to HIF1B and co-localizes with the HIF complex on DNA. The mass-spectrometry analysis of the AURKA complex further confirmed the presence of CBP and p300 along with other TFIIB/RNApol II components. Importantly, the expression of multiple HIF-dependent genes induced by nuclear AURKA (N-AURKA), including migration/invasion, survival/death, and stemness, promote early cancer dissemination. These results indicate that nuclear, but not cytoplasmic, AURKA is a novel driver of early metastasis. Analysis of clinical tumor specimens revealed a correlation between N-AURKA presence and decreased patient survival. Our results establish a mechanistic link between two critical pathways in cancer metastasis, identifying nuclear AURKA as a crucial upstream regulator of the HIF1 transcription complex and a target for anti-metastatic therapy.	[Whately, Kristina M.; Voronkova, Maria A.; Maskey, Abha; Loskutov, Juergen; Choi, Hyeran; Yanardag, Sila; Margaryan, Naira, V; Purazo, Marc L.; Pugacheva, Elena N.] West Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA; [Whately, Kristina M.; Voronkova, Maria A.; Maskey, Abha; Loskutov, Juergen; Yanardag, Sila; Wen, Sijin; Purazo, Marc L.; Hu, Gangqing; Pugacheva, Elena N.] West Virginia Univ, WVU Canc Inst, Sch Med, Morgantown, WV 26506 USA; [Gandhi, Jasleen; Hu, Gangqing] West Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; [Chen, Dongquan] UAB Comprehens Canc Ctr, Dept Med, Div Prevent Med, Birmingham, AL USA; [Wen, Sijin] West Virginia Univ, Sch Publ Hlth, Dept Biostat, Morgantown, WV 26506 USA; [Smolkin, Matthew B.] West Virginia Univ, Dept Pathol, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University; University of Alabama System; University of Alabama Birmingham; West Virginia University; West Virginia University	Pugacheva, EN (corresponding author), West Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA.; Pugacheva, EN (corresponding author), West Virginia Univ, WVU Canc Inst, Sch Med, Morgantown, WV 26506 USA.	epugacheva@hsc.wvu.edu		Yanardag, Sila/0000-0002-0658-3978; Whately, Kristina/0000-0002-5908-8145; Maskey, Abha/0000-0003-3688-5376; Gandhi, Jasleen/0000-0001-5724-4194; Voronkova, Maria/0000-0001-9778-5032	WVUCI; NIH [P20 RR016440, P30 RR032138/GM103488, P30GM103488, P30RR032138, RCP1101809, P20RR016440, U54GM104942, S10RR026378, GM104942, GM103434, OD016165, GM121322, P20GM103434, U54 GM-104942]; NIH-NCI [CA148671]; National Cancer Institute of the National Institutes of Health [CA148671]	WVUCI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank WVU HSC Office of Graduate Research and Education for outstanding administrative support, WVU Tissue Bank, Genetic Tumor Modeling Core, and Animal Models & Imaging Facilities, supported by the WVUCI and NIH grants P20 RR016440, P30 RR032138/GM103488, and S10RR026378. Flow Cytometry Facility was supported by NIH grants P30GM103488, P30RR032138, and RCP1101809. Bioinformatics Core by NIH grants P20GM103434 and U54 GM-104942. This work was supported by a grant from NIH-NCI CA148671 to ENP. Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award number CA148671 (to ENP). Small animal imaging and cell image analysis were performed in the West Virginia University Animal Models & Imaging Facility, supported by NIH grants P20RR016440, P30GM103488, U54GM104942, P20GM103434, and S10RR026378. The flow cytometry analysis was done in WVU Flow Cytometry & Single Cell Core Facility, supported by NIH grants GM121322, GM104942, GM103434, and OD016165. The genetic tumor modeling (GTM) core facility provided animal models supported by NIH grant GM121322. The WVU Bioinformatics Core Facility supported by NIH grants P20GM103434 and U54 GM-104942 assisted with RNA-Seq data analysis and interpretation.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Andrzejewski S, 2017, CELL METAB, V26, P778, DOI 10.1016/j.cmet.2017.09.006; Azab AK, 2012, BLOOD, V119, P5782, DOI 10.1182/blood-2011-09-380410; Baba Y, 2009, NEOPLASIA, V11, P418, DOI 10.1593/neo.09154; Bierie B, 2017, P NATL ACAD SCI USA, V114, pE2337, DOI 10.1073/pnas.1618298114; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Briassouli P, 2007, CANCER RES, V67, P1689, DOI 10.1158/0008-5472.CAN-06-2272; Brooks DLP, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0510-x; Chen A, 2018, ONCOGENE, V37, P4214, DOI 10.1038/s41388-018-0259-3; D'Assoro AB, 2014, ONCOGENE, V33, P599, DOI 10.1038/onc.2012.628; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; Dupuy F, 2015, CELL METAB, V22, P577, DOI 10.1016/j.cmet.2015.08.007; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Generali D, 2006, CLIN CANCER RES, V12, P4562, DOI 10.1158/1078-0432.CCR-05-2690; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; Gruber G, 2004, BREAST CANCER RES, V6, pR191, DOI 10.1186/bcr775; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hayashi Y, 2019, CANCER SCI, V110, P1510, DOI 10.1111/cas.13990; Ice RJ, 2013, CANCER RES, V73, P3168, DOI 10.1158/0008-5472.CAN-12-4008; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Jones BC, 2017, MOL CANCER RES, V15, P670, DOI 10.1158/1541-7786.MCR-16-0411; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kozyreva VK, 2016, MOL CANCER THER, V15, P1809, DOI 10.1158/1535-7163.MCT-15-0688; Mao JH, 2007, CANCER CELL, V11, P161, DOI 10.1016/j.ccr.2006.11.025; Melchionna R, 2010, CARDIOVASC RES, V86, P293, DOI 10.1093/cvr/cvp393; Nadler Y, 2008, CLIN CANCER RES, V14, P4455, DOI 10.1158/1078-0432.CCR-07-5268; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Orlando IMC, 2020, HAEMATOLOGICA, V105, P2774, DOI 10.3324/haematol.2019.236406; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Rankin EB, 2016, SCIENCE, V352, P175, DOI 10.1126/science.aaf4405; Schumacher JM, 1998, DEVELOPMENT, V125, P4391; SEMENZA GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI DOI 10.1016/J.BBAMCR.2015.05.036; Tanaka E, 2005, CLIN CANCER RES, V11, P1827, DOI 10.1158/1078-0432.CCR-04-1627; Tatsuka M, 2009, MOL CARCINOGEN, V48, P810, DOI 10.1002/mc.20525; Wang LH, 2010, CANCER RES, V70, P9118, DOI 10.1158/0008-5472.CAN-10-1246; Wang W, 2014, CLIN CHIM ACTA, V428, P32, DOI 10.1016/j.cca.2013.10.018; Xu HT, 2006, PATHOL INT, V56, P375, DOI 10.1111/j.1440-1827.2006.01974.x; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056919; Yang H, 2006, INT J CANCER, V119, P2304, DOI 10.1002/ijc.22154; Yang N, 2017, ONCOGENE, V36, P3428, DOI 10.1038/onc.2016.490; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zheng FM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10180	44	3	3	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 16	2021	40	37					5651	5664		10.1038/s41388-021-01969-1	http://dx.doi.org/10.1038/s41388-021-01969-1		JUL 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UR2PS	34326467	Green Accepted			2022-12-26	WOS:000679262900002
J	Ezenkwa, US; Abu Okolo, C; Ogun, GO; Akere, A; Ogunbiyi, OJ				Ezenkwa, Uchenna Simon; Abu Okolo, Clement; Ogun, Gabriel Olabiyi; Akere, Adegboyega; Ogunbiyi, Olufemi John			Cyclooxygenase-2 expression in colorectal carcinoma, adenomatous polyps and non-tumour bearing margins of resection tissues in a cohort of black Africans	PLOS ONE			English	Article							COLON-CANCER; MICROSATELLITE INSTABILITY; COX-2; NIGERIA; ANGIOGENESIS; SURVIVAL; SIZE; RISK	Background Emerging data suggest a negative role of cyclooxygenase-2 (COX-2) in colorectal carcinomas (CRC). Investigating this in developing communities such as ours helps to contribute to existing understanding of these lesions. Methods and findings Formalin-fixed paraffin-embedded CRC colectomy tissues and their corresponding non-tumour margins of resected tissues were sectioned and stained with COX-2 antibody. Adenomatous polyp tissues from non-cancer bearing individuals were similarly processed for comparison. COX-2 expression was scored for percentage (< 5% = 0; 6%-25% = 1; 26%-50% = 2; 51%-75% = 3; 76%-100% = 4) and intensity (no staining = 0; yellow = 2; yellowish-brown = 3, brown = 4). Total immunoscore (percentage + intensity score) >= 2 was regarded as positive COX-2 expression. Outcome was statistically evaluated with clinicopathological data to determine COX-2 expression-associated and predictor variables. Ninety-five CRC cases and 27 matched non-tumour tissues as well as 31 adenomatous polyps met the inclusion criteria. Individuals with CRC had a mean age of 56.1 +/- 12.6 years while those with adenomatous polyps had a median age of 65 years (range 43-88). COX-2 was differentially overexpressed in CRCs (69/95; 72.6%) and in adenomatous polyps (17/31; 54.8%) than in non-tumour tissues 5/27 (18.5%); p < 0.001). The difference in COX-2 expression between CRC and polyps was non-significant (p > 0.065). Tumour grade, advanced pT-stage, tumour-infiltrating lymphocytes, and dirty necrosis were also significantly associated with COX-2 expression (p < 0.035; 0.043, 0.035 and 0.004, respectively). Only dirty necrosis and Crohns-like lymphocytic aggregates predicted COX-2 expression (p < 0.05). Conclusion This study showed a progressive increase in COX-2 expression from normal to adenomatous polyp and CRC tissues, this being associated with poorer prognostic indicators. Although COX-2 appears early in CRC, it may play a secondary role in promoting tumour growth and invasiveness.	[Ezenkwa, Uchenna Simon; Abu Okolo, Clement; Ogun, Gabriel Olabiyi; Ogunbiyi, Olufemi John] Univ Coll Hosp, Dept Pathol, Ibadan, Nigeria; [Akere, Adegboyega] Univ Coll Hosp Ibadan, Dept Internal Med, Gastroenterol Unit, Ibadan, Nigeria	University of Ibadan; University College Hospital, Ibadan; University of Ibadan; University College Hospital, Ibadan	Ogunbiyi, OJ (corresponding author), Univ Coll Hosp, Dept Pathol, Ibadan, Nigeria.	fogunbiyi@gmail.com	Akere, Adegboyega/AHD-0744-2022; Ogun, Gabriel/AFQ-0418-2022; Ezenkwa, Uchenna/AAZ-9548-2021	Ogun, Gabriel/0000-0001-8535-3240; Ezenkwa, Uchenna/0000-0002-7022-8268; Ogunbiyi, Olufemi/0000-0002-8748-2879				Abdulkareem FB, 2008, WORLD J GASTROENTERO, V14, P6531, DOI 10.3748/wjg.14.6531; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Ayiomamitis GD., 2019, CANCERS BASEL, V11, P1, DOI [10.3390/cancers11101536, DOI 10.3390/CANCERS11101536]; Bayrak M., 2019, ANN MED RESERACH, V26, P393; Bosman FT, 2010, WHO CLASSIFICATION T, V3, P131; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Carus RA, 2014, ONCOL LETT, V8, P1397, DOI 10.3892/ol.2014.2345; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chell S, 2006, BBA-REV CANCER, V1766, P104, DOI 10.1016/j.bbcan.2006.05.002; Fujita T, 1998, CANCER RES, V58, P4823; Gospodarowicz M.K., 2017, TNM CLASSIFICATION M; Irabor D, 2009, EUR J CANCER CARE, V18, P110, DOI 10.1111/j.1365-2354.2008.00982.x; Irabor DO, 2010, COLORECTAL DIS, V12, pE43, DOI 10.1111/j.1463-1318.2009.01928.x; Irabor DO, 2017, ANTICANCER RES, V37, P2649, DOI 10.21873/anticanres.11612; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 2004, DIS MARKERS, V20, P215, DOI 10.1155/2004/197484; Kaya M, 2017, J CANCER RES THER, V13, P356, DOI 10.4103/0973-1482.174558; Lim SC, 2007, YONSEI MED J, V48, P495, DOI 10.3349/ymj.2007.48.3.495; Lin PC, 2013, ONCOL LETT, V6, P733, DOI 10.3892/ol.2013.1426; Liu B, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0260-7; Maekawa M, 1998, JPN J CLIN ONCOL, V28, P421, DOI 10.1093/jjco/28.7.421; Negi Ram Rattan, 2019, Asian Pac J Cancer Prev, V20, P1675, DOI 10.31557/APJCP.2019.20.6.1675; Ng K, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju345; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Peng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058891; Rawla P, 2019, GASTROENTEROL REV, V14, P26, DOI 10.5114/pg.2018.80001; Roelofs HMJ, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-1; Saha S, 2015, AM J SURG, V209, P570, DOI 10.1016/j.amjsurg.2014.12.008; Seno H, 2002, CANCER RES, V62, P506; Sheng J, 2020, INT J MED SCI, V17, P1095, DOI 10.7150/ijms.44439; Shimizu K, 2010, J THORAC ONCOL, V5, P585, DOI 10.1097/JTO.0b013e3181d60fd7; Sinicrope FA, 1999, GASTROENTEROLOGY, V117, P350, DOI 10.1053/gast.1999.0029900350; Van Dyke AL, 2008, CARCINOGENESIS, V29, P1781, DOI 10.1093/carcin/bgn107; Wang JP, 2018, CANCER EPIDEM BIOMAR, V27, P728, DOI 10.1158/1055-9965.EPI-17-0573; Wang QX, 2009, J CLIN BIOCHEM NUTR, V45, P163, DOI 10.3164/jcbn.09-21; Wu AW, 2004, WORLD J GASTROENTERO, V10, P2323; Wu QB, 2015, WORLD J GASTROENTERO, V21, P6206, DOI 10.3748/wjg.v21.i20.6206; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhu M, 2013, CELL PROLIFERAT, V46, P374, DOI 10.1111/cpr.12047	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255235	10.1371/journal.pone.0255235	http://dx.doi.org/10.1371/journal.pone.0255235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314467	gold, Green Published			2022-12-26	WOS:000685225200020
J	Notomi, S; Shiose, S; Ishikawa, K; Fukuda, Y; Kano, K; Mori, K; Wada, I; Kaizu, Y; Matsumoto, H; Akiyama, M; Sonoda, KH				Notomi, Shoji; Shiose, Satomi; Ishikawa, Keijiro; Fukuda, Yosuke; Kano, Kumiko; Mori, Kenichiro; Wada, Iori; Kaizu, Yoshihiro; Matsumoto, Hidetaka; Akiyama, Masato; Sonoda, Koh-Hei			Drusen and pigment abnormality predict the development of neovascular age-related macular degeneration in Japanese patients	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; PROSPECTIVE COHORT; SEVERITY SCALE; MULTICENTER; PREVALENCE; DIAGNOSIS; SUBTYPES; 5-YEAR	Drusen are known to be the important hallmark to predict the development of age-related macular degeneration (AMD). The prevalence of drusen is lower in Asians compared with Caucasians so that the role of signs constituting early AMD is not well established in Asian populations as in Western countries. In this study, we retrospectively investigated clinical characteristics and 5-year incidence of neovascular AMD (nAMD) in the fellow eye of unilateral nAMD patients. Of 296 consecutive unilateral nAMD patients who had been followed up more than 5 years, 170 typical AMD, 119 polypoidal choroidal vasculopathy, and 7 retinal angiomatous proliferation were included. To examine factors associated with nAMD occurrence in the fellow eye, drusen and pigmentary abnormality in the fellow eye were classified into 4 categories; Category 1: no or small drusen < 63 mu m (37.2%), Category 2: 63-125 mu m medium drusen or pigmentary abnormality (22.2%), Category 3: large drusen > 125 mu m (25.0%), Category P: pachydrusen (15.5%). The mean sub-foveal choroidal thickness (SFCT) was Category 1: 276 mu m, Category 2: 308 mu m, Category 3: 246 mu m, and Category P: 302 mu m, respectively. Of note, SFCT in Category 2 and Category P was significantly larger than those of Category 3. Finally, the 5-year incidence of nAMD in the fellow eye was 32/296 (10.8%); Category 1: 0/110 (0%), Category 2: 12/66 (18.2%), Category 3: 20/74 (27.0%), and Category P: 0/46 (0%). Thus, signs of intermediate AMD (large drusen) as well as those of early AMD, especially the pigmentary abnormality, may contribute to development of bilateral nAMD in Japanese patients.	[Notomi, Shoji; Shiose, Satomi; Ishikawa, Keijiro; Fukuda, Yosuke; Kano, Kumiko; Mori, Kenichiro; Wada, Iori; Kaizu, Yoshihiro; Sonoda, Koh-Hei] Kyushu Univ, Fac Med Sci, Dept Ophthalmol, Fukuoka, Japan; [Matsumoto, Hidetaka] Gunma Univ, Grad Sch Med, Dept Ophthalmol, Maebashi, Gumma, Japan; [Akiyama, Masato] Kyushu Univ, Fac Med Sci, Dept Ocular Pathol & Imaging Sci, Fukuoka, Japan	Kyushu University; Gunma University; Kyushu University	Notomi, S (corresponding author), Kyushu Univ, Fac Med Sci, Dept Ophthalmol, Fukuoka, Japan.	noutomi.shouji.926@m.kyushu-u.ac.jp	Akiyama, Masato/AHC-2589-2022	Matsumoto, Hidetaka/0000-0003-2311-0280; Notomi, Shoji/0000-0002-7935-4244	Japan Society for the Promotion of Science [JP19K09931]; Grant of The Clinical Research Promotion Foundation 2020	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grant of The Clinical Research Promotion Foundation 2020	Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research; JP19K09931. Grant of The Clinical Research Promotion Foundation 2020, Dr. Shoji Notomi.	Akagi-Kurashige Y, 2018, JPN J OPHTHALMOL, V62, P137, DOI 10.1007/s10384-017-0554-5; Bhisitkul RB, 2016, OPHTHALMOLOGY, V123, P1269, DOI 10.1016/j.ophtha.2016.01.033; CHANG B, 1995, OPHTHALMOLOGY, V102, P1380, DOI 10.1016/S0161-6420(95)30860-3; Cheung CMG, 2018, OPHTHALMOLOGY, V125, P708, DOI 10.1016/j.ophtha.2017.11.019; Coscas G, 2014, AM J OPHTHALMOL, V158, P309, DOI 10.1016/j.ajo.2014.05.004; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Fukuda Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48494-6; Cheung CM, 2018, OPHTHALMOL RETINA, V2, P1196, DOI 10.1016/j.oret.2018.06.014; Kawasaki R, 2008, OPHTHALMOLOGY, V115, P1376, DOI 10.1016/j.ophtha.2007.11.015; Klein R, 2006, OPHTHALMOLOGY, V113, P373, DOI 10.1016/j.ophtha.2005.12.013; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Lee J, 2019, AM J OPHTHALMOL, V208, P103, DOI 10.1016/j.ajo.2019.07.013; Lee J, 2020, RETINA-J RET VIT DIS, V40, P490, DOI 10.1097/IAE.0000000000002419; Miyake M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16204; Nakata I, 2013, AM J OPHTHALMOL, V156, P1002, DOI 10.1016/j.ajo.2013.06.007; Obata R, 2018, BRIT J OPHTHALMOL, V102, P1047, DOI 10.1136/bjophthalmol-2016-309980; Pang CE, 2015, RETINA-J RET VIT DIS, V35, P1, DOI 10.1097/IAE.0000000000000331; Sasaki M, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.3.23; Sasaki M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18487-4; Sasaki M, 2014, OPTOMETRY VISION SCI, V91, P849, DOI 10.1097/OPX.0000000000000317; Sheth J, 2020, EYE, V34, P1501, DOI 10.1038/s41433-020-0886-0; Spaide RF, 2018, RETINA-J RET VIT DIS, V38, P708, DOI 10.1097/IAE.0000000000001689; Tsujikawa A, 2018, JPN J OPHTHALMOL, V62, P127, DOI 10.1007/s10384-017-0556-3; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Wong CW, 2015, J CLIN MED, V4, P782, DOI 10.3390/jcm4050782; Yasuda M, 2009, OPHTHALMOLOGY, V116, P2135, DOI 10.1016/j.ophtha.2009.04.017	28	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255213	10.1371/journal.pone.0255213	http://dx.doi.org/10.1371/journal.pone.0255213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314466	gold, Green Published			2022-12-26	WOS:000685225200019
J	Woromogo, SH; Ledaga, NA; Yagata-Moussa, FE; Mihindou, AS				Woromogo, Sylvain Honore; Ledaga, Nathalie Ambounda; Yagata-Moussa, Felicite Emma; Mihindou, Astride Smeige			Uterine cervical neoplasms mass screening at the University Hospital Centre of Libreville, Gabon: Associated factors with precancerous and cancerous lesions	PLOS ONE			English	Article							VISUAL INSPECTION; ACETIC-ACID; RISK-FACTORS; ACCEPTABILITY; ORGANIZATION; FEASIBILITY; CRYOTHERAPY; GUIDELINES; WOMEN	The objectives of this study were to identify the associated factors with cancerous and precancerous lesions of cervix. In Africa, the incidence of uterine cervical neoplasms varies from one region to another, where most women with uterine cervical neoplasms are seen at an advanced stage. For this reason, uterine cervical neoplasms mass screening reduces the incidence and mortality due to this disease, similar to what is being done in Europe. A cross-sectional analytical study was conducted. Socio-demographic characteristics, gynaecological-obstetrical history, risk factors, data from visual inspection with acetic acid and visual inspection with Lugol, colposcopy impressions and results of cytological analysis were performed. A simple and multiple regression were performed to establish a statistically significant difference between certain factors and the presence of precancerous or cancerous lesions of uterine cervical. In this study, of 63 women diagnosed histologically, 43 had precancerous lesions and 20 had cancerous lesions. we found that being older than 35, having the first intercourse before 18, having an antecedent of STI, being a widow and using of tobacco were risk factors associated with precancerous lesions (p = 0.013 with OR = 3.44 (1.22-9.73), p = 0.009 with OR = 4.07 (1.69-13.08), p < 0.001 with OR = 3.80 (1.94-7.47), p < 0.001 with OR = 9.77 (3.87-24.70) and p < 0.001 with OR = 5.47 (2.60-11.52)) respectively. Only being older than 45, being a widow and using tobacco were risk factors associated with cancerous lesions (p = 0.021 with OR = 2.01 (1.58-3.56), p = 0.02 with OR = 2.96 (2.10-3.87), p = 0.041 with OR = 1.98 (1.46-2.44)) respectively. Among participants diagnosed with uterine cervical neoplasms, there was a significant association with the STI, marital status and smoking. Despite the integration of the detection of precancerous uterine cervical neoplasms lesions into health facilities in Gabon, uterine cervical neoplasms ranks second among women's cancers in terms of incidence and first in terms of mortality.	[Woromogo, Sylvain Honore; Ledaga, Nathalie Ambounda] InterState Ctr Higher Publ Hlth Educ Cent Africa, Brazzaville, Rep Congo; [Ledaga, Nathalie Ambounda; Mihindou, Astride Smeige] Univ Hosp Ctr Libreville, Gynecol & Obstet Serv, Libreville, Gabon; [Yagata-Moussa, Felicite Emma] Univ Bangui, Fac Hlth Sci, Bangui, Cent Afr Republ		Woromogo, SH (corresponding author), InterState Ctr Higher Publ Hlth Educ Cent Africa, Brazzaville, Rep Congo.	woromogos@gmail.com		WOROMOGO, SYLVAIN HONORE/0000-0002-4459-0597				Adefuye A, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/548150; Adefuye PO, 2015, INT J GYNECOL OBSTET, V129, P62, DOI 10.1016/j.ijgo.2014.10.032; [Anonymous], 2017, COMPR CERV CANC CONT; Bahmanyar ER, 2012, GYNECOL ONCOL, V127, P440, DOI 10.1016/j.ygyno.2012.08.033; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cohen PA, 2019, LANCET, V393, P169, DOI 10.1016/S0140-6736(18)32470-X; Denny L, 2002, CANCER-AM CANCER SOC, V94, P1699, DOI 10.1002/cncr.10381; Denny L, 2015, CANC DIS CONTROL PRI, V3rd; Denny L, 2012, DISCOV MED, V14, P125; Denny L, 2012, CANCER EPIDEM BIOMAR, V21, P1434, DOI 10.1158/1055-9965.EPI-12-0334; Elfstrom KM, 2015, EUR J CANCER, V51, P950, DOI 10.1016/j.ejca.2015.03.008; Fallala MS, 2015, AFR J PRIM HEALTH CA, V7, DOI 10.4102/phcfm.v7i1.742; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Hasanzadeh M, 2011, J OBSTET GYNAECOL RE, V37, P1802, DOI 10.1111/j.1447-0756.2011.01614.x; Kassa Roza Teshome, 2018, BMC Res Notes, V11, P145, DOI 10.1186/s13104-018-3244-6; Makuza JD, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.26.7116; Millogo F T, 2004, Bull Soc Pathol Exot, V97, P135; Mpiga E, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.165.7038; National Agency for Health Accreditation and Evaluation, 1999, J GYNECOL OBST BIO R, V28, P310; Ngoma T, 2010, INT J GYNECOL OBSTET, V109, P100, DOI 10.1016/j.ijgo.2009.11.025; Nkfusai NC, 2019, PAN AFR MED J, V32, DOI 10.11604/pamj.2019.32.174.16895; Phongsavan K, 2011, INT J GYNECOL OBSTET, V114, P268, DOI 10.1016/j.ijgo.2011.03.009; Salifou K, 2015, EUR SCI J, V11, P275; Sandjong Tietchou I, 2015, HLTH SCI DIS, P16; Santesso N, 2016, INT J GYNECOL OBSTET, V132, P252, DOI 10.1016/j.ijgo.2015.07.038; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Teame H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191506	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255289	10.1371/journal.pone.0255289	http://dx.doi.org/10.1371/journal.pone.0255289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297784	gold, Green Published			2022-12-26	WOS:000678128300013
J	Schuck, PL; Ball, LE; Stewart, JA				Schuck, P. Logan; Ball, Lauren E.; Stewart, Jason A.			The DNA-binding protein CST associates with the cohesin complex and promotes chromosome cohesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; REPLICATION FORKS; ROLES; CHECKPOINT; CTF4; WAPL	Sister chromatid cohesion (SCC), the pairing of sister chro-matids after DNA replication until mitosis, is established by loading of the cohesin complex on newly replicated chroma-tids. Cohesin must then be maintained until mitosis to prevent segregation defects and aneuploidy. However, how SCC is established and maintained until mitosis remains incompletely understood, and emerging evidence suggests that replication stress may lead to premature SCC loss. Here, we report that the ssDNA-binding protein CTC1-STN1-TEN1 (CST) aids in SCC. CST primarily functions in telomere length regulation but also has known roles in replication restart and DNA repair. After depletion of CST subunits, we observed an increase in the complete loss of SCC. In addition, we determined that CST associates with the cohesin complex. Unexpectedly, we did not find evidence of altered cohesin loading or mitotic progression in the absence of CST; however, we did find that treatment with various replication inhibitors increased the association between CST and cohesin. Because replication stress was recently shown to induce SCC loss, we hypothesized that CST may be required to maintain or remodel SCC after DNA replication fork stalling. In agreement with this idea, SCC loss was greatly increased in CST-depleted cells after exogenous replication stress. Based on our findings, we propose that CST aids in the maintenance of SCC at stalled replication forks to prevent premature cohesion loss.	[Schuck, P. Logan; Stewart, Jason A.] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Ball, Lauren E.] Med Univ South Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA	University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina	Stewart, JA (corresponding author), Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	jason.stewart@sc.edu		Ball, Lauren/0000-0001-6780-1679	NIH [K99 GM104409, R00 GM104409]; University of South Carolina; SPARC grant from the University of South Carolina	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina; SPARC grant from the University of South Carolina	This work was supported by funds from the NIH (K99 GM104409 and R00 GM104409 to J. A. S.) and by startup funds from the University of South Carolina. P. L. S. was supported in part by a SPARC grant from the University of South Carolina. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health or the University of South Carolina.	Ackerson SM, 2020, CELL CYCLE, V19, P3491, DOI 10.1080/15384101.2020.1849979; Alam Muhammad S, 2018, Curr Protoc Immunol, V123, pe58, DOI 10.1002/cpim.58; Benedict B, 2020, DEV CELL, V52, P683, DOI 10.1016/j.devcel.2020.01.024; Canudas S, 2009, J CELL BIOL, V187, P165, DOI 10.1083/jcb.200903096; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Chastain M, 2016, CELL REP, V16, P2048, DOI 10.1016/j.celrep.2016.08.008; Chen LY, 2013, GENE DEV, V27, P2099, DOI 10.1101/gad.222893.113; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Errico A, 2009, EMBO J, V28, P3681, DOI 10.1038/emboj.2009.304; Feng XY, 2017, NUCLEIC ACIDS RES, V45, P4281, DOI 10.1093/nar/gkx125; Ganduri S, 2017, NUCLEIC ACIDS RES, V45, P9455, DOI 10.1093/nar/gkx621; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; GOULIAN M, 1990, J BIOL CHEM, V265, P13221; Haarhuis JHI, 2014, DEV CELL, V31, P7, DOI 10.1016/j.devcel.2014.09.010; Hubner NC, 2010, CHROMOSOMA, V119, P149, DOI 10.1007/s00412-009-0244-2; Ivanov MP, 2018, EMBO J, V37, DOI 10.15252/embj.201797150; Kasbek C, 2013, J BIOL CHEM, V288, P30139, DOI 10.1074/jbc.M113.493478; Kim BJ, 2010, J BIOL CHEM, V285, P22782, DOI 10.1074/jbc.M110.134577; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Leylek TR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57530-9; Lim CJ, 2021, NAT REV MOL CELL BIO, V22, P283, DOI 10.1038/s41580-021-00328-y; Litwin I, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120581; Makrantoni V, 2018, CURR BIOL, V28, pR688, DOI 10.1016/j.cub.2018.05.019; Masamsetti VP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12255-w; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; Minamino M, 2018, CURR BIOL, V28, P2665, DOI 10.1016/j.cub.2018.06.037; Mirkovic M, 2015, CELL REP, V13, P469, DOI 10.1016/j.celrep.2015.09.020; Morales C, 2020, J BIOL CHEM, V295, P146, DOI 10.1074/jbc.RA119.011099; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Peters JM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011130; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Roy S, 2018, J CELL BIOL, V217, P1521, DOI 10.1083/jcb.201709121; Samora CP, 2016, MOL CELL, V63, P371, DOI 10.1016/j.molcel.2016.05.036; Schuck PL, 2019, METHODS MOL BIOL, V1999, P335, DOI 10.1007/978-1-4939-9500-4_24; Setiaputra D, 2019, EMBO REP, V20, DOI 10.15252/embr.201847560; Sigoillot FD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025511; Silva RD, 2018, CURR BIOL, V28, P2837, DOI 10.1016/j.cub.2018.06.062; Song JH, 2012, J BIOL CHEM, V287, P34325, DOI 10.1074/jbc.M112.400192; Stewart JA, 2018, FRONT BIOSCI-LANDMRK, V23, P1564, DOI 10.2741/4661; Stewart JA, 2012, EMBO J, V31, P3537, DOI 10.1038/emboj.2012.215; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Villa F, 2016, MOL CELL, V63, P385, DOI 10.1016/j.molcel.2016.06.009; Wang YL, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800270; Wutz G, 2017, EMBO J, V36, P3573, DOI 10.15252/embj.201798004; Yoshizawa-Sugata N, 2009, J BIOL CHEM, V284, P20718, DOI 10.1074/jbc.M806711200; Zhang MM, 2019, NUCLEIC ACIDS RES, V47, P5243, DOI 10.1093/nar/gkz264; Zheng G, 2018, ELIFE, V7, DOI 10.7554/eLife.33920	50	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101026	10.1016/j.jbc.2021.101026	http://dx.doi.org/10.1016/j.jbc.2021.101026			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34339741	gold, Green Published			2022-12-26	WOS:000706408900002
J	Spiteri, VA; Goodall, M; Doutch, J; Rambo, RP; Gor, J; Perkins, SJ				Spiteri, Valentina A.; Goodall, Margaret; Doutch, James; Rambo, Robert P.; Gor, Jayesh; Perkins, Stephen J.			Solution structures of human myeloma IgG3 antibody reveal extended Fab and Fc regions relative to the other IgG subclasses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; X-RAY; NEUTRON-SCATTERING; FORCE-FIELD; PROTEIN-A; SEDIMENTATION; COMPLEMENT; SIMULATION; HYDRATION; PACKAGE	Human immunoglobulin G subclass 3 (IgG3) possesses a uniquely long hinge region that separates its Fab antigen binding and Fc receptor-binding regions. Owing to this hinge length, the molecular structure of full-length IgG3 remains elusive, and the role of the two conserved Fc glycosylation sites are unknown. To address these issues, we subjected glycosylated and deglycosylated human myeloma IgG3 to multidisciplinary solution structure studies. Using analytical ultracentrifugation, the elongated structure of IgG3 was determined from the reduced sedimentation coefficients s(20,w)(0) of 5.82 to 6.29 S for both glycosylated and deglycosylated IgG3. X-ray and neutron scattering showed that the Guinier RG values were 6.95 nm for glycosylated IgG3 and were unchanged after deglycosylation, again indicating an elongated structure. The distance distribution function P(r) showed a maximum length of 25 to 28 nm and three distinct maxima. The molecular structure of IgG3 was determined using atomistic modeling based on molecular dynamics simulations of the IgG3 hinge and Monte Carlo simulations to identify physically realistic arrangements of the Fab and Fc regions. This resulted in libraries containing 135,135 and 73,905 glycosylated and deglycosylated IgG3 structures, respectively. Comparisons with the X-ray and neutron scattering curves gave 100 best -fit models for each form of IgG3 that accounted for the experimental scattering curves. These models revealed the first molecular structures for full-length IgG3. The structures exhibited relatively restricted Fab and Fc conformations joined by an extended semirigid hinge, which explains the potent effector functions of IgG3 relative to the other subclasses IgG1, IgG2, and IgG4.	[Spiteri, Valentina A.; Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, Div Biosci, London, England; [Goodall, Margaret] Univ Birmingham, Inst Biomed Res, Birmingham, W Midlands, England; [Doutch, James] STFC Rutherford Appleton Lab, ISIS Facil, Harwell Campus, Didcot, Oxon, England; [Rambo, Robert P.] Diamond Light Source Ltd, Harwell Sci & Innovat Campus, Didcot, Oxon, England	University of London; University College London; University of Birmingham; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Diamond Light Source	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Div Biosci, London, England.	s.perkins@ucl.ac.uk		Spiteri, Valentina/0000-0002-5002-4989; Perkins, Stephen/0000-0001-9218-9805; Gor, Jayesh/0000-0002-1654-1392; Doutch, James/0000-0003-0747-8368	EPSRC Centre for Doctoral Training in Emergent Macromolecular Therapies [EP/L015218/1]; Diamond Light Source Ltd. [STU0174]; ISIS neutron facility joint PhD studentship; EPSRC [EP/K039121/1]; NSF [CHE01265821]	EPSRC Centre for Doctoral Training in Emergent Macromolecular Therapies(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Diamond Light Source Ltd.; ISIS neutron facility joint PhD studentship; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NSF(National Science Foundation (NSF))	V. A. S. was supported by an EPSRC Centre for Doctoral Training in Emergent Macromolecular Therapies (EP/L015218/1), Diamond Light Source Ltd. (STU0174), and ISIS neutron facility joint PhD studentship. S. J. P. was supported by a joint EPSRC (EP/K039121/1) and NSF (CHE01265821) grant for CCP-SAS.	Appeltshauser L, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000817; Arnold O, 2014, NUCL INSTRUM METH A, V764, P156, DOI 10.1016/j.nima.2014.07.029; Basham M, 2015, J SYNCHROTRON RADIAT, V22, P853, DOI 10.1107/S1600577515002283; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bogdanos DP, 2005, HEPATOLOGY, V42, P458, DOI 10.1002/hep.20788; Bondza S, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.609941; Bonner A, 2009, MUCOSAL IMMUNOL, V2, P74, DOI 10.1038/mi.2008.68; BRADY RL, 1992, J MOL BIOL, V227, P253, DOI 10.1016/0022-2836(92)90695-G; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cowieson NP, 2020, J SYNCHROTRON RADIAT, V27, P1438, DOI 10.1107/S1600577520009960; Damelang T, 2019, TRENDS IMMUNOL, V40, P197, DOI 10.1016/j.it.2019.01.005; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; Davies AM, 2014, J MOL BIOL, V426, P630, DOI 10.1016/j.jmb.2013.10.039; de Taeye SW, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00740; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fleming PJ, 2018, BIOPHYS J, V114, P856, DOI 10.1016/j.bpj.2018.01.002; Glatter O., 1982, SMALL ANGLE X RAY SC; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; GREGORY L, 1987, MOL IMMUNOL, V24, P821, DOI 10.1016/0161-5890(87)90184-2; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Heenan R. K., 2011, NEUTRON NEWS, V22, P19, DOI DOI 10.1080/10448632.2011.569531; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Hui GK, 2019, J BIOL CHEM, V294, P10789, DOI 10.1074/jbc.RA118.007134; Hui GK, 2015, BIOCHEM J, V471, P167, DOI 10.1042/BJ20150612; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jefferis R, 2007, EXPERT OPIN BIOL TH, V7, P1401, DOI 10.1517/14712598.7.9.1401; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2017, J COMPUT CHEM, V38, P1114, DOI 10.1002/jcc.24660; Jo S, 2011, J COMPUT CHEM, V32, P3135, DOI 10.1002/jcc.21886; Liu XB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12097-6; Lu YL, 2007, BIOPHYS J, V93, P3733, DOI 10.1529/biophysj.107.108993; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Miller BT, 2008, J CHEM INF MODEL, V48, P1920, DOI 10.1021/ci800133b; Park SJ, 2019, GLYCOBIOLOGY, V29, P320, DOI 10.1093/glycob/cwz003; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Perkins SJ, 2016, J APPL CRYSTALLOGR, V49, P1861, DOI 10.1107/S160057671601517X; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Phillips JC, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0014475; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PILZ I, 1970, BIOCHEMISTRY-US, V9, P211, DOI 10.1021/bi00804a004; Plomp R, 2015, MOL CELL PROTEOMICS, V14, P1373, DOI 10.1074/mcp.M114.047381; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; PUMPHREY RSH, 1986, IMMUNOL TODAY, V7, P206, DOI 10.1016/0167-5699(86)90106-4; Raman EP, 2010, J PHYS CHEM B, V114, P12981, DOI 10.1021/jp105758h; Rayner LE, 2015, J BIOL CHEM, V290, P8420, DOI 10.1074/jbc.M114.631002; Rayner LE, 2014, J BIOL CHEM, V289, P20740, DOI 10.1074/jbc.M114.572404; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Richardson SI, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008064; Round A, 2015, ACTA CRYSTALLOGR D, V71, P67, DOI 10.1107/S1399004714026959; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shah IS, 2017, MOL IMMUNOL, V92, P28, DOI 10.1016/j.molimm.2017.10.001; Shaw A, 2019, NAT NANOTECHNOL, V14, P184, DOI 10.1038/s41565-018-0336-3; Spiteri V. A., 2021, THESIS U COLL LONDON; Spiteri VA, 2021, BIOPHYS J, V120, P1814, DOI 10.1016/j.bpj.2021.02.038; Stapleton NM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1608; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Strasser J, 2019, NANO LETT, V19, P4787, DOI 10.1021/acs.nanolett.9b02220; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; VANLOGHEM E, 1982, SCAND J IMMUNOL, V15, P275; WALKER MR, 1989, BIOCHEM J, V259, P347, DOI 10.1042/bj2590347; Wang B, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2019.1690959; Watson MC, 2013, J APPL CRYSTALLOGR, V46, P1171, DOI 10.1107/S002188981301666X; Wright DW, 2019, BIOPHYS J, V117, P2101, DOI 10.1016/j.bpj.2019.10.024; Wright DW, 2015, J APPL CRYSTALLOGR, V48, P953, DOI 10.1107/S1600576715007062; Wuhrer M, 2007, PROTEOMICS, V7, P4070, DOI 10.1002/pmic.200700289; Zhang HZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000387; Zhang WH, 2017, J MOL GRAPH MODEL, V73, P179, DOI 10.1016/j.jmgm.2017.02.010; Zheng W., 2020, EXP THER MED, V21, P1	79	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100995	10.1016/j.jbc.2021.100995	http://dx.doi.org/10.1016/j.jbc.2021.100995			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34302810	Green Published, gold			2022-12-26	WOS:000706418900012
J	McCorkle, JR; Gorski, JW; Liu, JP; Riggs, MB; McDowell, AB; Lin, N; Wang, C; Ueland, FR; Kolesar, JM				McCorkle, J. Robert; Gorski, Justin W.; Liu, Jinpeng; Riggs, McKayla B.; McDowell, Anthony B.; Lin, Nan; Wang, Chi; Ueland, Frederick R.; Kolesar, Jill M.			Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer	PLOS ONE			English	Article							REVERSES MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN GENE; PHASE-II TRIAL; EPITHELIAL OVARIAN; PERITONEAL CANCERS; CELL-LINES; COMBINATION; EXPRESSION; INHIBITION; CISPLATIN	Conventional frontline treatment for ovarian cancer consists of successive chemotherapy cycles of paclitaxel and platinum. Despite the initial favorable responses for most patients, chemotherapy resistance frequently leads to recurrent or refractory disease. New treatment strategies that circumvent or prevent mechanisms of resistance are needed to improve ovarian cancer therapy. We established in vitro paclitaxel-resistant ovarian cancer cell line and organoid models. Gene expression differences in resistant and sensitive lines were analyzed by RNA sequencing. We manipulated candidate genes associated with paclitaxel resistance using siRNA or small molecule inhibitors, and then screened the cells for paclitaxel sensitivity using cell viability assays. We used the Bliss independence model to evaluate the anti-proliferative synergy for drug combinations. ABCB1 expression was upregulated in paclitaxel-resistant TOV-21G (q < 1x10(-300)), OVCAR3 (q = 7.4x10(-156)) and novel ovarian tumor organoid (p = 2.4x10(-4)) models. Previous reports have shown some tyrosine kinase inhibitors can inhibit ABCB1 function. We tested a panel of tyrosine kinase inhibitors for the ability to sensitize resistant ABCB1-overexpressing ovarian cancer cell lines to paclitaxel. We observed synergy when we combined poziotinib or lapatinib with paclitaxel in resistant TOV-21G and OVCAR3 cells. Silencing ABCB1 expression in paclitaxel-resistant TOV-21G and OVCAR3 cells reduced paclitaxel IC50 by 20.7 and 6.2-fold, respectively. Furthermore, we demonstrated direct inhibition of paclitaxel-induced ABCB1 transporter activity by both lapatinib and poziotinib. In conclusion, lapatinib and poziotinib combined with paclitaxel synergizes to inhibit the proliferation of ABCB1-overexpressing ovarian cancer cells in vitro. The addition of FDA-approved lapatinib to second-line paclitaxel therapy is a promising strategy for patients with recurrent ovarian cancer.	[McCorkle, J. Robert; Gorski, Justin W.; Liu, Jinpeng; Ueland, Frederick R.; Kolesar, Jill M.] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40506 USA; [Gorski, Justin W.; Riggs, McKayla B.; McDowell, Anthony B.; Ueland, Frederick R.] Univ Kentucky, Coll Med, Div Gynecol Oncol, Dept Obstet & Gynecol, Lexington, KY USA; [Lin, Nan; Kolesar, Jill M.] Univ Kentucky, Coll Pharm, Lexington, KY 40506 USA; [Wang, Chi] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Kolesar, JM (corresponding author), Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY 40506 USA.; Kolesar, JM (corresponding author), Univ Kentucky, Coll Pharm, Lexington, KY 40506 USA.	jill.kolesar@uky.edu	McCorkle, Rob/AAH-3759-2019; Riggs, McKayla/GYV-4252-2022	McCorkle, Rob/0000-0002-5028-8853; Gorski, Justin/0000-0002-4272-0183	National Institute of Health [P30 CA177558, T32 CA160003]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support of this work was provided by the National Institute of Health (www.nih.gov): P30 CA177558 (JMK) and T32 CA160003 (JWG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ M, 1995, J CLIN INVEST, V95, P2205, DOI 10.1172/JCI117910; American Cancer Society, CANC STAT CTR OV 201; Barbuti AM, 2015, CANCERS, V7, P2360, DOI 10.3390/cancers7040897; Beaubier N, 2019, NAT BIOTECHNOL, V37, P1351, DOI 10.1038/s41587-019-0259-z; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BusinessWire, 2020, BUSINESS WIRE; Cha MY, 2012, INT J CANCER, V130, P2445, DOI 10.1002/ijc.26276; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Chien AJ, 2009, CLIN CANCER RES, V15, P5569, DOI 10.1158/1078-0432.CCR-09-0522; Christie EL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09312-9; Chung FS, 2016, AM J CANCER RES, V6, P1583; Coley HM, 2006, BIOCHEM PHARMACOL, V72, P941, DOI 10.1016/j.bcp.2006.07.022; Crawford RR, 2018, DRUG METAB DISPOS, V46, P567, DOI 10.1124/dmd.118.080663; Cripe LD, 2010, BLOOD, V116, P4077, DOI 10.1182/blood-2010-04-277269; Dai CL, 2008, CANCER RES, V68, P7905, DOI 10.1158/0008-5472.CAN-08-0499; Di Leo A, 2008, J CLIN ONCOL, V26, P5544, DOI 10.1200/JCO.2008.16.2578; Dohse M, 2010, DRUG METAB DISPOS, V38, P1371, DOI 10.1124/dmd.109.031302; Fan YF, 2018, CANCER LETT, V421, P186, DOI 10.1016/j.canlet.2018.01.021; Gelmon KA, 2015, J CLIN ONCOL, V33, P1574, DOI 10.1200/JCO.2014.56.9590; Gorski JW., 2020, SOC GYNECOLOGIC ONCO; Guan ZZ, 2013, J CLIN ONCOL, V31, P1947, DOI 10.1200/JCO.2011.40.5241; Guo XF, 2018, CANCER CHEMOTH PHARM, V82, P383, DOI 10.1007/s00280-018-3627-3; HAMILTON TC, 1983, CANCER RES, V43, P5379; He LY, 2018, METHODS MOL BIOL, V1711, P351, DOI 10.1007/978-1-4939-7493-1_17; HOLZMAYER TA, 1992, J NATL CANCER I, V84, P1486, DOI 10.1093/jnci/84.19.1486; Hu SY, 2009, CLIN CANCER RES, V15, P6062, DOI 10.1158/1078-0432.CCR-09-0048; Jagiello-Gruszfeld A, 2010, ONCOLOGY-BASEL, V79, P129, DOI 10.1159/000318043; Jin W, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.378; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kathawala RJ, 2015, DRUG RESIST UPDATE, V18, P1, DOI 10.1016/j.drup.2014.11.002; Kelly RJ, 2011, CLIN CANCER RES, V17, P569, DOI 10.1158/1078-0432.CCR-10-1725; Kessler M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9989; Kitazaki T, 2005, LUNG CANCER, V49, P337, DOI 10.1016/j.lungcan.2005.03.035; Kumar S, 2010, INT J WOMENS HEALTH, V2, P411, DOI 10.2147/IJWH.S7012; Lee PC, 2013, ONCOGENE, V32, P1144, DOI 10.1038/onc.2012.133; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li F, 2011, DRUG DELIV TRANSL RE, V1, P420, DOI 10.1007/s13346-011-0042-2; Ma SL, 2014, MOL MED, V20, P390, DOI 10.2119/molmed.2014.00059; Markman M, 2006, GYNECOL ONCOL, V101, P436, DOI 10.1016/j.ygyno.2005.10.036; Mi Y, 2007, BRIT J CANCER, V97, P934, DOI 10.1038/sj.bjc.6603985; Nanayakkara AK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19325-x; Osman MA, 2016, CLIN MED INSIGHTS-ON, V10, P35, DOI 10.4137/CMO.S38204; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; OZOLS RF, 1987, J CLIN ONCOL, V5, P641, DOI 10.1200/JCO.1987.5.4.641; Parekh H, 1997, BIOCHEM PHARMACOL, V53, P461, DOI 10.1016/S0006-2952(97)83383-7; Penson RT, 2004, GYNECOL ONCOL, V93, P98, DOI 10.1016/j.ygyno.2003.11.053; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; Pignata S, 2017, ANN ONCOL, V28, P51, DOI 10.1093/annonc/mdx441; Promega, TECHN B PGP GLO ASS; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roskoski R, 2014, PHARMACOL RES, V87, P42, DOI 10.1016/j.phrs.2014.06.001; Schondorf T, 2002, ANTICANCER RES, V22, P2199; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sun S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166058; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Vergara D, 2012, NANOMED-NANOTECHNOL, V8, P891, DOI 10.1016/j.nano.2011.10.014; Wu SS, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0775-3; Yardley DA, 2013, BREAST CANCER RES TR, V137, P457, DOI 10.1007/s10549-012-2341-9; Zhang YC, 2020, CANCERS, V12, DOI 10.3390/cancers12113249	63	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2021	16	8							e0254205	10.1371/journal.pone.0254205	http://dx.doi.org/10.1371/journal.pone.0254205			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IY	34347777	gold, Green Published			2022-12-26	WOS:000685264900015
J	Huang, LW; So, PK; Chen, YW; Leung, YC; Yao, ZP				Huang, Liwen; So, Pui-Kin; Chen, Yu Wai; Leung, Yun-Chung; Yao, Zhong-Ping			Interdomain flexibility and interfacial integrity of beta-lactamase inhibitory protein (BLIP) modulate its binding to class A beta 3-lactamases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-DEUTERIUM EXCHANGE; DYNAMICS; SIMULATIONS; CHALLENGES; AFFINITY; POTENT; STATE; TEM-1	beta-Lactamase inhibitory protein (BLIP) consists of a tandem repeat of alpha beta domains conjugated by an interdomain loop and can effectively bind and inactivate class A beta-lactamases, which are responsible for resistance of bacteria to beta-lactam antibiotics. The varied ability of BLIP to bind different beta-lactamases and the structural determinants for significant enhancement of BLIP variants with a point mutation are poorly understood. Here, we investigated the conformational dynamics of BLIP upon binding to three clinically prevalent class A beta-lactamases (TEM1, SHV1, and PC1) with dissociation constants between subnanomolar and micromolar. Hydrogen deuterium exchange mass spectrometry revealed that the flexibility of the interdomain region was significantly suppressed upon strong binding to TEM1, but was not significantly changed upon weak binding to SHV1 or PC1. E73M and K74G mutations in the interdomain region improved binding affinity toward SHV1 and PC1, respectively, showing significantly increased flexibility of the interdomain region compared to the wild-type and favorable conformational changes upon binding. In contrast, more rigidity of the interfacial loop 135-145 was observed in these BLIP mutants in both free and bound states. Consistently, molecular dynamics simulations of BLIP exhibited drastic changes in the flexibility of the loop 135-145 in all complexes. Our results indicated for the first time that higher flexibility of the interdomain linker, as well as more rigidity of the interfacial loop 135-145, could be desirable determinants for enhancing inhibition of BLIP to class A beta-lactamases. Together, these findings provide unique insights into the design of enhanced inhibitors.	[Huang, Liwen; So, Pui-Kin; Chen, Yu Wai; Leung, Yun-Chung; Yao, Zhong-Ping] Hong Kong Polytech Univ, State Key Lab Chem Biol & Drug Discovery, Res Inst Future Food, Hung Hom,Kowloon, Hong Kong, Peoples R China; [Huang, Liwen; So, Pui-Kin; Chen, Yu Wai; Leung, Yun-Chung; Yao, Zhong-Ping] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hung Hom, Kowloon, Hong Kong, Peoples R China; [Huang, Liwen; Yao, Zhong-Ping] Hong Kong Polytech Univ, State Key Lab Chinese Med & Mol Pharmacol Incubat, Shenzhen, Peoples R China; [Huang, Liwen; Yao, Zhong-Ping] Hong Kong Polytech Univ, Shenzhen Key Lab Food Biol Safety Control, Shenzhen Res Inst, Shenzhen, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University; Hong Kong Polytechnic University; Hong Kong Polytechnic University	Yao, ZP (corresponding author), Hong Kong Polytech Univ, State Key Lab Chem Biol & Drug Discovery, Res Inst Future Food, Hung Hom,Kowloon, Hong Kong, Peoples R China.; Yao, ZP (corresponding author), Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hung Hom, Kowloon, Hong Kong, Peoples R China.; Yao, ZP (corresponding author), Hong Kong Polytech Univ, State Key Lab Chinese Med & Mol Pharmacol Incubat, Shenzhen, Peoples R China.; Yao, ZP (corresponding author), Hong Kong Polytech Univ, Shenzhen Key Lab Food Biol Safety Control, Shenzhen Res Inst, Shenzhen, Peoples R China.	zhongping.yao@polyu.edu.hk	Chen, Yu Wai/AAJ-8037-2020; Yao, Zhong-Ping/K-2117-2014	Chen, Yu Wai/0000-0001-7833-7533; Yao, Zhong-Ping/0000-0003-3555-9632	Hong Kong Research Grants Council [153040/15P, 153348/16P, 153041/17P, 15304020, R5013-19F, C5031-14E, C4002-17G, R4005-18]; Natural Science Foundation of China [81874306]; China Resources Life Sciences Group Limited	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Resources Life Sciences Group Limited	This work was supported by Hong Kong Research Grants Council (Grant Nos. 153040/15P, 153348/16P, 153041/17P, 15304020, R5013-19F, C5031-14E, C4002-17G, and R4005-18), Natural Science Foundation of China (Grant No. 81874306), and China Resources Life Sciences Group Limited. We thank Prof Lars Konermann (Western Ontario University) for his support in the MD simulation, and The University Research Facility in Chemical and Environmental Analysis and The University Research Facility in Life Sciences of The Hong Kong Polytechnic University for their technical supports.	Bonomo Robert A, 2017, Cold Spring Harb Perspect Med, V7, DOI 10.1101/cshperspect.a025239; Brown KA, 2017, ANALYST, V142, P2874, DOI 10.1039/c7an00662d; Brown TD, 2020, NAT REV MATER, V5, P127, DOI 10.1038/s41578-019-0156-6; Bruix M, 2008, BIOPHYS J, V94, P2297, DOI 10.1529/biophysj.107.122952; Bush K, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025247; Calabrese AN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15702-1; Craig PO, 2011, J AM CHEM SOC, V133, P17463, DOI 10.1021/ja207506z; Guttman M, 2013, J AM SOC MASS SPECTR, V24, P1906, DOI 10.1007/s13361-013-0727-5; Hamuro Y, 2018, J AM SOC MASS SPECTR, V29, P623, DOI 10.1007/s13361-017-1860-3; Hanes MS, 2011, PROTEINS, V79, P1267, DOI 10.1002/prot.22961; Hanes MS, 2009, BIOCHEMISTRY-US, V48, P9185, DOI 10.1021/bi9007963; Harrison RA, 2016, CURR OPIN STRUC BIOL, V41, P187, DOI 10.1016/j.sbi.2016.08.003; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Huang LW, 2020, J AM CHEM SOC, V142, P13756, DOI 10.1021/jacs.0c04088; Huang LW, 2019, RAPID COMMUN MASS SP, V33, P83, DOI 10.1002/rcm.8307; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Maragakis P, 2008, J PHYS CHEM B, V112, P6155, DOI 10.1021/jp077018h; Martens C, 2019, NAT PROTOC, V14, P3183, DOI 10.1038/s41596-019-0219-6; Masson GR, 2017, EXPERT OPIN DRUG DIS, V12, P981, DOI 10.1080/17460441.2017.1363734; McAllister RG, 2015, BIOCHEMISTRY-US, V54, P2683, DOI 10.1021/acs.biochem.5b00215; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reynolds KA, 2008, J MOL BIOL, V382, P1265, DOI 10.1016/j.jmb.2008.05.051; Reynolds KA, 2006, J BIOL CHEM, V281, P26745, DOI 10.1074/jbc.M603878200; Skinner JJ, 2014, P NATL ACAD SCI USA, V111, P15975, DOI 10.1073/pnas.1404213111; STRYNADKA NCJ, 1994, NATURE, V368, P657, DOI 10.1038/368657a0; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P290, DOI 10.1038/nsb0396-290; Tooke CL, 2019, J MOL BIOL, V431, P3472, DOI 10.1016/j.jmb.2019.04.002; Trabjerg E, 2018, TRAC-TREND ANAL CHEM, V106, P125, DOI 10.1016/j.trac.2018.06.008; Vendruscolo M, 2003, J AM CHEM SOC, V125, P15686, DOI 10.1021/ja036523z; Wang JH, 2007, J BIOL CHEM, V282, P17676, DOI 10.1074/jbc.M611548200; Wang W, 2009, J AM CHEM SOC, V131, P787, DOI 10.1021/ja8076022; Yao ZP, 2006, J MOL BIOL, V363, P673, DOI 10.1016/j.jmb.2006.08.032; Ye X, 2019, P NATL ACAD SCI USA, V116, P7333, DOI 10.1073/pnas.1816184116; Yuan J, 2011, J MOL BIOL, V406, P730, DOI 10.1016/j.jmb.2011.01.014; Zhang Z, 2003, J BIOL CHEM, V278, P45706, DOI 10.1074/jbc.M308572200; Zhu SL, 2017, BIOCHEMISTRY-US, V56, P4127, DOI 10.1021/acs.biochem.7b00193	38	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100980	10.1016/j.jbc.2021.100980	http://dx.doi.org/10.1016/j.jbc.2021.100980			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34302811	gold, Green Published			2022-12-26	WOS:000690868100009
J	Jiang, CL; Chen, YF; Lin, FJ				Jiang, Chung-Lin; Chen, Ying-Fang; Lin, Fu-Jung			Apolipoprotein E deficiency activates thermogenesis of white adipose tissues in mice through enhancing beta-hydroxybutyrate production from precursor cells	FASEB JOURNAL			English	Article						apolipoprotein E; browning; white adipose tissue; beta-hydroxybutyrate	GENE-EXPRESSION; ADIPOCYTE PROGENITORS; LDL RECEPTOR; FATTY-ACIDS; BROWN; CD36; HYPERCHOLESTEROLEMIA; DIFFERENTIATION; IDENTIFICATION; ACCUMULATION	White adipose tissue (WAT) has the capacity to undergo a white-to-beige phenotypic switch, known as browning, in response to stimuli such as cold. However, the mechanism underlying beige adipocyte formation is largely unknown. Apolipoprotein E (ApoE) is highly induced in WAT and has been implicated in lipid metabolism. Here, we show that ApoE deficiency in mice increased oxygen consumption and thermogenesis and enhanced adipose browning pattern in inguinal WAT (iWAT), with associated characteristics such as increased Ucp1 and Ppar. expression. At the cellular level, ApoE deficient beige adipocytes had increased glucose uptake and higher mitochondrial respiration than wild-type cells. Mechanistically, we showed that ApoE deficient iWAT and primary adipose precursor cells activated the thermogenic genes program by stimulating the production of ketone body beta-hydroxybutyrate (beta HB), a novel adipose browning promoting factor. This was accompanied by increased expression of genes involved in ketogenesis and could be compromised by the treatment for ketogenesis inhibitors. Consistently, ApoE deficient mice show higher serum beta HB level than wild-type mice in the fed state and during cold exposure. Our results further demonstrate that the increased beta HB production in ApoE deficient adipose precursor cells could be attributed, at least in part, to enhanced Cd36 expression and CD36-mediated fatty acid utilization. Our findings uncover a previously uncharacterized role for ApoE in energy homeostasis via its cell-autonomous action in WAT.	[Jiang, Chung-Lin; Chen, Ying-Fang; Lin, Fu-Jung] Natl Taiwan Univ, Dept Biochem Sci & Technol, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan; [Lin, Fu-Jung] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University	Lin, FJ (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	fujlin@ntu.edu.tw		Jiang, Chung-Lin/0000-0001-8293-2984; LIN, FU-JUNG/0000-0003-4065-0983	Ministry of Science and Technology, Taiwan (MOST) [MOST 107--2320--B--002--004--MY3]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 107--2320--B--002--004--MY3	Adijanto J, 2014, J BIOL CHEM, V289, P20570, DOI 10.1074/jbc.M114.565457; Bartelt A, 2011, DIABETOLOGIA, V54, P2900, DOI 10.1007/s00125-011-2274-6; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Carriere A, 2014, DIABETES, V63, P3253, DOI 10.2337/db13-1885; Christiaens V, 2012, BBA-GEN SUBJECTS, V1820, P949, DOI 10.1016/j.bbagen.2012.04.001; Cinti S, 2018, TRENDS ENDOCRIN MET, V29, P651, DOI 10.1016/j.tem.2018.05.007; Coort SLM, 2002, MOL CELL BIOCHEM, V239, P213, DOI 10.1023/A:1020539932353; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; El-Lebedy D, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0329-1; Fabbiano S, 2016, CELL METAB, V24, P434, DOI 10.1016/j.cmet.2016.07.023; Gao H, 2017, STEM CELLS, V35, P1799, DOI 10.1002/stem.2635; Gao JH, 2007, DIABETES, V56, P24, DOI 10.2337/db06-0144; Grabacka MM, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00005; Huang ZH, 2015, J LIPID RES, V56, P215, DOI 10.1194/jlr.M050567; Huang ZH, 2009, AM J PHYSIOL-ENDOC M, V296, pE1110, DOI 10.1152/ajpendo.90964.2008; Hui XY, 2015, CELL METAB, V22, P279, DOI 10.1016/j.cmet.2015.06.004; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Ruiz-Ojeda FJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071040; Jones NS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010063; Lee CC, 2019, MOL CELL, V76, P500, DOI 10.1016/j.molcel.2019.07.026; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Locke M, 2009, ANZ J SURG, V79, P235, DOI 10.1111/j.1445-2197.2009.04852.x; Merat S, 1999, ARTERIOSCL THROM VAS, V19, P1223, DOI 10.1161/01.ATV.19.5.1223; Morroni M, 2004, P NATL ACAD SCI USA, V101, P16801, DOI 10.1073/pnas.0407647101; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Newman JC, 2017, ANNU REV NUTR, V37, P51, DOI 10.1146/annurev-nutr-071816-064916; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Nonaka Y, 2016, J OLEO SCI, V65, P693, DOI 10.5650/jos.ess16069; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Pepino MY, 2014, ANNU REV NUTR, V34, P281, DOI 10.1146/annurev-nutr-071812-161220; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Takagi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18944; Torres-Perez E, 2016, ATHEROSCLEROSIS, V245, P35, DOI 10.1016/j.atherosclerosis.2015.11.029; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wang WS, 2019, CELL METAB, V30, P174, DOI 10.1016/j.cmet.2019.05.005; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Xie ZY, 2016, MOL CELL, V62, P194, DOI 10.1016/j.molcel.2016.03.036; ZECHNER R, 1991, J BIOL CHEM, V266, P10583; Zhang HF, 2020, NAT CELL BIOL, V22, P18, DOI 10.1038/s41556-019-0440-0; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhuang QS, 2017, ONCOTARGET, V8, P55915, DOI 10.18632/oncotarget.19115	51	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21760	10.1096/fj.202100298RR	http://dx.doi.org/10.1096/fj.202100298RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34309918				2022-12-26	WOS:000678975300011
J	Prentoe, J; Janitzek, CM; Velazquez-Moctezuma, R; Goksoyr, L; Olsen, RW; Fanalista, M; Augestad, EH; Thrane, S; Pihl, AF; Gottwein, JM; Sander, AF; Bukh, J				Prentoe, Jannick; Janitzek, Christoph M.; Velazquez-Moctezuma, Rodrigo; Goksoyr, Louise; Olsen, Rebecca W.; Fanalista, Margherita; Augestad, Elias H.; Thrane, Susan; Pihl, Anne F.; Gottwein, Judith M.; Sander, Adam F.; Bukh, Jens			Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens	PLOS ONE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES; CELL-CULTURE SYSTEMS; TRANSMEMBRANE DOMAINS; MAJOR ROLE; GLYCOPROTEIN; HCV; IMMUNIZATION; REPLICATION; EXPRESSION	Yearly, about 1.5 million people become chronically infected with hepatitis C virus (HCV) and for the 71 million with chronic HCV infection about 400,000 die from related morbidities, including liver cirrhosis and cancer. Effective treatments exist, but challenges including cost-of-treatment and wide-spread undiagnosed infection, necessitates the development of vaccines. Vaccines should induce neutralizing antibodies (NAbs) against the HCV envelope (E) transmembrane glycoprotein 2, E2, which partly depends on its interaction partner, E1, for folding. Here, we generated three soluble HCV envelope protein antigens with the transmembrane regions deleted (i.e., fused peptide backbones), termed sE1E2 (E1 followed by E2), sE2E1 (E2 followed by E1), and sE21E (E2 followed by inverted E1). The E1 inversion for sE21E positions C-terminal residues of E1 near C-terminal residues of E2, which is in analogy to how they likely interact in native E1/E2 complexes. Probing conformational E2 epitope binding using HCV patient-derived human monoclonal antibodies, we show that sE21E was superior to sE2E1, which was consistently superior to sE1E2. This correlated with improved induction of NAbs by sE21E compared with sE2E1 and especially compared with sE1E2 in female BALB/c mouse immunizations. The deletion of the 27 N-terminal amino acids of E2, termed hypervariable region 1 (HVR1), conferred slight increases in antigenicity for sE2E1 and sE21E, but severely impaired induction of antibodies able to neutralize in vitro viruses retaining HVR1. Finally, comparing sE21E with sE2 in mouse immunizations, we show similar induction of heterologous NAbs. In summary, we find that C-terminal E2 fusion of E1 or 1E is superior to N-terminal fusion, both in terms of antigenicity and the induction of heterologous NAbs. This has relevance when designing HCV E1E2 vaccine antigens.	[Prentoe, Jannick; Velazquez-Moctezuma, Rodrigo; Fanalista, Margherita; Augestad, Elias H.; Pihl, Anne F.; Gottwein, Judith M.; Bukh, Jens] Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, Copenhagen Hepatitis C Program CO HEP, Copenhagen, Denmark; [Prentoe, Jannick; Velazquez-Moctezuma, Rodrigo; Fanalista, Margherita; Augestad, Elias H.; Pihl, Anne F.; Gottwein, Judith M.; Bukh, Jens] Hvidovre Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Janitzek, Christoph M.; Goksoyr, Louise; Olsen, Rebecca W.; Thrane, Susan; Sander, Adam F.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, Ctr Med Parasitol CMP, Copenhagen, Denmark; [Janitzek, Christoph M.; Goksoyr, Louise; Olsen, Rebecca W.; Thrane, Susan; Sander, Adam F.] Copenhagen Univ Hosp, Dept Infect Dis, Rigshosp, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Prentoe, J (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, Copenhagen Hepatitis C Program CO HEP, Copenhagen, Denmark.; Prentoe, J (corresponding author), Hvidovre Univ Hosp, Dept Infect Dis, Hvidovre, Denmark.	Jprentoe@sund.ku.dk		Thrane, Susan/0000-0001-6596-3527; Bertelsen, Adam Frederik Sander/0000-0002-8782-7830; Olsen, Rebecca Wendelboe/0000-0003-4034-4302; Goksoyr, Louise/0000-0003-4508-9857; Velazquez-Moctezuma, Rodrigo/0000-0001-9865-152X; Gottwein, Judith/0000-0003-2805-0256; Janitzek, Christoph Mikkel/0000-0001-6529-9355; Bukh, Jens/0000-0002-7815-4806; Prentoe, Jannick/0000-0003-2203-9478	Candys Foundation; Danish Council for Independent Research, Medical Sciences [11-116529]; Lundbeck Foundation [R324-2019-1375, R335-2019-2052]; Novo Nordisk Foundation; Danish Council for Independent Research, Medical Sciences; Danish Council for Independent Research; Novo Nordisk Prize; Novo Nordisk Foundation Distinguished Investigator Award; Lundbeck Foundation Fellowship	Candys Foundation; Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Novo Nordisk Prize; Novo Nordisk Foundation Distinguished Investigator Award; Lundbeck Foundation Fellowship	This work was supported by Ph.D. stipends from the Candys Foundation (EHA, AFP, JG, JB, JP), an individual DFF-postdoctoral grant from the Danish Council for Independent Research, Medical Sciences (URL: https://dff.dk/) (JP grant no. 11-116529), and research grants from the Lundbeck Foundation (URL: https://www.lundbeckfonden.com/en/; JB: grant no. N/A and JP: grant no. R324-2019-1375 and R335-2019-2052), the Novo Nordisk Foundation ((URL: https://novonordiskfonden.dk/en/; JG and JB), the Danish Council for Independent Research, Medical Sciences (JG and JB), and a Sapere Aude advanced top researcher grant from the Danish Council for Independent Research (JB). JB is the recipient of the 2015 Novo Nordisk Prize and the 2019 Novo Nordisk Foundation Distinguished Investigator Award. JP was awarded a 2019 Lundbeck Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2008, BBA-PROTEINS PROTEOM, V1784, P916, DOI 10.1016/j.bbapap.2008.02.009; Akazawa D, 2013, GASTROENTEROLOGY, V145, P447, DOI 10.1053/j.gastro.2013.05.007; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Augestad EH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb5938; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Bartenschlager R, 2018, VIRUS RES, V248, P53, DOI 10.1016/j.virusres.2018.02.016; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brazzoli M, 2005, VIROLOGY, V332, P438, DOI 10.1016/j.virol.2004.11.034; Bukh J., 2016, J HEPATOL, V65, pS2, DOI 10.1016/j.jhep.2016.07.035; Ciczora Y, 2007, J VIROL, V81, P2372, DOI 10.1128/JVI.02198-06; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; Cocquerel L, 2003, J VIROL, V77, P1604, DOI 10.1128/JVI.77.2.1604-1609.2003; De Beeck AO, 2000, J BIOL CHEM, V275, P31428, DOI 10.1074/jbc.M003003200; Deleersnyder V, 1997, J VIROL, V71, P697, DOI 10.1128/JVI.71.1.697-704.1997; Dubuisson J, 1996, J VIROL, V70, P778, DOI 10.1128/JVI.70.2.778-786.1996; Dubuisson J, 2008, CELL MICROBIOL, V10, P821, DOI 10.1111/j.1462-5822.2007.01107.x; Garcia-Machorro J, 2013, HUM VACC IMMUNOTHER, V9, P2326, DOI 10.4161/hv.25673; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2010, J VIROL, V84, P5277, DOI 10.1128/JVI.02667-09; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Guest JD, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015149118; GUPTASARMA P, 1992, FEBS LETT, V310, P205, DOI 10.1016/0014-5793(92)81333-H; Hadlock KG, 2000, J VIROL, V74, P10407, DOI 10.1128/JVI.74.22.10407-10416.2000; Keck ZY, 2008, J VIROL, V82, P6061, DOI 10.1128/JVI.02475-07; Keck ZY, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007772; Kefala A, 2017, ACTA CRYSTALLOGR F, V73, P51, DOI 10.1107/S2053230X16020173; Law JLM, 2018, J VIROL, V92, DOI 10.1128/JVI.02141-17; Law JLM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059776; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Li DP, 2017, J INFECT DIS, V215, P1824, DOI 10.1093/infdis/jix180; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lothert K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72328-5; Mathiesen CK, 2015, J VIROL, V89, P7758, DOI 10.1128/JVI.00039-15; Mathiesen CK, 2014, VIROLOGY, V458, P190, DOI 10.1016/j.virol.2014.03.021; Merola M, 2001, J VIROL, V75, P11205, DOI 10.1128/JVI.75.22.11205-11217.2001; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Michalak JP, 1997, J GEN VIROL, V78, P2299, DOI 10.1099/0022-1317-78-9-2299; Owsianka A, 2005, J VIROL, V79, P11095, DOI 10.1128/JVI.79.17.11095-11104.2005; Patel J, 2001, VIROLOGY, V279, P58, DOI 10.1006/viro.2000.0693; Pierce BG, 2020, J VIROL, V94, DOI 10.1128/JVI.00704-20; Pihl AF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35010-5; Prentoe J, 2019, P NATL ACAD SCI USA, V116, P10039, DOI 10.1073/pnas.1822002116; Prentoe J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02146; Prentoe J, 2016, GUT, V65, P1988, DOI 10.1136/gutjnl-2015-310300; Prentoe J, 2016, HEPATOLOGY, V64, P1881, DOI 10.1002/hep.28705; Prentoe J, 2011, J VIROL, V85, P2224, DOI 10.1128/JVI.01594-10; Ruwona TB, 2014, J VIROL, V88, P10459, DOI 10.1128/JVI.01584-14; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Sridhar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107647; Stamataki Z, 2007, VACCINE, V25, P7773, DOI 10.1016/j.vaccine.2007.08.053; Tello D, 2015, J VIROL METHODS, V213, P38, DOI 10.1016/j.jviromet.2014.11.020; Tello D, 2010, PROTEIN EXPRES PURIF, V71, P123, DOI 10.1016/j.pep.2010.02.012; Velazquez-Moctezuma R, 2019, J VIROL, V93, DOI 10.1128/JVI.01909-18; Velazquez-Moctezuma R, 2019, J INFECT DIS, V219, P68, DOI 10.1093/infdis/jiy481; Velazquez-Moctezuma R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006214; Vietheer PT, 2017, HEPATOLOGY, V65, P1117, DOI 10.1002/hep.28989; Wang XS, 2019, GUT, V68, P140, DOI 10.1136/gutjnl-2017-314870; World Health Organization, 2018, HEP C FACT SHEET HEP C FACT SHEET; Yanagi M, 1999, VIROLOGY, V262, P250, DOI 10.1006/viro.1999.9889; Yokokawa H, 2018, GUT, V67, P372, DOI 10.1136/gutjnl-2016-312208	61	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255336	10.1371/journal.pone.0255336	http://dx.doi.org/10.1371/journal.pone.0255336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329365	Green Published, gold			2022-12-26	WOS:000685248600015
J	Raleigh, MD; Beltraminelli, N; Fallot, S; LeSage, MG; Saykao, A; Pentel, PR; Fuller, S; Thisted, T; Biesova, Z; Horrigan, S; Sampey, D; Zhou, B; Kalnik, MW				Raleigh, Michael D.; Beltraminelli, Nicola; Fallot, Stephanie; LeSage, Mark G.; Saykao, Amy; Pentel, Paul R.; Fuller, Steve; Thisted, Thomas; Biesova, Zuzanna; Horrigan, Stephen; Sampey, Darryl; Zhou, Bin; Kalnik, Matthew W.			Attenuating nicotine's effects with high affinity human anti-nicotine monoclonal antibodies	PLOS ONE			English	Article							RECEPTOR PARTIAL AGONIST; SUSTAINED-RELEASE BUPROPION; SMOKING-CESSATION; CONJUGATE VACCINE; REDUCES NICOTINE; IN-VIVO; RATS; VARENICLINE; BINDING; IMMUNOGENICITY	Use of nicotine-specific monoclonal antibodies (mAbs) to sequester and reduce nicotine distribution to brain has been proposed as a therapeutic approach to treat nicotine addiction (the basis of tobacco use disorder). A series of monoclonal antibodies with high affinity for nicotine (nic center dot mAbs) was isolated from B-cells of vaccinated smokers. Genes encoding 32 unique nicotine binding antibodies were cloned, and the mAbs expressed and tested by surface plasmon resonance to determine their affinity for S-(-)-nicotine. The highest affinity nic center dot mAbs had binding affinity constants (K-D) between 5 and 67 nM. The 4 highest affinity nic center dot mAbs were selected to undergo additional secondary screening for antigen-specificity, protein properties (including aggregation and stability), and functional in vivo studies to evaluate their capacity for reducing nicotine distribution to brain in rats. The 2 most potent nic center dot mAbs in single-dose nicotine pharmacokinetic experiments were further tested in a dose-response in vivo study. The most potent lead, ATI-1013, was selected as the lead candidate based on the results of these studies. Pretreatment with 40 and 80 mg/kg ATI-1013 reduced brain nicotine levels by 56 and 95%, respectively, in a repeated nicotine dosing experiment simulating very heavy smoking. Nicotine self-administration was also significantly reduced in rats treated with ATI-1013. A pilot rat 30-day repeat-dose toxicology study (4x200mg/kg ATI-1013) in the presence of nicotine indicated no drug-related safety concerns. These data provide evidence that ATI-1013 could be a potential therapy for the treatment of nicotine addiction.	[Raleigh, Michael D.; LeSage, Mark G.; Saykao, Amy; Pentel, Paul R.] Hennepin Healthcare Res Inst, Minneapolis, MN USA; [Raleigh, Michael D.] Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA; [Beltraminelli, Nicola; Fallot, Stephanie] Blink Biomed, Marseille, France; [LeSage, Mark G.; Pentel, Paul R.; Fuller, Steve; Thisted, Thomas; Sampey, Darryl; Zhou, Bin; Kalnik, Matthew W.] Nic mAb Strateg Alliance, San Diego, CA USA; [Fuller, Steve; Thisted, Thomas; Biesova, Zuzanna; Kalnik, Matthew W.] Antidote Therapeut Inc, Woodbine, MD 21797 USA; [Horrigan, Stephen] Noble Life Sci, Woodbine, MD USA; [Sampey, Darryl] Biofactura Inc, Frederick, MD USA; [Zhou, Bin] Scripps Res Inst, La Jolla, CA 92037 USA	University of Minnesota System; University of Minnesota Twin Cities; Scripps Research Institute	Kalnik, MW (corresponding author), Nic mAb Strateg Alliance, San Diego, CA USA.; Kalnik, MW (corresponding author), Antidote Therapeut Inc, Woodbine, MD 21797 USA.	mkalnik@antidotetx.com			National Institute of Health - National Institute on Drug Abuse (NIDA) [R01 DA038877]; NIDA fund	National Institute of Health - National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDA fund	R01 DA038877 (MK PI) entitled "Lead Optimization and Preclinical Development of Nicotinespecific mAbs" as a Strategic Alliances for Medications Development to Treat Substance Use Disorders awarded by the National Institute of Health -National Institute on Drug Abuse (NIDA) https://www.drugabuse.gov/.NIDA funding was obtained based on the proposed studies, but the Institute had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. As the prime awardee of the Nic center dot mAb Strategic Alliance, Antidote Therapeutics (ATI) had a significant role in study design, data collection and analysis, decision to publish, or preparation of the manuscript as this program was run as a consortium with regular steering committee meetings with all subawardees and subcontractors, led by ATI.	Baird TJ, 2000, J PHARMACOL EXP THER, V295, P1127; BazinRedureau MI, 1997, J PHARM PHARMACOL, V49, P277, DOI 10.1111/j.2042-7158.1997.tb06795.x; Beerli RR, 2008, P NATL ACAD SCI USA, V105, P14336, DOI 10.1073/pnas.0805942105; Billen B, 2012, P NATL ACAD SCI USA, V109, P9173, DOI 10.1073/pnas.1116397109; Bogen IL, 2014, J PHARMACOL EXP THER, V349, P568, DOI 10.1124/jpet.113.212035; Cahill K, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009329.pub2, 10.1002/14651858.CD006103.pub6]; Carrera MRA, 2004, BIOORGAN MED CHEM, V12, P563, DOI 10.1016/j.bmc.2003.11.029; Cornish KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082557; Cornuz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002547; Dansirikul C, 2005, COMPUT BIOL MED, V35, P389, DOI 10.1016/j.compbiomed.2004.02.008; Esterlis I, 2013, AM J PSYCHIAT, V170, P399, DOI 10.1176/appi.ajp.2012.12060793; Fahim REF, 2013, EXPERT REV VACCINES, V12, P333, DOI [10.1586/erv.13.13, 10.1586/ERV.13.13]; Fahim REF, 2011, CNS NEUROL DISORD-DR, V10, P905; Furst DE, 2003, J RHEUMATOL, V30, P2563; GlaxoSmithKline, 2018, ZYB BUPR TABL PACK I ZYB BUPR TABL PACK I; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Gorelick DA, 2012, FUTURE MED CHEM, V4, P227, DOI [10.4155/FMC.11.190, 10.4155/fmc.11.190]; Harris AC, 2015, DRUG ALCOHOL DEPEN, V153, P330, DOI 10.1016/j.drugalcdep.2015.06.005; Hartmann-Boyce J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007072.pub2; Hatsukami DK, 2011, CLIN PHARMACOL THER, V89, P392, DOI 10.1038/clpt.2010.317; Hatsukami DK, 2005, CLIN PHARMACOL THER, V78, P456, DOI 10.1016/j.clpt.2005.08.007; HENNINGFIELD JE, 1985, J PHARMACOL EXP THER, V234, P1; Hicks MJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003611; Hieda Y, 1999, PSYCHOPHARMACOLOGY, V143, P150, DOI 10.1007/s002130050930; Hughes JR, 2011, NICOTINE TOB RES, V13, P1228, DOI 10.1093/ntr/ntr207; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Isomura S, 2001, J ORG CHEM, V66, P4115, DOI 10.1021/jo001442w; Jabbour E, 2020, LANCET HAEMATOL, V7, pE523, DOI 10.1016/S2352-3026(20)30144-7; JACOB P, 1981, J CHROMATOGR, V222, P61, DOI 10.1016/S0378-4347(00)81033-6; Jamal A, 2016, MMWR-MORBID MORTAL W, V65, P1205, DOI 10.15585/mmwr.mm6544a2; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Kalnik M., 2016, THERAPEUTIC VACCINES, V1 ed; Kalnik M, 2012, PCT/US patent, Patent No. 20110182918; Keenan KP, 1999, TOXICOL SCI, V52, P24, DOI 10.1093/toxsci/52.2.24; Kelley B, 2009, MABS-AUSTIN, V1, P443, DOI 10.4161/mabs.1.5.9448; Kelly RL, 2015, MABS-AUSTIN, V7, P770, DOI 10.1080/19420862.2015.1043503; Keyler DE, 2008, INT IMMUNOPHARMACOL, V8, P1589, DOI 10.1016/j.intimp.2008.07.001; Keyler D E, 1999, Nicotine Tob Res, V1, P241, DOI 10.1080/14622299050011361; Keyler DE, 2005, DRUG METAB DISPOS, V33, P1056, DOI 10.1124/dmd.105.004234; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; LeSage Mark G, 2016, Tob Regul Sci, V2, P329, DOI 10.18001/TRS.2.4.5; LeSage MG, 2010, PSYCHOPHARMACOLOGY, V209, P203, DOI 10.1007/s00213-010-1792-0; LeSage MG, 2003, PSYCHOPHARMACOLOGY, V170, P278, DOI 10.1007/s00213-003-1539-2; LeSage MG, 2002, PHARMACOL BIOCHEM BE, V72, P279, DOI 10.1016/S0091-3057(01)00775-4; Lockner JW, 2015, J MED CHEM, V58, P1005, DOI 10.1021/jm501625j; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; Maurer P, 2005, EUR J IMMUNOL, V35, P2031, DOI 10.1002/eji.200526285; McInnes IB, 2020, LANCET, V395, P1496, DOI 10.1016/S0140-6736(20)30564-X; Montoya ID, 2016, BIOLOGICS TREAT SUBS, V1; Mukhin A, 2013, J NUCL MED, V54; Office of the Surgeon General (US); Office on Smoking and Health (US), 2004, HLTH CONS SMOK REP S; Pentel PR, 2014, ADV PHARMACOL, V69, P553, DOI 10.1016/B978-0-12-420118-7.00014-7; Pfizer, 2018, CHANT VAR TABL PACK CHANT VAR TABL PACK; Raleigh MD, 2018, J PHARMACOL EXP THER, V365, P346, DOI 10.1124/jpet.117.247049; Raupach Tobias, 2012, Drugs, V72, pe1, DOI 10.2165/11599900-000000000-00000; Rollema H, 2007, NEUROPHARMACOLOGY, V52, P985, DOI 10.1016/j.neuropharm.2006.10.016; Rollema H, 2010, BRIT J PHARMACOL, V160, P334, DOI 10.1111/j.1476-5381.2010.00682.x; Rupprecht LE, 2018, PSYCHOPHARMACOLOGY, V235, P1131, DOI 10.1007/s00213-018-4830-y; Satoskar SD, 2003, INT IMMUNOPHARMACOL, V3, P957, DOI 10.1016/S1567-5769(03)00094-8; Saylor K, 2016, TOXICOL APPL PHARM, V307, P150, DOI 10.1016/j.taap.2016.07.017; Shukla AA, 2017, BIOENG TRANSL MED, V2, P58, DOI 10.1002/btm2.10061; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; WHO, 2019, WHO WHO REP GLOB TOB WHO WHO REP GLOB TOB; Xiao YX, 2004, J PHARMACOL EXP THER, V310, P98, DOI 10.1124/jpet.104.066787; Zhuang YL, 2016, EUR J CLIN PHARMACOL, V72, P1303, DOI 10.1007/s00228-016-2110-5	68	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0254247	10.1371/journal.pone.0254247	http://dx.doi.org/10.1371/journal.pone.0254247			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329335	gold, Green Published			2022-12-26	WOS:000685248600013
J	Li, Y; Xie, JC; Jiang, RG; Yan, DF				Li, Yang; Xie, Jiancang; Jiang, Rengui; Yan, Dongfei			Application of edge computing and GIS in ecological water requirement prediction and optimal allocation of water resources in irrigation area	PLOS ONE			English	Article							MANAGEMENT; DEMAND; OPTIMIZATION; DISTRICT	The purposes are to use water resources efficiently and ensure the sustainable development of social water resources. The edge computing technology and GIS (Geographic Information Science) image data are combined from the perspective of sustainable development. A prediction model for the water resources in the irrigation area is constructed. With the goal of maximizing comprehensive benefits, the optimal allocation of water quality and quantity of water resources is determined. Finally, the actual effect of the model is verified through specific instance data in a province. Results demonstrate that the proposed irrigation area ecological prediction model based on edge computing and GIS images can provide better performance than other state of the art models on water resources prediction. Specifically, the accuracy can remain above 90%. The proposed model for ecological water demand prediction in the irrigation area and optimal allocation of water resources is based on the principle of quality water supply. The optimal allocation of water resources reveals the sustainable development ideas and the requirements of the optimal allocation model, which is very reasonable. The improvement of the system is effective and feasible, and the optimal allocation results are reasonable. This allocation model aims at the water quality and quantity conditions, water conservancy project conditions, and specific water demand requirements in the study area. The calculation results have great practicability and a strong guiding significance for the sustainable utilization and management of the irrigation area.	[Li, Yang; Xie, Jiancang; Jiang, Rengui; Yan, Dongfei] Xian Univ Technol, State Key Lab Ecohydraul Northwest Arid Reg, Xian 710048, Peoples R China	Xi'an University of Technology	Li, Y (corresponding author), Xian Univ Technol, State Key Lab Ecohydraul Northwest Arid Reg, Xian 710048, Peoples R China.	dly_1@163.com	Yang, Li/AEF-7794-2022	Yang, Li/0000-0001-9230-8667				Arcari E., 2019, An Approximate Dynamic Programming Approach for Dual Stochastic Model Predictive Control, P112; Arfanuzzaman M, 2017, GLOB ECOL CONSERV, V10, P9, DOI 10.1016/j.gecco.2017.01.005; Behboudian M, 2021, SCI TOTAL ENVIRON, V751, DOI 10.1016/j.scitotenv.2020.141759; Chien FS, 2021, INT J HYDROGEN ENERG, V46, P7745, DOI 10.1016/j.ijhydene.2020.12.004; Florke M, 2018, NAT SUSTAIN, V1, P51, DOI 10.1038/s41893-017-0006-8; Fu HL, 2017, WATER-SUI, V9, DOI 10.3390/w9110846; Kasauli R, 2021, J SYST SOFTWARE, V172, DOI 10.1016/j.jss.2020.110851; Kattel GR, 2019, CRIT REV ENV SCI TEC, V49, P1107, DOI 10.1080/10643389.2019.1579621; Li CC, 2018, ECOL INDIC, V95, P930, DOI 10.1016/j.ecolind.2018.07.029; Li M, 2019, SCI TOTAL ENVIRON, V651, P1416, DOI 10.1016/j.scitotenv.2018.09.291; Liao XW, 2018, APPL ENERG, V226, P252, DOI 10.1016/j.apenergy.2018.05.132; Liu DD, 2018, J HYDROL, V556, P759, DOI 10.1016/j.jhydrol.2017.12.002; Liu J, 2021, COMPUT IND ENG, V155, DOI 10.1016/j.cie.2021.107212; Liu SY, 2017, J CLEAN PROD, V156, P962, DOI 10.1016/j.jclepro.2017.04.083; Ma T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14532-5; Men BH, 2019, WATER SUPPLY, V19, P1044, DOI 10.2166/ws.2018.152; Ricart S, 2020, WATER-SUI, V12, DOI 10.3390/w12041132; Shi W, 2019, ENVIRON POLLUT, V251, P792, DOI 10.1016/j.envpol.2019.04.119; Singh A, 2017, STOCH ENV RES RISK A, V31, P1147, DOI 10.1007/s00477-016-1326-3; Sun X, 2019, EKOLOJI, V28, P783; Wang H, 2018, INFORM SCIENCES, V438, P95, DOI 10.1016/j.ins.2018.01.041; Wang SG, 2019, J PARALLEL DISTR COM, V127, P160, DOI 10.1016/j.jpdc.2018.06.008; Wang XW, 2018, WATER-SUI, V10, DOI 10.3390/w10050608; Wang YZ, 2021, AGR WATER MANAGE, V245, DOI 10.1016/j.agwat.2020.106630; Wei HJ, 2018, ECOSYST SERV, V31, P44, DOI 10.1016/j.ecoser.2018.03.012; Yamamura Y, 2021, ECOL RES, V36, P161, DOI 10.1111/1440-1703.12195; Yan ZH, 2018, WATER-SUI, V10, DOI 10.3390/w10010087; Yang ZY, 2019, J ENVIRON MANAGE, V230, P221, DOI 10.1016/j.jenvman.2018.09.085; Yuan WL, 2021, ENERGIES, V14, DOI 10.3390/en14010047; Zhang HR, 2020, IEEE ACCESS, V8, P209074, DOI 10.1109/ACCESS.2020.3038381; Zhang YL, 2020, SCI TOTAL ENVIRON, V703, DOI 10.1016/j.scitotenv.2019.134958; Zhou ZL, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173045	32	2	2	12	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254547	10.1371/journal.pone.0254547	http://dx.doi.org/10.1371/journal.pone.0254547			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324531	Green Published, gold			2022-12-26	WOS:000685248200034
J	Wilde, H; Dennis, JM; McGovern, AP; Vollmer, SJ; Mateen, BA				Wilde, Harrison; Dennis, John M.; McGovern, Andrew P.; Vollmer, Sebastian J.; Mateen, Bilal A.			A national retrospective study of the association between serious operational problems and COVID-19 specific intensive care mortality risk	PLOS ONE			English	Article								Objectives To describe the relationship between reported serious operational problems (SOPs), and mortality for patients with COVID-19 admitted to intensive care units (ICUs). Design English national retrospective cohort study. Setting 89 English hospital trusts (i.e. small groups of hospitals functioning as single operational units). Patients All adults with COVID-19 admitted to ICU between 2nd April and 1st December, 2020 (n = 6,737). Interventions N/A Main outcomes and measures Hospital trusts routinely submit declarations of whether they have experienced 'serious operational problems' in the last 24 hours (e.g. due to staffing issues, adverse weather conditions, etc.). Bayesian hierarchical models were used to estimate the association between in-hospital mortality (binary outcome) and: 1) an indicator for whether a SOP occurred on the date of a patient's admission, and; 2) the proportion of the days in a patient's stay that had a SOP occur within their trust. These models were adjusted for individual demographic characteristics (age, sex, ethnicity), and recorded comorbidities. Results Serious operational problems (SOPs) were common; reported in 47 trusts (52.8%) and were present for 2,701 (of 21,716; 12.4%) trust days. Overall mortality was 37.7% (2,539 deaths). Admission during a period of SOPs was associated with a substantially increased mortality; adjusted odds ratio (OR) 1.34 (95% posterior credible interval (PCI): 1.07 to 1.68). Mortality was also associated with the proportion of a patient's admission duration that had concurrent SOPs; OR 1.47 (95% PCI: 1.10 to 1.96) for mortality where SOPs were present for 100% compared to 0% of the stay. Conclusion and relevance Serious operational problems at the trust-level are associated with a significant increase in mortality in patients with COVID-19 admitted to critical care. The link isn't necessarily causal, but this observation justifies further research to determine if a binary indicator might be a valid prognostic marker for deteriorating quality of care.	[Wilde, Harrison; Vollmer, Sebastian J.] Univ Warwick, Dept Stat, Coventry, W Midlands, England; [Dennis, John M.; McGovern, Andrew P.] Univ Exeter, Sch Med, Inst Biomed & Clin Sci, Exeter, Devon, England; [McGovern, Andrew P.] Royal Devon & Exeter NHS Fdn Trust, Diabet & Endocrinol, Exeter, Devon, England; [Vollmer, Sebastian J.; Mateen, Bilal A.] Alan Turing Inst, London, England; [Mateen, Bilal A.] UCL, Inst Hlth Informat, London, England	University of Warwick; University of Exeter; University of Exeter; University of London; University College London	Mateen, BA (corresponding author), Alan Turing Inst, London, England.; Mateen, BA (corresponding author), UCL, Inst Hlth Informat, London, England.	bilal.mateen@nhs.net		Mateen, Bilal Akhter/0000-0003-4423-6472; Wilde, Harrison/0000-0002-4391-8204; Dennis, John/0000-0002-7171-732X	Feuer International Scholarship in Artificial Intelligence; Research England's Expanding Excellence in England (E3) fund; Alan Turing Institute (EPSRC) [EP/N510129]; University of Warwick IAA funding; NIHR Exeter Clinical Research Facility	Feuer International Scholarship in Artificial Intelligence; Research England's Expanding Excellence in England (E3) fund; Alan Turing Institute (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Warwick IAA funding; NIHR Exeter Clinical Research Facility	The author(s) received no specific funding for this work. Unrelated to this study, HW is supported by the Feuer International Scholarship in Artificial Intelligence. JMD is supported by an Independent Fellowship funded by Research England's Expanding Excellence in England (E3) fund. SJV, and BAM are supported by The Alan Turing Institute (EPSRC grant EP/N510129/). SJV is supported by University of Warwick IAA funding. APM is supported by the NIHR Exeter Clinical Research Facility. The individual authors' funder had no role in in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, FIX EM DEP STAFF SYS; [Anonymous], 2021, GUARDIAN; [Anonymous], 2020, EVENING STANDARD; Bravata DM, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.34266; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Davies Nicholas G, 2021, Science, V372, DOI 10.1126/science.abg3055; Dennis JM, 2021, CRIT CARE MED, V49, P209, DOI 10.1097/CCM.0000000000004747; Dennis JM, 2021, DIABETES CARE, V44, P50, DOI 10.2337/dc20-1444; Ferguson N.M., 2020, REPORT 13 ESTIMATING, DOI [10.25561/77482, DOI 10.25561/77482]; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Iapichino G, 2004, INTENS CARE MED, V30, P290, DOI 10.1007/s00134-003-2113-4; Mateen BA, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-042945; Monthly Trust SitRep (MSitRep), CRIT CAR BED CAP URG; NHS England Patient Safety Domain, 2015, SER INC FRAM; Public Health England, COVID 19 HOSP ENGL S; Qian ZZ, 2020, INTENS CARE MED, V46, P1779, DOI 10.1007/s00134-020-06150-y; R Core Team, 2020, R LANG ENV STAT COMP; Schonfeld D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246793; Taccone FS., 2020, LANCET REG HEALTH-EU; West E, 2014, INT J NURS STUD, V51, P781, DOI 10.1016/j.ijnurstu.2014.02.007; Wilde H., 2021, ASS MECH VENTILATOR	22	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255377	10.1371/journal.pone.0255377	http://dx.doi.org/10.1371/journal.pone.0255377			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324569	Green Published, gold			2022-12-26	WOS:000685248200004
J	Kittelsen, KE; Gretarsson, P; Jensen, P; Christensen, JP; Toftaker, I; Moe, RO; Vasdal, G				Kittelsen, Kathe Elise; Gretarsson, Pall; Jensen, Per; Christensen, Jens Peter; Toftaker, Ingrid; Moe, Randi Oppermann; Vasdal, Guro			Keel bone fractures are more prevalent in White Leghorn hens than in Red Jungle fowl hens-A pilot study	PLOS ONE			English	Article							LAYING HENS; CHICKENS; DAMAGE	Fractures and deviations to the keel bone are common in commercial laying hens, with reported variations in occurrence across strains and breeds. The aetiology is not fully understood, however, modern genetics and selection for efficient egg production has been claimed to be important factors for the keel bone fractures. To explore this further, we investigated keel bones from two different breeds, representing different degrees of selection for egg production: Red jungle fowl (n = 82), and White Leghorn (n = 32), where the latter is a selected laying breed which is the origin for many modern laying hen hybrids. Keel bones from a total of 116 birds, 53 hens and 63 roosters, were examined by necropsy at 80 weeks of age. All birds were raised in modified aviaries in the same holding facility. Overall, 24.5% of the hens had one or more fractures to the keel, with a difference in the prevalence between hens from the two breeds (p<0.01): 10% (95% CI: 3.7-24%) in the Red Jungle fowl hens and 69% (95% CI: 37-90%) in the White Leghorn hens. No roosters, regardless of breed, had keel bone fractures. Mild to moderate keel bone deviations were present in 54% (95% CI: 25-80%) of the hens and 4.7% (95% CI: 0.5-30%) of the roosters, all White Leghorns.	[Kittelsen, Kathe Elise; Vasdal, Guro] Animalia, Oslo, Norway; [Gretarsson, Pall; Toftaker, Ingrid; Moe, Randi Oppermann] NMBU Norwegian Univ Life Sci, Fac Vet Med, Oslo, Norway; [Jensen, Per] Linkoping Univ, AVIAN Behav Genom & Physiol Grp, IFM Biol, Linkoping, Sweden; [Christensen, Jens Peter] Univ Copenhagen, Dept Vet & Anim Sci, Copenhagen, Denmark	Norwegian University of Life Sciences; Linkoping University; University of Copenhagen	Kittelsen, KE (corresponding author), Animalia, Oslo, Norway.	kathe.kittelsen@animalia.no	Moe, Randi O/D-3396-2013	Moe, Randi O/0000-0003-2519-1707; Christensen, Jens Peter/0000-0002-6430-9010	research council FORMAS [2019-02084]	research council FORMAS(Swedish Research Council Formas)	Per Jensen acknowledges financial support from the grant 2019-02084 from the research council FORMAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur S, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00129; Birchard SJ., 2005, SAUNDERS MANUAL SMAL, P861; Bishop SC, 2000, BRIT POULTRY SCI, V41, P33, DOI 10.1080/00071660086376; BUCKNER GD, 1949, POULTRY SCI, V28, P289, DOI 10.3382/ps.0280289; BUCKNER GD, 1948, POULTRY SCI, V27, P430, DOI 10.3382/ps.0270430; Budgell KL, 2004, CAN J ANIM SCI, V84, P745, DOI 10.4141/A04-040; Candelotto L, 2017, POULTRY SCI, V96, P3517, DOI 10.3382/ps/pex146; Casey-Trott T, 2015, POULTRY SCI, V94, P2339, DOI 10.3382/ps/pev223; Cheng HW, 2010, POULTRY SCI, V89, P805, DOI 10.3382/ps.2009-00361; Council FAW, 2010, OP OST BON FRACT LAY; Eusemann BK, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00081; Eusemann BK, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01846; Eusemann BK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194974; Fleming RH, 2004, BRIT POULTRY SCI, V45, P320, DOI 10.1080/00071660410001730815; Gebhardt-Henrich SG, 2015, ANIMALS, V5, P1192, DOI 10.3390/ani5040406; Harlander-Matauschek A, 2015, WORLD POULTRY SCI J, V71, P461, DOI 10.1017/S0043933915002135; Jung L, 2019, ANIMAL, V13, P2356, DOI 10.1017/S175173111900003X; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Kittelsen KE, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10112192; Kittelsen KE, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10091655; Leenstra F, 2016, WORLD POULTRY SCI J, V72, P21, DOI 10.1017/S0043933915002743; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Lohmann Tierzucht, 2016, BROWN LIT LAYERS MAN; Miele M, 2013, IMPROVING FARM ANIMAL WELFARE: SCIENCE AND SOCIETY WORKING TOGETHER: THE WELFARE QUALITY APPROACH, P19; Nasr MAF, 2013, APPL ANIM BEHAV SCI, V147, P127, DOI 10.1016/j.applanim.2013.04.015; Nasr MAF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042420; Nicol CJ., 2020, UNDERSTANDING BEHAV, P567; Pickel T, 2011, POULTRY SCI, V90, P715, DOI 10.3382/ps.2010-01025; Poland G., 2019, BSAVA MANUAL BACKYAR; Rodenburg TB, 2008, ANIM WELFARE, V17, P363; Rodriguez-Merchan EC, 2005, CLIN ORTHOP RELAT R, P8, DOI 10.1097/01.blo.0000155377.95940.81; Saeki Y., 1979, Japanese Poultry Science, V16, P121; Sandilands V, 2011, VET REC, V169, P411, DOI 10.1136/vr.d6564; Schutz K, 2002, BEHAV GENET, V32, P423, DOI 10.1023/A:1020880211144; Smith Carolynn L., 2017, Australian Zoologist, V39, P43, DOI 10.7882/AZ.2016.015; StataCorp, 2017, STAT REL 15 STAT SOF, DOI DOI 10.2307/2234838; Stratmann A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122568; Thofner I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229735; Tixier-Boichard M, 2012, WORLD POULTRY SCI J, V68, P307, DOI 10.1017/S0043933912000360; Toscano MJ, 2020, POULTRY SCI, V99, P4183, DOI 10.1016/j.psj.2020.05.035; Wang MS, 2020, CELL RES, V30, P693, DOI 10.1038/s41422-020-0349-y	41	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255234	10.1371/journal.pone.0255234	http://dx.doi.org/10.1371/journal.pone.0255234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314465	gold, Green Published			2022-12-26	WOS:000685225200005
J	Fougner, SL; Vanky, E; Lovvik, TS; Carlsen, SM				Fougner, Stine Lyngvi; Vanky, Eszter; Lovvik, Tone Shetelig; Carlsen, Sven Magnus			No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; BODY-MASS INDEX; WEIGHT-GAIN; METFORMIN; OBESITY; RISK; HYPERGLYCEMIA; OUTCOMES; PLACEBO; ASSOCIATIONS	Polycystic ovary syndrome (PCOS) is characterized by the presence of insulin resistance, and women with PCOS have high prevalence of gestational diabetes (GDM). Both conditions have been associated with increased risk for pregnancy complications such as preterm birth, preeclampsia and increased offspring birth weight. We aimed to estimate the prevalence of GDM in women with PCOS using both previous and new diagnostic criteria, and to analyse whether the risk of pregnancy complications increased with the presence of GDM. In addition, we aimed to assess the response to metformin treatment in PCOS women with GDM. We performed post-hoc analysis of three prospective, double blinded studies of altogether 791 pregnant women with PCOS randomized to either metformin or placebo treatment from first trimester to delivery. Glucose data allowing GDM classification after previous (WHO 1999) and new (WHO 2013 and Norwegian 2017) diagnostic criteria were available for 722 of the women. Complications such as preeclampsia, late miscarriage and preterm birth, birth weight and gestational age were correlated to the presence of GDM and metformin treatment. The prevalence of GDM was 28.3% (WHO 1999), 41.2% (WHO 2013) and 27.2% (Norwegian 2017). Having GDM already in first trimester associated with increased risk for late miscarriage (p<0.01). Having GDM according to newer criteria correlated to increased maternal age and BMI (p<0.001). Otherwise, having GDM (any criteria) correlated neither to the development of preeclampsia, nor to birth weight z-score or the proportion of offspring being large for gestational weight. Maternal age and BMI, parity and gestational weight gain, but not GDM or metformin treatment, were determinants for birth weight z-score. Conclusion: in pregnant women with PCOS, having GDM did not increase the risk for other pregnancy complications except for an increased risk for late miscarriage among those with GDM already in the first trimester.	[Fougner, Stine Lyngvi; Carlsen, Sven Magnus] Trondheim Reg & Univ Hosp, Dept Endocrinol, Clin Med, St Olavs Hosp, Trondheim, Norway; [Fougner, Stine Lyngvi; Vanky, Eszter; Lovvik, Tone Shetelig; Carlsen, Sven Magnus] Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, Trondheim, Norway; [Vanky, Eszter; Lovvik, Tone Shetelig] Trondheim Reg & Univ Hosp, Dept Obstet & Gynaecol, St Olavs Hosp, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Fougner, SL (corresponding author), Trondheim Reg & Univ Hosp, Dept Endocrinol, Clin Med, St Olavs Hosp, Trondheim, Norway.; Fougner, SL (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, Trondheim, Norway.	stine.fougner@ntnu.no	St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022		Central Norway Regional Health Authority; Norwegian University of Science and Technology; Research Council of Norway	Central Norway Regional Health Authority; Norwegian University of Science and Technology; Research Council of Norway(Research Council of Norway)	The pilot study had no external funding except for salary costs to the primary investigator (EV) from her institution (St. Olav's University Hospital and the Norwegian University of Science and Technology). For the pilot study and the PregMet study, Metformin and placebo tablets were delivered free of charge by Weifa A/S, Oslo, Norway. The PregMet study also received grants from the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology. The PregMet2 study received funding from The Research Council of Norway. None of the funders had any role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Abenhaim Haim A., 2007, Archives of Gynecology and Obstetrics, V275, P39, DOI 10.1007/s00404-006-0219-y; Alshammari A, 2010, J MATERN-FETAL NEO M, V23, P545, DOI 10.3109/14767050903214566; American Institute of Ultrasound in Medicine, 2020, J ULTRASOUND MED, V21, pE1; [Anonymous], 2016, MEDICINE, V95, pe3187; [Anonymous], 2013, DIAGN CRIT CLASS HYP; Berggren EK, 2015, AM J PERINAT, V32, P251, DOI 10.1055/s-0034-1383848; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Bozdag G, 2016, HUM REPROD, V31, P2841, DOI 10.1093/humrep/dew218; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Cassar S, 2016, HUM REPROD, V31, P2619, DOI 10.1093/humrep/dew243; Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chiswick C, 2015, LANCET DIABETES ENDO, V3, P778, DOI 10.1016/S2213-8587(15)00219-3; Dodd JM, 2019, LANCET DIABETES ENDO, V7, P15, DOI [10.1016/s2213-8587(18)30310-3, 10.1016/S2213-8587(18)30310-3]; Dodd JM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1285; Foo XY, 2016, BIRTH-ISS PERINAT C, V43, P358, DOI 10.1111/birt.12246; Freeze J, 2018, PROCEEDINGS OF THE 51ST ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES (HICSS), P913; Glintborg D, 2017, EUR J ENDOCRINOL, V176, pR53, DOI 10.1530/EJE-16-0373; Harper LM, 2015, AM J PERINAT, V32, P239, DOI 10.1055/s-0034-1383846; Kent J, 2018, J CLIN ENDOCR METAB, V103, P4315, DOI 10.1210/jc.2017-02764; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Lovvik TS, 2019, LANCET DIABETES ENDO, V7, P256, DOI 10.1016/S2213-8587(19)30002-6; Macut D, 2017, DIABETES RES CLIN PR, V130, P163, DOI 10.1016/j.diabres.2017.06.011; Maslova E, 2019, EUR J CLIN NUTR, V73, P1049, DOI 10.1038/s41430-018-0316-6; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mustaniemi S, 2018, ENDOCR CONNECT, V7, P859, DOI 10.1530/EC-18-0076; Niklasson A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-8; Palm CVB, 2018, DIABETES RES CLIN PR, V145, P167, DOI 10.1016/j.diabres.2018.04.030; Plows JF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113342; Ricart W, 2005, DIABETOLOGIA, V48, P1736, DOI 10.1007/s00125-005-1877-1; Roland MCP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039324; Sales WB, 2018, REV BRAS GINECOL OBS, V40, P180, DOI 10.1055/s-0038-1642632; Schaefer-Graf UM, 2002, J PERINAT MED, V30, P313, DOI 10.1515/JPM.2002.046; Sommer C, 2015, EUR J ENDOCRINOL, V172, P649, DOI 10.1530/EJE-15-0060; Stuebe AM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.035; Syngelaki A, 2016, NEW ENGL J MED, V374, P434, DOI 10.1056/NEJMoa1509819; Toulis KA, 2009, FERTIL STERIL, V92, P667, DOI 10.1016/j.fertnstert.2008.06.045; Truong YN, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.027; Vanky E, 2004, HUM REPROD, V19, P1734, DOI 10.1093/humrep/deh347; Vanky E, 2010, J CLIN ENDOCR METAB, V95, pE448, DOI 10.1210/jc.2010-0853; Yamamoto JM, 2018, DIABETES CARE, V41, P1346, DOI 10.2337/dc18-0102; Yogev Y, 2005, J MATERN-FETAL NEO M, V17, P29, DOI 10.1080/14767050400028766; 2018, CURR OPIN TOXICOL, V10	44	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254895	10.1371/journal.pone.0254895	http://dx.doi.org/10.1371/journal.pone.0254895			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297751	Green Published, gold			2022-12-26	WOS:000678128300069
J	Liu, GY				Liu, Gengyu			Traffic-related pollution history (1994-2014) determined using urban lake sediments from Nanjing, China	PLOS ONE			English	Article							HEAVY-METAL POLLUTION; DUST-LOADED LEAVES; MAGNETIC-PROPERTIES; SPATIAL VARIATION; LOESS DEPOSITS; AIR-POLLUTION; ROAD DUST; SUSCEPTIBILITY; IDENTIFICATION; SUBMICROMETER	With the development of urbanisation and the increasing number of modern vehicles, traffic contamination has become an important source of environmental pollution. Most previous studies have focused on using roadside soil or plants to determine the spatial pattern of traffic pollutants along roads and the factors that influence this pattern, whereas few studies have reconstructed pollution histories caused by traffic using suitable methods. In this study, two gravity cores were obtained from Qianhu Lake, which is in the Zhongshan tourist area of Nanjing City and is distant from industrial areas. An accurate chronological framework covering the period from 1994 to 2014 was established using the correlation between the variation in grain size of the sediment cores and the variation in annual rainfall in Nanjing City. Moreover, magnetic and chemical parameters were also measured, and the results demonstrated that concentration-related magnetic parameters exhibited different correlations with different heavy metal concentrations. These correlations were significantly positive for Zn, Pb, and Co; weakly positive for Ni; absent for Cr; and negative for V. Combined with statistical data on industrial emissions and private cars in Nanjing City since 1994, the observed variations in magnetic susceptibility, anhysteretic remanent magnetisation, saturation isothermal remanent magnetisation, Zn, Pb, and Co, were controlled by traffic activities in the tourist area but not by industry. Therefore, the variations in these parameters record the traffic pollution history of the study area. Combined with the obtained chronological framework, the traffic-related pollution history could be divided into two stages: 1) from 1994 to 2003, when traffic-related pollution became increasingly serious because of the exponential increase in the number of private cars and the prosperity of tourism; 2) from 2003 to 2014, when traffic-related pollution continuously increased but at a much slower rate than in stage 1. This slower rate of increase was probably related to the maximum carrying capacity of the tourist area and technological innovations in automobile manufacturing, as well as improvements in fuels.	[Liu, Gengyu] Fujian Normal Univ, Sch Geog Sci, Fuzhou, Peoples R China; [Liu, Gengyu] Fuzhou Invest & Surveying Inst, Fuzhou, Peoples R China	Fujian Normal University	Liu, GY (corresponding author), Fujian Normal Univ, Sch Geog Sci, Fuzhou, Peoples R China.; Liu, GY (corresponding author), Fuzhou Invest & Surveying Inst, Fuzhou, Peoples R China.	lugey@163.com		liu, gengyu/0000-0003-3541-3828				Ao H, 2010, EARTH PLANET SC LETT, V292, P191, DOI 10.1016/j.epsl.2010.01.035; Baldauf R, 2009, AIR QUAL ATMOS HLTH, V2, P1, DOI 10.1007/s11869-009-0028-0; Blaha U, 2011, ENVIRON SCI TECHNOL, V45, P686, DOI 10.1021/es1025905; Bucko MS, 2011, ENVIRON POLLUT, V159, P1266, DOI 10.1016/j.envpol.2011.01.030; Cao LW, 2015, ATMOS ENVIRON, V119, P304, DOI 10.1016/j.atmosenv.2015.06.017; Chen H, 2019, ENVIRON SCI POLLUT R, V26, P21964, DOI 10.1007/s11356-019-05399-1; Chen TH, 2005, EARTH PLANET SC LETT, V240, P790, DOI 10.1016/j.epsl.2005.09.026; China National Statistics Bureau, 2016, ANN REP STAT NAT EC; Davis AP, 2001, CHEMOSPHERE, V44, P997, DOI 10.1016/S0045-6535(00)00561-0; Deng C, 2001, PHYS CHEM EARTH PT A, V26, P873, DOI 10.1016/S1464-1895(01)00135-1; Dunlop D., 1997, ROCK MAGNETISM FUNDA, P1, DOI [10.1017/CBO9780511612794.002, DOI 10.1017/CBO9780511612794.002, DOI 10.1017/CBO9780511612794]; Gautam P, 2005, ATMOS ENVIRON, V39, P2201, DOI 10.1016/j.atmosenv.2005.01.006; Ge C, 2015, J GEOPHYS RES-SOL EA, V120, P4720, DOI 10.1002/2015JB011952; Goddu SR, 2004, PHYS CHEM EARTH, V29, P985, DOI 10.1016/j.pce.2004.02.002; Hao QZ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003765; Heidari M, 2021, CHEMOSPHERE, V273, DOI 10.1016/j.chemosphere.2021.129656; Heim S, 2013, ENVIRON CHEM LETT, V11, P255, DOI 10.1007/s10311-013-0409-3; HEWITT CN, 1990, SCI TOTAL ENVIRON, V93, P375; Hoffmann V, 1999, J GEOCHEM EXPLOR, V66, P313, DOI 10.1016/S0375-6742(99)00014-X; Hu S, 2003, PHYS CHEM EARTH, V28, P711, DOI 10.1016/S1474-7065(03)00129-3; Hu SY, 2008, CHINESE SCI BULL, V53, P1555, DOI 10.1007/s11434-008-0140-9; HUHN G, 1995, WATER AIR SOIL POLL, V84, P367, DOI 10.1007/BF00475349; Jelinowska A, 1997, GEOPHYS J INT, V129, P727, DOI 10.1111/j.1365-246X.1997.tb04508.x; Kang SC, 2016, ENVIRON SCI TECHNOL, V50, P2859, DOI 10.1021/acs.est.5b04172; Kapicka A, 2003, WATER AIR SOIL POLL, V148, P31, DOI 10.1023/A:1025429928763; Kardel F, 2012, ATMOS ENVIRON, V55, P111, DOI 10.1016/j.atmosenv.2012.03.025; Kennedy P., 2003, METALS PARTICULATE M; Kim JJ, 2008, ENVIRON HEALTH PERSP, V116, P1274, DOI 10.1289/ehp.10735; Liu QS, 2005, GEOPHYS J INT, V161, P102, DOI 10.1111/j.1365-246X.2005.02564.x; LIU XM, 1992, GEOPHYS J INT, V108, P301, DOI 10.1111/j.1365-246X.1992.tb00859.x; Liu XM, 1999, PHYS EARTH PLANET IN, V112, P191, DOI 10.1016/S0031-9201(99)00002-3; Ma MM, 2014, J APPL GEOPHYS, V107, P119, DOI 10.1016/j.jappgeo.2014.05.019; Ma MM, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5661-0; Ma MM, 2015, ENVIRON POLLUT, V204, P161, DOI 10.1016/j.envpol.2015.04.028; Ma MM, 2013, GEOPHYS J INT, V195, P75, DOI 10.1093/gji/ggt206; Ma MM, 2013, QUATERN INT, V296, P198, DOI 10.1016/j.quaint.2012.06.018; Maher BA, 2008, ATMOS ENVIRON, V42, P364, DOI 10.1016/j.atmosenv.2007.09.013; MAHER BA, 1994, EARTH PLANET SC LETT, V125, P461, DOI 10.1016/0012-821X(94)90232-1; Matzka J, 1999, ATMOS ENVIRON, V33, P4565, DOI 10.1016/S1352-2310(99)00229-0; Mitchell R, 2009, ATMOS ENVIRON, V43, P2095, DOI 10.1016/j.atmosenv.2009.01.042; Morawska L, 1998, ENVIRON SCI TECHNOL, V32, P2033, DOI 10.1021/es970826+; Moreno E, 2003, ATMOS ENVIRON, V37, P2967, DOI 10.1016/S1352-2310(03)00244-9; Narayana AC., 2021, MAR POLLUT BULL, V167, P1; Pearson RL, 2000, J AIR WASTE MANAGE, V50, P175, DOI 10.1080/10473289.2000.10463998; Qiao QQ, 2013, ATMOS ENVIRON, V74, P182, DOI 10.1016/j.atmosenv.2013.03.039; Rai PK, 2013, ATMOS ENVIRON, V72, P113, DOI 10.1016/j.atmosenv.2013.02.041; Ristovski ZD, 1998, ENVIRON SCI TECHNOL, V32, P3845, DOI 10.1021/es980102d; Roberts AP, 2011, REV GEOPHYS, V49, DOI 10.1029/2010RG000336; Salam MT, 2008, CURR OPIN PULM MED, V14, P3, DOI 10.1097/MCP.0b013e3282f1987a; Spassov S, 2004, GEOPHYS J INT, V159, P555, DOI [10.1111/j.1365-246X.2004.02438.x, 10.1111/j.1365-246X.2004.02438.X]; Thompson R., 1986, ENV MAGNETISM, DOI 10.1007/978-94-011-8036-8; Venn AJ, 2001, AM J RESP CRIT CARE, V164, P2177, DOI 10.1164/ajrccm.164.12.2106126; Wang B, 2014, ENVIRON POLLUT, V184, P335, DOI 10.1016/j.envpol.2013.08.024; Wang LS, 2019, ATMOS ENVIRON, V212, P231, DOI 10.1016/j.atmosenv.2019.05.039; Wang XS, 2007, ENVIRON GEOL, V52, P63, DOI 10.1007/s00254-006-0449-0; Westerlund K.-G., 2001, METAL EMISSIONS STOC, P3; Xia DS, 2008, ATMOS ENVIRON, V42, P2198, DOI 10.1016/j.atmosenv.2007.11.040; Yang T, 2009, GEOPHYS J INT, V179, P873, DOI 10.1111/j.1365-246X.2009.04315.x; Zhang CX, 2011, ENVIRON POLLUT, V159, P3057, DOI 10.1016/j.envpol.2011.04.006; Zhao GY, 2020, ENVIRON SCI POLLUT R, V27, P34966, DOI 10.1007/s11356-020-09771-4; ZHOU LP, 1990, NATURE, V346, P737, DOI 10.1038/346737a0; Zhu RX, 2001, SCI CHINA SER D, V44, P385, DOI 10.1007/BF02909777	62	0	0	7	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255395	10.1371/journal.pone.0255395	http://dx.doi.org/10.1371/journal.pone.0255395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339452	gold, Green Published			2022-12-26	WOS:000680243400032
J	Pagoulatou, S; Adamopoulos, D; Rovas, G; Bikia, V; Stergiopulos, N				Pagoulatou, Stamatia; Adamopoulos, Dionysios; Rovas, Georgios; Bikia, Vasiliki; Stergiopulos, Nikolaos			The effect of left ventricular contractility on arterial hemodynamics: A model-based investigation	PLOS ONE			English	Article							END-SYSTOLIC ELASTANCE; SINGLE-BEAT ESTIMATION; ONE-DIMENSIONAL MODEL; CARDIOVASCULAR EVENTS; PRESSURE; VOLUME; WAVE; ECHOCARDIOGRAPHY; DETERMINANTS; VALIDATION	Ventricular-arterial coupling is a major determinant of cardiovascular performance, however, there are still inherent difficulties in distinguishing ventricular from vascular effects on arterial pulse phenotypes. In the present study, we employed an extensive mathematical model of the cardiovascular system to investigate how sole changes in cardiac contractility might affect hemodynamics. We simulated two physiologically relevant cases of high and low contractility by altering the end-systolic elastance, E-es, (3 versus 1 mmHg/mL) under constant cardiac output and afterload, and subsequently performed pulse wave analysis and wave separation. The aortic forward pressure wave component was steeper for high E-es, which led to the change of the total pressure waveform from the characteristic Type A phenotype to Type C, and the decrease in augmentation index, AIx (-2.4% versus +18.1%). Additionally, the increase in E-es caused the pulse pressure amplification from the aorta to the radial artery to rise drastically (1.86 versus 1.39). Our results show that an increase in cardiac contractility alone, with no concomitant change in arterial properties, alters the shape of the forward pressure wave, which, consequently, changes central and peripheral pulse phenotypes. Indices based on the pressure waveform, like AIx, cannot be assumed to reflect only arterial properties.	[Pagoulatou, Stamatia; Rovas, Georgios; Bikia, Vasiliki; Stergiopulos, Nikolaos] Ecole Polytech Fed Lausanne EPFL, Inst Bioengn, Lab Hemodynam & Cardiovasc Technol LHTC, Lausanne, Switzerland; [Adamopoulos, Dionysios] Geneva Univ Hosp HUG, Cardiol Dept, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Pagoulatou, S (corresponding author), Ecole Polytech Fed Lausanne EPFL, Inst Bioengn, Lab Hemodynam & Cardiovasc Technol LHTC, Lausanne, Switzerland.	stamatia.pagoulatou@epfl.ch	Rovas, Georgios/GMX-3041-2022	Rovas, Georgios/0000-0002-4020-6826; Bikia, Vasiliki/0000-0002-4660-1560; Adamopoulos, Dionysios/0000-0003-4356-823X				Alastruey J, 2011, J BIOMECH, V44, P2250, DOI 10.1016/j.jbiomech.2011.05.041; Antonini-Canterin F, 2013, J CARDIOVASC ECHOGR, V23, P91, DOI 10.4103/2211-4122.127408; ARGENTA LC, 1976, ANN THORAC SURG, V22, P50, DOI 10.1016/S0003-4975(10)63953-7; Avolio AP, 2009, HYPERTENSION, V54, P375, DOI 10.1161/HYPERTENSIONAHA.109.134379; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; Chen CH, 2001, J AM COLL CARDIOL, V38, P2028, DOI 10.1016/S0735-1097(01)01651-5; Fok H, 2014, HYPERTENSION, V64, P1116, DOI 10.1161/HYPERTENSIONAHA.114.04050; Heusinkveld MHG, 2019, J APPL PHYSIOL, V127, P491, DOI 10.1152/japplphysiol.00769.2018; Kadry K, 2020, AM J PHYSIOL-HEART C, V319, pH882, DOI 10.1152/ajpheart.00172.2020; Kaya M, 2019, COMPUT BIOL MED, V113, DOI 10.1016/j.compbiomed.2019.103418; Kerckhoffs RCP, 2007, ANN BIOMED ENG, V35, P1, DOI 10.1007/s10439-006-9212-7; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lee HY, 2010, CIRC J, V74, P2257, DOI 10.1253/circj.CJ-10-0910; Little WC, 2009, J AM SOC ECHOCARDIOG, V22, P1246, DOI 10.1016/j.echo.2009.09.023; Lumens J, 2009, ANN BIOMED ENG, V37, P2234, DOI 10.1007/s10439-009-9774-2; McEniery CM, 2014, EUR HEART J, V35, P1719, DOI 10.1093/eurheartj/eht565; MIKULIC E, 1977, CIRCULATION, V56, P528, DOI 10.1161/01.CIR.56.4.528; Garcia MIM, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2260-1; Morimont P, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-13; Muller C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207537; Munir S, 2008, HYPERTENSION, V51, P112, DOI 10.1161/HYPERTENSIONAHA.107.096016; MURGO JP, 1980, CIRCULATION, V62, P105, DOI 10.1161/01.CIR.62.1.105; Mynard JP, 2012, INT J NUMER METH BIO, V28, P626, DOI 10.1002/cnm.1466; Mynard JP, 2015, ANN BIOMED ENG, V43, P1443, DOI 10.1007/s10439-015-1313-8; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; Ostadal P, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2654-8; Pagoulatou S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182173; Phan TS, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003069; Pini R, 2008, J AM COLL CARDIOL, V51, P2432, DOI 10.1016/j.jacc.2008.03.031; Reymond P, 2011, AM J PHYSIOL-HEART C, V301, pH1173, DOI 10.1152/ajpheart.00821.2010; Reymond P, 2009, AM J PHYSIOL-HEART C, V297, pH208, DOI 10.1152/ajpheart.00037.2009; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; SAGAWA K, 1977, AM J CARDIOL, V40, P748, DOI 10.1016/0002-9149(77)90192-8; Senzaki H, 1996, CIRCULATION, V94, P2497, DOI 10.1161/01.CIR.94.10.2497; Sharman JE, 2009, HYPERTENSION, V54, P1099, DOI 10.1161/HYPERTENSIONAHA.109.133066; Shi YB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-33; Shishido T, 2000, CIRCULATION, V102, P1983, DOI 10.1161/01.CIR.102.16.1983; STARLING MR, 1993, AM HEART J, V125, P1659, DOI 10.1016/0002-8703(93)90756-Y; Stergiopulos N, 1996, AM J PHYSIOL-HEART C, V270, pH2050, DOI 10.1152/ajpheart.1996.270.6.H2050; Stergiopulos N, 1999, AM J PHYSIOL-HEART C, V276, pH81; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; Sun ZJ, 2015, HYPERTENSION, V65, P252, DOI 10.1161/HYPERTENSIONAHA.114.03617; ten Brinke EA, 2010, J THORAC CARDIOV SUR, V140, P807, DOI 10.1016/j.jtcvs.2009.11.039; Turnbull F, 2003, LANCET, V362, P1527; WALLACE AG, 1963, AM J PHYSIOL, V205, P30, DOI 10.1152/ajplegacy.1963.205.1.30; WESTERHOF N, 1972, CARDIOVASC RES, V6, P648, DOI 10.1093/cvr/6.6.648	47	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255561	10.1371/journal.pone.0255561	http://dx.doi.org/10.1371/journal.pone.0255561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339454	gold, Green Published			2022-12-26	WOS:000680243400019
J	Cao, C; Han, PY; Liu, L; Tang, YM; Tian, SS; Zhang, K; Shi, L; Liu, ZQ; Zhuo, DX; Ge, WS; Gong, WC				Cao, Cheng; Han, Peiyi; Liu, Ling; Tang, Yiman; Tian, Shanshan; Zhang, Kai; Shi, Lei; Liu, Zhiqiang; Zhuo, Dexiang; Ge, Wenshu; Gong, Wenchen			Epithelial cell transforming factor ECT2 is an important regulator of DNA double-strand break repair and genome stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA SYNTHESIS; BRCT DOMAINS; DAMAGE RESPONSE; HISTONE H2AX; BINDING; PROTEIN; COMPLEX; MDC1; ATR; CYTOKINESIS	Proteins containing breast cancer type 1 (BRCA1) C-terminal domains play crucial roles in response to and repair of DNA damage. Epithelial cell transforming factor (epithelial cell transforming sequence 2 [ECT2]) is a member of the BRCA1 C-terminal protein family, but it is not known if ECT2 directly contributes to DNA repair. In this study, we report that ECT2 is recruited to DNA lesions in a poly (ADP-ribose) polymerase 1- dependent manner. Using co-immunoprecipitation analysis, we showed that ECT2 physically associates with KU70-KU80 and BRCA1, proteins involved in nonhomologous end joining and homologous recombination, respectively. ECT2 deficiency impairs the recruitment of KU70 and BRCA1 to DNA damage sites, resulting in defective DNA double-strand break repair, an accumulation of damaged DNA, and hypersensitivity of cells to genotoxic insults. Interestingly, we demonstrated that ECT2 promotes DNA repair and genome integrity largely independently of its canonical guanine nucleotide exchange activity. Together, these results suggest that ECT2 is directly involved in DNA double-strand break repair and is an important genome caretaker.	[Cao, Cheng; Han, Peiyi; Liu, Ling; Tian, Shanshan; Zhang, Kai; Shi, Lei; Liu, Zhiqiang; Gong, Wenchen] Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Prov & Minist Cosponsored Collaborat Innovat Ctr, Sch Basic Med Sci,Minist Educ,Key Lab Immune Micr, Tianjin, Peoples R China; [Tang, Yiman; Ge, Wenshu] Peking Univ, Dept Gen Dent 2, Sch & Hosp Stomatol, Beijing, Peoples R China; [Zhuo, Dexiang] Fujian Med Univ, Dept Lab Med, Cent Lab, Sanming Hosp 1, Sanming, Peoples R China	Tianjin Medical University; Peking University; Fujian Medical University	Gong, WC (corresponding author), Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Prov & Minist Cosponsored Collaborat Innovat Ctr, Sch Basic Med Sci,Minist Educ,Key Lab Immune Micr, Tianjin, Peoples R China.; Ge, WS (corresponding author), Peking Univ, Dept Gen Dent 2, Sch & Hosp Stomatol, Beijing, Peoples R China.; Zhuo, DX (corresponding author), Fujian Med Univ, Dept Lab Med, Cent Lab, Sanming Hosp 1, Sanming, Peoples R China.	wubishou@fjmu.edu.cn; esther1234@hsc.pku.edu.cn; gongwenchen@tmu.edu.cn	Liu, Zhiqiang/E-6950-2014	Liu, Zhiqiang/0000-0002-0677-8097; Han, Peiyi/0000-0001-9057-6676; Gong, Wenchen/0000-0002-7637-3538	National Natural Science Foundation of China [82071089, 81272827]; Tianjin Municipal Education Com-mission Scientific Research Project [2019KJ182]; Tianjin Fund for Distinguished Young Scientists [17JCJQJC46100, 18JCZDJC97400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Education Com-mission Scientific Research Project; Tianjin Fund for Distinguished Young Scientists	This work was supported by grants (82071089 to Wenshu Ge and 81272827 to D. Z.) from the National Natural Science Foundation of China, a grant (2019KJ182 to Wenchen Gong) from the Tianjin Municipal Education Com-mission Scientific Research Project, and grants (17JCJQJC46100 and 18JCZDJC97400 to L. S.) from the Tianjin Fund for Distinguished Young Scientists.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Bement WM, 2015, NAT CELL BIOL, V17, P1471, DOI 10.1038/ncb3251; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen MR, 2020, P NATL ACAD SCI USA, V117, P1027, DOI 10.1073/pnas.1913054117; Clouaire T, 2015, NUCLEUS-PHILA, V6, P107, DOI 10.1080/19491034.2015.1010946; Clouaire T, 2018, MOL CELL, V72, P250, DOI 10.1016/j.molcel.2018.08.020; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Daulat AM, 2019, BRIT J CANCER, V120, P931, DOI 10.1038/s41416-019-0448-z; Day M, 2018, ELIFE, V7, DOI 10.7554/eLife.39979; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fields AP, 2010, ADV ENZYME REGUL, V50, P190, DOI 10.1016/j.advenzreg.2009.10.010; Gerloff DL, 2012, FEBS LETT, V586, P2711, DOI 10.1016/j.febslet.2012.05.005; He D, 2016, SCI REP-UK, V6, DOI 10.1038/srep24504; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Huff Lauren P, 2013, Genes Cancer, V4, P460, DOI 10.1177/1947601913514851; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jacquet K, 2016, MOL CELL, V62, P409, DOI 10.1016/j.molcel.2016.03.031; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Justilien V, 2020, J BIOL CHEM, V295, P8214, DOI 10.1074/jbc.RA120.013175; Justilien V, 2017, CANCER CELL, V31, P256, DOI 10.1016/j.ccell.2016.12.010; Justilien V, 2011, J BIOL CHEM, V286, P8149, DOI 10.1074/jbc.M110.196113; Kim JE, 2005, J BIOL CHEM, V280, P5733, DOI 10.1074/jbc.M409298200; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lagana A, 2010, NAT CELL BIOL, V12, P1186, DOI 10.1038/ncb2129; Li M, 2014, CELL CYCLE, V13, P2944, DOI 10.4161/15384101.2014.947197; Li M, 2013, GENE DEV, V27, P1752, DOI 10.1101/gad.226357.113; Li M, 2013, CANCER CELL, V23, P693, DOI 10.1016/j.ccr.2013.03.025; Li ZM, 2018, CELL RES, V28, P756, DOI 10.1038/s41422-018-0048-0; Luijsterburg MS, 2016, MOL CELL, V61, P547, DOI 10.1016/j.molcel.2016.01.019; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Myler LR, 2017, MOL CELL, V67, P891, DOI 10.1016/j.molcel.2017.08.002; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Saito S, 2004, J BIOL CHEM, V279, P7169, DOI 10.1074/jbc.M306725200; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Schwertman P, 2016, NAT REV MOL CELL BIO, V17, P379, DOI 10.1038/nrm.2016.58; Scully R, 2019, NAT REV MOL CELL BIO, V20, P698, DOI 10.1038/s41580-019-0152-0; Seeber A, 2017, CURR OPIN GENET DEV, V43, P9, DOI 10.1016/j.gde.2016.10.005; Sheng ZZ, 2011, EVOL BIOINFORM, V7, P87, DOI 10.4137/EBO.S7084; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tanaka I, 2020, NUCLEIC ACIDS RES, V48, P2676, DOI 10.1093/nar/gkz1213; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang HK, 2018, J CLIN PATHOL, V71, P442, DOI 10.1136/jclinpath-2017-204569; Wang HK, 2020, ONCOTARGETS THER, V13, P12905, DOI 10.2147/OTT.S275725; Wang Q, 2016, J CLIN INVEST, V126, P2205, DOI 10.1172/JCI85747; Xiu YY, 2019, MOL CLIN ONCOL, V10, P497, DOI 10.3892/mco.2019.1832; Zhang Q, 2020, THERANOSTICS, V10, P10769, DOI 10.7150/thno.46878	57	1	1	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101036	10.1016/j.jbc.2021.101036	http://dx.doi.org/10.1016/j.jbc.2021.101036			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34343566	Green Published, gold			2022-12-26	WOS:000704369100014
J	Floy, ME; Givens, SE; Matthys, OB; Mateyka, TD; Kerr, CM; Steinberg, AB; Silva, AC; Zhang, JH; Mei, Y; Ogle, BM; McDevitt, TC; Kamp, TJ; Palecek, SP				Floy, Martha E.; Givens, Sophie E.; Matthys, Oriane B.; Mateyka, Taylor D.; Kerr, Charles M.; Steinberg, Alexandra B.; Silva, Ana C.; Zhang, Jianhua; Mei, Ying; Ogle, Brenda M.; McDevitt, Todd C.; Kamp, Timothy J.; Palecek, Sean P.			Developmental lineage of human pluripotent stem cell-derived cardiac fibroblasts affects their functional phenotype	FASEB JOURNAL			English	Article						cardiac; fibroblast; pluripotent stem cell	FACTOR BINDING PROTEIN-1; 2ND HEART; OUTFLOW TRACT; COLLAGEN; DIFFERENTIATION; CONTRIBUTE; PERLECAN; WNT5A; CARDIOMYOCYTES; HETEROGENEITY	Cardiac fibroblasts (CFBs) support heart function by secreting extracellular matrix (ECM) and paracrine factors, respond to stress associated with injury and disease, and therefore are an increasingly important therapeutic target. We describe how developmental lineage of human pluripotent stem cell-derived CFBs, epicardial (EpiC-FB), and second heart field (SHF-FB) impacts transcriptional and functional properties. Both EpiC-FBs and SHF-FBs exhibited CFB transcriptional programs and improved calcium handling in human pluripotent stem cell-derived cardiac tissues. We identified differences including in composition of ECM synthesized, secretion of growth and differentiation factors, and myofibroblast activation potential, with EpiC-FBs exhibiting higher stress-induced activation potential akin to myofibroblasts and SHF-FBs demonstrating higher calcification and mineralization potential. These phenotypic differences suggest that EpiC-FBs have utility in modeling fibrotic diseases while SHF-FBs are a promising source of cells for regenerative therapies. This work directly contrasts regional and developmental specificity of CFBs and informs CFB in vitro model selection.	[Floy, Martha E.; Mateyka, Taylor D.; Steinberg, Alexandra B.; Palecek, Sean P.] Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Hall, Madison, WI 53706 USA; [Givens, Sophie E.; Ogle, Brenda M.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA; [Matthys, Oriane B.] Univ Calif Berkeley, UC San Francisco, Grad Program Bioengn, Berkeley, CA USA; [Matthys, Oriane B.; Silva, Ana C.; McDevitt, Todd C.] Gladstone Inst Cardiovasc Dis, Gladstone Inst, San Francisco, CA USA; [Kerr, Charles M.] Med Univ South Carolina, Mol Cell Biol & Pathobiol Program, Charleston, SC 29425 USA; [Zhang, Jianhua; Kamp, Timothy J.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Mei, Ying] Clemson Univ, Dept Bioengn, Clemson, SC USA; [Ogle, Brenda M.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA	University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; University of California System; University of California San Francisco; The J David Gladstone Institutes; Medical University of South Carolina; University of Wisconsin System; University of Wisconsin Madison; Clemson University; University of Minnesota System; University of Minnesota Twin Cities	Palecek, SP (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Hall, Madison, WI 53706 USA.	sppalecek@wisc.edu		Matthys, Oriane/0000-0002-5530-7945; Floy, Martha/0000-0003-1992-5911; Kerr, Charles/0000-0001-8736-4795; Mei, Ying/0000-0002-8508-4076	NSF Engineering Research Center for Cell Manufacturing Technologies [NSF EEC-1648035, CBET-1066311, R01 EB007534]; National Science Foundation [1650113, 2019272038]; California Institute for Regenerative Medicine [LA1-08015]; NIH [T32 HL007260, F31 HL154665, R01 HL133308, R01 HL137204]	NSF Engineering Research Center for Cell Manufacturing Technologies(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NSF Engineering Research Center for Cell Manufacturing Technologies, Grant/Award Number: NSF EEC-1648035, CBET-1066311 and R01 EB007534; National Science Foundation, Grant/Award Number: 1650113 and 2019272038; California Institute for Regenerative Medicine, Grant/Award Number: LA1-08015; NIH, Grant/Award Number: T32 HL007260, F31 HL154665, R01 HL133308 and R01 HL137204	Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Ahmed T., 2020, STATPEARLS; Alfieri CM, 2010, DEV BIOL, V338, P127, DOI 10.1016/j.ydbio.2009.11.030; Ali SR, 2014, CIRC RES, V115, P625, DOI 10.1161/CIRCRESAHA.115.303794; [Anonymous], 2019, PHEN VAR STROM CELLS; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asp M, 2019, CELL, V179, P1647, DOI 10.1016/j.cell.2019.11.025; Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565; Bao XP, 2017, NAT PROTOC, V12, P1890, DOI 10.1038/nprot.2017.080; Bao XP, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0003; Bargehr J, 2019, NAT BIOTECHNOL, V37, P895, DOI 10.1038/s41587-019-0197-9; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cao JL, 2018, NAT REV CARDIOL, V15, P631, DOI 10.1038/s41569-018-0046-4; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; CHEN LB, 1978, CELL, V14, P377, DOI 10.1016/0092-8674(78)90123-X; Chen L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002571; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Cui YL, 2019, CELL REP, V26, P1934, DOI 10.1016/j.celrep.2019.01.079; Floy ME, 2020, STEM CELL RES, V45, DOI 10.1016/j.scr.2020.101831; George RM, 2019, ANAT REC, V302, P101, DOI 10.1002/ar.23910; Giacomelli E, 2020, CELL STEM CELL, V26, P862, DOI 10.1016/j.stem.2020.05.004; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Greulich F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156787; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; Hanson KP, 2013, TISSUE ENG PT A, V19, P1132, DOI [10.1089/ten.tea.2012.0316, 10.1089/ten.TEA.2012.0316]; Harrela M, 2002, HORM METAB RES, V34, P144, DOI 10.1055/s-2002-23198; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Harris GM, 2018, METHOD CELL BIOL, V143, P97, DOI 10.1016/bs.mcb.2017.08.007; Hookway TA, 2016, METHODS, V101, P11, DOI 10.1016/j.ymeth.2015.11.027; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Iwabu A, 2002, BASIC RES CARDIOL, V97, P214, DOI 10.1007/s003950200014; Iyer D, 2015, DEVELOPMENT, V142, P1528, DOI 10.1242/dev.119271; Jin G, 2020, ENGINEERING STRATEGIES FOR REGENERATIVE MEDICINE, P177, DOI 10.1016/B978-0-12-816221-7.00006-9; Jonsson Malin K B, 2016, JACC Basic Transl Sci, V1, P590, DOI 10.1016/j.jacbts.2016.07.007; Kostina A, 2018, J MOL CELL CARDIOL, V114, P211, DOI 10.1016/j.yjmcc.2017.11.009; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li D, 2016, DEV BIOL, V412, P18, DOI 10.1016/j.ydbio.2016.02.017; Li YZ, 2017, ACTA BIOMATER, V55, P120, DOI 10.1016/j.actbio.2017.04.027; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Liau B, 2017, SCI REP-UK, V7, DOI 10.1038/srep42290; Litvinukova M, 2020, NATURE, V588, P466, DOI 10.1038/s41586-020-2797-4; MacGrogan D, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a013912; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Mandegar MA, 2016, CELL STEM CELL, V18, P541, DOI 10.1016/j.stem.2016.01.022; MARIJIANOWSKI MMH, 1994, J AM COLL CARDIOL, V23, P1204, DOI 10.1016/0735-1097(94)90612-2; Masjedi S, 2016, CARDIOVASC PATHOL, V25, P185, DOI 10.1016/j.carpath.2015.12.002; Mayourian J, 2018, CIRC RES, V122, P167, DOI 10.1161/CIRCRESAHA.117.311589; McArthur L, 2015, BIOCHEM SOC T, V43, P513, DOI 10.1042/BST20150035; McNally EM, 2009, CIRC RES, V104, P285, DOI 10.1161/CIRCRESAHA.109.193680; Meilhac SM, 2018, NAT REV CARDIOL, V15, P705, DOI 10.1038/s41569-018-0086-9; Mienaltowski MJ, 2014, ADV EXP MED BIOL, V802, P5, DOI 10.1007/978-94-007-7893-1_2; Mittal A, 2013, DEV BIOL, V381, P73, DOI 10.1016/j.ydbio.2013.06.010; Moore-Morris T, 2014, J CLIN INVEST, V124, P2921, DOI 10.1172/JCI74783; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morita Y, 2016, J MOL CELL CARDIOL, V92, P158, DOI 10.1016/j.yjmcc.2016.02.008; Mueller KAL, 2013, J CARD FAIL, V19, P678, DOI 10.1016/j.cardfail.2013.09.001; Muhl L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17740-1; Naugle JE, 2006, AM J PHYSIOL-HEART C, V290, pH323, DOI 10.1152/ajpheart.00321.2005; Norris RA, 2009, J CELL COMMUN SIGNAL, V3, P275, DOI 10.1007/s12079-009-0063-5; Park S, 2018, CIRCULATION, V138, P1224, DOI 10.1161/CIRCULATIONAHA.118.035420; Pillai ICL, 2017, CELL STEM CELL, V20, P218, DOI 10.1016/j.stem.2016.10.005; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; PNAS, GENE SET ENRICHMENT; Rana MS, 2014, CIRC RES, V115, P790, DOI 10.1161/CIRCRESAHA.115.305020; Ridge LA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007068; Rodriguez KJ, 2011, MATRIX BIOL, V30, P70, DOI 10.1016/j.matbio.2010.09.001; Rudat C, 2012, CIRC RES, V111, P165, DOI 10.1161/CIRCRESAHA.112.273946; Sasse P, 2008, CARDIOVASC RES, V80, P435, DOI 10.1093/cvr/cvn225; Schleiffarth JR, 2007, PEDIATR RES, V61, P386, DOI 10.1203/pdr.0b013e3180323810; Schmuck EG, 2014, CARDIOVASC ENG TECHN, V5, P119, DOI 10.1007/s13239-013-0167-1; Schwach V, 2019, BIOMATER SCI-UK, V7, P3566, DOI 10.1039/c8bm01348a; Silva A., 2020, DEVELOPMENTAL COEMER; Sinha T, 2015, HUM MOL GENET, V24, P1704, DOI 10.1093/hmg/ddu584; Skelly DA, 2018, CELL REP, V22, P600, DOI 10.1016/j.celrep.2017.12.072; Snarr BS, 2007, DEV DYNAM, V236, P1287, DOI 10.1002/dvdy.21074; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Theocharidis G, 2016, J INVEST DERMATOL, V136, P74, DOI 10.1038/JID.2015.352; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Tucker NR, 2020, CIRCULATION, V142, P466, DOI 10.1161/CIRCULATIONAHA.119.045401; Unden AL, 2005, CLIN ENDOCRINOL, V63, P94, DOI 10.1111/j.1365-2265.2005.02306.x; Vidal R, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131092; Wang Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16204-w; Watanabe S, 2010, EUR J HEART FAIL, V12, P1214, DOI 10.1093/eurjhf/hfq166; Wessels A, 2012, DEV BIOL, V366, P111, DOI 10.1016/j.ydbio.2012.04.020; Williams C, 2014, ACTA BIOMATER, V10, P194, DOI 10.1016/j.actbio.2013.08.037; Witty AD, 2014, NAT BIOTECHNOL, V32, P1026, DOI 10.1038/nbt.3002; Wu CC, 2020, CIRC RES, V127, P896, DOI 10.1161/CIRCRESAHA.119.316303; Zhang H, 2019, CIRC RES, V125, P552, DOI 10.1161/CIRCRESAHA.119.315491; Zhang JH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09831-5; Zhao JM, 2017, STEM CELLS DEV, V26, P528, DOI 10.1089/scd.2016.0208; Zheng DP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03148-3; Zhou PZ, 2016, CIRC RES, V118, P368, DOI 10.1161/CIRCRESAHA.116.308139; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022	96	0	0	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2021	35	9							e21799	10.1096/fj.202100523R	http://dx.doi.org/10.1096/fj.202100523R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UJ2LG	34339055	Green Accepted			2022-12-26	WOS:000691122900059
J	Minicozzi, MR; Axlid, EG; von Hippel, FA; Espinoza, J; Funke, A; Phillips, QP; Buck, CL				Minicozzi, Michael R.; Axlid, Erik G.; von Hippel, Frank A.; Espinoza, Joseph; Funke, Aubrey; Phillips, Quentin P.; Buck, C. Loren			Perchlorate exposure does not induce obesity or non-alcoholic fatty liver disease in zebrafish	PLOS ONE			English	Article							THREESPINE STICKLEBACK; RISK-FACTOR; STEATOHEPATITIS; FISH; HYPOTHYROIDISM; POPULATION; ESTROGENS; INSULIN; MODELS; IMPACT	Perchlorate is a water-soluble contaminant found throughout the United States and many other countries. Perchlorate competitively inhibits iodide uptake at the sodium/iodide symporter, reducing thyroid hormone synthesis, which can lead to hypothyroidism and metabolic syndromes. Chronic perchlorate exposure induces hepatic steatosis and non-alcoholic fatty liver disease (NAFLD) in developing threespine stickleback (Gasterosteus aculeatus). We hypothesized that perchlorate would also induce zebrafish (Danio rerio) to develop phenotypes consistent with NAFLD and to accumulate lipids throughout the body. We exposed zebrafish embryos to four concentrations of perchlorate treated water (10 mu g/L, 10mg/L, 30mg/L, and 100mg/L) and a control (0mg/L) over the course of 133 days. Adult zebrafish were euthanized, sectioned, H&E and Oil Red-O stained, and analyzed for liver morphology and whole body lipid accumulation. In a representative section of the liver, we counted the number of lipid droplets and measured the area of each droplet and the total lipid area. For whole body analysis, we calculated the ratio of lipid area to body area within a section. We found that zebrafish exposed to perchlorate did not differ in any measured liver variables or whole body lipid area when compared to controls. In comparison to stickleback, we see a trend that control stickleback accumulate more lipids in their liver than do control zebrafish. Differences between the species indicate that obesogenic effects due to perchlorate exposure are not uniform across fish species, and likely are mediated by evolutionary differences related to geographic location. For example, high latitude fishes such as stickleback evolved to deposit lipid stores for over-winter survival, which may lead to more pronounced obesogenic effects than seen in tropical fish such as zebrafish.	[Minicozzi, Michael R.; Axlid, Erik G.; Phillips, Quentin P.] Minnesota State Univ, Dept Biol Sci, Mankato, MN 56001 USA; [von Hippel, Frank A.] Univ Arizona, Dept Commun Environm & Policy, Tucson, AZ USA; [Espinoza, Joseph; Funke, Aubrey; Buck, C. Loren] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	Minnesota State Colleges & Universities; Minnesota State University Mankato; University of Arizona; Northern Arizona University	Minicozzi, MR (corresponding author), Minnesota State Univ, Dept Biol Sci, Mankato, MN 56001 USA.	Michael.Minicozzi@mnsu.edu		Buck, Charles Loren/0000-0001-6008-7257; Axlid, Erik/0000-0002-2766-0506; Minicozzi, Michael/0000-0002-1779-3129	Technology Research Initiative Fund (TRIF), through Northern Arizona University; National Institute of General Medical Sciences of the National Institutes of Health [R25GM127199]; National Institute of Environmental Health Sciences [1RO1ES017039]	Technology Research Initiative Fund (TRIF), through Northern Arizona University; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for this work was provided by the Technology Research Initiative Fund (TRIF), through internal support by Northern Arizona University. Research reported in this publication was also supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R25GM127199, and by the National Institute of Environmental Health Sciences under Award Number 1RO1ES017039. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyoshi H, 2004, ZOOL SCI, V21, P841, DOI 10.2108/zsj.21.841; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Asaoka Y, 2013, DIS MODEL MECH, V6, P905, DOI 10.1242/dmm.011981; Baillie-Hamilton PF, 2002, J ALTERN COMPLEM MED, V8, P185, DOI 10.1089/107555302317371479; Bancroft JD, 2002, J NEUROPATH EXP NEUR, V5th; Bernhardt RR, 2008, BEHAVIOUR, V145, P527, DOI 10.1163/156853908792451511; Bernhardt RR, 2006, ENVIRON TOXICOL CHEM, V25, P2087, DOI 10.1897/05-454R.1; Biondi B, 2010, J CLIN ENDOCR METAB, V95, P3614, DOI 10.1210/jc.2010-1245; Blount BC, 2007, J EXPO SCI ENV EPID, V17, P400, DOI 10.1038/sj.jes.7500535; Blundell JE, 1997, ANN NY ACAD SCI, V827, P392, DOI 10.1111/j.1749-6632.1997.tb51850.x; Bruce KD, 2009, POSTGRAD MED J, V85, P614, DOI 10.1136/pgmj.2008.078014; Bruno S, 2005, BMJ-BRIT MED J, V330, P932, DOI 10.1136/bmj.38391.663287.E0; Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012; Chamorro-Garcia R, 2013, ENVIRON HEALTH PERSP, V121, P359, DOI 10.1289/ehp.1205701; Cooke PS, 2004, EXP BIOL MED, V229, P1127, DOI 10.1177/153537020422901107; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Duarte-Guterman P, 2014, GEN COMP ENDOCR, V203, P69, DOI 10.1016/j.ygcen.2014.03.015; Furin CG, 2015, GEN COMP ENDOCR, V219, P24, DOI 10.1016/j.ygcen.2015.04.002; Furin CG, 2012, EVOLUTION, V66, P3277, DOI 10.1111/j.1558-5646.2012.01672.x; GAO. U.S. Government Accountability Office, 2010, GAO10769 GAO US GOV; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Gardell AM, 2017, GEN COMP ENDOCR, V243, P60, DOI 10.1016/j.ygcen.2016.10.014; Greer MA, 2002, ENVIRON HEALTH PERSP, V110, P927, DOI 10.1289/ehp.02110927; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; Hammond RA, 2010, DIABETES METAB SYNDR, V3, P285, DOI [10.2147/DMSOTT.S7384, 10.2147/DMSO.S7384]; Hao CJ, 2012, BIOSCIENCE REP, V32, P619, DOI 10.1042/BSR20120042; Hebert JR, 2013, MAYO CLIN PROC, V88, P593, DOI 10.1016/j.mayocp.2013.04.005; Heindel J.J., 2014, CURR ENV HLTH REP, V1, P333; Heindel JJ, 2013, OBESITY, V21, P1079, DOI 10.1002/oby.20222; Hewitt KN, 2004, ENDOCRINOLOGY, V145, P1842, DOI 10.1210/en.2003-1369; Hruby A, 2015, PHARMACOECONOMICS, V33, P673, DOI 10.1007/s40273-014-0243-x; Janesick AS, 2016, AM J OBSTET GYNECOL, V214, P559, DOI 10.1016/j.ajog.2016.01.182; Kendall R.J., 2006, PERCHLORATE ECOTOXIC; Kirsch R, 2003, J GASTROEN HEPATOL, V18, P1272, DOI 10.1046/j.1440-1746.2003.03198.x; LAALE HW, 1977, J FISH BIOL, V10, P121, DOI 10.1111/j.1095-8649.1977.tb04049.x; Liangpunsakul S, 2003, J CLIN GASTROENTEROL, V37, P340, DOI 10.1097/00004836-200310000-00014; Lonardo A, 2006, J HEPATOL, V44, P1196, DOI 10.1016/j.jhep.2006.03.005; Maffei L, 2004, J CLIN ENDOCR METAB, V89, P61, DOI 10.1210/jc.2003-030313; MANDOUR T, 1977, EUR J CLIN INVEST, V7, P181, DOI 10.1111/j.1365-2362.1977.tb01595.x; Marino L, 2015, WORLD J GASTROENTERO, V21, P11053, DOI 10.3748/wjg.v21.i39.11053; Masuno H, 2002, J LIPID RES, V43, P676; Minicozzi MR, 2019, ENVIRON POLLUT, V251, P390, DOI 10.1016/j.envpol.2019.05.001; Mukhi S, 2007, TOXICOL SCI, V96, P246, DOI 10.1093/toxsci/kfm001; Mukhi S, 2007, GEN COMP ENDOCR, V150, P486, DOI 10.1016/j.ygcen.2006.11.013; Murray CW, 2008, J EXPO SCI ENV EPID, V18, P571, DOI 10.1038/sj.jes.7500648; Patino R, 2003, ENVIRON TOXICOL CHEM, V22, P1115, DOI [10.1897/1551-5028(2003)022&lt;1115:EOAPOT&gt;2.0.CO;2, 10.1002/etc.5620220520]; Petersen AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157792; Petersen AM, 2015, GEN COMP ENDOCR, V210, P130, DOI 10.1016/j.ygcen.2014.10.015; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Santhekadur PK, 2018, J HEPATOL, V68, P230, DOI 10.1016/j.jhep.2017.10.031; Sato T, 2003, BIOCHEM BIOPH RES CO, V300, P167, DOI 10.1016/S0006-291X(02)02774-2; Schultz ET, 1997, OECOLOGIA, V109, P516, DOI 10.1007/s004420050112; Shimizu I, 2003, LIVER INT, V23, P63, DOI 10.1034/j.1600-0676.2003.00811.x; TAKAHASHI H, 1977, Bulletin of the Faculty of Fisheries Hokkaido University, V28, P57; Teixeira D, 2015, J CLIN ENDOCR METAB, V100, P1792, DOI 10.1210/jc.2014-4136; Tracy RE, 2002, HISTOPATHOLOGY, V41, P75, DOI 10.1046/j.1365-2559.2002.01414.x; Traut W, 2001, CHROMOSOME RES, V9, P659, DOI 10.1023/A:1012956324417; Urbansky ET, 2001, ENVIRON POLLUT, V112, P299, DOI 10.1016/S0269-7491(00)00132-9; Van Herck MA, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101072; Wolff J, 1998, PHARMACOL REV, V50, P89; Zhong F, 2020, DIGESTION, V101, P522, DOI 10.1159/000501851	61	3	3	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2021	16	8							e0254500	10.1371/journal.pone.0254500	http://dx.doi.org/10.1371/journal.pone.0254500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IY	34347796	Green Published, gold			2022-12-26	WOS:000685264900052
J	Cambou, MC; Saad, E; McBride, K; Fuller, T; Swayze, E; Nielsen-Saines, K				Cambou, Mary Catherine; Saad, Eduardo; McBride, Kaitlyn; Fuller, Trevon; Swayze, Emma; Nielsen-Saines, Karin			Maternal HIV and syphilis are not syndemic in Brazil: Hot spot analysis of the two epidemics	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; HUMAN-IMMUNODEFICIENCY-VIRUS; CONGENITAL-SYPHILIS; PREGNANT-WOMEN; INCREASED RISK; INFECTION	While the annual incidence of HIV diagnosis in pregnancy in Brazil remains relatively stable, rates of maternal syphilis increased over six-fold in the past decade. We hypothesized that maternal HIV and syphilis are two distinct epidemics. Data on all cases of maternal HIV or syphilis detected in pregnancy between January 1, 2010 to December 31, 2018 were requested from the Brazilian Ministry of Health. In order to evaluate how the epidemics evolved over the time period, ArcGIS software was used to generate spatiotemporal maps of annual rates of detection of maternal HIV and syphilis in 2010 and 2018. We utilized Euclidean-distance hot spot analysis to identify state-specific clusters in 2010 and 2018. From 2010 to 2018, there were 66,631 cases of maternal HIV, 225,451 cases of maternal syphilis, and 150,414 cases of congenital syphilis in Brazil. The state of Rio Grande do Sul had the highest rate of maternal HIV detection in both 2010 and 2018. Hot spots of maternal HIV were identified in the three most Southern states in both 2010 and 2018 (99% confidence, z-score >2.58, p <0.01). While syphilis incidence >30 per 1,000 live births in 2018 in four states, only the two coastal states of Rio de Janeiro and Espirito Santo in Southeastern Brazil were significant hot spots (90% confidence, z-score 1.65-1.95, p <0.10). Contrary to the general assumption, HIV and syphilis epidemics in Brazil are not syndemic in pregnant women. There is a spatial cluster of maternal HIV in the South, while syphilis is increasing throughout the country, more recently on the coast. Focusing on maternal HIV hot spots in the Southern states is insufficient to curtail the maternal and congenital syphilis epidemics throughout the country. New strategies, including ongoing hot spot analysis, are urgently needed to monitor, identify and treat maternal syphilis.	[Cambou, Mary Catherine] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Dept Med, Los Angeles, CA 90095 USA; [Cambou, Mary Catherine; McBride, Kaitlyn] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA 90095 USA; [Saad, Eduardo; Fuller, Trevon; Nielsen-Saines, Karin] Univ Calif Los Angeles, David Geffen Sch Med, Div Pediat Infect Dis, Dept Pediat, Los Angeles, CA 90095 USA; [Swayze, Emma] Western Michigan Univ, Homer Stryker Sch Med, Dept Med, Kalamazoo, MI 49008 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Western Michigan University	Cambou, MC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Dept Med, Los Angeles, CA 90095 USA.; Cambou, MC (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA 90095 USA.	mcambou@mednet.ucla.edu		Cambou, Mary/0000-0003-2527-2574	UCLA Postdoctoral Fellowship Training Program in Global HIV Prevention Research, NIMH [T32MH080634]; UCLA South American Program in HIV Prevention Research Program, NIMH [R25MH08722]	UCLA Postdoctoral Fellowship Training Program in Global HIV Prevention Research, NIMH; UCLA South American Program in HIV Prevention Research Program, NIMH	MCC was supported by the UCLA Postdoctoral Fellowship Training Program in Global HIV Prevention Research (PIs: Currier and Gorbach), NIMH grant T32MH080634. EJS was supported by the UCLA South American Program in HIV Prevention Research Program (PI: Clark), NIMH grant R25MH08722. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189851; [Anonymous], 2021, OPENSTREETMAP COPYRI; [Anonymous], 2021, OPEN DATA COMMONS OP; [Anonymous], 2021, I BRASILEIRO GEOGRAF; [Anonymous], 2021, SISTEMA ELETRONICO I; [Anonymous], 2021, B EPIDEMIOLOGICO SIF; [Anonymous], 2021, PROTOCOLO CLIN DIRET; [Anonymous], 2021, B EPIDEMIOLOGICO HIV; Benzaken AS, 2019, AIDS RES THER, V16, DOI 10.1186/s12981-019-0234-2; Brandenburger D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247649; Caffe S, 2016, SEX TRANSM DIS, V43, P733, DOI 10.1097/OLQ.0000000000000528; Cambou M., 2020, 23 INT AIDS C 2020; Cerda Rodrigo, 2015, Open Forum Infect Dis, V2, pofv073, DOI 10.1093/ofid/ofv073; Chang BA, 2017, ANN EPIDEMIOL, V27, P231, DOI 10.1016/j.annepidem.2017.02.004; de Araujo CL, 2012, REV SAUDE PUBL, V46, P479, DOI 10.1590/S0034-89102012000300010; Bezerra MLDB, 2019, EMERG INFECT DIS, V25, P1469, DOI 10.3201/eid2508.180298; de Souza JM, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007122; Environmental Systems Research Institute (ESRI), 2021, HOT SPOT AN GET ORD; Getis A, 2007, REG SCI URBAN ECON, V37, P491, DOI 10.1016/j.regsciurbeco.2007.04.005; Joao EC, 2020, LANCET HIV, V7, pE322, DOI 10.1016/S2352-3018(20)30038-2; Kiarie James, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS1, DOI 10.1016/j.ijgo.2015.05.002; Kinikar A, 2017, SEX TRANSM DIS, V44, P371, DOI [10.1097/OLQ.0000000000000622, 10.1097/olq.0000000000000622]; Kojima N, 2016, CLIN INFECT DIS, V62, P265, DOI 10.1093/cid/civ842; Luu Minh, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS37, DOI 10.1016/j.ijgo.2015.04.011; Mario DN, 2019, CIENC SAUDE COLETIVA, V24, P1223, DOI 10.1590/1413-81232018243.13122017; Ministerio de Saude, 2021, PAIN IND EP 2021; Mwapasa V, 2006, AIDS, V20, P1869, DOI 10.1097/01.aids.0000244206.41500.27; Nunn AS, 2009, HEALTH AFFAIR, V28, P1103, DOI 10.1377/hlthaff.28.4.1103; Pascom ARP, 2020, INT J STD AIDS, V31, P903, DOI 10.1177/0956462420932688; Ruffinen CZ, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1155-y; Sohn AH, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18555; Swayze EJ, 2021, INT J INFECT DIS, V104, P27, DOI 10.1016/j.ijid.2020.12.076; Thome C, 2008, CLIN INFECT DIS, V47, P1114, DOI 10.1086/592124; Trinh TT, 2017, TROP MED INT HEALTH, V22, P1196, DOI 10.1111/tmi.12920; Monteiro MDV, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4566-3; World Health Organization, 2019, WHO VAL EL MOTH TO C; Yeganeh N, 2015, PEDIATR INFECT DIS J, V34, pE52, DOI 10.1097/INF.0000000000000578; Zulu LC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-285	38	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255590	10.1371/journal.pone.0255590	http://dx.doi.org/10.1371/journal.pone.0255590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343219	Green Published, gold			2022-12-26	WOS:000685264200037
J	Ma, ZW; Hou, WJ; Zhang, D				Ma, Zhengwei; Hou, Wenjia; Zhang, Dan			A credit risk assessment model of borrowers in P2P lending based on BP neural network	PLOS ONE			English	Article							DEFAULT PREDICTION; LOAN EVALUATION	Peer-to-Peer (P2P) lending provides convenient and efficient financing channels for small and medium-sized enterprises and individuals, and therefore it has developed rapidly since entering the market. However, due to the imperfection of the credit system and the influence of cyberspace restrictions, P2P network lending faces frequent borrower credit risk crises during the transaction process, with a high proportion of borrowers default. This paper first analyzes the basic development of China's P2P online lending and the credit risks of borrowers in the industry. Then according to the characteristics of P2P network lending and previous studies, a credit risk assessment indicators system for borrowers in P2P lending is formulated with 29 indicators. Finally, on the basis of the credit risk assessment indicators system constructed in this paper, BP neural network is built based on the BP algorithm, which is trained by the LM algorithm (Levenberg-Marquardt), Scaled Conjugate Gradient, and Bayesian Regularization respectively, to complete the credit risk assessment model. By comparing the results of three mentioned training methodologies, the BP neural network trained by the LM algorithm is finally adopted to construct the credit risk assessment model of borrowers in P2P lending, in which the input layer node is 9, the hidden layer node is 11 and output layer node is 1. The model can provide practical guidance for China and other countries' P2P lending platforms, and therefore to establish and improve an accurate and effective borrower credit risk management system.	[Ma, Zhengwei; Hou, Wenjia; Zhang, Dan] China Univ Petr, Sch Econ & Management, Beijing, Peoples R China	China University of Petroleum	Ma, ZW (corresponding author), China Univ Petr, Sch Econ & Management, Beijing, Peoples R China.	ma_zhengwei@163.com		Ma, Zhengwei/0000-0002-3783-8435	Philosophy and Social Science Foundation of China [:18BJY251]	Philosophy and Social Science Foundation of China	This paper is supported by the following fund, Philosophy and Social Science Foundation of China (ID:18BJY251).	Bai P., 2017, J S CHINA NORMAL U N, V49, P119, DOI [10.6054/j.jscnun.2017170, DOI 10.6054/J.JSCNUN.2017170]; [操玮 Cao Wei], 2018, [数据分析与知识发现, Data Analysis and Knowledge Discovery], V2, P65; Chen X, 2018, ECON MODEL, V68, P634, DOI 10.1016/j.econmod.2017.05.007; Ding L., 2017, REV INVESTMENT STUDI, V36, P41; Emekter R, 2015, APPL ECON, V47, P54, DOI 10.1080/00036846.2014.962222; Guo YH, 2016, EUR J OPER RES, V249, P417, DOI 10.1016/j.ejor.2015.05.050; Iyer R, 2009, SCREENING NEW CREDIT, DOI [10.2139/ssrn.1570115, DOI 10.2139/SSRN.1570115]; Jiang CQ, 2018, ANN OPER RES, V266, P511, DOI 10.1007/s10479-017-2668-z; Jiang M., 2014, CHINA SOFT SCI, P148, DOI [10.3969/j.issn.1002-9753.2014.12.014, DOI 10.3969/J.ISSN.1002-9753.2014.12.014]; Li HF, 2016, PROCEDIA COMPUT SCI, V91, P357, DOI 10.1016/j.procs.2016.07.095; Li Taiyong, 2013, Journal of Computer Applications, V33, P3094; Li WW, 2020, INT J GEOGR INF SCI, V34, P637, DOI 10.1080/13658816.2018.1542697; Ma L, 2018, DECIS SUPPORT SYST, V111, P60, DOI 10.1016/j.dss.2018.05.001; Ma ZW, 2020, ENERG ENVIRON-UK, V31, P1098, DOI 10.1177/0958305X19882405; Ma ZW, 2019, PETROL SCI, V16, P929, DOI 10.1007/s12182-019-0339-1; Malekipirbazari M, 2015, EXPERT SYST APPL, V42, P4621, DOI 10.1016/j.eswa.2015.02.001; Serrano-Cinca C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139427; Tan Z., 2017, J FINANCIAL DEV RES, P34, DOI [10.3969/j.issn.1674-2265.2017.11.006, DOI 10.3969/J.ISSN.1674-2265.2017.11.006]; Wang F, 2016, CHINA BUSINESS MARKE, V30, P121, DOI [10.3969/j.issn.1007-8266.2016.11.014, DOI 10.3969/J.ISSN.1007-8266.2016.11.014]; Wang H., 2014, CHINA IND EC, P136, DOI DOI 10.19581/J.CNKI.CIEJOURNAL.2014.04.011; Wang Z, 2018, ELECTRON COMMER R A, V27, P74, DOI 10.1016/j.elerap.2017.12.006; Xia YF, 2017, ELECTRON COMMER R A, V24, P30, DOI 10.1016/j.elerap.2017.06.004; Xiao M.J., 2015, THEORY PRACT FINANCE, V36, P2, DOI [10.16339/j.cnki.hdxbcjb.2015.01.001, DOI 10.16339/J.CNKI.HDXBCJB.2015.01.001]; Xin C., 2017, FINANCE ACCOUNTING M, P104; [杨立 Yang Li], 2018, [中国管理科学, Chinese Journal of Management Science], V26, P47; Ye X, 2018, ELECTRON COMMER R A, V32, P23, DOI 10.1016/j.elerap.2018.10.004; Zhang YS, 2017, LECT NOTES COMPUT SC, V10261, P215, DOI 10.1007/978-3-319-59072-1_26; Zhang YJ, 2016, PROCEDIA COMPUT SCI, V91, P168, DOI 10.1016/j.procs.2016.07.055; Zhang Z., 2012, CREDIT REFERENCE, V30, P25; Zhu C., 2017, FINANCIAL THEORY PRA, P60, DOI [10.3969/j.issn.1674-747X.2012.03.006, DOI 10.3969/J.ISSN.1674-747X.2012.03.006]	30	6	6	23	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255216	10.1371/journal.pone.0255216	http://dx.doi.org/10.1371/journal.pone.0255216			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343180	gold, Green Published			2022-12-26	WOS:000685264200012
J	Melica, V; Atkinson, S; Calambokidis, J; Lang, A; Scordino, J; Mueter, F				Melica, Valentina; Atkinson, Shannon; Calambokidis, John; Lang, Aimee; Scordino, Jonathan; Mueter, Franz			Application of endocrine biomarkers to update information on reproductive physiology in gray whale (Eschrichtius robustus)	PLOS ONE			English	Article							PROGESTERONE CONCENTRATIONS; KILLER WHALES; BLUE WHALES; NORTH; BLUBBER; PREGNANCY; TESTOSTERONE; POLLUTANTS; PROFILES; RESIDENT	Most of our knowledge on reproductive biology of gray whales dates back to scientific research conducted during commercial whaling in the late 1950s and 1960s. The goal of the present study was to provide updated insights on reproductive physiology of gray whales, using progesterone and testosterone as biomarkers. We measured hormone concentrations using enzyme immunoassay (EIA) techniques in blubber biopsies collected from 106 individual whales from March to November over a span of 12 years (2004-2016) between California and Alaska. We found testosterone concentrations in males to increase significantly with age (P = 0.03). Adult males showed significantly elevated testosterone concentrations when sampled in the fall compared to the summer (P = 0.01), likely indicating physiological preparation for mating. We measured testosterone concentrations in females of different age classes, but no statistical differences were found. We found significantly higher progesterone concentrations in pregnant females compared to non-pregnant females and adult males (P< 0.001), indicating progesterone is a valid biomarker for pregnancy in gray whales. Both female and male calves had elevated progesterone concentrations, suggesting maternal transfer via lactation. We fit a mixture of two normal distributions to progesterone data from all non-calf females to identify clusters of high and low progesterone and estimated the probability of being pregnant for whales of unknown reproductive status. With this approach we identified likely pregnant and non-pregnant animals. This study represents an important milestone on reproductive profiles in this population, that can be used to estimate more accurate and precise reproductive parameters to be used for better understanding population dynamics of gray whales.	[Melica, Valentina; Atkinson, Shannon; Mueter, Franz] Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Fisheries Dept, Juneau, AK 99801 USA; [Calambokidis, John] Cascadia Res, Olympia, WA USA; [Lang, Aimee] Ocean Associates Inc, La Jolla, CA USA; [Scordino, Jonathan] Makah Fisheries Management, Marine Mammal Program, Neah Bay, WA USA	University of Alaska System; University of Alaska Fairbanks	Melica, V (corresponding author), Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Fisheries Dept, Juneau, AK 99801 USA.	valentinamelica88@gmail.com		Melica, Valentina/0000-0002-1820-3418	University of Alaska Fairbanks, through the Resilience and Adaptation Program; University of Alaska Fairbanks, through the Calvin Lensink Fellowship; National Institute of General Medical Sciences of the National Institutes of Health [P20GM103395]; Biomedical Learning and Student Training (BLaST) program; National Institutes of Health Common Fund, through the Office of Strategic Coordination, Office of the NIH [RL5GM118990, TL4 GM118992, 1UL1GM118991]	University of Alaska Fairbanks, through the Resilience and Adaptation Program; University of Alaska Fairbanks, through the Calvin Lensink Fellowship; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biomedical Learning and Student Training (BLaST) program; National Institutes of Health Common Fund, through the Office of Strategic Coordination, Office of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was partially funded from University of Alaska Fairbanks, through the Resilience and Adaptation Program and the Calvin Lensink Fellowship. Research reported in this publication was partially supported by an Institutional Development Award (IdeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103395 and by Biomedical Learning and Student Training (BLaST) program and equipment fund, supported by National Institutes of Health Common Fund, through the Office of Strategic Coordination, Office of the NIH Director with the linked awards: RL5GM118990, TL4 GM118992 and 1UL1GM118991. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Open access publication fees were provided by the SeaDoc Society, a program of the University California Davis Karen C. Drayer Wildlife Health Center. One author, Dr. Aime ' e Lang, is employed by a commercial company Ocean Associates, Inc. The funder provided support in the form of salaries for author AL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	Agbayani S, 2020, J MAMMAL, V101, P742, DOI 10.1093/jmammal/gyaa028; AGUILAR A, 1994, ARCH ENVIRON CON TOX, V27, P546; Andrade JM, 2014, ANAL CHIM ACTA, V838, P1, DOI 10.1016/j.aca.2014.04.057; Atkinson S, 1997, Rev Reprod, V2, P175, DOI 10.1530/revreprod/2.3.175; Atkinson S, 1999, GEN COMP ENDOCR, V115, P323, DOI 10.1006/gcen.1999.7319; Atkinson S., 2017, Encyclopedia of Marine Mammals, VThird, P1190; Atkinson S, 2020, MAR MAMMAL SCI, V36, P6, DOI 10.1111/mms.12616; Atkinson S, 2019, MAR POLLUT BULL, V149, DOI 10.1016/j.marpolbul.2019.110593; Atkinson Shannon, 2007, P171; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bradford AL., 2010, 140 US DEP COMM; Busquets-Vass G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177880; Calambokidis J., 1994, GRAY WHALES WASHINGT; Calambokidis J., 2017, SCA17GW04 IWC; Calambokidis J., 2019, UPDATED ANAL ABUNDAN, P1; Calambokidis John, 2002, Journal of Cetacean Research and Management, V4, P267; Carone E, 2019, CONSERV PHYSIOL, V7, DOI 10.1093/conphys/coz059; Carretta J V., 2020, US PACIFIC MARINE MA, DOI [10.7289/V5/TM-SWFSC-577, DOI 10.7289/V5/TM-SWFSC-577]; Cates KA, 2019, GEN COMP ENDOCR, V279, P164, DOI 10.1016/j.ygcen.2019.03.013; Champagne CD, 2018, GEN COMP ENDOCR, V266, P178, DOI 10.1016/j.ygcen.2018.05.015; Champagne CD, 2017, MAR MAMMAL SCI, V33, P134, DOI 10.1111/mms.12352; Clark CT, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow050; D'Intino Anna M., 2013, Journal of Cetacean Research and Management, V13, P97; DalleLuche G., 2020, SCI REP-UK, V10, P1, DOI DOI 10.1038/S41598-020-58933; Darling J.D., 1984, P267; Demaster D.P., 1984, Reports of the International Whaling Commission Special Issue, P175; Findley Lloyd T., 2002, Journal of Cetacean Research and Management, V4, P27; Frasier Timothy R., 2011, Endangered Species Research, V14, P39, DOI 10.3354/esr00340; Hayden M, 2017, RAPID COMMUN MASS SP, V31, P1088, DOI 10.1002/rcm.7884; Hayes KRR., 2018, INFLUENCE LIFE HIST; Herman DP, 2009, MAR ECOL PROG SER, V392, P277, DOI 10.3354/meps08249; Hunt KE, 2018, CONSERV PHYSIOL, V6, DOI 10.1093/conphys/coy049; Hunt KE, 2017, CONSERV PHYSIOL, V5, DOI 10.1093/conphys/cox061; Inoue S, 2019, FISHERIES SCI, V85, P971, DOI 10.1007/s12562-019-01365-5; IWC, 2012, J CETACEAN RES MANAG, V11, P1; Jones M.L., 1984, GRAY WHALE ESCHRICHT; Jones M.L, 1990, REPORTS INT WHALING, V12, P177; KATO H, 1987, Scientific Reports of the Whales Research Institute Tokyo, P47; Kellar NM, 2013, ENDANGER SPECIES RES, V22, P61, DOI 10.3354/esr00537; Kellar NM, 2006, MAR MAMMAL SCI, V22, P1, DOI 10.1111/j.1748-7692.2006.00001.x; Kjeld M, 2004, CAN J FISH AQUAT SCI, V61, P230, DOI 10.1139/F03-159; Kjeld Matthias, 2006, Aquatic Mammals, V32, P75, DOI 10.1578/AM.32.1.2006.75; Koenker R., 2020, R package version 3, P1; Krahn MM, 2007, MAR POLLUT BULL, V54, P1903, DOI 10.1016/j.marpolbul.2007.08.015; Krahn Margaret M., 2004, Journal of Cetacean Research and Management, V6, P175; Krahn Margaret M., 2001, Journal of Cetacean Research and Management, V3, P19; Krahn MM, 2009, MAR POLLUT BULL, V58, P1522, DOI 10.1016/j.marpolbul.2009.05.014; Lang AR, 2014, MAR MAMMAL SCI, V30, P1473, DOI 10.1111/mms.12129; Lawson TM, 2020, SCI TOTAL ENVIRON, V722, DOI 10.1016/j.scitotenv.2020.137776; Lemos LS, 2020, CONSERV PHYSIOL, V8, DOI 10.1093/conphys/coaa110; LUNN NJ, 1994, J ANIM ECOL, V63, P827, DOI 10.2307/5260; Mansour AAH, 2002, MAR MAMMAL SCI, V18, P112, DOI 10.1111/j.1748-7692.2002.tb01022.x; Mate BR, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0071; Melica V, 2021, GEN COMP ENDOCR, V310, DOI 10.1016/j.ygcen.2021.113830; Noren DP, 2012, MAR MAMMAL SCI, V28, P154, DOI 10.1111/j.1748-7692.2011.00469.x; Norman AW., 2015, HORMONES, VThird, P255, DOI [10.1016/B978-0-08-091906-5.00012-4, DOI 10.1016/B978-0-08-091906-5.00012-4]; Norris D., 2006, VERTEBRATE ENDOCRINO; Oftedal OT, 1997, J MAMMARY GLAND BIOL, V2, P205, DOI 10.1023/A:1026328203526; Pallin L, 2018, CONSERV PHYSIOL, V6, DOI 10.1093/conphys/coy031; Pallin LJ, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180017; Perryman Wayne L., 2002, Journal of Cetacean Research and Management, V4, P155; PIKE GC, 1962, J FISH RES BOARD CAN, V19, P815, DOI 10.1139/f62-051; Pinheiro J, R PACKAGE VERSION; R Core Team, 2016, R FDN STAT COMP; Rice DV, 1971, AM SOC MAMMALOGISTS, V3, P142; RICE DW, 1984, US NMFS MAR FISH REV, V46, P7; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Robeck T. D, 2018, CRC HDB MARINE MAMMA, V3rd, P169; Robeck TR, 2004, BIOL REPROD, V71, P650, DOI 10.1095/biolreprod.104.027961; Robinson KP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185000; Rolland RM, 2005, GEN COMP ENDOCR, V142, P308, DOI 10.1016/j.ygcen.2005.02.002; Rolland Rosalind M., 2006, Journal of Cetacean Research and Management, V8, P121; SCHROEDER JP, 1989, J EXP ZOOL, V249, P316, DOI 10.1002/jez.1402490310; Scordino JJ., 2019, INVESTIG MAR MAMMAL; Shelden KEW, 2004, ECOL APPL, V14, P1789, DOI 10.1890/03-5349; Stewart Joshua D., 2021, NOAA Technical Memorandum NMFS-SWFSC, V639, P1; Sumich J.L., 1984, Murrelet, V65, P33, DOI 10.2307/3535288; SUMICH JL, 1986, J MAMMAL, V67, P179, DOI 10.2307/1381019; Swartz S.L., 1983, International Whaling Commission Report of the Commission, V33, P503; Swartz SL, 2018, ENCYCLOPEDIA OF MARINE MAMMALS, 3RD EDITION, P422; Urban JR., 2019, SCI COMM INT WHAT CO; Valenzuela-Molina M, 2018, GEN COMP ENDOCR, V261, P127, DOI 10.1016/j.ygcen.2018.02.015; Vu ET, 2015, MAR MAMMAL SCI, V31, P1258, DOI 10.1111/mms.12191; WEITKAMP LA, 1992, CAN J ZOOL, V70, P2275, DOI 10.1139/z92-304; Weller David W., 2012, Endangered Species Research, V18, P193, DOI 10.3354/esr00447; Weller DW., 2017, NOAA TECHNICAL MEMOR, DOI [10.7289/V5/TM-SWFSC-584NOAA, DOI 10.7289/V5/TM-SWFSC-584NOAA]; West KL, 2000, GEN COMP ENDOCR, V117, P218, DOI 10.1006/gcen.2000.7404; Zenkovich B. A., 1937, B FAR E BRANCH ACAD, V23, P9; Zenkovich BA, 1938, CR ACAD SCI URSS, V20, P203	89	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255368	10.1371/journal.pone.0255368	http://dx.doi.org/10.1371/journal.pone.0255368			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343192	Green Published, gold			2022-12-26	WOS:000685264200030
J	Suarez-Garcia, I; Perales-Fraile, I; Gonzalez-Garcia, A; Munoz-Blanco, A; Manzano, L; Fabregate, M; Diez-Manglano, J; Aizpuru, EF; Fernandez, FA; Garcia, AG; Gomez-Huelgas, R; Ramos-Rincon, JM				Suarez-Garcia, Ines; Perales-Fraile, Isabel; Gonzalez-Garcia, Andres; Munoz-Blanco, Arturo; Manzano, Luis; Fabregate, Martin; Diez-Manglano, Jesus; Aizpuru, Eva Fonseca; Fernandez, Francisco Arnalich; Garcia, Alejandra Garcia; Gomez-Huelgas, Ricardo; Ramos-Rincon, Jose-Manuel		SEMI-COVID-19 Network	In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; OUTCOMES; CANCER; INFECTION; PNEUMONIA; RISK	Background Whether immunosuppressed (IS) patients have a worse prognosis of COVID-19 compared to non-IS patients is not known. The aim of this study was to evaluate the clinical characteristics and outcome of IS patients hospitalized with COVID-19 compared to non-IS patients. Methods We designed a retrospective cohort study. We included all patients hospitalized with laboratory-confirmed COVID-19 from the SEMI-COVID-19 Registry, a large multicentre national cohort in Spain, from March 27(th) until June 19(th), 2020. We used multivariable logistic regression to assess the adjusted odds ratios (aOR) of in-hospital death among IS compared to non-IS patients. Results Among 13 206 included patients, 2 111 (16.0%) were IS. A total of 166 (1.3%) patients had solid organ (SO) transplant, 1081 (8.2%) had SO neoplasia, 332 (2.5%) had hematologic neoplasia, and 570 (4.3%), 183 (1.4%) and 394 (3.0%) were receiving systemic steroids, biological treatments, and immunosuppressors, respectively. Compared to non-IS patients, the aOR (95% CI) for in-hospital death was 1.60 (1.43-1.79) for all IS patients, 1.39 (1.18-1.63) for patients with SO cancer, 2.31 (1.76-3.03) for patients with haematological cancer and 3.12 (2.23-4.36) for patients with SO transplant. The aOR (95% CI) for death for patients who were receiving systemic steroids, biological treatments and immunosuppressors compared to non-IS patients were 2.16 (1.80-2.61), 1.97 (1.33-2.91) and 2.06 (1.64-2.60), respectively. IS patients had a higher odds than non-IS patients of in-hospital acute respiratory distress syndrome, heart failure, myocarditis, thromboembolic disease and multiorgan failure. Conclusions IS patients hospitalized with COVID-19 have a higher odds of in-hospital complications and death compared to non-IS patients.	[Suarez-Garcia, Ines] Hosp Univ Infanta Sofia, FIIB HUIS HHEN, Dept Internal Med, Infect Dis Grp, Madrid, Spain; [Suarez-Garcia, Ines; Perales-Fraile, Isabel] Univ Europea, Fac Ciencias Biomed & Salud, Madrid, Spain; [Perales-Fraile, Isabel] Hosp Univ Infanta Sofia, FIIB HUIS HHEN, Dept Internal Med, Madrid, Spain; [Gonzalez-Garcia, Andres] Hosp Univ Ramon y Cajal, Serv Med Interna IRYCIS, Unidad Enfermedades Sistem Autoinmunes & Minorita, Madrid, Spain; [Munoz-Blanco, Arturo] Hosp Univ Infanta Sofia, Dept Internal Med, Madrid, Spain; [Manzano, Luis; Fabregate, Martin] Hosp Univ Ramon y Cajal, IRYCIS, Serv Med Interna, Madrid, Spain; [Diez-Manglano, Jesus] Hosp Royo Vilanova, Serv Med Interna, Zaragoza, Spain; [Aizpuru, Eva Fonseca] Hosp Cabuenes, Serv Med Interna, Gijon, Asturias, Spain; [Fernandez, Francisco Arnalich] Hosp Univ La Paz, Serv Med Interna, Madrid, Spain; [Garcia, Alejandra Garcia] Hosp Gen Univ Gregorio Maranon, Serv Med Interna, Madrid, Spain; [Gomez-Huelgas, Ricardo] Univ Malaga UMA, Biomed Res Inst Malaga IBIMA, Reg Univ Hosp Malaga, Internal Med Dept, Malaga, Spain; [Ramos-Rincon, Jose-Manuel] Miguel Hernandez Univ Elche, Dept Clin Med, Alicante, Spain	Hospital Universitario Infanta Sofia; Hospital Universitario Infanta Sofia; Hospital Universitario Ramon y Cajal; Hospital Universitario Infanta Sofia; Hospital Universitario Ramon y Cajal; Hospital de Cabuenes; Hospital Universitario La Paz; General University Gregorio Maranon Hospital; Universidad de Malaga; Universidad Miguel Hernandez de Elche	Suarez-Garcia, I (corresponding author), Hosp Univ Infanta Sofia, FIIB HUIS HHEN, Dept Internal Med, Infect Dis Grp, Madrid, Spain.; Suarez-Garcia, I; Perales-Fraile, I (corresponding author), Univ Europea, Fac Ciencias Biomed & Salud, Madrid, Spain.; Perales-Fraile, I (corresponding author), Hosp Univ Infanta Sofia, FIIB HUIS HHEN, Dept Internal Med, Madrid, Spain.	inessuarez@hotmail.com; isabel.perales@salud.madrid.org	Díez-Manglano, J/AAC-3198-2020; Espinosa, Luis Manzano/AAB-1702-2020; Epelde, Francisco/AAT-7213-2021; Gomez-Huelgas, Ricardo/ABF-5100-2021; Fabregate, Martin/R-9439-2018	Díez-Manglano, J/0000-0002-3132-2171; Espinosa, Luis Manzano/0000-0002-0472-1820; Epelde, Francisco/0000-0001-5547-4025; Gomez-Huelgas, Ricardo/0000-0002-9909-3555; Fabregate, Martin/0000-0002-7378-4868				Abolghasemi S, 2020, TRANSPL INFECT DIS, V22, DOI 10.1111/tid.13413; Azkur AK, 2020, ALLERGY, V75, P1564, DOI 10.1111/all.14364; Casas-Rojo JM, 2020, REV CLIN ESP, V220, P480, DOI 10.1016/j.rce.2020.07.003; Dai MY, 2020, CANCER DISCOV, V10, P783, DOI 10.1158/2159-8290.CD-20-0422; De Luca G, 2020, LANCET RHEUMATOL, V2, pE465, DOI 10.1016/S2665-9913(20)30170-3; Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131; Fajgenbaum DC, 2020, INFECT DIS THER, V9, P435, DOI 10.1007/s40121-020-00303-8; Gao Y, 2020, J INFECTION, V81, pE93, DOI 10.1016/j.jinf.2020.05.017; Garassino MC, 2020, LANCET ONCOL, V21, P914, DOI 10.1016/S1470-2045(20)30314-4; Gill JS, 2003, J AM SOC NEPHROL, V14, P1636, DOI 10.1097/01.ASN.0000070621.06264.86; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Kuderer NM, 2020, LANCET, V395, P1907, DOI 10.1016/S0140-6736(20)31187-9; Lee LYW, 2020, LANCET ONCOL, V21, P1309, DOI 10.1016/S1470-2045(20)30442-3; Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6; Rodriguez-Garcia JL, 2021, RHEUMATOLOGY, V60, P399, DOI 10.1093/rheumatology/keaa587; Parra-Bracamonte GM, 2020, ANN EPIDEMIOL, V52, P93, DOI 10.1016/j.annepidem.2020.08.005; Memoli MJ, 2014, CLIN INFECT DIS, V58, P214, DOI 10.1093/cid/cit725; Minotti C, 2020, J INFECTION, V81, pE61, DOI 10.1016/j.jinf.2020.04.026; Miyashita H, 2020, ANN ONCOL, V31, P1088, DOI 10.1016/j.annonc.2020.04.006; Mohan S, 2020, J AM SOC NEPHROL, V31, P1150, DOI 10.1681/ASN.2020030375; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Pereira MR, 2020, AM J TRANSPLANT, V20, P1800, DOI 10.1111/ajt.15941; REDECAN, RED ESP REG CANC; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Robilotti EV, 2020, NAT MED, V26, P1218, DOI 10.1038/s41591-020-0979-0; Sheng CC, 2020, CLIN CARDIOL, V43, P1055, DOI 10.1002/clc.23451; Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012; Ullah W, 2020, J COMMUNITY HOSP INT, V10, P402, DOI 10.1080/20009666.2020.1798141; Wang K, 2020, CLIN INFECT DIS, V71, P2079, DOI 10.1093/cid/ciaa538; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Yang KY, 2020, LANCET ONCOL, V21, P904, DOI 10.1016/S1470-2045(20)30310-7; Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037; Youssef J, 2016, RHEUM DIS CLIN N AM, V42, P157, DOI 10.1016/j.rdc.2015.08.004; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu L, 2020, EUR UROL, V77, P748, DOI 10.1016/j.eururo.2020.03.039	38	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 3	2021	16	8							e0255524	10.1371/journal.pone.0255524	http://dx.doi.org/10.1371/journal.pone.0255524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6IR	34343222	Green Published, gold			2022-12-26	WOS:000685264200025
J	Li, Y; Dong, JL; Xiao, HW; Wang, B; Chen, ZY; Zhang, SQ; Jin, YX; Li, YL; Fan, SJ; Cui, M				Li, Yuan; Dong, Jiali; Xiao, Huiwen; Wang, Bin; Chen, Zhiyuan; Zhang, Shuqin; Jin, Yuxiao; Li, Yiliang; Fan, Saijun; Cui, Ming			Caloric restriction alleviates radiation injuries in a sex-dependent fashion	FASEB JOURNAL			English	Article						caloric restriction; intestinal microbiota; radiation injury; sex-specific	DIETARY RESTRICTION; DIMORPHISM; CANCER; MECHANISMS; PROTECTS; LIVER	Safe and effective regimens are still needed given the risk of radiation toxicity from iatrogenic irradiation. The gut microbiota plays an important role in radiation damage. Diet has emerged as a key determinant of the intestinal microbiome signature and function. In this report, we investigated whether a 30% caloric restriction (CR) diet may ameliorate radiation enteritis and hematopoietic toxicity. Experimental mice were either fed ad libitum (AL) or subjected to CR preconditioning for 10 days and then exposed to total body irradiation (TBI) or total abdominal irradiation (TAI). Gross examinations showed that short-term CR pretreatment restored hematogenic organs and improved the intestinal architecture in both male and female mice. Intriguingly, CR preconditioning mitigated radiation-induced systemic and enteric inflammation in female mice, while gut barrier function improved in irradiated males. 16S rRNA high-throughput sequencing showed that the frequency of pro-inflammatory microbes, including Helicobacter and Desulfovibrionaceae, was reduced in female mice after 10 days of CR preconditioning, while an enrichment of short-chain fatty acid (SCFA)-producing bacteria, such as Faecalibaculum, Clostridiales, and Lactobacillus, was observed in males. Using fecal microbiota transplantation (FMT) or antibiotic administration to alter the gut microbiota counteracted the short-term CR-elicited radiation tolerance of both male and female mice, further indicating that the radioprotection of a 30% CR diet depends on altering the gut microbiota. Together, our findings provide new insights into CR in clinical applications and indicate that a short-term CR diet prior to radiation modulates sex-specific gut microbiota configurations, protecting male and female mice against the side effects caused by radiation challenge.	[Li, Yuan; Dong, Jiali; Wang, Bin; Chen, Zhiyuan; Zhang, Shuqin; Li, Yiliang; Fan, Saijun; Cui, Ming] Chinese Acad Med Sci & Peking Union Med Coll, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, 238 Baidi Rd, Tianjin 300192, Peoples R China; [Xiao, Huiwen] Nankai Univ, Dept Microbiol, Coll Life Sci, Tianjin, Peoples R China; [Jin, Yuxiao] Soochow Univ, Dept Gen Surg, Affiliated Hosp 2, Suzhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Peking Union Medical College; Nankai University; Soochow University - China	Fan, SJ; Cui, M (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Radiat Med, Tianjin Key Lab Radiat Med & Mol Nucl Med, 238 Baidi Rd, Tianjin 300192, Peoples R China.	fansaijun@irm-cams.ac.cn; cuiming0403@bjmu.edu.cn			Science Foundation for Distinguished Young Scholars of Tianjin [20JCJQJC00100]; Natural Science Foundation of China [82003399, 81872555, 81730086]	Science Foundation for Distinguished Young Scholars of Tianjin; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Science Foundation for Distinguished Young Scholars of Tianjin, Grant/Award Number: 20JCJQJC00100; Natural Science Foundation of China, Grant/Award Number: 82003399, 81872555 and 81730086	Bae MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32225; Baruch EN, 2021, SCIENCE, V371, P602, DOI 10.1126/science.abb5920; Bonilla MD, 2019, INT J RADIAT ONCOL, V105, P537, DOI 10.1016/j.ijrobp.2019.06.2533; Brandhorst S, 2017, AGEING RES REV, V39, P68, DOI 10.1016/j.arr.2017.02.001; Caffa I, 2020, NATURE, V583, P620, DOI 10.1038/s41586-020-2502-7; Cai YP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61851-0; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Cho YE, 2021, HEPATOLOGY, V73, P2180, DOI 10.1002/hep.30652; Collins N, 2019, CELL, V178, P1088, DOI 10.1016/j.cell.2019.07.049; Conforti F, 2019, JNCI-J NATL CANCER I, V111, P772, DOI 10.1093/jnci/djz094; Conforti F, 2018, LANCET ONCOL, V19, P737, DOI 10.1016/S1470-2045(18)30261-4; Cook MB, 2011, CANCER EPIDEM BIOMAR, V20, P1629, DOI 10.1158/1055-9965.EPI-11-0246; Cui M, 2019, ADV SCI, V6, DOI 10.1002/advs.201901048; Cui M, 2017, EMBO MOL MED, V9, P448, DOI 10.15252/emmm.201606932; D'Abbondanza M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092748; Diaz-Ruiz A, 2019, J GERONTOL A-BIOL, V74, P155, DOI 10.1093/gerona/gly112; Downer S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2482; Gao X, 2019, NATURE, V572, P397, DOI 10.1038/s41586-019-1437-3; Gerdts E, 2019, NAT MED, V25, P1657, DOI 10.1038/s41591-019-0643-8; Gibbs VK, 2018, J GERONTOL A-BIOL, V73, P157, DOI 10.1093/gerona/glx127; Greenhill Claire, 2016, Nat Rev Endocrinol, V12, P496, DOI 10.1038/nrendo.2016.112; Guo H, 2020, SCIENCE, V370, P549, DOI 10.1126/science.aay9097; Guo TZ, 2019, PAIN, V160, P2013, DOI 10.1097/j.pain.0000000000001592; Hauer-Jensen M, 2014, NAT REV GASTRO HEPAT, V11, P470, DOI 10.1038/nrgastro.2014.46; Hines M, 2020, J NEUROSCI, V40, P37, DOI 10.1523/JNEUROSCI.0750-19.2019; Honjoh S, 2017, CELL REP, V21, P3646, DOI 10.1016/j.celrep.2017.11.108; Jairam V, 2019, JAMA ONCOL, V5, P1028, DOI 10.1001/jamaoncol.2019.0086; Jia FP, 2020, LIVER CANCER, V9, P529, DOI 10.1159/000508308; Jordan S, 2019, CELL, V178, P1102, DOI 10.1016/j.cell.2019.07.050; Kamran MZ, 2016, MED RES REV, V36, P461, DOI 10.1002/med.21386; Kelly CJ, 2013, MUCOSAL IMMUNOL, V6, P1110, DOI 10.1038/mi.2013.6; Kitzman DW, 2016, JAMA-J AM MED ASSOC, V315, P36, DOI 10.1001/jama.2015.17346; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kopeina GS, 2017, BBA-REV CANCER, V1867, P29, DOI 10.1016/j.bbcan.2016.11.002; Kraus WE, 2019, LANCET DIABETES ENDO, V7, P673, DOI 10.1016/S2213-8587(19)30151-2; Kumagai T, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101405; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Liu T, 2019, MBIO, V10, DOI 10.1128/mBio.02903-18; Lu LN, 2020, JPEN-PARENTER ENTER, V44, P1308, DOI 10.1002/jpen.1744; Maggi A, 2018, MOL METAB, V15, P3, DOI 10.1016/j.molmet.2018.02.012; Mutoh E, 2011, OBES RES CLIN PRACT, V5, pE119, DOI 10.1016/j.orcp.2010.12.006; Naghshi S, 2020, BMJ-BRIT MED J, V370, DOI [10.1136/bmj.m2412, 10.1136bmj.m2412]; Perry RJ, 2018, CELL METAB, V27, P210, DOI 10.1016/j.cmet.2017.10.004; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Ploeger JM, 2017, CANCER PREV RES, V10, P660, DOI 10.1158/1940-6207.CAPR-17-0174; Schoenberg MH, 2016, VISC MED, V32, P199, DOI 10.1159/000446492; Tonneau M, 2021, CANCER RADIOTHER, V25, P283, DOI 10.1016/j.canrad.2020.08.047; Tonneau M, 2021, RADIOTHER ONCOL, V156, P1, DOI 10.1016/j.radonc.2020.10.033; Tye H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06125-0; Viennois E, 2019, CELL MOL GASTROENTER, V8, P61, DOI 10.1016/j.jcmgh.2019.02.008; Wang P, 2020, INT J OBESITY, V44, P213, DOI 10.1038/s41366-019-0332-1; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Wu MN, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092809; Zhao RZ, 2020, NATURE, V577, P416, DOI 10.1038/s41586-019-1873-0; Zheng XJ, 2018, FRONT MED-PRC, V12, P634, DOI 10.1007/s11684-018-0670-8; Zhu YZ, 2019, CANCER LETT, V466, P35, DOI 10.1016/j.canlet.2019.08.017	57	1	1	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21787	10.1096/fj.202100351RR	http://dx.doi.org/10.1096/fj.202100351RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34320242				2022-12-26	WOS:000678975300017
J	Sladek, V; Yamamoto, Y; Harada, R; Shoji, M; Shigeta, Y; Sladek, V				Sladek, Vladimir; Yamamoto, Yuta; Harada, Ryuhei; Shoji, Mitsuo; Shigeta, Yasuteru; Sladek, Vladimir			pyProGA-A PyMOL plugin for protein residue network analysis	PLOS ONE			English	Article							MOLECULAR-ORBITAL METHOD; DYNAMICAL NETWORK; COMMUNICATION; PATHWAYS; MODEL; BINDING; SYSTEMS	The field of protein residue network (PRN) research has brought several useful methods and techniques for structural analysis of proteins and protein complexes. Many of these are ripe and ready to be used by the proteomics community outside of the PRN specialists. In this paper we present software which collects an ensemble of (network) methods tailored towards the analysis of protein-protein interactions (PPI) and/or interactions of proteins with ligands of other type, e.g. nucleic acids, oligosaccharides etc. In parallel, we propose the use of the network differential analysis as a method to identify residues mediating key interactions between proteins. We use a model system, to show that in combination with other, already published methods, also included in pyProGA, it can be used to make such predictions. Such extended repertoire of methods allows to cross-check predictions with other methods as well, as we show here. In addition, the possibility to construct PRN models from various kinds of input is so far a unique asset of our code. One can use structural data as defined in PDB files and/or from data on residue pair interaction energies, either from force-field parameters or fragment molecular orbital (FMO) calculations. pyProGA is a free open-source software available from https://gitlab.com/Vlado_S/pyproga.	[Sladek, Vladimir] Slovak Acad Sci, Inst Chem, Bratislava, Slovakia; [Yamamoto, Yuta] Rikkyo Univ, Dept Chem, Tokyo, Japan; [Harada, Ryuhei; Shoji, Mitsuo; Shigeta, Yasuteru] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki, Japan; [Sladek, Vladimir] Slovak Acad Sci, Inst Construct & Architecture, Bratislava, Slovakia	Slovak Academy of Sciences; Rikkyo University; University of Tsukuba; Slovak Academy of Sciences; Institute of Constrution and Architecture, SAS	Sladek, V (corresponding author), Slovak Acad Sci, Inst Chem, Bratislava, Slovakia.	sladek.vladimir@savba.sk		Sladek, Vladimir/0000-0001-5332-7558	Slovak Research and Development Agency (APVV) [APVV-19-0376]; Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Slovak Academy of Sciences (VEGA) [VEGA-2/0031/19, VEGA-2/0061/20]; MEXT Quantum Leap Flagship Program (MEXT Q-LEAP) [JPMXS0120330644]; Japan Agency for Medical Research and Development (AMED) [JP20ae0101047h0001]; Research and Development Operational Program - ERDF [ITMS 26230120002, 26210120002]	Slovak Research and Development Agency (APVV)(Slovak Research and Development Agency); Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Slovak Academy of Sciences (VEGA)(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); MEXT Quantum Leap Flagship Program (MEXT Q-LEAP); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Research and Development Operational Program - ERDF	This research was supported by the Slovak Research and Development Agency (APVV, https://www.apvv.sk/?lang=en) in the form of a grant awarded to VS (APVV-19-0376), the Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and The Slovak Academy of Sciences (VEGA, https://www.minedu.sk/vedeckagrantova-agentura-msvvas-sr-a-sav-vega/) in the form of grants awarded to VS (VEGA-2/0031/19, VEGA-2/0061/20), the MEXT Quantum Leap Flagship Program (MEXT Q-LEAP, https://www.jst.go.jp/stpp/q-leap/en/index.html) in the form of a grant awarded to YS (JPMXS0120330644), and in part by the Japan Agency for Medical Research and Development (AMED, https://www.amed.go.jp/en/) in the form of a grant awarded to YS (JP20ae0101047h0001). Part of the calculations were done at the Computing Center of SAS using the infrastructure from Project Nos. ITMS 26230120002 and 26210120002, supported by the Research and Development Operational Program funded by the ERDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Aydinkal RM, 2019, NUCLEIC ACIDS RES, V47, pW471, DOI 10.1093/nar/gkz390; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Capriotti E, 2004, BIOINFORMATICS, V20, P63, DOI 10.1093/bioinformatics/bth928; Case DA, 2012, AMBER 12; Chakrabarty B, 2016, NUCLEIC ACIDS RES, V44, pW375, DOI 10.1093/nar/gkw383; Contreras-Riquelme S, 2018, PEERJ, V6, DOI 10.7717/peerj.5998; del Sol A, 2005, BIOINFORMATICS, V21, P1311, DOI 10.1093/bioinformatics/bti167; Di Paola L, 2013, CHEM REV, V113, P1598, DOI 10.1021/cr3002356; Dimitri FedorovG., 2009, FRAGNEMT MOL ORBITAL; Doshi U, 2016, P NATL ACAD SCI USA, V113, P4735, DOI 10.1073/pnas.1523573113; Estrada E, 2004, PROTEINS, V54, P727, DOI 10.1002/prot.10609; Estrada E, 2020, CHAOS, V30, DOI 10.1063/5.0013029; Estrada E, 2010, BIOPHYS J, V98, P890, DOI 10.1016/j.bpj.2009.11.017; Fedorov DG, 2006, J COMPUT CHEM, V27, P976, DOI 10.1002/jcc.20406; Fedorov DG, 2020, J PHYS CHEM A, V124, P10346, DOI 10.1021/acs.jpca.0c08204; Fedorov DG, 2020, METHODS MOL BIOL, V2114, P49, DOI 10.1007/978-1-0716-0282-9_4; Fedorov DG, 2019, J CHEM THEORY COMPUT, V15, P5404, DOI 10.1021/acs.jctc.9b00715; Fedorov DG, 2017, WIRES COMPUT MOL SCI, V7, DOI 10.1002/wcms.1322; Fedorov DG, 2016, J PHYS CHEM A, V120, P2218, DOI 10.1021/acs.jpca.6b00163; Fedorov DG, 2012, PHYS CHEM CHEM PHYS, V14, P7562, DOI 10.1039/c2cp23784a; Fedorov DG, 2007, J COMPUT CHEM, V28, P222, DOI 10.1002/jcc.20496; Felline A, 2020, NUCLEIC ACIDS RES, V48, pW94, DOI 10.1093/nar/gkaa397; FIEDLER M, 1973, CZECH MATH J, V23, P298; Ghavasieh A, 2020, PHYS REV E, V102, DOI 10.1103/PhysRevE.102.052304; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; Gordon MS, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P1167, DOI 10.1016/B978-044451719-7/50084-6; Gordon MS, 2012, CHEM REV, V112, P632, DOI 10.1021/cr200093j; Green MC, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4790616; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; Guarnera E, 2017, BIOINFORMATICS, V33, P3996, DOI 10.1093/bioinformatics/btx430; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hamelryck T, 2003, BIOINFORMATICS, V19, P2308, DOI 10.1093/bioinformatics/btg299; Haratipour Z, 2019, PROTEIN J, V38, P497, DOI 10.1007/s10930-019-09850-7; Heifetz A, 2020, METHODS MOL BIOL, V2114, P187, DOI 10.1007/978-1-0716-0282-9_13; Higman VA, 2006, PHYSICA A, V368, P595, DOI 10.1016/j.physa.2006.01.062; Huang PS, 2016, NAT CHEM BIOL, V12, P29, DOI [10.1038/NCHEMBIO.1966, 10.1038/nchembio.1966]; Ishikawa T, 2009, J COMPUT CHEM, V30, P2594, DOI 10.1002/jcc.21265; Ishikura T, 2015, J COMPUT CHEM, V36, P1709, DOI 10.1002/jcc.23989; Jin YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058134; Kanna N, 1999, J MOL BIOL, V292, P441, DOI 10.1006/jmbi.1999.3058; Khor S, 2018, PROTEINS, V86, P924, DOI 10.1002/prot.25524; Khor S, 2016, J COMPLEX NETW, V4, P245, DOI 10.1093/comnet/cnv014; Khor S, 2017, J COMPLEX NETW, V5, P409, DOI 10.1093/comnet/cnw020; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leitner DM, 2008, ANNU REV PHYS CHEM, V59, P233, DOI 10.1146/annurev.physchem.59.032607.093606; Leitner David M, 2020, Biophys Rev, V12, P317, DOI 10.1007/s12551-020-00661-0; Li Q, 2019, BIOINFORMATICS, V35, P4664, DOI 10.1093/bioinformatics/btz298; Liang ZJ, 2020, BRIEF BIOINFORM, V21, P815, DOI 10.1093/bib/bbz029; Lim H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53216-z; Maruyama K, 2018, COMPUT THEOR CHEM, V1132, P23, DOI 10.1016/j.comptc.2018.04.001; Miao ZC, 2015, NUCLEIC ACIDS RES, V43, P5340, DOI 10.1093/nar/gkv446; Nakano T, 2012, CHEM PHYS LETT, V523, P128, DOI 10.1016/j.cplett.2011.12.004; Nemcovicova I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003224; Ota K, 2019, J PHYS CHEM B, V123, P768, DOI 10.1021/acs.jpcb.8b10489; Pasi M, 2012, J CHEM INF MODEL, V52, P1865, DOI 10.1021/ci300213c; Piovesan D, 2016, NUCLEIC ACIDS RES, V44, pW367, DOI 10.1093/nar/gkw315; Raimondi F, 2013, J CHEM THEORY COMPUT, V9, P2504, DOI 10.1021/ct400096f; Raval A, 2002, BIOINFORMATICS, V18, P788, DOI 10.1093/bioinformatics/18.6.788; Ribeiro AAST, 2014, J CHEM THEORY COMPUT, V10, P1762, DOI 10.1021/ct400977r; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schoenrock A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171920; Schrodinger L., 2020, PYMOL; Sercinoglu O, 2018, NUCLEIC ACIDS RES, V46, pW554, DOI 10.1093/nar/gky381; Shcherbinin D., 2019, CHALLENGES ADV COMPU, V27; Sladek V, 2020, J CHEM INF MODEL, V60, P1559, DOI 10.1021/acs.jcim.9b00942; Sladek V, 2018, J CHEM THEORY COMPUT, V14, P6623, DOI 10.1021/acs.jctc.8b00733; Sladek V, 2018, COMMUN NONLINEAR SCI, V61, P225, DOI 10.1016/j.cnsns.2018.02.012; Suenaga M., 2005, J COMPUT CHEM-JPN, V4, P25, DOI [10.2477/jccj.4.25, DOI 10.2477/JCCJ.4.25]; Tanaka S, 2020, J MOL GRAPH MODEL, V100, DOI 10.1016/j.jmgm.2020.107650; Tanaka S, 2014, PHYS CHEM CHEM PHYS, V16, P10310, DOI 10.1039/c4cp00316k; Taylor NR, 2013, COMPUT STRUCT BIOTEC, V5, DOI 10.5936/csbj.201302006; VanWart AT, 2012, J CHEM THEORY COMPUT, V8, P2949, DOI 10.1021/ct300377a; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Vijayabaskar MS, 2010, BIOPHYS J, V99, P3704, DOI 10.1016/j.bpj.2010.08.079; Viloria JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01498-6; Wang SS, 2017, COMMUN NONLINEAR SCI, V47, P151, DOI 10.1016/j.cnsns.2016.11.008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Woo HM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227598; Yamamoto Y, 2018, BIOCHEM BIOPH RES CO, V499, P239, DOI 10.1016/j.bbrc.2018.03.135; Yan WY, 2018, J CHEM INF MODEL, V58, P2024, DOI 10.1021/acs.jcim.8b00146; Yao XQ, 2019, ACCOUNTS CHEM RES, V52, P3455, DOI 10.1021/acs.accounts.9b00485; Yao XQ, 2019, J CHEM INF MODEL, V59, P3222, DOI 10.1021/acs.jcim.9b00320; Yeates TO, 2006, SCIENCE, V314, P1882, DOI 10.1126/science.1137400; Yin YP, 2012, J CHEM THEORY COMPUT, V8, P1176, DOI 10.1021/ct200806n; Yuan SG, 2017, WIRES COMPUT MOL SCI, V7, DOI 10.1002/wcms.1298	87	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2021	16	7							e0255167	10.1371/journal.pone.0255167	http://dx.doi.org/10.1371/journal.pone.0255167			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CU	34329304	Green Published, gold			2022-12-26	WOS:000685248600024
J	Bezsudnova, EY; Nikolaeva, AY; Bakunova, AK; Rakitina, TV; Suplatov, DA; Popov, VO; Boyko, KM				Bezsudnova, Ekaterina Yu.; Nikolaeva, Alena Yu.; Bakunova, Alina K.; Rakitina, Tatiana V.; Suplatov, Dmitry A.; Popov, Vladimir O.; Boyko, Konstantin M.			Probing the role of the residues in the active site of the transaminase from Thermobaculum terrenum	PLOS ONE			English	Article							AMINO-ACID AMINOTRANSFERASE; SUBSTRATE RECOGNITION; ESCHERICHIA-COLI; BIOINFORMATIC ANALYSIS; REACTION SPECIFICITY; BIOCATALYSIS; PURIFICATION; BACTERIAL	Creating biocatalysts for (R)-selective amination effectively is highly desirable in organic synthesis. Despite noticeable progress in the engineering of (R)-amine activity in pyridoxal-5'-phosphate-dependent transaminases of fold type IV, the specialization of the activity is still an intuitive task, as there is poor understanding of sequence-structure-function relationships. In this study, we analyzed this relationship in transaminase from Thermobaculum terrenum, distinguished by expanded substrate specificity and activity in reactions with L-amino acids and (R)-(+)-1-phenylethylamine using alpha-ketoglutarate and pyruvate as amino acceptors. We performed site-directed mutagenesis to create a panel of the enzyme variants, which differ in the active site residues from the parent enzyme to a putative transaminase specific to (R)-primary amines. The variants were examined in the overall transamination reactions and half-reaction with (R)-(+)-1-phenylethylamine. A structural analysis of the most prominent variants revealed a spatial reorganization in the active sites, which caused changes in activity. Although the specialization to (R)-amine transaminase was not implemented, we succeeded in understanding the role of the particular active site residues in expanding substrate specificity of the enzyme. We showed that the specificity for (R)-(+)-1-phenylethylamine in transaminase from T. terrenum arises without sacrificing the specificity for L-amino acids and alpha-ketoglutarate and in consensus with it.	[Bezsudnova, Ekaterina Yu.; Nikolaeva, Alena Yu.; Bakunova, Alina K.; Rakitina, Tatiana V.; Popov, Vladimir O.; Boyko, Konstantin M.] Russian Acad Sci, Res Ctr Biotechnol, Bach Inst Biochem, Moscow, Russia; [Rakitina, Tatiana V.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Suplatov, Dmitry A.] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University	Bezsudnova, EY (corresponding author), Russian Acad Sci, Res Ctr Biotechnol, Bach Inst Biochem, Moscow, Russia.	eubez@inbi.ras.ru	Rakitina, Tatiana V/F-8694-2014; Bakunova, Alina/ABD-9427-2021; Bezsudnova, Ekaterina/K-6603-2015	Rakitina, Tatiana V/0000-0002-3096-8659; Bezsudnova, Ekaterina/0000-0002-4954-7547; Bakunova, Alina/0000-0002-3884-3893; Popov, Vladimir/0000-0002-0133-7962	Russian Science Foundation [19-14-00164]; Russian Federal Space Agency; Ministry of Science and Higher Education of the Russian Federation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Federal Space Agency; Ministry of Science and Higher Education of the Russian Federation	The work was supported by the Russian Science Foundation (project no 19-14-00164) in part of biochemical and structural studies, by the Russian Federal Space Agency (protein crystallization), and by the Ministry of Science and Higher Education of the Russian Federation (bioinformatics analysis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badenhorst CPS, 2018, TRENDS BIOCHEM SCI, V43, P180, DOI 10.1016/j.tibs.2018.01.003; Beilsten-Edmands J, 2020, ACTA CRYSTALLOGR D, V76, P385, DOI 10.1107/S2059798320003198; Bezsudnova EY, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1572, DOI 10.1134/S0006297917130028; Bezsudnova EY, 2020, APPL MICROBIOL BIOT, V104, P2343, DOI 10.1007/s00253-020-10369-6; Bezsudnova EY, 2019, BIOCHIMIE, V158, P130, DOI 10.1016/j.biochi.2018.12.017; Bezsudnova EY, 2016, ARCH BIOCHEM BIOPHYS, V607, P27, DOI 10.1016/j.abb.2016.08.009; Bornscheuer UT, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2017.0063; Braunstein AE., 1973, ENZYMES, V3d, P379, DOI [10.1016/S1874-6047%2808%2960122-5, DOI 10.1016/S1874-6047%2808%2960122-5]; Brundiek H., 2016, TRANSAMINASES BIOSYN, P199, DOI [10.1002/9783527677122.ch10, DOI 10.1002/9783527677122.CH10]; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fuchikami Y, 1998, J BIOCHEM, V124, P905, DOI 10.1093/oxfordjournals.jbchem.a022206; Goto M, 2003, BIOCHEMISTRY-US, V42, P3725, DOI 10.1021/bi026722f; Gu XX, 2020, J ORG CHEM, V85, P6844, DOI 10.1021/acs.joc.0c00473; Guan LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10753; Hekkelman ML, 2010, NUCLEIC ACIDS RES, V38, pW719, DOI 10.1093/nar/gkq453; Hohne M, 2010, NAT CHEM BIOL, V6, P807, DOI [10.1038/nchembio.447, 10.1038/NCHEMBIO.447]; Iglesias C, 2017, APPL MICROBIOL BIOT, V101, P5677, DOI 10.1007/s00253-017-8309-2; INOUE K, 1988, J BIOCHEM-TOKYO, V104, P777, DOI 10.1093/oxfordjournals.jbchem.a122549; INOUE Y, 1989, J BIOL CHEM, V264, P9673; Isupov MN, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00007; Iwasaki A, 2012, APPL MICROBIOL BIOT, V93, P1563, DOI 10.1007/s00253-011-3580-0; Jiang JJ, 2015, APPL MICROBIOL BIOT, V99, P2613, DOI 10.1007/s00253-014-6056-1; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lyskowski A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087350; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Okada K, 2001, BIOCHEMISTRY-US, V40, P7453, DOI 10.1021/bi010384l; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pavkov-Keller T, 2016, SCI REP-UK, V6, DOI 10.1038/srep38183; Peisach D, 1998, BIOCHEMISTRY-US, V37, P4958, DOI 10.1021/bi972884d; Radkov AD, 2014, APPL MICROBIOL BIOT, V98, P5363, DOI 10.1007/s00253-014-5726-3; Savile CK, 2010, SCIENCE, V329, P305, DOI 10.1126/science.1188934; Schatzle S, 2009, ANAL CHEM, V81, P8244, DOI 10.1021/ac901640q; Skalden L, 2015, FEBS J, V282, P407, DOI 10.1111/febs.13149; Steffen-Munsberg F, 2015, BIOTECHNOL ADV, V33, P566, DOI 10.1016/j.biotechadv.2014.12.012; Stekhanova TN, 2017, ENZYME MICROB TECH, V96, P127, DOI 10.1016/j.enzmictec.2016.10.002; SUGIO S, 1995, BIOCHEMISTRY-US, V34, P9661, DOI 10.1021/bi00030a002; Suplatov D, 2021, METHODS MOL BIOL, V2231, P179, DOI 10.1007/978-1-0716-1036-7_12; Suplatov D, 2020, NUCLEIC ACIDS RES, V48, pW65, DOI 10.1093/nar/gkaa276; Suplatov DA, 2018, BIOINFORMATICS, V34, P1583, DOI 10.1093/bioinformatics/btx831; TANIZAWA K, 1989, J BIOL CHEM, V264, P2445; Telzerow A, 2019, ACS CATAL, V9, P1140, DOI 10.1021/acscatal.8b04524; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; Toney MD, 2011, BBA-PROTEINS PROTEOM, V1814, P1407, DOI 10.1016/j.bbapap.2011.05.019; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Voss M, 2020, ACS CHEM BIOL, V15, P416, DOI 10.1021/acschembio.9b00888; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu SK, 2021, ANGEW CHEM INT EDIT, V60, P88, DOI 10.1002/anie.202006648; Zeifman YS, 2019, BBA-PROTEINS PROTEOM, V1867, P575, DOI 10.1016/j.bbapap.2019.03.005	51	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255098	10.1371/journal.pone.0255098	http://dx.doi.org/10.1371/journal.pone.0255098			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324538	Green Published, gold			2022-12-26	WOS:000685248200010
J	Guarnizo-Herreno, CC; Torres, G; Buitrago, G				Guarnizo-Herreno, Carol C.; Torres, Gabriel; Buitrago, Giancarlo			Socioeconomic inequalities in birth outcomes: An 11-year analysis in Colombia	PLOS ONE			English	Article							HEALTH-INSURANCE; MORTALITY; CANCER; INCOME; FRAMEWORK; WEIGHT; LEVEL; FETAL; LIFE	Objective To examine socioeconomic inequalities in birth outcomes among infants born between 2008 and 2018 and assessed trends in inequalities during that period in Colombia, a middle-income country with high levels of inequality emerging from a long internal armed conflict. Methods Using birth certificate data in Colombia, we analysed the outcomes of low birth weight, an Apgar score <7 at 5 minutes after birth and the number of prenatal visits among full-term pregnancies. Maternal education and health insurance schemes were used as socioeconomic position (SEP) indicators. Inequalities were estimated using the prevalence/mean of the outcomes across categories of the SEP indicators and calculating the relative and slope indices of inequality (RII and SII, respectively). Results Among the 5,433,265 full-term singleton births analysed, there was a slight improvement in the outcomes analysed over the study period (lower low-birth-weight and Apgar<7 prevalence rates and higher number of prenatal visits). We observed a general pattern of social gradients and significant relative (RII) and absolute (SII) inequalities for all outcomes across both SEP indicators. RII and SII estimates with their corresponding CIs revealed a general picture of no significant changes in inequalities over time, with some particular, time-dependent exceptions. When comparing the initial and final years of our study period, inequalities in low birth weight related to maternal education increased while those in Apgar score Conclusion The lack of a consistent improvement in the magnitude of inequalities in birth outcomes over an 11-year period is a worrying issue because it could aggravate the cycle of inequality, given the influence of birth outcomes on health, social and economic outcomes throughout the life course. The findings of our analysis emphasize the importance of policies aimed at providing access to quality education and providing a health care system with universal coverage and high levels of integration.	[Guarnizo-Herreno, Carol C.] Univ Nacl Colombia, Fac Odontol, Dept Salud Colectiva, Bogota, Colombia; [Torres, Gabriel; Buitrago, Giancarlo] Univ Nacl Colombia, Inst Investigaciones Clinicas, Fac Med, Bogota, Colombia; [Buitrago, Giancarlo] Hosp Univ Nacl Colombia, Bogota, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia	Guarnizo-Herreno, CC (corresponding author), Univ Nacl Colombia, Fac Odontol, Dept Salud Colectiva, Bogota, Colombia.	ccguarnizoh@unal.edu.co		Buitrago, Giancarlo/0000-0002-7466-8244				Abadia CE, 2009, SOC SCI MED, V68, P1153, DOI 10.1016/j.socscimed.2008.12.049; Amaya-Guío Jairo, 2013, Rev Colomb Obstet Ginecol, V64, P245; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barros AJD, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002229; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bernal O, 2012, REV PANAM SALUD PUBL, V31, P181, DOI 10.1590/S1020-49892012000300001; Bhowmik J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231489; Blencowe H, 2019, LANCET GLOB HEALTH, V7, pE849, DOI 10.1016/S2214-109X(18)30565-5; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Buitrago G, EUR HLTH EC ASS EUHE; Cáceres-Manrique Flor de María, 2008, Rev. salud pública, V10, P94; Campbell EE, 2018, J BIOSOC SCI, V50, P102, DOI 10.1017/S0021932017000062; Colombia Implementation Working Group, 2018, CRVS COUNTR PERSP; De La Torre A, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0752-x; de Vries E, 2015, J EPIDEMIOL COMMUN H, V69, P408, DOI 10.1136/jech-2014-204650; de Vries E, 2015, CANCER EPIDEMIOL, V39, P91, DOI 10.1016/j.canep.2014.10.012; Ehrenstein V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-14; Ernstsen L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-266; Garcia-Ramirez J, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01241-0; Garcia-Subirats I, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-10; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Guarnizo-Herreno CC, 2019, J EPIDEMIOL COMMUN H, V73, P737, DOI 10.1136/jech-2018-212049; Guerrero R, 2011, SALUD PUBLICA MEXICO, V53, pS144; Houweling TAJ, 2017, J EPIDEMIOL COMMUN H, V71, P505, DOI 10.1136/jech-2016-207499; Hughes RA, 2019, INT J EPIDEMIOL, V48, P1294, DOI 10.1093/ije/dyz032; Instituto Nacional de Salud Colombia, 2020, B EP SEM SEM EP FEB; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; Jimenez JP, 2015, DESIGUALDAD CONCENTR; Kajantie E, 2005, INT J EPIDEMIOL, V34, P655, DOI 10.1093/ije/dyi048; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Khang YH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-66; Kim D, 2013, INT J ENV RES PUB HE, V10, P2296, DOI 10.3390/ijerph10062296; Lee KJ, 2021, J CLIN EPIDEMIOL, V134, P79, DOI 10.1016/j.jclinepi.2021.01.008; Li C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1738-x; Amaya-Lara JL, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0472-z; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Martinez M., THESIS U NACL COLOMB; Moreno-Betancur M, 2015, EPIDEMIOLOGY, V26, P518, DOI 10.1097/EDE.0000000000000311; O'Leary M, 2017, B WORLD HEALTH ORGAN, V95, P574, DOI 10.2471/BLT.16.180273; Odd DE, 2011, PEDIATRICS, V127, pE1498, DOI 10.1542/peds.2010-3604; Persson M, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k207; Pineros M, 2011, SALUD PUBLICA MEXICO, V53, P478; Raatikainen K, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-268; Rengifo-Reina Herney A, 2009, Rev. salud pública, V11, P526; Saleem S, 2014, B WORLD HEALTH ORGAN, V92, P605, DOI 10.2471/BLT.13.127464; Schneider F., 2002, WORKSH AUSTR NAT TAX; Silvestrin S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65445-8; Silvestrin S, 2013, J PEDIAT-BRAZIL, V89, P339, DOI 10.1016/j.jped.2013.01.003; Toro Roa JP, 2019, ACHIEVING HLTH OUTCO; United Nations, 2015, SUSTAINABLE DEV GOAL, DOI DOI 10.1163/157180910X12665776638740; WHO Reproductive Health Library, 2016, WHO REPR HLTH LIB; World Health Organization, 2008, GUID DRINK WAT QUAL, V1, DOI DOI 10.1007/S12403-018-0288-8	52	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255150	10.1371/journal.pone.0255150	http://dx.doi.org/10.1371/journal.pone.0255150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324557	gold, Green Published			2022-12-26	WOS:000685248200081
J	Lee, T; Rosario, H; Cifuentes, E; Cui, JW; Lin, EC; Miller, VA; Lin, HC				Lee, Tyler; Rosario, Hinette; Cifuentes, Elizabeth; Cui, Jiawei; Lin, Emery C.; Miller, Victoria A.; Lin, Henry C.			Review of interruptions in a pediatric subspecialty outpatient clinic	PLOS ONE			English	Review							INTERPERSONAL SKILLS; MEDICAL ENCOUNTER; COMMUNICATION; PHYSICIAN; DOCTOR; CARE; COMPETENCE; POWER	Introduction The objective of this study was to describe interruptions in the pediatric ambulatory setting and to assess their impact on perceived physician communication, patient satisfaction and recall of provided physician instructions. Methods An observational study was performed at the Children's Hospital of Philadelphia, Pediatric Gastroenterology clinic. Participation consisted of video recording the clinic visit and the caregiver completed post-visit surveys on communication and satisfaction. Video recordings were coded for interruptions, which were divided into 3 main categories: Visit Associated, Pediatric Associated, and Unanticipated. An interruption rate was calculated and correlated with the following outcome variables to assess the impact of interruptions: caregiver satisfaction, caregiver perception on the quality of physician communication, and caregiver instruction recall. Results There were 675 interruptions noted in the 81 clinic visits, with an average of 7.96 (sigma = 7.68) interruptions per visit. Six visits had no interruptions. The Patient was the most frequent interrupter. Significantly higher interruption rates occurred in clinic visits with younger patients (<7 years old) with most of the interruptions being Pediatric Associated interruptions. There was minimal correlation between the clinic visit interruption rate and caregiver satisfaction with the communication, caregiver perception of quality of communication, or caregiver instruction recall rate. Conclusion The effect of interruptions on the pediatric visit remains unclear. Interruptions may be part of the communication process to ensure alignment of the patient's agenda. Additional studies are needed to help determine the impact of interruptions and guide medical education on patient communication.	[Lee, Tyler] Philadelphia Coll Osteopath Med, Philadelphia, PA USA; [Lee, Tyler; Rosario, Hinette; Cifuentes, Elizabeth; Cui, Jiawei] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Lin, Emery C.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Miller, Victoria A.] Childrens Hosp Philadelphia, Div Adolescent Med, Philadelphia, PA 19104 USA; [Miller, Victoria A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lin, Henry C.] Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Gastroenterol, Doernbecher Childrens Hosp, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Oregon Health & Science University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Oregon Health & Science University	Lin, HC (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, Div Pediat Gastroenterol, Doernbecher Childrens Hosp, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.	linhe@ohsu.edu						[Anonymous], 2017, MEDSCAPE PHYS COMPEN; BECKMAN HB, 1984, ANN INTERN MED, V101, P692, DOI 10.7326/0003-4819-101-5-692; Benson BJ, 2014, ACAD PEDIATR, V14, pS55, DOI 10.1016/j.acap.2013.11.016; Blocker RC, 2017, J EMERG MED, V53, P798, DOI 10.1016/j.jemermed.2017.08.067; Brunett PH, 2001, ACAD MED, V76, P390, DOI 10.1097/00001888-200104000-00021; Byrne P.S., 1976, DOCTORS TALKING PATI; Calhoun AW, 2009, SIMUL HEALTHC, V4, P22, DOI 10.1097/SIH.0b013e318184377a; Chin J. J., 2002, SMJ Singapore Medical Journal, V43, P152; DeWane M, 2018, Int J Womens Dermatol, V4, P238, DOI 10.1016/j.ijwd.2017.12.002; Duffy FD, 2004, ACAD MED, V79, P495, DOI 10.1097/00001888-200406000-00002; FRANKEL RM, 1984, DISCOURSE PROCESS, V7, P135, DOI 10.1080/01638538409544587; GOLDBERG JA, 1990, J PRAGMATICS, V14, P883, DOI 10.1016/0378-2166(90)90045-F; Grundgeiger T, 2016, BMJ QUAL SAF, V25, P392, DOI 10.1136/bmjqs-2015-004083; Hall JA, 2002, PATIENT EDUC COUNS, V48, P69, DOI 10.1016/S0738-3991(02)00071-X; Hall LM, 2010, J PEDIATR NURS, V25, P167, DOI 10.1016/j.pedn.2008.09.005; IRISH JT, 1995, SOC SCI MED, V41, P873, DOI 10.1016/0277-9536(94)00399-E; Kaplan SH, 1996, ANN INTERN MED, V124, P497, DOI 10.7326/0003-4819-124-5-199603010-00007; Koong AYL, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0330-x; LARSSON US, 1987, SOC SCI MED, V25, P1129, DOI 10.1016/0277-9536(87)90354-6; Li Han Z, 2004, Commun Med, V1, P145, DOI 10.1515/come.2004.1.2.145; Marshall GN., 1994, PATIENT SATISFACTION; Marvel MK, 1999, JAMA-J AM MED ASSOC, V281, P283, DOI 10.1001/jama.281.3.283; Mauksch LB, 2008, ARCH INTERN MED, V168, P1387, DOI 10.1001/archinte.168.13.1387; Mauksch LB, 2017, JAMA-J AM MED ASSOC, V317, P1021, DOI 10.1001/jama.2016.16068; Mischler Elliott, 1984, DISCOURSE MED DIALEC; MISHRA S, 1987, WESTERN J MED, V147, P328; Oda Y, 2014, J CLIN BIOCHEM NUTR, V55, P72, DOI 10.3164/jcbn.14-29; Ospina NS, 2019, J GEN INTERN MED, V34, P36, DOI 10.1007/s11606-018-4540-5; Realini T, 1995, Arch Fam Med, V4, P1028, DOI 10.1001/archfami.4.12.1028; Rhoades DR, 2001, FAM MED, V33, P528; Rivera-Rodriguez AJ, 2010, QUAL SAF HEALTH CARE, V19, P304, DOI 10.1136/qshc.2009.033282; SCHEGLOFF EA, 1977, LANGUAGE, V53, P361, DOI 10.2307/413107; Schneider A, 2019, BMJ QUAL SAF, V28, P296, DOI 10.1136/bmjqs-2018-007811; STREET RL, 1988, HUM COMMUN RES, V15, P60, DOI 10.1111/j.1468-2958.1988.tb00171.x; STREET RL, 1991, MED CARE, V29, P1146, DOI 10.1097/00005650-199111000-00006; Teutsch C, 2003, MED CLIN N AM, V87, P1115, DOI 10.1016/S0025-7125(03)00066-X; WAITZKIN H, 1984, JAMA-J AM MED ASSOC, V252, P2441, DOI 10.1001/jama.252.17.2441; WEST C, 1984, SYMB INTERACT, V7, P87, DOI 10.1525/si.1984.7.1.87	38	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254528	10.1371/journal.pone.0254528	http://dx.doi.org/10.1371/journal.pone.0254528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324552	Green Published, gold			2022-12-26	WOS:000685248200040
J	Nguyen, HTT; Dinh, DX; Nguyen, VM				Nguyen, Huong Thi Thanh; Dinh, Dai Xuan; Nguyen, Van Minh			Knowledge, attitude and practices of community pharmacists regarding COVID-19: A paper-based survey in Vietnam	PLOS ONE			English	Article								Objective To survey the knowledge, attitude, and practices of Vietnamese pharmacists regarding the COVID-19 pandemic. Method This cross-sectional, paper-based study was conducted from June to August 2020. A validated questionnaire (Cronbach's alpha = 0.84) was used to interview 1,023 pharmacists in nine provinces of Vietnam. Analysis of covariance was employed to identify factors associated with the knowledge of pharmacists. The best model was chosen by using the Bayesian Model Averaging method in R software version 4.0.4. Results The mean knowledge score was 12.02 +/- 1.64 (range: 6-15), which indicated that 93.4% of pharmacists had good knowledge of COVID-19. There was no difference in the average score between males and females (p > 0.05). The multivariate linear regression model revealed that the knowledge was significantly associated with pharmacists' age, education level, and residence (p < 0.001). About attitude and practices, pharmacists daily sought and updated information on the COVID-19 pandemic through mass media and the internet (social network and online newspapers). Nearly 48% of them conceded that they communicated with customers when at least one person did not wear a face mask at the time of the COVID-19 outbreak. At medicine outlets, many measures were applied to protect pharmacists and customers, such as equipping pharmacists with face masks and hand sanitizers (95.0%), using glass shields (83.0%), and maintaining at least one-meter distance between two people (85.2%). Conclusion The pharmacists' knowledge of COVID-19 transmission, symptoms, and prevention was good. Many useful measures against the spread of this perilous virus were applied in medicine outlets. However, pharmacists should restrict forgetting to wear face masks in communication with medicine purchasers. The government and health agencies should have practical remedies to reduce the significant differences in the COVID-19 knowledge of pharmacists among provinces and education-level groups.	[Nguyen, Huong Thi Thanh; Dinh, Dai Xuan] Hanoi Univ Pharm, Dept Pharmaceut Management & PharmacoEcon, Hanoi, Vietnam; [Nguyen, Van Minh] Hanoi Univ Publ Hlth, Ctr Populat Hlth Sci, Hanoi, Vietnam	Hanoi University of Pharmacy; Hanoi University of Public Health	Dinh, DX (corresponding author), Hanoi Univ Pharm, Dept Pharmaceut Management & PharmacoEcon, Hanoi, Vietnam.	dinhxuandai.224@gmail.com	Dinh, Dai Xuan/ADC-5116-2022	Dinh, Dai Xuan/0000-0001-6387-2496; Nguyen, Huong/0000-0003-2191-6408				Al Mazrouei N, 2021, INT J PHARM PRACT, V29, P137, DOI 10.1093/ijpp/riaa003; Alrasheedy AA, 2021, RISK MANAG HEALTHC P, V14, P729, DOI 10.2147/RMHP.S292354; [Anonymous], 2020, RES SOC ADMIN PHARM, DOI [DOI 10.1016/j.sapharm.2020.02.003, 10.1016/j.sapharm.2020.02.003]; Basheti IA, 2021, RES SOC ADMIN PHARM, V17, P514, DOI 10.1016/j.sapharm.2020.04.020; Cacodcar JA., 2020, INT J COMMUNITY MED, V7, P5081, DOI [10.18203/2394-6040.ijcmph20205188, DOI 10.18203/2394-6040.IJCMPH20205188]; Cadogan CA, 2021, RES SOC ADMIN PHARM, V17, P2032, DOI 10.1016/j.sapharm.2020.03.015; Erku DA, 2021, RES SOC ADMIN PHARM, V17, P1954, DOI 10.1016/j.sapharm.2020.04.032; Gohel KH, 2021, CLIN EPIDEMIOL GLOB, V9, P104, DOI 10.1016/j.cegh.2020.07.008; Goode JVR, 2020, J AM PHARM ASSOC, V60, pE19, DOI 10.1016/j.japh.2020.08.017; Gross AE, 2020, J AM COLL CLIN PHARM, V3, P564, DOI DOI 10.1002/JAC5.1231; Hamza MS, 2021, J COMMUN HEALTH, V46, P139, DOI 10.1007/s10900-020-00859-z; Handicap International, 2009, KNOWLEDGE ATTITUDES; Hussain I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241467; Giao H, 2020, ASIAN PAC J TROP MED, V13, P260, DOI 10.4103/1995-7645.280396; Jalil MA, 2020, DISASTER MED PUBLIC, V14, P782, DOI 10.1017/dmp.2020.186; Jarab AS, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13696; Kara E, 2020, TURK J PHARM SCI, V17, P242, DOI 10.4274/tjps.galenos.2020.72325; Karasneh R, 2021, RES SOC ADMIN PHARM, V17, P1897, DOI 10.1016/j.sapharm.2020.04.027; Khan Z, 2020, DRUGS THER PERSPECT, V36, P215, DOI 10.1007/s40267-020-00717-x; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; Li HB, 2021, RES SOC ADMIN PHARM, V17, P1813, DOI 10.1016/j.sapharm.2020.04.003; Dinh L, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa047; Muhammad K, 2022, DISASTER MED PUBLIC, V16, P1864, DOI 10.1017/dmp.2021.54; Nguyen THD, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101651; NIOSH (National Institute for Occupational Safety and Health), 2019, DET PART FILT EFF LE; Quan NHK., 2021, ASIAN J HUMANIT SOC, V9, P19, DOI 10.24203/ajhss.v9i1.6531; Shrestha S, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312120974513; Strand MA, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200317; Tan SL, 2020, AM J HEALTH-SYST PH, V77, P1096, DOI 10.1093/ajhp/zxaa120; Tesfaye ZT, 2020, INTEGR PHARM RES PRA, V9, P105, DOI 10.2147/IPRP.S261275; Thunstrom L, 2020, J BENEFIT-COST ANAL, V11, P179, DOI 10.1017/bca.2020.12; Vietnam Ministry of Health, 2021, INF COV 19 VIR INF COV 19 VIR; World Health Organization, COV 19 VACC; World Health Organization, COR DIS COV 19 WEEKL COR DIS COV 19 WEEKL; World Health Organization, Q AS COV 19 REL HLTH Q AS COV 19 REL HLTH; World Health Organization, COR OV SYMPT PREV COR OV SYMPT PREV; Yimenu DK, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312120973498; Zeenny RM, 2020, J PHARM POLICY PRACT, V13, DOI 10.1186/s40545-020-00266-8; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255420	10.1371/journal.pone.0255420	http://dx.doi.org/10.1371/journal.pone.0255420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324597	Green Published, gold			2022-12-26	WOS:000685248200097
J	Gallo, G; Fyhrie, M; Paine, C; Ushakov, SV; Izuho, M; Gunchinsuren, B; Zwyns, N; Navrotsky, A				Gallo, Giulia; Fyhrie, Matthew; Paine, Cleantha; Ushakov, Sergey V.; Izuho, Masami; Gunchinsuren, Byambaa; Zwyns, Nicolas; Navrotsky, Alexandra			Characterization of structural changes in modern and archaeological burnt bone: Implications for differential preservation bias	PLOS ONE			English	Article							CHEMICAL-CHANGES; FTIR; DIAGENESIS; FIRE; SPECTROSCOPY; ELEMENTS; PATTERNS; CRYSTAL; TEETH; ATR	Structural and thermodynamic factors which may influence burnt bone survivorship in archaeological contexts have not been fully described. A highly controlled experimental reference collection of fresh, modern bone burned in temperature increments 100-1200C is presented here to document the changes to bone tissue relevant to preservation using Fourier transform infrared spectroscopy and X-ray diffraction. Specific parameters investigated here include the rate of organic loss, amount of bone mineral recrystallization, and average growth in bone mineral crystallite size. An archaeological faunal assemblage ca. 30,000 years ago from Tolbor-17 (Mongolia) is additionally considered to confirm visibility of changes seen in the modern reference sample and to relate structural changes to commonly used zooarchaeological scales of burning intensity. The timing of our results indicates that the loss of organic components in both modern and archaeological bone burnt to temperatures up to 700C are not accompanied by growth changes in the average crystallite size of bone mineral bioapatite, leaving the small and reactive bioapatite crystals of charred and carbonized bone exposed to diagenetic agents in depositional contexts. For bones burnt to temperatures of 700C and above, two major increases in average crystallite size are noted which effectively decrease the available surface area of bone mineral crystals, decreasing reactivity and offering greater thermodynamic stability despite the mechanical fragility of calcined bone. We discuss the archaeological implications of these observations within the context of Tolbor-17 and the challenges of identifying anthropogenic fire.	[Gallo, Giulia; Fyhrie, Matthew; Zwyns, Nicolas] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Gallo, Giulia; Zwyns, Nicolas] Univ Calif Davis, Ctr Expt Archaeol Davis, Davis, CA 95616 USA; [Paine, Cleantha] Univ Highlands & Isl, Archaeol Inst, Kirkwall, England; [Ushakov, Sergey V.; Navrotsky, Alexandra] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85281 USA; [Ushakov, Sergey V.; Navrotsky, Alexandra] Arizona State Univ, Ctr Mat Univ, Tempe, AZ 85281 USA; [Izuho, Masami] Tokyo Metropolitan Univ, Tokyo, Japan; [Gunchinsuren, Byambaa] Mongolia Acad Sci, Inst Hist & Archaeol, Ulaanbaatar, Mongolia; [Zwyns, Nicolas] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany	University of California System; University of California Davis; University of California System; University of California Davis; UHI Millennium Institute; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Tokyo Metropolitan University; Mongolian Academy of Sciences; National University of Mongolia; Max Planck Society	Gallo, G (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.; Gallo, G (corresponding author), Univ Calif Davis, Ctr Expt Archaeol Davis, Davis, CA 95616 USA.	gtgallo@ucdavis.edu	Byambaa, Gunchinsuren/AAS-6454-2021	Byambaa, Gunchinsuren/0000-0001-5052-5081; Fyhrie, Matthew/0000-0003-1886-6294	National Science Foundation [156074]; Ministry of Education, Culture, Sports, Science and Technology, Japan [1802]; UC Davis Cluster Grant "Archaeology and Soil Science Synergy"	National Science Foundation(National Science Foundation (NSF)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); UC Davis Cluster Grant "Archaeology and Soil Science Synergy"	NZ, Grant #156074, National Science Foundation (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1560784).MI PaleoAsia Project Grant No. 1802, FY2016-2020) from the Ministry of Education, Culture, Sports, Science and Technology, Japan ("Cultural history of PaleoAsia: Integrative research on the formative processes of modern human cultures in Asia," directed by Yoshihiro Nishiaki) (http://paleoasia.jp/en/).GG UC Davis Cluster Grant "Archaeology and Soil Science Synergy" (https://dhi.ucdavis.edu/events/20192020-dhi-transcollege-research-clusters-call-proposals).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baig AA, 1999, CALCIFIED TISSUE INT, V64, P329, DOI 10.1007/s002239900628; Baig AA., 1997, INFLUENCES CARBONATE; Bala Y, 2013, OSTEOPOROSIS INT, V24, P2153, DOI 10.1007/s00198-012-2228-y; Barkai R, 2017, CURR ANTHROPOL, V58, pS314, DOI 10.1086/691211; Beasley MM, 2014, J ARCHAEOL SCI, V46, P16, DOI 10.1016/j.jas.2014.03.008; Berna F, 2004, J ARCHAEOL SCI, V31, P867, DOI 10.1016/j.jas.2003.12.003; Binford L. R., 1977, THEORY BUILDING ARCH; Bruno TJ, 1999, APPL SPECTROSC REV, V34, P91, DOI 10.1081/ASR-100100840; Buikstra J.E., 1989, BONE MODIFICATION, P247; Costamagno S, 2005, BIOSPHERE TO LITHOSPHERE: NEW STUDIES IN VERTEBRATE TAPHONOMY, P51; Costamagno S., 2009, GESTON COMBUSTIBLES, V61; Dal Sasso G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30642-z; Denys C, 2002, ARCHAEOMETRY, V44, P469, DOI 10.1111/1475-4754.00079; Drouet C, 2018, AM MINERAL, V103, P550, DOI 10.2138/am-2018-6415; Ellingham STD, 2015, SCI JUSTICE, V55, P181, DOI 10.1016/j.scijus.2014.12.002; Etok SE, 2007, J MATER SCI, V42, P9807, DOI 10.1007/s10853-007-1993-z; Figueiredo M, 2010, CERAM INT, V36, P2383, DOI 10.1016/j.ceramint.2010.07.016; Gianfrate G, 2007, NUCL INSTRUM METH B, V259, P316, DOI 10.1016/j.nimb.2007.01.309; [Гладышев Сергей Анатольевич Gladyshev S.A.], 2013, [Вестник Новосибирского государственного университета. Серия: История, филология, Vestnik Novosibirskogo gosudarstvennogo universiteta. Seriya: Istoriya, filologiya], V12, P44; Gladyshev SA, 2012, QUATERN INT, V281, P36, DOI 10.1016/j.quaint.2012.01.032; Goldberg P, 2017, CURR ANTHROPOL, V58, pS175, DOI 10.1086/692729; Gowlett JAJ, 2006, CR PALEVOL, V5, P299, DOI 10.1016/j.crpv.2005.10.008; GRAYSON DK, 1989, J ARCHAEOL SCI, V16, P643, DOI 10.1016/0305-4403(89)90028-9; Greiner M, 2019, J ARCHAEOL SCI-REP, V25, P507, DOI 10.1016/j.jasrep.2019.05.009; Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064; HEDGES REM, 1995, J ARCHAEOL SCI, V22, P155, DOI 10.1006/jasc.1995.0017; Henry AG, 2018, QUATERN INT, V493, P96, DOI 10.1016/j.quaint.2018.06.037; Henry AG, 2017, CURR ANTHROPOL, V58, pS329, DOI 10.1086/692095; Herrmann NP, 1999, J FORENSIC SCI, V44, P461; Hollund HI, 2013, ARCHAEOMETRY, V55, P507, DOI 10.1111/j.1475-4754.2012.00695.x; Iriarte E, 2020, J ARCHAEOL SCI-REP, V30, DOI 10.1016/j.jasrep.2020.102211; Khatsenovich A.M., 2015, ARCHEOLOGIA ETHNOG C, V14, P38; KOEPPENKASTROP D, 1992, CHEM GEOL, V95, P251, DOI 10.1016/0009-2541(92)90015-W; Lam YM, 1999, AM ANTIQUITY, V64, P343, DOI 10.2307/2694283; Lanting JN, 2001, RADIOCARBON, V43, P249; Lebon M, 2016, RADIOCARBON, V58, P131, DOI 10.1017/RDC.2015.11; Lebon M, 2014, PALAEOGEOGR PALAEOCL, V416, P110, DOI 10.1016/j.palaeo.2014.08.001; Lebon M, 2008, ANAL BIOANAL CHEM, V392, P1479, DOI 10.1007/s00216-008-2469-y; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; LYMAN RL, 1984, J ANTHROPOL ARCHAEOL, V3, P259, DOI 10.1016/0278-4165(84)90004-7; Major I., 2018, RADIOCARBON; Martin R.B., 2015, SKELETAL TISSUE MECH; Maurer AF, 2014, PALAEOGEOGR PALAEOCL, V416, P17, DOI 10.1016/j.palaeo.2014.08.020; MCKINLEY JI, 1994, J ARCHAEOL SCI, V21, P339, DOI 10.1006/jasc.1994.1033; Mentzer SM, 2017, ARCHAEOL ANTHROP SCI, V9, P1017, DOI 10.1007/s12520-014-0219-y; Morin E., 2010, PALETHNOLOGIE, V2010, P209; Munson PJ, 2003, J ARCHAEOL SCI, V30, P405, DOI 10.1006/jasc.2002.0850; Nakamoto K., 1997, INFRARED RAMAN SPECT, V1B; Nielsen-Marsh C, 2000, HUMAN OSTEOLOGY ARCH, P439; Nielsen-Marsh CM, 2007, J ARCHAEOL SCI, V34, P1523, DOI 10.1016/j.jas.2006.11.012; Nielsen-Marsh CM, 2000, J ARCHAEOL SCI, V27, P1139, DOI 10.1006/jasc.1999.0537; Nyman JS, 2008, BONE, V42, P193, DOI 10.1016/j.bone.2007.09.049; Outram AK, 2001, J ARCHAEOL SCI, V28, P401, DOI 10.1006/jasc.2000.0619; Paschalis EP, 1996, CALCIFIED TISSUE INT, V59, P480, DOI 10.1007/BF00369214; Pfretzschner HU, 2004, CR PALEVOL, V3, P605, DOI 10.1016/j.crpv.2004.07.006; Pramanik S, 2013, MATERIALS, V6, P65, DOI 10.3390/ma6010065; Reidsma FH, 2016, J ARCHAEOL SCI-REP, V10, P282, DOI 10.1016/j.jasrep.2016.10.001; Rey C, 2009, OSTEOPOROSIS INT, V20, P1013, DOI 10.1007/s00198-009-0860-y; Reynard B, 1999, CHEM GEOL, V155, P233, DOI 10.1016/S0009-2541(98)00169-7; RIETVELD HM, 1969, J APPL CRYSTALLOGR, V2, P65, DOI 10.1107/S0021889869006558; Robinson S, 2003, J ARCHAEOL SCI, V30, P391, DOI 10.1006/jasc.2002.0849; Rollin-Martinet S, 2013, AM MINERAL, V98, P2037, DOI 10.2138/am.2013.4537; Rybin EP, 2020, QUATERN INT, V559, P133, DOI 10.1016/j.quaint.2020.06.022; Rybin EP, 2016, QUATERN INT, V425, P69, DOI 10.1016/j.quaint.2016.05.001; Sandgathe Dennis M., 2011, Paleoanthropology, V2011, P216; Schiegl S, 2003, GEOARCHAEOLOGY, V18, P541, DOI 10.1002/gea.10080; SHIPMAN P, 1984, J ARCHAEOL SCI, V11, P307, DOI 10.1016/0305-4403(84)90013-X; Smith CI, 2007, J ARCHAEOL SCI, V34, P1485, DOI 10.1016/j.jas.2006.11.006; Snoeck C, 2014, PALAEOGEOGR PALAEOCL, V416, P55, DOI 10.1016/j.palaeo.2014.08.002; Speth J.D., 2006, FARMING, V3, P1, DOI [10.3828/bfarm.2006.3.1, DOI 10.3828/BFARM.2006.3.1]; STINER MC, 1995, J ARCHAEOL SCI, V22, P223, DOI 10.1006/jasc.1995.0024; Stout S.D., 2019, ORTNERS IDENTIFICATI, P91, DOI 10.1016/B978-0-12-809738-0.00006-5; Tabarev A., 2012, STUDIA ARCHAEOLOGICA, V32, P26; Thery-Parusit I, 2002, J ARCHAEOL SCI, V29, P1415, DOI 10.1006/jasc.2001.0781; Thompson T., 2016, HDB FORENSIC ANTHR A, P295; Thompson TJU, 2013, J ARCHAEOL SCI, V40, P416, DOI 10.1016/j.jas.2012.07.008; Thompson TJU, 2009, J ARCHAEOL SCI, V36, P910, DOI 10.1016/j.jas.2008.11.013; Thompson TJU, 2004, FORENSIC SCI INT, V146, pS203, DOI 10.1016/j.forsciint.2004.09.063; Thompson TJU., 2015, ANAL BURNED HUMAN RE, P323, DOI [10.1016/B978-0-12-800451-7.00018-8, DOI 10.1016/B978-0-12-800451-7.00018-8]; Tripp JA, 2018, PALAEOGEOGR PALAEOCL, V511, P462, DOI 10.1016/j.palaeo.2018.09.012; Trueman CN, 2006, GEOCHIM COSMOCHIM AC, V70, P4343, DOI 10.1016/j.gca.2006.06.1556; Trueman CN, 2008, PALAEOGEOGR PALAEOCL, V266, P160, DOI 10.1016/j.palaeo.2008.03.038; Trueman CN, 2002, REV MINERAL GEOCHEM, V48, P489, DOI 10.2138/rmg.2002.48.13; Trueman CNG, 2004, J ARCHAEOL SCI, V31, P721, DOI 10.1016/j.jas.2003.11.003; Turner-Walker G., 2008, ADV HUM PALAEOPATHOL, P3, DOI [10.1002/9780470724187.ch1, DOI 10.1002/9780470724187.CH1]; Ubelaker DH, 2009, FORENSIC SCI INT, V183, P1, DOI 10.1016/j.forsciint.2008.09.019; van Hoesel A, 2019, J ARCHAEOL SCI-REP, V28, DOI 10.1016/j.jasrep.2019.102033; Villa Paola, 2004, Revue de Paleobiologie, V23, P705; VONENDT DW, 1984, J ARCHAEOL SCI, V11, P247, DOI 10.1016/0305-4403(84)90005-0; Wang XD, 2000, CLIN ORTHOP RELAT R, P228; Waterhouse K, 2013, J FORENSIC LEG MED, V20, P489, DOI 10.1016/j.jflm.2013.03.016; WEINER S, 1990, J ARCHAEOL SCI, V17, P187, DOI 10.1016/0305-4403(90)90058-D; Wescott DJ, 2019, FORENSIC SCI INT, V300, P164, DOI 10.1016/j.forsciint.2019.04.017; Zazzo A, 2011, PALAEOGEOGR PALAEOCL, V310, P52, DOI 10.1016/j.palaeo.2010.12.004; Zwyns N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47972-1; Zwyns N, 2014, QUATERN INT, V347, P53, DOI 10.1016/j.quaint.2014.05.043	96	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254529	10.1371/journal.pone.0254529	http://dx.doi.org/10.1371/journal.pone.0254529			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CM	34320009	Green Published, gold			2022-12-26	WOS:000685247800039
J	Lopacinska-Jorgensen, J; Oliveira, DVNP; Novotny, GW; Hogdall, CK; Hogdall, EV				Lopacinska-Jorgensen, Joanna; Oliveira, Douglas V. N. P.; Wayne Novotny, Guy; Hogdall, Claus K.; Hogdall, Estrid V.			Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer	PLOS ONE			English	Article							MESENCHYMAL SUBTYPE; GENES; PROLIFERATION; OPPORTUNITIES; CARCINOMAS; EXPRESSION; PROMOTES; INVASION; NETWORK; CELLS	Ovarian cancer (OC), the eighth-leading cause of cancer-related death among females worldwide, is mainly represented by epithelial OC (EOC) that can be further subdivided into four subtypes: serous (75%), endometrioid (10%), clear cell (10%), and mucinous (3%). Major reasons for high mortality are the poor biological understanding of the OC mechanisms and a lack of reliable markers defining each EOC subtype. MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression primarily by targeting messenger RNA (mRNA) transcripts. Their aberrant expression patterns have been associated with cancer development, including OC. However, the role of miRNAs in tumorigenesis is still to be determined, mainly due to the lack of consensus regarding optimal methodologies for identification and validation of miRNAs and their targets. Several tools for computational target prediction exist, but false interpretations remain a problem. The experimental validation of every potential miRNA-mRNA pair is not feasible, as it is laborious and expensive. In this study, we analyzed the correlation between global miRNA and mRNA expression patterns derived from microarray profiling of 197 EOC patients to identify the signatures of miRNA-mRNA interactions associated with overall survival (OS). The aim was to investigate whether these miRNA-mRNA signatures might have a prognostic value for OS in different subtypes of EOC. The content of our cohort (162 serous carcinomas, 15 endometrioid carcinomas, 11 mucinous carcinomas, and 9 clear cell carcinomas) reflects a real-world scenario of EOC. Several interaction pairs between 6 miRNAs (hsa-miR-126-3p, hsa-miR-223-3p, hsa-miR-23a-5p, hsa-miR-27a-5p, hsa-miR-486-5p, and hsa-miR-506-3p) and 8 mRNAs (ATF3, CH25H, EMP1, HBB, HBEGF, NAMPT, POSTN, and PROCR) were identified and the findings appear to be well supported by the literature. This indicates that our study has a potential to reveal miRNA-mRNA signatures relevant for EOC. Thus, the evaluation on independent cohorts will further evaluate the performance of such findings.	[Lopacinska-Jorgensen, Joanna; Oliveira, Douglas V. N. P.; Wayne Novotny, Guy; Hogdall, Estrid V.] Herlev Univ Hosp, Dept Pathol, Herlev, Denmark; [Hogdall, Claus K.] Univ Copenhagen, Dept Gynaecol, Juliane Marie Ctr, Rigshosp, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen	Hogdall, EV (corresponding author), Herlev Univ Hosp, Dept Pathol, Herlev, Denmark.	Estrid.hoegdall@regionh.dk	Lopacinska-Jørgensen, Joanna/AGO-3187-2022	Lopacinska-Jørgensen, Joanna/0000-0001-7803-425X; Nogueira Perez Oliveira, Douglas/0000-0002-3529-4219; Hogdall, Claus/0000-0002-5959-8874	Herlev Hospital Research Council; Mermaid Foundation; Danish Cancer Research Foundation	Herlev Hospital Research Council; Mermaid Foundation; Danish Cancer Research Foundation	This work was supported by: Herlev Hospital Research Council, URL: https://www.herlevhospital.dk/forskning/kontakt/Sider/Forskningsr%C3%A5d.aspx (EH received the funding), the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Mermaid Foundation, URL: http://www.mermaidprojektet.dk/(JLJ, CH and EH received the funding), the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Danish Cancer Research Foundation: URL:http://www.dansk-kraeftforsknings-fond.dk/(EH received the funding), the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alshamrani AA, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01084; Bagnoli M, 2016, LANCET ONCOL, V17, P1137, DOI 10.1016/S1470-2045(16)30108-5; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Berek JS, 2018, INT J GYNECOL OBSTET, V143, P59, DOI 10.1002/ijgo.12614; Chen YH, 2020, NUCLEIC ACIDS RES, V48, pD127, DOI 10.1093/nar/gkz757; Chu YW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58336-5; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Martinez-Gutierrez AD, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9071610; Desai Arpita, 2014, World J Transl Med, V3, P1; Desvignes T, 2020, BIOINFORMATICS, V36, P698, DOI 10.1093/bioinformatics/btz675; Ducros E, 2012, INT J ONCOL, V41, P433, DOI 10.3892/ijo.2012.1492; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Ferreira Patricia, 2020, Oncotarget, V11, P1085, DOI 10.18632/oncotarget.27246; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang HY, 2020, NUCLEIC ACIDS RES, V48, pD148, DOI 10.1093/nar/gkz896; International Diabetes Federation, 2019, IDF DIABETES ATLAS, VNinth; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobsen A, 2013, NAT STRUCT MOL BIOL, V20, P1325, DOI 10.1038/nsmb.2678; Karagkouni D, 2018, NUCLEIC ACIDS RES, V46, pD239, DOI 10.1093/nar/gkx1141; Kujawa KA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010149; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Li L, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/1056431; Liu X, 2015, INT J ONCOL, V46, P2467, DOI 10.3892/ijo.2015.2971; Liu Y, 2020, ONCOTARGETS THER, V13, P2047, DOI 10.2147/OTT.S240028; Loganantharaj R, 2017, METHODS MOL BIOL, V1617, P133, DOI 10.1007/978-1-4939-7046-9_10; Ma HY, 2016, ONCOTARGET, V7, P10594, DOI 10.18632/oncotarget.7236; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Mankoo PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024709; McDonald ME, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051175; Miles Gregory D, 2012, BMC Res Notes, V5, P164, DOI 10.1186/1756-0500-5-164; Mockly S, 2019, METHODS MOL BIOL, V1970, P291, DOI 10.1007/978-1-4939-9207-2_16; Momenimovahed Z, 2019, INT J WOMENS HEALTH, V11, P287, DOI 10.2147/IJWH.S197604; Oliveira DVNP, 2021, REPROD SCI, V28, P757, DOI 10.1007/s43032-020-00372-7; Orang AV, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/970607; Flores CP, 2017, INT J ONCOL, V50, P1461, DOI 10.3892/ijo.2017.3948; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Plotnikova O, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00933; Prahm KP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174300; Prat J, 2012, VIRCHOWS ARCH, V460, P237, DOI 10.1007/s00428-012-1203-5; R Core Team, 2020, R LANG ENV STAT COMP; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Ru YB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku631; Seo J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168412; Shackelford Rodney E, 2013, Genes Cancer, V4, P447, DOI 10.1177/1947601913507576; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shapira I, 2014, BRIT J CANCER, V110, P976, DOI 10.1038/bjc.2013.795; Shen YT, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0163-9; Shi M, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011505; Sorensen SM, 2016, CLIN EPIDEMIOL, V8, P485, DOI 10.2147/CLEP.S99479; Staicu CE, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010169; Sun J, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1874-9; Sun Y, 2015, CHIN J CANCER, V34, P28, DOI 10.5732/cjc.014.10284; Tan H, 2019, EBIOMEDICINE, V43, P82, DOI 10.1016/j.ebiom.2019.03.082; Tang XH, 2019, CANCER MED-US, V8, P6426, DOI 10.1002/cam4.2512; Tiberio P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731479; Vert A, 2017, ONCOTARGET, V8, P11692, DOI 10.18632/oncotarget.14302; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wang F, 2016, MOL CANCER THER, V15, P1123, DOI 10.1158/1535-7163.MCT-15-0943; Wang MY, 2020, J CELL MOL MED, V24, P6298, DOI 10.1111/jcmm.15271; Xia XY, 2020, NEOPLASMA, V67, P344, DOI 10.4149/neo_2020_190517N441; Xiao M, 2017, RNA BIOL, V14, P1326, DOI 10.1080/15476286.2015.1112487; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Yang ZY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49967-4; Yokoi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06434-4; Zhang SQ, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0357-1; Zhang WS, 2016, COMPUT BIOL CHEM, V63, P3, DOI 10.1016/j.compbiolchem.2016.02.005; Zhang Y, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/1618527	73	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0255142	10.1371/journal.pone.0255142	http://dx.doi.org/10.1371/journal.pone.0255142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320033	gold, Green Published			2022-12-26	WOS:000685247800046
J	Connelly, JT; Andama, A; Grant, BD; Ball, A; Mwebe, S; Asege, L; Nakaye, M; Lopez, BB; Hsieh, HV; Katumba, D; Mukwatamundu, J; Nalubega, M; Hunt, VM; Burkot, S; Ramachandraiah, H; Choudhary, A; Ignatowicz, L; Weigl, BH; Bachman, C; Mulondo, J; Semitala, F; Worodria, W; Pinter, A; Hamasur, B; Bell, D; Cattamanchi, A; Somoskovi, A				Connelly, John T.; Andama, Alfred; Grant, Benjamin D.; Ball, Alexey; Mwebe, Sandra; Asege, Lucy; Nakaye, Martha; Lopez, Brianda Barrios; Hsieh, Helen V.; Katumba, David; Mukwatamundu, Job; Nalubega, Mayimuna; Hunt, Victoria M.; Burkot, Stephen; Ramachandraiah, Harisha; Choudhary, Alok; Ignatowicz, Lech; Weigl, Bernhard H.; Bachman, Christine; Mulondo, Jerry; Semitala, Fred; Worodria, William; Pinter, Abraham; Hamasur, Beston; Bell, David; Cattamanchi, Adithya; Somoskovi, Akos			Field evaluation of a prototype tuberculosis lipoarabinomannan lateral flow assay on HIV-positive and HIV-negative patients	PLOS ONE			English	Article								Detection of tuberculosis at the point-of-care (POC) is limited by the low sensitivity of current commercially available tests. We describe a diagnostic accuracy field evaluation of a prototype urine Tuberculosis Lipoarabinomannan Lateral Flow Assay (TB-LAM LFA) in both HIV-positive and HIV-negative patients using fresh samples with sensitivity and specificity as the measures of accuracy. This prototype combines a proprietary concentration system with a sensitive LFA. In a prospective study of 292 patients with suspected pulmonary tuberculosis in Uganda, the clinical sensitivity and specificity was compared against a microbiological reference standard including sputum Xpert MTB/RIF Ultra and solid and liquid culture. TB-LAM LFA had an overall sensitivity of 60% (95%CI 51-69%) and specificity of 80% (95%CI 73-85%). When comparing HIV-positive (N = 86) and HIV-negative (N = 206) patients, there was no significant difference in sensitivity (sensitivity difference 8%, 95%CI -11% to +24%, p = 0.4351) or specificity (specificity difference -9%, 95%CI -24% to +4%, p = 0.2051). Compared to the commercially available Alere Determine TB-LAM Ag test, the TB-LAM LFA prototype had improved sensitivity in both HIV-negative (difference 49%, 95%CI 37% to 59%, p<0.0001) and HIV-positive patients with CD4+ T-cell counts >200cells/mu L (difference 59%, 95%CI 32% to 75%, p = 0.0009). This report is the first to show improved performance of a urine TB LAM test for HIV-negative patients in a high TB burden setting. We also offer potential assay refinement solutions that may further improve sensitivity and specificity.	[Connelly, John T.; Grant, Benjamin D.; Ball, Alexey; Lopez, Brianda Barrios; Hsieh, Helen V.; Hunt, Victoria M.; Weigl, Bernhard H.; Bachman, Christine; Bell, David; Somoskovi, Akos] Global Good Fund, Intellectual Ventures, Bellevue, WA 21738 USA; [Andama, Alfred; Semitala, Fred] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Andama, Alfred; Mwebe, Sandra; Asege, Lucy; Nakaye, Martha; Katumba, David; Mukwatamundu, Job; Nalubega, Mayimuna; Mulondo, Jerry; Semitala, Fred; Worodria, William] Infect Dis Res Collaborat, Kampala, Uganda; [Ramachandraiah, Harisha; Ignatowicz, Lech; Hamasur, Beston] Biopr AB, Solna, Sweden; [Choudhary, Alok; Pinter, Abraham] Rutgers State Univ, Publ Hlth Res Inst Ctr, New Jersey Med Sch, Newark, NJ USA; [Semitala, Fred] Makerere Univ, Joint AIDS Program, Kampala, Uganda; [Worodria, William] Mulago Natl Referral Hosp, Kampala, Uganda; [Hamasur, Beston] Karolinska Inst, Solna, Sweden; [Cattamanchi, Adithya] Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA; [Cattamanchi, Adithya] Univ Calif San Francisco UCSF, Div Pulm & Crit Care Med, San Francisco, CA USA; [Cattamanchi, Adithya] UCSF, Curry Int TB Ctr, Oakland, CA USA	Intellectual Ventures; Makerere University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Makerere University; Mulago National Referral Hospital; Karolinska Institutet; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Connelly, JT (corresponding author), Global Good Fund, Intellectual Ventures, Bellevue, WA 21738 USA.	john.connelly@ghlabs.org	Somoskovi, Akos/GMX-3546-2022		Bill and Melinda Gates Foundation Trust	Bill and Melinda Gates Foundation Trust	Funding was provided by the Bill and Melinda Gates Foundation Trust to Global Good Fund, providing support in the form of salaries for JTC, BDG, AB, BBL, HVH, BHW, VMH, SB, CB, DB, and AS, as well as financial support for the study. The funders did not have any role in study design, data collection and interpretation, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, US LAT FLOW UR LIP A; BAILY GVJ, 1967, B WORLD HEALTH ORGAN, V37, P875; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Broger T, 2020, J CLIN INVEST, V130, P5756, DOI 10.1172/JCI140461; Broger T, 2019, LANCET INFECT DIS, V19, P852, DOI 10.1016/S1473-3099(19)30001-5; Choudhary A, 2018, J IMMUNOL, V200, P3053, DOI 10.4049/jimmunol.1701673; Kim S, 2017, STAT METHODS MED RES, V26, P142, DOI 10.1177/0962280214541852; Lawn SD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-407; Lawn SD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-103; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Paris L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2807; Peter J., 2015, BMC INFECT DIS, P1, DOI [10.1186/s12879-014-0722-x, DOI 10.1186/S12879-014-0722-X]; Shah M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011420.pub2; Sigal GB, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01338-18; Wood A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214161; World Health Organization, 2021, TUB REP 2021; World Health Organization, 2019, LATERAL FLOW URINE L; World Health Organization, 2014, HIGH PRIOR TARG PROD; World Health Organization, 2021, 10 THREATS GLOB HLTH	19	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254156	10.1371/journal.pone.0254156	http://dx.doi.org/10.1371/journal.pone.0254156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310609	Green Published, gold			2022-12-26	WOS:000685224500021
J	Ferreto, LED; Guedes, S; Pauli, FB; Rovani, SS; Follador, FAC; Vieira, AP; Torres, RH; Coelho, HC; Wendt, GW				Defante Ferreto, Lirane Elize; Guedes, Stephanny; Braz Pauli, Fernando; Soligo Rovani, Samyra; Ani Caovilla Follador, Franciele; Paula Vieira, Ana; Himovski Torres, Renata; Colares Coelho, Harnoldo; Welter Wendt, Guilherme			Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study	PLOS ONE			English	Article							VIRAL-HEPATITIS; VIRUS-INFECTION; RISK BEHAVIORS; INJECT DRUGS; PREVALENCE; INMATES; INCARCERATION; TIME; TRANSMISSION; PEOPLE	The prevalence of hepatitis C virus (HCV) and the acquired immunodeficiency virus (HIV) is much higher in prisons than in community settings. Some explanatory factors for this burden include putative aspects of the prison environment, such as unprotected sexual relations and sexual violence, use of injectable drugs and syringe sharing. Nonetheless, efforts in better understanding the dynamics of both HCV and HIV are scarce in developing countries such as Brazil, which poses a risk not only to the inmates but to the community as well. In this investigation, we sought to determine the seroprevalence and sociodemographic and behavioral risk factors associated with HIV and anti-HCV antibodies among men detained at high-security institutions. This is an epidemiological, proportionally stratified observational study including 1,132 inmates aged 18 to 79 years-old (M-age = 32.58 +/- 10.18) from eleven high-security prisons located in the State of Parana, Brazil. We found that HIV and anti-HCV prevalence were 1.6% (95% CI: 1.0-2.5) and 2.7% (95% CI: 1.0-2.5), respectively. Risk factors associated with HIV included not receiving intimate visits (OR = 8.80, 95% CI: 1.15-66.88), already having another sexually transmitted infection (OR = 3.89, 95% CI: 1.47-10.29), and reporting attendance in HIV preventive campaigns (OR = 4.24, 95% CI: 1.58-11.36). Moreover, anti-HCV seroprevalence was associated with higher age (OR = 4.03, 95% CI: 1.61-10.07), criminal recidivism (OR = 2.58, 95% CI 1.02-6.52), and the use of injectable drugs (OR = 7.32, 95% CI 3.36-15.92). Although prisons might increase the risk for acquiring and transmitting HIV and HCV, the adoption of permanent epidemiological surveillance programs could help reducing the circulation of viruses, involving strategies focusing on screening, treating, and preventing infections to assure proper prisoner health. Moreover, these policies need to take place inside and outside the prison environment to offer continued assistance to former prisoners once they leave the institution.	[Defante Ferreto, Lirane Elize; Welter Wendt, Guilherme] Western Parana State Univ, Hlth Sci Ctr, Fac Med, Publ Hlth Lab, Francisco Beltrao, Brazil; [Defante Ferreto, Lirane Elize; Braz Pauli, Fernando; Soligo Rovani, Samyra; Ani Caovilla Follador, Franciele; Paula Vieira, Ana] Western Parana State Univ, Hlth Sci Ctr, Postgrad Program Appl Hlth Sci, Francisco Beltrao, Brazil; [Guedes, Stephanny] Western Parana State Univ, Fac Med, Cascavel, Brazil; [Himovski Torres, Renata] Penitentiary Dept, Div Publ Secur & Penitentiary Adm, Curitiba, Parana, Brazil; [Colares Coelho, Harnoldo] Sao Paulo State Univ, Dept Pharm, Ribeirao Preto, Brazil	Centro Universitario La Salle; Centro Universitario La Salle; Centro Universitario La Salle; Universidade Estadual do Oeste do Parana; Universidade Estadual Paulista	Wendt, GW (corresponding author), Western Parana State Univ, Hlth Sci Ctr, Fac Med, Publ Hlth Lab, Francisco Beltrao, Brazil.	guilhermewwendt@gmail.com	Ferreto, Lirane Elize Defante/AAJ-3668-2020	Ferreto, Lirane Elize Defante/0000-0002-0757-3659; BRAZ PAULI, FERNANDO/0000-0003-3473-2739; Wendt, Guilherme/0000-0002-9014-6120; Guedes, Sthefanny/0000-0002-0574-2535	Brazilian Ministry of Health [Ministerio da Saude] [797322/2013]	Brazilian Ministry of Health [Ministerio da Saude]	This study has been funded by the Brazilian Ministry of Health [Ministe ' rio da Sau ' de BR; grant 797322/2013].	Adams LM, 2013, AIDS BEHAV, V17, P2685, DOI 10.1007/s10461-011-9990-2; Alizadeh AHM, 2005, WORLD J GASTROENTERO, V11, P4085, DOI 10.3748/wjg.v11.i26.4085; [Anonymous], B EPIDEMIOLOGICO HEP; [Anonymous], Boletim Epidemiologico HIV/Aids 2020.; Bartlett SR, 2018, CLIN INFECT DIS, V67, P460, DOI 10.1093/cid/ciy210; Bautista-Arredondo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131718; Behzadifar M, 2018, HARM REDUCT J, V15, DOI 10.1186/s12954-018-0231-0; Benzaken AS, 2019, AIDS RES THER, V16, DOI 10.1186/s12981-019-0234-2; Benzaken AS, 2019, BRAZ J INFECT DIS, V23, P182, DOI 10.1016/j.bjid.2019.04.010; Beyrer C, 2016, LANCET, V388, P1033, DOI 10.1016/S0140-6736(16)30829-7; Bielen R, 2018, HARM REDUCT J, V15, DOI 10.1186/s12954-018-0230-1; Bromberg DJ, 2020, CURR OPIN HIV AIDS, V15, P232, DOI 10.1097/COH.0000000000000631; Cepeda JA, 2015, DRUG ALCOHOL DEPEN, V147, P196, DOI 10.1016/j.drugalcdep.2014.11.021; Cordeiro EL., 2018, Av En Enferm, V36, P170, DOI 10.15446/av.enferm.v36n2.68705; Dolan K, 2016, LANCET, V388, P1089, DOI 10.1016/S0140-6736(16)30466-4; Dolan K, 2015, INT J DRUG POLICY, V26, pS12, DOI 10.1016/j.drugpo.2014.10.012; Sgarbi RVE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139487; European Monitoring Centre for Drugs and Drug Addiction, 2012, PRIS DRUGS EUR PROBL, DOI [10.2810/73390, DOI 10.2810/73390]; Fiore V, 2021, INT J DRUG POLICY, V90, DOI 10.1016/j.drugpo.2020.103055; Gahrton C, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4581-3; Gough E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-777; Guimarães Mark Drew Crosland, 2017, Rev. bras. epidemiol., V20, P182, DOI 10.1590/1980-5497201700050015; Iguchi MY, 2002, PUBLIC HEALTH REP, V117, pS146; Jaquet A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1601-4; Johnson RC, 2009, J LAW ECON, V52, P251, DOI 10.1086/597102; Kuncio DE, 2015, J URBAN HEALTH, V92, P379, DOI 10.1007/s11524-015-9945-4; Kutateladze BL, 2014, CRIMINOLOGY, V52, P514, DOI 10.1111/1745-9125.12047; Larney S, 2013, HEPATOLOGY, V58, P1215, DOI 10.1002/hep.26387; Magri MC, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005886; McClelland RS, 2005, J INFECT DIS, V191, P333, DOI 10.1086/427262; McLeod KE, 2020, AM J PUBLIC HEALTH, V110, P303, DOI 10.2105/AJPH.2019.305465; Moazen B, 2018, EPIDEMIOL REV, V40, P58, DOI 10.1093/epirev/mxy002; Puga MAM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169195; Murphy Y., 2020, J COMMUNITY SAFETY W, V5, P19, DOI [10.35502/jcswb.122, DOI 10.35502/JCSWB.122, https://doi.org/10.35502/jcswb.122]; Ojikutu BO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198258; Opitz-Welke A, 2018, DTSCH ARZTEBL INT, V115, P808, DOI 10.3238/arztebl.2018.0808; Pedhambkar RB, 2001, SEX TRANSM INFECT, V77, P388, DOI 10.1136/sti.77.5.388; Pontali E, 2018, INT J DRUG POLICY, V59, P50, DOI 10.1016/j.drugpo.2018.06.017; Ravlija Jelena, 2014, Psychiatr Danub, V26 Suppl 2, P395; Soares MM, 2016, CIENC SAUDE COLETIVA, V21, P1999, DOI 10.1590/1413-81232015217.24102015; Spaulding AC, 2017, AIDS REV, V19, P134, DOI 10.24875/AIDSRev.M17000006; Varan AK, 2014, PUBLIC HEALTH REP, V129, P187, DOI 10.1177/003335491412900213; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; Wirtz AL, 2018, EPIDEMIOL REV, V40, P12, DOI 10.1093/epirev/mxy003; Yang SG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001893; Zampino R, 2015, WORLD J HEPATOL, V7, P2323, DOI 10.4254/wjh.v7.i21.2323	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255173	10.1371/journal.pone.0255173	http://dx.doi.org/10.1371/journal.pone.0255173			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TN	34310633	gold, Green Published			2022-12-26	WOS:000685224500009
J	Johnston, RD; Woodall, BM; Harrison, J; Campagna, SR; Fozo, EM				Johnston, Rachel D.; Woodall, Brittni M.; Harrison, Johnathan; Campagna, Shawn R.; Fozo, Elizabeth M.			Removal of peptidoglycan and inhibition of active cellular processes leads to daptomycin tolerance in Enterococcus faecalis	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; STATIONARY-PHASE; IN-VITRO; LIPOTEICHOIC ACID; PERSISTER CELLS; MEMBRANE DEPOLARIZATION; PSEUDOMONAS-AERUGINOSA; STREPTOCOCCUS-FAECALIS; PROTEIN-SYNTHESIS	Daptomycin is a cyclic lipopeptide antibiotic used in the clinic for treatment of severe enterococcal infections. Recent reports indicate that daptomycin targets active cellular processes, specifically, peptidoglycan biosynthesis. Within, we examined the efficacy of daptomycin against Enterococcus faecalis under a range of environmental growth conditions including inhibitors that target active cellular processes. Daptomycin was far less effective against cells in late stationary phase compared to cells in exponential phase, and this was independent of cellular ATP levels. Further, the addition of either the de novo protein synthesis inhibitor chloramphenicol or the fatty acid biosynthesis inhibitor cerulenin induced survival against daptomycin far better than controls. Alterations in metabolites associated with peptidoglycan synthesis correlated with protection against daptomycin. This was further supported as removal of peptidoglycan induced physiological daptomycin tolerance, a synergistic relation between daptomycin and fosfomycin, an inhibitor of the fist committed step peptidoglycan synthesis, was observed, as well as an additive effect when daptomycin was combined with ampicillin, which targets crosslinking of peptidoglycan strands. Removal of the peptidoglycan of Enterococcus faecium, Staphylococcus aureus, and Bacillus subtilis also resulted in significant protection against daptomycin in comparison to whole cells with intact cell walls. Based on these observations, we conclude that bacterial growth phase and metabolic activity, as well as the presence/absence of peptidoglycan are major contributors to the efficacy of daptomycin.	[Johnston, Rachel D.; Fozo, Elizabeth M.] Univ Tennessee, UT ORNL Grad Sch Genome Sci & Technol, Knoxville, TN 37996 USA; [Woodall, Brittni M.; Campagna, Shawn R.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA; [Harrison, Johnathan; Fozo, Elizabeth M.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Campagna, Shawn R.] Univ Tennessee, Biol & Small Mol Mass Spectrometry Core, Knoxville, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Fozo, EM (corresponding author), Univ Tennessee, UT ORNL Grad Sch Genome Sci & Technol, Knoxville, TN 37996 USA.; Fozo, EM (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	efozo@utk.edu		Fozo, Elizabeth/0000-0002-6928-2275; Woodall, Brittni/0000-0002-2597-7331	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [R01AI116571]	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was through National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID; https://www.niaid.nih.gov/) grant R01AI116571 to E.M.F. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALBORN WE, 1991, ANTIMICROB AGENTS CH, V35, P2282, DOI 10.1128/AAC.35.11.2282; ALLEN NE, 1987, ANTIMICROB AGENTS CH, V31, P1093, DOI 10.1128/AAC.31.7.1093; Amato SM, 2013, MOL CELL, V50, P475, DOI 10.1016/j.molcel.2013.04.002; ANDRIOLE VT, 1971, J INFECT DIS, V124, pS46, DOI 10.1093/infdis/124.Supplement_1.S46; [Anonymous], 2019, TR2195 3GPP; Arias CA, 2011, NEW ENGL J MED, V365, P892, DOI 10.1056/NEJMoa1011138; Balaban NQ, 2019, NAT REV MICROBIOL, V17, P441, DOI 10.1038/s41579-019-0196-3; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Berti AD, 2016, ANTIMICROB AGENTS CH, V60, P451, DOI 10.1128/AAC.02071-15; Bertsche U, 2011, ANTIMICROB AGENTS CH, V55, P3922, DOI 10.1128/AAC.01226-10; Bigger JW, 1944, LANCET, V2, P497; BOARETTI M, 1993, J ANTIMICROB CHEMOTH, V31, P227, DOI 10.1093/jac/31.2.227; BOARETTI M, 1995, ANTIMICROB AGENTS CH, V39, P2068, DOI 10.1128/AAC.39.9.2068; Boaretti M, 2003, ENVIRON MICROBIOL, V5, P986, DOI 10.1046/j.1462-2920.2003.00497.x; BOHANNON DE, 1991, J BACTERIOL, V173, P4482, DOI 10.1128/JB.173.14.4482-4492.1991; Borisova M, 2016, MBIO, V7, DOI 10.1128/mBio.00923-16; Cameron DR, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00303-18; CANEPARI P, 1990, ANTIMICROB AGENTS CH, V34, P1220, DOI 10.1128/AAC.34.6.1220; CARSON D, 1978, J BACTERIOL, V133, P472, DOI 10.1128/JB.133.2.472-476.1978; CDC, 2013, ANTIBIOTIC RESISTANC, DOI [DOI 10.15620/CDC:82532, 10.15620/cdc:82532]; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; CHEN W, 1986, APPL ENVIRON MICROB, V52, P612, DOI 10.1128/AEM.52.4.612-616.1986; Chen YF, 2014, BIOCHEMISTRY-US, V53, P5384, DOI 10.1021/bi500779g; Cohen NR, 2013, CELL HOST MICROBE, V13, P632, DOI 10.1016/j.chom.2013.05.009; Conlon BP, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.51, 10.1038/nmicrobiol.2016.51]; Descourouez JL, 2013, ANTIMICROB AGENTS CH, V57, P1518, DOI 10.1128/AAC.02099-12; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; DOYLE RJ, 1988, MICROBIOL REV, V52, P554, DOI 10.1128/MMBR.52.4.554-567.1988; Garcia-de-la-Maria C, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02633-17, 10.1128/aac.02633-17]; Germain E, 2015, P NATL ACAD SCI USA, V112, P5171, DOI 10.1073/pnas.1423536112; Gray DA, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9010017; Grein F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15257-1; Harp JR, 2016, APPL ENVIRON MICROB, V82, P4410, DOI 10.1128/AEM.00933-16; HIGGINS ML, 1974, J BACTERIOL, V118, P681, DOI 10.1128/JB.118.2.681-692.1974; HIGGINS ML, 1980, J BACTERIOL, V143, P989, DOI 10.1128/JB.143.2.989-994.1980; Hobby GL, 1942, P SOC EXP BIOL MED, V50, P281, DOI 10.3181/00379727-50-13773; Ishihama A, 1997, CURR OPIN GENET DEV, V7, P582, DOI 10.1016/S0959-437X(97)80003-2; Joers A, 2010, J BACTERIOL, V192, P3379, DOI 10.1128/JB.00056-10; Jung D, 2004, CHEM BIOL, V11, P949, DOI 10.1016/j.chembiol.2004.04.020; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Keren I, 2011, MBIO, V2, DOI 10.1128/mBio.00100-11; Kim Y, 2010, BIOCHEM BIOPH RES CO, V391, P209, DOI 10.1016/j.bbrc.2009.11.033; Kock H, 2004, MOL MICROBIOL, V51, P1087, DOI 10.1046/j.1365-2958.2003.03875.x; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Laganas V, 2003, ANTIMICROB AGENTS CH, V47, P2682, DOI 10.1128/AAC.47.8.2682-2684.2003; Lechner S, 2012, J MOL MICROB BIOTECH, V22, P235, DOI 10.1159/000342449; Lee SJ, 2020, J GYNECOL ONCOL, V31, DOI 10.3802/jgo.2020.31.e69; Lingscheid T, 2015, ANTIMICROB AGENTS CH, V59, P859, DOI 10.1128/AAC.04246-14; Link H, 2015, NAT METHODS, V12, P1091, DOI [10.1038/NMETH.3584, 10.1038/nmeth.3584]; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Luidalepp H, 2011, J BACTERIOL, V193, P3598, DOI 10.1128/JB.00085-11; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; MENGINLECREULX D, 1990, FEMS MICROBIOL LETT, V69, P245; MENGINLECREULX D, 1985, J BACTERIOL, V163, P208, DOI 10.1128/JB.163.1.208-212.1985; Mesnage S, 2008, J BIOL CHEM, V283, P19845, DOI 10.1074/jbc.M802323200; Mihailescu R, 2014, ANTIMICROB AGENTS CH, V58, P2547, DOI 10.1128/AAC.02420-12; Miller WR, 2019, MOL MICROBIOL, V111, P811, DOI 10.1111/mmi.14193; Mishra NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043958; Mitchell AM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00708-16; MOORE SA, 1983, J BIOL CHEM, V258, P6266; Muller A, 2016, P NATL ACAD SCI USA, V113, pE7077, DOI 10.1073/pnas.1611173113; Muraih JK, 2011, BBA-BIOMEMBRANES, V1808, P1154, DOI 10.1016/j.bbamem.2011.01.001; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; NEUHAUS FC, 1964, BIOCHEMISTRY-US, V3, P471, DOI 10.1021/bi00892a001; Pee CJE, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02105-18; PHAIR JP, 1969, APPL MICROBIOL, V18, P303, DOI 10.1128/AEM.18.3.303-306.1969; Prax M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150907; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; REEVE CA, 1984, J BACTERIOL, V160, P1041, DOI 10.1128/JB.160.3.1041-1046.1984; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Saiman L, 2007, PAEDIATR RESPIR REV, V8, P249, DOI 10.1016/j.prrv.2007.04.006; Saito HE, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01633-17; Saito HE, 2014, APPL ENVIRON MICROB, V80, P6527, DOI 10.1128/AEM.02044-14; Schellhorn HE, 1998, J BACTERIOL, V180, P6283; Shan Y, 2017, MBIO, V8, DOI 10.1128/mBio.02267-16; Silver LL, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a025262; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Smith JR, 2015, J ANTIMICROB CHEMOTH, V70, P1738, DOI 10.1093/jac/dkv007; Tkachenko AG, 2014, FEMS MICROBIOL LETT, V361, P25, DOI 10.1111/1574-6968.12613; Vazquez-Laslop N, 2006, J BACTERIOL, V188, P3494, DOI 10.1128/JB.188.10.3494-3497.2006; Verstraeten N, 2015, MOL CELL, V59, P9, DOI 10.1016/j.molcel.2015.05.011; Vogel SJ, 2014, LETT APPL MICROBIOL, V58, P370, DOI 10.1111/lam.12199; WALE LJ, 1989, J MED MICROBIOL, V30, P45, DOI 10.1099/00222615-30-1-45; Wang TB, 2017, SCI REP-UK, V7, DOI 10.1038/srep43839; White RL, 1996, ANTIMICROB AGENTS CH, V40, P1914, DOI 10.1128/AAC.40.8.1914; Wu YX, 2012, ANTIMICROB AGENTS CH, V56, P4922, DOI 10.1128/AAC.00921-12; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P3114, DOI 10.1128/AAC.49.8.3114-3121.2005; Yang SJ, 2010, ANTIMICROB AGENTS CH, V54, P3079, DOI 10.1128/AAC.00122-10; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018; Zhang TH, 2014, BBA-BIOMEMBRANES, V1838, P2425, DOI 10.1016/j.bbamem.2014.05.014; Zhang TH, 2013, BBA-BIOMEMBRANES, V1828, P302, DOI 10.1016/j.bbamem.2012.10.008	92	2	2	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254796	10.1371/journal.pone.0254796	http://dx.doi.org/10.1371/journal.pone.0254796			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297729	Green Published, gold			2022-12-26	WOS:000678128300025
J	Parveen, A; Bohnert, KR; da Silva, MT; Wen, YF; Bhat, R; Roy, A; Kumar, A				Parveen, Arshiya; Bohnert, Kyle R.; Tomaz da Silva, Meiricris; Wen, Yefei; Bhat, Raksha; Roy, Anirban; Kumar, Ashok			MyD88-mediated signaling intercedes in neurogenic muscle atrophy through multiple mechanisms	FASEB JOURNAL			English	Article						denervation; ER stress; inflammation; NF-kappa B; skeletal muscle; XBP1	PATTERN-RECOGNITION RECEPTORS; PROTEIN RESPONSE PATHWAYS; SKELETAL-MUSCLE; ER STRESS; AUTOPHAGY-LYSOSOME; TARGETED ABLATION; AMPK ACTIVATION; TOLL; MASS	Skeletal muscle atrophy is a debilitating complication of many chronic disease states and disuse conditions including denervation. However, molecular and signaling mechanisms of muscle wasting remain less understood. Here, we demonstrate that the levels of several toll-like receptors (TLRs) and their downstream signaling adaptor, myeloid differentiation primary response 88 (MyD88), are induced in skeletal muscle of mice in response to sciatic nerve denervation. Muscle-specific ablation of MyD88 mitigates denervation-induced skeletal muscle atrophy in mice. Targeted ablation of MyD88 suppresses the components of ubiquitin-proteasome system, autophagy, and FOXO transcription factors in skeletal muscle during denervation. We also found that specific inhibition of MyD88 reduces the activation of canonical nuclear factor-kappa (NF-kappa B) pathway and expression of receptors for inflammatory cytokines in denervated muscle. In contrast, inhibition of MyD88 stimulates the activation of non-canonical NF-kappa B signaling in denervated skeletal muscle. Ablation of MyD88 also inhibits the denervation-induced increase in phosphorylation of AMPK without having any effect on the phosphorylation of mTOR. Moreover, targeted ablation of MyD88 inhibits the activation of a few components of the unfolded protein response (UPR) pathways, especially X-box protein 1 (XBP1). Importantly, myofiber-specific ablation of XBP1 mitigates denervation-induced skeletal muscle atrophy in mice. Collectively, our experiments suggest that TLR-MyD88 signaling mediates skeletal muscle wasting during denervation potentially through the activation of canonical NF-kappa B signaling, AMPK and UPR pathways.	[Parveen, Arshiya; Tomaz da Silva, Meiricris; Wen, Yefei; Bhat, Raksha; Roy, Anirban; Kumar, Ashok] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Hlth Bldg 2,Room 5012,4849 Calhoun Rd, Houston, TX 77204 USA; [Bohnert, Kyle R.] St Ambrose Univ, Dept Kinesiol, Davenport, IA USA	University of Houston System; University of Houston	Kumar, A (corresponding author), Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Hlth Bldg 2,Room 5012,4849 Calhoun Rd, Houston, TX 77204 USA.	akumar43@Central.UH.EDU	Bhat, Raksha/GNW-3971-2022; Roy, Anirban/AAZ-4361-2021	Bhat, Raksha/0000-0002-0026-1118; Roy, Anirban/0000-0002-5625-5403; Tomaz da Silva, Meiricris/0000-0002-7479-2595; Kumar, Ashok/0000-0001-8571-2848	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR059810, AR068313]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR059810 and AR068313	Afroze D, 2019, FEBS J, V286, P379, DOI 10.1111/febs.14358; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Bakkar N, 2012, J CELL BIOL, V196, P497, DOI 10.1083/jcb.201108118; Bohnert KR, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00184-19; Bohnert KR, 2018, J CELL PHYSIOL, V233, P67, DOI 10.1002/jcp.25852; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bujak AL, 2015, CELL METAB, V21, P883, DOI 10.1016/j.cmet.2015.05.016; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Egawa T, 2015, AM J PHYSIOL-ENDOC M, V309, pE651, DOI 10.1152/ajpendo.00165.2015; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Enwere EK, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003086; Flamment M, 2012, TRENDS ENDOCRIN MET, V23, P381, DOI 10.1016/j.tem.2012.06.003; Gallot YS, 2019, FASEB J, V33, P1946, DOI 10.1096/fj.201800683RR; Guo YT, 2016, ARCH BIOCHEM BIOPHYS, V600, P56, DOI 10.1016/j.abb.2016.04.015; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Henriques-Pons A, 2014, HUM MOL GENET, V23, P2604, DOI 10.1093/hmg/ddt656; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hindi SM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98441; Hindi SM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01866-w; Hunter RB, 2002, FASEB J, V16, P529, DOI 10.1096/fj.01-0866com; Jackman RW, 2013, EXP PHYSIOL, V98, P19, DOI 10.1113/expphysiol.2011.063321; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kjobsted R, 2018, FASEB J, V32, P1741, DOI 10.1096/fj.201700442R; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Larsson L, 2019, PHYSIOL REV, V99, P427, DOI 10.1152/physrev.00061.2017; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Madaro L, 2018, NAT CELL BIOL, V20, P917, DOI 10.1038/s41556-018-0151-y; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Nakashima K, 2007, BIOSCI BIOTECH BIOCH, V71, P1650, DOI 10.1271/bbb.70057; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Razani B, 2011, IMMUNOL REV, V244, P44, DOI 10.1111/j.1600-065X.2011.01059.x; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Salcedo R, 2013, TRENDS IMMUNOL, V34, P379, DOI 10.1016/j.it.2013.03.008; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Sartori R, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20123-1; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Van Gammeren D, 2009, FASEB J, V23, P362, DOI 10.1096/fj.08-114249; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu ZG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002321; Yuasa K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26632-w; Zhang GH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00726-x; Zhu XX, 2019, J CACHEXIA SARCOPENI, V10, P378, DOI 10.1002/jcsm.12377	53	5	5	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21821	10.1096/fj.202100777RR	http://dx.doi.org/10.1096/fj.202100777RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34325487	Green Accepted			2022-12-26	WOS:000678975300020
J	Tian, QY; Fan, XF; Ma, JS; Li, DT; Han, YJ; Yin, XH; Wang, H; Huang, TT; Wang, ZL; Shentu, YP; Xue, F; Du, CK; Wang, YY; Mao, SZ; Fan, JM; Gong, YS				Tian, Qiuyun; Fan, Xiaofang; Ma, Jianshe; Li, Dantong; Han, Yujiao; Yin, Xianghong; Wang, Hui; Huang, Tingting; Wang, Zhenglu; Shentu, Yangping; Xue, Feng; Du, Congkuo; Wang, Yongyu; Mao, Sunzhong; Fan, Junming; Gong, Yongsheng			Critical role of VGLL4 in the regulation of chronic normobaric hypoxia-induced pulmonary hypertension in mice	FASEB JOURNAL			English	Article						hypoxia; pulmonary hypertension; STAT3; vascular remodeling; VGLL4	SMOOTH-MUSCLE-CELLS; ARTERIAL-HYPERTENSION; TUMOR-SUPPRESSOR; SIRT1 PROTECTS; PROLIFERATION; CANCER; METHYLATION; INHIBITION; INDUCTION; STAT3	Pulmonary hypertension (PH), a rare but deadly cardiopulmonary disorder, is characterized by extensive remodeling of pulmonary arteries resulting from enhancement of pulmonary artery smooth muscle cell proliferation and suppressed apoptosis; however, the underlying pathophysiological mechanisms remain largely unknown. Recently, epigenetics has gained increasing prominence in the development of PH. We aimed to investigate the role of vestigial-like family member 4 (VGLL4) in chronic normobaric hypoxia (CNH)-induced PH and to address whether it is associated with epigenetic regulation. The rodent model of PH was established by CNH treatment (10% O-2, 23 hours/day). Western blot, quantitative reverse transcription polymerase chain reaction, immunofluorescence, immunoprecipitation, and adeno-associated virus tests were performed to explore the potential mechanisms involved in CNH-induced PH in mice. VGLL4 expression was upregulated and correlated with CNH in PH mouse lung tissues in a time-dependent manner. VGLL4 colocalized with alpha-smooth muscle actin in cultured pulmonary arterial smooth muscle cells (PASMCs), and VGLL4 immunoactivity was increased in PASMCs following hypoxia exposure in vitro. VGLL4 knockdown attenuated CNH-induced PH and pulmonary artery remodeling by blunting signal transducer and activator of transcription 3 (STAT3) signaling; conversely, VGLL4 overexpression exacerbated the development of PH. CNH enhanced the acetylation of VGLL4 and increased the interaction of ac-H3K9/VGLL4 and ac-H3K9/STAT3 in the lung tissues, and levels of ac-H3K9, p-STAT3/STAT3, and proliferation-associated protein levels were markedly up-regulated, whereas apoptosis-related protein levels were significantly downregulated, in the lung tissues of mice with CNH-induced PH. Notably, abrogation of VGLL4 acetylation reversed CNH-induced PH and pulmonary artery remodeling and suppressed STAT3 signaling. Finally, STAT3 knockdown alleviated CNH-induced PH. In conclusion, VGLL4 acetylation upregulation could contribute to CNH-induced PH and pulmonary artery remodeling via STAT3 signaling, and abrogation of VGLL4 acetylation reversed CNH-induced PH. Pharmacological or genetic deletion of VGLL4 might be a potential target for therapeutic interventions in CNH-induced PH.	[Tian, Qiuyun; Fan, Xiaofang; Ma, Jianshe; Li, Dantong; Han, Yujiao; Yin, Xianghong; Wang, Hui; Huang, Tingting; Xue, Feng; Du, Congkuo; Wang, Yongyu; Mao, Sunzhong; Fan, Junming; Gong, Yongsheng] Wenzhou Med Univ, Sch Basic Med Sci, Inst Hypoxia Med, Wenzhou 325035, Zhejiang, Peoples R China; [Wang, Zhenglu] Wenzhou Med Univ, Renji Coll, Wenzhou, Peoples R China; [Shentu, Yangping] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pathol, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Fan, JM; Gong, YS (corresponding author), Wenzhou Med Univ, Sch Basic Med Sci, Inst Hypoxia Med, Wenzhou 325035, Zhejiang, Peoples R China.	fjmelite@163.com; fxbwzmc@126.com	huang, ting/GRR-3141-2022		Zhejiang Provincial Natural Science Foundation of China [LY20H010001, LY18H010007, LY17H010007]; National Natural Science Foundation of China [81900403, 31900685]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Zhejiang Provincial Natural Science Foundation of China, Grant/Award Number: LY20H010001, LY18H010007 and LY17H010007; National Natural Science Foundation of China, Grant/Award Number: 81900403 and 31900685	Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Bertero T, 2016, J CLIN INVEST, V126, P3313, DOI 10.1172/JCI86387; Bertero T, 2015, CELL REP, V13, P1016, DOI 10.1016/j.celrep.2015.09.049; Boucherat O, 2017, PULM CIRC, V7, P285, DOI 10.1177/2045893217701438; Cai ZY, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0068-3; Chelladurai P, 2021, BRIT J PHARMACOL, V178, P54, DOI 10.1111/bph.14932; Chen B, 2014, AM J PHYSIOL-LUNG C, V307, pL317, DOI 10.1152/ajplung.00285.2013; Chen F, 2016, FREE RADICAL BIO MED, V99, P167, DOI 10.1016/j.freeradbiomed.2016.08.003; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Courboulin A, 2012, EUR RESPIR J, V40, P618, DOI 10.1183/09031936.00084211; Courboulin A, 2011, J EXP MED, V208, P535, DOI 10.1084/jem.20101812; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; Dieffenbach PB, 2017, AM J PHYSIOL-LUNG C, V313, pL628, DOI 10.1152/ajplung.00173.2017; Ding MG, 2015, J CARDIOVASC PHARM, V65, P562, DOI 10.1097/FJC.0000000000000224; Fan JM, 2020, INT J BIOL SCI, V16, P515, DOI 10.7150/ijbs.34517; Fan JM, 2018, NEUROSCIENCE, V381, P22, DOI 10.1016/j.neuroscience.2018.04.013; Fan JM, 2016, HIGH ALT MED BIOL, V17, P43, DOI 10.1089/ham.2015.0086; Fang L, 2018, CANCER CELL, V34, P103, DOI 10.1016/j.ccell.2018.06.002; Gamen E, 2016, EUR RESPIR J, V48, P903, DOI 10.1183/13993003.01714-2015; Ghosh S, 2016, AM J PHYSIOL-LUNG C, V310, pL1199, DOI 10.1152/ajplung.00092.2016; Guignabert C, 2013, EUR RESPIR REV, V22, P543, DOI 10.1183/09059180.00007513; He JL, 2018, BRIT J PHARMACOL, V175, P1354, DOI 10.1111/bph.13806; Jiao S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14058; Kim J, 2017, J CLIN INVEST, V127, P3447, DOI 10.1172/JCI93825; Li N, 2015, AM J CANCER RES, V5, P1158; Lin ZQ, 2016, DEV CELL, V39, P466, DOI 10.1016/j.devcel.2016.09.005; Mao B, 2014, ONCOGENE, V33, P1468, DOI 10.1038/onc.2013.88; Mao SZ, 2014, PULM PHARMACOL THER, V27, P1, DOI 10.1016/j.pupt.2013.06.004; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Neto F, 2018, ELIFE, V7, DOI 10.7554/eLife.31037; Noman MZ, 2009, J IMMUNOL, V182, P3510, DOI 10.4049/jimmunol.0800854; Paffett ML, 2012, VASC PHARMACOL, V56, P64, DOI 10.1016/j.vph.2011.11.002; Paulin R, 2011, CIRCULATION, V123, P1205, DOI 10.1161/CIRCULATIONAHA.110.963314; Rai PR, 2008, AM J RESP CRIT CARE, V178, P558, DOI 10.1164/rccm.200709-1369PP; Samanta S, 2017, BBA-MOL BASIS DIS, V1863, P518, DOI 10.1016/j.bbadis.2016.11.030; Shen H, 2020, CIRCULATION, V142, P1190, DOI 10.1161/CIRCULATIONAHA.120.048191; Song HM, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0338-8; Stenmark KR, 2018, CARDIOVASC RES, V114, P551, DOI 10.1093/cvr/cvy004; Tian QY, 2020, TOXICOL APPL PHARM, V408, DOI 10.1016/j.taap.2020.115261; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; Wang Y, 2018, PHYSIOL GENOMICS, V50, P313, DOI 10.1152/physiolgenomics.00069.2017; Wu AL, 2019, EMBO J, V38, DOI 10.15252/embj.201899506; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yu W, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007977; Yuan WC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07394-5; Zhang EC, 2016, AM J CANCER RES, V6, P2901; Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001; Zhang WJ, 2014, CELL RES, V24, P331, DOI 10.1038/cr.2014.10; Zhao L, 2012, CIRCULATION, V126, P455, DOI 10.1161/CIRCULATIONAHA.112.103176; Zurlo G, 2018, J HYPERTENS, V36, P1164, DOI 10.1097/HJH.0000000000001676	50	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2021	35	8							e21822	10.1096/fj.202002650RR	http://dx.doi.org/10.1096/fj.202002650RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TR4ZX	34314061				2022-12-26	WOS:000678975300021
J	Watanabe, Y; Sasaki, T; Miyoshi, S; Shimizu, M; Yamauchi, Y; Sato, R				Watanabe, Yuichi; Sasaki, Takashi; Miyoshi, Shoko; Shimizu, Makoto; Yamauchi, Yoshio; Sato, Ryuichiro			Insulin-induced genes INSIG1 and INSIG2 mediate oxysterol-dependent activation of the PERK-eIF2 alpha-ATF4 axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; INTEGRATED STRESS-RESPONSE; HAMSTER OVARY CELLS; ER-STRESS; ENDOPLASMIC-RETICULUM; BINDING; ATF4; 25-HYDROXYCHOLESTEROL; TRANSCRIPTION; TRANSLATION	Y Insulin-induced genes (INSIGs) encode endoplasmic reticulum-resident proteins that regulate intracellular choles-terol metabolism. Oxysterols are oxygenated derivatives of cholesterol, some of which orchestrate lipid metabolism via interaction with INSIGs. Recently, it was reported that expression of activating transcription factor-4 (ATF4) was induced by certain oxysterols; the precise of mechanism is unclear. Herein, we show that INSIGs mediate ATF4 upregu-lation upon interaction with oxysterol. Oxysterols that possess a high affinity for INSIG, such as 27-and 25-hydroxycholesterol (25HC), markedly induced the increase of ATF4 protein when compared with other oxysterols. In addi-tion, ATF4 upregulation by these oxysterols was attenuated in INSIG1/2-deficient Chinese hamster ovary cells and recovered by either INSIG1 or INSIG2 rescue. Mechanistic studies revealed that the binding of 25HC to INSIG is critical for increased ATF4 protein via activation of protein kinase RNA-activated-like ER kinase and eukaryotic translation initiation factor 2 alpha. Knockout of INSIG1 or INSIG2 in human hepatoma Huh7 cells attenuated ATF4 protein upregulation, indicating that only one of the endogenous INSIGs, unlike overexpression of intrinsic INSIG1 or INSIG2, was insufficient for ATF4 in-duction. Furthermore, ATF4 proactively upregulated the cell death-inducible gene expression, such as Chop, Chac1, and Trb3, thereby markedly reducing cell viability with 25HC. These findings support a model whereby that INSIGs sense an increase in oxysterol in the endoplasmic reticulum and induce an increase of ATF4 protein via the protein kinase RNA-acti-vated-like ER kinase-eukaryotic translation initiation factor 2 alpha pathway, thereby promoting cell death.	[Watanabe, Yuichi; Sasaki, Takashi; Miyoshi, Shoko; Yamauchi, Yoshio; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Food Biochem Lab, Tokyo, Japan; [Shimizu, Makoto; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Nutrilife Sci Lab, Tokyo, Japan; [Sato, Ryuichiro] Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan	University of Tokyo; University of Tokyo	Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Food Biochem Lab, Tokyo, Japan.; Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Nutrilife Sci Lab, Tokyo, Japan.; Sato, R (corresponding author), Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan.	roysato@g.ecc.u-tokyo.ac.jp	Yamauchi, Yoshio/I-7539-2014; 渡邉, 雄一/AAX-1904-2021	Yamauchi, Yoshio/0000-0001-5559-4596; 渡邉, 雄一/0000-0002-1796-0660; Sasaki, Takashi/0000-0002-3352-0753	Japan Society for the Promotion of Science KAKENHI [JP15H05781, JP20H00408, JP17K15266, JP19K15764]; Japan Agency for Medical Research and Development (AMED-CREST) [16gm0910008h0001]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED-CREST)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant-in-aid for Scientific Research (S) JP15H05781 and (A) JP20H00408 (to R. S.), Grant-in-aid for Young Scientists JP17K15266 and JP19K15764 (to Y. W.), and the Japan Agency for Medical Research and Development (AMED-CREST) grant 16gm0910008h0001 (to R. S.).	Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Baek AE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00910-z; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Griffiths WJ, 2020, PROSTAG OTH LIPID M, V147, DOI 10.1016/j.prostaglandins.2019.106381; Guillemot-Legris O, 2016, TRENDS MOL MED, V22, P594, DOI 10.1016/j.molmed.2016.05.006; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13129; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Kim SM, 2017, ONCOTARGET, V8, P11855, DOI 10.18632/oncotarget.14416; Kranz P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.369; Kuan YC, 2020, J BIOL CHEM, V295, P3918, DOI 10.1074/jbc.RA119.011849; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012; Li JW, 2016, J LIPID RES, V57, P1845, DOI 10.1194/jlr.M069906; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Matsumoto H, 2013, BIOL OPEN, V2, P1084, DOI 10.1242/bio.20135033; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Mutemberezi V, 2016, PROG LIPID RES, V64, P152, DOI 10.1016/j.plipres.2016.09.002; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Qi XF, 2019, NATURE, V571, P279, DOI 10.1038/s41586-019-1286-0; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; SATO R, 1993, P NATL ACAD SCI USA, V90, P9261, DOI 10.1073/pnas.90.20.9261; Sekiya M, 2014, J LIPID RES, V55, P2082, DOI 10.1194/jlr.M050864; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Shibata N, 2013, J BIOL CHEM, V288, P35812, DOI 10.1074/jbc.M113.519637; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Takabe W, 2016, J LIPID RES, V57, P2005, DOI 10.1194/jlr.M068775; Tyagi R, 2015, CELL REP, V10, P684, DOI 10.1016/j.celrep.2015.01.014; Umetani M, 2014, CELL METAB, V20, P172, DOI 10.1016/j.cmet.2014.05.013; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wortel IMN, 2017, TRENDS ENDOCRIN MET, V28, P794, DOI 10.1016/j.tem.2017.07.003; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yuan Xi-Ming, 2016, J Cell Death, V9, P1, DOI 10.4137/JCD.S37841; Zu SL, 2020, CELL RES, V30, P1043, DOI 10.1038/s41422-020-00398-1	48	0	0	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100989	10.1016/j.jbc.2021.100989	http://dx.doi.org/10.1016/j.jbc.2021.100989			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34298014	gold, Green Published			2022-12-26	WOS:000690868100008
J	Li, XR; Ling, G				Li, Xiaoru; Ling, Guo			Combinatorial constraint coding based on the EORS algorithm in DNA storage	PLOS ONE			English	Article							CODES; INFORMATION; CAPACITY	The development of information technology has produced massive amounts of data, which has brought severe challenges to information storage. Traditional electronic storage media cannot keep up with the ever-increasing demand for data storage, but in its place DNA has emerged as a feasible storage medium with high density, large storage capacity and strong durability. In DNA data storage, many different approaches can be used to encode data into codewords. DNA coding is a key step in DNA storage and can directly affect storage performance and data integrity. However, since errors are prone to occur in DNA synthesis and sequencing, and non-specific hybridization is prone to occur in the solution, how to effectively encode DNA has become an urgent problem to be solved. In this article, we propose a DNA storage coding method based on the equilibrium optimization random search (EORS) algorithm, which meets the Hamming distance, GC content and no-runlength constraints and can reduce the error rate in storage. Simulation experiments have shown that the size of the DNA storage code set constructed by the EORS algorithm that meets the combination constraints has increased by an average of 11% compared with previous work. The increase in the code set means that shorter DNA chains can be used to store more data.	[Li, Xiaoru] Hulunbeier Vocat & Tech Coll, Hulunbeier, Inner Mongolia, Peoples R China; [Ling, Guo] Baidu Co Ltd, Shanghai, Peoples R China	Baidu	Li, XR (corresponding author), Hulunbeier Vocat & Tech Coll, Hulunbeier, Inner Mongolia, Peoples R China.	lxr_hlbezyjsxy@163.com			Baidu Co., Ltd.	Baidu Co., Ltd.	Baidu Co., Ltd. provided support in the form of salary to GL. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Appuswamy R., 2019, CIDR; Bancroft C, 2001, SCIENCE, V293, P1763; Bornholt J, 2017, IEEE MICRO, V37, P98, DOI 10.1109/MM.2017.70; Cao B, 2021, IEEE T NANOBIOSCI, V20, P212, DOI 10.1109/TNB.2021.3056351; Cao B, 2022, IEEE ACM T COMPUT BI, V19, P866, DOI 10.1109/TCBB.2020.3011582; Cao B, 2020, IEEE ACCESS, V8, P29547, DOI 10.1109/ACCESS.2020.2970838; Chen KK, 2020, NANO LETT, V20, P3754, DOI 10.1021/acs.nanolett.0c00755; Chen WD, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201901672; Davis J, 1996, ART J, V55, P70, DOI 10.2307/777811; Dorigo M, 2005, THEOR COMPUT SCI, V344, P243, DOI 10.1016/j.tcs.2005.05.020; Erlich Y, 2017, SCIENCE, V355, P950, DOI 10.1126/science.aaj2038; Faramarzi A, 2020, KNOWL-BASED SYST, V191, DOI 10.1016/j.knosys.2019.105190; Fei P, 2019, IEEE INT SYMP INFO, P76, DOI 10.1109/ISIT.2019.8849814; Goldman N, 2013, NATURE, V494, P77, DOI 10.1038/nature11875; Gong FM, 2020, COMPUT J, V63, P460, DOI 10.1093/comjnl/bxz049; Grass R.N., 2019, 831883 BIORXIV, DOI [10.1101/831883, DOI 10.1101/831883]; Immink KAS, 2018, IEEE COMMUN LETT, V22, P224, DOI 10.1109/LCOMM.2017.2775608; Lee HH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10258-1; Lenz A, 2020, IEEE T INFORM THEORY, V66, P2331, DOI 10.1109/TIT.2019.2961265; Limbachiya D, 2018, IEEE COMMUN LETT, V22, P1972, DOI 10.1109/LCOMM.2018.2861867; Lv ZB, 2021, NEUROCOMPUTING, V422, P214, DOI 10.1016/j.neucom.2020.09.056; Meiser LC, 2020, NAT PROTOC, V15, P86, DOI 10.1038/s41596-019-0244-5; Mirjalili S, 2014, ADV ENG SOFTW, V69, P46, DOI 10.1016/j.advengsoft.2013.12.007; Organick L, 2018, NAT BIOTECHNOL, V36, P242, DOI 10.1038/nbt.4079; Qiu JY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227222; Smith DH, 2011, DISCRETE MATH, V311, P1207, DOI 10.1016/j.disc.2010.03.005; Song LF, 2018, ACS SYNTH BIOL, V7, P866, DOI 10.1021/acssynbio.7b00382; Song WT, 2018, IEEE COMMUN LETT, V22, P2004, DOI 10.1109/LCOMM.2018.2866566; Takieldin R., 2020, IEICE T FUND ELECTR; Wang YX, 2019, IEEE COMMUN LETT, V23, P963, DOI 10.1109/LCOMM.2019.2912572; Wang Y, 2019, ANAL BIOCHEM, V583, DOI 10.1016/j.ab.2019.113363; Yazdi S. M. H. T., 2017, ARXIV170905214CSMATH; Yehezkeally Y, 2020, IEEE T INFORM THEORY, V66, P2658, DOI 10.1109/TIT.2019.2940256; Yin Q, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062191; Zhang XK, 2020, COMPUT STRUCT BIOTEC, V18, P2107, DOI 10.1016/j.csbj.2020.08.004; Zhang YY, 2019, J AM CHEM SOC, V141, P17861, DOI 10.1021/jacs.9b09116; Zhou SH, 2020, ENTROPY-SWITZ, V22, DOI 10.3390/e22101091	37	1	1	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255376	10.1371/journal.pone.0255376	http://dx.doi.org/10.1371/journal.pone.0255376			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324571	Green Published, gold			2022-12-26	WOS:000685248200005
J	Mallari, RJ; Avery, MB; Corlin, A; Eisenberg, A; Hammond, TC; Martin, NA; Barkhoudarian, G; Kelly, DF				Mallari, Regin Jay; Avery, Michael B.; Corlin, Alex; Eisenberg, Amalia; Hammond, Terese C.; Martin, Neil A.; Barkhoudarian, Garni; Kelly, Daniel F.			Streamlining brain tumor surgery care during the COVID-19 pandemic: A case-control study	PLOS ONE			English	Article							RATHKES CLEFT CYSTS; SKULL BASE; CRANIOTOMY; ENDONASAL; ADMISSION; PITUITARY; RECOVERY; CRANIOPHARYNGIOMAS; DISCHARGE; PROPOFOL	Background The COVID-19 pandemic forced a reconsideration of surgical patient management in the setting of scarce resources and risk of viral transmission. Herein we assess the impact of implementing a protocol of more rigorous patient education, recovery room assessment for non-ICU admission, earlier mobilization and post-discharge communication for patients undergoing brain tumor surgery. Methods A case-control retrospective review was undertaken at a community hospital with a dedicated neurosurgery and otolaryngology team using minimally invasive surgical techniques, total intravenous anesthesia (TIVA) and early post-operative imaging protocols. All patients undergoing craniotomy or endoscopic endonasal removal of a brain, skull base or pituitary tumor were included during two non-overlapping periods: March 2019-January 2020 (pre-pandemic epoch) versus March 2020-January 2021 (pandemic epoch with streamlined care protocol implemented). Data collection included demographics, preoperative American Society of Anesthesiologists (ASA) status, tumor pathology, and tumor resection and remission rates. Primary outcomes were ICU utilization and hospital length of stay (LOS). Secondary outcomes were complications, readmissions and reoperations. Findings Of 295 patients, 163 patients were treated pre-pandemic (58% women, mean age 53.2 +/- 16 years) and 132 were treated during the pandemic (52% women, mean age 52.3 +/- 17 years). From pre-pandemic to pandemic, ICU utilization decreased from 92(54%) to 43(29%) of operations (p<0.001) and hospital LOS <= 1 day increased from 21(12.2%) to 60(41.4%), p<0.001, respectively. For craniotomy cohort, median LOS was 2 days for both epochs; median ICU LOS decreased from 1 to 0 days (p<0.001), ICU use decreased from 73(80%) to 29(33%),(p<0.001). For endonasal cohort, median LOS decreased from 2 to 1 days; median ICU LOS was 0 days for both epochs; (p<0.001). There were no differences pre-pandemic versus pandemic in ASA scores, resection/remission rates, readmissions or reoperations. Conclusion This experience suggests the COVID-19 pandemic provided an opportunity for implementing a brain tumor care protocol to facilitate safely decreasing ICU utilization and accelerating discharge home without an increase in complications, readmission or reoperations. More rigorous patient education, recovery room assessment for non-ICU admission, earlier mobilization and post-discharge communication, layered upon a foundation of minimally invasive surgery, TIVA anesthesia and early post-operative imaging are possible contributors to these favorable trends.	[Mallari, Regin Jay; Avery, Michael B.; Corlin, Alex; Eisenberg, Amalia; Martin, Neil A.; Barkhoudarian, Garni; Kelly, Daniel F.] Providence St Johns Hlth Ctr, Pacific Neurosci Inst, Santa Monica, CA 90404 USA; [Hammond, Terese C.; Martin, Neil A.; Barkhoudarian, Garni; Kelly, Daniel F.] Providence St Johns Hlth Ctr, St Johns Canc Inst, Santa Monica, CA 90404 USA; [Hammond, Terese C.; Martin, Neil A.; Barkhoudarian, Garni; Kelly, Daniel F.] Formerly John Wayne Canc Inst, Santa Monica, CA 90404 USA	John Wayne Cancer Institute; John Wayne Cancer Institute	Kelly, DF (corresponding author), Providence St Johns Hlth Ctr, Pacific Neurosci Inst, Santa Monica, CA 90404 USA.; Kelly, DF (corresponding author), Providence St Johns Hlth Ctr, St Johns Canc Inst, Santa Monica, CA 90404 USA.; Kelly, DF (corresponding author), Formerly John Wayne Canc Inst, Santa Monica, CA 90404 USA.	dkelly@pacificneuro.org		Kelly, Daniel/0000-0002-8358-056X				Ansari SF, 2020, OPER NEUROSURG, V19, P667, DOI 10.1093/ons/opaa217; Aziz S, 2020, INTENS CARE MED, V46, P1303, DOI 10.1007/s00134-020-06092-5; Badenes R, 2017, CURR OPIN ANESTHESIO, V30, P540, DOI 10.1097/ACO.0000000000000503; Barkhoudarian G, 2019, PITUITARY, V22, P362, DOI 10.1007/s11102-019-00962-y; Beer-Furlan A, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00652; Caggiano C, 2018, WORLD NEUROSURG, V117, pE575, DOI 10.1016/j.wneu.2018.06.090; Cinotti R, 2018, ANESTHESIOLOGY, V129, P1111, DOI 10.1097/ALN.0000000000002426; Conger A, 2019, J NEUROSURG, V130, P861, DOI 10.3171/2017.11.JNS172141; Dasenbrock HH, 2015, NEUROSURG FOCUS, V39, DOI 10.3171/2015.10.FOCUS15386; de Almeida CC, 2018, NEUROCRIT CARE, V28, P35, DOI 10.1007/s12028-017-0433-4; Diaz FJ, 2014, ACTAS UROL ESP, V38, P355, DOI 10.1016/j.acuro.2013.12.004; Dusick JR, 2007, NEUROSURGERY, V60, P322, DOI 10.1227/01.NEU.0000255408.84269.A8; Dusick JR, 2008, SURG NEUROL, V70, P482, DOI 10.1016/j.surneu.2008.03.027; Fatemi N, 2008, NEUROSURGERY, V63, P709, DOI 10.1227/01.NEU.0000325725.77132.90; Fatemi N, 2009, NEUROSURGERY, V64, P269, DOI 10.1227/01.NEU.0000327857.22221.53; Florman JE, 2017, J NEUROSURG, V127, P1392, DOI 10.3171/2016.10.JNS16954; Fluss R, 2021, CLIN NEUROL NEUROSUR, V201, DOI 10.1016/j.clineuro.2020.106460; Fontanella MM, 2020, WORLD NEUROSURG, V139, pE818, DOI 10.1016/j.wneu.2020.04.204; Ghafil C, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.1320; Gozal YM, 2020, J NEUROSURG, V132, P380, DOI 10.3171/2018.10.JNS181480; Guan J, 2017, NEUROSURGERY, V64, P110, DOI 10.1093/neuros/nyx200; Hill CS, 2020, WORLD NEUROSURG, V140, pE395, DOI 10.1016/j.wneu.2020.05.246; Hughes MA, 2020, ACTA NEUROCHIR, V162, P1281, DOI 10.1007/s00701-020-04282-0; Ishii K, 2016, J CLIN ANESTH, V33, P428, DOI 10.1016/j.jclinane.2016.04.043; Jalilvand A, 2016, SURG OBES RELAT DIS, V12, P1737, DOI 10.1016/j.soard.2016.02.020; Jean WC, 2020, ACTA NEUROCHIR, V162, P1229, DOI 10.1007/s00701-020-04342-5; Karsy M, 2019, NEUROSURGERY, V84, P1104, DOI 10.1093/neuros/nyy269; Kelly DF, 2015, J NEURO-OPHTHALMOL, V35, P335, DOI 10.1097/WNO.0000000000000321; Khalafallah AM, 2020, WORLD NEUROSURG, V139, pE877, DOI 10.1016/j.wneu.2020.05.167; Kommers I, 2021, J NEURO-ONCOL, V152, P289, DOI 10.1007/s11060-021-03697-8; Lan Q, 2021, NEUROSURG REV, V44, P1, DOI 10.1007/s10143-019-01188-z; Mallari RJ., 2021, OPER NEUROSURG; Marigil M, 2018, NEUROSURG FOCUS, V44, DOI 10.3171/2018.3.FOCUS1831; McLaughlin N, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.8.FOCUS14445; Miura Y, 2012, J ANESTH, V26, P721, DOI 10.1007/s00540-012-1398-2; Mooney MA, 2019, NEUROSURGERY, V84, P1280, DOI 10.1093/neuros/nyy185; Nettleton J, 2020, BMJ OPEN QUAL, V9, DOI 10.1136/bmjoq-2018-000533; Neville IS, 2020, BMC SURG, V20, DOI 10.1186/s12893-020-00767-y; Nunez-Velasco S, 2020, WORLD NEUROSURG, V142, P506, DOI 10.1016/j.wneu.2020.05.019; Nunno A, 2019, WORLD NEUROSURG, V122, pE1505, DOI 10.1016/j.wneu.2018.11.091; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Pecorelli N, 2016, WORLD J GASTROENTERO, V22, P6456, DOI 10.3748/wjg.v22.i28.6456; Phua Jason, 2020, Lancet Respir Med, V8, P506, DOI 10.1016/S2213-2600(20)30161-2; Regenbogen SE, 2017, JAMA SURG, V152, DOI 10.1001/jamasurg.2017.0123; Richardson AM, 2019, WORLD NEUROSURG, V126, pE869, DOI 10.1016/j.wneu.2019.03.004; Senders JT, 2018, NEUROSURGERY, V83, P1249, DOI 10.1093/neuros/nyy001; Sheppard John P, 2019, Brain Tumor Res Treat, V7, P122, DOI 10.14791/btrt.2019.7.e29; Sivakumar W, 2019, WORLD NEUROSURG, V131, pE12, DOI 10.1016/j.wneu.2019.06.073; ter Laan M, 2020, NEUROSURGERY, V86, pE54, DOI 10.1093/neuros/nyz388; Thakur JD, 2020, NEUROSURG FOCUS, V49, DOI 10.3171/2020.7.FOCUS20515; Thakur JD, 2021, PITUITARY, V24, P14, DOI 10.1007/s11102-020-01081-9; Venkatraghavan L, 2016, CAN J ANESTH, V63, P1245, DOI 10.1007/s12630-016-0717-8; Vimawala S, 2020, INT FORUM ALLERGY RH, V10, P785, DOI 10.1002/alr.22540; Wong Stanley Sau Ching, 2020, Asian J Anesthesiol, V58, P79, DOI 10.6859/aja.202009_58(3).0001	54	3	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0254958	10.1371/journal.pone.0254958	http://dx.doi.org/10.1371/journal.pone.0254958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324519	gold, Green Published			2022-12-26	WOS:000685248200002
J	Meca-Lallana, JE; Maurino, J; Perez-Miralles, F; Forero, L; Sepulveda, M; Calles, C; Martinez-Gines, ML; Gonzalez-Suarez, I; Boyero, S; Romero-Pinel, L; Sempere, AP; Meca-Lallana, V; Querol, L; Costa-Frossard, L; Prefasi, D; Gomez-Ballesteros, R; Ballesteros, J				Meca-Lallana, Jose E.; Maurino, Jorge; Perez-Miralles, Francisco; Forero, Lucia; Sepulveda, Maria; Calles, Carmen; Martinez-Gines, Maria L.; Gonzalez-Suarez, Ines; Boyero, Sabas; Romero-Pinel, Lucia; Sempere, Angel P.; Meca-Lallana, Virginia; Querol, Luis; Costa-Frossard, Lucienne; Prefasi, Daniel; Gomez-Ballesteros, Rocio; Ballesteros, Javier			Quantifying the patient ' s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; DISABILITY; IMPAIRMENT; EXPERIENCE; LIFE	Background The assessment of self-reported outcomes in neuromyelitis optica spectrum disorder (NMOSD) is limited by the lack of validated disease-specific measures. The SymptoMScreen (SyMS) is a patient-reported questionnaire for measuring symptom severity in different domains affected by multiple sclerosis (MS), but has not been thoroughly evaluated in NMOSD. The aim of this study was to assess the psychometric properties of the SyMS in a sample of patients with NMOSD. Methods A non-interventional, cross-sectional study in adult subjects with NMOSD (Wingerchuk 2015 criteria) was conducted at 13 neuroimmunology clinics applying the SyMS. A non-parametric item response theory procedure, Mokken analysis, was performed to assess the underlying dimensional structure and scalability of items and overall questionnaire. All analyses were performed with R (v4.0.3) using the mokken library. Results A total of 70 patients were studied (mean age: 47.5 +/- 15 years, 80% female, mean Expanded Disability Status Scale score: 3.0 [interquartile range 1.5, 4.5]). Symptom severity was low (median SyMS score: 19.0 [interquartile range 10.0, 32.0]). The SyMS showed a robust internal reliability (Cronbach's alpha: 0.90 [95% confidence interval 0.86, 0.93]) and behaved as a unidimensional scale with all items showing scalability coefficients > 0.30. The overall SyMS scalability was 0.45 conforming to a medium scale according to Mokken's criteria. Fatigue and body pain were the domains with the highest scalability coefficients. The SyMS was associated with disability (rho: 0.586), and physical and psychological quality of life (rho: 0.856 and 0.696, respectively). Conclusions The SyMS shows appropriate psychometric characteristics and may constitute a valuable and easy-to-implement option to measure symptom severity in patients with NMOSD.	[Meca-Lallana, Jose E.] Hosp Univ Virgen Arrixaca, IMIB Arrixaca, Clin Neuroimmunol Unit, Dept Neurol, Murcia, Spain; [Meca-Lallana, Jose E.] Hosp Univ Virgen Arrixaca, IMIB Arrixaca, Multiple Sclerosis CSUR, Murcia, Spain; [Maurino, Jorge; Gomez-Ballesteros, Rocio; Ballesteros, Javier] Roche Farma, Med Dept, Madrid, Spain; [Perez-Miralles, Francisco] Hosp Univ & Politecn La Fe, Unit Neuroimmunol, Dept Neurol, Valencia, Spain; [Forero, Lucia] Hosp Univ Puerta Mar, Dept Neurol, Cadiz, Spain; [Sepulveda, Maria] Hosp Clin Barcelona, Dept Neurol, Barcelona, Spain; [Calles, Carmen] Hosp Univ Son Espases, Dept Neurol, Palma De Mallorca, Spain; [Martinez-Gines, Maria L.] Hosp Univ Gregorio Maranon, Dept Neurol, Madrid, Spain; [Gonzalez-Suarez, Ines] Hosp Univ Alvaro Cunqueiro, Dept Neurol, Vigo, Spain; [Boyero, Sabas] Hosp Univ Cruces, Dept Neurol, Bilbao, Spain; [Romero-Pinel, Lucia] Hosp Univ Bellvitge, Dept Neurol, Barcelona, Spain; [Sempere, Angel P.] Hosp Gen Univ Alicante, Dept Neurol, Alicante, Spain; [Meca-Lallana, Virginia] Hosp Univ La Princesa, Dept Neurol, Madrid, Spain; [Querol, Luis] Hosp Santa Creu & Sant Pau, Dept Neurol, Barcelona, Spain; [Costa-Frossard, Lucienne] Hosp Univ Ramon & Cajal, Dept Neurol, Madrid, Spain; [Ballesteros, Javier] Univ Basque Country UPV EHU, Dept Neurosci, Leioa, Spain; [Ballesteros, Javier] Univ Basque Country UPV EHU, CIBERSAM, Leioa, Spain; [Ballesteros, Javier] Biocruces Bizkaia Hlth Res Inst, Baracaldo, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Universitari i Politecnic La Fe; Universidad de Cadiz; Hospital Universitario Puerta del Mar; University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitari Son Espases; General University Gregorio Maranon Hospital; Hospital Universitario Cruces; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; General University Hospital of Alicante; Hospital de La Princesa; Hospital of Santa Creu i Sant Pau; Hospital Universitario Ramon y Cajal; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Basque Country	Maurino, J (corresponding author), Roche Farma, Med Dept, Madrid, Spain.	jorge.maurino@roche.com	Querol, Luis/H-2119-2015; Pérez-Miralles, Francisco Carlos/G-5067-2017	Querol, Luis/0000-0002-4289-8264; Pérez-Miralles, Francisco Carlos/0000-0003-3767-3738; Meca-Lallana, Virginia/0000-0001-9418-4127; Gonzalez-Suarez, Ines/0000-0002-9897-0771; Romero Pinel, Lucia/0000-0001-8054-0565; Gomez, Rocio/0000-0001-9582-9230; , IIS Galicia Sur/0000-0003-3812-7413	Medical Department of Roche Farma Spain [ML41397]	Medical Department of Roche Farma Spain	This study was funded by the Medical Department of Roche Farma Spain (ML41397). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asseyer S, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00778; Barzegar M, 2018, MULT SCLER RELAT DIS, V22, P161, DOI 10.1016/j.msard.2018.04.009; Beekman J, 2019, NEUROL-NEUROIMMUNOL, V6, DOI 10.1212/NXI.0000000000000580; Brichetto G, 2020, CURR OPIN NEUROL, V33, P295, DOI 10.1097/WCO.0000000000000821; Chamot E, 2014, MULT SCLER RELAT DIS, V3, P176, DOI 10.1016/j.msard.2013.06.005; Czarnecka D, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1842; Eaneff S, 2017, MULT SCLER RELAT DIS, V17, P116, DOI 10.1016/j.msard.2017.07.014; Fitzgerald KC, 2019, MULT SCLER RELAT DIS, V29, P86, DOI 10.1016/j.msard.2019.01.031; Green R, 2017, APPL NEUROPSYCH-ADUL, V24, P183, DOI 10.1080/23279095.2015.1125905; Green R, MULTIDIMENSIONAL ASS; Green Rivka, 2017, Mult Scler J Exp Transl Clin, V3, p2055217317728301, DOI 10.1177/2055217317728301; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Kister I., 2019, INT J MS CARE, V21, P75; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Marignier R, 2017, CURR OPIN NEUROL, V30, P208, DOI 10.1097/WCO.0000000000000455; Masuda H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0224419; Meca-Lallana J, 2020, NEUROL THER, V9, P173, DOI 10.1007/s40120-020-00176-6; Moghadasi AN, 2021, MULT SCLER RELAT DIS, V49, DOI 10.1016/j.msard.2021.102757; Mokken RJ., 2010, HDB MODERN ITEM RESP, P351; Moore P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011142; Mutch K, 2017, DISABIL REHABIL, V39, P1279, DOI 10.1080/09638288.2016.1193233; Mutch K, 2014, DISABIL REHABIL, V36, P1100, DOI 10.3109/09638288.2013.833301; Papp V, 2021, NEUROLOGY, V96, P59, DOI 10.1212/WNL.0000000000011153; Shi ZY, 2016, J NEUROIMMUNOL, V293, P54, DOI 10.1016/j.jneuroim.2016.02.011; Siritho S, 2018, MULT SCLER RELAT DIS, V24, P151, DOI 10.1016/j.msard.2018.07.004; van der Ark LA, 2007, J STAT SOFTW, V20; van der Ark LA, 2012, J STAT SOFTW, V48, P1; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729	28	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255317	10.1371/journal.pone.0255317	http://dx.doi.org/10.1371/journal.pone.0255317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324586	Green Published, gold			2022-12-26	WOS:000685248200087
J	Mistry, SK; Ali, ARMM; Yadav, UN; Ghimire, S; Hossain, MB; Das Shuvo, S; Saha, M; Sarwar, S; Nirob, MMH; Sekaran, VC; Harris, MF				Mistry, Sabuj Kanti; Ali, A. R. M. Mehrab; Yadav, Uday Narayan; Ghimire, Saruna; Hossain, Md. Belal; Das Shuvo, Suvasish; Saha, Manika; Sarwar, Sneha; Nirob, Md. Mohibur Hossain; Sekaran, Varalakshmi Chandra; Harris, Mark F.			Older adults with non-communicable chronic conditions and their health care access amid COVID-19 pandemic in Bangladesh: Findings from a cross-sectional study	PLOS ONE			English	Article							QUALITY-OF-LIFE; RURAL BANGLADESH; MULTIMORBIDITY; DISEASE; POCKET	Background Burgeoning burden of non-communicable disease among older adults is one of the emerging public health problems. In the COVID-19 pandemic, health services in low- and middle-income countries, including Bangladesh, have been disrupted. This may have posed challenges for older adults with non-communicable chronic conditions in accessing essential health care services in the current pandemic. The present study aimed at exploring the challenges experienced by older Bangladeshi adults with non-communicable chronic conditions in receiving regular health care services during the COVID-19 pandemic. Materials and methods The study followed a cross-sectional design and was conducted among 1032 Bangladeshi older adults aged 60 years and above during October 2020 through telephone interviews. Self-reported information on nine non-communicable chronic conditions (osteoarthritis, hypertension, heart disease, stroke, hypercholesterolemia, diabetes, chronic respiratory diseases, chronic kidney disease, cancer) was collected. Participants were asked if they faced any difficulties in accessing medicine and receiving routine medical care for their medical conditions during the COVID-19 pandemic. The association between non-communicable chronic conditions and accessing medication and health care was analysed using binary logic regression model. Results Most of the participants aged 60-69 years (77.8%), male (65.5%), married (81.4%), had no formal schooling (58.3%) and resided in rural areas (73.9%). Although more than half of the participants (58.9%) reported having a single condition, nearly one-quarter (22.9%) had multimorbidity. About a quarter of the participants reported difficulties accessing medicine (23%) and receiving routine medical care (27%) during the pandemic, and this was significantly higher among those suffering from multimorbidity. In the adjusted analyses, participants with at least one condition (AOR: 1.95, 95% CI: 1.33-2.85) and with multimorbidity (AOR: 4.75, 95% CI: 3.17-7.10) had a higher likelihood of experiencing difficulties accessing medicine. Similarly, participants with at least one condition (AOR: 3.08, 95% CI: 2.11-4.89) and with multimorbidity (AOR: 6.34, 95% CI: 4.03-9.05) were significantly more likely to face difficulties receiving routine medical care during the COVID-19 pandemic. Conclusions Our study found that a sizeable proportion of the older adults had difficulties in accessing medicine and receiving routine medical care during the pandemic. The study findings highlight the need to develop an appropriate health care delivery pathway and strategies to maintain essential health services during any emergencies and beyond. We also argue the need to prioritise the health of older adults with non-communicable chronic conditions in the centre of any emergency response plan and policies of Bangladesh.				smitra411@gmail.com	Hossain, M. Belal/AAU-7266-2020; Sekaran, Varalakshmi Chandra/AGK-4493-2022; Ali, ARM Mehrab/ABA-9605-2021	Hossain, M. Belal/0000-0003-4733-0018; Sekaran, Varalakshmi Chandra/0000-0003-3319-3075; Ali, ARM Mehrab/0000-0001-5442-7147; Hossain, Md. Belal/0000-0003-4603-863X; Yadav, Uday Narayan/0000-0002-6626-1604				Adams AM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233635; Afshar S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2008-7; Agborsangaya CB, 2013, QUAL LIFE RES, V22, P791, DOI 10.1007/s11136-012-0214-7; Aikins A., 2016, CHRONIC NONCOMMUNICA; Al-Zaman MS, 2020, AM J TROP MED HYG, V103, P1357, DOI 10.4269/ajtmh.20-0826; [Anonymous], 2018, LANCET, V391, P1637, DOI 10.1016/S0140-6736(18)30941-3; [Anonymous], 2005, STAT 2 M INT HLTH RE; Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00154; BBS, 2015, ELD POP BANGL CURR F; Benedetto U, 2018, EUR J CARDIO-THORAC, V53, P1112, DOI 10.1093/ejcts/ezy167; Bleich SN, 2011, HEALTH POLICY, V100, P282, DOI 10.1016/j.healthpol.2010.09.004; Blumenthal D, 2020, NEW ENGL J MED, V383, P1483, DOI 10.1056/NEJMsb2021088; Brown E, 2020, SCHIZOPHR RES, V222, P79, DOI 10.1016/j.schres.2020.05.005; Cakir B, 2020, J EPIDEMIOL GLOB HEA, V10, P115, DOI 10.2991/jegh.k.200520.001; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Chan EYY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155588; Datta BK, 2018, SSM-POPUL HLTH, V6, P252, DOI 10.1016/j.ssmph.2018.10.001; El-Khatib Z, 2020, J EPIDEMIOL GLOB HEA, V10, P192, DOI 10.2991/jegh.k.200725.001; Hossain MM, 2020, J GERONTOL SOC WORK, V63, P724, DOI 10.1080/01634372.2020.1772932; Huq NM, 2015, IRAN J PUBLIC HEALTH, V44, P1024; Forjaz MJ, 2015, EUR J INTERN MED, V26, P176, DOI 10.1016/j.ejim.2015.02.016; Joarder Taufique, 2019, Psyche (Camb Mass), V2019, P4954095, DOI 10.1155/2019/4954095; Keya KT, 2013, LANCET, V382, P17; Khan Nusrat, 2019, BMJ Open, V9, pe030886, DOI 10.1136/bmjopen-2019-030886; Khanam MA, 2011, J HEALTH POPUL NUTR, V29, P406, DOI 10.3329/jhpn.v29i4.8458; Kluge HHP, 2020, LANCET, V395, P1678, DOI 10.1016/S0140-6736(20)31067-9; Modesti PA., 2020, BMC MED, V18, P1, DOI [10.1186/s12916-019-1443-1, DOI 10.1186/S12916-019-1443-1]; Navickas Rokas, 2016, J Comorb, V6, P4, DOI 10.15256/joc.2016.6.72; Nguyen Hai, 2019, J Comorb, V9, p2235042X19870934, DOI 10.1177/2235042X19870934; Niger S, EFFICIENCY ANAL PUBL; Novosad P, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-043165; Porcheddu R, 2020, J INFECT DEV COUNTR, V14, P125, DOI 10.3855/jidc.12600; Rahman MS., 2020, DR SULAIMAN HABIB ME, V2, P83, DOI [10.2991/dsahmj.k.200630.001, DOI 10.2991/DSAHMJ.K.200630.001]; Sara Hasna Hena, 2018, Aging Med (Milton), V1, P267, DOI 10.1002/agm2.12047; Shadmi E, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01218-z; Stokes J, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003514; Thawani V, 2017, J PHARMACOL PHARMACO, V8, P134, DOI 10.4103/jpp.JPP_38_17; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, OLD PEOPL COVID 19; WHO, WHO COR DIS COVID 19; WHO, COVID 19 SIGN IMP HL; Yadav UN, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-041728; Yadav UN, 2021, HEALTH RES POLICY SY, V19, DOI 10.1186/s12961-020-00664-z; Yadav UN, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00508; Yoshida K, 2017, EPIDEMIOLOGY, V28, P387, DOI 10.1097/EDE.0000000000000627; Zhang ZH, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2018.12.10; Zhao QW, 2020, J MED VIROL, V92, P1915, DOI 10.1002/jmv.25889; Zulman DM, 2014, J GEN INTERN MED, V29, P529, DOI 10.1007/s11606-013-2616-9	48	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255534	10.1371/journal.pone.0255534	http://dx.doi.org/10.1371/journal.pone.0255534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324556	gold, Green Published			2022-12-26	WOS:000685248200016
J	Postigo-Zegarra, S; Julian, M; Schoeps, K; Montoya-Castilla, I				Postigo-Zegarra, Silvia; Julian, Martin; Schoeps, Konstanze; Montoya-Castilla, Inmaculada			Psychological adjustment of Spanish adolescents and their parents during COVID-19 lockdown: A mixed method approach	PLOS ONE			English	Article							REPORTING QUALITATIVE RESEARCH; MENTAL-HEALTH; DEPRESSION; STANDARDS; ANXIETY; RISK	Previous literature on the psychological impact of COVID-19 has shown a direct relationship between family conflicts and psychological distress among parents and their children during the domestic lockdown and social isolation; but there are also opportunities to enhance family bonding, encourage collective problem-solving and improve personal relationships. This study aimed to explore psychological adjustment processes of Spanish adolescents and their parents during the first month of lockdown by analyzing their narratives, perceived outcomes, protection and risk factors. A total of 142 people agreed to participate in this study. Of all participants, 61 were adolescents (M = 13.57; SD = 1.74; 57% women) and 81 were parents (M = 46.09; SD = 4.72; 91% mothers). All were Spanish residents and completed an online survey during the domestic lockdown in March 2020. From a qualitative design, methodology followed a mixed approach to analyze data. The results showed three different types of adaptation to lockdown and social isolation in both adolescents and their parents: 1) positive adjustment, 2) moderate adjustment, and 3) maladjustment. Most participants reported a good adjustment and only a 20% of parents and a 16% of adolescents stated that they had not been able to achieve a positive psychological adjustment. There are few significant quantitative differences between adolescents and their parents. The qualitative analysis of data showed that adolescents reported less psychological distress than their parents. The two most important protective factors were social support and keeping busy during lockdown. The most significant risk factors were loss of mobility and social isolation. The conclusions stressed that regarding psychological maladjustment, parents experienced feelings of uncertainty whereas adolescents experienced a kind of mourning process. These findings can be used to design and implement effective intervention measures for mental health and psychological well-being in such a difficult situation as domestic lockdown.	[Postigo-Zegarra, Silvia; Julian, Martin] Univ Europea Valencia, Dept Psychol, Fac Hlth Sci, Valencia, Spain; [Schoeps, Konstanze; Montoya-Castilla, Inmaculada] Univ Valencia, Dept Personal Assessment & Psychol Intervent, Fac Psychol, Valencia, Spain	University of Valencia	Montoya-Castilla, I (corresponding author), Univ Valencia, Dept Personal Assessment & Psychol Intervent, Fac Psychol, Valencia, Spain.	inmaculada.montoya@uv.es	Postigo, Silvia/K-3387-2017; Schoeps, Konstanze/C-1604-2018	Postigo, Silvia/0000-0003-4595-8063; Schoeps, Konstanze/0000-0002-6312-7055	Spanish Ministry of Science, Innovation and Universities (Ministerio de Ciencia, Innovacion y Universidades) [PSI2017-84005-R]; European Regional Development Fund (FEDER) form the European Union	Spanish Ministry of Science, Innovation and Universities (Ministerio de Ciencia, Innovacion y Universidades)(Spanish Government); European Regional Development Fund (FEDER) form the European Union	This research was supported by grants from the Spanish Ministry of Science, Innovation and Universities (Ministerio de Ciencia, Innovacion y Universidades) (PSI2017-84005-R), endorsed by the State Agency of Research and the European Regional Development Fund (FEDER) form the European Union.	Ausin B, 2021, J GENDER STUD, V30, P29, DOI 10.1080/09589236.2020.1799768; Braun V, 2021, INT J SOC RES METHOD, V24, P641, DOI 10.1080/13645579.2020.1805550; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Buzzi C., 2020, ITAL J PEDIATR, V46, P46, DOI [10.1186/s13052-020-0810-z, DOI 10.1186/S13052-020-0810-Z]; Cardenas MC, 2020, ACTA PAEDIATR, V109, P2187, DOI 10.1111/apa.15536; Chen FP, 2020, BRAIN BEHAV IMMUN, V88, P36, DOI 10.1016/j.bbi.2020.05.061; Femia Marzo P., 2012, MODELACION FENOMENOS, P125; Fioretti C, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.599531; Flick U., 2012, INTRO INVESTIGACION; Fontanesi L, 2020, PSYCHOL TRAUMA-US, V12, pS79, DOI 10.1037/tra0000672; Fullana MA, 2020, J AFFECT DISORDERS, V275, P80, DOI 10.1016/j.jad.2020.06.027; Gonzalez-Sanguino C, 2020, BRAIN BEHAV IMMUN, V87, P172, DOI 10.1016/j.bbi.2020.05.040; Groarke JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239698; Gunther-Bel C, 2020, FAM PROCESS, V59, P1060, DOI 10.1111/famp.12585; Kilincel S, 2021, ASIA-PAC PSYCHIAT, V13, DOI 10.1111/appy.12406; Lacomba-Trejo L, 2020, REV PSICOL CLIN NINO, V7, P66, DOI 10.21134/rpcna.2020.mon.2035; Levitt H. M., 2017, QUAL PSYCHOL, V4, P2, DOI [DOI 10.1037/QUP0000082, 10.1037/qup0000082]; Levitt HM, 2018, AM PSYCHOL, V73, P26, DOI 10.1037/amp0000151; Liang LL, 2020, PSYCHIAT QUART, V91, P841, DOI 10.1007/s11126-020-09744-3; Marianna C., 2020, ACAD INT SCI J, P22, DOI [10.7336/academicus.2020.22.08, DOI 10.7336/ACADEMICUS.2020.22.08]; Mazza C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176236; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Organizacion Mundial de la Salud, 2020, WHO ANN COVID 19 OUT; Orgiles M, 2022, CURR PSYCHOL, V41, P3156, DOI 10.1007/s12144-020-00849-3; Palgi Y, 2020, J AFFECT DISORDERS, V275, P109, DOI 10.1016/j.jad.2020.06.036; Peng M, 2020, J AFFECT DISORDERS, V275, P119, DOI 10.1016/j.jad.2020.06.035; Perez-Fuentes MD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235305; Qi M, 2020, J ADOLESCENT HEALTH, V67, P514, DOI 10.1016/j.jadohealth.2020.07.001; Rodriguez-Rey R, 2020, PSYCHOL TRAUMA-US, V12, P550, DOI 10.1037/tra0000943; Sandin B., 2020, RPPC, V25, P1, DOI DOI 10.5944/RPPC.27569; Stavridou A, 2020, PSYCHIAT CLIN NEUROS, V74, P615, DOI 10.1111/pcn.13134; Sullivan C., 2019, DOING QUALITATIVE RE, V2nd; Tamarit A, 2020, REV PSICOL CLIN NINO, V7, P73, DOI 10.21134/rpcna.2020.mon.2037; Tang WJ, 2020, PERS INDIV DIFFER, V165, DOI 10.1016/j.paid.2020.110131; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Twining P, 2017, COMPUT EDUC, V106, pA1, DOI 10.1016/j.compedu.2016.12.002	36	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0255149	10.1371/journal.pone.0255149	http://dx.doi.org/10.1371/journal.pone.0255149			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA6CQ	34324579	Green Published, gold			2022-12-26	WOS:000685248200102
J	Robson, SV; Seale, B; Theodor, JM				Robson, Selina Viktor; Seale, Brendon; Theodor, Jessica M.			The petrosal and basicranial morphology of Protoceras celer	PLOS ONE			English	Article							RUMINANT BONY LABYRINTH; SUBARCUATE FOSSA; INNER-EAR; ARTIODACTYLA; EOCENE; OLIGOCENE; ONTOGENY; MAMMALIA; ANATOMY; CRANIUM	Protoceratids are an extinct family of endemic North American artiodactyls. The phylogenetic position of protoceratids in relation to camelids and ruminants has been contentious for over a century. The petrosal morphology of basal (Leptotragulus) and derived (Syndyoceras) protoceratids has suggested that protoceratids are closely related to ruminants, whereas a prior description of a disarticulated intermediate protoceratid petrosal (Protoceras celer) indicated that protoceratids were closely related to camelids. This contradictory evidence implied that there were several character reversals within the protoceratid lineage and brought into question the utility of basicranial characters in artiodactyl phylogenetics. Here, we provide descriptions of an additional P. celer petrosal. The descriptions are based on data produced by computed tomography scans, which allowed us to image the petrosal in situ in the skull. Our results indicate that the petrosal morphology of P. celer is similar to that of other protoceratids, implying that, contrary to previous evidence, petrosal morphology is conserved within the Protoceratidae.	[Robson, Selina Viktor; Theodor, Jessica M.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada; [Seale, Brendon] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	University of Calgary; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Robson, SV (corresponding author), Univ Calgary, Dept Biol Sci, Calgary, AB, Canada.	selina.robson1@ucalgary.ca	Robson, Selina/GPG-1790-2022	Robson, Selina/0000-0002-4965-377X; Theodor, Jessica/0000-0002-5159-7041	NSERC Discovery Grant	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was funded by an NSERC Discovery Grant (https://www.nserc-crsng.gc.ca/ professors-professeurs/grants-subs/dgigp-psigp_ eng.asp) awarded to JMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Colbert EH, 1941, AM MUSEUM NOVIT, V1135, P1; Costeur L, 2017, J ANAT, V230, P347, DOI 10.1111/joa.12549; Costeur Loic, 2014, Zitteliana Reihe B, V32, P99; Dechaseaux C., 1967, Annales de Paleontologie Vertebres, V53, P27; Dechaseaux C., 1974, ANN PALEONTOLOGIE VE, V60, P59; Ekdale EG, 2009, THESIS U TEXAS AUSTI; Ekdale EG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066624; GANNON PJ, 1988, AM J PHYS ANTHROPOL, V77, P143, DOI 10.1002/ajpa.1330770202; Gazin C. L., 1955, Smithsonian Miscellaneous Collections, V128, P1; Geisler JH, 2007, ACTA PALAEONTOL POL, V52, P189; Gentry A.W., 1988, Systematics Association Special Volume Series, P235; Golz D.J., 1976, Science Bull nat Hist Mus Los Ang Cty, VNo. 26, P1; Hurzeler J., 1936, Abhandlungen der Schweizerischen Palaeontologischen Gesellschaft Geneve, V58, P1; JANIS C, 1982, BIOL REV, V57, P261, DOI 10.1111/j.1469-185X.1982.tb00370.x; Janis C.M., 1990, P255; Janis Christine M., 2014, Zitteliana Reihe B, V32, P15; Joeckel RM, 1996, J VERTEBR PALEONTOL, V16, P320, DOI 10.1080/02724634.1996.10011319; Marsh OC, 1891, AM J SCI, V41, p5A; Matthew WD, 1905, B AM MUS NAT HIST, V21, P21; MAZZONI A, 1970, LARYNGOSCOPE, V80, P69, DOI 10.1288/00005537-197001000-00006; Mennecart B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12848-9; Mennecart B, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1211665; Mennecart B, 2016, J MORPHOL, V277, P1329, DOI 10.1002/jmor.20579; Mennecart B, 2016, J ANAT, V229, P422, DOI 10.1111/joa.12487; Norris CA, 1999, J VERTEBR PALEONTOL, V19, P742, DOI 10.1080/02724634.1999.10011186; Norris CA, 2000, J VERTEBR PALEONTOL, V20, P341, DOI 10.1671/0272-4634(2000)020[0341:TCOLAH]2.0.CO;2; O'Leary MA, 2010, B AM MUS NAT HIST, P4; Orliac MJ, 2014, J MAMM EVOL, V21, P299, DOI 10.1007/s10914-014-9254-9; Orliac MJ, 2013, J SYST PALAEONTOL, V11, P925, DOI 10.1080/14772019.2012.704409; Orliac MJ, 2012, J ANAT, V221, P417, DOI 10.1111/j.1469-7580.2012.01562.x; Orliac MJ, 2017, J MORPHOL, V278, P1168, DOI 10.1002/jmor.20702; Osborn HF., 1892, B AM MUSEUM NAT HIST, V18, P351; PATTON T H, 1971, Bulletin of the American Museum of Natural History, V145, P123; PATTON T H, 1973, Bulletin of the American Museum of Natural History, V150, P347; Pearson HS, 1927, PHILOS T R SOC LON B, V25, P389; Prothero Donald R., 1998, P431; Prothero Donald R., 2004, P156; Prothero Donald R., 2007, P169; Sanchez-Villagra MR, 2002, ACTA THERIOL, V47, P1, DOI 10.1007/BF03193561; Scott W. B., 1940, Transactions of the American Philosophical Society Philadelphia, V28, P363, DOI 10.2307/1005504; Scott W.B., 1895, J MORPHOL, V2, P303; Scott WB, 1899, T WAGNER FREE I SCI, V6, P1; Silcox MT, 2009, J HUM EVOL, V56, P315, DOI 10.1016/j.jhevol.2008.10.007; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Spaulding M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007062; Spoor F, 2007, P NATL ACAD SCI USA, V104, P10808, DOI 10.1073/pnas.0704250104; Stirton R., 1967, RELATIONSHIPS PROTOC; Stirton RA, 1944, AM J SCI, V242, P633, DOI 10.2475/ajs.242.12.633; Theodor JM, 2010, J VERTEBR PALEONTOL, V30, P236, DOI 10.1080/02724630903415979; Webb S. D., 1965, Bulletin Los Angeles City Museum Sci, V1, P1; WEBB S D, 1980, Bulletin of the American Museum of Natural History, V167, P117; WEBB S D, 1981, Journal of Vertebrate Paleontology, V1, P357; WHITMORE F. C., 1953, U S GEOL SURV PROF PAPERS, V243-H, P117; Wilson JA, 1974, TEXAS MEMORIAL MUSEU, V23, P1; Wortman JL, 1898, B AMNH, V10, P1	55	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2021	16	7							e0251832	10.1371/journal.pone.0251832	http://dx.doi.org/10.1371/journal.pone.0251832			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CQ	34324518	Green Submitted, Green Published, gold			2022-12-26	WOS:000685248200033
J	Ramliana, L; Lalronunga, S; Singh, M				Ramliana, Lal; Lalronunga, Samuel; Singh, Mahender			Badis kaladanensis, a new fish species (Teleostei: Badidae) from Mizoram, northeast India	PLOS ONE			English	Article							WEST-BENGAL; DNA; MITOCHONDRIAL; PERCIFORMES; EVOLUTIONARY; DELIMITATION; TAXONOMY; SEQUENCE	Badis kaladanensis, a new percoid fish is described from the Kaladan basin of Mizoram, northeast India. It belongs to the Badis badis species group but can be easily distinguished from its congeners, except from B. kanabos and B. tuivaiei, in having a dark blotch on the dorsal fin between the base of 3(rd) to 5(th) spines. It is further distinguished from B. kanabos in having more scales in lateral row (27-30 vs. 25-26), more circumpeduncular scale rows (18-20 vs. 16-17) and smaller eye (7.5-8.9% SL vs. 9.5-12.7); and from B. tuivaiei in having fewer vertebrae (28-29 vs. 30-31) and more rakers on the first gill arch (9 vs. 6-8). The analysis of the mitochondrial DNA (coi and cytb) revealed the distinctness of B. kaladanensis from all other Badis species with the interspecific distance ranges from 5.4-20.4%. (coi) and 5.1-26.3% (cytb).	[Ramliana, Lal] Pachhunga Univ Coll, Dept Zool, Aizawl, Mizoram, India; [Lalronunga, Samuel] Mizoram Univ, Dept Zool, Aizawl, Mizoram, India; [Singh, Mahender] ICAR Natl Bur Fish Genet Resources, Mol Biol & Biotechnol Div, Lucknow, Uttar Pradesh, India	Mizoram University; Mizoram University; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Fish Genetic Resources	Singh, M (corresponding author), ICAR Natl Bur Fish Genet Resources, Mol Biol & Biotechnol Div, Lucknow, Uttar Pradesh, India.	dr.mahendersingh29@gmail.com		Lalronunga, Samuel/0000-0002-7542-4815; Singh, Mahender/0000-0001-5335-5460	Department of Biotechnology, Government of India [BT/388/NE/TBP/2012]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Lal Ramliana and Mahender Singh received project funding from Department of Biotechnology, Government of India (No. BT/388/NE/TBP/2012). http://dbtindia.gov.in/The DBT did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dahanukar N, 2015, ZOOTAXA, V3941, P429, DOI 10.11646/zootaxa.3941.3.9; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Eschmeyer WN, CATALOG FISHES GENER; Geetakumari K., 2011, Journal of Threatened Taxa, V3, P2085; Geetakumari Kh., 2010, Journal of Threatened Taxa, V2, P644; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Kar Devashish, 2007, Zoos Print Journal, V22, P2599; Karmakar AK, 2007, STATE FAUNA SERIES 1, V14; Kullander S, 2019, ZOOTAXA, V4586, P301, DOI 10.11646/zootaxa.4586.2.7; Kullander Sven O., 2002, Ichthyological Exploration of Freshwaters, V13, P295; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Ruber L, 2004, MOL PHYLOGENET EVOL, V32, P1010, DOI 10.1016/j.ympev.2004.04.020; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Sambrook J., 2001, MOL CLONING LAB MANU; Schindler I, 2010, VERTEBR ZOOL, V60, P209; SCHMIDT TR, 1993, COPEIA, P880; Valdesalici S, 2015, ZOOTAXA, V3986, P193, DOI 10.11646/zootaxa.3986.2.3; Valdesalici S, 2015, ZOOTAXA, V3985, P391, DOI 10.11646/zootaxa.3985.3.4; Vishwanath W., 2004, Zoos' Print Journal, V19, P1619; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878	21	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0246466	10.1371/journal.pone.0246466	http://dx.doi.org/10.1371/journal.pone.0246466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34319974	Green Published, gold			2022-12-26	WOS:000685247800010
J	Rousseau, RK; Szadkowski, L; Kovacs, CM; Saikali, MF; Nadeem, R; Malazogu, F; Huibner, S; Cummins, CL; Kaul, R; Walmsley, SL				Rousseau, Rodney K.; Szadkowski, Leah; Kovacs, Colin M.; Saikali, Michael F.; Nadeem, Rabea; Malazogu, Fat; Huibner, Sanja; Cummins, Carolyn L.; Kaul, Rupert; Walmsley, Sharon L.			Activation and gut-homing of peripheral T cells in HIV immunologic non-responders despite long term viral suppression	PLOS ONE			English	Article							MICROBIAL TRANSLOCATION; IMMUNE ACTIVATION; HLA-DR; INFLAMMATION; LYMPHOCYTES; EXPRESSION; MARKERS; COUNT; RISK; CD38	Objective Serious non-AIDS disease events (SNAE) are experienced disproportionately by immunologic non-responders (INRs), HIV-infected individuals who do not restore CD4 T cells in blood despite effective viral suppression. We aimed to characterize the inflammatory biomarker profile of the INR phenotype. Methods Blinded cross-sectional cohort study comparing markers of immune activation and gut homing between INR and non-INR individuals. HIV-positive participants had HIV RNA suppression on antiretroviral therapy and were categorized as either INR (N = 36) or Clinical Responders ("CR"; CD4>350/mm(3); N = 47). 18 HIV-negative comparator individuals were included. Cellular markers were assessed by flow cytometry, with soluble markers assessed by ELISA and LC/MS-MS. Multivariable linear regression models estimated the association between INR phenotype and markers, adjusting for age, sex, duration of ART, and recent infection/vaccination. Results INR participants demonstrated a reduced CD4/CD8 ratio (p<0.001), 35% more CD8 activation (p = 0.02), 36% greater alpha 4 beta 7+ CD4 T cells (p<0.01), 54% more HLA-DR+ CD4 T cells (p<0.001), and 20% higher plasma VCAM (p<0.01) compared to CRs. The INR phenotype was not associated with levels of Kyn/Trp, CRP, TNF, IFN gamma, IL-8, IL-6, sCD14, D-Dimer, I-FABP, MCP-1, ICAM or CD8%HLA-DR+. Conclusions Peripheral CD4 non-recovery during long-term treated HIV infection is characterized by elevated CD8 activation and CD4 gut homing. Gut-focused interventions may be warranted in the INR context, and CD8 activation may serve as a surrogate endpoint for clinical interventions.	[Rousseau, Rodney K.; Kaul, Rupert] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Szadkowski, Leah] Univ Hlth Network, Biostat Res Unit, Toronto, ON, Canada; [Kovacs, Colin M.] Maple Leaf Med Clin, Toronto, ON, Canada; [Kovacs, Colin M.; Nadeem, Rabea; Malazogu, Fat; Huibner, Sanja; Kaul, Rupert; Walmsley, Sharon L.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Saikali, Michael F.; Cummins, Carolyn L.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Kaul, Rupert; Walmsley, Sharon L.] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada; [Walmsley, Sharon L.] Toronto Gen Hosp, Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Kaul, R (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Kaul, R (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Kaul, R (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada.	rupert.kaul@utoronto.ca		Kaul, Rupert/0000-0002-1586-4093; Malazogu, Fat/0000-0002-8432-340X	Canadian Institutes of Health Research (CIHR) [MCT 94245]; Ontario HIV Treatment Network (OHTN) [ROG-G869]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario HIV Treatment Network (OHTN)	The study was funded by the Canadian Institutes of Health Research (CIHR; MCT 94245, SW) and the Ontario HIV Treatment Network (OHTN; ROG-G869, RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2019, LANCET HIV, V6, pE93, DOI 10.1016/S2352-3018(18)30295-9; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Dunham RM, 2014, JAIDS-J ACQ IMM DEF, V65, P133, DOI 10.1097/01.qai.0000437172.08127.0b; Engsig FN, 2014, CLIN INFECT DIS, V58, P1312, DOI 10.1093/cid/ciu038; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Girard A, 2016, JAIDS-J ACQ IMM DEF, V72, P259, DOI 10.1097/QAI.0000000000000943; Hao XP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9020; Huang Y, 2013, BIOANALYSIS, V5, P1397, DOI [10.4155/bio.13.74, 10.4155/BIO.13.74]; KESTENS L, 1992, AIDS, V6, P793, DOI 10.1097/00002030-199208000-00004; Lapadula G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124741; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Lichtenstein KA, 2010, CLIN INFECT DIS, V51, P435, DOI 10.1086/655144; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Marchetti G, 2013, CLIN MICROBIOL REV, V26, P2, DOI 10.1128/CMR.00050-12; Mavigner M, 2012, J CLIN INVEST, V122, P62, DOI 10.1172/JCI59011; Rousseau R, 2017, J IMMUNOL, V198; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Somsouk M, 2015, AIDS, V29, P43, DOI 10.1097/QAD.0000000000000511; Wong C, 2018, CLIN INFECT DIS, V66, P1230, DOI 10.1093/cid/cix998	20	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0254149	10.1371/journal.pone.0254149	http://dx.doi.org/10.1371/journal.pone.0254149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320023	gold, Green Published			2022-12-26	WOS:000685247800037
J	Taguchi, S; Koide, H; Oiwa, H; Hayashi, M; Ogawa, K; Ito, C; Nakashima, K; Yuasa, T; Yasumoto, A; Ando, H; Fujikake, A; Fukuoka, T; Tokui, K; Izumi, M; Tsunoda, Y; Kawagashira, Y; Okada, Y; Niwa, JI; Doyu, M				Taguchi, Soutarou; Koide, Hirofumi; Oiwa, Hiroko; Hayashi, Miku; Ogawa, Kazuhiro; Ito, Chihiro; Nakashima, Koji; Yuasa, Tomoko; Yasumoto, Akihiro; Ando, Hiroaki; Fujikake, Akifumi; Fukuoka, Takaaki; Tokui, Keisuke; Izumi, Masayuki; Tsunoda, Yuka; Kawagashira, Yuichi; Okada, Yohei; Niwa, Jun-ichi; Doyu, Manabu			Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease	PLOS ONE			English	Article							SYMPTOMS; ROTIGOTINE; PERGOLIDE	Objective To clarify whether antiparkinsonian drugs contribute to nocturnal sleep disturbances in patients with Parkinson's disease (PD). Background Although the major antiparkinsonian drugs L-dopa and dopamine agonists (DAs) have been found to affect sleep, little is known about the effects of specific drugs on sleep in PD patients. Methods The study participants consisted of 112 PD patients (median age 72.5 years [inter-quartile range: IQR 65-79]; mean disease duration 8.44 years [standard deviation: 7.33]; median Hoehn and Yahr stage 3 [IQR 2-3.75]) taking one of three types of non-ergot extended-release DAs (rotigotine 32; pramipexole 44; ropinirole 36) with or without L-dopa (median daily total dosage of antiparkinsonian drugs 525.5 mg [IQR 376.25-658] levodopa equivalent dose [LED]). Participants were assessed using the PD Sleep Scale-2 (PDSS-2). Results For the whole PD patient cohort, the PDSS-2 sleep disturbance domain score and the scores for item 1 assessing sleep quality and item 8 assessing nocturia were positively correlated with daily total dosage of antiparkinsonian drugs and dosage of L-dopa, but not with the dosage of DAs. Sub-analysis according to DA treatment revealed that DA dosage was not correlated with item 1 or 8 score in any of the subgroups. The LED ratio of rotigotine to the total dosage of antiparkinsonian drugs was inversely correlated with the item 1 score. Conclusions These data suggest that antiparkinsonian drugs, in particular L-dopa, adversely affect nocturnal sleep in PD patients, especially in terms of sleep quality and nocturia. Thus, adjusting both the total dosage of antiparkinsonian drugs and the dose-ratio of L-dopa might be key actions for alleviating poor sleep quality in patients with PD. Among DAs, we found a clear positive correlation between the dose-ratio of rotigotine and sleep quality. Thus, partial L-dopa replacement with rotigotine could improve sleep quality in patients with PD.	[Taguchi, Soutarou] Aichi Med Univ Hosp, Parkinsons Dis Adv Therapy Ctr, Nagakute, Aichi, Japan; [Taguchi, Soutarou; Koide, Hirofumi; Oiwa, Hiroko; Hayashi, Miku; Ogawa, Kazuhiro; Ito, Chihiro; Nakashima, Koji; Yuasa, Tomoko; Yasumoto, Akihiro; Ando, Hiroaki; Fujikake, Akifumi; Fukuoka, Takaaki; Tokui, Keisuke; Izumi, Masayuki; Tsunoda, Yuka; Kawagashira, Yuichi; Okada, Yohei; Niwa, Jun-ichi; Doyu, Manabu] Aichi Med Univ, Dept Neurol, Nagakute, Aichi, Japan	Aichi Medical University; Aichi Medical University	Doyu, M (corresponding author), Aichi Med Univ, Dept Neurol, Nagakute, Aichi, Japan.	mdoyu@aichi-med-u.ac.jp		TAGUCHI, Soutarou/0000-0002-9700-4192	Japan Society for the Promotion of Science [,19K17247]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The study received funding from the Japan Society for the Promotion of Science (grant-in-Aid for Young Scientists,19K17247) to ST. None of the funding sources impacted the study design, data collection, analysis, decision to publish, or preparation of this manuscript.	Albers JA, 2017, SLEEP MED, V35, P41, DOI 10.1016/j.sleep.2017.03.026; Chang CW, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00340; Chaudhuri KR, 2012, EUR J NEUROL, V19, P105, DOI 10.1111/j.1468-1331.2011.03442.x; Chung S, 2013, J CLIN SLEEP MED, V9, P1131, DOI 10.5664/jcsm.3150; Comella CL, 2005, NEUROLOGY, V64, P1450, DOI 10.1212/01.WNL.0000158652.74601.48; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Obeso JA, 2017, MOVEMENT DISORD, V32, P1, DOI 10.1002/mds.26904; Perez-Lloret S, 2010, CNS DRUGS, V24, P941, DOI 10.2165/11537810-000000000-00000; Pierantozzi M, 2016, SLEEP MED, V21, P140, DOI 10.1016/j.sleep.2016.01.016; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Suzuki K, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0525-5; Suzuki K, 2012, J NEUROL SCI, V318, P76, DOI 10.1016/j.jns.2012.03.022; Tagaya H, 2002, SLEEP MED, V3, P49, DOI 10.1016/S1389-9457(01)00116-2; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Trenkwalder C, 2011, MOVEMENT DISORD, V26, P644, DOI 10.1002/mds.23476; Trenkwalder C, 2011, MOVEMENT DISORD, V26, P90, DOI 10.1002/mds.23441; Verbaan D, 2008, MOVEMENT DISORD, V23, P35, DOI 10.1002/mds.21727; Winge K, 2006, MOVEMENT DISORD, V21, P737, DOI 10.1002/mds.20867; Wood M, 2015, BRIT J PHARMACOL, V172, P1124, DOI 10.1111/bph.12988; Zibetti M, 2013, ACTA NEUROL SCAND, V127, pe28, DOI 10.1111/ane.12075	20	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 28	2021	16	7							e0255274	10.1371/journal.pone.0255274	http://dx.doi.org/10.1371/journal.pone.0255274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA6CM	34320022	Green Published, gold			2022-12-26	WOS:000685247800030
J	D'Souza, NJ; Downing, K; Abbott, G; Orellana, L; Lioret, S; Campbell, KJ; Hesketh, KD				D'Souza, Ninoshka J.; Downing, Katherine; Abbott, Gavin; Orellana, Liliana; Lioret, Sandrine; Campbell, Karen J.; Hesketh, Kylie D.			A comparison of children's diet and movement behaviour patterns derived from three unsupervised multivariate methods	PLOS ONE			English	Article							OBESITY-RELATED BEHAVIORS; HORNS PARALLEL ANALYSIS; LATENT CLASS ANALYSIS; LIFE-STYLE BEHAVIORS; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; LONGITUDINAL ASSOCIATIONS; AUSTRALIAN CHILDREN; CLUSTER-ANALYSIS; WEIGHT STATUS	Background Behavioural patterns are typically derived using unsupervised multivariate methods such as principal component analysis (PCA), latent profile analysis (LPA) and cluster analysis (CA). Comparability and congruence between the patterns derived from these methods has not been previously investigated, thus it's unclear whether patterns from studies using different methods are directly comparable. This study aimed to compare behavioural patterns derived across diet, physical activity, sedentary behaviour and sleep domains, using PCA, LPA and CA in a single dataset. Methods Parent-report and accelerometry data from the second wave (2011/12; child age 6-8y, n = 432) of the HAPPY cohort study (Melbourne, Australia) were used to derive behavioural patterns using PCA, LPA and CA. Standardized variables assessing diet (intake of fruit, vegetable, sweet, and savoury discretionary items), physical activity (moderate- to vigorous-intensity physical activity [MVPA] from accelerometry, organised sport duration and outdoor playtime from parent report), sedentary behaviour (sedentary time from accelerometry, screen time, videogames and quiet playtime from parent report) and sleep (daily sleep duration) were included in the analyses. For each method, commonly used criteria for pattern retention were applied. Results PCA produced four patterns whereas LPA and CA each generated three patterns. Despite the number and characterisation of the behavioural patterns derived being non-identical, each method identified a healthy, unhealthy and a mixed pattern. Three common underlying themes emerged across the methods for each type of pattern: (i) High fruit and vegetable intake and high outdoor play ("healthy"); (ii) poor diet (either low fruit and vegetable intake or high discretionary food intake) and high sedentary behaviour ("unhealthy"); and (iii) high MVPA, poor diet (as defined above) and low sedentary time ("mixed"). Conclusion Within this sample, despite differences in the number of patterns derived by each method, a good degree of concordance across pattern characteristics was seen between the methods. Differences between patterns could be attributable to the underpinning statistical technique of each method. Therefore, acknowledging the differences between the methods and ensuring thorough documentation of the pattern derivation analyses is essential to inform comparison of patterns derived through a range of approaches across studies.	[D'Souza, Ninoshka J.; Downing, Katherine; Abbott, Gavin; Campbell, Karen J.; Hesketh, Kylie D.] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr, Geelong, Vic, Australia; [Orellana, Liliana] Deakin Univ, Biostat Unit, Geelong, Vic, Australia; [Lioret, Sandrine] Univ Paris, INSERM, INRAE, Res Ctr Epidemiol & Biostat CRESS, Paris, France; [D'Souza, Ninoshka J.; Downing, Katherine; Abbott, Gavin; Orellana, Liliana; Campbell, Karen J.; Hesketh, Kylie D.] Deakin Univ, Fac Hlth, Geelong, Vic, Australia	Deakin University; Deakin University; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Deakin University	D'Souza, NJ (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr, Geelong, Vic, Australia.; D'Souza, NJ (corresponding author), Deakin Univ, Fac Hlth, Geelong, Vic, Australia.	njdsouza@deakin.edu.au	; Orellana, Liliana/I-5249-2013	Lioret, Sandrine/0000-0002-2483-7820; Abbott, Gavin/0000-0003-4014-0705; Orellana, Liliana/0000-0003-3736-4337	Australian Research Council [DP140100554]; Deakin University Postgraduate Scholarship; Alfred Deakin Postdoctoral Research Fellowship; Australian Research Council Future Fellowship [FT130100637]	Australian Research Council(Australian Research Council); Deakin University Postgraduate Scholarship; Alfred Deakin Postdoctoral Research Fellowship; Australian Research Council Future Fellowship(Australian Research Council)	The HAPPY study was funded by an Australian Research Council Discovery Grant (DP140100554). NJD is supported by a Deakin University Postgraduate Scholarship, KLD is supported by an Alfred Deakin Postdoctoral Research Fellowship, KDH is supported by an Australian Research Council Future Fellowship (FT130100637).	Abbott G, 2016, J PHYS ACT HEALTH, V13, P269, DOI 10.1123/jpah.2015-0136; Beets MW, 2010, J PHYS ACT HEALTH, V7, P381, DOI 10.1123/jpah.7.3.381; Boone-Heinonen J, 2008, ANN BEHAV MED, V36, P217, DOI 10.1007/s12160-008-9074-3; Bucholz KK, 2000, ADDICTION, V95, P553, DOI 10.1046/j.1360-0443.2000.9545537.x; Cameron AJ, 2011, ANN EPIDEMIOL, V21, P95, DOI 10.1016/j.annepidem.2010.11.001; Carson V, 2016, J SCI MED SPORT, V19, P232, DOI 10.1016/j.jsams.2015.01.009; Chaput JP, 2017, OBES REV, V18, P7, DOI 10.1111/obr.12508; D'Souza NJ, 2020, OBES REV, V21, DOI 10.1111/obr.13029; Dinno A, 2009, STATA J, V9, P291, DOI 10.1177/1536867X0900900207; Dumuid D, 2018, PEDIATR OBES, V13, P111, DOI 10.1111/ijpo.12196; Fernandez-Alvira JM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-5; Gleason PM, 2015, J ACAD NUTR DIET, V115, P1072, DOI 10.1016/j.jand.2015.03.011; Gubbels Jessica S, 2013, Curr Nutr Rep, V2, P105; Gubbels JS, 2012, PUBLIC HEALTH NUTR, V15, P1402, DOI 10.1017/S1368980011003089; Halpin B., 2016, SOCIOLOGY DO SOCIOLOGY DO; Hayton JC, 2009, MULTIVAR BEHAV RES, V44, P389, DOI 10.1080/00273170902939033; Hearty AP, 2009, BRIT J NUTR, V101, P598, DOI 10.1017/S0007114508014128; Hinkley T, 2017, J PHYS ACT HEALTH, V14, P308, DOI 10.1123/jpah.2015-0700; Hinkley T, 2012, J SCI MED SPORT, V15, P407, DOI 10.1016/j.jsams.2011.12.009; Hoffmann K, 2004, AM J EPIDEMIOL, V159, P935, DOI 10.1093/aje/kwh134; Kovacs E, 2015, OBES REV, V16, P138, DOI 10.1111/obr.12349; Leech RM, 2015, INT J OBESITY, V39, P1079, DOI 10.1038/ijo.2015.66; Leech RM, 2014, EUR J CLIN NUTR, V68, P623, DOI 10.1038/ejcn.2013.295; Leech RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-4; Lioret S, 2008, J NUTR, V138, P101, DOI 10.1093/jn/138.1.101; Lioret S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030724; Lubans DR, 2011, OBES REV, V12, P781, DOI 10.1111/j.1467-789X.2011.00896.x; Magarey A, 2009, INT J PEDIATR OBES, V4, P257, DOI 10.3109/17477160902846161; Magee CA, 2013, J PAEDIATR CHILD H, V49, P291, DOI 10.1111/jpc.12163; Magidson J., 2002, CANADIAN J MARKETING, V20, P36, DOI DOI 10.1037/MET0000095; Mayne SL, 2020, PREV MED, V130, DOI 10.1016/j.ypmed.2019.105892; McAloney K, 2013, PREV MED, V56, P365, DOI 10.1016/j.ypmed.2013.03.002; Mihrshahi S, 2018, MED J AUSTRALIA, V209, P267, DOI 10.5694/mja18.00140; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Olds T, 2018, CHILD CARE HLTH DEV, V44, P117, DOI 10.1111/cch.12497; Parker KE, 2019, J SCI MED SPORT, V22, P319, DOI 10.1016/j.jsams.2018.08.015; Pronk NP, 2004, AM J PREV MED, V27, P25, DOI 10.1016/j.amepre.2004.04.022; Reedy J, 2010, AM J EPIDEMIOL, V171, P479, DOI 10.1093/aje/kwp393; Reilly JJ, 2008, ARCH DIS CHILD, V93, P614, DOI 10.1136/adc.2007.133272; Rodenburg G, 2013, APPETITE, V60, P123, DOI 10.1016/j.appet.2012.10.007; Seghers J, 2010, PUBLIC HEALTH NUTR, V13, P1838, DOI 10.1017/S1368980010000418; Sweetser P., 2012, AUST J EARLY CHILD, V37, P94, DOI DOI 10.1177/183693911203700413; Tein JY, 2013, STRUCT EQU MODELING, V20, P640, DOI 10.1080/10705511.2013.824781; Yannakoulia M, 2010, J PEDIATR-US, V157, P815, DOI 10.1016/j.jpeds.2010.04.077	45	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255203	10.1371/journal.pone.0255203	http://dx.doi.org/10.1371/journal.pone.0255203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TU	34314443	Green Published, gold			2022-12-26	WOS:000685225200041
J	Koob, C; Schropfer, K; Coenen, M; Kus, S; Schmidt, N				Koob, Clemens; Schroepfer, Kristina; Coenen, Michaela; Kus, Sandra; Schmidt, Nicole			Factors influencing study engagement during the COVID-19 pandemic: A cross-sectional study among health and social professions students	PLOS ONE			English	Article							WORK ENGAGEMENT; UNIVERSITY-STUDENTS; BURNOUT; LIFE; JOB	Background The aim of this study is to explore factors influencing the study engagement of health and social professions students during the COVID-19 pandemic. While antecedents of study engagement have been studied previously, the factors influencing engagement under pandemic conditions have not yet been investigated. Furthermore, there is a particular need for research among students in health and social professions programs, as these students are particularly affected by the pandemic. As theoretical basis, the study draws on the demands-resources-theory. It is hypothesized that pandemic-related study and personal resources drive engagement during the pandemic, and that pandemic-related demands negatively influence engagement. Method The study uses a cross-sectional survey to explore the hypothesized effects. The sample consists of 559 university students of health and social professions in Germany. The study was carried out in July 2020, towards the end of the first digital semester and after the first peak in COVID-19 cases. Data are analyzed using linear multiple regression analysis. Results The findings show that the demands-resources-theory is suitable to explain study engagement even under pandemic conditions. Suitable digital learning formats and social support are identified as important study resources for study engagement during major life events, while emotional resilience, active self-care and academic self-efficacy are identified as important personal resources. Conclusions Under pandemic conditions academic institutions should focus on providing beneficial teaching formats and innovative ways to support students lacking social networks. Besides, they should consider developing means to help students structuring daily life as well as establishing initiatives to strengthen students' self-efficacy beliefs.	[Koob, Clemens] Catholic Univ Appl Sci Munich, Dept Hlth & Nursing, Munich, Germany; [Schroepfer, Kristina; Coenen, Michaela; Kus, Sandra] Ludwig Maximilians Univ Munchen, Chair Publ Hlth & Hlth Serv Res, Dept Med Informat Proc Biometry & Epidemiol IBE, Munich, Germany; [Schroepfer, Kristina; Coenen, Michaela; Kus, Sandra] Pettenkofer Sch Publ Hlth, Munich, Germany; [Schmidt, Nicole] Catholic Univ Appl Sci Munich, Dept Social Work, Munich, Germany; [Schmidt, Nicole] Univ Hosp Geneva, Dept Gynecol & Obstet, Gynecol Div, Geneva, Switzerland	University of Munich; University of Geneva	Koob, C (corresponding author), Catholic Univ Appl Sci Munich, Dept Hlth & Nursing, Munich, Germany.	clemens.koob@ksh-m.de		Coenen, Michaela/0000-0001-7492-7907; Koob, Clemens/0000-0002-0291-6413				Al Omari O, 2019, J NURS MEAS, V27, P77, DOI 10.1891/1061-3749.27.1.77; Aristovnik A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12208438; Arndt C., 2020, ZWISCHEN NEUGIER VER, DOI [10.15480/882.3090, DOI 10.15480/882.3090]; Azila-Gbettor EM, 2021, J APPL RES HIGH EDUC, V13, P991, DOI 10.1108/JARHE-04-2020-0079; Bakker A.B., 2007, J MANAGE PSYCHOL, V22 (3), P309, DOI [10.1108/02683940710733115, DOI 10.1108/02683940710733115]; Bakker AB, 2007, J EDUC PSYCHOL, V99, P274, DOI 10.1037/0022-0663.99.2.274; Bakker AB, 2015, MOTIV EMOTION, V39, P49, DOI 10.1007/s11031-014-9422-5; Bakker AB, 2014, ANNU REV ORGAN PSYCH, V1, P389, DOI 10.1146/annurev-orgpsych-031413-091235; Bengel J., 2012, KOLN BZGA; Betsch C., 2020, GERMAN COVID 19 SNAP, DOI [10.23668/psycharchives.2904, DOI 10.23668/PSYCHARCHIVES.2904]; Betsch C., 2020, GERMAN COVID 19 SNAP, DOI [10.23668/psycharchives.3156, DOI 10.23668/PSYCHARCHIVES.3156, 10.23668/PSYCHARCHIVES.3156]; Binfet JT, 2018, J MENT HEALTH, V27, P197, DOI 10.1080/09638237.2017.1417551; Blayone T., 2018, INT J E LEARNING, V17, P425; Brand T., GESELLSCHAFTLICHER Z, P70; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Chen SQ, 2020, PSYCHOL TRAUMA-US, V12, pS51, DOI 10.1037/tra0000685; Cilliers JR, 2018, S AFR J HIGH EDUC, V32, P49, DOI 10.20853/32-1-1575; Cohen J.E., 1988, STAT POWER ANAL BEHA; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Drixler K, 2020, Z PSYCHOSOM MED PSYC, V66, P272, DOI 10.13109/zptm.2020.66.3.272; Edwards D, 2010, NURS EDUC TODAY, V30, P78, DOI 10.1016/j.nedt.2009.06.008; Elmer T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236337; Handel M, 2020, J RES TECHNOL EDUC, V54, P267, DOI 10.1080/15391523.2020.1846147; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hakanen JJ, 2006, J SCHOOL PSYCHOL, V43, P495, DOI 10.1016/j.jsp.2005.11.001; Hofmann Y., 2020, BETRAGE HOCHSCHULFOR, V42, P10; Hofmann Y., 2021, RESILIENZPOTENZIAL E, P32; Hughes MC, 2020, PEDAGOGY HEAL PROMOT, V6, P235, DOI 10.1177/2373379920950179; Islam MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238162; Judge TA, 2005, J APPL PSYCHOL, V90, P257, DOI 10.1037/0021-9010.90.2.257; Ketonen EE, 2019, LEARN INDIVID DIFFER, V69, P196, DOI 10.1016/j.lindif.2018.11.001; Klassen RM, 2018, PERSPECT MED EDUC, V7, P76, DOI 10.1007/s40037-018-0411-3; Kocalevent R-D., 2014, PSYCHOL SOZIAL WISSE, P43; Kocalevent RD, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0822-6; Lesener T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145183; Loscalzo Y, 2019, SOC INDIC RES, V142, P845, DOI 10.1007/s11205-018-1943-y; Luthans F, 2007, J MANAGE, V33, P321, DOI 10.1177/0149206307300814; Marcinowicz L, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0765-3; Marsh HW., 1992, LONGITUDINAL PERSPEC; Middendorff E., 2013, SOZIALERHEBUNG DTSCH, V20; Mottet TP, 2005, COMMUN RES REP, V22, P275, DOI 10.1080/000368105000317482; Nielsen TH, 2016, HEALTH ECON, V25, P497, DOI 10.1002/hec.3167; Persike M., 2016, SONDERAUSWERTUNG CHE; Podsakoff PM, 2012, ANNU REV PSYCHOL, V63, P539, DOI 10.1146/annurev-psych-120710-100452; Rautanen P, 2021, EUR J PSYCHOL EDUC, V36, P653, DOI 10.1007/s10212-020-00492-3; Rippe CB, 2021, J MARKET EDUC, V43, P260, DOI 10.1177/0273475320987287; RKI, COR SARS COV 2 7 TAG; Robins TG., 2015, AUSTRALASIAN J ORG P, V8, pE1, DOI [10.1017/orp.2014.7, DOI 10.1017/ORP.2014.7]; SALMELAARO K, 2017, BURNOUT RES, V0007; Satow L., 2012, STRESS COPING INVENT, DOI [10.23668/psycharchives.424, DOI 10.23668/PSYCHARCHIVES.424]; Schaufeli WB, 2002, J CROSS CULT PSYCHOL, V33, P464, DOI 10.1177/0022022102033005003; Schaufeli WB, 2017, ORGAN DYN, V46, P120, DOI 10.1016/j.orgdyn.2017.04.008; [Сорокин Михаил Юрьевич Sorokin M.Yu.], 2020, [Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, V.M. Bekhterev Review of Psychiatry and Medical Psychology, Obozrenie psikhiatrii i meditsinskoi psikhologii imeni V.M. Bekhtereva], P87, DOI 10.31363/2313-7053-2020-2-87-94; Statistisches Bundesamt (Destatis), REP FACHSERIE; Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2; van Grieken RA, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0331-7; Waldhauer J, 2018, BUNDESGESUNDHEITSBLA, V61, P374, DOI 10.1007/s00103-018-2704-4; Ware J.E., 2008, SF 36V2 HLTH SURVEY; Watkins R., 2008, PERFORM IMPROV Q, V17, P66, DOI [DOI 10.1111/J.1937-8327.2004.TB00321.X, 10.1111/j.1937-8327.2004.tb00321.x]; Weinstein N, 2009, J RES PERS, V43, P374, DOI 10.1016/j.jrp.2008.12.008; Wouters A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014779; Wurzer GM., 2016, STRESS COPING UBERPR; Xanthopoulou D., 2007, INT J STRESS MANAGE, V14, P121, DOI [10.1037/1072-5245.14.2.121, DOI 10.1037/10725245.14.2.121, DOI 10.1037/1072-5245.14.2.121]; Yu T, 2015, ONLINE LEARN, V19, P120; Zhang Q, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924994	65	12	12	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255191	10.1371/journal.pone.0255191	http://dx.doi.org/10.1371/journal.pone.0255191			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TU	34314450	gold, Green Published			2022-12-26	WOS:000685225200004
J	Yang, XD; Su, XY; Li, HL; Ma, RF; Qi, FJ; Cao, YE				Yang, Xiao-Dong; Su, Xin-Yi; Li, Hong-Li; Ma, Ren-Feng; Qi, Fang-Jie; Cao, Yue-E			Impacts of socio-economic determinants, spatial distance and climate factors on the confirmed cases and deaths of COVID-19 in China	PLOS ONE			English	Article							POPULATION; URBANIZATION; SPREAD; CORONAVIRUS; EPIDEMICS; MOBILITY	This study is to assess the influences of climate, socio-economic determinants, and spatial distance on the confirmed cases and deaths in the raise phase of COVID-19 in China. The positive confirmed cases and deaths of COVID-19 over the population size of 100,000 over every 5 consecutive days (the CCOPSPTT and DOPSPTT for short, respectively) covered from 25th January to 29th February, 2020 in five city types (i.e., small-, medium-, large-, very large- and super large-sized cities), along with the data of climate, socio-economic determinants, spatial distance of the target city to Wuhan city (DW, for short), and spatial distance between the target city and their local province capital city (DLPC, for short) were collected from the official websites of China. Then the above-mentioned influencing factors on CCOPSPTT and DOPSPTT were analyzed separately in Hubei and other provinces. The results showed that CCOPSPTT and DOPSPTT were significantly different among five city types outside Hubei province (p < 0.05), but not obviously different in Hubei province (p > 0.05). The CCOPSPTT had significant correlation with socio-economic determinants (GDP and population), DW, climate and time after the outbreak of COVID-19 outside Hubei province (p < 0.05), while was only significantly related with GDP in Hubei province (p < 0.05). The DOPSPTT showed significant correlation with socio-economic determinants, DW, time and CCOPSPTT outside Hubei province (p < 0.05), while was significantly correlated with GDP and CCOPSPTT in Hubei province (p < 0.05). Compared with other factors, socio-economic determinants have the largest relative contribution to variance of CCOPSPTT in all studied cities (> 78%). The difference of DOPSPTT among cities was mainly affected by CCOPSPTT. Our results showed that influences of city types on the confirmed cases and death differed between Hubei and other provinces. Socio-economic determinants, especially GDP, have higher impact on the change of COVID-19 transmission compared with other factors.	[Yang, Xiao-Dong; Su, Xin-Yi; Li, Hong-Li] Ningbo Univ, Dept Geog & Spatial Informat Tech, Ctr Land & Marine Spatial Utilizat & Governance R, Ningbo, Peoples R China; [Yang, Xiao-Dong; Li, Hong-Li] Ningbo Univ, Ningbo Univ Collaborat Innovat Ctr Land & Marine, Governance Res, Ningbo, Peoples R China; [Ma, Ren-Feng] Ningbo Univ, Inst East China Sea, Ningbo, Peoples R China; [Qi, Fang-Jie] Univ Newcastle, Global Ctr Environm Res, Adv Technol Ctr ATC Bldg, Fac Sci, Callaghan, NSW, Australia; [Qi, Fang-Jie] Univ Newcastle, Cooperat Res Ctr Contaminat Assessment & Remediat, Callaghan, NSW, Australia; [Cao, Yue-E] Shanghai Normal Univ, Sch Environm & Geog Sci, Shanghai, Peoples R China; [Cao, Yue-E] Xinjiang Univ, Inst Resources & Environm Sci, Urumqi, Peoples R China	Ningbo University; Ningbo University; Ningbo University; University of Newcastle; University of Newcastle; Shanghai Normal University; Xinjiang University	Cao, YE (corresponding author), Shanghai Normal Univ, Sch Environm & Geog Sci, Shanghai, Peoples R China.; Cao, YE (corresponding author), Xinjiang Univ, Inst Resources & Environm Sci, Urumqi, Peoples R China.	caoyuee@shu.edu.com	Ma, Renfeng/AAX-8655-2021	Ma, Renfeng/0000-0002-2987-5594	National Natural Science Foundation of China [41771174]; Natural Science Foundation of Ningbo [202003N4133]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Ningbo	This study was funded by National Natural Science Foundation of China to XDY (41871031; 31860111), National Natural Science Foundation of China to RFM (41771174), and Natural Science Foundation of Ningbo to XDY (202003N4133).	Alirol E, 2011, LANCET INFECT DIS, V11, P131, DOI 10.1016/S1473-3099(10)70223-1; Auler AC, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.139090; Aydogan Y., 2020, ARE COVID 19 CASES I, DOI [10.13140/RG.2.2.15986.66249/1, DOI 10.13140/RG.2.2.15986.66249/1]; Baidu, 2020, BIG DAT GLOB EP; Baker RE, 2020, SCIENCE, V369, P315, DOI 10.1126/science.abc2535; Bhadra A, 2021, MODEL EARTH SYST ENV, V7, P623, DOI 10.1007/s40808-020-00984-7; Calbi M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81780-w; Castillo-Chavez C, 2016, P NATL ACAD SCI USA, V113, P14582, DOI 10.1073/pnas.1604994113; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Copiello S, 2020, SCI TOTAL ENVIRON, V744, DOI 10.1016/j.scitotenv.2020.141028; Dalziel BD, 2018, SCIENCE, V362, P75, DOI 10.1126/science.aat6030; Deng XZ, 2008, J URBAN ECON, V63, P96, DOI 10.1016/j.jue.2006.12.006; Ding Y, 2020, SCI CHINA LIFE SCI, V63, P936, DOI 10.1007/s11427-020-1695-5; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Hassan MM, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13090194; Heibati B, 2021, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.605128; Hu H, 2013, MATH BIOSCI, V244, P125, DOI 10.1016/j.mbs.2013.04.013; Jiang YT, 2011, CHINA AGR ECON REV, V3, P297, DOI 10.1108/17561371111165752; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Lai J., 2020, **DATA OBJECT**; Liu JT, 2020, SCI TOTAL ENVIRON, V726, DOI 10.1016/j.scitotenv.2020.138513; Lu X, 2014, J ECONOMETRICS, V178, P194, DOI 10.1016/j.jeconom.2013.08.016; Luo W., 2020, MEDRXIV, DOI [10.1101/2020.02.12.20022467, DOI 10.1101/2020.02.12.20022467]; Maier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Neiderud Carl-Johan, 2015, Infection Ecology & Epidemiology, V5, P27060, DOI 10.3402/iee.v5.27060; NHC. National Health Commission of China, 2020, 2019 NCOV PREV CONTR; Paul R, 2020, J RURAL HEALTH, V36, P591, DOI 10.1111/jrh.12486; Pei Q, 2015, SOC SCI MED, V136, P73, DOI 10.1016/j.socscimed.2015.05.010; Prata DN, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138862; Qiu Y, 2020, J POPUL ECON, V33, P1127, DOI [10.1007/s00148-020-00778-2, 10.1101/2020.03.13.20035238]; Ribeiro HV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239699; Stier A., 2020, COVID 19 ATTACK RATE, DOI [10.1101/2020.03.22.20041004v2, DOI 10.1101/2020.03.22.20041004V2]; Stojkoski V., 2020, SOCIOECONOMIC DETERM; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Wei JT, 2020, INT J HYG ENVIR HEAL, V230, DOI 10.1016/j.ijheh.2020.113610; WHO, 2020, COR DIS COVID 19 SIT, V3, P30; Wu X, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd4049; Xie L, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244867; Xinhua, 2020, MOR MED ASS OFF HUB; Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5; Yang XD, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020484; Zhou XK, 2020, SCI CHINA LIFE SCI, V63, P1257, DOI 10.1007/s11427-020-1717-9; Zhu YJ, 2020, SCI TOTAL ENVIRON, V727, DOI 10.1016/j.scitotenv.2020.138704	50	5	5	11	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2021	16	7							e0255229	10.1371/journal.pone.0255229	http://dx.doi.org/10.1371/journal.pone.0255229			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TU	34314442	gold, Green Published			2022-12-26	WOS:000685225200034
J	Chen, PX; Li, S; Zhang, K; Zhao, RC; Cui, JF; Zhou, W; Liu, YC; Zhang, L; Cheng, YF				Chen, Pengxiang; Li, Song; Zhang, Ke; Zhao, Renchang; Cui, Jianfeng; Zhou, Wei; Liu, Yuchen; Zhang, Lin; Cheng, Yufeng			N-6-methyladenosine demethylase ALKBH5 suppresses malignancy of esophageal cancer by regulating microRNA biogenesis and RAI1 expression	ONCOGENE			English	Article							UP-REGULATION; NUCLEAR-RNA; METASTASIS; PROLIFERATION; TRANSITION; CARCINOMA; CELLS; YAP	N-6-Methyladenosine (m(6)A) is the most prevalent epigenetic RNA modification and is vital in regulating malignancies. The roles of m(6)A modifiers on noncoding RNAs have not been fully investigated in esophageal cancer. By screening all m(6)A modifiers, ALKBH5 was the most potent member related to patient outcomes and suppressing esophageal cancer malignancy in cell and animal models. It demethylated pri-miR-194-2 and inhibited miR-194-2 biogenesis through an m(6)A/DGCR8-dependent manner. RAI1, previously considered as a circadian clock transcriptional regulator, was the main target of miR-194-2. It enhanced transcription of Hippo pathway upstream genes by binding to their 3 ' UTR and suppressed YAP/TAZ nuclear translocation. The ALKBH5/miR-194-2/RAI1 axis was also validated in clinical samples. In addition, the increased malignancy by low ALKBH5 was abolished by the YAP inhibitor verteporfin. Our findings uncover a critical role of ALKBH5 in miRNAs biogenesis and provide novel insight for developing treatment strategies in esophageal cancer.	[Chen, Pengxiang; Zhou, Wei; Liu, Yuchen; Zhang, Lin; Cheng, Yufeng] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Radiat Oncol, Jinan, Peoples R China; [Chen, Pengxiang; Li, Song] Shandong Univ, Cheeloo Coll Med, Qilu Hosp, Lab Basic Med Sci, Jinan, Peoples R China; [Li, Song] Shandong Univ, Cheeloo Coll Med, Qilu Hosp, Dept Med Oncol, Jinan, Peoples R China; [Zhang, Ke] Shandong Univ, Cheeloo Coll Med, Qilu Hosp, Dept Gen Med, Jinan, Peoples R China; [Zhao, Renchang] Shandong Univ, Cheeloo Coll Med, Qilu Hosp, Thorac Surg Dept, Jinan, Peoples R China; [Cui, Jianfeng] Shandong Univ, Cheeloo Coll Med, Qilu Hosp, Dept Urol, Jinan, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Zhang, L; Cheng, YF (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Radiat Oncol, Jinan, Peoples R China.	linzhangsdu@163.com; yufengchengsdu@163.com	liu, yuchen/GYQ-6286-2022	Li, Song/0000-0002-5023-9111	National Natural Science Foundation of China [81773228, 81972850, 81601999]; Postdoctoral Science Foundation of China [2018M640637]; Special Fund for Taishan Scholar Project [ts20190973]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Special Fund for Taishan Scholar Project	Alexandra Marshall from Marshall Medical Communications provided editorial assistance during manuscript preparation. This study was supported by the National Natural Science Foundation of China (81773228 and 81972850 to Y.C.; 81601999 to L.Z.); Postdoctoral Science Foundation of China (2018M640637 to L.Z.), and Special Fund for Taishan Scholar Project (ts20190973 to Y.C.).	Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Barfield R, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz101; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Boone PM, 2011, AM J MED GENET A, V155A, P2024, DOI 10.1002/ajmg.a.34098; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen H, 2018, AM J RESP CELL MOL, V58, P391, DOI 10.1165/rcmb.2017-0237OC; Chen XY, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1033-z; Chen YH, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01239-w; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cui M, 2018, EXP THER MED, V15, P1048, DOI 10.3892/etm.2017.5492; Das R, 2017, CANCER RES, V77, P1021, DOI 10.1158/0008-5472.CAN-16-2529; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han B, 2020, NANOTOXICOLOGY, V14, P1, DOI 10.1080/17435390.2019.1661041; Han J, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1036-9; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hou HY, 2020, PATHOL RES PRACT, V216, DOI 10.1016/j.prp.2020.153087; Jaffrey SR, 2017, GENOME MED, V9, DOI 10.1186/s13073-016-0395-8; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Krzeszinski JY, 2014, NATURE, V512, P431, DOI 10.1038/nature13375; Lan Q, 2019, CANCER RES, V79, P1285, DOI 10.1158/0008-5472.CAN-18-2965; Li P, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0402-6; Liu JY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-349; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Ma JZ, 2017, HEPATOLOGY, V65, P529, DOI 10.1002/hep.28885; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Peng W, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1408-4; Qu Y, 2019, EXP THER MED, V18, P2993, DOI 10.3892/etm.2019.7896; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530; Shen C, 2020, CELL STEM CELL, V27, P64, DOI 10.1016/j.stem.2020.04.009; Song SM, 2014, CANCER RES, V74, P4170, DOI 10.1158/0008-5472.CAN-13-3569; Su XD, 2014, J THORAC DIS, V6, P949, DOI 10.3978/j.issn.2072-1439.2014.07.14; Tang B, 2020, MOL CANCER, V19, DOI 10.1186/s12943-019-1128-6; Thongon N, 2016, ONCOTARGET, V7, P26551, DOI 10.18632/oncotarget.8437; Wang C, 2016, BRIT J CANCER, V115, P1548, DOI 10.1038/bjc.2016.367; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wei HL, 2017, CANCER SCI, V108, P478, DOI 10.1111/cas.13138; Wu X, 2014, ONCOGENE, V33, P1506, DOI 10.1038/onc.2013.108; Xia TL, 2020, CANCER MANAG RES, V12, P5729, DOI 10.2147/CMAR.S245019; Yi YC, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01233-2; Zhang JL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09712-x; Zhang J, 2014, ONCOL REP, V31, P1157, DOI 10.3892/or.2013.2960; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049	49	10	10	4	19	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 16	2021	40	37					5600	5612		10.1038/s41388-021-01966-4	http://dx.doi.org/10.1038/s41388-021-01966-4		JUL 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UR2PS	34312488				2022-12-26	WOS:000678988300002
J	Chen, SW; Chou, SH; Tung, YC; Hsiao, FC; Ho, CT; Chan, YH; Wu, VCC; Chou, AH; Hsu, ME; Lin, PJ; Kao, WWY; Chu, PH				Chen, Shao-Wei; Chou, Shing-Hsien; Tung, Ying-Chang; Hsiao, Fu-Chih; Ho, Chien-Te; Chan, Yi-Hsin; Wu, Victor Chien-Chia; Chou, An-Hsun; Hsu, Ming-En; Lin, Pyng-Jing; Kao, Winston W. Y.; Chu, Pao-Hsien			Expression and role of lumican in acute aortic dissection: A human and mouse study	PLOS ONE			English	Article							PROTEOGLYCANS; ANEURYSMS	Introduction Aortic dissection (AD) is a life-threatening emergency, and lumican (LUM) is a potential Biomarker for AD diagnosis. We investigated LUM expression patterns in patients with AD and explored the molecular functions of Lum in AD mice model. Methods LUM expression patterns were analyzed using aortic tissues of AD patients, and serum soluble LUM (s-LUM) levels were compared between patients with acute AD (AAD) and chronic AD (CAD). Lum-knockout (Lum(-/-)) mice were challenged with beta-aminopropionitrile (BAPN) and angiotensin II (Ang II) to induce AD. The survival rate, AD incidence, and aortic aneurysm (AA) in these mice were compared with those in BAPN-Ang II-challenged wildtype (WT) mice. Tgf-beta/Smad2, Mmps, Lum, and Nox expression patterns were examined. Results LUM expression was detected in the intima and media of the ascending aorta in patients with AAD. Serum s-LUM levels were significantly higher in patients with AAD than CAD. Furthermore, AD-associated mortality and thoracic aortic rupture incidence were significantly higher in the Lum(-/-) AD mice than in the WT AD mice. However, no significant pathologic changes in AA were observed in the Lum(-/-) AD mice compared with the WT AD mice. The BAPN-Ang II-challenged WT and Lum(-/-) AD mice had higher Tgf-beta, p-Smad2, Mmp2, Mmp9, and Nox4 levels than those of non-AD mice. We also found that Lum expression was significantly higher in the BAPN-Ang II-challenged WT in comparison to the unchallenged WT mice. Conclusion LUM expression was altered in patients with AD display increased s-LUM in blood, and Lum(-/-) mice exhibited augmented AD pathogenesis. These findings support the notion that LUM is a biomarker signifying the pathogenesis of injured aorta seen in AAD. The presence of LUM is essential for maintenance of connective tissue integrity. Future studies should elucidate the mechanisms underlying LUM association in aortic changes.	[Chen, Shao-Wei; Hsu, Ming-En; Lin, Pyng-Jing] Chang Gung Univ, Chang Gung Mem Hosp, Div Thorac & Cardiovasc Surg, Linkou Med Ctr,Dept Surg, Taoyuan, Taiwan; [Chen, Shao-Wei] Chang Gung Mem Hosp, Ctr Big Data Analyt & Stat, Linkou Med Ctr, Taoyuan, Taiwan; [Chou, Shing-Hsien; Tung, Ying-Chang; Hsiao, Fu-Chih; Ho, Chien-Te; Chan, Yi-Hsin; Wu, Victor Chien-Chia; Chu, Pao-Hsien] Chang Gung Mem Hosp, Dept Cardiol, Linkou Med Ctr, Taoyuan, Taiwan; [Chou, An-Hsun; Hsu, Ming-En] Chang Gung Univ, Chang Gung Mem Hosp, Dept Anesthesiol, Linkou Med Ctr, Taoyuan, Taiwan; [Kao, Winston W. Y.] Univ Cincinnati, Dept Ophthalmol, Coll Med, Crawley Vis Res Ctr, Cincinnati, OH USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; University System of Ohio; University of Cincinnati	Chu, PH (corresponding author), Chang Gung Mem Hosp, Dept Cardiol, Linkou Med Ctr, Taoyuan, Taiwan.	taipei.chu@gmail.com	Chan, Yi-Hsin/ABA-5023-2021; Wu, Victor Chien-Chia/GXF-4623-2022; Wu, Victor Chien-Chia/ABB-6872-2021	Wu, Victor Chien-Chia/0000-0002-9918-4369; Wu, Victor Chien-Chia/0000-0002-9918-4369; Hsiao, Fu-Chih/0000-0002-1032-4979; Chan, Yi-Hsin/0000-0002-1406-8503	Chang Gung Memorial Hospital, Taiwan [CMRPG3K1951, CMRPG3J0661, BMRPD95, CMRPG5K0011, CMRPG3K0931]; Ministry of Science and Technology [MOST-108-2314-B-182A-141, MOST-1062314-B-182A-115-MY3]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by a grant from Chang Gung Memorial Hospital, Taiwan CMRPG3K1951, CMRPG3J0661, BMRPD95 (SWC), CMRPG5K0011 (CTH), CMRPG3K0931 (SHC). This work was also supported by the Ministry of Science and Technology grant Most MOST-108-2314-B-182A-141 (SWC), MOST-1062314-B-182A-115-MY3 (PHC).	Brezillon S, 2013, FEBS J, V280, P2369, DOI 10.1111/febs.12210; Chen SW, 2017, BIOCHEM BIOPH RES CO, V482, P1304, DOI 10.1016/j.bbrc.2016.12.033; Fan LM, 2014, CIRCULATION, V129, P2661, DOI 10.1161/CIRCULATIONAHA.113.005062; Fassot C, 2008, J HYPERTENS, V26, P747, DOI 10.1097/HJH.0b013e3282f4b3d0; Fischer JW, 2004, ARTERIOSCL THROM VAS, V24, P2391, DOI 10.1161/01.ATV.0000147029.63303.28; Gu GR, 2016, EXP THER MED, V11, P923, DOI 10.3892/etm.2016.3020; Gu GR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/920763; Heegaard AM, 2007, CIRCULATION, V115, P2731, DOI 10.1161/CIRCULATIONAHA.106.653980; Hsieh LTH, 2016, MATRIX BIOL, V49, P61, DOI 10.1016/j.matbio.2015.12.005; Hultgardh-Nilsson A, 2015, J INTERN MED, V278, P447, DOI 10.1111/joim.12400; Jiang YF, 2019, INTERACT CARDIOV TH, V28, P344, DOI 10.1093/icvts/ivy256; Jones JA, 2009, J VASC RES, V46, P119, DOI 10.1159/000151766; Kanematsu Y, 2010, HYPERTENSION, V55, P1267, DOI 10.1161/HYPERTENSIONAHA.109.140558; Kurihara T, 2012, CIRCULATION, V126, P3070, DOI 10.1161/CIRCULATIONAHA.112.097097; Maguire EM, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12030118; Meester JAN, 2017, GENET MED, V19, P386, DOI 10.1038/gim.2016.126; Mussa FF, 2016, JAMA-J AM MED ASSOC, V316, P754, DOI 10.1001/jama.2016.10026; Nienaber CA, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.53, 10.1038/nrdp.2016.71]; Onda M, 2002, EXP MOL PATHOL, V72, P142, DOI 10.1006/exmp.2002.2425; Pape LA, 2015, J AM COLL CARDIOL, V66, P350, DOI 10.1016/j.jacc.2015.05.029; Pedroza AJ, 2020, ARTERIOSCL THROM VAS, V40, P2195, DOI 10.1161/ATVBAHA.120.314670; Pietraszek K, 2014, FEBS LETT, V588, P4319, DOI 10.1016/j.febslet.2014.09.040; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Stasiak M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150226; Talusan P, 2005, MOL CELL PROTEOMICS, V4, P1350, DOI 10.1074/mcp.M500088-MCP200; Tang TT, 2020, CLIN CHIM ACTA, V501, P222, DOI 10.1016/j.cca.2019.10.042; Wu D, 2013, J SURG RES, V184, P907, DOI 10.1016/j.jss.2013.06.007; Xiao ZY, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6421451; Yang CJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219461	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0255238	10.1371/journal.pone.0255238	http://dx.doi.org/10.1371/journal.pone.0255238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UA5TN	34310653	gold, Green Published			2022-12-26	WOS:000685224500038
J	Shuang, L; Chen, XM; Shang, J				Shuang, Liu; Ximing, Chen; Jie, Shang			Research on the degree of coupling of the Internet development level and agricultural--Ecological efficiency based on 2009-2018 data from 13 major grain-producing areas in China	PLOS ONE			English	Article							FACTOR ENERGY EFFICIENCY; ENVIRONMENTAL EFFICIENCY; SECTORS; GROWTH; SYSTEM; THINGS; MODEL	Agricultural informatization and agricultural green development are important components of modern agricultural development, and coordination between the two is an important foundation for achieving sustainable agricultural development. This paper uses data from the 13 major grain producing areas in China from 2009 to 2018 to analyze the coordination of the Internet development level and the agricultural ecological-efficiency, and it further investigates the degree of coupling and coordination between the two. The results of theis study are as follows.(1) The Internet development level of China's 13 main grain production areas has been continuously improving. The average Internet penetration rate increased from 0.25 in 2008 to 0.54 in 2018. (2) The agricultural ecological efficiency of China's main grain production areas has gradually improved. The average value of agricultural ecological efficiency increased from 0.45 in 2009 to 0.79 in 2018. (3) The Internet development level in China's main grain production areas and the continuous improvement of coordination and degree of coupling of the agricultural ecological efficiency show that the interaction between them has led to continuous improvements in the agricultural informatization development and agricultural green development. However, the coordination between the two still has significant room for growth, and there is a certain gap between the different regions.	[Shuang, Liu; Ximing, Chen; Jie, Shang] Northeast Forestry Univ, Sch Econ & Management, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China	Shang, J (corresponding author), Northeast Forestry Univ, Sch Econ & Management, Harbin, Heilongjiang, Peoples R China.	shangjie2005@126.com		Chen, Ximing/0000-0001-6583-1030				Chang YT, 2013, ENERG POLICY, V58, P277, DOI 10.1016/j.enpol.2013.03.011; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Chen JD, 2020, J CLEAN PROD, V276, DOI 10.1016/j.jclepro.2020.123848; Chen JD, 2018, RENEW SUST ENERG REV, V94, P748, DOI 10.1016/j.rser.2018.06.050; Coluccia B, 2020, ECOL INDIC, V116, DOI 10.1016/j.ecolind.2020.106483; Dai MH, 2020, SUSTAIN COMPUT-INFOR, V28, DOI 10.1016/j.suscom.2020.100420; Dong FG, 2021, J CLEAN PROD, V283, DOI 10.1016/j.jclepro.2020.124633; dos Santos UJL, 2019, COMPUT ELECTRON AGR, V161, P202, DOI 10.1016/j.compag.2018.10.010; Fahad Aldosari, 2019, Journal of the Saudi Society of Agricultural Sciences, V18, P211, DOI 10.1016/j.jssas.2017.05.004; Gan L, 2020, SUSTAIN CITIES SOC, V58, DOI 10.1016/j.scs.2020.102136; Gao Y, 2020, J RURAL STUD, V76, P173, DOI 10.1016/j.jrurstud.2020.04.016; Han HB, 2020, J CLEAN PROD, V250, DOI 10.1016/j.jclepro.2019.119511; Han HB, 2018, ENVIRON SCI POLLUT R, V25, P32096, DOI 10.1007/s11356-018-3142-4; He Q, 2018, J CLEAN PROD, V176, P1091, DOI 10.1016/j.jclepro.2017.11.220; Heller MC, 2003, AGR SYST, V76, P1007, DOI 10.1016/S0308-521X(02)00027-6; [侯孟阳 Hou Mengyang], 2018, [资源科学, Resources Science], V40, P2475; Hu AG., 2016, J NATL ACAD ADM, P4; Huang ML., 2018, J HUAZHONG AGR U SOC, P37; Kaloxylos A, 2013, PROC TECH, V8, P51, DOI 10.1016/j.protcy.2013.11.009; Konefal J, 2019, RENEW AGR FOOD SYST, V34, P293, DOI 10.1017/S1742170517000461; [赖斯芸 Lai Siyun], 2004, [清华大学学报. 自然科学版, Journal of Tsinghua University(Science and Technology)], V44, P1184; Lai ZZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228426; Lin BQ, 2016, ECOL INDIC, V70, P480, DOI 10.1016/j.ecolind.2016.06.026; Liu PH, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105162; Liu YS, 2018, LAND USE POLICY, V74, P5, DOI 10.1016/j.landusepol.2017.07.005; [刘彦随 Liu Yansui], 2018, [地理学报, Acta Geographica Sinica], V73, P203; Liu ZJ, 2018, ECOL INDIC, V95, P370, DOI 10.1016/j.ecolind.2018.07.063; Lu H, 2018, J ENVIRON MANAGE, V207, P134, DOI 10.1016/j.jenvman.2017.11.033; Marshall A, 2020, J RURAL STUD, V80, P195, DOI 10.1016/j.jrurstud.2020.09.001; Pena CR, 2018, J CLEAN PROD, V197, P699, DOI 10.1016/j.jclepro.2018.06.227; Picazo-Tadeo AJ, 2011, J ENVIRON MANAGE, V92, P1154, DOI 10.1016/j.jenvman.2010.11.025; Sankar S, 2020, SUSTAIN COMPUT-INFOR, V28, DOI 10.1016/j.suscom.2020.100422; Schaltegger S., 1990, UNTERNEHMUNG, V44, P273; Shang Y, 2020, J KING SAUD UNIV SCI, V32, P1925; Shen Qiang, 2018, Information Processing in Agriculture, V5, P394, DOI 10.1016/j.inpa.2018.05.005; Shen ZY, 2018, CHINA ECON REV, V51, P83, DOI 10.1016/j.chieco.2018.04.014; Shi T, 2020, J CLEAN PROD, V244, DOI 10.1016/j.jclepro.2019.118739; Tone K, 2001, EUR J OPER RES, V130, P498, DOI 10.1016/S0377-2217(99)00407-5; Vuran MC, 2018, AD HOC NETW, V81, P160, DOI 10.1016/j.adhoc.2018.07.017; Wang B., 2018, CHIN RURAL EC, P46; [汪东芳 Wang Dongfang], 2019, [中国人口·资源与环境, China Population Resources and Environment], V29, P86; [吴小庆 Wu Xiaoqing], 2012, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V21, P714; Zhang L, 2019, SCI TOTAL ENVIRON, V665, P1017, DOI 10.1016/j.scitotenv.2019.02.162; Zou LL, 2020, J ENVIRON MANAGE, V263, DOI 10.1016/j.jenvman.2020.110400	44	5	5	23	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 26	2021	16	7							e0254078	10.1371/journal.pone.0254078	http://dx.doi.org/10.1371/journal.pone.0254078			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UA5TN	34310597	gold, Green Published			2022-12-26	WOS:000685224500019
J	Graham, KE; Buryn-Weitzel, JC; Lahiff, NJ; Wilke, C; Slocombe, KE				Graham, Kirsty E.; Buryn-Weitzel, Joanna C.; Lahiff, Nicole J.; Wilke, Claudia; Slocombe, Katie E.			Detecting joint attention events in mother-infant dyads: Sharing looks cannot be reliably identified by naive third-party observers	PLOS ONE			English	Article							SOCIAL-COMMUNICATION INTERVENTION; YOUNG-CHILDREN; INDIVIDUAL-DIFFERENCES; DEVELOPMENTAL-DISABILITIES; MEDIATED INTERVENTION; MULTIPLE DISABILITIES; COGNITIVE SKILLS; SYMBOLIC PLAY; LANGUAGE; ENGAGEMENT	Joint attention, or sharing attention with another individual about an object or event, is a critical behaviour that emerges in pre-linguistic infants and predicts later language abilities. Given its importance, it is perhaps surprising that there is no consensus on how to measure joint attention in prelinguistic infants. A rigorous definition proposed by Siposova & Carpenter (2019) requires the infant and partner to gaze alternate between an object and each other (coordination of attention) and exchange communicative signals (explicit acknowledgement of jointly sharing attention). However, Hobson and Hobson (2007) proposed that the quality of gaze between individuals is, in itself, a sufficient communicative signal that demonstrates sharing of attention. They proposed that observers can reliably distinguish "sharing", "checking", and "orienting" looks, but the empirical basis for this claim is limited as their study focussed on two raters examining looks from 11-year-old children. Here, we analysed categorisations made by 32 naive raters of 60 infant looks to their mothers, to examine whether they could be reliably distinguished according to Hobson and Hobson's definitions. Raters had overall low agreement and only in 3 out of 26 cases did a significant majority of the raters agree with the judgement of the mother who had received the look. For the looks that raters did agree on at above chance levels, look duration and the overall communication rate of the mother were identified as cues that raters may have relied upon. In our experiment, naive third party observers could not reliably determine the type of look infants gave to their mothers, which indicates that subjective judgements of types of look should not be used to identify mutual awareness of sharing attention in infants. Instead, we advocate the use of objective behaviour measurement to infer that interactants know they are 'jointly' attending to an object or event, and believe this will be a crucial step in understanding the ontogenetic and evolutionary origins of joint attention.	[Graham, Kirsty E.; Buryn-Weitzel, Joanna C.; Lahiff, Nicole J.; Wilke, Claudia; Slocombe, Katie E.] Univ York, Dept Psychol, York, N Yorkshire, England; [Graham, Kirsty E.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of York - UK; University of St Andrews	Graham, KE (corresponding author), Univ York, Dept Psychol, York, N Yorkshire, England.; Graham, KE (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	keg4@st-andrews.ac.uk	Graham, Kirsty Emma/AEP-6283-2022	Graham, Kirsty Emma/0000-0002-7422-7676; Buryn-Weitzel, Joanna Christiane/0000-0002-6014-4116	European Research Council [ERC_CoG 2016_724608]	European Research Council(European Research Council (ERC)European Commission)	This study was funded by an European Research Council Consolidator grant (ERC_CoG 2016_724608) awarded to KS (https://erc.europa.eu/funding/consolidator-grants).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarne P, 2010, J PRAGMATICS, V42, P3106, DOI 10.1016/j.pragma.2010.04.017; Adamson LB, 2019, CHILD DEV, V90, pe1, DOI 10.1111/cdev.12973; Adamson LB, 2010, J SPEECH LANG HEAR R, V53, P1769, DOI 10.1044/1092-4388(2010/09-0208); Adamson LB, 2010, J AUTISM DEV DISORD, V40, P665, DOI 10.1007/s10803-009-0914-1; Adamson LB, 2009, J AUTISM DEV DISORD, V39, P84, DOI 10.1007/s10803-008-0601-7; Aldrich NJ, 2015, INFANT BEHAV DEV, V41, P127, DOI 10.1016/j.infbeh.2015.08.005; Allely CS, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-147; Arens K, 2005, EDUC TRAIN DEV DISAB, V40, P158; Arnold A, 2000, J INTELLECT DEV DIS, V25, P207, DOI 10.1080/13269780050144271; BAKEMAN R, 1984, CHILD DEV, V55, P1278, DOI 10.2307/1129997; Bard KA, 2014, DEVELOPMENTAL SCI, V17, P682, DOI 10.1111/desc.12145; Bard KA, 2009, LEARNING FROM ANIMALS: EXAMINING THE NATURE OF HUMAN UNIQUENESS, P89; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benigno JP, 2007, J CHILD LANG, V34, P175, DOI 10.1017/S0305000906007732; Benigno JP, 2012, INFANT CHILD DEV, V21, P160, DOI 10.1002/icd.743; Bigelow AE, 2004, DEVELOPMENTAL SCI, V7, P518, DOI 10.1111/j.1467-7687.2004.00375.x; Bigelow AE, 2003, DEV PSYCHOPATHOL, V15, P259, DOI 10.1017/S0954579403000142; Bigelow AE, 2010, INFANT BEHAV DEV, V33, P50, DOI 10.1016/j.infbeh.2009.10.009; Brune CW, 2007, J COGN DEV, V8, P133, DOI 10.1080/15248370701202331; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; CARPENTER M, 1995, SOC DEV, V4, P217, DOI 10.1111/j.1467-9507.1995.tb00063.x; Charman T, 2000, COGNITIVE DEV, V15, P481, DOI 10.1016/S0885-2014(01)00037-5; Charman T, 2003, INT J LANG COMM DIS, V38, P265, DOI 10.1080/136820310000104830; Chiang CH, 2016, AUTISM, V20, P172, DOI 10.1177/1362361315575725; Childers JB, 2007, J CHILD LANG, V34, P199, DOI 10.1017/S0305000906007835; Christidou D, 2018, LEARN CULT SOC INTER, V19, P1, DOI 10.1016/j.lcsi.2018.03.008; Cleveland A, 2007, INFANT BEHAV DEV, V30, P499, DOI 10.1016/j.infbeh.2006.10.009; Clifford S, 2009, J AUTISM DEV DISORD, V39, P1369, DOI 10.1007/s10803-009-0748-x; Clifford SM, 2008, J AUTISM DEV DISORD, V38, P791, DOI 10.1007/s10803-007-0444-7; Conboy BT, 2015, DEV NEUROPSYCHOL, V40, P216, DOI 10.1080/87565641.2015.1014487; Craig TKJ, 2004, PSYCHOL MED, V34, P199, DOI 10.1017/S0033291703001120; Cress CJ, 2007, EDUC TRAIN DEV DISAB, V42, P152; de la Ossa JL, 2001, INT J BEHAV DEV, V25, P176, DOI 10.1080/01650250042000168; Depowski N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01556; Gaffan EA, 2010, SOC DEV, V19, P369, DOI 10.1111/j.1467-9507.2008.00533.x; Gauthier K, 2013, APPL PSYCHOLINGUIST, V34, P337, DOI 10.1017/S0142716411000725; Gonsiorowski A, 2016, J AUTISM DEV DISORD, V46, P691, DOI 10.1007/s10803-015-2596-1; Grossmann T, 2010, BIOL LETTERS, V6, P540, DOI 10.1098/rsbl.2009.1069; Gulsrud AC, 2007, AUTISM, V11, P535, DOI 10.1177/1362361307083255; Gulsrud AC, 2016, J CHILD PSYCHOL PSYC, V57, P606, DOI 10.1111/jcpp.12481; Hahn LJ, 2016, J SPEECH LANG HEAR R, V59, P1087, DOI 10.1044/2016_JSLHR-L-15-0005; Henderson EN, 2003, INFANCY, V4, P27, DOI 10.1207/S15327078IN0401_2; Hobson JA, 2007, DEV PSYCHOPATHOL, V19, P411, DOI 10.1017/S0954579407070204; Hughes ME, 2013, J PRAGMATICS, V56, P15, DOI 10.1016/j.pragma.2013.05.005; Ine H, 2011, RES DEV DISABIL, V32, P491, DOI 10.1016/j.ridd.2010.12.034; Ingersoll B, 2006, J AUTISM DEV DISORD, V36, P487, DOI 10.1007/s10803-006-0089-y; Johnson KC, 2008, OTOL NEUROTOL, V29, P246, DOI 10.1097/mao.0b013e318162f1f3; Kasari C, 2010, J AUTISM DEV DISORD, V40, P1045, DOI 10.1007/s10803-010-0955-5; Ketelaar L, 2012, J PEDIATR PSYCHOL, V37, P1041, DOI 10.1093/jpepsy/jss086; Kompatsiari K, 2018, SCI REP, V8, P1; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Landry SH, 2008, DEV PSYCHOL, V44, P1335, DOI 10.1037/a0013030; Larkin F, 2015, CLIN CHILD PSYCHOL P, V20, P239, DOI 10.1177/1359104513514065; Legerstee M, 2007, INFANT BEHAV DEV, V30, P296, DOI 10.1016/j.infbeh.2006.10.003; Macdonald RG, 2018, Q J EXP PSYCHOL, V71, P2162, DOI 10.1177/1747021817739221; Markus J, 2000, SOC DEV, V9, P302, DOI 10.1111/1467-9507.00127; Mastin JD, 2016, J CHILD LANG, V43, P235, DOI 10.1017/S0305000915000148; Matatyaho DJ, 2008, INFANCY, V13, P172, DOI 10.1080/15250000701795655; Moore C., 1995, JOINT ATTENTION ITS; Morales M, 2005, INT J BEHAV DEV, V29, P259, DOI 10.1080/01650250444000432; Morgan B, 2003, DEV PSYCHOL, V39, P646, DOI 10.1037/0012-1649.39.4.646; Najnin S, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00005; Neerinckx H, 2014, J INTELL DISABIL RES, V58, P721, DOI 10.1111/jir.12067; Nelson PB, 2008, DEVELOPMENTAL SCI, V11, P847, DOI 10.1111/j.1467-7687.2008.00733.x; Nielsen M, 2017, J EXP CHILD PSYCHOL, V162, P31, DOI 10.1016/j.jecp.2017.04.017; Nordahl-Hansen A, 2016, RES AUTISM SPECT DIS, V29-30, P19, DOI 10.1016/j.rasd.2016.05.005; Nowakowski ME, 2012, CLIN PEDIATR, V51, P1032, DOI 10.1177/0009922812441670; Nowakowski ME, 2011, CHILD PSYCHIAT HUM D, V42, P78, DOI 10.1007/s10578-010-0208-z; Nowakowski ME, 2009, AM ANN DEAF, V154, P15, DOI 10.1353/aad.0.0071; Pierce L, 2015, APPL PSYCHOLINGUIST, V36, P1223, DOI 10.1017/S0142716414000125; Pitman CA, 2009, J COMP PSYCHOL, V123, P334, DOI 10.1037/a0015840; Povis KT, 2015, VISIT STUD, V18, P168, DOI 10.1080/10645578.2015.1079095; R Core Team, R LANG ENV STAT COMP; Rice CE, 2016, TOP LANG DISORD, V36, P245, DOI 10.1097/TLD.0000000000000099; Richardson DC, 2007, PSYCHOL SCI, V18, P407, DOI 10.1111/j.1467-9280.2007.01914.x; Roy P, 2014, RES DEV DISABIL, V35, P2534, DOI 10.1016/j.ridd.2014.06.014; Sanefuji W, 2009, INFANT MENT HEALTH J, V30, P145, DOI 10.1002/imhj.20208; Saxon TF, 2000, J SCHOOL PSYCHOL, V38, P9, DOI 10.1016/S0022-4405(99)00034-5; Schechter DS, 2010, PSYCHIATRY, V73, P130, DOI 10.1521/psyc.2010.73.2.130; Schertz HH, 2018, J EARLY INTERVENTION, V40, P20, DOI 10.1177/1053815117737353; Schertz HH, 2004, J EARLY INTERVENTION, V27, P42, DOI 10.1177/105381510402700104; Shire SY, 2016, J AUTISM DEV DISORD, V46, P1737, DOI 10.1007/s10803-016-2702-z; Siposova B, 2019, COGNITION, V189, P260, DOI 10.1016/j.cognition.2019.03.019; Skarabela B, 2007, LINGUA, V117, P1837, DOI 10.1016/j.lingua.2006.11.010; Skarabela B, 2010, PROC ANN BUCLD, P385; Slaughter V, 2008, INFANCY, V13, P640, DOI 10.1080/15250000802458807; Smith JL, 2009, AUGMENT ALTERN COMM, V25, P165, DOI 10.1080/07434610902972410; Spector V, 2018, J AUTISM DEV DISORD, V48, P1508, DOI 10.1007/s10803-017-3404-x; Striano T, 2005, BRIT J DEV PSYCHOL, V23, P559, DOI 10.1348/026151005X26282; Striano T, 2005, COGNITION EMOTION, V19, P781, DOI 10.1080/02699930541000002; Striano T, 2009, EUR J DEV PSYCHOL, V6, P567, DOI 10.1080/17405620701480642; Suma K, 2016, J AUTISM DEV DISORD, V46, P2720, DOI 10.1007/s10803-016-2808-3; Sung JH, 2009, INT J BEHAV DEV, V33, P430, DOI 10.1177/0165025409338443; Tasker SL, 2008, DEV REV, V28, P263, DOI 10.1016/j.dr.2007.07.001; Tasker SL, 2010, J DEV PHYS DISABIL, V22, P509, DOI 10.1007/s10882-010-9189-x; TOMASELLO M, 1986, CHILD DEV, V57, P1454, DOI 10.2307/1130423; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Trautman CH, 2006, APPL PSYCHOLINGUIST, V27, P447, DOI 10.1017/S0142716406060358; Vismara LA, 2018, FOCUS AUTISM DEV DIS, V33, P67, DOI 10.1177/1088357616651064; Walberg JL, 2010, EDUC TRAIN AUTISM DE, V45, P69; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Yazbek A, 2006, BRIT J DEV PSYCHOL, V24, P589, DOI 10.1348/026151005X67539; Yont KM, 2003, APPL PSYCHOLINGUIST, V24, P581, DOI 10.1017/S0142716403000298; Yoon SA, 2014, J GENET PSYCHOL, V175, P494, DOI 10.1080/00221325.2014.964170; Yu C, 2017, CHILD DEV, V88, P2060, DOI 10.1111/cdev.12730; Yu C, 2017, COGNITIVE SCI, V41, P5, DOI 10.1111/cogs.12366; Yu C, 2016, CURR BIOL, V26, P1235, DOI 10.1016/j.cub.2016.03.026; Yu CC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056667, 10.1371/journal.pone.0054627]; Zampini L, 2015, J INTELL DISABIL RES, V59, P891, DOI 10.1111/jir.12191	112	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0255241	10.1371/journal.pone.0255241	http://dx.doi.org/10.1371/journal.pone.0255241			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TQ2PW	34297777	Green Published, gold, Green Accepted			2022-12-26	WOS:000678128300017
J	Keil, R; Hlava, S; Stanovsky, P; Zdimal, V; Stovicek, J; Trojanek, M; Drabek, J; Frybova, B; Petracek, V; Wasserbauer, M				Keil, Radan; Hlava, Stepan; Stanovsky, Petr; Zdimal, Vladimir; Stovicek, Jan; Trojanek, Milan; Drabek, Jiri; Frybova, Barbora; Petracek, Vojtech; Wasserbauer, Martin			Commonly available but highly effective protection against SARS-CoV-2 during gastrointestinal endoscopies	PLOS ONE			English	Article							N95 RESPIRATORS; INFLUENZA; COVID-19; MASKS	Background and aims SARS-CoV-2 is a worldwide serious health problem. The aim of this study was to demonstrate the number of potentially infectious particles present during endoscopic procedures and find effective tools to eliminate the risks of SARS-CoV-2 infection while performing them. Methods An experimental model which focused on aerosol problematics was made in a specialized laboratory. This model simulated conditions present during endoscopic procedures and monitored the formation of potentially infectious fluid particles from the patient's body, which pass through the endoscope and are then released into the environment. For this reason, we designed and tested a prototype of a protective cover for the endoscope's control body to prevent the release and spread of these fluid particles from its working channel. We performed measurements with and without the protective cover of the endoscope's control body. Results It was found that liquid coming through the working channel of the endoscope with forceps or other instruments inside generates droplets with a diameter in the range of 0.1-1.1 mm and an initial velocity of up to 0.9 m/s. The average number of particles per measurement per whole measured area without a protective cover on the endoscope control body was 51.1; with this protective cover on, the measurement was 0.0, pConclusions Our measurements proved that fluid particles are released from the working channel of an endoscope when forceps are inserted. A special protective cover for the endoscope control body, made out of breathable material (surgical cap) and designed by our team, was found to eliminate this release of potentially infectious fluid particles.	[Keil, Radan; Hlava, Stepan; Stovicek, Jan; Drabek, Jiri; Wasserbauer, Martin] Charles Univ Prague, Dept Internal Med, Fac Med 2, Prague, Czech Republic; [Keil, Radan; Hlava, Stepan; Stovicek, Jan; Drabek, Jiri; Wasserbauer, Martin] Motol Univ Hosp, Prague, Czech Republic; [Stanovsky, Petr; Zdimal, Vladimir] Czech Acad Sci, Inst Chem Proc Fundamentals, Prague, Czech Republic; [Trojanek, Milan] Charles Univ Prague, Med Fac 2, Dept Infect Dis 1, Prague, Czech Republic; [Trojanek, Milan] Hosp Na Bulovce, Prague, Czech Republic; [Frybova, Barbora] Charles Univ Prague, Fac Med 2, Dept Pediat Surg, Prague, Czech Republic; [Frybova, Barbora] Univ Hosp Motol, Prague, Czech Republic; [Petracek, Vojtech] Czech Tech Univ, Fac Nucl Sci & Phys Engn, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Czech Academy of Sciences; Institute of Chemical Process Fundamentals of the Czech Academy of Sciences; Charles University Prague; Bulovka University Hospital; Charles University Prague; Motol University Hospital; Czech Technical University Prague	Wasserbauer, M (corresponding author), Charles Univ Prague, Dept Internal Med, Fac Med 2, Prague, Czech Republic.; Wasserbauer, M (corresponding author), Motol Univ Hosp, Prague, Czech Republic.	martin.wasserbauer@fnmotol.cz	Stanovsky, Petr/A-2656-2013; Trojanek, Milan/AAK-7890-2020	Stanovsky, Petr/0000-0002-2944-6765; Trojanek, Milan/0000-0003-1488-6546	Ministry of Health, Czech Republic [00064203]	Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government)	The study was supported by Ministry of Health, Czech Republic - conceptual development of research organization, Motol University Hospital, Prague, Czech Republic 00064203.	Bahl P, 2022, J INFECT DIS, V225, P1561, DOI 10.1093/infdis/jiaa189; Bar-On YM, 2020, ELIFE, V9, DOI 10.7554/eLife.57309; Biggerstaff M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-480; Chan SM, 2020, GASTROENTEROLOGY, V159, P1949, DOI 10.1053/j.gastro.2020.07.002; Chou R, 2020, ANN INTERN MED, V173, P120, DOI 10.7326/M20-1632; De Grazia F, 2020, ENDOSCOPY, V52, P1146, DOI 10.1055/a-1206-0937; Gralnek IM, 2020, ENDOSCOPY, V52, P891, DOI 10.1055/a-1213-5761; Gralnek IM, 2020, NAT REV GASTRO HEPAT, V17, P444, DOI 10.1038/s41575-020-0312-x; Gralnek IM, 2020, ENDOSCOPY, V52, P483, DOI 10.1055/a-1155-6229; Gu JY, 2020, GASTROENTEROLOGY, V158, P1518, DOI 10.1053/j.gastro.2020.02.054; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Iqbal A, 2008, SURG ENDOSC, V22, P2571, DOI 10.1007/s00464-008-0080-0; Johnston ER, 2019, GASTROINTEST ENDOSC, V89, P818, DOI 10.1016/j.gie.2018.10.034; Ljubicic N, 2020, GASTROINTEST ENDOSC, V92, P428, DOI 10.1016/j.gie.2020.04.020; Long YL, 2020, J EVID-BASED MED, V13, P93, DOI 10.1111/jebm.12381; Lui RN, 2020, J GASTROEN HEPATOL, V35, P749, DOI 10.1111/jgh.15053; Lynch John B, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa1063; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Nguyen Long H, 2020, Lancet Public Health, V5, pe475, DOI [10.1101/2020.04.29.20084111, 10.1016/S2468-2667(20)30164-X]; Pan XF, 2020, LANCET INFECT DIS, V20, P410, DOI 10.1016/S1473-3099(20)30114-6; Perisetti A, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.587602; Perisetti A, 2019, GASTROINTEST ENDOSC, V90, P859, DOI 10.1016/j.gie.2019.06.016; Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272; Radonovich LJ, 2019, JAMA-J AM MED ASSOC, V322, P824, DOI 10.1001/jama.2019.11645; Repici A, 2020, GASTROENTEROLOGY, V159, P363, DOI 10.1053/j.gastro.2020.04.003; Repici A, 2020, GASTROINTEST ENDOSC, V92, P192, DOI 10.1016/j.gie.2020.03.019; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Song Y, 2020, GUT, V69, P1143, DOI 10.1136/gutjnl-2020-320891; Sultan S, 2020, GASTROENTEROLOGY, V159, P739, DOI 10.1053/j.gastro.2020.03.072; Toner E, 2006, BIOSECUR BIOTERROR, V4, P397, DOI 10.1089/bsp.2006.4.397; Wang X, 2020, J HOSP INFECT, V105, P104, DOI 10.1016/j.jhin.2020.02.021; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Xiao F, 2020, GASTROENTEROLOGY, V158, P1831, DOI 10.1053/j.gastro.2020.02.055; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	36	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2021	16	7							e0254979	10.1371/journal.pone.0254979	http://dx.doi.org/10.1371/journal.pone.0254979			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TQ2PW	34297736	gold, Green Published			2022-12-26	WOS:000678128300030
J	Colchero, MA; Guerrero-Lopez, CMCM; Barrientos-Gutierrez, TT; Salmeron, JJ; Bautista-Arredondo, S				Colchero, M. A.; Guerrero-Lopez C. M., Carlos M.; Barrientos-Gutierrez T., Tonatiuh; Salmeron J., Jorge; Bautista-Arredondo, Sergio			Willingness to pay for an intervention that reduces soda consumption among a sample of middle-class adult Mexicans	PLOS ONE			English	Article							SUGAR-SWEETENED BEVERAGES; EXCISE TAX; HEALTH; WEIGHT; COHORT	Background Despite the growing public awareness of the adverse health effects of sugar-sweetened beverages (SSB) consumption in Mexico, little is known about the population's intention to reduce SSB consumption and the social value of interventions to accomplish such behavioral change. Therefore, the objective of this study was to assess the willingness to pay (WTP) for an intervention that reduces soda consumption by half in Mexico. Methods We applied contingent valuation methods in a sample of 471 Mexican adults from a cohort study. We assessed the relative value of benefits by providing incremental information to participants in three scenarios: soda consumption reduction, + health benefits, + social benefits. To estimate factors associated with the WTP, we ran an interval regression. Results 87% of respondents reported they would like to reduce SSB consumption. High soda consumption, intention to reduce soda consumption and higher household income are associated with higher WTP. We found that the WTP increases as additional benefits are provided. The WTP, as a proportion of income, is higher for the lowest income level. Conclusion The average WTP per person may be seen as the minimum amount the country should invest on interventions to reduce soda consumption.	[Colchero, M. A.; Guerrero-Lopez C. M., Carlos M.; Bautista-Arredondo, Sergio] Ctr Hlth Syst Res, Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Barrientos-Gutierrez T., Tonatiuh] Ctr Populat Hlth Res, Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Salmeron J., Jorge] Univ Nacl Autonoma Mexico, Fac Med, Ctr Invest Polit Poblac & Salud, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico	Colchero, MA (corresponding author), Ctr Hlth Syst Res, Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico.	acolchero@insp.mx	Bautista-Arredondo, Sergio/N-7305-2016	Bautista-Arredondo, Sergio/0000-0001-8910-3011	Bloomberg Philanthropies; Instituto Nacional de Salud Publica; National Institutes of Health [R01DK108148]	Bloomberg Philanthropies; Instituto Nacional de Salud Publica; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded primarily by Bloomberg Philanthropies. The study also received funding from the Instituto Nacional de Salud Publica and the National Institutes of Health R01DK108148. Beyond financial support, funders had no role in the study design, data col-lection, analyses, or interpretation.	Afshin A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172277; Colchero MA, 2017, HEALTH AFFAIR, V36, P564, DOI 10.1377/hlthaff.2016.1231; Arrow K.J., 1993, REPORT NOAA PANEL CO, V58; Ashley EM, 2015, HEALTH ECON, V24, P617, DOI 10.1002/hec.3040; Backholer K, 2016, PUBLIC HEALTH NUTR, V19, P3070, DOI 10.1017/S136898001600104X; Barrientos-Gutierrez T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191383; Bennett DA, 2001, AUST NZ J PUBL HEAL, V25, P464, DOI 10.1111/j.1467-842X.2001.tb00294.x; Cawley J, 2008, ECON HUM BIOL, V6, P281, DOI 10.1016/j.ehb.2008.05.003; Colchero MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163463; Denova-Gutierrez E, 2016, SALUD PUBLICA MEXICO, V58, P708, DOI 10.21149/spm.v58i6.8299; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Gruber J, 2008, MODERN EC VIEW TOBAC; Hernandez-Avila M., 2016, ENCUESTA NACL SALUD; Instituto Nacional Estadistica y Geografia, 2019, ENC NAC INGR GAST HO ENC NAC INGR GAST HO; Long MW, 2015, AM J PREV MED, V49, P112, DOI 10.1016/j.amepre.2015.03.004; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Sanchez-Romero LM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002158; Martinez F.J., 2018, MICROECONOMIC MODELI; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Ng SW, 2019, PUBLIC HEALTH NUTR, V22, P750, DOI [10.1017/S136898001800321X, 10.1017/s136898001800321x]; Perez-Escamilla R, 2012, J ACAD NUTR DIET, V112, P671, DOI 10.1016/j.jand.2012.01.020; Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Stern D, 2017, AM J PUBLIC HEALTH, V107, P1801, DOI [10.2105/AJPH.2017.304008, 10.2105/ajph.2017.304008]; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Villalpando S, 2010, SALUD PUBLICA MEXICO, V52, pS19, DOI 10.1590/S0036-36342010000700005	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255100	10.1371/journal.pone.0255100	http://dx.doi.org/10.1371/journal.pone.0255100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TT3IC	34339421	gold, Green Published			2022-12-26	WOS:000680243400041
J	Manoel, RO; Rossini, BC; Cornacini, MR; Moraes, MLT; Cambuim, J; Alcantara, MAM; Silva, AM; Sebbenn, AM; Marino, CL				Manoel, Ricardo O.; Rossini, Bruno C.; Cornacini, Maiara R.; Moraes, Mario L. T.; Cambuim, Jose; Alcantara, Marcelo A. M.; Silva, Alexandre M.; Sebbenn, Alexandre M.; Marino, Celso L.			Landscape barriers to pollen and seed flow in the dioecious tropical tree Astronium fraxinifolium in Brazilian savannah	PLOS ONE			English	Article							SPATIAL GENETIC-STRUCTURE; LONG-DISTANCE POLLEN; FRAGMENTATION GENETICS; INBREEDING DEPRESSION; HYMENAEA-STIGONOCARPA; COMPUTER-PROGRAM; NEOTROPICAL TREE; MATING PATTERNS; REALIZED SEED; DISPERSAL	Gene flow studies provide information on gene exchange between populations, which is essential for developing genetic conservation strategies. Such analyses enable a better understanding of the life history and seed and pollen dispersal mechanisms of plant species. In this study, we investigate pollen and seed flow in a regenerant population of the pioneer species Astronium fraxinifolium in an area degraded during the construction of a hydroelectric dam. We mapped, sampled, sexed, and genotyped 386 individuals in the regenerant population (RP), as well as 128 adult trees located along two highways adjacent to the degraded area; one in Mato Grosso do Sul State (MS) and other in Sao Paulo State (SP). Parentage analyses was carried out for 370 individuals of the RP population, using as putative parents 348 individuals from RP and all 128 individuals sampled in MS and SP. Based on parentage analysis and eight microsatellite loci, our analyses revealed that for individuals of the RP with an identified father (pollen donor), 1.1% of the pollen was dispersed up to 532 m, while for those with an identified mother (seed donor), 0.5% of seeds were dispersed up to 4,782 m. However, a large proportion of pollen (76.5%) and seeds (57%) immigrated from trees outside the sampled populations. Pollen and seeds were dispersed through a pattern of isolation by distance. Genetic diversity was significantly similar between adults of both highway populations and individuals from RP, with significant levels of inbreeding detected only in RP. Our results demonstrate that the nearest trees contributed pollen and seeds for the recovery of the degraded area, indicating reproductive spatial isolation among the sampled populations due to the damming of the river. Such results help to understand the process of regeneration for A. fraxinifolium in regenerant populations to inform strategies for conservation and environmental recovery with this species.	[Manoel, Ricardo O.; Rossini, Bruno C.; Marino, Celso L.] UNESP, Inst Biotecnol, Botucatu, SP, Brazil; [Cornacini, Maiara R.; Alcantara, Marcelo A. M.; Marino, Celso L.] UNESP, Inst Biociencias, Botucatu, SP, Brazil; [Moraes, Mario L. T.; Cambuim, Jose; Silva, Alexandre M.] Univ Estadual Paulista, Fac Engn Ilha Solteira, Sao Paulo, Brazil; [Sebbenn, Alexandre M.] Inst Florestal Sao Paulo, Dept Melhoramento & Conservacao Genet, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Rossini, BC (corresponding author), UNESP, Inst Biotecnol, Botucatu, SP, Brazil.	bruno.rossini@unesp.br	Da Silva, Alexandre Marques/M-2234-2013; Rossini, Bruno Cesar Cesar/AAX-6765-2021; Alcântara, Marcelo Geada/GZK-3857-2022	Da Silva, Alexandre Marques/0000-0001-6939-8430; Rossini, Bruno Cesar Cesar/0000-0002-5685-9610; 	Sao Paulo Research Foundation (FAPESP) [2018/00898-0]; Alexandre M. Sebbenn and Made Desenvolvimento Cientifico e Tecnologico (CNPq); Conselho Nacional; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Alexandre M. Sebbenn and Made Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Conselho Nacional; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are thankful for the Sao Paulo Research Foundation (FAPESP grant number: 2018/00898-0, ROM) for the financial support of this work. Alexandre M. Sebbenn and Made Desenvolvimento Cientifico e Tecnologico (CNPq).rio L.T. Moraes were supported by research scholarships granted from the Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico (CNPq).	Aguiar A. V. de, 2001, Scientia Forestalis, P89; Aguiar BI, 2020, CONSERV GENET, V21, P305, DOI 10.1007/s10592-020-01250-0; Allem AC., 1991, CENARGEN, P1; Araujo FL, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019105; Austerlitz F, 2000, GENETICS, V154, P1309; Bacles CFE, 2006, SCIENCE, V311, P628, DOI 10.1126/science.1121543; Braga AC, 2011, HEREDITY, V106, P911, DOI 10.1038/hdy.2010.134; Breed MF, 2015, HEREDITY, V115, P108, DOI 10.1038/hdy.2013.48; Browne L, 2018, MOL ECOL, V27, P3055, DOI 10.1111/mec.14765; Caballero A, 2017, HEREDITY, V118, P177, DOI 10.1038/hdy.2016.80; Carvalho PER., 2010, ESPECIES ARBOREAS BR ESPECIES ARBOREAS BR, P231; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Collevatti RG, 2001, HEREDITY, V86, P60, DOI 10.1046/j.1365-2540.2001.00801.x; Collevatti RG, 2010, NAT CONSERVACAO, V8, P54, DOI 10.4322/natcon.00801008; Cornacini MR, 2017, SCI FOR, V45, P581, DOI 10.18671/scifor.v45n115.15; Cornacini MR., DETECTION APPL NOVEL; dos Santos JFC, 2016, REV ARVORE, V40, P803, DOI 10.1590/0100-67622016000500004; Cuenin N, 2019, J HERED, V110, P287, DOI 10.1093/jhered/esy069; de Oliveira SS, 2020, FOREST ECOL MANAG, V464, DOI 10.1016/j.foreco.2020.118040; Degen B., 2014, TROPICAL FORESTRY HD, P1; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Duminil J, 2016, HEREDITY, V116, P295, DOI 10.1038/hdy.2015.101; Dyer RJ, 2009, MOL ECOL RESOUR, V9, P110, DOI 10.1111/j.1755-0998.2008.02384.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Gaino APSC, 2010, CONSERV GENET, V11, P1631, DOI 10.1007/s10592-010-0046-3; Garcia AS, 2019, NEW FOREST, V50, P991, DOI 10.1007/s11056-019-09710-3; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; de Lima SCG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/848293; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Hadley AS, 2012, BIOL REV, V87, P526, DOI 10.1111/j.1469-185X.2011.00205.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hartl DL, 2007, PRINCIPLES POPULATIO, V4, DOI [10.1093/jhered/esm035, DOI 10.1093/JHERED/ESM035]; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; IBAMA-Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renovaveis, 1992, 37 IBAMA 37 IBAMA; Ismail SA, 2012, MOL ECOL, V21, P5484, DOI 10.1111/mec.12054; Ismail SA, 2017, NEW PHYTOL, V214, P1307, DOI 10.1111/nph.14427; Jolivet C, 2013, HEREDITY, V110, P439, DOI 10.1038/hdy.2012.103; Jones FA, 2006, MOL ECOL, V15, P3205, DOI 10.1111/j.1365-294X.2006.03023.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kamm U, 2009, HEREDITY, V103, P476, DOI 10.1038/hdy.2009.70; Kettle CJ, 2014, CONSERV GENET, V15, P1265, DOI 10.1007/s10592-014-0673-1; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Lander TA, 2011, CURR BIOL, V21, P1302, DOI 10.1016/j.cub.2011.06.045; Lindgren D, 1998, CAN J FOREST RES, V28, P276, DOI 10.1139/cjfr-28-2-276; Lobo D, 2011, DIVERS DISTRIB, V17, P287, DOI 10.1111/j.1472-4642.2010.00739.x; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; LORENZI H., 2009, ARVORES BRASILEIRAS, V3; Lowe AJ, 2015, HEREDITY, V115, P97, DOI 10.1038/hdy.2015.40; Martinez-Ramos M, 2016, P NATL ACAD SCI USA, V113, P5323, DOI 10.1073/pnas.1602893113; Merritt DM, 2006, RIVER RES APPL, V22, P1, DOI 10.1002/rra.890; MMA (Ministerio do Meio Ambiente), 2008, INSTR NORM 13; Moraes MA, 2018, ECOL EVOL, V8, P7800, DOI 10.1002/ece3.4253; Moran EV, 2011, MOL ECOL, V20, P1248, DOI 10.1111/j.1365-294X.2011.05019.x; Noreen AME, 2016, HEREDITY, V117, P472, DOI 10.1038/hdy.2016.64; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Pence CH, 2017, SYNTHESE, V194, P1967, DOI 10.1007/s11229-016-1031-2; Pereira LCSM, 2020, FOREST ECOL MANAG, V475, DOI 10.1016/j.foreco.2020.118414; Pometti C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192107; Potascheff CM, 2019, CONSERV GENET, V20, P1355, DOI 10.1007/s10592-019-01217-w; Pritchard JK, 2000, GENETICS, V155, P945; Sebbenn AM, 2011, HEREDITY, V106, P134, DOI 10.1038/hdy.2010.33; Sebbenn A.M., 2002, REV LNST FLOR, V14, P115; Solis-Hernandez W, 2019, REV BIOL TROP, V67, P95; Sork VL, 2006, LANDSCAPE ECOL, V21, P821, DOI 10.1007/s10980-005-5415-9; Souza FB., 2018, FOREST RES ENG INT J, V2, P98, DOI [10.15406/freij.2018.02.00033, DOI 10.15406/FREIJ.2018.02.00033]; Strassburg BBN, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0099; Tambarussi EV, 2017, CONSERV GENET, V18, P225, DOI 10.1007/s10592-016-0896-4; Taylor K, 2012, DIVERS DISTRIB, V18, P942, DOI 10.1111/j.1472-4642.2012.00926.x; de Moraes MLT, 2011, BIOTROPICA, V43, P192, DOI 10.1111/j.1744-7429.2010.00679.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Wang J, 2014, CONSERV GENET, V15, P1163, DOI 10.1007/s10592-014-0608-x; Wu HP, 2019, J CLEAN PROD, V221, P480, DOI 10.1016/j.jclepro.2019.03.001; Zhang ZY, 2007, BIOCHEM SYST ECOL, V35, P506, DOI 10.1016/j.bse.2007.01.014	76	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	8							e0255275	10.1371/journal.pone.0255275	http://dx.doi.org/10.1371/journal.pone.0255275			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TT3IC	34339479	gold, Green Published			2022-12-26	WOS:000680243400030
